Citrus Sinensis ID: 001274
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1109 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SHI2 | 1101 | Leucine-rich repeat recep | yes | no | 0.983 | 0.990 | 0.686 | 0.0 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.958 | 0.964 | 0.535 | 0.0 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.944 | 0.931 | 0.537 | 0.0 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.924 | 0.903 | 0.386 | 0.0 | |
| C0LGF5 | 1072 | Probable LRR receptor-lik | no | no | 0.930 | 0.962 | 0.399 | 0.0 | |
| Q9SSL9 | 1123 | Leucine-rich repeat recep | no | no | 0.922 | 0.910 | 0.379 | 0.0 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.915 | 0.906 | 0.383 | 0.0 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.893 | 0.793 | 0.394 | 0.0 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.898 | 0.872 | 0.377 | 0.0 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.899 | 0.796 | 0.388 | 0.0 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 1502 bits (3889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 752/1095 (68%), Positives = 880/1095 (80%), Gaps = 4/1095 (0%)
Query: 14 FYFALIFC-FSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDF 72
F +I C FS + V SL EEG LLEFKA L D + L SWN D PCNW G+ CT
Sbjct: 7 FLAIVILCSFSFILVRSLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTHL 66
Query: 73 K-VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNR 131
+ VTSVDL+G+NLSG LSP IC L L + N+S NF++G IP DL+ C SLE+LDLCTNR
Sbjct: 67 RTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNR 126
Query: 132 LHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKL 191
HGVIP QL I TL+KLYLCENY+FG IP +IGNL+SL+ELVIYSNNLTG IP S++KL
Sbjct: 127 FHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKL 186
Query: 192 RQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
RQLR+IRAG N SG IP EIS CE L+VLGLA+N LEG LP +LEKL+NLTDLILWQN
Sbjct: 187 RQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNR 246
Query: 252 LSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNC 311
LSGEIPP++GNI LE+LALHEN F+G +P+E+GKL+++K+LY+YTN+L G IP E+GN
Sbjct: 247 LSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNL 306
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINN 371
A EID SENQLTGFIP+E G I NL LL LFEN+L G IPRELG+LT L KLDLSIN
Sbjct: 307 IDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINR 366
Query: 372 LTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMY 431
L GTIP E Q L YLVDLQLFDN LEG IPP IG S+ SVLD+S N+L G IP H C +
Sbjct: 367 LNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRF 426
Query: 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR 491
Q LI LSLGSN+LSGNIP LKTC+SL +LMLG NQLTGSLPIE +NLQNL+ALEL+QN
Sbjct: 427 QTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNW 486
Query: 492 FSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNC 551
SG I ++GKL+NLERL L+ N F G IP E+GNL +V FNISSN L+G IP ELG+C
Sbjct: 487 LSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSC 546
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNI 611
V +QRLDLS N+F+G +ELGQLV LE+L+LSDN+LTG IP S G L RL ELQ+GGN+
Sbjct: 547 VTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNL 606
Query: 612 FSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGE 671
S +IPV LG+LT+LQI+LNISHNNLSG IP LGNLQMLE LYL+DN+L GEIPAS+G
Sbjct: 607 LSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGN 666
Query: 672 QMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLC-MLGSDCHQLMPPSHTPKKNW 730
MSLL+CN+SNNNLVGTVP+T VF+R+DSSNFAGN GLC S C L+P S + K NW
Sbjct: 667 LMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDS-KLNW 725
Query: 731 IKGGSTKEKLVSIISVIVGLISLSFIIGICWAMKCRKPAFVPLEEQKNPEVIDNYYFPKE 790
+ GS ++K+++I +++G + L +G+CW +K R+PAFV LE+Q P+V+D+YYFPK+
Sbjct: 726 LINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKK 785
Query: 791 GFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAE 850
GF Y L++AT NFSE V+GRGACGTVYKA ++ GEVIAVKK+ RGEGA++DNSF AE
Sbjct: 786 GFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAE 845
Query: 851 ISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
ISTLGKIRHRNIVKLYGFCYHQ+SNLLLYEYM GSLGEQL ++ CLLDW+ARYRIAL
Sbjct: 846 ISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIAL 905
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
GAAEGLCYLH+DCRP I+HRDIKSNNILLDE FQAHVGDFGLAKLIDL YSKSMSA+AGS
Sbjct: 906 GAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGS 965
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030
YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK PVQ LE GGDLV WVRRSI M+PT
Sbjct: 966 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPT 1025
Query: 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSS 1090
E+FD RLD + KRTV EM+L LKIALFC+S SP +RPTMREV+AM+ +AR S S SS
Sbjct: 1026 IEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEARGSSSLSSSS 1085
Query: 1091 PTSETPLEADASSRD 1105
TSETPLE SS++
Sbjct: 1086 ITSETPLEEANSSKE 1100
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1065 bits (2755), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 580/1083 (53%), Positives = 730/1083 (67%), Gaps = 20/1083 (1%)
Query: 13 LFYFALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDF 72
+F+ +L+ T L EG LLE K+ +D NL +WNS+D PC W GV C+++
Sbjct: 10 VFFISLLLILLISETTGLNLEGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNY 69
Query: 73 ----KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLC 128
+V S++L + LSG LSP I L L + ++S N ++G IP ++ NCSSLEIL L
Sbjct: 70 SSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLN 129
Query: 129 TNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI 188
N+ G IP ++ + +L L + N I G +P EIGNL SL +LV YSNN++G +P SI
Sbjct: 130 NNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSI 189
Query: 189 SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILW 248
L++L RAG N +SG +P EI CE L +LGLAQN L G LP E+ L+ L+ +ILW
Sbjct: 190 GNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILW 249
Query: 249 QNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL 308
+N SG IP I N SLE LAL++N G +PKELG L L+ LY+Y N LNGTIP E+
Sbjct: 250 ENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREI 309
Query: 309 GNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLS 368
GN + A+EID SEN LTG IP ELG I L LL LFEN L G+IP EL L L KLDLS
Sbjct: 310 GNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLS 369
Query: 369 INNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHL 428
IN LTG IPL FQ L L LQLF N L GTIPP +G S L VLD+S N+L G IP +L
Sbjct: 370 INALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYL 429
Query: 429 CMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488
C++ +I L+LG+N LSGNIP G+ TC++L+QL L +N L G P N++A+EL
Sbjct: 430 CLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELG 489
Query: 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHEL 548
QNRF G IP E+G L+RL L++N F G +P E+G L L T NISSN L+G +P E+
Sbjct: 490 QNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEI 549
Query: 549 GNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMG 608
NC LQRLD+ N F+G+ P E+G L LELLKLS+N L+G IP +LG L+RLTELQMG
Sbjct: 550 FNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMG 609
Query: 609 GNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPAS 668
GN+F+GSIP LG LT LQIALN+S+N L+G IP EL NL MLE L L++N L GEIP+S
Sbjct: 610 GNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSS 669
Query: 669 MGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLG-SDCHQLMP--PSHT 725
SLL N S N+L G +P + R I S+F GN GLC + C Q P PS +
Sbjct: 670 FANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQS 726
Query: 726 PKKNWIKGGSTKEKLVSIISVIVGLISLSFIIGICWAMK--CRKPAFVPLEEQKNPEVID 783
K GG K+++I + ++G +SL I I + M+ R A + Q + +D
Sbjct: 727 TGK---PGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLD 783
Query: 784 NYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGA-- 841
Y+ PKEGF + +L+ AT NF E V+GRGACGTVYKA L G +AVKK+ EG
Sbjct: 784 IYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNN 843
Query: 842 -TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLL 900
DNSF AEI TLG IRHRNIVKL+GFC HQ SNLLLYEYM GSLGE LH +C L
Sbjct: 844 NNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH--DPSCNL 901
Query: 901 DWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960
DW R++IALGAA+GL YLH+DC+P I HRDIKSNNILLD++F+AHVGDFGLAK+ID+P+
Sbjct: 902 DWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPH 961
Query: 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWV 1020
SKSMSAIAGSYGYIAPEYAYTMKVTEK DIYS+GVVLLEL+TGK+PVQ ++ GGD+V WV
Sbjct: 962 SKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWV 1021
Query: 1021 RRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080
R I +S + D RL L +R V M LKIAL C+S SP+ RP+MR+V+ M+I++
Sbjct: 1022 RSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIES 1081
Query: 1081 RQS 1083
+S
Sbjct: 1082 ERS 1084
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1051 bits (2718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 578/1076 (53%), Positives = 720/1076 (66%), Gaps = 29/1076 (2%)
Query: 29 SLTEEGVSLLEFK-ASLIDPSNNLESWNSSDMTPCNWIGVECTD---------FKVTSVD 78
SL +G LLE K D N L +WN D TPCNWIGV C+ VTS+D
Sbjct: 32 SLNSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLD 91
Query: 79 LHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPF 138
L +NLSGI+SP I L LV N++ N +TG IP ++ NCS LE++ L N+ G IP
Sbjct: 92 LSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPV 151
Query: 139 QLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIR 198
++ ++ LR +C N + G +PEEIG+L +LEELV Y+NNLTG +P S+ L +L R
Sbjct: 152 EINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFR 211
Query: 199 AGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPP 258
AG N SG IP EI +C L++LGLAQN + G LP E+ L L ++ILWQN SG IP
Sbjct: 212 AGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPK 271
Query: 259 TIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEID 318
IGN+ SLE LAL+ NS G +P E+G + LKKLY+Y N+LNGTIP ELG + +EID
Sbjct: 272 DIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEID 331
Query: 319 LSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPL 378
SEN L+G IP EL I L LL LF+N L G IP EL +L L KLDLSIN+LTG IP
Sbjct: 332 FSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPP 391
Query: 379 EFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLS 438
FQNLT + LQLF N L G IP +G+ S L V+D S N L G IPP +C LI L+
Sbjct: 392 GFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLN 451
Query: 439 LGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPP 498
LGSNR+ GNIPPG+ C+SL+QL + N+LTG P E L NLSA+EL QNRFSG +PP
Sbjct: 452 LGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPP 511
Query: 499 EIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLD 558
EIG + L+RLHL+ N F +P+E+ L +LVTFN+SSNSL+G IP E+ NC LQRLD
Sbjct: 512 EIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLD 571
Query: 559 LSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPV 618
LSRN F GS P ELG L LE+L+LS+N+ +G IP ++G L LTELQMGGN+FSGSIP
Sbjct: 572 LSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPP 631
Query: 619 ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVC 678
LG L++LQIA+N+S+N+ SG IP E+GNL +L L L++N L GEIP + SLL C
Sbjct: 632 QLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGC 691
Query: 679 NLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQLMPPSHT--PKKNWIKGGST 736
N S NNL G +P+T +F+ + ++F GN+GLC G PSH+ P + +K GS
Sbjct: 692 NFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLC--GGHLRS-CDPSHSSWPHISSLKAGSA 748
Query: 737 KEKLVSIISVIVGLISLSFIIGICWAMKCRKPA--FVPLEEQKNP--EVIDNYYFPKEGF 792
+ + II V +I I R P P K P + D Y+ PKE F
Sbjct: 749 RRGRIIIIVSSVIGGISLLLIAIVVHF-LRNPVEPTAPYVHDKEPFFQESDIYFVPKERF 807
Query: 793 KYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIK-----LRGEGATADNSF 847
++LEAT F + ++GRGACGTVYKA + +G+ IAVKK++ DNSF
Sbjct: 808 TVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSF 867
Query: 848 LAEISTLGKIRHRNIVKLYGFCYHQ--DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR 905
AEI TLGKIRHRNIV+LY FCYHQ +SNLLLYEYM GSLGE LHG K +DW R
Sbjct: 868 RAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHS-MDWPTR 926
Query: 906 YRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS 965
+ IALGAAEGL YLH+DC+P IIHRDIKSNNIL+DE F+AHVGDFGLAK+ID+P SKS+S
Sbjct: 927 FAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVS 986
Query: 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIH 1025
A+AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLEL+TGK+PVQ LE GGDL TW R I
Sbjct: 987 AVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIR 1046
Query: 1026 EMVPTSELFDKRL-DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080
+ TSE+ D L + + M KIA+ C+ +SP +RPTMREV+ M+I++
Sbjct: 1047 DHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIES 1102
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 689 bits (1779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/1089 (38%), Positives = 612/1089 (56%), Gaps = 64/1089 (5%)
Query: 16 FALIFCFSNVSVTSLTEEGVSLLEF-KASLIDPSNNLESWNSSDMTPCNWIGVECT--DF 72
+L F S ++ T E +L+ + +S P + WN SD PC W + C+ D
Sbjct: 22 LSLFLAFFISSTSASTNEVSALISWLHSSNSPPPSVFSGWNPSDSDPCQWPYITCSSSDN 81
Query: 73 K-VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNR 131
K VT +++ + L+ P I L + IS +TG+I +++ +CS L ++DL +N
Sbjct: 82 KLVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNS 141
Query: 132 LHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKL 191
L G IP L + L++L L N + G+IP E+G+ SL+ L I+ N L+ +P + K+
Sbjct: 142 LVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKI 201
Query: 192 RQLRVIRAGHNS-LSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQN 250
L IRAG NS LSG IP EI C L+VLGLA + G LP L +L L L ++
Sbjct: 202 STLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYST 261
Query: 251 HLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGN 310
LSGEIP +GN L L L++N SG LPKELGKL L+K+ ++ N L+G IP E+G
Sbjct: 262 MLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGF 321
Query: 311 CTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSIN 370
S IDLS N +G IP+ G L+ L +L LS N
Sbjct: 322 MKSLNAIDLSMNYFSGTIPKSFG------------------------NLSNLQELMLSSN 357
Query: 371 NLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCM 430
N+TG+IP N T LV Q+ N + G IPP IG+ L++ N L+G+IP L
Sbjct: 358 NITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAG 417
Query: 431 YQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQN 490
Q L L L N L+G++P GL R+L +L+L N ++G +P+E N +L L L N
Sbjct: 418 CQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNN 477
Query: 491 RFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGN 550
R +G IP IG L+NL L LSEN G +P E+ N L N+S+N+L G +P L +
Sbjct: 478 RITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSS 537
Query: 551 CVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGN 610
LQ LD+S N TG P+ LG L++L L LS N G IPSSLG L L + N
Sbjct: 538 LTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSN 597
Query: 611 IFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMG 670
SG+IP L + L IALN+S N+L G IP + L L L + N L G++ A G
Sbjct: 598 NISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSALSG 657
Query: 671 EQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLG-SDCHQLMPPSHTPKKN 729
+ +L+ N+S+N G +P++ VFR++ + GN GLC G C T ++
Sbjct: 658 LE-NLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQR- 715
Query: 730 WIKGGSTKEKLVSIISVIVGLISLSFIIGICWAMKCRKPAFVPLEEQKNPEVIDNYY--- 786
G +L I +++ + ++ ++G+ ++ ++ + + + E +N +
Sbjct: 716 ----GVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQ----MIRDDNDSETGENLWTWQ 767
Query: 787 ---FPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKK--------IK 835
F K F ++L+ EG VIG+G G VYKA + N EVIAVKK +
Sbjct: 768 FTPFQKLNFTVEHVLKC---LVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLN 824
Query: 836 LRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNK 895
+ + + +SF AE+ TLG IRH+NIV+ G C+++++ LL+Y+YM NGSLG LH
Sbjct: 825 EKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERS 884
Query: 896 QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955
C L W+ RY+I LGAA+GL YLH+DC P I+HRDIK+NNIL+ +F+ ++GDFGLAKL
Sbjct: 885 GVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKL 944
Query: 956 IDL-PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQ-SLELG 1013
+D +++S + IAGSYGYIAPEY Y+MK+TEK D+YS+GVV+LE++TGK P+ ++ G
Sbjct: 945 VDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG 1004
Query: 1014 GDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
+V WV++ + ++ D+ L + VEEM L +AL C + P +RPTM++V
Sbjct: 1005 LHIVDWVKK-----IRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDV 1059
Query: 1074 IAMMIDARQ 1082
AM+ + Q
Sbjct: 1060 AAMLSEICQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 665 bits (1717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/1094 (39%), Positives = 630/1094 (57%), Gaps = 62/1094 (5%)
Query: 14 FYFALIFCFSNVSVT----SLTEEGVSLLEFKASLIDPSNNL-ESWNSSDMTPCNWIGVE 68
F+F +FC S VS+ SL+ +G +LL K PS +L SW+ D TPC+W G+
Sbjct: 8 FFFLFLFC-SWVSMAQPTLSLSSDGQALLSLKR----PSPSLFSSWDPQDQTPCSWYGIT 62
Query: 69 CT-DFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDL 127
C+ D +V SV + L+ P + L L N+S ++G IP + L +LDL
Sbjct: 63 CSADNRVISVSIPDTFLNLSSIPDLSSLSSLQFLNLSSTNLSGPIPPSFGKLTHLRLLDL 122
Query: 128 CTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPAS 187
+N L G IP +L ++TL+ L L N + G IP +I NL +L+ L + N L G+IP+S
Sbjct: 123 SSNSLSGPIPSELGRLSTLQFLILNANKLSGSIPSQISNLFALQVLCLQDNLLNGSIPSS 182
Query: 188 ISKLRQLRVIRAGHNS-LSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLI 246
L L+ R G N+ L GPIP ++ + L LG A + L G +PS L NL L
Sbjct: 183 FGSLVSLQQFRLGGNTNLGGPIPAQLGFLKNLTTLGFAASGLSGSIPSTFGNLVNLQTLA 242
Query: 247 LWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPH 306
L+ +SG IPP +G L L LH N +G +PKELGKL ++ L ++ N L+G IP
Sbjct: 243 LYDTEISGTIPPQLGLCSELRNLYLHMNKLTGSIPKELGKLQKITSLLLWGNSLSGVIPP 302
Query: 307 ELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLD 366
E+ NC+S V D+S N LTG IP +LG + L LQL +NM G IP EL + L L
Sbjct: 303 EISNCSSLVVFDVSANDLTGDIPGDLGKLVWLEQLQLSDNMFTGQIPWELSNCSSLIALQ 362
Query: 367 LSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPP 426
L N L+G+IP + NL L L++N + GTIP G + L LD+S N L G IP
Sbjct: 363 LDKNKLSGSIPSQIGNLKSLQSFFLWENSISGTIPSSFGNCTDLVALDLSRNKLTGRIPE 422
Query: 427 HLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALE 486
L ++L L L N LSG +P + C+SL++L +G+NQL
Sbjct: 423 ELFSLKRLSKLLLLGNSLSGGLPKSVAKCQSLVRLRVGENQL------------------ 464
Query: 487 LYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPH 546
SG IP EIG+L+NL L L N+F G +P E+ N+ L ++ +N ++G IP
Sbjct: 465 ------SGQIPKEIGELQNLVFLDLYMNHFSGGLPYEISNITVLELLDVHNNYITGDIPA 518
Query: 547 ELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQ 606
+LGN VNL++LDLSRN FTG+ P G L L L L++N LTG IP S+ L +LT L
Sbjct: 519 QLGNLVNLEQLDLSRNSFTGNIPLSFGNLSYLNKLILNNNLLTGQIPKSIKNLQKLTLLD 578
Query: 607 MGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIP 666
+ N SG IP LGQ+T+L I L++S+N +G IP +L L++L L N L G+I
Sbjct: 579 LSYNSLSGEIPQELGQVTSLTINLDLSYNTFTGNIPETFSDLTQLQSLDLSSNSLHGDIK 638
Query: 667 ASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLC--MLGSDCHQLMPPSH 724
+G SL N+S NN G +P+T F+ I ++++ N LC + G C SH
Sbjct: 639 V-LGSLTSLASLNISCNNFSGPIPSTPFFKTISTTSYLQNTNLCHSLDGITCS-----SH 692
Query: 725 TPKKNWIKGGSTKEKLVSIISVIVGLISLSFIIGICWAMKCRKPAFVPLEEQKNPEVIDN 784
T + N +K K+V++ +VI+ I+++ + ++ +P ++
Sbjct: 693 TGQNNGVK----SPKIVALTAVILASITIAILAAWLLILRNNHLYKTSQNSSSSPSTAED 748
Query: 785 YYFPKEGFKYHNLLEATGN----FSEGAVIGRGACGTVYKATLANGEVIAVKKI-KLRG- 838
+ +P + L N ++ VIG+G G VYKA + NG+++AVKK+ K +
Sbjct: 749 FSYPWTFIPFQKLGITVNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAVKKLWKTKDN 808
Query: 839 --EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQ 896
EG + +SF AEI LG IRHRNIVKL G+C ++ LLLY Y NG+L + L GN+
Sbjct: 809 NEEGESTIDSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQGNRN 868
Query: 897 TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL- 955
LDW+ RY+IA+GAA+GL YLH+DC P I+HRD+K NNILLD +++A + DFGLAKL
Sbjct: 869 ---LDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKLM 925
Query: 956 IDLP-YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQ-SLELG 1013
++ P Y +MS +AGSYGYIAPEY YTM +TEK D+YS+GVVLLE+++G+S V+ + G
Sbjct: 926 MNSPNYHNAMSRVAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGRSAVEPQIGDG 985
Query: 1014 GDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
+V WV++ + P + D +L + V+EM L IA+FC + SP+ RPTM+EV
Sbjct: 986 LHIVEWVKKKMGTFEPALSVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSPVERPTMKEV 1045
Query: 1074 IAMMIDARQSVSDY 1087
+ ++++ + S ++
Sbjct: 1046 VTLLMEVKCSPEEW 1059
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 658 bits (1697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/1079 (37%), Positives = 590/1079 (54%), Gaps = 56/1079 (5%)
Query: 47 PSNNLESW--NSSDMTPCNWIGVECTDFK-VTSVDLHGLNLSGILSPRICDLPRLVEFNI 103
P +W N+S+ TPCNW G+ C D K V S++ +SG L P I +L L ++
Sbjct: 47 PPQVTSTWKINASEATPCNWFGITCDDSKNVASLNFTRSRVSGQLGPEIGELKSLQILDL 106
Query: 104 SMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEE 163
S N +G+IP+ L NC+ L LDL N IP L + L LYL N++ GE+PE
Sbjct: 107 STNNFSGTIPSTLGNCTKLATLDLSENGFSDKIPDTLDSLKRLEVLYLYINFLTGELPES 166
Query: 164 IGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGL 223
+ + L+ L + NNLTG IP SI ++L + N SG IP I L++L L
Sbjct: 167 LFRIPKLQVLYLDYNNLTGPIPQSIGDAKELVELSMYANQFSGNIPESIGNSSSLQILYL 226
Query: 224 AQNSLEGFLPSELE------------------------KLRNLTDLILWQNHLSGEIPPT 259
+N L G LP L +NL L L N G +PP
Sbjct: 227 HRNKLVGSLPESLNLLGNLTTLFVGNNSLQGPVRFGSPNCKNLLTLDLSYNEFEGGVPPA 286
Query: 260 IGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDL 319
+GN SL+ L + + SG +P LG L L L + N L+G+IP ELGNC+S + L
Sbjct: 287 LGNCSSLDALVIVSGNLSGTIPSSLGMLKNLTILNLSENRLSGSIPAELGNCSSLNLLKL 346
Query: 320 SENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLE 379
++NQL G IP LG + L L+LFEN G IP E+ + L +L + NNLTG +P+E
Sbjct: 347 NDNQLVGGIPSALGKLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVE 406
Query: 380 FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSL 439
+ L LF+N G IPP +GVNS L +D N L G IPP+LC +KL L+L
Sbjct: 407 MTEMKKLKIATLFNNSFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLCHGRKLRILNL 466
Query: 440 GSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPE 499
GSN L G IP + C+++ + +L +N L+G LP EF +LS L+ N F G IP
Sbjct: 467 GSNLLHGTIPASIGHCKTIRRFILRENNLSGLLP-EFSQDHSLSFLDFNSNNFEGPIPGS 525
Query: 500 IGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDL 559
+G +NL ++LS N F G IP ++GNL++L N+S N L G++P +L NCV+L+R D+
Sbjct: 526 LGSCKNLSSINLSRNRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDV 585
Query: 560 SRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVA 619
N GS P L L LS+N+ +G IP L L +L+ LQ+ N F G IP +
Sbjct: 586 GFNSLNGSVPSNFSNWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSS 645
Query: 620 LGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCN 679
+G + L L++S N L+G IP +LG+L L L + +N L G + G SLL +
Sbjct: 646 IGLIEDLIYDLDLSGNGLTGEIPAKLGDLIKLTRLNISNNNLTGSLSVLKG-LTSLLHVD 704
Query: 680 LSNNNLVGTVPNTTVFRRI-DSSNFAGNRGLCMLGSDCHQLMPPSHTPKKNWIKGGSTKE 738
+SNN G +P+ + + + S+F+GN LC+ S S + K +++
Sbjct: 705 VSNNQFTGPIPDNLEGQLLSEPSSFSGNPNLCIPHS--FSASNNSRSALKYCKDQSKSRK 762
Query: 739 KLVSIISVIVGLISLSFIIGICWAMKCRKPAFVPLEEQKNPEVIDNYYFPKE---GFKYH 795
+S +++ ++ + + + F+ L +K D Y F +E +
Sbjct: 763 SGLSTWQIVL----IAVLSSLLVLVVVLALVFICLRRRKGRPEKDAYVFTQEEGPSLLLN 818
Query: 796 NLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLG 855
+L AT N +E IGRGA G VY+A+L +G+V AVK++ A+ S + EI T+G
Sbjct: 819 KVLAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVFASH-IRANQSMMREIDTIG 877
Query: 856 KIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHG-NKQTCLLDWDARYRIALGAAE 914
K+RHRN++KL GF +D L+LY YM GSL + LHG + + +LDW ARY +ALG A
Sbjct: 878 KVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDWSARYNVALGVAH 937
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
GL YLHYDC P I+HRDIK NIL+D + + H+GDFGLA+L+D + S + + G+ GYI
Sbjct: 938 GLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLD-DSTVSTATVTGTTGYI 996
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELITGKSPV-QSLELGGDLVTWVRRS-------IHE 1026
APE A+ + D+YS+GVVLLEL+T K V +S D+V+WVR + + +
Sbjct: 997 APENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNVED 1056
Query: 1027 MVPT---SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082
MV T L D+ LD S + V ++T ++AL C+ P RPTMR+ + ++ D +
Sbjct: 1057 MVTTIVDPILVDELLDSSLREQVMQVT---ELALSCTQQDPAMRPTMRDAVKLLEDVKH 1112
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 654 bits (1686), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/1109 (38%), Positives = 599/1109 (54%), Gaps = 94/1109 (8%)
Query: 33 EGVSLLEFKASLIDPSNNLESW----NSSDMTPC-NWIGVECT----------------- 70
E +LL++K++ + S+ L SW N++ C +W GV C
Sbjct: 33 EANALLKWKSTFTN-SSKLSSWVHDANTNTSFSCTSWYGVSCNSRGSIEELNLTNTGIEG 91
Query: 71 ---DFKVTS------VDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSI--------- 112
DF S VDL LSG + P+ +L +L+ F++S N +TG I
Sbjct: 92 TFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGNLKN 151
Query: 113 ---------------PTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIF 157
P++L N S+ L L N+L G IP L + L LYL ENY+
Sbjct: 152 LTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLT 211
Query: 158 GEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEG 217
G IP E+GN+ S+ +L + N LTG+IP+++ L+ L V+ N L+G IPPEI E
Sbjct: 212 GVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMES 271
Query: 218 LEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFS 277
+ L L+QN L G +PS L L+NLT L L+QN+L+G IPP +GNI+S+ L L N +
Sbjct: 272 MTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLT 331
Query: 278 GGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPN 337
G +P LG L L LY+Y N L G IP ELGN S +++ L+ N+LTG IP G + N
Sbjct: 332 GSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKN 391
Query: 338 LCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLE 397
L L L+ N L G IP+ELG + + LDLS N LTG++P F N T L L L NHL
Sbjct: 392 LTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLS 451
Query: 398 GTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRS 457
G IPP + +SHL+ L + NN G P +C +KL +SL N L G IP L+ C+S
Sbjct: 452 GAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKS 511
Query: 458 LMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFV 517
L++ N+ TG + F +L+ ++ N+F G I K L L +S N
Sbjct: 512 LIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNIT 571
Query: 518 GYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVN 577
G IP+E+ N+ LV ++S+N+L G +P +GN NL RL L+ NQ +G P L L N
Sbjct: 572 GAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTN 631
Query: 578 LELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNL 637
LE L LS N + IP + +L ++ + N F GSIP L +LT L L++SHN L
Sbjct: 632 LESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLT-QLDLSHNQL 689
Query: 638 SGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRR 697
G IP +L +LQ L+ L L N L G IP + ++L ++SNN L G +P+T FR+
Sbjct: 690 DGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRK 749
Query: 698 IDSSNFAGNRGLCMLGSDCHQLMPPSHTPKKNWIKGGSTKEKLVSIISVIVGLISLSFII 757
+ N GLC + Q + P KK G LV I+ V+V I+
Sbjct: 750 ATADALEENIGLC--SNIPKQRLKPCRELKKPKKNGNLVVWILVPILGVLV-------IL 800
Query: 758 GIC-----WAMKCRKPAFVPLEEQKN--PEVIDNY-YFPKEG-FKYHNLLEATGNFSEGA 808
IC + ++ RK L+ +N PE +N F +G FKY +++E+T F
Sbjct: 801 SICANTFTYCIRKRK-----LQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTH 855
Query: 809 VIGRGACGTVYKATLANGEVIAVKK----IKLRGEGATADNSFLAEISTLGKIRHRNIVK 864
+IG G VY+A L + +IAVK+ I FL E+ L +IRHRN+VK
Sbjct: 856 LIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVK 914
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR 924
L+GFC H+ L+YEYME GSL + L +++ L W R + G A L Y+H+D
Sbjct: 915 LFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRI 974
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV 984
I+HRDI S NILLD ++ A + DFG AKL+ S + SA+AG+YGY+APE+AYTMKV
Sbjct: 975 TPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTD-SSNWSAVAGTYGYVAPEFAYTMKV 1033
Query: 985 TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044
TEKCD+YSFGV++LELI GK P GDLV+ + S E + + D+R+ +
Sbjct: 1034 TEKCDVYSFGVLILELIIGKHP-------GDLVSSLSSSPGEALSLRSISDERVLEPRGQ 1086
Query: 1045 TVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
E++ +++AL C +P +RPTM +
Sbjct: 1087 NREKLLKMVEMALLCLQANPESRPTMLSI 1115
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 652 bits (1682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/1032 (39%), Positives = 587/1032 (56%), Gaps = 41/1032 (3%)
Query: 69 CTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLC 128
C+D V + + LN G + + L L N++ N +TG IP+ L S L+ L L
Sbjct: 214 CSDLTVFTAAENMLN--GTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLM 271
Query: 129 TNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI 188
N+L G+IP L + L+ L L N + GEIPEE N++ L +LV+ +N+L+G++P SI
Sbjct: 272 ANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSI 331
Query: 189 -SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLIL 247
S L + LSG IP E+S+C+ L+ L L+ NSL G +P L +L LTDL L
Sbjct: 332 CSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYL 391
Query: 248 WQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHE 307
N L G + P+I N+ +L+ L L+ N+ G LPKE+ L +L+ L++Y N +G IP E
Sbjct: 392 HNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQE 451
Query: 308 LGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDL 367
+GNCTS ID+ N G IP +G + L LL L +N L G +P LG QL+ LDL
Sbjct: 452 IGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDL 511
Query: 368 SINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPH 427
+ N L+G+IP F L L L L++N L+G +P + +L+ +++S N L+G+I P
Sbjct: 512 ADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHP- 570
Query: 428 LCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALEL 487
LC + + +N IP L ++L +L LG+NQLTG +P ++ LS L++
Sbjct: 571 LCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDM 630
Query: 488 YQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE 547
N +G IP ++ + L + L+ N+ G IP +G L L +SSN ++P E
Sbjct: 631 SSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTE 690
Query: 548 LGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQM 607
L NC L L L N GS P+E+G L L +L L N+ +G++P ++G L++L EL++
Sbjct: 691 LFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRL 750
Query: 608 GGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPA 667
N +G IPV +GQL LQ AL++S+NN +G IP +G L LE L L NQL GE+P
Sbjct: 751 SRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPG 810
Query: 668 SMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQLMPPSHTPK 727
S+G+ SL N+S NNL G + F R + +F GN GLC GS + +
Sbjct: 811 SVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLC--GSPLSRC---NRVRS 863
Query: 728 KNWIKGGSTKEKLVSIISVIVGLISLSF-IIGICWAMKCRKPAFVPL------------E 774
N +G S + V IIS I L ++ I+ I K R F +
Sbjct: 864 NNKQQGLSARS--VVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSS 921
Query: 775 EQKNPEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKI 834
Q + + K ++ +++EAT N SE +IG G G VYKA L NGE +AVKKI
Sbjct: 922 SQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI 981
Query: 835 KLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS--NLLLYEYMENGSLGEQLH 892
L + ++ SF E+ TLG+IRHR++VKL G+C + NLL+YEYM+NGS+ + LH
Sbjct: 982 -LWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLH 1040
Query: 893 GNK-----QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV 947
+K + LLDW+AR RIA+G A+G+ YLH+DC P I+HRDIKS+N+LLD +AH+
Sbjct: 1041 EDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHL 1100
Query: 948 GDFGLAKLIDL---PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK 1004
GDFGLAK++ + S + A SYGYIAPEYAY++K TEK D+YS G+VL+E++TGK
Sbjct: 1101 GDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGK 1160
Query: 1005 SPVQSLELGG--DLVTWVRRSIHEM-VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSS 1061
P S+ G D+V WV + +L D +L + L+IAL C+
Sbjct: 1161 MPTDSV-FGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTK 1219
Query: 1062 TSPLNRPTMREV 1073
TSP RP+ R+
Sbjct: 1220 TSPQERPSSRQA 1231
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 652 bits (1681), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/1051 (37%), Positives = 594/1051 (56%), Gaps = 55/1051 (5%)
Query: 54 WNSSDMTPCN-WIGVECTDFK-VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGS 111
WNS D TPCN W + C+ +T +D+ + L L + L + IS +TG+
Sbjct: 61 WNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGT 120
Query: 112 IPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLE 171
+P L +C L++ L L N + G+IP + L +LE
Sbjct: 121 LPESLGDCLGLKV------------------------LDLSSNGLVGDIPWSLSKLRNLE 156
Query: 172 ELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNS-LEG 230
L++ SN LTG IP ISK +L+ + N L+G IP E+ + GLEV+ + N + G
Sbjct: 157 TLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISG 216
Query: 231 FLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRL 290
+PSE+ NLT L L + +SG +P ++G ++ LE L+++ SG +P +LG S L
Sbjct: 217 QIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSEL 276
Query: 291 KKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQG 350
L++Y N L+G+IP E+G T ++ L +N L G IP E+G NL ++ L N+L G
Sbjct: 277 VDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSG 336
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410
SIP +G+L+ L + +S N +G+IP N + LV LQL N + G IP +G + L
Sbjct: 337 SIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKL 396
Query: 411 SVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTG 470
++ N L+GSIPP L L L L N L+G IP GL R+L +L+L N L+G
Sbjct: 397 TLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSG 456
Query: 471 SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHL 530
+P E N +L L L NR +G IP IG L+ + L S N G +P E+G+ L
Sbjct: 457 FIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSEL 516
Query: 531 VTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTG 590
++S+NSL G++P+ + + LQ LD+S NQF+G P LG+LV+L L LS N +G
Sbjct: 517 QMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSG 576
Query: 591 AIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQM 650
+IP+SLG + L L +G N SG IP LG + L+IALN+S N L+G IP ++ +L
Sbjct: 577 SIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNK 636
Query: 651 LEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLC 710
L L L N L G++ A + +L+ N+S N+ G +P+ +FR++ + GN+ LC
Sbjct: 637 LSILDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLC 695
Query: 711 MLGSDCHQLMPPSHTPKKNWIKGGSTKEKLVSIISVIVGLISLSFIIGICWAMKCRKPAF 770
D L + T++ +++ +I + L I+G ++ R+
Sbjct: 696 SSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVL-MILGAVAVIRARR--- 751
Query: 771 VPLEEQKNPEVIDNYY-----FPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLAN 825
++ +++ E+ + Y F K F ++ E VIG+G G VY+A + N
Sbjct: 752 -NIDNERDSELGETYKWQFTPFQKLNFSVDQIIRC---LVEPNVIGKGCSGVVYRADVDN 807
Query: 826 GEVIAVKKI---KLRG----EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878
GEVIAVKK+ + G + +SF AE+ TLG IRH+NIV+ G C+++++ LL+
Sbjct: 808 GEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLM 867
Query: 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNIL 938
Y+YM NGSLG LH + + LDWD RYRI LGAA+GL YLH+DC P I+HRDIK+NNIL
Sbjct: 868 YDYMPNGSLGSLLHERRGSS-LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNIL 926
Query: 939 LDEEFQAHVGDFGLAKLIDL-PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVL 997
+ +F+ ++ DFGLAKL+D + + +AGSYGYIAPEY Y+MK+TEK D+YS+GVV+
Sbjct: 927 IGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVV 986
Query: 998 LELITGKSPVQ-SLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIA 1056
LE++TGK P+ ++ G LV WVR++ + E+ D L + +EM L A
Sbjct: 987 LEVLTGKQPIDPTVPEGIHLVDWVRQNRGSL----EVLDSTLRSRTEAEADEMMQVLGTA 1042
Query: 1057 LFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087
L C ++SP RPTM++V AM+ + +Q +Y
Sbjct: 1043 LLCVNSSPDERPTMKDVAAMLKEIKQEREEY 1073
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 651 bits (1679), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/1036 (38%), Positives = 593/1036 (57%), Gaps = 39/1036 (3%)
Query: 69 CTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLC 128
CT + + + LN G L + L L N+ N +G IP+ L + S++ L+L
Sbjct: 215 CTSLALFAAAFNRLN--GSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLI 272
Query: 129 TNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI 188
N+L G+IP +L + L+ L L N + G I EE + LE LV+ N L+G++P +I
Sbjct: 273 GNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTI 332
Query: 189 -SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLIL 247
S L+ + LSG IP EIS C+ L++L L+ N+L G +P L +L LT+L L
Sbjct: 333 CSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYL 392
Query: 248 WQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHE 307
N L G + +I N+ +L+ L+ N+ G +PKE+G L +L+ +Y+Y N +G +P E
Sbjct: 393 NNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVE 452
Query: 308 LGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDL 367
+GNCT EID N+L+G IP +G + +L L L EN L G+IP LG Q+ +DL
Sbjct: 453 IGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDL 512
Query: 368 SINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPH 427
+ N L+G+IP F LT L +++N L+G +P + +L+ ++ S N +GSI P
Sbjct: 513 ADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISP- 571
Query: 428 LCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALEL 487
LC + + N G+IP L +L +L LG+NQ TG +P F + LS L++
Sbjct: 572 LCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDI 631
Query: 488 YQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE 547
+N SG+IP E+G + L + L+ NY G IP+ +G L L +SSN G++P E
Sbjct: 632 SRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTE 691
Query: 548 LGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQM 607
+ + N+ L L N GS P+E+G L L L L +N+L+G +PS++G L++L EL++
Sbjct: 692 IFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRL 751
Query: 608 GGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPA 667
N +G IPV +GQL LQ AL++S+NN +G IP + L LE+L L NQL+GE+P
Sbjct: 752 SRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPG 811
Query: 668 SMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQLMPPSHTPK 727
+G+ SL NLS NNL G + F R + F GN GLC GS P SH +
Sbjct: 812 QIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLC--GS------PLSHCNR 861
Query: 728 KNWIKGGSTKEKLVSIISVIVGLISLSF-IIGICWAMKCRKPAFVPLEEQKNPEVIDNYY 786
S K V IIS I L +++ ++ I K F + + ++
Sbjct: 862 AGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSS 921
Query: 787 F---------PKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLR 837
K K+ +++EAT +E +IG G G VYKA L NGE IAVKKI L
Sbjct: 922 SQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI-LW 980
Query: 838 GEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS--NLLLYEYMENGSLGEQLHGNK 895
+ ++ SF E+ TLG IRHR++VKL G+C + NLL+YEYM NGS+ + LH N+
Sbjct: 981 KDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANE 1040
Query: 896 QTC---LLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952
T +L W+ R +IALG A+G+ YLHYDC P I+HRDIKS+N+LLD +AH+GDFGL
Sbjct: 1041 NTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGL 1100
Query: 953 AKLIDLPY---SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009
AK++ Y ++S + AGSYGYIAPEYAY++K TEK D+YS G+VL+E++TGK P ++
Sbjct: 1101 AKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEA 1160
Query: 1010 L-ELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTV--EEMTLF--LKIALFCSSTSP 1064
+ + D+V WV ++ + P SE +K +D K + EE + L+IAL C+ + P
Sbjct: 1161 MFDEETDMVRWV-ETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYP 1219
Query: 1065 LNRPTMREVIAMMIDA 1080
RP+ R+ +++
Sbjct: 1220 QERPSSRQASEYLLNV 1235
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1109 | ||||||
| 225470798 | 1111 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.998 | 0.740 | 0.0 | |
| 147827247 | 1271 | hypothetical protein VITISV_009202 [Viti | 0.995 | 0.868 | 0.741 | 0.0 | |
| 356555150 | 1110 | PREDICTED: leucine-rich repeat receptor- | 0.991 | 0.990 | 0.715 | 0.0 | |
| 356528726 | 1123 | PREDICTED: leucine-rich repeat receptor- | 0.978 | 0.966 | 0.726 | 0.0 | |
| 224117534 | 1103 | predicted protein [Populus trichocarpa] | 0.973 | 0.979 | 0.744 | 0.0 | |
| 186478575 | 1101 | leucine-rich receptor-like protein kinas | 0.983 | 0.990 | 0.686 | 0.0 | |
| 5734762 | 1133 | Similar to leucine-rich receptor-like pr | 0.982 | 0.962 | 0.687 | 0.0 | |
| 297844664 | 1107 | leucine-rich repeat family protein [Arab | 0.983 | 0.985 | 0.681 | 0.0 | |
| 34395052 | 1109 | putative LRR receptor-like kinase [Oryza | 0.960 | 0.960 | 0.632 | 0.0 | |
| 125557263 | 1109 | hypothetical protein OsI_24925 [Oryza sa | 0.960 | 0.960 | 0.632 | 0.0 |
| >gi|225470798|ref|XP_002263001.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1674 bits (4335), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 823/1111 (74%), Positives = 944/1111 (84%), Gaps = 2/1111 (0%)
Query: 1 MARQGISSHTQKLF-YFALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDM 59
MAR + Q F YF L+ C V V SL EEG LLEF+ SLIDP NNL SW++ D+
Sbjct: 1 MARHRTTPPVQNRFHYFLLVLCCCLVFVASLNEEGNFLLEFRRSLIDPGNNLASWSAMDL 60
Query: 60 TPCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANC 119
TPCNW G+ C D KVTS++LHGLNLSG LS R C LP+L N+S NF++G I +LA C
Sbjct: 61 TPCNWTGISCNDSKVTSINLHGLNLSGTLSSRFCQLPQLTSLNLSKNFISGPISENLAYC 120
Query: 120 SSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNN 179
LEILDLCTNR H +P +LF + L+ LYLCENYI+GEIP+EIG+LTSL+ELVIYSNN
Sbjct: 121 RHLEILDLCTNRFHDQLPTKLFKLAPLKVLYLCENYIYGEIPDEIGSLTSLKELVIYSNN 180
Query: 180 LTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKL 239
LTGAIP SISKL++L+ IRAGHN LSG IPPE+SECE LE+LGLAQN LEG +P EL++L
Sbjct: 181 LTGAIPRSISKLKRLQFIRAGHNFLSGSIPPEMSECESLELLGLAQNRLEGPIPVELQRL 240
Query: 240 RNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNE 299
++L +LILWQN L+GEIPP IGN SLE+LALH+NSF+G PKELGKL++LK+LY+YTN+
Sbjct: 241 KHLNNLILWQNLLTGEIPPEIGNFSSLEMLALHDNSFTGSPPKELGKLNKLKRLYIYTNQ 300
Query: 300 LNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQL 359
LNGTIP ELGNCTSAVEIDLSEN LTGFIP+EL IPNL LL LFEN+LQGSIP+ELGQL
Sbjct: 301 LNGTIPQELGNCTSAVEIDLSENHLTGFIPKELAHIPNLRLLHLFENLLQGSIPKELGQL 360
Query: 360 TQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNN 419
QL LDLSINNLTGTIPL FQ+LT+L DLQLFDNHLEGTIPP IGVNS+LS+LD+S NN
Sbjct: 361 KQLRNLDLSINNLTGTIPLGFQSLTFLEDLQLFDNHLEGTIPPLIGVNSNLSILDMSANN 420
Query: 420 LDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNL 479
L G IP LC +QKLIFLSLGSNRLSGNIP LKTC+ L+QLMLG NQLTGSLP+E L
Sbjct: 421 LSGHIPAQLCKFQKLIFLSLGSNRLSGNIPDDLKTCKPLIQLMLGDNQLTGSLPVELSKL 480
Query: 480 QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNS 539
QNLSALELYQNRFSGLI PE+GKL NL+RL LS NYFVG+IP E+G LE LVTFN+SSN
Sbjct: 481 QNLSALELYQNRFSGLISPEVGKLGNLKRLLLSNNYFVGHIPPEIGQLEGLVTFNVSSNW 540
Query: 540 LSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599
LSG+IP ELGNC+ LQRLDLSRN FTG+ PEELG+LVNLELLKLSDN+L+G IP SLGGL
Sbjct: 541 LSGSIPRELGNCIKLQRLDLSRNSFTGNLPEELGKLVNLELLKLSDNRLSGLIPGSLGGL 600
Query: 600 ARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
RLTELQMGGN+F+GSIPV LG L ALQI+LNISHN LSG IP +LG LQMLE++YL++N
Sbjct: 601 TRLTELQMGGNLFNGSIPVELGHLGALQISLNISHNALSGTIPGDLGKLQMLESMYLNNN 660
Query: 660 QLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGS-DCHQ 718
QL+GEIPAS+G+ MSLLVCNLSNNNLVGTVPNT VF+R+DSSNF GN GLC +GS CH
Sbjct: 661 QLVGEIPASIGDLMSLLVCNLSNNNLVGTVPNTPVFQRMDSSNFGGNSGLCRVGSYRCHP 720
Query: 719 LMPPSHTPKKNWIKGGSTKEKLVSIISVIVGLISLSFIIGICWAMKCRKPAFVPLEEQKN 778
PS++PK +WIK GS++EK+VSI SV+VGL+SL F +G+CWA+K R+ AFV LE+Q
Sbjct: 721 SSTPSYSPKGSWIKEGSSREKIVSITSVVVGLVSLMFTVGVCWAIKHRRRAFVSLEDQIK 780
Query: 779 PEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRG 838
P V+DNYYFPKEG Y +LLEATGNFSE A+IGRGACGTVYKA +A+GE+IAVKK+K RG
Sbjct: 781 PNVLDNYYFPKEGLTYQDLLEATGNFSESAIIGRGACGTVYKAAMADGELIAVKKLKSRG 840
Query: 839 EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC 898
+GATADNSF AEISTLGKIRHRNIVKL+GFCYHQDSNLLLYEYMENGSLGEQLHG + C
Sbjct: 841 DGATADNSFRAEISTLGKIRHRNIVKLHGFCYHQDSNLLLYEYMENGSLGEQLHGKEANC 900
Query: 899 LLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958
LLDW+ARY+IALG+AEGL YLHYDC+P IIHRDIKSNNILLDE QAHVGDFGLAKL+D
Sbjct: 901 LLDWNARYKIALGSAEGLSYLHYDCKPQIIHRDIKSNNILLDEMLQAHVGDFGLAKLMDF 960
Query: 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVT 1018
P SKSMSA+AGSYGYIAPEYAYTMK+TEKCDIYSFGVVLLELITG++PVQ LE GGDLVT
Sbjct: 961 PCSKSMSAVAGSYGYIAPEYAYTMKITEKCDIYSFGVVLLELITGRTPVQPLEQGGDLVT 1020
Query: 1019 WVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078
WVRRSI VPTSE+ DKRLDLSAKRT+EEM+L LKIALFC+S SPLNRPTMREVI M++
Sbjct: 1021 WVRRSICNGVPTSEILDKRLDLSAKRTIEEMSLVLKIALFCTSQSPLNRPTMREVINMLM 1080
Query: 1079 DARQSVSDYPSSPTSETPLEADASSRDSIAP 1109
DAR++ D P SPTSETPL+ DAS R + P
Sbjct: 1081 DAREAYCDSPVSPTSETPLDDDASCRGFMEP 1111
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147827247|emb|CAN70971.1| hypothetical protein VITISV_009202 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1669 bits (4323), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 820/1106 (74%), Positives = 941/1106 (85%), Gaps = 2/1106 (0%)
Query: 1 MARQGISSHTQKLF-YFALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDM 59
MAR + Q F YF L+ C V V SL EEG LLEF+ SLIDP NNL SW++ D+
Sbjct: 1 MARHRTTPPVQNRFHYFLLVLCCCLVFVASLNEEGNFLLEFRRSLIDPGNNLASWSAMDL 60
Query: 60 TPCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANC 119
TPCNW G+ C D KVTS++LHGLNLSG LS +C LP+L N+S NF++G I +LA C
Sbjct: 61 TPCNWTGISCNDSKVTSINLHGLNLSGTLSSSVCQLPQLTSLNLSKNFISGPISENLAYC 120
Query: 120 SSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNN 179
LEILDLCTNR H +P +LF + L+ LYLCENYI+GEIP+EIG+LTSL+ELVIYSNN
Sbjct: 121 RHLEILDLCTNRFHDQLPTKLFKLAPLKVLYLCENYIYGEIPDEIGSLTSLKELVIYSNN 180
Query: 180 LTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKL 239
LTGAIP SISKL++L+ IRAGHN LSG IPPE+SECE LE+LGLAQN LEG +P EL++L
Sbjct: 181 LTGAIPRSISKLKRLQFIRAGHNFLSGSIPPEMSECESLELLGLAQNRLEGPIPVELQRL 240
Query: 240 RNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNE 299
+L +LILWQN L+GEIPP IGN SLE+LALH+NSF+G PKELGKL++LK+LY+YTN+
Sbjct: 241 EHLNNLILWQNLLTGEIPPEIGNFSSLEMLALHDNSFTGSPPKELGKLNKLKRLYIYTNQ 300
Query: 300 LNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQL 359
LNGTIP ELGNCTSAVEIDLSEN LTGFIP+EL IPNL LL LFEN+LQG+IP+ELGQL
Sbjct: 301 LNGTIPQELGNCTSAVEIDLSENHLTGFIPKELAHIPNLRLLHLFENLLQGTIPKELGQL 360
Query: 360 TQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNN 419
QL LDLSINNLTGTIPL FQ+LT+L DLQLFDNHLEGTIPP IGVNS+LS+LD+S NN
Sbjct: 361 KQLQNLDLSINNLTGTIPLGFQSLTFLEDLQLFDNHLEGTIPPLIGVNSNLSILDMSANN 420
Query: 420 LDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNL 479
L G IP LC +QKLIFLSLGSNRLSGNIP LKTC+ L+QLMLG NQLTGSLP+E L
Sbjct: 421 LSGHIPAQLCKFQKLIFLSLGSNRLSGNIPDDLKTCKPLIQLMLGDNQLTGSLPVELSKL 480
Query: 480 QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNS 539
QNLSALELYQNRFSGLI PE+GKL NL+RL LS NYFVG+IP E+G LE LVTFN+SSN
Sbjct: 481 QNLSALELYQNRFSGLISPEVGKLGNLKRLLLSNNYFVGHIPPEIGQLEGLVTFNVSSNW 540
Query: 540 LSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599
LSG+IP ELGNC+ LQRLDLSRN FTG+ PEELG+LVNLELLKLSDN+L+G IP SLGGL
Sbjct: 541 LSGSIPRELGNCIKLQRLDLSRNSFTGNLPEELGKLVNLELLKLSDNRLSGLIPGSLGGL 600
Query: 600 ARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
RLTELQMGGN+F+GSIPV LG L ALQI+LNISHN LSG IP +LG LQMLE++YL++N
Sbjct: 601 TRLTELQMGGNLFNGSIPVELGHLGALQISLNISHNALSGTIPGDLGKLQMLESMYLNNN 660
Query: 660 QLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGS-DCHQ 718
QL+GEIPAS+G+ MSLLVCNLSNNNLVGTVPNT VF+R+DSSNF GN GLC +GS CH
Sbjct: 661 QLVGEIPASIGDLMSLLVCNLSNNNLVGTVPNTPVFQRMDSSNFGGNSGLCRVGSYRCHP 720
Query: 719 LMPPSHTPKKNWIKGGSTKEKLVSIISVIVGLISLSFIIGICWAMKCRKPAFVPLEEQKN 778
PS++PK +WIK GS++EK+VSI SV+VGL+SL F +G+CWA+K R+ AFV LE+Q
Sbjct: 721 SSTPSYSPKGSWIKEGSSREKIVSITSVVVGLVSLMFTVGVCWAIKHRRRAFVSLEDQIK 780
Query: 779 PEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRG 838
P V+DNYYFPKEG Y +LLEATGNFSE A+IGRGACGTVYKA +A+GE+IAVKK+K RG
Sbjct: 781 PNVLDNYYFPKEGLTYQDLLEATGNFSESAIIGRGACGTVYKAAMADGELIAVKKLKSRG 840
Query: 839 EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC 898
+GATADNSF AEISTLGKIRHRNIVKL+GFCYHQDSNLLLYEYMENGSLGEQLHG + C
Sbjct: 841 DGATADNSFRAEISTLGKIRHRNIVKLHGFCYHQDSNLLLYEYMENGSLGEQLHGKEANC 900
Query: 899 LLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958
LLDW+ARY+IALG+AEGL YLHYDC+P IIHRDIKSNNILLDE QAHVGDFGLAKL+D
Sbjct: 901 LLDWNARYKIALGSAEGLSYLHYDCKPQIIHRDIKSNNILLDEMLQAHVGDFGLAKLMDF 960
Query: 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVT 1018
P SKSMSA+AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITG++PVQ LE GGDLVT
Sbjct: 961 PCSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGRTPVQPLEQGGDLVT 1020
Query: 1019 WVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078
WVRRSI VPTSE+ DKRLDLSAKRT+EEM+L LKIALFC+S SP+NRPTMREVI M++
Sbjct: 1021 WVRRSICNGVPTSEILDKRLDLSAKRTIEEMSLVLKIALFCTSQSPVNRPTMREVINMLM 1080
Query: 1079 DARQSVSDYPSSPTSETPLEADASSR 1104
DAR++ D P SPTSETPL+ DAS R
Sbjct: 1081 DAREAYCDSPVSPTSETPLDDDASCR 1106
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555150|ref|XP_003545899.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1607 bits (4161), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 789/1103 (71%), Positives = 923/1103 (83%), Gaps = 3/1103 (0%)
Query: 1 MARQGISSHTQKLFYFALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMT 60
MA + S H Y L FC V V S+ EEG+SLL FKASL+DP+NNL +W+SSD+T
Sbjct: 1 MALECSSFHFLNGVYMVLFFCLGIVLVNSVNEEGLSLLRFKASLLDPNNNLYNWDSSDLT 60
Query: 61 PCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCS 120
PCNW GV CT VTSV L+ LNLSG L+P IC+LP+L+E N+S NF++G IP +C
Sbjct: 61 PCNWTGVYCTGSVVTSVKLYQLNLSGTLAPAICNLPKLLELNLSKNFISGPIPDGFVDCG 120
Query: 121 SLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNL 180
LE+LDLCTNRLHG + ++ I TLRKLYLCENY++GE+P E+GNL SLEELVIYSNNL
Sbjct: 121 GLEVLDLCTNRLHGPLLNPIWKITTLRKLYLCENYMYGEVPAELGNLVSLEELVIYSNNL 180
Query: 181 TGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLR 240
TG IP+SI KL+QL+VIR+G N+LSGPIP EISEC+ LE+LGLAQN LEG +P ELEKL+
Sbjct: 181 TGRIPSSIGKLKQLKVIRSGLNALSGPIPAEISECQSLEILGLAQNQLEGSIPRELEKLQ 240
Query: 241 NLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNEL 300
NLT+++LWQN+ SGEIPP IGNI SLELLALH+NS SGG+PKELGKLS+LK+LY+YTN L
Sbjct: 241 NLTNILLWQNYFSGEIPPEIGNISSLELLALHQNSLSGGVPKELGKLSQLKRLYMYTNML 300
Query: 301 NGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLT 360
NGTIP ELGNCT A+EIDLSEN L G IP+ELG+I NL LL LFEN LQG IPRELGQL
Sbjct: 301 NGTIPPELGNCTKAIEIDLSENHLIGTIPKELGMISNLSLLHLFENNLQGHIPRELGQLR 360
Query: 361 QLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNL 420
L LDLS+NNLTGTIPLEFQNLTY+ DLQLFDN LEG IPPH+G +L++LD+S NNL
Sbjct: 361 VLRNLDLSLNNLTGTIPLEFQNLTYMEDLQLFDNQLEGVIPPHLGAIRNLTILDISANNL 420
Query: 421 DGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQ 480
G IP +LC YQKL FLSLGSNRL GNIP LKTC+SL+QLMLG N LTGSLP+E Y L
Sbjct: 421 VGMIPINLCGYQKLQFLSLGSNRLFGNIPYSLKTCKSLVQLMLGDNLLTGSLPVELYELH 480
Query: 481 NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSL 540
NL+ALELYQN+FSG+I P IG+LRNLERL LS NYF GY+P E+GNL LVTFN+SSN
Sbjct: 481 NLTALELYQNQFSGIINPGIGQLRNLERLGLSANYFEGYLPPEIGNLTQLVTFNVSSNRF 540
Query: 541 SGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLA 600
SG+I HELGNCV LQRLDLSRN FTG P ++G LVNLELLK+SDN L+G IP +LG L
Sbjct: 541 SGSIAHELGNCVRLQRLDLSRNHFTGMLPNQIGNLVNLELLKVSDNMLSGEIPGTLGNLI 600
Query: 601 RLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQ 660
RLT+L++GGN FSGSI + LG+L ALQIALN+SHN LSG+IP LGNLQMLE+LYL+DN+
Sbjct: 601 RLTDLELGGNQFSGSISLHLGKLGALQIALNLSHNKLSGLIPDSLGNLQMLESLYLNDNE 660
Query: 661 LIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSD-CHQL 719
L+GEIP+S+G +SL++CN+SNN LVGTVP+TT FR++D +NFAGN GLC +G++ CH
Sbjct: 661 LVGEIPSSIGNLLSLVICNVSNNKLVGTVPDTTTFRKMDFTNFAGNNGLCRVGTNHCHPS 720
Query: 720 MPPSHTPKKNWIKGGSTKEKLVSIISVIVGLISLSFIIGICWAM-KCRKPAFVPLEEQKN 778
+ PSH K +WI+ GS++EK+VSI+S +VGL+SL FI+ IC+AM + + AFV LE Q
Sbjct: 721 LSPSHAAKHSWIRNGSSREKIVSIVSGVVGLVSLIFIVCICFAMRRGSRAAFVSLERQIE 780
Query: 779 PEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRG 838
V+DNYYFPKEGF Y +LLEATGNFSE AV+GRGACGTVYKA +++GEVIAVKK+ RG
Sbjct: 781 THVLDNYYFPKEGFTYQDLLEATGNFSEAAVLGRGACGTVYKAAMSDGEVIAVKKLNSRG 840
Query: 839 EGA-TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQT 897
EGA D SFLAEISTLGKIRHRNIVKLYGFCYH+DSNLLLYEYMENGSLGEQLH + T
Sbjct: 841 EGANNVDRSFLAEISTLGKIRHRNIVKLYGFCYHEDSNLLLYEYMENGSLGEQLHSSVTT 900
Query: 898 CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957
C LDW +RY++ALGAAEGLCYLHYDC+P IIHRDIKSNNILLDE FQAHVGDFGLAKLID
Sbjct: 901 CALDWGSRYKVALGAAEGLCYLHYDCKPQIIHRDIKSNNILLDEMFQAHVGDFGLAKLID 960
Query: 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLV 1017
YSKSMSA+AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLEL+TG+SPVQ LE GGDLV
Sbjct: 961 FSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELVTGRSPVQPLEQGGDLV 1020
Query: 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
T VRR+I VPTSELFDKRL+LSA +TVEEM+L LKIALFC+STSPLNRPTMREVIAM+
Sbjct: 1021 TCVRRAIQASVPTSELFDKRLNLSAPKTVEEMSLILKIALFCTSTSPLNRPTMREVIAML 1080
Query: 1078 IDARQSVSDYPSSPTSETPLEAD 1100
IDAR+ VS+ P+SPTSE+PL+ D
Sbjct: 1081 IDAREYVSNSPTSPTSESPLDED 1103
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528726|ref|XP_003532950.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1606 bits (4158), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 792/1090 (72%), Positives = 918/1090 (84%), Gaps = 5/1090 (0%)
Query: 16 FALIFCFS-NVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSS-DMTPCNWIGVECTDFK 73
L+FC V V S+ EEG+SLL FKASL+DP+NNL +W+SS D+TPCNW GV CT
Sbjct: 1 MVLLFCLGIMVLVNSVNEEGLSLLRFKASLLDPNNNLYNWDSSSDLTPCNWTGVYCTGSV 60
Query: 74 VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
VTSV L+ LNLSG L+P IC+LP+L+E N+S NF++G IP +C LE+LDLCTNRLH
Sbjct: 61 VTSVKLYQLNLSGALAPSICNLPKLLELNLSKNFISGPIPDGFVDCCGLEVLDLCTNRLH 120
Query: 134 GVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQ 193
G + ++ I TLRKLYLCENY+FGE+PEE+GNL SLEELVIYSNNLTG IP+SI KL+Q
Sbjct: 121 GPLLTPIWKITTLRKLYLCENYMFGEVPEELGNLVSLEELVIYSNNLTGRIPSSIGKLKQ 180
Query: 194 LRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLS 253
LRVIRAG N+LSGPIP EISECE LE+LGLAQN LEG +P EL+KL+NLT+++LWQN S
Sbjct: 181 LRVIRAGLNALSGPIPAEISECESLEILGLAQNQLEGSIPRELQKLQNLTNIVLWQNTFS 240
Query: 254 GEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTS 313
GEIPP IGNI SLELLALH+NS GG+PKE+GKLS+LK+LYVYTN LNGTIP ELGNCT
Sbjct: 241 GEIPPEIGNISSLELLALHQNSLIGGVPKEIGKLSQLKRLYVYTNMLNGTIPPELGNCTK 300
Query: 314 AVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLT 373
A+EIDLSEN L G IP+ELG+I NL LL LFEN LQG IPRELGQL L LDLS+NNLT
Sbjct: 301 AIEIDLSENHLIGTIPKELGMISNLSLLHLFENNLQGHIPRELGQLRVLRNLDLSLNNLT 360
Query: 374 GTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQK 433
GTIPLEFQNLTY+ DLQLFDN LEG IPPH+GV +L++LD+S NNL G IP +LC YQK
Sbjct: 361 GTIPLEFQNLTYMEDLQLFDNQLEGVIPPHLGVIRNLTILDISANNLVGMIPINLCGYQK 420
Query: 434 LIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFS 493
L FLSLGSNRL GNIP LKTC+SL+QLMLG N LTGSLP+E Y L NL+ALELYQN+FS
Sbjct: 421 LQFLSLGSNRLFGNIPYSLKTCKSLVQLMLGDNLLTGSLPVELYELHNLTALELYQNQFS 480
Query: 494 GLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVN 553
G+I P IG+LRNLERL LS NYF GY+P E+GNL LVTFN+SSN SG+IPHELGNCV
Sbjct: 481 GIINPGIGQLRNLERLRLSANYFEGYLPPEIGNLPQLVTFNVSSNRFSGSIPHELGNCVR 540
Query: 554 LQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS 613
LQRLDLSRN FTG P E+G LVNLELLK+SDN L+G IP +LG L RLT+L++GGN FS
Sbjct: 541 LQRLDLSRNHFTGMLPNEIGNLVNLELLKVSDNMLSGEIPGTLGNLIRLTDLELGGNQFS 600
Query: 614 GSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQM 673
GSI LG+L ALQIALN+SHN LSG+IP LGNLQMLE+LYL+DN+L+GEIP+S+G +
Sbjct: 601 GSISFHLGRLGALQIALNLSHNKLSGLIPDSLGNLQMLESLYLNDNELVGEIPSSIGNLL 660
Query: 674 SLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSD-CHQLMPPSHTPKKNWIK 732
SL++CN+SNN LVGTVP+TT FR++D +NFAGN GLC +G++ CHQ + PSH K +WI+
Sbjct: 661 SLVICNVSNNKLVGTVPDTTTFRKMDFTNFAGNNGLCRVGTNHCHQSLSPSHAAKHSWIR 720
Query: 733 GGSTKEKLVSIISVIVGLISLSFIIGICWAMKCR-KPAFVPLEEQKNPEVIDNYYFPKEG 791
GS++E +VSI+S +VGL+SL FI+ IC+AM+ R + AFV LE Q V+DNYYFPKEG
Sbjct: 721 NGSSREIIVSIVSGVVGLVSLIFIVCICFAMRRRSRAAFVSLEGQTKTHVLDNYYFPKEG 780
Query: 792 FKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGA-TADNSFLAE 850
F Y +LLEATGNFSE AV+GRGACGTVYKA +++GEVIAVKK+ RGEGA D SFLAE
Sbjct: 781 FTYQDLLEATGNFSEAAVLGRGACGTVYKAAMSDGEVIAVKKLNSRGEGANNVDKSFLAE 840
Query: 851 ISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
ISTLGKIRHRNIVKLYGFCYH+DSNLLLYEYMENGSLGEQLH + TC LDW +RY+IAL
Sbjct: 841 ISTLGKIRHRNIVKLYGFCYHEDSNLLLYEYMENGSLGEQLHSSATTCALDWGSRYKIAL 900
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
GAAEGLCYLHYDC+P IIHRDIKSNNILLDE FQAHVGDFGLAKLID YSKSMSA+AGS
Sbjct: 901 GAAEGLCYLHYDCKPQIIHRDIKSNNILLDEVFQAHVGDFGLAKLIDFSYSKSMSAVAGS 960
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030
YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITG+SPVQ LE GGDLVT VRR+I VP
Sbjct: 961 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGRSPVQPLEQGGDLVTCVRRAIQASVPA 1020
Query: 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSS 1090
SELFDKRL+LSA +TVEEM+L LKIALFC+STSPLNRPTMREVIAM+IDAR+ VS+ P+S
Sbjct: 1021 SELFDKRLNLSAPKTVEEMSLILKIALFCTSTSPLNRPTMREVIAMLIDAREYVSNSPTS 1080
Query: 1091 PTSETPLEAD 1100
PTSE+PL+ D
Sbjct: 1081 PTSESPLDED 1090
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224117534|ref|XP_002317600.1| predicted protein [Populus trichocarpa] gi|222860665|gb|EEE98212.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1599 bits (4141), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 811/1090 (74%), Positives = 911/1090 (83%), Gaps = 10/1090 (0%)
Query: 16 FALIFC---FSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVEC-TD 71
F L+F F V V SL +EG LLEF S+IDP NNL+ WNS D+TPCNW GV C T+
Sbjct: 15 FCLVFLMLYFHFVFVISLNQEGAFLLEFTKSVIDPDNNLQGWNSLDLTPCNWKGVGCSTN 74
Query: 72 FKVTSVDLHGLNLSGILS--PRIC-DLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLC 128
KVTS++LHGLNLSG LS IC +LP LV N+S NF +G IP L C +LEILDLC
Sbjct: 75 LKVTSLNLHGLNLSGSLSTTASICHNLPGLVMLNMSSNFFSGPIPQYLDECHNLEILDLC 134
Query: 129 TNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI 188
TNR G P L +NTLR LY CENYIFGEI EIGNLT LEELVIYSNNLTG IP SI
Sbjct: 135 TNRFRGEFPTHLCTLNTLRLLYFCENYIFGEISREIGNLTLLEELVIYSNNLTGTIPVSI 194
Query: 189 SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILW 248
+L+ L+VIRAG N +GPIPPEISECE LE+LGLAQN +G LP EL+KL+NLT+LILW
Sbjct: 195 RELKHLKVIRAGLNYFTGPIPPEISECESLEILGLAQNRFQGSLPRELQKLQNLTNLILW 254
Query: 249 QNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL 308
QN LSGEIPP IGNI +LE++ALHENSFSG LPKELGKLS+LKKLY+YTN LNGTIP EL
Sbjct: 255 QNFLSGEIPPEIGNISNLEVIALHENSFSGFLPKELGKLSQLKKLYIYTNLLNGTIPREL 314
Query: 309 GNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLS 368
GNC+SA+EIDLSEN+L+G +PRELG IPNL LL LFEN LQGSIP+ELG+LTQLH DLS
Sbjct: 315 GNCSSALEIDLSENRLSGTVPRELGWIPNLRLLHLFENFLQGSIPKELGELTQLHNFDLS 374
Query: 369 INNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHL 428
IN LTG+IPLEFQNLT L +LQLFDNHLEG IP IG NS+LSVLD+S NNL GSIPP+L
Sbjct: 375 INILTGSIPLEFQNLTCLEELQLFDNHLEGHIPYLIGYNSNLSVLDLSANNLVGSIPPYL 434
Query: 429 CMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488
C YQ LIFLSLGSNRL GNIP GLKTC+SL QLMLG N LTGSLP+E Y LQNLS+LE++
Sbjct: 435 CRYQDLIFLSLGSNRLFGNIPFGLKTCKSLKQLMLGGNLLTGSLPVELYQLQNLSSLEIH 494
Query: 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHEL 548
QNRFSG IPP IGKL NL+RL LS+NYF G IP E+GNL LV FNISSN LSG IPHEL
Sbjct: 495 QNRFSGYIPPGIGKLGNLKRLLLSDNYFFGQIPPEIGNLTQLVAFNISSNGLSGGIPHEL 554
Query: 549 GNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMG 608
GNC+ LQRLDLSRNQFTGS PEE+G LVNLELLKLSDN++TG IPS+LG L RLTELQMG
Sbjct: 555 GNCIKLQRLDLSRNQFTGSLPEEIGWLVNLELLKLSDNRITGEIPSTLGSLDRLTELQMG 614
Query: 609 GNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPAS 668
GN+FSG+IPV LGQLT LQIALNISHN LSG IP +LG LQMLE+LYL+DNQL+GEIPAS
Sbjct: 615 GNLFSGAIPVELGQLTTLQIALNISHNRLSGTIPKDLGKLQMLESLYLNDNQLVGEIPAS 674
Query: 669 MGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGS-DCHQLMPPSHTPK 727
+GE +SLLVCNLSNNNL G VPNT F+++DS+NFAGN GLC GS CH +P S TPK
Sbjct: 675 IGELLSLLVCNLSNNNLEGAVPNTPAFQKMDSTNFAGNNGLCKSGSYHCHSTIP-SPTPK 733
Query: 728 KNWIKGGSTKEKLVSIISVIVGLISLSFIIGICWAMKCRKPAFVPLEEQKNPEVIDNYYF 787
KNWIK S++ KLV+IIS +GL+SL FI+GIC AM R+PAFV LE+ P+V DNYYF
Sbjct: 734 KNWIKESSSRAKLVTIISGAIGLVSLFFIVGICRAMMRRQPAFVSLEDATRPDVEDNYYF 793
Query: 788 PKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSF 847
PKEGF Y++LL ATGNFSE AVIGRGACGTVYKA +A+GEVIAVKK+K G GA++DNSF
Sbjct: 794 PKEGFSYNDLLVATGNFSEDAVIGRGACGTVYKAVMADGEVIAVKKLKSSGAGASSDNSF 853
Query: 848 LAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYR 907
AEI TLGKIRHRNIVKL+GFCYHQD N+LLYEYM NGSLGEQLHG+ +TC LDW+ARY+
Sbjct: 854 RAEILTLGKIRHRNIVKLFGFCYHQDYNILLYEYMPNGSLGEQLHGSVRTCSLDWNARYK 913
Query: 908 IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967
I LGAAEGLCYLHYDC+P IIHRDIKSNNILLDE QAHVGDFGLAKLID P+SKSMSA+
Sbjct: 914 IGLGAAEGLCYLHYDCKPRIIHRDIKSNNILLDELLQAHVGDFGLAKLIDFPHSKSMSAV 973
Query: 968 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM 1027
AGSYGYIAPEYAYT+KVTEKCDIYSFGVVLLELITGK PVQ LE GGDLVTWVRRSI +
Sbjct: 974 AGSYGYIAPEYAYTLKVTEKCDIYSFGVVLLELITGKPPVQCLEQGGDLVTWVRRSIQDP 1033
Query: 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087
PTSE+FD RLDLS K T+EEM+L LKIALFC+STSPLNRPTMREVIAMMIDAR++
Sbjct: 1034 GPTSEIFDSRLDLSQKSTIEEMSLVLKIALFCTSTSPLNRPTMREVIAMMIDAREAAVSS 1093
Query: 1088 PS-SPTSETP 1096
PS SPT+E+P
Sbjct: 1094 PSESPTAESP 1103
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186478575|ref|NP_173166.2| leucine-rich receptor-like protein kinase [Arabidopsis thaliana] gi|325511358|sp|Q9SHI2.2|Y1723_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230; Flags: Precursor gi|332191440|gb|AEE29561.1| leucine-rich receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1502 bits (3889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 752/1095 (68%), Positives = 880/1095 (80%), Gaps = 4/1095 (0%)
Query: 14 FYFALIFC-FSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDF 72
F +I C FS + V SL EEG LLEFKA L D + L SWN D PCNW G+ CT
Sbjct: 7 FLAIVILCSFSFILVRSLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTHL 66
Query: 73 K-VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNR 131
+ VTSVDL+G+NLSG LSP IC L L + N+S NF++G IP DL+ C SLE+LDLCTNR
Sbjct: 67 RTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNR 126
Query: 132 LHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKL 191
HGVIP QL I TL+KLYLCENY+FG IP +IGNL+SL+ELVIYSNNLTG IP S++KL
Sbjct: 127 FHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKL 186
Query: 192 RQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
RQLR+IRAG N SG IP EIS CE L+VLGLA+N LEG LP +LEKL+NLTDLILWQN
Sbjct: 187 RQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNR 246
Query: 252 LSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNC 311
LSGEIPP++GNI LE+LALHEN F+G +P+E+GKL+++K+LY+YTN+L G IP E+GN
Sbjct: 247 LSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNL 306
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINN 371
A EID SENQLTGFIP+E G I NL LL LFEN+L G IPRELG+LT L KLDLSIN
Sbjct: 307 IDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINR 366
Query: 372 LTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMY 431
L GTIP E Q L YLVDLQLFDN LEG IPP IG S+ SVLD+S N+L G IP H C +
Sbjct: 367 LNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRF 426
Query: 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR 491
Q LI LSLGSN+LSGNIP LKTC+SL +LMLG NQLTGSLPIE +NLQNL+ALEL+QN
Sbjct: 427 QTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNW 486
Query: 492 FSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNC 551
SG I ++GKL+NLERL L+ N F G IP E+GNL +V FNISSN L+G IP ELG+C
Sbjct: 487 LSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSC 546
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNI 611
V +QRLDLS N+F+G +ELGQLV LE+L+LSDN+LTG IP S G L RL ELQ+GGN+
Sbjct: 547 VTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNL 606
Query: 612 FSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGE 671
S +IPV LG+LT+LQI+LNISHNNLSG IP LGNLQMLE LYL+DN+L GEIPAS+G
Sbjct: 607 LSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGN 666
Query: 672 QMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLC-MLGSDCHQLMPPSHTPKKNW 730
MSLL+CN+SNNNLVGTVP+T VF+R+DSSNFAGN GLC S C L+P S + K NW
Sbjct: 667 LMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDS-KLNW 725
Query: 731 IKGGSTKEKLVSIISVIVGLISLSFIIGICWAMKCRKPAFVPLEEQKNPEVIDNYYFPKE 790
+ GS ++K+++I +++G + L +G+CW +K R+PAFV LE+Q P+V+D+YYFPK+
Sbjct: 726 LINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKK 785
Query: 791 GFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAE 850
GF Y L++AT NFSE V+GRGACGTVYKA ++ GEVIAVKK+ RGEGA++DNSF AE
Sbjct: 786 GFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAE 845
Query: 851 ISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
ISTLGKIRHRNIVKLYGFCYHQ+SNLLLYEYM GSLGEQL ++ CLLDW+ARYRIAL
Sbjct: 846 ISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIAL 905
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
GAAEGLCYLH+DCRP I+HRDIKSNNILLDE FQAHVGDFGLAKLIDL YSKSMSA+AGS
Sbjct: 906 GAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGS 965
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030
YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK PVQ LE GGDLV WVRRSI M+PT
Sbjct: 966 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPT 1025
Query: 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSS 1090
E+FD RLD + KRTV EM+L LKIALFC+S SP +RPTMREV+AM+ +AR S S SS
Sbjct: 1026 IEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEARGSSSLSSSS 1085
Query: 1091 PTSETPLEADASSRD 1105
TSETPLE SS++
Sbjct: 1086 ITSETPLEEANSSKE 1100
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|5734762|gb|AAD50027.1|AC007651_22 Similar to leucine-rich receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1499 bits (3881), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 752/1094 (68%), Positives = 879/1094 (80%), Gaps = 4/1094 (0%)
Query: 14 FYFALIFC-FSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDF 72
F +I C FS + V SL EEG LLEFKA L D + L SWN D PCNW G+ CT
Sbjct: 7 FLAIVILCSFSFILVRSLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTHL 66
Query: 73 K-VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNR 131
+ VTSVDL+G+NLSG LSP IC L L + N+S NF++G IP DL+ C SLE+LDLCTNR
Sbjct: 67 RTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNR 126
Query: 132 LHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKL 191
HGVIP QL I TL+KLYLCENY+FG IP +IGNL+SL+ELVIYSNNLTG IP S++KL
Sbjct: 127 FHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKL 186
Query: 192 RQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
RQLR+IRAG N SG IP EIS CE L+VLGLA+N LEG LP +LEKL+NLTDLILWQN
Sbjct: 187 RQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNR 246
Query: 252 LSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNC 311
LSGEIPP++GNI LE+LALHEN F+G +P+E+GKL+++K+LY+YTN+L G IP E+GN
Sbjct: 247 LSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNL 306
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINN 371
A EID SENQLTGFIP+E G I NL LL LFEN+L G IPRELG+LT L KLDLSIN
Sbjct: 307 IDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINR 366
Query: 372 LTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMY 431
L GTIP E Q L YLVDLQLFDN LEG IPP IG S+ SVLD+S N+L G IP H C +
Sbjct: 367 LNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRF 426
Query: 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR 491
Q LI LSLGSN+LSGNIP LKTC+SL +LMLG NQLTGSLPIE +NLQNL+ALEL+QN
Sbjct: 427 QTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNW 486
Query: 492 FSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNC 551
SG I ++GKL+NLERL L+ N F G IP E+GNL +V FNISSN L+G IP ELG+C
Sbjct: 487 LSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSC 546
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNI 611
V +QRLDLS N+F+G +ELGQLV LE+L+LSDN+LTG IP S G L RL ELQ+GGN+
Sbjct: 547 VTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNL 606
Query: 612 FSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGE 671
S +IPV LG+LT+LQI+LNISHNNLSG IP LGNLQMLE LYL+DN+L GEIPAS+G
Sbjct: 607 LSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGN 666
Query: 672 QMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLC-MLGSDCHQLMPPSHTPKKNW 730
MSLL+CN+SNNNLVGTVP+T VF+R+DSSNFAGN GLC S C L+P S + K NW
Sbjct: 667 LMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDS-KLNW 725
Query: 731 IKGGSTKEKLVSIISVIVGLISLSFIIGICWAMKCRKPAFVPLEEQKNPEVIDNYYFPKE 790
+ GS ++K+++I +++G + L +G+CW +K R+PAFV LE+Q P+V+D+YYFPK+
Sbjct: 726 LINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKK 785
Query: 791 GFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAE 850
GF Y L++AT NFSE V+GRGACGTVYKA ++ GEVIAVKK+ RGEGA++DNSF AE
Sbjct: 786 GFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAE 845
Query: 851 ISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
ISTLGKIRHRNIVKLYGFCYHQ+SNLLLYEYM GSLGEQL ++ CLLDW+ARYRIAL
Sbjct: 846 ISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIAL 905
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
GAAEGLCYLH+DCRP I+HRDIKSNNILLDE FQAHVGDFGLAKLIDL YSKSMSA+AGS
Sbjct: 906 GAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGS 965
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030
YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK PVQ LE GGDLV WVRRSI M+PT
Sbjct: 966 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPT 1025
Query: 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSS 1090
E+FD RLD + KRTV EM+L LKIALFC+S SP +RPTMREV+AM+ +AR S S SS
Sbjct: 1026 IEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEARGSSSLSSSS 1085
Query: 1091 PTSETPLEADASSR 1104
TSETPLE SS+
Sbjct: 1086 ITSETPLEEANSSK 1099
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297844664|ref|XP_002890213.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297336055|gb|EFH66472.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1484 bits (3841), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 746/1095 (68%), Positives = 879/1095 (80%), Gaps = 4/1095 (0%)
Query: 14 FYFALIFC-FSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDF 72
F +I C FS + V SL EEG LLEFKA L D + L SWN D PCNW G+ECT
Sbjct: 7 FSAIVILCSFSFILVRSLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIECTRI 66
Query: 73 K-VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNR 131
+ VTSVDL+G+NLSG LSP IC L L + N+S NF++G IP DL+ C SLE+LDLCTNR
Sbjct: 67 RTVTSVDLNGMNLSGTLSPLICKLYGLRKLNVSTNFISGPIPRDLSLCRSLEVLDLCTNR 126
Query: 132 LHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKL 191
HGVIP QL I TL+KLYLCENY+FG IP +IG+L+SL+ELVIYSNNLTG IP S KL
Sbjct: 127 FHGVIPIQLTMIITLKKLYLCENYLFGTIPRQIGSLSSLQELVIYSNNLTGVIPPSTGKL 186
Query: 192 RQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
R LR+IRAG N+ SG IP EIS CE L+VLGLA+N LEG LP +LEKL+NLTDLILWQN
Sbjct: 187 RLLRIIRAGRNAFSGVIPSEISGCESLKVLGLAENLLEGSLPMQLEKLQNLTDLILWQNR 246
Query: 252 LSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNC 311
LSGEIPP++GNI LE+LALHEN F+G +P+E+GKL+++K+LY+YTN+L G IP E+GN
Sbjct: 247 LSGEIPPSVGNITKLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNL 306
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINN 371
T A EID SENQLTGFIP+E G I NL LL LFEN+L G IPRELG+LT L KLDLSIN
Sbjct: 307 TDAAEIDFSENQLTGFIPKEFGQILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINR 366
Query: 372 LTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMY 431
L GTIP E Q LTYLVDLQLFDN LEGTIPP IG S+ SVLD+S N L G IP H C +
Sbjct: 367 LNGTIPRELQFLTYLVDLQLFDNQLEGTIPPLIGFYSNFSVLDMSANYLSGPIPAHFCRF 426
Query: 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR 491
Q LI LS+GSN+L+GNIP LKTC+SL +LMLG N LTGSLP E +NLQNL+ALEL+QN
Sbjct: 427 QTLILLSVGSNKLTGNIPRDLKTCKSLTKLMLGDNWLTGSLPAELFNLQNLTALELHQNW 486
Query: 492 FSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNC 551
SG I ++GKL+NLERL L+ N F G IP E+G L +V NISSN L+G IP ELG+C
Sbjct: 487 LSGNISADLGKLKNLERLRLANNNFTGEIPPEIGYLTKIVGLNISSNQLTGHIPKELGSC 546
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNI 611
V +QRLDLS N+F+G P++LGQLVNLE+L+LSDN+LTG IP S G L RL ELQ+GGN+
Sbjct: 547 VTIQRLDLSGNRFSGYIPQDLGQLVNLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNL 606
Query: 612 FSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGE 671
S +IPV LG+LT+LQI+LNISHNNLSG IP LGNLQMLE LYL+DN+L GEIPAS+G
Sbjct: 607 LSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGN 666
Query: 672 QMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLC-MLGSDCHQLMPPSHTPKKNW 730
MSLL+CN+SNNNLVGTVP+T VF+R+DSSNFAGN LC S C L+P S + K +W
Sbjct: 667 LMSLLICNVSNNNLVGTVPDTAVFQRMDSSNFAGNHRLCNSQSSHCQPLVPHSDS-KLSW 725
Query: 731 IKGGSTKEKLVSIISVIVGLISLSFIIGICWAMKCRKPAFVPLEEQKNPEVIDNYYFPKE 790
+ GS ++K+++I +++G + L + ICWA+K R+PAFV LE+Q P+V+D+YYFPK+
Sbjct: 726 LVNGSQRQKILTITCMVIGSVFLITFLAICWAIKRREPAFVALEDQTKPDVMDSYYFPKK 785
Query: 791 GFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAE 850
GF Y L++AT NFSE ++GRGACGTVYKA +++GEVIAVKK+ RGEGA++DNSF AE
Sbjct: 786 GFTYQGLVDATRNFSEDVLLGRGACGTVYKAEMSDGEVIAVKKLNSRGEGASSDNSFRAE 845
Query: 851 ISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
ISTLGKIRHRNIVKLYGFCYHQ+SNLLLYEYM GSLGEQL ++ CLLDW+ARY+IAL
Sbjct: 846 ISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYKIAL 905
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
GAAEGLCYLH+DCRP I+HRDIKSNNILLDE FQAHVGDFGLAKLIDL YSKSMSA+AGS
Sbjct: 906 GAAEGLCYLHHDCRPQIVHRDIKSNNILLDELFQAHVGDFGLAKLIDLSYSKSMSAVAGS 965
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030
YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK PVQ LE GGDLV WVRRSI MVPT
Sbjct: 966 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMVPT 1025
Query: 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSS 1090
E+FD RLD + KRT+ EM+L LKIALFC+S SP +RPTMREV+AM+ +AR S S SS
Sbjct: 1026 IEMFDARLDTNDKRTIHEMSLVLKIALFCTSNSPASRPTMREVVAMITEARGSSSLSTSS 1085
Query: 1091 PTSETPLEADASSRD 1105
TSETPLE SS++
Sbjct: 1086 ITSETPLEEANSSKE 1100
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|34395052|dbj|BAC84715.1| putative LRR receptor-like kinase [Oryza sativa Japonica Group] gi|215769107|dbj|BAH01336.1| unnamed protein product [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 1327 bits (3434), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 679/1073 (63%), Positives = 825/1073 (76%), Gaps = 8/1073 (0%)
Query: 37 LLEFKASLIDPSNNLESWNSSDMT----PCNWIGVECTD-FKVTSVDLHGLNLSGILSPR 91
L+EFK L D L SW+++ + PC W G+ C+ +VT+V LHGLNL G LS
Sbjct: 35 LMEFKTKLDDVDGRLSSWDAAGGSGGGDPCGWPGIACSAAMEVTAVTLHGLNLHGELSAA 94
Query: 92 ICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYL 151
+C LPRL N+S N + G++P LA C +LE+LDL TN LHG IP L + +LR+L+L
Sbjct: 95 VCALPRLAVLNVSKNALAGALPPGLAACRALEVLDLSTNSLHGGIPPSLCSLPSLRQLFL 154
Query: 152 CENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPE 211
EN++ GEIP IGNLT+LEEL IYSNNLTG IP +I+ L++LR+IRAG N LSGPIP E
Sbjct: 155 SENFLSGEIPAAIGNLTALEELEIYSNNLTGGIPTTIAALQRLRIIRAGLNDLSGPIPVE 214
Query: 212 ISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLAL 271
IS C L VLGLAQN+L G LP EL +L+NLT LILWQN LSGEIPP +G+I SLE+LAL
Sbjct: 215 ISACASLAVLGLAQNNLAGELPGELSRLKNLTTLILWQNALSGEIPPELGDIPSLEMLAL 274
Query: 272 HENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRE 331
++N+F+GG+P+ELG L L KLY+Y N+L+GTIP ELG+ SAVEIDLSEN+LTG IP E
Sbjct: 275 NDNAFTGGVPRELGALPSLAKLYIYRNQLDGTIPRELGDLQSAVEIDLSENKLTGVIPGE 334
Query: 332 LGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQL 391
LG IP L LL LFEN LQGSIP ELG+LT + ++DLSINNLTGTIP+EFQNLT L LQL
Sbjct: 335 LGRIPTLRLLYLFENRLQGSIPPELGELTVIRRIDLSINNLTGTIPMEFQNLTDLEYLQL 394
Query: 392 FDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPG 451
FDN + G IPP +G S+LSVLD+S N L GSIPPHLC +QKLIFLSLGSNRL GNIPPG
Sbjct: 395 FDNQIHGVIPPMLGAGSNLSVLDLSDNRLTGSIPPHLCKFQKLIFLSLGSNRLIGNIPPG 454
Query: 452 LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHL 511
+K CR+L QL LG N LTGSLP+E L+NLS+L++ +NRFSG IPPEIGK R++ERL L
Sbjct: 455 VKACRTLTQLQLGGNMLTGSLPVELSLLRNLSSLDMNRNRFSGPIPPEIGKFRSIERLIL 514
Query: 512 SENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEE 571
SENYFVG IP +GNL LV FNISSN L+G IP EL C LQRLDLS+N TG P+E
Sbjct: 515 SENYFVGQIPPGIGNLTKLVAFNISSNQLTGPIPRELARCTKLQRLDLSKNSLTGVIPQE 574
Query: 572 LGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALN 631
LG LVNLE LKLSDN L G +PSS GGL+RLTELQMGGN SG +PV LGQLTALQIALN
Sbjct: 575 LGTLVNLEQLKLSDNSLNGTVPSSFGGLSRLTELQMGGNRLSGQLPVELGQLTALQIALN 634
Query: 632 ISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPN 691
+S+N LSG IP +LGNL MLE LYL++N+L GE+P+S GE SLL CNLS NNL G +P+
Sbjct: 635 VSYNMLSGEIPTQLGNLHMLEFLYLNNNELEGEVPSSFGELSSLLECNLSYNNLAGPLPS 694
Query: 692 TTVFRRIDSSNFAGNRGLCML-GSDCHQLMPPSHTPKKNWI-KGGSTKEKLVSIISVIVG 749
TT+F+ +DSSNF GN GLC + G C L ++ ++ + K +EK++SI S+++
Sbjct: 695 TTLFQHMDSSNFLGNNGLCGIKGKSCSGLSGSAYASREAAVQKKRLLREKIISISSIVIA 754
Query: 750 LISLSFIIGICWAMKCRKPAFVPLEEQKNPEVIDNYYFPKEGFKYHNLLEATGNFSEGAV 809
+SL I +CW++K + P V EE+K +YF KE + L++ T +FSE AV
Sbjct: 755 FVSLVLIAVVCWSLKSKIPDLVSNEERKT-GFSGPHYFLKERITFQELMKVTDSFSESAV 813
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
IGRGACGTVYKA + +G +AVKK+K +GEG+ D SF AEI+TLG +RHRNIVKLYGFC
Sbjct: 814 IGRGACGTVYKAIMPDGRRVAVKKLKCQGEGSNVDRSFRAEITTLGNVRHRNIVKLYGFC 873
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIH 929
+QD NL+LYEYM NGSLGE LHG+K CLLDWD RYRIALGAAEGL YLH DC+P +IH
Sbjct: 874 SNQDCNLILYEYMANGSLGELLHGSKDVCLLDWDTRYRIALGAAEGLRYLHSDCKPKVIH 933
Query: 930 RDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 989
RDIKSNNILLDE +AHVGDFGLAKLID+ S++MSAIAGSYGYIAPEYA+TMKVTEKCD
Sbjct: 934 RDIKSNNILLDEMMEAHVGDFGLAKLIDISNSRTMSAIAGSYGYIAPEYAFTMKVTEKCD 993
Query: 990 IYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEM 1049
IYSFGVVLLEL+TG+SP+Q LE GGDLV VRR + SE+FD RL+L+++R +EE+
Sbjct: 994 IYSFGVVLLELVTGQSPIQPLEQGGDLVNLVRRMTNSSTTNSEIFDSRLNLNSRRVLEEI 1053
Query: 1050 TLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSSPTSETPLEADAS 1102
+L LKIALFC+S SPL+RP+MREVI+M++DAR S D SSP SE P+E D+S
Sbjct: 1054 SLVLKIALFCTSESPLDRPSMREVISMLMDARASAYDSFSSPASEAPIEDDSS 1106
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|125557263|gb|EAZ02799.1| hypothetical protein OsI_24925 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 1325 bits (3429), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 679/1073 (63%), Positives = 824/1073 (76%), Gaps = 8/1073 (0%)
Query: 37 LLEFKASLIDPSNNLESWNSSDMT----PCNWIGVECTD-FKVTSVDLHGLNLSGILSPR 91
L+EFK L D L SW+++ + PC W G+ C+ +VT+V LHGLNL G LS
Sbjct: 35 LMEFKTKLDDVDGRLSSWDAAGGSGGGDPCGWPGIACSAAMEVTAVTLHGLNLHGELSAA 94
Query: 92 ICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYL 151
+C LPRL N+S N + G++P LA C +LE+LDL TN LHG IP L + +LR+L+L
Sbjct: 95 VCALPRLAVLNVSKNALAGALPPGLAACRALEVLDLSTNSLHGGIPPSLCSLPSLRQLFL 154
Query: 152 CENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPE 211
EN++ GEIP IGNLT+LEEL IYSNNLTG IP +I+ L++LR+IRAG N LSGPIP E
Sbjct: 155 SENFLSGEIPAAIGNLTALEELEIYSNNLTGGIPTTIAALQRLRIIRAGLNDLSGPIPVE 214
Query: 212 ISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLAL 271
IS C L VLGLAQN+L G LP EL +L+NLT LILWQN LSGEIPP +G+I SLE+LAL
Sbjct: 215 ISACASLAVLGLAQNNLAGELPGELSRLKNLTTLILWQNALSGEIPPELGDIPSLEMLAL 274
Query: 272 HENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRE 331
++N+F+GG+P+ELG L L KLY+Y N+L+GTIP ELG+ SAVEIDLSEN+LTG IP E
Sbjct: 275 NDNAFTGGVPRELGALPSLAKLYIYRNQLDGTIPRELGDLQSAVEIDLSENKLTGVIPGE 334
Query: 332 LGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQL 391
LG IP L LL LFEN LQGSIP ELG+L + ++DLSINNLTGTIP+EFQNLT L LQL
Sbjct: 335 LGRIPTLRLLYLFENRLQGSIPPELGELNVIRRIDLSINNLTGTIPMEFQNLTDLEYLQL 394
Query: 392 FDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPG 451
FDN + G IPP +G S+LSVLD+S N L GSIPPHLC +QKLIFLSLGSNRL GNIPPG
Sbjct: 395 FDNQIHGVIPPMLGAGSNLSVLDLSDNRLTGSIPPHLCKFQKLIFLSLGSNRLIGNIPPG 454
Query: 452 LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHL 511
+K CR+L QL LG N LTGSLP+E L+NLS+L++ +NRFSG IPPEIGK R++ERL L
Sbjct: 455 VKACRTLTQLQLGGNMLTGSLPVELSLLRNLSSLDMNRNRFSGPIPPEIGKFRSIERLIL 514
Query: 512 SENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEE 571
SENYFVG IP +GNL LV FNISSN L+G IP EL C LQRLDLS+N TG P+E
Sbjct: 515 SENYFVGQIPPGIGNLTKLVAFNISSNQLTGPIPRELARCTKLQRLDLSKNSLTGVIPQE 574
Query: 572 LGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALN 631
LG LVNLE LKLSDN L G IPSS GGL+RLTELQMGGN SG +PV LGQLTALQIALN
Sbjct: 575 LGTLVNLEQLKLSDNSLNGTIPSSFGGLSRLTELQMGGNRLSGQLPVELGQLTALQIALN 634
Query: 632 ISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPN 691
+S+N LSG IP +LGNL MLE LYL++N+L GE+P+S GE SLL CNLS NNL G +P+
Sbjct: 635 VSYNMLSGEIPTQLGNLHMLEFLYLNNNELEGEVPSSFGELSSLLECNLSYNNLAGPLPS 694
Query: 692 TTVFRRIDSSNFAGNRGLCML-GSDCHQLMPPSHTPKKNWI-KGGSTKEKLVSIISVIVG 749
TT+F+ +DSSNF GN GLC + G C L ++ ++ + K +EK++SI S+++
Sbjct: 695 TTLFQHMDSSNFLGNNGLCGIKGKSCSGLSGSAYASREAAVQKKRLLREKIISISSIVIA 754
Query: 750 LISLSFIIGICWAMKCRKPAFVPLEEQKNPEVIDNYYFPKEGFKYHNLLEATGNFSEGAV 809
+SL I +CW++K + P V EE+K +YF KE + L++ T +FSE AV
Sbjct: 755 FVSLVLIAVVCWSLKSKIPDLVSNEERKT-GFSGPHYFLKERITFQELMKVTDSFSESAV 813
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
IGRGACGTVYKA + +G +AVKK+K +GEG+ D SF AEI+TLG +RHRNIVKLYGFC
Sbjct: 814 IGRGACGTVYKAIMPDGRRVAVKKLKCQGEGSNVDRSFRAEITTLGNVRHRNIVKLYGFC 873
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIH 929
+QD NL+LYEYM NGSLGE LHG+K CLLDWD RYRIALGAAEGL YLH DC+P +IH
Sbjct: 874 SNQDCNLILYEYMANGSLGELLHGSKDVCLLDWDTRYRIALGAAEGLRYLHSDCKPKVIH 933
Query: 930 RDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 989
RDIKSNNILLDE +AHVGDFGLAKLID+ S++MSAIAGSYGYIAPEYA+TMKVTEKCD
Sbjct: 934 RDIKSNNILLDEMMEAHVGDFGLAKLIDISNSRTMSAIAGSYGYIAPEYAFTMKVTEKCD 993
Query: 990 IYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEM 1049
IYSFGVVLLEL+TG+SP+Q LE GGDLV VRR + SE+FD RL+L+++R +EE+
Sbjct: 994 IYSFGVVLLELVTGQSPIQPLEQGGDLVNLVRRMTNSSTTNSEIFDSRLNLNSRRVLEEI 1053
Query: 1050 TLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSSPTSETPLEADAS 1102
+L LKIALFC+S SPL+RP+MREVI+M++DAR S D SSP SE P+E D+S
Sbjct: 1054 SLVLKIALFCTSESPLDRPSMREVISMLMDARASAYDSFSSPASEAPIEDDSS 1106
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1109 | ||||||
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.983 | 0.990 | 0.673 | 0.0 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.973 | 0.960 | 0.515 | 1.3e-283 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.968 | 0.974 | 0.520 | 1.9e-282 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.587 | 0.570 | 0.392 | 5.2e-186 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.586 | 0.572 | 0.393 | 4.9e-181 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.587 | 0.597 | 0.391 | 3.9e-179 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.574 | 0.510 | 0.379 | 3.6e-176 | |
| TAIR|locus:2131518 | 1091 | AT4G26540 [Arabidopsis thalian | 0.586 | 0.595 | 0.388 | 4.5e-176 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.576 | 0.510 | 0.370 | 4.1e-175 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.884 | 0.875 | 0.389 | 2.3e-174 |
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3746 (1323.7 bits), Expect = 0., P = 0.
Identities = 737/1095 (67%), Positives = 854/1095 (77%)
Query: 14 FYFALIFC-FSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDF 72
F +I C FS + V SL EEG LLEFKA L D + L SWN D PCNW G+ CT
Sbjct: 7 FLAIVILCSFSFILVRSLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTHL 66
Query: 73 K-VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNR 131
+ VTSVDL+G+NLSG LSP IC L L + N+S NF++G IP DL+ C SLE+LDLCTNR
Sbjct: 67 RTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNR 126
Query: 132 LHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKL 191
HGVIP QL I TL+KLYLCENY+FG IP +IGNL+SL+ELVIYSNNLTG IP S++KL
Sbjct: 127 FHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKL 186
Query: 192 RQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
RQLR+IRAG N SG IP EIS CE L+VLGLA+N LEG LP +LEKL+NLTDLILWQN
Sbjct: 187 RQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNR 246
Query: 252 LSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNC 311
LSGEIPP++GNI LE+LALHEN F+G +P+E+GKL+++K+LY+YTN+L G IP E+GN
Sbjct: 247 LSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNL 306
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINN 371
A EID SENQLTGFIP+E G I NL LL LFEN+L G IPRELG+LT L KLDLSIN
Sbjct: 307 IDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINR 366
Query: 372 LTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMY 431
L GTIP E Q L YLVDLQLFDN LEG IPP IG S+ SVLD+S N+L G IP H C +
Sbjct: 367 LNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRF 426
Query: 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR 491
Q LI LSLGSN+LSGNIP LKTC+SL +LMLG NQLTGSLPIE +NLQNL+ALEL+QN
Sbjct: 427 QTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNW 486
Query: 492 FSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNC 551
SG I ++GKL+NLERL L+ N F G IP E+GNL +V FNISSN L+G IP ELG+C
Sbjct: 487 LSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSC 546
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNI 611
V +QRLDLS N+F+G +ELGQLV LE+L+LSDN+LTG IP S G L RL ELQ+GGN+
Sbjct: 547 VTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNL 606
Query: 612 FSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGE 671
S +IPV LG+LT+LQI+LNISHNNLSG IP LGNLQMLE LYL+DN+L GEIPAS+G
Sbjct: 607 LSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGN 666
Query: 672 QMXXXXXXXXXXXXXGTVPNTTVFRRIDSSNFAGNRGLC-MLGSDCHQLMPPSHTPKKNW 730
M GTVP+T VF+R+DSSNFAGN GLC S C L+P S + K NW
Sbjct: 667 LMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDS-KLNW 725
Query: 731 IKGGSTKEKXXXXXXXXXXXXXXXXXXXXCWAMKCRKPAFVPLEEQKNPEVIDNYYFPKE 790
+ GS ++K CW +K R+PAFV LE+Q P+V+D+YYFPK+
Sbjct: 726 LINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKK 785
Query: 791 GFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAE 850
GF Y L++AT NFSE V+GRGACGTVYKA ++ GEVIAVKK+ RGEGA++DNSF AE
Sbjct: 786 GFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAE 845
Query: 851 ISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
ISTLGKIRHRNIVKLYGFCYHQ+SNLLLYEYM GSLGEQL ++ CLLDW+ARYRIAL
Sbjct: 846 ISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIAL 905
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
GAAEGLCYLH+DCRP I+HRDIKSNNILLDE FQAHVGDFGLAKLIDL YSKSMSA+AGS
Sbjct: 906 GAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGS 965
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030
YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK PVQ LE GGDLV WVRRSI M+PT
Sbjct: 966 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPT 1025
Query: 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSS 1090
E+FD RLD + KRTV EM+L LKIALFC+S SP +RPTMREV+AM+ +AR S S SS
Sbjct: 1026 IEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEARGSSSLSSSS 1085
Query: 1091 PTSETPLEADASSRD 1105
TSETPLE SS++
Sbjct: 1086 ITSETPLEEANSSKE 1100
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2725 (964.3 bits), Expect = 1.3e-283, P = 1.3e-283
Identities = 573/1112 (51%), Positives = 720/1112 (64%)
Query: 12 KLFYFALIFCFSNVSVTS--LTEEGVSLLEFK-ASLIDPSNNLESWNSSDMTPCNWIGVE 68
K + ++F + + TS L +G LLE K D N L +WN D TPCNWIGV
Sbjct: 13 KSMFVGVLFLLTLLVWTSESLNSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVN 72
Query: 69 CTD---------FKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANC 119
C+ VTS+DL +NLSGI+SP I L LV N++ N +TG IP ++ NC
Sbjct: 73 CSSQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNC 132
Query: 120 SSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNN 179
S LE++ L N+ G IP ++ ++ LR +C N + G +PEEIG+L +LEELV Y+NN
Sbjct: 133 SKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNN 192
Query: 180 LTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKL 239
LTG +P S+ L +L RAG N SG IP EI +C L++LGLAQN + G LP E+ L
Sbjct: 193 LTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGML 252
Query: 240 RNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNE 299
L ++ILWQN SG IP IGN+ SLE LAL+ NS G +P E+G + LKKLY+Y N+
Sbjct: 253 VKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQ 312
Query: 300 LNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQL 359
LNGTIP ELG + +EID SEN L+G IP EL I L LL LF+N L G IP EL +L
Sbjct: 313 LNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKL 372
Query: 360 TQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNN 419
L KLDLSIN+LTG IP FQNLT + LQLF N L G IP +G+ S L V+D S N
Sbjct: 373 RNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQ 432
Query: 420 LDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNL 479
L G IPP +C LI L+LGSNR+ GNIPPG+ C+SL+QL + N+LTG P E L
Sbjct: 433 LSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKL 492
Query: 480 QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNS 539
NLSA+EL QNRFSG +PPEIG + L+RLHL+ N F +P+E+ L +LVTFN+SSNS
Sbjct: 493 VNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNS 552
Query: 540 LSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599
L+G IP E+ NC LQRLDLSRN F GS P ELG L LE+L+LS+N+ +G IP ++G L
Sbjct: 553 LTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNL 612
Query: 600 ARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
LTELQMGGN+FSGSIP LG L++LQIA+N+S+N+ SG IP E+GNL +L L L++N
Sbjct: 613 THLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNN 672
Query: 660 QLIGEIPASMGEQMXXXXXXXXXXXXXGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQL 719
L GEIP + G +P+T +F+ + ++F GN+GLC G
Sbjct: 673 HLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLC--GGHLRSC 730
Query: 720 MPPSHT--PKKNWIKGGSTKEKXXXXXXXXXXXXXXXXXXXXCWAMKCRKPA--FVPLEE 775
PSH+ P + +K GS + + R P P
Sbjct: 731 -DPSHSSWPHISSLKAGSAR-RGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVH 788
Query: 776 QKNP--EVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKK 833
K P + D Y+ PKE F ++LEAT F + ++GRGACGTVYKA + +G+ IAVKK
Sbjct: 789 DKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKK 848
Query: 834 IKLRGEGAT-----ADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSNLLLYEYMENGS 886
++ EG DNSF AEI TLGKIRHRNIV+LY FCYHQ +SNLLLYEYM GS
Sbjct: 849 LESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGS 908
Query: 887 LGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH 946
LGE LHG K + DW R+ IALGAAEGL YLH+DC+P IIHRDIKSNNIL+DE F+AH
Sbjct: 909 LGELLHGGKSHSM-DWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAH 967
Query: 947 VGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
VGDFGLAK+ID+P SKS+SA+AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLEL+TGK+P
Sbjct: 968 VGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAP 1027
Query: 1007 VQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTV-EEMTLFLKIALFCSSTSPL 1065
VQ LE GGDL TW R I + TSE+ D L + M KIA+ C+ +SP
Sbjct: 1028 VQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPS 1087
Query: 1066 NRPTMREVIAMMIDARQSVSDYPSSPT-SETP 1096
+RPTMREV+ M+I++ + S T S+ P
Sbjct: 1088 DRPTMREVVLMLIESGERAGKVIVSTTCSDLP 1119
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2714 (960.4 bits), Expect = 1.9e-282, P = 1.9e-282
Identities = 569/1094 (52%), Positives = 712/1094 (65%)
Query: 13 LFYFALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDF 72
+F+ +L+ T L EG LLE K+ +D NL +WNS+D PC W GV C+++
Sbjct: 10 VFFISLLLILLISETTGLNLEGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNY 69
Query: 73 ----KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLC 128
+V S++L + LSG LSP I L L + ++S N ++G IP ++ NCSSLEIL L
Sbjct: 70 SSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLN 129
Query: 129 TNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI 188
N+ G IP ++ + +L L + N I G +P EIGNL SL +LV YSNN++G +P SI
Sbjct: 130 NNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSI 189
Query: 189 SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILW 248
L++L RAG N +SG +P EI CE L +LGLAQN L G LP E+ L+ L+ +ILW
Sbjct: 190 GNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILW 249
Query: 249 QNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL 308
+N SG IP I N SLE LAL++N G +PKELG L L+ LY+Y N LNGTIP E+
Sbjct: 250 ENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREI 309
Query: 309 GNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLS 368
GN + A+EID SEN LTG IP ELG I L LL LFEN L G+IP EL L L KLDLS
Sbjct: 310 GNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLS 369
Query: 369 INNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHL 428
IN LTG IPL FQ L L LQLF N L GTIPP +G S L VLD+S N+L G IP +L
Sbjct: 370 INALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYL 429
Query: 429 CMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488
C++ +I L+LG+N LSGNIP G+ TC++L+QL L +N L G P N++A+EL
Sbjct: 430 CLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELG 489
Query: 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHEL 548
QNRF G IP E+G L+RL L++N F G +P E+G L L T NISSN L+G +P E+
Sbjct: 490 QNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEI 549
Query: 549 GNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMG 608
NC LQRLD+ N F+G+ P E+G L LELLKLS+N L+G IP +LG L+RLTELQMG
Sbjct: 550 FNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMG 609
Query: 609 GNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPAS 668
GN+F+GSIP LG LT LQIALN+S+N L+G IP EL NL MLE L L++N L GEIP+S
Sbjct: 610 GNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSS 669
Query: 669 MGEQMXXXXXXXXXXXXXGTVPNTTVFRRIDSSNFAGNRGLCMLG-SDCHQLMP--PSHT 725
G +P + R I S+F GN GLC + C Q P PS +
Sbjct: 670 FANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQS 726
Query: 726 PKKNWIKGGSTKEKXXXXXXXXXXXXXXXXXXXXCWAMK--CRKPAFVPLEEQKNPEVID 783
K GG K + M+ R A + Q + +D
Sbjct: 727 TGK---PGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLD 783
Query: 784 NYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGAT- 842
Y+ PKEGF + +L+ AT NF E V+GRGACGTVYKA L G +AVKK+ EG
Sbjct: 784 IYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNN 843
Query: 843 --ADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLL 900
DNSF AEI TLG IRHRNIVKL+GFC HQ SNLLLYEYM GSLGE LH +C L
Sbjct: 844 NNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHD--PSCNL 901
Query: 901 DWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960
DW R++IALGAA+GL YLH+DC+P I HRDIKSNNILLD++F+AHVGDFGLAK+ID+P+
Sbjct: 902 DWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPH 961
Query: 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWV 1020
SKSMSAIAGSYGYIAPEYAYTMKVTEK DIYS+GVVLLEL+TGK+PVQ ++ GGD+V WV
Sbjct: 962 SKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWV 1021
Query: 1021 RRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080
R I +S + D RL L +R V M LKIAL C+S SP+ RP+MR+V+ M+I++
Sbjct: 1022 RSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIES 1081
Query: 1081 RQSVSDYPSSPTSE 1094
+S + T E
Sbjct: 1082 ERSEGEQEHLDTEE 1095
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1137 (405.3 bits), Expect = 5.2e-186, Sum P(2) = 5.2e-186
Identities = 258/658 (39%), Positives = 372/658 (56%)
Query: 14 FYFALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSN-NLESWNSSDMTPCN-WIGVECTD 71
F+F IFCFS E + +S PS+ +L +WNS D TPCN W + C+
Sbjct: 20 FFFIFIFCFSLSDAEQNPEASILYSWLHSSSPTPSSLSLFNWNSIDNTPCNNWTFITCSS 79
Query: 72 FK-VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTN 130
+T +D+ + L L + L + IS +TG++P L +C L++LDL +N
Sbjct: 80 QGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSN 139
Query: 131 RLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISK 190
L G IP+ L + L L L N + G+IP +I + L+ L+++ N LTG+IP + K
Sbjct: 140 GLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGK 199
Query: 191 LRQLRVIRAGHNS-LSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQ 249
L L VIR G N +SG IP EI +C L VLGLA+ S+ G LPS L KL+ L L ++
Sbjct: 200 LSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYT 259
Query: 250 NHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELG 309
+SGEIP +GN L L L+ENS SG +P+E+G+L++L++L+++ N L G IP E+G
Sbjct: 260 TMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIG 319
Query: 310 NCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSI 369
NC++ IDLS N L+G IP +G + L + +N GSIP + + L +L L
Sbjct: 320 NCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDK 379
Query: 370 NNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLC 429
N ++G IP E LT L + N LEG+IPP + + L LD+S N+L G+IP L
Sbjct: 380 NQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLF 439
Query: 430 MYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQ 489
M + L L L SN LSG IP + C SL++L LG N++TG +P +L+ ++ L+
Sbjct: 440 MLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSS 499
Query: 490 NRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELG 549
NR G +P EIG L+ + LS N G +P+ V +L L ++S+N SG IP LG
Sbjct: 500 NRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLG 559
Query: 550 NCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT-ELQMG 608
V+L +L LS+N F+GS P LG L+LL L N+L+G IPS LG + L L +
Sbjct: 560 RLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLS 619
Query: 609 GNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIP 666
N +G IP + L L I L++SHN L G + L N++ L +L + N G +P
Sbjct: 620 SNRLTGKIPSKIASLNKLSI-LDLSHNMLEGDLA-PLANIENLVSLNISYNSFSGYLP 675
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1076 (383.8 bits), Expect = 4.9e-181, Sum P(2) = 4.9e-181
Identities = 259/658 (39%), Positives = 362/658 (55%)
Query: 17 ALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSNNLES-WNSSDMTPCNWIGVECT--DFK 73
+L F S ++ T E +L+ + S P ++ S WN SD PC W + C+ D K
Sbjct: 23 SLFLAFFISSTSASTNEVSALISWLHSSNSPPPSVFSGWNPSDSDPCQWPYITCSSSDNK 82
Query: 74 -VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRL 132
VT +++ + L+ P I L + IS +TG+I +++ +CS L ++DL +N L
Sbjct: 83 LVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSL 142
Query: 133 HGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLR 192
G IP L + L++L L N + G+IP E+G+ SL+ L I+ N L+ +P + K+
Sbjct: 143 VGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKIS 202
Query: 193 QLRVIRAGHNS-LSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
L IRAG NS LSG IP EI C L+VLGLA + G LP L +L L L ++
Sbjct: 203 TLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTM 262
Query: 252 LSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNC 311
LSGEIP +GN L L L++N SG LPKELGKL L+K+ ++ N L+G IP E+G
Sbjct: 263 LSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFM 322
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINN 371
S IDLS N +G IP+ G + NL L L N + GSIP L T+L + + N
Sbjct: 323 KSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQ 382
Query: 372 LTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMY 431
++G IP E L L + N LEG IP + +L LD+S N L GS+P L
Sbjct: 383 ISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQL 442
Query: 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR 491
+ L L L SN +SG IP + C SL++L L N++TG +P LQNLS L+L +N
Sbjct: 443 RNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENN 502
Query: 492 FSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNC 551
SG +P EI R L+ L+LS N GY+P + +L L ++SSN L+G IP LG+
Sbjct: 503 LSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHL 562
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT-ELQMGGN 610
++L RL LS+N F G P LG NL+LL LS N ++G IP L + L L + N
Sbjct: 563 ISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWN 622
Query: 611 IFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPAS 668
G IP + L L + L+ISHN LSG + L L+ L +L + N+ G +P S
Sbjct: 623 SLDGFIPERISALNRLSV-LDISHNMLSGDLS-ALSGLENLVSLNISHNRFSGYLPDS 678
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1161 (413.8 bits), Expect = 3.9e-179, Sum P(2) = 3.9e-179
Identities = 260/664 (39%), Positives = 385/664 (57%)
Query: 14 FYFALIF---CFSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECT 70
F+ L+F F ++ S+ E+G++LL +K+ L + L SW +S+ PC W+G++C
Sbjct: 9 FFLFLLFHSSLFFSIPCFSIDEQGLALLSWKSQLNISGDALSSWKASESNPCQWVGIKCN 68
Query: 71 DF-KVTSVDLHGLNLSGIL-SPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLC 128
+ +V+ + L ++ G L + + + L +++ +TGSIP +L + S LE+LDL
Sbjct: 69 ERGQVSEIQLQVMDFQGPLPATNLRQIKSLTLLSLTSVNLTGSIPKELGDLSELEVLDLA 128
Query: 129 TNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI 188
N L G IP +F + L+ L L N + G IP E+GNL +L EL ++ N L G IP +I
Sbjct: 129 DNSLSGEIPVDIFKLKKLKILSLNTNNLEGVIPSELGNLVNLIELTLFDNKLAGEIPRTI 188
Query: 189 SKLRQLRVIRAGHN-SLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLIL 247
+L+ L + RAG N +L G +P EI CE L LGLA+ SL G LP+ + L+ + + L
Sbjct: 189 GELKNLEIFRAGGNKNLRGELPWEIGNCESLVTLGLAETSLSGRLPASIGNLKKVQTIAL 248
Query: 248 WQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHE 307
+ + LSG IP IGN L+ L L++NS SG +P +G+L +L+ L ++ N L G IP E
Sbjct: 249 YTSLLSGPIPDEIGNCTELQNLYLYQNSISGSIPVSMGRLKKLQSLLLWQNNLVGKIPTE 308
Query: 308 LGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDL 367
LG C +DLSEN LTG IPR G +PNL LQL N L G+IP EL T+L L++
Sbjct: 309 LGTCPELFLVDLSENLLTGNIPRSFGNLPNLQELQLSVNQLSGTIPEELANCTKLTHLEI 368
Query: 368 SINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPH 427
N ++G IP LT L + N L G IP + L +D+S NNL GSIP
Sbjct: 369 DNNQISGEIPPLIGKLTSLTMFFAWQNQLTGIIPESLSQCQELQAIDLSYNNLSGSIPNG 428
Query: 428 LCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALEL 487
+ + L L L SN LSG IPP + C +L +L L N+L G++P E NL+NL+ +++
Sbjct: 429 IFEIRNLTKLLLLSNYLSGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDI 488
Query: 488 YQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTF-NISSNSLSGTIPH 546
+NR G IPPEI +LE + L N G +P G L + F ++S NSL+G++P
Sbjct: 489 SENRLIGNIPPEISGCTSLEFVDLHSNGLTGGLP---GTLPKSLQFIDLSDNSLTGSLPT 545
Query: 547 ELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT-EL 605
+G+ L +L+L++N+F+G P E+ +L+LL L DN TG IP+ LG + L L
Sbjct: 546 GIGSLTELTKLNLAKNRFSGEIPREISSCRSLQLLNLGDNGFTGEIPNELGRIPSLAISL 605
Query: 606 QMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEI 665
+ N F+G IP LT L L++SHN L+G + L +LQ L +L + N+ GE+
Sbjct: 606 NLSCNHFTGEIPSRFSSLTNLG-TLDVSHNKLAGNLNV-LADLQNLVSLNISFNEFSGEL 663
Query: 666 PASM 669
P ++
Sbjct: 664 PNTL 667
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1080 (385.2 bits), Expect = 3.6e-176, Sum P(2) = 3.6e-176
Identities = 244/643 (37%), Positives = 360/643 (55%)
Query: 69 CTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLC 128
C+D V + + LN G + + L L N++ N +TG IP+ L S L+ L L
Sbjct: 214 CSDLTVFTAAENMLN--GTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLM 271
Query: 129 TNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI 188
N+L G+IP L + L+ L L N + GEIPEE N++ L +LV+ +N+L+G++P SI
Sbjct: 272 ANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSI 331
Query: 189 -SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLIL 247
S L + LSG IP E+S+C+ L+ L L+ NSL G +P L +L LTDL L
Sbjct: 332 CSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYL 391
Query: 248 WQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHE 307
N L G + P+I N+ +L+ L L+ N+ G LPKE+ L +L+ L++Y N +G IP E
Sbjct: 392 HNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQE 451
Query: 308 LGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDL 367
+GNCTS ID+ N G IP +G + L LL L +N L G +P LG QL+ LDL
Sbjct: 452 IGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDL 511
Query: 368 SINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPH 427
+ N L+G+IP F L L L L++N L+G +P + +L+ +++S N L+G+I P
Sbjct: 512 ADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHP- 570
Query: 428 LCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALEL 487
LC + + +N IP L ++L +L LG+NQLTG +P ++ LS L++
Sbjct: 571 LCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDM 630
Query: 488 YQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE 547
N +G IP ++ + L + L+ N+ G IP +G L L +SSN ++P E
Sbjct: 631 SSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTE 690
Query: 548 LGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQM 607
L NC L L L N GS P+E+G L L +L L N+ +G++P ++G L++L EL++
Sbjct: 691 LFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRL 750
Query: 608 GGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPA 667
N +G IPV +GQL LQ AL++S+NN +G IP +G L LE L L NQL GE+P
Sbjct: 751 SRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPG 810
Query: 668 SMGEQMXXXXXXXXXXXXXGTVPNTTVFRRIDSSNFAGNRGLC 710
S+G+ G + F R + +F GN GLC
Sbjct: 811 SVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLC 851
|
|
| TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1114 (397.2 bits), Expect = 4.5e-176, Sum P(2) = 4.5e-176
Identities = 257/661 (38%), Positives = 376/661 (56%)
Query: 12 KLFYFALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTD 71
+L +F+ + CF + SL ++G +LL +K+ L + SW+ +D +PCNW+GV+C
Sbjct: 7 RLSFFSSLLCFFFIPCFSLDQQGQALLSWKSQLNISGDAFSSWHVADTSPCNWVGVKCNR 66
Query: 72 F-KVTSVDLHGLNLSGILS-PRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCT 129
+V+ + L G++L G L + L L +S +TG IP ++ + + LE+LDL
Sbjct: 67 RGEVSEIQLKGMDLQGSLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSD 126
Query: 130 NRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASIS 189
N L G IP ++F + L+ L L N + G IP EIGNL+ L EL+++ N L+G IP SI
Sbjct: 127 NSLSGDIPVEIFRLKKLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIG 186
Query: 190 KLRQLRVIRAGHN-SLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILW 248
+L+ L+V+RAG N +L G +P EI CE L +LGLA+ SL G LP+ + L+ + + ++
Sbjct: 187 ELKNLQVLRAGGNKNLRGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIY 246
Query: 249 QNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL 308
+ LSG IP IG L+ L L++NS SG +P +G L +L+ L ++ N L G IP EL
Sbjct: 247 TSLLSGPIPDEIGYCTELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTEL 306
Query: 309 GNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLS 368
GNC ID SEN LTG IPR G + NL LQL N + G+IP EL T+L L++
Sbjct: 307 GNCPELWLIDFSENLLTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEID 366
Query: 369 INNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHL 428
N +TG IP NL L + N L G IP + L +D+S N+L GSIP +
Sbjct: 367 NNLITGEIPSLMSNLRSLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEI 426
Query: 429 CMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488
+ L L L SN LSG IPP + C +L +L L N+L GS+P E NL+NL+ +++
Sbjct: 427 FGLRNLTKLLLLSNDLSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDIS 486
Query: 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNL--EHLVTFNISSNSLSGTIPH 546
+NR G IPP I +LE L L N G S +G + L + S N+LS T+P
Sbjct: 487 ENRLVGSIPPAISGCESLEFLDLHTNSLSG---SLLGTTLPKSLKFIDFSDNALSSTLPP 543
Query: 547 ELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT-EL 605
+G L +L+L++N+ +G P E+ +L+LL L +N +G IP LG + L L
Sbjct: 544 GIGLLTELTKLNLAKNRLSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISL 603
Query: 606 QMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEI 665
+ N F G IP L L + L++SHN L+G + L +LQ L +L + N G++
Sbjct: 604 NLSCNRFVGEIPSRFSDLKNLGV-LDVSHNQLTGNLNV-LTDLQNLVSLNISYNDFSGDL 661
Query: 666 P 666
P
Sbjct: 662 P 662
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1054 (376.1 bits), Expect = 4.1e-175, Sum P(2) = 4.1e-175
Identities = 240/648 (37%), Positives = 362/648 (55%)
Query: 65 IGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEI 124
IG CT + + + LN G L + L L N+ N +G IP+ L + S++
Sbjct: 212 IG-NCTSLALFAAAFNRLN--GSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQY 268
Query: 125 LDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAI 184
L+L N+L G+IP +L + L+ L L N + G I EE + LE LV+ N L+G++
Sbjct: 269 LNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSL 328
Query: 185 PASI-SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLT 243
P +I S L+ + LSG IP EIS C+ L++L L+ N+L G +P L +L LT
Sbjct: 329 PKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELT 388
Query: 244 DLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGT 303
+L L N L G + +I N+ +L+ L+ N+ G +PKE+G L +L+ +Y+Y N +G
Sbjct: 389 NLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGE 448
Query: 304 IPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLH 363
+P E+GNCT EID N+L+G IP +G + +L L L EN L G+IP LG Q+
Sbjct: 449 MPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMT 508
Query: 364 KLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDG 422
+DL+ N L+G+IP F LT L +++N L+G +P + +N +L+ ++ S N +G
Sbjct: 509 VIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSL-INLKNLTRINFSSNKFNG 567
Query: 423 SIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNL 482
SI P LC + + N G+IP L +L +L LG+NQ TG +P F + L
Sbjct: 568 SISP-LCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISEL 626
Query: 483 SALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSG 542
S L++ +N SG+IP E+G + L + L+ NY G IP+ +G L L +SSN G
Sbjct: 627 SLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVG 686
Query: 543 TIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARL 602
++P E+ + N+ L L N GS P+E+G L L L L +N+L+G +PS++G L++L
Sbjct: 687 SLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKL 746
Query: 603 TELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLI 662
EL++ N +G IPV +GQL LQ AL++S+NN +G IP + L LE+L L NQL+
Sbjct: 747 FELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLV 806
Query: 663 GEIPASMGEQMXXXXXXXXXXXXXGTVPNTTVFRRIDSSNFAGNRGLC 710
GE+P +G+ G + F R + F GN GLC
Sbjct: 807 GEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLC 852
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1694 (601.4 bits), Expect = 2.3e-174, P = 2.3e-174
Identities = 393/1009 (38%), Positives = 554/1009 (54%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRL 132
K+ DL +L+G +SP + +L L + N++T IP++L N S+ L L N+L
Sbjct: 127 KLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKL 186
Query: 133 HGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLR 192
G IP L + L LYL ENY+ G IP E+GN+ S+ +L + N LTG+IP+++ L+
Sbjct: 187 TGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLK 246
Query: 193 QLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHL 252
L V+ N L+G IPPEI E + L L+QN L G +PS L L+NLT L L+QN+L
Sbjct: 247 NLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYL 306
Query: 253 SGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCT 312
+G IPP +GNI+S+ L L N +G +P LG L L LY+Y N L G IP ELGN
Sbjct: 307 TGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNME 366
Query: 313 SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNL 372
S +++ L+ N+LTG IP G + NL L L+ N L G IP+ELG + + LDLS N L
Sbjct: 367 SMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKL 426
Query: 373 TGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQ 432
TG++P F N T L L L NHL G IPP + +SHL+ L + NN G P +C +
Sbjct: 427 TGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGR 486
Query: 433 KLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRF 492
KL +SL N L G IP L+ C+SL++ N+ TG + F +L+ ++ N+F
Sbjct: 487 KLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKF 546
Query: 493 SGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCV 552
G I K L L +S N G IP+E+ N+ LV ++S+N+L G +P +GN
Sbjct: 547 HGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLT 606
Query: 553 NLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIF 612
NL RL L+ NQ +G P L L NLE L LS N + IP + +L ++ + N F
Sbjct: 607 NLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKF 666
Query: 613 SGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQ 672
GSIP L +LT L L++SHN L G IP +L +LQ L+ L L N L G IP +
Sbjct: 667 DGSIP-RLSKLTQLT-QLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGM 724
Query: 673 MXXXXXXXXXXXXXGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQLMPPSHTPKKNWIK 732
+ G +P+T FR+ + N GLC + Q + P KK
Sbjct: 725 IALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLC--SNIPKQRLKPCRELKKPKKN 782
Query: 733 GGSTKEKXXXXXXXXXXXXXXXXXXXXCWAMKCRKPAFVPLEEQKN--PEVIDNY-YFPK 789
G C ++ RK L+ +N PE +N F
Sbjct: 783 GNLVVWILVPILGVLVILSICANTFTYC--IRKRK-----LQNGRNTDPETGENMSIFSV 835
Query: 790 EG-FKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIK--LRGEGA--TAD 844
+G FKY +++E+T F +IG G VY+A L + +IAVK++ + E +
Sbjct: 836 DGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVK 894
Query: 845 NSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDA 904
FL E+ L +IRHRN+VKL+GFC H+ L+YEYME GSL + L +++ L W
Sbjct: 895 QEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTK 954
Query: 905 RYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964
R + G A L Y+H+D I+HRDI S NILLD ++ A + DFG AKL+ S +
Sbjct: 955 RINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTD-SSNW 1013
Query: 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSI 1024
SA+AG+YGY+APE+AYTMKVTEKCD+YSFGV++LELI GK P GDLV+ + S
Sbjct: 1014 SAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHP-------GDLVSSLSSSP 1066
Query: 1025 HEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
E + + D+R+ + E++ +++AL C +P +RPTM +
Sbjct: 1067 GEALSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSI 1115
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SHI2 | Y1723_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6867 | 0.9837 | 0.9909 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1109 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-162 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-19 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-11 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 5e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 504 bits (1299), Expect = e-162
Identities = 360/1096 (32%), Positives = 523/1096 (47%), Gaps = 153/1096 (13%)
Query: 9 HTQKLFYFALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVE 68
F L F F N S+ EE LL FK+S+ DP L +WNSS C W G+
Sbjct: 7 QHCPYLIFMLFFLFLNFSM-LHAEELELLLSFKSSINDPLKYLSNWNSSA-DVCLWQGIT 64
Query: 69 CTDF-KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDL-ANCSSLEILD 126
C + +V S+DL G N+SG +S I LP + N+S N ++G IP D+ SSL L+
Sbjct: 65 CNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLN 124
Query: 127 LCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPA 186
L N G IP I L L L N + GEIP +IG+ +SL+ L + N L G IP
Sbjct: 125 LSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 187 SISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLI 246
S++ L L E L LA N L G +P EL ++++L +
Sbjct: 183 SLTNLTSL------------------------EFLTLASNQLVGQIPRELGQMKSLKWIY 218
Query: 247 LWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPH 306
L N+LSGEIP IG + SL L L N+ +G +P LG L L+ L++Y N+L+G IP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 307 ELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLD 366
+ + + +DLS+N L+G IP + + NL +L LF N
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN-------------------- 318
Query: 367 LSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPP 426
N TG IP+ +L L LQL+ N G IP ++G +++L+VLD+S NNL G IP
Sbjct: 319 ----NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 427 HLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALE 486
LC L L L SN L G IP L CRSL ++ L N +G LP EF L + L+
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 487 LYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPH 546
+ N G I + +L+ L L+ N F G +P G+
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-------------------- 474
Query: 547 ELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQ 606
L+ LDLSRNQF+G+ P +LG L L LKLS+NKL+G IP L +L
Sbjct: 475 -----KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKL---- 525
Query: 607 MGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIP 666
++L++SHN LSG IP + +L L L NQL GEIP
Sbjct: 526 ---------------------VSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP 564
Query: 667 ASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQLMPPSHTP 726
++G SL+ N+S+N+L G++P+T F I++S AGN LC G D +PP
Sbjct: 565 KNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC--GGDTTSGLPPCKRV 622
Query: 727 KKN---WIKGGSTKEKLVSIISVIVGLISLSFIIGICWAMKCRKPAFVPLEEQKNPEVID 783
+K W T L + + + + FI G R + E ++ +
Sbjct: 623 RKTPSWWFYITCT---LGAFLVLALVAFGFVFIRG-------RNNLELKRVENED-GTWE 671
Query: 784 NYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGAT 842
+F + K + + + E VI RG G YK ++ NG VK+I
Sbjct: 672 LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN------D 725
Query: 843 ADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDW 902
++ +EI+ +GK++H NIVKL G C + L++EY+E +L E L L W
Sbjct: 726 VNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSW 779
Query: 903 DARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962
+ R +IA+G A+ L +LH C P ++ ++ I++D + + H+ L L+
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKC 838
Query: 963 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQ-SLELGGDLVTWVR 1021
+S+ Y+APE T +TEK DIY FG++L+EL+TGKSP + G +V W R
Sbjct: 839 FISS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR 893
Query: 1022 RSIHEMVPTSELFDKRLDLSAKRTV----EEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
+ D +D S + V E+ + +AL C++T P RP +V+ +
Sbjct: 894 YCYSDC-----HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
Query: 1078 IDARQSVSDYPSSPTS 1093
+S S SS +
Sbjct: 949 ----ESASRSSSSCVT 960
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 4e-50
Identities = 91/272 (33%), Positives = 130/272 (47%), Gaps = 20/272 (7%)
Query: 804 FSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+ +G G+ GTVYKA G+++AVK +K R E + D + EI L ++ H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
V+L +D L+ EY E G L + L + L + +A+ +IAL GL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAK-KIALQILRGLEYLH-- 115
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE-YAYT 981
IIHRD+K NILLDE + DFGLAK + S S++ G+ Y+APE
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSS-SLTTFVGTPWYMAPEVLLGG 173
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041
K D++S GV+L EL+TGK P + L +RR + + E
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL-IRRILGPPLEFDEPKWSSGSEE 232
Query: 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
AK +++ L P RPT E+
Sbjct: 233 AKDLIKKC---LN-------KDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 5e-47
Identities = 72/204 (35%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 804 FSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+ +G G+ G VY A G+++A+K IK + + L EI L K++H NI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-KIKKDRERILREIKILKKLKHPNI 59
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
V+LY +D L+ EY E G L + L K+ L + +AR+ L YLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARF-YLRQILSALEYLHSK 116
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
I+HRD+K NILLDE+ + DFGLA+ +D + ++ G+ Y+APE
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFVGTPEYMAPEVLLGK 171
Query: 983 KVTEKCDIYSFGVVLLELITGKSP 1006
+ DI+S GV+L EL+TGK P
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-46
Identities = 79/194 (40%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G G GTVY A G+ +A+K IK + L EI L K+ H NIVKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
++ L+ EY E GSL + L N+ L D RI L EGL YLH II
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLH---SNGII 114
Query: 929 HRDIKSNNILLDE-EFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE-YAYTMKVTE 986
HRD+K NILLD + + DFGL+KL+ S + I G+ Y+APE +E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSE 173
Query: 987 KCDIYSFGVVLLEL 1000
K DI+S GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 809 VIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKIRHRN 861
+G GA G VYK TL +AVK +K EGA+ + FL E S + K+ H N
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPN 62
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
IV+L G C + ++ EYM G L + L + + L ++AL A+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGMEYLE- 119
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL-PYSKSMSAIAGSYGYIAPEYAY 980
+ +HRD+ + N L+ E + DFGL++ I Y + ++APE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 981 TMKVTEKCDIYSFGVVLLELIT-GKSP 1006
K T K D++SFGV+L E+ T G+ P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 69/209 (33%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 809 VIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKIRHRN 861
+G GA G VYK L +AVK +K E A+ FL E + K+ H N
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHPN 62
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
+VKL G C ++ ++ EYME G L L N+ L AL A G+ YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE- 119
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS---YGYIAPEY 978
+ IHRD+ + N L+ E + DFGL++ + Y G ++APE
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL---YDDDYYRKRGGKLPIRWMAPES 174
Query: 979 AYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
K T K D++SFGV+L E+ T G+ P
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 2e-43
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 30/218 (13%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
++ G ++GRG+ G+VY A GE++AVK ++L G+ + EI L ++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 862 IVKLYGFCYHQDSN-LLLY-EYMENGSLGEQLHGNKQ----------TCLLDWDARYRIA 909
IV+ YG ++ N L ++ EY+ GSL L + +L
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL--------- 111
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIA 968
EGL YLH I+HRDIK NIL+D + + DFG AK + D+ + ++
Sbjct: 112 ----EGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164
Query: 969 GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
G+ ++APE + DI+S G ++E+ TGK P
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 7e-43
Identities = 72/211 (34%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 807 GAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKIRH 859
G +G GA G VYK TL +AVK +K E A+ FL E + K+ H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK---EDASEQQIEEFLREARIMRKLDH 60
Query: 860 RNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
NIVKL G C ++ +++ EYM G L + L N+ L AL A G+ YL
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYL 119
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI---AP 976
+ IHRD+ + N L+ E + DFGL++ + Y + G I AP
Sbjct: 120 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL---YDDDYYKVKGGKLPIRWMAP 173
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
E K T K D++SFGV+L E+ T G+ P
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 8e-43
Identities = 75/206 (36%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 804 FSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
F IG+G G VYKA G+ +A+K IKL E + EI L K +H NI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL--ESKEKKEKIINEIQILKKCKHPNI 59
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
VK YG Y + L ++ E+ GSL + L QT A Y + +GL YLH
Sbjct: 60 VKYYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA-Y-VCKELLKGLEYLH- 115
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK-LIDLPYSKSMSAIAGSYGYIAPEYAY 980
IIHRDIK+ NILL + + + DFGL+ L D +M G+ ++APE
Sbjct: 116 --SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVIN 170
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSP 1006
K DI+S G+ +EL GK P
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 74/290 (25%), Positives = 119/290 (41%), Gaps = 51/290 (17%)
Query: 809 VIGRGACGTVYKATL---ANGEVI-AVKKIKLRGEGATADN--SFLAEISTLGKIRHRNI 862
+G GA G VYK L AVK +K E A+ + FL E + K+ H N+
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEERKDFLKEARVMKKLGHPNV 58
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR------YRIALGAAEGL 916
V+L G C ++ L+ EYME G L + L ++ + A+ A+G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI-- 974
YL +HRD+ + N L+ E+ + DFGL++ + I
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL--PIRW 173
Query: 975 -APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032
APE T K D++SFGV+L E+ T G +P + + E
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP------------------YPGLSNEE 215
Query: 1033 LFDK-----RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
+ + RL + +E+ ++ L C P +RPT E++ +
Sbjct: 216 VLEYLRKGYRLPKP-EYCPDELY---ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 78/209 (37%), Positives = 110/209 (52%), Gaps = 16/209 (7%)
Query: 803 NFSEGAVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
N+ G +IGRGA G VYK L G+ +A+K+I L A S + EI L ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCLLDWDARY-RIALGAAEGLCY 918
IVK G DS ++ EY ENGSL + + G L+ A Y L +GL Y
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV---AVYVYQVL---QGLAY 114
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSAIAGSYGYIAPE 977
LH +IHRDIK+ NIL ++ + DFG+A KL D SK +++ G+ ++APE
Sbjct: 115 LH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLND--VSKDDASVVGTPYWMAPE 169
Query: 978 YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ DI+S G ++EL+TG P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-32
Identities = 86/302 (28%), Positives = 127/302 (42%), Gaps = 21/302 (6%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRH-R 860
++ +G G+ G VY A + +++A+K + + E + FL EI L + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
NIVKLY F + S L+ EY++ GSL + L + L I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 921 YDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKLIDLPYSKS-----MSAIAGSYGYI 974
IIHRDIK NILLD + + DFGLAKL+ P S S S G+ GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 975 APEYAYTM---KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031
APE + + DI+S G+ L EL+TG P + E + + I E+ S
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG-EKNSSATSQTLKIILELPTPS 234
Query: 1032 ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSSP 1091
+ L K + P NR + ++ + A + + S
Sbjct: 235 LASPLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290
Query: 1092 TS 1093
Sbjct: 291 LL 292
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 39/278 (14%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
IG+G+ G VY ++G++ +K+I L L E+ L K+ H NI+K Y
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 868 FCYHQDSNLLLYEYMENGSLGEQLHGNKQTC-------LLDWDARYRIALGAAEGLCYLH 920
+ ++ EY + G L +++ K+ +LDW + + L L YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKYLH 120
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEY 978
I+HRDIK NI L +GDFG++K++ + +K++ G+ Y++PE
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV---VGTPYYLSPEL 174
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038
K DI+S G VL EL T K P + L L + + + +P+ + L
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-LALKILKGQYPPIPSQ--YSSEL 231
Query: 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076
+ V + L P RP++ +++
Sbjct: 232 ----RNLVSSL-L---------QKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 20/213 (9%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
V+G+G+ G VYK G++ A+KKI + G+ L E+ TL +VK YG
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF-RKQLLRELKTLRSCESPYVVKCYG 66
Query: 868 FCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
Y + ++ EYM+ GSL + L K+ + IA +GL YLH HI
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHTK--RHI 121
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE------YAYT 981
IHRDIK +N+L++ + + + DFG++K+++ + + + G+ Y++PE Y+Y
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSY- 179
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQSLELGG 1014
DI+S G+ LLE GK P
Sbjct: 180 -----AADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 73/208 (35%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 807 GAVIGRGACGTVYKA-TLANGEVIAVKKIKL-RGEGATADNSFLAEISTLGKIRHRNIVK 864
G IG G G VY A L GE++AVK+I++ + T E+ L ++H N+VK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLVK 63
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR 924
YG H++ + EY G+L E L + +LD L EGL YLH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLH---S 117
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI---DLPYSKSMSAIAGSYGYIAPEYAYT 981
I+HRDIK NI LD +GDFG A + + + ++AG+ Y+APE
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 982 MKVTEK---CDIYSFGVVLLELITGKSP 1006
K DI+S G V+LE+ TGK P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 71/207 (34%), Positives = 105/207 (50%), Gaps = 26/207 (12%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G G G V+ T +AVK +K G + +FL E + K+RH +V+LY C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 870 YHQDSNLLLYEYMENGSLGEQLH---GNKQ--TCLLDWDARYRIALGAAEGLCYLHYDCR 924
++ ++ EYM GSL + L G K L+D +A AEG+ YL
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQIAEGMAYLE---S 121
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSA---IAGSYGYIAPEYAY 980
+ IHRD+ + NIL+ E + DFGLA+LI D Y+ A I + APE A
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK----WTAPEAAN 177
Query: 981 TMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ T K D++SFG++L E++T G+ P
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 71/208 (34%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 804 FSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+ IG GA G VYKAT A G+ +A+KK++LR + + EI + +H NI
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNI 77
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE---GLCY 918
V Y Y L ++ EYM+ GSL + + N +IA E GL Y
Sbjct: 78 VDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRM-----NEPQIAYVCREVLQGLEY 131
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
LH ++IHRDIKS+NILL ++ + DFG A + SK S + G+ ++APE
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEV 187
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
K DI+S G++ +E+ G+ P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
GA IG+G G V +V AVK +K + A +FLAE S + +RH N+V+L
Sbjct: 11 GATIGKGEFGDVMLGDYRGQKV-AVKCLK--DDSTAAQ-AFLAEASVMTTLRHPNLVQLL 66
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
G + ++ EYM GSL + L ++ ++ + AL EG+ YL +
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGMEYLE---EKN 122
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY--GYIAPEYAYTMKV 984
+HRD+ + N+L+ E+ A V DFGLAK S +G + APE K
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK------EASQGQDSGKLPVKWTAPEALREKKF 176
Query: 985 TEKCDIYSFGVVLLELIT-GKSP 1006
+ K D++SFG++L E+ + G+ P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
+G G+ G+VYKA G+V+A+K + + + + EIS L + IVK YG
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYG 65
Query: 868 FCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
Y ++++L ++ EY GS+ + + +T L + I +GL YLH
Sbjct: 66 -SYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLH---SNK 119
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
IHRDIK+ NILL+EE QA + DFG++ +L D + + G+ ++APE +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 986 EKCDIYSFGVVLLELITGKSP 1006
K DI+S G+ +E+ GK P
Sbjct: 178 NKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 74/256 (28%), Positives = 117/256 (45%), Gaps = 15/256 (5%)
Query: 810 IGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG+G+ G V+K A+ V A+K+I L + E L K+ I++ Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE- 66
Query: 869 CYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
+ L ++ EY ENG L + L + L + D +R + GL +LH I
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPE-DQVWRFFIQILLGLAHLH---SKKI 122
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEK 987
+HRDIKS N+ LD +GD G+AKL+ + + I G+ Y++PE EK
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNEK 181
Query: 988 CDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT------SELFDKRLDLS 1041
D+++ GVVL E TGK P + G L+ + R + V ++L D+ L
Sbjct: 182 SDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240
Query: 1042 AKRTVEEMTLFLKIAL 1057
++ + L +L
Sbjct: 241 YRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 809 VIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
VIG GA VY A L N E +A+K+I L + D E+ + + H N+VK Y
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-LRKEVQAMSQCNHPNVVKYYT 66
Query: 868 FCYHQDSNLLLYEYMENGSLGEQL-HGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
D L+ Y+ GSL + + + LD + +GL YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLH---SNG 122
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP---YSKSMSAIAGSYGYIAPE-----Y 978
IHRDIK+ NILL E+ + DFG++ + K G+ ++APE +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y K DI+SFG+ +EL TG +P
Sbjct: 183 GY----DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 69/211 (32%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 810 IGRGACGTVYKATLAN-----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864
+G G G V GE +AVK + GE + F EI L + H NIVK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRTLDHENIVK 70
Query: 865 LYGFCY--HQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
G C S L+ EY+ +GSL + L ++ L + + +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF--SSQICKGMDYLG-- 126
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI----DLPYSKSMSAIAGSYGYIAPEY 978
IHRD+ + NIL++ E + DFGLAK++ D Y K + Y APE
Sbjct: 127 -SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP-IFWY-APEC 183
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009
T K + D++SFGV L EL T P QS
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 9e-27
Identities = 71/215 (33%), Positives = 99/215 (46%), Gaps = 35/215 (16%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVK-----KIKLRGEGATADNSFLAEISTLGKIRHRNIV 863
+G+G+ G V G++ A+K KI R E L E + L +I H IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHT----LTERNILSRINHPFIV 56
Query: 864 KLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE---GLCY 918
KL+ + + + L L+ EY G L L +K+ + AR Y AAE L Y
Sbjct: 57 KLH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFY-----AAEIVLALEY 108
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
LH II+RD+K NILLD + + DFGLAK + G+ Y+APE
Sbjct: 109 LH---SLGIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEV 164
Query: 979 ----AYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009
Y V D +S GV+L E++TGK P +
Sbjct: 165 LLGKGYGKAV----DWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 809 VIGRGACGTVYKATLANG------EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+G GA G V+ + E++AVK +K A F E L +H NI
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENI 70
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQL--HG--------NKQTCL-LDWDARYRIALG 911
VK YG C D ++++EYME+G L + L HG L +IA+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS- 970
A G+ YL H +HRD+ + N L+ + +GDFG+++ + Y+ + G
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV---YTTDYYRVGGHT 184
Query: 971 ---YGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++ PE K T + D++SFGVVL E+ T GK P
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G G G V++ N +A+K +K + F E+ L ++RH++++ L+ C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILK--SDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIH 929
+ ++ E ME GSL L + + +L + +A AEG+ YL + IH
Sbjct: 72 SVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127
Query: 930 RDIKSNNILLDEEFQAHVGDFGLAKLIDLP-YSKSMSAIAGSYGYIAPEYAYTMKVTEKC 988
RD+ + NIL+ E+ V DFGLA+LI Y S I Y + APE A + K
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKS 185
Query: 989 DIYSFGVVLLELIT-GKSP 1006
D++SFG++L E+ T G+ P
Sbjct: 186 DVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 41/213 (19%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLR--GEGATADNSFLAEISTLGKIRHRNIVKLY 866
+G G G VYKA GE++A+KKI+L EG + + L EIS L +++H NIVKL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS--TALREISLLKELKHPNIVKLL 64
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE----------GL 916
+ + L++EY + L LD + L GL
Sbjct: 65 DVIHTERKLYLVFEYCDM-----DLKK-----YLD---KRPGPLSPNLIKSIMYQLLRGL 111
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
Y H I+HRD+K NIL++ + + DFGLA+ +P + + Y AP
Sbjct: 112 AYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW-YRAP 167
Query: 977 E-----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
E Y+ V DI+S G + E+ITGK
Sbjct: 168 EILLGSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
+G G G V K G+++AVK I+L A L E+ L K IV YG
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-QKQILRELDILHKCNSPYIVGFYG 66
Query: 868 FCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
Y+ + EYM+ GSL + L + + +IA+ +GL YLH I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGR--IPERILGKIAVAVLKGLTYLHEKH--KI 122
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTE 986
IHRD+K +NIL++ Q + DFG++ +L++ S + G+ Y+APE +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVN---SLAK-TFVGTSSYMAPERIQGNDYSV 178
Query: 987 KCDIYSFGVVLLELITGKSPV 1007
K DI+S G+ L+EL TG+ P
Sbjct: 179 KSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 68/231 (29%), Positives = 101/231 (43%), Gaps = 35/231 (15%)
Query: 797 LLEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLG 855
L + TG F VIG G G VYKA G+++A+K + + + + E + L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILR 57
Query: 856 KI-RHRNIVKLYGFCY-------HQDSNLLLYEYMENGS---LGEQLHGNKQTCLLDWDA 904
K H NI YG + + D L+ E GS L + L + +W A
Sbjct: 58 KYSNHPNIATFYG-AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 905 RYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964
Y I GL YLH +IHRDIK NILL + + + DFG++ +D +
Sbjct: 117 -Y-ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 965 SAIAGSYGYIAPE---------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ I Y ++APE +Y + D++S G+ +EL GK P
Sbjct: 172 TFIGTPY-WMAPEVIACDEQPDASYDA----RSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 9e-25
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVK---KIKLRGEGATADNSFLAEISTLGKI- 857
+F G +IG G+ TV A + A+K K +L E E L ++
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV--KYVKIEKEVLTRLN 59
Query: 858 RHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
H I+KLY + + + NL + EY NG L + + K L + R+ A L
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR--KYGSLDEKCTRFYAAE-ILLAL 115
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS--------------- 961
YLH IIHRD+K NILLD++ + DFG AK++D S
Sbjct: 116 EYLH-SKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 962 KSMSAIAGSY-G---YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ S+ G Y++PE + D+++ G ++ +++TGK P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 8/198 (4%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G G G V++ N +AVK +K G FLAE + K+RH +++LY C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIH 929
++ ++ E M+ GSL E L G L +A A G+ YL + IH
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLE---AQNYIH 126
Query: 930 RDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 989
RD+ + N+L+ E V DFGLA++I ++ + APE A + + K D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 990 IYSFGVVLLELIT-GKSP 1006
++SFG++L E++T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 72/205 (35%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G G VYKA +A GE++A+K IKL G + EIS L + RH NIV +G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE-PGDDFE-IIQQEISMLKECRHPNIVAYFG- 67
Query: 869 CYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE---GLCYLHYDCR 924
Y + L ++ EY GSL + + + +IA E GL YLH
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL-----SELQIAYVCRETLKGLAYLH---E 119
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA---YT 981
IHRDIK NILL E+ + DFG++ + +K S I Y ++APE A
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY-WMAPEVAAVERK 178
Query: 982 MKVTEKCDIYSFGVVLLELITGKSP 1006
KCDI++ G+ +EL + P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
IG+G+ GTV K ++G+++ K+I ++E++ L +++H NIV+ Y
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 868 FCYHQDSNLLLYEYME---NGSLGEQL--HGNKQTCLLDWDARYRIALGAAEGLCYLHY- 921
SN LY ME G L QL K+ ++ + +RI L H
Sbjct: 67 R-IIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 922 -DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSA--IAGSYGYIAPEY 978
D ++HRD+K NI LD +GDFGLAK++ S A G+ Y++PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG---HDSSFAKTYVGTPYYMSPEQ 181
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQ 1008
M EK DI+S G ++ EL P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G G VYKA GE++A+KKIKLR E + L EI L ++ H NI+KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
H+ L++E+M+ L + + ++ L +GL + H I+
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCH---SHGIL 120
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV-TEK 987
HRD+K N+L++ E + DFGLA+ P + + Y APE K +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-YRAPELLLGDKGYSTP 179
Query: 988 CDIYSFGVVLLELITGK 1004
DI+S G + EL++ +
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 90/291 (30%), Positives = 149/291 (51%), Gaps = 44/291 (15%)
Query: 803 NFSEGAVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFL--------AEIST 853
+ +G +IG+G G VY A + GE++AVK+++L A +S +EI T
Sbjct: 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 854 LGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCLLDWDARYRIALG 911
L + H NIV+ GF ++ + EY+ GS+G L +G + L+ + +
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL--- 118
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS-AIAGS 970
EGL YLH I+HRD+K++N+L+D + + DFG++K D Y + ++ GS
Sbjct: 119 --EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 971 YGYIAPE--YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028
++APE ++Y+ + K DI+S G V+LE+ G+ P E +I M
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-----------AIAAMF 222
Query: 1029 PTSELFDKRLDLSAKRTVEEMTLFL-KIAL-F---CSSTSPLNRPTMREVI 1074
+L +KR SA ++++ L +AL F C + +P NRPT RE++
Sbjct: 223 ---KLGNKR---SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
IG G G V+ +A+K I+ EGA ++ F+ E + K+ H +V+LYG C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIH 929
+ L++E+ME+G L + L + + + L EG+ YL +IH
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 930 RDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKC 988
RD+ + N L+ E V DFG+ + + D Y+ S + + +PE K + K
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 989 DIYSFGVVLLELIT-GKSP 1006
D++SFGV++ E+ + GK+P
Sbjct: 183 DVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 83/281 (29%), Positives = 129/281 (45%), Gaps = 43/281 (15%)
Query: 807 GAVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNS---FLAEISTLGKIRHRNI 862
G ++G G+ G+VY+ L +G+ AVK++ L +G T + EI+ L K++H NI
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCLLDWDARYRIALGAAEGLCYLH 920
V+ G +D+ + E + GSL + L +G+ ++ R + GL YLH
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH 119
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK-LIDLPYSKSMSAIAGSYGYIAPEY- 978
+ +HRDIK NIL+D + DFG+AK +++ ++KS GS ++APE
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK---GSPYWMAPEVI 173
Query: 979 ----AYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034
Y + DI+S G +LE+ TGK P LE + R +P
Sbjct: 174 AQQGGYGLAA----DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPD---- 225
Query: 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
LS E F+ L C P RPT E++
Sbjct: 226 ----HLSD-----EAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 78/283 (27%), Positives = 120/283 (42%), Gaps = 27/283 (9%)
Query: 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
E + +G GA G+V K L N +I K L E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 862 IVKLYGFCY-HQDSNL-LLYEYMENGSLGEQLHGN--KQTCLLDWDARYRIALGAAEGLC 917
IVK YG S++ + EY E GSL + ++ K+ + +IA +GL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
YLH IIHRDIK +NILL + Q + DFG++ +L S + + S+ Y+APE
Sbjct: 120 YLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSF-YMAPE 173
Query: 978 YAYTMKVTEKCDIYSFGVVLLELITGKSPV---QSLELGG-DLVTWVRRSIHEMVPTSEL 1033
+ D++S G+ LLE+ + P LG +L++++ P EL
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-----PNPEL 228
Query: 1034 FDKRLDLSAKRT-VEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
D + EE F+K L P RPT +++
Sbjct: 229 KD---EPGNGIKWSEEFKDFIKQCL---EKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 71/225 (31%), Positives = 98/225 (43%), Gaps = 54/225 (24%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSF----LAEISTLGKIRHRNIVK 864
IG G G VYKA GE++A+KKI++ E F + EI L K+RH NIV+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENE----KEGFPITAIREIKLLQKLRHPNIVR 62
Query: 865 LY--------GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAA--- 913
L G Y +++EYM++ L G LLD +
Sbjct: 63 LKEIVTSKGKGSIY------MVFEYMDH-----DLTG-----LLD-SPEVKFTESQIKCY 105
Query: 914 -----EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIA 968
EGL YLH I+HRDIK +NIL++ + + DFGLA+ S +
Sbjct: 106 MKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162
Query: 969 GSYGYIAPEY-----AYTMKVTEKCDIYSFGVVLLELITGKSPVQ 1008
+ Y PE Y +V D++S G +L EL GK Q
Sbjct: 163 ITLWYRPPELLLGATRYGPEV----DMWSVGCILAELFLGKPIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 803 NFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLA---EISTLGKIR 858
N+ G ++G+GA G VY + G +AVK++ + A EI L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 859 HRNIVKLYGFCYHQDSNLLLY-EYMENGSLGEQL--HGNKQTCLLDWDAR---YRIALGA 912
H IV+ YG C D L ++ EYM GS+ +QL +G L + R +I
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQIL--- 114
Query: 913 AEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS--MSAIAGS 970
EG+ YLH I+HRDIK NIL D +GDFG +K + S M ++ G+
Sbjct: 115 -EGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011
+++PE K D++S G ++E++T K P E
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 5e-23
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVI----AVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
V+G GA GTVYK + GE + A+K ++ A+ L E + + H +
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHPH 70
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEGLC 917
+V+L G C L+ + M G L + + +K LL+W + A+G+
Sbjct: 71 VVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMS 123
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY--GYIA 975
YL ++HRD+ + N+L+ + DFGLAKL+D K A G ++A
Sbjct: 124 YLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD-VDEKEYHAEGGKVPIKWMA 179
Query: 976 PEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
E T K D++S+GV + EL+T G P
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 70/206 (33%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-EISTLGKIRHRNIVKLY 866
IG+G+ G VYKA +V+A+K I L E A + + EI L + R I K Y
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDL--EEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 867 GFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
G + + S L ++ EY GS + L + LD I GL YLH + +
Sbjct: 66 G-SFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEEGK- 119
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
IHRDIK+ NILL EE + DFG++ + SK + G+ ++APE
Sbjct: 120 --IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-RNTFVGTPFWMAPEVIKQSGYD 176
Query: 986 EKCDIYSFGVVLLELITGKSPVQSLE 1011
EK DI+S G+ +EL G+ P+ L
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSDLH 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 7e-23
Identities = 90/282 (31%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 809 VIGRGACGTV--YKATLAN---GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIV 863
V+G G G V Y AN GE++AVK +K R G + + EI+ L + H NIV
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSGWKKEINILKTLYHENIV 69
Query: 864 KLYGFCYHQ--DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
K G C Q L+ EY+ GSL + L +K L+ A EG+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLH- 124
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI---DLPYSKSMSAIAGSYGYIAPEY 978
H IHRD+ + N+LLD + +GDFGLAK + Y + + Y A E
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQS-----LELGGDLVTWVRRSIHEMVPTSEL 1033
K + D++SFGV L EL+T QS E+ G ++ +V EL
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG-----PKQGQMTVVRLIEL 236
Query: 1034 FDKRLDLSA-KRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
++ + L K +E+ + +K C T RPT R +I
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKN---CWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G G G V+ +A+K I+ EGA +++ F+ E + K+ H N+V+LYG C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQT----CLLDWDARYRIALGAAEGLCYLHYDCRP 925
Q ++ EYM NG L L K LLD + E + YL +
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYLESNG-- 120
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAK-LIDLPYSKSMSA---IAGSYGYIAPEYAYT 981
IHRD+ + N L+ E+ V DFGLA+ ++D Y+ S + + PE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA----PPEVFDY 175
Query: 982 MKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ + K D++SFGV++ E+ + GK P
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLR-GEGATADNSFLAEISTLGKIRHR 860
+ IG GA G V+KA GE +A+KK+ LR EG N L EI L +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQACQHP 59
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+VKL H +L+ EYM L E L +++ L + + +G+ Y+H
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLR-DEERPLPEAQVK-SYMRMLLKGVAYMH 116
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
I+HRD+K N+L+ + + DFGLA+L + S + Y APE Y
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 981 -TMKVTEKCDIYSFGVVLLELITGKSP 1006
K D+++ G + EL+ G SP
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNG-SP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G+G+ G+VYK L++ + A+K++ L + EI L + H NI+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII----- 62
Query: 869 CYHQ---DSNLL--LYEYMENGSLGEQL-HGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
Y + D N L + EY G L + + K+ L+ +RI + GL LH
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH-- 120
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSA--IAGSYGYIAPEYAY 980
I+HRD+KS NILL +GD G++K++ K A G+ Y+APE
Sbjct: 121 -EQKILHRDLKSANILLVANDLVKIGDLGISKVL-----KKNMAKTQIGTPHYMAPEVWK 174
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040
+ K DI+S G +L E+ T P ++ + DL V+R + +P
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLRYKVQRGKYPPIPP---------- 223
Query: 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
+++ F++ P RP +++A
Sbjct: 224 ---IYSQDLQNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHRNIVKLYG 867
IG G+ G VY A + EV+A+KK+ G+ + + E+ L ++RH N ++ Y
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 868 FCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
CY ++ L+ EY GS + L +K+ L I GA +GL YLH R
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKKP--LQEVEIAAICHGALQGLAYLHSHER-- 136
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM---K 983
IHRDIK+ NILL E + DFG A L+ ++ G+ ++APE M +
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPYWMAPEVILAMDEGQ 190
Query: 984 VTEKCDIYSFGVVLLELITGKSP 1006
K D++S G+ +EL K P
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 4e-22
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADN----SFLAEISTLGKI 857
+ +G +G G VYKA G ++A+KKIKL GE A + + L EI L ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKL-GERKEAKDGINFTALREIKLLQEL 59
Query: 858 RHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
+H NI+ L + SN+ L++E+ME L E++ +K L D + L GL
Sbjct: 60 KHPNIIGLLD-VFGHKSNINLVFEFME-TDL-EKVIKDKSIVLTPADIK-SYMLMTLRGL 115
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
YLH I+HRD+K NN+L+ + + DFGLA+ P K M+ + Y AP
Sbjct: 116 EYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVVTRWYRAP 171
Query: 977 EYAY-TMKVTEKCDIYSFGVVLLELITGK 1004
E + D++S G + EL+
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G G G VY+ +AVK +K E FL E + + +I+H N+V+L G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
C + ++ E+M G+L + L + ++ +A + + YL + + I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE---KKNFI 126
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS---YGYIAPEYAYTMKVT 985
HRD+ + N L+ E V DFGL++L+ + +A AG+ + APE K +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 986 EKCDIYSFGVVLLELIT-GKSPVQSLEL 1012
K D+++FGV+L E+ T G SP ++L
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDL 211
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 25/206 (12%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G G G V+ +A+K +K +G+ + +FLAE + + +++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 870 YHQDSNLLLYEYMENGSL--------GEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
Q+ ++ EYMENGSL G +L NK L+D A+ AEG+ ++
Sbjct: 71 T-QEPIYIITEYMENGSLVDFLKTPEGIKLTINK---LIDMAAQ------IAEGMAFIE- 119
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
R + IHRD+++ NIL+ E + DFGLA+LI+ + + APE
Sbjct: 120 --RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177
Query: 982 MKVTEKCDIYSFGVVLLELIT-GKSP 1006
T K D++SFG++L E++T G+ P
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 8e-22
Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G+G G V+ T +A+K +K G + +FL E + K+RH +V+LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIH 929
++ ++ EYM GSL + L G L +A A G+ Y+ R + +H
Sbjct: 71 -SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVH 125
Query: 930 RDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 989
RD+++ NIL+ E V DFGLA+LI+ + + APE A + T K D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 990 IYSFGVVLLELIT-GKSP 1006
++SFG++L EL T G+ P
Sbjct: 186 VWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 71/220 (32%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 810 IGRGACGTVYKATLAN------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIV 863
+G GA G V+ A N ++AVK +K E A D AE+ T+ ++H++IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV--LQHQHIV 70
Query: 864 KLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCL----------LDWDARYRIALG 911
+ YG C L+++EYM +G L L HG L L IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS- 970
A G+ YL H +HRD+ + N L+ + +GDFG+++ I YS + G
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRVGGRT 184
Query: 971 ---YGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++ PE K T + DI+SFGVVL E+ T GK P
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 63/211 (29%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 810 IGRGACGTVYKA---TLANGE---VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIV 863
+G GA G VYK +A+K +K E F E + ++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-FRQEAELMSDLQHPNIV 71
Query: 864 KLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC-------------LLDWDARYRIAL 910
L G C + +L+EY+ +G L E L N LD IA+
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAG 969
A G+ YL H +HRD+ + N L+ E + DFGL++ I Y + S
Sbjct: 132 QIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 970 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLEL 1000
++ PE K T + DI+SFGVVL E+
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 809 VIGRGACGTVYKATLA-NGE---VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864
VIG G G V + L G+ +A+K +K G FL E S +G+ H NI++
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK-AGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR 924
L G +++ EYMENGSL + L N + G A G+ YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP---YSKSMSAIAGSYGYIAPEYAYT 981
+HRD+ + NIL++ V DFGL++ ++ Y+ I + APE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAY 182
Query: 982 MKVTEKCDIYSFGVVLLELIT-GKSP 1006
K T D++SFG+V+ E+++ G+ P
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKIRHRNIVKLYG 867
IG+G G VYK L +AVK + D FL E L + H NIVKL G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCR---STLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 868 FCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
C + ++ E + GSL L K L +++L AA G+ YL
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI-----APEYAYTM 982
IHRD+ + N L+ E + DFG+++ + + ++ I APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEE----GGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 983 KVTEKCDIYSFGVVLLELIT-GKSP 1006
+ T + D++S+G++L E + G +P
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTP 195
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-21
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 15/207 (7%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
G +IG G G V + G+ +AVK IK TA +FL E + + K+ H+N+V+L
Sbjct: 11 GEIIGEGEFGAVLQGEYT-GQKVAVKNIKC---DVTA-QAFLEETAVMTKLHHKNLVRLL 65
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
G H +++ E M G+L L + L+ + +L AEG+ YL
Sbjct: 66 GVILHNGLYIVM-ELMSKGNLVNFLR-TRGRALVSVIQLLQFSLDVAEGMEYLE---SKK 120
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTE 986
++HRD+ + NIL+ E+ A V DFGLA++ + S + + APE K +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKHKKFSS 176
Query: 987 KCDIYSFGVVLLELIT-GKSPVQSLEL 1012
K D++S+GV+L E+ + G++P + L
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMSL 203
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 76/267 (28%), Positives = 118/267 (44%), Gaps = 28/267 (10%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G G G V+ +A+K I EGA ++ F+ E + K+ H +V+LYG C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIH 929
Q ++ E+MENG L L + L D + EG+ YL R IH
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGK--LSKDMLLSMCQDVCEGMEYLE---RNSFIH 123
Query: 930 RDIKSNNILLDEEFQAHVGDFGLAK-LIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKC 988
RD+ + N L+ V DFG+ + ++D Y+ S A + PE K + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA-KFPVKWSPPEVFNFSKYSSKS 182
Query: 989 DIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVE 1047
D++SFGV++ E+ T GK P + + ++V + R L+ +L A TV
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRG-------FRLYRPKL---ASMTVY 231
Query: 1048 EMTLFLKIALFCSSTSPLNRPTMREVI 1074
E + C P RPT E++
Sbjct: 232 E------VMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 74/224 (33%), Positives = 105/224 (46%), Gaps = 31/224 (13%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G G VY+A +GE++A+KK+++ E S L EI+ L +RH NIV+L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 869 CY--HQDSNLLLYEYMENGSLGEQLHGNKQT-------CLLDWDARYRIALGAAEGLCYL 919
H DS L+ EY E L L C + L GL YL
Sbjct: 75 VVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKC---------LMLQLLRGLQYL 124
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA 979
H + IIHRD+K +N+LL ++ + DFGLA+ LP K M+ + Y APE
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVVTLWYRAPELL 180
Query: 980 YTMKV-TEKCDIYSFGVVLLELIT------GKSPVQSLELGGDL 1016
T D+++ G +L EL+ GKS ++ L+L L
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 810 IGRGACGTVYKATL------ANGEV-IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+G GA G VY+ T +G + +AVK ++ +G FL E + H NI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR-KGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNK----QTCLLDWDARYRIALGAAEGLCY 918
VKL G C + ++ E ME G L L + LL I L A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQA-----HVGDFGLAKLIDLPYSKSMSAIAGS--- 970
L + H IHRD+ + N L+ E+ +GDFGLA+ I Y G
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI---YKSDYYRKEGEGLL 175
Query: 971 -YGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++APE K T + D++SFGV++ E++T G+ P
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-21
Identities = 70/226 (30%), Positives = 110/226 (48%), Gaps = 27/226 (11%)
Query: 809 VIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG+G G V G +AVK IK ATA +FLAE S + ++RH N+V+L G
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIK---NDATA-QAFLAEASVMTQLRHSNLVQLLGV 67
Query: 869 CYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
+ L ++ EYM GSL + L ++ +L D + +L E + YL + +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEK 987
+HRD+ + N+L+ E+ A V DFGL K S + + APE K + K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 988 CDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032
D++SFG++L E+ + G+ P + R + ++VP E
Sbjct: 180 SDVWSFGILLWEIYSFGRVP------------YPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 15/217 (6%)
Query: 804 FSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATAD----NSFLAEISTLGKIRH 859
+++G V+G+GA GTVY G++IAVK+++L A E+ L ++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 860 RNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
NIV+ G C ++ + E++ GS+ L N+ L + + +G+ YL
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFC-KYTKQILDGVAYL 118
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-----DLPYSKSMSAIAGSYGYI 974
H +C ++HRDIK NN++L + DFG A+ + +S + ++ G+ ++
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011
APE K DI+S G + E+ TGK P+ S++
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 69/216 (31%), Positives = 115/216 (53%), Gaps = 23/216 (10%)
Query: 806 EGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATAD-------NSFLAEISTLGKI 857
+GA+IG G+ G+VY A +GE++AVK+++L A++ ++ EI+ L ++
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCLLDWDARYRIALGAAEG 915
+H NIV+ G D + EY+ GS+ L +G + L+ R + +G
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-----KG 118
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL-----PYSKSMSAIAGS 970
L YLH IIHRDIK NIL+D + + DFG++K ++ + + ++ GS
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
++APE T K DI+S G +++E++TGK P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 73/288 (25%), Positives = 115/288 (39%), Gaps = 42/288 (14%)
Query: 810 IGRGACGTVYKATLAN---GEVIAVKKIKLRGEGATAD--NSFLAEISTLGKIRHRNIVK 864
+G+G+ G VY+ GE IK E A+ FL E S + + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHG----NKQTCLLDWDARYRIALGAAE---GLC 917
L G L++ E M G L L + L + AAE G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI---DL--PYSKSMSAIAGSYG 972
YL +HRD+ + N ++ E+ +GDFG+ + I D K + +
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031
++APE T K D++SFGVVL E+ T + P Q L +E V
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-------------NEEVLKF 233
Query: 1032 ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079
+ LDL + L++ C +P RPT E+++ + D
Sbjct: 234 VIDGGHLDLP--ENCPDK--LLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVK---KIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864
VIG+GA G V ++ A+K K K +G+ + L E L ++ H +V
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSV--RNVLNERRILQELNHPFLVN 64
Query: 865 L-YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIA-LGAAEGLCYLHYD 922
L Y F ++ L++ + + G L + H +++ + ++ I + A L YLH
Sbjct: 65 LWYSFQDEENMYLVV-DLLLGGDL--RYHLSQKVKFSEEQVKFWICEIVLA--LEYLH-- 117
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
IIHRDIK +NILLDE+ H+ DF +A + ++ +G+ GY+APE
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIA--TKVTPDTLTTSTSGTPGYMAPEVLCRQ 174
Query: 983 KVTEKCDIYSFGVVLLELITGKSP 1006
+ D +S GV E + GK P
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-20
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G G G V+ N +AVK +K G + +FL E + + ++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQT-----CLLDWDARYRIALGAAEGLCYLHYDCR 924
++ ++ EYM GSL + L ++ L+D+ A+ AEG+ Y+ R
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIE---R 121
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV 984
+ IHRD+++ N+L+ E + DFGLA++I+ + + APE
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 985 TEKCDIYSFGVVLLELIT-GKSP 1006
T K D++SFG++L E++T GK P
Sbjct: 182 TIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 6e-20
Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 32/221 (14%)
Query: 810 IGRGACGTVYKATLAN------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIV 863
+G GA G V+ A N ++AVK +K A D F E L ++H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIV 70
Query: 864 KLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCLLDWDAR-----------YRIAL 910
K YG C D ++++EYM++G L + L HG L+D R IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAG- 969
A G+ YL H +HRD+ + N L+ +GDFG+++ + YS + G
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDYYRVGGH 184
Query: 970 ---SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++ PE K T + D++SFGV+L E+ T GK P
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-20
Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNS---FLAEISTLGKIRH---RN 861
+IGRGA G VY+ + G V+A+K I L T D+ E++ L ++R N
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 862 IVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
I K YG Y + L ++ EY E GS+ + K + +Y I++ E L L
Sbjct: 64 ITKYYG-SYLKGPRLWIIMEYAEGGSVRTLM---KAGPI---AEKY-ISVIIREVLVALK 115
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY-- 978
Y + +IHRDIK+ NIL+ + DFG+A L++ SK S G+ ++APE
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFVGTPYWMAPEVIT 174
Query: 979 ---AYTMKVTEKCDIYSFGVVLLELITGKSPVQSLEL 1012
Y K DI+S G+ + E+ TG P ++
Sbjct: 175 EGKYYDTKA----DIWSLGITIYEMATGNPPYSDVDA 207
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 7e-20
Identities = 66/184 (35%), Positives = 95/184 (51%), Gaps = 17/184 (9%)
Query: 826 GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS-NL-LLYEYME 883
GEV+AVKK++ D F EI L ++H NIVK G CY NL L+ EY+
Sbjct: 33 GEVVAVKKLQHSTAEHLRD--FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 884 NGSLGEQLHGNKQTCLLDWDARYRIALGAAE---GLCYLHYDCRPHIIHRDIKSNNILLD 940
GSL + L +++ D R ++ L A++ G+ YL +HRD+ + NIL++
Sbjct: 91 YGSLRDYLQKHRERL----DHR-KLLLYASQICKGMEYLG---SKRYVHRDLATRNILVE 142
Query: 941 EEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLL 998
E + +GDFGL K++ D Y K + APE K + D++SFGVVL
Sbjct: 143 SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202
Query: 999 ELIT 1002
EL T
Sbjct: 203 ELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G G G V+ T +AVK +K G + SFL E + K+RH +V+LY
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY-------RIALGAAEGLCYLHYD 922
++ ++ EYM GSL + L D + R +A A G+ Y+
Sbjct: 71 -SEEPIYIVTEYMSKGSLLDFLK--------DGEGRALKLPNLVDMAAQVAAGMAYIE-- 119
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
R + IHRD++S NIL+ + + DFGLA+LI+ + + APE A
Sbjct: 120 -RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 983 KVTEKCDIYSFGVVLLELIT-GKSP 1006
+ T K D++SFG++L EL+T G+ P
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-20
Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 16/218 (7%)
Query: 803 NFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKL---RGEGATADNSFLAEISTLGKIR 858
N+ G ++GRGA G VY A+ G +AVK++ E + N+ EI L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 859 HRNIVKLYGFCY--HQDSNLLLY-EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEG 915
H IV+ YG C ++ L ++ EYM GS+ +QL K L + R +G
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQG 118
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY--SKSMSAIAGSYGY 973
+ YLH + I+HRDIK NIL D +GDFG +K I + ++ G+ +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 974 IAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011
++PE K D++S ++E++T K P E
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 73/220 (33%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 800 ATGNFSE---GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLG 855
A + SE IG GA GTVYK G + A+K I E EI L
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR-RQICREIEILR 127
Query: 856 KIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEG 915
+ H N+VK + H +L E+M+ GSL E H + L D +A G
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTHIADEQFLAD------VARQILSG 180
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG----LAKLIDLPYSKSMSAIAGSY 971
+ YLH R HI+HRDIK +N+L++ + DFG LA+ +D P + S+ IA
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSVGTIA--- 233
Query: 972 GYIAPEYAYT-----MKVTEKCDIYSFGVVLLELITGKSP 1006
Y++PE T DI+S GV +LE G+ P
Sbjct: 234 -YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 810 IGRGACGTVYKATLAN------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIV 863
+G GA G V+ A N ++AVK +K + A D F E L ++H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--FHREAELLTNLQHEHIV 70
Query: 864 KLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCL--------LDWDARYRIALGAA 913
K YG C D ++++EYM++G L + L HG + L IA A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAG---- 969
G+ YL H +HRD+ + N L+ E +GDFG+++ + YS + G
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV---YSTDYYRVGGHTML 184
Query: 970 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++ PE K T + D++S GVVL E+ T GK P
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 65/216 (30%), Positives = 111/216 (51%), Gaps = 21/216 (9%)
Query: 802 GNFSEGAVIGRGACGTVYKATL---ANGEV-IAVKKIKLRGEGATADNSFLAEISTLGKI 857
+ ++ VIG G G V++ L EV +A+K +K G FL+E S +G+
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQRQDFLSEASIMGQF 63
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL--GAAEG 915
H NI++L G +++ EYMENG+L + L + ++ + + + G A G
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAG 119
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLP---YSKSMSAIAGSY 971
+ YL + +HRD+ + NIL++ + V DFGL++++ D P Y+ S I
Sbjct: 120 MKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PI 174
Query: 972 GYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ APE K T D++SFG+V+ E+++ G+ P
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 810 IGRGACGTVYKATL--ANGEVI--AVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
+G G+ G V + + G+VI AVK +K + + + FL E + + + H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLK-SDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQ-----TCLLDWDARYRIALGAAEGLCYLH 920
YG +++ E GSL ++L + + L D+ A+ A G+ YL
Sbjct: 62 YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMRYLE 114
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP--YSKSMSAIAGSYGYIAPEY 978
IHRD+ + NILL + + +GDFGL + + + + + + APE
Sbjct: 115 ---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 979 AYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
T + D++ FGV L E+ T G+ P
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 56/204 (27%), Positives = 108/204 (52%), Gaps = 8/204 (3%)
Query: 803 NFSEGAVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
NF + +G G TVYK GE++A+K+I L E T + + EIS + +++H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-IREISLMKELKHEN 59
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
IV+L+ + ++ +L++EYM+ L + + + LD + +G+ + H
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
+ ++HRD+K N+L+++ + + DFGLA+ +P + + + + Y AP+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW-YRAPDVLLG 174
Query: 982 MKV-TEKCDIYSFGVVLLELITGK 1004
+ + DI+S G ++ E+ITG+
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIK---LRGEGATADNSFLAEISTLGKIRHRNIVKL 865
I +GA G V+ A + G++ A+K IK + + + L E L + + +VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQV--DQVLTERDILSQAQSPYVVKL 58
Query: 866 YGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR 924
Y + + NL L+ EY+ G L L L + AR IA L YLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIA-EIVLALEYLH---S 111
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-------DLPYSKSMSAIAGSYGYIAPE 977
IIHRD+K +NIL+D + DFGL+K+ K I G+ YIAPE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 978 YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
++ D +S G +L E + G P
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G G G V +A+K IK EG+ +++ F+ E + K+ H +V+LYG C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 870 YHQDSNLLLYEYMENGS----LGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
Q ++ EYM NG L E + + LL+ + EG+ YL
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE------MCKDVCEGMAYLE---SK 119
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAK-LIDLPYSKSMSAIAGSYGYIAPEYAYTMKV 984
IHRD+ + N L+D++ V DFGL++ ++D Y+ S+ + + PE K
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLLYSKF 178
Query: 985 TEKCDIYSFGVVLLELIT-GKSP 1006
+ K D+++FGV++ E+ + GK P
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-19
Identities = 40/82 (48%), Positives = 57/82 (69%)
Query: 518 GYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVN 577
G+IP+++ L HL + N+S NS+ G IP LG+ +L+ LDLS N F GS PE LGQL +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 578 LELLKLSDNKLTGAIPSSLGGL 599
L +L L+ N L+G +P++LGG
Sbjct: 492 LRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 60/216 (27%), Positives = 88/216 (40%), Gaps = 38/216 (17%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKKIKLRGEGAT-ADNSFLAEISTLGKIRHRNIVKLYG 867
+G G G V + + A+K +K R T +E L + H IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 868 FCYHQDSNLL--LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
+D + L EY G L L ++ AR+ IA YLH
Sbjct: 60 -RTFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIA-CVVLAFEYLH---NR 112
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS------AIAGSYGYIAPE-- 977
II+RD+K N+LLD G KL+D ++K + G+ Y+APE
Sbjct: 113 GIIYRDLKPENLLLDSN--------GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEII 164
Query: 978 ----YAYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009
Y ++ D +S G++L EL+TG+ P
Sbjct: 165 LNKGYDFS------VDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 9e-19
Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 810 IGRGACGTVYKAT---LANGE---VIAVKKIKLRGEGATAD--NSFLAEISTLGKIRHRN 861
IG+GA G V++A L E ++AVK +K E A+AD F E + + + H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGN--KQTC-LLDWDARYR----------- 907
IVKL G C LL+EYM G L E L + C L + R
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 908 -----IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP-YS 961
IA A G+ YL +HRD+ + N L+ E + DFGL++ I Y
Sbjct: 130 TEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT 1002
K+ A ++ PE + + T + D++++GVVL E+ +
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 76/285 (26%), Positives = 132/285 (46%), Gaps = 54/285 (18%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G G G V+ AT +AVK +K G+ + +FLAE + + ++H +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 870 YHQDSNLLLYEYMENGSLGEQL---HGNKQTC--LLDWDARYRIALGAAEGLCYLHYDCR 924
++ ++ E+M GSL + L G+KQ L+D+ A+ AEG+ ++ +
Sbjct: 71 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIE---Q 120
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV 984
+ IHRD+++ NIL+ + DFGLA++I+ + + APE
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 985 TEKCDIYSFGVVLLELIT-GKSP---------VQSLELGGDLVTWVRRSIHEMVPTSELF 1034
T K D++SFG++L+E++T G+ P +++LE G R E P EL+
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG------YRMPRPENCP-EELY 233
Query: 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079
+ I + C P RPT + +++ D
Sbjct: 234 N-------------------IMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKL----RGEGATADNSFLAEISTLGKI 857
+ +G +G GA + Y+A + G ++AVK++ E + EI + ++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLH--GNKQTCLLDWDARYRIALGAAEG 915
H +I+++ G L E+M GS+ L G + ++ G
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRG 115
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQ-AHVGDFGLAKLIDLPYSKS---MSAIAGSY 971
L YLH + IIHRD+K N+L+D Q + DFG A + + + + G+
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 972 GYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
++APE + CD++S G V++E+ T K P
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 1e-18
Identities = 76/268 (28%), Positives = 132/268 (49%), Gaps = 22/268 (8%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG+GA GTV+ A +A G+ +A+K+I L+ + + EI + ++++ NIV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDS 84
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
D ++ EY+ GSL + + +TC+ +IA E L L + +I
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV---TETCM----DEAQIAAVCRECLQALEFLHANQVI 137
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKC 988
HRDIKS+N+LL + + DFG I P S + G+ ++APE K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 989 DIYSFGVVLLELITG------KSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR---LD 1039
DI+S G++ +E++ G ++P+++L L T ++ ++ P F R +D
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256
Query: 1040 LSAKRTVEEMTL--FLKIALFCSSTSPL 1065
+ + + +E+ FLK+A SS +PL
Sbjct: 257 VEKRGSAKELLQHPFLKLAKPLSSLTPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 78/286 (27%), Positives = 134/286 (46%), Gaps = 40/286 (13%)
Query: 810 IGRGACGTVYKATLANG--EVIAVKKIKLR----GEGA-TADNSF---LAEISTLGK-IR 858
+G GA G VYK N ++A+K+I + G+ D S ++E++ + + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQ---LHGNKQTCLLD--WDARYRIALGAA 913
H NIV+ Y D ++ + +E LGE L KQ + W+ ++ L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGY 973
L YLH + R I+HRD+ NNI+L E+ + + DFGLAK P SK ++++ G+ Y
Sbjct: 126 --LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESK-LTSVVGTILY 179
Query: 974 IAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033
PE EK D+++FG +L ++ T + P S + L T + +++E +P +
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-LSLATKIVEAVYEPLP-EGM 237
Query: 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079
+ + + C + RP + +V AM+ D
Sbjct: 238 YSEDVTDVITS--------------CLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 10/206 (4%)
Query: 803 NFSEGAVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
NF + IG G G VYKA GEV+A+KKI+L E ++ + EIS L ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCL-LDWDARYRIALGAAEGLCYLH 920
IVKL + ++ L++E++ + L + + + + + L Y L C+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
++HRD+K N+L++ E + DFGLA+ +P ++ + + Y APE
Sbjct: 120 -----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILL 173
Query: 981 TMKV-TEKCDIYSFGVVLLELITGKS 1005
K + DI+S G + E++T ++
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 23/205 (11%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G+G G V+ T +A+K +K G +FL E + K+RH +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY-------RIALGAAEGLCYLHYD 922
++ ++ E+M GSL + L + D +Y +A A+G+ Y+
Sbjct: 71 -SEEPIYIVTEFMGKGSLLDFLK--------EGDGKYLKLPQLVDMAAQIADGMAYIE-- 119
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
R + IHRD+++ NIL+ + + DFGLA+LI+ + + APE A
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 983 KVTEKCDIYSFGVVLLELIT-GKSP 1006
+ T K D++SFG++L EL+T G+ P
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 809 VIGRGACG--TVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
V+G+GA G T+Y+ T + V+ K++ L L EI L ++H NI+ Y
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVV-WKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 867 GFCYHQDSNLLL--YEYMENGSLGEQLHGNKQTCLLDWDARYRIAL--GAAEGLCYLHYD 922
+ D N LL EY G+L +++ K + + + Y+H
Sbjct: 66 N--HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF---EEEMVLWYLFQIVSAVSYIH-- 118
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
+ I+HRDIK+ NI L + +GDFG++K++ YS + + + Y Y++PE +
Sbjct: 119 -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY-YMSPELCQGV 176
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP---TSELFDKRLD 1039
K K DI++ G VL EL+T K + +LV + + + V +SEL
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNP-LNLVVKIVQGNYTPVVSVYSSEL------ 229
Query: 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078
V P RPT EV+ +
Sbjct: 230 ---ISLVHS----------LLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 75/295 (25%), Positives = 122/295 (41%), Gaps = 53/295 (17%)
Query: 807 GAVIGRGACGTVYKATL------ANGEVIAVKKIKL-RGEGATADNSFLAEISTLGKI-R 858
G +G GA G V KA +AVK +K E +D ++E+ + I +
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD--LVSEMEMMKMIGK 74
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNK---QTCLLDWDARYR-------- 907
H+NI+ L G C + ++ EY +G+L + L + + D
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 908 --IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSM 964
A A G+ +L IHRD+ + N+L+ E+ + DFGLA+ I + Y +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSI 1024
+ ++APE + T + D++SFGV+L E+ T LGG S
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---------LGG--------SP 234
Query: 1025 HEMVPTSELFD-----KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
+ +P ELF R++ T E L C P RPT ++++
Sbjct: 235 YPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRD----CWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 78/239 (32%), Positives = 117/239 (48%), Gaps = 32/239 (13%)
Query: 777 KNPEVIDNYYF--PKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLAN-GEVIAVKK 833
K+PE+ D +Y P+E F L E IG G+ G VY AT ++ EV+AVKK
Sbjct: 6 KDPEIADLFYKDDPEEIFV--GLHE----------IGHGSFGAVYFATNSHTNEVVAVKK 53
Query: 834 IKLRGEGATAD-NSFLAEISTLGKIRHRNIVKLYGFCYHQD-SNLLLYEYMENGSLGEQL 891
+ G+ + E+ L +++H N ++ G CY ++ + L+ EY GS + L
Sbjct: 54 MSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG-CYLKEHTAWLVMEYCL-GSASDLL 111
Query: 892 HGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951
+K+ L I GA +GL YLH +IHRDIK+ NILL E Q + DFG
Sbjct: 112 EVHKKP--LQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG 166
Query: 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTE---KCDIYSFGVVLLELITGKSPV 1007
A S ++ G+ ++APE M + K D++S G+ +EL K P+
Sbjct: 167 SASK-----SSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 67/291 (23%), Positives = 126/291 (43%), Gaps = 35/291 (12%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGE------VIAVKKIKLRGEGATADNSFLAEISTLGK 856
N E +GRG G V+ A E ++ VK ++ + + F E+ K
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRK 64
Query: 857 IRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCL------LDWDARYRIAL 910
+ H+N+V+L G C + + ++ EY + G L + L K L + +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK-LIDLPYSKSMSAIAG 969
A G+ +L +HRD+ + N L+ + + V L+K + + Y K +A+
Sbjct: 125 QIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI- 180
Query: 970 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMV 1028
++APE + K D++SFGV++ E+ T G+ P L S E++
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL------------SDEEVL 228
Query: 1029 PTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079
+ L +L+L L+ K+ C + +P +RP+ E+++ + +
Sbjct: 229 --NRLQAGKLELPVPEGCPS-RLY-KLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-18
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 804 FSEGAVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHRN 861
FS+ IG G+ G VY A + N EV+A+KK+ G+ + + E+ L K+RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
++ G + + L+ EY GS + L +K+ L + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH- 132
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
++IHRD+K+ NILL E +GDFG A ++ + G+ ++APE
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILA 185
Query: 982 MKVTE---KCDIYSFGVVLLELITGKSPV 1007
M + K D++S G+ +EL K P+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 38/212 (17%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G G VYKA GE++A+KKI+L E ++ + EIS L ++ H NIV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 869 CYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH------Y 921
H ++ L L++E++ + L + + D+ L YL+
Sbjct: 67 -VHSENKLYLVFEFL-DLDLKKYM-----------DSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 922 DCRPH-IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP---YSKSMSAIAGSYGYIAPE 977
C H ++HRD+K N+L+D E + DFGLA+ +P Y+ + + Y APE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL----WYRAPE 169
Query: 978 Y-----AYTMKVTEKCDIYSFGVVLLELITGK 1004
Y+ V DI+S G + E++ +
Sbjct: 170 ILLGSRQYSTPV----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 14/217 (6%)
Query: 803 NFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATAD---NSFLAEISTLGKIR 858
N+ G ++G+GA G VY A+ G +AVK+++ E N+ EI L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 859 HRNIVKLYGFCYH-QDSNLLLY-EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
H IV+ YG + L ++ E+M GS+ +QL K L + + EG+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGV 119
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP--YSKSMSAIAGSYGYI 974
YLH + I+HRDIK NIL D +GDFG +K + M ++ G+ ++
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011
+PE K DI+S G ++E++T K P E
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 61/181 (33%), Positives = 85/181 (46%), Gaps = 10/181 (5%)
Query: 826 GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN--LLLYEYME 883
GE +AVK +K G EI L + H NIVK G C N L+ E++
Sbjct: 33 GEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 884 NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF 943
+GSL E L NK L +Y + + +G+ YL +HRD+ + N+L++ E
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKYAVQI--CKGMDYLG---SRQYVHRDLAARNVLVESEH 146
Query: 944 QAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELI 1001
Q +GDFGL K I D Y + + APE K D++SFGV L EL+
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
Query: 1002 T 1002
T
Sbjct: 207 T 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 70/275 (25%), Positives = 126/275 (45%), Gaps = 37/275 (13%)
Query: 809 VIGRGACGTVYKATLANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHRNIVKLYG 867
+I ++YK N EVI ++ K +G + EI L +I NI+K+YG
Sbjct: 27 LIKENDQNSIYKGIFNNKEVI-IRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 868 FCYHQDSNL----LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH-YD 922
F +L L+ EY G L E L K L + + +A+ +GL L+ Y
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYT 142
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
+P+ +++ S + L+ E ++ + GL K++ P K+++ + Y + + +
Sbjct: 143 NKPY---KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDI 195
Query: 983 --KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040
+ T K DIYS GVVL E+ TGK P ++L + I++++ ++ +L L
Sbjct: 196 FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---------KEIYDLI-INKNNSLKLPL 245
Query: 1041 SAKRTVEEMTLFLK-IALFCSSTSPLNRPTMREVI 1074
+K I C+S + RP ++E++
Sbjct: 246 DCPL-------EIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 77/280 (27%), Positives = 114/280 (40%), Gaps = 47/280 (16%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G GA G VYKA + A KI ++ F+ EI L + +H NIV LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED-FMVEIDILSECKHPNIVGLYEAY 71
Query: 870 YHQDSNLLLYEYMENGSLG----EQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
++++ +L E+ + G+L E G L + E L +LH
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERG------LTEPQIRYVCRQMLEALNFLH---SH 122
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY--TMK 983
+IHRD+K+ NILL + + DFG++ K + I Y ++APE T K
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY-WMAPEVVACETFK 181
Query: 984 VTE---KCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD----- 1035
K DI+S G+ L+EL + P HE+ P L
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPH-----------------HELNPMRVLLKILKSE 224
Query: 1036 -KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
LD +K + FLK L P +RPT E++
Sbjct: 225 PPTLDQPSKWSSSFND-FLKSCL---VKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 8e-18
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 803 NFSEGAVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLA---EISTLGKIR 858
N+ G ++G+GA G VY + G +A K+++ E A EI L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 859 HRNIVKLYGFCY--HQDSNLLLY-EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEG 915
H IV+ YG C + L ++ EYM GS+ +QL K L + EG
Sbjct: 63 HERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEG 118
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL--PYSKSMSAIAGSYGY 973
+ YLH + I+HRDIK NIL D +GDFG +K + + ++ G+ +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 974 IAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
++PE K D++S G ++E++T K P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG+GA GTVY A +A G+ +A+K++ L+ + + EI + + +H NIV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDS 84
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWD--ARYRIALGAAEGLCYLHYDCRPH 926
D ++ EY+ GSL + + +TC+ + A R L A E +LH +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALE---FLHSN---Q 135
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTE 986
+IHRDIKS+NILL + + DFG I P S + G+ ++APE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 987 KCDIYSFGVVLLELITGKSP 1006
K DI+S G++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 809 VIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
V+G GA G V K A GE++A+KK K + + L E+ L ++RH NIV L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 868 FCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
+ L++EY+E +L E L + L DA + + Y H +I
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGG--LPPDAVRSYIWQLLQAIAYCH---SHNI 121
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE-----YAYTM 982
IHRDIK NIL+ E + DFG A+ + + ++ + Y APE Y
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181
Query: 983 KVTEKCDIYSFGVVLLELITG 1003
V D+++ G ++ EL+ G
Sbjct: 182 PV----DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 38/278 (13%)
Query: 810 IGRGACGTVYKAT--LANGEVI--AVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
+G G G+V K + +G+ + AVK +K + A FL E S + ++ H IV+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC---LLDWDARYRIALGAAEGLCYLHYD 922
G C + +L+ E G L + L ++ L + A A G+ YL
Sbjct: 62 IGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE-- 112
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAY 980
H +HRD+ + N+LL QA + DFG+++ + Y ++ +A + APE
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 981 TMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039
K + K D++S+GV L E + G P ++ G +++ M+ + E RL
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVI--------AMLESGE----RLP 218
Query: 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
+ E ++ L C P +RPT E+ +
Sbjct: 219 RPEECPQEIYSIMLS----CWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 801 TGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKL-RGEGATADNSFLAEISTLGKIR 858
GNF IG+G VYKA L +G V+A+KK+++ A A L EI L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 859 HRNIVKLY-GFCYHQDSNLLLYEYMENGSLGEQL-HGNKQTCLLDWDARYRIALGAAEGL 916
H N++K F + + N++L E + G L + H KQ L+ ++ + L
Sbjct: 61 HPNVIKYLASFIENNELNIVL-ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSA--IAGSYGYI 974
++H I+HRDIK N+ + +GD GL + SK+ +A + G+ Y+
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVGTPYYM 173
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+PE + K DI+S G +L E+ +SP
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 68/229 (29%), Positives = 95/229 (41%), Gaps = 34/229 (14%)
Query: 800 ATGNFSEGAVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR 858
++ +G G G VYKA + G V+A+KKI + E + L EI L K++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 859 HRNIVKLYGFCY-----HQDSNLLLY---EYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
H N+V L + +Y YM++ G L N L + + L
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSVKLTESQIKC-YML 122
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
EG+ YLH HI+HRDIK+ NIL+D + + DFGLA+ D P G
Sbjct: 123 QLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 971 ---YG-------YIAPEYA-----YTMKVTEKCDIYSFGVVLLELITGK 1004
Y Y PE YT V DI+ G V E+ T +
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKK-----IKLRGEGATADNSFLAEISTLGKIRHRNIV 863
+G+G G V + G++ A KK +K R A L E L K+ R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA----LNEKKILEKVSSRFIV 56
Query: 864 KLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
L + + +L L+ M G L ++ + + A + AA+ +C L +
Sbjct: 57 SL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFY----AAQIICGLEHL 111
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
+ I++RD+K N+LLD+ + D GLA ++L K + AG+ GY+APE
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQ 1008
D ++ G L E+I G+SP +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 69/208 (33%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLA-EISTLGKIRHRNIVKLYG 867
+G G G VYKA L GE+ AVK IKL D S + EI + + +H NIV +G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE---PGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 868 FCYHQDSNLLLYEYMENGSLGEQLH--GNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
++ + EY GSL + H G + + R + +GL YLH +
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK- 127
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMK-- 983
+HRDIK NILL + + DFG+A I +K S I Y ++APE A K
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY-WMAPEVAAVEKNG 184
Query: 984 -VTEKCDIYSFGVVLLELITGKSPVQSL 1010
+ CDI++ G+ +EL + P+ L
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-17
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHRN 861
F++ IG G+ G VY A EV+A+KK+ G+ + + E+ L +I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
++ G + + L+ EY GS + L +K+ L I GA +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHS 143
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
++IHRDIK+ NILL E Q + DFG A + S + S + Y ++APE
Sbjct: 144 H---NMIHRDIKAGNILLTEPGQVKLADFGSASIA----SPANSFVGTPY-WMAPEVILA 195
Query: 982 MKVTE---KCDIYSFGVVLLELITGKSPV 1007
M + K D++S G+ +EL K P+
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-17
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 10/208 (4%)
Query: 804 FSEGAVIGRGACGTVYKATL-ANGEVIAVKKI-KLRGEGATADNSFLAEISTLGKIRHRN 861
F + V+G+G G V + A G++ A KK+ K R + ++ L E L K+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 862 IVKLYGFCYH-QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+V L + Y +D+ L+ M G L ++ + R AAE C L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF----EEGRAVFYAAEICCGLE 116
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
+ I++RD+K NILLD+ + D GLA + +P +++ G+ GY+APE
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVK 174
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSPVQ 1008
+ T D ++ G +L E+I G+SP Q
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 17/201 (8%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G+ G V AT + G +AVKK+ LR + E+ + +H NIV++Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 869 CYHQDSNLLLYEYMENGSLGEQL-HGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
D ++ E++E G+L + + H ++ + + L + L +LH +
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLAVLKALSFLHAQ---GV 136
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
IHRDIKS++ILL + + + DFG + ++P KS+ G+ ++APE +
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPEVISRLPYG 193
Query: 986 EKCDIYSFGVVLLELITGKSP 1006
+ DI+S G++++E++ G+ P
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 809 VIGRGACGTVYKATLANGEVI----AVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864
VIG+G G VY TL + + AVK + R FL E + H N++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN-RITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 865 LYGFCYHQD-SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALG--AAEGLCYLHY 921
L G C + S L++ YM++G L + + + I G A+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV----KDLIGFGLQVAKGMEYL-- 114
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG------YIA 975
+HRD+ + N +LDE F V DFGLA+ I Y K ++ G ++A
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI---YDKEYYSVHNHTGAKLPVKWMA 170
Query: 976 PEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
E T K T K D++SFGV+L EL+T G P
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 202
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 69/270 (25%), Positives = 135/270 (50%), Gaps = 22/270 (8%)
Query: 810 IGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G+ G V AT+ ++G+++AVKK+ LR + E+ + +H N+V++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
D ++ E++E G+L + + + ++ + + L + L LH +I
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKC 988
HRDIKS++ILL + + + DFG + + S + Y ++APE + +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY-WMAPELISRLPYGPEV 197
Query: 989 DIYSFGVVLLELITG------KSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL---D 1039
DI+S G++++E++ G + P++++++ D + +++H++ P+ + F RL D
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 1040 LSAKRTVEEMTL--FLKIALFCSSTSPLNR 1067
+ + T E+ FL A S PL R
Sbjct: 258 PAQRATAAELLKHPFLAKAGPPSCIVPLMR 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 7e-17
Identities = 40/89 (44%), Positives = 60/89 (67%)
Query: 221 LGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGL 280
LGL L GF+P+++ KLR+L + L N + G IPP++G+I SLE+L L NSF+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 281 PKELGKLSRLKKLYVYTNELNGTIPHELG 309
P+ LG+L+ L+ L + N L+G +P LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 73/277 (26%), Positives = 124/277 (44%), Gaps = 29/277 (10%)
Query: 803 NFSEGAVIGRGACGTVY--KATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
+ + V+GRGA G V+ + VI +K+I + + E L + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVI-IKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
NI++ Y + +++ EY G+L E + + LLD D I + L LH
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDT---ILHFFVQILLALH 115
Query: 921 YDCRPHIIHRDIKSNNILLDE-EFQAHVGDFGLAKLIDLPYSKS-MSAIAGSYGYIAPEY 978
+ I+HRD+K+ NILLD+ + +GDFG++K++ SKS + G+ YI+PE
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPEL 172
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038
+K DI++ G VL EL + K ++ L LV + P S+ + L
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSG--TFAPISDRYSPDL 229
Query: 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
++ + M + P RP + +++A
Sbjct: 230 ----RQLILSML----------NLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-17
Identities = 65/235 (27%), Positives = 107/235 (45%), Gaps = 37/235 (15%)
Query: 803 NFSEGAVIGRGACGTVYKAT------LANGEVIAVKKIKLRGEGATADNSFLAEISTLGK 856
N G +G G G V KAT A +AVK +K ++ L+E + L +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQ 59
Query: 857 IRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLH-------------GNKQTCLLDWD 903
+ H +++KLYG C LL+ EY + GSL L GN+ + LD
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 904 ARYRIALG--------AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955
+ +G + G+ YL ++HRD+ + N+L+ E + + DFGL++
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 956 I---DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ D +S I ++A E + T + D++SFGV+L E++T G +P
Sbjct: 177 VYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 38/217 (17%)
Query: 804 FSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR---H 859
+ E A IG GA GTVYKA L G +A+KK+++ S L EI+ L ++ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 860 RNIVKLYGFCY-HQDSN----LLLYEYMENGSLGEQLHGNKQTCL---LDWDARYRIALG 911
NIV+L C+ + L++E+++ + L C L + +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS--AIAG 969
G+ +LH I+HRD+K NIL+ + Q + DFGLA++ YS M+ ++
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI----YSFEMALTSVVV 168
Query: 970 SYGYIAPE------YAYTMKVTEKCDIYSFGVVLLEL 1000
+ Y APE YA D++S G + EL
Sbjct: 169 TLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 37/280 (13%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869
+G G G+V K + KK+ G ++ L E+ + + R IV YG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 870 YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIH 929
++++ + E+M+ GSL K+ + + +IA+ EGL YL+ I+H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMH 127
Query: 930 RDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSAIA----GSYGYIAPEYAYTMKV 984
RDIK +NIL++ Q + DFG++ +LI+ +IA G+ Y++PE K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELIN--------SIADTFVGTSTYMSPERIQGGKY 179
Query: 985 TEKCDIYSFGVVLLELITGKSPVQSLELGGD-------LVTWVRRSIHEMVPTSELFDKR 1037
T K D++S G+ ++EL GK P + D ++ +++ + E P
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR------- 232
Query: 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
L + E++ F+ C P RPT +++ AM
Sbjct: 233 --LPSSDFPEDLRDFVDA---CLLKDPTERPTPQQLCAMP 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH-RNIVKLYG 867
IGRGA GTV K G ++AVK+I+ + L ++ + + IVK YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 868 FCYHQDSNLLLYEYMENG--SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
+ + + E M+ + ++ ++ + + +IA+ + L YL +
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVI-PEEILGKIAVATVKALNYLKEEL-- 127
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSAIAGSYGYIAPEY------ 978
IIHRD+K +NILLD + DFG++ +L+D S + + AG Y+APE
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSAR 184
Query: 979 -AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y + + D++S G+ L E+ TGK P
Sbjct: 185 DGYDV----RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G GTV+KA E++A+K+++L + +S L EI L +++H+NIV+LY
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD- 66
Query: 869 CYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARY--RIALGAAEGLCYLHYDCRP 925
H D L L++EY + + L +C D D +GL + H
Sbjct: 67 VLHSDKKLTLVFEYCD-----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH--- 118
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV- 984
+++HRD+K N+L+++ + + DFGLA+ +P + SA + Y P+ + K+
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLY 177
Query: 985 TEKCDIYSFGVVLLELITGKSPV 1007
+ D++S G + EL P+
Sbjct: 178 STSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G+G G+VYK G +A+K+I+L + + N + E+ L K IV YG
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF-NQIIMELDILHKAVSPYIVDFYGA 67
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
+ + + + EYM+ GSL + G T + D RI +GL +L + +II
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNII 125
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTE-- 986
HRD+K N+L++ Q + DFG++ +L S + + I G Y+APE + +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNI-GCQSYMAPERIKSGGPNQNP 182
Query: 987 ----KCDIYSFGVVLLELITGKSP 1006
+ D++S G+ +LE+ G+ P
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 67/217 (30%), Positives = 100/217 (46%), Gaps = 42/217 (19%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR--NIVKLY 866
IG G CG VYK G V+AVK+++ R + L ++ + K H IVK Y
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR-RTGNKEENKRILMDLDVVLK-SHDCPYIVKCY 80
Query: 867 GFCYHQDSNLLL-YEYME----------NGSLGEQLHGNKQTCLLDWDARYRIALGAAEG 915
G + DS++ + E M G + E + G ++ + +
Sbjct: 81 G-YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-------------KMTVAIVKA 126
Query: 916 LCYLHYDCRPH-IIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSAIAGSYGY 973
L YL H +IHRD+K +NILLD + DFG++ +L+D SK+ + AG Y
Sbjct: 127 LHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAY 180
Query: 974 IAPEYAYTMKVTEKCDI----YSFGVVLLELITGKSP 1006
+APE K DI +S G+ L+EL TG+ P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 809 VIGRGACGTVYKATL---ANGEV-IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864
VIG G G V + L E+ +A+K +K G FL+E S +G+ H NI+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDC 923
L G +++ E+MENG+L L N Q ++ R G A G+ YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL---S 123
Query: 924 RPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS--MSAIAGSYG--YIAPEYA 979
+ +HRD+ + NIL++ V DFGL++ ++ S S++ G + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 980 YTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
K T D++S+G+V+ E+++ G+ P
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL--- 865
I G G VY+A GE++A+KK+K+ E + L EI+ L K++H NIV +
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEV 72
Query: 866 -YGFCYHQDSNLLLYEYMENG--SLGEQLHGNKQT----CLLDWDARYRIALGAAEGLCY 918
G + D ++ EY+E+ SL E + CL+ L G+ +
Sbjct: 73 VVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM---------LQLLSGVAH 121
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
LH I+HRD+K++N+LL+ + DFGLA+ P K + + + Y APE
Sbjct: 122 LH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVVTLWYRAPEL 177
Query: 979 AY-TMKVTEKCDIYSFGVVLLELITGK 1004
+ + D++S G + EL+T K
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 4e-16
Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG+GA GTVY A +A G+ +A+K++ L+ + + EI + + ++ NIV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDS 84
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
D ++ EY+ GSL + + +TC+ D + + L +LH + +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV---TETCM-DEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKC 988
HRDIKS+NILL + + DFG I P S + G+ ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 989 DIYSFGVVLLELITGKSP 1006
DI+S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVK---KIKLRGEGAT--ADNSFLAEISTLGKI 857
+ + +G GA G VY+ + AV+ +K E + ++ FL E + K
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNK----QTCLLDWDARYRIALGAA 913
H+NIV+L G + + +L E M G L L N+ + L A A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ---AHVGDFGLAKLIDLPYSKSMSAIAGS 970
+G YL + H IHRDI + N LL + A + DFG+A+ I Y S G
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI---YRASYYRKGGR 180
Query: 971 ----YGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++ PE T K D++SFGV+L E+ + G P
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 5e-16
Identities = 77/268 (28%), Positives = 131/268 (48%), Gaps = 22/268 (8%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG+GA GTVY A +A G+ +A++++ L+ + + EI + + ++ NIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDS 85
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
D ++ EY+ GSL + + +TC+ + +IA E L L + +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV---TETCMDEG----QIAAVCRECLQALEFLHSNQVI 138
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKC 988
HRDIKS+NILL + + DFG I P S + G+ ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 989 DIYSFGVVLLELITG------KSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR---LD 1039
DI+S G++ +E+I G ++P+++L L T ++ ++ F R +D
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 1040 LSAKRTVEEMT--LFLKIALFCSSTSPL 1065
+ + + +E+ FLKIA SS +PL
Sbjct: 258 VEKRGSAKELLQHQFLKIAKPLSSLTPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 6e-16
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 41/219 (18%)
Query: 810 IGRGACGTVYKATLAN---GEVIAVKKIK---LRGEGATADNSFLAEISTLGKIRHRNIV 863
IGRG G VYKA N G+ A+KK K + G + S EI+ L +++H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQ--SACREIALLRELKHENVV 65
Query: 864 KLYG-FCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR------YRIALGAAEG 915
L F H D ++ LL++Y E+ L + + ++Q + ++I G
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQI----LNG 120
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAH----VGDFGLAKLIDLPYSKSMSAIAG-- 969
+ YLH + ++HRD+K NIL+ E +GD GLA+L + P K ++ +
Sbjct: 121 VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LKPLADLDPVV 176
Query: 970 -SYGYIAPEYA-----YTMKVTEKCDIYSFGVVLLELIT 1002
+ Y APE YT + DI++ G + EL+T
Sbjct: 177 VTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 6e-16
Identities = 67/241 (27%), Positives = 94/241 (39%), Gaps = 66/241 (27%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-----EISTLGKIRHRNI 862
IG GA G V A G +A+KKI D+ A EI L +RH NI
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI-----SNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 863 VKLYGFCYHQDSN-----LLLYEYME---------NGSLGEQLHGNKQTCLLDWDARYRI 908
+ L ++ E ME L + H Q L Y+I
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDD-HI--QYFL------YQI 112
Query: 909 ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS--MSA 966
GL YLH ++IHRD+K +NIL++ + DFGLA+ +D + ++
Sbjct: 113 LR----GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT- 164
Query: 967 IAGSY----GYIAPE-----YAYTMKVTEKCDIYSFGVVLLELIT------GKSPVQSLE 1011
Y Y APE YT + DI+S G + EL+T G+ + L
Sbjct: 165 ---EYVVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKPLFPGRDYIDQLN 217
Query: 1012 L 1012
L
Sbjct: 218 L 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G G VYKA + GE+ A+K IKL E EI + +H NIV +G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKL--EPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
+D + E+ GSL + H R L +GL YLH + +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL---QGLYYLHSKGK---M 128
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMK---VT 985
HRDIK NILL + + DFG++ I +K S I Y ++APE A +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPY-WMAPEVAAVERKGGYN 187
Query: 986 EKCDIYSFGVVLLELITGKSPVQSL 1010
+ CDI++ G+ +EL + P+ L
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVK-KIKLRGE--GATADNSFLAEISTLGKIRHRNIVK 864
V+G GA GTVYK + GE + + IK+ E G A+ F+ E + + H ++V+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEGLCYLH 920
L G C L+ + M +G L + +H +K LL+W + A+G+ YL
Sbjct: 74 LLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY--GYIAPEY 978
++HRD+ + N+L+ + DFGLA+L++ K +A G ++A E
Sbjct: 127 ---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMALEC 182
Query: 979 AYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ K T + D++S+GV + EL+T G P
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 14/211 (6%)
Query: 804 FSEGAVIGRGACGTVYKATL-ANGEVIAVKKI-KLRGEGATADNSFLAEISTLGKIRHRN 861
F + V+G+G G V + A G++ A K++ K R + ++ L E L K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 862 IVKLYGFCYH-QDSNLLLYEYMENGSLGEQLH--GNKQTCLLDWDARYRIALGAAEGLCY 918
+V L + Y +D+ L+ M G L ++ GN R AAE LC
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF------EEERALFYAAEILCG 114
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
L R + ++RD+K NILLD+ + D GLA + +P +S+ G+ GY+APE
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEV 172
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009
+ T D + G ++ E+I G+SP +
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 9e-16
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+F + +G G G V K +G ++A K I L + A N + E+ L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIR-NQIIRELKVLHECNSPY 60
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
IV YG Y + E+M+ GSL + L K+ + + +I++ GL YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMS-AIAGSYGYIAPEYA 979
+ I+HRD+K +NIL++ + + DFG++ +LID SM+ + G+ Y++PE
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERL 170
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSPV 1007
T + DI+S G+ L+E+ G+ P+
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 76/305 (24%), Positives = 124/305 (40%), Gaps = 75/305 (24%)
Query: 804 FSEGAVIGRGACGTVYKATLANGEV----IAVKKIKLRGEGATADNSFLAEISTLGKIRH 859
G ++G G G+V + L+ + +AVK +KL + FL+E + + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 860 RNIVKLYGFCYHQDSN------LLLYEYMENGSLGEQLHGNK----------QTCLLDWD 903
N++KL G C+ S +++ +M++G L L ++ QT L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL---- 116
Query: 904 ARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS 963
+ + A G+ YL + IHRD+ + N +L E+ V DFGL+K I YS
Sbjct: 117 ---KFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI---YS-- 165
Query: 964 MSAIAGSY-----------GYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP---VQ 1008
G Y +IA E T K D+++FGV + E+ T G++P V+
Sbjct: 166 -----GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220
Query: 1009 SLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP 1068
+ E+ L R E EL+D + C P +RP
Sbjct: 221 NHEIYDYLRHGNRLKQPEDCL-DELYD-------------------LMYSCWRADPKDRP 260
Query: 1069 TMREV 1073
T ++
Sbjct: 261 TFTKL 265
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 33/210 (15%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G G VYK G+++A+KKI+L E ++ + EIS L +++H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 869 CYHQDSNL-LLYE--------YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
Q+S L L++E Y+++ G+ + L Y+I +G+ +
Sbjct: 68 -LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL-----YQI----LQGILFC 117
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY- 978
H ++HRD+K N+L+D + + DFGLA+ +P + + Y APE
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW-YRAPEVL 173
Query: 979 ----AYTMKVTEKCDIYSFGVVLLELITGK 1004
Y+ V DI+S G + E+ T K
Sbjct: 174 LGSPRYSTPV----DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 809 VIGRGACGTVYKATLANG-EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
V+G G+ G N + A+K+I+L + ++S E L K++H NIV +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVA-FK 64
Query: 868 FCYHQDSNL-LLYEYMENGSLGEQLHGNK-----QTCLLDWDARYRIALGAAEGLCYLHY 921
+ D +L ++ EY + G L +++ + + +L W + + LG ++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ--MCLGVQ----HIH- 117
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
++HRDIKS NI L + + +GDFG A+L+ P + + + + Y Y+ PE
Sbjct: 118 --EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY-YVPPEIWEN 174
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQS 1009
M K DI+S G +L EL T K P Q+
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 809 VIGRGACGTVYKATL---ANGEV-IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864
VIG G G V L E+ +A+K +K G FL+E S +G+ H NI+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL------GAAEGLCY 918
L G +++ EYMENGSL L + D ++ + G A G+ Y
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKH--------DGQFTVIQLVGMLRGIASGMKY 121
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLP---YSKSMSAIAGSYGYI 974
L +HRD+ + NIL++ V DFGL++++ D P Y+ I +
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWT 176
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
APE K T D++S+G+V+ E+++ G+ P
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 35/231 (15%)
Query: 797 LLEATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLG 855
L + G F V+G G G VYK + G++ A+K + + + + EI+ L
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEIKLEINMLK 67
Query: 856 KI-RHRNIVKLYGFCY------HQDSNLLLYEYMENGSLGEQLHGNKQTCLL-DWDARYR 907
K HRNI YG H D L+ E+ GS+ + + K L DW A
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-- 125
Query: 908 IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967
I GL +LH +IHRDIK N+LL E + + DFG++ +D + + I
Sbjct: 126 ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 182
Query: 968 AGSYGYIAPE-----------YAYTMKVTEKCDIYSFGVVLLELITGKSPV 1007
Y ++APE Y Y + DI+S G+ +E+ G P+
Sbjct: 183 GTPY-WMAPEVIACDENPDATYDY------RSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 34/223 (15%)
Query: 803 NFSEGAVIGRGACGTVYKAT---LANGEV---IAVKKIKLRGEGATADNS----FLAEI- 851
N S G +G GA G V +AT L+ + +AVK +K TA +S ++E+
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK-----PTAHSSEREALMSELK 90
Query: 852 --STLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIA 909
S LG H NIV L G C L++ EY G L L +++ L D +
Sbjct: 91 IMSHLGN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFS 147
Query: 910 LGAAEGLCYLHY-DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIA 968
A+G+ +L +C IHRD+ + N+LL + DFGLA+ I + S +
Sbjct: 148 YQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI---MNDSNYVVK 200
Query: 969 GS----YGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
G+ ++APE + T + D++S+G++L E+ + G +P
Sbjct: 201 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 9/209 (4%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRH 859
NF IGRG VY+AT L +G +A+KK+++ A A + EI L ++ H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 860 RNIVKLYG-FCYHQDSNLLLYEYMENGSLGEQL-HGNKQTCLLDWDARYRIALGAAEGLC 917
N++K Y F + N++L E + G L + H KQ L+ ++ + L
Sbjct: 62 PNVIKYYASFIEDNELNIVL-ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
++H ++HRDIK N+ + +GD GL + + + S + Y Y++PE
Sbjct: 121 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPE 176
Query: 978 YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ K DI+S G +L E+ +SP
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G G VYKA E IA+KKI+L E ++ + EIS L +++H NIV+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR------YRIALGAAEGLCYLHYD 922
+ + L++EY++ L + H + + + R Y+I G A C+ H
Sbjct: 70 VHSEKRLYLVFEYLD---LDLKKHMD-SSPDFAKNPRLIKTYLYQILRGIA--YCHSH-- 121
Query: 923 CRPHIIHRDIKSNNILLDEEFQA-HVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE---- 977
++HRD+K N+L+D A + DFGLA+ +P + + Y APE
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW-YRAPEILLG 177
Query: 978 -YAYTMKVTEKCDIYSFGVVLLELITGK 1004
Y+ V DI+S G + E++ K
Sbjct: 178 SRHYSTPV----DIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 28/216 (12%)
Query: 809 VIGRGACGTV-YKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY- 866
V+G GA GTV +++GE AVK + + G N AE+ L +IVK +
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 867 GFCYHQDSN-------LLLYEYMENGSLGEQLHGNKQTCLLDWDAR----YRIALGAAEG 915
F N L+ +Y G L +++ +T R + L +
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT------NRTFREHEAGLLFIQV 152
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS-----AIAGS 970
L +H+ H+IHRDIKS NILL +GDFG +K+ Y+ ++S G+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM----YAATVSDDVGRTFCGT 208
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y+APE ++K D++S GV+L EL+T K P
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G+ G V AT + G+ +AVKK+ LR + E+ + H N+V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
D ++ E++E G+L + + + ++ + + L L YLH +I
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLH---NQGVI 140
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKC 988
HRDIKS++ILL + + + DFG + K S + Y ++APE + +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY-WMAPEVISRLPYGTEV 199
Query: 989 DIYSFGVVLLELITGKSP 1006
DI+S G++++E+I G+ P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 71/296 (23%), Positives = 126/296 (42%), Gaps = 44/296 (14%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH-RNIVKLYG 867
+GRGA G V K + G ++AVK+I+ + L ++ + V YG
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 868 FCYHQDSNLLLYEYMENGSLGE---QLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR 924
+ + + E M+ SL + +++ T + D +IA+ + L YLH +
Sbjct: 68 ALFREGDVWICMEVMDT-SLDKFYKKVYDKGLT--IPEDILGKIAVSIVKALEYLH--SK 122
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSAIAGSYGYIAPE------ 977
+IHRD+K +N+L++ Q + DFG++ L+D +K++ AG Y+APE
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-SVAKTID--AGCKPYMAPERINPEL 179
Query: 978 --YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035
Y + K D++S G+ ++EL TG+ P S +++ + E P
Sbjct: 180 NQKGYDV----KSDVWSLGITMIELATGRFPYDSW---KTPFQQLKQVVEEPSPQ----- 227
Query: 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM--MIDARQSVSDYPS 1089
L A++ E F+ C + RP E++ +D S
Sbjct: 228 ----LPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQHPFFELHLSKNTDVAS 276
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 70/225 (31%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 796 NLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLG 855
+L + T + IG+G G VYK T N + ++ +K+ + D AE + L
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVT--NKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73
Query: 856 KI-RHRNIVKLYGFCYHQDSNL-----LLYEYMENGSLGEQLHGN-KQTCLLDWDARYRI 908
+ H N+VK YG Y D + L+ E GS+ E + G LD I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 909 ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL-AKLIDLPYSKSMSAI 967
GA GL +LH + IIHRD+K NNILL E + DFG+ A+L ++ S
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-- 188
Query: 968 AGSYGYIAPEY-----AYTMKVTEKCDIYSFGVVLLELITGKSPV 1007
G+ ++APE Y +CD++S G+ +EL G P+
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-15
Identities = 76/263 (28%), Positives = 117/263 (44%), Gaps = 17/263 (6%)
Query: 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLI 496
L L +N ++ P +L +L L N++ SLP NL NL L+L N S +
Sbjct: 121 LDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-L 178
Query: 497 PPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQR 556
P + L NL L LS N +P E+ L L ++S+NS+ + L N NL
Sbjct: 179 PKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSG 236
Query: 557 LDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSI 616
L+LS N+ PE +G L NLE L LS+N+++ SSLG L L EL + GN S ++
Sbjct: 237 LELSNNKLEDL-PESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNAL 293
Query: 617 PVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLL 676
P+ L L++ LN+ EL +L + N + +
Sbjct: 294 PLIALLLLLLELLLNLLLTL----KALELKLNSILLNNNILSNGETSS------PEALSI 343
Query: 677 VCNLSNNNLVGTVPNTTVFRRID 699
+ +L+N + + + R
Sbjct: 344 LESLNNLWTLDNALDESNLNRYI 366
|
Length = 394 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-15
Identities = 78/309 (25%), Positives = 126/309 (40%), Gaps = 55/309 (17%)
Query: 807 GAVIGRGACGTVYKATLANGE--------VIAVKKIKLRGEGATADNSFLAEISTLGKI- 857
G +G G G V +A + +AVK +K D + L L K+
Sbjct: 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK--DNATDKDLADLISEMELMKLI 74
Query: 858 -RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC-------------LLDWD 903
+H+NI+ L G C + ++ EY G+L E L + L +
Sbjct: 75 GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 904 ARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSK 962
A A G+ YL IHRD+ + N+L+ E+ + DFGLA+ + D+ Y K
Sbjct: 135 DLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 963 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRR 1022
S ++APE + T + D++SFG+++ E+ T LGG
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT---------LGG-------- 234
Query: 1023 SIHEMVPTSELFD-----KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
S + +P ELF R+D + T E L + C P RPT ++++ +
Sbjct: 235 SPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRE----CWHAVPTQRPTFKQLVEAL 290
Query: 1078 IDARQSVSD 1086
+VS+
Sbjct: 291 DKVLAAVSE 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 62/224 (27%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKK------IKLRGEGATADNSFLAEISTLG 855
+F +G G+ G V +G+ A+K +KL+ L E L
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV-----LNEKRILQ 56
Query: 856 KIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLH-----GNKQTCLLDWDARYRIA 909
IRH +V LYG + DSNL L+ EY+ G L L Y
Sbjct: 57 SIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF------Y--- 106
Query: 910 LGAAE---GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSA 966
AA+ L YLH I++RD+K N+LLD + + DFG AK +
Sbjct: 107 --AAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYT 157
Query: 967 IAGSYGYIAPEY----AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ G+ Y+APE Y V D ++ G+++ E++ G P
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 807 GAVIGRGACGTVYKAT--LANGEVI--AVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
G IG G G VY+ E I AVK K + + FL E + + H +I
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
VKL G +++ E G L L NK + L Y L A L YL
Sbjct: 70 VKLIGVITENPVWIVM-ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA--LAYLE-- 124
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYIAPEYAYT 981
+HRDI + N+L+ +GDFGL++ + D Y K+ S ++APE
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA-SKGKLPIKWMAPESINF 182
Query: 982 MKVTEKCDIYSFGVVLLE-LITGKSPVQSLE 1011
+ T D++ FGV + E L+ G P Q ++
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 804 FSEGAVIGRGACGTVYKATL-ANGEVIAVKKI-KLRGEGATADNSFLAEISTLGKIRHRN 861
F V+G+G G V + A G++ A KK+ K R + + L E L K+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 862 IVKLYGFCYH-QDSNLLLYEYMENGSLGEQLH--GNKQTCLLDWDARYRIALGAAEGLCY 918
+V L + Y +D+ L+ M G L ++ GN +D + R AAE C
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-----GFDEQ-RAIFYAAELCCG 114
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
L R I++RD+K NILLD+ + D GLA + +P +++ G+ GY+APE
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEV 172
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
K T D + G ++ E+I G+SP
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 77/288 (26%), Positives = 114/288 (39%), Gaps = 55/288 (19%)
Query: 806 EGAVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864
E V+G+G G VY A L+ IA+K+I R EI+ ++HRNIV+
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV--QPLHEEIALHSYLKHRNIVQ 69
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR 924
G + E + GSL L + EGL YLH +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN-- 127
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI-------AGSYGYIAPE 977
I+HRDIK +N+L++ G+ K+ D SK ++ I G+ Y+APE
Sbjct: 128 -QIVHRDIKGDNVLVNTY-------SGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE 179
Query: 978 YAYTMKVTEK--------CDIYSFGVVLLELITGKSPVQSLELGGDLVTWVR---RSIHE 1026
V +K DI+S G ++E+ TGK P +ELG + IH
Sbjct: 180 ------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--IELGEPQAAMFKVGMFKIHP 231
Query: 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
+P S L AK + L C P R + +++
Sbjct: 232 EIPES------LSAEAKNFI----------LRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 5e-15
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSF-----LAEISTLGKI-RHRNI 862
+G G G+VY A GE++A+KK+K S+ L E+ +L K+ H NI
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK------KKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
VKL D ++EYME G+L + + K + R I +GL ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRS-IIYQILQGLAHIH-- 116
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID--LPYSKSMSAIAGSYGYIAPEY-- 978
+ HRD+K N+L+ + DFGLA+ I PY+ +S + Y APE
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS----TRWYRAPEILL 171
Query: 979 ---AYTMKVTEKCDIYSFGVVLLELITGK 1004
+Y+ V DI++ G ++ EL T +
Sbjct: 172 RSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 24/190 (12%)
Query: 828 VIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGS 886
++AVK LR + TA N FL EI + ++++ NI++L G C D ++ EYMENG
Sbjct: 46 LVAVKM--LRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 887 LGEQL----------HGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNN 936
L + L H N + + Y +A+ A G+ YL + +HRD+ + N
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLY-MAVQIASGMKYL---ASLNFVHRDLATRN 159
Query: 937 ILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS----YGYIAPEYAYTMKVTEKCDIYS 992
L+ + + DFG+++ + YS I G ++A E K T D+++
Sbjct: 160 CLVGNHYTIKIADFGMSRNL---YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216
Query: 993 FGVVLLELIT 1002
FGV L E+ T
Sbjct: 217 FGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
IG G+ G +Y A ++ E +K+I L + E+ L K++H NIV +
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 868 FCYHQDSNLLLYEYMENGSLGEQLHGNK-----QTCLLDWDARYRIALGAAEGLCYLHYD 922
++ EY + G L ++++ + + +L W + I+LG L ++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ--ISLG----LKHIH-- 118
Query: 923 CRPHIIHRDIKSNNILLDEEFQ-AHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
I+HRDIKS NI L + A +GDFG+A+ ++ + + + Y Y++PE
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY-YLSPEICQN 176
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQS 1009
K DI+S G VL EL T K P +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 808 AVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
IG G G VYKA GE++A+KK++L E + + EI L ++ HRNIV L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 867 GFCYHQDSNL----------LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAA--E 914
+ L L++EYM++ L G ++ L+ + + + E
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDH-----DLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
GL Y H + + +HRDIK +NILL+ + Q + DFGLA+L + S+ + + Y
Sbjct: 128 GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 975 APEYAY-TMKVTEKCDIYSFGVVLLELITGKSPVQ-SLELG 1013
PE + D++S G +L EL T K Q + EL
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 64/238 (26%), Positives = 118/238 (49%), Gaps = 21/238 (8%)
Query: 810 IGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G+ G V A +G +AVK + LR + E+ + +H+N+V++Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
+ +L E+++ G+L + + + L+ + + + LCYLH +I
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAYTMKVTE 986
HRDIKS++ILL + + + DFG I D+P KS+ G+ ++APE
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPEVISRTPYGT 196
Query: 987 KCDIYSFGVVLLELITGK------SPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038
+ DI+S G++++E++ G+ SPVQ+++ D ++ H++ P F +R+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 68/251 (27%), Positives = 114/251 (45%), Gaps = 19/251 (7%)
Query: 810 IGRGACGTVYKATLANGEV-IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G GA G V A +A+KK+ + A E+ L + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLD- 81
Query: 869 CYHQDSNLLLYE--YMENGSLGEQLHG-NKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
+ S+L ++ Y+ +G L+ K L D ++ + GL Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYIH---SA 137
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKV 984
IIHRD+K +NI ++E+ + + DFGLA+ D M+ + Y APE M
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHY 193
Query: 985 TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-VPTSELFDKRLDLSAK 1043
+ DI+S G ++ EL+TGK +L G D + ++R ++ + P EL K SA+
Sbjct: 194 NQTVDIWSVGCIMAELLTGK----TLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249
Query: 1044 RTVEEMTLFLK 1054
++ + K
Sbjct: 250 NYIQSLPQMPK 260
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-14
Identities = 82/300 (27%), Positives = 126/300 (42%), Gaps = 61/300 (20%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIK-----------LRGEGATADNS-FLAEISTL 854
G +G G G V A E I + K K L+ + D S ++E+ +
Sbjct: 17 GKPLGEGCFGQVVMA-----EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMM 71
Query: 855 GKI-RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNK--------QTC-----LL 900
I +H+NI+ L G C +L EY G+L E L + TC L
Sbjct: 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 901 DWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLP 959
+ A A G+ YL IHRD+ + N+L+ E+ + DFGLA+ + ++
Sbjct: 132 TFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188
Query: 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTW 1019
Y K + ++APE + T + D++SFGV+L E+ T LGG
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---------LGG----- 234
Query: 1020 VRRSIHEMVPTSELFD-----KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
S + +P ELF R+D A T E L++ I C P RPT ++++
Sbjct: 235 ---SPYPGIPVEELFKLLKEGHRMDKPANCTHE---LYM-IMRECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 804 FSEGAVIGRGACGTVYKATL-ANGEVIAVKKI-KLRGEGATADNSFLAEISTLGKIRHRN 861
F V+G+G G V + A G++ A KK+ K R + + L E L K+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 862 IVKLYGFCYH-QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+V L + Y +D+ L+ M G L ++ R AAE C L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF----DEERAVFYAAEITCGLE 116
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
R I++RD+K NILLD+ + D GLA +++P +++ G+ GY+APE
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVK 174
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSPVQ 1008
+ T D + G ++ E+I GKSP +
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 74/246 (30%), Positives = 100/246 (40%), Gaps = 58/246 (23%)
Query: 802 GNFSEGAVIGRGACGTVY----KATLANGEVIAVKKIK-----LRGEGATADNSFLAEIS 852
+F VIGRGA G V+ K T G+V A+K ++ R + A AE
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDT---GQVYAMKVLRKSDMIKRNQIA----HVRAERD 53
Query: 853 TLGKIRHRNIVKLYGFCYHQDSNLLLY--EYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
L IVKLY QD L EYM G L L ++ + AR+ IA
Sbjct: 54 ILADADSPWIVKLY--YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFYIA- 108
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLI----DLPYSKSM 964
E + L + IHRDIK +NIL+D + H+ DFGL K + D Y +
Sbjct: 109 ---ELVLALDSVHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLND 163
Query: 965 S------------------------AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLEL 1000
S + G+ YIAPE +CD +S GV+L E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223
Query: 1001 ITGKSP 1006
+ G P
Sbjct: 224 LYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADN---SFLAEISTLGKIRHR-NIVK 864
I +GA G+VY A + G+ A+K +K A N + AE + + + K
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLK--KSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLL--DWDARYRIALGAAE---GLCYL 919
LY +D L+ EY+ G + K L DW +Y AE G+ L
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQY-----IAEVVLGVEDL 113
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA 979
H IIHRDIK N+L+D+ + DFGL++ G+ Y+APE
Sbjct: 114 HQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----KKFVGTPDYLAPETI 165
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ + D +S G V+ E + G P
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 30/222 (13%)
Query: 806 EGAVIGRGACGTVYKAT-LANGEVI----AVKKIKLRGEGATADNSFLA---EISTLGKI 857
+ ++G G GTV+K + G+ I A+K I+ R + +F + +G +
Sbjct: 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR----SGRQTFQEITDHMLAMGSL 66
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAA 913
H IV+L G C S L+ + GSL + + ++ + LL+W + A
Sbjct: 67 DHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIA 119
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM--SAIAGSY 971
+G+ YL ++HR++ + NILL + + DFG+A L+ P K S
Sbjct: 120 KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL-YPDDKKYFYSEHKTPI 175
Query: 972 GYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLEL 1012
++A E + T + D++S+GV + E+++ G P +
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 39/277 (14%)
Query: 809 VIGRGACGTVYKATLA-NGEVIAVK-KIKLRGEGAT--ADNSFLAEISTLGKIRHRNIVK 864
V+G GA GTVYK +GE + + IK+ E + A+ L E + + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEGLCYLH 920
L G C L+ + M G L + + NK LL+W + A+G+ YL
Sbjct: 74 LLGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY--GYIAPEY 978
+ R ++HRD+ + N+L+ + DFGLA+L+D+ A G ++A E
Sbjct: 127 -EVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDID-ETEYHADGGKVPIKWMALES 182
Query: 979 AYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037
+ T + D++S+GV + EL+T G P + R I +++ E R
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---------AREIPDLLEKGE----R 229
Query: 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
L T++ + +K C RP RE++
Sbjct: 230 LPQPPICTIDVYMIMVK----CWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-14
Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 42/217 (19%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVKKIKL----------------RGEGATADNSFLAEI 851
V+G+G+ G V A L GE AVK +K R +N FL +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 852 STLGKIRHRNIVKLYGFCYHQDSNLLLY--EYMENGSLGEQLHGNKQTCLLDWDARYRIA 909
+C Q L + E++ G L + + L YR
Sbjct: 62 ----------------YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL------YRAT 99
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAG 969
AAE +C L + II+RD+K +N++LD + + DFG+ K +++ S G
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCG 158
Query: 970 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ YIAPE +K T D +SFGV+L E++ G+SP
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 47/141 (33%), Positives = 71/141 (50%), Gaps = 9/141 (6%)
Query: 868 FCYHQDSNLLLY--EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
FC Q L + EY+ G L + + + D R AAE +C L + +
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFD---EARARFYAAEIICGLQFLHKK 115
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
II+RD+K +N+LLD++ + DFG+ K ++ S G+ YIAPE K
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 986 EKCDIYSFGVVLLELITGKSP 1006
E D +SFGV+L E++ G+SP
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 3e-14
Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 31/211 (14%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGAT-ADNSFLAEISTLGKIR-HRNIVKLY 866
+G+GA G V+KA EV+A+KKI AT A +F EI L ++ H NIVKL
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVKLL 73
Query: 867 GFCYHQDSNLLLY---EYMENGSLGEQLHGN-KQTCLLDWDARYRIALGAAEGLCYLHYD 922
+++ +Y EYME LH + L D RY I + L Y+H
Sbjct: 74 NV-IKAENDKDIYLVFEYMET-----DLHAVIRANILEDVHKRY-IMYQLLKALKYIH-- 124
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY----GYIAPE- 977
++IHRD+K +NILL+ + + + DFGLA+ + + + Y Y APE
Sbjct: 125 -SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 978 ----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
YT V D++S G +L E++ GK
Sbjct: 184 LLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 809 VIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKI-RHRNIVKL 865
VIG G G V KA + + IK E A+ D+ F E+ L K+ H NI+ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY------- 918
G C H+ L EY +G+L + L +++ +L+ D + IA A L
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 919 ------LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
+ Y + IHRD+ + NIL+ E + A + DFGL++ ++ K+M +
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--PVR 188
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++A E T D++S+GV+L E+++ G +P
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 808 AVIGRGACGTV----YKATLANGEVIAVKKIKLRGEGATAD--NSFLAE---ISTLGKIR 858
AV+GRG G V YK T GE+ A+K +K +G+ D S + E T R
Sbjct: 5 AVLGRGHFGKVLLAEYKKT---GELYAIKALK-KGDIIARDEVESLMCEKRIFETANSER 60
Query: 859 HRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE--- 914
H +V L+ C+ + ++ + EY G L +H + + R AA
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-------EPRAVFYAACVVL 112
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
GL YLH + I++RD+K +N+LLD E + DFGL K + + S G+ ++
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFGDRTSTFCGTPEFL 168
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
APE T D + GV++ E++ G+SP
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 79/283 (27%), Positives = 115/283 (40%), Gaps = 53/283 (18%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G GA G VYKA G + A K I+ + E D ++ EI L H IVKL G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YMVEIEILATCNHPYIVKLLGA 77
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYR------IALGAAEGLCYLHYD 922
Y ++ E+ G++ +L+ D I E L YLH
Sbjct: 78 FYWDGKLWIMIEFCPGGAV--------DAIMLELDRGLTEPQIQVICRQMLEALQYLH-- 127
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY-- 980
IIHRD+K+ N+LL + + DFG++ + S I Y ++APE
Sbjct: 128 -SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY-WMAPEVVMCE 185
Query: 981 TMKVTE---KCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD-- 1035
TMK T K DI+S G+ L+E+ + P HE+ P L
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPH-----------------HELNPMRVLLKIA 228
Query: 1036 ----KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
L +K ++ E FLK AL P RP+ +++
Sbjct: 229 KSEPPTLSQPSKWSM-EFRDFLKTAL---DKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 804 FSEGAVIGRGACGTVYKATLANGE-VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
F++ IG+G+ G V+K + V+A+K I L E EI+ L + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYV 64
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE---GLCY 918
K YG Y + + L ++ EY+ GS + L +D ++IA E GL Y
Sbjct: 65 TKYYG-SYLKGTKLWIIMEYLGGGSALDLLRAGP------FD-EFQIATMLKEILKGLDY 116
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSAIAGSYGYIAPE 977
LH + + IHRDIK+ N+LL E+ + DFG+A +L D + + G+ ++APE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE 171
Query: 978 YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
K DI+S G+ +EL G+ P
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-14
Identities = 39/90 (43%), Positives = 56/90 (62%), Gaps = 1/90 (1%)
Query: 557 LDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSI 616
L L G P ++ +L +L+ + LS N + G IP SLG + L L + N F+GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 617 PVALGQLTALQIALNISHNNLSGVIPYELG 646
P +LGQLT+L+I LN++ N+LSG +P LG
Sbjct: 483 PESLGQLTSLRI-LNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 10/193 (5%)
Query: 809 VIGRGACGTVYKATLANGEVIAVKKIKLRGEGATAD--NSFLAEISTLGKIRHRNIVKLY 866
++G+G G V+K TL + +AVK K E + FL+E L + H NIVKL
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCK---EDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
G C + ++ E + G L K L + AL AA G+ YL +
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLE---SKN 113
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTE 986
IHRD+ + N L+ E + DFG+++ D S + APE + +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 987 KCDIYSFGVVLLE 999
+ D++S+G++L E
Sbjct: 174 ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 68/244 (27%), Positives = 117/244 (47%), Gaps = 29/244 (11%)
Query: 810 IGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
IG G+ G KA L +G+ +K+I + E++ L ++H NIV+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 866 YGFCYHQDSNL-LLYEYMENGSLGEQLHGNK-----QTCLLDWDARYRIALGAAEGLCYL 919
Y + ++ NL ++ +Y E G L ++++ + + +LDW + +AL
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK-------- 115
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA 979
H R I+HRDIKS NI L ++ +GDFG+A++++ + + I Y Y++PE
Sbjct: 116 HVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPY-YLSPEIC 173
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG--DLVTWVRRSIHEMVPTSELFDKR 1037
K DI++ G VL E+ T K + E G +LV + R + V + +D R
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLK---HAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLR 230
Query: 1038 LDLS 1041
+S
Sbjct: 231 NLVS 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 49/268 (18%)
Query: 829 IAVKKIKLRGEGATADN--SFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMENG 885
+AVK +K + AT + ++E+ + I +H+NI+ L G C ++ EY G
Sbjct: 50 VAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 106
Query: 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY-------------LHYDCRPHIIHRDI 932
+L E L + + Y IA E + + + Y IHRD+
Sbjct: 107 NLREYLRARRP---PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDL 163
Query: 933 KSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIY 991
+ N+L+ E + DFGLA+ + ++ Y K + ++APE + T + D++
Sbjct: 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223
Query: 992 SFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD-----KRLDLSAKRTV 1046
SFGV++ E+ T LGG S + +P ELF R+D A T
Sbjct: 224 SFGVLMWEIFT---------LGG--------SPYPGIPVEELFKLLKEGHRMDKPANCT- 265
Query: 1047 EEMTLFLKIALFCSSTSPLNRPTMREVI 1074
E+ + ++ C P +RPT ++++
Sbjct: 266 NELYMMMRD---CWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 31/192 (16%)
Query: 829 IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLG 888
+AVK ++ A FL E+ L ++ NI +L G C ++ EYMENG L
Sbjct: 49 VAVKVLR-PDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 889 EQL-----------HGNK---QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKS 934
+ L +K + LL +A A G+ YL + +HRD+ +
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLL------YMATQIASGMRYLE---SLNFVHRDLAT 158
Query: 935 NNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS----YGYIAPEYAYTMKVTEKCDI 990
N L+ + + + DFG+++ +L YS + G ++A E K T K D+
Sbjct: 159 RNCLVGKNYTIKIADFGMSR--NL-YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215
Query: 991 YSFGVVLLELIT 1002
++FGV L E++T
Sbjct: 216 WAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 804 FSEGAVIGRGACGTVYKATLANGE-VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
F++ IG+G+ G V+K + V+A+K I L E EI+ L + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYV 64
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
K YG Y +D+ L ++ EY+ GS + L LD I +GL YLH
Sbjct: 65 TKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHS 119
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSAIAGSYGYIAPEYAY 980
+ + IHRDIK+ N+LL E + + DFG+A +L D + + G+ ++APE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIK 174
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSPVQSL 1010
K DI+S G+ +EL G+ P L
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 9/208 (4%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKL-RGEGATADNSFLAEISTLGKIRHR 860
NF IGRG VY+AT L + + +A+KK+++ A A + EI L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 861 NIVK-LYGFCYHQDSNLLLYEYMENGSLGEQL-HGNKQTCLLDWDARYRIALGAAEGLCY 918
N++K L F + N++L E + G L + + + KQ L+ ++ + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVL-ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
+H ++HRDIK N+ + +GD GL + + + S + Y Y++PE
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPER 177
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ K DI+S G +L E+ +SP
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 78/300 (26%), Positives = 126/300 (42%), Gaps = 61/300 (20%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIK-----------LRGEGATADNS-FLAEISTL 854
G +G G G V A E I + K K L+ + D S ++E+ +
Sbjct: 23 GKPLGEGCFGQVVMA-----EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77
Query: 855 GKI-RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQ---------TCLLDWDA 904
I +H+NI+ L G C ++ EY G+L E L + T + +
Sbjct: 78 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 905 RYR----IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLP 959
++ A A G+ YL IHRD+ + N+L+ E+ + DFGLA+ I +
Sbjct: 138 SFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 194
Query: 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTW 1019
Y K + ++APE + T + D++SFGV+L E+ T LGG
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LGG----- 240
Query: 1020 VRRSIHEMVPTSELFD-----KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
S + VP ELF R+D + T E+ + ++ C P RPT ++++
Sbjct: 241 ---SPYPGVPVEELFKLLKEGHRMDKPSNCT-NELYMMMRD---CWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 67/261 (25%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKK------IKLRGEGATADNSFLAEISTLG 855
+ +G G G V+ + A+K I+L+ E + E L
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN-----EKRVLK 56
Query: 856 KIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHG----NKQTCLLDWDARYRIAL 910
++ H I++L+ + H L +L EY+ G L L + T L Y
Sbjct: 57 EVSHPFIIRLF-WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-----Y---- 106
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK-LIDLPYSKSMSAIAG 969
A+E +C L Y I++RD+K NILLD+E + DFG AK L D ++ + G
Sbjct: 107 -ASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCG 160
Query: 970 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029
+ Y+APE + + D ++ G+++ E++ G P G I+E +
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---------IYEKIL 211
Query: 1030 TSEL-FDKRLDLSAKRTVEEM 1049
+L F + LDL AK ++++
Sbjct: 212 AGKLEFPRHLDLYAKDLIKKL 232
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
++G G GTVYKA L ++AVK I L ++E+ L K I+ YG
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPL-DITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 868 FCYHQDSNLLLYEYMENGSLG------EQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
+ ++ + E+M+ GSL E + G RIA+ +GL YL
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLG-------------RIAVAVVKGLTYL-- 111
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY----GYIAPE 977
I+HRD+K +N+L++ Q + DFG++ ++ +++IA +Y Y+APE
Sbjct: 112 -WSLKILHRDVKPSNMLVNTRGQVKLCDFGVS-------TQLVNSIAKTYVGTNAYMAPE 163
Query: 978 YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ D++S G+ +EL G+ P
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 25/211 (11%)
Query: 809 VIGRGACGTVY---KATLAN-GEVIAVK-----KIKLRGEGATADNSFLAEISTLGKIRH 859
V+G+G+ G V+ K T + G++ A+K +K+R T E L ++ H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK-----MERDILAEVNH 57
Query: 860 RNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
IVKL+ + + + L L+ +++ G L +L +K+ + D ++ +A A L +
Sbjct: 58 PFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDH 113
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK-LIDLPYSKSMSAIAGSYGYIAPE 977
LH II+RD+K NILLDEE + DFGL+K ID + K + G+ Y+APE
Sbjct: 114 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPE 168
Query: 978 YAYTMKVTEKCDIYSFGVVLLELITGKSPVQ 1008
T+ D +SFGV++ E++TG P Q
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 809 VIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKI-RHRNIVKL 865
VIG G G V +A + + IK+ E A+ ++ F E+ L K+ H NI+ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQL---------------HGNKQTCLLDWDARYRIAL 910
G C ++ + EY G+L + L HG T L + A
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST--LTSQQLLQFAS 126
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
A G+ Y IHRD+ + N+L+ E + + DFGL++ ++ K+M +
Sbjct: 127 DVATGM---QYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL--P 181
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++A E T K D++SFGV+L E+++ G +P
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 73/288 (25%), Positives = 122/288 (42%), Gaps = 49/288 (17%)
Query: 804 FSEGAVIGRGACGTVYKAT-LANGEVIAVK-KIKLRGEGAT--ADNSFLAEISTLGKIRH 859
F + V+G GA GTVYK + GE + + IK E + A+ L E + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 860 RNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEG 915
++ +L G C L+ + M G L + + +K LL+W + A+G
Sbjct: 69 PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY--GY 973
+ YL ++HRD+ + N+L+ + DFGLAKL+ K A G +
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD-EKEYHAEGGKVPIKW 177
Query: 974 IAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032
+A E T + D++S+GV + EL+T G P ++ +P SE
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP------------------YDGIPASE 219
Query: 1033 LFD-----KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
+ +RL T++ + +K C +RP RE+I
Sbjct: 220 ISSILEKGERLPQPPICTIDVYMIMVK----CWMIDADSRPKFRELII 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-13
Identities = 49/152 (32%), Positives = 69/152 (45%), Gaps = 20/152 (13%)
Query: 614 GSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQM 673
G IP + +L LQ ++N+S N++ G IP LG++ LE L L N G IP S+G+
Sbjct: 432 GFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 674 SLLVCNLSNNNLVGTVPNTTVFRRID--SSNFAGNRGLCMLGS--DCHQLMPPSHTPKKN 729
SL + NL+ N+L G VP R + S NF N GLC + C +
Sbjct: 491 SLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVG------ 544
Query: 730 WIKGGSTKEKLVSIISVIVGLISLSFIIGICW 761
K+ V V + L I +CW
Sbjct: 545 --------AKIGIAFGVSVAFLFL-VICAMCW 567
|
Length = 623 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 804 FSEGAVIGRGACGTVYKATLANG-EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
F++ IG+G+ G VYK EV+A+K I L E EI+ L + I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYI 64
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
+ YG Y + + L ++ EY+ GS + L L+ I +GL YLH
Sbjct: 65 TRYYG-SYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHS 119
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSAIAGSYGYIAPEYAY 980
+ + IHRDIK+ N+LL E+ + DFG+A +L D + + G+ ++APE
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIK 174
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSPVQSL 1010
K DI+S G+ +EL G+ P L
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+F + +G G G V K +G ++A K I L + A N + E+ L +
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIR-NQIIRELQVLHECNSPY 64
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
IV YG Y + E+M+ GSL + L K+ + + ++++ GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMS-AIAGSYGYIAPEYA 979
+ I+HRD+K +NIL++ + + DFG++ +LID SM+ + G+ Y++PE
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERL 174
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSPV 1007
+ + DI+S G+ L+EL G+ P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 56/220 (25%), Positives = 106/220 (48%), Gaps = 16/220 (7%)
Query: 810 IGRGACGTVYKA---TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
+G G GTV K + + +AVK +K + L E + + ++ + IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDW-DARYRIALGAAEGLCYLHYDCRP 925
G C +S +L+ E E G L + L NK + + +++++G + Y
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG-------MKYLEET 114
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAYTMK 983
+ +HRD+ + N+LL + A + DFGL+K + D Y K+ + + APE K
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 984 VTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRR 1022
+ K D++SFGV++ E + G+ P + ++ G ++ +
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMK-GNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 23/225 (10%)
Query: 797 LLEATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLG 855
L + G F ++G G G VYK + G++ A+K + + G+ + EI+ L
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLK 57
Query: 856 KI-RHRNIVKLYGFCYHQ------DSNLLLYEYMENGSLGEQLHGNKQTCLLD-WDARYR 907
K HRNI YG + D L+ E+ GS+ + + K L + W A
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-- 115
Query: 908 IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967
I GL +LH + +IHRDIK N+LL E + + DFG++ +D + + I
Sbjct: 116 ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 172
Query: 968 AGSYGYIAPEYAYTMKVTE-----KCDIYSFGVVLLELITGKSPV 1007
Y ++APE + + K D++S G+ +E+ G P+
Sbjct: 173 GTPY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-13
Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 16/148 (10%)
Query: 29 SLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPC-----NWIGVECTDFKVTS---VDLH 80
+L EE +L K+SL P WN PC W G +C +D
Sbjct: 369 TLLEEVSALQTLKSSLGLPLR--FGWNGD---PCVPQQHPWSGADCQFDSTKGKWFIDGL 423
Query: 81 GLN---LSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIP 137
GL+ L G + I L L N+S N + G+IP L + +SLE+LDL N +G IP
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 138 FQLFFINTLRKLYLCENYIFGEIPEEIG 165
L + +LR L L N + G +P +G
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 6e-13
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 806 EGAVIGRGACGTVYKATLANG---EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
EG +GRG G VYKA +G + A+K+I EG S EI+ L +++H N+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNV 60
Query: 863 VKLYG-FCYHQDSNL-LLYEYMENG-----SLGEQLHGNKQTCLLDWDARYRIALGAAEG 915
+ L F H D + LL++Y E+ NK+ L + +G
Sbjct: 61 IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 916 LCYLHYDCRPHIIHRDIKSNNILL----DEEFQAHVGDFGLAKLIDLPYS--KSMSAIAG 969
+ YLH + ++HRD+K NIL+ E + + D G A+L + P + +
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 970 SYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGK 1004
++ Y APE + T+ DI++ G + EL+T +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 6e-13
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 806 EGAVIGRGACGTVYKATLANG---EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
EG +GRG G VYKA +G A+K+I EG S EI+ L +++H N+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNV 60
Query: 863 VKLYG-FCYHQDSNL-LLYEYMENG-----SLGEQLHGNKQTCLLDWDARYRIALGAAEG 915
+ L F H D + LL++Y E+ NK+ L + +G
Sbjct: 61 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 916 LCYLHYDCRPHIIHRDIKSNNILL----DEEFQAHVGDFGLAKLIDLPYS--KSMSAIAG 969
+ YLH + ++HRD+K NIL+ E + + D G A+L + P + +
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 970 SYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGK 1004
++ Y APE + T+ DI++ G + EL+T +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-13
Identities = 55/196 (28%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G G+ TVYK + NG+++A+K I+L+ E T + + E S L ++H NIV L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHANIVLLHDI 71
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
+ +++ L++EY+ L + + +K L + GL Y+H + +I+
Sbjct: 72 IHTKETLTLVFEYVHT-DLCQYM--DKHPGGLHPENVKLFLFQLLRGLSYIH---QRYIL 125
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKC 988
HRD+K N+L+ + + + DFGLA+ +P S + S + Y P+ C
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 989 -DIYSFGVVLLELITG 1003
D++ G + +E+I G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 7e-13
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 24/155 (15%)
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
+ N +KLY ++L+ +Y+++G L + L + L +I E L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALND 124
Query: 919 LHYDCRPHIIHRDIKSNNILLDE-EFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
LH +IIH DIK N+L D + + ++ D+GL K+I P S G+ Y +PE
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPE 176
Query: 978 ------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y + D ++ GV+ EL+TGK P
Sbjct: 177 KIKGHNYDVSF------DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 7e-13
Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 20/203 (9%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYG 867
+G+G G V+ A + GE++A+K++K L E L + +VKL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 868 FCYHQDSNLLL-YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY---LHYDC 923
+ + D L L EY+ G L N L + AR+ +A E LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMA----EMFEAVDALH--- 118
Query: 924 RPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMK 983
IHRD+K N L+D + DFGL+K I + Y+ S + GS Y+APE
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI-VTYANS---VVGSPDYMAPEVLRGKG 174
Query: 984 VTEKCDIYSFGVVLLELITGKSP 1006
D +S G +L E + G P
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 809 VIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKI-RHRNIVKL 865
VIG G G V KA + + IK E A+ D+ F E+ L K+ H NI+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQL---------------HGNKQTCLLDWDARYRIAL 910
G C H+ L EY +G+L + L + T L A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST--LSSQQLLHFAA 119
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
A G+ YL + IHRD+ + NIL+ E + A + DFGL++ ++ K+M +
Sbjct: 120 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--P 174
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++A E T D++S+GV+L E+++ G +P
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-13
Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+F + + +G G G V+K + +G ++A K I L + A N + E+ L +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIR-NQIIRELQVLHECNSPY 64
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
IV YG Y + E+M+ GSL + L K+ + ++++ +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMS-AIAGSYGYIAPEYA 979
+ I+HRD+K +NIL++ + + DFG++ +LID SM+ + G+ Y++PE
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERL 174
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSPV 1007
+ + DI+S G+ L+E+ G+ P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-13
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL-- 865
++G+G+ G V+ A L + A+K +K + L + + + ++ L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK--------KDVVLMDDDVECTMVEKRVLSLAW 53
Query: 866 ------YGFCYHQDSNLLLY--EYMENGSLGEQLHGNKQTCLLDWDARY---RIALGAAE 914
+ +C Q L + EY+ G L + Q+C ++ R AAE
Sbjct: 54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI----QSC-----HKFDLPRATFYAAE 104
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
+C L + I++RD+K +NILLD + + DFG+ K L +K+ G+ YI
Sbjct: 105 IICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT-CTFCGTPDYI 163
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
APE K D +SFGV+L E++ G+SP
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 799 EATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKI-KLRGEGATADNSFLAEISTLGK 856
E T + + +G GA G V A G+ +A+KKI K A ++ E+ L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKH 65
Query: 857 IRHRNIVKLYGFCYHQDSNLLLYE--YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE 914
+RH NI+ L D + E Y LG LH + L+
Sbjct: 66 LRHENIISL------SDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILR 119
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
GL Y+H ++HRD+K +NIL++E + DFGLA++ D M+ + Y
Sbjct: 120 GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYVSTRYYR 172
Query: 975 APEYAYT-MKVTEKCDIYSFGVVLLELITGK 1004
APE T K + DI+S G + E++ GK
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 17/219 (7%)
Query: 807 GAVIGRGACGTVYKATLANGEVI---AVKKIKLRGEGATADNSFLAEISTLGKIRHRNIV 863
G +G G G+V + L + I AVK +K+ + FL+E + + H N++
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 864 KLYGFCYHQDSN------LLLYEYMENGSLGEQLHGNK---QTCLLDWDARYRIALGAAE 914
+L G C + +++ +M++G L L ++ L + A
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGY 973
G+ YL IHRD+ + N +L+E V DFGL+K I + Y + +
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 974 IAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLE 1011
IA E T K D++SFGV + E+ T G++P +E
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 18/153 (11%)
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSL----GEQLHGNKQTCLLDWDARYRIALGAAEGL 916
N+V L+ + +DS L+ ++ E G L + L+ + C+ W A +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN-IPEECVKRWAAEMVVALDA---- 100
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
LH R I+ RD+ NNILLD+ + H+ ++ ++ S A+ Y AP
Sbjct: 101 --LH---REGIVCRDLNPNNILLDD--RGHIQLTYFSRWSEVEDSCDGEAV--ENMYCAP 151
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009
E + TE CD +S G +L EL+TGK+ V+
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVEC 184
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 74/278 (26%), Positives = 106/278 (38%), Gaps = 31/278 (11%)
Query: 810 IGRGACGTVYKATLANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKIRHRNIVKLYG 867
IG G G V G A +K AT D FL E+ ++ H N+++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 868 FCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY--RIALGAAEGLCYLHYDCRP 925
C LL+ E+ G L L N+ R+A A GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP--YSKSMSAIAGSYGYIAPEYA---- 979
IH D+ N L + +GD+GLA L P Y + A ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 980 ---YTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035
T+K +I+S GV + EL T P L ++ V R +P +L
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-DEQVLKQVVREQDIKLPKPQL-- 235
Query: 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
L S + + ++ FC P RPT EV
Sbjct: 236 -DLKYSDR--------WYEVMQFC-WLDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 41/97 (42%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 180 LTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKL 239
L G IP ISKLR L+ I NS+ G IPP + LEVL L+ NS G +P L +L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 240 RNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSF 276
+L L L N LSG +P +G LH SF
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGG------RLLHRASF 520
|
Length = 623 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 66/247 (26%), Positives = 109/247 (44%), Gaps = 34/247 (13%)
Query: 810 IGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864
+G A G +YK L + +++A+K +K F E S + ++ H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQL-----HGNKQTCLLDWDARYR----------IA 909
L G + +L+EY+ G L E L H + C D D + IA
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSD-VGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 910 LGAAEGLCYL--HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSA 966
+ A G+ YL H+ +H+D+ + NIL+ E+ + D GL++ I Y +
Sbjct: 131 IQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 967 IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIH 1025
++ PE K + DI+SFGVVL E+ + G P +++ VR+
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQEVIEMVRK--R 242
Query: 1026 EMVPTSE 1032
+++P SE
Sbjct: 243 QLLPCSE 249
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 808 AVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATAD-NSFLAEISTLGKI-RHRNIVK 864
V+G+G+ G V A L E+ AVK +K D + E L +H + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 865 LYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE---GLCYLH 920
L+ C+ L + EY+ G L H + + AR+ AAE GL +LH
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFY----AAEIVLGLQFLH 113
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
II+RD+K +N+LLD E + DFG+ K + + S G+ YIAPE
Sbjct: 114 ---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVTTSTFCGTPDYIAPEILS 169
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSP 1006
D ++ GV+L E++ G+SP
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G G TVYK + ++A+K+I+L E A + + E+S L ++H NIV L+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDI 72
Query: 869 CYHQDSNLLLYEYMENGSLGEQLH--GNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
+ + S L++EY++ L + L GN ++ GL Y H R
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGN----SINMHNVKLFLFQLLRGLNYCH---RRK 124
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY-TMKVT 985
++HRD+K N+L++E + + DFGLA+ +P +K+ S + Y P+ + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 986 EKCDIYSFGVVLLELITGK 1004
+ D++ G + E+ TG+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 83/302 (27%), Positives = 128/302 (42%), Gaps = 54/302 (17%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
VIG+G+ G V A GE +A+KKI E + L EI L +RH +IV++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 868 FCYHQDSN-----LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL-GAAEGLCYLHY 921
+++E ME+ L + + N ++ L L Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT----PEHHQFFLYQLLRALKYIH- 120
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK--LIDLPYSKSMSAIAGSYGYIAPEY- 978
++ HRD+K NIL + + + + DFGLA+ D P + + + Y APE
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 979 -AYTMKVTEKCDIYSFGVVLLELIT------GKSPVQSLELGGDL--------VTWV--- 1020
++ K T DI+S G + E++T GK+ V L+L DL ++ V
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238
Query: 1021 --RRSIHEM-----VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
RR + M VP S+ F D A R +E + F P +RPT E
Sbjct: 239 KARRYLSSMRKKQPVPFSQKFPN-ADPLALRLLERLLAF----------DPKDRPTAEEA 287
Query: 1074 IA 1075
+A
Sbjct: 288 LA 289
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 804 FSEGAVIGRGACGTVYKATL----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH 859
F+ G ++G+G G+V +A L + + +AVK +K ++ FL E + + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 860 RNIVKLYGFCYHQDSN------LLLYEYMENGSL---------GEQLHGNKQTCLLDWDA 904
N++KL G + +++ +M++G L GE+ L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 905 RYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKS 963
R + A G+ YL + IHRD+ + N +L+E V DFGL+K I Y +
Sbjct: 117 --RFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 964 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLE 1011
A ++A E T D+++FGV + E++T G++P +E
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 808 AVIGRGACGTVYKATL-ANGEVIAVK----KIKLRGEGATADNSFLAEISTLGK-IRHRN 861
VIG+G+ G V A ++G AVK K L+ + N +AE + L K ++H
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK---EQNHIMAERNVLLKNLKHPF 57
Query: 862 IVKL-YGFCYHQDSNLLLY--EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
+V L Y F Q + L + +Y+ G L H ++ C L+ AR+ A A + Y
Sbjct: 58 LVGLHYSF---QTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVASAIGY 111
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
LH +II+RD+K NILLD + + DFGL K P ++ S G+ Y+APE
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFCGTPEYLAPEV 167
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG 1013
D + G VL E++ G P S ++
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 67/288 (23%), Positives = 121/288 (42%), Gaps = 42/288 (14%)
Query: 810 IGRGACGTVYKATLANGEV-------IAVKKIKLRGEGATADN--SFLAEISTLGKIRHR 860
+G+G+ G VY+ +A G V +A+K + E A+ FL E S + +
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCH 69
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENG-------SLGEQLHGNKQTCLLDWDARYRIALGAA 913
++V+L G L++ E M G SL ++ N ++A A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYG 972
+G+ YL+ + +HRD+ + N ++ E+F +GDFG+ + I + Y +
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031
+++PE T D++SFGVVL E+ T + P Q + + V
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---------NEQVLRFVMEG 237
Query: 1032 ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079
L DK + + ++ C +P RP+ E+I+ + +
Sbjct: 238 GLLDKPDNCP--------DMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 29/195 (14%)
Query: 828 VIAVKKIKLRGEGA-TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGS 886
++AVK LR + A N FL E+ L +++ NI++L G C +D ++ EYMENG
Sbjct: 48 LVAVKI--LRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 887 LGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI----------------IHR 930
L + L + L D + A+ A L + Y H+ +HR
Sbjct: 106 LNQFLSSHH---LDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162
Query: 931 DIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS----YGYIAPEYAYTMKVTE 986
D+ + N L+ E + DFG+++ + Y+ I G ++A E K T
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNL---YAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219
Query: 987 KCDIYSFGVVLLELI 1001
D+++FGV L E++
Sbjct: 220 ASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 810 IGRGACGTVYKATLANGEVIAVKK-IKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G GA G VYKA V+A K I + E D ++ EI L H NIVKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED--YMVEIDILASCDHPNIVKLLDA 70
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
Y++++ +L E+ G++ + + + L + R + E L YLH + II
Sbjct: 71 FYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KII 125
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTE-- 986
HRD+K+ NIL + + DFG++ + S I Y ++APE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRP 184
Query: 987 ---KCDIYSFGVVLLELITGKSPVQSL 1010
K D++S G+ L+E+ + P L
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 7e-12
Identities = 54/190 (28%), Positives = 81/190 (42%), Gaps = 43/190 (22%)
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
GL YLH I+HRDIK N+L++ + DFGLA++ + SK M+ + Y
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171
Query: 975 APEYA-----YTMKVTEKCDIYSFGVVLLELITGK------SPVQSLELGGDL------- 1016
APE YT V DI+S G + EL+ + SP+Q L+L DL
Sbjct: 172 APEILMGSRHYTSAV----DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227
Query: 1017 ---------VTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALF-----CSST 1062
+ R H+ L+ LS++ T E + L ++ +F S+
Sbjct: 228 AMRSACEGARAHILRGPHKPPSLPVLY----TLSSQATHEAVHLLCRMLVFDPDKRISAA 283
Query: 1063 SPLNRPTMRE 1072
L P + E
Sbjct: 284 DALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-12
Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 1/104 (0%)
Query: 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLI 496
L L + L G IP + R L + L N + G++P ++ +L L+L N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 497 PPEIGKLRNLERLHLSENYFVGYIPSEVGN-LEHLVTFNISSNS 539
P +G+L +L L+L+ N G +P+ +G L H +FN + N+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526
|
Length = 623 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 36/210 (17%)
Query: 809 VIGRGACGTVYKA-TLANGEVIAVKKIKLRG-EGA--TADNSFLAEISTLGKIRHRNIVK 864
+G G+ TVYK + G+++A+K+I+L EGA TA + E S L ++H NIV
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA----IREASLLKDLKHANIVT 67
Query: 865 LYGFCYHQDSNLLLYEYMENG------SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
L+ + + + L++EY++ G L + L +++ GL Y
Sbjct: 68 LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFL-----FQLL----RGLAY 118
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
H + ++HRD+K N+L+ E + + DFGLA+ +P SK+ S + Y P+
Sbjct: 119 CH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-SKTYSNEVVTLWYRPPDV 174
Query: 979 -----AYTMKVTEKCDIYSFGVVLLELITG 1003
Y+ + D++ G + E+ TG
Sbjct: 175 LLGSTEYSTSL----DMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G G TV+K + ++A+K+I+L E A + + E+S L ++H NIV L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKNLKHANIVTLHDI 71
Query: 869 CYHQDSNLLLYEYMENGSLGEQLH--GNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
+ + L++EY+++ L + L GN L+ GL Y H +
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY-TMKVT 985
I+HRD+K N+L++E+ + + DFGLA+ +P +K+ S + Y P+ + + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 986 EKCDIYSFGVVLLELITGK 1004
D++ G +L E+ TG+
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G G+ TVYK + NG+++A+K I ++ E + + E S L ++H NIV L+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA-IREASLLKGLKHANIVLLHDI 71
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
+ +++ ++EYM Q L ++ R GL Y+H HI+
Sbjct: 72 IHTKETLTFVFEYMHTDL--AQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQHIL 125
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY-TMKVTEK 987
HRD+K N+L+ + + DFGLA+ +P S++ S+ + Y P+ +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 988 CDIYSFGVVLLELITGKSPV 1007
DI+ G + +E++ G P
Sbjct: 185 LDIWGAGCIFIEMLQG-QPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 810 IGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATAD--NSFLAEISTLGKIRHRNIVKLY 866
IGRG G V+ L A+ +AVK + E D FL E L + H NIV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL------GAAEGLCYLH 920
G C + ++ E ++ G T L R ++ AA G+ YL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDF--------LTFLRTEGPRLKVKELIQMVENAAAGMEYLE 111
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL-IDLPYSKSMSAIAGSYGYIAPEYA 979
H IHRD+ + N L+ E+ + DFG+++ D Y+ + + APE
Sbjct: 112 ---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 980 YTMKVTEKCDIYSFGVVLLELIT-GKSPVQSL 1010
+ + + D++SFG++L E + G P +L
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANL 200
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 10/222 (4%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKKI-KLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
+G+G G V + N G++ A KK+ K R + + + L E L K+ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 868 FCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
+ + ++L L+ M G L ++ N L+ + + G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLH---SMD 115
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTE 986
I++RD+K N+LLD++ + D GLA ++L K+++ AG+ GY+APE +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 987 KCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028
D ++ G + E++ G++P + + RR++ + V
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 809 VIGRGACGTVYKATLANGEVI-AVKKIKLRG-EGATADNSFLAEISTLGK-IRHRNIVKL 865
VIG+G+ G V A E AVK ++ + + ++E + L K ++H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 866 YGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR 924
+ F + L + +Y+ G L H ++ C L+ AR+ A A L YLH
Sbjct: 62 H-FSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARF-YAAEIASALGYLH---S 114
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV 984
+I++RD+K NILLD + + DFGL K ++ ++ + S G+ Y+APE +
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 985 TEKCDIYSFGVVLLELITGKSPVQS 1009
D + G VL E++ G P S
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 53/188 (28%), Positives = 89/188 (47%), Gaps = 21/188 (11%)
Query: 828 VIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGS 886
++AVK LR + A N FL EI + +++ NI++L C D ++ EYMENG
Sbjct: 48 LVAVKM--LREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 887 LGEQLHGNK-QTCLLDWDARY-------RIALGAAEGLCYLHYDCRPHIIHRDIKSNNIL 938
L + L ++ Q D +A A G+ YL + +HRD+ + N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCL 162
Query: 939 LDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS----YGYIAPEYAYTMKVTEKCDIYSFG 994
+ + + + DFG+++ + YS I G +++ E K T D+++FG
Sbjct: 163 VGKNYTIKIADFGMSRNL---YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 219
Query: 995 VVLLELIT 1002
V L E++T
Sbjct: 220 VTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVK-----KIKLRGEGATADNSFLAEISTLGK-IRHRN 861
VIG+G+ G V A A+G+ AVK I + E +AE + L K ++H
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE----QKHIMAERNVLLKNVKHPF 57
Query: 862 IVKL-YGFCYHQDSNLLLY--EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
+V L Y F Q ++ L + +Y+ G L H ++ + AR+ A A L Y
Sbjct: 58 LVGLHYSF---QTADKLYFVLDYVNGGELF--FHLQRERSFPEPRARF-YAAEIASALGY 111
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
LH +II+RD+K NILLD + + DFGL K + +SK+ S G+ Y+APE
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEV 167
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009
D + G VL E++ G P S
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 68/219 (31%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 803 NFSEGAVIGRGACGTVY----KATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR 858
+F +++GRG G V KAT G++ A+K +K A SF E + I
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 859 HRN-IVKL-YGFCYHQDSN--LLLYEYMENGSLGEQLHGNKQTCLLDWD-ARYRIALGAA 913
+ I +L Y F QD + L+ EY G L L N+ D D A++ +A
Sbjct: 59 NSPWIPQLQYAF---QDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLA---- 109
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGY 973
E + +H + +HRDIK N+L+D + DFG A + + G+ Y
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 974 IAPEYAYTMKVTEK------CDIYSFGVVLLELITGKSP 1006
IAPE TM K CD +S GV+ E+I G+SP
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-11
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 809 VIGRGACGTVYKATLAN--GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
++GR + AT + E + K + L E A +E+ L H IVK +
Sbjct: 74 LVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYAR--SELHCLAACDHFGIVKHF 131
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCL--LDWDAR---YRIALGAAEGLCYLHY 921
D LL+ EY G L +Q+ + L +++ Y+I L E +H
Sbjct: 132 DDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDE----VHS 187
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS-----AIAGSYGYIAP 976
++HRD+KS NI L +GDFG +K YS S+S + G+ Y+AP
Sbjct: 188 RK---MMHRDLKSANIFLMPTGIIKLGDFGFSK----QYSDSVSLDVASSFCGTPYYLAP 240
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELITGKSPVQ 1008
E + ++K D++S GV+L EL+T P +
Sbjct: 241 ELWERKRYSKKADMWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-11
Identities = 35/88 (39%), Positives = 46/88 (52%)
Query: 365 LDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSI 424
L L L G IP + L +L + L N + G IPP +G + L VLD+S N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 425 PPHLCMYQKLIFLSLGSNRLSGNIPPGL 452
P L L L+L N LSG +P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 13/162 (8%)
Query: 848 LAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHG-NKQTCLLDWDARY 906
LAE + L ++ IV L F + L L NG GE H ++ AR+
Sbjct: 41 LAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFING--GELFHHLQREGRFDLSRARF 97
Query: 907 RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVG--DFGLAKLIDLPYSKSM 964
A E LC L + ++I+RD+K NILLD +Q H+ DFGL KL ++
Sbjct: 98 YTA----ELLCALENLHKFNVIYRDLKPENILLD--YQGHIALCDFGLCKL-NMKDDDKT 150
Query: 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ G+ Y+APE T+ D ++ GV+L E++TG P
Sbjct: 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 66/252 (26%), Positives = 112/252 (44%), Gaps = 32/252 (12%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY-- 866
+G GA G+V A GE +A+KK+ + E++ L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 867 ---GFCYHQDSNL-LLYEYME---NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
+ + L+ YM+ +G L +K L+ Y++ LC L
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV-----YQM-------LCGL 130
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA 979
Y IIHRD+K N+ ++E+ + + DFGLA+ D M+ + Y APE
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVI 186
Query: 980 YT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-VPTSELFDKR 1037
M + DI+S G ++ E++TGK +L G D + + + + VP E K
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242
Query: 1038 LDLSAKRTVEEM 1049
D +AK ++ +
Sbjct: 243 EDKAAKSYIKSL 254
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-11
Identities = 21/42 (50%), Positives = 26/42 (61%), Gaps = 1/42 (2%)
Query: 30 LTEEGVSLLEFKASL-IDPSNNLESWNSSDMTPCNWIGVECT 70
L ++ +LL FK+SL DPS L SWN S PC+W GV C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSF---LAE--ISTLGKIRHRNI 862
V+G+G+ G V A L EV A+K L+ + D+ + E I L +H +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAA-KHPFL 58
Query: 863 VKLYGFCYHQDSNLLLY--EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
L+ C Q + L + EY+ G L Q+ +++ +D R AAE L
Sbjct: 59 TALH--CCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-----FDEP-RSRFYAAEVTLALM 110
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
+ R +I+RD+K +NILLD E + DFG+ K L + + G+ YIAPE
Sbjct: 111 FLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPDYIAPEILQ 169
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSPVQS 1009
++ D ++ GV++ E++ G+ P ++
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 793 KYHNLLEATGNFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEI 851
KY NL ++G G+ G V K G+++A+KK + + EI
Sbjct: 2 KYENL----------GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREI 51
Query: 852 STLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGE-QLHGNKQTCLLDWDARYRIAL 910
L ++RH N+V L + L++E++++ L + + + N LD +
Sbjct: 52 RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLF 107
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
G+ + H +IIHRDIK NIL+ + + DFG A+ + P +A
Sbjct: 108 QILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR 164
Query: 971 YGYIAPEYAY-TMKVTEKCDIYSFGVVLLELITG 1003
+ Y APE K DI++ G ++ E++TG
Sbjct: 165 W-YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-11
Identities = 36/85 (42%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 466 NQ-LTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV 524
NQ L G +P + L++L ++ L N G IPP +G + +LE L LS N F G IP +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 525 GNLEHLVTFNISSNSLSGTIPHELG 549
G L L N++ NSLSG +P LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 6e-11
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 44/218 (20%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIK--------LRGEGATADNSFLAEISTLGKIRH 859
IG GA G V AT G +A+KKI R L EI L + +H
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT---------LREIKILRRFKH 62
Query: 860 RNIVKLY------GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDA----RYRIA 909
NI+ + F D ++ E ME L+ +T L D Y+I
Sbjct: 63 ENIIGILDIIRPPSFESFNDV-YIVQELMET-----DLYKLIKTQHLSNDHIQYFLYQI- 115
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL--PYSKSMSAI 967
GL Y+H +++HRD+K +N+LL+ + DFGLA++ D ++ ++
Sbjct: 116 ---LRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 968 AGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGK 1004
+ Y APE K T+ DI+S G +L E+++ +
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
V+G+G+ G V +G+ +KK+ LR + E L +++H NIV Y
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYR 65
Query: 868 FCYHQDSNLLLYEYM---ENGSLGEQLHGNKQTCLL-----DWDARYRIALGAAEGLCYL 919
+ + + LLY M E G L +L K L +W + +AL YL
Sbjct: 66 ESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ------YL 118
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA 979
H HI+HRD+K+ N+ L VGD G+A++++ + + I Y Y++PE
Sbjct: 119 H---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY-YMSPELF 174
Query: 980 YTMKVTEKCDIYSFGVVLLELITGK 1004
K D+++ G + E+ T K
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
IG GA G V A +G+ +A+KKI + T L E+ L +H NI+ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 868 FCY----HQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY------RIALGAAEGLC 917
++ + ME+ L +H ++ L + RY R GL
Sbjct: 72 ILRPPGADFKDVYVVMDLMES-DLHHIIHSDQP--LTEEHIRYFLYQLLR-------GLK 121
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID---LPYSKSMSAIAGSYGYI 974
Y+H +IHRD+K +N+L++E+ + +GDFG+A+ + + M+ + Y
Sbjct: 122 YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 975 APEYAYTM-KVTEKCDIYSFGVVLLELI------TGKSPVQSLEL 1012
APE ++ + T D++S G + E++ GK+ V L+L
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL 223
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-11
Identities = 83/311 (26%), Positives = 131/311 (42%), Gaps = 29/311 (9%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG GA G V A G +AVKK+ + T E+ L + H+NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
Q S L E+ + + E + N Q ++ D R++ + LC + + I
Sbjct: 89 FTPQKS---LEEFQDVYLVMELMDANLCQVIHMELDHE-RMSYLLYQMLCGIKHLHSAGI 144
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEK 987
IHRD+K +NI++ + + DFGLA+ + M+ + Y APE M E
Sbjct: 145 IHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKEN 202
Query: 988 CDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVE 1047
DI+S G ++ EL+ G Q G D + + I ++ S F RL + + VE
Sbjct: 203 VDIWSVGCIMGELVKGSVIFQ----GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE 258
Query: 1048 EMTLFLKIA---LFCSSTSP-------LNRPTMREVIAMMI----DARQSVSD---YPSS 1090
+ I+ LF P L R++++ M+ D R SV + +P
Sbjct: 259 NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318
Query: 1091 PTSETPLEADA 1101
P EA+A
Sbjct: 319 TVWYDPAEAEA 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 809 VIGRGACGTVYKATLANGEVIAVKKI----KLRGEGATADNSFLAEISTLGKIRHRNIVK 864
VIGRGA G V L N + + KI ++ TA F E L ++ I
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA--CFREERDVLVNGDNQWITT 65
Query: 865 LYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIA--LGAAEGLCYLHY 921
L+ + + ++NL L+ +Y G L L + D AR+ +A + A + + LHY
Sbjct: 66 LH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYLAEMVIAIDSVHQLHY 123
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFG-LAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
+HRDIK +NIL+D + DFG KL++ +S A+ G+ YI+PE
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQ 176
Query: 981 TM-----KVTEKCDIYSFGVVLLELITGKSP 1006
M K +CD +S GV + E++ G++P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 32/233 (13%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G+ G V+K G+++A+KK + L EI L +++H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH-YDCRPHI 927
+ L++EY ++ L E L N + + +I + + + H ++C
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNE-LEKNPRG--VPEHLIKKIIWQTLQAVNFCHKHNC---- 121
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY-----AYTM 982
IHRD+K NIL+ ++ Q + DFG A+++ P +A + Y APE Y
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-YRAPELLVGDTQYGP 180
Query: 983 KVTEKCDIYSFGVVLLELIT------GKSPVQSLELGGDLVTWVRRSIHEMVP 1029
V D+++ G V EL+T GKS V L L +R+++ +++P
Sbjct: 181 PV----DVWAIGCVFAELLTGQPLWPGKSDVDQLYL-------IRKTLGDLIP 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 17/245 (6%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G GA G+V A + +AVKK+ + E+ L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 869 CYHQDSNLLLYE-YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
S E Y+ +G L+ + L + + GL Y+H I
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SAGI 139
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTE 986
IHRD+K +N+ ++E+ + + DFGLA+ D M+ + Y APE M +
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYRAPEIMLNWMHYNQ 195
Query: 987 KCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV--PTSELFDKRLDLSAKR 1044
DI+S G ++ EL+ GK +L G D + ++R I E+V P+ E+ K A++
Sbjct: 196 TVDIWSVGCIMAELLKGK----ALFPGNDYIDQLKR-IMEVVGTPSPEVLKKISSEHARK 250
Query: 1045 TVEEM 1049
++ +
Sbjct: 251 YIQSL 255
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G G TV+K + ++A+K+I+L E A + + E+S L ++H NIV L+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDI 72
Query: 869 CYHQDSNLLLYEYMENG------SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
+ S L++EY++ G + + L Y+I GL Y H
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL-----YQIL----RGLAYCH-- 121
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY-T 981
R ++HRD+K N+L++E + + DFGLA+ +P +K+ S + Y P+ +
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGS 179
Query: 982 MKVTEKCDIYSFGVVLLELITGK 1004
+ + + D++ G + E+ +G+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 33/85 (38%), Positives = 48/85 (56%)
Query: 125 LDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAI 184
L L L G IP + + L+ + L N I G IP +G++TSLE L + N+ G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 185 PASISKLRQLRVIRAGHNSLSGPIP 209
P S+ +L LR++ NSLSG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 34/78 (43%), Positives = 46/78 (58%)
Query: 300 LNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQL 359
L G IP+++ I+LS N + G IP LG I +L +L L N GSIP LGQL
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 360 TQLHKLDLSINNLTGTIP 377
T L L+L+ N+L+G +P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-10
Identities = 69/261 (26%), Positives = 115/261 (44%), Gaps = 34/261 (13%)
Query: 113 PTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEE 172
++L ++L LDL N + + P + L++L L +N I +P + NL +L+
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKN 167
Query: 173 LVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFL 232
L + N+L+ +P +S L L + N +S +PPEI LE L L+ NS+
Sbjct: 168 LDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII--- 222
Query: 233 PSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKK 292
E+ ++ N+++L L L N LP+ +G LS L+
Sbjct: 223 ----------------------ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLET 259
Query: 293 LYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSI 352
L + N++ + LG+ T+ E+DLS N L+ +P L L L L +L
Sbjct: 260 LDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALL--LLLLELLLNLLLT-LK 314
Query: 353 PRELGQLTQLHKLDLSINNLT 373
EL + L ++ N T
Sbjct: 315 ALELKLNSILLNNNILSNGET 335
|
Length = 394 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 809 VIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN-----I 862
VIGRG+ V L N ++ A+K +K + D+ + + T + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVK---KELVHDDEDIDWVQTEKHVFEQASSNPFL 58
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
V L+ C+ S L L+ EY+ G L H +Q L + AR+ AAE L++
Sbjct: 59 VGLHS-CFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFY----AAEICIALNF 111
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
II+RD+K +N+LLD + + D+G+ K P + S G+ YIAPE
Sbjct: 112 LHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRG 170
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVT 1018
+ D ++ GV++ E++ G+SP + D+ T
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 43/246 (17%)
Query: 810 IGRGACGTVYKATL-ANGEVIAVKKI------KLRG-EGATADNSFLAEISTLGKIRHRN 861
+G+G G V + A G++ A KK+ K +G EGA + LA K+ R
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILA------KVHSRF 54
Query: 862 IVKL-YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWD----ARYRIALGAAEGL 916
IV L Y F D L++ M G L ++ +D + R A+ +
Sbjct: 55 IVSLAYAFQTKTDLCLVM-TIMNGGDLRYHIYN------VDEENPGFPEPRACFYTAQII 107
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS-AIAGSYGYIA 975
L + + II+RD+K N+LLD + + D GLA ++L +S + AG+ G++A
Sbjct: 108 SGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMA 165
Query: 976 PEYAYTMKVTEKCDIYSFGVVLLELITGKSP-------VQSLELGGDLVTWVRRSIHEMV 1028
PE + D ++ GV L E+I + P V++ EL +R +++ V
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-------QRILNDSV 218
Query: 1029 PTSELF 1034
+ F
Sbjct: 219 TYPDKF 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-10
Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 30/224 (13%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKI-KLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
IG+G G VY A +A+KKI + E FL E + H IV +Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 868 FCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGA--------AEGLCYL 919
C D Y+E +L L Q L + + ++GA + Y+
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK--------LIDLPYSKS-------- 963
H ++HRD+K +NILL + + D+G A L+D+ +
Sbjct: 130 H---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 964 -MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
I G+ Y+APE + +E DIY+ GV+L +++T P
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 81/345 (23%), Positives = 130/345 (37%), Gaps = 88/345 (25%)
Query: 807 GAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKI- 857
G +GRGA G V +A+ A+ +AVK +K EGATA + + E+ L I
Sbjct: 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLK---EGATASEYKALMTELKILIHIG 68
Query: 858 RHRNIVKLYG--------------FCYHQD-SNLL-----LYEYMENGSLGEQLHGNKQT 897
H N+V L G +C + SN L + N S ++ K+
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEG 128
Query: 898 CLLDWDARYRIALGAAEG-----------------------------LCY-------LHY 921
D+ A+ G + Y + +
Sbjct: 129 KKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEF 188
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYA 979
IHRD+ + NILL E + DFGLA+ I D Y + A ++APE
Sbjct: 189 LASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPESI 247
Query: 980 YTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038
+ T + D++SFGV+L E+ + G SP +++ + ++ P
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP--------- 298
Query: 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083
+ E+ I L C +P +RPT E++ ++ D Q
Sbjct: 299 ----EYATPEI---YSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 803 NFSEGAVIGRGACGTVY---KATLAN-GEVIAVK---KIKLRGEGATADNSFLAEISTLG 855
NF V+G GA G V+ K + G++ A+K K + + TA+++ E L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLE 59
Query: 856 KIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGA-A 913
+R + + + D+ L L+ +Y+ G L L+ + + R+ +
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE----SEVRVYIAEIV 115
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGY 973
L +LH + II+RDIK NILLD E + DFGL+K + + G+ Y
Sbjct: 116 LALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172
Query: 974 IAPEYAYTMKV--TEKCDIYSFGVVLLELITGKSP 1006
+APE + D +S GV+ EL+TG SP
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 48/208 (23%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 829 IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLG 888
+A+K +K E + D + E + ++ + IV++ G C ++ +L+ E G L
Sbjct: 25 VAIKVLKNENEKSVRD-EMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLN 82
Query: 889 EQLHGNKQTCLLD--WDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH 946
+ L G K + + +++++G + Y + +HRD+ + N+LL + A
Sbjct: 83 KFLSGKKDEITVSNVVELMHQVSMG-------MKYLEGKNFVHRDLAARNVLLVNQHYAK 135
Query: 947 VGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-G 1003
+ DFGL+K + D Y K+ SA + APE K + + D++S+G+ + E + G
Sbjct: 136 ISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYG 195
Query: 1004 KSPVQSLELGGDLVTWVRRSIHEMVPTS 1031
+ P + ++ G ++++++ + P
Sbjct: 196 QKPYKKMK-GPEVMSFIEQGKRLDCPAE 222
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 808 AVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR---HRNIV 863
A IG GA GTVYKA +G +A+K ++++ S + E++ L ++ H NIV
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 864 KLYGFCYHQDSN-----LLLYEYMENGSLGEQLHGNKQTCL-------LDWDARYRIALG 911
+L C ++ L++E+++ + +T L L + +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ---------DLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY 971
GL +LH +C I+HRD+K NIL+ Q + DFGLA++ +++ + +
Sbjct: 117 FLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTL 171
Query: 972 GYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK 1004
Y APE D++S G + E+ K
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 809 VIGRGACGTVYKATLAN-GEVIAVK-----KIKLR-GEGATADNSFLAEISTLGKIRHRN 861
+IGRG G VY A+ G++ A+K +IK++ GE + + + + G
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC---P 57
Query: 862 IVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+ + +H L + + M G L H ++ + + R+ A E + L
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDL--HYHLSQHGVFSEKEMRFY----ATEIILGLE 111
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
+ +++RD+K NILLDE + D GLA D K +++ G++GY+APE
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGYMAPEVLQ 168
Query: 981 TMKVTE-KCDIYSFGVVLLELITGKSPVQ 1008
+ D +S G +L +L+ G SP +
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 47/231 (20%)
Query: 808 AVIGRGACGTVYKA-TLANG-EVIAVKKIKLRGEGATADNSFLAEISTLGKIR---HRNI 862
A IG GA G V+KA L NG +A+K+++++ S + E++ L + H N+
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 863 VKLYGFCY---------------HQDSNLLLY--EYMENGSLGEQLHGNKQTCLLDWDAR 905
V+L+ C H D +L Y + E G E + D
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK----------DMM 116
Query: 906 YRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS 965
+++ GL +LH ++HRD+K NIL+ Q + DFGLA++ + +++
Sbjct: 117 FQLL----RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALT 167
Query: 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLE------LITGKSPVQSL 1010
++ + Y APE D++S G + E L G S V L
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 58/239 (24%), Positives = 99/239 (41%), Gaps = 39/239 (16%)
Query: 846 SFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR 905
SF S + ++ H+++V YG C D ++++ EY++ GSL L NK + W
Sbjct: 45 SFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK-- 102
Query: 906 YRIALGAAEGLCY-LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID------- 957
L A+ L + LH+ + H ++ + N+LL E G+ KL D
Sbjct: 103 ----LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158
Query: 958 LPYSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITG-KSPVQSLELGGD 1015
LP + I ++ PE + ++ D +SFG L E+ +G P+ +L+
Sbjct: 159 LPKEILLERIP----WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214
Query: 1016 LVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
L + ++ R L A + E L + C P RP+ R +I
Sbjct: 215 L---------------QFYEDRHQLPAPKWTELANLINQ----CMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 56/200 (28%), Positives = 81/200 (40%), Gaps = 37/200 (18%)
Query: 813 GACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL-----YG 867
G+ G V+ AT V KI +G + L E L + H +++++ G
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSG 129
Query: 868 --FCY---HQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
C H S+L Y + L D I EGL YLH
Sbjct: 130 AITCMVLPHYSSDLYTYLTKRSRPL-------------PIDQALIIEKQILEGLRYLH-- 174
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS-AIAGSYGYIAPEYAYT 981
IIHRD+K+ NI +++ Q +GD G A+ P +AG+ APE
Sbjct: 175 -AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ---FPVVAPAFLGLAGTVETNAPEVLAR 230
Query: 982 MKVTEKCDIYSFGVVLLELI 1001
K K DI+S G+VL E++
Sbjct: 231 DKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 810 IGRGACGTV-YKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G GA GTV G +A+KK+ + E+ L ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD- 81
Query: 869 CYHQDSNL-------LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
+ D +L L+ +M LG+ + K L D + +GL Y+H
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK----LSEDRIQFLVYQMLKGLKYIH- 135
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
IIHRD+K N+ ++E+ + + DFGLA+ D M+ + Y APE
Sbjct: 136 --AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYRAPEVILN 189
Query: 982 -MKVTEKCDIYSFGVVLLELITGK 1004
M T+ DI+S G ++ E++TGK
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 809 VIGRGACGTVYKATLANGEVI-AVKKIKLRGEGATADNSFLAEISTLGKI-----RHRNI 862
VIGRG+ V L E I A+K +K + D+ + + T + H +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVK---KELVNDDEDIDWVQTEKHVFEQASNHPFL 58
Query: 863 VKLYGFCYHQDSNLL-LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
V L+ C+ +S L + EY+ G L H +Q L + AR+ A + L YLH
Sbjct: 59 VGLHS-CFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLH- 113
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
II+RD+K +N+LLD E + D+G+ K P + S G+ YIAPE
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRG 170
Query: 982 MKVTEKCDIYSFGVVLLELITGKSP 1006
D ++ GV++ E++ G+SP
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYG 867
IG+G G V+K NG AVK + + D AE + L + H N+VK YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 868 FCYHQDSN-----LLLYEYMENGSLGEQLHGN-KQTCLLDWDARYRIALGAAEGLCYLHY 921
Y +D L+ E GS+ + + G K+ ++ I A GL +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGL-AKLIDLPYSKSMSAIAGSYGYIAPEY-- 978
+ IHRD+K NNILL E + DFG+ A+L ++ S G+ ++APE
Sbjct: 143 N---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIA 197
Query: 979 ---AYTMKVTEKCDIYSFGVVLLELITGKSPVQSL 1010
+CD++S G+ +EL G P+ L
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 30/222 (13%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN-IVKLYG 867
IG G G VYKA G+++A+KK +L + + L EIS L + IV+L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 868 FCYHQDSN-----LLLYEYMENGSLGE--QLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+ ++ N L++EY+++ L + +G L +G+ + H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQA-HVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY- 978
+ ++HRD+K N+L+D++ + D GL + +P I + Y APE
Sbjct: 128 ---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW-YRAPEVL 183
Query: 979 ----AYTMKVTEKCDIYSFGVVLLELIT------GKSPVQSL 1010
Y+ V DI+S G + E+ G S +Q L
Sbjct: 184 LGSTHYSTPV----DIWSVGCIFAEMSRKQPLFPGDSELQQL 221
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY-- 866
+G G+ G V+ A ++ + +AVKKI L + L EI + ++ H NIVK+Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 867 ------------GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE 914
G +S ++ EYME L L +Q L + AR
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLSEEHARL-FMYQLLR 125
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLD-EEFQAHVGDFGLAKLIDLPYSKS--MSAIAGSY 971
GL Y+H +++HRD+K N+ ++ E+ +GDFGLA+++D YS +S +
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 972 GYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGK 1004
Y +P + T+ D+++ G + E++TGK
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 46/231 (19%)
Query: 807 GAVIGRGACGTVYKA-TLANGEVIAVKKIKLR--GEGATADNSF----------LAEIST 853
GA +G G G V KA G+++A+KK+K+ T D L E+
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 854 LGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGE------QLHGNKQTCLLDWDARYR 907
+ +I+H NI+ L D L+ + M L + +L ++ C+L
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCIL------- 125
Query: 908 IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA----------KLID 957
L GL LH + + +HRD+ NI ++ + + DFGLA L
Sbjct: 126 --LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 958 LPYSKS---MSAIAGSYGYIAPEYAY-TMKVTEKCDIYSFGVVLLELITGK 1004
+ M++ + Y APE K D++S G + EL+TGK
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-----RHRNI 862
VIGRG+ V L + A+K IK + D+ + + T + H +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIK---KELVNDDEDIDWVQTEKHVFETASNHPFL 58
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
V L+ C+ +S L + E++ G L H +Q L + AR+ +AE L++
Sbjct: 59 VGLHS-CFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFY----SAEISLALNF 111
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
II+RD+K +N+LLD E + D+G+ K + + S G+ YIAPE
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 982 MKVTEKCDIYSFGVVLLELITGKSP 1006
D ++ GV++ E++ G+SP
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-10
Identities = 34/89 (38%), Positives = 48/89 (53%)
Query: 317 IDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTI 376
+ L L GFIP ++ + +L + L N ++G+IP LG +T L LDLS N+ G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 377 PLEFQNLTYLVDLQLFDNHLEGTIPPHIG 405
P LT L L L N L G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-10
Identities = 33/89 (37%), Positives = 46/89 (51%)
Query: 269 LALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFI 328
L L G +P ++ KL L+ + + N + G IP LG+ TS +DLS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 329 PRELGLIPNLCLLQLFENMLQGSIPRELG 357
P LG + +L +L L N L G +P LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 809 VIGRGACGTVYKATLAN-GEVIAVK-----KIKLRGEGATADNS--FLAEISTLGKIRHR 860
+IGRG G VY A+ G++ A+K +IK++ A N L+ +ST
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST----GDC 56
Query: 861 NIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE---GL 916
+ + +H L + + M G L H ++ + + R+ AAE GL
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEAEMRFY----AAEIILGL 110
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
++H +++RD+K NILLDE + D GLA D K +++ G++GY+AP
Sbjct: 111 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGYMAP 164
Query: 977 E-YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011
E + D +S G +L +L+ G SP + +
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK---- 864
IG+G G VY+ + + A+K + + +A+ I RNI+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL--------SKKEIVAKKEVAHTIGERNILVRTLL 52
Query: 865 -----LYG--FCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
+ G F + DS+L L+ +YM G L H K+ + A++ IA E +
Sbjct: 53 DESPFIVGLKFSFQTDSDLYLVTDYMSGGELF--WHLQKEGRFSEDRAKFYIA----ELV 106
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
L + + I++RD+K NILLD + DFGL+K +L +K+ + G+ Y+AP
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAP 165
Query: 977 EYAYTMK-VTEKCDIYSFGVVLLELITGKSP 1006
E K T+ D +S GV++ E+ G SP
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 809 VIGRGACGTVYKATLAN-GEVIAVK---KIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864
VIGRGA G V + N G+V A+K K ++ TA F E L R I
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETA--CFREERDVLVNGDRRWITN 65
Query: 865 L-YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWD-------ARYRIA--LGAAE 914
L Y F QD N L Y M+ G+ L T L ++ AR+ +A + A +
Sbjct: 66 LHYAF---QDENNL-YLVMDYYVGGDLL-----TLLSKFEDRLPEDMARFYLAEMVLAID 116
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIA-GSYGY 973
+ L Y +HRDIK +N+LLD+ + DFG + L L S +A G+ Y
Sbjct: 117 SVHQLGY------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDY 169
Query: 974 IAPEYAYTM-----KVTEKCDIYSFGVVLLELITGKSP 1006
I+PE M + +CD +S GV + E++ G++P
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 67/284 (23%), Positives = 115/284 (40%), Gaps = 34/284 (11%)
Query: 810 IGRGACGTVYKAT---LANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKIRHRNIVK 864
+G+G+ G VY+ + GE +K E A+ FL E S + ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQL-------HGNKQTCLLDWDARYRIALGAAEGLC 917
L G L++ E M +G L L N ++A A+G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYIAP 976
YL+ +HRD+ + N ++ +F +GDFG+ + I + Y + ++AP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035
E T D++SFGVVL E+ + + P Q L + + V D
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---------NEQVLKFVMDGGYLD 241
Query: 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079
+ D +R + M + C +P RPT E++ ++ D
Sbjct: 242 -QPDNCPERVTDLMRM-------CWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 66/210 (31%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 809 VIGRGACGTVYKATLANGEVIAVKKIKLRGE----GATADNSFLAEISTLGKIRHRNIVK 864
VIGRGA G V + + E I KI + E TA F E + L + I
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETA--CFREERNVLVNGDCQWITT 65
Query: 865 L-YGFCYHQDSN--LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
L Y F QD N L+ +Y G L L + D AR+ IA E + +H
Sbjct: 66 LHYAF---QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYIA----EMVLAIHS 117
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
+ H +HRDIK +N+LLD + DFG ++ + S G+ YI+PE
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 982 M-----KVTEKCDIYSFGVVLLELITGKSP 1006
M K +CD +S GV + E++ G++P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVKKIK----LRGEGATADNSFLAEISTLGKIR-HRNI 862
V+G+G+ G V A L +G + AVK +K L+ + + E L R H +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECT---MTEKRILSLARNHPFL 58
Query: 863 VKLYGFCYHQDSNLLLY--EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE---GLC 917
+LY C Q + L + E++ G L H K + AR+ AAE L
Sbjct: 59 TQLY--CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFY----AAEITSALM 110
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
+LH II+RD+K +N+LLD E + DFG+ K + K+ S G+ YIAPE
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPE 166
Query: 978 YAYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009
M D ++ GV+L E++ G +P ++
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 39/210 (18%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYG 867
IG G V KA + G+ A+K +K + N+ L EI L ++ H NI++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPNILRLIE 65
Query: 868 FCYHQDSNLL----------LYEYMENGS--LGEQLHGNKQTCLLDWDARYRIALGAAEG 915
+ + + L LYE ++ L E+ + LL +
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLL-------------KS 112
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID--LPYSKSMSAIAGSYGY 973
L ++H R I HRDIK NIL+ ++ + DFG + I PY++ +S + Y
Sbjct: 113 LDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS----TRWY 164
Query: 974 IAPEYAYTMKV-TEKCDIYSFGVVLLELIT 1002
APE T K DI++ G V E+++
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 25/185 (13%)
Query: 784 NYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGAT 842
+ F E KY L A IG+G G V+KA +++A+KK+ + E
Sbjct: 4 EFPFCDEVSKYEKL----------AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG 53
Query: 843 ADNSFLAEISTLGKIRHRNIVKLYGFCY--------HQDSNLLLYEYMENGSLGEQLHGN 894
+ L EI L ++H N+V L C ++ S L++E+ E+ G + N
Sbjct: 54 FPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKN 113
Query: 895 KQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954
+ L + ++ L GL Y+H R I+HRD+K+ NIL+ ++ + DFGLA+
Sbjct: 114 VKFTLSEIKKVMKMLL---NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
Query: 955 LIDLP 959
L
Sbjct: 168 AFSLS 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 913 AEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
A GL +LH II+RD+K +N++LD E + DFG+ K K+ G+
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKTTRTFCGTPD 166
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
YIAPE + D ++FGV+L E++ G+ P
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 809 VIGRGACGTVY----KATLANGEVIAVKKIK-----LRGEGATADNSFLAEISTLGKIRH 859
++G+G G V KAT G+ A+K +K + E A L E L RH
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHT----LTESRVLQNTRH 54
Query: 860 RNIVKL-YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGA--AEGL 916
+ L Y F H D + EY G L H +++ + AR+ GA L
Sbjct: 55 PFLTALKYSFQTH-DRLCFVMEYANGGELF--FHLSRERVFSEDRARF---YGAEIVSAL 108
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
YLH +++RD+K N++LD++ + DFGL K + +M G+ Y+AP
Sbjct: 109 GYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAP 164
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E D + GVV+ E++ G+ P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-09
Identities = 52/194 (26%), Positives = 82/194 (42%), Gaps = 17/194 (8%)
Query: 826 GEVIAVKKIK-LRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL-LYEYME 883
G +A+K ++ E F E + ++ H NIV L L ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 884 NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---D 940
+L E L + L R+ L + L H I+HRD+K NI++
Sbjct: 63 GRTLREVLAADG---ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 941 EEFQAHVGDFGLAKL------IDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFG 994
A V DFG+ L D+ + + G+ Y APE VT D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 995 VVLLELITGKSPVQ 1008
++ LE +TG+ VQ
Sbjct: 177 LIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 71/250 (28%), Positives = 99/250 (39%), Gaps = 71/250 (28%)
Query: 809 VIGRGACGTV----YKATLANGEVIAVKKIK----LRGEGAT---ADNSFLAEISTLGKI 857
VIGRGA G V K T G + A+KK++ L E A+ LAE
Sbjct: 8 VIGRGAFGEVRLVQKKDT---GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW-- 62
Query: 858 RHRNIVKLYGFCYHQDSN--LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIA--LGAA 913
+VKLY QD N L+ EY+ G + L K+ + + R+ IA + A
Sbjct: 63 ----VVKLY--YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAI 114
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK------------------- 954
+ + L Y IHRDIK +N+LLD + + DFGL
Sbjct: 115 DSIHKLGY------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 955 -----LIDLPYSKSMSA-------------IAGSYGYIAPEYAYTMKVTEKCDIYSFGVV 996
I P S A G+ YIAPE ++CD +S GV+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228
Query: 997 LLELITGKSP 1006
+ E++ G P
Sbjct: 229 MYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 80/313 (25%), Positives = 131/313 (41%), Gaps = 33/313 (10%)
Query: 810 IGRGACGTV---YKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
IG GA G V Y A L +A+KK+ + T E+ + + H+NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
Q S L E+ + + E + N Q ++ D R++ + LC + +
Sbjct: 90 NVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLLYQMLCGIKHLHSA 145
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
IIHRD+K +NI++ + + DFGLA+ + M+ + Y APE M
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYK 203
Query: 986 EKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRT 1045
E DI+S G ++ E+I G L G D + + I ++ F K+L + +
Sbjct: 204 ENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 1046 VEEM---------TLFLKIALFCSST-SPLNRPTMREVIAMM--IDARQSVS-----DYP 1088
VE LF + S + L R++++ M IDA + +S +P
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 1089 SSPTSETPLEADA 1101
P EA+A
Sbjct: 320 YINVWYDPSEAEA 332
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 17/214 (7%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGE-------VIAVKKIKLRGEGATADNSFLAEISTLG 855
NF V+G GA G V+ +G + +KK + + T +++ E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLE 59
Query: 856 KIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE 914
IR + + + D+ L L+ +Y+ G L L ++ + + + E
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF------KEQEVQIYSGE 113
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
+ L + + II+RDIK NILLD + DFGL+K + + G+ Y+
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 975 APEYAYTMKV--TEKCDIYSFGVVLLELITGKSP 1006
AP+ + D +S GV++ EL+TG SP
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-09
Identities = 64/249 (25%), Positives = 112/249 (44%), Gaps = 23/249 (9%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
+G GA G+V A G +AVKK+ + E+ L ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 869 -----CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC 923
+ +++ L ++ L + K L D ++ I GL Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLI-YQILRGLKYIH--- 137
Query: 924 RPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-M 982
IIHRD+K +N+ ++E+ + + DFGLA+ D M+ + Y APE M
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWM 193
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-VPTSELFDKRLDLS 1041
+ DI+S G ++ EL+TG+ +L G D + ++ + + P +EL K S
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGR----TLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 1042 AKRTVEEMT 1050
A+ ++ +T
Sbjct: 250 ARNYIQSLT 258
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 7/198 (3%)
Query: 808 AVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
V+G GA G V K E++A+KK K E + L E+ L ++ NIV+L
Sbjct: 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
+ L++EY+E L E L + Y L A C+ +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCH-----KND 120
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTE 986
I+HRDIK N+L+ + DFG A+ + + + + + Y +PE +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 987 KCDIYSFGVVLLELITGK 1004
D++S G +L EL G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 810 IGRGACGTVYKATLANGEV--IAVKKIKLRG--EGATADNSFLAEISTLGKIRHRNIVKL 865
+G G+ G V AT N + +A+K+ + + D+ F +E L I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNL 96
Query: 866 YGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALG---AAEGLCYLHY 921
YG + +S L L+ E++ G L NK R+ +G AA+ + Y
Sbjct: 97 YG-SFKDESYLYLVLEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQIVLIFEY 146
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
+I++RD+K N+LLD++ + DFG AK++D + G+ YIAPE
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLN 202
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011
+ + D ++ G+ + E++ G P + E
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPFYANE 232
|
Length = 340 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 24/160 (15%)
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
IHRD+ + NILL E + DFGLA+ I D Y + SA ++APE + T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-PLKWMAPESIFDKVYT 254
Query: 986 EKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL-DLSAK 1043
+ D++SFGV+L E+ + G SP +++ +E F +RL D +
Sbjct: 255 TQSDVWSFGVLLWEIFSLGASPYPGVQI------------------NEEFCQRLKDGTRM 296
Query: 1044 RTVEEMTLFL-KIALFCSSTSPLNRPTMREVIAMMIDARQ 1082
R E T + +I L C P RPT ++ ++ D Q
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-09
Identities = 69/256 (26%), Positives = 105/256 (41%), Gaps = 24/256 (9%)
Query: 770 FVPLEEQKNPEVIDNYY--FPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGE 827
F L + KN IDN+ + K K L ++ VIGRGA G V + +
Sbjct: 12 FPALRKNKN---IDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQ 68
Query: 828 VIAVKKIKLRGEGATADNS--FLAEISTLGKIRHRNIVKLYGFCYHQDSNLL--LYEYME 883
+ K+ + E +S F E + +V+L FC QD L + EYM
Sbjct: 69 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMP 126
Query: 884 NGSLGEQLHGNKQTCLLDWDARYRIA-LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE 942
G L + ++D + A AE + L +IHRD+K +N+LLD+
Sbjct: 127 GGDL--------VNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH 178
Query: 943 FQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSFGVVLL 998
+ DFG +D G+ YI+PE + +CD +S GV L
Sbjct: 179 GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238
Query: 999 ELITGKSPVQSLELGG 1014
E++ G +P + L G
Sbjct: 239 EMLVGDTPFYADSLVG 254
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-09
Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 17/236 (7%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGE-------VIAVKKIKLRGEGATADNSFLAEISTLG 855
NF V+G GA G V+ G + ++K L + T +++ E + L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT-RTERNVLE 59
Query: 856 KIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE 914
+R + + + ++ L L+ +Y+ G + L+ + R G E
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSG--E 113
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
+ L + + I++RDIK NILLD E + DFGL+K + + G+ Y+
Sbjct: 114 IILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 975 APEYAYTMKVTEKC-DIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029
APE K D +S G+++ EL+TG SP +LE + + V R I + P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPF-TLEGERNTQSEVSRRILKCDP 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 30/206 (14%)
Query: 810 IGRGACGTVY----KATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
+G+G+ GTVY K +A + +K+I + E L K+ H IVK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC-------LLDWDARYRIALGAAEGLCY 918
+ +D+ ++ EY E L +L K T + +W + + G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI----DLPYSKSMSAIAGSYGYI 974
+H + I+HRD+K+ NI L +GDFG+++L+ DL + G+ Y+
Sbjct: 122 MH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA-----TTFTGTPYYM 172
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLEL 1000
+PE K DI+S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 6e-09
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IGRGA G V A E +A+KKI + L EI L + H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 869 CY--HQDS---NLLLYEYMENGSLGEQLHG---NKQTCLLDWDARYRIALGAAEGLCYLH 920
H+++ ++YE M+ LH + QT L D +Y + GL Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELMDT-----DLHQIIRSSQT-LSDDHCQYFL-YQLLRGLKYIH 125
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY-- 978
+++HRD+K +N+LL+ + DFGLA+ M+ + Y APE
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 979 ---AYTMKVTEKCDIYSFGVVLLELITGK 1004
YT + D++S G + EL+ K
Sbjct: 182 NCSEYTTAI----DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-09
Identities = 37/100 (37%), Positives = 47/100 (47%), Gaps = 4/100 (4%)
Query: 908 IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSA 966
I E L YLH IIHRD+K+ NI LDE A +GDFG A KL P +
Sbjct: 190 IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 967 IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+G+ +PE K DI+S G+VL E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-09
Identities = 65/229 (28%), Positives = 97/229 (42%), Gaps = 35/229 (15%)
Query: 803 NFSEGAVIGRGACGTV----YKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR 858
+F VIGRGA G V +K++ +V A+K + +D++F E + +
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAFFWEERDI--MA 98
Query: 859 HRN---IVKLYGFCYHQDSNLL--LYEYMENGSLGEQLHGNKQTCLLDWDARYR----IA 909
H N IV+L QD L + EYM G L L N W Y +A
Sbjct: 99 HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPE-KWARFYTAEVVLA 154
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAG 969
L A + + IHRD+K +N+LLD+ + DFG +D G
Sbjct: 155 LDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG 205
Query: 970 SYGYIAPEYAYTMKVT----EKCDIYSFGVVLLELITGKSPVQSLELGG 1014
+ YI+PE + +CD +S GV L E++ G +P + L G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-09
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 810 IGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-------- 858
+G+GA G V A A E +A+KKI N F +I +R
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKIT---------NVFSKKILAKRALRELKLLRHF 58
Query: 859 --HRNIVKLYGF---CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAA 913
H+NI LY + L LYE + L + + + DA ++ +
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT----DAHFQSFI--Y 112
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS---MSAIAGS 970
+ LC L Y +++HRD+K N+L++ + + + DFGLA+ ++ M+ +
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 971 YGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGK 1004
Y APE + + T+ D++S G +L EL+ K
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-08
Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 16/242 (6%)
Query: 810 IGRGACGTV---YKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
IG GA G V Y A L +A+KK+ + T E+ + + H+NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
Q S L E+ + + E + N Q ++ D R++ + LC + +
Sbjct: 83 NVFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHE-RMSYLLYQMLCGIKHLHSA 138
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
IIHRD+K +NI++ + + DFGLA+ + M+ + Y APE M
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYK 196
Query: 986 EKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRT 1045
E DI+S G ++ E++ K L G D + + I ++ F K+L + +
Sbjct: 197 ENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 1046 VE 1047
VE
Sbjct: 253 VE 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 30/226 (13%)
Query: 809 VIGRGACGTVYKATLA-NGEVIAVK----KIKL-RGEGATADNSFLAEISTLGK-IRHRN 861
VIG+G+ G V A +G+ AVK KI L R E +AE + L K ++H
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE----QKHIMAERNVLLKNVKHPF 57
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
+V L+ + + +++ G L H ++ + AR+ A A L YLH
Sbjct: 58 LVGLHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLH- 113
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
+I++RD+K NILLD + + DFGL K + S + + G+ Y+APE
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM 1027
D + G VL E++ G P R + EM
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYC------------RDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 798 LEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI 857
L G F + ++ A G Y + EVI K E A L E L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD-----EVAHT----LTENRVLQNS 52
Query: 858 RHRNIVKL-YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGA--AE 914
RH + L Y F H D + EY G L H +++ + AR+ GA
Sbjct: 53 RHPFLTALKYSFQTH-DRLCFVMEYANGGELF--FHLSRERVFSEDRARF---YGAEIVS 106
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
L YLH + ++++RD+K N++LD++ + DFGL K + +M G+ Y+
Sbjct: 107 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYL 163
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
APE D + GVV+ E++ G+ P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 18/210 (8%)
Query: 798 LEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI 857
L G F + ++ A G Y + EVI K E A L E L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKD-----EVAHT----LTESRVLKNT 52
Query: 858 RHRNIVKL-YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
RH + L Y F +D + EY+ G L H +++ + R+ AE +
Sbjct: 53 RHPFLTSLKYSF-QTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFY----GAEIV 105
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
L Y I++RD+K N++LD++ + DFGL K + + +M G+ Y+AP
Sbjct: 106 SALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKE-GITDAATMKTFCGTPEYLAP 164
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E D + GVV+ E++ G+ P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-08
Identities = 27/79 (34%), Positives = 43/79 (54%)
Query: 158 GEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEG 217
G IP +I L L+ + + N++ G IP S+ + L V+ +NS +G IP + +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 218 LEVLGLAQNSLEGFLPSEL 236
L +L L NSL G +P+ L
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 11/100 (11%)
Query: 912 AAE---GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK--LIDLPYSKSMSA 966
AAE GL +LH R II+RD+K +N++LD E + DFG+ K ++D +++
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF-- 161
Query: 967 IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
G+ YIAPE + D +++GV+L E++ G+ P
Sbjct: 162 -CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 798 LEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI 857
L G F + ++ A G Y + EVI K E A + E L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-----EVAHT----VTESRVLQNT 52
Query: 858 RHRNIVKL-YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
RH + L Y F H D + EY G L H +++ + AR+ AE +
Sbjct: 53 RHPFLTALKYAFQTH-DRLCFVMEYANGGELF--FHLSRERVFTEERARFY----GAEIV 105
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
L Y +++RDIK N++LD++ + DFGL K + +M G+ Y+AP
Sbjct: 106 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAP 164
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E D + GVV+ E++ G+ P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-08
Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 33/242 (13%)
Query: 810 IGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G G V+ E K I RG + + E++ + +++H+NIV+ Y
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR-YID 79
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCL-----LDWDARYRIALGAAEGLCYLH-YD 922
+ +N LY ME G+ L N Q C ++ A I L Y H
Sbjct: 80 RFLNKANQKLYILMEFCDAGD-LSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLK 138
Query: 923 CRPH---IIHRDIKSNNILLDEEFQ-----------------AHVGDFGLAKLIDLPYSK 962
P+ ++HRD+K NI L + A +GDFGL+K I + S
Sbjct: 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SM 197
Query: 963 SMSAIAGSYGYIAPEYAY--TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWV 1020
+ S + Y Y +PE T +K D+++ G ++ EL +GK+P L++ +
Sbjct: 198 AHSCVGTPY-YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISEL 256
Query: 1021 RR 1022
+R
Sbjct: 257 KR 258
|
Length = 1021 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 11/102 (10%)
Query: 912 AAE---GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK--LIDLPYSKSMSA 966
AAE GL +LH II+RD+K +N++LD E + DFG+ K + D +K+
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF-- 161
Query: 967 IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQ 1008
G+ YIAPE + D ++FGV+L E++ G++P +
Sbjct: 162 -CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 67/295 (22%), Positives = 105/295 (35%), Gaps = 47/295 (15%)
Query: 809 VIGR----GACGTVYKATLANGEVIAVKKIKLRGEGATADNSFL-AEISTLGKIRHRNIV 863
+IG+ + K ++AVKKI L + D L EI T +++H NI+
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNIL 62
Query: 864 KLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
Y + DS L ++ M GS E L L A I L Y+H
Sbjct: 63 P-YVTSFIVDSELYVVSPLMAYGSC-EDLLKTHFPEGLPELAIAFILKDVLNALDYIH-- 118
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHV-----------GDFGLAKLIDLPYSKSMSAIAGSY 971
IHR +K+++ILL + + + + D P S +
Sbjct: 119 -SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS-----SVKNL 172
Query: 972 GYIAPEYAYT--MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029
+++PE EK DIYS G+ EL G P + + L+ VR ++ ++
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD 232
Query: 1030 TSELFDKRLDLSAKRTVEEMTL----------------FLKIALFCSSTSPLNRP 1068
S +S R+ E F + C P +RP
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 810 IGRGACGTVYKATL---ANGE---VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIV 863
+G G VYK L A GE +A+K +K + EG + F E +++H NIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE-EFKHEAMMRSRLQHPNIV 71
Query: 864 KLYGFCYHQDSNLLLYEYMENGSLGEQL-----HGNKQTCLLDWDAR--------YRIAL 910
L G + +++ Y + L E L H + + D + I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAG 969
A G+ +L H++H+D+ + N+L+ ++ + D GL + + Y K M
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 970 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT 1002
+++PE K + DI+S+GVVL E+ +
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 21/210 (10%)
Query: 835 KLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGN 894
K+ G +F S + ++ H+++VKLYG C +D N+++ EY++ G L LH
Sbjct: 36 KVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHRE 94
Query: 895 KQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL-----DEEFQ--AHV 947
K L W + +A A L YL ++H ++ NIL+ +E + +
Sbjct: 95 KNNVSLHW--KLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149
Query: 948 GDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY--TMKVTEKCDIYSFGVVLLELIT-GK 1004
D G+ + L + + I +IAPE +T D +SFG LLE+ + G+
Sbjct: 150 SDPGIPITV-LSREERVERIP----WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
Query: 1005 SPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034
P+ +L + + M +EL
Sbjct: 205 EPLSTLSSSEKERFYQDQHRLPMPDCAELA 234
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 26/162 (16%)
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
IHRD+ + NILL E + DFGLA+ I D Y + A ++APE + T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYT 259
Query: 986 EKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVP---TSELFDKRLDLS 1041
+ D++SFGV+L E+ + G SP +++ + ++ P T E++ LD
Sbjct: 260 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-- 317
Query: 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083
C P RPT E++ + + Q+
Sbjct: 318 -----------------CWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIK----LRGEGATADNSFLAEISTLGKI 857
+F G +G G+ G V A GE A+K +K L+ + E S L ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV---QHVAQEKSILMEL 75
Query: 858 RHRNIVKLYGFCYHQDSNLL--LYEYMENGSLGEQLHGNKQTCLLDWDARYRIA--LGAA 913
H IV + C QD N + L E++ G L L K + A++ A + A
Sbjct: 76 SHPFIVNMM--CSFQDENRVYFLLEFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAF 131
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYG 972
E YLH II+RD+K N+LLD + V DFG AK + D ++ + G+
Sbjct: 132 E---YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPE 180
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y+APE + + D ++ GV+L E I G P
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 72/251 (28%), Positives = 109/251 (43%), Gaps = 26/251 (10%)
Query: 834 IKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG-FCYHQDSNLLLYEYMENGSLGEQLH 892
IK G TA E L I H +I++L G F Y++ + L+L Y + L L
Sbjct: 122 IKAGQRGGTA-----TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLA 174
Query: 893 GNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952
+ + D A R L A + YLH + IIHRDIK+ NI ++ +GDFG
Sbjct: 175 AKRNIAICDILAIERSVLRAIQ---YLHEN---RIIHRDIKAENIFINHPGDVCLGDFGA 228
Query: 953 AKL-IDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK-SPVQSL 1010
A +D+ +K AG+ APE DI+S G+VL E+ T S +
Sbjct: 229 ACFPVDINANK-YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287
Query: 1011 ELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTS--PLNRP 1068
L GD + R I ++ S + A+ ++E+ + L +S P +RP
Sbjct: 288 GLDGDCDS--DRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGL-----AKKSSRKPGSRP 340
Query: 1069 TMREVIAMMID 1079
+ + ID
Sbjct: 341 LWTNLYELPID 351
|
Length = 391 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 61/239 (25%), Positives = 94/239 (39%), Gaps = 56/239 (23%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSF---LAEISTLGKIRHRNIVK 864
++G+G G V+ L G++ A+K + + N L E L + H +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDK--KEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC---YLHY 921
LY + L+ +Y G L L CL + AR+ AAE L YLH
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY----AAEVLLALEYLHL 121
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAK------------LIDLPYSKSMSAI 967
I++RD+K NILL E H+ DF L+K L S+++I
Sbjct: 122 L---GIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 968 A----------------GSYGYIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
G+ YIAPE + V D ++ G++L E++ G +P
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 67/259 (25%), Positives = 114/259 (44%), Gaps = 30/259 (11%)
Query: 770 FVPLEEQKNPEVIDNYY--FPKEGFKYHNLLEATGNFSEGAVIGRGACGTV----YKATL 823
F L + KN IDN+ + K +L ++ VIGRGA G V +K+T
Sbjct: 12 FPALRKNKN---IDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST- 67
Query: 824 ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN-IVKLYGFCYHQDSNL-LLYEY 881
+V A+K + +D++F E + + +V+L+ + + D L ++ EY
Sbjct: 68 --RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEY 124
Query: 882 MENGSLGEQLHGNKQTCLLDWDARYRIA--LGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939
M G L + + W AR+ A + A + + + + IHRD+K +N+LL
Sbjct: 125 MPGGDLVNLM--SNYDVPEKW-ARFYTAEVVLALDAIHSMGF------IHRDVKPDNMLL 175
Query: 940 DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSFGV 995
D+ + DFG ++ G+ YI+PE + +CD +S GV
Sbjct: 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235
Query: 996 VLLELITGKSPVQSLELGG 1014
L E++ G +P + L G
Sbjct: 236 FLYEMLVGDTPFYADSLVG 254
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 829 IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLG 888
+A+ ++ G FLAE TLG+ H NIV+L G ++ +++ EYM NG+L
Sbjct: 36 VAIHTLR-AGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 889 EQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVG 948
L K L + G A G+ YL +H+ + ++ +L++ + +
Sbjct: 95 SFLR--KHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKIS 149
Query: 949 DFGLAKLIDLPYSKSMSAIAGSYG------YIAPEYAYTMKVTEKCDIYSFGVVLLELIT 1002
F L K AI + + APE + D++SFG+V+ E+++
Sbjct: 150 GFR-----RLQEDK-SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
Query: 1003 -GKSP 1006
G+ P
Sbjct: 204 YGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-07
Identities = 32/82 (39%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 393 DNH-LEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPG 451
DN L G IP I HL +++S N++ G+IPP L L L L N +G+IP
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 452 LKTCRSLMQLMLGQNQLTGSLP 473
L SL L L N L+G +P
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-07
Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 39/184 (21%)
Query: 850 EISTLGKIRHRNIVKL--------YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLD 901
EI LG++ H NI+K+ + Q + LY +M + + K LL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-----KDRPLL- 266
Query: 902 WDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961
R I + LC + Y +IHRDIK NI L+ + + +GDFG A +P+
Sbjct: 267 KQTR-AIM---KQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA----MPFE 318
Query: 962 KSMSAIAGSYGYI------APEYAYTMKVTEKCDIYSFGVVLLELIT---------GKSP 1006
K A YG++ +PE E DI+S G++LL++++ G P
Sbjct: 319 KER--EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376
Query: 1007 VQSL 1010
+ L
Sbjct: 377 GKQL 380
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 49/189 (25%), Positives = 75/189 (39%), Gaps = 52/189 (27%)
Query: 862 IVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWD-ARYRIALGAAEGLCYL 919
+VKLY + + NL + +Y+ G + L + + + D AR+ IA E C +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFYIA----ELTCAI 114
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI------------DLPYSKSMS-- 965
+ IHRDIK +NIL+D + + DFGL D SM
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 966 ----------------------------AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVL 997
++ G+ YIAPE T+ CD +S GV+L
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234
Query: 998 LELITGKSP 1006
E++ G+ P
Sbjct: 235 YEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 67/249 (26%), Positives = 109/249 (43%), Gaps = 28/249 (11%)
Query: 809 VIGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
IG GA G V A G+ +A+KK+ + T E+ + + H+NI+ L
Sbjct: 23 PIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLN 82
Query: 868 FCYHQDSNLL----LYEYME--NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC---Y 918
+ +L +Y ME + +L + + LD + R++ + LC +
Sbjct: 83 -VFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHE---RMSYLLYQMLCGIKH 133
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
LH IIHRD+K +NI++ + + DFGLA+ S M+ + Y APE
Sbjct: 134 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 188
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038
M E DI+S G ++ E+I G L G D + + I ++ S+ F RL
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEMIRG----TVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244
Query: 1039 DLSAKRTVE 1047
+ + VE
Sbjct: 245 QPTVRNYVE 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 67/264 (25%), Positives = 101/264 (38%), Gaps = 78/264 (29%)
Query: 803 NFSEGAVIGRGACGTV-YKATLANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKIRH 859
+F VIG+GA G V G++ A+K + L+ E D AE L +
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 860 RNIVKLY-GFCYHQDSNLL--LYEYMENGSLGEQLHGNKQTCLLDWD------ARYRIA- 909
+V LY F QD+ L + E++ G L T L+ +D R+ +A
Sbjct: 61 PWVVSLYYSF---QDAQYLYLIMEFLPGGDL--------MTMLIKYDTFSEDVTRFYMAE 109
Query: 910 -LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA----KLIDLPYSK-- 962
+ A E + L + IHRDIK +NIL+D + DFGL+ K D Y +
Sbjct: 110 CVLAIEAVHKLGF------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 963 -----------------------SMS-----------------AIAGSYGYIAPEYAYTM 982
+MS + G+ YIAPE
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 983 KVTEKCDIYSFGVVLLELITGKSP 1006
++CD +S G ++ E + G P
Sbjct: 224 GYGQECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-07
Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 30/158 (18%)
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS----YGYIAPEYAYTMK 983
IHRD+ + NILL + DFGLA+ I + S + G+ ++APE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIR---NDSNYVVKGNARLPVKWMAPESIFNCV 292
Query: 984 VTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPT---SELFDKRLD 1039
T + D++S+G++L E+ + G SP + + ++ + P SE++D
Sbjct: 293 YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD---- 348
Query: 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
I C PL RPT ++++ ++
Sbjct: 349 ---------------IMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-06
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 27/183 (14%)
Query: 900 LDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959
LD D R + A+G+ +L + IHRD+ + N+LL + A + DFGLA+ I
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI--- 262
Query: 960 YSKSMSAIAGS----YGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGG 1014
+ S + G+ ++APE + T + D++S+G++L E+ + GKSP +
Sbjct: 263 MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI---- 318
Query: 1015 DLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
V ++MV R D + E+ +K+ C + P RPT ++
Sbjct: 319 ----LVNSKFYKMVKRGYQMS-RPDFAPP----EIYSIMKM---CWNLEPTERPTFSQIS 366
Query: 1075 AMM 1077
++
Sbjct: 367 QLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 809 VIGRGACGTVYKATLA----NGEVIAVKKIK----LRGEGATADNSFLAEISTLGKIRHR 860
V+G+G G V++ G++ A+K +K +R + TA AE + L ++H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVKHP 60
Query: 861 NIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
IV L + + L L+ EY+ G L L ++ ++ A + ++ + L +L
Sbjct: 61 FIVDLI-YAFQTGGKLYLILEYLSGGELFMHLE--REGIFMEDTACFYLS-EISLALEHL 116
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA 979
H + II+RD+K NILLD + + DFGL K + G+ Y+APE
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEIL 172
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ D +S G ++ +++TG P
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 84/368 (22%), Positives = 134/368 (36%), Gaps = 90/368 (24%)
Query: 804 FSEGAVIGRGACGTVYKA-TLANGEVIAVKKIK-----LRGEGATADNSFLAEISTLGKI 857
F + +G GA G V A + + A+K ++ LR + A AE L +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVK----AERDILAEA 58
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCLLDWDARYRIALGAAEG 915
+ +V+LY +D+ + +Y+ G + L G L AR+ IA E
Sbjct: 59 DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL----ARFYIA----EL 110
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI------------DLPYSKS 963
C + + IHRDIK +NIL+D + + DFGL D S
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 964 MS----------------------------------AIAGSYGYIAPEYAYTMKVTEKCD 989
M ++ G+ YIAPE T+ CD
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230
Query: 990 IYSFGVVLLELITGKSPVQS---LELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTV 1046
+S GV+L E++ G+ P + LE ++ W + S+H +P AK +
Sbjct: 231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVINW-QTSLH--IP----------PQAKLSP 277
Query: 1047 EEMTLFLKIALFCSSTSP-LNRPTMREVIAM----MIDARQSVSDYPSSPTSETPLEADA 1101
E L +K+ C L + E+ A ID + + + D
Sbjct: 278 EASDLIIKL---CRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDT 334
Query: 1102 SSRDSIAP 1109
S+ D + P
Sbjct: 335 SNFDPVDP 342
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 810 IGRGACGTVYKATLANGEVIA---VKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
IG G G V + + +A VK++K + N FL + ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 867 GFCYHQDSNLLLYEYMENGSLG------EQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
G C LL++EY E G L + N Q LL R+A A G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTHMH 116
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSAIAGSYGYIAPEYA 979
+ + +H D+ N L + VGD+G+ Y ++ ++APE
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 980 -------YTMKVTEKCDIYSFGVVLLEL 1000
T + T+ ++++ GV L EL
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 23/174 (13%)
Query: 847 FLAEISTLGKIRHRNIVKLYGFCYHQ-DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR 905
L E L + H+NI+ + C + +LY YM G+L L Q C L
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL----QQCRLGEANN 110
Query: 906 YR---------IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956
+ +A+ A G+ YLH + +IH+DI + N ++DEE Q + D L++
Sbjct: 111 PQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR-- 165
Query: 957 DLPYSKSMSAIAGSY---GYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
DL ++A E + + D++SFGV+L EL+T G++P
Sbjct: 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-06
Identities = 24/58 (41%), Positives = 30/58 (51%)
Query: 553 NLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGN 610
NL+ LDLS N+ T L NL++L LS N LT P + GL L L + GN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 65/253 (25%), Positives = 103/253 (40%), Gaps = 62/253 (24%)
Query: 803 NFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HR 860
+F VIGRGA G V + G V A+K ++ AD + E +G IR R
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR------KAD---MLEKEQVGHIRAER 52
Query: 861 NI---------VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
+I VK++ + + NL L+ E++ G + L K+ L + + ++ IA
Sbjct: 53 DILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIA- 108
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-------------- 956
E + + + IHRDIK +N+LLD + + DFGL +
Sbjct: 109 ---ETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165
Query: 957 ----DLPYSKSMS----------------AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVV 996
D + S + G+ YIAPE + CD +S GV+
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 997 LLELITGKSPVQS 1009
+ E++ G P S
Sbjct: 226 MYEMLIGYPPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 48/173 (27%), Positives = 82/173 (47%), Gaps = 13/173 (7%)
Query: 846 SFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR 905
+F S + ++ H++IV LYG C N+++ E++E G L +H +++ +L +
Sbjct: 50 AFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--RKSDVLTTPWK 107
Query: 906 YRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKLID--LPYSK 962
+++A A L YL ++H ++ + NILL E G F KL D +P +
Sbjct: 108 FKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITV 162
Query: 963 -SMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLEL-ITGKSPVQSLEL 1012
S +IAPE K + D +SFG L E+ G+ P++ L
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 810 IGRGACGTVYKATLANG---EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
IG G G V + +G + VK++++ FL E ++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR--YRIALGAAEGLCYLHYDCR 924
G C LL+ E+ G L L ++ L+ D R+A A GL +LH +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---K 118
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKL-IDLPYSKSMSAIAGSYGYIAPEYA---- 979
+ IH D+ N LL + +GD+GL+ Y + + +IAPE
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 980 ---YTMKVTEKCDIYSFGVVLLEL 1000
+ T++ +++S GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-06
Identities = 61/234 (26%), Positives = 87/234 (37%), Gaps = 49/234 (20%)
Query: 479 LQNLSALELYQNRFSGL----IPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFN 534
L L L L N + + +L+ L LS N G IP + +L
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSL------- 73
Query: 535 ISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAP---EELGQLVNLELLKLSDNKLTGA 591
L LQ LDLS N E L + +L+ LKL++N L
Sbjct: 74 ----------LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDR 123
Query: 592 ----IPSSLGGLA-RLTELQMGGNIFSG----SIPVALGQLTALQIALNISHNNLSG--- 639
+ L L L +L +G N G ++ AL L+ LN+++N +
Sbjct: 124 GLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKE-LNLANNGIGDAGI 182
Query: 640 -VIPYELGNLQMLEALYLDDNQL-------IGEIPASMGEQMSLLVCNLSNNNL 685
+ L LE L L++N L + E AS SL V NL +NNL
Sbjct: 183 RALAEGLKANCNLEVLDLNNNGLTDEGASALAETLAS---LKSLEVLNLGDNNL 233
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-06
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
G +IG G+ G VY+A + E +A+KK+ + N E+ + + H NI+ L
Sbjct: 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVL---QDPQYKNR---ELLIMKNLNHINIIFL 124
Query: 866 YGFCYHQ-----DSNLLLYEYMENGSLGEQLHG-------NKQTCLLDWDARYRIALGAA 913
+ Y + + N+ L ME + + +H N L Y L A
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVME--FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQA-HVGDFGLAKLIDLPYSKSMSAIAGSYG 972
L Y+H I HRD+K N+L+D + DFG AK + L +S+S I +
Sbjct: 183 --LAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL-LAGQRSVSYICSRF- 235
Query: 973 YIAPEYAY-TMKVTEKCDIYSFGVVLLELITG 1003
Y APE T D++S G ++ E+I G
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-05
Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 7/94 (7%)
Query: 907 RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS- 965
R L A + Y+H IIHRDIK+ N+L++ +GDFG A +S
Sbjct: 267 RQLLSAID---YIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320
Query: 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLE 999
IAG+ APE T DI+S G+V+ E
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 37/185 (20%), Positives = 66/185 (35%), Gaps = 33/185 (17%)
Query: 805 SEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIV- 863
S ++ G VY + + + +K R +GA E++ L + + +
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYV-LKINPSREKGAD----REREVAILQLLARKGLPV 55
Query: 864 -KLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
K+ + LL E++E +L E + + + IA AE L LH
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQL 105
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
+ H D+ NIL+D+ + +ID Y+ YG A + A +
Sbjct: 106 PLLVLCHGDLHPGNILVDDG--------KILGIIDWEYA--------GYGPPAFDLAAAL 149
Query: 983 KVTEK 987
Sbjct: 150 LFNLL 154
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 62/246 (25%), Positives = 99/246 (40%), Gaps = 48/246 (19%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADN--SFLAEISTLGKIRHR 860
+F VIGRGA G V + I KI + + + AE L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 861 NIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIA--LGAAEGLC 917
+VK++ + + NL L+ E++ G + L K+ L + ++ IA + A + +
Sbjct: 62 WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIH 118
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-------------KLIDLP----- 959
L + IHRDIK +N+LLD + + DFGL L P
Sbjct: 119 QLGF------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 960 ------------YSKSMSAIA----GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITG 1003
+ K+ +A G+ YIAPE + CD +S GV++ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 1004 KSPVQS 1009
P S
Sbjct: 233 YPPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-05
Identities = 55/170 (32%), Positives = 76/170 (44%), Gaps = 29/170 (17%)
Query: 810 IGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATAD-------NSFLAEISTLGKIRHRN 861
I RGA G VY N ++ AVK +K AD + AE L +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVK------KADMINKNMVHQVQAERDALALSKSPF 65
Query: 862 IVKLYGFCYHQDSNL-LLYEYMENGSLGEQLH--GNKQTCLLDWD-ARYRIALGAAEGLC 917
IV LY + +N+ L+ EY+ G + LH G D + A I+ A L
Sbjct: 66 IVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYG-----YFDEEMAVKYIS-EVALALD 118
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967
YLH R IIHRD+K +N+L+ E + DFGL+K + L +M I
Sbjct: 119 YLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK-VTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 60/252 (23%), Positives = 89/252 (35%), Gaps = 47/252 (18%)
Query: 234 SELEKLRNLTDLILWQNHLSGE----IPPTIGNIQSLELLALHENSFSGGLPKE------ 283
L KL L L L N L E + + SL+ L L N +G +P+
Sbjct: 17 ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQ 75
Query: 284 -LGKLSRLKKLYVYTNELNGTIPHELGNCTSAV---EIDLSENQLTGFIPRELG-----L 334
L K L++L + N L L + + E+ L+ N L R L L
Sbjct: 76 GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDL 135
Query: 335 IPNLCLLQLFENMLQG----SIPRELGQLTQLHKLDLSINNLTG----TIPLEFQNLTYL 386
P L L L N L+G ++ + L L +L+L+ N + + + L
Sbjct: 136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNL 195
Query: 387 VDLQLFDNHLEGTIPPHIGV---------NSHLSVLDVSMNNLDGSIPPHLC-----MYQ 432
L L +N L G L VL++ NNL + L
Sbjct: 196 EVLDLNNNGLT-----DEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNI 250
Query: 433 KLIFLSLGSNRL 444
L+ LSL N +
Sbjct: 251 SLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 1e-04
Identities = 20/60 (33%), Positives = 29/60 (48%), Gaps = 2/60 (3%)
Query: 146 LRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSL 204
L+ L L N + IP+ L +L+ L + NNLT P + S L LR + N+L
Sbjct: 2 LKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 21/60 (35%), Positives = 30/60 (50%)
Query: 529 HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588
+L + ++S+N L+ NL+ LDLS N T +PE L +L L LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 20/61 (32%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 505 NLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQ 563
NL+ L LS N IP L +L ++S N+L+ P +L+ LDLS N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 564 F 564
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 62/231 (26%), Positives = 92/231 (39%), Gaps = 53/231 (22%)
Query: 810 IGRGACG--TVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
IGRG C +VY A G ++ V+ L + E+ RH NI+ +
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 867 G-------------FCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAA 913
F + +N LL Y G + E L GN I GA
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGN-------------ILFGAL 111
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG- 972
GL YLH + IHR+IK+++IL+ + V GL+ L L + + + +
Sbjct: 112 RGLNYLHQN---GYIHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQ 166
Query: 973 -------YIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSL 1010
+++PE Y Y +K DIYS G+ EL TG+ P Q +
Sbjct: 167 FSTSVLPWLSPELLRQDLYGYNVK----SDIYSVGITACELATGRVPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 36/131 (27%), Positives = 56/131 (42%), Gaps = 18/131 (13%)
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
+HRD+ + N+L+ E + DFGLA+ I D Y S ++APE + T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL-PLKWMAPESIFNNLYT 319
Query: 986 EKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPT-------------- 1030
D++SFG++L E+ T G +P L + ++R P
Sbjct: 320 TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCW 379
Query: 1031 SELFDKRLDLS 1041
E F+ R D S
Sbjct: 380 EEKFEIRPDFS 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 5e-04
Identities = 23/85 (27%), Positives = 32/85 (37%), Gaps = 25/85 (29%)
Query: 577 NLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNN 636
NL+ L LS+N+LT + GL L L ++S NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVL-------------------------DLSGNN 35
Query: 637 LSGVIPYELGNLQMLEALYLDDNQL 661
L+ + P L L +L L N L
Sbjct: 36 LTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 23/61 (37%), Positives = 29/61 (47%), Gaps = 2/61 (3%)
Query: 433 KLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR 491
L L L +NRL+ IP G K +L L L N LT P F L +L +L+L N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 492 F 492
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 19/104 (18%)
Query: 918 YLH-YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK-----LIDLPYSKSMSA----- 966
YLH Y I+HRD+K +N+L+ + DFGL+K L Y +
Sbjct: 116 YLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 967 ----IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ G+ YIAPE + D ++ G++L E + G P
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1109 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.46 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.16 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.16 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.13 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.07 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.02 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.97 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.69 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.65 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.64 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.53 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.48 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.37 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.36 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.36 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-118 Score=1156.42 Aligned_cols=945 Identities=34% Similarity=0.548 Sum_probs=636.1
Q ss_pred CcccccchhHHHHHHHHHHHHhhcccCCCchhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCccceeeecC-CeEEEEec
Q 001274 1 MARQGISSHTQKLFYFALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTD-FKVTSVDL 79 (1109)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~all~~k~~~~~~~~~~~~W~~~~~~~c~w~gv~C~~-~~v~~l~l 79 (1109)
|||.|---+-. ++++.+++++.. ++. .++|+.||++||+++.||.+.+++|+.. .+||.|.||+|++ .+|+++||
T Consensus 1 ~~~~~~~~~~~-~~~~~~~~~~~~-~~~-~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~~~~v~~L~L 76 (968)
T PLN00113 1 MAKKGPQHCPY-LIFMLFFLFLNF-SML-HAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDL 76 (968)
T ss_pred CCCCCCCCCCh-HHHHHHHHHHHc-cCC-CHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCCCCcEEEEEe
Confidence 67776544433 333333333322 222 4578999999999999998889999865 4899999999984 68999999
Q ss_pred cCccccccccccccCccccceeecccCccCCCCCcccc-CCCCCceEEccCCcccccCCchhhccccceEEEcccccccc
Q 001274 80 HGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLA-NCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFG 158 (1109)
Q Consensus 80 ~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 158 (1109)
++++++|.+++.+..+++|+.|+|++|.++|.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+|++|.+++
T Consensus 77 ~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~ 154 (968)
T PLN00113 77 SGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSG 154 (968)
T ss_pred cCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccc
Confidence 99999999999999999999999999999998887755 888999999999988887775 446777777777777777
Q ss_pred cccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhc
Q 001274 159 EIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEK 238 (1109)
Q Consensus 159 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 238 (1109)
.+|..++++++|++|+|++|.+++.+|..++++++|++|++++|.+++.+|..++++++|++|+|++|.+++.+|..+++
T Consensus 155 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 234 (968)
T PLN00113 155 EIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG 234 (968)
T ss_pred cCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhc
Confidence 77777777777777777777777777777777777777777666666666666666666666666655555555555555
Q ss_pred cccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEE
Q 001274 239 LRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEID 318 (1109)
Q Consensus 239 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 318 (1109)
+++|++|+|++|++++.+|..++++++|++|++++|++++.+|.. +.++++|++|+
T Consensus 235 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~------------------------l~~l~~L~~L~ 290 (968)
T PLN00113 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS------------------------IFSLQKLISLD 290 (968)
T ss_pred CCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchh------------------------HhhccCcCEEE
Confidence 555555555555555555555555555555555555554444444 44445555555
Q ss_pred ccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccc
Q 001274 319 LSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEG 398 (1109)
Q Consensus 319 Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 398 (1109)
|++|.+++.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++++
T Consensus 291 Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~ 370 (968)
T PLN00113 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG 370 (968)
T ss_pred CcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEe
Confidence 55555555555555555555555555555555666667777777778888888777777777777777777666666665
Q ss_pred cCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccC
Q 001274 399 TIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYN 478 (1109)
Q Consensus 399 ~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 478 (1109)
.+|..+..+++|+.|++++|++.+ .+ |..+.+
T Consensus 371 ~~p~~~~~~~~L~~L~l~~n~l~~------------------------~~------------------------p~~~~~ 402 (968)
T PLN00113 371 EIPEGLCSSGNLFKLILFSNSLEG------------------------EI------------------------PKSLGA 402 (968)
T ss_pred eCChhHhCcCCCCEEECcCCEecc------------------------cC------------------------CHHHhC
Confidence 444444333333333333333332 22 222333
Q ss_pred CcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeee
Q 001274 479 LQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLD 558 (1109)
Q Consensus 479 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 558 (1109)
+++|+.|+|++|++++..|..|..+++|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.||
T Consensus 403 ~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ 481 (968)
T PLN00113 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLD 481 (968)
T ss_pred CCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEE
Confidence 3334444444444444444444444455555555555555444444455555555555555555555433 234555666
Q ss_pred cCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCcccc
Q 001274 559 LSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLS 638 (1109)
Q Consensus 559 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~ 638 (1109)
|++|++++..|..|..+++|+.|+|++|++.+.+|..+.++++|++ |+|++|.++
T Consensus 482 ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~-------------------------L~Ls~N~l~ 536 (968)
T PLN00113 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS-------------------------LDLSHNQLS 536 (968)
T ss_pred CcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCE-------------------------EECCCCccc
Confidence 6666655555555555555555555555555555555555554444 455555666
Q ss_pred ccccccccCccccceeecCCCccccCCchhhhccccceEEEccCcccccccCCCcccccccCCcccCCCCccccC-----
Q 001274 639 GVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLG----- 713 (1109)
Q Consensus 639 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~~----- 713 (1109)
|.+|..|+.+++|+.|||++|+++|.+|..+..+.+|+.+++++|+++|.+|..++|.++...+|.||+.+||..
T Consensus 537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~ 616 (968)
T PLN00113 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL 616 (968)
T ss_pred ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCC
Confidence 677777888899999999999999999999999999999999999999999999999999999999999999842
Q ss_pred CCcccCCCCCCCCCCccccCCCCccceeeeehhhHHHHHHHHHHH-hhhhceecCCCCCCccccCCcccccccCCCCCCC
Q 001274 714 SDCHQLMPPSHTPKKNWIKGGSTKEKLVSIISVIVGLISLSFIIG-ICWAMKCRKPAFVPLEEQKNPEVIDNYYFPKEGF 792 (1109)
Q Consensus 714 ~~c~~~~~p~~~~~~~~~~~~~~~~~~~~ii~~~~g~~~~~~i~~-~~~~~~~rk~~~~~~~~~~~~~~~~~~~~~~~~~ 792 (1109)
++|.. . .....+.+ ++++++++++++++++ ++++++.|+....+..+...... +...+.....
T Consensus 617 ~~c~~-------------~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 680 (968)
T PLN00113 617 PPCKR-------------V-RKTPSWWF-YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTW-ELQFFDSKVS 680 (968)
T ss_pred CCCcc-------------c-cccceeee-ehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccc-cccccccccc
Confidence 12211 0 01112222 2233333332322222 22222222211111111111100 0001111111
Q ss_pred CHHHHHHHhcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe
Q 001274 793 KYHNLLEATGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH 871 (1109)
Q Consensus 793 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 871 (1109)
...........|...+.||+|+||+||+|++ .+++.||||+++.... ...+|++++++++|||||+++|+|.+
T Consensus 681 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 681 KSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEc
Confidence 1112233345688889999999999999986 4789999998863221 12356889999999999999999999
Q ss_pred CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 872 QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 872 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
++..++||||+++|+|.++++. ++|..+.+++.||++|++|||+.++++|+||||||+||+++.++..++. ||
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 9999999999999999999963 7899999999999999999998778899999999999999999888875 66
Q ss_pred ccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcc-cCCcHHHHHHHhhhccCCC
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE-LGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~ 1030 (1109)
.+..... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||+... ......+|.+...... ..
T Consensus 828 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 901 (968)
T PLN00113 828 LPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC-HL 901 (968)
T ss_pred ccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc-ch
Confidence 5543221 122367899999999999999999999999999999999999996432 3445667766543322 23
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
...+++.+........++..++.+++.+||+.||++||+|+||+++|+++....
T Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 344444443333345566778899999999999999999999999999886543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-61 Score=623.94 Aligned_cols=515 Identities=37% Similarity=0.548 Sum_probs=372.9
Q ss_pred CCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCcccc-ccccchhhhcccccccccCchhhhcccccccee
Q 001274 168 TSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEIS-ECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLI 246 (1109)
Q Consensus 168 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 246 (1109)
.+++.|+|++|++++.+|..|..+++|++|+|++|++++.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4677888888888877777777777777777777777766665543 566666666666666555553 3345555555
Q ss_pred cccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccC
Q 001274 247 LWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTG 326 (1109)
Q Consensus 247 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~ 326 (1109)
|++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|++++|.+.+.+|..++++++
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~------------- 213 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKS------------- 213 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCC-------------
Confidence 5555555555555555555555555555555555555555555555555555554444444444444
Q ss_pred CCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccc
Q 001274 327 FIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGV 406 (1109)
Q Consensus 327 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 406 (1109)
|+.|+|++|.+.+.+|..+.++++|++|++++|++++.+|..|.++++|+.|++++|.+.+.+|..+..
T Consensus 214 -----------L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 282 (968)
T PLN00113 214 -----------LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282 (968)
T ss_pred -----------ccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhh
Confidence 445555555555555555555666666666666666556666666666666666666666666666666
Q ss_pred cCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceec
Q 001274 407 NSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALE 486 (1109)
Q Consensus 407 ~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 486 (1109)
+++|++|++++|.+.+.+|..+..+++|++|++++|.+.+.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|+
T Consensus 283 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~ 362 (968)
T PLN00113 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD 362 (968)
T ss_pred ccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEE
Confidence 66666666666666666666666666677777777777666666677777777777777777777777777788888888
Q ss_pred cccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCcc
Q 001274 487 LYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG 566 (1109)
Q Consensus 487 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 566 (1109)
|++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|++++|++++
T Consensus 363 Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 442 (968)
T PLN00113 363 LSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442 (968)
T ss_pred CCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccC
Confidence 88888887778888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCcccccccccccc
Q 001274 567 SAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELG 646 (1109)
Q Consensus 567 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~ 646 (1109)
.+|..+..+++|+.|+|++|++.+.+|..++ .++|+.|++++|++++.+|..+.+++.|. .|+|++|++++.+|..++
T Consensus 443 ~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~ 520 (968)
T PLN00113 443 RINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELM-QLKLSENKLSGEIPDELS 520 (968)
T ss_pred ccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhhhhccC-EEECcCCcceeeCChHHc
Confidence 8888888888888888888888888877664 57888899999999888888888888886 589999999999999999
Q ss_pred CccccceeecCCCccccCCchhhhccccceEEEccCcccccccCCC-cccccccCCcccCCCCcc
Q 001274 647 NLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNT-TVFRRIDSSNFAGNRGLC 710 (1109)
Q Consensus 647 ~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~~c 710 (1109)
++++|++|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|.. ..+..+....+.+|+..+
T Consensus 521 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 521 SCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred CccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 9999999999999999999999999999999999999999999974 223344445566776543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=429.43 Aligned_cols=290 Identities=48% Similarity=0.790 Sum_probs=249.3
Q ss_pred CCCCCCHHHHHHHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEE
Q 001274 788 PKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867 (1109)
Q Consensus 788 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 867 (1109)
+...|.+.++..+|++|...+.||+|+||.||+|..++++.||||++.....+. .++|.+|++++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 456689999999999999999999999999999999989999999886443322 566999999999999999999999
Q ss_pred EEEeCC-ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 001274 868 FCYHQD-SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH 946 (1109)
Q Consensus 868 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 946 (1109)
||.+.+ +.++|||||++|+|.++++..... .++|..|.+||.++|+||+|||+.+...||||||||+|||+|+++.+|
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 999998 499999999999999999987653 589999999999999999999998888999999999999999999999
Q ss_pred EeeccccccccCCCCCCcccc-ccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcc--cCCcHHHHHHHh
Q 001274 947 VGDFGLAKLIDLPYSKSMSAI-AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE--LGGDLVTWVRRS 1023 (1109)
Q Consensus 947 l~DFG~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~--~~~~~~~~~~~~ 1023 (1109)
|+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||++.|++||+.+.+... ....+.+|+...
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999754421 1222222 79999999999999999999999999999999999999887543 344588998776
Q ss_pred hhccCCCchhhhhhcchhhcccH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1024 IHEMVPTSELFDKRLDLSAKRTV-EEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
+... ...+++|+.+... .... ++..++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 297 ~~~~-~~~eiiD~~l~~~-~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEG-EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCc-chhheeCCCccCC-CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 6665 5788888887632 2232 6888899999999999999999999999999665443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=405.34 Aligned_cols=262 Identities=35% Similarity=0.534 Sum_probs=215.2
Q ss_pred CCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-ceEEEEEec
Q 001274 804 FSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD-SNLLLYEYM 882 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 882 (1109)
+...+.+|+|+||+||+|.+.....||||++..........++|.+|+.++.+++|||||+++|+|.... ..++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3344569999999999999975555999999866555444779999999999999999999999999988 789999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCCCceeeCCCC-ceEEeeccccccccCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH-IIHRDIKSNNILLDEEF-QAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~ 960 (1109)
++|+|.++++.. ....+++..+++++.+||+||.||| +.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999884 2234999999999999999999999 556 99999999999999997 99999999998765322
Q ss_pred CCCccccccccceecccccc--CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 961 SKSMSAIAGSYGYIAPEYAY--TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
...+...||+.|||||++. ..+|+.|+||||||+++|||+||+.||.+....+.....+....+...+
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--------- 268 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--------- 268 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC---------
Confidence 3445578999999999999 6699999999999999999999999999765422221222222222111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
......+..++.+||+.||++||++.+++..|+.++.....
T Consensus 269 -------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 269 -------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 11334678899999999999999999999999988776544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=404.03 Aligned_cols=257 Identities=30% Similarity=0.463 Sum_probs=218.0
Q ss_pred CCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEecc
Q 001274 804 FSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYME 883 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 883 (1109)
++..+.||+|.||+||.|+++....||||.++.. ....++|.+|+++|++++|++||+++|+|..++..+||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 4456789999999999999988889999999843 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCC
Q 001274 884 NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS 963 (1109)
Q Consensus 884 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 963 (1109)
.|+|.+|++... ...+...+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+|||+|+...++....
T Consensus 285 ~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 999999999732 224889999999999999999999 8899999999999999999999999999999766556656
Q ss_pred ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhh
Q 001274 964 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042 (1109)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1109)
.....-+..|+|||.+..++|+.|||||||||++|||+| |+.||..+. ..+..+.+.+..+-.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-n~ev~~~le~GyRlp--------------- 424 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-NEEVLELLERGYRLP--------------- 424 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-HHHHHHHHhccCcCC---------------
Confidence 666778899999999999999999999999999999999 999988654 222233333222211
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1043 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.+..++..+.++|..||+.+|++||||+.+...+++.....
T Consensus 425 -~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 425 -RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred -CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 12334557889999999999999999999999888876543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=380.60 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=221.1
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-ceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD-SNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 880 (1109)
+.+..+.||+|..|+||+++++ +++.+|+|++.. .......+++.+|+++++..+||+||.++|+|.... ...++||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 4556678999999999999976 688999999943 344556788999999999999999999999999999 4999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||++|+|++++...+. +++...-+|+.+|++||.|||+ +++||||||||+|||++..|.|||+|||.+......
T Consensus 159 YMDgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999987654 8999999999999999999994 279999999999999999999999999999877633
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCc-ccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSL-ELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||... ....+..+.+.....+..|..+.
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~------ 304 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE------ 304 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc------
Confidence 446789999999999999999999999999999999999999999865 23345566666655544332111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.....+|..|+..|++.||.+||+++|+++|-+-.....
T Consensus 305 ------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 305 ------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred ------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 023457899999999999999999999999976654443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=394.67 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=218.2
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.+|..++.||+|||+.||++++ .+|+.||+|++..+.. .....+...+|+++.+.++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999997 7899999999975422 2334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
|+|+.++|.+++++.+. +++.+++.+++||+.|+.||| +.+|||||||..|++++++.++||+|||+|.....+
T Consensus 98 ELC~~~sL~el~Krrk~---ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKP---LTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcCC---CCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999985554 999999999999999999999 889999999999999999999999999999988743
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.+...+.+|||.|.|||++....++..+||||+|||+|-|+.|++||+... +.+...........+
T Consensus 172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~----vkety~~Ik~~~Y~~--------- 237 (592)
T KOG0575|consen 172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT----VKETYNKIKLNEYSM--------- 237 (592)
T ss_pred -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch----HHHHHHHHHhcCccc---------
Confidence 455678899999999999999999999999999999999999999998643 222222221111111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
+.....+..++|.++++.+|++|||+.+|+.+-.......
T Consensus 238 -----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 238 -----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFT 277 (592)
T ss_pred -----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCc
Confidence 1122234668999999999999999999999987744443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=377.83 Aligned_cols=258 Identities=29% Similarity=0.376 Sum_probs=214.1
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCc-----chhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGA-----TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
+.|.+.+.||+|+||.|-+|.. ++|+.||||++..+.... .....+.+|+++|++++|||||+++++|...++.
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 5788889999999999999974 579999999997653222 1233467999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC---CceEEeeccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE---FQAHVGDFGL 952 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~ 952 (1109)
|+||||++||+|.+.+-.++. +.+.....+++|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999988765 788888999999999999999 8899999999999999765 7899999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCC---CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCC
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV---TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 1029 (1109)
|+..+ ....+.+.+||+.|.|||++.++.+ ..++||||+||++|-+++|..||.+-.....+.+.+... ..+
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G---~y~ 400 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG---RYA 400 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC---ccc
Confidence 99876 3455678999999999999987653 348899999999999999999998655444455544432 222
Q ss_pred CchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1030 TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
..+..+. +..++..++|.+|+..||++|||+.|++++-|.-
T Consensus 401 f~p~~w~----------~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 401 FGPLQWD----------RISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred ccChhhh----------hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 2222222 2234678999999999999999999999998765
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=377.44 Aligned_cols=202 Identities=30% Similarity=0.489 Sum_probs=184.2
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
..++|...+.||+|+||+||+|+++ ++..||||.+....-.....+....|+.+++.++|||||++++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3468888999999999999999965 689999999986655566677889999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC------CceEEeeccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE------FQAHVGDFGL 952 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DFG~ 952 (1109)
||||.||+|.+|++..+. ++++.++.++.|||.|+++|| +++||||||||+|||++.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999998764 999999999999999999999 8899999999999999765 5689999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~ 1009 (1109)
|+... ......+.+|++.|||||++..++|+.|+|+||+|+++|+|++|+.||+.
T Consensus 162 AR~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 162 ARFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 99886 23344678999999999999999999999999999999999999999984
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=390.98 Aligned_cols=491 Identities=29% Similarity=0.418 Sum_probs=231.7
Q ss_pred CCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCccccccccccee
Q 001274 118 NCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVI 197 (1109)
Q Consensus 118 ~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 197 (1109)
.-..|+.|+|++|.+. .+...+.++..|..|++++|+++ +.|++++.+..++.|+.++|++. .+|..++.+..|+.|
T Consensus 43 ~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l 119 (565)
T KOG0472|consen 43 EQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKL 119 (565)
T ss_pred hhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhh
Confidence 3344555555555554 33334445555555555555554 44555555555555555555555 555555555555555
Q ss_pred ccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccce
Q 001274 198 RAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFS 277 (1109)
Q Consensus 198 ~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 277 (1109)
+.++|.+. .+|++++.+..|+.|+..+|+++ ..|..+..+.+|..|++.+|+++...|..+ +++.|++||+.+|-++
T Consensus 120 ~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~ 196 (565)
T KOG0472|consen 120 DCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE 196 (565)
T ss_pred hcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh
Confidence 55555555 45555555555555555555555 345555555555555555555552222222 2555555555555554
Q ss_pred ecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccc-cCCCCcceEecccccccCcccccc
Q 001274 278 GGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPREL-GLIPNLCLLQLFENMLQGSIPREL 356 (1109)
Q Consensus 278 ~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l 356 (1109)
.+|..++.+.+|..||+.+|++. .+| +|..|+.|.+|+++.|+|. .+|.+. ..++++..|+|.+|++. +.|+.+
T Consensus 197 -tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~ 271 (565)
T KOG0472|consen 197 -TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEI 271 (565)
T ss_pred -cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHH
Confidence 45555555555555555555554 333 4555555555555555554 223222 24555555555555554 344445
Q ss_pred cCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhccc--cc
Q 001274 357 GQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQ--KL 434 (1109)
Q Consensus 357 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~--~L 434 (1109)
+-+.+|++||+|+|.|+ ..|..++++ .|+.|.+.+|.+. .+-...+.+-+ -|
T Consensus 272 clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr------------------------TiRr~ii~~gT~~vL 325 (565)
T KOG0472|consen 272 CLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR------------------------TIRREIISKGTQEVL 325 (565)
T ss_pred HHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH------------------------HHHHHHHcccHHHHH
Confidence 55555555555555554 344444444 4444555554444 22111111100 01
Q ss_pred ceeec--CCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccc--cccEEE
Q 001274 435 IFLSL--GSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLR--NLERLH 510 (1109)
Q Consensus 435 ~~L~L--~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~ 510 (1109)
++|.= ..-.++..-...-. .-+ ...+..| ....+.+.+.|+++.-+++.+..+.|..-. -.+..+
T Consensus 326 KyLrs~~~~dglS~se~~~e~------~~t----~~~~~~~-~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~Vn 394 (565)
T KOG0472|consen 326 KYLRSKIKDDGLSQSEGGTET------AMT----LPSESFP-DIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVN 394 (565)
T ss_pred HHHHHhhccCCCCCCcccccc------cCC----CCCCccc-chhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEe
Confidence 22110 00000000000000 000 0000001 112234455555555555532222222111 144555
Q ss_pred ccCCccCCCCChhhcccccccE-EecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccc
Q 001274 511 LSENYFVGYIPSEVGNLEHLVT-FNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589 (1109)
Q Consensus 511 Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 589 (1109)
++.|++. .+|..+..++.+.+ +++++|.++ -+|..+..+++|..|+|++|.+. .+|.+++.+..|+.|+++.|++.
T Consensus 395 fskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr 471 (565)
T KOG0472|consen 395 FSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR 471 (565)
T ss_pred cccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc
Confidence 5566555 34555554444333 334444443 55555555666666666666555 45556666666666666666555
Q ss_pred cccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhh
Q 001274 590 GAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASM 669 (1109)
Q Consensus 590 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~ 669 (1109)
.+|.....+..++.+-. ++|++....|..+.++.+|.+|||.+|.|. .||+.+
T Consensus 472 -~lP~~~y~lq~lEtlla-------------------------s~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~L 524 (565)
T KOG0472|consen 472 -MLPECLYELQTLETLLA-------------------------SNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPIL 524 (565)
T ss_pred -cchHHHhhHHHHHHHHh-------------------------ccccccccChHHhhhhhhcceeccCCCchh-hCChhh
Confidence 44544443333332222 223333333333555556666666666665 566666
Q ss_pred hccccceEEEccCcccc
Q 001274 670 GEQMSLLVCNLSNNNLV 686 (1109)
Q Consensus 670 ~~l~~L~~l~ls~N~l~ 686 (1109)
+++.+|+.|++++|+++
T Consensus 525 gnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 525 GNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccceeEEEecCCccC
Confidence 66666666666666665
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=386.95 Aligned_cols=473 Identities=33% Similarity=0.480 Sum_probs=324.4
Q ss_pred ccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEee
Q 001274 97 RLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIY 176 (1109)
Q Consensus 97 ~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 176 (1109)
.|+.|.++.|.++ .+-+.+.++..|++|++.+|++. ..|.+++.+..++.|+.++|+++ ++|++++.+.+|..|+.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 4556667777666 34456788888888888888887 78888899999999999999986 889999999999999999
Q ss_pred cCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCC
Q 001274 177 SNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEI 256 (1109)
Q Consensus 177 ~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 256 (1109)
+|++. ++|++++.+-.|..++..+|+++ ..|+.+.++.+|..|++.+|++....|..+. ++.|++||..+|.++ .+
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tl 198 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TL 198 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cC
Confidence 99998 88999999999999999999999 7888999999999999999999965555555 999999999999998 89
Q ss_pred CCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcc-cCCCCcCcEEEccCCcccCCCcccccCC
Q 001274 257 PPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHE-LGNCTSAVEIDLSENQLTGFIPRELGLI 335 (1109)
Q Consensus 257 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~-l~~l~~L~~L~Ls~n~l~~~~p~~l~~l 335 (1109)
|+.++.+.+|+.|+|.+|+|. .+| +|+.+..|++|+++.|+|. .+|.+ ..++.++..|||.+|+++ ..|+.+..+
T Consensus 199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL 274 (565)
T KOG0472|consen 199 PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL 274 (565)
T ss_pred ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence 999999999999999999998 667 8999999999999999998 55555 558999999999999999 678899999
Q ss_pred CCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcc------cccceEEccccccc---c------cC
Q 001274 336 PNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNL------TYLVDLQLFDNHLE---G------TI 400 (1109)
Q Consensus 336 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~---~------~~ 400 (1109)
.+|.+|++++|.|+ ..|..++++ +|+.|-+.+|.+.. +-..+-+. +.|+. ....-.++ | ..
T Consensus 275 rsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs-~~~~dglS~se~~~e~~~t~ 350 (565)
T KOG0472|consen 275 RSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRS-KIKDDGLSQSEGGTETAMTL 350 (565)
T ss_pred hhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHH-hhccCCCCCCcccccccCCC
Confidence 99999999999999 568889999 99999999999973 33222221 22222 01111111 1 00
Q ss_pred CC----cccccCcCcEEEeccccccCccchhhhcccc---cceeecCCccccCCCCCCCccccccceeecccccccccCC
Q 001274 401 PP----HIGVNSHLSVLDVSMNNLDGSIPPHLCMYQK---LIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLP 473 (1109)
Q Consensus 401 p~----~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 473 (1109)
|. ......+.+.|+++.-+++. +|.......+ ....+++.|++. .+|..+..+..+.+.
T Consensus 351 ~~~~~~~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~------------ 416 (565)
T KOG0472|consen 351 PSESFPDIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTD------------ 416 (565)
T ss_pred CCCcccchhhhhhhhhhccccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHH------------
Confidence 11 11222345555555555552 3332222222 444555555554 334444444333222
Q ss_pred ccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCC
Q 001274 474 IEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVN 553 (1109)
Q Consensus 474 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 553 (1109)
+.+++|.++ -+|..+..+++|..|+|++|-+. .+|..++.+..|+.||+|+|++. .+|.++..+..
T Consensus 417 -----------l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~ 482 (565)
T KOG0472|consen 417 -----------LVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQT 482 (565)
T ss_pred -----------HHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHH
Confidence 233333332 34445555555555555555444 34555555555555555555555 45554444444
Q ss_pred CCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccc
Q 001274 554 LQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 554 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 613 (1109)
|+.+-.++|++....|+.+.++.+|.+|||.+|.+. .+|..++++++|++|++.||+|.
T Consensus 483 lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 483 LETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 444444555555333334555555555555555555 44555555666666666666555
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=353.91 Aligned_cols=267 Identities=21% Similarity=0.364 Sum_probs=214.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+.|+...++|+|+||+||+++.+ +|+.||||++.....++...+-.++|++++++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999976 69999999998776666667788999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||+. ++.+-+...... ++...+.+++.|+++|+.|+| ++++|||||||+||+++.+|.+|+||||+|+.... .
T Consensus 82 ~~dh-TvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNG--VPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecch-HHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 9976 555666665543 899999999999999999999 88999999999999999999999999999998764 3
Q ss_pred CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC-chhhhhhc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT-SELFDKRL 1038 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1038 (1109)
....+.++.|..|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+..+. +....++....+..|- ..++....
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-DQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-DQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH-HHHHHHHHHHcccCHHHHHHhccCC
Confidence 445577889999999999887 78999999999999999999999999875432 2223333333333221 11111000
Q ss_pred -------------chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1039 -------------DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1039 -------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
..-.+..+.......+++.+|++.||.+|++-+|++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00011223333468899999999999999999999865
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=389.74 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=219.0
Q ss_pred CCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
...+.++||.|.||+||+|+++ ....||||.++. +.......+|+.|+.||.+++||||+++.|+.......+||
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 3456789999999999999975 245799999984 44556678999999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
+|||++|+|+.||+.+.++ +++.+...+.++||.||.||- ++++|||||.++||||+.+..+|++|||++|..++
T Consensus 709 TEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999998765 999999999999999999999 88999999999999999999999999999998764
Q ss_pred CCCCCccc--cccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 959 PYSKSMSA--IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 959 ~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
+.....+. -.-+.+|.|||.+..++++.++|||||||++||.++ |..||.++.. ++...-+...++-..
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyRLPp------- 855 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYRLPP------- 855 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccCCCC-------
Confidence 43222222 234689999999999999999999999999999888 9999987652 233333332222221
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
+.+++..+.++|..||+.|-.+||.|.||+.+|.+.....
T Consensus 856 ---------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 856 ---------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ---------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 4456678999999999999999999999999999876553
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=394.70 Aligned_cols=265 Identities=29% Similarity=0.458 Sum_probs=217.7
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
.+.+..+.||+|+||+||+|+.. +.+.||||.++... .....++|.+|++++..++|||||+++|+|..+++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 45566789999999999999843 35679999998553 334578999999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCC-----------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQT-----------CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ 944 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 944 (1109)
++|+|||..|||.+||+...+. ..++..+.+.||.|||.||+||- ++.+|||||.++|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence 9999999999999999755432 12788899999999999999999 779999999999999999999
Q ss_pred eEEeeccccccccC-CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHH
Q 001274 945 AHVGDFGLAKLIDL-PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRR 1022 (1109)
Q Consensus 945 ~kl~DFG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~ 1022 (1109)
|||+|||+++..-. ++.+......-+++|||||.+..++|+.++|||||||++||+++ |+.||.+...+ +.++.++.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-EVIe~i~~ 720 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-EVIECIRA 720 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-HHHHHHHc
Confidence 99999999986543 33333335567889999999999999999999999999999999 99999876532 22232322
Q ss_pred hhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 001274 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087 (1109)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 1087 (1109)
..- . ..+..++.+++.+|..||+..|++||+++||-..|....+..+..
T Consensus 721 g~l--L--------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~ 769 (774)
T KOG1026|consen 721 GQL--L--------------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY 769 (774)
T ss_pred CCc--c--------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence 110 0 113344567899999999999999999999999998887655443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.42 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=212.2
Q ss_pred cCCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEE-EEeCCc-eEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF-CYHQDS-NLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~-~~lv 878 (1109)
.+|++.++||.|.||+||++. ..+|..||.|.+....-+..+.++...|+.++++++|||||+++++ +.++.. .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357888999999999999998 5589999999998666666677889999999999999999999984 334444 7899
Q ss_pred EEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 879 YEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRP-HIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
||||..|+|..+++..+ .++.+++..+++++.|++.||.++|+.+.+ -|+||||||.||+++.+|.+|++|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999986543 344699999999999999999999964322 3999999999999999999999999999988
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
... .......+|||.||+||.+.+.+|+.|+||||+||++|||..-+.||.+. .+.+.-++......+. ..
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~--~p-- 249 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPP--LP-- 249 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCC--Cc--
Confidence 632 33346679999999999999999999999999999999999999999863 4555544444443321 11
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
..-..+.+..++..|+..||+.||+.-.+++.+..
T Consensus 250 --------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 --------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11223457789999999999999996555554433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=354.91 Aligned_cols=253 Identities=26% Similarity=0.324 Sum_probs=211.3
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc-chhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA-TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.++|++.++||+|+||+||.++.+ +++.||+|+++.+..-. .+.+...+|..++.+++||.||+++-.|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 368999999999999999999855 68999999997653322 3466788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
+||+.||.|..++.+.+. +++..++..+..|+.||.||| +++||||||||+|||+|.+|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999987665 999999999999999999999 88999999999999999999999999999985432
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
......+++||+.|||||++.+..|+.++|.||+|+++|||++|..||.+ .+...+.+.......+....
T Consensus 178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~----~~~~~~~~~I~~~k~~~~p~----- 247 (357)
T KOG0598|consen 178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA----EDVKKMYDKILKGKLPLPPG----- 247 (357)
T ss_pred -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC----ccHHHHHHHHhcCcCCCCCc-----
Confidence 23344568999999999999999999999999999999999999999985 34444444444443111111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCC----CHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRP----TMREVIAMM 1077 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP----t~~evl~~L 1077 (1109)
. ......+++.+.+..||++|- .+.+|.+|-
T Consensus 248 -----~---ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hp 282 (357)
T KOG0598|consen 248 -----Y---LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHP 282 (357)
T ss_pred -----c---CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCc
Confidence 0 112456899999999999994 677776653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=367.23 Aligned_cols=276 Identities=20% Similarity=0.290 Sum_probs=219.1
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCC-ceEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQD-SNLL 877 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 877 (1109)
.++|...++||.|.||.||+|+. .++..||||+++.+... +++-.-++|++.++++. ||||+++.+++.+.+ ..|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 46888999999999999999984 47999999999876554 44555679999999998 999999999999988 8899
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
|||||+ .+|+++++... +.+++..++.|+.||++||+|+| ++|+.|||+||+|||+.....+||+|||+||...
T Consensus 88 VfE~Md-~NLYqLmK~R~--r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc
Confidence 999995 59999998773 45999999999999999999999 8899999999999999999999999999999775
Q ss_pred CCCCCCccccccccceecccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCchhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSELFD 1035 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1035 (1109)
.....+.++.|..|+|||++. .+.|+.+.||||+|||++|+.+-+..|.+..+.+.+ .+...-.. |..+.+.
T Consensus 162 --SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi----~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 162 --SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI----YKICEVLGTPDKDSWP 235 (538)
T ss_pred --cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH----HHHHHHhCCCccccch
Confidence 345567789999999999876 456899999999999999999999999875433222 22111111 1111111
Q ss_pred h------hcchh---------hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 001274 1036 K------RLDLS---------AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPS 1089 (1109)
Q Consensus 1036 ~------~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 1089 (1109)
. .+... .........++.+++.+|+.|||.+||||+|++++-...........+
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~~a 304 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGSSA 304 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccccccc
Confidence 1 01000 111223556788999999999999999999999997665555544433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.13 Aligned_cols=268 Identities=27% Similarity=0.335 Sum_probs=216.3
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--CceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 878 (1109)
+.|+..++||+|.||.||+|++ .+|+.||+|++...........-..+|+.++++++||||+++.+...+. ...|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4566678999999999999984 5799999999987776666677788999999999999999999998876 688999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
+|||+. +|.-++....-+ |++.++..+++|++.||+|+| .++|+|||||.+|||||.+|.+||+|||+|+.+..
T Consensus 197 FeYMdh-DL~GLl~~p~vk--ft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVK--FTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCCCcc--cChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999976 887777664433 999999999999999999999 88999999999999999999999999999998876
Q ss_pred CCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
......+..+.|..|+|||.+.|. .|+.++|+||.|||+.||++|+..|++.. -++.+...++-...+.+.+.+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t----EveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT----EVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc----HHHHHHHHHHHhCCCChhcccc
Confidence 666667888899999999999875 59999999999999999999999998643 3334444433333222222221
Q ss_pred cchh----------hcccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1038 LDLS----------AKRTVEE-----MTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1038 ~~~~----------~~~~~~~-----~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.... ......+ .....+++..++..||.+|.||.++++.-..
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 1110 0111111 2347789999999999999999999876543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=369.08 Aligned_cols=268 Identities=28% Similarity=0.432 Sum_probs=216.5
Q ss_pred HHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.-.+++.+...||+|.||+||+|+|.. .||||++.......+..+.|.+|+.++++-||.||+-+.|||..+.. .||
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 334566778899999999999999863 59999999988888889999999999999999999999999998877 999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
+.||+|.+|+.+++..+.+ ++....+.|++||++||.||| .++|||||||..||++.++++|||+|||++..-.+
T Consensus 466 TqwCeGsSLY~hlHv~etk--fdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETK--FDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred ehhccCchhhhhccchhhh--hhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 9999999999999987654 999999999999999999999 88999999999999999999999999999965432
Q ss_pred CC-CCCccccccccceeccccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 959 PY-SKSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 959 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
-. ........|...|||||++.. .+|++.+||||||+++|||+||..||..-. .+..-|+. -++.. +.
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dqIifmV--GrG~l-~p--- 612 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQIIFMV--GRGYL-MP--- 612 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhheEEEe--ccccc-Cc---
Confidence 11 112234457889999999874 369999999999999999999999998321 11111111 11111 00
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 1087 (1109)
++. .....+.+++.+++..||..++++||.+.+|+..|+....+.+.-
T Consensus 613 --d~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki 660 (678)
T KOG0193|consen 613 --DLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKI 660 (678)
T ss_pred --cch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccc
Confidence 000 113344567889999999999999999999999999888764333
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=372.89 Aligned_cols=370 Identities=26% Similarity=0.269 Sum_probs=245.7
Q ss_pred cchhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEee
Q 001274 217 GLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVY 296 (1109)
Q Consensus 217 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~ 296 (1109)
.-+.|++++|++....+..|.++++|+.+++..|.++ .||...+...+|+.|+|.+|.|+..-.+.+.-++.|+.|||+
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3456888888888888888889999999999999998 888877777789999999998887777788888888888888
Q ss_pred cccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCC
Q 001274 297 TNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTI 376 (1109)
Q Consensus 297 ~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 376 (1109)
.|.|+...-.+|..-.++++|+|++|+|+..-...|..+.+|..|.|+.|.++...+..|.++++|+.|||..|+|.-.-
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 88888555556777678888888888888766666666666666666666666666666666666666666666665332
Q ss_pred CcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCcccc
Q 001274 377 PLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCR 456 (1109)
Q Consensus 377 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 456 (1109)
-..|.++++|+.|.|..|.+.......|..+.++++|+|+.|+++..-..+ +.+++
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~------------------------lfgLt 293 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGW------------------------LFGLT 293 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccc------------------------ccccc
Confidence 445666666666666666666555555555555555555555555444444 44455
Q ss_pred ccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecc
Q 001274 457 SLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNIS 536 (1109)
Q Consensus 457 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 536 (1109)
+|++|+|++|.|..+.++.+.-.++|++|+|++|+|+...++.|..|+.|++|.|++|.++.+-...|..+++|++|||+
T Consensus 294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 55555555555555555555555555555555555555555555555555555555555554444555555555555555
Q ss_pred cCcccccCC---cCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccc
Q 001274 537 SNSLSGTIP---HELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIF 612 (1109)
Q Consensus 537 ~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 612 (1109)
+|.|+..+. ..|..|++|+.|+|.+|+|..+.-.+|.++.+|+.|||.+|.|..+.|++|..+ .|++|.++.-.|
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF 451 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence 555554433 235566677777777777764444567777777777777777777777777777 777777665443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=361.40 Aligned_cols=255 Identities=25% Similarity=0.311 Sum_probs=211.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 878 (1109)
.+|..++.||+|+|++||+|+.. .++.||||++..+-.. ....+.+..|-.+|.+| .||.|++++-.|+++...|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 57889999999999999999854 6999999999654322 22345677899999999 899999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
+||+++|+|.+++++.+. +++...+.++.+|+.|++||| +.|||||||||+|||+|+|++++|+|||.|+.+..
T Consensus 153 Le~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999998865 999999999999999999999 88999999999999999999999999999987743
Q ss_pred CCCC----------C--ccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 959 PYSK----------S--MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 959 ~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
.... . ...++||-.|.+||++.....+..+|+|+|||++|+|+.|++||.+..+.-.+...+. -
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~----l 302 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA----L 302 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH----h
Confidence 2111 1 1457899999999999999999999999999999999999999986543222222222 1
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
..+..+-+ .+.+.+++.+.+..||.+|+|.++|.+|....
T Consensus 303 ~y~fp~~f--------------p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 303 DYEFPEGF--------------PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred cccCCCCC--------------CHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 11111111 13567899999999999999999999886443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=360.29 Aligned_cols=271 Identities=24% Similarity=0.391 Sum_probs=227.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.+....+.+.+.+|+++++.++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999866 68899999998888877788889999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+.| +|..++...+. ++++.++.++.+++.|+.||| +.+|+|||+||+||+++..|.+|++|||+|+.+.. .
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9977 99999987665 999999999999999999999 88999999999999999999999999999997753 2
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
....+.+.||+-|||||++.+++|+..+|+||+||++||+++|++||.. ..+...++....+....
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~v~~---------- 219 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDPVKP---------- 219 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCCCCC----------
Confidence 3334667899999999999999999999999999999999999999974 34555555555554322
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-HHHhhhccCCCCCCCCcccccc
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM-MIDARQSVSDYPSSPTSETPLE 1098 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~-L~~~~~~~~~~~~~~~~~~~~~ 1098 (1109)
+......|..++...+..||.+|.+-.+++.| +++......+.++.++-.++..
T Consensus 220 ----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spft 274 (808)
T KOG0597|consen 220 ----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFT 274 (808)
T ss_pred ----cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccc
Confidence 22344568899999999999999999999877 3444334444444444444433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.78 Aligned_cols=268 Identities=22% Similarity=0.309 Sum_probs=212.5
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.+|...+++|+|.||.||+|++ ++|+.||||+++.............+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677888999999999999985 579999999998775554556778899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||+. +|+..++.... .++..++..++.++++|++|+| .+.|+||||||.|+|++++|.+||+|||+|+.+..+.
T Consensus 82 fm~t-dLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9964 99999987654 4899999999999999999999 7899999999999999999999999999999887443
Q ss_pred CCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.. ....+.|..|+|||.+.|. .|+..+||||.||++.||+-|.+-|.+..+ .+.+...++-...+.+-..+.+.
T Consensus 156 ~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD----idQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD----IDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch----HHHHHHHHHHcCCCCcccCcccc
Confidence 33 3334789999999998875 599999999999999999999887775432 22222222221111111111110
Q ss_pred h-------------h-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1040 L-------------S-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1040 ~-------------~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
. . ......+.....+++.+++..+|.+|.++.|++++-...
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 0 0 012233345568999999999999999999999886544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=370.98 Aligned_cols=359 Identities=23% Similarity=0.246 Sum_probs=294.9
Q ss_pred cceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccc
Q 001274 267 ELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFEN 346 (1109)
Q Consensus 267 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n 346 (1109)
+.|++++|+++..-+..|.++++|+++++.+|.++ .+|........|+.|+|.+|.|+.+-.+.+..++.|+.|+|+.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 44666666666555666666666666666666665 55554444455666666666666666666666666666666666
Q ss_pred cccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccch
Q 001274 347 MLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPP 426 (1109)
Q Consensus 347 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~ 426 (1109)
.|+.+.-..|..-.++++|+|++|.|+..-...|.++.+|..|.|+.|+++...+..|..+++|+.|+|..|+|.-.---
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l 239 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL 239 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhh
Confidence 66665556666667777778888877766677777777777788888887765556666678888888888877744456
Q ss_pred hhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccc
Q 001274 427 HLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNL 506 (1109)
Q Consensus 427 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 506 (1109)
.|.++++|+.|.|..|.|.......|..+.++++|+|..|+++..-..++.++++|+.|+||+|.|..+.++.+...++|
T Consensus 240 tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL 319 (873)
T KOG4194|consen 240 TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL 319 (873)
T ss_pred hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccc
Confidence 78889999999999999998888899999999999999999999889999999999999999999999999999999999
Q ss_pred cEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCC---cccccccccceecc
Q 001274 507 ERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAP---EELGQLVNLELLKL 583 (1109)
Q Consensus 507 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~L 583 (1109)
++|+|++|+|+...+..|..|..|++|+|++|+|..+-...|..+++|++|||++|.|+..+. ..|.++++|+.|+|
T Consensus 320 ~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l 399 (873)
T KOG4194|consen 320 KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRL 399 (873)
T ss_pred eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheee
Confidence 999999999999999999999999999999999998888899999999999999999986554 35889999999999
Q ss_pred cccccccccCcccCCCcccceeeccCccccccccccccccchhh
Q 001274 584 SDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQ 627 (1109)
Q Consensus 584 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~ 627 (1109)
.+|+|..+...+|.++..|+.|||.+|.+...-|.+|..+ .|.
T Consensus 400 ~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk 442 (873)
T KOG4194|consen 400 TGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELK 442 (873)
T ss_pred cCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhh
Confidence 9999998878899999999999999999998889998876 443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=362.98 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=211.4
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
..|....+||+|+.|.||.|+. .+++.||||++..+... ..+-+.+|+.+|+..+|+|||.+++.|...+..++|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4677778999999999999984 47899999999876654 45668899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||+||+|.+.+.... +++.++..|+.++++||+||| .++|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~- 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE- 422 (550)
T ss_pred ecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccc-
Confidence 999999999987654 899999999999999999999 889999999999999999999999999999887633
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.....+.+||+.|||||++....|+.|+||||||++++||+.|..||-.. ..+.. +........| ++
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE---~PlrA-lyLIa~ng~P--~l------- 489 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE---NPLRA-LYLIATNGTP--KL------- 489 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC---ChHHH-HHHHhhcCCC--Cc-------
Confidence 33557789999999999999999999999999999999999999998742 12211 1111111111 11
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.........|.+|+.+|++.||++||+|.|+++|-.-
T Consensus 490 --k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 490 --KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred --CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 1122223468899999999999999999999998544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.92 Aligned_cols=266 Identities=25% Similarity=0.335 Sum_probs=214.9
Q ss_pred cCCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|+...+||.|..++||+|+ .+.++.||||++.....+.. .+.+.+|+..|+.++||||++++..|..+...++||.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 578888999999999999998 45789999999987755443 6789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||.+|++.+.++..-.. .+++..+..|.+++++||.||| .+|.||||||+.|||++.+|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999876544 3999999999999999999999 8899999999999999999999999999886554322
Q ss_pred CCC---ccccccccceeccccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 961 SKS---MSAIAGSYGYIAPEYAYT--MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 961 ~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.+. ....+||+.|||||++.. ..|+.|+||||||++..||.+|..||....+-.. +...+....|....
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv----Ll~tLqn~pp~~~t-- 254 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV----LLLTLQNDPPTLLT-- 254 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH----HHHHhcCCCCCccc--
Confidence 111 145689999999999553 4599999999999999999999999987543222 22223333322110
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.....+........|..++..|++.||++|||+++++++-+..
T Consensus 255 --~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk 297 (516)
T KOG0582|consen 255 --SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK 297 (516)
T ss_pred --ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence 0111112233334789999999999999999999999875544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.70 Aligned_cols=260 Identities=31% Similarity=0.449 Sum_probs=208.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC--ceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD--SNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 878 (1109)
.+|...+.||+|+||+||++... +|+..|||.+...... ..+.+.+|+.++++++|||||+++|...... ..+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 46778899999999999999865 4899999999755221 2567899999999999999999999755544 58899
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeecccccccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-EFQAHVGDFGLAKLID 957 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~ 957 (1109)
|||+++|+|.+++.+.+. .+++..+++.+.||++|++||| +++||||||||+|||++. ++.+||+|||.++...
T Consensus 95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999998775 3999999999999999999999 889999999999999999 7999999999998765
Q ss_pred C--CCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhh-hccCCCchh
Q 001274 958 L--PYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSI-HEMVPTSEL 1033 (1109)
Q Consensus 958 ~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1033 (1109)
. ..........||+.|||||++..+ ....++||||+||++.||+||+.||... ....+++-... ....| .
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~~~P---~ 243 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGREDSLP---E 243 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccCCCC---C
Confidence 2 222334567899999999999963 3345999999999999999999999864 11112222111 11111 1
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
+. ........+|+.+|+..+|++||||.+++++........
T Consensus 244 ip----------~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 244 IP----------DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CC----------cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 11 112234668999999999999999999999988776555
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=359.07 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=222.2
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
+-|+.++.||.|+.|.|-.|++ .+|+.+|||++.... ........+.+|+-+|+.+.||||+++++++....+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 6788999999999999999985 589999999997652 22334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|-|.+++..++. +++.++.+++.||+.|+.|+| ..+|+|||+||+|+|+|..+.+||+|||+|..-.
T Consensus 92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 99999999999988776 899999999999999999999 7899999999999999999999999999998643
Q ss_pred CCCCccccccccceeccccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVT-EKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.+....+.||++.|.|||++.|.+|+ .++||||.|||+|.|+||+.||+ ++.+.....+..++.+.+...
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd----DdNir~LLlKV~~G~f~MPs~----- 234 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD----DDNIRVLLLKVQRGVFEMPSN----- 234 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC----CccHHHHHHHHHcCcccCCCc-----
Confidence 34556788999999999999999984 79999999999999999999998 466677766666666544322
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
...++.+++.+|+..||++|.|++||.+|.+-...
T Consensus 235 ---------Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 235 ---------ISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ---------CCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 22357799999999999999999999999865543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=366.44 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=213.6
Q ss_pred cCCCCCceEecCCcceEEEEEecC--C---cEEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN--G---EVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~--~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
.+....++||+|+||.||+|+++. + ..||||..+... .......+|++|+++|+.++|||||+++|++....+.
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344556899999999999998652 2 238999988532 4556778999999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++|||+|.||+|.+|+++++.. ++..++.+++.++|.||+||| ++++|||||.++|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~--v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKS--LPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCC--CCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999999988763 899999999999999999999 88999999999999999999999999999985
Q ss_pred ccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHH-HHhhhccCCCchh
Q 001274 956 IDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWV-RRSIHEMVPTSEL 1033 (1109)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~ 1033 (1109)
.. .+........-+.+|+|||.+..+.|+.++|||||||++||+++ |..||.+.... +...++ ...++...+
T Consensus 312 ~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-~v~~kI~~~~~r~~~~---- 385 (474)
T KOG0194|consen 312 GS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-EVKAKIVKNGYRMPIP---- 385 (474)
T ss_pred Cc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-HHHHHHHhcCccCCCC----
Confidence 43 11111112246789999999999999999999999999999999 89999875422 222222 222221111
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 1087 (1109)
...+..+..++.+||..+|++||+|.++.+.++.+.......
T Consensus 386 ------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 386 ------------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ------------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 122345668888999999999999999999999987776543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=388.32 Aligned_cols=262 Identities=30% Similarity=0.452 Sum_probs=214.6
Q ss_pred cCCCCCceEecCCcceEEEEEec--CCc----EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--NGE----VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
...+..+.||+|+||.||+|... ++. .||||.++.. ....+..+|.+|+.+|++++|||||+++|+|.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 34556789999999999999854 343 4899988733 3455678999999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCC----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQ----TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
+|++|||++|+|..|+++.+. ...++..+.+.++.+||+|+.||+ ++++|||||.++|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987632 234899999999999999999999 8899999999999999999999999999
Q ss_pred cccccc-CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCC
Q 001274 952 LAKLID-LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 952 ~a~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 1029 (1109)
+|+.+. .++........-+..|||||.+..+.|+.|+|||||||++||++| |..||.+....+....+.+.. .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---R-- 922 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---R-- 922 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---c--
Confidence 999443 333333333345679999999999999999999999999999999 999998755333322233321 1
Q ss_pred CchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1030 TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
+ +.+..+...++++|..||+.+|++||+++.+++.+..+....
T Consensus 923 --------L----~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 923 --------L----DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred --------c----CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 1 112334456789999999999999999999999988887665
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=359.17 Aligned_cols=243 Identities=30% Similarity=0.447 Sum_probs=203.0
Q ss_pred CceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCC
Q 001274 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGS 886 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 886 (1109)
.+-||.|+.|.||+|+++ ++.||||+++. .-..+++-+++++|+||+.|.|+|......|||||||..|-
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 456899999999999996 78999999861 12367889999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCccc
Q 001274 887 LGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSA 966 (1109)
Q Consensus 887 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 966 (1109)
|+..|+.... ++......|.++||.||.||| .++|||||||.-||||..+..|||+|||-++..... .....
T Consensus 199 L~~VLka~~~---itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS 270 (904)
T KOG4721|consen 199 LYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS 270 (904)
T ss_pred HHHHHhccCc---cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence 9999987654 888899999999999999999 789999999999999999999999999999876522 33456
Q ss_pred cccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccH
Q 001274 967 IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTV 1046 (1109)
Q Consensus 967 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
++||..|||||++...+.++|+||||||||+|||+||..||.+....+.+...-. ..+. ...+.
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs--------------NsL~--LpvPs 334 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS--------------NSLH--LPVPS 334 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC--------------Cccc--ccCcc
Confidence 7899999999999999999999999999999999999999986542111111000 0011 11233
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1047 EEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1047 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.++.-|.-+++.||+..|..||+|++|+.|+.-+...
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 4455678899999999999999999999999776544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=356.36 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=215.0
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC---cchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCc
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG---ATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 874 (1109)
..++|..++.||+|+||+||.|++. +++.||||++...... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4578999999999999999999854 6899999977643111 123456678999999998 9999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEeecccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLA 953 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a 953 (1109)
.++||||+.||+|.+++...+. +.+.++..+++|++.|++|+| +++|+||||||+||+++.+ +.+||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999988443 889999999999999999999 8899999999999999999 99999999999
Q ss_pred ccccCCCCCCccccccccceeccccccCCC-CC-ccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAYTMK-VT-EKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++ .......+....+.....
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d----~~~~~l~~ki~~~~~~~p 243 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD----SNVPNLYRKIRKGEFKIP 243 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC----ccHHHHHHHHhcCCccCC
Confidence 9774 2345567789999999999999988 85 789999999999999999999986 233333333333333222
Q ss_pred hhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1032 ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
..++ ...+..++.+|+..+|.+|+++.+|+++-|...
T Consensus 244 ~~~~-------------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 SYLL-------------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCcC-------------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 2221 245779999999999999999999998877765
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=351.23 Aligned_cols=265 Identities=25% Similarity=0.392 Sum_probs=215.6
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.....++++||+|.||.|.++....+..||||+++.. .+.....+|.+|+++|.+++||||++++|+|..+++.++|+|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3456778999999999999999988899999999744 334456899999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc-CC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID-LP 959 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~-~~ 959 (1109)
||++|+|.+|+.++.... ...+...+|+.||+.||+||. +.++||||+.++|+|+++++++||+|||+++.+- .+
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999998875432 455667789999999999999 7799999999999999999999999999999543 23
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh--CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT--GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
+.......+-+++|||||.+.-++++.++|||+||+++||+++ ...||..... +..++-.......... ..
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~--~~---- 764 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGR--QV---- 764 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCc--ce----
Confidence 3444455677899999999999999999999999999999987 7789876542 2222222222222211 11
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
-..++..+...+.++|.+||..|-++||+++++...|.+.
T Consensus 765 ---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1122444556788999999999999999999999888653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.59 Aligned_cols=269 Identities=25% Similarity=0.269 Sum_probs=213.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--CCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--QDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 878 (1109)
+.|+..+.|++|+||.||+|+++ +++.||+|+++.......-.-..++|+.++.+++|||||.+-.+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46888899999999999999976 68999999998665444444567899999999999999999988764 4578999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
||||+. +|...+...+.. +...++..++.|+++|++||| ...|+|||||++|+|+...|.+||+|||+||.+..
T Consensus 156 Me~~Eh-DLksl~d~m~q~--F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQP--FLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999976 999999887743 999999999999999999999 77899999999999999999999999999998874
Q ss_pred CCCCCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
+ ....+..+-|..|+|||.+.+.+ |+.+.||||+|||+.||+++++.|.+...-+ .+...+.....+.+...+.
T Consensus 230 p-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d----Ql~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 230 P-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID----QLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred C-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH----HHHHHHHHhCCCccccCCC
Confidence 4 34467778899999999998765 9999999999999999999999998654332 2333333322222222211
Q ss_pred cchh-----------------hcccHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1038 LDLS-----------------AKRTVE-EMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1038 ~~~~-----------------~~~~~~-~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
+..- ..+... -.+..++++...+..||.+|-||.|.+++=+...
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 1100 000000 1245778999999999999999999998866554
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=386.23 Aligned_cols=507 Identities=29% Similarity=0.347 Sum_probs=420.6
Q ss_pred EeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccc
Q 001274 77 VDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYI 156 (1109)
Q Consensus 77 l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l 156 (1109)
+|.++.++. .||..+-.-..++.|+++.|.+-..--+...+.-+|+.|||++|++. ..|..+..+.+|+.|.++.|.|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 455555544 34444444455888999988765321233444556999999999987 7999999999999999999999
Q ss_pred cccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhh
Q 001274 157 FGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSEL 236 (1109)
Q Consensus 157 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 236 (1109)
. ..|.+++++.+|++|.|.+|++. ..|.++..+++|++|+++.|++. .+|..+..+..++.+..++|..... +
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----l 153 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----L 153 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----h
Confidence 7 78899999999999999999998 89999999999999999999998 8999999999999999999933322 3
Q ss_pred hccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcE
Q 001274 237 EKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVE 316 (1109)
Q Consensus 237 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 316 (1109)
+... ++.++|..|.+.+.++..+.+++. .|+|++|.+. ...+..+.+|+.|....|++... --..++|+.
T Consensus 154 g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~ 223 (1081)
T KOG0618|consen 154 GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL----EISGPSLTA 223 (1081)
T ss_pred cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE----EecCcchhe
Confidence 3333 899999999999999999998877 8999999987 34678899999999999998732 223478999
Q ss_pred EEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccc
Q 001274 317 IDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHL 396 (1109)
Q Consensus 317 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 396 (1109)
|+.++|.++...+ -....+|++++++.|++++ +|+|++.+.+|+.|+..+|+|+ .+|..+...++|+.|.+.+|.+
T Consensus 224 L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel 299 (1081)
T KOG0618|consen 224 LYADHNPLTTLDV--HPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNEL 299 (1081)
T ss_pred eeeccCcceeecc--ccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhh
Confidence 9999999984433 2345789999999999995 4599999999999999999997 7899999999999999999999
Q ss_pred cccCCCcccccCcCcEEEeccccccCccchhhhcccc-cceeecCCccccCCCCCCCccccccceeecccccccccCCcc
Q 001274 397 EGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQK-LIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE 475 (1109)
Q Consensus 397 ~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 475 (1109)
+ -+|......+.|++|||..|+|....+..|..+.. |..|+.+.|++.......=...+.|+.|++.+|+++...-..
T Consensus 300 ~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~ 378 (1081)
T KOG0618|consen 300 E-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPV 378 (1081)
T ss_pred h-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhh
Confidence 8 67888888999999999999998655555555554 899999999998665444456788999999999999877778
Q ss_pred ccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCC
Q 001274 476 FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQ 555 (1109)
Q Consensus 476 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 555 (1109)
+.+..+|+.|+|++|++.......+.++..|++|+||+|+++ .+|..+.++..|++|...+|+|. ..| .+..++.|+
T Consensus 379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~ 455 (1081)
T KOG0618|consen 379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK 455 (1081)
T ss_pred hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence 889999999999999999776678889999999999999999 57899999999999999999998 778 899999999
Q ss_pred eeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCc
Q 001274 556 RLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGN 610 (1109)
Q Consensus 556 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 610 (1109)
.+|+|.|+|+...-..--.-++|++|||++|.-....-..|..+..+..+++.-|
T Consensus 456 ~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 456 VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred EEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 9999999998543222222288999999999855455667777778877777766
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=335.76 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=204.1
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhcc--CCCCceeeEEEEEEeCC----ce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGK--IRHRNIVKLYGFCYHQD----SN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~ 875 (1109)
...+..+++|+|+||.||+|.++ ++.||||++. ....+.|.+|-+|.+. ++|+||++++++-...+ +.
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 34455678999999999999986 5999999997 3356678888887665 58999999999877665 77
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhc------CCCCeEecCCCCCceeeCCCCceEEee
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD------CRPHIIHRDIKSNNILLDEEFQAHVGD 949 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~D 949 (1109)
++|+||.+.|+|.+||..+. ++|.+..+|+..+++||+|||++ .+++|+|||||.+||||..|+++.|+|
T Consensus 284 wLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred eEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 89999999999999998764 89999999999999999999976 367899999999999999999999999
Q ss_pred ccccccccCCCC-CCccccccccceeccccccCCC-CC-----ccchhHHHHHHHHHHHhCCCCCCC--ccc--------
Q 001274 950 FGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMK-VT-----EKCDIYSFGVVLLELITGKSPVQS--LEL-------- 1012 (1109)
Q Consensus 950 FG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlGvll~elltg~~pf~~--~~~-------- 1012 (1109)
||+|..+..... .+....+||.+|||||++.+.. +. .+.||||+|.++|||+++..-++. ..+
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999998763322 2234578999999999987653 22 368999999999999997654421 100
Q ss_pred --C-C---cHHH-HHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1013 --G-G---DLVT-WVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1013 --~-~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
. . +..+ .+++..+..++ +.+. .-..+..+.+.+..||+.||+.|.|+.=|-+.+.+.....+
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p--~~W~---------~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIP--DAWR---------KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCCh--hhhh---------cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0 0 1111 11111111111 1111 11445678899999999999999999999999999887776
Q ss_pred C
Q 001274 1086 D 1086 (1109)
Q Consensus 1086 ~ 1086 (1109)
.
T Consensus 509 ~ 509 (534)
T KOG3653|consen 509 D 509 (534)
T ss_pred c
Confidence 4
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=323.60 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=205.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|+..+.||.|+||.|.+++.+ +|..+|+|++..... .....+...+|..+++.+.||.++++++.+.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57889999999999999999966 689999999974422 1223456778999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||++||.|..++++.+. +++..++.++.+|+.|++||| +.+|++||+||+|||+|.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 99999999999998765 999999999999999999999 8899999999999999999999999999999765
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
....+.+||+.|+|||++..++|..++|.|||||++|||+.|..||.+... ...-.+...........
T Consensus 196 --~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~~------ 263 (355)
T KOG0616|consen 196 --GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPSY------ 263 (355)
T ss_pred --CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCcc------
Confidence 335678999999999999999999999999999999999999999986543 12222222222222111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCC-----CCHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNR-----PTMREVIAMMI 1078 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~R-----Pt~~evl~~L~ 1078 (1109)
-...+.+++.+.++.|-.+| +-..+|..|-+
T Consensus 264 --------fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~w 299 (355)
T KOG0616|consen 264 --------FSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPW 299 (355)
T ss_pred --------cCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcc
Confidence 12245688888899998888 34556665543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=360.04 Aligned_cols=263 Identities=26% Similarity=0.439 Sum_probs=205.0
Q ss_pred hcCCCCCceEecCCcceEEEEEe------cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCC
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 873 (1109)
.++|++.++||+|+||.||+|++ .+++.||||+++.. ......+.+.+|+.+++++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 36789999999999999999974 23568999998733 2233456789999999999 8999999999887654
Q ss_pred -ceEEEEEeccCCCHHHHhccCCC--------------------------------------------------------
Q 001274 874 -SNLLLYEYMENGSLGEQLHGNKQ-------------------------------------------------------- 896 (1109)
Q Consensus 874 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 896 (1109)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999875321
Q ss_pred ---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC-CCccccccccc
Q 001274 897 ---TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYG 972 (1109)
Q Consensus 897 ---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~ 972 (1109)
...+++.++..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++....... .......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 123778889999999999999999 78999999999999999999999999999986532211 11223346788
Q ss_pred eeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHH
Q 001274 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTL 1051 (1109)
Q Consensus 973 y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
|+|||++.+..++.++|||||||++|||++ |..||.+..........+.. ... .. ........
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~~-~~------------~~~~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD---GTR-MR------------APENATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc---CCC-CC------------CCCCCCHH
Confidence 999999999999999999999999999997 99999864322222221111 110 00 00111235
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1052 FLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1052 ~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 77999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=343.04 Aligned_cols=260 Identities=25% Similarity=0.282 Sum_probs=209.1
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
..++|+..++||+|+||.||+|+-+ +|..+|+|+++...- .....+.+..|-.+|...++|+||+++-.|++.++.|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3468999999999999999999854 699999999975422 22345678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||++||++..+|.+.+. +++..++..+.+++-|++.+| +.|||||||||+|+|||..|++||+|||++..+.
T Consensus 219 iMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999987664 999999999999999999999 8899999999999999999999999999985332
Q ss_pred C----------------------CCCC-----Cc-------------------cccccccceeccccccCCCCCccchhH
Q 001274 958 L----------------------PYSK-----SM-------------------SAIAGSYGYIAPEYAYTMKVTEKCDIY 991 (1109)
Q Consensus 958 ~----------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~Dvw 991 (1109)
. +... .. ...+|||.|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 00 124699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCC---
Q 001274 992 SFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP--- 1068 (1109)
Q Consensus 992 SlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP--- 1068 (1109)
|+|||+|||+.|.+||.+..+.+.....+.....-..|.. .+...+..++|.+|+. ||++|-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 9999999999999999875544333333332211111111 1111456789999999 999996
Q ss_pred CHHHHHHHHHHh
Q 001274 1069 TMREVIAMMIDA 1080 (1109)
Q Consensus 1069 t~~evl~~L~~~ 1080 (1109)
.+.||.+|-+..
T Consensus 438 G~~EIK~HPfF~ 449 (550)
T KOG0605|consen 438 GAEEIKKHPFFK 449 (550)
T ss_pred cHHHHhcCCccc
Confidence 588888776544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.44 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=212.4
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++++.||+|.||.||.|+. +++..||+|++...... .....++.+|+++-..++||||.+++++|.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 6899999999999999999985 46888999999654221 233567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||.++|++...++..... .+++.....++.|+|.|+.|+| .++||||||||+|+|++.++.+||+|||.+....
T Consensus 102 Eya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999854432 3888899999999999999999 8899999999999999999999999999998643
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.....+.+||..|.+||+..+..++.++|+|++|++.||++.|..||+....++.+.+..+..+.
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-------------- 240 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-------------- 240 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc--------------
Confidence 44556789999999999999999999999999999999999999999865422222222221111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.+........++|.+|+..+|.+|.+..|++++-+-.
T Consensus 241 ----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 241 ----FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred ----CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 1111223467899999999999999999999987643
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.54 Aligned_cols=264 Identities=24% Similarity=0.375 Sum_probs=220.3
Q ss_pred HHHHHhcCCCCCceEecCCcceEEEEEecC-CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc
Q 001274 796 NLLEATGNFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 796 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 874 (1109)
+++....+.....+||-|.||.||.|.|+. .-.||||.++ .+....++|++|+.+|+.++|||+|+++|+|..+..
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 344444566777899999999999999874 5679999998 445678899999999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.|||+|||.+|+|.+|+++.... .++....+.++.||+.||+||. .+++|||||.++|+||.++-.|||+|||+++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999876543 3777788899999999999999 8899999999999999999999999999999
Q ss_pred cccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
.+..+......+...++.|.|||-+-...++.|+|||+|||++||+.| |-.||.+.+. ....+.+.+.++..
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-SqVY~LLEkgyRM~------ 486 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYGLLEKGYRMD------ 486 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHhcccccc------
Confidence 987665555666677899999999999999999999999999999999 8899986431 11111222211111
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.+..+...++++|..||+|.|.+||+++|+-+.++....+
T Consensus 487 ----------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 487 ----------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ----------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 1233456789999999999999999999999988876543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.59 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=212.7
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.+|++.+.||+|.||+|-+|+. ..|+.||||.++..... ....-.+.+|++||..++||||+.++++|...+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677888999999999999984 68999999998754332 233456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||..+|.|++|+.+.+. +++.+++.++.||+.|+.|+| +.+++|||||.+|||+|.++.+||+|||++..+.
T Consensus 133 EYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~-- 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA-- 204 (668)
T ss_pred EecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc--
Confidence 99999999999988765 999999999999999999999 8899999999999999999999999999998775
Q ss_pred CCCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
...-.++++|++-|.+||++.+.+| ++.+|-||+||++|-++.|..||++.+ ....++....+....
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D----hk~lvrQIs~GaYrE-------- 272 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD----HKRLVRQISRGAYRE-------- 272 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----HHHHHHHhhcccccC--------
Confidence 3344578999999999999999998 578999999999999999999998643 334444333322110
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
++.+.....+|.+|+..+|++|.|..+|..|-|--
T Consensus 273 -------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 273 -------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 00111245789999999999999999999987643
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=342.90 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=214.0
Q ss_pred cCCCCCceEecCCcceEEEEEec---CCc--EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA---NGE--VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
......++||+|.||.||+|... .|+ .||||..+... ..+..+.|++|+.+|+.++||||++++|+|.+ .+.+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 44556689999999999999743 233 58899887543 34457889999999999999999999999976 5789
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+|||.++.|.|..|++.++.. ++......++.||+.||+||| ++.+|||||.++||||.....+|++|||+++.+
T Consensus 467 ivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999988765 899999999999999999999 889999999999999999999999999999998
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
+.+.........-++.|||||.+..++++.++|||.|||++||++. |..||++....+.+ ..+.. .+.
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEn--GeR-------- 610 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIEN--GER-------- 610 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecC--CCC--------
Confidence 7655555555566889999999999999999999999999999998 99999976522211 10110 001
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
...+..++..++.++.+||.+||.+||++.++...|.++.+
T Consensus 611 ------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 ------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11244556678899999999999999999999999988876
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.30 Aligned_cols=250 Identities=28% Similarity=0.390 Sum_probs=207.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
..|+..+.||+|.||.||+|.+. .++.||+|++.... .....+++.+|+.++..++++||.++++.+..+...+++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 35667789999999999999864 68999999997653 34456788999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||.||++.+.++.... +++.....|+++++.|+.|+| ..+.+|||||+.||++..+|.+|++|||++.......
T Consensus 92 y~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999999986553 577788889999999999999 6799999999999999999999999999998776443
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
... .+++||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+.+..+-.. .-.+| +-..+
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv---------lflIp--k~~PP---- 229 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV---------LFLIP--KSAPP---- 229 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE---------EEecc--CCCCC----
Confidence 333 788999999999999998999999999999999999999999986542100 00000 00011
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+.+|+..|++.+|+.||+|.+++++
T Consensus 230 --~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 --RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1122334568899999999999999999999866
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=341.50 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=200.1
Q ss_pred ceEecCCcceEEEEEecCCcEEEEEEeeccCCCcch-hHHHHHHHHHhccCCCCceeeEEEEEEe----CCceEEEEEec
Q 001274 808 AVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATA-DNSFLAEISTLGKIRHRNIVKLYGFCYH----QDSNLLLYEYM 882 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 882 (1109)
..||+|++|.||+|.+ +|+.||||+++........ .+.+.+|++++++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6899999999999998 5899999999754332222 4678899999999999999999999877 34678999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 962 (1109)
++|+|.+++..... +++....+++.+++.|+.|||.. .+++||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~g~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 105 TRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCCcHHHHHhhCCC---CChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence 99999999987543 88999999999999999999931 37889999999999999999999999999865422
Q ss_pred CccccccccceeccccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 963 SMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ..+.............
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~----~~~~~~~i~~~~~~~~--------- 242 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT----TKEIYDLIINKNNSLK--------- 242 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhcCCCCC---------
Confidence 123467889999999876 679999999999999999999999998543 2222222211111100
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
.+......+.+++.+||+.||++|||++|+++.|+....
T Consensus 243 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 243 ---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 011223468899999999999999999999999988754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=345.23 Aligned_cols=267 Identities=21% Similarity=0.300 Sum_probs=205.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|+++ +++.||+|+++.........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999976 68899999997654444445678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|++++.+..+..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMPN---GVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999877765543322 3889999999999999999999 7899999999999999999999999999998764333
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh-------
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL------- 1033 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------- 1033 (1109)
........|++.|+|||++.+..++.++||||+||++|||++|+.||.+....+.... +.... ...+....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~ 232 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT-IQKVL-GPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhh-CCCCHHHHHhhhccc
Confidence 3333456789999999999998999999999999999999999999986432111111 11100 00000000
Q ss_pred -h----hhhc----chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1034 -F----DKRL----DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1034 -~----~~~~----~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
+ .+.. .............+.+++.+|++.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 0000 00000011123468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=375.21 Aligned_cols=506 Identities=28% Similarity=0.335 Sum_probs=257.6
Q ss_pred EEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccc
Q 001274 125 LDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSL 204 (1109)
Q Consensus 125 L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l 204 (1109)
+|+|..++. .+|..+..-..++.|++..|.+-...-+.+.+.-.|+.|||++|++. ..|..+..+.+|+.|+++.|.|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 344555554 45555544444666666666554322233333444677777776665 6666777777777777777777
Q ss_pred cCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhh
Q 001274 205 SGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKEL 284 (1109)
Q Consensus 205 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l 284 (1109)
. ..|.+.+++.+|++|.|.+|.+. .+|..+..+++|+.|+++.|++. .+|..+..++.++.+..++|... ..+
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~----~~l 153 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKI----QRL 153 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhh----hhh
Confidence 6 56666677777777777777766 56777777777777777777776 66777777777777777777222 122
Q ss_pred hccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccE
Q 001274 285 GKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHK 364 (1109)
Q Consensus 285 ~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 364 (1109)
+... .+.+++..|.+.+.++..+.+++. .|||++|.+.. -.+..+++|+.|....|++.... -..++|+.
T Consensus 154 g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~ 223 (1081)
T KOG0618|consen 154 GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLSNLANLEVLHCERNQLSELE----ISGPSLTA 223 (1081)
T ss_pred cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhhhccchhhhhhhhcccceEE----ecCcchhe
Confidence 3322 666677777776666666666555 57777776651 12334445555555555444211 12244555
Q ss_pred EEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccc
Q 001274 365 LDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRL 444 (1109)
Q Consensus 365 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l 444 (1109)
|+.++|.++...+. + --.+|+.++++.|+++ .+|++++.+.+|+.++..+|++. .+|..+...++|++|.+..|.+
T Consensus 224 L~a~~n~l~~~~~~-p-~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel 299 (1081)
T KOG0618|consen 224 LYADHNPLTTLDVH-P-VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNEL 299 (1081)
T ss_pred eeeccCcceeeccc-c-ccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhh
Confidence 55555555422111 1 1123445555555554 23345555555555555555552 3444444445555555555555
Q ss_pred cCCCCCCCccccccceeecccccccccCCccccCCcc-cceeccccccccCCCCccccccccccEEEccCCccCCCCChh
Q 001274 445 SGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQN-LSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSE 523 (1109)
Q Consensus 445 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 523 (1109)
. -+|+....+++|++|+|..|+|....+..|.-+.. |+.|+.+.|++....--.=..++.|+.|++.+|.+++..-..
T Consensus 300 ~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~ 378 (1081)
T KOG0618|consen 300 E-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPV 378 (1081)
T ss_pred h-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhh
Confidence 4 23334444445555555555554222222222221 444444444444221111112233444444444444433333
Q ss_pred hcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccc
Q 001274 524 VGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT 603 (1109)
Q Consensus 524 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 603 (1109)
+.+.++|+.|+|++|+|.......+.++..|++|+||+|.++ .+|..+..+..|++|...+|++. ..| .+..++.|+
T Consensus 379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~ 455 (1081)
T KOG0618|consen 379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK 455 (1081)
T ss_pred hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence 444444444444444444222223334444444444444444 34444444444444444444443 223 334444444
Q ss_pred eeeccCccccccccccccccchhhhhhccCCcccccc-ccccccCccccceeecCCCccccCCchhhhccccceEEEccC
Q 001274 604 ELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGV-IPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSN 682 (1109)
Q Consensus 604 ~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~ 682 (1109)
. +|+|.|+|+.. +|..... ++|++|||++|.-.-.--..|..+.++..+++.-
T Consensus 456 ~-------------------------lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~ 509 (1081)
T KOG0618|consen 456 V-------------------------LDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITL 509 (1081)
T ss_pred E-------------------------EecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheeccc
Confidence 4 44444444422 3333322 6788888888874323334566666666666665
Q ss_pred c
Q 001274 683 N 683 (1109)
Q Consensus 683 N 683 (1109)
|
T Consensus 510 ~ 510 (1081)
T KOG0618|consen 510 N 510 (1081)
T ss_pred C
Confidence 5
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.54 Aligned_cols=256 Identities=26% Similarity=0.298 Sum_probs=203.2
Q ss_pred CCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 804 FSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
|+..+.||+|+||+||+|+. .+++.||+|++...... ......+.+|++++++++|++|+++++++...+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999986 47899999998644221 22345678999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++|+|.+++..... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--~ 155 (285)
T cd05631 82 MNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--G 155 (285)
T ss_pred cCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC--C
Confidence 999999988864332 23899999999999999999999 78999999999999999999999999999986532 1
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......||..|+|||++.+..++.++||||+||++|||++|+.||............... ..... ..+
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~---~~~------- 224 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-VKEDQ---EEY------- 224 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-hhccc---ccC-------
Confidence 2223457899999999999999999999999999999999999999864322111111111 11100 000
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMID 1079 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~~ 1079 (1109)
.......+.+++.+||+.||++||+ +++++++-+.
T Consensus 225 ---~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~ 264 (285)
T cd05631 225 ---SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264 (285)
T ss_pred ---CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence 1111235778999999999999997 8999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=329.54 Aligned_cols=268 Identities=23% Similarity=0.261 Sum_probs=209.2
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC------------cchhHHHHHHHHHhccCCCCceeeEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG------------ATADNSFLAEISTLGKIRHRNIVKLY 866 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~l~ 866 (1109)
..++|++.+.||+|.||.|-+|+.. +++.||||++...... ....+...+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3478999999999999999999965 7999999999654211 11225788999999999999999999
Q ss_pred EEEEeC--CceEEEEEeccCCCHHHHhccCCCCCC-CChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 001274 867 GFCYHQ--DSNLLLYEYMENGSLGEQLHGNKQTCL-LDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF 943 (1109)
Q Consensus 867 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 943 (1109)
++..+. +..|+|+|||..|.+.. .. ..+. +++.++++++.+++.||+||| .+|||||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w-~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKW-CP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCcccc-CC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence 998764 56799999999887632 22 2223 899999999999999999999 77999999999999999999
Q ss_pred ceEEeeccccccccCC----CCCCccccccccceeccccccCCC----CCccchhHHHHHHHHHHHhCCCCCCCcccCCc
Q 001274 944 QAHVGDFGLAKLIDLP----YSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSFGVVLLELITGKSPVQSLELGGD 1015 (1109)
Q Consensus 944 ~~kl~DFG~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvll~elltg~~pf~~~~~~~~ 1015 (1109)
++||+|||.+..+... ........+||+.|+|||...++. .+.+.||||+||++|.|+.|+.||-+. .
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~----~ 323 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD----F 323 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc----h
Confidence 9999999999866221 111224578999999999988733 357899999999999999999999742 2
Q ss_pred HHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCCC
Q 001274 1016 LVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSS 1090 (1109)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~ 1090 (1109)
..+...+...+.... . ...+..+.+.++|.++++.||++|.+..+|..|.|..........+.
T Consensus 324 ~~~l~~KIvn~pL~f----------P--~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~ 386 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEF----------P--ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSE 386 (576)
T ss_pred HHHHHHHHhcCcccC----------C--CcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCC
Confidence 223333322222111 1 12244567889999999999999999999999999887765554433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.78 Aligned_cols=251 Identities=20% Similarity=0.230 Sum_probs=205.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999975 689999999974322 1223456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++...+. +++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD- 153 (291)
T ss_pred eCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-
Confidence 99999999999976543 889999999999999999999 78999999999999999999999999999986542
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
......|++.|+|||++.+..++.++||||+||++|||++|+.||.... ................
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~-------- 218 (291)
T cd05612 154 ---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN----PFGIYEKILAGKLEFP-------- 218 (291)
T ss_pred ---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCcCCC--------
Confidence 2234568999999999999999999999999999999999999997532 2222222222211111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHHHh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMIDA 1080 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~~~ 1080 (1109)
......+.+++.+|++.||.+||+ +.|++++-+..
T Consensus 219 ------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 219 ------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred ------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 011235678999999999999995 99999887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=347.75 Aligned_cols=243 Identities=27% Similarity=0.360 Sum_probs=202.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 878 (1109)
++|...++||+|.||+|++|..+ +++.||||+++.... ..++.+..+.|.+|+... +||.++.++..|+..++.|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 68999999999999999999976 688999999986643 344567788898888777 699999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+.||++..+.+.. .+++..++.++..|+.||+||| +++|||||||.+|||+|.+|++||+|||+++..-
T Consensus 448 mey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m- 519 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM- 519 (694)
T ss_pred EEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC-
Confidence 9999999954443322 2999999999999999999999 8899999999999999999999999999998543
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.......+++||+.|+|||++.+..|+.++|.|||||++|||+.|..||.+..+ +++++..+
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------------ee~FdsI~ 581 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------------EEVFDSIV 581 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH------------------HHHHHHHh
Confidence 133456789999999999999999999999999999999999999999986431 22222222
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTM 1070 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~ 1070 (1109)
.....++.-...+...++.+++..+|++|.-+
T Consensus 582 ~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22223334444567899999999999999766
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=323.43 Aligned_cols=272 Identities=26% Similarity=0.327 Sum_probs=212.8
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe-----CCc
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH-----QDS 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 874 (1109)
..+|...+.||+|+||.|+.|.++ +|+.||||++..........++-.+|++++++++|+||+.+.+++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 356666789999999999999865 78999999998665666677889999999999999999999999876 245
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.|+|+|+| +.+|.+.++.... ++.+.+..++.||++|+.|+| +.+|+|||+||.|++++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccccee
Confidence 79999999 5699999987654 899999999999999999999 8899999999999999999999999999999
Q ss_pred cccCC-CCCCccccccccceecccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 955 LIDLP-YSKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 955 ~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
..... ....++.++.|..|+|||++. ...|+.+.||||.||++.||++|+.-|.+.. ....+.....-...+++
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d----~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD----YVHQLQLILELLGTPSE 249 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc----hHHHHHHHHHhcCCCCH
Confidence 87532 233457889999999999875 5679999999999999999999999998643 22222222221111111
Q ss_pred hhhhhcc------------hhh-----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1033 LFDKRLD------------LSA-----KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1033 ~~~~~~~------------~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.....+. ... ...........+++.+|+..||.+|+|++|+++|---..-.
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 1111110 000 01112224578999999999999999999999996555433
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=352.91 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=206.1
Q ss_pred hcCCCCCceEecCCcceEEEEEe------cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCC
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 873 (1109)
.++|++.++||+|+||+||+|++ .++..||||+++... .....+.+.+|+++++.+ +||||++++++|...+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 35788999999999999999963 246689999986432 233456788999999999 8999999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCC---------------------------------------------------------
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQ--------------------------------------------------------- 896 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 896 (1109)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999865321
Q ss_pred ---------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 897 ---------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 897 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
...+++..+.+++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 113788899999999999999999 77999999999999999999999999999986543221
Q ss_pred CC-ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 962 KS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 962 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.. .....++..|+|||++.+..++.++|||||||++|||++ |..||............+........+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 339 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP---------- 339 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCC----------
Confidence 11 122345678999999999999999999999999999998 889987654333333333322111100
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
......+.+++.+||+.||++||+|.||+++|++.
T Consensus 340 ------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=340.28 Aligned_cols=263 Identities=24% Similarity=0.397 Sum_probs=201.9
Q ss_pred cCCCCCceEecCCcceEEEEEecC-----------------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceee
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN-----------------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 864 (1109)
++|++.++||+|+||.||+|++++ +..||+|.+.... ......++.+|++++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 578899999999999999997532 3469999886432 2334567999999999999999999
Q ss_pred EEEEEEeCCceEEEEEeccCCCHHHHhccCCC----------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 001274 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQ----------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928 (1109)
Q Consensus 865 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 928 (1109)
+++++...+..++||||+++|+|.+++..... ...+++..+.+++.||+.|++||| +.+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 99999999999999999999999999854321 123688889999999999999999 77999
Q ss_pred ecCCCCCceeeCCCCceEEeeccccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh--CCC
Q 001274 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT--GKS 1005 (1109)
Q Consensus 929 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt--g~~ 1005 (1109)
||||||+||+++.++.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865322211 1223345788999999998899999999999999999987 566
Q ss_pred CCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1006 PVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1006 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
||...... .....+......... .... .........+.+++.+||+.||++|||+.+|.+.|+
T Consensus 241 p~~~~~~~-~~~~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE-QVIENAGEFFRDQGR--QVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH-HHHHHHHHHhhhccc--cccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 77654321 222222221111100 0000 001122346789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=333.26 Aligned_cols=256 Identities=20% Similarity=0.324 Sum_probs=203.9
Q ss_pred cCCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
.+|++.+.||+|+||.||+|.++ .+..||+|+++.... ......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 46888999999999999999753 366899999874422 2334678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|+|.+++..... .+++..++.++.|++.|++||| +.+++||||||+||+++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999976543 3899999999999999999999 7799999999999999999999999999876543
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
...........++..|+|||++.+..++.++|||||||++||+++ |+.||..... .+.+........ ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~----~~~~~~~~~~~~-~~----- 228 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG----QDVIKAVEDGFR-LP----- 228 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHHHCCCC-CC-----
Confidence 211111122345678999999999999999999999999999876 9999975432 122222111110 00
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
........+.+++.+||+.+|++||++.++.+.|.+.
T Consensus 229 -------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 -------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0111234578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=347.18 Aligned_cols=245 Identities=22% Similarity=0.261 Sum_probs=199.2
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
+.||+|+||.||+|+.+ +|+.||+|+++.... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 689999999974322 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCcc
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS 965 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 965 (1109)
+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~ 153 (323)
T cd05571 81 ELFFHLSRERV---FSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMK 153 (323)
T ss_pred cHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCccc
Confidence 99999976543 899999999999999999999 78999999999999999999999999999875321 122334
Q ss_pred ccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhccc
Q 001274 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRT 1045 (1109)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............... .
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~~~~~~~~~--------------p 215 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELILMEEIRF--------------P 215 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC----HHHHHHHHHcCCCCC--------------C
Confidence 5679999999999999999999999999999999999999997532 222222222111111 0
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 001274 1046 VEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMM 1077 (1109)
Q Consensus 1046 ~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 1077 (1109)
......+.+++.+||+.||++|| ++.+++++-
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~ 252 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR 252 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence 11123567899999999999999 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.85 Aligned_cols=275 Identities=25% Similarity=0.358 Sum_probs=212.3
Q ss_pred CCHHHHHHHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhcc--CCCCceeeEEEEE
Q 001274 792 FKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGK--IRHRNIVKLYGFC 869 (1109)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~ 869 (1109)
..+--.....++....+.||+|.||+||+|++. |+.||||++..+ +++.+.+|.++++. ++|+||..+++.-
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 333334455567888899999999999999996 899999999844 44567777777665 5999999999986
Q ss_pred EeCC----ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCceeeC
Q 001274 870 YHQD----SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD-----CRPHIIHRDIKSNNILLD 940 (1109)
Q Consensus 870 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIll~ 940 (1109)
..+. ..++|++|.+.|||++||..+. ++.+..++++..+|.||+|||.+ .++.|.|||||..||||.
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 5543 4589999999999999998743 89999999999999999999954 477899999999999999
Q ss_pred CCCceEEeeccccccccCCC---CCCccccccccceeccccccCCC----C--CccchhHHHHHHHHHHHhC--------
Q 001274 941 EEFQAHVGDFGLAKLIDLPY---SKSMSAIAGSYGYIAPEYAYTMK----V--TEKCDIYSFGVVLLELITG-------- 1003 (1109)
Q Consensus 941 ~~~~~kl~DFG~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlGvll~elltg-------- 1003 (1109)
.++.+.|+|+|+|....... .......+||.+|||||++...- | -..+||||||.++||+.-+
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 99999999999998775432 12235568999999999986432 2 2369999999999999753
Q ss_pred --CCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1004 --KSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1004 --~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
+.||.+.-+.+.-.+-+++.+-... ..+.++.+ -...+....+.++|..||..+|..|-|+-.+.+.+.++.
T Consensus 431 ey~~Pyyd~Vp~DPs~eeMrkVVCv~~-~RP~ipnr-----W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 431 EYQLPYYDVVPSDPSFEEMRKVVCVQK-LRPNIPNR-----WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred hhcCCcccCCCCCCCHHHHhcceeecc-cCCCCCcc-----cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 3577766544444444443322211 11111111 125567788999999999999999999999999998886
Q ss_pred h
Q 001274 1082 Q 1082 (1109)
Q Consensus 1082 ~ 1082 (1109)
+
T Consensus 505 ~ 505 (513)
T KOG2052|consen 505 N 505 (513)
T ss_pred c
Confidence 5
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=345.65 Aligned_cols=249 Identities=24% Similarity=0.273 Sum_probs=204.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+++ +++.||+|+++.... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999975 689999999974321 1233467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGR---FPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD- 170 (329)
T ss_pred cCCCCChHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence 99999999999976543 789999999999999999999 78999999999999999999999999999986542
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+..........+....
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~p~~------ 237 (329)
T PTZ00263 171 ---RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT----PFRIYEKILAGRLKFPNW------ 237 (329)
T ss_pred ---CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCCcCCCCC------
Confidence 2234578999999999999999999999999999999999999997432 222222222221111111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMI 1078 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~ 1078 (1109)
....+.+++.+||+.||++||+ ++++++|-+
T Consensus 238 --------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 238 --------FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred --------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 1134678999999999999997 799987754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.10 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=203.4
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
.+|++.+.||+|+||.||+|+++++..+|+|.+... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 457888999999999999999888889999987632 22346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++|+|.++++.... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.++.......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 81 MENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999976443 3889999999999999999999 77999999999999999999999999999986542222
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+.+........+.. +
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~----~~~~~~~i~~~~~~~~----~---- 223 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS----NYEVVEMISRGFRLYR----P---- 223 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHHCCCCCCC----C----
Confidence 22233345678999999998899999999999999999999 899987532 2222222222111100 0
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
......+.+++.+||+.+|++||+++++++.|
T Consensus 224 -----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 -----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01123578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=339.04 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=217.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc-eEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS-NLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 879 (1109)
++|..++++|+|+||.++.++++ ++..||+|++..........+...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999865 68899999998877766667788999999999999999999999999888 89999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
+||+||++.+.+.+.+. ..++++.+..++.|++.|+.||| +..|+|||||+.||+++.++.|||+|||+|+....+
T Consensus 84 ~Y~eGg~l~~~i~~~k~-~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG-VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999987762 34999999999999999999999 779999999999999999999999999999988743
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1038 (1109)
. ......+||+.|+.||.+.+.+|..|+||||+||++|||++-+++|.+.. ....+.+...... |.
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~----m~~Li~ki~~~~~~Pl-------- 226 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN----MSELILKINRGLYSPL-------- 226 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc----hHHHHHHHhhccCCCC--------
Confidence 2 34567899999999999999999999999999999999999999998643 3344444333331 11
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
+......+..++..|++.+|+.||++.+++.+.
T Consensus 227 ------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 227 ------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred ------CccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 222234577999999999999999999999873
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=350.29 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=204.7
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 874 (1109)
++|++.+.||+|+||.||+|++. ++..||||+++.... ......+.+|+++++.+ +|+||++++++|...+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 57889999999999999999742 245799999974422 23456788999999999 89999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCC----------------------------------------------------------
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQ---------------------------------------------------------- 896 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 896 (1109)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864321
Q ss_pred ---------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCC-ccc
Q 001274 897 ---------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS-MSA 966 (1109)
Q Consensus 897 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~ 966 (1109)
...+++..+.+++.||++||+||| +++|+||||||+||+++.++.+||+|||+++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 123788889999999999999999 7899999999999999999999999999998654222111 122
Q ss_pred cccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhccc
Q 001274 967 IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRT 1045 (1109)
Q Consensus 967 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
..++..|+|||++.+..++.++|||||||++|||++ |+.||............+........+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------- 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP---------------- 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC----------------
Confidence 335678999999999999999999999999999998 999998644322222222211110000
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1046 VEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1046 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
......+.+++.+||+.||++||++.+++++|+++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 001235789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=344.63 Aligned_cols=272 Identities=24% Similarity=0.374 Sum_probs=208.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||.||+|++. ++..||+|.+.... .....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 68899999999999999999875 68889999887432 22345679999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.+++..... +++..+..++.|++.|+.|||+. .+|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 156 (331)
T cd06649 84 HMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (331)
T ss_pred cCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc--
Confidence 9999999999976543 88999999999999999999932 3699999999999999999999999999976532
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc-C--C--------
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-V--P-------- 1029 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~--~-------- 1029 (1109)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ..+...+....... . +
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccccCCccccCcccc
Confidence 222345789999999999999999999999999999999999999975321 11111111000000 0 0
Q ss_pred ---------------C---chhhhhhcch--hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1030 ---------------T---SELFDKRLDL--SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1030 ---------------~---~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
. .+..+..... ...........+.+++.+||+.||++|||+.|++++.+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0 0000000000 0000111234688999999999999999999999998765433
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=334.96 Aligned_cols=263 Identities=22% Similarity=0.340 Sum_probs=200.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|+.+ +++.||+|+++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 57899999999999999999865 689999999874432 2234567899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++ +|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~- 156 (288)
T cd07871 84 YLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP- 156 (288)
T ss_pred CCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC-
Confidence 9974 99998876543 3788999999999999999999 789999999999999999999999999999765422
Q ss_pred CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCchhhhhh-
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSELFDKR- 1037 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~- 1037 (1109)
........+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... +.+........ +..+.+...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK----EELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhhccc
Confidence 122234568899999998875 56899999999999999999999999754322 21211111100 011111000
Q ss_pred --------c----chh--hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1038 --------L----DLS--AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1038 --------~----~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
. ... ..........+.+++.+|++.||.+|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000 00001112356799999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=305.07 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=205.5
Q ss_pred cCCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----ce
Q 001274 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD-----SN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 875 (1109)
++|++.+.+|+|||+.||.++ ..+++.||+|++.... .+..+..++|++..++++|||+++++++...+. ..
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 689999999999999999998 5678999999997654 346678899999999999999999998875543 47
Q ss_pred EEEEEeccCCCHHHHhccCCCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQT-CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
|++++|...|+|.+.+...+.+ ..+++.+.++|+.+|++||++||+. ..+++||||||.||++.+++.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999765433 3599999999999999999999955 4459999999999999999999999999987
Q ss_pred cccCCCCCCc--------cccccccceeccccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHh
Q 001274 955 LIDLPYSKSM--------SAIAGSYGYIAPEYAYT---MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRS 1023 (1109)
Q Consensus 955 ~~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~ 1023 (1109)
.......... .....|..|+|||.+.- ...++++|||||||++|+|+.|..||+.....+.-...
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL---- 253 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL---- 253 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE----
Confidence 6532211111 23357899999998863 44789999999999999999999999743211110000
Q ss_pred hhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1024 IHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.+....+.. .......+.+.+++.+|++.||.+||++.+++..+...
T Consensus 254 --------Av~n~q~s~--P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 --------AVQNAQISI--PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------eeecccccc--CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 000111111 11222456788999999999999999999999988764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.02 Aligned_cols=257 Identities=22% Similarity=0.284 Sum_probs=207.8
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+.|++.+.||+|.|+.||++.. .+|+.+|+|++....-.....+++.+|++|.+.++|||||++.+.+......|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 5677778899999999999864 579999999987665555567889999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceEEeecccccccc
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD---EEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a~~~~ 957 (1109)
+|+|++|..-+-... ..++..+-..++||++++.|+| ..+|||||+||+|+++. ..-.+|++|||+|....
T Consensus 91 ~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred cccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999977665432 2788888899999999999999 78999999999999994 34469999999999876
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
......+.+|||+|||||++...+|+..+|||+.||++|-++.|+.||.+-.. ..+.+.+. .+........
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~---~g~yd~~~~~--- 235 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIK---AGAYDYPSPE--- 235 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHh---ccccCCCCcc---
Confidence 44455778999999999999999999999999999999999999999985321 22222222 2222111100
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
-....+...+++.+|+..||.+|.|+.|.+.|-|-.
T Consensus 236 -------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 236 -------WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred -------cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 011123456899999999999999999998776543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=323.00 Aligned_cols=263 Identities=26% Similarity=0.289 Sum_probs=198.4
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc-----eE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS-----NL 876 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~ 876 (1109)
.|...+++|.|+||.||+|... +++.||||++-.... .-.+|+++|+.++|||||++.-+|..... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 5677889999999999999854 579999999963322 22379999999999999999998875432 24
Q ss_pred EEEEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEeeccccc
Q 001274 877 LLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAK 954 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~ 954 (1109)
+|||||+. +|.++++... ....++...++-++.||++|+.||| +.+|+||||||.|+|+|.+ |.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999986 9998887421 1123888889999999999999999 7899999999999999976 899999999999
Q ss_pred cccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhh-------hc
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSI-------HE 1026 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~-------~~ 1026 (1109)
.... ......+..|..|+|||.+.+. .|+.+.||||.||++.||+-|+.-|.+.+..+.+++.++-.- ..
T Consensus 175 ~L~~--~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 175 VLVK--GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eecc--CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 8763 3444667789999999998875 599999999999999999999999987554444444433211 11
Q ss_pred cCCCc-hhhhhhcchhh---cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1027 MVPTS-ELFDKRLDLSA---KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1027 ~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
+.+.. +.-.+.+.... -..........+++.+++..+|.+|.++.|++.+-
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~ 307 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP 307 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence 11100 00000110000 01223335578999999999999999999999773
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=345.21 Aligned_cols=258 Identities=22% Similarity=0.238 Sum_probs=206.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||.||+|++. +++.||||+++.... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999976 589999999975422 1234467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGV---LSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999976543 889999999999999999999 77999999999999999999999999999986542
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ..+.. ...........++
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~i~~-~~~~~~~~~~~~~--- 225 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-ENLKY-WKETLQRPVYDDP--- 225 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-HHHHh-ccccccCCCCCcc---
Confidence 234557899999999999999999999999999999999999999754321111 11111 0010000000000
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......+.+++.+|+..+|++||++.+++++-+.
T Consensus 226 -----~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~ 260 (333)
T cd05600 226 -----RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFF 260 (333)
T ss_pred -----ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCccc
Confidence 01123457789999999999999999999988543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=336.27 Aligned_cols=268 Identities=22% Similarity=0.365 Sum_probs=202.7
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.++||+|+||+||+|+.. +++.||||+++.... ......+.+|+++++.++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 368999999999999999999976 689999999874432 223446788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||++ +++.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 83 EYVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred ECCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 9995 688888866543 3888999999999999999999 789999999999999999999999999999754322
Q ss_pred CCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc-CCCchhhh--
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-VPTSELFD-- 1035 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-- 1035 (1109)
........+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+... ..+.+....... .+....+.
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 -SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD---IQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred -CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHHhCCCChhhccch
Confidence 222344568899999998875 4588999999999999999999999986432 222222111100 00000000
Q ss_pred --------hhcchhhccc-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1036 --------KRLDLSAKRT-------VEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1036 --------~~~~~~~~~~-------~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......... ......+.+++.+|++.||++|||+.|++++-+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 0000000000 0011346789999999999999999999987654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=342.06 Aligned_cols=256 Identities=23% Similarity=0.238 Sum_probs=203.2
Q ss_pred CCCCCceEecCCcceEEEEEe----cCCcEEEEEEeeccCC--CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCce
Q 001274 803 NFSEGAVIGRGACGTVYKATL----ANGEVIAVKKIKLRGE--GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 875 (1109)
+|++.+.||+|+||+||+|+. .+++.||+|++..... .....+.+.+|+++++++ +|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999975 3588999999964321 122345678899999999 589999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++||||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999976543 899999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCCCCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 956 IDLPYSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
.............||+.|+|||++.+.. ++.++||||+||++|||++|+.||.....................+..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--- 231 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC---
Confidence 5433333334567999999999988654 789999999999999999999999754333333332222222111111
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHH
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMI 1078 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~ 1078 (1109)
......+.+++.+||+.||++|| ++++++++-+
T Consensus 232 -----------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 232 -----------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred -----------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 11123567899999999999999 7889987743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.96 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=207.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCc-eeeEEEEEEeCC------
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN-IVKLYGFCYHQD------ 873 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 873 (1109)
..|...++||+|+||+||+|+.+ +|+.||+|++......+.......+|+.+++.++|+| ||++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34566678999999999999854 7899999999877554445567789999999999999 999999998877
Q ss_pred ceEEEEEeccCCCHHHHhccCCCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQT-CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
..++|+||++ -+|..++...... ..++...+..++.||+.|++||| +++|+||||||+||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 6789999995 5999999876532 23777889999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
|+....+. ......++|..|+|||++.+. .|+...||||+||++.||++++.-|.+..+ .+.....++-...+.
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----IDQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHHHcCCCC
Confidence 99665332 234566789999999999987 689999999999999999999999987554 222222222221111
Q ss_pred hhhhhhc------c-----hh-hccc----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1032 ELFDKRL------D-----LS-AKRT----VEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1032 ~~~~~~~------~-----~~-~~~~----~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
+...+.. . .. .... ........+++.+|++.+|.+|.|++.+++|-
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 1110000 0 00 0000 01113578999999999999999999999883
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=346.38 Aligned_cols=263 Identities=21% Similarity=0.192 Sum_probs=201.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.+|++.++||+|+||.||+|++. +++.||+|+.. ...+.+|++++++++||||+++++++......++|+|
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 57999999999999999999864 68899999653 2346789999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
++. ++|..++..... +++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|+......
T Consensus 164 ~~~-~~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 164 RYK-TDLYCYLAAKRN---IAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred cCC-CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 995 689888866543 889999999999999999999 7799999999999999999999999999997543222
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCccc---CCcHHHHHHHhhhccCCCc-h----
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLEL---GGDLVTWVRRSIHEMVPTS-E---- 1032 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~-~---- 1032 (1109)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..+....+........+.. +
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 2333456799999999999999999999999999999999999988653221 0011111111111100000 0
Q ss_pred ---hhhhhc-------------chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1033 ---LFDKRL-------------DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1033 ---~~~~~~-------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
..+... .............+.+++.+|++.||++|||+.|++++-+.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 000000 00000011234468899999999999999999999988765
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=337.97 Aligned_cols=243 Identities=24% Similarity=0.285 Sum_probs=197.1
Q ss_pred EecCCcceEEEEEec-CCcEEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCH
Q 001274 810 IGRGACGTVYKATLA-NGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSL 887 (1109)
Q Consensus 810 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 887 (1109)
||+|+||+||+|+.. +++.||+|+++... ........+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 58899999987432 1223456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCcccc
Q 001274 888 GEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967 (1109)
Q Consensus 888 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 967 (1109)
.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... .......
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 153 (312)
T cd05585 81 FHHLQREGR---FDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTF 153 (312)
T ss_pred HHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccc
Confidence 999976543 899999999999999999999 789999999999999999999999999999754321 2223446
Q ss_pred ccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHH
Q 001274 968 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVE 1047 (1109)
Q Consensus 968 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
.||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+..+.......... ..
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~----~~~~~~~~~~~~~~~~--------------~~ 215 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN----VNEMYRKILQEPLRFP--------------DG 215 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC----HHHHHHHHHcCCCCCC--------------Cc
Confidence 79999999999999999999999999999999999999997532 2233333222221111 11
Q ss_pred HHHHHHHHHHhccCCCCCCCCC---HHHHHHHH
Q 001274 1048 EMTLFLKIALFCSSTSPLNRPT---MREVIAMM 1077 (1109)
Q Consensus 1048 ~~~~~~~li~~cl~~dP~~RPt---~~evl~~L 1077 (1109)
....+.+++.+||+.||++||+ +.|++.+-
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 1235678999999999999974 67777663
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=350.93 Aligned_cols=260 Identities=24% Similarity=0.317 Sum_probs=208.3
Q ss_pred cCCCCCceEecCCcceEEEEEecCC-cEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEE-EEe------C
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANG-EVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGF-CYH------Q 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~ 872 (1109)
.++++.+.|.+|||+.||.|++..+ ..||+|++... +....+.+.+|+++|+.|+ |+|||.+++. ... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4677889999999999999997765 99999999755 4456788999999999996 9999999993 221 1
Q ss_pred CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
-+.++.||||+||.|-+++.++...+ |++.++++|+.++++|+++||.. ..+|||||||.+|||+..++..||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 25679999999999999998766544 99999999999999999999965 77899999999999999999999999999
Q ss_pred cccccCCCCCCc--------cccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHH
Q 001274 953 AKLIDLPYSKSM--------SAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVR 1021 (1109)
Q Consensus 953 a~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~ 1021 (1109)
|...-....... -....|+.|+|||++. +.+.++|+|||++||+||-|+....||+....-
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 874432221111 1124789999999864 677999999999999999999999999864210
Q ss_pred HhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1022 RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
.++...+... ........+..+|..||+.+|.+||++.+|++.+.++.....
T Consensus 265 ----------aIlng~Y~~P--~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 265 ----------AILNGNYSFP--PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ----------eEEeccccCC--CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 1111111111 123445678899999999999999999999999998876643
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=345.20 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=206.6
Q ss_pred hcCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCC
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQD 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 873 (1109)
.++|+++++||+|+||.||+|++. .+..||||+++... .....+.+.+|++++++++ ||||+++++++...+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 468899999999999999999753 13479999996432 2334567899999999996 999999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCC---------------------------------------------------------
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQ--------------------------------------------------------- 896 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 896 (1109)
..++||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999865321
Q ss_pred ------------------------------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 001274 897 ------------------------------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD 940 (1109)
Q Consensus 897 ------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~ 940 (1109)
...+++..+..++.||++|++||| +.+|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence 113778888999999999999999 78999999999999999
Q ss_pred CCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHH
Q 001274 941 EEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVT 1018 (1109)
Q Consensus 941 ~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~ 1018 (1109)
.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 999999999999986542211 11223456788999999999999999999999999999997 9999875432222222
Q ss_pred HHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1019 WVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
.+.. ..... ........+.+++.+||+.+|++||++.++.++|++..+
T Consensus 352 ~~~~----~~~~~------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 KIKS----GYRMA------------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHhc----CCCCC------------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 2221 11000 011123457899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=341.72 Aligned_cols=245 Identities=21% Similarity=0.258 Sum_probs=198.3
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
+.||+|+||.||+|+.. +|+.||+|+++.... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999865 689999999975422 2233456778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCcc
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS 965 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 965 (1109)
+|..++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~-~~~~~~ 153 (323)
T cd05595 81 ELFFHLSRERV---FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMK 153 (323)
T ss_pred cHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-CCCccc
Confidence 99998876543 899999999999999999999 78999999999999999999999999999875321 122234
Q ss_pred ccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhccc
Q 001274 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRT 1045 (1109)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...............
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~~~~~~~~~p-------------- 215 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFP-------------- 215 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCCCC--------------
Confidence 46789999999999999999999999999999999999999975321 222222211111110
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 001274 1046 VEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMM 1077 (1109)
Q Consensus 1046 ~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 1077 (1109)
......+.+++.+||+.||++|| ++.+++++-
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 11123567999999999999998 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=334.32 Aligned_cols=265 Identities=23% Similarity=0.364 Sum_probs=199.0
Q ss_pred cCCCCCceEecCCcceEEEEEec--CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC---CCCceeeEEEEEEe-----
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI---RHRNIVKLYGFCYH----- 871 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 871 (1109)
++|++.+.||+|+||+||+|++. +++.||+|+++...........+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37889999999999999999863 468899999876544333345566777777665 69999999999863
Q ss_pred CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 872 QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 872 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
....++||||++ ++|.+++...... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 6999998764432 3889999999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.+...+.. .. .+..
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~-~~--~~~~ 230 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV-IG--LPGE 230 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHH-hC--CCCh
Confidence 99865422 2334557899999999999889999999999999999999999999864322222222111 10 0011
Q ss_pred hhhhhhc-------chhh-----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1032 ELFDKRL-------DLSA-----KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1032 ~~~~~~~-------~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
+.+.... .... .........+.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 1110000 0000 0011123456799999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=340.25 Aligned_cols=271 Identities=23% Similarity=0.374 Sum_probs=206.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||.||+|++. +++.||+|.+.... .......+.+|++++++++|+||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 68999999999999999999876 68889999886432 22345678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.+++...+. +++..+..++.+++.|+.|||+. .+++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-- 156 (333)
T cd06650 84 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (333)
T ss_pred cCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh--
Confidence 9999999999976543 78899999999999999999932 3799999999999999999999999999975532
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc---------
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS--------- 1031 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------- 1031 (1109)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||...... .....+...........
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK-ELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred -hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh-HHHHHhcCcccCCccccccCcccCCc
Confidence 1223456899999999999989999999999999999999999999753311 11111100000000000
Q ss_pred ------------------hhhhhhcchhh-c-ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1032 ------------------ELFDKRLDLSA-K-RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1032 ------------------~~~~~~~~~~~-~-~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
...+....... . .......++.+++.+||+.||++|||+.|++++-+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00000000000 0 000112457899999999999999999999988766543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=341.41 Aligned_cols=268 Identities=25% Similarity=0.349 Sum_probs=200.6
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----ceE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD-----SNL 876 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 876 (1109)
+|++.++||+|+||.||+|+.. +++.||||++............+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788899999999999999865 6899999998754333334567889999999999999999999886433 469
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+. ++|.+++..... +++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD---LTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhccc---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 689998876543 899999999999999999999 779999999999999999999999999999854
Q ss_pred cCCCC--CCccccccccceeccccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 957 DLPYS--KSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 957 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..... ....+...... +...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~~~--~~~~ 230 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGT--PSPE 230 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCC--CCHH
Confidence 32111 12234578999999999875 678999999999999999999999997533111 11111111000 0110
Q ss_pred hhhhh-----------cchh-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1033 LFDKR-----------LDLS-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1033 ~~~~~-----------~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
..... +... ..........+.+++.+||+.||++|||++|++++-+..
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~ 294 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence 00000 0000 000001124567999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=328.57 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=205.6
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 578899999999999999999888889999988632 22456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.++++.... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999999976432 23788999999999999999999 77999999999999999999999999999987643222
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||++.+..++.++||||+||++|||+| |+.||...... .....+.. ......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~----~~~~~~-------- 225 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMSALQR----GYRMPR-------- 225 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-HHHHHHHc----CCCCCC--------
Confidence 22233446778999999998899999999999999999998 99999753211 11111111 111000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......+.+++.+|+..+|++||+++++.+.|++
T Consensus 226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 ----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00112357789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=341.40 Aligned_cols=249 Identities=23% Similarity=0.287 Sum_probs=203.2
Q ss_pred cCCCCCceEecCCcceEEEEEecC--CcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN--GEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
++|++.+.||+|+||.||+|++++ +..||+|++..... .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 578899999999999999998543 36899999864322 223446788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKR---FPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999976553 899999999999999999999 78999999999999999999999999999986542
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .................
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~----- 250 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIYQKILEGIIYFPKF----- 250 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHHHHHhcCCCCCCCC-----
Confidence 22345799999999999998999999999999999999999999975321 11122222211111110
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMI 1078 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~ 1078 (1109)
....+.+++.+|++.||++|+ ++++++++-+
T Consensus 251 ---------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 251 ---------LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred ---------CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 112467899999999999995 8999998854
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=338.08 Aligned_cols=246 Identities=22% Similarity=0.264 Sum_probs=199.5
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 689999999974422 2234467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCcc
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS 965 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 965 (1109)
+|..++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~~ 153 (328)
T cd05593 81 ELFFHLSRERV---FSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMK 153 (328)
T ss_pred CHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCC-cccccc
Confidence 99998876543 899999999999999999999 78999999999999999999999999999875431 122234
Q ss_pred ccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhccc
Q 001274 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRT 1045 (1109)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.... ................
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~----~~~~~~~~~~~~~~~p-------------- 215 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELILMEDIKFP-------------- 215 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC----HHHHHHHhccCCccCC--------------
Confidence 4679999999999999999999999999999999999999997532 2222222221111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHH
Q 001274 1046 VEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMI 1078 (1109)
Q Consensus 1046 ~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~ 1078 (1109)
......+.+++.+|++.||++|| ++.|++++-+
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 01123567899999999999997 8999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=326.62 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=202.7
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.+.||+|+||+||+|+++++..||+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 4678889999999999999998777789999886332 2346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++|+|.+++..... .+++..+..++.||+.|++||| +.+++|+||||+||+++.++.+||+|||.++....+..
T Consensus 81 ~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 81 MSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999976543 3899999999999999999999 78999999999999999999999999999886543222
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+..........+..
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~~~--------- 222 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SETVEKVSQGLRLYR--------- 222 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHHhcCCCCCC---------
Confidence 22223345678999999998889999999999999999999 9999875431 111111111111000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.......+.+++.+||+.+|++||++.++++.+
T Consensus 223 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 223 ----PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred ----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 001124678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=340.97 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=198.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.+|+..++||+|+||+||+|++. +++.||||++.... .....+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 35667789999999999999865 68999999986432 22335678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.... ...+..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999986532 2566778899999999999999 7899999999999999999999999999998664221
Q ss_pred CCCccccccccceeccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||.... ..+.............+.
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~----- 295 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWASLMCAICMSQPPE----- 295 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CccHHHHHHHHhccCCCC-----
Confidence 12234578999999998743 234568999999999999999999997322 222222222211111100
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
........+.+++.+||+.||++||++.|++++-+-...
T Consensus 296 --------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 296 --------APATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred --------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 011122457899999999999999999999998665543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.49 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=206.1
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.++|++.+.||+|+||.||+|.+.+++.||+|.++... ...+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 35788899999999999999998778899999986432 235678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++.... ...+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999997654 224899999999999999999999 7899999999999999999999999999998765222
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.........+..|+|||++.+..++.++||||||+++|||++ |+.||.+... ....... .......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~-~~~~~~~-------- 224 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVLQQV-DQGYRMP-------- 224 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH-HcCCCCC--------
Confidence 222222334568999999999999999999999999999999 9999875331 1111111 1111000
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
........+.+++.+|++.+|++||++.++++.|+.
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 ----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 011122467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=347.85 Aligned_cols=254 Identities=26% Similarity=0.318 Sum_probs=205.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|.+.+.||+|+||+||+|+.. +++.||||+++..... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999975 6899999999754221 234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999998763 3899999999999999999999 789999999999999999999999999999866432
Q ss_pred C----------------------------CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 001274 960 Y----------------------------SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011 (1109)
Q Consensus 960 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~ 1011 (1109)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112234568999999999999999999999999999999999999997543
Q ss_pred cCCcHHHHHHHhhh--ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHH
Q 001274 1012 LGGDLVTWVRRSIH--EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT-MREVIAMMI 1078 (1109)
Q Consensus 1012 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~~L~ 1078 (1109)
. ......... ....... .......+.+++.+|+. ||++||+ +++++++.+
T Consensus 235 ~----~~~~~~i~~~~~~~~~p~------------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 235 L----QETYNKIINWKESLRFPP------------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred H----HHHHHHHhccCCcccCCC------------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 1 111111111 1100000 00023457789999997 9999999 999998854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=345.11 Aligned_cols=257 Identities=22% Similarity=0.282 Sum_probs=198.6
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.|+..+.||+|+||+||+|++. +++.||||++..... .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999864 688999999975432 22344678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRMEV---FPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999976543 889999999999999999999 7899999999999999999999999999976431100
Q ss_pred C----------------------------------------------CCccccccccceeccccccCCCCCccchhHHHH
Q 001274 961 S----------------------------------------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFG 994 (1109)
Q Consensus 961 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 994 (1109)
. ......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHh--ccCCCCCCCCCHHH
Q 001274 995 VVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALF--CSSTSPLNRPTMRE 1072 (1109)
Q Consensus 995 vll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dP~~RPt~~e 1072 (1109)
|++|||++|+.||............+. ....... .. .......+.+++.+ |+..+|..||++.|
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~----~~--------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVIN--WENTLHI----PP--------QVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHc--cccccCC----CC--------CCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 999999999999975432111111110 0000000 00 00111245567766 56667777999999
Q ss_pred HHHHHHH
Q 001274 1073 VIAMMID 1079 (1109)
Q Consensus 1073 vl~~L~~ 1079 (1109)
++++-+.
T Consensus 302 ~l~hp~f 308 (381)
T cd05626 302 IKAHPFF 308 (381)
T ss_pred HhcCccc
Confidence 9988543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.27 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=207.2
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcch------hHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATA------DNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
...|...+.+|.|..++|-++.+ ++|.++|+|++......... .++-.+|+.|++++ .||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 34677778899999999998865 47889999999755332211 24556799999998 799999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
...++|+|.|+.|.|.+|+...- +++++..++|+.|+.+|++||| ...||||||||+|||++++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccce
Confidence 99999999999999999997654 3999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceeccccccC------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYT------MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
|+.+. ........+||++|.|||.+.. ..|+..+|+|+.||++|-++.|..||.....--. ++....+
T Consensus 170 a~~l~--~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM----LR~ImeG 243 (411)
T KOG0599|consen 170 ACQLE--PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM----LRMIMEG 243 (411)
T ss_pred eeccC--CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH----HHHHHhc
Confidence 99876 4556678899999999998763 3588899999999999999999999975321111 1111111
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
... .....=.+......++|.+|++.||++|-|++|+++|-+..
T Consensus 244 kyq----------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 244 KYQ----------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred ccc----------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 111 11111122234567999999999999999999999997764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=335.26 Aligned_cols=246 Identities=23% Similarity=0.277 Sum_probs=198.2
Q ss_pred ceEecCCcceEEEEEe----cCCcEEEEEEeeccCC--CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 808 AVIGRGACGTVYKATL----ANGEVIAVKKIKLRGE--GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++||+|+||.||+++. .+++.||||+++.... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 3578999999974321 122335677899999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++|+|.+++..... +.+..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 154 (323)
T cd05584 82 LSGGELFMHLEREGI---FMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-G 154 (323)
T ss_pred CCCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-C
Confidence 999999999976543 788899999999999999999 789999999999999999999999999998754321 2
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .................
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~----~~~~~~~~~~~~~~~~~--------- 221 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN----RKKTIDKILKGKLNLPP--------- 221 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC----HHHHHHHHHcCCCCCCC---------
Confidence 22234578999999999999899999999999999999999999997532 22222222222211111
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMI 1078 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~ 1078 (1109)
.....+.+++.+|++.||++|| ++.+++++-+
T Consensus 222 -----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 222 -----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred -----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 1123567999999999999999 8999988643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=343.80 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=202.6
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ........+.+|+.+++.++||||+++++++..++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3468999999999999999999975 58899999986432 122234567899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|+|.+++.... +++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|....
T Consensus 121 v~Ey~~gg~L~~~l~~~~----~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999996542 788999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCCCccccccccceeccccccCCC----CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
...........||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ...............
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~~-- 267 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----VGTYSKIMDHKNSLN-- 267 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCcccC--
Confidence 33222234567999999999987643 78899999999999999999999975332 222222111110000
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHHHHh
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLN--RPTMREVIAMMIDA 1080 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~L~~~ 1080 (1109)
+. ........+.+++.+|+..+|.+ ||++.|++++-+..
T Consensus 268 ~p--------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~ 308 (370)
T cd05621 268 FP--------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308 (370)
T ss_pred CC--------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence 00 01111234667888888755544 89999999986543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=337.85 Aligned_cols=261 Identities=27% Similarity=0.430 Sum_probs=204.7
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC-C
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ-D 873 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 873 (1109)
++|++.+.||+|+||.||+|+.. +++.||+|+++... .....+.+.+|+++++++ +|+||++++++|... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 57889999999999999999642 35789999986432 223446688899999999 899999999988754 4
Q ss_pred ceEEEEEeccCCCHHHHhccCCC---------------------------------------------------------
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQ--------------------------------------------------------- 896 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 896 (1109)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 57899999999999999864321
Q ss_pred -CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC-CCcccccccccee
Q 001274 897 -TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYI 974 (1109)
Q Consensus 897 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~ 974 (1109)
...+++..+..++.||+.|++||| +.+|+||||||+||+++.++.++|+|||+++....... .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 124789999999999999999999 77999999999999999999999999999986542211 1122345677899
Q ss_pred ccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHH
Q 001274 975 APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFL 1053 (1109)
Q Consensus 975 aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1109)
|||++.+..++.++||||+||++|||++ |..||.+....+.....+........ .......+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA----------------PEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC----------------CccCCHHHH
Confidence 9999999999999999999999999998 99999764332222222221111000 011124578
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1054 KIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1054 ~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
+++.+||+.+|++||++.|++++|+++.+
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=329.06 Aligned_cols=258 Identities=26% Similarity=0.283 Sum_probs=204.3
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.|++.++||+|+||+||++... +++.||+|++...... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999864 6899999998643221 2223557789999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.+++..... ..+++..+..++.|++.|+.||| +.+++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~-- 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE-- 154 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC--
Confidence 9999999988865432 23899999999999999999999 77999999999999999999999999999986532
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
........|+..|+|||++.+..++.++||||+||++|||++|+.||.+....... +.+......... .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~---~------- 223 (285)
T cd05605 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEVERRVKEDQE---E------- 223 (285)
T ss_pred CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHHHHHhhhccc---c-------
Confidence 12223457899999999999999999999999999999999999999854321111 111111111100 0
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHHh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMIDA 1080 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~~ 1080 (1109)
........+.+++.+||+.||++|| ++++++++-+..
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05605 224 ---YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265 (285)
T ss_pred ---cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence 0111233577999999999999999 899998875544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=335.93 Aligned_cols=267 Identities=26% Similarity=0.353 Sum_probs=207.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-C-----CceeeEEEEEEeCCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-H-----RNIVKLYGFCYHQDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~ 874 (1109)
.+|.+.+.||+|+||.|-+|.+. +++.||||+++.. ..-..+-..|+.++..++ | -|+|+++++|...++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 38899999999999999999854 6999999999833 223455667899999986 4 389999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC--CceEEeeccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE--FQAHVGDFGL 952 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFG~ 952 (1109)
.|||+|.+. -+|+++++.++.. .++...++.|+.||+.||.+|| +.+|||+||||+|||+... ..+||+|||.
T Consensus 263 lciVfELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999995 5999999987654 4999999999999999999999 8899999999999999644 3799999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
|+... .....+.-+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+..+.+.+...+. .+ + .|...
T Consensus 338 Sc~~~----q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e-~l-G-~Pp~~ 410 (586)
T KOG0667|consen 338 SCFES----QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE-VL-G-LPPPK 410 (586)
T ss_pred ccccC----CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH-Hh-C-CCCHH
Confidence 98754 223367788899999999999999999999999999999999888876442222211111 00 0 11111
Q ss_pred hhh----------h-----------------------------hcc---h------hhcccHHHHHHHHHHHHhccCCCC
Q 001274 1033 LFD----------K-----------------------------RLD---L------SAKRTVEEMTLFLKIALFCSSTSP 1064 (1109)
Q Consensus 1033 ~~~----------~-----------------------------~~~---~------~~~~~~~~~~~~~~li~~cl~~dP 1064 (1109)
+++ . ... . .......+...|.+++.+|+.+||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 111 0 000 0 000111344669999999999999
Q ss_pred CCCCCHHHHHHHHHHhhhc
Q 001274 1065 LNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1065 ~~RPt~~evl~~L~~~~~~ 1083 (1109)
.+|+|+.++++|-+--...
T Consensus 491 ~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTGTS 509 (586)
T ss_pred hhcCCHHHHhcCccccccc
Confidence 9999999999997665333
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=323.53 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=205.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.+|.+.++||+|+||.||+|.++ .++.||+|++... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 45778899999999999999865 5889999988632 2345678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... ..+++..+..++.|+++|++||| +.+++||||||+||++++++.+||+|||.++......
T Consensus 83 ~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 83 FMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred eCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 9999999999976432 23899999999999999999999 7799999999999999999999999999998765322
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+.. ..+........ ....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~----~~~~~~~~~~~-~~~~-------- 225 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLEKG-YRME-------- 225 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHHCC-CCCC--------
Confidence 222222334678999999999999999999999999999998 999987532 22222221111 1000
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
........+.+++.+||+.+|++||++.+++++|+.+
T Consensus 226 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 ----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111224678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=332.13 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=203.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCc----EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGE----VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
.+|+..+.||+|+||+||+|++. +++ .||+|+++.. ......+++.+|+.+++.++||||++++|+|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46899999999999999999854 333 4899998633 2233456788999999999999999999998764 578
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+|+||+++|+|.+++...... +++..+.+++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~--~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhcccc--CCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999999875543 889999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCCC-ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 957 DLPYSKS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 957 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+... .......... ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-~~~~~~~~~~--~~~~~~--- 233 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG--ERLPQP--- 233 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhCC--CCCCCC---
Confidence 4322211 122335678999999999999999999999999999998 9999875321 1111111110 000100
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
......+.+++.+||+.+|++||++.+++..+..+....
T Consensus 234 -----------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 234 -----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 011234678999999999999999999999998886554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=343.64 Aligned_cols=257 Identities=22% Similarity=0.246 Sum_probs=203.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|.+.+.||+|+||+||+|+.. +++.||+|+++.... .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999865 689999999975432 2234566889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999987633 3899999999999999999999 789999999999999999999999999999876533
Q ss_pred CCCCccccccccceecccccc------CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 960 YSKSMSAIAGSYGYIAPEYAY------TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
.........||+.|+|||++. +..++.++||||+||++|||++|+.||..... ............ ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i~~~~~-~~~- 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS----AKTYNNIMNFQR-FLK- 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH----HHHHHHHHcCCC-ccC-
Confidence 222223456899999999986 45678999999999999999999999975331 122221111100 000
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
+. ........+.+++.+|++ +|++||++++++++-+
T Consensus 230 ~~--------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 230 FP--------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred CC--------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 00 001122356789999998 9999999999998744
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.48 Aligned_cols=248 Identities=26% Similarity=0.335 Sum_probs=196.6
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHh---ccCCCCceeeEEEEEEeCCceEEE
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTL---GKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
|++.+.||+|+||.||+|++. +++.||||+++.... .....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999865 689999999974421 122334566666554 567899999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++|+|..++... .+++..+..++.||+.|++||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999888643 2899999999999999999999 78999999999999999999999999999875431
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.........|++.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+............
T Consensus 154 -~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~----~~~~~~~i~~~~~~~-------- 220 (324)
T cd05589 154 -FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD----EEEVFDSIVNDEVRY-------- 220 (324)
T ss_pred -CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCC--------
Confidence 1222345679999999999999999999999999999999999999997532 222222221111110
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMM 1077 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 1077 (1109)
.......+.+++.+|++.||.+|| ++.+++++-
T Consensus 221 ------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 221 ------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred ------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 011123467899999999999999 688887764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.29 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=202.8
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGS 886 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 886 (1109)
-+||+|.||+||-|++. +...+|||.+..+... ..+....|+...++++|+|||+++|.+..+++.-|.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr--~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR--EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccch--hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 37999999999999976 4667999999765433 45568899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-CCCceEEeeccccccccCCCCCCcc
Q 001274 887 LGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD-EEFQAHVGDFGLAKLIDLPYSKSMS 965 (1109)
Q Consensus 887 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~ 965 (1109)
|.+.++..=+.-.-.+.++-...+||++||.||| +..|||||||-+||||+ -.|.+||+|||-+++.. .......
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TE 734 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTE 734 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc-cCCcccc
Confidence 9999986544322377788889999999999999 77999999999999995 68999999999998775 3455667
Q ss_pred ccccccceeccccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhc
Q 001274 966 AIAGSYGYIAPEYAYTMK--VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAK 1043 (1109)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
++.||..|||||++..++ |+.++|||||||++.||.||++||-.....+. ...+-. + ....+.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkVG---m----------yKvHP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKVG---M----------YKVHPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhhc---c----------eecCCC
Confidence 889999999999998664 89999999999999999999999976542211 111100 0 111222
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1044 RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1044 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.+.+...+...+|.+|+.+||.+||+|.++++.-
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 3445556788999999999999999999998653
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=337.24 Aligned_cols=270 Identities=24% Similarity=0.269 Sum_probs=202.5
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD----- 873 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 873 (1109)
..++|++.+.||+|+||.||+|++. +++.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999865 6899999999755444445667889999999999999999999986543
Q ss_pred -ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 874 -SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 874 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999965 66666643 2788899999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHH----------
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRR---------- 1022 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~---------- 1022 (1109)
++.... ........+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.............
T Consensus 170 a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 975432 22234457899999999999999999999999999999999999999854321111111000
Q ss_pred --------hhhccC-----CCchhhhhhcc-hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1023 --------SIHEMV-----PTSELFDKRLD-LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1023 --------~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
...... ...+.+..... ............+.+++.+|++.||++|||+.|++++-+-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 000000 00000000000 00000111234578999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=350.25 Aligned_cols=257 Identities=26% Similarity=0.352 Sum_probs=206.9
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD----- 873 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 873 (1109)
..++|.+.+.||+|+||+||+|+.. +++.||||++............+.+|+..+..++|+||+++.+.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999854 7899999999766555555667889999999999999999988775433
Q ss_pred ---ceEEEEEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 001274 874 ---SNLLLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGD 949 (1109)
Q Consensus 874 ---~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 949 (1109)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|+| +.+|+||||||+||+++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 2579999999999999986532 2234899999999999999999999 78999999999999999999999999
Q ss_pred ccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 950 FGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 950 FG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.+........
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~----~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE----NMEEVMHKTLAGRY 262 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHhcCCC
Confidence 999986542221 2234567999999999999999999999999999999999999999743 23333333222221
Q ss_pred CCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1029 PTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.. . .......+.+++.+||+.||++||++.+++++
T Consensus 263 ~~---~----------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 DP---L----------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC---C----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 0 11122457799999999999999999999876
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=315.95 Aligned_cols=258 Identities=22% Similarity=0.241 Sum_probs=210.9
Q ss_pred cCCCCCceEecCCcceEEEEEecC-CcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|+..+.||+|.-|+||+++..+ +..+|+|++...... .....+...|.+|++.++||.++.+|+.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 467778899999999999999764 589999999654322 334567788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC-
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL- 958 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~- 958 (1109)
|||+||+|....+++..+ .+++..++.++..|+-||+||| ..|||+|||||+||||.++|++-++||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999988877655 4999999999999999999999 88999999999999999999999999998743311
Q ss_pred --------------------------------CCC----------------------CCccccccccceeccccccCCCC
Q 001274 959 --------------------------------PYS----------------------KSMSAIAGSYGYIAPEYAYTMKV 984 (1109)
Q Consensus 959 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 984 (1109)
... ......+||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 01123469999999999999999
Q ss_pred CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCC
Q 001274 985 TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSP 1064 (1109)
Q Consensus 985 ~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP 1064 (1109)
+.++|.|+|||++|||+.|+.||.+....+.+...+.+...- | . ..+....+.++|.+.+..||
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F--p------------~--~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF--P------------E--EPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC--C------------C--CCcchhHHHHHHHHHhccCh
Confidence 999999999999999999999999866555554444321110 0 0 11233467899999999999
Q ss_pred CCCCC----HHHHHHHHHH
Q 001274 1065 LNRPT----MREVIAMMID 1079 (1109)
Q Consensus 1065 ~~RPt----~~evl~~L~~ 1079 (1109)
++|.. |+||.+|-..
T Consensus 377 ~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred hhhhccccchHHhhcCccc
Confidence 99999 9999988543
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=342.49 Aligned_cols=258 Identities=22% Similarity=0.263 Sum_probs=203.5
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.++|++.++||+|+||+||+|+.. +++.||+|++..... .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 357889999999999999999865 688999999964321 122345577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++|+|.+++.... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 122 ~Ey~~gg~L~~~l~~~~----l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999986542 788889999999999999999 78999999999999999999999999999986643
Q ss_pred CCCCCccccccccceeccccccCC----CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTM----KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
..........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+... ............... +
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~~--~ 268 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMDHKNSLT--F 268 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----HHHHHHHHcCCCcCC--C
Confidence 222223456799999999998653 478999999999999999999999985332 222222111110000 0
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHHHH
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLN--RPTMREVIAMMID 1079 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~L~~ 1079 (1109)
.. .......+.+++.+|++.+|.+ ||++.|++++-+.
T Consensus 269 ~~--------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 269 PD--------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred CC--------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 00 1112245778999999999988 9999999988543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=322.31 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=201.8
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
.+|++.+.||+|+||.||+|+++++..+|+|++.... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3578889999999999999998877889999886322 2345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.++.......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 81 MANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999976543 3899999999999999999999 77999999999999999999999999999986542222
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.. .....
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~----~~~~~--------- 221 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVVESVSA----GYRLY--------- 221 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHHHc----CCcCC---------
Confidence 11222234568999999999999999999999999999999 89998753321 11111111 11000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
........+.+++.+||..+|++|||+.|+++.|
T Consensus 222 ---~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 ---RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=329.13 Aligned_cols=249 Identities=34% Similarity=0.519 Sum_probs=192.0
Q ss_pred CceEecCCcceEEEEEec-----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 807 GAVIGRGACGTVYKATLA-----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
.+.||+|.||.||+|.+. .+..|+||.++.. ......+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccccc
Confidence 468999999999999876 3678999999642 3333468899999999999999999999999988889999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC-
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY- 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 960 (1109)
+++|+|.+++..... ..+++..+..|+.||++||.||| +.+++|+||+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccc-ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999988721 13899999999999999999999 6799999999999999999999999999998763211
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
............|+|||.+.+..++.++||||||+++|||++ |+.||.... ..++...........
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~----~~~~~~~~~~~~~~~--------- 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD----NEEIIEKLKQGQRLP--------- 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC----HHHHHHHHHTTEETT---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc----cccccccccccccce---------
Confidence 112233457788999999999999999999999999999999 788987542 222222221111100
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
........+.+++.+||+.+|++||+|.++++.|
T Consensus 226 ----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111223577999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=325.62 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=198.6
Q ss_pred EecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCH
Q 001274 810 IGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSL 887 (1109)
Q Consensus 810 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 887 (1109)
||+|+||+||+|.+. +++.||+|++...... ....+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 6899999998643221 12235677899999999999999999999999999999999999999
Q ss_pred HHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCccc
Q 001274 888 GEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSA 966 (1109)
Q Consensus 888 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 966 (1109)
.+++.... ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.++|+|||.+...... ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~-~~~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-QSKTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC-Cccccc
Confidence 98875422 2234899999999999999999999 789999999999999999999999999999765422 122334
Q ss_pred cccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccH
Q 001274 967 IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTV 1046 (1109)
Q Consensus 967 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...................... ...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT--------------YPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCC--------------Ccc
Confidence 578999999999999999999999999999999999999997543222222222211111110 011
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHH
Q 001274 1047 EEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMID 1079 (1109)
Q Consensus 1047 ~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~ 1079 (1109)
.....+.+++.+|++.||++|| ++++++++-+.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence 1234577999999999999999 78888887544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=321.31 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=205.4
Q ss_pred cCCCCCceEecCCcceEEEEEecC----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||+||+|+++. ...||||+++... .......+.+|+.++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 578899999999999999998742 4579999886432 33345678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++++|.+++..... .+++..+.+++.|++.|++||| +.+|+||||||+||++++++.++++|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999976544 3899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 958 LPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 958 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+. .... ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~---~~~~-~~~--- 229 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVE---DGYR-LPP--- 229 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-HHHHHHHH---cCCC-CCC---
Confidence 21111 1122345678999999999999999999999999999998 9999865321 11111111 1110 000
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.......+.+++.+||+.+|++||++.+++++|.++
T Consensus 230 ---------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 ---------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=328.62 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=204.9
Q ss_pred cCCCCCceEecCCcceEEEEEecC------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++|++.+.||+|+||.||+|.... ...||+|.++... .......+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468888999999999999998642 2579999886432 233456789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCC-------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 001274 876 LLLYEYMENGSLGEQLHGNKQT-------------CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE 942 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 942 (1109)
+++|||+++|+|.+++...... ..+++..+..++.|++.|++||| +.+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence 9999999999999999754221 24788899999999999999999 7799999999999999999
Q ss_pred CceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHH
Q 001274 943 FQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWV 1020 (1109)
Q Consensus 943 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~ 1020 (1109)
+.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+... .+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH
Confidence 9999999999986532221 12233456788999999998899999999999999999998 9999975432 1222222
Q ss_pred HHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1021 RRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.. ...+. ........+.+++.+||+.||.+||+++||+++|..
T Consensus 240 ~~---~~~~~-------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RS---RQLLP-------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred Hc---CCcCC-------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 21 11100 011223568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.68 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=207.3
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
..+|++.++||+|+||+||+|+..+++.||+|++.... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45788899999999999999998889999999987432 2235678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999976543 24899999999999999999999 7799999999999999999999999999998664322
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
. ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+. ......
T Consensus 159 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~~~~---~~~~~~--------- 224 (261)
T cd05148 159 Y-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYDQIT---AGYRMP--------- 224 (261)
T ss_pred c-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHHHHH---hCCcCC---------
Confidence 1 1223456778999999998899999999999999999998 89999753311 1111111 111000
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
........+.+++.+||+.||++|||++++++.|+.
T Consensus 225 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 ----CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 011222457799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=322.55 Aligned_cols=262 Identities=22% Similarity=0.344 Sum_probs=208.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.++||+|+||.||+|+.. +++.||||+++.... .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999865 789999998864322 2334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 880 EYMENGSLGEQLHGNKQ-TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
||+++|+|.+++..... ...+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988854321 224788999999999999999999 78999999999999999999999999999886542
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
. ........++..|+|||++.+..++.++||||+|+++|||++|+.||.... ....++.........+..
T Consensus 159 ~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~------- 228 (267)
T cd08228 159 K-TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLFSLCQKIEQCDYPPL------- 228 (267)
T ss_pred h-hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc--ccHHHHHHHHhcCCCCCC-------
Confidence 2 112233468889999999998889999999999999999999999986432 122222222111111100
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
........+.+++.+||+.+|++||++.+|++.+.+..
T Consensus 229 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 -----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01122345789999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=335.92 Aligned_cols=246 Identities=22% Similarity=0.263 Sum_probs=198.2
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
+.||+|+||+||+|+.. +++.||+|+++.... .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 689999999975422 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR-PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
+|..++..... +++..+..++.||+.||+||| + .+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (325)
T cd05594 81 ELFFHLSRERV---FSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATM 153 (325)
T ss_pred cHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccc
Confidence 99998876543 899999999999999999999 5 69999999999999999999999999998754311 2223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ................
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~----~~~~~~~i~~~~~~~p------------- 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELILMEEIRFP------------- 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC----HHHHHHHHhcCCCCCC-------------
Confidence 44579999999999999999999999999999999999999997532 2222222211111111
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMI 1078 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~ 1078 (1109)
......+.+++.+|++.||++|+ ++.+++++-+
T Consensus 217 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 217 -RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred -CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 01123567899999999999996 9999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=343.50 Aligned_cols=268 Identities=22% Similarity=0.259 Sum_probs=203.2
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----ceE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD-----SNL 876 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 876 (1109)
+|+..++||+|+||+||+|++. +++.||||++..........+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999864 7899999998654333344567889999999999999999999998776 789
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+. ++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 58888876544 3899999999999999999999 789999999999999999999999999999865
Q ss_pred cCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
............+++.|+|||++.+. .++.++||||+||++|||++|+.||.+....... ..+..... .. ..+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~g-~~-~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL-DLITDLLG-TP-SLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHcC-CC-CHHHHH
Confidence 43333333445688999999998874 4799999999999999999999999764321111 11111000 00 000000
Q ss_pred h-----------------hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1036 K-----------------RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1036 ~-----------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
. ...............+.+++.+|++.||++|||+.|++++-+-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 292 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence 0 00000000111234578999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=340.16 Aligned_cols=203 Identities=26% Similarity=0.353 Sum_probs=175.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+.. +++.||+|++..... .......+.+|+.++.+++|++|+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999999999999865 689999999974321 1223456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++...+. +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT---LTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999976543 899999999999999999999 789999999999999999999999999998754311
Q ss_pred CC----------------------------------CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCC
Q 001274 960 YS----------------------------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKS 1005 (1109)
Q Consensus 960 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~ 1005 (1109)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 00123579999999999999999999999999999999999999
Q ss_pred CCCCc
Q 001274 1006 PVQSL 1010 (1109)
Q Consensus 1006 pf~~~ 1010 (1109)
||.+.
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 99753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=332.78 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=197.0
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccC-CCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRG-EGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||+||+|+.+ +++.||||+++... ......+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999987432 1223445677888888776 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|.+++..... +++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~i~~~~~---l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~-~~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSRR---FDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTT 153 (320)
T ss_pred chHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-CCCcc
Confidence 999999876543 899999999999999999999 78999999999999999999999999999875431 12223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+..............
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~----~~~~~~~i~~~~~~~~~------------ 217 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN----EDDLFEAILNDEVVYPT------------ 217 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHHHHHHhcCCCCCCC------------
Confidence 44578999999999999999999999999999999999999997533 22222222222211111
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTM------REVIAMMI 1078 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~------~evl~~L~ 1078 (1109)
.....+.+++.+|++.||++||++ .+++++-+
T Consensus 218 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 218 --WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred --CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 112356789999999999999998 77776643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=343.39 Aligned_cols=256 Identities=24% Similarity=0.296 Sum_probs=201.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+.. +++.||||++..... .......+.+|+++++.++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999975 689999999974321 1233456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||+++.....
T Consensus 81 E~~~~g~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKDT---FTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999976543 899999999999999999999 789999999999999999999999999998754311
Q ss_pred CCC-------------------------------------CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh
Q 001274 960 YSK-------------------------------------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT 1002 (1109)
Q Consensus 960 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt 1002 (1109)
... .....+||+.|+|||++.+..++.++||||+||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHHH
Q 001274 1003 GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT---MREVIAMMI 1078 (1109)
Q Consensus 1003 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~evl~~L~ 1078 (1109)
|..||..... .+............. +... ......+.+++.+|+. +|.+|++ ++|++++-+
T Consensus 235 G~~Pf~~~~~----~~~~~~i~~~~~~~~--~~~~--------~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 235 GYPPFCSDNP----QETYRKIINWKETLQ--FPDE--------VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred CCCCCCCCCH----HHHHHHHHcCCCccC--CCCC--------CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 9999975432 122221111110000 0000 0112346688888886 8999998 999988754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=322.39 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=203.7
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||+||+|+++++..||+|+++... ...+.+.+|++++++++|+||+++++++. .+..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 5789999999999999999998777789999987432 23457899999999999999999999874 4567999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++|+|.+++..... ..+++..+..++.|+++||+|+| +.+++||||||+||+++.++.++|+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999976432 23789999999999999999999 78999999999999999999999999999986653332
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||+..+..++.++||||+|+++|||+| |..||...... ........ ..+..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~~~~~-~~~~~--------- 223 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVER-GYRMP--------- 223 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHHHHhc-CCCCC---------
Confidence 22233456778999999998899999999999999999999 88888653211 11111111 11000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
...+....+.+++.+|++.+|++||+++++++.|+..
T Consensus 224 ---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0122334678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=321.99 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=202.8
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++|++++++++++. ....++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 47888999999999999999988888999999874322 3457899999999999999999999875 4568999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... ..+++..+..++.+++.|++||| +.+++||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999999976432 23899999999999999999999 77999999999999999999999999999986543222
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||+..+..++.++||||||+++|||++ |+.||.+.. ..+......... +..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----~~~~~~~~~~~~-~~~--------- 223 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----NREVLEQVERGY-RMP--------- 223 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHHHcCC-CCC---------
Confidence 22223345678999999988899999999999999999999 889987532 112222111111 000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
........+.+++.+|++.+|++|||++++.+.|++
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 ---CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011122458899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=343.12 Aligned_cols=254 Identities=23% Similarity=0.269 Sum_probs=198.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.++||+|+||+||+|+.. +++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888999999999999999864 789999999864321 2233466888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYDT---FSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999976543 889999999999999999999 789999999999999999999999999999643210
Q ss_pred CCC----------------------------------------------CccccccccceeccccccCCCCCccchhHHH
Q 001274 960 YSK----------------------------------------------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSF 993 (1109)
Q Consensus 960 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 993 (1109)
... .....+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCcccCCcHHHHHHHhhh--ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCC---C
Q 001274 994 GVVLLELITGKSPVQSLELGGDLVTWVRRSIH--EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNR---P 1068 (1109)
Q Consensus 994 Gvll~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---P 1068 (1109)
||++|||++|+.||..... .+....... ....... .......+.+++.+|+. +|.+| +
T Consensus 235 Gvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~------------~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS----HETYRKIINWRETLYFPD------------DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred chhhhhhhcCCCCCCCCCH----HHHHHHHHccCCccCCCC------------CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 9999999999999975331 111111111 1110000 00112346789999997 66665 6
Q ss_pred CHHHHHHHHH
Q 001274 1069 TMREVIAMMI 1078 (1109)
Q Consensus 1069 t~~evl~~L~ 1078 (1109)
++.|++++-+
T Consensus 298 ~~~~~l~hp~ 307 (377)
T cd05629 298 GAHEIKSHPF 307 (377)
T ss_pred CHHHHhcCCC
Confidence 9999998854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.59 Aligned_cols=244 Identities=24% Similarity=0.311 Sum_probs=192.1
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||+||+|+.. +++.||+|+++.... .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 588999999975321 122334556677776654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-~~~~ 153 (316)
T cd05592 81 GDLMFHIQSSGR---FDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-EGKA 153 (316)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC-CCcc
Confidence 999999876543 899999999999999999999 789999999999999999999999999999754321 1223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.+... .+............ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~----~--------- 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DELFDSILNDRPHF----P--------- 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCC----C---------
Confidence 455789999999999999999999999999999999999999975431 22222211111111 0
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMR-EVIAM 1076 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~-evl~~ 1076 (1109)
......+.+++.+||+.+|++||++. ++.++
T Consensus 217 -~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 217 -RWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred -CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11123467899999999999999875 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=328.07 Aligned_cols=258 Identities=22% Similarity=0.363 Sum_probs=202.6
Q ss_pred HhcCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 873 (1109)
..++|+..+.||+|+||.||+|++. .++.||||++.... ......++.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4578999999999999999999753 25679999885332 2234567889999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCC-------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQ-------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH 946 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 946 (1109)
..++||||+++|+|.+++..... ...+++..+..++.|+++|++||| +.+++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence 99999999999999999865332 123678889999999999999999 77999999999999999999999
Q ss_pred EeeccccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhh
Q 001274 947 VGDFGLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSI 1024 (1109)
Q Consensus 947 l~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~ 1024 (1109)
++|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||..... .+..+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----~~~~~~~~ 235 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----EQVLRFVM 235 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH
Confidence 9999998755322111 1122345778999999999899999999999999999999 7889875321 22222211
Q ss_pred hccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1025 HEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
....+. . .......+.+++.+||+.+|++|||+.|++++++
T Consensus 236 ~~~~~~--~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 EGGLLD--K-----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCcCC--C-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111110 0 1112235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=324.47 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=196.3
Q ss_pred EecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCH
Q 001274 810 IGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSL 887 (1109)
Q Consensus 810 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 887 (1109)
||+|+||+||+++.+ +|+.||+|++...... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 6899999998643221 12234566799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCcccc
Q 001274 888 GEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967 (1109)
Q Consensus 888 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 967 (1109)
.+++..... ..+++..+..++.||+.|++||| +.+|+||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQR 154 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeecc
Confidence 988865432 23889999999999999999999 789999999999999999999999999999865421 222345
Q ss_pred ccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHH
Q 001274 968 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVE 1047 (1109)
Q Consensus 968 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
.|+..|+|||++.+..++.++||||+||++|||++|+.||..........+..+.......+.. ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~ 221 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-------------HQN 221 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-------------ccc
Confidence 6899999999999989999999999999999999999999764332222232232222111100 001
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1048 EMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1048 ~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
....+.+++.+||+.||++||+++|+++.+.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 1235679999999999999999976654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=331.43 Aligned_cols=249 Identities=23% Similarity=0.295 Sum_probs=198.5
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCC-CceeeEEEEEEeCCceEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRH-RNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 879 (1109)
+|++.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+..|.+++..++| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999865 578999999974321 22344667889999999976 56889999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF- 153 (324)
T ss_pred cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-
Confidence 99999999999976543 889999999999999999999 78999999999999999999999999999875321
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.........||+.|+|||++.+..++.++||||+||++|||+||+.||.+.. ..+..............
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~----~~~~~~~i~~~~~~~~~------- 222 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----EDELFQSIMEHNVSYPK------- 222 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCC-------
Confidence 1222344578999999999999999999999999999999999999997533 22222222211111110
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTM-----REVIAM 1076 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~~ 1076 (1109)
.....+.+++.+|++.||++|++. +++.++
T Consensus 223 -------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 223 -------SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112356789999999999999986 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=335.43 Aligned_cols=244 Identities=25% Similarity=0.285 Sum_probs=196.3
Q ss_pred ceEecCCcceEEEEEe----cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEecc
Q 001274 808 AVIGRGACGTVYKATL----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYME 883 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 883 (1109)
+.||+|+||+||+++. .+|+.||+|+++...........+..|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999975 358899999997543333334567789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCC
Q 001274 884 NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS 963 (1109)
Q Consensus 884 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 963 (1109)
+|+|.+++.+... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 82 ~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~ 154 (318)
T cd05582 82 GGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKK 154 (318)
T ss_pred CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCc
Confidence 9999999976543 899999999999999999999 789999999999999999999999999999865422 122
Q ss_pred ccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhc
Q 001274 964 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAK 1043 (1109)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||.... ..+..............
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~----~~~~~~~i~~~~~~~p~----------- 219 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD----RKETMTMILKAKLGMPQ----------- 219 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC----HHHHHHHHHcCCCCCCC-----------
Confidence 344678999999999999899999999999999999999999997532 22222222221111111
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 001274 1044 RTVEEMTLFLKIALFCSSTSPLNRPTM-----REVIAM 1076 (1109)
Q Consensus 1044 ~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~~ 1076 (1109)
.....+.+++.+||+.||++||++ .+++++
T Consensus 220 ---~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 220 ---FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred ---CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 112346789999999999999994 556544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=331.61 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=197.0
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||+||+|+.+ +++.||+|+++.... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 688999999975422 223345677888888776 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|..++..... +++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~~---l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQRK---LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTT 153 (329)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcc
Confidence 999998876543 899999999999999999999 779999999999999999999999999999754311 2223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCccc----CCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLEL----GGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......++......... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~- 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------R- 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------C-
Confidence 446789999999999999999999999999999999999999964321 11222222222211110 0
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPT------MREVIAMM 1077 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt------~~evl~~L 1077 (1109)
.+......+.+++.+||+.||++||+ +++++++-
T Consensus 224 ---~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 224 ---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 01111235678999999999999998 57887763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=332.16 Aligned_cols=246 Identities=24% Similarity=0.318 Sum_probs=197.6
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
++||+|+||+||+|+.+ +++.||+|+++.... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999865 578999999974321 223345677888888766 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|..++..... +++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05591 81 GDLMFQIQRSRK---FDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTT 153 (321)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC-Cccc
Confidence 999999876543 889999999999999999999 789999999999999999999999999998754321 2223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .................
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~----~~~~~~~i~~~~~~~p~------------ 217 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN----EDDLFESILHDDVLYPV------------ 217 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC----HHHHHHHHHcCCCCCCC------------
Confidence 44578999999999999999999999999999999999999997543 22222222222211111
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRP-------TMREVIAMMI 1078 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RP-------t~~evl~~L~ 1078 (1109)
.....+.+++.+|++.||++|| ++.+++++-+
T Consensus 218 --~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 218 --WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred --CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 0123567899999999999999 8899987753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=330.48 Aligned_cols=255 Identities=25% Similarity=0.303 Sum_probs=213.7
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 877 (1109)
...|++.+.||.|.||.||+++.+ +|+.+|+|++..+... ....+.+.+|+++|+++. |||||.+.++|......++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 357888899999999999999976 4999999999765433 224568899999999998 9999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC----CceEEeecccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE----FQAHVGDFGLA 953 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a 953 (1109)
|||++.||.|.+.+... . +++.++..++.||+.++.||| +.+|+|||+||+|+|+... +.+|++|||+|
T Consensus 114 vmEL~~GGeLfd~i~~~--~--~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--H--YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc--c--CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999876 2 899999999999999999999 7899999999999999533 57999999999
Q ss_pred ccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
..... .......+||+.|+|||++...+|+.++||||+||++|.|++|..||.+...........+. .......
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~----~~~f~~~ 260 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG----DFDFTSE 260 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC----CCCCCCC
Confidence 98774 55667889999999999999999999999999999999999999999875533333322222 1111111
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.-......+.+++.+|+..||.+|+|+.++++|-|
T Consensus 261 ----------~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 261 ----------PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ----------CccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 11122345678999999999999999999999876
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=336.56 Aligned_cols=265 Identities=23% Similarity=0.268 Sum_probs=202.5
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD----- 873 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 873 (1109)
..++|++.+.||+|+||.||+|++. .++.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999865 6889999999754444445567889999999999999999999876543
Q ss_pred -ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 874 -SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 874 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
..|+||||+++ ++.+++.. .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 46899999965 77777743 2788899999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCc
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTS 1031 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 1031 (1109)
++.... ........+|..|+|||++.+..++.++||||+||++|||++|+.||.+..... .......... +..
T Consensus 173 a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~~ 246 (364)
T cd07875 173 ARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID----QWNKVIEQLGTPCP 246 (364)
T ss_pred ccccCC--CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCCH
Confidence 986542 222344578999999999999999999999999999999999999997543211 1111111110 000
Q ss_pred hhhh-----------hh--------------c--chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1032 ELFD-----------KR--------------L--DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1032 ~~~~-----------~~--------------~--~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
+... .+ . .............+.+++.+|++.||.+|||+.|++++-+-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 0000 00 0 00000011122457899999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=319.69 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=203.9
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 5788999999999999999998889999999987332 23567899999999999999999999864 4678999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... ..+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999999876443 24899999999999999999999 78999999999999999999999999999986653222
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||++.+..++.++||||||+++||+++ |+.||.+... .+.......... . +.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~-~-~~------- 224 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQNLERGYR-M-PR------- 224 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHHHcCCC-C-CC-------
Confidence 22233456778999999998899999999999999999999 9999975331 111111111110 0 00
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
......++.+++.+||+.+|++||+++++++.|+.
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 ----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01112358899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.30 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=215.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+=|...+.||+|.|..|-+|++- +|+.||||++....-.......+.+|++.|+.++|||||++|++...+...|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777789999999999999854 79999999998766665566778899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee-CCCCceEEeeccccccccCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL-DEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DFG~a~~~~~~ 959 (1109)
.-++|+|.+|+-++... +.+....+++.||+.|+.|+| +..+|||||||+||.+ ..-|-||++|||++..+.
T Consensus 98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-- 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-- 170 (864)
T ss_pred ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC--
Confidence 99999999999877654 999999999999999999999 8899999999999877 567899999999998776
Q ss_pred CCCCccccccccceeccccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVT-EKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
......+.+|+..|-|||++.+..|+ +++||||+|||+|-++.|+.||+.....+.+. ..+
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT------------------mIm 232 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT------------------MIM 232 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh------------------hhh
Confidence 34566788999999999999999997 68999999999999999999999654322221 122
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
+..+..+.--..++.++|..|+..||.+|.+.++|+..-|
T Consensus 233 DCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 233 DCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred cccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 2222233444567889999999999999999999987755
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=334.00 Aligned_cols=249 Identities=23% Similarity=0.290 Sum_probs=198.0
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
+|++.+.||+|+||+||+|+.. +++.||||+++.... .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 578999999975422 122334567788888777 5899999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW- 153 (323)
T ss_pred cCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCC-
Confidence 99999999999876543 889999999999999999999 77999999999999999999999999999975431
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..............
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~--------- 220 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAY--------- 220 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCC---------
Confidence 12223445789999999999999999999999999999999999999975432 22222211111111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTM-----REVIAM 1076 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~~ 1076 (1109)
+......+.+++.+|++.||++|++. .++.++
T Consensus 221 -----p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 221 -----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -----CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 01112356789999999999999984 677655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=330.95 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=198.6
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
++||+|+||+||+|++. +++.||+|+++..... ....+.+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 6889999999754322 22345678899999888 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|.+++...+. +++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQRK---LPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTT 153 (329)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCcc
Confidence 999998876543 899999999999999999999 78999999999999999999999999999875321 12223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCccc----CCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLEL----GGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||+.... .....++.......... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 224 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------RI 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------CC
Confidence 456789999999999999999999999999999999999999974321 11222233222221110 00
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPT------MREVIAMMI 1078 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt------~~evl~~L~ 1078 (1109)
+......+.+++.+|++.||++||+ +++++++-+
T Consensus 225 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 225 ----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred ----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 0011234678999999999999997 788887643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=339.44 Aligned_cols=262 Identities=20% Similarity=0.240 Sum_probs=203.0
Q ss_pred HHHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc
Q 001274 797 LLEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 797 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 874 (1109)
+....++|++.+.||+|+||.||+|+++ +++.||+|++..... .......+.+|+.+++.++||||+++++++..++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3445579999999999999999999976 688999999864321 12234567889999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+++|+|.+++.... +++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999986542 788889999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCCCccccccccceeccccccCCC----CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
..............||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... .............
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~- 265 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMNHKNS- 265 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCc-
Confidence 76432222334567999999999987543 78999999999999999999999985332 2222221111100
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHHHH
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLN--RPTMREVIAMMID 1079 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~L~~ 1079 (1109)
... . ........+.+++.+|+..++.+ ||++.|++++.+.
T Consensus 266 ~~~-~--------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 266 LTF-P--------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred ccC-C--------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 000 0 01112235678999999844433 7899999998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=320.29 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=206.6
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|...+.||+|+||.||+|+.+ +++.|++|.+..........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999865 689999999976554555667899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... ..+++..+..++.+++.|+.||| +.+++|+||||+||+++.++.++|+|||+++..... .
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~-~ 155 (256)
T cd08529 81 AENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-T 155 (256)
T ss_pred CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-c
Confidence 999999999976522 24889999999999999999999 779999999999999999999999999998866532 2
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......+++.|+|||+..+..++.++||||||+++|||++|+.||.... .............+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~---------- 221 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN----QGALILKIIRGVFPPV---------- 221 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCC----------
Confidence 22234568889999999999999999999999999999999999997543 1122222222111100
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+||+.+|++||++.+++++
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11223457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=324.86 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=204.1
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++|.+.+.||+|+||.||+|+.. +++.||||+++.... ....+.+.+|++++++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 56888899999999999999863 247899999874322 22457899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCC-----------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQ-----------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ 944 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 944 (1109)
++||||+++++|.+++...+. ...+++..+..++.|++.|+.||| +.+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 999999999999999976432 234788999999999999999999 789999999999999999999
Q ss_pred eEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHH
Q 001274 945 AHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRR 1022 (1109)
Q Consensus 945 ~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~ 1022 (1109)
++|+|||.++....... .......+++.|+|||++.+..++.++||||+||++|||++ |+.||..... .+.+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~----~~~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN----EEVIEC 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Confidence 99999999975432211 11223346788999999999999999999999999999999 9999875432 122222
Q ss_pred hhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
......+.. .......+.+++.+||+.+|++||++.||++.|.
T Consensus 237 ~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ITQGRLLQR-------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHcCCcCCC-------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111000 0112245789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=328.98 Aligned_cols=244 Identities=25% Similarity=0.304 Sum_probs=193.0
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||.||+|+++ +++.||+|+++.... .......+..|..++... +||+|+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 688999999975421 122345566788887654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|..++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+++.... .....
T Consensus 81 g~L~~~i~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRA 153 (316)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc-CCCce
Confidence 999999876543 889999999999999999999 78999999999999999999999999999874321 12223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .................
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~----~~~~~~~~~~~~~~~~~------------ 217 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD----EDELFESIRVDTPHYPR------------ 217 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCC------------
Confidence 45678999999999999999999999999999999999999997532 12222221111111100
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMR-EVIAM 1076 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~-evl~~ 1076 (1109)
.....+.+++.+|++.||++||++. ++.++
T Consensus 218 --~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 218 --WITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred --CCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0123467899999999999999984 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.69 Aligned_cols=247 Identities=31% Similarity=0.459 Sum_probs=204.3
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
|.-.+.||+|+||.||-|++. +.+.||||++...+.+ .+...+++.|+..+++++|||++.+-|+|..+...++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 455678999999999999965 6889999999876544 34567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
| -|+-.+++...+.. +.+.++..|+.+.+.||+||| +.+.||||||+.|||+++.|.||++|||.|....
T Consensus 108 C-lGSAsDlleVhkKp--lqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred H-hccHHHHHHHHhcc--chHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence 9 56888888766543 889999999999999999999 7899999999999999999999999999998654
Q ss_pred CCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 962 KSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
....++|||.|||||++. .+.|+-|+||||+|++..|+...++|+..+.. ..-+........|.
T Consensus 178 -PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MSALYHIAQNesPt-------- 244 (948)
T KOG0577|consen 178 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNESPT-------- 244 (948)
T ss_pred -chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----HHHHHHHHhcCCCC--------
Confidence 234579999999999986 56799999999999999999999999765431 11111111112111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
-...+....|..|+..|++.-|.+|||.++++.+-
T Consensus 245 ----Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 245 ----LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ----CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 11455667899999999999999999999987653
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=332.78 Aligned_cols=245 Identities=25% Similarity=0.303 Sum_probs=196.9
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||+||+|++. +++.||||+++.... .......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 578999999975421 223345677888888877 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|..++..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~ 153 (318)
T cd05570 81 GDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL-GGVTT 153 (318)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCc-CCCcc
Confidence 999999876543 899999999999999999999 78999999999999999999999999999875321 12222
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....|++.|+|||++.+..++.++||||+||++|||++|+.||.... ...............
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~~~~~i~~~~~~~-------------- 215 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDELFQSILEDEVRY-------------- 215 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcCCCCC--------------
Confidence 34568999999999999999999999999999999999999997533 222222211111110
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTM-----REVIAMM 1077 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~~L 1077 (1109)
.......+.+++.+||+.||.+||++ .+++++-
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 01112357799999999999999999 8888763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=334.50 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=209.6
Q ss_pred CCCCceEecCCcceEEEEEe-cCC----cEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 804 FSEGAVIGRGACGTVYKATL-ANG----EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.+..++||+|+||+||+|.+ .+| -+||||++.. .......+++++|+.+|.+++|||+++++|+|.... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 44567999999999999974 344 3689998863 345566789999999999999999999999998766 7899
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
++||+.|+|.+|++.++.. +-.+..+.|..|||+||.||| ++++|||||.++||||.....+||+|||+|+....
T Consensus 776 tq~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999999987765 888999999999999999999 77999999999999999999999999999998764
Q ss_pred CCCCC-ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 959 PYSKS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 959 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
+.... .....-++.|||-|.+...+|+.++|||||||++||++| |..|+++.. .+++.+.++..-+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-~~eI~dlle~geR----------- 918 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-AEEIPDLLEKGER----------- 918 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-HHHhhHHHhcccc-----------
Confidence 33322 233445778999999999999999999999999999999 999998654 2223333332111
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
...+.-+...++.++.+||..|+..||+|+++.+.+.+....
T Consensus 919 -----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 919 -----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 112233344578999999999999999999999988776444
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=336.72 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=205.5
Q ss_pred HhcCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeC
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQ 872 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 872 (1109)
..++|.+.++||+|+||.||+|++. .++.||+|+++.... ....+.+.+|++++.++. ||||+++++++...
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 3457888999999999999999853 346899999974422 233457889999999997 99999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCC--------------------------------------------------------
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQ-------------------------------------------------------- 896 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 896 (1109)
+..++||||+++|+|.++++..+.
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999975421
Q ss_pred ---------------------------------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCce
Q 001274 897 ---------------------------------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNI 937 (1109)
Q Consensus 897 ---------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 937 (1109)
...+++..+..++.|++.|++||| +.+++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceE
Confidence 123677888999999999999999 78999999999999
Q ss_pred eeCCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCc
Q 001274 938 LLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGD 1015 (1109)
Q Consensus 938 ll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~ 1015 (1109)
+++.++.+|++|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999986532211 11223456788999999998889999999999999999998 8999875432221
Q ss_pred HHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1016 LVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
....+.. + .... ........+.+++.+||..+|++||+++||++.|+++.
T Consensus 351 ~~~~~~~---~-~~~~------------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYNAIKR---G-YRMA------------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHc---C-CCCC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111 1 1000 00111246789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=341.58 Aligned_cols=255 Identities=22% Similarity=0.261 Sum_probs=195.4
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+|+..++||+|+||+||+|+.. +++.||+|++..... .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 688999999874321 12234578899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMGI---FPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999976543 788999999999999999999 7799999999999999999999999999975321000
Q ss_pred C----------------------------------------------CCccccccccceeccccccCCCCCccchhHHHH
Q 001274 961 S----------------------------------------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFG 994 (1109)
Q Consensus 961 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 994 (1109)
. ......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCC---HH
Q 001274 995 VVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT---MR 1071 (1109)
Q Consensus 995 vll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~ 1071 (1109)
|++|||++|+.||...... +............. ... .......+.+++.+++ .+|++|++ +.
T Consensus 236 vil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~--~p~--------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPL----ETQMKVINWQTSLH--IPP--------QAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred HHHHHHHhCCCCCCCCCHH----HHHHHHHccCCCcC--CCC--------cccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 9999999999999754321 11111111000000 000 0001123456666654 59999997 99
Q ss_pred HHHHHHH
Q 001274 1072 EVIAMMI 1078 (1109)
Q Consensus 1072 evl~~L~ 1078 (1109)
++++|-+
T Consensus 301 ei~~hp~ 307 (382)
T cd05625 301 EIKAHPF 307 (382)
T ss_pred HHhcCCC
Confidence 9887743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=317.59 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=210.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+.+|++++++++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 799999998864322 2233567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 880 EYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
||+++|+|.+++.... ....+++..+..++.+++.|++||| +.+++||||+|+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2234889999999999999999999 78999999999999999999999999999876542
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
. ........++..|+|||++.+..++.++||||+||++|+|++|+.||.... ....+..........+.. .
T Consensus 159 ~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~--~---- 229 (267)
T cd08224 159 K-TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKIEKCDYPPL--P---- 229 (267)
T ss_pred C-CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC--ccHHHHHhhhhcCCCCCC--C----
Confidence 2 112233468889999999999899999999999999999999999986432 222222222111111100 0
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.......+.+++.+||+.+|++||++.+|++++.++.
T Consensus 230 ------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0122345779999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=346.00 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=201.7
Q ss_pred CCCCCceEecCCcceEEEEEec-C-CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-N-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.|.+.+.||+|+||.||+|... + ++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 4888999999999999999754 3 6788888765332 2334567789999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 881 YMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
|+++|+|.+++.... ....+++..+..++.||+.||+|+| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999999886432 2234889999999999999999999 789999999999999999999999999999876432
Q ss_pred CC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.+........+..
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~----~~~~~~~~~~~~~~~~------- 291 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----QREIMQQVLYGKYDPF------- 291 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCC-------
Confidence 22 12344579999999999999999999999999999999999999997532 2233332222221100
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+||+.||++||++++++.+
T Consensus 292 ------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 ------PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ------CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 01112357799999999999999999999754
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=327.36 Aligned_cols=244 Identities=24% Similarity=0.336 Sum_probs=192.9
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhcc-CCCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGK-IRHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||+||+|++. +++.||||+++.... .......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 578999999975421 12234556678888776 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (316)
T cd05619 81 GDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKT 153 (316)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCce
Confidence 999999976433 889999999999999999999 789999999999999999999999999998753211 1223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+..+........ +..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~~i~~~~~~----~~~-------- 217 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD----EEELFQSIRMDNPC----YPR-------- 217 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCC----CCc--------
Confidence 44578999999999999999999999999999999999999997533 12222221111110 010
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMR-EVIAM 1076 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~-evl~~ 1076 (1109)
.....+.+++.+||+.||++||++. ++.++
T Consensus 218 --~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 218 --WLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred --cCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 1113467899999999999999997 67654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=319.76 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=202.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC---cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG---ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|+..+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46889999999999999999864 6899999998644222 1223568899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
|+||+++++|.+++..... +++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||.++...
T Consensus 82 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999976543 788999999999999999999 7899999999999999999999999999997654
Q ss_pred CCCCCCc--cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 958 LPYSKSM--SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 958 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
....... ....++..|+|||++.+..++.++||||+|+++|||++|+.||..... . ............ ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~-~~~~~~~~~~~~--~~~- 228 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---M-AAIFKIATQPTN--PQL- 228 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---H-HHHHHHhccCCC--CCC-
Confidence 2211111 334578899999999999999999999999999999999999875321 1 111111111100 000
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.......+.+++.+||..+|.+|||+.+++++.
T Consensus 229 ---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 229 ---------PSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ---------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 111223577899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.47 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=201.9
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||.||+|.++.+..||+|++.... ...+.+.+|++++++++|+|++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4688889999999999999998877789999876332 23467889999999999999999999875 4568999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... ..+++..+..++.|++.|++||| +.+++|+||||+||++++++.++|+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 82 MGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999976432 23789999999999999999999 77999999999999999999999999999986643222
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||+..+..++.++||||+|+++|||++ |+.||.+.... ....++.. . ....
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~---~-~~~~--------- 223 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLEQVER---G-YRMP--------- 223 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc---C-CCCC---------
Confidence 22233456778999999998899999999999999999999 89998753211 11111111 1 1100
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
........+.+++.+||..+|++||+++++++.|++
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 ---CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=334.69 Aligned_cols=269 Identities=22% Similarity=0.256 Sum_probs=202.4
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD----- 873 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 873 (1109)
..++|++.+.||+|+||.||+|++. .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 6889999999755444445567889999999999999999999886543
Q ss_pred -ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 874 -SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 874 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
..++||||+++ ++.+++.. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999965 67666643 2788899999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHh---------
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRS--------- 1023 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~--------- 1023 (1109)
++.... ........+|..|+|||++.+..++.++||||+||++|||++|+.||.+..........+...
T Consensus 166 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 986542 222344578999999999999999999999999999999999999997543211111111100
Q ss_pred ---------hhccCCC-----chhhhhh-cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1024 ---------IHEMVPT-----SELFDKR-LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1024 ---------~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
....... ...+... ..............+.+++.+|++.||++|||+.|++++-+-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 0000000 0000000 000000011123457899999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=322.64 Aligned_cols=254 Identities=27% Similarity=0.381 Sum_probs=200.7
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 5799999999999999999996 4688999999864322 234567899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.++++.... +++..+..++.|++.|+.||| +.+|+|||++|+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd06646 87 YCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT- 159 (267)
T ss_pred CCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc-
Confidence 9999999999875443 889999999999999999999 779999999999999999999999999999865422
Q ss_pred CCCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
........+++.|+|||.+. ...++.++||||+||++|||++|+.||...........+.. ...... .
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~-----~ 230 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK----SNFQPP-----K 230 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec----CCCCCC-----C
Confidence 12223456888999999874 44578899999999999999999999864321111100000 000000 0
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.. ........+.+++.+||+.+|++||+++++++++
T Consensus 231 ~~----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LK----DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Cc----cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 0111234678999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=328.70 Aligned_cols=268 Identities=22% Similarity=0.348 Sum_probs=203.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|.+.++||+|+||+||+|+.+ +++.||+|+++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 57889999999999999999865 688899999875432 2234567889999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++ ++.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++......
T Consensus 85 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 85 YLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 9975 88888866543 3788999999999999999999 7899999999999999999999999999997654221
Q ss_pred CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc-
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL- 1038 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1038 (1109)
.......+++.|+|||++.+ ..++.++||||+||++|||+||+.||.+....+......+ .... +..+.+....
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~ 234 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR-LLGT--PTEETWPGISS 234 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCC--CCHHHHhhhcc
Confidence 22234467899999998865 4689999999999999999999999975432222111111 1100 0011100000
Q ss_pred -------chh-------hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1039 -------DLS-------AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1039 -------~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
... ..........+.+++.+|++.||++|||++|++++-+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 290 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence 000 000011234567999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=334.14 Aligned_cols=244 Identities=25% Similarity=0.296 Sum_probs=193.0
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHH-HhccCCCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEIS-TLGKIRHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||+||+|++. +++.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 689999999974322 1122344555555 46789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|.+++..... +++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~ 153 (323)
T cd05575 81 GELFFHLQRERS---FPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTT 153 (323)
T ss_pred CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCcc
Confidence 999999876543 889999999999999999999 78999999999999999999999999999875321 12223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.............
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~------------- 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----TAEMYDNILNKPLRLK------------- 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC----HHHHHHHHHcCCCCCC-------------
Confidence 45578999999999999999999999999999999999999997532 2222222222211110
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH----HHHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMR----EVIAM 1076 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~----evl~~ 1076 (1109)
......+.+++.+|++.||++||+++ +++++
T Consensus 217 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 217 -PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred -CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 01123577899999999999999984 66654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=319.54 Aligned_cols=258 Identities=22% Similarity=0.361 Sum_probs=200.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCc----EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGE----VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.+.||+|+||+||+|++. +++ .|++|++... .......++..|+..+++++||||+++++++. ....+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 46888899999999999999864 444 4777776422 22233457788888999999999999999875 45578
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+++||+++|+|.+++..... .+++..+..++.||+.|++||| +++++||||||+||+++.++.+||+|||.++..
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999976543 3899999999999999999999 779999999999999999999999999999865
Q ss_pred cCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 957 DLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 957 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
..... .......++..|+|||++.++.++.++|||||||++||+++ |+.||.+... ....+++.... ..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~--~~~~~~-- 234 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEKGE--RLAQPQ-- 234 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCC--cCCCCC--
Confidence 32211 11233457788999999999999999999999999999998 9999975431 11122222110 000000
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.....+..++.+||+.+|++|||+.|+++.+..+.+.
T Consensus 235 ------------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 235 ------------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ------------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0112467889999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=323.33 Aligned_cols=266 Identities=30% Similarity=0.405 Sum_probs=200.5
Q ss_pred CCCCceEecCCcceEEEEEe-----cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--CceE
Q 001274 804 FSEGAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSNL 876 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 876 (1109)
|+..+.||+|+||+||++.. .+++.||+|.++... .......+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48889999999999988642 357889999987432 223456788999999999999999999988764 3578
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++++|.+++.... +++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||+++..
T Consensus 85 lv~e~~~~~~l~~~~~~~~----l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEecCCCCCCHHHHHHHcC----CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999997542 899999999999999999999 779999999999999999999999999999866
Q ss_pred cCCCCC--CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc--cCCCch
Q 001274 957 DLPYSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE--MVPTSE 1032 (1109)
Q Consensus 957 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~ 1032 (1109)
...... ......++..|+|||+..+..++.++||||||+++|||++|+.||..... ...+........ .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK--KFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc--hhhhhhcccccccchhhhhh
Confidence 422111 11223456679999999988999999999999999999999999864321 111111000000 000000
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
..+..... .........+.+++.+||+.+|++|||++++++.++.+.
T Consensus 236 ~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111000 001122356889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.09 Aligned_cols=267 Identities=24% Similarity=0.296 Sum_probs=196.7
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC---CCCceeeEEEEEEeC-----C
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI---RHRNIVKLYGFCYHQ-----D 873 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 873 (1109)
+|++.+.||+|+||+||+|++. +++.||+|.++...........+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999865 689999999875433333334566777777665 799999999988652 3
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA 953 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 953 (1109)
..++||||++ ++|.+++..... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 4689999997 489888876432 23899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhh---ccCCC
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIH---EMVPT 1030 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~---~~~~~ 1030 (1109)
+.... ........+|..|+|||++.+..++.++||||+||++|||++|+.||.................. ...+.
T Consensus 156 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSC--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccC--cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 86542 12223456889999999999999999999999999999999999999754322222111111000 00000
Q ss_pred c-----hhhhhh-cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1031 S-----ELFDKR-LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1031 ~-----~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
. ..+.+. .........+....+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000 000000111223457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=342.24 Aligned_cols=256 Identities=22% Similarity=0.259 Sum_probs=197.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.+|++.++||+|+||+||+|+.. +++.||||++..... .......+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999865 689999999864321 1223456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++...+. +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLGI---FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999976543 788999999999999999999 789999999999999999999999999997532100
Q ss_pred C------------------------------------------CCCccccccccceeccccccCCCCCccchhHHHHHHH
Q 001274 960 Y------------------------------------------SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVL 997 (1109)
Q Consensus 960 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll 997 (1109)
. ........||+.|+|||++.+..++.++||||+||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001234799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCC---CHHHHH
Q 001274 998 LELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP---TMREVI 1074 (1109)
Q Consensus 998 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP---t~~evl 1074 (1109)
|||++|+.||..... .+............ . ... .......+.+++.+|+ .+|++|+ ++.+++
T Consensus 235 yell~G~~Pf~~~~~----~~~~~~i~~~~~~~-~-~~~--------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 235 YEMLVGQPPFLADTP----AETQLKVINWETTL-H-IPS--------QAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eehhhCCCCCCCCCH----HHHHHHHhccCccc-c-CCC--------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999999975432 11111111100000 0 000 0011223556777765 4999999 999999
Q ss_pred HHHH
Q 001274 1075 AMMI 1078 (1109)
Q Consensus 1075 ~~L~ 1078 (1109)
++-+
T Consensus 300 ~h~~ 303 (376)
T cd05598 300 AHPF 303 (376)
T ss_pred CCCC
Confidence 8844
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=349.75 Aligned_cols=265 Identities=25% Similarity=0.307 Sum_probs=204.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.++||+|+||+||+|++. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999865 5899999998743222 233467899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCC--------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 880 EYMENGSLGEQLHGNKQ--------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
||++||+|.+++..... ....++..+.+++.||++||+||| +.+|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123567788899999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCC-----------------CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 001274 952 LAKLIDLPYS-----------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG 1014 (1109)
Q Consensus 952 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~ 1014 (1109)
+++....... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521100 01123468999999999999999999999999999999999999997532111
Q ss_pred cHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhcc
Q 001274 1015 DLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP-TMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~ 1084 (1109)
.. ........ ... .+ ..+....+.+++.+|++.||++|| +++++.+.++...+..
T Consensus 239 -i~--~~~~i~~P---~~~-~p--------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 -IS--YRDVILSP---IEV-AP--------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred -hh--hhhhccCh---hhc-cc--------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00 00100000 000 00 112224577899999999999996 5677777777765543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.82 Aligned_cols=361 Identities=29% Similarity=0.438 Sum_probs=238.6
Q ss_pred EEEccCCccc-CCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccc
Q 001274 316 EIDLSENQLT-GFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDN 394 (1109)
Q Consensus 316 ~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 394 (1109)
-+|+|+|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..++.|+.+.+.+|
T Consensus 11 GvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N 88 (1255)
T KOG0444|consen 11 GVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDN 88 (1255)
T ss_pred cccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhcc
Confidence 3444444444 234444444445555555444444 45566666666666666666665 44455666666666666666
Q ss_pred cccc-cCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCC
Q 001274 395 HLEG-TIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLP 473 (1109)
Q Consensus 395 ~l~~-~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 473 (1109)
++.. -+|..+..+..|.+||||+|++. ..|..+-.-.++..|+|++|+|..+..+.|.+++.|-.|+|++|++. .+|
T Consensus 89 ~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LP 166 (1255)
T KOG0444|consen 89 NLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLP 166 (1255)
T ss_pred ccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcC
Confidence 6642 35556666666666666666666 55666666666666666666666555555666666667777777766 445
Q ss_pred ccccCCcccceeccccccccCCCCccccccccccEEEccCCccC-CCCChhhcccccccEEecccCcccccCCcCCCCCC
Q 001274 474 IEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFV-GYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCV 552 (1109)
Q Consensus 474 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 552 (1109)
.....+.+|++|+|++|.+....-..+..+++|+.|++++.+=+ .-+|.++..+.+|..+|||.|.+. .+|+++-+++
T Consensus 167 PQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~ 245 (1255)
T KOG0444|consen 167 PQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLR 245 (1255)
T ss_pred HHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhh
Confidence 55666777777777777665443344555666777777765432 246777777777777777777777 7777777777
Q ss_pred CCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccc-ccccccccccchhhhhhc
Q 001274 553 NLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS-GSIPVALGQLTALQIALN 631 (1109)
Q Consensus 553 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~l~~~L~ 631 (1109)
+|+.|+||+|+|+ .+....+...+|++|+||.|+++ .+|+++..|++|+.|++.+|+++ .-||..|++|..|. .+.
T Consensus 246 ~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Le-vf~ 322 (1255)
T KOG0444|consen 246 NLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLE-VFH 322 (1255)
T ss_pred hhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhH-HHH
Confidence 7777777777777 45555666677777777777777 67777777777777777777776 35777777777776 367
Q ss_pred cCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEccCcccc
Q 001274 632 ISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLV 686 (1109)
Q Consensus 632 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~ 686 (1109)
.++|+|. .+|+.+..+..|+.|.|++|+|. ++|..+--++.|++|||..|+=-
T Consensus 323 aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 323 AANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred hhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 7777776 67777777788888888888877 77777777777888888777543
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=319.38 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=206.5
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.++|++.++||+|+||+||+|..++++.||||.+.... ...+++.+|++++++++|+||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 46789999999999999999998888899999987432 245678999999999999999999999998899999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... ..+++..+..++.+++.|++||| +.+++|+||||+||+++.++.++++|||.+.......
T Consensus 82 ~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999977542 23899999999999999999999 7799999999999999999999999999998664322
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........++..|+|||.+.+..++.++||||+|+++||+++ |+.||.+... ...............
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~~~~~~~~~~~-------- 225 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVLEQVERGYRMPR-------- 225 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCC--------
Confidence 222223345678999999998899999999999999999999 9999965331 122222111110000
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 226 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 -----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00112457899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.22 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=206.4
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
.+|.+.+.||+|+||+||++... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 56888999999999999999742 34568999886332 23456789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCC----------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 001274 876 LLLYEYMENGSLGEQLHGNKQ----------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQA 945 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 945 (1109)
++||||+++++|.+++...+. ...+++..+..++.|++.|++||| +.+++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence 999999999999999975431 123899999999999999999999 7799999999999999999999
Q ss_pred EEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHh
Q 001274 946 HVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRS 1023 (1109)
Q Consensus 946 kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~ 1023 (1109)
+|+|||.++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... .+.....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----~~~~~~i 235 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEVIECI 235 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH
Confidence 9999999986532211 11123345778999999999899999999999999999999 8999875432 1112221
Q ss_pred hhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1024 IHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
........ .......+.+++.+||+.+|.+|||+.++.+.|+++....
T Consensus 236 ~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 236 TQGRVLQR-------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HcCCcCCC-------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 11111000 0011235789999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=319.66 Aligned_cols=255 Identities=25% Similarity=0.316 Sum_probs=201.5
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
|+..+.||+|+||+||+|++. +++.||+|++...... ......+.+|++++++++|++|+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666789999999999999865 6899999998643222 12234578899999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++...+. ..+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~--~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--G 155 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCC--C
Confidence 999999988865432 23899999999999999999999 78999999999999999999999999999976532 1
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||........... +........ ..+
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~-~~~~~~~~~---~~~------- 224 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE-VDRRVLETE---EVY------- 224 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhhhccc---ccc-------
Confidence 222345789999999999999999999999999999999999999975432111111 111111110 011
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMI 1078 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~ 1078 (1109)
.......+.+++.+|++.||++||+ +.+++++-+
T Consensus 225 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05632 225 ---SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263 (285)
T ss_pred ---CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChh
Confidence 1111234678999999999999999 788887743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=322.50 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=204.2
Q ss_pred cCCCCCceEecCCcceEEEEEecC-Cc--EEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN-GE--VIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||.||+|+.++ +. .+++|.++.. ......+.+.+|++++.++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 478889999999999999998653 33 4788887632 2223446788999999999 79999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 001274 878 LYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ 944 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 944 (1109)
||||+++++|.+++..... ...+++..+..++.|++.|++||| +.+|+||||||+||+++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCe
Confidence 9999999999999975431 124788999999999999999999 789999999999999999999
Q ss_pred eEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHh
Q 001274 945 AHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRS 1023 (1109)
Q Consensus 945 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~ 1023 (1109)
+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||.... ..+.....
T Consensus 158 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~----~~~~~~~~ 231 (297)
T cd05089 158 SKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT----CAELYEKL 231 (297)
T ss_pred EEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHH
Confidence 999999998743211 11111233567999999999899999999999999999998 999997533 22222221
Q ss_pred hhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1024 IHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
.....+. ........+.+++.+||+.+|.+||+++++++.|..+......
T Consensus 232 ~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 232 PQGYRME-------------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred hcCCCCC-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111100 0011123577999999999999999999999999988876533
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.39 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=202.6
Q ss_pred CCceEecCCcceEEEEEec--CCc--EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 806 EGAVIGRGACGTVYKATLA--NGE--VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 806 ~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
..++||+|.||.||+|.|+ .|+ .||||.++...... ...+|++|+.+|.+++|+|++++||+..+ ....+|||.
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 3467999999999999876 343 58999998554443 56789999999999999999999999887 778899999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
++.|+|.+.|++ ..+..+-......++.|||.||.||. .+++|||||.++|+++-....|||+|||+.+-+.....
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999998 33345888899999999999999999 78999999999999999999999999999997753322
Q ss_pred CC--ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 962 KS--MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 962 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.. .....-++.|+|||.+....|+.++|||+|||++|||+| |..||-+... .+.++. +.. .+
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL~~-iD~----~e------ 332 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQILKN-IDA----GE------ 332 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----HHHHHh-ccc----cc------
Confidence 21 123345778999999999999999999999999999999 8899986432 122221 110 00
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.......+.+.+++++..||...|++||||.+|.+.+-
T Consensus 333 --rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 333 --RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred --cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 01124455677999999999999999999999985543
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.76 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=196.9
Q ss_pred eEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 809 VIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 809 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
+||+|+||.||+|.++ ++..||+|+++.........+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999643 5788999998755444445678899999999999999999999875 45678999999999
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCC--
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS-- 963 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-- 963 (1109)
+|.+++..... +++..+..++.|++.|++|+| +++|+||||||+||+++.++.+||+|||.++.........
T Consensus 81 ~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNKH---VTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999976443 899999999999999999999 7899999999999999999999999999998664322211
Q ss_pred ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhh
Q 001274 964 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042 (1109)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1109)
.....++..|+|||++....++.++|||||||++|||++ |+.||..... ......+..... .+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~i~~~~~--~~~------------ 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMIESGER--MEC------------ 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHCCCC--CCC------------
Confidence 122234678999999988889999999999999999998 9999975431 122222221100 000
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1043 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.......+.+++.+||+.||++||++++|++.|++.
T Consensus 220 --~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 --PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 011223577999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=321.41 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=206.5
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++|.+.+.||+|+||.||+|+.. ++..|++|.++... ....+.+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 46788899999999999999742 34568888876322 23346788999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 001274 876 LLLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE 942 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 942 (1109)
++||||+++++|.+++..... ...+++..+..++.||+.|++||| +++++||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence 999999999999999975431 123789999999999999999999 7899999999999999999
Q ss_pred CceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHH
Q 001274 943 FQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWV 1020 (1109)
Q Consensus 943 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~ 1020 (1109)
+.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||+| |+.||..... .+.+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~ 235 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----TEVI 235 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 9999999999976542211 11223456788999999999999999999999999999999 9999865331 1122
Q ss_pred HHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1021 RRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
........+.. .......+.+++.+||+.+|++||++.+|++++.++....
T Consensus 236 ~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 236 ECITQGRVLER-------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred HHHhCCCCCCC-------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 21111111100 0112245789999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.85 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=201.5
Q ss_pred cCCCCCceEecCCcceEEEEEe-----cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
.+|++.++||+|+||+||+|+. .+++.||+|.++... .......+.+|++++++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4678889999999999999974 246789999987432 2234467889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCC--------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 001274 877 LLYEYMENGSLGEQLHGNKQ--------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE 942 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 942 (1109)
+||||+++++|.+++..... ...+++..+..++.|++.|++||| +.+++||||||+||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCC
Confidence 99999999999999853321 124788899999999999999999 7799999999999999999
Q ss_pred CceEEeeccccccccCCC-CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHH
Q 001274 943 FQAHVGDFGLAKLIDLPY-SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWV 1020 (1109)
Q Consensus 943 ~~~kl~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~ 1020 (1109)
+.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+... ....+.+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH
Confidence 999999999998653221 112233446778999999998899999999999999999999 9999875321 1112222
Q ss_pred HHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1021 RRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.. ... .. . .......+.+++.+||+.||++||++.++.+++.
T Consensus 240 ~~---~~~-~~--~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 240 RK---RQL-LP--C----------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred Hc---CCc-CC--C----------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 11 111 00 0 0011235778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=319.69 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=201.8
Q ss_pred CCCCceEecCCcceEEEEEecC----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc-----
Q 001274 804 FSEGAVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS----- 874 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 874 (1109)
|.+.+.||+|+||.||+|.+.. +..||+|+++...........+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 3679999997554444445678999999999999999999998876554
Q ss_pred -eEEEEEeccCCCHHHHhccCC---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 001274 875 -NLLLYEYMENGSLGEQLHGNK---QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDF 950 (1109)
Q Consensus 875 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 950 (1109)
.++||||+++|+|..++.... ....+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 1224899999999999999999999 779999999999999999999999999
Q ss_pred cccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 951 GLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 951 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
|.++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.+... .+..........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~~ 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDYLRHGNR 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCC
Confidence 999865422211 1122345678999999988899999999999999999999 8899875331 122222111111
Q ss_pred CCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1029 PTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
+. ........+.+++.+||+.||.+||++.|+++.|.++
T Consensus 234 ~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 LK-------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC-------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0111234678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.49 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=195.8
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGS 886 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 886 (1109)
+.||+|+||+||+|++. +++.||+|.+... ........+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36899999999999865 6899999987633 223345678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc-c
Q 001274 887 LGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM-S 965 (1109)
Q Consensus 887 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~-~ 965 (1109)
|.+++..... .+++..+..++.|+++||+||| +.+++||||||+||+++.++.+|++|||.++.......... .
T Consensus 80 L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 80 FLTFLRTEGP--RLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999976443 3889999999999999999999 78999999999999999999999999999976442111111 1
Q ss_pred ccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....+..|+|||.+.++.++.++||||+|+++|||++ |..||...... .....+. ...+. . .
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-~~~~~~~----~~~~~-~-----------~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-QTREAIE----QGVRL-P-----------C 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-HHHHHHH----cCCCC-C-----------C
Confidence 1123567999999999999999999999999999998 88888643211 1111111 11100 0 0
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.......+.+++.+|++.+|++||++.++.++|.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=320.22 Aligned_cols=269 Identities=22% Similarity=0.322 Sum_probs=201.6
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|++.+.||+|+||.||+|+.+ +++.||+|+++.........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999865 689999999875544334456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
++ ++|.+++........+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++.....+.
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 689888876544345899999999999999999999 7899999999999999999999999999997654221
Q ss_pred CCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc---cCC---Cchhh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE---MVP---TSELF 1034 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~---~~~---~~~~~ 1034 (1109)
.......+++.|+|||++.+. .++.++||||+||++|||+||+.||.+................. ..+ ....+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 122334568899999988654 47899999999999999999999997543211111111110000 000 00000
Q ss_pred hhhcchh-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1035 DKRLDLS-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1035 ~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
....... .........++.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 00001123456799999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.68 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=198.3
Q ss_pred ceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCH
Q 001274 808 AVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSL 887 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 887 (1109)
++||+|+||.||+|...+++.||+|++.... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999998888999999886432 223345688999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCcccc
Q 001274 888 GEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967 (1109)
Q Consensus 888 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 967 (1109)
.+++..... .+++..+..++.+++.|+.|+| +.+++||||||+||+++.++.+|++|||+++.............
T Consensus 80 ~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 80 LSFLRKKKD--ELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 999876543 3789999999999999999999 78999999999999999999999999999975442222122223
Q ss_pred ccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccH
Q 001274 968 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTV 1046 (1109)
Q Consensus 968 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
.+++.|+|||++.+..++.++||||||+++||+++ |..||...... ..... ........ . ..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~~-~~~~~~~~-~-----------~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QAREQ-VEKGYRMS-C-----------PQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHH-HHcCCCCC-C-----------CC
Confidence 44678999999998899999999999999999999 99999754211 11111 11111000 0 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1047 EEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1047 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.....+.+++.+||+.+|++||++.|++++|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12346889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=308.97 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=206.7
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
|.+..+||+|+||.||+|.++ .|+.||||++... ...+++.+|+.+|++++.|++|++||.+......++|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 445668999999999999865 7999999999743 35678999999999999999999999999999999999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 962 (1109)
-.|+..+.++.... ++++.++..+.+..++||+||| ...=||||||+.|||++.+|.+|++|||+|-.+.. .-.
T Consensus 111 GAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMA 184 (502)
T KOG0574|consen 111 GAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMA 184 (502)
T ss_pred CCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh-hHH
Confidence 99999999987654 4999999999999999999999 66779999999999999999999999999976542 122
Q ss_pred CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhh
Q 001274 963 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1109)
...++.||+.|||||++..-.|+.++||||+|+...||..|++||.+..+- +..+. +|. ......
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-------RAIFM--IPT------~PPPTF 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-------RAIFM--IPT------KPPPTF 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-------ceeEe--ccC------CCCCCC
Confidence 335678999999999999999999999999999999999999999864421 11111 010 001112
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1043 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
+.+.+....|.+++..|+-..|++|.|+.++++|-
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 23445566799999999999999999999998763
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=351.43 Aligned_cols=260 Identities=21% Similarity=0.340 Sum_probs=201.6
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--CceE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSNL 876 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 876 (1109)
..++|.+.++||+|+||+||+|++. +++.||+|++............+..|+.++++++|||||+++++|... ...|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3468999999999999999999865 577899999876544445567789999999999999999999988654 4578
Q ss_pred EEEEeccCCCHHHHhccCCC-CCCCChHHHHHHHHHHHHHHHHHhhcC----CCCeEecCCCCCceeeCC----------
Q 001274 877 LLYEYMENGSLGEQLHGNKQ-TCLLDWDARYRIALGAAEGLCYLHYDC----RPHIIHRDIKSNNILLDE---------- 941 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~Dlkp~NIll~~---------- 941 (1109)
+||||+++|+|.+++..... ...+++..++.|+.||+.||+|||... ..+||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 99999999999999975321 124899999999999999999999431 146999999999999964
Q ss_pred -------CCceEEeeccccccccCCCCCCccccccccceeccccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCccc
Q 001274 942 -------EFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSFGVVLLELITGKSPVQSLEL 1012 (1109)
Q Consensus 942 -------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~ 1012 (1109)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~- 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN- 247 (1021)
T ss_pred cccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-
Confidence 345899999999865421 22234578999999999864 458899999999999999999999997532
Q ss_pred CCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1013 GGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.....+....... ... .......+.++|..||+.+|++||++.|++.+-+
T Consensus 248 --~~~qli~~lk~~p--~lp------------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 248 --NFSQLISELKRGP--DLP------------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred --cHHHHHHHHhcCC--CCC------------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 2222222211111 000 0011235779999999999999999999997643
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=332.41 Aligned_cols=259 Identities=22% Similarity=0.257 Sum_probs=197.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888999999999999999965 68999999986421 12223456888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... .+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999976433 2889999999999999999999 789999999999999999999999999999765432
Q ss_pred CCCCccccccccceeccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
.........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+.......... ....
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~----~~~~~~~i~~~~~-~~~~- 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKE-HFQF- 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC----HHHHHHHHHcCCC-cccC-
Confidence 2222233568999999999863 457889999999999999999999997532 2222222111110 0000
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHHH
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSST--SPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~--dP~~RPt~~evl~~L~ 1078 (1109)
... .......+.+++.+|+.. ++..||++.+++++-+
T Consensus 230 ~~~-------~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 230 PPD-------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred CCc-------cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 000 001123456777776654 3444889999998854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=324.23 Aligned_cols=258 Identities=24% Similarity=0.417 Sum_probs=205.2
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 874 (1109)
++|.+.+.||+|+||.||+|... .+..||||+++... .....+.+.+|+++++++ +|+||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 57889999999999999999742 34579999886432 223456788999999999 79999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+++|+|.++++..... .+++.++..++.|++.|++||| +.+++|+||||+||+++.++.++++|||.++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~-~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRES-FLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999764432 3799999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 955 LIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 955 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
........ ......++..|+|||++.+..++.++||||+||++|||++ |+.||............+.. .....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~- 264 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMA- 264 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc----CCcCC-
Confidence 65422111 1122345778999999999999999999999999999998 99998754432222222211 11000
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
. .......+.+++.+|++.+|++||++.|+++.|.+.
T Consensus 265 -~----------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 -Q----------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -C----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 001123688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.88 Aligned_cols=257 Identities=24% Similarity=0.354 Sum_probs=198.2
Q ss_pred CCCCceEecCCcceEEEEEecC-Cc--EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC------Cc
Q 001274 804 FSEGAVIGRGACGTVYKATLAN-GE--VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ------DS 874 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 874 (1109)
|.++++||+|+||.||+|++.+ ++ .||+|.++.........+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999998754 33 689998875544445567889999999999999999999987532 24
Q ss_pred eEEEEEeccCCCHHHHhccCC---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 875 NLLLYEYMENGSLGEQLHGNK---QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
.++||||+++|+|.+++.... ....+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 589999999999998874321 1234889999999999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCC
Q 001274 952 LAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 952 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 1029 (1109)
+++........ ......+++.|+|||+..+..++.++||||||+++|||++ |+.||..... .+...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~~~ 233 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----SEIYDYLRQGNRL 233 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHcCCCC
Confidence 99865422111 1122345778999999999999999999999999999999 8889875321 1111111111100
Q ss_pred CchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1030 TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
. ........+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 234 -~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 -K------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -C------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0011223578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=322.08 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=203.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.+|++.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 57888999999999999999864 689999999875432 234678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++.... +++.++..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||.+......
T Consensus 98 ~~~~~~L~~~~~~~~----~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~- 169 (296)
T cd06654 98 YLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169 (296)
T ss_pred ccCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccc-
Confidence 999999999986532 788999999999999999999 779999999999999999999999999998765321
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
........+++.|+|||++.+..++.++|||||||++|+|++|+.||........ .........+...
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~-------- 237 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----LYLIATNGTPELQ-------- 237 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh----HHHHhcCCCCCCC--------
Confidence 1122334688899999999988899999999999999999999999975332111 1111111110000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
........+.+++.+||..+|++||++.+++++-+..
T Consensus 238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~ 274 (296)
T cd06654 238 ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (296)
T ss_pred ---CccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhh
Confidence 0111224577899999999999999999999875443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.17 Aligned_cols=365 Identities=30% Similarity=0.415 Sum_probs=246.8
Q ss_pred ccchhhhccccccc-ccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEE
Q 001274 216 EGLEVLGLAQNSLE-GFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLY 294 (1109)
Q Consensus 216 ~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 294 (1109)
+-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+++|++|.+++|++. .+-..++.|+.|+.+.
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 33445677777776 467888888888888888888887 78888888888888888888877 5566777888888888
Q ss_pred eeccccc-CccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCccc
Q 001274 295 VYTNELN-GTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLT 373 (1109)
Q Consensus 295 l~~n~l~-~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 373 (1109)
+..|++. ..+|..+..+..|+.||||+|+++ ..|..+..-+++-.|+|++|+|..+.-.
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~------------------- 144 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNS------------------- 144 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCch-------------------
Confidence 8888875 456778888888888888888887 3444444444444444444444433333
Q ss_pred CCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccc-cCCCCCCC
Q 001274 374 GTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRL-SGNIPPGL 452 (1109)
Q Consensus 374 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l-~~~~~~~~ 452 (1109)
.|.+++.|-.|+|++|++. .+|+.+..+.+|++|+|++|.+...--..+..+++|+.|++++.+= ...+|.++
T Consensus 145 -----lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsl 218 (1255)
T KOG0444|consen 145 -----LFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSL 218 (1255)
T ss_pred -----HHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCch
Confidence 3444444444455555544 4444455555555555555554433333344455556666655432 23466677
Q ss_pred ccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccE
Q 001274 453 KTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVT 532 (1109)
Q Consensus 453 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 532 (1109)
..+.+|..++|+.|.+. +.|+.+.++.+|+.|+||+|+|+.+ .-..+...+|++|+||.|+++ ..|+.++.+++|+.
T Consensus 219 d~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL-~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k 295 (1255)
T KOG0444|consen 219 DDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITEL-NMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK 295 (1255)
T ss_pred hhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeee-eccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence 77777777777777776 6677777777777777777777743 334555667777777777777 57777777777777
Q ss_pred EecccCccc-ccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcc
Q 001274 533 FNISSNSLS-GTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNI 611 (1109)
Q Consensus 533 L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 611 (1109)
|++.+|+++ .-+|+.++.+.+|+.+..++|.+. ..|+.++.+..|+.|.|+.|++. .+|+.+.-|+.|+.||+..|+
T Consensus 296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred HHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 777777775 236777777777777777777776 67777777777777777777776 567777777777777777775
Q ss_pred cc
Q 001274 612 FS 613 (1109)
Q Consensus 612 l~ 613 (1109)
-.
T Consensus 374 nL 375 (1255)
T KOG0444|consen 374 NL 375 (1255)
T ss_pred Cc
Confidence 43
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=329.59 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=197.0
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 879 (1109)
+|+..+.||+|+||+||+|+.. +++.||+|++..... .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999865 689999999974321 2233456778888988885 578888999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999999876543 899999999999999999999 789999999999999999999999999998754321
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ...............
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~~~~~~~p-------- 221 (323)
T cd05615 155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSIMEHNVSYP-------- 221 (323)
T ss_pred -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCC--------
Confidence 1222345689999999999999999999999999999999999999975432 222222221111110
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTM-----REVIAM 1076 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~~ 1076 (1109)
......+.+++.+|++.+|.+|++. +++.++
T Consensus 222 ------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 222 ------KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ------ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 0112356789999999999999984 556555
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=317.22 Aligned_cols=261 Identities=23% Similarity=0.377 Sum_probs=208.0
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||.||+|+. .+++.||||.+..... ......++.+|+++++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 4789999998864332 2234467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 880 EYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
||+++++|.+++.... ....+++..+..++.||++|+.||| +.+++|+||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 1234899999999999999999999 78999999999999999999999999999876542
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
. ........++..|+|||++.+..++.++||||+|+++|||++|..||..... ...+..+.......+..
T Consensus 159 ~-~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~------- 228 (267)
T cd08229 159 K-TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEQCDYPPL------- 228 (267)
T ss_pred C-CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc--hHHHHhhhhhcCCCCCC-------
Confidence 2 1222345688999999999998999999999999999999999999864321 12222221111111000
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
........+.+++.+||+.+|++||||.+|++.+++.
T Consensus 229 -----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 -----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0111234688999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=319.05 Aligned_cols=257 Identities=25% Similarity=0.317 Sum_probs=202.8
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
|+..+.||+|+||+||+|.+. +++.||+|.+...... ......+.+|+.++++++|++++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999865 6899999998644222 22235577899999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... ..+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 155 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-- 155 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC--
Confidence 999999998865432 23899999999999999999999 789999999999999999999999999998764321
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||......... +......... ...+
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~~---~~~~------- 224 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEV---QEEY------- 224 (285)
T ss_pred ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhhh---hhhc-------
Confidence 2223447899999999999999999999999999999999999999854321111 1111111100 0000
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHHHh
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMIDA 1080 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~~~ 1080 (1109)
.......+.+++.+||+.||++||| +.|++++-+..
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 225 ---SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred ---CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 1111234679999999999999999 89999876654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=342.66 Aligned_cols=265 Identities=22% Similarity=0.281 Sum_probs=194.6
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-------
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ------- 872 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 872 (1109)
.++|++.++||+|+||+||+|+.. +++.||||++... .....+|+.+++.++|+||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 357999999999999999999864 6899999988532 12345799999999999999999887432
Q ss_pred -CceEEEEEeccCCCHHHHhccC-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEee
Q 001274 873 -DSNLLLYEYMENGSLGEQLHGN-KQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGD 949 (1109)
Q Consensus 873 -~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D 949 (1109)
...++||||+++ ++.+++... .....+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeec
Confidence 135689999975 777766432 12234899999999999999999999 78999999999999998665 799999
Q ss_pred ccccccccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 950 FGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 950 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
||+|+.... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+......+...++.. . .
T Consensus 215 FGla~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~-~--~ 289 (440)
T PTZ00036 215 FGSAKNLLA--GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL-G--T 289 (440)
T ss_pred cccchhccC--CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-C--C
Confidence 999986542 2223345789999999998764 68999999999999999999999997643222222222110 0 0
Q ss_pred CCchhhh-----------hhcc---hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1029 PTSELFD-----------KRLD---LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1029 ~~~~~~~-----------~~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
+..+.+. +... ............+.+++.+||+.||++|||+.|++++-+..
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 0000000 0000 00000111234678999999999999999999999886643
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=332.97 Aligned_cols=239 Identities=23% Similarity=0.296 Sum_probs=189.9
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHH-HhccCCCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEIS-TLGKIRHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||+||+|+.. +|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 689999999974421 1223345556655 46778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|..++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~ 153 (325)
T cd05604 81 GELFFHLQRERS---FPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTT 153 (325)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC-CCCCc
Confidence 999998876543 899999999999999999999 78999999999999999999999999999875321 12223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.............
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~~~~~~~~~~~------------- 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD----VAEMYDNILHKPLVLR------------- 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC----HHHHHHHHHcCCccCC-------------
Confidence 45679999999999999999999999999999999999999997532 2222222222211110
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMR 1071 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~ 1071 (1109)
......+.+++.+|++.+|++||+++
T Consensus 217 -~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 217 -PGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred -CCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 01123567899999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=320.31 Aligned_cols=261 Identities=22% Similarity=0.368 Sum_probs=206.7
Q ss_pred hcCCCCCceEecCCcceEEEEEecC-----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe-CCc
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLAN-----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH-QDS 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 874 (1109)
.++|++.+.||+|+||.||+|.+.+ +..||+|+++.. ......+.+.+|+.++++++|+||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4678889999999999999998765 688999988632 233445778899999999999999999998776 467
Q ss_pred eEEEEEeccCCCHHHHhccCCCC-----CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQT-----CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGD 949 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 949 (1109)
.++++||+++++|.+++...... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998764322 34899999999999999999999 78999999999999999999999999
Q ss_pred ccccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhcc
Q 001274 950 FGLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEM 1027 (1109)
Q Consensus 950 FG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 1027 (1109)
||+++.+...... ......++..|+|||++.+..++.++||||+|+++||+++ |+.||..... .....++.. .
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~----~ 235 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAYLKD----G 235 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHHHHHc----C
Confidence 9999865322211 1122345778999999998889999999999999999999 9999975321 111122111 1
Q ss_pred CCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
..... .......+.+++.+||+.||++|||+.++++.|..+..
T Consensus 236 ~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 YRLAQ------------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCC------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11000 11122457899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=318.92 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=201.4
Q ss_pred CCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|+..++||+|+||.||+|++ .+++.||+|++.... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 577889999999999999986 468899999986432 233456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|..+. .+++..+..++.|++.|++||| +.+|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997652 2678889999999999999999 789999999999999999999999999999865422
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc---HHHHHHHhhhccCCCchhhhhhc
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGD---LVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
......++..|+|||++.+..++.++||||+|+++|+|++|+.||........ .............+. .
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 220 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-------L 220 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-------C
Confidence 22345789999999999999999999999999999999999999975432111 111111111111000 0
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
. .......+.+++.+|++.+|++||+++|++++.+...
T Consensus 221 ~-----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 221 P-----VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred C-----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 0 0111235779999999999999999999998865543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=322.77 Aligned_cols=255 Identities=32% Similarity=0.481 Sum_probs=201.8
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
|++++.||+|+||+||+|+.. +++.||+|++..............+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566789999999999999976 5678999999865433333334456999999999999999999999999999999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 962 (1109)
++++|.+++.... .+++..+..++.|+++||+||| +.+++|+||||+||+++.++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred ccccccccccccc---cccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cccc
Confidence 9999999998333 3899999999999999999999 6799999999999999999999999999997642 1233
Q ss_pred Cccccccccceecccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 963 SMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
......++..|+|||++. +..++.++||||+|+++|+|++|..||...... +.............+ . .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~~-----~-----~ 222 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKILKRPLP-----S-----S 222 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHHHHTHHH-----H-----H
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhhhhccccccc-----c-----c
Confidence 345567899999999998 888999999999999999999999999864111 111111111111100 0 0
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
..........+.+++.+||+.||++||++.+++++
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000112578899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=331.90 Aligned_cols=240 Identities=23% Similarity=0.269 Sum_probs=188.7
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHH-HhccCCCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEIS-TLGKIRHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||+||+|++. +++.||+|++...... ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 5788999999743211 112234444544 56788999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|.+++..... +++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~~~---~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~-~~~~~ 153 (325)
T cd05602 81 GELFYHLQRERC---FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTT 153 (325)
T ss_pred CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccccc-CCCCc
Confidence 999999976543 788888999999999999999 78999999999999999999999999999975431 12223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+............
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~-------------- 215 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAEMYDNILNKPLQL-------------- 215 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC----HHHHHHHHHhCCcCC--------------
Confidence 45679999999999999999999999999999999999999997533 222222221111110
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMRE 1072 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~e 1072 (1109)
.......+.+++.+|++.||.+||++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 0111235678999999999999998774
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=320.72 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=202.9
Q ss_pred CCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
+|++.+.||+|+||.||+|+.. ....||+|.+.... .......+.+|+++++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999753 23568888876332 2234567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCC---------------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 001274 877 LLYEYMENGSLGEQLHGNK---------------------QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSN 935 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~ 935 (1109)
+||||+++|+|.+++.... ....+++..+..++.|++.|++||| +.+++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhh
Confidence 9999999999999986421 1124788999999999999999999 789999999999
Q ss_pred ceeeCCCCceEEeeccccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccC
Q 001274 936 NILLDEEFQAHVGDFGLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELG 1013 (1109)
Q Consensus 936 NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~ 1013 (1109)
||++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.+...
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~- 235 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP- 235 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999999999865322111 1122345678999999988889999999999999999999 9999875321
Q ss_pred CcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1014 GDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
......+.. ..... ........+.+++.+||+.+|++||+++++++.|+++..
T Consensus 236 ~~~~~~~~~----~~~~~------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLKT----GYRME------------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHhC----CCCCC------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111222111 11000 011122457799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=332.46 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=191.4
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHH-HhccCCCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEIS-TLGKIRHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
++||+|+||+||+|++. +++.||+|++..... .......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 688999999864321 1122344555554 57889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|..++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05603 81 GELFFHLQRERC---FLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETT 153 (321)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcc
Confidence 999988875443 788899999999999999999 789999999999999999999999999998753221 2223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...............
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~-------------- 215 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----VSQMYDNILHKPLQL-------------- 215 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC----HHHHHHHHhcCCCCC--------------
Confidence 44578999999999999999999999999999999999999997532 222222222221111
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH----HHHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMR----EVIAM 1076 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~----evl~~ 1076 (1109)
.......+.+++.+|++.||.+||++. +++++
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 111123577899999999999999764 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=320.38 Aligned_cols=267 Identities=22% Similarity=0.371 Sum_probs=203.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|+..+.||+|+||.||+|+++ +++.||+|++..........+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999976 68999999987544333344668899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|++++++..+...... +++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCCC---CCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999888887755432 899999999999999999999 7799999999999999999999999999998764322
Q ss_pred CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC-------ch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT-------SE 1032 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~ 1032 (1109)
.......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.+....+.... +........+. ..
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 -DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL-IRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred -ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCChHHhhhccccc
Confidence 12234467889999999876 5588999999999999999999999975432211111 11111110000 00
Q ss_pred hh----hhhcchh---hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1033 LF----DKRLDLS---AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1033 ~~----~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.+ .+..... ..........+.+++.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 0000000 00001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=313.32 Aligned_cols=251 Identities=24% Similarity=0.448 Sum_probs=202.3
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
.+|++.+.||+|+||.||+|.+.+++.+|+|+++... .....+.+|++++++++||+++++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 4677889999999999999998778899999886332 2345789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... .+++..+..++.+++.|++||| +.+++||||||+||+++.++.++|+|||.++.......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 81 MEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999999976543 2789999999999999999999 77999999999999999999999999999976542222
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++.+|+|||++.++.++.++||||+|+++|||++ |+.||.... .............. ..+..
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~~~~~~----~~~~~-- 225 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS----NSEVVETINAGFRL----YKPRL-- 225 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC----HHHHHHHHhCCCCC----CCCCC--
Confidence 22223345678999999998899999999999999999998 999987432 12222221111000 00000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
....+.+++.+||+.+|++||++.+++++|
T Consensus 226 -------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 -------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 124688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=329.06 Aligned_cols=262 Identities=26% Similarity=0.417 Sum_probs=202.6
Q ss_pred cCCCCCceEecCCcceEEEEEe------cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC-C
Q 001274 802 GNFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ-D 873 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 873 (1109)
++|++.+.||+|+||+||+|++ .+++.||||+++... .......+.+|+.++.++ +|+||+++++++... .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 5799999999999999999973 247889999997432 223456788999999999 689999999988654 4
Q ss_pred ceEEEEEeccCCCHHHHhccCCC---------------------------------------------------------
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQ--------------------------------------------------------- 896 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 896 (1109)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999864321
Q ss_pred -------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC-CCccccc
Q 001274 897 -------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIA 968 (1109)
Q Consensus 897 -------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~ 968 (1109)
...+++..+..++.||++|++||| +.+|+||||||+||+++.++.+||+|||+++....... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 113678888999999999999999 78999999999999999999999999999986532211 1112234
Q ss_pred cccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHH
Q 001274 969 GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVE 1047 (1109)
Q Consensus 969 gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
++..|+|||++.+..++.++||||||+++|||++ |..||............+....... ... .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~--------------~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APD--------------Y 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC--CCC--------------C
Confidence 5678999999999999999999999999999997 9999875432222211111110000 000 0
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1048 EMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1048 ~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
....+.+++.+||+.+|++||++.|++++|+.+.+.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 113578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=315.03 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=203.7
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.++|++.++||+|+||.||+|.+.++..||+|+++.. ....+.+.+|++++++++|+||+++++++.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3678899999999999999999877888999988632 2245678899999999999999999999887 77899999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999976432 23788999999999999999999 7799999999999999999999999999997654322
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........++..|+|||++.+..++.++|||||||++|++++ |+.||..... ......+.. .....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~~~~~~~----~~~~~-------- 223 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALER----GYRMP-------- 223 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHhC----CCCCC--------
Confidence 222223345678999999998889999999999999999999 8999875321 111121111 11100
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
........+.+++.+||+.+|++||++.++.+.|..
T Consensus 224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011122457899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=322.50 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=204.7
Q ss_pred hcCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCC
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 873 (1109)
.++|+..+.||+|+||.||+|... ....||+|.+.... .......+.+|+++++++ +|+||+++++++..++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 357888899999999999999864 23679999887432 223446688999999999 8999999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 001274 874 SNLLLYEYMENGSLGEQLHGNK-------------QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD 940 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~ 940 (1109)
..++||||+++|+|.++++... ....+++..+..++.|++.|++||| +.+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence 9999999999999999996431 1234889999999999999999999 78999999999999999
Q ss_pred CCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHH
Q 001274 941 EEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVT 1018 (1109)
Q Consensus 941 ~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~ 1018 (1109)
.++.+|++|||.++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-ELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-HHHH
Confidence 999999999999986543221 11122345678999999998899999999999999999998 99998753311 1111
Q ss_pred HHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1019 WVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.+. .... .. ........+.+++.+||+.+|++||||.|+++.|+.+.
T Consensus 246 ~~~---~~~~-~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLK---EGYR-ME------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHH---cCCc-CC------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 1110 00 01112235779999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=313.96 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=203.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CC---cEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NG---EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
.+|+..+.||+|+||.||+|+.+ ++ ..||+|+++... .....+.+.+|++++++++|+|++++.+++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 46778899999999999999865 23 378999886432 23345678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++++|.+++..... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999976443 3899999999999999999999 7799999999999999999999999999998654
Q ss_pred CCCCCCc--cccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 958 LPYSKSM--SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 958 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
....... .....+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+..+...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~~~i~~~~-~~~~-- 231 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAINDGF-RLPA-- 231 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHhcCC-CCCC--
Confidence 2221111 11223567999999998889999999999999999998 9999975331 22222211111 1000
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
..+....+.+++.+||+.+|++||++.+|++.|.++
T Consensus 232 ----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 ----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=322.41 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=201.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+.|++.++||+|+||.||+|++. +++.||+|++... .....+.+.+|+++++.++|+||+++++++..+...++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 56888999999999999999975 5889999998643 23345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|..++..... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+......
T Consensus 90 ~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 90 FCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred cCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 9999999988765433 3899999999999999999999 789999999999999999999999999998754321
Q ss_pred CCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
........++..|+|||++. ...++.++|||||||++|||++|+.||..... ............+ . ..
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~-~-~~- 236 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSEPP-T-LS- 236 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----HHHHHHHhcCCCc-c-CC-
Confidence 12223456788999999885 34578899999999999999999999875331 1111111111110 0 00
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
........+.+++.+||+.+|++||++.+++++-+
T Consensus 237 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 237 --------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred --------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 01112235778999999999999999999998744
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=318.04 Aligned_cols=259 Identities=23% Similarity=0.411 Sum_probs=203.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCc----EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGE----VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
.+|+..++||+|+||+||+|++. +++ .||+|+++... .....+.+.+|+.+++.++|+||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 57888999999999999999853 444 48999886432 23345678899999999999999999999875 4578
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+++||+++|+|.++++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999976543 3899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 957 DLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 957 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
...... ......++..|+|||+..+..++.++|||||||++|||++ |..||..... .....++..... .+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~--~~~---- 232 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REIPDLLEKGER--LPQ---- 232 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCc--CCC----
Confidence 422111 1122345678999999999999999999999999999998 8999875321 122222221110 000
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.......+.+++.+||+.||++||++.++++.+..+....
T Consensus 233 ----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 233 ----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0112235778999999999999999999999998776544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=324.89 Aligned_cols=249 Identities=22% Similarity=0.263 Sum_probs=196.5
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||+||+|+.. +++.||+|+++..... ....+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6789999999754221 22345678899998888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|..++..... +++..+..++.||+.|++||| +.+|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~~~---l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-~~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQRK---LPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG-PGDTT 153 (327)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccC-CCCce
Confidence 999998876543 899999999999999999999 78999999999999999999999999999875321 12223
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC--CcHHHHHHHhhhcc-CCCchhhhhhcchh
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG--GDLVTWVRRSIHEM-VPTSELFDKRLDLS 1041 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 1041 (1109)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....+.+....... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 222 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI----------- 222 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC-----------
Confidence 4567999999999999999999999999999999999999999753321 11222222222111 100
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPT------MREVIAMM 1077 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt------~~evl~~L 1077 (1109)
+......+.+++.+|++.||++|++ +.+++++-
T Consensus 223 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 223 ---PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 0111234678999999999999998 46777664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=320.45 Aligned_cols=263 Identities=22% Similarity=0.368 Sum_probs=207.1
Q ss_pred hcCCCCCceEecCCcceEEEEEec--------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEe
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA--------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYH 871 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 871 (1109)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+... ......+.+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 367888999999999999999741 2457999988633 2233456788999999999 89999999999999
Q ss_pred CCceEEEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcee
Q 001274 872 QDSNLLLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNIL 938 (1109)
Q Consensus 872 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl 938 (1109)
.+..++||||+++|+|.+++..... ...+++..+..++.||++|+.||| +.+++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence 9999999999999999999976421 123788899999999999999999 789999999999999
Q ss_pred eCCCCceEEeeccccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcH
Q 001274 939 LDEEFQAHVGDFGLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDL 1016 (1109)
Q Consensus 939 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~ 1016 (1109)
++.++.+||+|||.++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||.... .
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~ 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----V 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----H
Confidence 999999999999999866422211 1223345678999999999899999999999999999998 788886432 2
Q ss_pred HHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1017 VTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.++........ ... ........+.+++.+||+.+|++||++.|+++.|.++....
T Consensus 246 ~~~~~~~~~~~-~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 246 EELFKLLKEGH-RMD------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHHHcCC-cCC------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 22222211111 000 01122346788999999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=332.00 Aligned_cols=268 Identities=23% Similarity=0.307 Sum_probs=202.0
Q ss_pred HHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-----
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ----- 872 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 872 (1109)
+..++|++.+.||+|+||+||+|++. +++.||||++..........+.+.+|++++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 44578999999999999999999864 688999999875433333446678999999999999999999987643
Q ss_pred -CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 873 -DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 873 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
...++++|++ +++|.+++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 78998887543 2899999999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
+++.... ......+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+.........+... .. .+.
T Consensus 164 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~--~~~ 236 (343)
T cd07878 164 LARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV-VG--TPS 236 (343)
T ss_pred cceecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-hC--CCC
Confidence 9986542 2344578999999999877 56899999999999999999999999753321111111110 00 011
Q ss_pred chhhhhh-----------cchhhcc-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1031 SELFDKR-----------LDLSAKR-----TVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1031 ~~~~~~~-----------~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.+..... +...... .......+.+++.+|++.||++|||+.|++++-+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 1111000 0000000 0001234679999999999999999999999876654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=327.75 Aligned_cols=271 Identities=20% Similarity=0.221 Sum_probs=199.5
Q ss_pred CCceEecC--CcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 806 EGAVIGRG--ACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 806 ~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
+.++||+| +|++||+++.+ +|+.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 68899999864 7899999999755444444567788999999999999999999999999999999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC-
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS- 961 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 961 (1109)
++|+|.+++...... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999654322 3889999999999999999999 77999999999999999999999999986543321110
Q ss_pred C-----CccccccccceeccccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-----C
Q 001274 962 K-----SMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-----P 1029 (1109)
Q Consensus 962 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----~ 1029 (1109)
. ......++..|+|||++.+ ..++.++||||+||++|||++|+.||..................... +
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 0 0122346778999999876 45899999999999999999999999754322211111111100000 0
Q ss_pred Cchh--------hhhhcch---------------hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1030 TSEL--------FDKRLDL---------------SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1030 ~~~~--------~~~~~~~---------------~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
..+. .+..... ...........+.+++.+||+.||++|||++|++++-+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 0000 0000000 0001112234688999999999999999999999886553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=330.82 Aligned_cols=258 Identities=22% Similarity=0.244 Sum_probs=197.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.++||+|+||+||+++.+ +++.||+|++.... ........+.+|+.++..++|++|+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999875 57889999986321 11223345788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... .+++..+..++.||+.|++||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976433 2899999999999999999999 789999999999999999999999999999765322
Q ss_pred CCCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 960 YSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+............ . +
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~-~-~ 229 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKERF-Q-F 229 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC----HHHHHHHHhCCCccc-c-C
Confidence 222223457999999999986 3468899999999999999999999997532 222222221111000 0 0
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHHH
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPL--NRPTMREVIAMM 1077 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~--~RPt~~evl~~L 1077 (1109)
.. ........+.+++.+|+..+|. .|++++|++++-
T Consensus 230 p~-------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~ 267 (332)
T cd05623 230 PA-------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267 (332)
T ss_pred CC-------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence 00 0111223566788887755444 478999999884
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.71 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=198.8
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC-----
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ----- 872 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----- 872 (1109)
+.+.|+..+.||+|+||+||+|+.. +++.||+|++.... .....+.+|+.+++++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4577888899999999999999865 68899999987432 2346788999999998 799999999998753
Q ss_pred -CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 873 -DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 873 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
...++||||+++++|.+++..... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCC
Confidence 357899999999999999976432 24889999999999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
+++..... ........|+..|+|||++. +..++.++||||+||++|||++|+.||...... ..... ....
T Consensus 157 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~~~-~~~~ 231 (272)
T cd06637 157 VSAQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFL-IPRN 231 (272)
T ss_pred Cceecccc-cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHH-HhcC
Confidence 99865422 22234457889999999986 345888999999999999999999999743311 11111 0000
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
+..... .......+.+++.+||..+|++|||+.+++++
T Consensus 232 --~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 --PAPRLK----------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --CCCCCC----------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000000 01122357899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=321.59 Aligned_cols=261 Identities=22% Similarity=0.343 Sum_probs=203.9
Q ss_pred HhcCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 873 (1109)
..++|++.++||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.++++++|+||+++++++...+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4578999999999999999999743 24579999886332 2233456889999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCC-------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQ-------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH 946 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 946 (1109)
..++||||+++|+|.+++..... ....++..+..++.|++.|++||| +++|+||||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 123567788899999999999999 78999999999999999999999
Q ss_pred EeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhh
Q 001274 947 VGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSI 1024 (1109)
Q Consensus 947 l~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~ 1024 (1109)
++|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||.+... .+......
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~ 235 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQVLKFVM 235 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH
Confidence 999999985532211 11122345678999999999999999999999999999999 7889875331 22222211
Q ss_pred hccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1025 HEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
....... .......+.+++.+|++.+|++|||+.++++.+....
T Consensus 236 ~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 DGGYLDQ-------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCCCCCC-------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111000 0111246889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=331.51 Aligned_cols=258 Identities=21% Similarity=0.248 Sum_probs=199.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... ........+.+|..++..++|++|+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 68899999986422 11223455788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999976433 3889999999999999999999 789999999999999999999999999999866533
Q ss_pred CCCCccccccccceeccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
.........||+.|+|||++.+ +.++.++||||+||++|||++|+.||.... ..+............ . +
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~-~-~ 229 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHEERF-Q-F 229 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC----HHHHHHHHHcCCCcc-c-C
Confidence 2222234579999999999875 467899999999999999999999997532 222222211111000 0 0
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHH
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLN--RPTMREVIAMM 1077 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~L 1077 (1109)
... .......+.+++.+|+..++.+ |+++++++++-
T Consensus 230 p~~-------~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 230 PSH-------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred CCc-------cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 000 0111235678888888865544 56899998774
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=320.12 Aligned_cols=263 Identities=23% Similarity=0.360 Sum_probs=200.4
Q ss_pred cCCCCCceEecCCcceEEEEEecC---------------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN---------------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 866 (1109)
++|++.++||+|+||.||+|+..+ ...||+|+++... .......+.+|++++++++|+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 578899999999999999997542 2358999986432 233456789999999999999999999
Q ss_pred EEEEeCCceEEEEEeccCCCHHHHhccCCC---------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCce
Q 001274 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQ---------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNI 937 (1109)
Q Consensus 867 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 937 (1109)
+++...+..++||||+++++|.+++..... ...+++..+.+++.|++.|++||| +.+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 999999999999999999999999865321 113688899999999999999999 78999999999999
Q ss_pred eeCCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh--CCCCCCCcccCC
Q 001274 938 LLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT--GKSPVQSLELGG 1014 (1109)
Q Consensus 938 ll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt--g~~pf~~~~~~~ 1014 (1109)
+++.++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 999999999999999976532211 11123345778999999998899999999999999999998 56677643321
Q ss_pred cHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1015 DLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.....+.......... .+.. ........+.+++.+||+.+|++||++.+|++.|.
T Consensus 240 ~~~~~~~~~~~~~~~~--~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQ--IYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhcccc--ccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111111000 0000 00111246889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=313.77 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=201.8
Q ss_pred CCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCC----cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEG----ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
+|+..+.||+|+||+||+|...+++.||||.++..... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 57889999999999999999888999999998754322 12235688899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++++|.+++..... +++..+..++.|++.|++||| +.+|+|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999976543 789999999999999999999 77999999999999999999999999999875421
Q ss_pred C-----CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 959 P-----YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 959 ~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
. .........++..|+|||++.+..++.++||||+|+++|||++|+.||........... +.. .....+ +.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~-~~~~~~--~~ 230 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-IGA-HRGLMP--RL 230 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-hhh-ccCCCC--CC
Confidence 1 11112345688999999999998999999999999999999999999975432111111 110 000100 00
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+||+.+|++||++.+++++
T Consensus 231 -----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 231 -----------PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -----------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11122457789999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=320.51 Aligned_cols=263 Identities=23% Similarity=0.368 Sum_probs=202.8
Q ss_pred cCCCCCceEecCCcceEEEEEecC-----------------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceee
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN-----------------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 864 (1109)
++|++.+.||+|+||.||+|+..+ +..||+|++.... .....+.+.+|++++++++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 578999999999999999997542 2458999887432 2234567889999999999999999
Q ss_pred EEEEEEeCCceEEEEEeccCCCHHHHhccCCC--------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 001274 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQ--------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNN 936 (1109)
Q Consensus 865 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 936 (1109)
+++++..++..++||||+++++|.+++..... ...+++..+..++.|++.|++||| +.+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 99999999999999999999999999976541 124899999999999999999999 7799999999999
Q ss_pred eeeCCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh--CCCCCCCcccC
Q 001274 937 ILLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT--GKSPVQSLELG 1013 (1109)
Q Consensus 937 Ill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt--g~~pf~~~~~~ 1013 (1109)
|+++.++.++|+|||.++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976532221 11223456788999999998899999999999999999998 67787643311
Q ss_pred CcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1014 GDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
............... ..... ........+.+++.+||+.||++|||+.|+++.|.
T Consensus 241 -~~~~~~~~~~~~~~~-~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 -QVIENAGHFFRDDGR-QIYLP--------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -HHHHHHHhccccccc-cccCC--------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111111000 00000 01112246889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=323.10 Aligned_cols=265 Identities=24% Similarity=0.394 Sum_probs=205.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCc--EEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGE--VIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||.||+|+++ ++. .+|+|.++.. ........+.+|++++.++ +|+||+++++++...+..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 47888899999999999999864 454 4577766522 2233456788999999999 89999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 001274 878 LYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ 944 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 944 (1109)
||||+++++|.++++.... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 9999999999999975431 124789999999999999999999 789999999999999999999
Q ss_pred eEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHh
Q 001274 945 AHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRS 1023 (1109)
Q Consensus 945 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~ 1023 (1109)
+||+|||+++.... ........++..|+|||++.+..++.++|||||||++|||+| |..||..... .+.....
T Consensus 163 ~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKL 236 (303)
T ss_pred EEeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh----HHHHHHH
Confidence 99999999864321 111112234678999999988889999999999999999998 9999975331 1111111
Q ss_pred hhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 001274 1024 IHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPS 1089 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 1089 (1109)
....... ........+.+++.+||+.+|++||++.+++++++++......+..
T Consensus 237 -~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~ 289 (303)
T cd05088 237 -PQGYRLE------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 289 (303)
T ss_pred -hcCCcCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhh
Confidence 1110000 0011123577999999999999999999999999988776654443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=320.95 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=205.9
Q ss_pred cCCCCCceEecCCcceEEEEEec--------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
++|.+.+.||+|+||.||+|++. +...||+|.++... .......+.+|+++++++ +|+||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 57899999999999999999753 23569999987432 233445788899999999 799999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 939 (1109)
+..++||||+++|+|.+++..... ...+++.++.+++.|++.|++||| +.+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 999999999999999999976432 124889999999999999999999 7799999999999999
Q ss_pred CCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLV 1017 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~ 1017 (1109)
+.++.+||+|||.++....... .......++..|+|||++.+..++.++||||+||++|||++ |+.||.... ..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~----~~ 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VE 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----HH
Confidence 9999999999999876542111 11122234568999999998889999999999999999998 888886432 22
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
+..... ....... ........+.+++.+||+.+|++||++.++++.|.++....
T Consensus 250 ~~~~~~-~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 ELFKLL-KEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHH-HcCCCCC------------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 222211 1111000 01112246778999999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=313.99 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=203.7
Q ss_pred cCCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||.||+|++. .+..||+|.++... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888999999999999999863 23479999886432 23345688999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++++|.+++..... .+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||.++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999976543 3899999999999999999999 7899999999999999999999999999998664
Q ss_pred CCCCCCc--cccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 958 LPYSKSM--SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 958 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
....... ....++..|+|||++.+..++.++||||||+++||+++ |+.||...... .....+.. . ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~~~~~---~-~~~~--- 229 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAIEE---G-YRLP--- 229 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHHHHhC---C-CcCC---
Confidence 3222111 12233568999999999899999999999999999887 99998754321 11122211 1 1000
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
........+.+++.+||+.+|++||+|.++++.|..+
T Consensus 230 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 ---------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111224577999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.45 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=207.9
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|+..+.||+|+||.||.++.. +++.|++|++..........+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788899999999999999854 688999999876654555667889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... ..+++..+..++.|+++|++||| +.+++||||+|+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 999999999976532 24899999999999999999999 77999999999999999999999999999986643221
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
......+++.|+|||+..+..++.++||||+|+++|||++|+.||.... ..+..........+..
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~~~~~~~~~~~~~---------- 221 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN----PLNLVVKIVQGNYTPV---------- 221 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHcCCCCCC----------
Confidence 2334568999999999998889999999999999999999999987432 2233332222221110
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.......+.+++.+||+.+|++||++.++++++
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011123577899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.43 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=194.9
Q ss_pred eEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 809 VIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 809 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
.||+|+||.||+|.+. ++..||+|++.... .....+.+.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999753 35579999886432 2333467899999999999999999999875 45789999999999
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCC--
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS-- 963 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-- 963 (1109)
+|.+++..... .+++..+.+++.|++.|++||| +.+++||||||+||+++.++.+||+|||.++.........
T Consensus 80 ~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 80 PLNKFLSGKKD--EITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99999975443 3899999999999999999999 7799999999999999999999999999998654222111
Q ss_pred ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhh
Q 001274 964 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042 (1109)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1109)
.....++..|+|||++.+..++.++|||||||++||+++ |+.||..... .++.........+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~~~------------ 218 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----PEVMSFIEQGKRLD------------ 218 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHHHCCCCCC------------
Confidence 122234578999999988889999999999999999997 9999975431 12221111111000
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1043 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.+......+.+++.+||..+|++||++.+|.+.|+...
T Consensus 219 -~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 219 -CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 01112346778999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.71 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=203.4
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-CceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ-DSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 880 (1109)
+|++.+.||+|++|.||+|+.+ +++.||+|++..........+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999865 578999999976544444566788999999999999999999987644 45789999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... ..+++.++..++.+++.|++||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~- 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ- 155 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc-
Confidence 9999999999976432 23899999999999999999999 789999999999999999999999999999866422
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
........+++.|+|||+..+..++.++||||+|+++|+|++|+.||.... .............+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~----~~~~~~~~~~~~~~~---------- 221 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD----MNSLVYRIIEGKLPP---------- 221 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcCCCC----------
Confidence 222334568899999999999999999999999999999999999987432 222222222221110
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
........+.+++.+||+.+|++||++.+++++
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011222467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=323.12 Aligned_cols=262 Identities=25% Similarity=0.381 Sum_probs=205.8
Q ss_pred cCCCCCceEecCCcceEEEEEec--------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
.+|++.+.||+|+||.||+|+.. .+..||+|.++.. ......+.+.+|+++++++ +|+||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 57889999999999999999742 1236899988633 2233456789999999999 899999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 939 (1109)
+..++||||+++|+|.+++..... ...+++..+..++.|++.|++||| +.+++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence 999999999999999999975321 224788999999999999999999 7899999999999999
Q ss_pred CCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLV 1017 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~ 1017 (1109)
+.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.+.. ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~ 243 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VE 243 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----HH
Confidence 9999999999999986542211 11122334568999999999999999999999999999999 888887532 22
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
++......... .. ........+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus 244 ~~~~~~~~~~~-~~------------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 ELFKLLKEGHR-MD------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHcCCC-CC------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 22222111111 00 01112245789999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=311.35 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=202.3
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|++.++||+|+||.||+++.. +++.||+|.++.... ....+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4778899999999999999865 688999999864322 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
++++++.+++..... ..+++..+..++.|++.|+.||| +.+++|+||||+||++++++.++++|||.+...... .
T Consensus 80 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~ 154 (255)
T cd08219 80 CDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-G 154 (255)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-c
Confidence 999999998865432 23788999999999999999999 789999999999999999999999999999765422 1
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......++..|+|||++.+..++.++||||+|+++|+|++|+.||.... ............... .
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~---~------- 220 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS----WKNLILKVCQGSYKP---L------- 220 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC----HHHHHHHHhcCCCCC---C-------
Confidence 22234568889999999999899999999999999999999999997432 222222211111110 0
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+||+.||++||++.+++..
T Consensus 221 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01112347789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=333.81 Aligned_cols=256 Identities=23% Similarity=0.295 Sum_probs=197.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|+..+.||+|+||+||+|+.+ +++.||+|++..... .......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999865 689999999974321 2233456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999976543 899999999999999999999 789999999999999999999999999998754211
Q ss_pred CC----------------------------------CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCC
Q 001274 960 YS----------------------------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKS 1005 (1109)
Q Consensus 960 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~ 1005 (1109)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 00123479999999999999999999999999999999999999
Q ss_pred CCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHHH
Q 001274 1006 PVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT---MREVIAMMI 1078 (1109)
Q Consensus 1006 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~evl~~L~ 1078 (1109)
||..... ............ ...+.+.. .....+.+++.+++ .+|++|++ +.|+++|-+
T Consensus 235 Pf~~~~~----~~~~~~i~~~~~--~~~~p~~~--------~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 235 PFCSETP----QETYRKVMNWKE--TLVFPPEV--------PISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred CCCCCCH----HHHHHHHHcCCC--ceecCCCC--------CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCC
Confidence 9975432 111111111000 00000000 01124556777765 49999984 788887743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=331.56 Aligned_cols=266 Identities=22% Similarity=0.235 Sum_probs=201.9
Q ss_pred hcCCCCCceEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
..+|.+.+.||+|+||.||+|... .++.||+|.+.. .....+|++++++++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~-------~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTG-------GKTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccc-------cccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 468999999999999999999753 367899998752 1345689999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
|||++. ++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||+++...
T Consensus 164 v~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999995 68888885433 3899999999999999999999 7799999999999999999999999999997654
Q ss_pred CCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 958 LPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 958 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....... ..++............+..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS-SQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH-HHHHHHHHHhccCccccCC
Confidence 3222 2223567999999999999999999999999999999999999999765432211 1111111100000000000
Q ss_pred ---------------hcch--hhcc---cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1037 ---------------RLDL--SAKR---TVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1037 ---------------~~~~--~~~~---~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.... .... .......+..++.+|++.||++||++.|++.+-+...
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 0000 0000 0011235678999999999999999999999976654
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=318.70 Aligned_cols=256 Identities=22% Similarity=0.331 Sum_probs=201.1
Q ss_pred CCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
+|++.++||+|+||+||+|++. +++.||+|+++.... ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4667789999999999999853 257899999974432 223466889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 001274 877 LLYEYMENGSLGEQLHGNK-------------QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF 943 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 943 (1109)
+++||+++++|.+++.... ....+++..+.+++.|++.|++|+| +++|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 9999999999999985321 1123788889999999999999999 78999999999999999999
Q ss_pred ceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHH
Q 001274 944 QAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVR 1021 (1109)
Q Consensus 944 ~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~ 1021 (1109)
.+||+|||+++....... .......+++.|+|||++.+..++.++||||+||++|||++ |..||.+.. ..++..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~~~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----NQDVIE 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH
Confidence 999999999886542221 11223446788999999998899999999999999999998 888887532 222222
Q ss_pred HhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1022 RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
......... + .......+.+++.+||+.+|++||++++|++.|+.
T Consensus 238 ~i~~~~~~~---~----------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQVLP---C----------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCcCC---C----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222211110 0 11123457799999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=316.62 Aligned_cols=265 Identities=28% Similarity=0.375 Sum_probs=199.5
Q ss_pred cCCCCCceEecCCcceEEEEEe-----cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--Cc
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 874 (1109)
.+|++.+.||+|+||+||+|+. .+++.||+|+++... ....+.+.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4788899999999999999974 257899999986432 23456788999999999999999999987543 45
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+++|+|.+++..... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 7899999999999999976543 3899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCCC--ccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC---C
Q 001274 955 LIDLPYSKS--MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV---P 1029 (1109)
Q Consensus 955 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~ 1029 (1109)
......... .....++..|+|||+..+..++.++||||+||++|||++|..|+..... .+.+....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 231 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-----EFMRMMGNDKQGQMI 231 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-----hhhhhcccccccccc
Confidence 664222111 1122344569999999988999999999999999999998877543210 11110000000 0
Q ss_pred Cc---hhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1030 TS---ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1030 ~~---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.. +....... ..........+.+++.+||+.+|++||||.|+++.|+.+
T Consensus 232 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKNNGR--LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhcCCc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 00000000 000112234688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=319.69 Aligned_cols=271 Identities=25% Similarity=0.371 Sum_probs=205.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||.||+|++. ++..||+|.+.... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36888999999999999999865 67889999886432 22334568899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... +++..+..++.|+++||.|||+. .+++||||||+||+++.++.++|+|||++......
T Consensus 80 y~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 80 HMDGGSLDQVLKKAGR---IPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred ccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999976543 88999999999999999999932 48999999999999999999999999998754321
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC----------
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT---------- 1030 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---------- 1030 (1109)
......++..|+|||++.+..++.++||||||+++|||++|+.||..... .....+...........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCC
Confidence 22345788999999999888899999999999999999999999864321 11111111100000000
Q ss_pred ---------chhhhhhcchh-hcc-cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1031 ---------SELFDKRLDLS-AKR-TVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1031 ---------~~~~~~~~~~~-~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
.+..+...... ... .......+.+++.+||+.+|++||++.+++++.+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000000000 000 00123357899999999999999999999999876543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=339.27 Aligned_cols=267 Identities=19% Similarity=0.238 Sum_probs=195.2
Q ss_pred HHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC------CCceeeEEEEEEe
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR------HRNIVKLYGFCYH 871 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~ 871 (1109)
...++|++.++||+|+||+||+|++. .++.||||+++... .....+..|+++++.++ |.+++++++++..
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 34578999999999999999999865 58899999986321 12334556666666654 4568999998876
Q ss_pred C-CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCceeeCCCC------
Q 001274 872 Q-DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR-PHIIHRDIKSNNILLDEEF------ 943 (1109)
Q Consensus 872 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~------ 943 (1109)
. .+.++|||++ +++|.+++.+... +++..+..++.||+.||+||| . .+||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGP---FSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccc
Confidence 5 4678999988 7789998876543 899999999999999999999 5 4999999999999998765
Q ss_pred ----------ceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC
Q 001274 944 ----------QAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG 1013 (1109)
Q Consensus 944 ----------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~ 1013 (1109)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999886432 2234568999999999999999999999999999999999999999754321
Q ss_pred CcHHHHHHHhhhccCCC-----------chhhhh------hcch---------hhcccHHHHHHHHHHHHhccCCCCCCC
Q 001274 1014 GDLVTWVRRSIHEMVPT-----------SELFDK------RLDL---------SAKRTVEEMTLFLKIALFCSSTSPLNR 1067 (1109)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~-----------~~~~~~------~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~R 1067 (1109)
+ ....+.... +..+. .+.+.. .... ...........+.+|+.+|+++||++|
T Consensus 352 ~-~~~~i~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 352 E-HLHLMEKTL-GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred H-HHHHHHHHc-CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 1 111111110 00000 000000 0000 000001123457899999999999999
Q ss_pred CCHHHHHHHHHHhh
Q 001274 1068 PTMREVIAMMIDAR 1081 (1109)
Q Consensus 1068 Pt~~evl~~L~~~~ 1081 (1109)
||++|+++|-+...
T Consensus 430 ~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 430 LNARQMTTHPYVLK 443 (467)
T ss_pred CCHHHHhcCccccc
Confidence 99999999876543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=332.67 Aligned_cols=263 Identities=21% Similarity=0.233 Sum_probs=197.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.+|.+.+.||+|+||.||+|++. .++.||||... ...+.+|++++++++|+|||++++++...+..++|||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 47999999999999999999875 57889999643 2346789999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
++. ++|.+++..... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 241 ~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 995 789888865433 3899999999999999999999 7899999999999999999999999999998654222
Q ss_pred CC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC---C----cHHHHHHHhhhc--cCCC
Q 001274 961 SK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG---G----DLVTWVRRSIHE--MVPT 1030 (1109)
Q Consensus 961 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~---~----~~~~~~~~~~~~--~~~~ 1030 (1109)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..|+...... . .+...++..... ..+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 11 123457999999999999999999999999999999999988765432211 1 111222211100 0000
Q ss_pred ---chhhhhhc-------c--hh---hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1031 ---SELFDKRL-------D--LS---AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1031 ---~~~~~~~~-------~--~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
........ . .. ..........+.+++.+||+.||.+|||+.|++++-+
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 00000000 0 00 0000011124778999999999999999999998754
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=318.19 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=204.5
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.+|++.+.||.|+||+||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4688899999999999999985 4789999999874432 235678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++... .+++.++..++.+++.|++||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 97 YLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred ecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999998653 2899999999999999999999 7899999999999999999999999999987654221
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... +..........+...
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----~~~~~~~~~~~~~~~-------- 236 (296)
T cd06655 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RALYLIATNGTPELQ-------- 236 (296)
T ss_pred -ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCcccC--------
Confidence 1223346888999999999988999999999999999999999999754321 111111111110000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
........+.+++.+||..||++||++.+++++=+..
T Consensus 237 ---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 237 ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred ---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 0111123577899999999999999999999886654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=317.21 Aligned_cols=263 Identities=22% Similarity=0.371 Sum_probs=200.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-----------------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceee
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-----------------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 864 (1109)
++|++.++||+|+||+||+++.. ++..||+|++.... .......+.+|+++++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 46889999999999999998643 23468999886432 2234567899999999999999999
Q ss_pred EEEEEEeCCceEEEEEeccCCCHHHHhccCCCC--------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 001274 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQT--------CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNN 936 (1109)
Q Consensus 865 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 936 (1109)
+++++...+..++||||+++|+|.+++...... ..+++..+..++.|++.|++||| +.+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 999999999999999999999999998764321 23778889999999999999999 7799999999999
Q ss_pred eeeCCCCceEEeeccccccccCCCCCC-ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh--CCCCCCCcccC
Q 001274 937 ILLDEEFQAHVGDFGLAKLIDLPYSKS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT--GKSPVQSLELG 1013 (1109)
Q Consensus 937 Ill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt--g~~pf~~~~~~ 1013 (1109)
|+++.++.++++|||+++......... .....++..|+|||+..++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999998653221111 122344678999999888899999999999999999998 77888654321
Q ss_pred CcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1014 GDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
... ............ . ... .........+.+++.+||+.||++||++.+|++.|.
T Consensus 241 ~~~-~~~~~~~~~~~~-~-~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVI-ENTGEFFRDQGR-Q-VYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHH-HHHHHHHhhccc-c-ccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111 111111111000 0 000 001112246889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=311.17 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=196.8
Q ss_pred ceEecCCcceEEEEEec-C---CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEecc
Q 001274 808 AVIGRGACGTVYKATLA-N---GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYME 883 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 883 (1109)
++||+|+||.||+|++. . +..||+|.+...... ...+.+.+|+++++.++|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 46999999999999753 2 268999998744332 35567899999999999999999999876 456799999999
Q ss_pred CCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCC
Q 001274 884 NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS 963 (1109)
Q Consensus 884 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 963 (1109)
+|+|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||.++.........
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999998765 3899999999999999999999 7799999999999999999999999999998664322211
Q ss_pred c--cccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 964 M--SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 964 ~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+... .+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~~~~~~----~~~~--------- 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLESG----ERLP--------- 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHHcC----CcCC---------
Confidence 1 12223568999999999999999999999999999998 9999975431 1222222211 1000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
........+.+++.+||..+|++||++.++++.|++..
T Consensus 219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01112246789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=311.78 Aligned_cols=254 Identities=30% Similarity=0.418 Sum_probs=203.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||.||+|+.. +++.+|+|++...... ..+.+.+|++++++++||||+++++++...+..+++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 57888999999999999999865 5788999999754322 45778999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~- 154 (262)
T cd06613 81 YCGGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT- 154 (262)
T ss_pred CCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh-
Confidence 9999999999876532 2899999999999999999999 779999999999999999999999999999765422
Q ss_pred CCCccccccccceeccccccCC---CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTM---KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
........++..|+|||++.+. .++.++||||+|+++|||++|+.||......... .............
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~---- 226 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL----FLISKSNFPPPKL---- 226 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhccCCCccc----
Confidence 1122345678899999998877 8899999999999999999999999754311111 1111111100000
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.........+.+++.+||..+|++|||+.+++.+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 -----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0112233468899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=320.21 Aligned_cols=196 Identities=28% Similarity=0.468 Sum_probs=160.5
Q ss_pred CceEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--CCceEEEEEe
Q 001274 807 GAVIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--QDSNLLLYEY 881 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 881 (1109)
+++||+|+||+||+|+.+ +++.||+|++.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999864 46789999986332 23457789999999999999999998864 3457899999
Q ss_pred ccCCCHHHHhccCC------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee----CCCCceEEeecc
Q 001274 882 MENGSLGEQLHGNK------QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL----DEEFQAHVGDFG 951 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG 951 (1109)
+. ++|.+++.... ....+++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 95 58888775321 1124889999999999999999999 7799999999999999 466799999999
Q ss_pred ccccccCCCC--CCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCc
Q 001274 952 LAKLIDLPYS--KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSL 1010 (1109)
Q Consensus 952 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~ 1010 (1109)
+++....... .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9987643221 122456789999999998874 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.44 Aligned_cols=251 Identities=29% Similarity=0.427 Sum_probs=200.9
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcc-------hhHHHHHHHHHhccCCCCceeeEEEEEEeCCc
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGAT-------ADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 874 (1109)
+|.+.+.||+|+||.||+|... +++.||+|.+........ ..+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999864 688999998865432211 12568899999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+++++|.+++..... +++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC---ccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999976543 888999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCC-----CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCC
Q 001274 955 LIDLPYS-----KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 955 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 1029 (1109)
....... .......++..|+|||++.+..++.++||||+|+++|+|++|+.||...... ..+........+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~ 230 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QAIFKIGENASP 230 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HHHHHHhccCCC
Confidence 6642111 1112345788999999999989999999999999999999999999753211 111111111000
Q ss_pred CchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1030 TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
. ........+.+++.+||+.||.+||++.|++++
T Consensus 231 --~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 231 --E-----------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --c-----------CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 011123457799999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.03 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=203.2
Q ss_pred cCCCCCceEecCCcceEEEEEecC----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
.+|.+.++||+|+||.||+|.+.+ ...||||...... .....+.+.+|++++++++|+||+++++++.+ +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 468888999999999999998643 3468999886432 23345678999999999999999999998875 55789
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|+|.+++..... .+++..+..++.+++.|++||| +.+++||||||+||+++.++.++++|||.++...
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999976543 3899999999999999999999 7799999999999999999999999999998654
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
...........++..|+|||++....++.++||||||+++||+++ |..||...... .....+... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~~--~~~~~------ 229 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRIENG--ERLPM------ 229 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcC--CcCCC------
Confidence 322111223334568999999988889999999999999999996 99999754321 111111110 00000
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+|+..+|++|||+.++++.|..+...
T Consensus 230 --------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 230 --------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111223678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=317.88 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=202.9
Q ss_pred cCCCCCceEecCCcceEEEEEecC------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++|++.+.||+|+||.||+|.+++ +..||+|.+.... .......+.+|+.+++.++|+||+++++++......
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 578889999999999999998642 3689999986332 223446788999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCC-------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 001274 876 LLLYEYMENGSLGEQLHGNKQ-------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVG 948 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 948 (1109)
++||||+++|+|.+++..... ...+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 999999999999999965432 123688899999999999999999 7899999999999999999999999
Q ss_pred eccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhc
Q 001274 949 DFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 949 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
|||.++....... .......++..|+|||++.+..++.++|||||||++||+++ |..||.+... ......+. ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~~~~---~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVI---DG 237 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-HHHHHHHh---cC
Confidence 9999986542221 12233456789999999988889999999999999999998 9999875321 11122121 11
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
..+ .. .......+.+++.+||+.+|++|||+.++++.|+
T Consensus 238 ~~~--~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHL--DL-----------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCC--CC-----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 100 00 0111346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.22 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=205.6
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|+..+.||+|+||+||+++.. +++.||+|++..........+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5788899999999999999864 689999999975544444556889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999999876432 13788999999999999999999 7799999999999999999999999999998654221
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......+++.|+|||+..+..++.++|||||||++|+|++|+.||... ...+.+.....+..+..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~~~~~~~~~~~~~~~~~---------- 221 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG----NMKNLVLKIIRGSYPPV---------- 221 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC----CHHHHHHHHhcCCCCCC----------
Confidence 1122345788999999999999999999999999999999999998742 23333333222222110
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+||+.+|++||++.+|+++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 ---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11123357899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.07 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=199.2
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe-CCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH-QDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 880 (1109)
.+|++.+.||+|+||.||+|..+ ++.||+|.++.. ...+.+.+|+.++++++|+|++++++++.. .+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 47888999999999999999875 788999988632 234678899999999999999999997654 456899999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.++.....
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 81 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 155 (256)
T ss_pred CCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence 9999999999976543 23789999999999999999999 779999999999999999999999999998754321
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.....++..|+|||++.+..++.++||||+||++|||++ |+.||.... ..+.......+.. . ..
T Consensus 156 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~----~~~~~~~~~~~~~-~-~~------ 220 (256)
T cd05082 156 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPRVEKGYK-M-DA------ 220 (256)
T ss_pred ---CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHhcCCC-C-CC------
Confidence 122345678999999998889999999999999999998 999987432 2222222111110 0 00
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......+.+++.+||+.+|++|||+.+++++|..
T Consensus 221 -----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 -----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11123467799999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=315.99 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=199.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 46777889999999999999864 68899999987442 2234567889999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++...+. +++.++..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd06645 87 FCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT- 159 (267)
T ss_pred ccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-
Confidence 9999999999876543 899999999999999999999 779999999999999999999999999998765422
Q ss_pred CCCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
........|+..|+|||++. ...++.++||||+||++|||++|+.||............. ......... ..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~----~~~~~~~~~-~~- 233 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT----KSNFQPPKL-KD- 233 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh----ccCCCCCcc-cc-
Confidence 22223457899999999874 4568899999999999999999999986533211111111 111100000 00
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+|++.+|++||++++++++
T Consensus 234 -------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 -------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -------cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00112357789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=328.02 Aligned_cols=193 Identities=26% Similarity=0.353 Sum_probs=165.4
Q ss_pred HHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
....+|++.+.||+|+||.||+|+.. +++.||+|+... .....|+.++++++|+||+++++++...+..++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 34468999999999999999999875 577899987531 123569999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+. ++|.+++..... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||.++...
T Consensus 135 v~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEccC-CcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999995 688888865443 3899999999999999999999 7799999999999999999999999999997533
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPV 1007 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf 1007 (1109)
. ........||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 V--APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c--CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 12223457899999999999999999999999999999999965554
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.94 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=200.9
Q ss_pred hcCCCCCceEecCCcceEEEEEecC------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLAN------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 874 (1109)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... .......+.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4678899999999999999998653 5678888876332 22334678999999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCC----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---ceEE
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQ----TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF---QAHV 947 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 947 (1109)
.++||||+++++|.+++..... ...+++..+.+++.||+.|++||| +.+++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976532 124899999999999999999999 77999999999999998654 6999
Q ss_pred eeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhh
Q 001274 948 GDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIH 1025 (1109)
Q Consensus 948 ~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 1025 (1109)
+|||+++....... ........+..|+|||++.+..++.++|||||||++|||++ |..||..... .+.......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~----~~~~~~~~~ 236 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----QEVMEFVTG 236 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHc
Confidence 99999986532211 11112234568999999999999999999999999999997 9999975331 122221111
Q ss_pred ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1026 EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
... .. ........+.+++.+|++.+|++||++.+|+++|.
T Consensus 237 ~~~-~~------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GGR-LD------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCc-CC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 110 00 01112246789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.20 Aligned_cols=249 Identities=29% Similarity=0.459 Sum_probs=203.5
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.+.||.|+||.||+|... ++.||+|+++.... ..+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 57888999999999999999875 78999999974422 456789999999999999999999999998999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-- 155 (256)
T cd05039 82 MAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-- 155 (256)
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc--
Confidence 999999999976543 23899999999999999999999 789999999999999999999999999999865321
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
......+..|+|||++.++.++.++||||+|+++|||++ |+.||.... ..+... ......... .
T Consensus 156 --~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~-~~~~~~~~~-~------- 220 (256)
T cd05039 156 --QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVP-HVEKGYRME-A------- 220 (256)
T ss_pred --cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH-HHhcCCCCC-C-------
Confidence 112345678999999998899999999999999999998 999987532 111111 111111000 0
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......+.+++.+||..+|++||++.|++++|..
T Consensus 221 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 ----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 01112467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=318.43 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=204.1
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||.||+|+. .+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 6899999999999999999986 4789999999974432 234668899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++.... +++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||.+.......
T Consensus 97 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999986532 788999999999999999999 7799999999999999999999999999987654221
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......+++.|+|||+..+..++.++||||+||++|+|++|+.||......... ........+..
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~----~~~~~~~~~~~--------- 235 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLIATNGTPEL--------- 235 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe----eeeccCCCCCC---------
Confidence 1223446888999999999988999999999999999999999999753321110 00000000000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.........+.+++.+||+.+|++||++++++++-+..
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 273 (297)
T cd06656 236 --QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273 (297)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence 00111223467899999999999999999999975443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=318.79 Aligned_cols=268 Identities=25% Similarity=0.357 Sum_probs=204.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||.||+|+++ +++.||+|+++.........+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999876 58899999987554444455788999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|++++.+..+...... +++..+..++.||+.|++||| +.+++||||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777666544332 899999999999999999999 7799999999999999999999999999998765333
Q ss_pred CCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC-c------h
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT-S------E 1032 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~------~ 1032 (1109)
........++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+.... .........+. . .
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL-IQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCHHHhhhcccCc
Confidence 2233445678899999999888 789999999999999999999999975432111111 11111000000 0 0
Q ss_pred hhhh-hc-------chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1033 LFDK-RL-------DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1033 ~~~~-~~-------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.+.. .. .............+.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 00 00000111124668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.70 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=203.2
Q ss_pred hcCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 874 (1109)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... .....+.+.+|+.++++++||||+++++++..++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 357889999999999999999863 46789999886432 22345678899999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCC-------------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQ-------------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSN 935 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~ 935 (1109)
.++||||+++|+|.+++..... ...+++..+..++.|++.|++||| +.+++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence 9999999999999999974321 123788889999999999999999 779999999999
Q ss_pred ceeeCCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccC
Q 001274 936 NILLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELG 1013 (1109)
Q Consensus 936 NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~ 1013 (1109)
||+++.++.++|+|||.++....... ........++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-- 237 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-- 237 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 99999999999999999875432211 11122345678999999998999999999999999999998 888986432
Q ss_pred CcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1014 GDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
..+............ ........+.+++.+||+.+|++|||+.|+++.|++
T Consensus 238 --~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 --HEEVIYYVRDGNVLS-------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHHHHHhcCCCCC-------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 122222211111100 001122457889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.42 Aligned_cols=259 Identities=28% Similarity=0.388 Sum_probs=206.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||.|+||+||+|... ++..||+|++....... ..+.+.+|+++++.++|+||+++++.+..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 46889999999999999999854 68899999986443322 56778999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
++++++|.++++.......+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999999976543234899999999999999999999 7899999999999999999999999999997665322
Q ss_pred CC---CccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 961 SK---SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 961 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. ......++..|+|||++... .++.++|||||||++|||++|+.||.............. ...+ .+..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~~~~---~~~~ 229 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ----NDPP---SLET 229 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc----CCCC---CcCC
Confidence 22 12344688999999998877 789999999999999999999999975443222222221 1110 0000
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.. ........+.+++.+||+.||++||++.+++++
T Consensus 230 ~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 230 GA-----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cc-----ccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 011223467899999999999999999999876
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.72 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=202.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CC---cEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NG---EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||.||+|++. ++ ..||||+++.. ......++|..|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 45788899999999999999865 23 36999998643 223345689999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++++|.+++..... .+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++++|||.+....
T Consensus 83 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 83 ITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999976543 3899999999999999999999 7899999999999999999999999999987654
Q ss_pred CCCCCC-cc-cc--ccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 958 LPYSKS-MS-AI--AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 958 ~~~~~~-~~-~~--~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
...... .. .. ..+..|+|||++.+..++.++||||+||++|||++ |..||...... ....++. ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~i~----~~~~~~~ 232 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAIE----QDYRLPP 232 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHHHH----cCCcCCC
Confidence 221111 11 11 12457999999999999999999999999999987 99999754311 1222221 1111000
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
..+....+.+++.+||+.+|.+||++++++.+|+.+
T Consensus 233 ------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 ------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111224577899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.98 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=204.8
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|++.+.||+|+||+||+|++. +++.||+|.++... .......+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 6788899999999999999976 78999999887432 223346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|..++........+++..+..++.+++.|+.|||+ +.+|+||||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999998764322348999999999999999999994 248999999999999999999999999999765321
Q ss_pred CCccccccccceeccccccCCC------CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMK------VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
......++..|+|||++.+.. ++.++||||+||++|||++|+.||..... ......+........+ .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~--~--- 229 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-ANIFAQLSAIVDGDPP--T--- 229 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-hhHHHHHHHHhhcCCC--C---
Confidence 223346788999999986543 58899999999999999999999975321 1111111111111110 0
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
........+.+++.+||+.+|++||++.+++++-+.....
T Consensus 230 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 230 --------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred --------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 0112334577899999999999999999999986654433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=318.75 Aligned_cols=263 Identities=25% Similarity=0.416 Sum_probs=205.0
Q ss_pred cCCCCCceEecCCcceEEEEEec--------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
++|.+.++||+|+||.||+|+.. ....||+|.++... .......+.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 57888999999999999999742 24568999886432 233456788999999999 699999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 939 (1109)
+..++||||+++|+|.+++..... ...+++..+.+++.|++.|+.||| +.+++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 999999999999999999965421 124889999999999999999999 7899999999999999
Q ss_pred CCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLV 1017 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~ 1017 (1109)
+.++.+||+|||.++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-EELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-HHHH
Confidence 9999999999999986542111 11122234567999999998899999999999999999999 8899865321 1111
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
..+. .... .. ........+.+++.+||+.+|++||++.++++.|.++.....
T Consensus 247 ~~~~---~~~~-~~------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 247 KLLR---EGHR-MD------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHH---cCCC-CC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 1111 1110 00 011112356789999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=309.78 Aligned_cols=254 Identities=31% Similarity=0.455 Sum_probs=203.3
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|+..+.||+|+||.||+|... +++.||+|.++.........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 689999999986544434567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... +++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGRI---LDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcCC---CChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999976532 788999999999999999999 78999999999999999999999999999987653322
Q ss_pred CCc---cccccccceeccccccCCC---CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 962 KSM---SAIAGSYGYIAPEYAYTMK---VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 962 ~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
... ....+++.|+|||++.+.. ++.++||||||+++||+++|+.||....... ...........+ .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~---~~~ 228 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFHVGAGHKP---PIP 228 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHHHhcCCCC---CCC
Confidence 211 2356788999999998766 8899999999999999999999997543111 111111111100 000
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
. .......+.+++.+||+.+|++||++.|++.+
T Consensus 229 ~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 229 D--------SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred c--------ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 01112346789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.08 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=200.8
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
.+|+..++||+|+||.||+|+.. ++..||+|.+... .......+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 46788899999999999999632 3567899987633 233456799999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCC------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 001274 876 LLLYEYMENGSLGEQLHGNKQT------------CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF 943 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 943 (1109)
++||||+++++|.+++...... ..+++..+..++.|++.|++||| +.+++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCC
Confidence 9999999999999999764321 23789999999999999999999 78999999999999999999
Q ss_pred ceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHH
Q 001274 944 QAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVR 1021 (1109)
Q Consensus 944 ~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~ 1021 (1109)
.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+...
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~ 235 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----TEAIE 235 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH----HHHHH
Confidence 999999999975532211 11122345678999999999999999999999999999998 8999865331 11121
Q ss_pred HhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1022 RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
......... ........+.+++.+||+.||++||+++||.+.|+
T Consensus 236 ~~~~~~~~~-------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CITQGRELE-------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHcCccCC-------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111000 00111235779999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=317.48 Aligned_cols=261 Identities=26% Similarity=0.362 Sum_probs=200.3
Q ss_pred HHHHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEE---
Q 001274 796 NLLEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCY--- 870 (1109)
Q Consensus 796 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 870 (1109)
.+....++|++.+.||+|+||+||+|+.. +++.||+|++... ......+.+|+.+++++ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34456689999999999999999999865 6889999987632 22345678899999999 6999999999884
Q ss_pred --eCCceEEEEEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 001274 871 --HQDSNLLLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV 947 (1109)
Q Consensus 871 --~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 947 (1109)
.++..++||||+++++|.+++.... ....+++..+..++.|+++|+.||| +.+++||||||+||+++.++.+++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEE
Confidence 3456799999999999999876422 2234888999999999999999999 779999999999999999999999
Q ss_pred eeccccccccCCCCCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHH
Q 001274 948 GDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRR 1022 (1109)
Q Consensus 948 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~ 1022 (1109)
+|||.++..... ........|++.|+|||++. +..++.++||||+||++|||++|+.||......... ..
T Consensus 166 ~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~----~~ 240 (286)
T cd06638 166 VDFGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL----FK 240 (286)
T ss_pred ccCCceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH----hh
Confidence 999999865422 12223446899999999875 345789999999999999999999998754321111 11
Q ss_pred hhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
...... ..... .......+.+++.+||+.||++||++.|++++.+
T Consensus 241 ~~~~~~--~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 241 IPRNPP--PTLHQ---------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred ccccCC--CcccC---------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 001000 00000 0011235779999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=311.11 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=202.7
Q ss_pred cCCCCCceEecCCcceEEEEEecC-CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|+..+.||+|+||.||+|+..+ ++.||+|.+.... ..+.+.+|++++++++|+||+++++++...+..++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 578888999999999999999764 8899999986432 25789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... .+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 79 YCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 9999999999975443 3899999999999999999999 7799999999999999999999999999998664322
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||......... ....... .. ...
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~----~~~~~~~--~~-----~~~- 220 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI----FMIPNKP--PP-----TLS- 220 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh----hhhccCC--CC-----CCC-
Confidence 1223345788999999999999999999999999999999999999753321111 0000000 00 000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
........+.+++.+||+.+|++|||+.|++++
T Consensus 221 ---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 ---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred ---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 011122457899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.52 Aligned_cols=239 Identities=23% Similarity=0.380 Sum_probs=186.6
Q ss_pred ceEecCCcceEEEEEecC-------------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc
Q 001274 808 AVIGRGACGTVYKATLAN-------------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 874 (1109)
+.||+|+||.||+|+... ...||+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999997532 2258888875332 2344578889999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc-------eEE
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ-------AHV 947 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl 947 (1109)
.++||||+++|+|..++..... .+++..+.+++.||++|++||| +++|+||||||+||+++.++. +++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999999999876443 3899999999999999999999 789999999999999987664 899
Q ss_pred eeccccccccCCCCCCccccccccceecccccc-CCCCCccchhHHHHHHHHHHH-hCCCCCCCcccCCcHHHHHHHhhh
Q 001274 948 GDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSFGVVLLELI-TGKSPVQSLELGGDLVTWVRRSIH 1025 (1109)
Q Consensus 948 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvll~ell-tg~~pf~~~~~~~~~~~~~~~~~~ 1025 (1109)
+|||.+..... .....++..|+|||++. +..++.++|||||||++|||+ +|+.||.... ..+... ...
T Consensus 154 ~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----~~~~~~-~~~ 223 (262)
T cd05077 154 SDPGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT----LAEKER-FYE 223 (262)
T ss_pred CCCCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc----hhHHHH-HHh
Confidence 99999875431 12345788899999887 566899999999999999998 5888876432 111111 011
Q ss_pred ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1026 EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
..... .......+.+++.+||+.||++||++.+|++++
T Consensus 224 ~~~~~--------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQCML--------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCccC--------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11000 001123577999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=319.01 Aligned_cols=267 Identities=22% Similarity=0.318 Sum_probs=202.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|.+.++||+|+||.||+|+++ +++.||+|.++..... .....+.+|++++++++|+||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 57899999999999999999865 6889999998744322 234567789999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|++ ++|.+++..... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 997 599998876543 3889999999999999999999 7899999999999999999999999999997654221
Q ss_pred CCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCchhhhhhc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSELFDKRL 1038 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1038 (1109)
.......+++.|+|||++.+. .++.++||||+||++|||++|+.||..... .+.+........ +....+....
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV----EEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCChhhchhhh
Confidence 122334578899999988754 478899999999999999999999975432 111111111000 0011110000
Q ss_pred --------chh-------hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1039 --------DLS-------AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1039 --------~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
... ..........+.+++.+|++.||.+|||++|++++-+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 000 000011123567899999999999999999999876553
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=293.22 Aligned_cols=282 Identities=23% Similarity=0.302 Sum_probs=212.8
Q ss_pred HHhcCCCCCceEecCCcceEEEEEec---C--CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe-C
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLA---N--GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH-Q 872 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 872 (1109)
+....|+....||+|.||.||+|..+ + ...+|+|+++.............+|+..++.++|||++.+..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 44568999999999999999999532 2 3379999998775555566778899999999999999999999877 7
Q ss_pred CceEEEEEeccCCCHHHHhccCC--CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC----CceE
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNK--QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE----FQAH 946 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~k 946 (1109)
...++++||++. +|.+.++-+. ..+.++...+..|+.||+.|+.||| +.-|+||||||.||||..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence 788999999986 8888885433 2346899999999999999999999 5679999999999999887 8999
Q ss_pred EeeccccccccCCCCC--CccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccC-----CcHHH
Q 001274 947 VGDFGLAKLIDLPYSK--SMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELG-----GDLVT 1018 (1109)
Q Consensus 947 l~DFG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~-----~~~~~ 1018 (1109)
|+|||+++.+..+... ....++-|+.|+|||.+.+.+ |+.+.|||+.||++.||+|-++-|.+.+.. .-..+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999988755432 235677899999999998765 899999999999999999999888765421 11223
Q ss_pred HHHHhhhccCCCchhhhhhcchhhc-------------cc---HH-------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001274 1019 WVRRSIHEMVPTSELFDKRLDLSAK-------------RT---VE-------EMTLFLKIALFCSSTSPLNRPTMREVIA 1075 (1109)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~---~~-------~~~~~~~li~~cl~~dP~~RPt~~evl~ 1075 (1109)
.+.+.++-...+.+...+.+..-++ .. .. ......+++.+++..||.+|.|+.+.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 3333333222111111111100000 00 00 0122678999999999999999999999
Q ss_pred HHHHhhhcc
Q 001274 1076 MMIDARQSV 1084 (1109)
Q Consensus 1076 ~L~~~~~~~ 1084 (1109)
+........
T Consensus 337 h~yF~~d~l 345 (438)
T KOG0666|consen 337 HPYFTEDPL 345 (438)
T ss_pred ccccccCCC
Confidence 876655443
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=315.29 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=199.8
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
|++.+.||+|+||.||+|+.. ++..+|+|.+.... ....+.+.+|+++++.++|||++++++++..++..++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 566788999999999999876 57788888885332 234567889999999999999999999999999999999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 962 (1109)
++++|..++..... .+++..+..++.|+++||.||| +.+++||||||+||+++.++.+|++|||++...... ..
T Consensus 85 ~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~ 158 (282)
T cd06643 85 AGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQ 158 (282)
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc-cc
Confidence 99999998865333 3899999999999999999999 779999999999999999999999999998765321 12
Q ss_pred Cccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 963 SMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
......++..|+|||++. +..++.++||||+||++|||++|+.||...... +.+........+.. ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~-~~--- 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKSEPPTL-AQ--- 230 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----HHHHHHhhcCCCCC-CC---
Confidence 223456889999999874 455788999999999999999999998754321 11111111111100 00
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.......+.+++.+||+.+|++||++.+++++-+..
T Consensus 231 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 266 (282)
T cd06643 231 -------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT 266 (282)
T ss_pred -------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence 011123577999999999999999999999876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.73 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=194.3
Q ss_pred eEecCCcceEEEEEecC-Cc--EEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 809 VIGRGACGTVYKATLAN-GE--VIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 809 ~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
.||+|+||.||+|++++ +. .+|+|.++.. ......+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 58999999999998753 43 4688877632 2223456788999999999 899999999999999999999999999
Q ss_pred CCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 885 GSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 885 gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
|+|.+++..... ...+++..+..++.|++.|++||| +.+++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 999999975431 123789999999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||.... ..+....... ....
T Consensus 158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~----~~~~~~~~~~-~~~~ 230 (270)
T cd05047 158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYEKLPQ-GYRL 230 (270)
T ss_pred Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC----HHHHHHHHhC-CCCC
Confidence 9864321 111112234567999999988899999999999999999997 999996532 1122221111 1000
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
. ........+.+++.+||+.+|.+|||+.++++.|.++.
T Consensus 231 ~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 E------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C------------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 01112235779999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.60 Aligned_cols=268 Identities=25% Similarity=0.322 Sum_probs=205.1
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|++.+.||+|+||.||+|++. +++.||+|++..........+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999865 689999999986554344457899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+ +++|.+++..... .+++.++..++.||++|++||| +.+++|+||||+||+++.++.++++|||.+........
T Consensus 81 ~-~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEER--PLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 9999999876543 3899999999999999999999 77999999999999999999999999999987653322
Q ss_pred CCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCC--------C--
Q 001274 962 KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP--------T-- 1030 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~-- 1030 (1109)
.......++..|+|||++.+. .++.++||||+|+++|||++|+.||.+....... ..+........+ .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL-AIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH-HHHHHHcCCCChHHHhhccCcch
Confidence 223445688999999998754 4689999999999999999998887643321111 111111110000 0
Q ss_pred -chhh-hhhcchh-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1031 -SELF-DKRLDLS-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1031 -~~~~-~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.... ....... .....+....+.+++.+|++.+|++||++++++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000 0000000 000112236788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=314.29 Aligned_cols=257 Identities=23% Similarity=0.376 Sum_probs=203.4
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
.+|+..+.||+|+||+||+|+.+ +.+.||+|.+.... .....+.+.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 47888999999999999999864 24678998875322 222356799999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCCC------CCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTC------LLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGD 949 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~------~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 949 (1109)
++||||+++|+|.+++....... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999997655221 4899999999999999999999 77999999999999999999999999
Q ss_pred ccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 950 FGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 950 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
||++...............++..|+|||.+.+..++.++||||+|+++|+|++ |..||..... ...+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~~~~~~~~ 236 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLNRLQAGKL 236 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHHHHHcCCc
Confidence 99987543222223344466788999999988889999999999999999999 8889864321 111221111111
Q ss_pred CCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1029 PTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
... . .......+.+++.+||+.+|++||++.|+++++.
T Consensus 237 ~~~--~----------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ELP--V----------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCC--C----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 0 0112236789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=311.07 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=190.4
Q ss_pred ceEecCCcceEEEEEecC---CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLAN---GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||.||+|.+.+ +..+|+|+++.... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 368999999999998643 45789998864432 23345788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC--CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC-
Q 001274 885 GSLGEQLHGNKQ--TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS- 961 (1109)
Q Consensus 885 gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 961 (1109)
|+|.++++.... ....++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999975432 223577788899999999999999 77999999999999999999999999999975432211
Q ss_pred CCccccccccceeccccccCC-------CCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTM-------KVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
.......++..|+|||++.+. .++.++||||||+++|||++ |+.||......... ........ ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~----~~~~~~~~--~~~ 230 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL----TYTVREQQ--LKL 230 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH----HHHhhccc--CCC
Confidence 112234577889999988642 35789999999999999997 99999754322111 11111110 000
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
..+.. .......+.+++.+|| .+|++|||++||+..|.
T Consensus 231 ~~~~~------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 01110 0111234678999999 58999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.97 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=192.9
Q ss_pred ceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEE-eCCceEEEEEec
Q 001274 808 AVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCY-HQDSNLLLYEYM 882 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 882 (1109)
+.||+|+||+||+|.+. ++..||+|++... ......+.+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999853 2457999987532 22234567889999999999999999999876 455678999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC-
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS- 961 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 961 (1109)
++|+|.+++...... .++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 80 KHGDLRNFIRSETHN--PTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999999765432 677888999999999999999 77999999999999999999999999999975532111
Q ss_pred --CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhC-CCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 962 --KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITG-KSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 962 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.......++..|+|||++.+..++.++|||||||++|||++| ..||.... ..+..........+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~~~~~~~~~~~~~~------- 223 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFDITVYLLQGRRLLQ------- 223 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHhcCCCCCC-------
Confidence 111233457789999999988999999999999999999995 55565322 2222222221111100
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.......+.+++.+||+.+|++||++.|+++.++.+.
T Consensus 224 ------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 ------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0011235779999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=315.85 Aligned_cols=260 Identities=28% Similarity=0.401 Sum_probs=201.5
Q ss_pred cCCCCCceEecCCcceEEEEEe-----cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--Cc
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 874 (1109)
.-|++.+.||+|+||.||+|+. .++..||+|.++... .....+.+.+|++++++++|||++++.+++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3568889999999999999974 357889999986442 233456789999999999999999999998875 56
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+++++|.+++..... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 7899999999999999976543 3899999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCC--CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCccc----------CC-cHHHHHH
Q 001274 955 LIDLPYSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLEL----------GG-DLVTWVR 1021 (1109)
Q Consensus 955 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~----------~~-~~~~~~~ 1021 (1109)
........ ......++..|+|||+..+..++.++|||||||++|||++++.|+..... +. ....++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 66422211 11234567789999999988899999999999999999998776432110 00 1111111
Q ss_pred HhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1022 RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
. ...... . .........+.+++.+||+.+|++||++.++++.++.+
T Consensus 238 ~-~~~~~~--------~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 V-LEEGKR--------L----PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred H-HHcCcc--------C----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1 111000 0 00111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.61 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=198.1
Q ss_pred ceEecCCcceEEEEEecC--C--cEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEecc
Q 001274 808 AVIGRGACGTVYKATLAN--G--EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYME 883 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 883 (1109)
++||+|++|.||+|++.+ + ..||+|.+...... ...+.+.+|++++++++|+||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999998643 3 36899998754332 456789999999999999999999999988 88899999999
Q ss_pred CCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC-
Q 001274 884 NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK- 962 (1109)
Q Consensus 884 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~- 962 (1109)
+++|.+++..... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9999999987552 24899999999999999999999 789999999999999999999999999999876432211
Q ss_pred -CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 963 -SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 963 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
......++..|+|||++.+..++.++||||+||++|||++ |+.||..... .+..+..........
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~~--------- 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILKKIDKEGERLE--------- 221 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhcCCcCC---------
Confidence 1123456788999999999999999999999999999999 9999975322 122221111110000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
........+.+++.+||+.+|++||+++++++.|.
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01112346789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=316.43 Aligned_cols=264 Identities=23% Similarity=0.373 Sum_probs=199.3
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|+..+.||+|+||.||+|++. +|+.||+|+++...........+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999875 689999999975543333446678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
++ ++|.+++..... .+++..+..++.||++|+.||| +.+++||||||+||+++.++.+||+|||.++......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 96 588888765433 3899999999999999999999 7799999999999999999999999999998654221
Q ss_pred CCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc-hh------
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS-EL------ 1033 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~------ 1033 (1109)
.......++..|+|||++.+.. ++.++||||+||++|||+||+.||..... ..+..+.......... ..
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC---HHHHHHHHHHHhCCCChHHhHHhhh
Confidence 2223446788999999987654 78999999999999999999998653221 1111111111000000 00
Q ss_pred ---------hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1034 ---------FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1034 ---------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
+...... ..........+.+++.+||+.||++|||+++++++-
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 231 LPDYKPYPMYPATTSL-VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred cccccccCCCCCcchh-hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 0000000 000111234577999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.46 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=196.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC---cchhHHHHHHHHHhccCCCCceeeEEEEEEeC--Cce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG---ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 875 (1109)
.+|+..+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999864 6899999988644322 12345688899999999999999999988753 567
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++++||+++++|.+++..... +++.....++.|++.||+||| +.+|+||||+|+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999976543 788999999999999999999 77999999999999999999999999999976
Q ss_pred ccCCC--CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 956 IDLPY--SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 956 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
..... ........++..|+|||++.+..++.++||||+||++|||++|+.||..... ...+........ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~~~~~~~--~~~ 229 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPT--NPQ 229 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHHHhcCCC--CCC
Confidence 53211 1112334578899999999998999999999999999999999999975421 111111111110 000
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
+ .......+..++ .||..+|++||+++||+++-
T Consensus 230 ~----------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp 262 (266)
T cd06651 230 L----------PSHISEHARDFL-GCIFVEARHRPSAEELLRHP 262 (266)
T ss_pred C----------chhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence 0 111123345566 68889999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=309.74 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=198.0
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
+++.+.....||+|+||.||+|++. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 4455666678999999999999855 67889999886432 23456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeecccccccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-EFQAHVGDFGLAKLID 957 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~ 957 (1109)
+||+++++|.+++.........++..+..++.||+.|++||| +.+|+||||||+||+++. ++.++|+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999976432211278888899999999999999 779999999999999976 6799999999987653
Q ss_pred CCCCCCccccccccceeccccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMK--VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.. ........++..|+|||++.+.. ++.++||||+|+++|+|++|+.||........ ..+ ........+ .
T Consensus 161 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~-~~~~~~~~~---~-- 232 (268)
T cd06624 161 GI-NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMF-KVGMFKIHP---E-- 232 (268)
T ss_pred cC-CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHh-hhhhhccCC---C--
Confidence 21 22223446889999999987644 78999999999999999999999875321111 111 110000000 0
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
........+.+++.+||+.+|++|||+.|++++
T Consensus 233 --------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 233 --------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011122457789999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.93 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=204.3
Q ss_pred CCCCCceEecCCcceEEEEEecC-CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
.|.++..||.|+||.||+|..++ +-..|.|++... ..+..++|+-|++|+..++||+||++++.|...+..+++.||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 46677789999999999998664 444567777543 244678899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
|.||-.+..+-.-+. .+++.++..+++|+++||.||| +.+|||||||+.|||++-+|.++++|||++..... ..
T Consensus 111 C~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~ 184 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TR 184 (1187)
T ss_pred cCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh-HH
Confidence 999999998876654 3999999999999999999999 77999999999999999999999999999875431 23
Q ss_pred CCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 962 KSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.....+.||+.|||||+.. ..+|++++||||||+++.||..+.+|-.... ....+-+......|. +.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln----pMRVllKiaKSePPT--Ll-- 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLKIAKSEPPT--LL-- 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc----hHHHHHHHhhcCCCc--cc--
Confidence 3446789999999999865 5689999999999999999999999965432 222222222222211 11
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.+......|.+|+.+|+..+|..||+++++++|-
T Consensus 257 -------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 257 -------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred -------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 2334456799999999999999999999998653
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.55 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=206.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|+.. +++.||+|++.... .....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46788899999999999999865 68899999886432 23345678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++...+. +++..+..++.+++.|+.|||+ ..+++||||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKKGGP---IPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 9999999999876543 8999999999999999999993 248999999999999999999999999998754311
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC-------cHHHHHHHhhhccCCCchh
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG-------DLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 1033 (1109)
......++..|+|||++.+..++.++|||||||++|+|++|+.||....... ...++......+..+.
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 232 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR--- 232 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC---
Confidence 1223568999999999988899999999999999999999999998543211 1122222222211100
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.. ..+....+.+++.+||+.||++||++.|++++.....
T Consensus 233 ----~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 233 ----LP-----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ----CC-----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00 0112345789999999999999999999999865544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=318.64 Aligned_cols=267 Identities=24% Similarity=0.381 Sum_probs=202.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|+..++||+|+||.||+|+++ +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888899999999999999976 58999999986544333345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|++++++.++...... +++..+..++.||+.|++||| +.+++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887765432 899999999999999999999 7799999999999999999999999999998654322
Q ss_pred CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCC-------Cch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP-------TSE 1032 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~ 1032 (1109)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||............. .......+ ...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII-KCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-HHhCCCchhhHHHhccch
Confidence 22334567899999999875 447889999999999999999999987432111111111 00000000 000
Q ss_pred hhhhhcchh-------hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1033 LFDKRLDLS-------AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1033 ~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
......... ..........+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000 00011223568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=315.74 Aligned_cols=263 Identities=28% Similarity=0.388 Sum_probs=202.8
Q ss_pred CCHHHHHHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEE
Q 001274 792 FKYHNLLEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFC 869 (1109)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 869 (1109)
+.+.++..+.++|.+.+.||+|+||.||+|..+ +++.||+|++... ......+.+|+.+++++ +|||++++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 344455566789999999999999999999864 6889999988632 22345678899999998 899999999998
Q ss_pred EeCC-----ceEEEEEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 001274 870 YHQD-----SNLLLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF 943 (1109)
Q Consensus 870 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 943 (1109)
...+ ..++||||+++++|.++++... ....+++..+..++.|++.|+.||| +.+++||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCC
Confidence 7543 5789999999999999886422 1224899999999999999999999 77999999999999999999
Q ss_pred ceEEeeccccccccCCCCCCccccccccceeccccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHH
Q 001274 944 QAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM-----KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVT 1018 (1109)
Q Consensus 944 ~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~ 1018 (1109)
.+||+|||.++...... .......++..|+|||++... .++.++||||+||++|||++|+.||...........
T Consensus 166 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~ 244 (291)
T cd06639 166 GVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244 (291)
T ss_pred CEEEeecccchhccccc-ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence 99999999988654221 112334678899999987643 368899999999999999999999975432111111
Q ss_pred HHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1019 WVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
...... ....+ ..+....+.+++.+||+.+|++||++.|++++
T Consensus 245 ----~~~~~~--~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 ----IPRNPP--PTLLH---------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ----HhcCCC--CCCCc---------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111 11100 11122357899999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=316.07 Aligned_cols=259 Identities=24% Similarity=0.414 Sum_probs=201.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCc----EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGE----VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
.+|+..+.||+|+||.||+|.+. +++ .||+|.+.... ......++.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 56788899999999999999864 444 47888876332 223345688999999999999999999998754 467
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+++||+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999999976543 3889999999999999999999 779999999999999999999999999999865
Q ss_pred cCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 957 DLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 957 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
...... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ......++.... ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~--~~~~~--- 233 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TREIPDLLEKGE--RLPQP--- 233 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHCCC--CCCCC---
Confidence 422211 1223345778999999999999999999999999999998 999987532 111222222110 01000
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
......+..++.+||..+|++||+++++++.+..+....
T Consensus 234 -----------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 234 -----------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 011235678999999999999999999999999875544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=315.17 Aligned_cols=255 Identities=26% Similarity=0.377 Sum_probs=202.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|++. +++.||+|.+... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 46888889999999999999865 6889999998643 22345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... .+++..+..++.|++.|+.||| +.+|+|+||||+||+++.++.++|+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (280)
T cd06611 83 FCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST- 156 (280)
T ss_pred ccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc-
Confidence 9999999999876543 3899999999999999999999 779999999999999999999999999998755321
Q ss_pred CCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
........+++.|+|||++. +..++.++||||+|+++|||++|+.||...... +.+........+. +.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~---~~ 229 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLLKILKSEPPT---LD 229 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHHHHhcCCCCC---cC
Confidence 22223456889999999874 345788999999999999999999999754321 1111111111100 00
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
........+.+++.+||+.+|++||++.+++++-+-
T Consensus 230 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 230 --------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred --------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 011112357789999999999999999999988554
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=311.78 Aligned_cols=254 Identities=29% Similarity=0.377 Sum_probs=205.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|+..+.||.|+||.||+|++. +++.||+|++.... .......+.+|+++++.++|+||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 36788899999999999999865 68999999987443 23345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++... .+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++++|||.++......
T Consensus 80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 80 YCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999999999764 3899999999999999999999 7899999999999999999999999999998765322
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||++.+..++.++||||||+++|||+||+.||...... ...........+ ....
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~--~~~~----- 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVLFLIPKNNPP--SLEG----- 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHHHHhhhcCCC--CCcc-----
Confidence 2233456888999999999988999999999999999999999999754311 111111111110 0000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
......+.+++.+||..+|++||++++++++-+-.
T Consensus 221 -----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~ 255 (274)
T cd06609 221 -----NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIK 255 (274)
T ss_pred -----cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhc
Confidence 00223577899999999999999999999875544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=309.50 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=204.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
..|+..+.||+|+||.||+|.+. +++.||+|+++... .......+.+|++++++++|+||+++++++.+....++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 35777789999999999999865 58899999987432 23345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++... .+++..+..++.|++.|++|+| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 154 (277)
T cd06640 83 YLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT- 154 (277)
T ss_pred cCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCC-
Confidence 99999999998753 2788899999999999999999 789999999999999999999999999999765422
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
........++..|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~------------ 218 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----RVLFLIPKNNP------------ 218 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----hHhhhhhcCCC------------
Confidence 11223346788999999999889999999999999999999999998753311 11111000000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
..........+.+++.+||+.+|++||++.+++++-+..
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06640 219 -PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV 257 (277)
T ss_pred -CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence 011223345678999999999999999999999886543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.99 Aligned_cols=250 Identities=29% Similarity=0.394 Sum_probs=201.4
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC---cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG---ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
+|+..+.||+|+||+||+|... +++.||+|.+...... .+..+.+.+|+++++.++|+||+++++++..++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999876 7899999998754321 23456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++++|.+++..... +++..+..++.|++.|++||| +.+++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999976543 789999999999999999999 77999999999999999999999999999886542
Q ss_pred CCCCCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
.. ......++..|+|||.+.... ++.++|+||+|+++|+|++|+.||..... ........... .... +
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~-~~~~-~--- 223 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIGRSK-ELPP-I--- 223 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHHhcc-cCCC-c---
Confidence 22 234456888999999988776 89999999999999999999999975431 11111111100 0000 0
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+||+.+|.+||++.+++.+
T Consensus 224 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 -------PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11112356789999999999999999999865
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.04 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=203.3
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|+..+.||+|+||.||+|... +++.||+|.+..........+.+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 688999999976544445567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEeeccccccccCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~~~~~ 960 (1109)
+++++|.+++..... ..+++..+..++.++++|++||| +.+++|+||+|+||+++.+ +.+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~- 155 (256)
T cd08220 81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK- 155 (256)
T ss_pred CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-
Confidence 999999999976432 23789999999999999999999 7799999999999999855 46899999999866422
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||++.+..++.++||||+|+++|+|++|+.||.... .............. ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~----~~~~~~~~~~~~~~--~~------- 221 (256)
T cd08220 156 -SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN----LPALVLKIMSGTFA--PI------- 221 (256)
T ss_pred -ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc----hHHHHHHHHhcCCC--CC-------
Confidence 22234568889999999998889999999999999999999999997533 22222222111110 00
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+||+.+|++|||+.|++++
T Consensus 222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00122357799999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.71 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=197.9
Q ss_pred ceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCH
Q 001274 808 AVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSL 887 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 887 (1109)
++||+|+||.||+|.+.+++.||+|++...... ...+.+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999999877999999988754332 3456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc-cc
Q 001274 888 GEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM-SA 966 (1109)
Q Consensus 888 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~-~~ 966 (1109)
.+++..... .+++..+..++.+++.|++||| +.+++||||||+||+++.++.++|+|||.++.......... ..
T Consensus 80 ~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 80 LTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999976543 3789999999999999999999 77999999999999999999999999999976542111111 12
Q ss_pred cccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhccc
Q 001274 967 IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRT 1045 (1109)
Q Consensus 967 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
...+..|+|||++.++.++.++||||+||++|||+| |..||..... ......+.. ..... ..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-~~~~~~~~~----~~~~~------------~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTRERIES----GYRMP------------AP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-HHHHHHHhc----CCCCC------------CC
Confidence 234567999999998899999999999999999999 8888865431 111111111 10000 01
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1046 VEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1046 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
......+.+++.+||..+|.+||++.|+++.|.
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 112246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=311.28 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=187.8
Q ss_pred eEecCCcceEEEEEecC---CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 809 VIGRGACGTVYKATLAN---GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 809 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
+||+|+||+||+|...+ ...+|+|.+... ........+.+|+++++.++|+||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 346788876532 22334467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC-CC
Q 001274 886 SLGEQLHGNKQT--CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY-SK 962 (1109)
Q Consensus 886 sL~~~l~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~ 962 (1109)
+|.+++...... ...++.....++.||+.|++||| +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999765431 23567788899999999999999 7899999999999999999999999999987543211 11
Q ss_pred CccccccccceeccccccC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 963 SMSAIAGSYGYIAPEYAYT-------MKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
......+++.|+|||++.. ..++.++||||+||++|||++ |..||....... ........... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~~~~~--~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----VLKQVVREQDI--KLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHHHhhccCc--cCC
Confidence 1233456778999998643 456889999999999999999 788887543211 11211111110 000
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.+.. .......+..++..|| .||++|||+++|++.+
T Consensus 232 ~~~~------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 KPQL------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCcc------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0000 1112234667888898 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=310.92 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=203.9
Q ss_pred HhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 878 (1109)
....|++.++||.||.+.||++...+.+.||+|++.....+......|.+|+..+.++ .|.+||++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3467889999999999999999988889999999987766667778899999999999 599999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||- ..+|.++|.+.... ++.-.++.+.+|++.|+.++| ..||||.||||.|+++-. |.+||+|||.|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9987 46999999876653 332277889999999999999 789999999999999875 5899999999987764
Q ss_pred CCCC-CccccccccceeccccccCCC-----------CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 959 PYSK-SMSAIAGSYGYIAPEYAYTMK-----------VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 959 ~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
+... .....+||+.||+||.+.... .++++||||+||++|+|+.|+.||... ...+.+...-
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~n~~aKl~aI 585 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------INQIAKLHAI 585 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------HHHHHHHHhh
Confidence 3322 225678999999999886432 567899999999999999999999742 2222222111
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
..|-.++-.+... ...++.++|..|+.+||.+||+..+++++-
T Consensus 586 ~~P~~~Iefp~~~--------~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 586 TDPNHEIEFPDIP--------ENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred cCCCccccccCCC--------CchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 1121111111111 112378999999999999999999999764
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=314.16 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=200.3
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|+..+.||+|+||.||+|+.+ +++.||||+++...........+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999865 689999999875544444456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+. ++|.+++..... ..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+|++|||.++......
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 689888865432 24899999999999999999999 7799999999999999999999999999987654221
Q ss_pred CCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh-----
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD----- 1035 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1035 (1109)
.......++..|+|||++.+.. ++.++||||||+++|||+||+.||.............+.. ..+....+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL---GTPDEVVWPGVTSL 231 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh---CCCChhhhhhhhHH
Confidence 1223335678899999887654 6889999999999999999999997543222222211110 000000000
Q ss_pred --------hhcchh-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1036 --------KRLDLS-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1036 --------~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
+..... ..........+.+++.+||+.||++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000 00001112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=325.52 Aligned_cols=245 Identities=23% Similarity=0.241 Sum_probs=190.0
Q ss_pred EecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC---CCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 810 IGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI---RHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 810 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
||+|+||+||+|+.. +++.||||++..... .......+..|..++... +||+|+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 689999999864321 112233455677776655 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|.+++..... +++..+..++.||++||+||| +.+|+||||||+||+++.++.++|+|||+++.... .....
T Consensus 81 g~L~~~l~~~~~---~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~-~~~~~ 153 (330)
T cd05586 81 GELFWHLQKEGR---FSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT-DNKTT 153 (330)
T ss_pred ChHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC-CCCCc
Confidence 999999876543 899999999999999999999 77999999999999999999999999999875431 12223
Q ss_pred cccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhc
Q 001274 965 SAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAK 1043 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
....||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+............. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~---~-------- 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED----TQQMYRNIAFGKVRFP---K-------- 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC----HHHHHHHHHcCCCCCC---C--------
Confidence 456799999999998765 48999999999999999999999997532 2222222221111110 0
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCC----CHHHHHHHHH
Q 001274 1044 RTVEEMTLFLKIALFCSSTSPLNRP----TMREVIAMMI 1078 (1109)
Q Consensus 1044 ~~~~~~~~~~~li~~cl~~dP~~RP----t~~evl~~L~ 1078 (1109)
......+.+++.+||+.||.+|| ++.+++++-+
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 00123466899999999999998 6778877643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=310.38 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=204.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCc----EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGE----VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.+.||+|+||+||+|.++ +++ .||+|...... .......+.+|+.++++++|+||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 57888899999999999999864 333 58898876432 23345678899999999999999999999887 7889
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++|+|.+++...... +++..+..++.||+.|++||| +.+++||||||+||+++.++.+||+|||.++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999999875443 899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCCC-ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 957 DLPYSKS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 957 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
....... .....++..|+|||.+....++.++||||||+++||+++ |+.||.... ..++............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~~~~~~~~--- 232 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP----AVEIPDLLEKGERLPQ--- 232 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC----HHHHHHHHhCCCCCCC---
Confidence 5222111 122234678999999988899999999999999999999 999997543 1222221111110000
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.......+.+++.+||..+|.+||++.++++.+.++....
T Consensus 233 ----------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 233 ----------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 0011134678999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=305.60 Aligned_cols=249 Identities=28% Similarity=0.443 Sum_probs=201.5
Q ss_pred ceEecCCcceEEEEEecC----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEecc
Q 001274 808 AVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYME 883 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 883 (1109)
+.||+|+||.||+|.... +..||+|.++...... ..+.+.+|+++++.++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 468999999999998653 7889999997543332 46788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 884 NGSLGEQLHGNKQ------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 884 ~gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
+++|.+++..... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.++...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999987521 134899999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 958 LPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 958 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.... .......++..|+|||.+....++.++||||+|+++|||++ |..||.... ..+.......... .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~~~~~~-~----- 226 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----NEEVLEYLRKGYR-L----- 226 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHHHcCCC-C-----
Confidence 3221 22234567889999999998899999999999999999999 699997642 1222222111110 0
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.........+.+++.+||+.+|++||++.|++++|
T Consensus 227 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 227 -------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred -------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00111134688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=314.56 Aligned_cols=196 Identities=28% Similarity=0.467 Sum_probs=159.7
Q ss_pred CceEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--CCceEEEEEe
Q 001274 807 GAVIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--QDSNLLLYEY 881 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 881 (1109)
+.+||+|+||+||+|+.+ ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 368999999999999864 35789999886332 23467899999999999999999998854 4567899999
Q ss_pred ccCCCHHHHhccCC------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee----CCCCceEEeecc
Q 001274 882 MENGSLGEQLHGNK------QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL----DEEFQAHVGDFG 951 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG 951 (1109)
++ ++|.+++.... ....+++..+..++.||+.||.||| +.+|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 96 47877764321 1224888999999999999999999 7799999999999999 566799999999
Q ss_pred ccccccCCCC--CCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCc
Q 001274 952 LAKLIDLPYS--KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSL 1010 (1109)
Q Consensus 952 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~ 1010 (1109)
+++....... .......+|+.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9987643221 122345789999999998764 5899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=310.23 Aligned_cols=266 Identities=21% Similarity=0.325 Sum_probs=198.6
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
++++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+++++.++|+||+++++++..++..++|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3578999999999999999999864 688999999864432 22334678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+. +++.+++..... .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred Eeccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 99995 678777755433 2788889999999999999999 77999999999999999999999999999975432
Q ss_pred CCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCchhh--
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSELF-- 1034 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~-- 1034 (1109)
.. .......++..|+|||++.+. .++.++||||+||++|||++|+.||++.... .+.+........ +....+
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV---FEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH---HHHHHHHHHHcCCCChhhhhh
Confidence 21 112334578899999998764 5788999999999999999999999754321 111111111000 000000
Q ss_pred --------hhhcchh-------hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1035 --------DKRLDLS-------AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1035 --------~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
....... ..........+.+++.+|+..||++|||+.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000 00001113467799999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=307.39 Aligned_cols=253 Identities=27% Similarity=0.394 Sum_probs=197.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC---cchhHHHHHHHHHhccCCCCceeeEEEEEEeC--Cce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG---ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 875 (1109)
.+|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999865 5899999988643222 12345788899999999999999999988764 456
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++||||+++++|.+++..... +++....+++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 799999999999999876543 788889999999999999999 77999999999999999999999999999986
Q ss_pred ccCCC--CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 956 IDLPY--SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 956 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||..... ... +....... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~-~~~~~~~~--~~~~ 229 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAA-IFKIATQP--TNPV 229 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHH-HHHHhcCC--CCCC
Confidence 53211 1122334688899999999988899999999999999999999999975321 111 11111111 0000
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
........+..++.+|+. +|++||+++|++++-
T Consensus 230 ----------~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 230 ----------LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred ----------CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 112223457788899984 899999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=307.74 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=204.5
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--CCceEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--QDSNLLLY 879 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 879 (1109)
+|++.+.||.|+||.||+|... +++.||+|++..........+.+..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999854 68899999987655445556778899999999999999999998764 34568999
Q ss_pred EeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDC--RPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
||+++++|.+++.... ....+++..+..++.|+++|++|||..+ +.+++|+||+|+||+++.++.+|++|||.+...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999986532 1234899999999999999999999543 568999999999999999999999999999876
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
..... ......++..|+|||++.+..++.++||||||+++|+|++|+.||.... .....+.......+ .
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~--~---- 229 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----QLQLASKIKEGKFR--R---- 229 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HHHHHHHHhcCCCC--C----
Confidence 53221 1234568899999999999889999999999999999999999997543 22222221111110 0
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
........+.+++.+|++.+|++||++.+|+++
T Consensus 230 -------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 -------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011223467899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=342.40 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=212.0
Q ss_pred cCCCCCceEecCCcceEEEEEec----C----CcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA----N----GEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
.+..+.+.+|+|+||.||+|... . ...||||..+..... .+.+.+..|+++|+.+ +|+||+.++|+|...
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 44556679999999999999732 1 457999999855444 6678899999999999 699999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCC-----CC--------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNK-----QT--------CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 939 (1109)
+..++|+||++.|+|.++++..+ .. ..++..+...++.|||.||+||+ +.++|||||.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEe
Confidence 99999999999999999998776 00 13888999999999999999999 7899999999999999
Q ss_pred CCCCceEEeeccccccccCCCCCCccccc--cccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYSKSMSAIA--GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDL 1016 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~ 1016 (1109)
..+..+||+|||+|+.............. -+..|||||.+....|+.|+|||||||++|||+| |..||.+.....++
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 99999999999999965433332222222 4567999999999999999999999999999999 99999874433344
Q ss_pred HHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1017 VTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
.++++...+... +..+..++..+|..||+.+|++||++.++++.+.....
T Consensus 532 ~~~l~~G~r~~~----------------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 532 LEFLKEGNRMEQ----------------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHhcCCCCCC----------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 444443322221 12223467899999999999999999999999998543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=311.63 Aligned_cols=261 Identities=28% Similarity=0.388 Sum_probs=204.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--CCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--QDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 874 (1109)
++|+..+.||+|+||.||+|++. +++.||||+++..... ...+.+.+|+++++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46778899999999999999853 3688999999744332 346789999999999999999999999887 557
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+++++|.+++..... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 8999999999999999987654 3899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCC--CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC----------cHHHHHHH
Q 001274 955 LIDLPYSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG----------DLVTWVRR 1022 (1109)
Q Consensus 955 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~----------~~~~~~~~ 1022 (1109)
........ ......++..|+|||+..+..++.++||||||+++|||++|+.|+....... .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76522111 1112345567999999998899999999999999999999999986532111 00111111
Q ss_pred hhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
....... ..........+.+++.+||+.+|++||+|.||+++|..+
T Consensus 238 ~~~~~~~------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGER------------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCc------------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111100 000112235688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=312.89 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=199.7
Q ss_pred HHHHHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEe-
Q 001274 795 HNLLEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYH- 871 (1109)
Q Consensus 795 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 871 (1109)
.++....+.|++.+.||+|+||.||+|++. +++.||+|++... ......+..|+.+++++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 344455678999999999999999999864 6889999988643 22345688899999998 79999999999853
Q ss_pred -----CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 001274 872 -----QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH 946 (1109)
Q Consensus 872 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 946 (1109)
.+..+++|||+++|+|.+++...... .+++..+..++.||+.|++||| +.+++||||+|+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 45679999999999999998764422 3788888999999999999999 77999999999999999999999
Q ss_pred EeeccccccccCCCCCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHH
Q 001274 947 VGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVR 1021 (1109)
Q Consensus 947 l~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~ 1021 (1109)
|+|||++....... .......++..|+|||++. +..++.++||||+||++|||++|+.||..........
T Consensus 162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---- 236 (282)
T cd06636 162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---- 236 (282)
T ss_pred EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----
Confidence 99999987654221 1223456889999999876 3468889999999999999999999997533111111
Q ss_pred HhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1022 RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.. .... ..... .......+.+++.+||+.||++||++.|++++
T Consensus 237 ~~-~~~~-~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 LI-PRNP-PPKLK----------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hH-hhCC-CCCCc----------ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 0000 00000 11122468899999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=309.82 Aligned_cols=256 Identities=30% Similarity=0.465 Sum_probs=199.5
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc--------chhHHHHHHHHHhccCCCCceeeEEEEEEeCC
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA--------TADNSFLAEISTLGKIRHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 873 (1109)
+|...+.||+|+||.||+|... +++.||+|.++...... ...+.+.+|++++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778889999999999999854 68999999886432111 11346788999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA 953 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 953 (1109)
..++||||+++++|.++++... .+++..+..++.||+.|+.||| +.+++||||+|+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999998764 3889999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCCC-ccccccccceeccccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 954 KLIDLPYSKS-MSAIAGSYGYIAPEYAYTMK--VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 954 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
+......... .....++..|+|||++.... ++.++||||+|+++||+++|+.||..... . ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~-~~~~~~~~~~~-- 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---I-AAMFKLGNKRS-- 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---H-HHHHHhhcccc--
Confidence 8654222111 23346788999999987654 88999999999999999999999864321 1 11111111000
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
...+... ........+.+++.+||..+|++||++++++++
T Consensus 230 ~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPPD------VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCcc------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000000 111223467889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=308.75 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=200.9
Q ss_pred CCCCCceEecCCcceEEEEEecC--CcEEEEEEeeccCC--------CcchhHHHHHHHHHhcc-CCCCceeeEEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLAN--GEVIAVKKIKLRGE--------GATADNSFLAEISTLGK-IRHRNIVKLYGFCYH 871 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 871 (1109)
+|++.+.||+|+||.||+|+++. ++.+|+|.+..... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999764 78899998864321 12233557788888865 799999999999999
Q ss_pred CCceEEEEEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 001274 872 QDSNLLLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDF 950 (1109)
Q Consensus 872 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 950 (1109)
++..++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+ ..+++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999875421 12248899999999999999999993 257999999999999999999999999
Q ss_pred cccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 951 GLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 951 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
|.+....... ......++..|+|||++.+..++.++||||||+++|||++|+.||.... ...............
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~ 232 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----MLSLATKIVEAVYEP 232 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC----HHHHHHHHhhccCCc
Confidence 9998654322 3345568899999999999889999999999999999999999986432 222222211111110
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.. .......+.+++.+||+.||++||++.|+.++++
T Consensus 233 --~~----------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 --LP----------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --CC----------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 0011235778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=312.46 Aligned_cols=268 Identities=25% Similarity=0.338 Sum_probs=202.4
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC---cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG---ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
+|+..+.||+|+||.||+|... +++.||||++...... ......+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999865 6899999999754332 22345677899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+ +|+|.+++..... .+++..+..++.||++||+||| +.+++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSI--VLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 8999999976542 3899999999999999999999 78999999999999999999999999999987653
Q ss_pred CCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh-
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK- 1036 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1036 (1109)
.. .......+++.|+|||++.+ ..++.++||||+||++|||++|..||.+........... ..... +....+..
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~ 230 (298)
T cd07841 155 PN-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF-EALGT--PTEENWPGV 230 (298)
T ss_pred CC-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHH-HHcCC--Cchhhhhhc
Confidence 21 22233456788999998865 457899999999999999999987776533211111111 11000 00000000
Q ss_pred ---------hc--chh-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1037 ---------RL--DLS-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1037 ---------~~--~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.. ... ..........+.+++.+||+.+|++|||++|++++-+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~ 286 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence 00 000 000112245688999999999999999999999874433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=313.58 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=200.6
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
.|+..+.||+|+||.||+|.+. +++.||+|.+..... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3555678999999999999865 578899998864322 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++... .+++..+..++.|+++|+.||| +.+++|+||+|+||+++.++.++++|||++...... .
T Consensus 84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-~ 155 (277)
T cd06642 84 LGGGSALDLLKPG----PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-Q 155 (277)
T ss_pred cCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCc-c
Confidence 9999999998653 2789999999999999999999 789999999999999999999999999999765421 1
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......++..|+|||++.+..++.++|||||||++|||++|+.||....... .... .....+. .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~-~~~~~~~------~---- 220 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----VLFL-IPKNSPP------T---- 220 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----HHhh-hhcCCCC------C----
Confidence 12233467889999999999899999999999999999999999987433111 1111 1111000 0
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
........+.+++.+||+.+|++||++.+++++-+-
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06642 221 --LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256 (277)
T ss_pred --CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence 011223457799999999999999999999987653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=305.58 Aligned_cols=237 Identities=24% Similarity=0.418 Sum_probs=188.5
Q ss_pred ceEecCCcceEEEEEecCCc-----------EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 808 AVIGRGACGTVYKATLANGE-----------VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
+.||+|+||.||+|.+.+.. .|++|.+.... .....+.+|+.++++++||||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 36899999999999876432 47777765332 125788999999999999999999999988 7789
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-------ceEEee
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-------QAHVGD 949 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~D 949 (1109)
+||||+++|+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+|++|
T Consensus 77 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999999987553 3899999999999999999999 78999999999999999888 799999
Q ss_pred ccccccccCCCCCCccccccccceeccccccCC--CCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhc
Q 001274 950 FGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM--KVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 950 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
||++..... .....++..|+|||++.+. .++.++||||+|+++|||++ |..||..... .....+.. ...
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~~~~~~~--~~~ 223 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SEKERFYQ--DQH 223 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hhHHHHHh--cCC
Confidence 999986542 2233567789999998876 78999999999999999999 5777765431 11111111 000
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
..+. .....+.+++.+||..+|++||++.++++.|
T Consensus 224 ~~~~----------------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 224 RLPM----------------PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCC----------------CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 0014678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=310.20 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=198.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|+.+ +++.||+|.+...... .....+.+|++++++++|+||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999875 6899999998754322 233457789999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++ +|.+++..... .+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||.++....+.
T Consensus 84 ~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9974 99998876543 3889999999999999999999 7899999999999999999999999999987543211
Q ss_pred CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCchhhh---
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSELFD--- 1035 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--- 1035 (1109)
.......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... .+.+........ +..+.+.
T Consensus 158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV---EDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHHHHhcCCCChhhhhhhh
Confidence 11122346788999999876 45899999999999999999999999754311 111111111100 0000000
Q ss_pred ---------------hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1036 ---------------KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1036 ---------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
....... ........+.+++.+|++.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000 001112456799999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=316.46 Aligned_cols=258 Identities=22% Similarity=0.271 Sum_probs=204.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc-chhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA-TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|+..+.||+|+||+||+|+.. +++.||+|.+....... ...+.+.+|++++++++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999875 58999999997543321 24567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++..... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999999875432 24899999999999999999999 789999999999999999999999999998754321
Q ss_pred CCC----------------------------CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 001274 960 YSK----------------------------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011 (1109)
Q Consensus 960 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~ 1011 (1109)
... ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 0112467889999999999899999999999999999999999997543
Q ss_pred cCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCC----HHHHHHHHHH
Q 001274 1012 LGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT----MREVIAMMID 1079 (1109)
Q Consensus 1012 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt----~~evl~~L~~ 1079 (1109)
..... ............ .......+.+++.+||..+|++||+ ++|++++-+.
T Consensus 237 ~~~~~----~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 237 RDETF----SNILKKEVTFPG------------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred hHHHH----HHHhcCCccCCC------------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 22111 111111111000 1112346889999999999999999 7777776443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=347.26 Aligned_cols=257 Identities=31% Similarity=0.422 Sum_probs=209.7
Q ss_pred hcCCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
+-+|+...+||.|.||.||.|. ..+|+..|||.++.........+...+|+.++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4488889999999999999998 557999999999877665666778889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
|||++|+|.+.+...+. .++.....+..|++.|++||| +.|||||||||.||+++.+|.+|.+|||.|+.....
T Consensus 1314 EyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999976543 566677788999999999999 889999999999999999999999999999987644
Q ss_pred CC---CCccccccccceeccccccCCC---CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 960 YS---KSMSAIAGSYGYIAPEYAYTMK---VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 960 ~~---~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
.. ...+...||+.|||||++.+.. ...++||||+|||+.||+||+.||...+.+=.+...+.. +..|..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~---gh~Pq~-- 1462 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA---GHKPQI-- 1462 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc---cCCCCC--
Confidence 21 2225678999999999998654 567899999999999999999999865432222222222 222111
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
+.....+..+|+..|+..||++|.++.|++++=..
T Consensus 1463 -----------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1463 -----------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred -----------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 11123456789999999999999999988877543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=307.67 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=186.2
Q ss_pred eEecCCcceEEEEEecCCc---EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 809 VIGRGACGTVYKATLANGE---VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 809 ~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
+||+|+||+||+|+..++. .+++|.++... .....+.+.+|+.+++.++||||+++++++......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5899999999999754333 45566654322 2234578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC-CCCC
Q 001274 886 SLGEQLHGNKQ-TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP-YSKS 963 (1109)
Q Consensus 886 sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~ 963 (1109)
+|.+++..... ....++..+..++.||+.||+||| +.+++||||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 223667778899999999999999 779999999999999999999999999998643211 1111
Q ss_pred ccccccccceeccccccC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 964 MSAIAGSYGYIAPEYAYT-------MKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.....++..|+|||+... ..++.++|||||||++|||++ |..||..... .+.......+.. ....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~~~~~--~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD----REVLNHVIKDQQ--VKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhhcc--cccCC
Confidence 234567889999998753 245789999999999999997 5668764332 222222111111 11111
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
+... ......+.+++.+|| .+|++||++++|++.|
T Consensus 232 ~~~~------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 232 PQLE------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CccC------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1111 011235677899999 6799999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.26 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=214.6
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.+.|.+.+.||+|.|++|..|++. ++..||||.+....-+......+.+|+++|+.++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467889999999999999999865 6999999999877666666666899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+.+|.+.+|+.+++. +.+..+..++.|+..|++|+| ++.|||||||++||+++.+..+||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec--
Confidence 99999999999998876 566888999999999999999 8899999999999999999999999999999886
Q ss_pred CCCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.....++.+|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||++.. +.+.-...+.+..
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~----lk~Lr~rvl~gk~---------- 272 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN----LKELRPRVLRGKY---------- 272 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----cccccchheeeee----------
Confidence 4555678899999999999999887 579999999999999999999998532 2221111111111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
....... ..+.+++.+++-.+|.+|++.+++.++-|.-.
T Consensus 273 rIp~~ms----~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 273 RIPFYMS----CDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred cccceee----chhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 1111111 23558999999999999999999998876543
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=309.04 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=197.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHH-hccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEIST-LGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||.||+|++. +|+.||+|+++..... .....+..|+.+ ++..+||||+++++++..++..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 36888899999999999999875 6999999998754322 233456666665 56678999999999999999999999
Q ss_pred EeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 880 EYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRP-HIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||++ |+|.+++.... ....+++..+..++.||+.|++||| +. +++||||||+||+++.++.+||+|||.++...
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9996 68888875422 2234899999999999999999999 55 89999999999999999999999999998654
Q ss_pred CCCCCCccccccccceeccccccC----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYT----MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
.. .......++..|+|||++.+ ..++.++||||+||++|||++|+.||..... .. +.+........+. .
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~-~~~~~~~~~~~~~--~ 228 (283)
T cd06617 156 DS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PF-QQLKQVVEEPSPQ--L 228 (283)
T ss_pred cc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CH-HHHHHHHhcCCCC--C
Confidence 21 11223467889999998865 4578899999999999999999999974321 11 1111111111110 0
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
. .......+.+++.+||..+|++||++.+++++-+....
T Consensus 229 ~----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 229 P----------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred C----------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0 00112457899999999999999999999987655543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=308.42 Aligned_cols=238 Identities=20% Similarity=0.324 Sum_probs=185.3
Q ss_pred eEecCCcceEEEEEecC-------------------------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCcee
Q 001274 809 VIGRGACGTVYKATLAN-------------------------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIV 863 (1109)
Q Consensus 809 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 863 (1109)
+||+|+||.||+|.... ...||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 68999999999997421 1358888885332 22345788999999999999999
Q ss_pred eEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 001274 864 KLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF 943 (1109)
Q Consensus 864 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 943 (1109)
++++++......++||||+++|+|..++..... .+++..+..++.||++||+||| +++|+||||||+||+++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccC
Confidence 999999999999999999999999999876443 3889999999999999999999 78999999999999997643
Q ss_pred -------ceEEeeccccccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHH-hCCCCCCCcccCC
Q 001274 944 -------QAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELI-TGKSPVQSLELGG 1014 (1109)
Q Consensus 944 -------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~ell-tg~~pf~~~~~~~ 1014 (1109)
.++++|||.+..... .....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~-----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALS-----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCcccccccc-----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 489999998864321 122356788999998875 56899999999999999995 6999987543211
Q ss_pred cHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1015 DLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
....... .....+ .....+.+++.+||+.+|++||+|.++++.|
T Consensus 230 -~~~~~~~----~~~~~~--------------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 -KERFYEK----KHRLPE--------------PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHHHHHh----ccCCCC--------------CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1111111 110000 0112477899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=319.55 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=202.4
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD----- 873 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 873 (1109)
..++|+..+.||+|+||.||+|+.. +++.||+|++..........+.+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999865 7899999998644333444567788999999999999999999886543
Q ss_pred -ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 874 -SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 874 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
..++||||+. ++|.+++... +++..+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 4689999996 5888877542 788899999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc-CCCc
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-VPTS 1031 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 1031 (1109)
++..... .......++..|+|||++.+..++.++||||+||++|+|++|+.||........ ........ .+..
T Consensus 165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~ 238 (353)
T cd07850 165 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ----WNKIIEQLGTPSD 238 (353)
T ss_pred ceeCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHhcCCCCH
Confidence 9865422 223345678899999999999999999999999999999999999975431111 11111000 0000
Q ss_pred h--------------------------hhhhhcchh--hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1032 E--------------------------LFDKRLDLS--AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1032 ~--------------------------~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
+ .+....... ..........+.+++.+|++.||++|||+.|++++-+-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 0 000000000 000112345678999999999999999999999886544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=307.59 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=206.9
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|+..+.||+|+||.||+|.++ +++.||+|.+..... ....+.+.+|++++++++||||+++++++...+..++|+||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5777889999999999999876 689999999875432 24556789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR-PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
+++++|.+++..... .+++..+.+++.|++.|++|+| + .+++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQG--RIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999976532 3889999999999999999999 6 799999999999999999999999999987654221
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcc-cCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE-LGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
. ....++..|+|||++.+..++.++||||+|+++|+|++|+.||.... ......+.++.......+.. .
T Consensus 156 ~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~----- 225 (265)
T cd06605 156 A---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL--P----- 225 (265)
T ss_pred h---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC--C-----
Confidence 1 12568889999999999999999999999999999999999997542 11223333333222211110 0
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......+.+++.+||..+|++|||+.+++.+-+.
T Consensus 226 -----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 226 -----SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred -----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 00023457899999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=305.63 Aligned_cols=255 Identities=23% Similarity=0.400 Sum_probs=201.8
Q ss_pred CCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCC----cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEG----ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
+|+..+.||+|+||.||+|+. .+++.||+|++...... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 47899999998743321 1234678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeeccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAKLI 956 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~ 956 (1109)
||||+++++|.+++..... +++..+..++.|++.|+.||| +.+++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999976543 889999999999999999999 78999999999999998776 5999999999766
Q ss_pred cCCCCC---CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 957 DLPYSK---SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 957 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
...... ......++..|+|||++.+..++.++||||+|+++|+|++|..||........ ...+........ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~-~~-- 230 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFKIASATT-AP-- 230 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHHHhccCC-CC--
Confidence 432111 11234678899999999888899999999999999999999999974332211 122211111110 00
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.........+.+++.+|++.+|++||++.+++++
T Consensus 231 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 231 ---------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0111223457789999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=303.31 Aligned_cols=247 Identities=27% Similarity=0.448 Sum_probs=197.9
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.+.||+|+||.||+|.. +++.||+|+++.. ...+.+.+|+.++++++|||++++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4688899999999999999975 5788999998632 2346788999999999999999999998654 57999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 80 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 80 MSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999976543 23789999999999999999999 789999999999999999999999999998754321
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
......+..|+|||++.+..++.++||||+|+++|||++ |+.||.... ..+........ .... .
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~~~-~~~~-~------- 218 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS----LKEVKECVEKG-YRME-P------- 218 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC----HHHHHHHHhCC-CCCC-C-------
Confidence 122344678999999998899999999999999999998 999987543 22222211111 1000 0
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......+.+++.+||+.+|++||+++++++.+++
T Consensus 219 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 ----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11122457799999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=313.47 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=199.8
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
|.....||+|+||.||++... ++..||||++.... ....+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 333467999999999999864 68899999986432 234567889999999999999999999999999999999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 962 (1109)
++++|.+++... .+++..+..++.||+.|++||| +.+|+||||||+||+++.++.++|+|||++...... ..
T Consensus 102 ~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-~~ 173 (292)
T cd06658 102 EGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-VP 173 (292)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc-cc
Confidence 999999988543 2789999999999999999999 779999999999999999999999999998765422 12
Q ss_pred CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhh
Q 001274 963 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1109)
......++..|+|||++.+..++.++||||+|+++|||++|+.||..... ...+....... +. . ..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~~~-~~--~----~~--- 239 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAMRRIRDNL-PP--R----VK--- 239 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcC-CC--c----cc---
Confidence 22345688999999999988999999999999999999999999874321 11111111111 00 0 00
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1043 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
........+..++.+||..||++|||+++++++-+...
T Consensus 240 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 240 -DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred -cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 01112235778999999999999999999998755443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=308.02 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=200.2
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCC----
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQD---- 873 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---- 873 (1109)
.+++|++.+.||+|+||+||+|+.+ +++.||+|++.... ...+.+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4578999999999999999999975 67899999987432 2456788999999999 7999999999997654
Q ss_pred --ceEEEEEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 001274 874 --SNLLLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDF 950 (1109)
Q Consensus 874 --~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 950 (1109)
..++||||+++++|.+++.... ....+++..+..++.|+++|+.||| +.+++|+||+|+||+++.++.++++||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence 3799999999999999986533 1234899999999999999999999 789999999999999999999999999
Q ss_pred cccccccCCCCCCccccccccceeccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhh
Q 001274 951 GLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIH 1025 (1109)
Q Consensus 951 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~ 1025 (1109)
|.+...... ........++..|+|||++.. ..++.++||||+||++|+|++|+.||........... ...
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~ 232 (275)
T cd06608 158 GVSAQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK----IPR 232 (275)
T ss_pred ccceecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH----hhc
Confidence 998765422 222234568899999998753 3477899999999999999999999975322111111 111
Q ss_pred ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1026 EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
... ... .........+.+++.+||..||++|||+.|++++
T Consensus 233 ~~~--~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 NPP--PTL---------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cCC--CCC---------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 110 000 0111233467899999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=305.43 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=199.2
Q ss_pred CCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC------
Q 001274 804 FSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD------ 873 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 873 (1109)
|.+.+.||+|+||+||+|.+. +++.||||+++.........+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 3688999999765444455677899999999999999999999886543
Q ss_pred ceEEEEEeccCCCHHHHhccCC---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 001274 874 SNLLLYEYMENGSLGEQLHGNK---QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDF 950 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 950 (1109)
..++++||+++|+|.+++.... ....+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875321 1224788999999999999999999 779999999999999999999999999
Q ss_pred cccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 951 GLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 951 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
|.++....... .......++..|++||......++.++||||+|+++|||++ |+.||.+... .+..........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~~ 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLIKGNR 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHHcCCc
Confidence 99986542211 11123345678999999998889999999999999999999 8888875321 111111111110
Q ss_pred CCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1029 PTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.. ........+.+++.+||+.+|++||++.++++.|+.+
T Consensus 234 -~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 -LK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -CC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0011224688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=312.72 Aligned_cols=271 Identities=28% Similarity=0.365 Sum_probs=202.6
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--CceEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSNLL 877 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 877 (1109)
.++|++.+.||+|+||.||+|++. +|+.||+|+++...........+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357899999999999999999865 689999999975543333344567899999999999999999998765 45799
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||++ ++|.+++..... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+....
T Consensus 86 v~e~~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPT--PFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 488888876433 3899999999999999999999 7799999999999999999999999999998765
Q ss_pred CCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh-
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD- 1035 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1035 (1109)
... .......++..|+|||++.+ ..++.++||||+||++|||++|+.||.+......... +...... +....+.
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~-~~~~~~~--~~~~~~~~ 235 (309)
T cd07845 160 LPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL-IIQLLGT--PNESIWPG 235 (309)
T ss_pred Ccc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCC--CChhhchh
Confidence 321 22233345788999998875 4578999999999999999999999975432111111 1111000 0000000
Q ss_pred --------------hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1036 --------------KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1036 --------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
................+.+++.+|++.||++|||+.|++++-+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0000000000112345778999999999999999999999877653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.41 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=208.2
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|++.+.||+|++|.||+|+.. +++.||||++...... ...+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 6788899999999999999876 5899999998754332 4467899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR-PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
+++++|.+++.... .+++..+..++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999997653 3899999999999999999999 7 899999999999999999999999999998664222
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+..........+. .
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~---~------ 223 (264)
T cd06623 155 -DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICDGPPPS---L------ 223 (264)
T ss_pred -CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHhcCCCCC---C------
Confidence 122245678899999999999999999999999999999999999976532 12233333222221110 0
Q ss_pred hhcccHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1041 SAKRTVE-EMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1041 ~~~~~~~-~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
... ....+.+++.+||+.+|++||++.+++++-+
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 111 2346789999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=312.49 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=200.0
Q ss_pred CCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 806 EGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 806 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
....||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 3457999999999999865 689999999864432 2346688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
++|..++... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++....... ...
T Consensus 103 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 103 GALTDIVSQT----RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 9999987542 2889999999999999999999 7899999999999999999999999999987554221 222
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....++..|+|||++.+..++.++||||+||++|||++|+.||..... .+.+........+....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~----------- 239 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKRLRDSPPPKLKN----------- 239 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhccCCCCccc-----------
Confidence 345688999999999998999999999999999999999999974321 11111111111000000
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.......+.+++.+||+.+|++||++.+++++-+...
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence 0111235778999999999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=308.71 Aligned_cols=249 Identities=22% Similarity=0.274 Sum_probs=203.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999865 689999999864322 1233467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++..... +++..+..++.|+++||.||| +.+++||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGR---FPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999977643 899999999999999999999 789999999999999999999999999999865422
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... .............+...
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~------- 219 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN----PIQIYEKILEGKVRFPS------- 219 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCccCCc-------
Confidence 234468899999999988889999999999999999999999997533 11112221121111111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMI 1078 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~ 1078 (1109)
.....+.+++.+||..+|.+|+ +++|++++-+
T Consensus 220 -------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 220 -------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred -------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 1123567899999999999999 8888887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=310.02 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=203.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 68889999999999999999854 68899999986432 2234678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++.... +++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 97 YLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred cCCCCcHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999987542 788999999999999999999 7899999999999999999999999999987654221
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......+++.|+|||++.+..++.++||||||+++|++++|+.||......... ........+. +.
T Consensus 170 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~----~~~~~~~~~~---~~----- 236 (293)
T cd06647 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLIATNGTPE---LQ----- 236 (293)
T ss_pred -cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe----eehhcCCCCC---CC-----
Confidence 2223346888999999998888999999999999999999999999753321111 1000000000 00
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
........+.+++.+||+.+|++||++.+++.+-+..
T Consensus 237 ---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~ 273 (293)
T cd06647 237 ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (293)
T ss_pred ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 0111223577899999999999999999999986553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=310.64 Aligned_cols=253 Identities=29% Similarity=0.438 Sum_probs=200.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.+|+..+.||+|+||+||+|+.. +++.||+|++...... ....+.+.+|+++++.++||||+++.+++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 46888899999999999999865 6899999998644322 233467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||++ |++.+++..... .+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~- 167 (307)
T cd06607 95 EYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP- 167 (307)
T ss_pred HhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC-
Confidence 9996 577777754333 3899999999999999999999 77999999999999999999999999999875431
Q ss_pred CCCCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 960 YSKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.....++..|+|||++. ...++.++||||||+++|||++|+.||.... .............+. .
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~----~~~~~~~~~~~~~~~--~--- 234 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIAQNDSPT--L--- 234 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc----HHHHHHHHhcCCCCC--C---
Confidence 12346788999999874 4568899999999999999999999987532 111111111111100 0
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
........+.+++.+||+.+|++||++.+++.+.+...
T Consensus 235 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 235 -------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred -------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 01123346889999999999999999999998866543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=310.48 Aligned_cols=265 Identities=25% Similarity=0.323 Sum_probs=200.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--CceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 878 (1109)
++|++.+.||+|+||.||+|.++ +++.||+|.++...........+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888899999999999999976 588999999975544333345677899999999999999999998877 789999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||++ ++|.+++..... .+++..+..++.||+.||+||| +.+++|+||||+||+++.++.++|+|||.++....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 599998876543 3899999999999999999999 77999999999999999999999999999987653
Q ss_pred CCCCCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh--
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD-- 1035 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1035 (1109)
.. .......+++.|+|||++.+.. ++.++||||+|+++|||++|+.||............. ..... +....+.
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~-~~~~~--~~~~~~~~~ 234 (293)
T cd07843 159 PL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF-KLLGT--PTEKIWPGF 234 (293)
T ss_pred Cc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhCC--CchHHHHHh
Confidence 22 2223345788999999887654 6899999999999999999999997543211111111 10000 0000000
Q ss_pred -------------hhcch-hhcccHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1036 -------------KRLDL-SAKRTVE-EMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1036 -------------~~~~~-~~~~~~~-~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
..... ....... ....+.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 0000000 24457799999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=310.71 Aligned_cols=254 Identities=21% Similarity=0.252 Sum_probs=198.2
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+|++.+.||+|+||.||+++.. .++.||+|.+...... ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6888899999999999999865 5789999998744221 2234578899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... +++..+..++.|++.|+.||| +.+++||||||+||+++.++.++++|||.++......
T Consensus 82 ~~~g~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 82 YVEGGDCATLLKNIGA---LPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred cCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999976543 899999999999999999999 7799999999999999999999999999986421110
Q ss_pred CC--------------CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 961 SK--------------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 961 ~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.||.+.. ..++.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~----~~~~~~~~~~~ 231 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT----PEELFGQVISD 231 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhc
Confidence 00 0112457889999999998899999999999999999999999997432 22333322222
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
..+.... .......+.+++.+||+.+|++||++.++.+.+
T Consensus 232 ~~~~~~~-----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 232 DIEWPEG-----------DEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred ccCCCCc-----------cccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 1111000 001223567999999999999999954444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.03 Aligned_cols=265 Identities=24% Similarity=0.396 Sum_probs=201.3
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|++.++||+|++|+||+|+.. +++.||||+++.... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4788899999999999999975 689999999975432 23345677899999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++ +|.+++........+++..+..++.|++.|++||| +.+++||||||+||++++++.++++|||.++......
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 985 89888876554345899999999999999999999 7799999999999999999999999999997654221
Q ss_pred CCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh------
Q 001274 962 KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF------ 1034 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 1034 (1109)
.......++..|+|||++.+. .++.++||||+||++|||++|+.||.+....+......... . .+....+
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~ 231 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM-G--TPTESTWPGISQL 231 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-C--CCChhhHHHHhcC
Confidence 122334578899999988664 47899999999999999999999997543222111111110 0 0000000
Q ss_pred ---hhhcch----h-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1035 ---DKRLDL----S-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1035 ---~~~~~~----~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
...... . ..........+.+++.+|++.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 0 00011223567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=300.44 Aligned_cols=252 Identities=31% Similarity=0.463 Sum_probs=200.0
Q ss_pred CCCCceEecCCcceEEEEEecC-----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 804 FSEGAVIGRGACGTVYKATLAN-----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
+++.+.||.|+||.||+|++.+ +..||+|+++... .....+.+..|+++++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999998653 3889999986432 222567889999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++++|.+++...... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+.....
T Consensus 80 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999999764432 2799999999999999999999 78999999999999999999999999999986653
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
..........++..|+|||.+.+..++.++||||+|+++|||++ |+.||.... ................
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~----~~~~~~~~~~~~~~~~------ 225 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS----NEEVLEYLKKGYRLPK------ 225 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHhcCCCCCC------
Confidence 32211112336789999999988889999999999999999999 788886522 2222222111111000
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.......+.+++.+|++.+|++|||+.|+++.|
T Consensus 226 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 -------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011234678899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=307.12 Aligned_cols=239 Identities=21% Similarity=0.368 Sum_probs=186.4
Q ss_pred ceEecCCcceEEEEEecC--------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 808 AVIGRGACGTVYKATLAN--------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 368999999999997542 2348888775322 233467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc--------eEEeecc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ--------AHVGDFG 951 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DFG 951 (1109)
||+++|+|.++++..+. .+++..+..++.||+.|++||| +++|+||||||+||+++.++. ++++|||
T Consensus 79 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999986554 3899999999999999999999 789999999999999987765 6999999
Q ss_pred ccccccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCC-CCCCCcccCCcHHHHHHHhhhccCC
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGK-SPVQSLELGGDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~ 1029 (1109)
.+..... .....++..|+|||++.+. .++.++||||+||++|||++|. .||..... ...... ......
T Consensus 154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~----~~~~~~-~~~~~~ 223 (258)
T cd05078 154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS----QKKLQF-YEDRHQ 223 (258)
T ss_pred cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH----HHHHHH-HHcccc
Confidence 8875431 2234678889999999864 5799999999999999999985 55543221 111110 011000
Q ss_pred CchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1030 TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
. .......+.+++.+||+.+|++|||++++++.|
T Consensus 224 ~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 224 L--------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred C--------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 001113578999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=304.80 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=203.3
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|+..+.||+|+||.||+|..+ ++..||+|.+..........+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999865 588999999876543334556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeeccccccccCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~ 960 (1109)
+++++|.+++..... ..+++..+..++.|+++|++||| +.+++|+||||+||++++++ .++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999976443 23789999999999999999999 77999999999999999886 46999999998664221
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......|++.|+|||+..+..++.++||||+|+++|||++|+.||.... ..+++........+. .
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~--~------- 222 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN----LHQLVLKICQGYFAP--I------- 222 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhcccCCC--C-------
Confidence 12233458889999999988889999999999999999999999987432 233333222221110 0
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+||+.+|++|||+.|++++
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11112357799999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=306.91 Aligned_cols=264 Identities=26% Similarity=0.334 Sum_probs=202.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC--ceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD--SNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 878 (1109)
++|+..+.||.|++|.||+|.+. +++.||+|.+..... ......+.+|++++++++||||+++++++.... ..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 36778899999999999999975 688999998874322 234567899999999999999999999986543 57899
Q ss_pred EEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 879 YEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
|||+++++|.+++.... ....+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999998875422 1223788999999999999999999 7799999999999999999999999999987553
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC-CcHHHHHHHhhhccCCCchhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG-GDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ....+.......... ... ..
T Consensus 157 ~~---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~ 230 (287)
T cd06621 157 NS---LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--PEL-KD 230 (287)
T ss_pred cc---ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--hhh-cc
Confidence 21 112345788899999999999999999999999999999999999864221 111222221111010 000 00
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
. ..........+.+++.+||+.+|++|||+.|++++-+-
T Consensus 231 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 231 E----PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred C----CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 0 00011123467899999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=304.93 Aligned_cols=251 Identities=26% Similarity=0.367 Sum_probs=201.1
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
-|+..+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3667889999999999999864 688999998864322 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++... .+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++++|||++...... .
T Consensus 84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-~ 155 (277)
T cd06641 84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-Q 155 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccc-h
Confidence 9999999998653 2789999999999999999999 789999999999999999999999999998765421 1
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......++..|+|||++.+..++.++||||+||++|+|++|..||..... ............+ .+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~---~~------- 221 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLFLIPKNNPP---TL------- 221 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHHHHHhcCCCC---CC-------
Confidence 122334678899999999988899999999999999999999999875321 1111111111100 00
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......+.+++.+||+.+|++||++.+++++-+-
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 256 (277)
T cd06641 222 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256 (277)
T ss_pred ---CcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 11122457789999999999999999999997433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=317.56 Aligned_cols=274 Identities=25% Similarity=0.304 Sum_probs=212.4
Q ss_pred CCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC------ce
Q 001274 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD------SN 875 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 875 (1109)
-|...+.||+|+||.||+|+. +.|+.||||.+.... .....+...+|++++++++|+|||+++++-.... ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 455667899999999999994 579999999997654 3445677889999999999999999998755433 56
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC--CCC--ceEEeecc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD--EEF--QAHVGDFG 951 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DFG 951 (1109)
.+|||||.+|||+..+..-...+.+++.+.+.+..+++.||.||| +.+|+||||||.||++- .+| .-||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 899999999999999988777778999999999999999999999 77999999999999993 334 47999999
Q ss_pred ccccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc-CC
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-VP 1029 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~ 1029 (1109)
.|+..+. .......+||..|.+||++.. +.|+..+|.|||||++||.+||..||..........+.+....... .+
T Consensus 170 ~Arel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 170 AARELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 9998763 345678899999999999984 8899999999999999999999999987664433222222211111 11
Q ss_pred Cchhhh----------hhcchhhcccHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHHhhh
Q 001274 1030 TSELFD----------KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP--TMREVIAMMIDARQ 1082 (1109)
Q Consensus 1030 ~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP--t~~evl~~L~~~~~ 1082 (1109)
...... ..+.............+.+.+..++.++|++|- .+.+....+.+++.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 111111 112222334455566788888889999999998 66666666666544
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=316.39 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=199.4
Q ss_pred CCceEecCCcceEEEEEec-CCcEEEEEEeecc--CCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc--eEEEEE
Q 001274 806 EGAVIGRGACGTVYKATLA-NGEVIAVKKIKLR--GEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS--NLLLYE 880 (1109)
Q Consensus 806 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 880 (1109)
...+||+|+|-+||+|.+. +|-.||=-.++.+ .......+.|..|+.+++.|+||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999875 5777763222222 2334445889999999999999999999999988765 568999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeeccccccccCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-EFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~ 959 (1109)
.|..|+|..|+++.+. ++.+.+..|+.||++||.|||++ .++|||||||-+||+|++ .|.|||+|+|+|......
T Consensus 124 L~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999998876 88999999999999999999988 889999999999999965 589999999999976532
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
......|||.|||||++. ..|++.+||||||++++||+|+..||..-. ...+.-++...+..| . .+.+.-
T Consensus 200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~---n~AQIYKKV~SGiKP-~-sl~kV~- 269 (632)
T KOG0584|consen 200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT---NPAQIYKKVTSGIKP-A-ALSKVK- 269 (632)
T ss_pred ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC---CHHHHHHHHHcCCCH-H-HhhccC-
Confidence 223478999999999877 789999999999999999999999997432 223333333333322 1 111111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
..++.+||.+|+.. .+.|||+.|++.+-...
T Consensus 270 ---------dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~ 300 (632)
T KOG0584|consen 270 ---------DPEVREFIEKCLAT-KSERLSAKELLKDPFFD 300 (632)
T ss_pred ---------CHHHHHHHHHHhcC-chhccCHHHHhhChhhc
Confidence 13577999999999 99999999999775443
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=303.99 Aligned_cols=250 Identities=28% Similarity=0.445 Sum_probs=194.9
Q ss_pred ceEecCCcceEEEEEecC-------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 808 AVIGRGACGTVYKATLAN-------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+.||+|+||.||+|+..+ ++.||||.+... ........+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998642 257899988633 222345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCC----CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-----ceEEeecc
Q 001274 881 YMENGSLGEQLHGNK----QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-----QAHVGDFG 951 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DFG 951 (1109)
|+++++|.+++.... ....+++..+..++.|++.|++||| +.+++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999997532 1223788999999999999999999 77999999999999999887 89999999
Q ss_pred ccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCC
Q 001274 952 LAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 952 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 1029 (1109)
+++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||..... .+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~~~~- 231 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHVTAGGR- 231 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHHHHHhcCCc-
Confidence 9975532211 11122345678999999999999999999999999999998 9999874321 111111111100
Q ss_pred CchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1030 TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
. . ........+.+++.+||..+|++||++.++++.|.
T Consensus 232 ~--------~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 L--------Q----KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred c--------C----CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 0 01112346789999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=309.37 Aligned_cols=267 Identities=21% Similarity=0.298 Sum_probs=198.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCc-----
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDS----- 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 874 (1109)
++|+..+.||+|+||.||+|++. +++.||+|+++...........+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999865 6899999998755433334467889999999995 6999999999987665
Q ss_pred eEEEEEeccCCCHHHHhccCCC--CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeecc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQ--TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-EFQAHVGDFG 951 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG 951 (1109)
.++||||+++ ++.+++..... ...+++..+..++.||+.||.||| +++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 89888865432 234899999999999999999999 789999999999999998 8999999999
Q ss_pred ccccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
.++...... .......+++.|+|||++.+ ..++.++||||+|+++|||++|..||.+.............. ..+.
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~---~~~~ 232 (295)
T cd07837 157 LGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL---GTPT 232 (295)
T ss_pred cceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh---CCCC
Confidence 998654221 11223356788999998865 457999999999999999999999997533211111111110 0011
Q ss_pred chhhhhhc-----------c-hh-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1031 SELFDKRL-----------D-LS-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1031 ~~~~~~~~-----------~-~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
...+.... . .. ..........+.+++.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 11100000 0 00 00011233557899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=330.96 Aligned_cols=275 Identities=20% Similarity=0.191 Sum_probs=192.4
Q ss_pred HhcCCCCCceEecCCcceEEEEEecC--CcEEEEEEee---------------ccCCCcchhHHHHHHHHHhccCCCCce
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLAN--GEVIAVKKIK---------------LRGEGATADNSFLAEISTLGKIRHRNI 862 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~---------------~~~~~~~~~~~~~~E~~~l~~l~h~ni 862 (1109)
..++|++.++||+|+||+||+|..+. +..+++|.+. ...........+.+|++++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34789999999999999999987542 2222222110 001112234568899999999999999
Q ss_pred eeEEEEEEeCCceEEEEEeccCCCHHHHhccCCC--CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 001274 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQ--TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD 940 (1109)
Q Consensus 863 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~ 940 (1109)
+++++++...+..|+|+|++. +++.+++..... ........+..++.||+.||+||| +++||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 999999999999999999995 577777754321 112345667789999999999999 78999999999999999
Q ss_pred CCCceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHH
Q 001274 941 EEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWV 1020 (1109)
Q Consensus 941 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~ 1020 (1109)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++............
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~- 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL- 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH-
Confidence 9999999999999876533333334567999999999999999999999999999999999987654322211111111
Q ss_pred HHhhhc------cCCC--chhhhhhcch----hhcc------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1021 RRSIHE------MVPT--SELFDKRLDL----SAKR------TVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1021 ~~~~~~------~~~~--~~~~~~~~~~----~~~~------~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
...... ..+. ...++..... .... .......+.+++.+|++.||.+|||+.|++++-+.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 111110 0000 0000000000 0000 00112346678999999999999999999987554
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=308.11 Aligned_cols=264 Identities=24% Similarity=0.361 Sum_probs=200.3
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
|++.++||.|++|+||+|++. +|+.||+|++..........+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999865 7999999999755433334467889999999999999999999999999999999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 962 (1109)
+ ++|.+++..... ..+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||.++...... .
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-R 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-c
Confidence 5 699999876552 23899999999999999999999 7799999999999999999999999999997654221 1
Q ss_pred CccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh-----
Q 001274 963 SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK----- 1036 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1036 (1109)
......++..|+|||++.+. .++.++||||+|+++|||++|+.||.............+.. ..+....+..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL---GTPDEDVWPGVTSLP 231 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---CCCChHHhhhhhhch
Confidence 12233568899999988764 57899999999999999999999997543222222221110 0000000000
Q ss_pred ----hc-ch----hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1037 ----RL-DL----SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1037 ----~~-~~----~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.. .. ...........+.+++.+|++.+|++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00 000011122457799999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=309.32 Aligned_cols=268 Identities=29% Similarity=0.370 Sum_probs=201.8
Q ss_pred HHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC----
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD---- 873 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 873 (1109)
...++|++.+.||+|+||.||+|..+ +++.||+|+++...........+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999975 5899999999765443344567788999999999999999999987654
Q ss_pred ------ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 001274 874 ------SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV 947 (1109)
Q Consensus 874 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 947 (1109)
..++|+||+++ ++..++..... .+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLV--HFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEe
Confidence 68999999976 77777765432 3899999999999999999999 779999999999999999999999
Q ss_pred eeccccccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 948 GDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 948 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
+|||.+...............++..|+|||++.+ ..++.++||||+||++|||++|+.||........... +......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~-~~~~~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL-ISRLCGS 236 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCC
Confidence 9999998765333222233456788999998765 3578999999999999999999999975332211111 1111111
Q ss_pred cCCC--chhh--------h------hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1027 MVPT--SELF--------D------KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1027 ~~~~--~~~~--------~------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
..+. .++. + ...... .......+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREE---FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhh---cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1000 0000 0 000000 00113468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=310.81 Aligned_cols=270 Identities=24% Similarity=0.343 Sum_probs=197.4
Q ss_pred CCCCCceEecCCcceEEEEEec---CCcEEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--CceE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA---NGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSNL 876 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 876 (1109)
+|++.++||+|+||.||+|... +++.||+|.+.... ......+.+.+|+.++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999865 47899999997532 1122345678899999999999999999999988 7889
Q ss_pred EEEEeccCCCHHHHhccCCC--CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC----CCceEEeec
Q 001274 877 LLYEYMENGSLGEQLHGNKQ--TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE----EFQAHVGDF 950 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DF 950 (1109)
+||||+++ ++.+++..... ...+++..+..++.||+.|++||| +.+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67776643221 124889999999999999999999 789999999999999999 999999999
Q ss_pred cccccccCCCC--CCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCc-----HHHHHHH
Q 001274 951 GLAKLIDLPYS--KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGD-----LVTWVRR 1022 (1109)
Q Consensus 951 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~-----~~~~~~~ 1022 (1109)
|+++....... .......++..|+|||++.+. .++.++||||+||++|||++|+.||........ ....+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986643222 122345678899999988764 578999999999999999999999986542210 0001111
Q ss_pred hhhccCCCchh----------hhh----h--cchh-------hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1023 SIHEMVPTSEL----------FDK----R--LDLS-------AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1023 ~~~~~~~~~~~----------~~~----~--~~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
........... +.. . .... ..........+.+++.+|+++||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11100000000 000 0 0000 00000223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=305.77 Aligned_cols=264 Identities=27% Similarity=0.339 Sum_probs=200.7
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--CceEEEEE
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSNLLLYE 880 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 880 (1109)
|++.+.||+|+||.||+|+.. +++.||+|++............+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999876 588999999986543334456788999999999999999999999988 78999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++ +|.+++..... .+++..+..++.||++|++||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~-~l~~~~~~~~~--~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPEV--KFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 89888866532 3899999999999999999999 7799999999999999999999999999998765433
Q ss_pred CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC----CC-----
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV----PT----- 1030 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~----- 1030 (1109)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..+........ +.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL-EKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchhhccccccch
Confidence 222334456788999998765 45789999999999999999999999754321111 11111111000 00
Q ss_pred -------chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1031 -------SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1031 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......... .........+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLRE--FFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHH--HhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000 0000124568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=303.91 Aligned_cols=250 Identities=24% Similarity=0.292 Sum_probs=202.9
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+|++.+.||+|+||.||+|+++ +++.||+|++...... ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 6899999999754322 2346789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++.... .+++..+..++.|+++|+.||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999999997653 3889999999999999999999 7799999999999999999999999999988654221
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
......++..|+|||++.+..++.++||||+|+++|+|++|+.||...... .............+ ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~---~~------ 221 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETADV---LY------ 221 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhccccc---cC------
Confidence 223456788999999999888999999999999999999999999854321 12222222111100 00
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCH--HHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTM--REVIA 1075 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~--~evl~ 1075 (1109)
.......+.+++.+||+.||.+||++ +|+++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 222 ----PATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ----cccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11122567899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=304.61 Aligned_cols=259 Identities=20% Similarity=0.244 Sum_probs=186.3
Q ss_pred cCCCCCceEecCCcceEEEEEecC----CcEEEEEEeeccCCCcchh---------HHHHHHHHHhccCCCCceeeEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATAD---------NSFLAEISTLGKIRHRNIVKLYGF 868 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~---------~~~~~E~~~l~~l~h~niv~l~~~ 868 (1109)
++|++.++||+|+||+||+|++.+ +..+|+|+........... .....+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 589999999999999999998654 3456666543322211111 112234455667799999999997
Q ss_pred EEeCC----ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 001274 869 CYHQD----SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ 944 (1109)
Q Consensus 869 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 944 (1109)
+.... ..++++|++. .++.+.+..... .++..+..++.|+++|++||| +.+|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKC---KNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhcc---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence 76544 3467888774 466666654332 577888999999999999999 789999999999999999999
Q ss_pred eEEeeccccccccCCCC------CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHH
Q 001274 945 AHVGDFGLAKLIDLPYS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVT 1018 (1109)
Q Consensus 945 ~kl~DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~ 1018 (1109)
++|+|||+|+....... .......||+.|+|||+..+..++.++||||+||++|||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999986632111 111234699999999999999999999999999999999999999987643332222
Q ss_pred HHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1019 WVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.....+......... . .......+.+++..||+.+|++||+++++++.+
T Consensus 245 ~~~~~~~~~~~~~~~-----~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRLHEGKI-----K-----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHHHHhhhhhh-----c-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111111111100000 0 111235688999999999999999999999865
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=302.81 Aligned_cols=250 Identities=24% Similarity=0.279 Sum_probs=197.7
Q ss_pred EecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCH
Q 001274 810 IGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSL 887 (1109)
Q Consensus 810 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 887 (1109)
||+|+||+||+|... +++.||+|++...... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 6899999998643221 22345677899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCcccc
Q 001274 888 GEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967 (1109)
Q Consensus 888 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 967 (1109)
.+++..... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||.+..... .......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGR 154 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccc
Confidence 999976553 24899999999999999999999 77999999999999999999999999999876542 2223345
Q ss_pred ccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHH
Q 001274 968 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVE 1047 (1109)
Q Consensus 968 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
.++..|+|||++.+..++.++||||+||++|+|++|+.||...................... ....
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~ 220 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVE--------------YPDK 220 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccccc--------------CCcc
Confidence 67889999999988889999999999999999999999997644322222221111111100 0111
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHH
Q 001274 1048 EMTLFLKIALFCSSTSPLNRP-----TMREVIAMMID 1079 (1109)
Q Consensus 1048 ~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~ 1079 (1109)
....+.+++.+||+.+|++|| ++.+++++-+-
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 134577999999999999999 77778876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=307.96 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=200.3
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
|...+.||+|+||.||+|+.. +++.||+|++...... ......+.+|++++++++|+|++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667788999999999999864 6889999998644222 23345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
++ |++.+++..... .+++..+..++.+++.|+.||| +.+|+||||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 107 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred CC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 97 578777755433 3899999999999999999999 77999999999999999999999999999875431
Q ss_pred CCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 962 KSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.....+++.|+|||++. .+.++.++|||||||++|||++|+.||...... ...........+..
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~------- 244 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNESPTL------- 244 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHhccCCCC-------
Confidence 22346788999999874 456899999999999999999999998753211 11111111111100
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
........+.+++.+||+.+|++||++.+++++.+......
T Consensus 245 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 245 -----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred -----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 01112245789999999999999999999999887765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=303.39 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=200.3
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
.|...+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 3555679999999999999864 68899999886432 23455688999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||.+.......
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~- 169 (285)
T cd06648 98 LEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV- 169 (285)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-
Confidence 9999999998762 2889999999999999999999 7899999999999999999999999999887553221
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......|++.|+|||+..+..++.++||||+||++|||++|+.||.... .............+. ..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----~~~~~~~~~~~~~~~--~~------- 236 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----PLQAMKRIRDNLPPK--LK------- 236 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----HHHHHHHHHhcCCCC--Cc-------
Confidence 12233568899999999998889999999999999999999999986422 222222221111100 00
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
........+.+++.+||+.+|++||++.+++++-
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 0111224688999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=303.92 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=200.6
Q ss_pred CCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC---CCceeeEEEEEEeCCceEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR---HRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 878 (1109)
.|+..+.||+|+||.||+|.+ .+++.||+|.+.... .....+.+.+|++++++++ |||++++++++..+...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 467788999999999999986 478999999986432 2334567889999998886 99999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++++|.++++.. .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999999998653 3899999999999999999999 77999999999999999999999999999987653
Q ss_pred CCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
.. .......|+..|+|||++.++ .++.++|||||||++|+|++|+.||..... ....... ....+ ..
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~-~~~~~-~~----- 221 (277)
T cd06917 154 NS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA----FRAMMLI-PKSKP-PR----- 221 (277)
T ss_pred Cc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh----hhhhhcc-ccCCC-CC-----
Confidence 22 223345688999999988754 478999999999999999999999975431 1111110 01100 00
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
+.. ......+.+++.+||+.||++||++.+++++-+.
T Consensus 222 ~~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 222 LED-----NGYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred CCc-----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 000 0123457899999999999999999999987655
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=307.08 Aligned_cols=268 Identities=24% Similarity=0.351 Sum_probs=199.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|++|+||+|+++ +++.||+|++..........+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47888999999999999999875 68999999986544333345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeeccccccccCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-EFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~ 959 (1109)
|++ +++.+++..... ..+++..+..++.||+.||+||| +++++||||+|+||+++. ++.+||+|||.+......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 588888765433 23678888899999999999999 779999999999999985 567999999999765422
Q ss_pred CCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh--
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK-- 1036 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1036 (1109)
........+++.|+|||++.+. .++.++||||+||++|+|+||+.||......+........ .. .+....+..
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~ 232 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRI-LG--TPNEETWPGVT 232 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hC--CCChhhccccc
Confidence 1222334578899999988764 5789999999999999999999999754322111111110 00 001111000
Q ss_pred ----------hcc-hh-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1037 ----------RLD-LS-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1037 ----------~~~-~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
... .. ..........+.+++.+|++.+|++||++.+++++-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~ 286 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 000 00 0001112345789999999999999999999998743
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=279.50 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=199.6
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+.+....||.|.-|+||+++.. .|..+|||.+... .+.++.++++..+.++... +.|+||+.+|||..+...++.||
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3445567999999999999965 5899999999744 3455667788888887666 48999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
.|. ...+.+++.-+.. +++..+-++...++.||.||.+ +++|+|||+||+|||+|+.|.+|++|||.+-++- +
T Consensus 172 lMs-~C~ekLlkrik~p--iPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv--d 244 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGP--IPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV--D 244 (391)
T ss_pred HHH-HHHHHHHHHhcCC--chHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee--c
Confidence 984 4666676655443 8888888999999999999986 4599999999999999999999999999997665 2
Q ss_pred CCCccccccccceeccccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
+...+...|.+.|||||.+.- ..|+.++||||||+.++|+.||+.||.+-..+ .+.+.....+..| ..+..
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe~ltkvln~ePP---~L~~~ 318 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FEVLTKVLNEEPP---LLPGH 318 (391)
T ss_pred ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HHHHHHHHhcCCC---CCCcc
Confidence 344556678999999998864 35899999999999999999999999864322 2333333332221 11111
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.. -...|.+++..|++.|+.+||...+++++-
T Consensus 319 ~g--------FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 319 MG--------FSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred cC--------cCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 11 123688999999999999999999998764
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=304.24 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=207.1
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
..+.|+..+.||+|+||.||+|.++ +++.||+|++..... ..+.+.+|+++++.++|+|++++++++...+..++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3456888889999999999999976 688999999974432 456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
+||+++++|.+++..... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 94 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNFV--RMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999987652 3899999999999999999999 78999999999999999999999999999876542
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.. .......++..|+|||++.+..++.++|||||||++|+|++|+.||...... ...........+. ...
T Consensus 169 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~--~~~--- 238 (286)
T cd06614 169 EK-SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----RALFLITTKGIPP--LKN--- 238 (286)
T ss_pred ch-hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCC--Ccc---
Confidence 21 1223345788999999999888999999999999999999999998743211 1111111111110 000
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.......+.+++.+||+.+|.+||++.+++++-+...
T Consensus 239 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 239 ------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 1112245779999999999999999999998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=303.22 Aligned_cols=255 Identities=25% Similarity=0.276 Sum_probs=201.3
Q ss_pred CCCCCceEecCCcceEEEEEe----cCCcEEEEEEeeccCC--CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCce
Q 001274 803 NFSEGAVIGRGACGTVYKATL----ANGEVIAVKKIKLRGE--GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 875 (1109)
+|++.+.||+|+||.||+|+. .+|+.||+|+++.... .....+.+.+|+++++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 3689999999874321 122346678899999999 589999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++||||+++++|.+++..... +++..+..++.|+++||.||| +.+++||||+|+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRER---FKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999976543 788999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCCCCccccccccceeccccccCC--CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 956 IDLPYSKSMSAIAGSYGYIAPEYAYTM--KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
.............++..|+|||++.+. .++.++||||+|+++|+|++|+.||.....................+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 232 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP-- 232 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC--
Confidence 543222223345688999999998753 4678999999999999999999999743333333333333222221111
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMM 1077 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 1077 (1109)
......+.+++.+||+.+|++|| ++.+++.+-
T Consensus 233 ------------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~ 269 (290)
T cd05613 233 ------------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP 269 (290)
T ss_pred ------------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCc
Confidence 11223577999999999999997 778887763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=304.07 Aligned_cols=259 Identities=23% Similarity=0.257 Sum_probs=194.1
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeC--CceEEEE
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQ--DSNLLLY 879 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 879 (1109)
|++.++||+|+||.||+|+.. +++.||+|+++...... ......+|+.+++++. |+|++++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 567789999999999999865 68999999987543222 2234557888898885 99999999999987 8889999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||++ +++.+++..... .+++..+..++.|++.||+||| +.+++||||+|+||+++. +.+||+|||.++.....
T Consensus 80 e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 80 ELMD-MNLYELIKGRKR--PLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred ecCC-ccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9997 588888875433 3899999999999999999999 779999999999999999 99999999999866422
Q ss_pred CCCCccccccccceecccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.......++..|+|||++. ++.++.++||||+||++|||++|+.||.+.... +........... ..+.+.+..
T Consensus 153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~ 226 (282)
T cd07831 153 --PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIHDVLGT---PDAEVLKKF 226 (282)
T ss_pred --CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHHHHcCC---CCHHHHHhh
Confidence 2223346788999999765 455789999999999999999999999754321 111111111110 000000000
Q ss_pred chh---------------hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1039 DLS---------------AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1039 ~~~---------------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
... ..........+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000 00011234678899999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=312.27 Aligned_cols=268 Identities=27% Similarity=0.343 Sum_probs=200.7
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCC--ce
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQD--SN 875 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~ 875 (1109)
..++|++.+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++++ +|+||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999875 688999999864433334455677899999999 9999999999986543 57
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++||||++ ++|.+++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||.++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5999988764 3789999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCC----CCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 956 IDLPYS----KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 956 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
...... .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+............. . + .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~-~-~-~~~ 233 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV-I-G-PPS 233 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-h-C-CCC
Confidence 542221 12234568899999998765 45789999999999999999999999754321111111110 0 0 000
Q ss_pred ch------------hhhhhc----chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1031 SE------------LFDKRL----DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1031 ~~------------~~~~~~----~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.+ .++... .............+.+++.+||+.+|++|||+.+++++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~ 297 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence 00 000000 0000001112356789999999999999999999998843
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=297.44 Aligned_cols=257 Identities=25% Similarity=0.279 Sum_probs=205.5
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.+.|+.-++||+|+||.||-++.. +|+.||.|++..+.. ....+...+.|-.++.++..+.||.+--+|...+..|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 357888899999999999999854 699999998853321 122345577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
+..|.||+|.-++...+. ..+++..++..+.+|+-||++|| +.+||+||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~- 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP- 338 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC-
Confidence 999999999999987764 34999999999999999999999 7799999999999999999999999999999775
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
........+||.+|||||++....|+...|.||+||++|||+.|+.||........-.+.-+....+..
T Consensus 339 -~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~---------- 407 (591)
T KOG0986|consen 339 -EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE---------- 407 (591)
T ss_pred -CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh----------
Confidence 344556669999999999999999999999999999999999999999864422221122222111111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMM 1077 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 1077 (1109)
+++..-.++...+....++.||++|. .+++|.+|-
T Consensus 408 ----ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 408 ----EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred ----hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 11111223455777888899999985 466777663
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=309.59 Aligned_cols=267 Identities=22% Similarity=0.281 Sum_probs=198.2
Q ss_pred eEecC--CcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 809 VIGRG--ACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 809 ~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
.||+| +||+||+|++. +++.||+|++..........+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 45666 99999999874 7999999998765444445578889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCC--
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS-- 963 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-- 963 (1109)
++.+++...... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFPE-GMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999998765432 3889999999999999999999 7799999999999999999999999998654332111110
Q ss_pred ----ccccccccceeccccccCC--CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc------
Q 001274 964 ----MSAIAGSYGYIAPEYAYTM--KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS------ 1031 (1109)
Q Consensus 964 ----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------ 1031 (1109)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||................ ...+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGP--PYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCC--CCCCccccccch
Confidence 0112345679999998764 47899999999999999999999997543221111111100 000000
Q ss_pred ---------------------------hhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1032 ---------------------------ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1032 ---------------------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
....... ...........+.+++.+||+.||++|||+.|++++-+.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL--RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccc--cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 0000000 0111223456789999999999999999999999886654433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=304.13 Aligned_cols=258 Identities=24% Similarity=0.241 Sum_probs=201.5
Q ss_pred CCCCCceEecCCcceEEEEEe----cCCcEEEEEEeeccCC--CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCce
Q 001274 803 NFSEGAVIGRGACGTVYKATL----ANGEVIAVKKIKLRGE--GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 875 (1109)
+|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+.+|+++++++ +|++|+++++++..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999974 2578899999874321 122345688999999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++||||+++|+|.+++.... .+++..+..++.|+++||.||| ..+++||||+|+||+++.++.++++|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999987643 2889999999999999999999 78999999999999999999999999999886
Q ss_pred ccCCCCCCccccccccceeccccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 956 IDLPYSKSMSAIAGSYGYIAPEYAYTMK--VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
.............++..|+|||++.+.. .+.++||||+|+++|||++|..||..........+..+.......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK- 233 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc-
Confidence 5433222223456889999999987765 7889999999999999999999996432222223333322222211111
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.....+.+++.+||+.+|++|||+.++.+.+...
T Consensus 234 -------------~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 234 -------------TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -------------ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1123467899999999999999988777665443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=294.73 Aligned_cols=250 Identities=30% Similarity=0.433 Sum_probs=203.2
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|++++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4777889999999999999975 688999999974432 3557889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... .+++..+..++.|++.|+.||| ..+++||||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 79 CSGGSLKDLLKSTNQ--TLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCCcHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999999877542 3899999999999999999999 78999999999999999999999999999987653221
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.....++..|+|||++.+..++.++||||+|+++|+|++|+.||..... ............ .....
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~--~~~~~------ 219 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP----MKALFKIATNGP--PGLRN------ 219 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch----HHHHHHHHhcCC--CCcCc------
Confidence 3345688899999999988899999999999999999999999875321 111111111110 00000
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+||+.||++|||+.|++++
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 ---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11113457899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=301.87 Aligned_cols=266 Identities=25% Similarity=0.318 Sum_probs=199.2
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC---CCCceeeEEEEEEeCCc-----
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI---RHRNIVKLYGFCYHQDS----- 874 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 874 (1109)
|++.+.||+|+||.||+|+++ +++.||+|+++...........+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999976 489999999975544333345566788776655 69999999999988776
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.+++|||+. ++|.+++...... .+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.+||+|||.+.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKP-GLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 4898888764432 4899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc---cCCCc
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE---MVPTS 1031 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~ 1031 (1109)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||......+....+....... ..+..
T Consensus 156 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 156 IYSFE--MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eccCC--cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 76422 12233457889999999999999999999999999999999999987543222222222111000 00000
Q ss_pred h-----hhhhhcchh-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1032 E-----LFDKRLDLS-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1032 ~-----~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
. .+....... .....+....+.+++.+||+.||++||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 000000000 01112234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=307.29 Aligned_cols=267 Identities=22% Similarity=0.340 Sum_probs=197.6
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc-----
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS----- 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 874 (1109)
.++|++.++||+|+||.||+|+.. +++.||||++............+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467999999999999999999865 68999999987544333334556789999999999999999999876543
Q ss_pred ---eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 875 ---NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 875 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
.++||||+. +++.+++..... .+++.++..++.||+.|++||| +.+++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 489999996 588888865432 3899999999999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCCC---CccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc
Q 001274 952 LAKLIDLPYSK---SMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM 1027 (1109)
Q Consensus 952 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 1027 (1109)
.+......... ......++..|+|||++.+.. ++.++||||+|+++|||++|+.||...... .....+.... +.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~~-~~ 242 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQLC-GS 242 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh-CC
Confidence 99866432211 123345788999999887654 788999999999999999999998754321 1111111111 11
Q ss_pred CCCchhhhhh--------cchhhc---------ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1028 VPTSELFDKR--------LDLSAK---------RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1028 ~~~~~~~~~~--------~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.+. +.+... ...... ........+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITP-EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCh-hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 000000 000000 000012346789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=305.90 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=196.6
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+|...++||+|+||.||++++. +++.||+|++...... .....+.+|+.++.++. |+||+++++++..++..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4556678999999999999865 6899999998744322 34567889999999996 9999999999999999999999
Q ss_pred eccCCCHHHHh---ccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 881 YMENGSLGEQL---HGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 881 ~~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
|+.. ++.++. .... ...+++..+..++.+++.|++|||+ ..+++||||||+||+++.++.++|+|||+++...
T Consensus 84 ~~~~-~l~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 555433 2221 1248999999999999999999993 2489999999999999999999999999997654
Q ss_pred CCCCCCccccccccceeccccccCC---CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTM---KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
.. .......++..|+|||++.+. .++.++||||+||++|||++|+.||.... ...+.+........+. .
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~---~ 231 (288)
T cd06616 160 DS--IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKGDPPI---L 231 (288)
T ss_pred cC--CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcCCCCCc---C
Confidence 22 122334678899999998876 68999999999999999999999997532 1222222222211110 0
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
. ..........+.+++.+||+.+|++|||+.+|+++-+..
T Consensus 232 ~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 271 (288)
T cd06616 232 S------NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271 (288)
T ss_pred C------CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 0 000112234678999999999999999999999885543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=313.00 Aligned_cols=268 Identities=23% Similarity=0.310 Sum_probs=201.1
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----c
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD-----S 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 874 (1109)
.++|.+.+.||+|+||+||+|+.. +++.||||++............+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357899999999999999999864 6899999998754333344566788999999999999999999886543 4
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+. ++|.+++..... +++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQT---LSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 689888876543 899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
...... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||.+...... ...+....... ..+.
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~--~~~~ 232 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ-LKLITELLGSP--SEED 232 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCC--ChHH
Confidence 664221 22234567889999998765 4689999999999999999999999975421111 11111100000 0000
Q ss_pred hh-----------hhcchh-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1034 FD-----------KRLDLS-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1034 ~~-----------~~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.. +..... ..........+.+++.+||+.+|++|||+++++++-+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~ 294 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence 00 000000 00011233557899999999999999999999999443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=329.97 Aligned_cols=253 Identities=28% Similarity=0.448 Sum_probs=192.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe---------
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--------- 871 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 871 (1109)
.+|++.+.||+||||.||+++.+ ||+.||||++.... .......+.+|+..+.+++|||||+++..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 46777889999999999999976 89999999998776 45566778899999999999999999631100
Q ss_pred ---------------------------------------------------------------------C----------
Q 001274 872 ---------------------------------------------------------------------Q---------- 872 (1109)
Q Consensus 872 ---------------------------------------------------------------------~---------- 872 (1109)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhh
Q 001274 873 -------------------------------DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921 (1109)
Q Consensus 873 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 921 (1109)
...||-||||+..++.++++.+... -.....++++.+|++|+.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH- 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIH- 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHH-
Confidence 0137889999998888888776532 146788999999999999999
Q ss_pred cCCCCeEecCCCCCceeeCCCCceEEeecccccccc-----------------CCCCCCccccccccceeccccccCCC-
Q 001274 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID-----------------LPYSKSMSAIAGSYGYIAPEYAYTMK- 983 (1109)
Q Consensus 922 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~- 983 (1109)
+.|||||||||.||+++++..|||+|||+|.... .......+..+||.-|+|||++.+..
T Consensus 715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 8899999999999999999999999999998721 01112335678999999999987654
Q ss_pred --CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccC
Q 001274 984 --VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSS 1061 (1109)
Q Consensus 984 --~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 1061 (1109)
|+.|+||||+|||++||+. ||....+......-++ .+..|.+. ....+....=.++|+++++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR---~g~iP~~~----------~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR---KGSIPEPA----------DFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc---cCCCCCCc----------ccccccchHHHHHHHHHhc
Confidence 9999999999999999974 5664322222222122 22222221 1122223334589999999
Q ss_pred CCCCCCCCHHHHHHH
Q 001274 1062 TSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1062 ~dP~~RPt~~evl~~ 1076 (1109)
.||.+||||.|++..
T Consensus 857 hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 857 HDPSKRPTATELLNS 871 (1351)
T ss_pred CCCccCCCHHHHhhc
Confidence 999999999999853
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=303.36 Aligned_cols=263 Identities=27% Similarity=0.368 Sum_probs=202.2
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
|++.+.||+|++|.||+|... +++.+|+|++............+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999865 6899999998755444344567889999999999999999999999999999999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 962 (1109)
++ ++.+++..... .+++..+..++.|+++|+.||| +.+|+|+||||+||+++.++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhhcc--cCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 75 88888876432 3899999999999999999999 7799999999999999999999999999998765332 1
Q ss_pred CccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc--
Q 001274 963 SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD-- 1039 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1039 (1109)
......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+.... +....... ....+.....
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~ 230 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK-IFRTLGTP--DPEVWPKFTSLA 230 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHcCCC--chHhcccchhhh
Confidence 22334678889999998876 789999999999999999999999975432111111 11111100 0000000000
Q ss_pred -------------hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1040 -------------LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1040 -------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
............+.+++.+||+.||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000112234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=293.32 Aligned_cols=250 Identities=30% Similarity=0.453 Sum_probs=204.1
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|++.+.||+|++|.||+|+.. +++.||+|.+..........+.+.+|++++++++|+|++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 678999999986654434567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++.... .+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999997653 3899999999999999999999 78999999999999999999999999999987653222
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
......++..|+|||+..+..++.++||||+|+++|+|++|+.||.... ..............+.
T Consensus 155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~----------- 219 (254)
T cd06627 155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN---PMAALFRIVQDDHPPL----------- 219 (254)
T ss_pred -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHhccCCCCC-----------
Confidence 1234567889999999988889999999999999999999999987543 1111111111111111
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+|++.+|++||++.+++.+
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 01112457799999999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=295.19 Aligned_cols=247 Identities=26% Similarity=0.304 Sum_probs=191.9
Q ss_pred HHHHhcCCCCCceE--ecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 797 LLEATGNFSEGAVI--GRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 797 ~~~~~~~~~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
.....++|.+.+.+ |+|+||.||+++.+ +++.+|+|.+....... .|+.....+ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 33445677777776 99999999999864 68889999986432111 122222222 799999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeecc
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFG 951 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG 951 (1109)
+..++||||+++++|.+++.... .+++..+..++.|+++|+.||| +.+++||||||+||+++.++ .++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 99999999999999999997654 3899999999999999999999 78999999999999999998 99999999
Q ss_pred ccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC-cHHHHHHHhhhccCCC
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG-DLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 1030 (1109)
.++..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||....... ....+.... ....+.
T Consensus 156 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (267)
T PHA03390 156 LCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPF 229 (267)
T ss_pred cceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCc
Confidence 98765421 23467889999999999999999999999999999999999998543222 112222221 111110
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT-MREVIAM 1076 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~~ 1076 (1109)
.......+.+++.+|++.+|++||+ +++++++
T Consensus 230 --------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 230 --------------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred --------------ccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 1122345789999999999999996 6998865
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=299.36 Aligned_cols=248 Identities=24% Similarity=0.250 Sum_probs=190.3
Q ss_pred eEecCCcceEEEEEec-CCcEEEEEEeeccCCCcc-hhHHHHHHHHHh---ccCCCCceeeEEEEEEeCCceEEEEEecc
Q 001274 809 VIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGAT-ADNSFLAEISTL---GKIRHRNIVKLYGFCYHQDSNLLLYEYME 883 (1109)
Q Consensus 809 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 883 (1109)
.||+|+||.||+|+.. +++.||+|.+........ ....+.+|..++ ...+|++|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999865 689999999865432212 223344554433 34479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCC
Q 001274 884 NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS 963 (1109)
Q Consensus 884 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 963 (1109)
+|+|.+++...+. +++..+..++.|++.|++||| +.+|+||||||+||+++.++.++++|||++...... .
T Consensus 81 ~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~ 151 (279)
T cd05633 81 GGDLHYHLSQHGV---FSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---K 151 (279)
T ss_pred CCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---C
Confidence 9999999876543 899999999999999999999 779999999999999999999999999999755321 1
Q ss_pred ccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhh
Q 001274 964 MSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042 (1109)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1109)
.....|+..|+|||++.+ ..++.++||||+||++|||++|..||...... ...............
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~------------- 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTLTVNVE------------- 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-CHHHHHHHhhcCCcC-------------
Confidence 223468999999998864 56899999999999999999999999754321 111111111110000
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHHh
Q 001274 1043 KRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMIDA 1080 (1109)
Q Consensus 1043 ~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~~ 1080 (1109)
........+.+++.+|++.||++|| ++++++++.+..
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~ 259 (279)
T cd05633 218 -LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259 (279)
T ss_pred -CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence 0111224577899999999999999 699999986544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=311.95 Aligned_cols=273 Identities=22% Similarity=0.326 Sum_probs=205.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe----CCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH----QDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 876 (1109)
++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 68899999999999999999865 69999999997554333445677889999999999999999998764 34578
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+. ++|.+++..... +++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 689998876543 899999999999999999999 779999999999999999999999999999765
Q ss_pred cCCCCCC---ccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 957 DLPYSKS---MSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 957 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
....... .....++..|+|||++.+ ..++.++||||+||++|||++|+.||.+....... ..+..... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~-~~~~~~~g--~~~~~ 234 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-KLILSVLG--SPSEE 234 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH-HHHHHHhC--CChhH
Confidence 4322111 134578889999998765 45899999999999999999999999754321111 11111000 00111
Q ss_pred hhhh-----------hcchhhc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1033 LFDK-----------RLDLSAK-----RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1033 ~~~~-----------~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.++. ....... ........+.+++.+||+.+|++||++++++.+-+......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 1000 0000000 01122456889999999999999999999999877664433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=308.67 Aligned_cols=268 Identities=24% Similarity=0.316 Sum_probs=198.5
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----c
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD-----S 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 874 (1109)
.++|++.++||+|+||.||+|++. +++.||+|++.... .......+.+|+.++++++|+||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 468999999999999999999864 68999999986332 2234456888999999999999999999876543 4
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++|+||++ +++.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECccccee
Confidence 689999996 4888877543 2899999999999999999999 7899999999999999999999999999997
Q ss_pred cccCCCCC--CccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 955 LIDLPYSK--SMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 955 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
........ ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||.+...... ...+...... +..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~--~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGT--PSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCC--CCH
Confidence 65422111 1234568899999998754 5689999999999999999999999975321111 1111110100 000
Q ss_pred hhhhhh-----------cchhhc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1032 ELFDKR-----------LDLSAK-----RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1032 ~~~~~~-----------~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
+.+... ...... ........+.+++.+||+.+|++|||+.|++++-+-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 100000 000000 0011234588999999999999999999999984433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=332.42 Aligned_cols=269 Identities=22% Similarity=0.202 Sum_probs=212.7
Q ss_pred HHHHHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeC
Q 001274 795 HNLLEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 795 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 872 (1109)
.++....++|.+.++||+|+||.|..++++ +++.||+|++..-.-- .....-|..|-.+|..-+.+.|+.+.-.|++.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 344455678999999999999999999976 6889999998642111 12345688899999999999999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
.+.|+|||||+||+|..++.+... ++++.++.++..|+.||+.+| +.|+|||||||+|||+|..|++|++|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~---~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDR---LPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCC---ChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999988773 999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceecccccc----C-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAY----T-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM 1027 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 1027 (1109)
+..++.+........+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||......+.+-..+...-.-.
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS 301 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence 9888766566667789999999999986 3 5699999999999999999999999985432222222111110111
Q ss_pred CCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHHHHhhhcc
Q 001274 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT---MREVIAMMIDARQSV 1084 (1109)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~evl~~L~~~~~~~ 1084 (1109)
+| + ..+..+...++|.+.+. +|+.|.. +.++..|.+..-...
T Consensus 302 FP--~------------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 302 FP--D------------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred CC--c------------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 11 0 11223445567766544 6888888 999998876554333
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=297.46 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=197.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC---CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--Cce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG---EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 875 (1109)
.+|++.+.||+|+||.||+|++. +++.||+|++.... ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999864 68999999885432 1223446788999999999999999999998764 357
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++|+||+++++|.+++..... +++..+.+++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999876543 788999999999999999999 77999999999999999999999999999986
Q ss_pred ccCCC--CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 956 IDLPY--SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 956 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+....... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~--~~~~ 229 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AAIFKIATQP--TKPM 229 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----HHHHHHHcCC--CCCC
Confidence 53211 11123456889999999999888999999999999999999999999753211 1111111111 1111
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
+ .......+.+++.+||+ +|.+||++.+++.+
T Consensus 230 ~----------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 230 L----------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred C----------CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1 11222457899999999 47999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=296.23 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=206.9
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|++.+.||.|+||.||+|.+. +++.||+|++..........+.+.+|+++++.++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999965 689999999986655445667889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 882 MENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
+++++|.+++.... ....+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 1234899999999999999999999 7799999999999999999999999999998665322
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......+++.|+|||...+..++.++||||+|+++|+|++|+.||.... ..+..........+. .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~--~------- 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----LLELALKILKGQYPP--I------- 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc----HHHHHHHHhcCCCCC--C-------
Confidence 12234568889999999998899999999999999999999999987533 222222222211110 0
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.......+.+++.+||..+|++||++.+++++
T Consensus 224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00112457799999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=294.96 Aligned_cols=248 Identities=23% Similarity=0.254 Sum_probs=200.3
Q ss_pred EecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCH
Q 001274 810 IGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSL 887 (1109)
Q Consensus 810 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 887 (1109)
||.|+||.||+|+.. +++.||+|++..... .....+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 589999999975432 223456799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCcccc
Q 001274 888 GEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967 (1109)
Q Consensus 888 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 967 (1109)
.+++.+... +++..+..++.|++.|++|+| +.+++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDRGL---FDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhcCC---CCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999976543 889999999999999999999 7899999999999999999999999999998664221 22334
Q ss_pred ccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHH
Q 001274 968 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVE 1047 (1109)
Q Consensus 968 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
.++..|+|||++.+..++.++|+||+|+++|+|++|+.||..... +..+............ .....
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~------------~~~~~ 218 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DPMEIYNDILKGNGKL------------EFPNY 218 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CHHHHHHHHhccCCCC------------CCCcc
Confidence 678899999999888899999999999999999999999975432 2233333322111000 00111
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHHH
Q 001274 1048 EMTLFLKIALFCSSTSPLNRPT-----MREVIAMMID 1079 (1109)
Q Consensus 1048 ~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~~ 1079 (1109)
....+.+++.+||+.+|++||+ ++|++++-+.
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence 1346789999999999999999 8888886654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=306.10 Aligned_cols=269 Identities=21% Similarity=0.216 Sum_probs=196.0
Q ss_pred CceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCC
Q 001274 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGS 886 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 886 (1109)
++.+|.|+++.||++.. +++.||||++..........+.+.+|++++++++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33444444544444444 68999999997654444556789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC-----
Q 001274 887 LGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS----- 961 (1109)
Q Consensus 887 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~----- 961 (1109)
+.+++...... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++|||.+........
T Consensus 86 l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFPE-GLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999764322 3788999999999999999999 77999999999999999999999999998875532111
Q ss_pred -CCccccccccceeccccccCC--CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-----C----
Q 001274 962 -KSMSAIAGSYGYIAPEYAYTM--KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-----P---- 1029 (1109)
Q Consensus 962 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----~---- 1029 (1109)
.......++..|+|||++.+. .++.++||||+||++|||++|+.||..........+.......... +
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 111334577889999998763 5889999999999999999999999864322222221111100000 0
Q ss_pred -Cch----hhhh--hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1030 -TSE----LFDK--RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1030 -~~~----~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
... ..+. ...............+.+++.+||+.+|++|||+.+++++-+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 000 0000 00000111222234678999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=295.30 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=204.7
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|++.++||+|+||.||+++.. +++.+|+|++............+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999855 688999999976544444566788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 882 MENGSLGEQLHGNKQ-TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
+++++|.+++..... ...+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999866321 234889999999999999999999 789999999999999999999999999999876532
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
......++..|+|||.+.+..++.++|+||+|+++|||++|+.||.... ..+..........+.
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~---------- 220 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS----MQDLRYKVQRGKYPP---------- 220 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCC----------
Confidence 2223457889999999999999999999999999999999999997543 122222111111110
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
........+.+++.+|++.+|++||++.+++++
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011233457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=292.93 Aligned_cols=253 Identities=29% Similarity=0.425 Sum_probs=206.4
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--CceEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSNLLLY 879 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 879 (1109)
+|+..+.||+|++|.||+|... +++.|++|++..........+.+.+|++++++++|+||+++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 689999999975544345567899999999999999999999999988 8899999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++.... .+++..+..++.|+++|++||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999998765 3899999999999999999999 789999999999999999999999999999876533
Q ss_pred CCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
... ......++..|+|||...+..++.++||||+|+++|+|++|+.||.... .............. ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~-~~~------ 224 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---NPMAALYKIGSSGE-PPE------ 224 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHhccccCC-CcC------
Confidence 221 1234568889999999998889999999999999999999999997543 11121111111000 000
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
........+.+++.+|++.+|++||++.|++.+
T Consensus 225 -----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 -----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 011113568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=305.62 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=196.8
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC------
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD------ 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 873 (1109)
.++|...+.||+|+||.||+|++. +++.||||+++...........+.+|++++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368989999999999999999864 6899999998754333333456889999999999999999999987543
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA 953 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 953 (1109)
..++|+||+.. ++..+... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 35899999964 77766521 2889999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc-CCCc
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-VPTS 1031 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 1031 (1109)
+.... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||.+... ...+....... .+..
T Consensus 165 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTGVPGP 236 (342)
T ss_pred cCCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCH
Confidence 75431 2234567889999999876 4688999999999999999999999985321 11111111111 0000
Q ss_pred hhhhhhc-----------chhhc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhh
Q 001274 1032 ELFDKRL-----------DLSAK-----RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM--MIDAR 1081 (1109)
Q Consensus 1032 ~~~~~~~-----------~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 1081 (1109)
...+... ..... ........+.+++.+||+.||++||++++++.+ ++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000000 00000 001122457799999999999999999999977 54443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=306.30 Aligned_cols=268 Identities=26% Similarity=0.308 Sum_probs=206.0
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----ceE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD-----SNL 876 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 876 (1109)
+|++.+.||+|+||.||+|+.. +++.||||++..........+.+.+|+.+++.++|+||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999975 5899999999755433445678999999999999999999999988775 789
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||++ ++|.+++.... .+++..+..++.+++.||+||| +.+|+||||||+||+++.++.++|+|||.+...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58988887654 3899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCC--CCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCch
Q 001274 957 DLPYS--KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSE 1032 (1109)
Q Consensus 957 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 1032 (1109)
..... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...... +.......... +..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI----DQLNLIVEVLGTPSEE 229 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHhcCCCChh
Confidence 53321 123445678899999999888 7899999999999999999999999754321 11111111110 0000
Q ss_pred hhh-----------hhcchhh-----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1033 LFD-----------KRLDLSA-----KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1033 ~~~-----------~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
... ....... .........+.+++.+||+.+|++||++.+++++-+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 000 0000000 001112356789999999999999999999999855443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=256.35 Aligned_cols=264 Identities=23% Similarity=0.351 Sum_probs=204.8
Q ss_pred CCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|...++||+|.||+||+|+ +++++.||+|.+..............+|+-+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667789999999999998 45689999999988777666677889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
|. .+|..|.....+. ++.+.++.++.|+++|+.++| ++++.|||+||.|.+++.+|.+|++|||+++.++.+.
T Consensus 83 cd-qdlkkyfdslng~--~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGD--LDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hh-HHHHHHHHhcCCc--CCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 95 5898888765554 899999999999999999999 7899999999999999999999999999999877443
Q ss_pred CCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
......+.|..|++|+++.+.+ |+...|+||.||++.|+.. |++.|.+. +..+.+++.+.-.....+--.+.+.
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~----dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC----cHHHHHHHHHHHhCCCccccCCccc
Confidence 2345567799999999999876 7899999999999999998 55556643 3333444333322211111111110
Q ss_pred h----------hh-----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1040 L----------SA-----KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1040 ~----------~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
. .. ...+.-...-.+++++.+.-+|.+|.++++.+++-
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 0 00 00111112345677777888999999999988764
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=300.06 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=198.2
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGS 886 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 886 (1109)
.+||+|+||.||+|..+ +++.||||++.... ......+.+|+.+++.++|+|++++++++...+..++||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 57999999999999864 78999999885432 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCccc
Q 001274 887 LGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSA 966 (1109)
Q Consensus 887 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 966 (1109)
|.+++... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++....... .....
T Consensus 104 L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 104 LTDIVTHT----RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 99987543 2789999999999999999999 7799999999999999999999999999987654221 22234
Q ss_pred cccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccH
Q 001274 967 IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTV 1046 (1109)
Q Consensus 967 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
..++..|+|||++.+..++.++||||+|+++|||++|+.||..... .+..... ....+.. .. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~~~~-~~~~~~~------~~----~~~ 240 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMI-RDNLPPK------LK----NLH 240 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH-HhhCCcc------cC----Ccc
Confidence 5688999999999888899999999999999999999999874321 1111111 1111100 00 011
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1047 EEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1047 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
.....+.+++.+||+.+|.+||++.+++++=+....
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 112346789999999999999999999987554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=308.11 Aligned_cols=271 Identities=25% Similarity=0.327 Sum_probs=202.9
Q ss_pred HHHHHHhcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-
Q 001274 795 HNLLEATGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ- 872 (1109)
Q Consensus 795 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 872 (1109)
.++...+++|.+.+.||+|+||.||+|.. .+++.||+|+++.........+.+.+|++++++++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34556778999999999999999999985 4789999999874433333456788999999999999999999988643
Q ss_pred -----CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 001274 873 -----DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV 947 (1109)
Q Consensus 873 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 947 (1109)
...+++++++ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence 2357788877 78998887643 2899999999999999999999 789999999999999999999999
Q ss_pred eeccccccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 948 GDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 948 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
+|||+++... .......++..|+|||++.+ ..++.++||||+||++|||++|+.||.............+..
T Consensus 162 ~dfg~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--- 234 (345)
T cd07877 162 LDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--- 234 (345)
T ss_pred eccccccccc----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---
Confidence 9999998643 22234567889999998866 568899999999999999999999997533211111111110
Q ss_pred cCCCchhhhhh-----------cchhhc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1027 MVPTSELFDKR-----------LDLSAK-----RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1027 ~~~~~~~~~~~-----------~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
..+........ +..... ........+.+++.+|++.||++||++.+++++-+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 00011111000 000000 0001234577999999999999999999999987644
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=284.05 Aligned_cols=253 Identities=24% Similarity=0.286 Sum_probs=204.1
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.++|...++||+|.||+|-+++-+ .++.||+|+++....- .++...-..|-++++..+||.+..+--.|+..+..|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888899999999999999855 7999999999755322 23344566889999999999999998889999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+.||.|.-++.+.+ .+++...+.....|+.||.||| +.+||+||+|.+|.|+|.||++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999998887654 3899999999999999999999 7799999999999999999999999999998543
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.+......++||+.|.|||++....|+.++|.|.+||++|||+.|+.||...+. +.+.+.+.. +. +
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeLIl~---ed-----~----- 385 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFELILM---ED-----L----- 385 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-hHHHHHHHh---hh-----c-----
Confidence 345566889999999999999999999999999999999999999999985431 122222211 11 1
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMI 1078 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~ 1078 (1109)
. .+.....+...++...+..||.+|. .+.||.++-.
T Consensus 386 k----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 386 K----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF 426 (516)
T ss_pred c----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence 1 1111112345678888999999994 4777776643
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=299.90 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=197.2
Q ss_pred cCCCCCceEecCCcceEEEEEecC-CcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|.+++ ++.||||.++.... ......+..|+.++.+. +|+||+++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 568889999999999999999764 89999999974422 22345667788777666 5999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||++ +++.+++..... .+++..+..++.|++.|++|||+. .+|+||||+|+||+++.++.+||+|||.+......
T Consensus 94 e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 577777655333 389999999999999999999931 48999999999999999999999999999765422
Q ss_pred CCCCccccccccceeccccccCCC----CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.......++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .+..........+..+.
T Consensus 169 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~-- 241 (296)
T cd06618 169 --KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEPPSLPP-- 241 (296)
T ss_pred --CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCCCCCCCC--
Confidence 1223345788999999987654 789999999999999999999999753211 12222222221111000
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.......+.+++.+||+.||++||++.+++++.+..
T Consensus 242 ---------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 242 ---------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred ---------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 001224578999999999999999999999887644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=304.91 Aligned_cols=265 Identities=24% Similarity=0.305 Sum_probs=199.9
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD----- 873 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 873 (1109)
..++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4578999999999999999999854 7899999998643333333456889999999999999999999987654
Q ss_pred -ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 874 -SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 874 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
..++||||+ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||||+||+++.++.++++|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 348999999 77998887642 2899999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
+..... ......+++.|+|||++.+ ..++.++||||+|+++|++++|+.||...... ..............
T Consensus 165 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~ 236 (343)
T cd07880 165 ARQTDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL----DQLMEIMKVTGTPS 236 (343)
T ss_pred cccccc----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCC
Confidence 986542 2233467889999998876 45889999999999999999999999753321 11111111111000
Q ss_pred hhhhhhcchh-----------------hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1032 ELFDKRLDLS-----------------AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1032 ~~~~~~~~~~-----------------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
..+...+... ..........+.+++.+|++.||++|||+.+++++-+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~ 302 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence 0010000000 000011233578999999999999999999999775443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=302.74 Aligned_cols=269 Identities=27% Similarity=0.323 Sum_probs=196.3
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC------
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD------ 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 873 (1109)
.++|++.++||+|+||.||+|++. +++.||+|++............+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999865 6899999998754333333456788999999999999999999875543
Q ss_pred --ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 874 --SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 874 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
..++||||+.+ ++...+..... .+++..+..++.|+++||+||| +.+++||||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~--~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSV--KLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999964 77777765433 3899999999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCC----------CccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHH
Q 001274 952 LAKLIDLPYSK----------SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWV 1020 (1109)
Q Consensus 952 ~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~ 1020 (1109)
+++........ ......+++.|+|||++.+. .++.++||||+||++|||++|+.||.+...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99765422111 11233567889999987654 58899999999999999999999997543221111111
Q ss_pred HHhhhccCC----------Cch--hhhhhcchh-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1021 RRSIHEMVP----------TSE--LFDKRLDLS-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1021 ~~~~~~~~~----------~~~--~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
. ......+ ... ......... ..........+.+++.+|++.+|++|||+.|++.+
T Consensus 241 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 K-LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred H-HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1 1110000 000 000000000 00001112457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=303.67 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=201.9
Q ss_pred HHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe-CCce
Q 001274 798 LEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH-QDSN 875 (1109)
Q Consensus 798 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 875 (1109)
...+++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999865 78999999886443333445678899999999999999999999876 4578
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++|+||+ +++|.+++.... +++.....++.|+++|++||| +.+++||||+|+||+++.++.++|+|||.+..
T Consensus 86 ~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 568988886432 788888899999999999999 78999999999999999999999999999875
Q ss_pred ccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 956 IDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
.. .......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||........... +...... +..++.
T Consensus 158 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~-~~~~~~~--~~~~~~ 230 (328)
T cd07856 158 QD----PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI-ITDLLGT--PPDDVI 230 (328)
T ss_pred cC----CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCC--CCHHHH
Confidence 43 12234467889999998766 5689999999999999999999999975432111111 1110000 001110
Q ss_pred hh-----------hcchhhccc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1035 DK-----------RLDLSAKRT-----VEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1035 ~~-----------~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.. ......... ......+.+++.+|++.+|++||++.+++.+-+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~ 292 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence 00 000000000 11235688999999999999999999999885443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=302.34 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=198.1
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.|...+.||+|+||.||+|+.. +++.||+|.+..... ......++.+|+++++.++|+|++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666788999999999999965 678899999864322 22334568899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+. |++.+++..... .+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 96 YCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred ccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 996 688777754433 3889999999999999999999 77999999999999999999999999999876542
Q ss_pred CCCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
.....++..|+|||++. ...++.++||||+||++|||++|+.||...... ...........+..
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~------ 234 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNESPAL------ 234 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH----HHHHHHhhcCCCCc------
Confidence 12346788999999875 356788999999999999999999998753211 11111111111100
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
........+.+++.+||+.+|++||++.+++++.+...
T Consensus 235 ------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 235 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 01122345779999999999999999999999876655
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=292.96 Aligned_cols=248 Identities=23% Similarity=0.234 Sum_probs=190.0
Q ss_pred eEecCCcceEEEEEec-CCcEEEEEEeeccCCCc-chhHHHHHHHH---HhccCCCCceeeEEEEEEeCCceEEEEEecc
Q 001274 809 VIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA-TADNSFLAEIS---TLGKIRHRNIVKLYGFCYHQDSNLLLYEYME 883 (1109)
Q Consensus 809 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 883 (1109)
.||+|+||.||+|+.. +++.||+|.+....... .....+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3799999999999864 58899999987543221 12223344433 4455689999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCC
Q 001274 884 NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS 963 (1109)
Q Consensus 884 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 963 (1109)
+|+|.+++.... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++...... .
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~ 151 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---K 151 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---C
Confidence 999999887544 3899999999999999999999 779999999999999999999999999998755321 2
Q ss_pred ccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhh
Q 001274 964 MSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042 (1109)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1109)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||....... ...............
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~------------ 218 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVEL------------ 218 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-hHHHHHHhhccCCCC------------
Confidence 2345789999999998754 68999999999999999999999997643211 111111111111000
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHHh
Q 001274 1043 KRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMIDA 1080 (1109)
Q Consensus 1043 ~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~~ 1080 (1109)
.......+.+++.+|+..+|++|| ++.+++++-+..
T Consensus 219 --~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~ 259 (278)
T cd05606 219 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259 (278)
T ss_pred --CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence 011124678999999999999999 999999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=289.48 Aligned_cols=266 Identities=25% Similarity=0.317 Sum_probs=207.9
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-C-C----ceeeEEEEEEeCC
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-H-R----NIVKLYGFCYHQD 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~ 873 (1109)
+++|.+...+|+|.||.|-++.+. .+..||||+++... .-.++.+-|+++++++. + | -+|.+.+||...+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 579999999999999999999865 57899999997332 23455677999999993 2 2 4788999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC------------
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE------------ 941 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------------ 941 (1109)
+.|+|+|.+ |-|+.+++..+... .++...++.|+.|++++++||| +.+++|.||||+||++.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~-~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYI-PFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCcc-ccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCc
Confidence 999999999 67999999886643 5999999999999999999999 889999999999999931
Q ss_pred --------CCceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC
Q 001274 942 --------EFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG 1013 (1109)
Q Consensus 942 --------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~ 1013 (1109)
+..++++|||.|+... ......+.|..|+|||++.+-.|+.++||||+|||++|+.||...|+..+.-
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceec----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 3458999999998643 3346778999999999999999999999999999999999999999876522
Q ss_pred CcHHHHHHHhhhccCCCchhhhhh-------------------------------cchhhcccHHHHHHHHHHHHhccCC
Q 001274 1014 GDLVTWVRRSIHEMVPTSELFDKR-------------------------------LDLSAKRTVEEMTLFLKIALFCSST 1062 (1109)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~li~~cl~~ 1062 (1109)
+.+ ..+.... +..|. .++.+. +.........+...+++++.+|+..
T Consensus 316 EHL-aMMerIl-Gp~P~-~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 316 EHL-AMMERIL-GPIPS-RMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred HHH-HHHHHhh-CCCcH-HHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 211 2222221 12211 111111 0001112345566799999999999
Q ss_pred CCCCCCCHHHHHHHHHHhh
Q 001274 1063 SPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1063 dP~~RPt~~evl~~L~~~~ 1081 (1109)
||.+|+|++|++.+-....
T Consensus 393 DP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFAR 411 (415)
T ss_pred CccccccHHHHhcCHHhhc
Confidence 9999999999998876543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=277.15 Aligned_cols=257 Identities=23% Similarity=0.282 Sum_probs=201.8
Q ss_pred hcCCCCC-ceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEe----CC
Q 001274 801 TGNFSEG-AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYH----QD 873 (1109)
Q Consensus 801 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~ 873 (1109)
+++|++. ++||-|-.|.|-.+..+ +++.+|+|++. ......+|++..-.. .|||||.++++|.. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3455543 57999999999999765 68999999986 234456888876555 79999999999864 33
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEeec
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE---EFQAHVGDF 950 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DF 950 (1109)
...+|||.|+||.|...+..++.. .+++.++..|++||+.|+.||| +.+|.||||||+|+|... +-.+|++||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccc
Confidence 456899999999999999887654 4999999999999999999999 889999999999999964 457999999
Q ss_pred cccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc-c--
Q 001274 951 GLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE-M-- 1027 (1109)
Q Consensus 951 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~-~-- 1027 (1109)
|+|+.... .....+.+-|+.|.|||++-..+|+..+|+||+||++|-|+.|..||...... .+.--++..+.. .
T Consensus 209 GFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 209 GFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKRRIRTGQYE 285 (400)
T ss_pred ccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-cCChhHHhHhhccCcc
Confidence 99997653 34556778899999999999999999999999999999999999999875532 211112222211 1
Q ss_pred CCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
+|..++ ....+...++|+.++..+|++|.|..+++++-|-....
T Consensus 286 FP~pEW------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 286 FPEPEW------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred CCChhH------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 111111 12234567899999999999999999999988765443
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=298.69 Aligned_cols=248 Identities=30% Similarity=0.447 Sum_probs=195.2
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
|...++||+|+||+||+|+.. +++.||+|++...... ......+.+|+++++.++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999864 6889999998654322 22345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+. |++.+++..... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 103 ~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 578777765433 3899999999999999999999 7799999999999999999999999999986432
Q ss_pred CCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 962 KSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
......++..|+|||++. ...++.++||||+||++|||++|..||..... ............+. ..
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~~~~~~--~~---- 241 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNDSPT--LQ---- 241 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCC--CC----
Confidence 123456888999999974 45688999999999999999999999875321 12222211111111 00
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.......+.+++.+||+.+|++||++.+++.+-+
T Consensus 242 ------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 242 ------SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 0111234678999999999999999999997743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=300.81 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=202.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 878 (1109)
++|...+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999865 689999999865322 2233567889999999998 99999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++++|.+++.... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999998764 3899999999999999999999 77999999999999999999999999999986543
Q ss_pred CCC-------------------CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHH
Q 001274 959 PYS-------------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTW 1019 (1109)
Q Consensus 959 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~ 1019 (1109)
... .......++..|+|||+..+..++.++||||+|+++|++++|+.||...... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~ 230 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----LT 230 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----HH
Confidence 221 1123345788999999998888999999999999999999999999854311 11
Q ss_pred HHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCH----HHHHHH
Q 001274 1020 VRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTM----REVIAM 1076 (1109)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~----~evl~~ 1076 (1109)
........... .......+.+++.+||+.+|++||++ .+++++
T Consensus 231 ~~~~~~~~~~~--------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 231 FQKILKLEYSF--------------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHhcCCCC--------------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11111111111 11113457899999999999999999 887765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=291.29 Aligned_cols=245 Identities=23% Similarity=0.247 Sum_probs=188.2
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHh-ccCCCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTL-GKIRHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+.||+|+||.||+|+.. +++.||+|++...... ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 6899999998643221 11223445555544 455899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
++|.+++..... +++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||+++.... .
T Consensus 82 ~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKTLGG---LPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999976543 889999999999999999999 77999999999999999999999999999875432 2
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
....++..|+|||++.+..++.++||||+|+++|||++|..||..... ................. .
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~----------~ 216 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DAVFDNILSRRINWPEE----------V 216 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhcccCCCCc----------c
Confidence 234578899999999888899999999999999999999999975321 12222111111100000 0
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHH
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMR---EVIAMM 1077 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~---evl~~L 1077 (1109)
.......+.+++.+||+.+|++||++. |++.+-
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 111234578999999999999999664 555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=303.86 Aligned_cols=269 Identities=23% Similarity=0.288 Sum_probs=199.2
Q ss_pred cCCC-CCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcc------------hhHHHHHHHHHhccCCCCceeeEEE
Q 001274 802 GNFS-EGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGAT------------ADNSFLAEISTLGKIRHRNIVKLYG 867 (1109)
Q Consensus 802 ~~~~-~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~~ 867 (1109)
++|. +.+.||+|+||+||+|++. +++.||||+++....... ....+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4577999999999999865 689999999864422210 1125778999999999999999999
Q ss_pred EEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 001274 868 FCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV 947 (1109)
Q Consensus 868 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 947 (1109)
++...+..++||||++ |+|.+++..... +++.....++.|++.|++||| +.+++||||+|+||+++.++.+++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR---LTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEE
Confidence 9999999999999996 699999865433 899999999999999999999 789999999999999999999999
Q ss_pred eeccccccccCCC-------------CCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccC
Q 001274 948 GDFGLAKLIDLPY-------------SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELG 1013 (1109)
Q Consensus 948 ~DFG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~ 1013 (1109)
+|||.++....+. ........++..|+|||++.+. .++.++||||+||++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999997654111 1111233467889999998764 4689999999999999999999999754322
Q ss_pred CcHHHHHHHhhhccCCCchhhhhhc------------chh-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1014 GDLVTWVRRSIHEMVPTSELFDKRL------------DLS-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
+....... ..... ....+.... ... ..........+.+++.+|++.+|++||+++|++.+-+..
T Consensus 241 ~~~~~i~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 241 DQLGRIFE-LLGTP--NEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHHHH-HhCCC--chhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 11111111 11100 000000000 000 000111234577999999999999999999999887654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=296.29 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=197.1
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEEEEe
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
|++.+.||+|+||+||+|+.. +++.||||++...... .......+|+..+++++ |+|++++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 567789999999999999975 5789999998644322 23334567999999998 99999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+ +|++.+++..... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-- 152 (283)
T cd07830 80 M-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-- 152 (283)
T ss_pred C-CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--
Confidence 9 8899998876542 23899999999999999999999 779999999999999999999999999999865421
Q ss_pred CCccccccccceecccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCC--------Cch
Q 001274 962 KSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP--------TSE 1032 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~ 1032 (1109)
.......++..|+|||++. ...++.++||||||+++|||++|+.||......+....... ....... ...
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS-VLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHH-hcCCCChhhhhhHhhhhc
Confidence 2223456788999999875 44578999999999999999999999865432111111100 0000000 000
Q ss_pred hhhhhcchh-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1033 LFDKRLDLS-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1033 ~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.++...... ..........+.+++.+||+.+|++|||+.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 00001113568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=280.62 Aligned_cols=265 Identities=24% Similarity=0.352 Sum_probs=201.2
Q ss_pred CHHHHHHHhcCCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEE
Q 001274 793 KYHNLLEATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCY 870 (1109)
Q Consensus 793 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 870 (1109)
++++.+.-++ +.||+|+|+.|--+. ..+|..||||++... .......+.+|++++.+. .|+||+.++++|.
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 4555554444 479999999999886 678999999999744 334567788999999999 6999999999999
Q ss_pred eCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---ceEE
Q 001274 871 HQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF---QAHV 947 (1109)
Q Consensus 871 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 947 (1109)
+++..|+|||.|.||.|..++++.+. +++.++.++.++|+.||+||| .+||.|||+||+|||-.... -+||
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceee
Confidence 99999999999999999999988765 999999999999999999999 88999999999999996654 4899
Q ss_pred eeccccccccCC--C----CCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccC---
Q 001274 948 GDFGLAKLIDLP--Y----SKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELG--- 1013 (1109)
Q Consensus 948 ~DFG~a~~~~~~--~----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~--- 1013 (1109)
+||.++...... - .....+.+|+-.|||||+.. ...|+.++|.||+|||+|-|+.|..||.+.-..
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 999988654311 1 11224457888999999764 235899999999999999999999999875421
Q ss_pred ---CcHH----HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1014 ---GDLV----TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1014 ---~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
+... ..+-+.+++.. -++-++.. .....+..+++...+..|+.+|.++.+++.+-+-
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGk--YeFPdkdW-------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGK--YEFPDKDW-------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccC--CcCChhhh-------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 1111 11111122111 01111111 1122345577888888999999999999986543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=287.97 Aligned_cols=257 Identities=26% Similarity=0.354 Sum_probs=199.2
Q ss_pred cCCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCCcch-----hHHHHHHHHHhccCCCCceeeEEEEEEe-CCc
Q 001274 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATA-----DNSFLAEISTLGKIRHRNIVKLYGFCYH-QDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 874 (1109)
++|-...+||+|||+.||+|. ....+.||||+-.......++ .+...+|..|.+.++||.||++++++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 477788899999999999997 456889999987644322222 2346689999999999999999999975 567
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceEEeecc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD---EEFQAHVGDFG 951 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG 951 (1109)
.|-|.|||+|.+|+-|++.++- +++++++.|+.||+.||.||.+. +.+|||-||||.|||+- .-|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 7899999999999999987764 89999999999999999999976 88999999999999994 45789999999
Q ss_pred ccccccCCCCCCc------cccccccceeccccccCC----CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHH
Q 001274 952 LAKLIDLPYSKSM------SAIAGSYGYIAPEYAYTM----KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVR 1021 (1109)
Q Consensus 952 ~a~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~ 1021 (1109)
+++.++.+..... ....||..|++||.+.-+ +.+.|+||||.||++|+.+.|+.||.......++.+...
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 9998875443321 345799999999987633 468899999999999999999999986443333222111
Q ss_pred --HhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1022 --RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1022 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
....-.+|..+.+ ..+...||.+|+.+.-++|....++..+
T Consensus 699 IlkAtEVqFP~KPvV--------------sseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVV--------------SSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hhcceeccCCCCCcc--------------CHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 0011111221111 1245689999999999999888777644
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=295.14 Aligned_cols=246 Identities=27% Similarity=0.353 Sum_probs=194.8
Q ss_pred EecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCH
Q 001274 810 IGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSL 887 (1109)
Q Consensus 810 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 887 (1109)
||+|+||.||+|++. +++.||+|++..... .....+.+.+|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999976 489999999864322 123456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC------
Q 001274 888 GEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS------ 961 (1109)
Q Consensus 888 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~------ 961 (1109)
.+++.... .+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997654 3899999999999999999999 77999999999999999999999999999875432211
Q ss_pred -CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 -KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||+..+..++.++||||+|+++||+++|+.||.... ..+..........+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~-------- 222 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET----PEEIFQNILNGKIEWPE-------- 222 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCcCCCc--------
Confidence 12234567889999999998889999999999999999999999997433 22222221111111110
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.......+.+++.+||+.+|++|||+.++.+.+
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 223 ----DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred ----cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 000134678999999999999999994444444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=297.30 Aligned_cols=266 Identities=23% Similarity=0.291 Sum_probs=195.9
Q ss_pred CCCCCceEecCCcceEEEEEec-C--CcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC----Cc
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-N--GEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ----DS 874 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 874 (1109)
+|++.+.||+|+||.||+|+.. + +..||+|++..........+.+.+|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999865 4 77899999874433333456788999999999 599999999875432 34
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++++||+. ++|.+++..... +++..+..++.||+.||+||| +.+++||||||+||+++.++.+||+|||.++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQP---LTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889885 689998865443 899999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCC---CCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-C
Q 001274 955 LIDLPYS---KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-P 1029 (1109)
Q Consensus 955 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~ 1029 (1109)
....... .......|+..|+|||+..+ ..++.++||||+||++|+|++|+.||...... ........... +
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~ 229 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV----DQLNQILQVLGTP 229 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH----HHHHHHHHHhCCC
Confidence 6542211 11234578999999998765 46899999999999999999999999754311 11111111000 0
Q ss_pred Cchhhhh-----------hcchhh-----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1030 TSELFDK-----------RLDLSA-----KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1030 ~~~~~~~-----------~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
..+.+.. ...... .........+.+++.+|++.+|++|||+.|++.+-+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 0000000 000000 0001113468899999999999999999999988653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=282.14 Aligned_cols=267 Identities=18% Similarity=0.264 Sum_probs=210.6
Q ss_pred HHHHHHhcCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEE
Q 001274 795 HNLLEATGNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868 (1109)
Q Consensus 795 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 868 (1109)
.++.....+++....+-+|.||.||.|.|. +.+.|.||.++.. ...-....+..|.-.+..+.|||+..+.++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 345555667888889999999999999653 3456788888633 233445678899999999999999999999
Q ss_pred EEeC-CceEEEEEeccCCCHHHHhc-----cCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 001274 869 CYHQ-DSNLLLYEYMENGSLGEQLH-----GNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE 942 (1109)
Q Consensus 869 ~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 942 (1109)
+.++ +..+++|.++.-|+|..++. +......++..+...++.|++.|++||| ++++||.||.++|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhh
Confidence 8764 56789999999999999998 3333345778888999999999999999 8899999999999999999
Q ss_pred CceEEeeccccccccCCCCCC-ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHH
Q 001274 943 FQAHVGDFGLAKLIDLPYSKS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWV 1020 (1109)
Q Consensus 943 ~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~ 1020 (1109)
.++||+|=.++|..-..+... ....-.+..||+||.+....|+.++|||||||++|||+| |+.|+...++.+ +
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-----m 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-----M 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-----H
Confidence 999999999998664333332 344557889999999999999999999999999999999 999987543211 1
Q ss_pred HHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1021 RRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
..++.+.... ..+..++.+++.+|.-||..+|++||+++|++.-|.+...
T Consensus 508 ~~ylkdGyRl------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 508 EHYLKDGYRL------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred HHHHhcccee------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 2222222111 1233455678899999999999999999999998877543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=294.69 Aligned_cols=265 Identities=27% Similarity=0.356 Sum_probs=200.8
Q ss_pred CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 804 FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
|+..+.||+|+||.||+|+.. +++.||+|++..........+.+..|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556778999999999999865 5899999999865433444567889999999999999999999999999999999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 962 (1109)
+ ++|.+++..... .+++..+..++.+++.|++||| +.+|+||||+|+||+++.++.++|+|||.++...... .
T Consensus 81 ~-~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~ 153 (282)
T cd07829 81 D-MDLKKYLDKRPG--PLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-R 153 (282)
T ss_pred C-cCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-c
Confidence 7 599999987532 3899999999999999999999 7799999999999999999999999999998664322 1
Q ss_pred CccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC--------C---C
Q 001274 963 SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV--------P---T 1030 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------~---~ 1030 (1109)
......++..|+|||++.+. .++.++||||+||++|||++|+.||............. ....... . .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF-QILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-HHhCCCcHHHHHhhcccccc
Confidence 22334567789999998776 78999999999999999999999997533211111111 1000000 0 0
Q ss_pred chhhhhhcchhh-cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1031 SELFDKRLDLSA-KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1031 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
...+........ .........+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000000 0011113568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=306.12 Aligned_cols=265 Identities=26% Similarity=0.334 Sum_probs=201.4
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc----
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS---- 874 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 874 (1109)
..++|++.+.||+|+||.||+|+.. +++.||||++..........+.+.+|+.++++++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3468999999999999999999975 68899999986443333344667889999999999999999998876655
Q ss_pred --eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 875 --NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 875 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
.++|+||+ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||||+||+++.++.++|+|||.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence 79999999 67999988753 2899999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CC
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PT 1030 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 1030 (1109)
+...... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+... ............ +.
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~----~~~~~~i~~~~~~~~ 236 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH----IDQLKRIMNLVGTPD 236 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCC
Confidence 9865422 334567889999998765 3678999999999999999999999975332 111111111110 11
Q ss_pred chhhhhhcch-----------h-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1031 SELFDKRLDL-----------S-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1031 ~~~~~~~~~~-----------~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.....+.... . ..........+.+++.+|++.+|++|||+.+++++-+-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~ 302 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence 1111100000 0 000011245688999999999999999999999875444
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=294.66 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=200.2
Q ss_pred CceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 807 GAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
.+.||+|.||+||-|++ ++|+.||||++.+-.-....+....+|+.|++.++||.||.+...|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 36899999999999985 47999999999766566666788999999999999999999999999999999999999665
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC---CceEEeeccccccccCCCCC
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE---FQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~~ 962 (1109)
-|+-.+...+.+ +++.....+..||+.||.||| -++|+|+||||+|||+.+. ..+||+|||+|+.+....
T Consensus 649 MLEMILSsEkgR--L~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILSSEKGR--LPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHHhhccc--chHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 555555544443 899999999999999999999 7899999999999999543 479999999999887332
Q ss_pred CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhh
Q 001274 963 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1109)
-....+||+.|.|||++..+.|...-||||.||++|--++|..||.. ++++.+.++.... +.|..++
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE---dEdIndQIQNAaF-MyPp~PW--------- 788 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE---DEDINDQIQNAAF-MYPPNPW--------- 788 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC---ccchhHHhhcccc-ccCCCch---------
Confidence 23567899999999999999999999999999999999999999975 4455555553211 1121111
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1043 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.+......++|...++..=++|-+..+.+.+.|
T Consensus 789 ---~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 789 ---SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred ---hhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 111234567888888888888888877765543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=320.91 Aligned_cols=147 Identities=32% Similarity=0.399 Sum_probs=131.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|.+.++||+|+||+||+|++. +++.||||+++.... .......+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999976 689999999974322 2223467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
||+++++|.+++..... +++..++.++.||+.||+||| ..+||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~---l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999976543 788999999999999999999 7799999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=301.40 Aligned_cols=268 Identities=23% Similarity=0.315 Sum_probs=195.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--------
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ-------- 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 872 (1109)
++|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 68999999999999999999864 689999999875433 3456788999999999999999999776543
Q ss_pred ------CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-CCCce
Q 001274 873 ------DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD-EEFQA 945 (1109)
Q Consensus 873 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 945 (1109)
...++||||++ ++|.+++... .+++..+..++.||++|+.||| +.+|+||||||+||+++ .++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceE
Confidence 34689999997 5898888643 2889999999999999999999 77999999999999997 45678
Q ss_pred EEeeccccccccCCCCCC--ccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHH
Q 001274 946 HVGDFGLAKLIDLPYSKS--MSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRR 1022 (1109)
Q Consensus 946 kl~DFG~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~ 1022 (1109)
+++|||.++......... .....++..|+|||++.+ ..++.++||||+||++|||++|+.||.+.............
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998654221111 123357889999998654 56889999999999999999999999754321111111110
Q ss_pred hhhccC--------CCchhhhhhcchh----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1023 SIHEMV--------PTSELFDKRLDLS----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1023 ~~~~~~--------~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
...... ............. ..........+.+++.+|++.||++|||+.|++++-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 000000 0000000000000 00001122457799999999999999999999987554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=288.64 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=196.1
Q ss_pred CCCCCceEecCCcceEEEEEecC-CcEEEEEEeeccC---CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRG---EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
+|.+.++||+|+||+||+|++.. +..+++|+++... ........+..|+.++++++||||+++++++...+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998653 4556666654321 1222344677899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 879 YEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
|||+++++|.+++.... ....+++..+..++.|++.|+.||| +.+++|+||+|+||+++. +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999886422 1234899999999999999999999 789999999999999975 569999999997654
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
.. ........++..|+|||...+..++.++||||+|+++|+|++|..||... ..............+.
T Consensus 157 ~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~------- 224 (260)
T cd08222 157 GS-CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ----NFLSVVLRIVEGPTPS------- 224 (260)
T ss_pred CC-cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHHcCCCCC-------
Confidence 22 12223456788999999998888999999999999999999999998642 2222222222221111
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
........+.+++.+||+.+|++||++.|++++
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 011223467889999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-33 Score=275.58 Aligned_cols=260 Identities=27% Similarity=0.355 Sum_probs=199.9
Q ss_pred CCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEEec
Q 001274 805 SEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 805 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
+....||.|+||+|++-.++ .|+..|||++..... ..+.+++..|.+...+- +.||||+++|++..++..++.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 34457999999999999865 799999999986544 34567788888875554 7899999999999999999999999
Q ss_pred cCCCHHHHhccC--CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 883 ENGSLGEQLHGN--KQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 883 ~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
. .|++.+.... ..+..+++...-.|..-.++||+||.+ +.+|||||+||+|||++..|.+|++|||.+-.+..
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-- 220 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-- 220 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence 5 5776554221 012238888888898899999999986 45899999999999999999999999999876542
Q ss_pred CCCccccccccceeccccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
+...+.-.|...|||||.+.. ..|+.++||||+|+++||+.||+.||..+. ...+.+.....+..|... .+
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~---svfeql~~Vv~gdpp~l~-~~--- 293 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD---SVFEQLCQVVIGDPPILL-FD--- 293 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH---HHHHHHHHHHcCCCCeec-Cc---
Confidence 223344468888999998863 358999999999999999999999998653 355556655555543211 11
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
....+....+..++..|+..|-..||.+.++.++-.-.+
T Consensus 294 ----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 294 ----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred ----ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 112223346789999999999999999999987644333
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=281.16 Aligned_cols=242 Identities=24% Similarity=0.277 Sum_probs=191.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 878 (1109)
.+|....+||+|+||+|.+|..+ +.+.||||+++..... .+..+--+.|-+++... +-|.++++..+|+..+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 57888999999999999999865 4678999999865322 22233445677777665 568999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+.||+|-..+++.+. +.+..+...|..||-||-+|| +++||+||||.+|||+|.+|++||+|||+++.--
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni- 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 501 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc-
Confidence 999999999999988765 888899999999999999999 8899999999999999999999999999998532
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
-......+.+||+.|+|||++...+|+.++|.|||||++|||+.|+.||++.. -.+..+........
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD----E~elF~aI~ehnvs--------- 568 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----EDELFQAIMEHNVS--------- 568 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHHccCc---------
Confidence 12344567899999999999999999999999999999999999999998633 22222222222211
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCC
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRP 1068 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 1068 (1109)
++..-..+...+....+...|.+|.
T Consensus 569 -----yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 -----YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -----CcccccHHHHHHHHHHhhcCCcccc
Confidence 1111123344566667778888884
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=280.84 Aligned_cols=269 Identities=22% Similarity=0.297 Sum_probs=204.3
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-----C---CceeeEEEEEEe
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-----H---RNIVKLYGFCYH 871 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~ 871 (1109)
.++|.+.++||-|.|++||+|++. +.+.||+|+.+.. ..-.+..+.|++++++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 379999999999999999999864 6789999999832 223456778999999883 3 479999999976
Q ss_pred C----CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-----
Q 001274 872 Q----DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE----- 942 (1109)
Q Consensus 872 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----- 942 (1109)
. .+.|+|+|+. |.+|..++.....+ .++...+.+|++||+.||.|||.+| +|||.||||+|||+..+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence 4 4779999999 77999998765533 4999999999999999999999887 99999999999999200
Q ss_pred --------------------------------------------------------------------------------
Q 001274 943 -------------------------------------------------------------------------------- 942 (1109)
Q Consensus 943 -------------------------------------------------------------------------------- 942 (1109)
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 001274 943 -------------------------------------------------------------------------------- 942 (1109)
Q Consensus 943 -------------------------------------------------------------------------------- 942 (1109)
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence
Q ss_pred -CceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC-----CcH
Q 001274 943 -FQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG-----GDL 1016 (1109)
Q Consensus 943 -~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~-----~~~ 1016 (1109)
-+|||+|||-|+.... ..+.-..|..|+|||++.+..|+..+||||++|++|||+||...|+..... ++-
T Consensus 390 di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred ceeEEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 0156666666665432 222334678899999999999999999999999999999999999865421 222
Q ss_pred HHHHHHhhhcc--------CCCchhhhhh-----------------cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 001274 1017 VTWVRRSIHEM--------VPTSELFDKR-----------------LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMR 1071 (1109)
Q Consensus 1017 ~~~~~~~~~~~--------~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ 1071 (1109)
...+-+....+ ....++++++ +...+....++..+|.+|+.-|++.+|++||||+
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 22222111111 1122233221 1222556778889999999999999999999999
Q ss_pred HHHHHHHHh
Q 001274 1072 EVIAMMIDA 1080 (1109)
Q Consensus 1072 evl~~L~~~ 1080 (1109)
+.+++-|-.
T Consensus 546 ~cl~hPwLn 554 (590)
T KOG1290|consen 546 QCLKHPWLN 554 (590)
T ss_pred HHhcCcccc
Confidence 999987654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=281.95 Aligned_cols=242 Identities=26% Similarity=0.319 Sum_probs=195.0
Q ss_pred EecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCH
Q 001274 810 IGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSL 887 (1109)
Q Consensus 810 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 887 (1109)
||+|+||.||++... +++.||+|.+...... ......+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 5899999998754322 22456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCcccc
Q 001274 888 GEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967 (1109)
Q Consensus 888 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 967 (1109)
.+++..... +++..+..++.|+++|+.|+| +.+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSKEGR---FSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 999976543 899999999999999999999 7799999999999999999999999999998654221 223445
Q ss_pred ccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHH
Q 001274 968 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVE 1047 (1109)
Q Consensus 968 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
.++..|+|||...+..++.++|+||+|+++|++++|+.||..... ............+....
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~-------------- 215 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKDPLRFPEF-------------- 215 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcCCCCCCCC--------------
Confidence 678899999999988899999999999999999999999964322 22222222211111111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH---HHHHHH
Q 001274 1048 EMTLFLKIALFCSSTSPLNRPTM---REVIAM 1076 (1109)
Q Consensus 1048 ~~~~~~~li~~cl~~dP~~RPt~---~evl~~ 1076 (1109)
....+.+++.+||..||++||++ .++.++
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 12356789999999999999999 555543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=299.45 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=207.7
Q ss_pred HhcCCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEe-----C
Q 001274 800 ATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYH-----Q 872 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~ 872 (1109)
-++.|++...||.|.+|.||+++ .++++.+|||+.. ...+..+++..|.++++.. .|||++.++|++.. +
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~---~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMD---PTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeec---CCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34678888999999999999998 4578999999886 3344667788999999888 69999999999875 4
Q ss_pred CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
+..++|||||.+||..++++... ...+.|..+..|+..++.|+.||| ...++|||||-.|||++.++.||++|||+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeee
Confidence 67899999999999999998876 345999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceeccccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhh-c
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTM-----KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIH-E 1026 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~-~ 1026 (1109)
+...+.. .....+.+||+.|||||++... .|+..+|+||+|++..||-.|.+|+.++.+- +..+. .
T Consensus 170 SaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------raLF~Ip 241 (953)
T KOG0587|consen 170 SAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLIP 241 (953)
T ss_pred eeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------hhhccCC
Confidence 9877632 3334567899999999998744 3778999999999999999999998765421 11111 1
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
..|... ........++|.++|..|+..|.++||++.+++++
T Consensus 242 RNPPPk---------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 242 RNPPPK---------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCcc---------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111111 12345566789999999999999999999998765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=269.73 Aligned_cols=273 Identities=23% Similarity=0.357 Sum_probs=201.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--------C
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--------Q 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 872 (1109)
+.|....+||+|.||+||+|+.+ +|+.||+|++-.......-.....+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666678999999999999865 57889998875443333344567899999999999999999988753 2
Q ss_pred CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
...|+||.+|+. +|.-.+.....+ ++..++.++++++..||.|+| +..|+|||+||.|+|++.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr--~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVR--FSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcccc--ccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 346899999976 888888765443 899999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCC---CCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHH----hh
Q 001274 953 AKLIDLPY---SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRR----SI 1024 (1109)
Q Consensus 953 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~----~~ 1024 (1109)
++.+..+. ....+..+.|..|++||.+.+. .|+.+.|||..||++.||+||.+-+++......+ ..+.. ..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql-~~Is~LcGs~t 249 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL-HLISQLCGSIT 249 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH-HHHHHHhccCC
Confidence 98664322 2223456679999999998865 5899999999999999999999998865432221 11211 11
Q ss_pred hccCCCc---hhhhhh----cch-hhcccHHHH------HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1025 HEMVPTS---ELFDKR----LDL-SAKRTVEEM------TLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1025 ~~~~~~~---~~~~~~----~~~-~~~~~~~~~------~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.+.+|.- +++... +.. ..+...+.. ....+++.+++..||.+|+++.+++.+-+.-.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 1111111 111111 000 000111111 24678999999999999999999998766543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=290.20 Aligned_cols=243 Identities=23% Similarity=0.260 Sum_probs=197.3
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 878 (1109)
++.|.....+|.|+|+.|-.+.+ .+++..+||++.... .+-.+|+.++... +||||+++.+.+.++.+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 66888888999999999998875 468899999997542 2233567666555 799999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee-CCCCceEEeecccccccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL-DEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DFG~a~~~~ 957 (1109)
||++.|+-+.+.+...+. +. .++..|+.+|+.|+.||| ++|+||||+||+|||+ +..++++|+|||.++...
T Consensus 395 ~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999988888876654 33 677889999999999999 7899999999999999 699999999999998765
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
.. ..+-+-|..|.|||+.....|++++|+||+|+++|+|++|+.||.....+ .+.......+..
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~--------- 531 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF--------- 531 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc---------
Confidence 33 33446688999999999999999999999999999999999999865433 111111111110
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.........+++.+|++.||.+||+|.++..+-+.
T Consensus 532 -------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 -------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11122356789999999999999999999999887
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=278.03 Aligned_cols=219 Identities=24% Similarity=0.253 Sum_probs=174.8
Q ss_pred CCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCHHHHh
Q 001274 813 GACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQL 891 (1109)
Q Consensus 813 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 891 (1109)
|.||.||++++. +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999865 68999999987432 2334555555667999999999999999999999999999999998
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCcccccccc
Q 001274 892 HGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY 971 (1109)
Q Consensus 892 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~ 971 (1109)
..... +++..+..++.|+++|++|+| +.+++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 77 ~~~~~---l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 77 SKFLN---IPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred HHhcC---CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 76543 899999999999999999999 789999999999999999999999999988655421 22334567
Q ss_pred ceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHH
Q 001274 972 GYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTL 1051 (1109)
Q Consensus 972 ~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
.|+|||+..+..++.++||||+|+++|||++|+.|+...... ..... .... .......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~~~--------~~~~----~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INTHT--------TLNI----PEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------ccccc--------ccCC----cccCCHH
Confidence 899999998888999999999999999999999887532100 00000 0000 0111235
Q ss_pred HHHHHHhccCCCCCCCCCH
Q 001274 1052 FLKIALFCSSTSPLNRPTM 1070 (1109)
Q Consensus 1052 ~~~li~~cl~~dP~~RPt~ 1070 (1109)
+.+++.+|++.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 7789999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-31 Score=283.71 Aligned_cols=259 Identities=21% Similarity=0.248 Sum_probs=212.0
Q ss_pred cCCCCCceEecCCcceEEEEEecCCc-EEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGE-VIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.+++.+..||-|+||.|=+++.+... .+|+|+++... ......+.+..|-++|...+.|.||++|-.|.+..+.|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667788999999999999876433 48888886542 23345567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
|-|-||.+...++..+. ++....+.++.-+++|++||| +++||+|||||+|.+++.+|-+|+.|||+|+.+.
T Consensus 500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~-- 571 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG-- 571 (732)
T ss_pred HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhc--
Confidence 99999999999988765 889999999999999999999 8899999999999999999999999999999876
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.....-+++||+.|.|||++..+..+.++|.||+|+++||+++|.+||.+..+-..+...++..-.-.+
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~----------- 640 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF----------- 640 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc-----------
Confidence 455567889999999999999999999999999999999999999999976533332222222111111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHHHhhhcc
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMIDARQSV 1084 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~~~~~~~ 1084 (1109)
+....+...+++.+....+|.+|.- ..||.+|-|..-...
T Consensus 641 -----Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 641 -----PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred -----ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 1122234568888888999999976 889999988764443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=298.77 Aligned_cols=267 Identities=19% Similarity=0.195 Sum_probs=172.8
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-C----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEE------
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-N----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF------ 868 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------ 868 (1109)
..++|+..++||+|+||+||+|++. + +..||||++..... .+....| .++...+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 3468999999999999999999975 4 68999998763221 1111111 1111122222221111
Q ss_pred EEeCCceEEEEEeccCCCHHHHhccCCCC-----------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 001274 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQT-----------------CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRD 931 (1109)
Q Consensus 869 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 931 (1109)
+......++||||+++++|.+++...... .......+..++.||+.||+||| +.+|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCc
Confidence 24556789999999999999998754311 00123345679999999999999 77999999
Q ss_pred CCCCceeeCC-CCceEEeeccccccccCCCCCCccccccccceeccccccCC----------------------CCCccc
Q 001274 932 IKSNNILLDE-EFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM----------------------KVTEKC 988 (1109)
Q Consensus 932 lkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 988 (1109)
|||+|||++. ++.+||+|||+|+..............+++.|+|||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999986 57999999999986643333334556789999999965322 234567
Q ss_pred hhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh---hhh----hcchhhcccHHHHHHHHHHHHhccC
Q 001274 989 DIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL---FDK----RLDLSAKRTVEEMTLFLKIALFCSS 1061 (1109)
Q Consensus 989 DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----~~~~~~~~~~~~~~~~~~li~~cl~ 1061 (1109)
||||+||++|||+++..|+.. ....+.+...........+ ... ......+..........+++.+|++
T Consensus 361 DVwSlGviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999998776542 1111111110000000000 000 0000000001112235689999999
Q ss_pred CCCCCCCCHHHHHHHHHHh
Q 001274 1062 TSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1062 ~dP~~RPt~~evl~~L~~~ 1080 (1109)
.||++|||++|+++|-+..
T Consensus 436 ~dP~kR~ta~e~L~Hpff~ 454 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFD 454 (566)
T ss_pred CCcccCCCHHHHhCCcCcC
Confidence 9999999999999986543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-31 Score=263.52 Aligned_cols=264 Identities=24% Similarity=0.292 Sum_probs=199.3
Q ss_pred CCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-----ceEEE
Q 001274 805 SEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD-----SNLLL 878 (1109)
Q Consensus 805 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 878 (1109)
+-.+.||.|+||.||.+.+. +|+.||.|++......-...+.+.+|++++..++|.|+...++.-+... +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34468999999999999875 7999999999765555556688999999999999999999988766543 45788
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
+|.|. .+|.+.+-.-.. ++.+.+..+..||++|+.||| +.+|.||||||.|.+++.+..+||+|||+|+..+.
T Consensus 136 TELmQ-SDLHKIIVSPQ~---Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSPQA---LTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheeccCCC---CCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 99884 577777754333 888999999999999999999 88999999999999999999999999999998876
Q ss_pred CCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
+....++..+-|..|+|||.+++. .|+.+.||||.||++.|++.++..|+...+.+.+. .+.... + .|..+.+...
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~-lItdLL-G-TPs~EaMr~A 285 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ-MIIDLL-G-TPSQEAMKYA 285 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH-HHHHHh-C-CCcHHHHHHH
Confidence 666677777889999999999875 58999999999999999999999988654221111 111000 0 0111111100
Q ss_pred c------------chh-------hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1038 L------------DLS-------AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1038 ~------------~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
. ... .......-.+...+..+++..||.+|.+.++.+.++.
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0 000 0001111223456777899999999999999987764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=266.61 Aligned_cols=240 Identities=31% Similarity=0.410 Sum_probs=193.6
Q ss_pred CcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCHHHHhc
Q 001274 814 ACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLH 892 (1109)
Q Consensus 814 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 892 (1109)
+||.||+|... +++.||+|++........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999976 489999999975433211 5789999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCccccccccc
Q 001274 893 GNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972 (1109)
Q Consensus 893 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~ 972 (1109)
.... +++..+..++.++++++.||| +.+++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus 80 ~~~~---~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 80 KRGR---LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred hccC---CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 6543 789999999999999999999 7799999999999999999999999999998765321 3344567889
Q ss_pred eeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHH
Q 001274 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLF 1052 (1109)
Q Consensus 973 y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
|+|||...+..++.++||||+|+++|++++|..||..........+... ......... .......+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~-----------~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---KPKPPFPPP-----------EWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---ccCCCCccc-----------cccCCHHH
Confidence 9999999988899999999999999999999999875322222222221 111110000 00022467
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1053 LKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1053 ~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
.+++.+|+..+|++||++.+++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhhC
Confidence 899999999999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=286.33 Aligned_cols=263 Identities=20% Similarity=0.277 Sum_probs=182.4
Q ss_pred hcCCCCCceEecCCcceEEEEEe-----------------cCCcEEEEEEeeccCCCc------------chhHHHHHHH
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-----------------ANGEVIAVKKIKLRGEGA------------TADNSFLAEI 851 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~E~ 851 (1109)
.++|++.++||+|+||+||+|.+ .+++.||||++....... ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999963 235689999986432211 0112344577
Q ss_pred HHhccCCCCce-----eeEEEEEEe--------CCceEEEEEeccCCCHHHHhccCCC---------------------C
Q 001274 852 STLGKIRHRNI-----VKLYGFCYH--------QDSNLLLYEYMENGSLGEQLHGNKQ---------------------T 897 (1109)
Q Consensus 852 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~ 897 (1109)
.++.+++|.++ ++++++|.. .+..++||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 677777753 3567999999999999999875321 1
Q ss_pred CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCccccccccceeccc
Q 001274 898 CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977 (1109)
Q Consensus 898 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE 977 (1109)
..+++..+..++.|++.|+.|+| +.+|+||||||+||+++.++.+||+|||+++..............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12467788899999999999999 779999999999999999999999999999765422222222234578999999
Q ss_pred cccCCC--------------------C--CccchhHHHHHHHHHHHhCCC-CCCCccc--------CCcHHHHHHHhhhc
Q 001274 978 YAYTMK--------------------V--TEKCDIYSFGVVLLELITGKS-PVQSLEL--------GGDLVTWVRRSIHE 1026 (1109)
Q Consensus 978 ~~~~~~--------------------~--~~~~DvwSlGvll~elltg~~-pf~~~~~--------~~~~~~~~~~~~~~ 1026 (1109)
.+.... | ..+.||||+||++|||++|.. ||..... ..+...|.. ....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~~~ 459 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YKGQ 459 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hccc
Confidence 875432 1 134799999999999999875 6653210 011111111 0000
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHHHHH
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSP---LNRPTMREVIAMMID 1079 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP---~~RPt~~evl~~L~~ 1079 (1109)
.. .. ...........+++.+++..+| .+|+|++|+++|-+.
T Consensus 460 ~~----------~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 460 KY----------DF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred CC----------Cc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 00 00 0111223456788999998765 789999999988654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=239.00 Aligned_cols=218 Identities=25% Similarity=0.388 Sum_probs=174.0
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
+.......||+|+||.|-+.++ .+|+..|+|.+..+-. ....+..+.|+.+..+. ..|.+|.++|....+...++.|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 4555667899999999998885 4799999999976543 34566788888886554 7999999999999999999999
Q ss_pred EeccCCCHHHHhccC-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 880 EYMENGSLGEQLHGN-KQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|.|. .||+.+-++. +....+++.-.-+|+..+.+||.|||++ ..+||||+||+|||++.+|++|+||||.+-.+.+
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9995 5887775432 2223488999999999999999999974 5899999999999999999999999999977652
Q ss_pred CCCCCccccccccceeccccccC----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYT----MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
+ -..+.-.|...|||||.+.. ..|+.|+||||+|+.+.||.+++.||+.. ....+.++..+.+..
T Consensus 202 S--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w---~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 202 S--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW---GTPFQQLKQVVEEPS 270 (282)
T ss_pred h--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc---CCHHHHHHHHhcCCC
Confidence 2 22222357778999998753 36899999999999999999999999864 344455555555544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=256.59 Aligned_cols=257 Identities=21% Similarity=0.278 Sum_probs=198.5
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcch-hHHHHHHHHHhccC-CCCceeeEEEEEEeCCceE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATA-DNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 876 (1109)
..++|...++||.|+|++|-.++++ +.+.||+|+++..-.+.++ ..=...|-.+..+. +||.+|.+..+|+.+...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3468999999999999999999965 6788999999865333222 23345566666555 7999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+|.||++||+|--++++... ++++.++.....|.-|+.||| ++|||+||+|.+||++|..|++|++|+|+++.-
T Consensus 328 fvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999999877766554 999999999999999999999 889999999999999999999999999999864
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcc---cCCcHHHHHHHhhhccCCCchh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE---LGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
-. ......+++||+.|.|||++.+..|+..+|.|++||+++||+.|+.||+-.. .+....+.+-..+.+
T Consensus 402 l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile------- 473 (593)
T KOG0695|consen 402 LG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE------- 473 (593)
T ss_pred CC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-------
Confidence 42 2344567899999999999999999999999999999999999999998544 222222222221111
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCC------CHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP------TMREVIAM 1076 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP------t~~evl~~ 1076 (1109)
+.+..+.... -+...++..-+..||.+|. -++++..+
T Consensus 474 --kqiriprsls----vkas~vlkgflnkdp~erlgc~~~~g~~dik~h 516 (593)
T KOG0695|consen 474 --KQIRIPRSLS----VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH 516 (593)
T ss_pred --hcccccceee----hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc
Confidence 1111111111 1244677778899999884 35566544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=288.73 Aligned_cols=244 Identities=24% Similarity=0.308 Sum_probs=186.8
Q ss_pred CCceEecCCcce-EEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEEecc
Q 001274 806 EGAVIGRGACGT-VYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYME 883 (1109)
Q Consensus 806 ~~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 883 (1109)
-.+.+|+|+-|+ ||+|..+ |+.||||.+-. +...-..+|+..++.- +|||||++++.-.++...||+.|.|.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC-CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 346789999986 6999986 88999998852 2344567899999888 69999999999899999999999995
Q ss_pred CCCHHHHhccCCCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---C--CceEEeecccccccc
Q 001274 884 NGSLGEQLHGNKQT-CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE---E--FQAHVGDFGLAKLID 957 (1109)
Q Consensus 884 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DFG~a~~~~ 957 (1109)
.+|.+++...... ........+.+..|++.|++||| +.+||||||||.||||+. + .+++|+|||+++...
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6999999874211 11121455788999999999999 779999999999999965 2 579999999999876
Q ss_pred CCCC--CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 958 LPYS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 958 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
.... ....+..||-+|+|||++....-+.++||||+||++|+.++ |.+||.+.-. + -.....+......+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-----R-~~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-----R-QANILTGNYTLVHLE 736 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-----h-hhhhhcCccceeeec
Confidence 3322 22356789999999999999888899999999999999999 5999975321 1 011111111111110
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
...++ +..++|.+|++.+|..||+|.+|+.|
T Consensus 737 ---------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 737 ---------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ---------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 01111 56799999999999999999999854
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=270.72 Aligned_cols=209 Identities=25% Similarity=0.340 Sum_probs=175.4
Q ss_pred HhcCCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
...-|..++.||-|+||+|.+++ .++...||+|.+...+.- ......+.+|-.|+...+.+.||+++-.|++.+..|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 34568888999999999999997 445678999988644321 2234557789999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||+|++||++-.+|.+.+- |.+..++..+..+.-|+++.| +.|+|||||||+|||||.||++||+|||++.-+.
T Consensus 707 VMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccce
Confidence 9999999999999987664 889999999999999999999 8999999999999999999999999999985331
Q ss_pred ---------CCCCCC--------------------------------ccccccccceeccccccCCCCCccchhHHHHHH
Q 001274 958 ---------LPYSKS--------------------------------MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVV 996 (1109)
Q Consensus 958 ---------~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvl 996 (1109)
...... ....+||+.|+|||++....|+..+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 000000 012359999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCcccCC
Q 001274 997 LLELITGKSPVQSLELGG 1014 (1109)
Q Consensus 997 l~elltg~~pf~~~~~~~ 1014 (1109)
+|||+.|+.||.+....+
T Consensus 861 l~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHHhhCCCCccCCCCCc
Confidence 999999999998765443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=253.02 Aligned_cols=262 Identities=23% Similarity=0.288 Sum_probs=203.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC------c
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD------S 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 874 (1109)
.+|...+.+|.|+- .|-.|.+. .+++||+|++..........+...+|...+..+.|+||++++.++.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 47777888999988 66666644 6899999999776666667788899999999999999999999997654 4
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.|+|||+| .++|...+... ++-+.+..|..|++.|+.||| +.+|+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME-----LDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhc
Confidence 68999999 46898888732 667788999999999999999 8899999999999999999999999999999
Q ss_pred cccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
..+. ...++.++.|..|+|||++.+..|.+.+||||.||++.||++|+.-|.+. +.+.+|.+..-.-..|....+
T Consensus 167 ~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~---d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 167 TEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK---DHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred ccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc---hHHHHHHHHHHHhcCCCHHHH
Confidence 7652 24667889999999999999999999999999999999999999988742 222223221111111111111
Q ss_pred hhhcc---------------------------hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1035 DKRLD---------------------------LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1035 ~~~~~---------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
++-.. ...+...-......+++.+|+-.+|++|-+++++++|--
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 10000 001111122334778999999999999999999998853
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=239.11 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=197.2
Q ss_pred hcCCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCc--eE
Q 001274 801 TGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDS--NL 876 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~--~~ 876 (1109)
.++|++.+++|.|.|++||.|. ..+.+.++||+++ +...+.+.+|+.+++.++ ||||++++++..++.. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4688999999999999999998 5578999999998 345678999999999996 9999999999987654 57
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEeecccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKL 955 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~ 955 (1109)
+|+||+.+.+....... ++..+++..+.+++.||+|+| ++||+|||+||.|+|+|.. ..++++|+|+|.+
T Consensus 112 LiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 99999999887666543 677788899999999999999 8899999999999999854 5799999999987
Q ss_pred ccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCC-cHHHHHHHh--------h-
Q 001274 956 IDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGG-DLVTWVRRS--------I- 1024 (1109)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~-~~~~~~~~~--------~- 1024 (1109)
+... ......+.+..|--||.+-.- .|+..-|+|||||++..|+..+.||-...... .++..++-. +
T Consensus 183 YHp~--~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 183 YHPG--KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred cCCC--ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 6522 222334567778999987654 58999999999999999999999986543222 222221100 0
Q ss_pred hccCCCchhhhhhcchhhc----------ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1025 HEMVPTSELFDKRLDLSAK----------RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.-....++-++..+....+ ...-...+..+++.+.+..|-.+||||+|.+.|-...
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 0001111112211111100 0001124578999999999999999999999886543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=268.19 Aligned_cols=268 Identities=22% Similarity=0.255 Sum_probs=211.2
Q ss_pred HHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC------CCceeeEEEEEE
Q 001274 798 LEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR------HRNIVKLYGFCY 870 (1109)
Q Consensus 798 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~ 870 (1109)
+.-..+|.+....|+|-||+|..|++. .|+.||||++.. +..-.+.=++|+++++++. --|+++++-.|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 344579999999999999999999865 588999999972 2333455678999999994 347899999999
Q ss_pred eCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEee
Q 001274 871 HQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGD 949 (1109)
Q Consensus 871 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~D 949 (1109)
...+.|+|+|... -+|.+.+++.+....+....+..+++|+.-||.+|. ..+|+|.||||+||||++. ..+||||
T Consensus 505 hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 505 HKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeecc
Confidence 9999999999884 599999999888777999999999999999999999 6799999999999999865 4689999
Q ss_pred ccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCC
Q 001274 950 FGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 950 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 1029 (1109)
||.|.... ....+.+..+..|+|||++.|.+|+...|+||.||++||+.||+..|.+....+++.-++.- .+.+|
T Consensus 581 fGSA~~~~---eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~--KGk~p 655 (752)
T KOG0670|consen 581 FGSASFAS---ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL--KGKFP 655 (752)
T ss_pred Cccccccc---cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh--cCCCc
Confidence 99998765 23345566677899999999999999999999999999999999999876654444333221 11111
Q ss_pred C---------chhhhhhcch-----------------------------------hhcccHHHHHHHHHHHHhccCCCCC
Q 001274 1030 T---------SELFDKRLDL-----------------------------------SAKRTVEEMTLFLKIALFCSSTSPL 1065 (1109)
Q Consensus 1030 ~---------~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~cl~~dP~ 1065 (1109)
- ..-||+.+.. ..+.......+|..++.+|+..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 0 0111111100 0122334456789999999999999
Q ss_pred CCCCHHHHHHHH
Q 001274 1066 NRPTMREVIAMM 1077 (1109)
Q Consensus 1066 ~RPt~~evl~~L 1077 (1109)
+|.|..+++.|-
T Consensus 736 KRit~nqAL~Hp 747 (752)
T KOG0670|consen 736 KRITVNQALKHP 747 (752)
T ss_pred hcCCHHHHhcCC
Confidence 999999998774
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=239.22 Aligned_cols=250 Identities=19% Similarity=0.321 Sum_probs=190.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEE-EEeCCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGF-CYHQDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv 878 (1109)
+.|.+.+.+|+|.||.+-+++++ ..+.+++|.+.. .....++|.+|...--.+ .|.||+.-+++ |+..+..+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~---p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR---PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc---chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 57888999999999999999976 578899998873 334578899999887677 58899877764 5667778899
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee--CCCCceEEeeccccccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL--DEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DFG~a~~~ 956 (1109)
+||++.|+|.+-+...+ +-+....+++.|++.|+.||| ++++||||||.+|||| .+..++|++|||..+..
T Consensus 101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999999887644 778888999999999999999 8899999999999999 34458999999999865
Q ss_pred cCCCCCCccccccccceeccccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCCcc-cCCcHHHHHHHhhhccCCC
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTM-----KVTEKCDIYSFGVVLLELITGKSPVQSLE-LGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvll~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~ 1030 (1109)
+.. .....-+..|.+||..... ...+.+|||.||+++|.++||+.||+... .+..+.+|.+-..+.....
T Consensus 174 g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 174 GTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred Cce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 411 1222345569999976543 24678999999999999999999999654 4455666666544433333
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
...+.+ -.+...++..+-+..+|++|--..++.++
T Consensus 250 P~~F~~-----------fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 250 PKKFNP-----------FSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred chhhcc-----------cCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 222221 11245677888899999999444444433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-28 Score=262.79 Aligned_cols=200 Identities=26% Similarity=0.323 Sum_probs=171.8
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC------cchhHHHHHHHHHhccCC---CCceeeEEEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG------ATADNSFLAEISTLGKIR---HRNIVKLYGFCY 870 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 870 (1109)
..+|...+.+|+|+||.||.|.++ +...|+||.+.+...- ......+-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 457889999999999999999976 4567888888644211 111223557999999996 999999999999
Q ss_pred eCCceEEEEEec-cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 001274 871 HQDSNLLLYEYM-ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGD 949 (1109)
Q Consensus 871 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 949 (1109)
+++..|++||.- ++-+|.+++..+.. +++.++..|++||+.|+++|| +.+|||||||-+||.++.+|-+|++|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEee
Confidence 999999999964 45689999987665 899999999999999999999 78999999999999999999999999
Q ss_pred ccccccccCCCCCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 001274 950 FGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQS 1009 (1109)
Q Consensus 950 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~ 1009 (1109)
||.|.... ......++||.+|.|||++.+.+| +..-|||++|+++|-++....||..
T Consensus 714 fgsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99998754 455677899999999999999887 5678999999999999999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=237.69 Aligned_cols=211 Identities=39% Similarity=0.579 Sum_probs=182.6
Q ss_pred EecCCcceEEEEEecC-CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCHH
Q 001274 810 IGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLG 888 (1109)
Q Consensus 810 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 888 (1109)
||+|++|.||+++..+ ++.+++|++....... ..+.+.+|++.++.++|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999764 8999999997443221 3467999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeeccccccccCCCCCCcccc
Q 001274 889 EQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-EFQAHVGDFGLAKLIDLPYSKSMSAI 967 (1109)
Q Consensus 889 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~ 967 (1109)
+++..... .+++..+..++.++++++.+|| +.+++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 80 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 80 DLLKENEG--KLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 99976532 3889999999999999999999 779999999999999999 89999999999986653211 23335
Q ss_pred ccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccH
Q 001274 968 AGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTV 1046 (1109)
Q Consensus 968 ~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
.+...|++||..... .++.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577889999998887 788999999999999999
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1047 EEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1047 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
..+.+++.+|++.+|++||++++++++
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356789999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-27 Score=262.74 Aligned_cols=253 Identities=28% Similarity=0.372 Sum_probs=202.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|.....+|.|.||.||+|++. .++..|||+++..... ......+|+-+++..+|+|||.++|.+...+..+++||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 57888889999999999999965 6899999999865433 45567789999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||.+|+|.+.-+..+. +++.+...+++..++|++||| +++=+|||||-.||++++.|.+|++|||.+..+...
T Consensus 93 ycgggslQdiy~~Tgp---lselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred ecCCCcccceeeeccc---chhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh-
Confidence 9999999998887665 899999999999999999999 778899999999999999999999999998766522
Q ss_pred CCCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
-.+...+.||+.|||||+.. .+.|..++|||+.|+...|+-.-+.|-.+... .+...-...........-
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----mr~l~LmTkS~~qpp~lk--- 238 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----MRALFLMTKSGFQPPTLK--- 238 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----HHHHHHhhccCCCCCccc---
Confidence 23345678999999999753 56699999999999999999887777433221 111111111111111111
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
......+.|-+|++.|+..+|.+||++..++.+
T Consensus 239 ------Dk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 239 ------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ------CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 133444578899999999999999999887643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=236.95 Aligned_cols=200 Identities=36% Similarity=0.526 Sum_probs=172.6
Q ss_pred CCCCceEecCCcceEEEEEecC-CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 804 FSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
|...+.||+|++|+||+|...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 5667899999999999999764 899999999744322 24678889999999999999999999999999999999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 962 (1109)
++++|.+++...... +++..+..++.+++.++.+|| +.+++|+|++|+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 80 EGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999999765432 788999999999999999999 779999999999999999999999999999876533211
Q ss_pred Cccccccccceeccccc-cCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 001274 963 SMSAIAGSYGYIAPEYA-YTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvll~elltg~~pf~~ 1009 (1109)
......++..|++||+. ....++.++|||++|++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 23445678889999998 677788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-24 Score=275.72 Aligned_cols=306 Identities=22% Similarity=0.262 Sum_probs=167.4
Q ss_pred cceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEccc
Q 001274 290 LKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSI 369 (1109)
Q Consensus 290 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 369 (1109)
|+.|++.++.+. .+|..+ ...+|++|+|++|++. .++..+..+++|+.|+|+++.....+|. ++.+++|++|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence 444444444443 333333 2344444444444444 2333344444444444444433333332 44445555555554
Q ss_pred CcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCC
Q 001274 370 NNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIP 449 (1109)
Q Consensus 370 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 449 (1109)
|.....+|..+.++++|+.|++++|..-+.+|..+ .+++|++|++++|.....+|.. ..+|++|+|++|.+. .+|
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP 741 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFP 741 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-ccc
Confidence 44333445555555555555555543333444433 3455555555555433333321 234555555555554 233
Q ss_pred CCCccccccceeecccccc-------cccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCCh
Q 001274 450 PGLKTCRSLMQLMLGQNQL-------TGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPS 522 (1109)
Q Consensus 450 ~~~~~l~~L~~L~L~~N~l-------~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 522 (1109)
..+ .+++|.+|.+.++.. ....+..+...++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|.
T Consensus 742 ~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~ 820 (1153)
T PLN03210 742 SNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT 820 (1153)
T ss_pred ccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC
Confidence 322 345555555544221 112222233446777777777776666777777777788888877654445665
Q ss_pred hhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccc-cccccccCcccCCCcc
Q 001274 523 EVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD-NKLTGAIPSSLGGLAR 601 (1109)
Q Consensus 523 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~ 601 (1109)
.+ ++++|+.|+|++|.....+|.. .++|+.|+|++|.++ .+|..+..+++|+.|+|++ |++. .+|..+..+++
T Consensus 821 ~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~ 894 (1153)
T PLN03210 821 GI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKH 894 (1153)
T ss_pred CC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccC
Confidence 55 6777888888776554455543 356777888888877 5777778888888888877 4454 46666777778
Q ss_pred cceeeccCcc
Q 001274 602 LTELQMGGNI 611 (1109)
Q Consensus 602 L~~L~l~~N~ 611 (1109)
|+.++++++.
T Consensus 895 L~~L~l~~C~ 904 (1153)
T PLN03210 895 LETVDFSDCG 904 (1153)
T ss_pred CCeeecCCCc
Confidence 8888887774
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-26 Score=241.66 Aligned_cols=399 Identities=22% Similarity=0.221 Sum_probs=229.3
Q ss_pred eEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceecccc-ccccCCCCccccccccchhhhccc
Q 001274 147 RKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGH-NSLSGPIPPEISECEGLEVLGLAQ 225 (1109)
Q Consensus 147 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~l~~l~~L~~L~L~~ 225 (1109)
..++|..|+|+...|.+|+.+.+|+.|||++|+|+..-|++|..|..|..|.+.+ |+|+......|++|..|+.|.+.-
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNa 149 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNA 149 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcCh
Confidence 3444444555444445556666666666666666655566666666555555444 566644445566666777777777
Q ss_pred ccccccCchhhhccccccceecccccccCCCCC-Cccccccccceeeeeccce------------ecCchhhhccCccce
Q 001274 226 NSLEGFLPSELEKLRNLTDLILWQNHLSGEIPP-TIGNIQSLELLALHENSFS------------GGLPKELGKLSRLKK 292 (1109)
Q Consensus 226 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~------------~~~p~~l~~l~~L~~ 292 (1109)
|++.-.....|..|++|..|.|.+|.+. .++. +|..+.+++.+.+..|.+- ...|..++...-..-
T Consensus 150 n~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 150 NHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 7766666666777777777777777776 4443 6677777777777766621 223334444444444
Q ss_pred EEeecccccCccCcccCC-CCcCcEEEccCCcccCCCc-ccccCCCCcceEecccccccCcccccccCCCCccEEEcccC
Q 001274 293 LYVYTNELNGTIPHELGN-CTSAVEIDLSENQLTGFIP-RELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSIN 370 (1109)
Q Consensus 293 L~l~~n~l~~~~~~~l~~-l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N 370 (1109)
..+.++++..+-+..|.. +.++..=-.+.+...+..| ..|..+++|+.|+|++|+++++.+.+|..+..+++|.|..|
T Consensus 229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N 308 (498)
T KOG4237|consen 229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRN 308 (498)
T ss_pred HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcc
Confidence 455555554333332221 1122221222332333333 35667777777777777777777777777777777777777
Q ss_pred cccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCcc-chhhhcccccceeecCCccccCCCC
Q 001274 371 NLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSI-PPHLCMYQKLIFLSLGSNRLSGNIP 449 (1109)
Q Consensus 371 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~~ 449 (1109)
+|...-...|.++..|+.|+|++|+|+-..|..|..+..|..|+|-.|.+.--- -.|+.. .|..+.-.|..|
T Consensus 309 ~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~~~~~ 381 (498)
T KOG4237|consen 309 KLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVVGNPR 381 (498)
T ss_pred hHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhhCCCCCCCC
Confidence 776555566777777777777777777777777777777777777666553110 001110 111222111111
Q ss_pred CCCccccccceeecccccccc---cCCcccc---------CCcccceec-cccccccCCCCccccccccccEEEccCCcc
Q 001274 450 PGLKTCRSLMQLMLGQNQLTG---SLPIEFY---------NLQNLSALE-LYQNRFSGLIPPEIGKLRNLERLHLSENYF 516 (1109)
Q Consensus 450 ~~~~~l~~L~~L~L~~N~l~~---~~p~~~~---------~l~~L~~L~-L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 516 (1109)
-..-..++.+.++.+.+.. ..|++.. .++-+.+.. -|++.++ .+|..+. ..-++|++.+|.+
T Consensus 382 --Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~ 456 (498)
T KOG4237|consen 382 --CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAI 456 (498)
T ss_pred --CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchh
Confidence 1111234444454443321 1222211 123333333 3333343 4555443 2467889999999
Q ss_pred CCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCC
Q 001274 517 VGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRN 562 (1109)
Q Consensus 517 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 562 (1109)
+ .+|.. .+.+| .+|+|+|+|+..--..|.++++|.+|-||+|
T Consensus 457 ~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 457 T-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred c-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 8 56766 67778 8899999998766778899999999999887
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-26 Score=244.44 Aligned_cols=426 Identities=22% Similarity=0.255 Sum_probs=234.0
Q ss_pred ccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeec-ccccC
Q 001274 224 AQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYT-NELNG 302 (1109)
Q Consensus 224 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~-n~l~~ 302 (1109)
++-.++ .+|..+. ..-+.++|..|+|+...|.+|+.+.+|+.|||++|+|+.+-|++|.+|.+|..|.+.+ |+|+.
T Consensus 54 r~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 54 RGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred cCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 333344 4554443 3566788888888866677888888888888888888888888888888888877766 88886
Q ss_pred ccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCccc---------
Q 001274 303 TIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLT--------- 373 (1109)
Q Consensus 303 ~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~--------- 373 (1109)
.....|.++.+|+-|.+.-|++.-...+.|..+++|..|.+.+|.+..+-...|..+..++.+.+..|.+-
T Consensus 131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla 210 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLA 210 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhh
Confidence 55567888888888888888888777778888888888888888887555557777888888888777732
Q ss_pred ---CCCCcchhcccccceEEcccccccccCCCccccc-CcCcEEEeccccccCccc-hhhhcccccceeecCCccccCCC
Q 001274 374 ---GTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDGSIP-PHLCMYQKLIFLSLGSNRLSGNI 448 (1109)
Q Consensus 374 ---~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~ 448 (1109)
...|..++...-..-..+.++++....+..|... ..+..=-.+.+...++.| ..|.++++|+.|+|++|+|+++.
T Consensus 211 ~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~ 290 (498)
T KOG4237|consen 211 DDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIE 290 (498)
T ss_pred hHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhh
Confidence 1223334444434444444444443333333221 111111111222222222 23555555555555555555555
Q ss_pred CCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCC-CChhhccc
Q 001274 449 PPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGY-IPSEVGNL 527 (1109)
Q Consensus 449 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l 527 (1109)
+.+|.++..+++|+|..|+|..+....|.++..|++|+|++|+|+...|..|..+..|.+|.|-.|.+.-- --.+++.
T Consensus 291 ~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~- 369 (498)
T KOG4237|consen 291 DGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE- 369 (498)
T ss_pred hhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-
Confidence 55555555555555555555555455555555555555555555555555555555555555555544310 0011111
Q ss_pred ccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCcc---CCCcccccccccceecccccccccccCcccCCCcccce
Q 001274 528 EHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG---SAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTE 604 (1109)
Q Consensus 528 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 604 (1109)
.|..+.-.| .|.. .+-..++.++++.+.+.. ..|++.+..+ .+..-..++-+.+
T Consensus 370 ------Wlr~~~~~~-~~~C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~---------------s~~cP~~c~c~~t 426 (498)
T KOG4237|consen 370 ------WLRKKSVVG-NPRC-QSPGFVRQIPISDVAFGDFRCGGPEELGCLT---------------SSPCPPPCTCLDT 426 (498)
T ss_pred ------HHhhCCCCC-CCCC-CCCchhccccchhccccccccCCccccCCCC---------------CCCCCCCcchhhh
Confidence 111222111 1211 111234455555554331 1222211110 0000111222322
Q ss_pred eeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEccCc
Q 001274 605 LQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNN 683 (1109)
Q Consensus 605 L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N 683 (1109)
..=-.|+....+|..+..-.. .|++.+|.++ .+|.+ .+++| .+|||+|+++-.--..|.++..|.+|-||+|
T Consensus 427 VvRcSnk~lk~lp~~iP~d~t---elyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 427 VVRCSNKLLKLLPRGIPVDVT---ELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hHhhcccchhhcCCCCCchhH---HHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 221222222244444432222 3567777776 44554 56667 7777777777555566777777777777776
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=236.55 Aligned_cols=266 Identities=26% Similarity=0.350 Sum_probs=196.2
Q ss_pred HHhcCCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCC
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 873 (1109)
.....|..+++||+|.|++||+|.+. .++.||+|.+... .....+.+|++++..+ .+.||+++.+++..++
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44567889999999999999999743 4678999999643 2456688999999999 5899999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-CCCceEEeeccc
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD-EEFQAHVGDFGL 952 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~ 952 (1109)
...+|+||++.....++... ++..++...+..++.||.++| ..|||||||||.|++.+ ..++-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechh
Confidence 99999999999999888865 667888999999999999999 88999999999999997 456889999999
Q ss_pred cccccCCC------C-------C------------------------------CccccccccceeccccccCC-CCCccc
Q 001274 953 AKLIDLPY------S-------K------------------------------SMSAIAGSYGYIAPEYAYTM-KVTEKC 988 (1109)
Q Consensus 953 a~~~~~~~------~-------~------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~ 988 (1109)
|...+... . . ......||++|+|||++..- .-+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97321000 0 0 00123599999999998754 468899
Q ss_pred hhHHHHHHHHHHHhCCCCCCCcccC-CcHHHHHH--------H--hhhcc--------CCC-chhhh--hhcc-----h-
Q 001274 989 DIYSFGVVLLELITGKSPVQSLELG-GDLVTWVR--------R--SIHEM--------VPT-SELFD--KRLD-----L- 1040 (1109)
Q Consensus 989 DvwSlGvll~elltg~~pf~~~~~~-~~~~~~~~--------~--~~~~~--------~~~-~~~~~--~~~~-----~- 1040 (1109)
||||.||++.-+++++.||.....+ +.+.+.+. + ...+. .+. .+... ..+. .
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999998654422 22222211 1 01111 000 00000 0000 0
Q ss_pred -----hhcc-cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1041 -----SAKR-TVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1041 -----~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.... .......+.+++.+|+..+|.+|-|+++.++|-
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0000 001123688999999999999999999999774
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-25 Score=218.74 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=196.9
Q ss_pred CCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
+.....+|.+...|+.|+|+++ |..+++|++..+.......++|..|.-.++-+.||||.+++|.|.......++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3445568899999999999997 566777888877777777789999999999999999999999999999999999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 962 (1109)
+.|+|+..+++...- .++-.++.+++.+||+|++|||+- +.-|.---+....|++|++.+++|+= +-+++. .
T Consensus 270 p~gslynvlhe~t~v-vvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs-----f 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSV-VVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS-----F 341 (448)
T ss_pred cchHHHHHHhcCccE-EEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee-----e
Confidence 999999999986542 467789999999999999999976 44455567899999999999888742 111111 1
Q ss_pred CccccccccceeccccccCCCCC---ccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 963 SMSAIAGSYGYIAPEYAYTMKVT---EKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
...+..-.+.|++||.+..++-+ +++|+|||++++||+.|...||.+...-+--.....+..+..+
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i----------- 410 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI----------- 410 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC-----------
Confidence 11122346789999999887754 5899999999999999999999876532221222222222222
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
++...+.+.+++.-|+..||.+||.+..|+-.|++..
T Consensus 411 -----ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 -----PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -----CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2223346778999999999999999999999988753
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=269.01 Aligned_cols=339 Identities=23% Similarity=0.258 Sum_probs=246.8
Q ss_pred chhhhccCccceEEeecccc------cCccCcccCCCC-cCcEEEccCCcccCCCcccccCCCCcceEecccccccCccc
Q 001274 281 PKELGKLSRLKKLYVYTNEL------NGTIPHELGNCT-SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIP 353 (1109)
Q Consensus 281 p~~l~~l~~L~~L~l~~n~l------~~~~~~~l~~l~-~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 353 (1109)
+.+|.++++|+.|.+..+.. ...+|..+..++ +|+.|++.+|.++ .+|..+ .+.+|+.|++.+|.+. .++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 45677788888888866532 234566666654 6888888888887 456555 4688888999888877 466
Q ss_pred ccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccc
Q 001274 354 RELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQK 433 (1109)
Q Consensus 354 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~ 433 (1109)
..+..+++|++|+|++++..+.+| .+..+++|+.|+|++|.....+|..++.+++|+.|++++|.....+|..+ ++++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 777888889999998876544666 47788888999998887666788888888889999998875555666554 6888
Q ss_pred cceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccc-------cCCCCccccccccc
Q 001274 434 LIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRF-------SGLIPPEIGKLRNL 506 (1109)
Q Consensus 434 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l-------~~~~p~~~~~l~~L 506 (1109)
|+.|++++|...+.+|.. .++|++|++++|.+. .+|..+ .+++|+.|++.++.. ....+..+...++|
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL 780 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL 780 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence 888888888665555543 357888888888887 455544 577888888876432 21222223345688
Q ss_pred cEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceeccccc
Q 001274 507 ERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDN 586 (1109)
Q Consensus 507 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 586 (1109)
+.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|+|++|..-..+|.. ..+|+.|+|++|
T Consensus 781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n 856 (1153)
T PLN03210 781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT 856 (1153)
T ss_pred hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence 889998887777788888888899999998875444777665 6888899999887654455543 357888889888
Q ss_pred ccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCc
Q 001274 587 KLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHN 635 (1109)
Q Consensus 587 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N 635 (1109)
.++ .+|.++..+++|+.|+|++|+-...+|..+.+++.|. .++++++
T Consensus 857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~-~L~l~~C 903 (1153)
T PLN03210 857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLE-TVDFSDC 903 (1153)
T ss_pred CCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCC-eeecCCC
Confidence 887 5788888888899999888544446777777777765 2555443
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=214.16 Aligned_cols=172 Identities=23% Similarity=0.233 Sum_probs=128.4
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|+|.++++..+. .+++..+..++.||+.||+||| +.+ ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-----
Confidence 689999976443 3999999999999999999999 445 999999999999999 9999865421
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcc
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKR 1044 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
...||+.|+|||++.+..++.++|||||||++|||+||+.||............+........+.. +.. ..
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~---~~ 133 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD-----RSN---LE 133 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-----ccc---HH
Confidence 125789999999999999999999999999999999999999754322222211111111111000 000 00
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.+|++||++.|++++++.....
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 111113588999999999999999999999999887543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-24 Score=269.69 Aligned_cols=199 Identities=17% Similarity=0.191 Sum_probs=140.9
Q ss_pred cCCC-CceeeEEEEEE-------eCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCe
Q 001274 856 KIRH-RNIVKLYGFCY-------HQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927 (1109)
Q Consensus 856 ~l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 927 (1109)
.++| +||++++++|. ..+..+.++||+ +++|.+++.... ..+++.++..++.||++||+||| +++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAH---SQGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 4455 57888888772 234567788988 669999997543 23899999999999999999999 7899
Q ss_pred EecCCCCCceeeCC-------------------CCceEEeeccccccccCCCC---------------CCccccccccce
Q 001274 928 IHRDIKSNNILLDE-------------------EFQAHVGDFGLAKLIDLPYS---------------KSMSAIAGSYGY 973 (1109)
Q Consensus 928 vH~Dlkp~NIll~~-------------------~~~~kl~DFG~a~~~~~~~~---------------~~~~~~~gt~~y 973 (1109)
+||||||+|||++. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999955 44566666666653211000 001123578899
Q ss_pred eccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHH
Q 001274 974 IAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFL 1053 (1109)
Q Consensus 974 ~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1109)
+|||++.+..|+.++|||||||++|||++|..|+.... ..+........+.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~~~~~~-------------~~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHRVLPPQ-------------ILLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHhhcChh-------------hhhcCHHHH
Confidence 99999999999999999999999999999988865311 11111111111100 001112345
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1054 KIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1054 ~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.++.+||+.+|.+||+|.|++++-+.
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhchhh
Confidence 78889999999999999999987654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=225.37 Aligned_cols=262 Identities=22% Similarity=0.259 Sum_probs=198.6
Q ss_pred CCCCCceEecCCcceEEEEEecCC--cEEEEEEeeccCCCcchhHHHHHHHHHhccCCC----CceeeEEEEE-EeCCce
Q 001274 803 NFSEGAVIGRGACGTVYKATLANG--EVIAVKKIKLRGEGATADNSFLAEISTLGKIRH----RNIVKLYGFC-YHQDSN 875 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~ 875 (1109)
+|.+.++||+|+||.||.|..... ..+|+|......... ...+..|..++..+.. +++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999997643 578888876432221 1157778888888862 5889999988 477788
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-----CceEEeec
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-----FQAHVGDF 950 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DF 950 (1109)
++||+.+ |.+|.++..... ...++..++.+|+.|++.+|+++| +.|++||||||.|+++... ..+++.||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 9999998 889999886665 335999999999999999999999 8899999999999999765 46999999
Q ss_pred cccc--cccCCCC------CC-ccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHH
Q 001274 951 GLAK--LIDLPYS------KS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVR 1021 (1109)
Q Consensus 951 G~a~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~ 1021 (1109)
|+|+ .+..... .. .....||..|+++++..+...+++.|+||++.++.|+..|..||..............
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998 3321111 11 2345699999999999999999999999999999999999999986653333222222
Q ss_pred HhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1022 RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
......... ........+.++...+-..+...+|....+...+.+.....
T Consensus 252 ~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 252 DPRKLLTDR-------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred Hhhhhcccc-------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 211111110 01111234555666566689999999999999998887665
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=246.22 Aligned_cols=261 Identities=30% Similarity=0.353 Sum_probs=126.3
Q ss_pred ccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCC
Q 001274 362 LHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGS 441 (1109)
Q Consensus 362 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 441 (1109)
-..|++++|+|+ .+|..+. ++|+.|++.+|+++. +|. .+++|++|++++|+|+.. |.. .++|+.|++++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcc-cCc---ccccceeeccC
Confidence 455666666666 4454443 356666666666652 333 135566666666666532 321 23455555555
Q ss_pred ccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCC
Q 001274 442 NRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIP 521 (1109)
Q Consensus 442 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 521 (1109)
|.++. +|.. ..+|+.|++++|+++. +|. .+++|+.|+|++|+|+++ |... .+|+.|++++|+|++ +|
T Consensus 272 N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~N~L~~-LP 338 (788)
T PRK15387 272 NPLTH-LPAL---PSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASL-PALP---SELCKLWAYNNQLTS-LP 338 (788)
T ss_pred Cchhh-hhhc---hhhcCEEECcCCcccc-ccc---cccccceeECCCCccccC-CCCc---ccccccccccCcccc-cc
Confidence 55542 2221 1334455555555552 222 124455555555555532 2211 234445555555543 23
Q ss_pred hhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcc
Q 001274 522 SEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLAR 601 (1109)
Q Consensus 522 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 601 (1109)
.. ..+|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +|... ++
T Consensus 339 ~l---p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-LP~l~---s~ 403 (788)
T PRK15387 339 TL---PSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVLP---SE 403 (788)
T ss_pred cc---ccccceEecCCCccC-CCCCCC---cccceehhhccccc-cCccc---ccccceEEecCCcccC-CCCcc---cC
Confidence 21 124455555555555 233221 23444555555554 23322 1234444444444442 22211 23
Q ss_pred cceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEcc
Q 001274 602 LTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLS 681 (1109)
Q Consensus 602 L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls 681 (1109)
|+. |++++|+|++ +|.. ..+|+.|+|++|+|+ .+|..+.++..|..++|+
T Consensus 404 L~~-------------------------LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 404 LKE-------------------------LMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred CCE-------------------------EEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 444 4555555553 3432 234566666666665 566666666666677777
Q ss_pred CcccccccCC
Q 001274 682 NNNLVGTVPN 691 (1109)
Q Consensus 682 ~N~l~g~~p~ 691 (1109)
+|+|+|.+|+
T Consensus 454 ~N~Ls~~~~~ 463 (788)
T PRK15387 454 GNPLSERTLQ 463 (788)
T ss_pred CCCCCchHHH
Confidence 7777666654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=240.32 Aligned_cols=267 Identities=30% Similarity=0.366 Sum_probs=152.5
Q ss_pred ccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcc
Q 001274 289 RLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLS 368 (1109)
Q Consensus 289 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 368 (1109)
.-..|++++|.++ .+|..+. .+|+.|++++|+++. +|. .++ +|++|+++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~------------------------~Lk~LdLs 250 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPP------------------------ELRTLEVS 250 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCC------------------------CCcEEEec
Confidence 3456677777776 4565554 356677777776663 232 123 45555555
Q ss_pred cCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCC
Q 001274 369 INNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNI 448 (1109)
Q Consensus 369 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 448 (1109)
+|+|+ .+|.. .++|+.|++++|.++ .+|.. ...|+.|++++|+++.. |. .+++|+.|+|++|+|+++
T Consensus 251 ~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L- 317 (788)
T PRK15387 251 GNQLT-SLPVL---PPGLLELSIFSNPLT-HLPAL---PSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL- 317 (788)
T ss_pred CCccC-cccCc---ccccceeeccCCchh-hhhhc---hhhcCEEECcCCccccc-cc---cccccceeECCCCccccC-
Confidence 55554 22321 234455555555554 22221 13455555555555532 22 124556666666666542
Q ss_pred CCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccc
Q 001274 449 PPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLE 528 (1109)
Q Consensus 449 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 528 (1109)
|.. ..+|+.|++++|++++ +|.. ..+|++|+|++|+|+++ |.. .++|+.|++++|+|++ +|.. ..
T Consensus 318 p~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~-LP~l---~~ 382 (788)
T PRK15387 318 PAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTS-LPAL---PS 382 (788)
T ss_pred CCC---cccccccccccCcccc-cccc---ccccceEecCCCccCCC-CCC---Ccccceehhhcccccc-Cccc---cc
Confidence 221 1245566666666664 3321 14677777777777743 332 2456677777777774 4432 24
Q ss_pred cccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeecc
Q 001274 529 HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMG 608 (1109)
Q Consensus 529 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 608 (1109)
+|+.|+|++|+|+ .+|... ++|+.|++++|+|++ +|..+ .+|+.|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 5777777777777 355432 467777888888773 56432 35677777777777 567777777777777777
Q ss_pred Ccccccccccccccc
Q 001274 609 GNIFSGSIPVALGQL 623 (1109)
Q Consensus 609 ~N~l~~~~p~~~~~l 623 (1109)
+|+|++.+|..+..+
T Consensus 454 ~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 454 GNPLSERTLQALREI 468 (788)
T ss_pred CCCCCchHHHHHHHH
Confidence 777777666655433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=201.35 Aligned_cols=262 Identities=21% Similarity=0.304 Sum_probs=198.3
Q ss_pred cCCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
-.|+++++||+|.||.++.|+ +-++++||||.-..+. +..++..|.+..+.+ ..++|..++-+..++.+..+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 479999999999999999998 4579999999775433 345677888888887 4689999998888888999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-----ceEEeeccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-----QAHVGDFGLAK 954 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DFG~a~ 954 (1109)
|.. |-||+++..-.+.+ |+.+++..+|.|++.-++|+| ++..|+|||||+|+||...+ .+.++|||+|+
T Consensus 104 dLL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 999 88999998776654 999999999999999999999 78999999999999997543 69999999999
Q ss_pred cccCCCCCCc------cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHh-hhcc
Q 001274 955 LIDLPYSKSM------SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRS-IHEM 1027 (1109)
Q Consensus 955 ~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~-~~~~ 1027 (1109)
.+.++..... +...||-+||+-....+++-+.+.|+=|+|-++...+-|..||++......-...-+-. ....
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 8865543332 45679999999999999999999999999999999999999999876332211111100 0011
Q ss_pred CCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.+..++. ...+++....++.++ ..+-++-|..+-+..-+..+....
T Consensus 258 T~i~~Lc--------~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 258 TPIEVLC--------EGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred CCHHHHH--------hcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhc
Confidence 1111111 123344444444444 556677788877766666554443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=194.89 Aligned_cols=202 Identities=23% Similarity=0.325 Sum_probs=170.9
Q ss_pred HhcCCCCCceEecCCcceEEEEE-ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCC-CceeeEEEEEEeCCceEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH-RNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 877 (1109)
..+.|.++++||.|+||.+|.|. ..+|+.||||+-.... .......|.++.+.+++ ..|..+.-+..+.++..+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 34789999999999999999997 5689999999876433 23457789999999965 678888888889999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC---CceEEeeccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE---FQAHVGDFGLAK 954 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~ 954 (1109)
||+.. |-+|++...-.... ++.++++..+-|++.-++|+| .+++|||||||+|+|+.-+ ..+.++|||+|+
T Consensus 89 VMdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchh
Confidence 99998 78999888655443 899999999999999999999 7799999999999999644 468999999998
Q ss_pred cccCCCCCC------ccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 001274 955 LIDLPYSKS------MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011 (1109)
Q Consensus 955 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~ 1011 (1109)
.+.+..... .....||.+|.+-....+...+.+.|+-|+|.++..+--|..||++..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 774322221 245679999999998888889999999999999999999999999865
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=221.01 Aligned_cols=167 Identities=23% Similarity=0.196 Sum_probs=128.9
Q ss_pred HhcCCCCCceEecCCcceEEEEEec--CCcEEEEEEeeccCC---CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA--NGEVIAVKKIKLRGE---GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 874 (1109)
..++|.+.+.||+|+||+||+|+++ +++.||||+...... .....+.+.+|++++++++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3468999999999999999999864 577889998752211 12235668999999999999999853322 246
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCceeeCCCCceEEeecccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDI-KSNNILLDEEFQAHVGDFGLA 953 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFG~a 953 (1109)
.++||||++|++|.. ... .. ...++.++++||+||| +.+|+|||| ||+|||++.++.+||+|||+|
T Consensus 93 ~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 799999999999963 211 11 1467889999999999 789999999 999999999999999999999
Q ss_pred ccccCCCC-------CCccccccccceeccccccCC
Q 001274 954 KLIDLPYS-------KSMSAIAGSYGYIAPEYAYTM 982 (1109)
Q Consensus 954 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~ 982 (1109)
+....... .......+++.|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 87653221 111345688899999988754
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=240.28 Aligned_cols=374 Identities=21% Similarity=0.268 Sum_probs=222.3
Q ss_pred chhHHHHHHHHHHhcCCCCCCCCC----CCCCCCCCCccce----------------eeecCCeEEEEeccCcccccccc
Q 001274 30 LTEEGVSLLEFKASLIDPSNNLES----WNSSDMTPCNWIG----------------VECTDFKVTSVDLHGLNLSGILS 89 (1109)
Q Consensus 30 ~~~~~~all~~k~~~~~~~~~~~~----W~~~~~~~c~w~g----------------v~C~~~~v~~l~l~~~~l~g~~~ 89 (1109)
..+|.+++++..+.+.=|. .+++ |++.+ ++|.-.. |.|....||.+..-+...+....
T Consensus 61 ~~~~~~~~~~~~~~l~~p~-~~~~~~~~~~~~~-~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~~~ 138 (754)
T PRK15370 61 SPEEIKSKFECLRMLAFPA-YADNIQYSRGGAD-QYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASSAS 138 (754)
T ss_pred CHHHHHHHHHHHHHhcCCc-hhhccccccCCCC-cccccCCcchhhheeeecCCceEEecCCCcccccccccccccccCC
Confidence 3457789999999997553 3555 98764 8897655 77887778777766533222211
Q ss_pred cc--ccCccccceeecccCccCCCCC---ccc-----cCCCCCceEEccCCcccccCCchhhccccceEEEccccccccc
Q 001274 90 PR--ICDLPRLVEFNISMNFVTGSIP---TDL-----ANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGE 159 (1109)
Q Consensus 90 ~~--~~~l~~L~~L~ls~n~~~~~~p---~~l-----~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 159 (1109)
.+ ..+.... .=+-..+.-.+.-+ ..+ +-..+.+.|+|+++.++ .+|..+. ++|+.|+|++|.++ .
T Consensus 139 ~~~~~~~~~~~-w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-s 213 (754)
T PRK15370 139 GSKDAVNYELI-WSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-S 213 (754)
T ss_pred CCCChhhHHHH-HHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-c
Confidence 10 0000000 00000000000000 001 11134566777777666 3554442 46777777777776 4
Q ss_pred ccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhcc
Q 001274 160 IPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKL 239 (1109)
Q Consensus 160 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 239 (1109)
+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. .+|++|+|++|+++ .+|..+.
T Consensus 214 LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~-- 282 (754)
T PRK15370 214 LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP-- 282 (754)
T ss_pred CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--
Confidence 555443 46777777777776 4565443 35777777777776 5565553 46777777777777 3555543
Q ss_pred ccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEc
Q 001274 240 RNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDL 319 (1109)
Q Consensus 240 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 319 (1109)
.+|++|+|++|+|+ .+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|
T Consensus 283 ~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~L 353 (754)
T PRK15370 283 EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDV 353 (754)
T ss_pred CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEEC
Confidence 46777788888777 4555443 467778888887773 454433 577888888888774 555553 57888888
Q ss_pred cCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcch----hcccccceEEccccc
Q 001274 320 SENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEF----QNLTYLVDLQLFDNH 395 (1109)
Q Consensus 320 s~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~ 395 (1109)
++|+++. +|..+ .++|+.|+|++|.++. +|..+. ..|+.|++++|+|+ .+|..+ ..++.+..|++.+|.
T Consensus 354 s~N~L~~-LP~~l--p~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Np 426 (754)
T PRK15370 354 SKNQITV-LPETL--PPTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNP 426 (754)
T ss_pred CCCCCCc-CChhh--cCCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCC
Confidence 8888873 45444 3678888888888874 455443 36888888888887 455443 345778888888888
Q ss_pred ccccCCCcccccCcCcEEEeccccccCc-cchhhhcccccceeecCCccc
Q 001274 396 LEGTIPPHIGVNSHLSVLDVSMNNLDGS-IPPHLCMYQKLIFLSLGSNRL 444 (1109)
Q Consensus 396 l~~~~p~~~~~~~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~L~~N~l 444 (1109)
++. ..+.+|+.| ++.+.+.|. ++...+.+.+++....-.+.+
T Consensus 427 ls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~ 469 (754)
T PRK15370 427 FSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAV 469 (754)
T ss_pred ccH------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHH
Confidence 862 344555555 444555442 233344445555433333333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-19 Score=206.30 Aligned_cols=260 Identities=30% Similarity=0.378 Sum_probs=200.3
Q ss_pred CCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcc-hhHHHHHHHHHhccCCCC-ceeeEEEEEEeCCceEEEEEe
Q 001274 804 FSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGAT-ADNSFLAEISTLGKIRHR-NIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 881 (1109)
|...+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999986 7889999976654432 467899999999999988 799999999777778999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeeccccccccCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~ 960 (1109)
+.++++.+++........++......++.|++.++.|+| +.+++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977765432123888999999999999999999 77899999999999999998 79999999998654332
Q ss_pred CC-----CccccccccceeccccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccC---CcHHHHHHHhhhccCC
Q 001274 961 SK-----SMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSFGVVLLELITGKSPVQSLELG---GDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 961 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~ 1029 (1109)
.. ......++..|+|||.+.+ ..+....|+||+|++++++++|..||...... ......+.......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS-- 234 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc--
Confidence 21 2456789999999999987 57889999999999999999999997654321 11222222111110
Q ss_pred CchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1030 TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
......... .......+.+++.+|+..+|..|.++.+....
T Consensus 235 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSN------PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccc------cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 01223457789999999999999999988876
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=229.53 Aligned_cols=246 Identities=27% Similarity=0.429 Sum_probs=147.9
Q ss_pred cCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcc
Q 001274 313 SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLF 392 (1109)
Q Consensus 313 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 392 (1109)
+...|+++++.++. +|..+ .++|+.|+|++|.++. +|..+. .+|++|++++|+|+ .+|..+.
T Consensus 179 ~~~~L~L~~~~Lts-LP~~I--p~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~----------- 240 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACI--PEQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP----------- 240 (754)
T ss_pred CceEEEeCCCCcCc-CCccc--ccCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh-----------
Confidence 45678888887774 34333 2345555555555552 333322 24555555555555 2333221
Q ss_pred cccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccC
Q 001274 393 DNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSL 472 (1109)
Q Consensus 393 ~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 472 (1109)
.+|+.|+|++|++. .+|..+. .+|+.|++++|+|+. +|..+. ++|+.|++++|++++ +
T Consensus 241 ---------------~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-L 298 (754)
T PRK15370 241 ---------------DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-L 298 (754)
T ss_pred ---------------ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-C
Confidence 23445555555544 2333332 345555566555553 343332 356666666666664 3
Q ss_pred CccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCC
Q 001274 473 PIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCV 552 (1109)
Q Consensus 473 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 552 (1109)
|..+. ++|+.|++++|+++.+ |..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. +
T Consensus 299 P~~lp--~sL~~L~Ls~N~Lt~L-P~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~ 367 (754)
T PRK15370 299 PAHLP--SGITHLNVQSNSLTAL-PETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--P 367 (754)
T ss_pred cccch--hhHHHHHhcCCccccC-Ccccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--C
Confidence 33332 3677777777777753 43332 577888888888875 555543 67888888888887 5666553 5
Q ss_pred CCCeeecCCCcCccCCCcccccccccceecccccccccccCc----ccCCCcccceeeccCcccc
Q 001274 553 NLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPS----SLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 553 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~ 613 (1109)
+|+.|+|++|+|+ .+|..+. .+|+.|++++|+|+ .+|. .++.++++..|++.+|+++
T Consensus 368 ~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 368 TITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 7888888888888 4666554 36888888888887 3444 3444577888888888876
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=231.62 Aligned_cols=261 Identities=21% Similarity=0.244 Sum_probs=192.7
Q ss_pred CCCceEecCCcceEEEEEec-CCcEEEEEEeec---cCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 805 SEGAVIGRGACGTVYKATLA-NGEVIAVKKIKL---RGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 805 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
...+.+|.|++|.|+.+... ....++.|.+.. .... ......+..|+-+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34578999999988877633 344455554432 1111 111222667888888899999988887777777666669
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
|||++ +|..++..... +...++..+++|+..|++|+| ..|+.|||+|++|+++..+|.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99999877533 788899999999999999999 889999999999999999999999999999877544
Q ss_pred CC---CCccccccccceeccccccCCCCCc-cchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 960 YS---KSMSAIAGSYGYIAPEYAYTMKVTE-KCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 960 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.. ....+.+|+-.|+|||++.+..|++ ..||||.|+++..|.+|+.||......++....... ... .
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~--~~~---~---- 544 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY--SDQ---R---- 544 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc--ccc---c----
Confidence 43 2346778999999999999999975 689999999999999999999866533322100000 000 0
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
...............+...++.++++++|.+|-|+++|++.=|...
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 0000111112233456778999999999999999999998766543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=186.52 Aligned_cols=142 Identities=20% Similarity=0.178 Sum_probs=108.3
Q ss_pred CceEecCCcceEEEEEecCCcEEEEEEeeccCCCcch-------h-----------------HHHHHHHHHhccCCCCce
Q 001274 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATA-------D-----------------NSFLAEISTLGKIRHRNI 862 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~-------~-----------------~~~~~E~~~l~~l~h~ni 862 (1109)
...||+|+||.||+|...+|+.||||+++........ . ....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999999754221111 0 122359999999987776
Q ss_pred eeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCCCceeeCC
Q 001274 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL-HYDCRPHIIHRDIKSNNILLDE 941 (1109)
Q Consensus 863 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlkp~NIll~~ 941 (1109)
.....+.. ...++||||++++++........ .+++.....++.|++.++.|+ | +.+|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-
Confidence 43332222 23489999999887755432222 388899999999999999999 6 66999999999999998
Q ss_pred CCceEEeecccccccc
Q 001274 942 EFQAHVGDFGLAKLID 957 (1109)
Q Consensus 942 ~~~~kl~DFG~a~~~~ 957 (1109)
++.++++|||+|...+
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=188.57 Aligned_cols=173 Identities=14% Similarity=0.113 Sum_probs=134.3
Q ss_pred HhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcch-hH------HHHHHHHHhccCCCCceeeEEEEEEeC
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATA-DN------SFLAEISTLGKIRHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~-~~------~~~~E~~~l~~l~h~niv~l~~~~~~~ 872 (1109)
..++|+..+++|.|+||.||.+.. ++..+|||.+.......+. .. .+.+|++.+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 358999999999999999999766 5778999999754332221 11 267999999999999999998886643
Q ss_pred --------CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 001274 873 --------DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ 944 (1109)
Q Consensus 873 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 944 (1109)
...++||||++|.+|.++.. ++. ....+++.++..+| +.|++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-
Confidence 35789999999999988731 232 24558999999999 88999999999999999998
Q ss_pred eEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHH
Q 001274 945 AHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELI 1001 (1109)
Q Consensus 945 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ell 1001 (1109)
++++|||..+....+... ..+.....|..++|+|+||+.+....
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754311111 11344556778999999999987653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.1e-20 Score=215.89 Aligned_cols=251 Identities=20% Similarity=0.212 Sum_probs=182.9
Q ss_pred CCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHH--hccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEIST--LGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+|...+.+|.+.|=+|.+|++++|. |+||++-..+.. -..+.|.++++- ...++|||++++..+-..+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~-~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPT-ISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCC-CCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667788999999999999998887 899999755432 223344443333 445589999999888777788899999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|..+ +|++.+....- +...+...|+.|++.|+.-+| +.||.|||||.+|||++.-.-+.|+||..-+..--+.
T Consensus 102 yvkh-nLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhccchH---HHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9965 99999987653 788888999999999999999 8899999999999999999999999998766432222
Q ss_pred CCC--c----cccccccceeccccccCC----------C-CCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHH
Q 001274 961 SKS--M----SAIAGSYGYIAPEYAYTM----------K-VTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRR 1022 (1109)
Q Consensus 961 ~~~--~----~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~ 1022 (1109)
+.. . .+...-..|.|||.+... . .+++-||||+||++.|+++ |++||.- .+...-
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aY 247 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAY 247 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhH
Confidence 211 1 222334579999977542 1 5678999999999999999 7888862 122221
Q ss_pred hhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.-.+.......+.+..+ ..+..++..|++.||++|.+|+++++.-++
T Consensus 248 r~~~~~~~e~~Le~Ied----------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIED----------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred hccCccCHHHHHHhCcC----------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 11111111111111111 136689999999999999999999987433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=179.91 Aligned_cols=142 Identities=19% Similarity=0.188 Sum_probs=110.3
Q ss_pred CceEecCCcceEEEEEecCCcEEEEEEeeccCCCcch------------------------hHHHHHHHHHhccCCCCce
Q 001274 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATA------------------------DNSFLAEISTLGKIRHRNI 862 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni 862 (1109)
...||+|+||.||+|++.+|+.||||++......... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999999754221100 1123578899999999887
Q ss_pred eeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCceeeCC
Q 001274 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR-PHIIHRDIKSNNILLDE 941 (1109)
Q Consensus 863 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~ 941 (1109)
.....+... ..++||||++++++........ .++..+..+++.|++.++.++| . .||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV---PLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc---cCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence 544433332 3589999999886544322222 2678889999999999999999 5 7999999999999999
Q ss_pred CCceEEeecccccccc
Q 001274 942 EFQAHVGDFGLAKLID 957 (1109)
Q Consensus 942 ~~~~kl~DFG~a~~~~ 957 (1109)
++.++|+|||+++...
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=184.30 Aligned_cols=194 Identities=23% Similarity=0.285 Sum_probs=137.3
Q ss_pred CCCceeeEEEEEEeC---------------------------CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHH
Q 001274 858 RHRNIVKLYGFCYHQ---------------------------DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910 (1109)
Q Consensus 858 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 910 (1109)
+|||||++.++|.+. ...|+||...+ .+|.+|+..+. .+......+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 599999999887542 23488998885 49999997654 56667788999
Q ss_pred HHHHHHHHHhhcCCCCeEecCCCCCceee--CCCC--ceEEeecccccccc-----CCCCCCccccccccceeccccccC
Q 001274 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILL--DEEF--QAHVGDFGLAKLID-----LPYSKSMSAIAGSYGYIAPEYAYT 981 (1109)
Q Consensus 911 ~i~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DFG~a~~~~-----~~~~~~~~~~~gt~~y~aPE~~~~ 981 (1109)
|+++|+.||| ++||.|||+|.+||++ |+|+ .++|+|||.+---+ -++........|.-.-||||+...
T Consensus 349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999 8899999999999999 3443 57899999874321 122222334457778999999875
Q ss_pred CC------CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc-CCCchhhhhhcchhhcccHHHHHHHHH
Q 001274 982 MK------VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-VPTSELFDKRLDLSAKRTVEEMTLFLK 1054 (1109)
Q Consensus 982 ~~------~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1109)
.+ .-.|+|.|+.|.+.||+++...||.+.. +...+... +.+.. .++ +......+.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--em~L~~r~-Yqe~qLPal--------------p~~vpp~~rq 488 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--EMLLDTRT-YQESQLPAL--------------PSRVPPVARQ 488 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc--hheechhh-hhhhhCCCC--------------cccCChHHHH
Confidence 54 2358999999999999999999998632 11111100 11111 111 1122234678
Q ss_pred HHHhccCCCCCCCCCHHHHHHH
Q 001274 1055 IALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1055 li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
++...++.||++|++..-....
T Consensus 489 lV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHHHHhcCCccccCCccHHHhH
Confidence 8999999999999996544433
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-20 Score=174.71 Aligned_cols=164 Identities=34% Similarity=0.597 Sum_probs=81.6
Q ss_pred CCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCee
Q 001274 478 NLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRL 557 (1109)
Q Consensus 478 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 557 (1109)
++++.+.|.||+|+++ .+|+.+..+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. +.|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3444555555555555 33444555555555555555555 34445555555555555555554 455555555555555
Q ss_pred ecCCCcCcc-CCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCcc
Q 001274 558 DLSRNQFTG-SAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNN 636 (1109)
Q Consensus 558 ~Ls~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~ 636 (1109)
||++|++.. .+|..|..++.|+.|+|++|.+. .+|..+++++.|++ |.+..|.
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-------------------------~lp~dvg~lt~lqi-l~lrdnd 161 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-------------------------ILPPDVGKLTNLQI-LSLRDND 161 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-------------------------cCChhhhhhcceeE-EeeccCc
Confidence 555555432 23444444444444444444443 33333333333332 3333333
Q ss_pred ccccccccccCccccceeecCCCccccCCchhhhcc
Q 001274 637 LSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQ 672 (1109)
Q Consensus 637 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l 672 (1109)
+- .+|.+++.|++|+.|.+++|+|+ .+|++++++
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 33 45666666666666666666665 555555543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.8e-18 Score=171.36 Aligned_cols=188 Identities=14% Similarity=0.069 Sum_probs=138.3
Q ss_pred CCceEecCCcceEEEEEecCCcEEEEEEeeccCCC--cchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEEEEec
Q 001274 806 EGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEG--ATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 806 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
+...|+.|+||+||.+.. .+++++.+.+.....- ......+.+|+++++++. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999998776 5788887777633221 111225789999999995 5889999886 4579999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCceeeCCCCceEEeeccccccccCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDI-KSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+|.+|.+.... ....++.|+++++.++| +.||+|||| ||+||+++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99998654321 11347789999999999 789999999 79999999999999999999986543221
Q ss_pred C----C---c-----cccccccceeccccccCC-CCC-ccchhHHHHHHHHHHHhCCCCCCCcc
Q 001274 962 K----S---M-----SAIAGSYGYIAPEYAYTM-KVT-EKCDIYSFGVVLLELITGKSPVQSLE 1011 (1109)
Q Consensus 962 ~----~---~-----~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvll~elltg~~pf~~~~ 1011 (1109)
. . . .....++.|++|+...-- ..+ ...+.++-|..+|.++||+.+..+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 0 011256677777743321 233 56788999999999999999866443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-19 Score=203.51 Aligned_cols=187 Identities=27% Similarity=0.309 Sum_probs=157.9
Q ss_pred EecCCcceEEEEE----ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEEEEeccC
Q 001274 810 IGRGACGTVYKAT----LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 810 lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
+|+|+||.|+.++ .+.+..+|.|+.+..............|..++...+ ||.+|++.-.++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999875 234778999988755333222235667888888886 99999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
|.+...+..... +++.........++-+++++| +.+++|||+|++||+++.+|++++.|||.++..-..
T Consensus 82 g~lft~l~~~~~---f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~----- 150 (612)
T KOG0603|consen 82 GDLFTRLSKEVM---FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE----- 150 (612)
T ss_pred chhhhccccCCc---hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhh-----
Confidence 999888876554 777788888888999999999 889999999999999999999999999999865311
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~ 1009 (1109)
...+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 151 ~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 151 KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 1128999999999988 567899999999999999999999985
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.1e-18 Score=180.81 Aligned_cols=235 Identities=21% Similarity=0.267 Sum_probs=149.0
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCC----------CceeeEEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRH----------RNIVKLYGFCY 870 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 870 (1109)
.+..++.||.|+++.||.+++. +++++|||++...... ....+++.+|.-....+.+ -.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455678999999999999976 5899999999766533 2245667777655555432 12222222221
Q ss_pred e---------CC--------ceEEEEEeccCCCHHHHhcc---CCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 001274 871 H---------QD--------SNLLLYEYMENGSLGEQLHG---NKQ-TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIH 929 (1109)
Q Consensus 871 ~---------~~--------~~~lv~e~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 929 (1109)
. .. ..+++|+-+ .++|.+++.. ... ...+....+..+..|+++.+++|| ..|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence 1 11 225678877 4688877542 111 112344555677799999999999 779999
Q ss_pred cCCCCCceeeCCCCceEEeeccccccccCCCCCCccccccccceeccccccC--------CCCCccchhHHHHHHHHHHH
Q 001274 930 RDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT--------MKVTEKCDIYSFGVVLLELI 1001 (1109)
Q Consensus 930 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvll~ell 1001 (1109)
+||+|+|++++.+|.++++||+.....+... .....+..|.+||.... ..++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999999887654211 11345578999997643 24788999999999999999
Q ss_pred hCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCC
Q 001274 1002 TGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNR 1067 (1109)
Q Consensus 1002 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 1067 (1109)
+|+.||........ ... ... ...+.++.+..+|..+++++|++|
T Consensus 245 C~~lPf~~~~~~~~--------------~~~----~f~----~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEAD--------------PEW----DFS----RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGST--------------SGG----GGT----TSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccc--------------ccc----cch----hcCCcCHHHHHHHHHHccCCcccC
Confidence 99999985431111 000 111 112445678899999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.8e-18 Score=191.12 Aligned_cols=220 Identities=25% Similarity=0.377 Sum_probs=164.2
Q ss_pred hccCCCCceeeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 001274 854 LGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIK 933 (1109)
Q Consensus 854 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 933 (1109)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.....+ +++.-...++++|+.||.|+|+. . -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~--~d~~F~~s~~rdi~~Gl~ylh~s-~-i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIK--LDYFFILSFIRDISKGLAYLHNS-P-IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccC--ccHHHHHHHHHHHHHHHHHHhcC-c-ceeeeeec
Confidence 46789999999999999999999999999999999999874433 88889999999999999999953 2 22999999
Q ss_pred CCceeeCCCCceEEeeccccccccC-CCCCCccccccccceeccccccCCC-------CCccchhHHHHHHHHHHHhCCC
Q 001274 934 SNNILLDEEFQAHVGDFGLAKLIDL-PYSKSMSAIAGSYGYIAPEYAYTMK-------VTEKCDIYSFGVVLLELITGKS 1005 (1109)
Q Consensus 934 p~NIll~~~~~~kl~DFG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGvll~elltg~~ 1005 (1109)
..|+++|..+.+|++|||+...... ..........-..-|.|||.+.... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999999886642 1111122223455699999887642 4678999999999999999999
Q ss_pred CCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1006 PVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1006 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
||.......+..+.+....... ...+.+.+... .+....+..++..||..+|++||++++|-..++.+....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~---~~~~rP~i~~~----~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGG---SNPFRPSIELL----NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccccCChHHHHHHHHhcC---CCCcCcchhhh----hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 9986543333223332211101 11111111111 122336889999999999999999999998887776543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=7e-20 Score=207.82 Aligned_cols=207 Identities=22% Similarity=0.251 Sum_probs=108.8
Q ss_pred eeecccCccC-CCCCccccCCCCCceEEccCCccccc----CCchhhccccceEEEcccccccc------cccccccCcC
Q 001274 100 EFNISMNFVT-GSIPTDLANCSSLEILDLCTNRLHGV----IPFQLFFINTLRKLYLCENYIFG------EIPEEIGNLT 168 (1109)
Q Consensus 100 ~L~ls~n~~~-~~~p~~l~~l~~L~~L~Ls~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~------~~p~~l~~l~ 168 (1109)
.|+|..+.++ +..+..+..+..|++|+|+++.+++. ++..+...+++++|+++++.+.+ .++..++.++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4677777776 34556666777788888888877543 33444455667777777776652 2334555566
Q ss_pred CCceEEeecCCCCCCCCcccccccc---cceeccccccccCCCCccccccccchhhhcccccccccCchhhhcc-ccccc
Q 001274 169 SLEELVIYSNNLTGAIPASISKLRQ---LRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKL-RNLTD 244 (1109)
Q Consensus 169 ~L~~L~L~~n~l~~~~p~~~~~l~~---L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~ 244 (1109)
+|++|++++|.+.+..+..+..+.+ |+.|++++|.+++... ..+...+..+ ++|+.
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~--------------------~~l~~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGL--------------------RLLAKGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHH--------------------HHHHHHHHhCCCCceE
Confidence 6666666666665544444444433 5555555555442100 0112223333 45555
Q ss_pred eecccccccCC----CCCCccccccccceeeeeccceec----CchhhhccCccceEEeecccccCc----cCcccCCCC
Q 001274 245 LILWQNHLSGE----IPPTIGNIQSLELLALHENSFSGG----LPKELGKLSRLKKLYVYTNELNGT----IPHELGNCT 312 (1109)
Q Consensus 245 L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~n~l~~~----~~~~l~~l~ 312 (1109)
|+|++|.+++. ++..+..+.+|++|++++|.+++. ++..+..+++|++|++++|.+++. +...+..++
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 55555555421 122233334555555555555422 222334445566666666655422 223344555
Q ss_pred cCcEEEccCCcccC
Q 001274 313 SAVEIDLSENQLTG 326 (1109)
Q Consensus 313 ~L~~L~Ls~n~l~~ 326 (1109)
+|++|++++|.+++
T Consensus 222 ~L~~L~ls~n~l~~ 235 (319)
T cd00116 222 SLEVLNLGDNNLTD 235 (319)
T ss_pred CCCEEecCCCcCch
Confidence 66666666666553
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.5e-20 Score=208.71 Aligned_cols=249 Identities=24% Similarity=0.264 Sum_probs=152.4
Q ss_pred EeccCccccc-cccccccCccccceeecccCccCCC----CCccccCCCCCceEEccCCcccc------cCCchhhcccc
Q 001274 77 VDLHGLNLSG-ILSPRICDLPRLVEFNISMNFVTGS----IPTDLANCSSLEILDLCTNRLHG------VIPFQLFFINT 145 (1109)
Q Consensus 77 l~l~~~~l~g-~~~~~~~~l~~L~~L~ls~n~~~~~----~p~~l~~l~~L~~L~Ls~n~l~~------~~~~~l~~l~~ 145 (1109)
|+|.++++++ .....+..+++|+.|+++++.+++. +++.+...+.|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 5666666663 3334455677788888888888543 56667778888899998888762 23345666778
Q ss_pred ceEEEcccccccccccccccCcCC---CceEEeecCCCCC----CCCcccccc-cccceeccccccccCC----CCcccc
Q 001274 146 LRKLYLCENYIFGEIPEEIGNLTS---LEELVIYSNNLTG----AIPASISKL-RQLRVIRAGHNSLSGP----IPPEIS 213 (1109)
Q Consensus 146 L~~L~L~~n~l~~~~p~~l~~l~~---L~~L~L~~n~l~~----~~p~~~~~l-~~L~~L~l~~n~l~~~----~p~~l~ 213 (1109)
|++|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 999999999888766766666666 9999999998873 233445566 7788888888887742 223344
Q ss_pred ccccchhhhccccccccc----CchhhhccccccceecccccccCC----CCCCccccccccceeeeeccceecCchhhh
Q 001274 214 ECEGLEVLGLAQNSLEGF----LPSELEKLRNLTDLILWQNHLSGE----IPPTIGNIQSLELLALHENSFSGGLPKELG 285 (1109)
Q Consensus 214 ~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 285 (1109)
.+.+|++|++++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++.....+.
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 242 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA 242 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence 555677777777766632 223344445677777776666532 223344455566666666665543222222
Q ss_pred c-----cCccceEEeecccccC----ccCcccCCCCcCcEEEccCCccc
Q 001274 286 K-----LSRLKKLYVYTNELNG----TIPHELGNCTSAVEIDLSENQLT 325 (1109)
Q Consensus 286 ~-----l~~L~~L~l~~n~l~~----~~~~~l~~l~~L~~L~Ls~n~l~ 325 (1109)
. .+.|++|++++|.++. .+...+..+++|+++++++|.++
T Consensus 243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 1 2455555555555541 12223333345555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-19 Score=168.43 Aligned_cols=167 Identities=26% Similarity=0.487 Sum_probs=120.8
Q ss_pred cccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceee
Q 001274 527 LEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQ 606 (1109)
Q Consensus 527 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 606 (1109)
+.+++.|.||+|+++ .+|..+..+.+|+.|++++|+|+ .+|..+..+++|+.|+++-|++. ..|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 344445555555555 44445555555555555555555 45555555555555555555555 5555566666666666
Q ss_pred ccCcccc-ccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEccCccc
Q 001274 607 MGGNIFS-GSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNL 685 (1109)
Q Consensus 607 l~~N~l~-~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l 685 (1109)
|+.|++. ..+|..|+.++.|+ .|+|+.|.+. .+|.++++|++||.|.+.+|.|. ++|.+++.+..|++|.+.+|+|
T Consensus 109 ltynnl~e~~lpgnff~m~tlr-alyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLR-ALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred ccccccccccCCcchhHHHHHH-HHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 6666554 36788888888887 6999999998 78999999999999999999998 8999999999999999999999
Q ss_pred ccccCCCccccccc
Q 001274 686 VGTVPNTTVFRRID 699 (1109)
Q Consensus 686 ~g~~p~~~~~~~~~ 699 (1109)
+-..|..+++....
T Consensus 186 ~vlppel~~l~l~~ 199 (264)
T KOG0617|consen 186 TVLPPELANLDLVG 199 (264)
T ss_pred eecChhhhhhhhhh
Confidence 98888776655443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.5e-18 Score=203.11 Aligned_cols=195 Identities=24% Similarity=0.287 Sum_probs=159.5
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC---CCceeeEEEEEEeCCceEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR---HRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 877 (1109)
...|.+.+.||+|+||+||+|...+|+.||+|+-+.... + +|.-=.+++.+|+ -+.|..+..++...+.-++
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--W---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--e---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 357888899999999999999988899999998764332 1 2333344455555 2345566666667788899
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-------CCCceEEeec
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD-------EEFQAHVGDF 950 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl~DF 950 (1109)
|+||.+.|+|.+++...+. ++|..+..++.|+++.+++|| ..+|||+||||+|+|+. ....++|+||
T Consensus 772 v~ey~~~Gtlld~~N~~~~---m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKV---MDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhccCCC---CCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 9999999999999985554 899999999999999999999 88999999999999994 2346999999
Q ss_pred cccccccC-CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 001274 951 GLAKLIDL-PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006 (1109)
Q Consensus 951 G~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~p 1006 (1109)
|.+..+.. +........++|-.+-.+|+..+++|++.+|-|.++.+++-|+.|++-
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99976542 233455777899999999999999999999999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=164.72 Aligned_cols=137 Identities=20% Similarity=0.237 Sum_probs=104.9
Q ss_pred CCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-----CCCceeeEEEEEEeCC---ce
Q 001274 804 FSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-----RHRNIVKLYGFCYHQD---SN 875 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~ 875 (1109)
+...+.||+|+||.||. .-+++.. +||++..... ...+.+.+|+++++.+ .||||++++|++..+. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34457899999999995 3223444 7888865332 2456789999999999 5799999999998864 33
Q ss_pred E-EEEEe--ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHH-HHHhhcCCCCeEecCCCCCceeeCC----CCceEE
Q 001274 876 L-LLYEY--MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL-CYLHYDCRPHIIHRDIKSNNILLDE----EFQAHV 947 (1109)
Q Consensus 876 ~-lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl 947 (1109)
+ +|+|| +++|+|.+++.... +++. ..++.+++.++ +||| +.+|+||||||+||+++. ++.++|
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 3 78999 66799999996532 5554 35677888777 9999 789999999999999974 348999
Q ss_pred eecccc
Q 001274 948 GDFGLA 953 (1109)
Q Consensus 948 ~DFG~a 953 (1109)
+||+-+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=167.26 Aligned_cols=148 Identities=18% Similarity=0.181 Sum_probs=113.4
Q ss_pred HHhcCCCCCceEecCCcceEEEEE--ecCCcEEEEEEeeccCCCcc----------------------hhHHHHHHHHHh
Q 001274 799 EATGNFSEGAVIGRGACGTVYKAT--LANGEVIAVKKIKLRGEGAT----------------------ADNSFLAEISTL 854 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~E~~~l 854 (1109)
.....|.+.+.||+|+||.||+|+ ..+|+.||+|+++....... ....+..|++.+
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 333468889999999999999998 45899999999975421100 012356899999
Q ss_pred ccCCCC--ceeeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC-eEecC
Q 001274 855 GKIRHR--NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH-IIHRD 931 (1109)
Q Consensus 855 ~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~D 931 (1109)
+++.+. .+.+++++ ...++||||++++++..+...... ....+...++.||+.++.+|| ..+ ++|||
T Consensus 105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~D 174 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVE---PEEEEEFELYDDILEEMRKLY---KEGELVHGD 174 (237)
T ss_pred HHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCC---cchHHHHHHHHHHHHHHHHHH---hcCCEEeCC
Confidence 999753 34444443 235899999999888766533222 556667899999999999999 778 99999
Q ss_pred CCCCceeeCCCCceEEeecccccccc
Q 001274 932 IKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 932 lkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
|||+||+++ ++.++++|||.+....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 8899999999988654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.8e-16 Score=191.21 Aligned_cols=149 Identities=32% Similarity=0.513 Sum_probs=117.9
Q ss_pred CCchhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCC-----ccceeeecC------CeEEEEeccCccccccccccccCcc
Q 001274 28 TSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPC-----NWIGVECTD------FKVTSVDLHGLNLSGILSPRICDLP 96 (1109)
Q Consensus 28 ~~~~~~~~all~~k~~~~~~~~~~~~W~~~~~~~c-----~w~gv~C~~------~~v~~l~l~~~~l~g~~~~~~~~l~ 96 (1109)
.+...|..||++||+++.+|.. .+|+++ +| .|.||+|+. .+|+.++|+++++.|.+|+.++.++
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~g~---~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~ 442 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR--FGWNGD---PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR 442 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc--CCCCCC---CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence 4456789999999999977652 589753 34 799999952 2588888888888888888888888
Q ss_pred ccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCc-CCCceEEe
Q 001274 97 RLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNL-TSLEELVI 175 (1109)
Q Consensus 97 ~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~L 175 (1109)
+|+.|+|++|.++|.+|..++.+++|++|||++|+++|.+|..++.+++|++|+|++|.++|.+|..++.+ .++..+++
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~ 522 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEe
Confidence 88888888888888888888888888888888888888888888888888888888888888888777653 45666777
Q ss_pred ecCCCC
Q 001274 176 YSNNLT 181 (1109)
Q Consensus 176 ~~n~l~ 181 (1109)
.+|...
T Consensus 523 ~~N~~l 528 (623)
T PLN03150 523 TDNAGL 528 (623)
T ss_pred cCCccc
Confidence 776543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.8e-16 Score=160.31 Aligned_cols=143 Identities=20% Similarity=0.177 Sum_probs=110.7
Q ss_pred HHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcc--------------------hhHHHHHHHHHhccCC
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGAT--------------------ADNSFLAEISTLGKIR 858 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------~~~~~~~E~~~l~~l~ 858 (1109)
.....|.+.+.||+|+||.||+|..++|+.||||++........ ....+..|..++.++.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 33334788899999999999999988899999998764321100 1123567888888887
Q ss_pred CC--ceeeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 001274 859 HR--NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNN 936 (1109)
Q Consensus 859 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 936 (1109)
|+ .+...++ ....++||||+++++|...... .....++.+++.++.++| ..+++||||||+|
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~N 155 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFN 155 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCccc
Confidence 76 4444443 2456899999999998765321 234578899999999999 7899999999999
Q ss_pred eeeCCCCceEEeecccccccc
Q 001274 937 ILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 937 Ill~~~~~~kl~DFG~a~~~~ 957 (1109)
|++++++.++|+|||.+....
T Consensus 156 ill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEcCCCcEEEEECCccccCC
Confidence 999999999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-15 Score=160.71 Aligned_cols=136 Identities=20% Similarity=0.280 Sum_probs=113.7
Q ss_pred ceEecCCcceEEEEEecCCcEEEEEEeeccCCCcc------hhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 808 AVIGRGACGTVYKATLANGEVIAVKKIKLRGEGAT------ADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+.||+|++|.||+|++ .+..|++|+......... ....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 577899998653322111 124577899999999999988777777777888999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++|++|.+++.... + .+..++.+++.++.++| ..+++|||++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 78889999999999999 78999999999999999 78999999998874
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-15 Score=180.65 Aligned_cols=139 Identities=19% Similarity=0.264 Sum_probs=112.6
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCC------cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEG------ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
..|...++||+|+||+||+|.+.+. .+++|+...+... ....+.+.+|+++++.++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4556788999999999999987644 3444443222111 11235688999999999999998888888877888
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++||||+++++|.+++. ....++.++++++.||| +.+++|||+||+||++ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998875 34678999999999999 7899999999999999 677999999999985
Q ss_pred c
Q 001274 956 I 956 (1109)
Q Consensus 956 ~ 956 (1109)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.3e-16 Score=182.77 Aligned_cols=208 Identities=25% Similarity=0.303 Sum_probs=142.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.+|..++.|-.|+||.||.++++ ..+.+|+| +... ..+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq-------~lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ-------NLILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-cccc-------chhhhc--cccccCCccee-----------------
Confidence 57888999999999999999977 46778884 3311 111111 33333444444
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+=...++..+. ++.+. +.+++|+| +.+|+|||+||+|.+|+.-|++|++|||+++......
T Consensus 136 ----gDc~tllk~~g~---lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP---LPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhcccCCC---Ccchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 333334433222 33333 67899999 8899999999999999999999999999986542111
Q ss_pred C--------------CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 961 S--------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 961 ~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
. ...+..+||+.|+|||++..+.|+..+|.|++|+++||.+.|+.||.+... .+.+...+.+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp----eelfg~visd 273 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELFGQVISD 273 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH----HHHHhhhhhh
Confidence 0 011456899999999999999999999999999999999999999986432 2333333333
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCC
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT 1069 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt 1069 (1109)
.+...+- + .....+...++.+.++.+|..|--
T Consensus 274 ~i~wpE~-d----------ea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 274 DIEWPEE-D----------EALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hcccccc-C----------cCCCHHHHHHHHHHHHhChHhhcc
Confidence 3222211 1 111234567888888999999843
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-15 Score=157.43 Aligned_cols=133 Identities=20% Similarity=0.287 Sum_probs=107.3
Q ss_pred eEecCCcceEEEEEecCCcEEEEEEeeccCCCcc------hhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 809 VIGRGACGTVYKATLANGEVIAVKKIKLRGEGAT------ADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 809 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
.||+|+||+||+|++ ++..|++|+......... ....+.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999996 478899998654322111 1256778999999998887655555566677789999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+|++|.+++.... . .++.+++.++.++| +.+++|||++|+||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875421 1 78999999999999 88999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.3e-16 Score=172.87 Aligned_cols=175 Identities=25% Similarity=0.329 Sum_probs=132.7
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA 953 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 953 (1109)
+.|+.|++|+..+|.+|+.........++.....++.|++.|++| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 568999999999999999876665668899999999999999999 38899999999999999999999999998
Q ss_pred ccccCCC-----CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhcc
Q 001274 954 KLIDLPY-----SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEM 1027 (1109)
Q Consensus 954 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 1027 (1109)
....... ....+..+||..||+||.+.+..|+.|+||||+|++++|+++ =..+|+.. ......-.+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-------~t~~d~r~g~ 476 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-------ATLTDIRDGI 476 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-------HhhhhhhcCC
Confidence 7665333 223456789999999999999999999999999999999987 33333211 1111111122
Q ss_pred CCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001274 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074 (1109)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl 1074 (1109)
+|..-+.+ . +.=..++.+++...|++||++.++.
T Consensus 477 ip~~~~~d---------~----p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 477 IPPEFLQD---------Y----PEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred CChHHhhc---------C----cHHHHHHHHhcCCCcccCchHHHHh
Confidence 22111111 1 1224688999999999999655543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.3e-14 Score=148.73 Aligned_cols=138 Identities=23% Similarity=0.298 Sum_probs=98.5
Q ss_pred CceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHH----------------------HHHHHHhccCCCC--ce
Q 001274 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSF----------------------LAEISTLGKIRHR--NI 862 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~E~~~l~~l~h~--ni 862 (1109)
.+.||+|+||+||+|++.+++.||||++............+ ..|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987432221111111 3455556555433 24
Q ss_pred eeEEEEEEeCCceEEEEEeccCCCHHHH-hccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCceeeC
Q 001274 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQ-LHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR-PHIIHRDIKSNNILLD 940 (1109)
Q Consensus 863 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~ 940 (1109)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++| . .+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE
Confidence 444432 346899999998554221 11111 11 567789999999999999 6 7999999999999999
Q ss_pred CCCceEEeecccccccc
Q 001274 941 EEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 941 ~~~~~kl~DFG~a~~~~ 957 (1109)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.7e-14 Score=141.51 Aligned_cols=135 Identities=22% Similarity=0.187 Sum_probs=112.9
Q ss_pred CCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCC--CceeeEEEEEEeCCceEEEEEecc
Q 001274 806 EGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH--RNIVKLYGFCYHQDSNLLLYEYME 883 (1109)
Q Consensus 806 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~ 883 (1109)
+.+.||+|.++.||+++..+ ..+++|....... ...+.+|+..++.++| ..+++++++....+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 45789999999999999864 7899998863321 4578899999999976 589999998888888999999999
Q ss_pred CCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 884 NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 884 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++.+..+ +......++.+++++++++|.....+++|+|++|+||+++.++.++++|||.++.
T Consensus 77 g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8777543 4456677899999999999954335799999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-15 Score=167.09 Aligned_cols=192 Identities=34% Similarity=0.483 Sum_probs=120.2
Q ss_pred ccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecC
Q 001274 481 NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLS 560 (1109)
Q Consensus 481 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 560 (1109)
.-...||+.|++. .+|..+..+-.|+.+.|.+|.|. .+|..++++..|++|||+.|+++ ..|..+..|+ |+.|-++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 3344555555555 34555555555555555555555 45555555666666666666665 4555555544 5566666
Q ss_pred CCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCcccccc
Q 001274 561 RNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGV 640 (1109)
Q Consensus 561 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~ 640 (1109)
+|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|.+. .+|+++..|+- +.||+|+|+++ .
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpL--i~lDfScNkis-~ 225 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPL--IRLDFSCNKIS-Y 225 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCce--eeeecccCcee-e
Confidence 66665 45555665556666666666665 45555666666666666666665 55555554433 24788888887 7
Q ss_pred ccccccCccccceeecCCCccccCCchhhhccc---cceEEEccCc
Q 001274 641 IPYELGNLQMLEALYLDDNQLIGEIPASMGEQM---SLLVCNLSNN 683 (1109)
Q Consensus 641 ~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~---~L~~l~ls~N 683 (1109)
+|..|.+|+.|++|-|.+|.|. ..|+.++..- -.++|+..-.
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred cchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 8999999999999999999998 8888876543 3455655443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.5e-13 Score=145.42 Aligned_cols=137 Identities=19% Similarity=0.230 Sum_probs=106.2
Q ss_pred CceEe-cCCcceEEEEEecCCcEEEEEEeeccCC-----------CcchhHHHHHHHHHhccCCCCce--eeEEEEEEeC
Q 001274 807 GAVIG-RGACGTVYKATLANGEVIAVKKIKLRGE-----------GATADNSFLAEISTLGKIRHRNI--VKLYGFCYHQ 872 (1109)
Q Consensus 807 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 872 (1109)
...|| .|+.|+||.++.. +..++||.+...+. .......+.+|++++.+++|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 9999999999885 77899998853211 11233567889999999988774 6677664433
Q ss_pred Cc----eEEEEEeccC-CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 001274 873 DS----NLLLYEYMEN-GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV 947 (1109)
Q Consensus 873 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 947 (1109)
.. .++|||+++| .+|.+++.... ++.. .+.+|+.++.+|| +.||+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP----LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC----CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 69988876432 4443 3568999999999 889999999999999999999999
Q ss_pred eecccccc
Q 001274 948 GDFGLAKL 955 (1109)
Q Consensus 948 ~DFG~a~~ 955 (1109)
+|||.++.
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.1e-15 Score=176.53 Aligned_cols=261 Identities=24% Similarity=0.283 Sum_probs=194.5
Q ss_pred cCCCCCceEecCCcceEEEEEec--CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 878 (1109)
..|...+.||+|+|+.|-.+... ....+|+|.+..........+....|..+-+.+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45777788999999999888653 3445677766654433344455556888877776 99999999999999999999
Q ss_pred EEeccCCCHHHHh-ccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeeccccccc
Q 001274 879 YEYMENGSLGEQL-HGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAKLI 956 (1109)
Q Consensus 879 ~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~ 956 (1109)
.+|.+++++.+-+ ..... ..+.........|+..++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998888 43321 26667778899999999999995 34899999999999999999 9999999999876
Q ss_pred cC--CCCCCcccccc-ccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCccc-CCcHHHHHHHhhh-ccCCC
Q 001274 957 DL--PYSKSMSAIAG-SYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLEL-GGDLVTWVRRSIH-EMVPT 1030 (1109)
Q Consensus 957 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~-~~~~~~~~~~~~~-~~~~~ 1030 (1109)
.. .........+| ++.|+|||...+.. .....|+||.|+++.-+++|..||+.... ......|...... ...+.
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 54 22333355678 99999999988854 46789999999999999999999986542 2233333333211 01111
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
. .......++..+++..+|+.|.+.+++...-+...
T Consensus 256 ~---------------~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 256 N---------------SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred c---------------cCChhhhhcccccccCCchhccccccccccccccc
Confidence 1 11123557788888899999999998876544433
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=9.7e-14 Score=169.06 Aligned_cols=115 Identities=37% Similarity=0.571 Sum_probs=64.7
Q ss_pred cceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEcc
Q 001274 602 LTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLS 681 (1109)
Q Consensus 602 L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls 681 (1109)
++.|+|++|.+.|.+|..++++..|+ .|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..++++++|++|+|+
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~-~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCC-EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 34444555555555555555554443 35555555555555556666666666666666666666666666666666666
Q ss_pred CcccccccCCCc--ccccccCCcccCCCCcccc--CCCcc
Q 001274 682 NNNLVGTVPNTT--VFRRIDSSNFAGNRGLCML--GSDCH 717 (1109)
Q Consensus 682 ~N~l~g~~p~~~--~~~~~~~~~~~~n~~~c~~--~~~c~ 717 (1109)
+|+++|.+|..- .+.......+.||+.+|+. .+.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 666666666431 1112233457888888874 34553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4e-13 Score=156.99 Aligned_cols=259 Identities=33% Similarity=0.438 Sum_probs=181.2
Q ss_pred EEEeccccccCccchhhhcccccceeecCCccccCCCCCCCcccc-ccceeecccccccccCCccccCCcccceeccccc
Q 001274 412 VLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCR-SLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQN 490 (1109)
Q Consensus 412 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 490 (1109)
.++++.|.+.. ....+..++.++.|++.+|.++ .+++...... +|+.|++++|++. .+|..+.++++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 46666666532 2233445567778888888877 4455555553 7888888888888 45566788899999999999
Q ss_pred cccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCc
Q 001274 491 RFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPE 570 (1109)
Q Consensus 491 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 570 (1109)
+++.+ |...+.+++|+.|++++|+++ .+|.....+..|++|.+++|.+. ..+..+.++.++..|.+++|++. .++.
T Consensus 174 ~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhhhh-hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 99854 555557888999999999998 46766666777999999999655 56777888999999999999987 4578
Q ss_pred ccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccc
Q 001274 571 ELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQM 650 (1109)
Q Consensus 571 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~ 650 (1109)
.+..+.+|++|++++|.++...+ ++.+.+++.|++++|.+....|.............+ +.++ ..+..+.....
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~ 323 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLN---LLLT-LKALELKLNSI 323 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhccchhHHhhhh---hhhh-ccccccccccc
Confidence 88889999999999999985544 888899999999999998777766554443322111 2222 23334444455
Q ss_pred cceeecCCCccccCCchhhhccccceEEEccCcc
Q 001274 651 LEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNN 684 (1109)
Q Consensus 651 L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~ 684 (1109)
+...++..|... ..|..+.....+..+++..+.
T Consensus 324 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 356 (394)
T COG4886 324 LLNNNILSNGET-SSPEALSILESLNNLWTLDNA 356 (394)
T ss_pred cccccccccccc-ccchhhcccccccCceecccc
Confidence 555566666655 555555555555555444443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-14 Score=160.36 Aligned_cols=172 Identities=30% Similarity=0.476 Sum_probs=86.2
Q ss_pred cCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccc
Q 001274 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488 (1109)
Q Consensus 409 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 488 (1109)
.-...||+.|++. .+|..++.+..|+.+.|.+|.+. .+|..++++..|..|+|+.|+++ ..
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~l---------------- 136 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HL---------------- 136 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cC----------------
Confidence 3344566666665 45555666666666666666555 34444444444444555554444 33
Q ss_pred cccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCC
Q 001274 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSA 568 (1109)
Q Consensus 489 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 568 (1109)
|..+..|+ |+.|-+++|+++ .+|..++.+.+|..||.+.|.+. .+|..++++.+|+.|++..|++. .+
T Consensus 137 --------p~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~l 204 (722)
T KOG0532|consen 137 --------PDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DL 204 (722)
T ss_pred --------ChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hC
Confidence 33344333 444555555544 34444444445555555555554 44444555555555555555544 34
Q ss_pred CcccccccccceecccccccccccCcccCCCcccceeeccCcccc
Q 001274 569 PEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 569 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 613 (1109)
|+++.. -.|..||+|.|++. .+|-.|..|..|++|-|.+|+|.
T Consensus 205 p~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 205 PEELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred CHHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 444442 23444555555554 44555555555555555555554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-11 Score=143.96 Aligned_cols=146 Identities=18% Similarity=0.231 Sum_probs=101.9
Q ss_pred CCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcc--------------------------------------hh
Q 001274 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGAT--------------------------------------AD 844 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~ 844 (1109)
.|. .+.||.|++|.||+|++++|+.||||+.+......- .+
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 444 368999999999999999999999999853210000 01
Q ss_pred HHHHHHHHHhccC----CCCceeeEEEEE-EeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHH-HHHH
Q 001274 845 NSFLAEISTLGKI----RHRNIVKLYGFC-YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE-GLCY 918 (1109)
Q Consensus 845 ~~~~~E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~ 918 (1109)
-+|.+|++.+.++ +|..-+.+-.++ ......++||||++|+++.++....... . .+..++..+++ .+..
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQ 272 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHH
Confidence 1355566665555 233333333333 2345679999999999998876532211 2 23456666665 4677
Q ss_pred HhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 919 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
+| ..|++|+|+||.||+++.++.++++|||++....
T Consensus 273 l~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88 7799999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-12 Score=153.47 Aligned_cols=197 Identities=34% Similarity=0.500 Sum_probs=103.9
Q ss_pred eEEccCCcccccCCchhhccccceEEEcccccccccccccccCcC-CCceEEeecCCCCCCCCcccccccccceeccccc
Q 001274 124 ILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLT-SLEELVIYSNNLTGAIPASISKLRQLRVIRAGHN 202 (1109)
Q Consensus 124 ~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n 202 (1109)
.|+++.|.+.. ....+..++.++.|++.+|.++ .+|...+.++ +|++|++++|++. .+|..+.++++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 45666665532 2223334455666666666664 4555555553 6666666666665 44455556666666666666
Q ss_pred cccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCch
Q 001274 203 SLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPK 282 (1109)
Q Consensus 203 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 282 (1109)
+++ .+|...+.+++|+.|++++|+++ .+|..+..+..|++|.+++|++. .++..+.++..+..|.+.+|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 665 44444445555555555555555 34444444444555555555433 34444555555555555555554 2244
Q ss_pred hhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCc
Q 001274 283 ELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIP 329 (1109)
Q Consensus 283 ~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p 329 (1109)
.++.++++++|++++|.++.. +. ++.+.+++.||+++|.+....|
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred hhccccccceecccccccccc-cc-ccccCccCEEeccCccccccch
Confidence 555555555555555555522 22 5555555555555555554433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.3e-11 Score=119.46 Aligned_cols=138 Identities=13% Similarity=0.139 Sum_probs=99.5
Q ss_pred ceEecCCcceEEEEEecC-------CcEEEEEEeeccCCC----------c----------chhHHHH----HHHHHhcc
Q 001274 808 AVIGRGACGTVYKATLAN-------GEVIAVKKIKLRGEG----------A----------TADNSFL----AEISTLGK 856 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~----------~----------~~~~~~~----~E~~~l~~ 856 (1109)
..||.|.-+.||.|...+ +..+|||+++..... . ...+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 579999998653110 0 1122333 78889888
Q ss_pred CCC--CceeeEEEEEEeCCceEEEEEeccCCCHHH-HhccCCCCCCCChHHHHHHHHHHHHHHHHH-hhcCCCCeEecCC
Q 001274 857 IRH--RNIVKLYGFCYHQDSNLLLYEYMENGSLGE-QLHGNKQTCLLDWDARYRIALGAAEGLCYL-HYDCRPHIIHRDI 932 (1109)
Q Consensus 857 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dl 932 (1109)
+.. -++...+++ ...++||||+.++.+.. .++.. .++..+...+..+++.+|..+ | +.++||+|+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 843 355566654 56799999997654321 22211 144556677889999999999 7 679999999
Q ss_pred CCCceeeCCCCceEEeecccccccc
Q 001274 933 KSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 933 kp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
++.||+++ ++.++++|||.+...+
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999998665
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8.3e-12 Score=129.88 Aligned_cols=205 Identities=23% Similarity=0.280 Sum_probs=140.4
Q ss_pred HHhccCCCCceeeEEEEEEeCC-----ceEEEEEeccCCCHHHHhccCCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCC
Q 001274 852 STLGKIRHRNIVKLYGFCYHQD-----SNLLLYEYMENGSLGEQLHGNKQ-TCLLDWDARYRIALGAAEGLCYLHYDCRP 925 (1109)
Q Consensus 852 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 925 (1109)
..+-++.|.|||+++.|+.+.. ...++.|||..|++..+|++.+. ...+..+.-.+|+.||..||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 3344557999999999987654 35789999999999999976432 23477778889999999999999976 89
Q ss_pred CeEecCCCCCceeeCCCCceEEeeccccccc---cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh
Q 001274 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLI---DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT 1002 (1109)
Q Consensus 926 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt 1002 (1109)
.|+|+.+.-+-|++..+|-+|+.--.-.... ............+-++|.|||+=.....+.++|||+||....||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999998888432111100 0000111122346789999998777778889999999999999988
Q ss_pred CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1003 GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1003 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
+..--..........+-+...+... ..- .=..++.+|++..|..||+|++++.|.
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~l---en~-----------------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGL---ENG-----------------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcceeehhhhhhhheeec---cCc-----------------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 7653111110011111111111110 000 012567889999999999999987653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-11 Score=139.73 Aligned_cols=251 Identities=23% Similarity=0.220 Sum_probs=183.4
Q ss_pred cCCCCCceEec--CCcceEEEEEe---cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGR--GACGTVYKATL---ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 875 (1109)
..|.....+|. |.+|.||.++. .++..+|+|+-+...........-.+|+...+++ .|++.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999986 3688899998765555444555566788887777 599999988889999999
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHH----HHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEeec
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE----GLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDF 950 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DF 950 (1109)
++-+|++ +.++.++.+..... ++.........+..+ |+.++| ..+++|-|+||.||+...+ ...+++||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~--~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNF--LPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeeccc-cchhHHhhhccccc--CCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence 9999999 57888888765432 677777778888888 999999 7799999999999999999 89999999
Q ss_pred cccccccCCCCCCc----cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 951 GLAKLIDLPYSKSM----SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 951 G~a~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
|+...+........ ....|...|++||... +-++.+.|+|++|.++.+-.++-.+.-.. ....|.. .+.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g----~~~~W~~--~r~ 340 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG----KNSSWSQ--LRQ 340 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC----CCCCccc--ccc
Confidence 99887753321111 1225677899999654 46788999999999999999987764321 0011111 011
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
..-..+..+. ....+...+..+++.+|..|++++.+..+
T Consensus 341 ~~ip~e~~~~-----------~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 341 GYIPLEFCEG-----------GSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccCchhhhcC-----------cchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1011111111 11123347778999999999999888654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.1e-10 Score=133.33 Aligned_cols=147 Identities=15% Similarity=0.186 Sum_probs=98.1
Q ss_pred HhcCCCCCceEecCCcceEEEEEecC-CcEEEEEEeeccCCC----------------------------c----c----
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEG----------------------------A----T---- 842 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------~----~---- 842 (1109)
....|.. +.||+|++|.||+|++++ |+.||||+.+..... . +
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 789999999999999887 999999999633100 0 0
Q ss_pred --hhHHHHHHHHHhccCC----CCceeeEEEEEEe-CCceEEEEEeccCCCHHHH--hccCCC-CCCCChHHHHHHHHHH
Q 001274 843 --ADNSFLAEISTLGKIR----HRNIVKLYGFCYH-QDSNLLLYEYMENGSLGEQ--LHGNKQ-TCLLDWDARYRIALGA 912 (1109)
Q Consensus 843 --~~~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~-~~~l~~~~~~~i~~~i 912 (1109)
.+-++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++ +...+. ...+....+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 0123555665555552 4444554444443 5677999999999999774 222221 0112222333333333
Q ss_pred HHHHHHHhhcCCCCeEecCCCCCceeeCCCC----ceEEeecccccccc
Q 001274 913 AEGLCYLHYDCRPHIIHRDIKSNNILLDEEF----QAHVGDFGLAKLID 957 (1109)
Q Consensus 913 ~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~a~~~~ 957 (1109)
. ..|++|+|+||.||+++.++ .+++.|||++....
T Consensus 277 f----------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F----------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H----------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3 45999999999999999888 99999999997654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.6e-12 Score=129.69 Aligned_cols=134 Identities=26% Similarity=0.313 Sum_probs=96.7
Q ss_pred cccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCC
Q 001274 475 EFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNL 554 (1109)
Q Consensus 475 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 554 (1109)
....++-|+++|||+|.|+ .+.+...-++.++.|++|+|.|..+ ..+..+++|+.||||+|.++ .+..|-..+-++
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3444566778888888887 3455666677888888888888744 33777788888888888887 566677777788
Q ss_pred CeeecCCCcCccCCCcccccccccceecccccccccccC-cccCCCcccceeeccCccccc
Q 001274 555 QRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIP-SSLGGLARLTELQMGGNIFSG 614 (1109)
Q Consensus 555 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 614 (1109)
+.|.|++|.|. .-..++++-+|..||+++|+|..... ..+++||-|+.+.|.+|++.+
T Consensus 355 KtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 355 KTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeeehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 88888888876 23467777778888888888774322 457777777777777777763
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.1e-10 Score=129.23 Aligned_cols=168 Identities=17% Similarity=0.211 Sum_probs=129.2
Q ss_pred EecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCC
Q 001274 822 TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLD 901 (1109)
Q Consensus 822 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~ 901 (1109)
+..++.+|.|++.+.... .......+-++.++.+|||+|++++..+...+..|+|+|.+. -|..++.+. .
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~ 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------G 102 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------H
Confidence 345788999998875543 344557788899999999999999999999999999999985 577777653 3
Q ss_pred hHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCccccccccceeccccccC
Q 001274 902 WDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981 (1109)
Q Consensus 902 ~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 981 (1109)
...+...+.||+.||.|||+.| +++|++|..+.|+|+..|..||++|.++....... .......--..|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~-~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN-APAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC-cccccchhhhcccChhhcCc
Confidence 5567778999999999999754 89999999999999999999999999886543111 11122222334667764432
Q ss_pred CCCCccchhHHHHHHHHHHHhCC
Q 001274 982 MKVTEKCDIYSFGVVLLELITGK 1004 (1109)
Q Consensus 982 ~~~~~~~DvwSlGvll~elltg~ 1004 (1109)
.. -..|.|-||+++||++.|.
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCcc
Confidence 22 3469999999999999993
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.7e-12 Score=136.72 Aligned_cols=244 Identities=21% Similarity=0.250 Sum_probs=133.0
Q ss_pred ccccceEEEccccccccc----ccccccCcCCCceEEeec---CCCCCCCCcccc-------cccccceeccccccccCC
Q 001274 142 FINTLRKLYLCENYIFGE----IPEEIGNLTSLEELVIYS---NNLTGAIPASIS-------KLRQLRVIRAGHNSLSGP 207 (1109)
Q Consensus 142 ~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~---n~l~~~~p~~~~-------~l~~L~~L~l~~n~l~~~ 207 (1109)
.+..+++++|++|.|..+ +...+.+.++|++.++++ -++...+|..+. ..++|++|+||.|-+.-.
T Consensus 28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~ 107 (382)
T KOG1909|consen 28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK 107 (382)
T ss_pred ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence 345555566666655433 334455566666666664 223334443322 224566666666655433
Q ss_pred CCcc----ccccccchhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCc--
Q 001274 208 IPPE----ISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLP-- 281 (1109)
Q Consensus 208 ~p~~----l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-- 281 (1109)
.+.. ++.+..|++|.|.+|.+.-.--..+++ -|.+|. .|+. .+.-+.|+++..++|++.....
T Consensus 108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ga~~ 176 (382)
T KOG1909|consen 108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK-------AASKPKLRVFICGRNRLENGGATA 176 (382)
T ss_pred chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc-------cCCCcceEEEEeeccccccccHHH
Confidence 3322 345667777777777765322222221 133322 2211 2233578888888888864433
Q ss_pred --hhhhccCccceEEeecccccC----ccCcccCCCCcCcEEEccCCcccCCC----cccccCCCCcceEecccccccCc
Q 001274 282 --KELGKLSRLKKLYVYTNELNG----TIPHELGNCTSAVEIDLSENQLTGFI----PRELGLIPNLCLLQLFENMLQGS 351 (1109)
Q Consensus 282 --~~l~~l~~L~~L~l~~n~l~~----~~~~~l~~l~~L~~L~Ls~n~l~~~~----p~~l~~l~~L~~L~L~~n~l~~~ 351 (1109)
..|...+.|+.+.++.|.|.. .+...+..+++|+.|||.+|.++... ...+..+++|+.|++.+|.+...
T Consensus 177 ~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~ 256 (382)
T KOG1909|consen 177 LAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENE 256 (382)
T ss_pred HHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccc
Confidence 345566888888888888852 12345778888888888888887322 33445556666666666666544
Q ss_pred cccccc-----CCCCccEEEcccCcccC----CCCcchhcccccceEEcccccc
Q 001274 352 IPRELG-----QLTQLHKLDLSINNLTG----TIPLEFQNLTYLVDLQLFDNHL 396 (1109)
Q Consensus 352 ~p~~l~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l 396 (1109)
-..+|. ..+.|+.|.+.+|.++. .+.......+.|..|+|++|.+
T Consensus 257 Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 257 GAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 333221 24556666666666642 1112233345555555555555
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.1e-10 Score=118.94 Aligned_cols=127 Identities=21% Similarity=0.209 Sum_probs=94.5
Q ss_pred ceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCcee-eEEEEEEeCCceEEEEEeccCCC
Q 001274 808 AVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIV-KLYGFCYHQDSNLLLYEYMENGS 886 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs 886 (1109)
+.++.|.++.||+++.. ++.|++|....... ....+.+|+++++.+.+.+++ +++.+ .....++||||++|.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCc
Confidence 56899999999999875 77899998753221 223567899999888654444 44443 3344689999999988
Q ss_pred HHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC-----eEecCCCCCceeeCCCCceEEeecccccc
Q 001274 887 LGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH-----IIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 887 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
+... . . ....++.+++++++.|| ..+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~----~----~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE----D----F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----c----c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7543 0 1 11245678999999999 445 59999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.3e-11 Score=126.51 Aligned_cols=135 Identities=28% Similarity=0.335 Sum_probs=102.5
Q ss_pred CCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccc
Q 001274 451 GLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHL 530 (1109)
Q Consensus 451 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 530 (1109)
.+...+-|+++||++|.|+ .+..+..-++.++.|++|+|.|..+ +.+..|++|+.||||+|.++. +..+-..+-++
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCE
Confidence 3344566777777777776 3455666678888888888888754 448888888999999988873 45566677888
Q ss_pred cEEecccCcccccCCcCCCCCCCCCeeecCCCcCccC-CCcccccccccceecccccccccc
Q 001274 531 VTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGS-APEELGQLVNLELLKLSDNKLTGA 591 (1109)
Q Consensus 531 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~ 591 (1109)
++|.|+.|.|... ..++.+-+|..||+++|+|... --..+++++.|+.+.|.+|.+.+.
T Consensus 355 KtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 355 KTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred eeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 8899999988732 4578888999999999998732 224688999999999999999854
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8e-12 Score=146.05 Aligned_cols=245 Identities=29% Similarity=0.321 Sum_probs=137.7
Q ss_pred CCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceee
Q 001274 359 LTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLS 438 (1109)
Q Consensus 359 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 438 (1109)
+..++.+.+..|.+. .+-..+..+++|+.|++.+|+|... ...+..+++|++|++++|.|+.+. .+..+..|+.|+
T Consensus 71 l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence 334444445555554 2223345555566666666666532 222455666666666666665442 244455566666
Q ss_pred cCCccccCCCCCCCccccccceeecccccccccCC-ccccCCcccceeccccccccCCCCccccccccccEEEccCCccC
Q 001274 439 LGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLP-IEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFV 517 (1109)
Q Consensus 439 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 517 (1109)
+++|.|+.. ..+..+++|+.+++++|++..+-+ . ...+.+++.+++.+|.+..+ ..+..+..+..+++..|.++
T Consensus 147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccce
Confidence 666666533 345556667777777777764444 2 35566677777777777633 34455555555677777666
Q ss_pred CCCChhhcccc--cccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccc---c
Q 001274 518 GYIPSEVGNLE--HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGA---I 592 (1109)
Q Consensus 518 ~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~---~ 592 (1109)
..-+ +..+. +|+.+++++|.+. .++..+..+..+..|++++|++.. -..+.....+..+.+..|++... .
T Consensus 222 ~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (414)
T KOG0531|consen 222 KLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISN--LEGLERLPKLSELWLNDNKLALSEAIS 296 (414)
T ss_pred eccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccc--cccccccchHHHhccCcchhcchhhhh
Confidence 4322 22222 3677777777776 444556666777777777777652 22345555666666666665522 1
Q ss_pred Ccc-cCCCcccceeeccCcccccccc
Q 001274 593 PSS-LGGLARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 593 p~~-~~~l~~L~~L~l~~N~l~~~~p 617 (1109)
... ....+.++.+.+..|+.....+
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 297 QEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ccccccccccccccccccCccccccc
Confidence 111 3445566666666666654433
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.2e-12 Score=145.53 Aligned_cols=149 Identities=30% Similarity=0.353 Sum_probs=68.6
Q ss_pred cccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEc
Q 001274 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHL 511 (1109)
Q Consensus 432 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 511 (1109)
..++.+++..|.+.. +-..+..+++|+.|++.+|+|..+.. .+..+++|++|+|++|.|+.+ ..+..++.|+.|++
T Consensus 72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l 147 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNL 147 (414)
T ss_pred HhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccc--cchhhccchhhhee
Confidence 334444444444442 12223444455555555555543221 134455555555555555544 23444444555555
Q ss_pred cCCccCCCCChhhcccccccEEecccCcccccCCcC-CCCCCCCCeeecCCCcCccCCCcccccccccceecccccccc
Q 001274 512 SENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589 (1109)
Q Consensus 512 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 589 (1109)
++|.|+.+ ..+..++.|+.+++++|++...-+ . ...+.+|+.+++.+|.+. ....+..+..+..+++..|+++
T Consensus 148 ~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 148 SGNLISDI--SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred ccCcchhc--cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccce
Confidence 55555532 233445555555555555552222 1 344555555555555554 2233334444444455555554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.2e-11 Score=117.07 Aligned_cols=105 Identities=27% Similarity=0.320 Sum_probs=25.5
Q ss_pred cccceeecccccccccCCcccc-CCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhh-cccccccEE
Q 001274 456 RSLMQLMLGQNQLTGSLPIEFY-NLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTF 533 (1109)
Q Consensus 456 ~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L 533 (1109)
.++++|+|++|+|+.+- .++ .+.+|+.|+|++|.|+.+ +.+..+++|++|++++|+|+.+ ...+ ..+++|+.|
T Consensus 19 ~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EE
T ss_pred ccccccccccccccccc--chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEE
Confidence 34455555555555321 222 345555555666555543 2355555566666666665532 2222 345555666
Q ss_pred ecccCcccccCC-cCCCCCCCCCeeecCCCcCc
Q 001274 534 NISSNSLSGTIP-HELGNCVNLQRLDLSRNQFT 565 (1109)
Q Consensus 534 ~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 565 (1109)
+|++|+|...-- ..+..+++|+.|+|.+|.++
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 666665542110 22344555555555555554
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.7e-12 Score=132.29 Aligned_cols=217 Identities=26% Similarity=0.282 Sum_probs=99.5
Q ss_pred eEEEEeccCcccc----ccccccccCccccceeecccCccCC----CCCc-------cccCCCCCceEEccCCcccccCC
Q 001274 73 KVTSVDLHGLNLS----GILSPRICDLPRLVEFNISMNFVTG----SIPT-------DLANCSSLEILDLCTNRLHGVIP 137 (1109)
Q Consensus 73 ~v~~l~l~~~~l~----g~~~~~~~~l~~L~~L~ls~n~~~~----~~p~-------~l~~l~~L~~L~Ls~n~l~~~~~ 137 (1109)
.++.|+|+||.+. ..+.+.|.+.++|+.-++|+ .++| .+|+ .+..+++|++||||.|.|....+
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd-~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD-MFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh-hhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 4667777776553 22345555666666666664 2233 2333 34445566666666666655444
Q ss_pred chhh----ccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCC----
Q 001274 138 FQLF----FINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIP---- 209 (1109)
Q Consensus 138 ~~l~----~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---- 209 (1109)
..|. .+..|++|+|.+|.+.-.-...++. .|.+|. .|+ -++.-.+||++..++|++.....
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ga~~~A 178 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENGGATALA 178 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccccHHHHH
Confidence 4332 2445555555555543211111111 111111 110 11222455555555555542221
Q ss_pred ccccccccchhhhccccccccc----CchhhhccccccceecccccccCC----CCCCccccccccceeeeeccceecCc
Q 001274 210 PEISECEGLEVLGLAQNSLEGF----LPSELEKLRNLTDLILWQNHLSGE----IPPTIGNIQSLELLALHENSFSGGLP 281 (1109)
Q Consensus 210 ~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p 281 (1109)
..|...+.|+.+.++.|.|... +...+..+++|+.|||.+|-++.. +...+..+++|+.|++++|.++....
T Consensus 179 ~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga 258 (382)
T KOG1909|consen 179 EAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGA 258 (382)
T ss_pred HHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccH
Confidence 2233445555555555555321 123344555555666655555522 22334444555555555555554333
Q ss_pred hhhh-----ccCccceEEeeccccc
Q 001274 282 KELG-----KLSRLKKLYVYTNELN 301 (1109)
Q Consensus 282 ~~l~-----~l~~L~~L~l~~n~l~ 301 (1109)
.+|. ..++|+.|.|.+|.++
T Consensus 259 ~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 259 IAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred HHHHHHHhccCCCCceeccCcchhH
Confidence 3322 2345555555555554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-10 Score=133.27 Aligned_cols=252 Identities=20% Similarity=0.183 Sum_probs=178.3
Q ss_pred HHhcCCCCCceEecCCcceEEEEEe--cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCce
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATL--ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 875 (1109)
....+|..+..||.|.|+.|+.... .++..|++|.....-........-..|+.+...+ .|.++++....+...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456889999999999999999863 4688899998875544433444445666666666 588888887777777778
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEeeccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAK 954 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~ 954 (1109)
|+=-|||++++......... .+++..++++..|++.++.++| ++.++|+|+||+||++..+ +..++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence 89999999999877763222 3788889999999999999999 8899999999999999886 788999999987
Q ss_pred cccCCCCCCcccccccccee--ccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 955 LIDLPYSKSMSAIAGSYGYI--APEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
.+.. ........-++. +|+......+..++|++|||.-+.|.++|..--+... .|.. ...+..+.
T Consensus 416 ~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------~~~~-i~~~~~p~-- 482 (524)
T KOG0601|consen 416 RLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------QSLT-IRSGDTPN-- 482 (524)
T ss_pred ccce----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc------ccee-eecccccC--
Confidence 4321 111112222333 5555556678899999999999999999875422111 1111 00111110
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.......+..+...+...++..||.+.+...+.....
T Consensus 483 ------------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 483 ------------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ------------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 1111134566777788999999999998877665543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.6e-11 Score=117.66 Aligned_cols=126 Identities=32% Similarity=0.387 Sum_probs=40.1
Q ss_pred ccCCcccceeccccccccCCCCcccc-ccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCC-CCCCC
Q 001274 476 FYNLQNLSALELYQNRFSGLIPPEIG-KLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHEL-GNCVN 553 (1109)
Q Consensus 476 ~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 553 (1109)
+.+..++++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+.+ ..+..+++|++|++++|+|+. +...+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 44555677888888888754 3455 467777788888877754 246667777777777777773 33333 35677
Q ss_pred CCeeecCCCcCccCC-CcccccccccceecccccccccccC---cccCCCcccceee
Q 001274 554 LQRLDLSRNQFTGSA-PEELGQLVNLELLKLSDNKLTGAIP---SSLGGLARLTELQ 606 (1109)
Q Consensus 554 L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~ 606 (1109)
|+.|+|++|+|...- -..+..+++|+.|+|.+|+++...- ..+..+|+|+.||
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 777777777776321 1345566677777777777663211 1344556666655
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.02 E-value=5.6e-11 Score=128.62 Aligned_cols=214 Identities=22% Similarity=0.199 Sum_probs=111.2
Q ss_pred cCCCCCceEEccCCcccccCC-chhhccccceEEEccccccccc--ccccccCcCCCceEEeecCCCCCCCCccc-cccc
Q 001274 117 ANCSSLEILDLCTNRLHGVIP-FQLFFINTLRKLYLCENYIFGE--IPEEIGNLTSLEELVIYSNNLTGAIPASI-SKLR 192 (1109)
Q Consensus 117 ~~l~~L~~L~Ls~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~--~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~~l~ 192 (1109)
.++++|+...|.+..+....- .....+++++.|||+.|-+..- +-.-...|++|+.|.|+.|++........ .-++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 567778888888877763322 2455678888888888877642 23345667788888888887763222221 3456
Q ss_pred ccceeccccccccCCCC-ccccccccchhhhcccccccccCchhhhccccccceecccccccCCCC--CCccccccccce
Q 001274 193 QLRVIRAGHNSLSGPIP-PEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIP--PTIGNIQSLELL 269 (1109)
Q Consensus 193 ~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L 269 (1109)
+|+.|.|+.|.++..-- ..+..+++|+.|+|..|.....-......+..|+.|||++|.+- ..+ ...+.++.|+.|
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhh
Confidence 66666666666653211 11234556666666666422222223334445555555555544 222 234444555555
Q ss_pred eeeeccceec-CchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCC-cccccCCCCcceEeccccc
Q 001274 270 ALHENSFSGG-LPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFI-PRELGLIPNLCLLQLFENM 347 (1109)
Q Consensus 270 ~L~~N~l~~~-~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~L~~n~ 347 (1109)
+++.+.+... .|+. ..-.-....++|++|+++.|++...- -..+..+++|+.|.+..|.
T Consensus 277 nls~tgi~si~~~d~-------------------~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ 337 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDV-------------------ESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNY 337 (505)
T ss_pred hccccCcchhcCCCc-------------------cchhhhcccccceeeecccCccccccccchhhccchhhhhhccccc
Confidence 5555544321 1111 00000233455666666666653211 1233445566666666666
Q ss_pred ccC
Q 001274 348 LQG 350 (1109)
Q Consensus 348 l~~ 350 (1109)
+..
T Consensus 338 ln~ 340 (505)
T KOG3207|consen 338 LNK 340 (505)
T ss_pred ccc
Confidence 553
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.3e-11 Score=127.34 Aligned_cols=206 Identities=25% Similarity=0.269 Sum_probs=94.4
Q ss_pred ccccceEEcccccccccCC--CcccccCcCcEEEeccccccCccc--hhhhcccccceeecCCccccCCCCCCC-ccccc
Q 001274 383 LTYLVDLQLFDNHLEGTIP--PHIGVNSHLSVLDVSMNNLDGSIP--PHLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRS 457 (1109)
Q Consensus 383 l~~L~~L~L~~N~l~~~~p--~~~~~~~~L~~L~Ls~N~l~~~~~--~~l~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~ 457 (1109)
+.+|++..|.+.... ..+ .....+++++.||||.|-+....+ .....+++|+.|+|+.|++.--..... ..++.
T Consensus 120 ~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 120 LKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred HHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 344444444444443 111 133345555555555555543222 233456666666666666652221111 13445
Q ss_pred cceeeccccccccc-CCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCC-ChhhcccccccEEec
Q 001274 458 LMQLMLGQNQLTGS-LPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYI-PSEVGNLEHLVTFNI 535 (1109)
Q Consensus 458 L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L 535 (1109)
|+.|.|+.|.++-. +......+++|+.|+|.+|....+.......+..|++|||++|++.... -...+.++.|+.|++
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl 278 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL 278 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence 55566666555411 1112334556666666666432232333344555666666666554321 023445555555666
Q ss_pred ccCccccc-CCcC-----CCCCCCCCeeecCCCcCccC-CCcccccccccceecccccccc
Q 001274 536 SSNSLSGT-IPHE-----LGNCVNLQRLDLSRNQFTGS-APEELGQLVNLELLKLSDNKLT 589 (1109)
Q Consensus 536 s~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~ 589 (1109)
+.+.+..+ .|+. ...+++|++|+++.|+|... .-..+..+++|+.|....|.++
T Consensus 279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 66555532 1222 23455566666666665411 1112333444444444444444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.6e-09 Score=104.34 Aligned_cols=134 Identities=23% Similarity=0.296 Sum_probs=100.8
Q ss_pred ceEecCCcceEEEEEecCCcEEEEEEeeccCCCcch------hHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 808 AVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATA------DNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
..+++|+-+.||.+.+. |.++++|.-..+...... .+.-.+|+.++.+++--.|..-+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999875 455777765444332222 23456799999888655555555556677888999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
++|..|.+++... ...++..+-.-+.-|| ..+|+|+|+.++||.+..+. +.++|||++...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999998888654 1345556666677899 88999999999999998875 999999999853
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.4e-10 Score=142.01 Aligned_cols=290 Identities=22% Similarity=0.261 Sum_probs=178.2
Q ss_pred CccccceeecccCccCCCCCccccCCCCCceEEccCCc--ccccCCch-hhccccceEEEcccccccccccccccCcCCC
Q 001274 94 DLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNR--LHGVIPFQ-LFFINTLRKLYLCENYIFGEIPEEIGNLTSL 170 (1109)
Q Consensus 94 ~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~--l~~~~~~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 170 (1109)
+...++...+-+|.+.- ++.. ..+++|+.|-+..|. +. .++.. |..++.|+.|||++|.--+++|.+|++|-+|
T Consensus 521 ~~~~~rr~s~~~~~~~~-~~~~-~~~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIEH-IAGS-SENPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred chhheeEEEEeccchhh-ccCC-CCCCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 34566666666666542 2222 234478888888886 44 44444 6668999999999888878899999999999
Q ss_pred ceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccc--cccCchhhhccccccceecc
Q 001274 171 EELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSL--EGFLPSELEKLRNLTDLILW 248 (1109)
Q Consensus 171 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l--~~~~p~~l~~l~~L~~L~L~ 248 (1109)
++|+|+++.+. .+|..+++|++|.+|++..+.-...+|..+..+.+|++|.+..-.. +...-..+.+|.+|+.|...
T Consensus 598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 99999999988 8899999999999999998876656677777789999988877652 22333344455555555543
Q ss_pred cccccCCCCCCcccccccc----ceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCC------cCcEEE
Q 001274 249 QNHLSGEIPPTIGNIQSLE----LLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCT------SAVEID 318 (1109)
Q Consensus 249 ~N~l~~~~p~~l~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~------~L~~L~ 318 (1109)
.... .+-..+..+..|. .+.+..+... ..+..++.+.+|+.|.+.++.+............ ++..+.
T Consensus 677 ~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~ 753 (889)
T KOG4658|consen 677 ISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVS 753 (889)
T ss_pred cchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHH
Confidence 3322 1111222233333 3333333332 4556778888888888888887643332221111 222222
Q ss_pred ccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCC-CCcchhcccccceEEc
Q 001274 319 LSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGT-IPLEFQNLTYLVDLQL 391 (1109)
Q Consensus 319 Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L 391 (1109)
..++..- ..+.+....++|+.|++..+.....+......+..+..+-+..+.+.+. .-.....++++..+.+
T Consensus 754 ~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 754 ILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred hhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence 2222211 1233444667888888887776666666666666666666666666654 2344445555544433
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.3e-09 Score=101.92 Aligned_cols=146 Identities=20% Similarity=0.219 Sum_probs=109.7
Q ss_pred CCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcc------hhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 806 EGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGAT------ADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 806 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
....+-+|+-+.|+++.+. |+.+.||.-..+..... ..+...+|++.+.+++--.|..-.-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4568899999999999986 78888886654433221 2346778999998887556655555677777889999
Q ss_pred EeccC-CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---ceEEeecccccc
Q 001274 880 EYMEN-GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF---QAHVGDFGLAKL 955 (1109)
Q Consensus 880 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~ 955 (1109)
||++| .++.+++....... ........++..|-+.+.-|| ..+|+|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 47888887654331 222233678889999999999 88999999999999996554 468999999975
Q ss_pred c
Q 001274 956 I 956 (1109)
Q Consensus 956 ~ 956 (1109)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.6e-10 Score=138.15 Aligned_cols=86 Identities=31% Similarity=0.376 Sum_probs=43.0
Q ss_pred cccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCCCcccccccc
Q 001274 188 ISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLE 267 (1109)
Q Consensus 188 ~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 267 (1109)
|..++.|++|||++|.=-+.+|.+++++-+|++|+|++..+. .+|..+.+|+.|.+|++..+.-...+|..+..+++|+
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr 645 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLR 645 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhccccc
Confidence 344455555555544433445555555555555555555554 4555555555555555555543333444444455555
Q ss_pred ceeeeec
Q 001274 268 LLALHEN 274 (1109)
Q Consensus 268 ~L~L~~N 274 (1109)
+|.+..-
T Consensus 646 ~L~l~~s 652 (889)
T KOG4658|consen 646 VLRLPRS 652 (889)
T ss_pred EEEeecc
Confidence 5555443
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.8e-10 Score=83.63 Aligned_cols=40 Identities=50% Similarity=0.977 Sum_probs=30.9
Q ss_pred hhHHHHHHHHHHhcC-CCCCCCCCCCCCC-CCCCccceeeec
Q 001274 31 TEEGVSLLEFKASLI-DPSNNLESWNSSD-MTPCNWIGVECT 70 (1109)
Q Consensus 31 ~~~~~all~~k~~~~-~~~~~~~~W~~~~-~~~c~w~gv~C~ 70 (1109)
.+|++||++||+++. ||.+.+++|+.+. .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 568999999999998 6778999999763 699999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.5e-09 Score=111.62 Aligned_cols=143 Identities=20% Similarity=0.284 Sum_probs=109.9
Q ss_pred ceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCC--ceeeEEEEEEeCC---ceEEEEEec
Q 001274 808 AVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR--NIVKLYGFCYHQD---SNLLLYEYM 882 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~ 882 (1109)
+.++.|.++.||+++..+|+.+++|........ .....+.+|+++++.+++. .+.+++.+....+ ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999999876789999987533221 1345688999999999653 4566777765532 568999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD---------------------------------------- 922 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------- 922 (1109)
+|.++.+.+.. . .++..+...++.++++++.+||+.
T Consensus 83 ~G~~l~~~~~~-~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR-P---ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC-C---CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99888776532 1 267778888888999999998842
Q ss_pred -------------CCCCeEecCCCCCceeeCC--CCceEEeecccccc
Q 001274 923 -------------CRPHIIHRDIKSNNILLDE--EFQAHVGDFGLAKL 955 (1109)
Q Consensus 923 -------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~ 955 (1109)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0256899999999999998 67789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.3e-09 Score=130.22 Aligned_cols=250 Identities=20% Similarity=0.225 Sum_probs=167.5
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.+.+.+.+-+-.|.++.++.++-. .|...++|+......- ....+....+-.+.-..++|-+++..--+......++|
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 356677778889999999988633 3444444444322111 11122233333333334567666655555566778999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc-
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID- 957 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~- 957 (1109)
++|..++++..-++..+. .+.+..+.....+..+.+||| ...++|||++|.|.+...++..+++|||......
T Consensus 883 ~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999887663 455555666677888999999 6679999999999999999999999998332110
Q ss_pred --------------------CCCC---------CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001274 958 --------------------LPYS---------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQ 1008 (1109)
Q Consensus 958 --------------------~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 1008 (1109)
+... .......+|+.|.+||...+......+|.|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0000 11233568999999999999999999999999999999999999998
Q ss_pred CcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 001274 1009 SLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMR 1071 (1109)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ 1071 (1109)
+......+ +.......+.... ..+......+++.+.+..+|.+|-.|.
T Consensus 1037 a~tpq~~f----~ni~~~~~~~p~g-----------~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF----ENILNRDIPWPEG-----------PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhhh----hccccCCCCCCCC-----------ccccChhhhhhhhhhhccCchhccCcc
Confidence 65432222 2222222111111 122223456777788888999997776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.4e-08 Score=99.68 Aligned_cols=128 Identities=24% Similarity=0.319 Sum_probs=83.5
Q ss_pred eEEEEEecCCcEEEEEEeeccCCC-----------cc-------------hhHHHHHHHHHhccCCCC--ceeeEEEEEE
Q 001274 817 TVYKATLANGEVIAVKKIKLRGEG-----------AT-------------ADNSFLAEISTLGKIRHR--NIVKLYGFCY 870 (1109)
Q Consensus 817 ~Vy~~~~~~~~~vavK~~~~~~~~-----------~~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 870 (1109)
.||.|...+|..+|||..+..... .. ......+|++.|.++..- ++.+.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999988999999998653110 00 013466899999999755 45566544
Q ss_pred eCCceEEEEEecc--CCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCceeeCCCCceEE
Q 001274 871 HQDSNLLLYEYME--NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY-LHYDCRPHIIHRDIKSNNILLDEEFQAHV 947 (1109)
Q Consensus 871 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 947 (1109)
...++||||++ |..+..+... . ++......++.+++..+.. +| ..|+||+|+.+.||+++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence 35689999998 5444433222 1 1234556677788875555 57 7799999999999999988 9999
Q ss_pred eecccccccc
Q 001274 948 GDFGLAKLID 957 (1109)
Q Consensus 948 ~DFG~a~~~~ 957 (1109)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.1e-07 Score=100.88 Aligned_cols=271 Identities=14% Similarity=0.146 Sum_probs=160.9
Q ss_pred CCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEE------EeCC-ceEE
Q 001274 806 EGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFC------YHQD-SNLL 877 (1109)
Q Consensus 806 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~~~-~~~l 877 (1109)
.++.||+|+.+.+|-.--- +.. +.|++...... ... +.+..|... .||-+-.-+.|= -+.. ...+
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa--~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPA--AQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecchh-hch-hheeecCCCch--HHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 4568999999999965321 112 44666533211 111 223333333 566433212211 1111 2457
Q ss_pred EEEeccCCC-HHHHhcc---CCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 001274 878 LYEYMENGS-LGEQLHG---NKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA 953 (1109)
Q Consensus 878 v~e~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 953 (1109)
.|..+++.- ...+... ...-....|.-..+++..++.+.+.|| ..|.+-+|+.++|+||.+++.+++.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccce
Confidence 777776542 2222211 111124789999999999999999999 779999999999999999999999986544
Q ss_pred ccccCCCCCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhC-CCCCCCcccC----CcHH-HHHHH
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITG-KSPVQSLELG----GDLV-TWVRR 1022 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg-~~pf~~~~~~----~~~~-~~~~~ 1022 (1109)
.... ........+|...|++||.-. +..-+...|-|.+||++++++.| ++||.+.... .... +....
T Consensus 165 qi~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 165 QINA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 3322 233345567889999999644 33456789999999999999885 9999875411 1111 11111
Q ss_pred hhhccCCCc-hhhhhhcchhhcccHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 001274 1023 SIHEMVPTS-ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTS--PLNRPTMREVIAMMIDARQSVSDYPSSP 1091 (1109)
Q Consensus 1023 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d--P~~RPt~~evl~~L~~~~~~~~~~~~~~ 1091 (1109)
.+....... .............. ...+..+..+|+... +.-|||++..+..|..+.++......+.
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~L---pp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a 311 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSML---PPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSA 311 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhc---CHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcc
Confidence 111110000 00000000001111 123556667777654 6789999999999988877765554443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.9e-09 Score=84.52 Aligned_cols=59 Identities=41% Similarity=0.564 Sum_probs=26.3
Q ss_pred cccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCc
Q 001274 505 NLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQ 563 (1109)
Q Consensus 505 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 563 (1109)
+|++|++++|+|+.+.+..|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333444444444444444444444444444444444444444443
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.1e-08 Score=100.52 Aligned_cols=139 Identities=25% Similarity=0.241 Sum_probs=98.1
Q ss_pred CCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCC--------------------cchhHHHHHHHHHhccCCCC--c
Q 001274 804 FSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEG--------------------ATADNSFLAEISTLGKIRHR--N 861 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~--n 861 (1109)
..++.+||.|.-|.||.|..+.|.++|||.-+..... ........+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4466899999999999999999999999965322100 11123566889999988644 5
Q ss_pred eeeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC
Q 001274 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE 941 (1109)
Q Consensus 862 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 941 (1109)
+.+.+++ +.+.+||||++|--|...- ++......++..|++-+...- ..||||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEec
Confidence 6665554 5678999999885554322 122233344444554444444 458999999999999999
Q ss_pred CCceEEeecccccccc
Q 001274 942 EFQAHVGDFGLAKLID 957 (1109)
Q Consensus 942 ~~~~kl~DFG~a~~~~ 957 (1109)
||.++++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998877544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.69 E-value=1e-08 Score=84.11 Aligned_cols=59 Identities=34% Similarity=0.546 Sum_probs=30.0
Q ss_pred ccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCc
Q 001274 481 NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNS 539 (1109)
Q Consensus 481 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 539 (1109)
+|++|++++|+|+.+.+..|.++++|++|++++|+++.+.|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34455555555554444455555555555555555554444455555555555555554
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.1e-09 Score=124.91 Aligned_cols=127 Identities=30% Similarity=0.385 Sum_probs=99.5
Q ss_pred cccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcC-CCCCCCCCeee
Q 001274 480 QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQRLD 558 (1109)
Q Consensus 480 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ 558 (1109)
..|.+.+.++|++. .....+.-++.|+.|+|++|+++.. +.+..+++|++|||++|.+. .+|.. ...+ .|+.|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeee
Confidence 46778888899987 4466788888999999999999865 47888999999999999998 55542 2333 499999
Q ss_pred cCCCcCccCCCcccccccccceecccccccccccC-cccCCCcccceeeccCcccc
Q 001274 559 LSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIP-SSLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 559 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 613 (1109)
|++|.++. -..+.+|++|+.|||++|-|.+--. .-++.|..|+.|+|.||++-
T Consensus 239 lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 239 LRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99999873 2457888999999999998875422 23456778899999999886
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.5e-07 Score=98.97 Aligned_cols=143 Identities=16% Similarity=0.092 Sum_probs=98.8
Q ss_pred ceEecCCcceEEEEEecCCcEEEEEEeeccCCCc---------chhHHHHHHHHHhccCCCCc--eeeEEEEEEe-----
Q 001274 808 AVIGRGACGTVYKATLANGEVIAVKKIKLRGEGA---------TADNSFLAEISTLGKIRHRN--IVKLYGFCYH----- 871 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~----- 871 (1109)
+.+-+.....|+++.. +|+.|.||......... .....+.+|...+.++...+ ....+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777766 47889999774322110 01114778888887774322 2344444432
Q ss_pred CCceEEEEEeccCC-CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-------CC
Q 001274 872 QDSNLLLYEYMENG-SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-------EF 943 (1109)
Q Consensus 872 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------~~ 943 (1109)
....++|||++++. +|.+++..... ...+...+..++.+++..+.-|| ..||+|+|++++|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence 23468999999886 89888853211 12456677889999999999999 889999999999999975 46
Q ss_pred ceEEeecccccc
Q 001274 944 QAHVGDFGLAKL 955 (1109)
Q Consensus 944 ~~kl~DFG~a~~ 955 (1109)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998863
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.4e-09 Score=121.08 Aligned_cols=181 Identities=28% Similarity=0.295 Sum_probs=127.9
Q ss_pred CccccccccccEEEccCCccCCCCChhhccc-ccccEEecccCcccc---cCCcC---CCC---CCCCCeeecCCCcCcc
Q 001274 497 PPEIGKLRNLERLHLSENYFVGYIPSEVGNL-EHLVTFNISSNSLSG---TIPHE---LGN---CVNLQRLDLSRNQFTG 566 (1109)
Q Consensus 497 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~---~~p~~---~~~---l~~L~~L~Ls~N~l~~ 566 (1109)
|-.+....+|+.|.|.++.|... ..+..+ .+|++|. .+|.+.. ++... +.+ ...|...+.++|+++
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLI-CHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhh-hhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 44567788999999999988641 122222 2344443 3343321 11111 111 236778889999998
Q ss_pred CCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccc-cccccchhhhhhccCCccccccccccc
Q 001274 567 SAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPV-ALGQLTALQIALNISHNNLSGVIPYEL 645 (1109)
Q Consensus 567 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~l~~~L~Ls~N~l~~~~p~~~ 645 (1109)
.+.+++.-++.|+.|||++|+++... .+..++.|++|||+.|.+. .+|. ....+. |+ .|++++|.++... .+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~-~L~lrnN~l~tL~--gi 250 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQ-LLNLRNNALTTLR--GI 250 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-he-eeeecccHHHhhh--hH
Confidence 67888888999999999999998664 7888999999999999998 4443 233333 54 4899999998653 47
Q ss_pred cCccccceeecCCCccccCCc-hhhhccccceEEEccCcccccc
Q 001274 646 GNLQMLEALYLDDNQLIGEIP-ASMGEQMSLLVCNLSNNNLVGT 688 (1109)
Q Consensus 646 ~~l~~L~~L~Ls~N~l~~~ip-~~~~~l~~L~~l~ls~N~l~g~ 688 (1109)
.+|++|+.|||++|-|++.-- .-+..+.+|.+|+|.+|++.+.
T Consensus 251 e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 251 ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 899999999999999986443 2256678899999999998765
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.2e-06 Score=93.64 Aligned_cols=169 Identities=18% Similarity=0.285 Sum_probs=125.8
Q ss_pred cceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe----CCceEEEEEeccC-CCHH
Q 001274 815 CGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH----QDSNLLLYEYMEN-GSLG 888 (1109)
Q Consensus 815 fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~ 888 (1109)
-.+.|++... ||..|+.|++...... .......-+++++++.|+|+|++.+++.. +-..++||+|.++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3478999854 8999999999432221 11123355788999999999999998873 3467899999986 4677
Q ss_pred HHhccCCCC------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 889 EQLHGNKQT------------CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 889 ~~l~~~~~~------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
++-...... ...++...+.++.|+..||.++| +.|..-+-|.+.+|+++++.+++|+..|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 665432221 23678899999999999999999 779999999999999999999999988877665
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~p 1006 (1109)
..+... | +. --.+-|.=.+|.+++.|.||..-
T Consensus 444 ~~d~~~-------------~--le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPTE-------------P--LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCCc-------------c--hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 432211 0 11 12357899999999999999653
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.46 E-value=4e-09 Score=108.68 Aligned_cols=235 Identities=18% Similarity=0.186 Sum_probs=124.6
Q ss_pred C-ccceeeecCCeEEEEeccCccccccccccccCccc--cceeecccCccCCC-CCccccCC-CCCceEEccCCccccc-
Q 001274 62 C-NWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPR--LVEFNISMNFVTGS-IPTDLANC-SSLEILDLCTNRLHGV- 135 (1109)
Q Consensus 62 c-~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~--L~~L~ls~n~~~~~-~p~~l~~l-~~L~~L~Ls~n~l~~~- 135 (1109)
| +|+|+.=+..--+.+|+.+.+|. |..++.+.+ +..+.+..-.+... +.+.+.-+ ++|++||||+..++..
T Consensus 125 C~Rfyr~~~de~lW~~lDl~~r~i~---p~~l~~l~~rgV~v~Rlar~~~~~prlae~~~~frsRlq~lDLS~s~it~st 201 (419)
T KOG2120|consen 125 CKRFYRLASDESLWQTLDLTGRNIH---PDVLGRLLSRGVIVFRLARSFMDQPRLAEHFSPFRSRLQHLDLSNSVITVST 201 (419)
T ss_pred HHHHhhccccccceeeeccCCCccC---hhHHHHHHhCCeEEEEcchhhhcCchhhhhhhhhhhhhHHhhcchhheeHHH
Confidence 5 48886666667888898887764 233333322 22223332222222 22222222 4588888888877642
Q ss_pred CCchhhccccceEEEcccccccccccccccCcCCCceEEeecC-CCCCC-CCcccccccccceeccccccccCCCCccc-
Q 001274 136 IPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSN-NLTGA-IPASISKLRQLRVIRAGHNSLSGPIPPEI- 212 (1109)
Q Consensus 136 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~l~~n~l~~~~p~~l- 212 (1109)
.-.-+..+.+|+.|.|.++.+...|...|+...+|+.|+|+.+ .|+.. ..--+.+++.|..|+|+++.++...-..+
T Consensus 202 l~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~~~~Vtv~V 281 (419)
T KOG2120|consen 202 LHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDELNLSWCFLFTEKVTVAV 281 (419)
T ss_pred HHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhcCchHhhccchhhhHHH
Confidence 2223456778888888888888878788888888888888874 44421 11123555666666666665543221111
Q ss_pred cc-cccchhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeec-cceecCchhhhccCcc
Q 001274 213 SE-CEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHEN-SFSGGLPKELGKLSRL 290 (1109)
Q Consensus 213 ~~-l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L 290 (1109)
.. -++|+.|+|+++.=. -....+..-...+++|.+|||++| .++...-..|.+++.|
T Consensus 282 ~hise~l~~LNlsG~rrn---------------------l~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L 340 (419)
T KOG2120|consen 282 AHISETLTQLNLSGYRRN---------------------LQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYL 340 (419)
T ss_pred hhhchhhhhhhhhhhHhh---------------------hhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchh
Confidence 11 123444444443210 000011111223445555555554 2343344455666666
Q ss_pred ceEEeecccccCccCc---ccCCCCcCcEEEccCC
Q 001274 291 KKLYVYTNELNGTIPH---ELGNCTSAVEIDLSEN 322 (1109)
Q Consensus 291 ~~L~l~~n~l~~~~~~---~l~~l~~L~~L~Ls~n 322 (1109)
++|.++.|.. .+|. .+...++|++||..++
T Consensus 341 ~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 341 QHLSLSRCYD--IIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred eeeehhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence 6666666653 3443 3566677888887654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-06 Score=103.05 Aligned_cols=149 Identities=17% Similarity=0.202 Sum_probs=96.7
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCC--------------------c------------------c
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEG--------------------A------------------T 842 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------~------------------~ 842 (1109)
...|.. +.|+.++-|.||+|++++|+.||||+.+..-.. . .
T Consensus 125 F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 125 FSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 334443 689999999999999999999999987532100 0 0
Q ss_pred hhHHHHHHHHHhccCC----CCceeeEEEEEE-eCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHH
Q 001274 843 ADNSFLAEISTLGKIR----HRNIVKLYGFCY-HQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917 (1109)
Q Consensus 843 ~~~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~ 917 (1109)
.+-++.+|+..+.+++ ..--+.+-.++. ......++|||++|-.+.+...-.... ++.+.+.....++.--.-
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~ia~~~~~~f~~q~ 281 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKELAELLVRAFLRQL 281 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHHHHHHHHHHHHHH
Confidence 0123445655555552 222233333333 356779999999998888874322221 443333333333222222
Q ss_pred HHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 918 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
+-| |++|.|.+|.||+++.+|++.+.|||+.....
T Consensus 282 ~~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 282 LRD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred Hhc-----CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 334 99999999999999999999999999987664
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.3e-08 Score=101.90 Aligned_cols=216 Identities=21% Similarity=0.189 Sum_probs=131.6
Q ss_pred hhccccceEEEccccccccccc----ccccCcCCCceEEeecC---CCCCCCCcccccccccceeccccccccCCCCccc
Q 001274 140 LFFINTLRKLYLCENYIFGEIP----EEIGNLTSLEELVIYSN---NLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEI 212 (1109)
Q Consensus 140 l~~l~~L~~L~L~~n~l~~~~p----~~l~~l~~L~~L~L~~n---~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l 212 (1109)
+..+..++.++||+|.|..+-. ..|.+-.+|++.+++.- +....++.++. .+-+.+
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~-----------------~Ll~aL 88 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLV-----------------MLLKAL 88 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHH-----------------HHHHHH
Confidence 3446667777777777765433 33455566666666652 11222222211 112345
Q ss_pred cccccchhhhcccccccccCchh----hhccccccceecccccccCCCC-CC-------------ccccccccceeeeec
Q 001274 213 SECEGLEVLGLAQNSLEGFLPSE----LEKLRNLTDLILWQNHLSGEIP-PT-------------IGNIQSLELLALHEN 274 (1109)
Q Consensus 213 ~~l~~L~~L~L~~n~l~~~~p~~----l~~l~~L~~L~L~~N~l~~~~p-~~-------------l~~l~~L~~L~L~~N 274 (1109)
..|++|+..+||.|.+....|.. +++-+.|+||.|++|.+. .+. .- ..+-+.|++..+..|
T Consensus 89 lkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlG-p~aG~rigkal~~la~nKKaa~kp~Le~vicgrN 167 (388)
T COG5238 89 LKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLG-PIAGGRIGKALFHLAYNKKAADKPKLEVVICGRN 167 (388)
T ss_pred hcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCC-ccchhHHHHHHHHHHHHhhhccCCCceEEEeccc
Confidence 56777777777777776555543 455677888888888765 222 11 234467999999999
Q ss_pred cceecCchh-----hhccCccceEEeecccccCcc-----CcccCCCCcCcEEEccCCcccCCC----cccccCCCCcce
Q 001274 275 SFSGGLPKE-----LGKLSRLKKLYVYTNELNGTI-----PHELGNCTSAVEIDLSENQLTGFI----PRELGLIPNLCL 340 (1109)
Q Consensus 275 ~l~~~~p~~-----l~~l~~L~~L~l~~n~l~~~~-----~~~l~~l~~L~~L~Ls~n~l~~~~----p~~l~~l~~L~~ 340 (1109)
++.. .|.. +..-.+|+.+.+..|.|.-.. -..+..+.+|+.|||..|.++-.. ...+..++.|+.
T Consensus 168 Rlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrE 246 (388)
T COG5238 168 RLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRE 246 (388)
T ss_pred hhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhh
Confidence 9873 3322 223368999999999886321 123566789999999999987432 234455667777
Q ss_pred EecccccccCcccccc----c--CCCCccEEEcccCcccC
Q 001274 341 LQLFENMLQGSIPREL----G--QLTQLHKLDLSINNLTG 374 (1109)
Q Consensus 341 L~L~~n~l~~~~p~~l----~--~l~~L~~L~Ls~N~l~~ 374 (1109)
|.+.+|.++.....++ . ..++|..|-..+|...+
T Consensus 247 L~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~ 286 (388)
T COG5238 247 LRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRG 286 (388)
T ss_pred ccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcC
Confidence 8877777765443322 1 24566666667666654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.5e-08 Score=91.40 Aligned_cols=114 Identities=21% Similarity=0.303 Sum_probs=63.9
Q ss_pred ccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecc
Q 001274 504 RNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKL 583 (1109)
Q Consensus 504 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 583 (1109)
..|+..+|++|.+....+..-...+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.+. ..|..+..|.+|..|+.
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 34455566666666433333334456666677777776 56666667777777777777766 56666666666666666
Q ss_pred cccccccccCcccCCCcccceeeccCccccccccccc
Q 001274 584 SDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVAL 620 (1109)
Q Consensus 584 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 620 (1109)
.+|.+..+.-+ +---+.....++.++++.+.-|..+
T Consensus 131 ~~na~~eid~d-l~~s~~~al~~lgnepl~~~~~~kl 166 (177)
T KOG4579|consen 131 PENARAEIDVD-LFYSSLPALIKLGNEPLGDETKKKL 166 (177)
T ss_pred CCCccccCcHH-HhccccHHHHHhcCCcccccCcccc
Confidence 66666533222 2111222333445555555444433
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.3e-08 Score=90.63 Aligned_cols=136 Identities=22% Similarity=0.270 Sum_probs=78.6
Q ss_pred cccEEecccCcccccCCcC---CCCCCCCCeeecCCCcCccCCCcccccc-cccceecccccccccccCcccCCCcccce
Q 001274 529 HLVTFNISSNSLSGTIPHE---LGNCVNLQRLDLSRNQFTGSAPEELGQL-VNLELLKLSDNKLTGAIPSSLGGLARLTE 604 (1109)
Q Consensus 529 ~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 604 (1109)
.+..++|++++|- .+++. +.....|+..+|++|.+. .+|..|... +.++.|+|++|+|+ .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4555666666664 33333 233344555566666666 455555433 35666666666665 34444555555555
Q ss_pred eeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEccCcc
Q 001274 605 LQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNN 684 (1109)
Q Consensus 605 L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~ 684 (1109)
|+++.|++ . ..|..+..|.+|-.||..+|.+- +||-.+..-......++.+++
T Consensus 105 lNl~~N~l-------------------------~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnep 157 (177)
T KOG4579|consen 105 LNLRFNPL-------------------------N-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEP 157 (177)
T ss_pred cccccCcc-------------------------c-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCc
Confidence 55555544 4 34555666777777888888776 677554443444455667777
Q ss_pred cccccCCCcc
Q 001274 685 LVGTVPNTTV 694 (1109)
Q Consensus 685 l~g~~p~~~~ 694 (1109)
|.+..|...|
T Consensus 158 l~~~~~~klq 167 (177)
T KOG4579|consen 158 LGDETKKKLQ 167 (177)
T ss_pred ccccCccccc
Confidence 8777776544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1109 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-61 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-61 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-60 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-60 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-27 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-24 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-23 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 6e-11 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 6e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-11 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 6e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-10 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-07 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 4e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-07 | ||
| 1xku_A | 330 | Crystal Structure Of The Dimeric Protein Core Of De | 6e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-07 | ||
| 1xcd_A | 329 | Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo | 7e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 7e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-06 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 4e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-06 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 6e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-06 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-05 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 5e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 6e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 4e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 4e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-05 | ||
| 2ft3_A | 332 | Crystal Structure Of The Biglycan Dimer Core Protei | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-05 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 626 bits (1617), Expect = 0.0
Identities = 211/651 (32%), Positives = 307/651 (47%), Gaps = 23/651 (3%)
Query: 73 KVTSVDLHGLNLSGILSPR--ICDLPRLVEFNISMNFVTGSIPT-DLANCSSLEILDLCT 129
+TS+DL +LSG ++ + L N+S N + +SLE+LDL
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160
Query: 130 NRLHGVIPFQLFFINT---LRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPA 186
N + G + L+ L + N I G++ + +LE L + SNN + IP
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP- 217
Query: 187 SISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLI 246
+ L+ + N LSG IS C L++L ++ N G +P L++L L
Sbjct: 218 FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLS 275
Query: 247 LWQNHLSGEIPPTI-GNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIP 305
L +N +GEIP + G +L L L N F G +P G S L+ L + +N +G +P
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335
Query: 306 HE-LGNCTSAVEIDLSENQLTGFIPRELG-LIPNLCLLQLFENMLQGSIPRELGQ--LTQ 361
+ L +DLS N+ +G +P L L +L L L N G I L Q
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 362 LHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLD 421
L +L L N TG IP N + LV L L N+L GTIP +G S L L + +N L+
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 422 GSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQN 481
G IP L + L L L N L+G IP GL C +L + L N+LTG +P L+N
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
Query: 482 LSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLS 541
L+ L+L N FSG IP E+G R+L L L+ N F G IP+ + + I++N ++
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIA 571
Query: 542 GTIPHELGNCVNLQRLDLSRN--QFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599
G + N + + N +F G E+L +L ++ G +
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631
Query: 600 ARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
+ L M N+ SG IP +G + L I LN+ HN++SG IP E+G+L+ L L L N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFI-LNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 660 QLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLC 710
+L G IP +M L +LSNNNL G +P F + F N GLC
Sbjct: 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = 2e-94
Identities = 114/387 (29%), Positives = 160/387 (41%), Gaps = 39/387 (10%)
Query: 315 VEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTG 374
IDLS L ++ L LT L L LS +++ G
Sbjct: 53 TSIDLSSKPLNVGF---------------------SAVSSSLLSLTGLESLFLSNSHING 91
Query: 375 TIPLEFQNLTYLVDLQLFDNHLEGTIPP--HIGVNSHLSVLDVSMNNLDGSIP-PHLCMY 431
++ F+ L L L N L G + +G S L L+VS N LD
Sbjct: 92 SVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKL 150
Query: 432 QKLIFLSLGSNRLSGNIPPGLKT---CRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488
L L L +N +SG G C L L + N+++G + + NL L++
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFLDVS 208
Query: 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHEL 548
N FS I P +G L+ L +S N G + L NISSN G IP
Sbjct: 209 SNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL- 266
Query: 549 GNCVNLQRLDLSRNQFTGSAPEEL-GQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQM 607
+LQ L L+ N+FTG P+ L G L L LS N GA+P G + L L +
Sbjct: 267 -PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL 325
Query: 608 GGNIFSGSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQM-LEALYLDDNQLIGEI 665
N FSG +P+ L ++ L++ L++S N SG +P L NL L L L N G I
Sbjct: 326 SSNNFSGELPMDTLLKMRGLKV-LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPI 384
Query: 666 PASMGEQM--SLLVCNLSNNNLVGTVP 690
++ + +L L NN G +P
Sbjct: 385 LPNLCQNPKNTLQELYLQNNGFTGKIP 411
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-39
Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 11/196 (5%)
Query: 501 GKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLS 560
K+ +++ N + S + +L L + +S++ ++G++ +L LDLS
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 561 RNQFTGSAPE--ELGQLVNLELLKLSDNKLTGAIPSSLG-GLARLTELQMGGNIFSGSIP 617
RN +G LG L+ L +S N L S G L L L + N SG+
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 618 VAL---GQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMS 674
V L+ L IS N +SG + + LE L + N IP +G+ +
Sbjct: 169 VGWVLSDGCGELKH-LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSA 224
Query: 675 LLVCNLSNNNLVGTVP 690
L ++S N L G
Sbjct: 225 LQHLDISGNKLSGDFS 240
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-25
Identities = 50/160 (31%), Positives = 69/160 (43%), Gaps = 1/160 (0%)
Query: 50 NLESWNSSDMTPCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVT 109
+ N +I K + L GI S ++ L NI+
Sbjct: 563 GKIAANFIAGKRYVYIK-NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
Query: 110 GSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTS 169
G N S+ LD+ N L G IP ++ + L L L N I G IP+E+G+L
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681
Query: 170 LEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIP 209
L L + SN L G IP ++S L L I +N+LSGPIP
Sbjct: 682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 369 bits (950), Expect = e-119
Identities = 123/290 (42%), Positives = 168/290 (57%), Gaps = 9/290 (3%)
Query: 792 FKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEI 851
F L A+ NFS ++GRG G VYK LA+G ++AVK++K + F E+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK-EERTQGGELQFQTEV 78
Query: 852 STLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHG-NKQTCLLDWDARYRIAL 910
+ HRN+++L GFC LL+Y YM NGS+ L + LDW R RIAL
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
G+A GL YLH C P IIHRD+K+ NILLDEEF+A VGDFGLAKL+D + +A+ G+
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGD----LVTWVRRSIHE 1026
G+IAPEY T K +EK D++ +GV+LLELITG+ L D L+ WV+ + +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG-LLK 257
Query: 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076
L D L EE+ +++AL C+ +SP+ RP M EV+ M
Sbjct: 258 EKKLEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 377 bits (969), Expect = e-117
Identities = 138/649 (21%), Positives = 229/649 (35%), Gaps = 46/649 (7%)
Query: 75 TSVDLHGLNLSGILSPRICDLPR-LVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
D L L+ + DLP + N++ N + + S L LD+ N +
Sbjct: 7 EVADCSHLKLTQVPD----DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 134 GVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQ 193
+ P + L+ L L N + + T+L EL + SN++ K +
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 194 LRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELE--KLRNLTDLILWQNH 251
L + HN LS + E L+ L L+ N ++ EL+ +L L L N
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 252 LSGEIPPTIGNIQSLELLALHENSFSGGLPKELG---KLSRLKKLYVYTNELNGTIPHEL 308
+ P I L L L+ L ++L + ++ L + ++L+ T
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 309 GNC--TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLD 366
T+ +DLS N L +P L L N +Q L L + L+
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 367 L---------SINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSM 417
L S+ +L FQ L L L + DN + G +L L +S
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 418 NNLDGSIPPHLCMYQ----KLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLP 473
+ + L L+L N++S L L LG N++ L
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 474 I-EFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYF--VGYIPSEVGNLEHL 530
E+ L+N+ + L N++ L + +L+RL L V PS L +L
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482
Query: 531 VTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTG 590
++S+N+++ L L+ LDL N +L + G
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA----------------RLWKHANPG 526
Query: 591 AIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQM 650
L GL+ L L + N F L L+I +++ NNL+ + N
Sbjct: 527 GPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI-IDLGLNNLNTLPASVFNNQVS 585
Query: 651 LEALYLDDNQLIGEIPASMGEQM-SLLVCNLSNNNLVGTVPNTTVFRRI 698
L++L L N + G +L ++ N T + F
Sbjct: 586 LKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNW 634
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 368 bits (948), Expect = e-114
Identities = 121/643 (18%), Positives = 212/643 (32%), Gaps = 42/643 (6%)
Query: 74 VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
+T ++L L + + +L ++ N ++ P L++L+L N L
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 134 GVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQ 193
+ F L +L+L N I +L L + N L+ + +L
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 194 LRVIRAGHNSLSGPIPPEISECEG--LEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
L+ + +N + E+ L+ L L+ N ++ F P + L L L
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 252 LSGEIPPTIG---NIQSLELLALHENSFSGGLPKELG--KLSRLKKLYVYTNELNGTIPH 306
L + + S+ L+L + S K + L L + N LN
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 307 ELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLD 366
L N + L + N+ L L + K
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS---------------FTKQS 311
Query: 367 LSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPP 426
+S+ +L FQ L L L + DN + G +L L +S +
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 427 HLCMYQ----KLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPI-EFYNLQN 481
+ L L+L N++S L L LG N++ L E+ L+N
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 482 LSALELYQNRFSGLIPPEIGKLRNLERLHLSENYF--VGYIPSEVGNLEHLVTFNISSNS 539
+ + L N++ L + +L+RL L V PS L +L ++S+N+
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 540 LSGTIPHELGNCVNLQRLDLSRNQFT--------GSAPEELGQLVNLELLKLSDNKLTGA 591
++ L L+ LDL N G L L +L +L L N
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 592 IPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELG-NLQM 650
L L + +G N + +L+ LN+ N ++ V G +
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS-LNLQKNLITSVEKKVFGPAFRN 610
Query: 651 LEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTT 693
L L + N + + N ++ N+ +
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWI---NETHTNIPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-113
Identities = 143/634 (22%), Positives = 224/634 (35%), Gaps = 41/634 (6%)
Query: 121 SLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNL 180
S E+ D +L +P L + L L N + + L L + N +
Sbjct: 5 SHEVADCSHLKLTQ-VPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 181 TGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLR 240
+ P KL L+V+ HN LS + C L L L NS++ + K +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 241 NLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELG--KLSRLKKLYVYTN 298
NL L L N LS T +++L+ L L N +EL S LKKL + +N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 299 ELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQ---LFENMLQGSIPRE 355
++ P + L+ QL + +L L ++ L + L +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 356 LGQL--TQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVL 413
L T L LDLS NNL F L L L N+++ + ++ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 414 D---------VSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLG 464
+ +S+ +L + L L++ N + G +L L L
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 465 QNQLTGSLPIE--FYNLQN--LSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYI 520
+ + F +L + L L L +N+ S + L +LE L L N +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 521 PSEV-GNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG--SAPEELGQLVN 577
+ LE++ +S N + +LQRL L R S+P L N
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481
Query: 578 LELLKLSDNKLTGAIPSSLGGLARLTELQMGGN--------IFSGSIPVALGQLTALQIA 629
L +L LS+N + L GL +L L + N G L L+ L I
Sbjct: 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI- 540
Query: 630 LNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTV 689
LN+ N + +L L+ + L N L + Q+SL NL N +
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600
Query: 690 PNT--TVFRRIDSSNFAGNRGLCMLGSDCHQLMP 721
FR + + N C C +
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDC----TCESIAW 630
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 6e-86
Identities = 102/581 (17%), Positives = 180/581 (30%), Gaps = 70/581 (12%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLA--NCSSLEILDLCTN 130
+ ++DL LS L L E +S N + +L SSL+ L+L +N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 131 RLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIG---NLTSLEELVIYSNNLTGAIPAS 187
++ P I L L+L + + E++ TS+ L + ++ L+ +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 188 ISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLIL 247
L+ L +L L+ N+L L L L
Sbjct: 242 FLGLKWTN----------------------LTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279
Query: 248 WQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHE 307
N++ ++ + ++ L L + + L
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS---------------LASLPKIDDFS 324
Query: 308 LGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELG----QLTQLH 363
+++ +N + G + NL L L + + LH
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 364 KLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDG 422
L+L+ N ++ F L +L L L N + + ++ + +S N
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 423 SIPPHLCMYQKLIFLSLGSNRLSG--NIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQ 480
+ L L L L + P + R+L L L N + L+
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 481 NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSL 540
L L+L N + L ++ G + L HL N+ SN
Sbjct: 505 KLEILDLQHNNLA----------------RLWKHANPGGPIYFLKGLSHLHILNLESNGF 548
Query: 541 SGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLG-GL 599
+ L+ +DL N V+L+ L L N +T G
Sbjct: 549 DEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF 608
Query: 600 ARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGV 640
LTEL M N F + + +N +H N+ +
Sbjct: 609 RNLTELDMRFNPFDCTCE----SIAWFVNWINETHTNIPEL 645
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-57
Identities = 97/584 (16%), Positives = 168/584 (28%), Gaps = 94/584 (16%)
Query: 22 FSNVSVTSLTE---EGVSLLEFKASLIDPSNNLE----SWNSSDMTPCNWIGVECTDFKV 74
+ +SL + + EF L + + + +E + +
Sbjct: 165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSI 224
Query: 75 TSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANC--SSLEILDLCTNRL 132
++ L LS T ++L +LDL N L
Sbjct: 225 RNLSLSNSQLSTT------------------------SNTTFLGLKWTNLTMLDLSYNNL 260
Query: 133 HGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLR 192
+ V ++ L +L N I + L ++ L + + +I
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS------- 313
Query: 193 QLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHL 252
SL + LE L + N + G + L NL L L +
Sbjct: 314 --------LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 253 SGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCT 312
S L L +F S L L + N+++
Sbjct: 366 S--------------LRTLTNETFVS------LAHSPLHILNLTKNKISKIESDAFSWLG 405
Query: 313 SAVEIDLSENQLTGFIP-RELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINN 371
+DL N++ + +E + N+ + L N + L +L L
Sbjct: 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465
Query: 372 LTG--TIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLC 429
L + P FQ L L L L +N++ + L +LD+ NNL
Sbjct: 466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA-------- 517
Query: 430 MYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQ 489
L + G LK L L L N F +L L ++L
Sbjct: 518 --------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569
Query: 490 NRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVG-NLEHLVTFNISSNSLSGTIPHEL 548
N + L +L+ L+L +N G +L ++ N T
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA 629
Query: 549 G-----NCVNLQRLDLSRNQFTGSAPEELGQ-LVNLELLKLSDN 586
N + +LS + + P G + + D+
Sbjct: 630 WFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDS 673
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 372 bits (958), Expect = e-116
Identities = 107/627 (17%), Positives = 204/627 (32%), Gaps = 75/627 (11%)
Query: 28 TSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNW------------IGVECTDF-KV 74
++ ++L E +L + + + + + NW GV +V
Sbjct: 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQ--PGANWNFNKELDMWGAQPGVSLNSNGRV 83
Query: 75 TSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTG----SIPTDLANCSSLEILDLCTN 130
T + L G SG + I L L + + P ++ S E
Sbjct: 84 TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM 143
Query: 131 RLHGVIPFQLFFINT--LRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI 188
+ L K + + I + ++ SNN+T + ++
Sbjct: 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAV 202
Query: 189 SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILW 248
+L +LR G++ E E E E + + L++LTD+ ++
Sbjct: 203 MRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVEVY 257
Query: 249 QNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL 308
++P + + ++L+ + N G + + +
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQ----------------LKDDWQALADA 301
Query: 309 GNCTSAVEIDLSENQL-TGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDL 367
I + N L T + L + L +L+ N L+G +P G +L L+L
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNL 360
Query: 368 SINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNS--HLSVLDVSMNNLDG--- 422
+ N +T + +L N L+ IP S +S +D S N +
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 423 ----SIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTG-------S 471
+ P + ++L +N++S T L + L N LT
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 472 LPIEFYNLQNLSALELYQNRFSGLIPPEI--GKLRNLERLHLSENYFVGYIPSEVGNLEH 529
F N L++++L N+ + + + L L + LS N F P++ N
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537
Query: 530 LVTFNI------SSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKL 583
L F I N P + C +L +L + N E++ N+ +L +
Sbjct: 538 LKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDI 594
Query: 584 SDNKLTGAIPSSLGGLARLTELQMGGN 610
DN S + + +
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = 3e-99
Identities = 70/556 (12%), Positives = 151/556 (27%), Gaps = 96/556 (17%)
Query: 163 EIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLG 222
+ + + L + +G +P +I +L +L V+ G +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL------------ 123
Query: 223 LAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLEL--LALHENSFSGGL 280
F P + + + H +L ++ + +
Sbjct: 124 --------FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSI 175
Query: 281 PKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCL 340
K + ++ +N + + + T + + + E N
Sbjct: 176 KKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY 234
Query: 341 LQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHL---- 396
Q + + + L L +++ +P + L + + + N
Sbjct: 235 AQQY-----KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 397 ----EGTIPPHIGVNSHLSVLDVSMNNL-DGSIPPHLCMYQKLIFLSLGSNRLSGNIPPG 451
+ V + ++ + NNL + L +KL L N+L G P
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPA 348
Query: 452 LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPP-EIGKLRNLERLH 510
+ L L L NQ+T + + L N+ + + + + +
Sbjct: 349 FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAID 408
Query: 511 LSENYFVGY-------IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQ 563
S N + ++ + N+S+N +S L ++L N
Sbjct: 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM 468
Query: 564 FTG-------SAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSI 616
T E L + L NKLT +
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFR------------------- 508
Query: 617 PVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLL 676
L L +++S+N+ S P + N L+ + + +
Sbjct: 509 ---ATTLPYLVG-IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR---------------- 547
Query: 677 VCNLSNNNLVGTVPNT 692
+ N + P
Sbjct: 548 --DAQGNRTLREWPEG 561
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 3e-68
Identities = 63/437 (14%), Positives = 133/437 (30%), Gaps = 56/437 (12%)
Query: 76 SVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGV 135
+ + + +L L + + +PT L ++++++ NR
Sbjct: 229 NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 136 IPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNL-TGAIPASISKLRQL 194
+ + + ++ + I NNL T + S+ K+++L
Sbjct: 289 E----------------QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332
Query: 195 RVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSG 254
++ +N L G P L L LA N + + + +L N L
Sbjct: 333 GMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK- 390
Query: 255 EIPPT--IGNIQSLELLALHENSFSG-------GLPKELGKLSRLKKLYVYTNELNGTIP 305
IP ++ + + N L K + + + N+++
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450
Query: 306 HELGNCTSAVEIDLSENQLTGF-------IPRELGLIPNLCLLQLFENMLQGSIPREL-- 356
+ I+L N LT L + L N L + +
Sbjct: 451 ELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRA 509
Query: 357 GQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFD------NHLEGTIPPHIGVNSHL 410
L L +DLS N+ + P + N + L + + N P I + L
Sbjct: 510 TTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568
Query: 411 SVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTG 470
+ L + N++ + + + L + N + ML ++
Sbjct: 569 TQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ- 624
Query: 471 SLPIEFYNLQNLSALEL 487
+++ AL++
Sbjct: 625 -------DIRGCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-32
Identities = 29/232 (12%), Positives = 63/232 (27%), Gaps = 37/232 (15%)
Query: 466 NQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVG----YIP 521
+ + + ++ L L SG +P IG+L LE L L + + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 522 SEVGNLEHLVTFNISSNSLSGTIPHELG--NCVNLQRLDLSRNQFTGSAPEELGQLVNLE 579
+ T + +L + ++ + S + +
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 580 LLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSG 639
+ N +T + ++ L +L + MG + F + N +
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN------ENSEYAQQYK 239
Query: 640 VIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPN 691
+ NL+ L + + N + +P
Sbjct: 240 TEDLKWDNLKDLTDVEV------------------------YNCPNLTKLPT 267
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 324 bits (834), Expect = e-102
Identities = 109/294 (37%), Positives = 153/294 (52%), Gaps = 22/294 (7%)
Query: 792 FKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEI 851
+L EAT NF +IG G G VYK L +G +A+K+ E + F EI
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR--RTPESSQGIEEFETEI 86
Query: 852 STLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHG-NKQTCLLDWDARYRIAL 910
TL RH ++V L GFC ++ +L+Y+YMENG+L L+G + T + W+ R I +
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS-AIAG 969
GAA GL YLH IIHRD+KS NILLDE F + DFG++K +S + G
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 970 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPV-QSLELGGD-LVTWVR-----R 1022
+ GYI PEY ++TEK D+YSFGVVL E++ +S + QSL L W
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076
+ ++V D L K E + F A+ C + S +RP+M +V+
Sbjct: 264 QLEQIV------DPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-102
Identities = 123/623 (19%), Positives = 202/623 (32%), Gaps = 48/623 (7%)
Query: 75 TSVDLHGLNLSGILSPRICDLPR-LVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
+ LN I +LP ++S N + + L++LDL +
Sbjct: 10 ITYQCMELNFYKIPD----NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 134 GVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQ 193
+ ++ L L L N I L+SL++LV NL I L+
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 194 LRVIRAGHNSL-SGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLT----DLILW 248
L+ + HN + S +P S LE L L+ N ++ ++L L + L L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 249 QNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKE-LGKLSRLKKLYVYTNELNGTIPHE 307
N ++ I P L L L N S + K + L+ L+ + E
Sbjct: 186 LNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR------ 238
Query: 308 LGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGS---IPRELGQLTQLHK 364
+E L F L + NL + + L I LT +
Sbjct: 239 ------------NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS 286
Query: 365 LDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSI 424
L + F L+L + + L + + G
Sbjct: 287 FSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRL-----TFTSNKGGN 339
Query: 425 PPHLCMYQKLIFLSLGSNRLS--GNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNL 482
L FL L N LS G SL L L N + + F L+ L
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQL 398
Query: 483 SALELYQNRFSGLIPPEI-GKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLS 541
L+ + + + LRNL L +S + L L ++ NS
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 542 GTIPHE-LGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLA 600
+ NL LDLS+ Q +P L +L++L +S N L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 601 RLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYE--LGNLQMLEALYLDD 658
L L N S L + LN++ N+ + ++ L ++ L ++
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEV 578
Query: 659 NQLIGEIPASMGEQMSLLVCNLS 681
++ P+ M +L N++
Sbjct: 579 ERMECATPSDKQ-GMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = 4e-99
Identities = 112/562 (19%), Positives = 196/562 (34%), Gaps = 32/562 (5%)
Query: 150 YLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIP 209
Y C F +IP+ + S + L + N L S +L+V+ +
Sbjct: 12 YQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 210 PEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELL 269
L L L N ++ L +L L+ + +L+ IG++++L+ L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 270 ALHENSFSGG-LPKELGKLSRLKKLYVYTNELNGTIPHELGNCTS----AVEIDLSENQL 324
+ N LP+ L+ L+ L + +N++ +L + +DLS N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 325 TGFIPRELGLIPNLCLLQLFENMLQGSIPRE-LGQLTQLHKLDLSINNLTGTIPLE---- 379
P I L L L N ++ + + L L L + LE
Sbjct: 190 NFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 380 --FQNLTYLVDLQLFDNHLE---GTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKL 434
+ L L + +L+ I +++S + ++
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF--GW 306
Query: 435 IFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR--F 492
L L + + LK+ + L G +L +L L+L +N F
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361
Query: 493 SGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE-LGNC 551
G +L+ L LS N + + S LE L + ++L +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAI-PSSLGGLARLTELQMGGN 610
NL LD+S + L +LE+LK++ N P L LT L +
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 611 IFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMG 670
P A L++LQ+ LN+SHNN + + L L+ L N ++ +
Sbjct: 481 QLEQLSPTAFNSLSSLQV-LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539
Query: 671 EQMSLLVC-NLSNNNLVGTVPN 691
S L NL+ N+ T +
Sbjct: 540 HFPSSLAFLNLTQNDFACTCEH 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = 3e-96
Identities = 107/595 (17%), Positives = 190/595 (31%), Gaps = 44/595 (7%)
Query: 74 VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
++DL L + S P L ++S + + S L L L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 134 GVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGA-IPASISKLR 192
+ +++L+KL E + IG+L +L+EL + N + +P S L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 193 QLRVIRAGHNSLSGPIPPEISECEGLEV----LGLAQNSLEGFLPSELEKLRNLTDLILW 248
L + N + ++ + + L L+ N + P +++ L L L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLR 208
Query: 249 QNHLSGEIPPT-IGNIQSLELLALHENSFSGG---LPKELGKLSRLKKLYVYTNELNGTI 304
N S + T I + LE+ L F + L L L + L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY-- 266
Query: 305 PHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHK 364
+D + I + N+ L ++
Sbjct: 267 ------------LDYYLDD----IIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQH 308
Query: 365 LDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLD--G 422
L+L L+ ++L L +G L LD+S N L G
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363
Query: 423 SIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE-FYNLQN 481
L +L L N + + L L + L F +L+N
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 482 LSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSL 540
L L++ L +LE L ++ N F ++ L +L ++S L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 541 SGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLA 600
P + +LQ L++S N F L +L++L S N + + L
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542
Query: 601 R-LTELQMGGNIFSGSIPVA--LGQLTALQIALNISHNNLSGVIPYELGNLQMLE 652
L L + N F+ + L + + L + + P + + +L
Sbjct: 543 SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ-LLVEVERMECATPSDKQGMPVLS 596
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-61
Identities = 86/426 (20%), Positives = 131/426 (30%), Gaps = 44/426 (10%)
Query: 304 IPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLH 363
IP L S +DLS N L P L +L L +Q L+ L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 364 KLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDG- 422
L L+ N + F L+ L L + +L IG L L+V+ N +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 423 SIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSL----MQLMLGQNQLTGSLPIEFYN 478
+P + L L L SN++ L+ + + L L N + P F
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 479 LQNLSALELYQNRFSGLIPPE-IGKLRNLERLHLSENYFVGYIPSEV---GNLEHLVTFN 534
+ L L L N S + I L LE L F E LE L
Sbjct: 200 I-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 535 ISSNSLS------GTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588
I L+ I N+ L + L+L + K
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316
Query: 589 T-------------------GAIPSSLGGLARLTELQMGGN--IFSGSIPVALGQLTALQ 627
G S L L L + N F G + T+L+
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 628 IALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQM-SLLVCNLSNNNLV 686
L++S N + + L+ LE L + L S+ + +L+ ++S+ +
Sbjct: 377 Y-LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 687 GTVPNT 692
Sbjct: 435 VAFNGI 440
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-40
Identities = 44/237 (18%), Positives = 77/237 (32%), Gaps = 10/237 (4%)
Query: 481 NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSL 540
+ L+L N L L+ L LS +L HL T ++ N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 541 SGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGA-IPSSLGGL 599
+LQ+L +G L L+ L ++ N + +P L
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 600 ARLTELQMGGNIFSGSIPVALGQLTALQIA---LNISHNNLSGVIPYELGNLQMLEALYL 656
L L + N L L + + L++S N ++ + P ++ L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTL 207
Query: 657 DDNQLIGEIPASMGEQMSLL-VCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCML 712
+N + + + ++ L V L N + D S G L +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEF----RNEGNLEKFDKSALEGLCNLTIE 260
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-37
Identities = 46/222 (20%), Positives = 78/222 (35%), Gaps = 11/222 (4%)
Query: 477 YNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNIS 536
+ N++ + N + IP + + + L LS N + L ++S
Sbjct: 5 EVVPNITYQCMELNFYK--IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 537 SNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSL 596
+ + +L L L+ N A L +L+ L + L +
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 597 GGLARLTELQMGGN-IFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEA-- 653
G L L EL + N I S +P LT L+ L++S N + + +L L +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH-LDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 654 --LYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTT 693
L L N + I +++ L L NN V T
Sbjct: 180 LSLDLSLNP-MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-100
Identities = 106/294 (36%), Positives = 144/294 (48%), Gaps = 17/294 (5%)
Query: 792 FKYHNLLEATGNFSE------GAVIGRGACGTVYKATLANGEVIAVKKIKLRG--EGATA 843
F ++ L T NF E G +G G G VYK + N +AVKK+
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 844 DNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWD 903
F EI + K +H N+V+L GF D L+Y YM NGSL ++L T L W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 904 ARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS 963
R +IA GAA G+ +LH + IHRDIKS NILLDE F A + DFGLA+ +
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 964 MS-AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRR 1022
M+ I G+ Y+APE ++T K DIYSFGVVLLE+ITG V L+
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249
Query: 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076
E + DK+++ + +VE M +A C RP +++V +
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEAM---YSVASQCLHEKKNKRPDIKKVQQL 300
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 308 bits (790), Expect = 1e-92
Identities = 120/599 (20%), Positives = 196/599 (32%), Gaps = 24/599 (4%)
Query: 76 SVDLHGLNLSGILSPRICDLPRLVEF-NISMNFVTGSIPTDLANCSSLEILDLCTNRLHG 134
+ + L L+ I P LP E S N + T + +L LDL +++
Sbjct: 16 TYNCENLGLNEI--PG--TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 135 VIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQL 194
+ + L L L N + + +L+ L ++ + + L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 195 RVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLS- 253
+ G N +S P+ E L+VL N++ ++ L+ T+L L N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 254 GEIPPTIGNIQSLELLALHENSFSGGLPKELG--KLSRLKKLYVYTNELNGTIPHELGNC 311
I P + + L + K L + L + P
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 312 --TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSI 369
S I+L ++ L L L L +P L L+ L KL LS
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 370 NNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDGSIPPHL 428
N + N L L + N + N +L LD+S ++++ S +L
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 429 CMYQ--KLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSAL 485
+ L L+L N K C L L L +L F NL L L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 486 ELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVG---NLEHLVTFNISSNSLSG 542
L + L L+ L+L N+F + L L +S LS
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 543 TIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARL 602
H + + +DLS N+ T S+ E L L + L L+ N ++ +PS L L++
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQ 549
Query: 603 TELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
+ + N + + L N +L + L D L
Sbjct: 550 RTINLRQNPLDCTC-----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 1e-86
Identities = 102/528 (19%), Positives = 179/528 (33%), Gaps = 18/528 (3%)
Query: 177 SNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSEL 236
+ L IP ++ + N L S L L L + +
Sbjct: 21 NLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF 77
Query: 237 EKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVY 296
+ L L+L N L + ++L+ L + S L L+ LY+
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 297 TNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ-GSIPRE 355
+N ++ + +D N + ++ + L L N I
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPG 197
Query: 356 LGQLTQLHKLDLSINNLTGTIP--LEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSV- 412
L+ I L+ + L D E P +SV
Sbjct: 198 AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVE 257
Query: 413 -LDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGS 471
+++ + + L L L + LS +P GL +L +L+L N+
Sbjct: 258 SINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENL 316
Query: 472 LPIEFYNLQNLSALELYQNRFSGLIPPE-IGKLRNLERLHLSEN--YFVGYIPSEVGNLE 528
I N +L+ L + N + + L NL L LS + ++ NL
Sbjct: 317 CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS 376
Query: 529 HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEE-LGQLVNLELLKLSDNK 587
HL + N+S N C L+ LDL+ + + L L++L LS +
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436
Query: 588 LTGAIPSSLGGLARLTELQMGGNIFSGSIPV---ALGQLTALQIALNISHNNLSGVIPYE 644
L + GL L L + GN F +L L L+I L +S +LS + +
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI-LVLSFCDLSSIDQHA 495
Query: 645 LGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNT 692
+L+M+ + L N+L + + NL++N++ +P+
Sbjct: 496 FTSLKMMNHVDLSHNRLTS-SSIEALSHLKGIYLNLASNHISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-58
Identities = 75/385 (19%), Positives = 123/385 (31%), Gaps = 13/385 (3%)
Query: 316 EIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGT 375
+ L IP L + L+ N+L +L L LDL+ +
Sbjct: 16 TYNCENLGLNE-IPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 376 IPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLI 435
FQ+ L L L N L + L L + L + L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 436 FLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR-FSG 494
L LGSN +S P L L N + + +LQ + L L N
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 495 LIPPEIGKLRNLERLHLSENYFVGYIPSEVGN--LEHLVTFNISSNSLSGTIPHELGNC- 551
I P + L+ + I + N ++ L P
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 552 -VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGN 610
++++ ++L ++ F + L+ L L+ L+ +PS L GL+ L +L + N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311
Query: 611 IFSGSIPVALGQLTALQIALNISHNNLSGVIPYE-LGNLQMLEALYLDDNQL--IGEIPA 667
F ++ +L L+I N + L NL+ L L L + +
Sbjct: 312 KFENLCQISASNFPSLTH-LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 668 SMGEQMSLLVCNLSNNNLVGTVPNT 692
+ L NLS N +
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEA 395
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-53
Identities = 64/352 (18%), Positives = 110/352 (31%), Gaps = 10/352 (2%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410
IP L L+ S N L F L L L L + L
Sbjct: 26 EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 411 SVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTG 470
L ++ N L L + L L +S L ++L L LG N ++
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 471 SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENY-FVGYIPSEVGNLEH 529
+ + + L L+ N L ++ L+ L L+ N + I +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 530 LVTFNISSNSLSGTIPHELGNC--VNLQRLDLSRNQFTGSAPEELGQLVNLEL--LKLSD 585
+ N I L N +L +P L + + + L
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 586 NKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYEL 645
+ ++ + L EL + S +P L L+ L+ L +S N +
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKK-LVLSANKFENLCQISA 321
Query: 646 GNLQMLEALYLDDNQLIGEIPASMGEQM-SLLVCNLSNNNLVGTVPNTTVFR 696
N L L + N E+ E + +L +LS++++ + R
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 6e-85
Identities = 78/302 (25%), Positives = 116/302 (38%), Gaps = 31/302 (10%)
Query: 413 LDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSG--NIPPGLKTCRSLMQLML-GQNQLT 469
D G + ++ L L L IP L L L + G N L
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 470 GSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEH 529
G +P L L L + SG IP + +++ L L S N G +P + +L +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 530 LVTFNISSNSLSGTIPHELGNCVNLQR-LDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588
LV N +SG IP G+ L + +SRN+ TG P L NL + LS N L
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNML 209
Query: 589 TGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNL 648
G G ++ + N + + +G L L++ +N + G +P L L
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG-LDLRNNRIYGTLPQGLTQL 267
Query: 649 QMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRG 708
+ L +L N+S NNL G +P +R D S +A N+
Sbjct: 268 KFLHSL------------------------NVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 709 LC 710
LC
Sbjct: 304 LC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 270 bits (694), Expect = 9e-83
Identities = 94/401 (23%), Positives = 142/401 (35%), Gaps = 97/401 (24%)
Query: 32 EEGVSLLEFKASLIDPSNNLESWN-SSDMTPCNWIGVECTDFKVTSVDLHGLNLSGILSP 90
++ +LL+ K L +P+ L SW ++D W+GV C
Sbjct: 6 QDKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDT------------------- 45
Query: 91 RICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLY 150
+ LDL L P
Sbjct: 46 -------------------------DTQTYRVNNLDLSGLNLPKPYP------------- 67
Query: 151 LCENYIFGEIPEEIGNLTSLEELVIYS-NNLTGAIPASISKLRQLRVIRAGHNSLSGPIP 209
IP + NL L L I NNL G IP +I+KL QL + H ++SG IP
Sbjct: 68 ---------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118
Query: 210 PEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSL-EL 268
+S+ + L L + N+L G LP + L NL + N +SG IP + G+ L
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 269 LALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFI 328
+ + N +G +P L+ L + + N L G G+ + +I L++N L +
Sbjct: 179 MTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 329 PRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVD 388
++G L+ LDL N + GT+P L +L
Sbjct: 238 G-------------------------KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 389 LQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLC 429
L + N+L G IP G V + N P C
Sbjct: 273 LNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 7e-82
Identities = 84/276 (30%), Positives = 130/276 (47%), Gaps = 7/276 (2%)
Query: 346 NMLQGSIPRELGQLTQLHKLDLSINNLTGT--IPLEFQNLTYLVDLQLFD-NHLEGTIPP 402
G + Q +++ LDLS NL IP NL YL L + N+L G IPP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 403 HIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLM 462
I + L L ++ N+ G+IP L + L+ L N LSG +PP + + +L+ +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 463 LGQNQLTGSLPIEFYNLQNLS-ALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIP 521
N+++G++P + + L ++ + +NR +G IPP L NL + LS N G
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDAS 214
Query: 522 SEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELL 581
G+ ++ +++ NSL+ + ++G NL LDL N+ G+ P+ L QL L L
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 582 KLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIP 617
+S N L G IP G L R N P
Sbjct: 274 NVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-73
Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 7/278 (2%)
Query: 201 HNSLSGPIPPEISECEGLEVLGLAQNSLEG--FLPSELEKLRNLTDLILW-QNHLSGEIP 257
+ + G + ++ + L L+ +L +PS L L L L + N+L G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 258 PTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEI 317
P I + L L + + SG +P L ++ L L N L+GT+P + + + V I
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 318 DLSENQLTGFIPRELGLIPNLC-LLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTI 376
N+++G IP G L + + N L G IP L L +DLS N L G
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDA 213
Query: 377 PLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIF 436
+ F + + L N L + +G++ +L+ LD+ N + G++P L + L
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPI 474
L++ N L G IP G + N+ P+
Sbjct: 273 LNVSFNNLCGEIPQGGN-LQRFDVSAYANNKCLCGSPL 309
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 2e-83
Identities = 87/558 (15%), Positives = 177/558 (31%), Gaps = 74/558 (13%)
Query: 154 NYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEIS 213
+ + ++ N + L + G +P +I +L +L+V+ G +S +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 214 ECEGLEVLGLAQNSLEGFLPSE-LEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALH 272
E ++ ++ + L+ + L L Q+ ++ P + I+ ++L
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLK 426
Query: 273 ENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPREL 332
+ TN + I + T I + + T
Sbjct: 427 DTQIGN-----------------LTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNIAVD 468
Query: 333 GLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLF 392
N + +EN L L ++L +P +L L L +
Sbjct: 469 WEDANSDYAKQYEN-----EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523
Query: 393 DNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPP-- 450
N + K+ +G N L P
Sbjct: 524 CNRGISAAQLKADWTR---------------LADDEDTGPKIQIFYMGYNNLEE-FPASA 567
Query: 451 GLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGK-LRNLERL 509
L+ L L N++ L F L+ L+L N+ IP + +E L
Sbjct: 568 SLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGL 624
Query: 510 HLSENYFVGYIPS--EVGNLEHLVTFNISSNSLSGTIPH-----ELGNCVNLQRLDLSRN 562
S N IP+ ++ + + + S N + + + +N + LS N
Sbjct: 625 GFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683
Query: 563 QFTGSAPEELGQLVNLELLKLSDNKLT-------GAIPSSLGGLARLTELQMGGNIFSGS 615
+ E + + LS+N +T + LT + + N + S
Sbjct: 684 EIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-S 742
Query: 616 IP--VALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYL------DDNQLIGEIPA 667
+ L L +++S+N S P + N L+A + + N+++ + P
Sbjct: 743 LSDDFRATTLPYLSN-MDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
Query: 668 SMGEQMSLLVCNLSNNNL 685
+ SL+ + +N++
Sbjct: 801 GITTCPSLIQLQIGSNDI 818
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-56
Identities = 63/435 (14%), Positives = 124/435 (28%), Gaps = 42/435 (9%)
Query: 79 LHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPF 138
L + + + N + +N L ++L +P
Sbjct: 450 LQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD 509
Query: 139 QLFFINTLRKLYLCENYI---------FGEIPEEIGNLTSLEELVIYSNNLTGAIPAS-- 187
L+ + L+ L + N + + ++ ++ + NNL PAS
Sbjct: 510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASAS 568
Query: 188 ISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLIL 247
+ K+ +L ++ HN + L L L N +E + L
Sbjct: 569 LQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGF 626
Query: 248 WQNHLSGEIPPT--IGNIQSLELLALHENSFSG-----GLPKELGKLSRLKKLYVYTNEL 300
N L IP ++ + + N + K + + NE+
Sbjct: 627 SHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEI 685
Query: 301 NGTIPHELGNCTSAVEIDLSENQLT-------GFIPRELGLIPNLCLLQLFENMLQGSIP 353
+ I LS N +T L + L N L S+
Sbjct: 686 QKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLS 744
Query: 354 REL--GQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQL------FDNHLEGTIPPHIG 405
+ L L +D+S N + + P + N + L + N + P I
Sbjct: 745 DDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT 803
Query: 406 VNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQ 465
L L + N++ + L +L L + N + +L
Sbjct: 804 TCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLY 860
Query: 466 NQLTGSLPIEFYNLQ 480
++ + ++
Sbjct: 861 DKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-32
Identities = 35/297 (11%), Positives = 86/297 (28%), Gaps = 14/297 (4%)
Query: 411 SVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTG 470
+ + + + I + + L + R + +
Sbjct: 255 ANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLN-WNFNKELDMWGD 313
Query: 471 SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHL 530
++ N ++ L L G +P IG+L L+ L +
Sbjct: 314 QPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTP 373
Query: 531 VTFNISSNSLSGTIPHE-LGNCVNLQRLDLSRNQFTG---SAPEELGQLVNLELLKLSD- 585
+ + L L DL ++ P + ++L+ ++ +
Sbjct: 374 DMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL 433
Query: 586 -NKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYE 644
N++T I ++ L +L + + F+ + N +
Sbjct: 434 TNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWED------ANSDYAKQYENEELS 486
Query: 645 LGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSS 701
NL+ L + L + + ++P + + L N++ N + + R+
Sbjct: 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 3e-82
Identities = 101/571 (17%), Positives = 179/571 (31%), Gaps = 34/571 (5%)
Query: 110 GSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTS 169
GS+ + ++ +L +P + ++ + + L N + N +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 170 LEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLE 229
L+ L + + + L L + N + P S LE L + L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 230 GFLPSELEKLRNLTDLILWQNHLSG-EIPPTIGNIQSLELLALHENSFSGGLPKELGKLS 288
+ +L L L + N + ++P N+ +L + L N +L L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 289 RLK----KLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGL-IPNLCLLQL 343
L + N ++ I + E+ L N + I + + L + +L
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 344 FENMLQG---------SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDN 394
+ SI L +T L+ N ++F L + + L
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDE-FRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 395 HLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKT 454
+ + + L + L L L L+L N+ S I
Sbjct: 296 SI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGS--ISFKKVA 348
Query: 455 CRSLMQLMLGQNQLTGSLPIEFYNLQ--NLSALELYQNRFSGLIPPEIGKLRNLERLHLS 512
SL L L +N L+ S + +L +L L+L N ++ L L+ L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQ 407
Query: 513 ENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGS-APE 570
+ +LE L+ +IS + +L L ++ N F +
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
Query: 571 ELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIAL 630
NL L LS +L L RL L M N QL +L L
Sbjct: 468 VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST-L 526
Query: 631 NISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
+ S N + + L L +N +
Sbjct: 527 DCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 1e-79
Identities = 107/555 (19%), Positives = 174/555 (31%), Gaps = 32/555 (5%)
Query: 75 TSVDLHGLNLSGILSPRICDLPR-LVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
+ LS + D+P ++S N + +N S L+ LDL +
Sbjct: 14 ITYQCMDQKLSKVPD----DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE 69
Query: 134 GVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQ 193
+ ++ L L L N I P LTSLE LV L I +L
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129
Query: 194 LRVIRAGHNSLSG-PIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTD----LILW 248
L+ + HN + +P S L + L+ N ++ ++L+ LR L +
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
Query: 249 QNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGK-LSRLKKLYVYTNELNGTIPHE 307
N + I L L L N S + K + L+ L + E E
Sbjct: 190 LNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 308 LGNCT--------SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQL 359
+ + + E L+ + + N+ + L + ++ +
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKH 306
Query: 360 TQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNN 419
+ L + L +L +L L L N +I LS LD+S N
Sbjct: 307 FKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNA 361
Query: 420 LD--GSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE-F 476
L G L L L N + L L + L F
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 477 YNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNI 535
+L+ L L++ L +L L ++ N F S V N +L ++
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480
Query: 536 SSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSS 595
S L LQ L++S N QL +L L S N++ +
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
Query: 596 LGGLARLTELQMGGN 610
L + N
Sbjct: 541 QHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 1e-66
Identities = 96/506 (18%), Positives = 155/506 (30%), Gaps = 34/506 (6%)
Query: 206 GPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQS 265
G + P I + L +P ++ + ++ L N L + N
Sbjct: 2 GSLNPCIEVVPNITYQ-CMDQKLSK-VPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 266 LELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLT 325
L+ L L K L L L + N + P TS + E +L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 326 GFIPRELGLIPNLCLLQLFENMLQG-SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLT 384
+G + L L + N + +P LT L +DLS N + + Q L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 385 YL----VDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMY-QKLIFLSL 439
+ L + N ++ I L L + N +I L L
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 440 GSNRLSGN---------IPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQN 490
I GL + L ++F+ L N+SA+ L
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTID-EFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 491 RFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGN 550
L ++ K + L + P+ +L L + ++ N S I +
Sbjct: 296 SIKYL--EDVPKHFKWQSLSIIRCQL-KQFPT--LDLPFLKSLTLTMNKGS--ISFKKVA 348
Query: 551 CVNLQRLDLSRNQFTGSAPE--ELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMG 608
+L LDLSRN + S +L L LS N + ++ GL L L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQ 407
Query: 609 GNIFSGSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPA 667
+ A L L L+IS+ N L L L + N +
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLY-LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466
Query: 668 SMGEQM-SLLVCNLSNNNLVGTVPNT 692
++ +L +LS L
Sbjct: 467 NVFANTTNLTFLDLSKCQLEQISWGV 492
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-34
Identities = 43/272 (15%), Positives = 87/272 (31%), Gaps = 14/272 (5%)
Query: 446 GNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRN 505
G++ P ++ ++ +L+ +P + + + ++L N L
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 506 LERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFT 565
L+ L LS L HL ++ N + P +L+ L +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 566 GSAPEELGQLVNLELLKLSDNKLTGA-IPSSLGGLARLTELQMGGNIFSGSIPVALGQLT 624
+GQL+ L+ L ++ N + +P+ L L + + N L L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 625 ALQIA---LNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMS-LLVCNL 680
L++S N + + ++ L L L N I + + ++ L V L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 681 SNNNLVGTVPNTTVFRRIDSSNFAGNRGLCML 712
+ S G + +
Sbjct: 237 ILGEFKDERNLEI----FEPSIMEGLCDVTID 264
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 1e-75
Identities = 79/311 (25%), Positives = 118/311 (37%), Gaps = 34/311 (10%)
Query: 791 GFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAE 850
NL + V RG G V+KA L E +AVK ++ + S+ E
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK-----QSWQNE 66
Query: 851 --ISTLGKIRHRNIVKLYGFCYHQDSN----LLLYEYMENGSLGEQLHGNKQTCLLDWDA 904
+ +L ++H NI++ G S L+ + E GSL + L N + W+
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNE 122
Query: 905 RYRIALGAAEGLCYLHYD-------CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957
IA A GL YLH D +P I HRDIKS N+LL A + DFGLA +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 958 LPYSK-SMSAIAGSYGYIAPEYA-----YTMKVTEKCDIYSFGVVLLELITGKSPVQSL- 1010
S G+ Y+APE + + D+Y+ G+VL EL + +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 1011 ---ELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAK-RTVEEMTLFLKIALFCSSTSPLN 1066
L + S+ +M KR L + M + + C
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 1067 RPTMREVIAMM 1077
R + V +
Sbjct: 303 RLSAGCVGERI 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-65
Identities = 87/307 (28%), Positives = 132/307 (42%), Gaps = 29/307 (9%)
Query: 804 FSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIV 863
V+GRGA G V KA + +A+K+I+ E +F+ E+ L ++ H NIV
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE----RKAFIVELRQLSRVNHPNIV 64
Query: 864 KLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC 923
KLYG C + L+ EY E GSL LHG + L ++G+ YLH
Sbjct: 65 KLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 924 RPHIIHRDIKSNNILLDEEFQ-AHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
+IHRD+K N+LL + DFG A I M+ GS ++APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGS 178
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042
+EKCD++S+G++L E+IT + P + + W +H R L
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---VHN--------GTRPPLI- 226
Query: 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV--SDYPSSPTSETPLEAD 1100
K + + + C S P RP+M E++ +M + +D P + L
Sbjct: 227 KNLPKPIESLMTR---CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPG 283
Query: 1101 ASSRDSI 1107
R
Sbjct: 284 EDGRVEP 290
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 5e-65
Identities = 86/290 (29%), Positives = 143/290 (49%), Gaps = 22/290 (7%)
Query: 803 NFSE---GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH 859
+ + IG G+ GTV++A +G +AVK + + A N FL E++ + ++RH
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 860 RNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
NIV G + ++ EY+ GSL LH + LD R +A A+G+ YL
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA 979
H + P I+HR++KS N+L+D+++ V DFGL++L + S SA AG+ ++APE
Sbjct: 154 H-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA-AGTPEWMAPEVL 211
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039
EK D+YSFGV+L EL T + P +L +V V KRL+
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLN-PAQVVAAVGFK-----------CKRLE 259
Query: 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPS 1089
+ + ++ ++ C + P RP+ ++ ++ +S P+
Sbjct: 260 IP-RNLNPQVAAIIEG---CWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 3e-63
Identities = 106/520 (20%), Positives = 189/520 (36%), Gaps = 27/520 (5%)
Query: 159 EIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGL 218
+IP+ + S + L + N L S +L+V+ + L
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 219 EVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSF-S 277
L L N ++ L +L L+ + +L+ IG++++L+ L + N S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 278 GGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTS----AVEIDLSENQLTGFIPRELG 333
LP+ L+ L+ L + +N++ +L + +DLS N + FI
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 334 LIPNLCLLQLFENMLQGSIPRE-LGQLTQLHKLDL------SINNLTGTIPLEFQNLTYL 386
L L L N ++ + + L L L + NL + L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 387 VDLQLFDNHLEGTIPPHIGVNSHLSVLD-VSMNNLDGSIPPHLCMYQKLIFLSLGSNRLS 445
+ +L+ + I + + L+ + S+ ++ L L + +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF- 316
Query: 446 GNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR--FSGLIPPEIGKL 503
P LK +SL +L N+ + +L +L L+L +N F G
Sbjct: 317 -GQFPTLK-LKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 504 RNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQRLDLSRN 562
+L+ L LS N + + S LE L + ++L + NL LD+S
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 563 QFTGSAPEELGQLVNLELLKLSDNKLTGAIPS-SLGGLARLTELQMGGNIFSGSIPVALG 621
+ L +LE+LK++ N L LT L + P A
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 622 QLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
L++LQ+ LN++ N L V L L+ ++L N
Sbjct: 492 SLSSLQV-LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-53
Identities = 91/504 (18%), Positives = 154/504 (30%), Gaps = 56/504 (11%)
Query: 201 HNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI 260
+ IP + + L L+ N L L L L + +
Sbjct: 16 ELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ------- 65
Query: 261 GNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLS 320
+ + ++ LS L L + N + +S ++
Sbjct: 66 ---------TIEDGAYQS--------LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 321 ENQLTGFIPRELGLIPNLCLLQLFENMLQ-GSIPRELGQLTQLHKLDLSINNLTGTIPLE 379
E L +G + L L + N++Q +P LT L LDLS N + +
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 380 FQNLTYL----VDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMY-QKL 434
+ L + + L L N + I P L L + N ++ L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227
Query: 435 IFLSL------GSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGS---LPIEFYNLQNLSAL 485
L L L+ +L L + F L N+S+
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 486 ELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIP 545
L + + + L L F + ++ +L+ L +SN
Sbjct: 288 SLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAFS 342
Query: 546 HELGNCVNLQRLDLSRNQFT--GSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT 603
+ +L+ LDLSRN + G + +L+ L LS N + + S+ GL +L
Sbjct: 343 --EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE 399
Query: 604 ELQMGGNIFSGSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLI 662
L + L L L+ISH + L LE L + N
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIY-LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 663 GEIPASMGEQMSLLVC-NLSNNNL 685
+ ++ L +LS L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQL 482
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-38
Identities = 92/448 (20%), Positives = 142/448 (31%), Gaps = 66/448 (14%)
Query: 304 IPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLH 363
IP L S +DLS N L P L +L L +Q L+ L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 364 KLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNL-DG 422
L L+ N + F L+ L L + +L IG L L+V+ N +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 423 SIPPHLCMYQKLIFLSLGSNR-----------------------LSGN----IPPGLKTC 455
+P + L L L SN+ LS N I PG
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 456 RSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSG---LIPPEIGKLRNLERLHL 511
L +L L N + ++ L L L F L + L L L +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 512 SENY------FVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFT 565
E ++ I L ++ +F++ S ++ + N Q L+L +F
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG 317
Query: 566 GSAPEELGQLV-------------------NLELLKLSDNKLT--GAIPSSLGGLARLTE 604
+L L +LE L LS N L+ G S G L
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 605 LQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYE-LGNLQMLEALYLDDNQLIG 663
L + N ++ L L+ L+ H+NL + + +L+ L L +
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEH-LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 664 EIPASMGEQMSLLVCNLSNNNLVGTVPN 691
SL V ++ N+
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-26
Identities = 43/236 (18%), Positives = 79/236 (33%), Gaps = 8/236 (3%)
Query: 481 NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSL 540
+ L+L N L L+ L LS +L HL T ++ N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 541 SGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT-GAIPSSLGGL 599
+LQ+L +G L L+ L ++ N + +P L
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 600 ARLTELQMGGNIFSGSIPVALGQLTALQIA---LNISHNNLSGVIPYELGNLQMLEALYL 656
L L + N L L + + L++S N ++ + P ++ L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTL 207
Query: 657 DDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCML 712
+N + + + ++ L + ++G N + D S G L +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGL---EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 69/372 (18%), Positives = 125/372 (33%), Gaps = 70/372 (18%)
Query: 36 SLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDL 95
+ NLE ++ S + + +E +F++ +D + ++ + + L
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE--EFRLAYLDYYLDDIIDLFNC----L 281
Query: 96 PRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENY 155
+ F++ + + D + + L+L + +L +L++L N
Sbjct: 282 TNVSSFSLVSVTIE-RVK-DFSYNFGWQHLELVNCKFGQFPTLKL---KSLKRLTFTSNK 336
Query: 156 IFGEIPEEIGNLTSLEELVIYSNNLT--GAIPASISKLRQLRVIRAGHNSLSGPIPPEIS 213
G E+ +L SLE L + N L+ G S L+ + N + +
Sbjct: 337 G-GNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFL 393
Query: 214 ECEGLEVLGLAQNSLEGFLP-SELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALH 272
E LE L ++L+ S LRNL L + H + SLE+L +
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 273 ENSFSGGLPKE-LGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRE 331
NSF + +L L L DLS+ QL
Sbjct: 454 GNSFQENFLPDIFTELRNLTFL------------------------DLSQCQLE------ 483
Query: 332 LGLIPNLCLLQLFENMLQGSIPRE-LGQLTQLHKLDLSINNLTGTIPLE-FQNLTYLVDL 389
+ L+ L L+++ N L ++P F LT L +
Sbjct: 484 -------------------QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKI 523
Query: 390 QLFDNHLEGTIP 401
L N + + P
Sbjct: 524 WLHTNPWDCSCP 535
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 6e-63
Identities = 102/517 (19%), Positives = 178/517 (34%), Gaps = 76/517 (14%)
Query: 145 TLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSL 204
L++ + + E+P E N+ S E + P + R++ V R
Sbjct: 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL- 69
Query: 205 SGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQ 264
L L L LP +L L+ N L+ E+P +++
Sbjct: 70 ----------DRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLK 114
Query: 265 SLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQL 324
SL + + + S P L+ L V N+L +P EL N + ID+ N L
Sbjct: 115 SLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL 165
Query: 325 TGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLT 384
L P+L + N L+ +P EL L L + N+L +P +L
Sbjct: 166 KKLPD----LPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLE 218
Query: 385 YLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRL 444
+V +N L P + L+ + N L ++P L L++ N L
Sbjct: 219 SIV---AGNNIL--EELPELQNLPFLTTIYADNNLL-KTLPDLPP---SLEALNVRDNYL 269
Query: 445 SGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLR 504
+ ++P ++ L + L+ P NL L N L
Sbjct: 270 T-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRSL----CDLPP 317
Query: 505 NLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQF 564
+LE L++S N + +P+ LE L S N L+ +P NL++L + N
Sbjct: 318 SLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQ---NLKQLHVEYNPL 369
Query: 565 TGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLT 624
P+ + +L + ++ L +P L +L + N P +
Sbjct: 370 R-EFPDIPESVEDLRM----NSHLA-EVPELPQ---NLKQLHVETNPLR-EFPDIPESVE 419
Query: 625 ALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
L ++ + + LE + +
Sbjct: 420 ----DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-57
Identities = 109/515 (21%), Positives = 176/515 (34%), Gaps = 77/515 (14%)
Query: 88 LSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLF------ 141
++PR L E + +T +P + N S + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 142 -------FINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQL 194
+L L + +PE +L E LV N+LT +P L+ L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGL-SSLPELPPHL---ESLVASCNSLT-ELPELPQSLKSL 116
Query: 195 RVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSG 254
V +LS P LE LG++ N LE LP EL+ L + + N L
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK- 166
Query: 255 EIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSA 314
++P + LE +A N LP EL L L +Y N L +P +
Sbjct: 167 KLPDLPPS---LEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLE-- 218
Query: 315 VEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTG 374
I N L EL +P L + N+L+ ++P L L+ D + +L
Sbjct: 219 -SIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL-- 272
Query: 375 TIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKL 434
P Q+LT+L + + L P +L L+ S N + S+ L
Sbjct: 273 --PELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDLP---PSL 319
Query: 435 IFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSG 494
L++ +N+L +P L +L+ N L +P QNL L + N
Sbjct: 320 EELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE 371
Query: 495 LIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNL 554
P + +L +P NL+ L ++ +N L P + +
Sbjct: 372 F-PDIPESVEDLRMNSHLAE-----VPELPQNLKQL---HVETNPLR-EFPDIPES---V 418
Query: 555 QRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
+ L ++ + LE +
Sbjct: 419 EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-43
Identities = 66/357 (18%), Positives = 116/357 (32%), Gaps = 52/357 (14%)
Query: 329 PRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVD 388
PR + L + L +P E + + + + P +
Sbjct: 5 PRNVSNT-FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 389 LQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNI 448
+L D ++ L+++ L S+P L L N L+ +
Sbjct: 63 SRLRDC-----------LDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-EL 106
Query: 449 PPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLER 508
P ++ +SL+ L+ P L L + N+ L PE+ L+
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFLKI 157
Query: 509 LHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSA 568
+ + N +P +LE + +N L EL N L + N
Sbjct: 158 IDVDNNSLK-KLPDLPPSLEFI---AAGNNQL--EELPELQNLPFLTAIYADNNSLK-KL 210
Query: 569 PEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQI 628
P+ +LE + +N L L L LT + N+ ++P L
Sbjct: 211 PDLPL---SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE---- 260
Query: 629 ALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNL 685
ALN+ N L+ +P +L L+ + L P +L N S+N +
Sbjct: 261 ALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEI 309
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-16
Identities = 37/195 (18%), Positives = 70/195 (35%), Gaps = 39/195 (20%)
Query: 519 YIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNL 578
+I + L S++L+ +P E N + + +++ +AP G+ +
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 579 EL-------------LKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTA 625
+ L+L++ L+ ++P L L N + +P L +
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKS 115
Query: 626 LQIALNISHNNLSGVIPY---------------ELGNLQMLEALYLDDNQLIGEIPASMG 670
L + N + LS + P EL N L+ + +D+N L ++P
Sbjct: 116 LLV-DNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPP 173
Query: 671 EQMSLLVCNLSNNNL 685
SL NN L
Sbjct: 174 ---SLEFIAAGNNQL 185
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 3e-62
Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 36/287 (12%)
Query: 804 FSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKL-----RGEGATADNSFLAEISTLGKI 857
IG+G G V+K + + V+A+K + L E F E+ + +
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
H NIVKLYG + ++ E++ G L +L + W + R+ L A G+
Sbjct: 81 NHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIE 136
Query: 918 YLHYDCRPHIIHRDIKSNNILLDE-----EFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
Y+ + P I+HRD++S NI L A V DFGL++ S+S + G++
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGNFQ 191
Query: 973 YIAPE--YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030
++APE A TEK D YSF ++L ++TG+ P E + ++ E
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD--EYSYGKIKFINMIREE---- 245
Query: 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
R + + + +++ C S P RP ++ +
Sbjct: 246 ----GLRPTIP-EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 5e-62
Identities = 110/484 (22%), Positives = 192/484 (39%), Gaps = 43/484 (8%)
Query: 162 EEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVL 221
L + V+ N+T + + L Q+ ++A + + L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 222 GLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLP 281
+ N L + L+ L L D+++ N ++ P + N+ +L L L N +
Sbjct: 74 NFSNNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--I 127
Query: 282 KELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLL 341
L L+ L +L + +N ++ L TS ++ NQ+T P L + L L
Sbjct: 128 DPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-NQVTDLKP--LANLTTLERL 182
Query: 342 QLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIP 401
+ N + S L +LT L L + N ++ PL LT L +L L N L+
Sbjct: 183 DISSNKV--SDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--I 236
Query: 402 PHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQL 461
+ ++L+ LD++ N + P L KL L LG+N++S L +L L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNL 292
Query: 462 MLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIP 521
L +NQL PI NL+NL+ L LY N S + P + L L+RL N
Sbjct: 293 ELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--V 346
Query: 522 SEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELL 581
S + NL ++ + N +S P L N + +L L+ +T + + +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 582 KLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLT---ALQIALNISHNNLS 638
K L P+++ TE + N+ S +++ + + + S
Sbjct: 405 KNVTGALI--APATISDGGSYTEPDITWNLPSY-----TNEVSYTFSQPVTIGKGTTTFS 457
Query: 639 GVIP 642
G +
Sbjct: 458 GTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-61
Identities = 102/444 (22%), Positives = 161/444 (36%), Gaps = 36/444 (8%)
Query: 242 LTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELN 301
L + Q+ +I + L + + + L ++ L +
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI- 58
Query: 302 GTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQ 361
+ + +I+ S NQLT P L + L + + N + P L LT
Sbjct: 59 -KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113
Query: 362 LHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLD 421
L L L N +T PL+ NLT L L+L N + + + + L L N +
Sbjct: 114 LTGLTLFNNQITDIDPLK--NLTNLNRLELSSNTI--SDISALSGLTSLQQLSFG-NQVT 168
Query: 422 GSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQN 481
P L L L + SN++S L +L L+ NQ++ P+ L N
Sbjct: 169 DLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLG--ILTN 222
Query: 482 LSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLS 541
L L L N+ + + L NL L L+ N P + L L + +N +S
Sbjct: 223 LDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 542 GTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLAR 601
P L L L+L+ NQ + L NL L L N ++ P + L +
Sbjct: 279 NISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTK 332
Query: 602 LTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
L L N S L LT + L+ HN +S + P L NL + L L+D
Sbjct: 333 LQRLFFYNNKVSDVSS--LANLTNINW-LSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 662 IGEIPASMGEQMSLLVCNLSNNNL 685
P + +S+ +
Sbjct: 388 TN-APVNYKANVSIPNTVKNVTGA 410
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 6e-61
Identities = 99/481 (20%), Positives = 187/481 (38%), Gaps = 36/481 (7%)
Query: 116 LANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVI 175
+ L + + + + L I + + + L +L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVSQTDL--DQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 176 YSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSE 235
+N LT P + L +L I +N ++ P ++ L L L N +
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDP 129
Query: 236 LEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYV 295
L+ L NL L L N +S + + SL+ L+ K L L+ L++L +
Sbjct: 130 LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDI 184
Query: 296 YTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRE 355
+N++ + L T+ + + NQ++ P LG++ NL L L N L+
Sbjct: 185 SSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGT 238
Query: 356 LGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDV 415
L LT L LDL+ N ++ PL LT L +L+L N + P + + L+ L++
Sbjct: 239 LASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISP--LAGLTALTNLEL 294
Query: 416 SMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE 475
+ N L+ P + + L +L+L N +S P + + L +L N+++
Sbjct: 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSS 348
Query: 476 FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNI 535
NL N++ L N+ S L P + L + +L L++ + + N+ T
Sbjct: 349 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKN 406
Query: 536 SSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSS 595
+ +L P + + + D++ N + E + +G +
Sbjct: 407 VTGAL--IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQP 463
Query: 596 L 596
L
Sbjct: 464 L 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-43
Identities = 77/381 (20%), Positives = 144/381 (37%), Gaps = 28/381 (7%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRL 132
+T + L ++ I + +L L +S N ++ + L+ +SL+ L N++
Sbjct: 113 NLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQV 167
Query: 133 HGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLR 192
+ P TL +L + N + + LT+LE L+ +N ++ P + L
Sbjct: 168 TDLKPLANL--TTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILT 221
Query: 193 QLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHL 252
L + N L ++ L L LA N + + L L LT+L L N +
Sbjct: 222 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQI 277
Query: 253 SGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCT 312
S P + + +L L L+EN + L L L +Y N ++ P + + T
Sbjct: 278 SNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLT 331
Query: 313 SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNL 372
+ N+++ L + N+ L N + P L LT++ +L L+
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 373 TGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQ 432
T N++ ++ L P I + D++ N +
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFS 444
Query: 433 KLIFLSLGSNRLSGNIPPGLK 453
+ + + G+ SG + LK
Sbjct: 445 QPVTIGKGTTTFSGTVTQPLK 465
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (540), Expect = 3e-61
Identities = 65/321 (20%), Positives = 111/321 (34%), Gaps = 45/321 (14%)
Query: 792 FKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAE- 850
N +IGRG G VYK +L + +AVK +F+ E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-----QNFINEK 56
Query: 851 -ISTLGKIRHRNIVKLYGFCYHQDSN-----LLLYEYMENGSLGEQLHGNKQTCLLDWDA 904
I + + H NI + ++ LL+ EY NGSL + L + DW +
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVS 112
Query: 905 RYRIALGAAEGLCYLHYD------CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID- 957
R+A GL YLH + +P I HRD+ S N+L+ + + DFGL+ +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 958 ------LPYSKSMSAIAGSYGYIAPEYA-------YTMKVTEKCDIYSFGVVLLELITGK 1004
+ + G+ Y+APE ++ D+Y+ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 1005 S------PVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTL--FLKIA 1056
+ V ++ + +M +R + + +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 1057 LFCSSTSPLNRPTMREVIAMM 1077
C R T + M
Sbjct: 293 EDCWDQDAEARLTAQXAEERM 313
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-60
Identities = 75/288 (26%), Positives = 132/288 (45%), Gaps = 37/288 (12%)
Query: 803 NFSE---GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATAD--NSFLAEISTLGKI 857
+F+E +IG G G VY+A G+ +AVK + + + + E +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
+H NI+ L G C + + L+ E+ G L L G + + D A+ A G+
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMN 119
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAH--------VGDFGLAKLIDLPYSKSMSAIAG 969
YLH + IIHRD+KS+NIL+ ++ + + DFGLA+ + + + AG
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAG 176
Query: 970 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029
+Y ++APE ++ D++S+GV+L EL+TG+ P + ++ G + V +
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAMN------ 229
Query: 1030 TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
L + T E F K+ C + P +RP+ ++ +
Sbjct: 230 -----KLALPIP--STCPEP--FAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 8e-60
Identities = 78/309 (25%), Positives = 121/309 (39%), Gaps = 47/309 (15%)
Query: 807 GAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
G V+G+G G K T GEV+ +K++ E FL E+ + + H N++K
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHPNVLKF 72
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
G Y + EY++ G+L + W R A A G+ YLH
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SM 127
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLID-------------LPYSKSMSAIAGSYG 972
+IIHRD+ S+N L+ E V DFGLA+L+ P K + G+
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSL-----ELGGDLVTWVRRSIHEM 1027
++APE EK D++SFG+VL E+I + + G ++ ++ R
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN 247
Query: 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV-SD 1086
P S F I + C P RP+ ++ + R +
Sbjct: 248 CPPS--------------------FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
Query: 1087 YPSSPTSET 1095
P P E
Sbjct: 288 LPLGPQLEQ 296
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-59
Identities = 79/283 (27%), Positives = 122/283 (43%), Gaps = 40/283 (14%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
G IG G+ GTVYK +G+V AVK + + +F E+ L K RH NI+
Sbjct: 29 GQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 867 GFCYHQDSNLLLY---EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC 923
G+ L ++ E SL LH ++ + IA A G+ YLH
Sbjct: 87 GYSTAPQ----LAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLH--- 137
Query: 924 RPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY-SKSMSAIAGSYGYIAPE---YA 979
IIHRD+KSNNI L E+ +GDFGLA S ++GS ++APE
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWV-----RRSIHEMVPTSELF 1034
+ + + D+Y+FG+VL EL+TG+ P ++ D + + V ++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSN--C 254
Query: 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
KR+ ++ C RP+ ++A +
Sbjct: 255 PKRM--------------KRLMAECLKKKRDERPSFPRILAEI 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-59
Identities = 63/291 (21%), Positives = 117/291 (40%), Gaps = 40/291 (13%)
Query: 803 NFSE---GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH 859
F + G +IG+G G VY +GEV A++ I + + +F E+ + RH
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 860 RNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
N+V G C ++ + +L + K LD + +IA +G+ YL
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYL 146
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY----SKSMSAIAGSYGYIA 975
H I+H+D+KS N+ D + + DFGL + + + G ++A
Sbjct: 147 H---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 976 PE---------YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026
PE + ++ D+++ G + EL + P ++ +I
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---------AIIW 253
Query: 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
+ + +LS +E++ I LFC + RPT +++ M+
Sbjct: 254 QM----GTGMKPNLSQIGMGKEIS---DILLFCWAFEQEERPTFTKLMDML 297
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-59
Identities = 57/283 (20%), Positives = 102/283 (36%), Gaps = 33/283 (11%)
Query: 803 NFSE---GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH 859
+F + + G ++K G I VK +K+R F E L H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 860 RNIVKLYGFCYHQDSNLL--LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
N++ + G C + + +M GSL LH ++D + AL A G+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMA 125
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
+LH P I + S ++++DE+ A + + S + ++APE
Sbjct: 126 FLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPE 178
Query: 978 ---YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034
D++SF V+L EL+T + P L ++ V
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALE----------- 226
Query: 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
R + ++ +KI C + P RP ++ ++
Sbjct: 227 GLRPTIP-PGISPHVSKLMKI---CMNEDPAKRPKFDMIVPIL 265
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-55
Identities = 71/295 (24%), Positives = 117/295 (39%), Gaps = 34/295 (11%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAE--ISTLGKIRHRNIVK 864
+G+G G V++ + GE +AVK R E S+ E + +RH NI+
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE-----KSWFRETELYNTVMLRHENILG 66
Query: 865 LYGFCYHQDSNLLLY----EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+ Y E GSL + L LD + RI L A GL +LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLH 122
Query: 921 YD-----CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK---SMSAIAGSYG 972
+ +P I HRD+KS NIL+ + Q + D GLA + ++ + G+
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 973 YIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSP---VQSLELGGDLVTWVRRS 1023
Y+APE ++ DI++FG+VL E+ V+ + V S
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 1024 IHEMVPTSELFDKRLDL-SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
+M + +R ++ + + +T K+ C +P R T + +
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-55
Identities = 71/295 (24%), Positives = 119/295 (40%), Gaps = 34/295 (11%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAE--ISTLGKIRHRNIVK 864
IG+G G V++ GE +AVK R E S+ E I +RH NI+
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILG 100
Query: 865 LYGFCYHQDSN----LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+ L+ +Y E+GSL + L+ + + ++AL A GL +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLH 156
Query: 921 YD-----CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK---SMSAIAGSYG 972
+ +P I HRD+KS NIL+ + + D GLA D + + G+
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 973 YIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSP---VQSLELGGDLVTWVRRS 1023
Y+APE + ++ DIY+ G+V E+ S + +L + S
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 1024 IHEMVPTSELFDKRLDL-SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
+ EM R ++ + ++ E + + KI C + R T + +
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-55
Identities = 69/355 (19%), Positives = 136/355 (38%), Gaps = 26/355 (7%)
Query: 284 LGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQL 343
L+ + + + + S ++ ++ ++ + + NL L L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQG--IEYLTNLEYLNL 73
Query: 344 FENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPH 403
N + P L L +L L + N +T QNLT L +L L ++++
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISP 127
Query: 404 IGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLML 463
+ + + L++ N+ S L L +L++ +++ + L L L
Sbjct: 128 LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSL 184
Query: 464 GQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSE 523
NQ+ P+ +L +L Y N+ + + P + + L L + N P
Sbjct: 185 NYNQIEDISPLA--SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238
Query: 524 VGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKL 583
+ NL L I +N +S + + + L+ L++ NQ + L L L L L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 584 SDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLS 638
++N+L +GGL LT L + N + P L L+ + + ++ +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS-ADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-55
Identities = 81/396 (20%), Positives = 150/396 (37%), Gaps = 52/396 (13%)
Query: 290 LKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349
L +N P + + L + +T + + ++ L + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 350 GSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSH 409
SI + LT L L+L+ N +T PL NL L +L + N + T + ++
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 410 LSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLT 469
L L ++ +N+ P L K+ L+LG+N ++ P L L L + ++++
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVK 168
Query: 470 GSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEH 529
PI NL +L +L L N+ + P + L +L N P V N+
Sbjct: 169 DVTPIA--NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 530 LVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
L + I +N ++ P L N L L++ NQ + + L L++L + N+++
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 590 GAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQ 649
S L L++L L +++N L +G L
Sbjct: 279 D--ISVLNNLSQLNSL-------------------------FLNNNQLGNEDMEVIGGLT 311
Query: 650 MLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNL 685
L L+L N + P + + + +N +
Sbjct: 312 NLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 7e-55
Identities = 90/369 (24%), Positives = 150/369 (40%), Gaps = 27/369 (7%)
Query: 242 LTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELN 301
L ++ +I P ++ L + S + +L + KL V ++
Sbjct: 2 AATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 302 GTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQ 361
+I + T+ ++L+ NQ+T P L + L L + N + + L LT
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 362 LHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLD 421
L +L L+ +N++ PL NLT + L L NH + + + L+ L V+ + +
Sbjct: 112 LRELYLNEDNISDISPLA--NLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168
Query: 422 GSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQN 481
P + L LSL N++ P L + SL NQ+T P+ N+
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVA--NMTR 222
Query: 482 LSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLS 541
L++L++ N+ + L P + L L L + N + V +L L N+ SN +S
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 542 GTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLAR 601
L N L L L+ NQ E +G L NL L LS N +T P L L++
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334
Query: 602 LTELQMGGN 610
+
Sbjct: 335 MDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-52
Identities = 82/369 (22%), Positives = 145/369 (39%), Gaps = 27/369 (7%)
Query: 146 LRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLS 205
L I +I +L V+ ++T + +L + + ++
Sbjct: 2 AATLATLPAPI-NQI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 206 GPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQS 265
I LE L L N + S L L LT+L + N ++ + N+ +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 266 LELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLT 325
L L L+E++ S L L+++ L + N + L N T + ++E+++
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVK 168
Query: 326 GFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTY 385
P + + +L L L N ++ P L LT LH +N +T P+ N+T
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVA--NMTR 222
Query: 386 LVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLS 445
L L++ +N + P + S L+ L++ N + S + KL L++GSN++S
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQIS 278
Query: 446 GNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRN 505
L L L L NQL L NL+ L L QN + + P + L
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334
Query: 506 LERLHLSEN 514
++ +
Sbjct: 335 MDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 9e-47
Identities = 71/348 (20%), Positives = 142/348 (40%), Gaps = 25/348 (7%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRL 132
+ L +++ +++ +L + + ++ V SI + ++LE L+L N++
Sbjct: 23 EGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQI 78
Query: 133 HGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLR 192
+ P L LY+ N I + NLT+L EL + +N++ P ++ L
Sbjct: 79 TDISPLSNL--VKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLT 132
Query: 193 QLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHL 252
++ + G N +S GL L + ++ ++ + + L +L L L N +
Sbjct: 133 KMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDV--TPIANLTDLYSLSLNYNQI 189
Query: 253 SGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCT 312
P + ++ SL + N + + ++RL L + N++ P L N +
Sbjct: 190 EDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLS 243
Query: 313 SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNL 372
+++ NQ++ + + L +L + N + S L L+QL+ L L+ N L
Sbjct: 244 QLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQL 299
Query: 373 TGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNL 420
LT L L L NH+ P + S + D + +
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 5e-20
Identities = 38/179 (21%), Positives = 68/179 (37%), Gaps = 12/179 (6%)
Query: 75 TSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHG 134
S+ L+ + I + L L F +N +T P +AN + L L + N++
Sbjct: 180 YSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
Query: 135 VIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQL 194
+ P ++ L L + N I + +LT L+ L + SN ++ + ++ L QL
Sbjct: 236 LSPLA--NLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQL 289
Query: 195 RVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLS 253
+ +N L I L L L+QN + L L + +
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI--RPLASLSKMDSADFANQVIK 346
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-55
Identities = 71/295 (24%), Positives = 116/295 (39%), Gaps = 34/295 (11%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFL--AEISTLGKIRHRNIVK 864
IG+G G V+ GE +AVK E S+ EI +RH NI+
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILG 95
Query: 865 LYGFCYHQDSN----LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+ L+ +Y ENGSL + L LD + ++A + GLC+LH
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLH 151
Query: 921 YD-----CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK---SMSAIAGSYG 972
+ +P I HRD+KS NIL+ + + D GLA ++ + G+
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 973 YIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSP---VQSLELGGDLVTWVRRS 1023
Y+ PE + D+YSFG++L E+ V+ +L + S
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 1024 IHEMVPTSELFDKRLDLSAKRTVEE-MTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
+M + R + + +E + K+ C + +P +R T V +
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-54
Identities = 95/554 (17%), Positives = 182/554 (32%), Gaps = 55/554 (9%)
Query: 118 NCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYS 177
+C + + D + IP L ++ L L N I ++ +L+ L++ S
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 178 NNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPE-ISECEGLEVLGLAQNSLEGF-LPSE 235
+ + + L L + N LS + L+ L L N + + S
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 236 LEKLRNLTDLILWQNHLSGEIPP-TIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLY 294
L NL L + EI + SL L + S + L + + L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 295 VYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPR 354
++ +E + +S ++L + L F L + ++
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 355 ELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLD 414
+L +L + L ++ +EF + T + + + L
Sbjct: 239 SFNELLKLLRYILELSE------VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292
Query: 415 VSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSL- 472
+ L + + +K+ +++ ++++ +P + +SL L L +N +
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYL 351
Query: 473 --PIEFYNLQNLSALELYQNRFSGL--IPPEIGKLRNLERLHLSENYFVGYIPSEVGNLE 528
+L L L QN + + L+NL L +S N F +P E
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPE 410
Query: 529 HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588
+ N+SS + + + L+ LD+S N + L L+ L +S NKL
Sbjct: 411 KMRFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNNNLDSFSLF----LPRLQELYISRNKL 463
Query: 589 TGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNL 648
++P L + + IS N L V L
Sbjct: 464 K-------------------------TLP-DASLFPVLLV-MKISRNQLKSVPDGIFDRL 496
Query: 649 QMLEALYLDDNQLI 662
L+ ++L N
Sbjct: 497 TSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-46
Identities = 95/543 (17%), Positives = 185/543 (34%), Gaps = 69/543 (12%)
Query: 74 VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
+ S+DL ++ I + L + + + + SLE LDL N L
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 134 GVIPFQLFFINTLRKLYLCENYIFG-EIPEEIGNLTSLEELVIYSNNLTGAIPA-SISKL 191
+ +++L+ L L N + NLT+L+ L I + I + L
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 192 RQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
L + SL + + L L + L + L ++ L L +
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 252 LSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNC 311
L+ + + + S + +L +L + + +E+
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE---------- 257
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINN 371
D + N L F P E ++ L + + + +L +
Sbjct: 258 ----FDDCTLNGLGDFNPSESDVVSELGKV----------------ETVTIRRLHIPQFY 297
Query: 372 LTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDGSIPPHLCM 430
L + + L + + + ++ + +P + L LD+S N
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSEN------------ 344
Query: 431 YQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE---FYNLQNLSALEL 487
++ L ++ G P SL L+L QN L S+ L+NL++L++
Sbjct: 345 --LMVEEYLKNSACKGAWP-------SLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDI 394
Query: 488 YQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE 547
+N F +P + L+LS + + + L ++S+N+L +
Sbjct: 395 SRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLF 449
Query: 548 LGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQM 607
L LQ L +SRN+ + L ++K+S N+L L L ++ +
Sbjct: 450 L---PRLQELYISRNKLK--TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504
Query: 608 GGN 610
N
Sbjct: 505 HTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-42
Identities = 86/482 (17%), Positives = 153/482 (31%), Gaps = 32/482 (6%)
Query: 79 LHGLNLSG----ILSPRICD-LPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
L L L + L L ++S N ++ + SSL+ L+L N
Sbjct: 52 LQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
Query: 134 GVIPFQLF-FINTLRKLYLCENYIFGEIPEE-IGNLTSLEELVIYSNNLTGAIPASISKL 191
+ LF + L+ L + F EI LTSL EL I + +L S+ +
Sbjct: 112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171
Query: 192 RQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
R + + + + + + L L +L F S L + +
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231
Query: 252 LSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNC 311
S + + L L + + +E +
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVET 285
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQ-LTQLHKLDLSIN 370
+ + + + L + L+ + + + + + +P Q L L LDLS N
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSEN 344
Query: 371 NLTGTI---PLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLS---VLDVSMNNLDGSI 424
+ L L L NHL ++ + L LD+S N +
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTF-HPM 402
Query: 425 PPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSA 484
P +K+ FL+L S + + + +L L + N L S + LQ L
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNNNLD-SFSLFLPRLQELY- 457
Query: 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544
+ +N+ L P+ L + +S N L L + +N +
Sbjct: 458 --ISRNKLKTL--PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513
Query: 545 PH 546
P
Sbjct: 514 PR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-41
Identities = 70/428 (16%), Positives = 133/428 (31%), Gaps = 18/428 (4%)
Query: 265 SLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQL 324
+++ L L N + +L + L+ L + ++ +N + S +DLS+N L
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 325 TGFIPRELGLIPNLCLLQLFENMLQG-SIPRELGQLTQLHKLDLSINNLTGTIPLE-FQN 382
+ G + +L L L N Q + LT L L + I F
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 383 LTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSN 442
LT L +L++ L + + L + ++ + + + +L L
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 443 RLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGK 502
L+ L + + + F L L L E
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL------LRYILELSEVEFDD 260
Query: 503 LRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRN 562
+ + + +I L + ++R+ + +
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 563 QFTGSAPEELGQLVNLELLKLSDNKLTGAI---PSSLGGLARLTELQMGGNIFS--GSIP 617
+ L +LE L LS+N + + G L L + N
Sbjct: 321 KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380
Query: 618 VALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLV 677
L L L L+IS N +P + + L L + + + + + +L
Sbjct: 381 EILLTLKNLTS-LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI-RVVKTCIPQTLEVL- 436
Query: 678 CNLSNNNL 685
++SNNNL
Sbjct: 437 -DVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-31
Identities = 71/408 (17%), Positives = 136/408 (33%), Gaps = 48/408 (11%)
Query: 310 NCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSI 369
+C ++ D T IP GL + L L N + +L L L L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 370 NNLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPH-IGVNSHLSVLDVSMNNLDGSIPPH 427
+ + TI + F +L L L L DNHL ++ G S L L++ N ++
Sbjct: 60 SRIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVT 116
Query: 428 LCMYQ--KLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSA 484
L L +G+ I SL +L + L +++++
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176
Query: 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544
L L+ + + L+ L ++ L L + + S + E + S
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 545 PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTE 604
+ L R L L +E + N L PS ++ L +
Sbjct: 237 DESFNELLKLLRYILE--------------LSEVEFDDCTLNGLGDFNPSESDVVSELGK 282
Query: 605 LQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGE 664
++ ++ L+I L + L+ ++ + +++++ +
Sbjct: 283 VE----------------TVTIRR-LHIPQFYLFYDLSTVYSLLEKVKRITVENSK-VFL 324
Query: 665 IPASMGEQM-SLLVCNLSNNNLVGTVPNTTVFRRIDSS----NFAGNR 707
+P S + + SL +LS N +V + + S + N
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-27
Identities = 70/424 (16%), Positives = 126/424 (29%), Gaps = 71/424 (16%)
Query: 75 TSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHG 134
+++ L+L S + + + + ++ + SS+ L+L L
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
Query: 135 VIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQL 194
L + E L L ++ + +
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCTLN 264
Query: 195 RVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSG 254
+ + E + L + Q L L + L + + + + +
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF- 323
Query: 255 EIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSA 314
+ + L L+ L
Sbjct: 324 ---------------LVPCSFSQH--------LKSLEFL--------------------- 339
Query: 315 VEIDLSENQLTGFIPRE---LGLIPNLCLLQLFENMLQGSIPRELG---QLTQLHKLDLS 368
DLSEN + + G P+L L L +N L+ S+ + L L LD+S
Sbjct: 340 ---DLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDIS 395
Query: 369 INNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHL 428
N +P Q + L L + + + L VLDVS NNLD S L
Sbjct: 396 RNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFL 450
Query: 429 CMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488
+L L + N+L +P L+ + + +NQL F L +L + L+
Sbjct: 451 ---PRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505
Query: 489 QNRF 492
N +
Sbjct: 506 TNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 38/210 (18%), Positives = 73/210 (34%), Gaps = 17/210 (8%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSI---PTDLANCSSLEILDLCT 129
KV + + + + L L ++S N + SL+ L L
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 130 NRLHGVIPFQLFFIN--TLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPAS 187
N L + + L L + N +P+ + L + S + +
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTC 428
Query: 188 ISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLIL 247
I + L V+ +N+L + L+ L +++N L+ LP L + +
Sbjct: 429 I--PQTLEVLDVSNNNLDS-FSLFLPR---LQELYISRNKLK-TLPDAS-LFPVLLVMKI 480
Query: 248 WQNHLSGEIPP-TIGNIQSLELLALHENSF 276
+N L +P + SL+ + LH N +
Sbjct: 481 SRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-52
Identities = 109/584 (18%), Positives = 190/584 (32%), Gaps = 54/584 (9%)
Query: 77 VDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVI 136
NL+ + L +S N++ + L++L+L + I
Sbjct: 9 AFYRFCNLTQVPQ----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 137 PFQLF-FINTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAI--PASISKLR 192
+ F + LR L L + I + + L L EL +Y L+ A+ L+
Sbjct: 65 DKEAFRNLPNLRILDLGSSKI-YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 193 QLRVIRAGHNSLSG-PIPPEISECEGLEVLGLAQNSLEGFLPSELEKLR--NLTDLILWQ 249
L + N + + P + L+ + + N + ELE L+ L+ L
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 250 NHLSGEIPPTIGN-IQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL 308
N L + G + + L SG + ++N ++ + L
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSL 236
Query: 309 GNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFE-----NMLQGSIPRELGQLTQLH 363
+ + + + L + + R L L
Sbjct: 237 ILAHHIMGAGFGFHNIKDP---DQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLK 293
Query: 364 KLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDG 422
L+L+ N + F L L L L N L + ++ +D+ N++
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAI 352
Query: 423 SIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNL 482
+KL L L N L+ + S+ + L N+L +LP +
Sbjct: 353 IQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLV-TLPKINLTANLI 406
Query: 483 SALELYQNRFSGL-IPPEIGKLRNLERLHLSENYFVGYIPSEV--GNLEHLVTFNISSNS 539
L +NR L I + ++ +L+ L L++N F + L + N
Sbjct: 407 H---LSENRLENLDILYFLLRVPHLQILILNQNRF-SSCSGDQTPSENPSLEQLFLGENM 462
Query: 540 LSGTIPHEL-----GNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPS 594
L EL +LQ L L+ N P L L L L+ N+LT +
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHN 522
Query: 595 SLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLS 638
L A L L + N P L+ L+I+HN
Sbjct: 523 DL--PANLEILDISRNQLLAPNPDVFVSLS----VLDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 6e-50
Identities = 118/563 (20%), Positives = 204/563 (36%), Gaps = 41/563 (7%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTD-LANCSSLEILDLCTNR 131
+ L + + + L +L + + +I + N +L ILDL +++
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84
Query: 132 LHGVIPFQLFFINTLRKLYLCENYIFGEI--PEEIGNLTSLEELVIYSNNLTG-AIPASI 188
++ + P + L +L L + + NL +L L + N + + S
Sbjct: 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSF 144
Query: 189 SKLRQLRVIRAGHNSLSGPIPPEISECEG--LEVLGLAQNSLEGFLPSELEKLRN-LTDL 245
KL L+ I N + E+ +G L LA NSL + + K N ++
Sbjct: 145 GKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204
Query: 246 ILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIP 305
+L +S GN ++++ N+ S L + + +
Sbjct: 205 VLEILDVS-------GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPD 256
Query: 306 HEL--GNCTSAVE-IDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQL 362
G S+V +DLS + R + +L +L L N + L L
Sbjct: 257 QNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNL 316
Query: 363 HKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLD 421
L+LS N L F L + + L NH+ I L LD+ N L
Sbjct: 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNAL- 374
Query: 422 GSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTG-SLPIEFYNLQ 480
+ + + L N+L +P K + + L +N+L + +
Sbjct: 375 ----TTIHFIPSIPDIFLSGNKLV-TLP---KINLTANLIHLSENRLENLDILYFLLRVP 426
Query: 481 NLSALELYQNRFSGLIPPEI-GKLRNLERLHLSENYFVGYIPSEV-----GNLEHLVTFN 534
+L L L QNRFS + + +LE+L L EN +E+ L HL
Sbjct: 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486
Query: 535 ISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPS 594
++ N L+ P + L+ L L+ N+ T + +L NLE+L +S N+L P
Sbjct: 487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPD 544
Query: 595 SLGGLARLTELQMGGNIFSGSIP 617
L+ L + N F
Sbjct: 545 V---FVSLSVLDITHNKFICECE 564
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-46
Identities = 114/583 (19%), Positives = 198/583 (33%), Gaps = 97/583 (16%)
Query: 159 EIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEI-SECEG 217
++P+ L + E L++ N + +S L QL+++ G I E
Sbjct: 18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 218 LEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPP--TIGNIQSLELLALHENS 275
L +L L + + P + L +L +L L+ LS + N+++L L L +N
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134
Query: 276 FSG-GLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSA--VEIDLSENQLTGFIPREL 332
L GKL+ LK + +N++ HEL L+ N L + +
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194
Query: 333 GLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLF 392
G N F NM L LD+S N T I F
Sbjct: 195 GKCMNP-----FRNM-------------VLEILDVSGNGWTVDIT------------GNF 224
Query: 393 DNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL 452
N + + + + H+ +N+ N +G +
Sbjct: 225 SNAISKSQAFSLILAHHIMGAGFGFHNIK----------------DPDQNTFAGLARSSV 268
Query: 453 KTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLS 512
+ L L + F L++L L L N+ + + L NL+ L+LS
Sbjct: 269 RH------LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS 322
Query: 513 ENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEEL 572
N S L + ++ N ++ LQ LDL N T +
Sbjct: 323 YNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TI 377
Query: 573 GQLVNLELLKLSDNKLTG---------------------AIPSSLGGLARLTELQMGGNI 611
+ ++ + LS NKL I L + L L + N
Sbjct: 378 HFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNR 437
Query: 612 FSG-SIPVALGQLTALQIALNISHNNLSGVIPYEL-----GNLQMLEALYLDDNQLIGEI 665
FS S + +L+ L + N L EL L L+ LYL+ N + +
Sbjct: 438 FSSCSGDQTPSENPSLEQ-LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY-LNSL 495
Query: 666 PASMGEQM-SLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNR 707
P + + +L +L++N L + + + ++ + + N+
Sbjct: 496 PPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQ 537
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-38
Identities = 76/455 (16%), Positives = 149/455 (32%), Gaps = 33/455 (7%)
Query: 250 NHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHE-L 308
+L+ ++P + + E L L N L +L+ L + + TI E
Sbjct: 14 CNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAF 69
Query: 309 GNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSI--PRELGQLTQLHKLD 366
N + +DL +++ P + +L L+L+ L ++ L L +LD
Sbjct: 70 RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLD 129
Query: 367 LSINNLTG-TIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGV--NSHLSVLDVSMNNLDGS 423
LS N + + F L L + N + + LS ++ N+L
Sbjct: 130 LSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSR 189
Query: 424 IPPHLC-MYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNL 482
+ + L +SGN ++ N ++ S ++
Sbjct: 190 VSVDWGKCMNPFRNMVLEILDVSGN-------GWTVDITGNFSNAISKSQAFSLILAHHI 242
Query: 483 SALELYQNRFSGLIPPEIGKLR--NLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNS 539
+ L ++ L LS + + S V L+ L N++ N
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNK 301
Query: 540 LSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599
++ NLQ L+LS N L + + L N + + L
Sbjct: 302 INKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361
Query: 600 ARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
+L L + N + + + ++ + +S N L + L ++L +N
Sbjct: 362 EKLQTLDLRDNALT-----TIHFIPSIPD-IFLSGNKLVTLPKINLT----ANLIHLSEN 411
Query: 660 QLIGEIPASMGEQM-SLLVCNLSNNNLVGTVPNTT 693
+L ++ L + L+ N + T
Sbjct: 412 RLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT 446
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-25
Identities = 82/466 (17%), Positives = 150/466 (32%), Gaps = 44/466 (9%)
Query: 22 FSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDFKVTSVDLHG 81
+ +L+ SL + + N + V + V
Sbjct: 168 LEPLQGKTLSF--FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS 225
Query: 82 LNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLAN--CSSLEILDLCTNRLHGVIPFQ 139
+S + + ++ + + A SS+ LDL + +
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV 285
Query: 140 LFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRA 199
+ L+ L L N I E L +L+ L + N L ++ L ++ I
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345
Query: 200 GHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPT 259
N ++ E L+ L L N+L + + + ++ D+ L N L +P
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPK- 398
Query: 260 IGNIQSLELLALHENSFSG-GLPKELGKLSRLKKLYVYTNELNGTIPHEL-GNCTSAVEI 317
+ L+ L EN + L ++ L+ L + N + + S ++
Sbjct: 399 --INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456
Query: 318 DLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIP 377
L EN L EL L+ L L L+ N L P
Sbjct: 457 FLGENMLQLAWETELC-------------------WDVFEGLSHLQVLYLNHNYLNSLPP 497
Query: 378 LEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFL 437
F +LT L L L N L + + + ++L +LD+S N L + P ++ L L
Sbjct: 498 GVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPD--VFVSLSVL 552
Query: 438 SLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLS 483
+ N+ + + + N P + Y + S
Sbjct: 553 DITHNKFICECEL-----STFINWLNHTNVTIAGPPADIYCVYPDS 593
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-24
Identities = 56/296 (18%), Positives = 91/296 (30%), Gaps = 35/296 (11%)
Query: 407 NSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQ 465
+ + NL +P L L L N + + L L LG
Sbjct: 3 SFDGRIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGS 57
Query: 466 NQLTGSLPIE-FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYI--PS 522
++ E F NL NL L+L ++ L P L +L L L +
Sbjct: 58 QYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDG 117
Query: 523 EVGNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQRLDLSRNQFTGSAPEELGQL--VNLE 579
NL+ L ++S N + H G +L+ +D S NQ EL L L
Sbjct: 118 YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS 177
Query: 580 LLKLSDNKLTGAIPSSLGGLA------RLTELQMGGNIFSGSIPVALGQLTALQIALNIS 633
L+ N L + G L L + GN ++
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT-------------VDITGNF 224
Query: 634 HNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASM---GEQMSLLVCNLSNNNLV 686
N +S + L + + I + + + S+ +LS+ +
Sbjct: 225 SNAISKSQAFSLILAHHIMGAGFGFHN-IKDPDQNTFAGLARSSVRHLDLSHGFVF 279
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-22
Identities = 81/375 (21%), Positives = 134/375 (35%), Gaps = 25/375 (6%)
Query: 74 VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
V +DL + + S L L N++ N + +L++L+L N L
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
Query: 134 GVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQ 193
+ + + + + L +N+I + L L+ L + N LT +I +
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPS 382
Query: 194 LRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSE-LEKLRNLTDLILWQNHL 252
+ I N L ++ ++ L++N LE L ++ +L LIL QN
Sbjct: 383 IPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF 438
Query: 253 SGEIPP--TIGNIQSLELLALHENSFSGGLPKEL-----GKLSRLKKLYVYTNELNGTIP 305
S T SLE L L EN EL LS L+ LY+ N LN P
Sbjct: 439 S-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPP 497
Query: 306 HELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKL 365
+ T+ + L+ N+LT L NL +L + N L P L L
Sbjct: 498 GVFSHLTALRGLSLNSNRLTVLSHN--DLPANLEILDISRNQLLAPNPD---VFVSLSVL 552
Query: 366 DLSINNLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSI 424
D++ N L F N ++ + + S +S+ +S D
Sbjct: 553 DITHNKFICECELSTFINWLNHTNVTIAGPP-ADIYCVYPDSFSGVSLFSLSTEGCDEEE 611
Query: 425 PPHLCMYQKLIFLSL 439
+ I ++
Sbjct: 612 VLKSLKFSLFIVCTV 626
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 28/161 (17%), Positives = 40/161 (24%), Gaps = 52/161 (32%)
Query: 536 SSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSS 595
+L+ +P L +RL LS N L L+LL+L I
Sbjct: 12 RFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67
Query: 596 LGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALY 655
A L L+I L++ + + + P L L L
Sbjct: 68 -----------------------AFRNLPNLRI-LDLGSSKIYFLHPDAFQGLFHLFEL- 102
Query: 656 LDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFR 696
L L V FR
Sbjct: 103 -----------------------RLYFCGLSDAVLKDGYFR 120
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-51
Identities = 63/332 (18%), Positives = 100/332 (30%), Gaps = 27/332 (8%)
Query: 260 IGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDL 319
+ E L ++ L + R N +
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETR 63
Query: 320 SENQLTGFIPRELGLI--PNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIP 377
+ L L P L+L L P + +L+ L + + L +P
Sbjct: 64 TGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP 120
Query: 378 LEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFL 437
Q L L L N L +P I + L L + +P L
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA-------- 171
Query: 438 SLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIP 497
S + + +L L L + SLP NLQNL +L++ + S L
Sbjct: 172 -------STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-G 222
Query: 498 PEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRL 557
P I L LE L L + P G L + S T+P ++ L++L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282
Query: 558 DLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
DL P + QL ++ + +
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-50
Identities = 59/338 (17%), Positives = 103/338 (30%), Gaps = 28/338 (8%)
Query: 350 GSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSH 409
GS + L + + H NS+
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-----NSN 56
Query: 410 LSVLDVSMNNLDGSIPPHL--CMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQ 467
++ + L + L L S L P L + +
Sbjct: 57 NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 468 LTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNL 527
L LP L L L +N L P I L L L + + +P + +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 528 EHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNK 587
+ E VNLQ L L S P + L NL+ LK+ ++
Sbjct: 174 D---------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 588 LTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGN 647
L+ A+ ++ L +L EL + G + P G L+ L + + +P ++
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR-LILKDCSNLLTLPLDIHR 275
Query: 648 LQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNL 685
L LE L L + +P+ + + + + + +
Sbjct: 276 LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-47
Identities = 61/351 (17%), Positives = 114/351 (32%), Gaps = 32/351 (9%)
Query: 302 GTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQ 361
G+ H + + + + L +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLS---QWQRHYNADRNRW-HSAWRQANSNN 57
Query: 362 LHKLDLSINNLTGTIPLEFQNLTY--LVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNN 419
+ L ++ T V L+L L P SHL + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 420 LDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLML-GQNQLTGSLPIEFYN 478
L +P + + L L+L N L +P + + L +L + +LT LP +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT-ELPEPLAS 172
Query: 479 LQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSN 538
E L NL+ L L +P+ + NL++L + I ++
Sbjct: 173 TD---------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
Query: 539 SLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD-NKLTGAIPSSLG 597
LS + + + L+ LDL + P G L+ L L D + L +P +
Sbjct: 217 PLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIH 274
Query: 598 GLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNL 648
L +L +L + G + +P + QL A I + + + + + +
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCI-ILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-44
Identities = 53/360 (14%), Positives = 102/360 (28%), Gaps = 51/360 (14%)
Query: 157 FGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECE 216
G + + E L + +S+ ++ +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSN 56
Query: 217 GLEVLGLAQNSLEGFLPSELEKLR--NLTDLILWQNHLSGEIPPTIGNIQSLELLALHEN 274
++ +L+ LE L L L + P + L+ + +
Sbjct: 57 NPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 275 SFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGL 334
LP + + + L+ L + N L +P + + E+ + +P L
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA- 171
Query: 335 IPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDN 394
E L L L L + ++P NL L L++ ++
Sbjct: 172 --------------STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
Query: 395 HLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKT 454
L + P I L LD+ + PP L L L
Sbjct: 217 PLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC------------ 263
Query: 455 CRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSEN 514
+ L +LP++ + L L L+L +P I +L + + +
Sbjct: 264 -----------SNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 56/294 (19%), Positives = 112/294 (38%), Gaps = 18/294 (6%)
Query: 79 LHGLNLSGILSP-RICDLPRLVEFNISMNFVTGSIPTDLANCSS--LEILDLCTNRLHGV 135
+ + + S R + + + + L + + L+L + L
Sbjct: 38 HYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-Q 95
Query: 136 IPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLR 195
P Q F ++ L+ + + + E+P+ + LE L + N L A+PASI+ L +LR
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153
Query: 196 VIRAGHNSLSGPIPPEISECEG---------LEVLGLAQNSLEGFLPSELEKLRNLTDLI 246
+ +P ++ + L+ L L + LP+ + L+NL L
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212
Query: 247 LWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPH 306
+ + LS + P I ++ LE L L + P G + LK+L + T+P
Sbjct: 213 IRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271
Query: 307 ELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLT 360
++ T ++DL +P + +P C++ + ++
Sbjct: 272 DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-41
Identities = 57/330 (17%), Positives = 107/330 (32%), Gaps = 22/330 (6%)
Query: 110 GSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTS 169
GS + S E L + L + ++ Y + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVL---SQWQRHYNADRNRW-HSAWRQANSNN 57
Query: 170 LEELVIYSNNLTGAIPASISKLRQ--LRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNS 227
+ L A + Q + L P + L+ + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAG 115
Query: 228 LEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGK- 286
L LP +++ L L L +N L +P +I ++ L L++ LP+ L
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 287 --------LSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNL 338
L L+ L + + ++P + N + + + + L+ + + +P L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 339 CLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEG 398
L L + P G L +L L + T+PL+ LT L L L
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 399 TIPPHIGVNSHLSVLDVSMNNLDGSIPPHL 428
+P I ++ V +L + H
Sbjct: 292 RLPSLIAQLPANCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 50/282 (17%), Positives = 81/282 (28%), Gaps = 22/282 (7%)
Query: 422 GSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQN 481
GS H L + L + + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 482 LSALELYQNRFSGLIPPEIGKLR--NLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNS 539
+ L L P + L HL I +
Sbjct: 58 PQIETRTGRALKAT-ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 540 LSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLG-- 597
L +P + L+ L L+RN + P + L L L + +P L
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 598 -------GLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQM 650
GL L L++ S+P ++ L L+ L I ++ LS + + +L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS-LKIRNSPLSA-LGPAIHHLPK 230
Query: 651 LEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNT 692
LE L L + P G + L L + + + T+P
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 15/104 (14%), Positives = 26/104 (25%), Gaps = 24/104 (23%)
Query: 78 DLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIP 137
DL G P L + ++P D+ + LE LD
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLD----------- 283
Query: 138 FQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLT 181
L +P I L + +++ +
Sbjct: 284 -------------LRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
IGRG+ TVYK +A +++ R + F E L ++H NIV+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 866 YGFCYH---QDSNLLLY-EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
Y ++L E M +G+L L K+ ++ +GL +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH- 146
Query: 922 DCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
P IIHRD+K +NI + +GD GLA L ++K++ G+ ++APE Y
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEM-Y 202
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSP 1006
K E D+Y+FG+ +LE+ T + P
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 3e-45
Identities = 65/484 (13%), Positives = 141/484 (29%), Gaps = 29/484 (5%)
Query: 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSL 170
+I N + +I + + L + +++L L N + ++ T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 171 EELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEG 230
E L + SN L + L LR + +N + E+ +E L A N++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 231 FLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSG-GLPKELGKLSR 289
+ + ++ L N ++ G ++ L L N +
Sbjct: 114 V---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 290 LKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349
L+ L + N + + ++ +DLS N+L F+ E + + L N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 350 GSIPRELGQLTQLHKLDLSINNL-TGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNS 408
I + L L DL N GT+ F + + ++ + +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECT 284
Query: 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGN----IPPGLKTCRSLMQLMLG 464
++ + P L G+ + + ++
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 465 QNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV 524
+ Q + Q LE + + L+ + +
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIE-LQHAT 403
Query: 525 GNLEHLVTFNISSNSLS-GTIPHELGNCVNLQRLDLSRNQFT-----GSAPEELGQLVNL 578
L + + ++ D+ +++ T + ++L +L
Sbjct: 404 EEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADL 463
Query: 579 ELLK 582
L
Sbjct: 464 ALAS 467
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 3e-45
Identities = 62/413 (15%), Positives = 120/413 (29%), Gaps = 21/413 (5%)
Query: 279 GLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNL 338
+ + +R K V + L + + + E+DLS N L+ +L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 339 CLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEG 398
LL L N+L +L L+ L LDL+ N + E + L +N++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 399 TIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSG-NIPPGLKTCRS 457
+ G + ++ N + ++ +L L N + N + +
Sbjct: 113 RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 458 LMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFV 517
L L L N + + + L L+L N+ + + PE + + L N V
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227
Query: 518 GYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVN 577
I + ++L F++ N N + +++ + +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 578 LELLKLSDNKLTGAIPSSLGGLARLT----ELQMGGNIFSGSIPVALGQLTALQIALNIS 633
L L L L G + + + ++
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE-IDAL 344
Query: 634 HNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLV 686
VI Q L L ++ L +
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI 397
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-45
Identities = 74/472 (15%), Positives = 141/472 (29%), Gaps = 43/472 (9%)
Query: 218 LEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFS 277
++ + +SL+ L S + N+ +L L N LS + LELL L N
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 278 GGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPN 337
+L LS L+ L + N + EL S + + N ++
Sbjct: 72 E--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRG---QG 121
Query: 338 LCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTG-TIPLEFQNLTYLVDLQLFDNHL 396
+ L N + + G +++ LDL +N + + L L L N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 397 EGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCR 456
+ + + L LD+S N L + P + ++SL +N+L I L+ +
Sbjct: 182 Y-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 457 SLMQLMLGQNQL-TGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENY 515
+L L N G+L F Q + + + L + H
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295
Query: 516 FVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQL 575
+ L+ ++L L ++ E
Sbjct: 296 C---EDLPAPFADRLIALKRKEHAL----------------LSGQGSETE-RLECERENQ 335
Query: 576 VNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIAL--NIS 633
+ + I L+ + L L +
Sbjct: 336 ARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG 395
Query: 634 HNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNL 685
L E LQ+L A+ ++ E + + ++ ++ +
Sbjct: 396 QIELQHATE-EQSPLQLLRAIVKRYEEMYVEQQSV--QNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 63/432 (14%), Positives = 124/432 (28%), Gaps = 31/432 (7%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIP-----------------TD 115
V +DL G LS I + + +L N+S N + ++ +
Sbjct: 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQE 94
Query: 116 LANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVI 175
L S+E L N + + + +YL N I + G + ++ L +
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 176 YSNNLTG-AIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPS 234
N + + L + +N + + ++ L+ L L+ N L F+
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGP 208
Query: 235 ELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLY 294
E + +T + L N L I + Q+LE L N F G ++ +
Sbjct: 209 EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQT 266
Query: 295 VYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGS--- 351
V + CT + L + QGS
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE 326
Query: 352 -IPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410
+ E + ++D I + L+ L+ + ++ L
Sbjct: 327 RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386
Query: 411 SVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTG 470
+ ++ + ++ + Q++ T
Sbjct: 387 DGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET- 445
Query: 471 SLPIEFYNLQNL 482
L E L+ L
Sbjct: 446 QLAEENARLKKL 457
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-42
Identities = 77/396 (19%), Positives = 135/396 (34%), Gaps = 28/396 (7%)
Query: 319 LSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPL 378
I L + + E L + + +
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 69
Query: 379 EFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDGSIPPHLCMY-QKLIF 436
+ + L L D +E I + + L + N + +PPH+ L
Sbjct: 70 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV 127
Query: 437 LSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSG 494
L L N LS ++P G+ L L + N L + + F +L L+L NR +
Sbjct: 128 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH 185
Query: 495 LIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNL 554
+ ++ + +L ++S N S + + + S NS++ + + V L
Sbjct: 186 V---DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVEL 234
Query: 555 QRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614
L L N T L L + LS N+L + + RL L + N
Sbjct: 235 TILKLQHNNLT--DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV- 291
Query: 615 SIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMS 674
++ + + L++ L++SHN+L + LE LYLD N I + S +
Sbjct: 292 ALNLYGQPIPTLKV-LDLSHNHLL-HVERNQPQFDRLENLYLDHNS-IVTLKLSTHHTLK 348
Query: 675 LLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLC 710
L LS+N+ +FR + C
Sbjct: 349 NL--TLSHNDWDCN-SLRALFRNVARPAVDDADQHC 381
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 4e-41
Identities = 76/364 (20%), Positives = 134/364 (36%), Gaps = 29/364 (7%)
Query: 303 TIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRE-LGQLTQ 361
I L ++ + + E + N ++ + ++ +P L Q
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 362 LHKLDLSINNLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNN 419
+ L+L+ + I F + L + N + +PPH+ N L+VL + N+
Sbjct: 77 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 420 LDGSIPPHLCMY-QKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIEFY 477
L S+P + KL LS+ +N L I + SL L L N+LT ++
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLS 189
Query: 478 NLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISS 537
+ +L + N S + +E L S N + V L +
Sbjct: 190 LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQH 241
Query: 538 NSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLG 597
N+L+ L N L +DLS N+ ++ LE L +S+N+L A+
Sbjct: 242 NNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ 298
Query: 598 GLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLD 657
+ L L + N + Q L+ L + HN++ + +L L+ L L
Sbjct: 299 PIPTLKVLDLSHNHLL-HVERNQPQFDRLEN-LYLDHNSIVTL---KLSTHHTLKNLTLS 353
Query: 658 DNQL 661
N
Sbjct: 354 HNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-37
Identities = 71/361 (19%), Positives = 127/361 (35%), Gaps = 22/361 (6%)
Query: 231 FLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRL 290
+ S L+ D+ + + + +++ ++ L ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 291 KKLYVYTNELNGTIPHE-LGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349
+ L + ++ I + ++ + N + P +P L +L L N L
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 350 GSIPREL-GQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNS 408
S+PR + +L L +S NNL FQ T L +LQL N L + +
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIP 192
Query: 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQL 468
L +VS N L ++ + + L N ++ + + L L L N L
Sbjct: 193 SLFHANVSYNLLS-TLAIPI----AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL 244
Query: 469 TGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLE 528
T N L ++L N ++ K++ LERL++S N V + +
Sbjct: 245 T-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 301
Query: 529 HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588
L ++S N L + L+ L L N +L L+ L LS N
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDW 357
Query: 589 T 589
Sbjct: 358 D 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-36
Identities = 99/568 (17%), Positives = 186/568 (32%), Gaps = 40/568 (7%)
Query: 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEI-GNLTS 169
I ++L + + F+ +N + + + + ++P + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQ 76
Query: 170 LEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQNSL 228
+E L + + + + ++ + G N++ +PP + L VL L +N L
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDL 135
Query: 229 EGFLPSELEKLRNLTDLILWQNHLSGEIPP-TIGNIQSLELLALHENSFSGGLPKELGKL 287
LT L + N+L I T SL+ L L N + + L +
Sbjct: 136 SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLI 191
Query: 288 SRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENM 347
L V N L+ L + E+D S N + + + L +L+L N
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNN 243
Query: 348 LQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN 407
L L L ++DLS N L + F + L L + +N L + +
Sbjct: 244 LT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 300
Query: 408 SHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQ 467
L VLD+S N+L + + + +L L L N + + T +L L L N
Sbjct: 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHND 356
Query: 468 LTG-SLPIEFYNLQNLSALELYQNRFSGLI------------PPEIGKLRNLERLHLSEN 514
SL F N+ + + Q+ P L+ + + E
Sbjct: 357 WDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEK 416
Query: 515 YFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQ 574
+ + V + G +P + + + +L R + E++ Q
Sbjct: 417 VQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNEL-RAEVQQLTNEQIQQ 475
Query: 575 LVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISH 634
L+ L + GLAR + +F+ +L Q +
Sbjct: 476 EQLLQGLHAEIDTNLRRYRLPKDGLARSS--DNLNKVFTHLKERQAFKLRETQARRTEAD 533
Query: 635 NNLSGVIPYELGNLQMLEALYLDDNQLI 662
E N+ + + L +
Sbjct: 534 AKQKETEDLEQENIALEKQLDNKRAKQA 561
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-36
Identities = 81/519 (15%), Positives = 159/519 (30%), Gaps = 63/519 (12%)
Query: 157 FGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEI-SEC 215
+ I + ++ I L +++ ++++ +P +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSF 74
Query: 216 EGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI-GNIQSLELLALHEN 274
+E+L L +E + L + N + +PP + N+ L +L L N
Sbjct: 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN 133
Query: 275 SFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGL 334
S +L L + N L TS + LS N+LT
Sbjct: 134 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV------- 186
Query: 335 IPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDN 394
+L + L ++S N L+ + +L N
Sbjct: 187 --------------------DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 221
Query: 395 HLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPG-LK 453
+ + VN L++L + NNL + L Y L+ + L N L I
Sbjct: 222 SIN-VVRG--PVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFV 275
Query: 454 TCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSE 513
+ L +L + N+L +L + + L L+L N + + LE L+L
Sbjct: 276 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDH 333
Query: 514 NYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELG 573
N V + L +S N L N+ R + +L
Sbjct: 334 NSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLE 388
Query: 574 Q----------LVNLELLKLSDNKLT---GAIPSSLGGLARLTELQMGGNIFSGSIPVAL 620
++ L ++ + + +Q + + V L
Sbjct: 389 HGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPL 448
Query: 621 GQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
L+ +N + + ++ Q+L+ L+ + +
Sbjct: 449 QGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEID 487
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-41
Identities = 81/328 (24%), Positives = 132/328 (40%), Gaps = 50/328 (15%)
Query: 359 LTQLHKLDLSINNLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSM 417
L++ + LT T+P ++T L + DN+L ++P L L+VS
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPAHITTL---VIPDNNLT-SLPALPP---ELRTLEVSG 90
Query: 418 NNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFY 477
N L S+P +L S L +P GL L + NQLT SLP+
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCK------LWIFGNQLT-SLPVLPP 141
Query: 478 NLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISS 537
LQ LS + N+ + L P L +L N +P L+ L ++S
Sbjct: 142 GLQELS---VSDNQLASL-PALPS---ELCKLWAYNNQLT-SLPMLPSGLQEL---SVSD 190
Query: 538 NSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLG 597
N L+ ++P L +L N+ T S P L+ L +S N+LT ++P
Sbjct: 191 NQLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLT-SLPVLPS 241
Query: 598 GLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLD 657
L EL + GN + S+P+ L +L ++ N L+ +P L +L + L+
Sbjct: 242 ---ELKELMVSGNRLT-SLPMLPSGLLSL----SVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 658 DNQLIGEIPASMGEQMSLLVCNLSNNNL 685
N L E +++ + +
Sbjct: 293 GNPLS-ERTLQALREITSA--PGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-39
Identities = 73/342 (21%), Positives = 125/342 (36%), Gaps = 44/342 (12%)
Query: 265 SLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQL 324
+L + E+ + LP L + L + N L ++P + +++S NQL
Sbjct: 41 GNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLT-SLPALPPELRT---LEVSGNQL 93
Query: 325 TGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLT 384
T +P + L + +P L KL + N LT ++P+ L
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLT----HLPALPSGLC---KLWIFGNQLT-SLPVLPPGLQ 144
Query: 385 YLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRL 444
L + DN L ++P L L N L S+P L LS+ N+L
Sbjct: 145 EL---SVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQL 193
Query: 445 SGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLR 504
+ ++P L +L N+LT SLP L L + NR + L P +L+
Sbjct: 194 A-SLPTLPS---ELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSL-PVLPSELK 244
Query: 505 NLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQF 564
L +S N +P L L ++ N L+ +P L + + ++L N
Sbjct: 245 EL---MVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
Query: 565 TGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQ 606
+ + L ++ + + A S+ L
Sbjct: 297 SERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA 338
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-35
Identities = 77/366 (21%), Positives = 124/366 (33%), Gaps = 49/366 (13%)
Query: 91 RICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLY 150
R C N+ + +T ++P L + + L + N L +P LR L
Sbjct: 35 RACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPAL---PPELRTLE 87
Query: 151 LCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPP 210
+ N + +P L L +L PA S L +L + N L+ +P
Sbjct: 88 VSGNQL-TSLPVLPPGLLELSIFSNPLTHL----PALPSGLCKLWI---FGNQLTS-LPV 138
Query: 211 EISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLA 270
GL+ L ++ N L LP+ +L L + N L+ +P +Q L
Sbjct: 139 LPP---GLQELSVSDNQLAS-LPALPSELCKLW---AYNNQLT-SLPMLPSGLQELS--- 187
Query: 271 LHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPR 330
+ +N + LP + L KL+ Y N L ++P E+ +S N+LT +P
Sbjct: 188 VSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPSGLK---ELIVSGNRLTS-LPV 238
Query: 331 ELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQ 390
L L + N L S+P L L + N LT +P +L+ +
Sbjct: 239 LPS---ELKELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVN 290
Query: 391 LFDNHLEGTIPPHIGVNSHLSVLD----VSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSG 446
L N L + + + S P L R
Sbjct: 291 LEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGE 349
Query: 447 NIPPGL 452
P
Sbjct: 350 PAPADR 355
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 42/218 (19%), Positives = 70/218 (32%), Gaps = 26/218 (11%)
Query: 79 LHGLNLSG----ILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHG 134
L L++S L +L +L +N + S+P A S L+ L + NRL
Sbjct: 183 LQELSVSDNQLASLPTLPSELYKLWAYNNRLT----SLP---ALPSGLKELIVSGNRLTS 235
Query: 135 VIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQL 194
+ + L++L + N + +P L SL +Y N LT +P S+ L
Sbjct: 236 LPVL----PSELKELMVSGNRL-TSLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSE 286
Query: 195 RVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSG 254
+ N LS + E + S + R L
Sbjct: 287 TTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLV--- 343
Query: 255 EIPPTIGNIQSLELL-ALHENSFSGGLPKELGKLSRLK 291
P G + + + L +LS +
Sbjct: 344 --PAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETE 379
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-41
Identities = 75/395 (18%), Positives = 128/395 (32%), Gaps = 49/395 (12%)
Query: 270 ALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIP 329
+ L +++ + E + + + +
Sbjct: 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 62
Query: 330 RELGLIPNLCLLQLFENMLQGSIPRE-LGQLTQLHKLDLSINNLTGTIPLE-FQNLTYLV 387
L + LL L + ++ I + KL + N + +P FQN+ L
Sbjct: 63 ALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLT 120
Query: 388 DLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGN 447
L L N L ++P I N+ KL LS+ +N L
Sbjct: 121 VLVLERNDLS-SLPRGIFHNTP-----------------------KLTTLSMSNNNLE-R 155
Query: 448 IPPG-LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNL 506
I + SL L L N+LT ++ + +L + N S + +
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIAV 207
Query: 507 ERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG 566
E L S N + V L + N+L T L N L +DLS N+
Sbjct: 208 EELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEK 262
Query: 567 SAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTAL 626
++ LE L +S+N+L A+ + L L + N + Q L
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 320
Query: 627 QIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
+ L + HN++ + +L L+ L L N
Sbjct: 321 EN-LYLDHNSIVTL---KLSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-40
Identities = 70/377 (18%), Positives = 138/377 (36%), Gaps = 30/377 (7%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SH 409
I L + + + + E L + ++ + +P + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 410 LSVLDVSMNNLDGSIPPH-LCMYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQ 467
+ +L+++ ++ I + + L +G N + +PP + L L+L +N
Sbjct: 71 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 128
Query: 468 LTGSLPIE-FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGN 526
L+ SLP F+N L+ L + N + +L+ L LS N ++
Sbjct: 129 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SL 184
Query: 527 LEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDN 586
+ L N+S N LS L + ++ LD S N V L +LKL N
Sbjct: 185 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHN 236
Query: 587 KLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELG 646
LT + L L E+ + N + ++ L+ L IS+N L +
Sbjct: 237 NLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER-LYISNNRLV-ALNLYGQ 292
Query: 647 NLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGN 706
+ L+ L L N + + + + L L +N++V T+ +T + + + N
Sbjct: 293 PIPTLKVLDLSHNH-LLHVERNQPQFDRLENLYLDHNSIV-TLKLST-HHTLKNLTLSHN 349
Query: 707 RGLCMLGSDCHQLMPPS 723
+ + + +
Sbjct: 350 D----WDCNSLRALFRN 362
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-40
Identities = 70/360 (19%), Positives = 127/360 (35%), Gaps = 20/360 (5%)
Query: 231 FLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRL 290
+ S L+ D+ + + + +++ ++ L ++
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 291 KKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQG 350
+ L + ++ + + ++ + N + P +P L +L L N L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 351 SIPREL-GQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSH 409
S+PR + +L L +S NNL FQ T L +LQL N L + +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPS 187
Query: 410 LSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLT 469
L +VS N L ++ + + L N ++ + + L L L N LT
Sbjct: 188 LFHANVSYNLLS-TLAIPI----AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT 239
Query: 470 GSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEH 529
N L ++L N ++ K++ LERL++S N V + +
Sbjct: 240 -DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296
Query: 530 LVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
L ++S N L + L+ L L N + L L+ L LS N
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-40
Identities = 73/418 (17%), Positives = 141/418 (33%), Gaps = 52/418 (12%)
Query: 184 IPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLT 243
I +++ + + E +++ +++ + L+ R +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 244 DLILWQNHLSGEIPPTI-GNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNG 302
L L + EI +++ L + N+ P + L L + N+L+
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 303 TIPHEL-GNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQ-LT 360
++P + N + +S N L I + Q T
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-------------------------RIEDDTFQATT 165
Query: 361 QLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNL 420
L L LS N LT ++ + L + N L + + + LD S N++
Sbjct: 166 SLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 217
Query: 421 DGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE-FYNL 479
+ + + +L L L N L+ L L+++ L N+L + F +
Sbjct: 218 N-VVRGPVN--VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKM 271
Query: 480 QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNS 539
Q L L + NR + + L+ L LS N+ + ++ + L + NS
Sbjct: 272 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329
Query: 540 LSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLG 597
+ T+ L L+ L LS N + ++ L N+ + D I L
Sbjct: 330 IV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-35
Identities = 77/370 (20%), Positives = 140/370 (37%), Gaps = 33/370 (8%)
Query: 82 LNLSGILSPRICDLPRLVEFNISMNFVTGSIPTD-LANCSSLEILDLCTNRLHGVIPFQL 140
L + + +P L + +E+L+L ++ + +
Sbjct: 31 QTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAF 89
Query: 141 FFINTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASI-SKLRQLRVIR 198
+ +T++KLY+ N I +P + N+ L LV+ N+L+ ++P I +L +
Sbjct: 90 AYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147
Query: 199 AGHNSLSGPIPPEI-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIP 257
+N+L I + L+ L L+ N L +L + +L + N LS
Sbjct: 148 MSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS---- 199
Query: 258 PTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEI 317
T+ ++E L NS + + + L L + N L T L N VE+
Sbjct: 200 -TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEV 253
Query: 318 DLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIP 377
DLS N+L + + L L + N L ++ + L LDLS N+L +
Sbjct: 254 DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 311
Query: 378 LEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFL 437
L +L L N + T+ + L L +S N+ D C + +F
Sbjct: 312 RNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD-------CNSLRALFR 361
Query: 438 SLGSNRLSGN 447
++ +
Sbjct: 362 NVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-35
Identities = 74/407 (18%), Positives = 135/407 (33%), Gaps = 50/407 (12%)
Query: 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEI-GNLTS 169
I ++L + + F+ +N + + + + ++P + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQ 70
Query: 170 LEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQNSL 228
+E L + + + + ++ + G N++ +PP + L VL L +N L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDL 129
Query: 229 EGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLS 288
LT L + N+L + +++F +
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLE----------------RIEDDTFQA--------TT 165
Query: 289 RLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENML 348
L+ L + +N L + L S ++S N L+ L + + L N +
Sbjct: 166 SLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 217
Query: 349 QGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN- 407
+ +L L L NNLT N LV++ L N LE I H V
Sbjct: 218 N-VVRG--PVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKM 271
Query: 408 SHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQ 467
L L +S N L ++ + L L L N L ++ L L L N
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329
Query: 468 LTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSEN 514
+ +L + L L L N + RN+ R + +
Sbjct: 330 IV-TLKLS--THHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-31
Identities = 66/357 (18%), Positives = 122/357 (34%), Gaps = 26/357 (7%)
Query: 75 TSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTD-LANCSSLEILDLCTNRLH 133
V + + + + ++ N++ + I T A +++ L + N +
Sbjct: 48 KIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106
Query: 134 GVIPFQLFFINTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASI-SKL 191
+ P + L L L N + +P I N L L + +NNL I
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 164
Query: 192 RQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
L+ ++ N L+ + S L ++ N L S L + +L N
Sbjct: 165 TSLQNLQLSSNRLTH-VDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNS 216
Query: 252 LSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNC 311
++ + L +L L N+ + L L ++ + NEL + H
Sbjct: 217 IN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM 271
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINN 371
+ +S N+L + IP L +L L N L + R Q +L L L N+
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329
Query: 372 LTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHL 428
+ T+ L +L L N + + +++ V + I L
Sbjct: 330 IV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQL 381
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-40
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 809 VIGRGACGTVYKATLANGEV-IAVKKIKLRGEGATAD--NSFLAEISTLGKIRHRNIVKL 865
IGRG G V+ L +AVK + E D FL E L + H NIV+L
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
G C + ++ E ++ G L L ++ AA G+ YL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYI-----APEYA 979
IHRD+ + N L+ E+ + DFG+++ D Y+ S G + APE
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS-----GGLRQVPVKWTAPEAL 287
Query: 980 YTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ + + D++SFG++L E + G SP
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-40
Identities = 79/332 (23%), Positives = 138/332 (41%), Gaps = 22/332 (6%)
Query: 316 EIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGT 375
+ + +P G+ LL L +N ++ E L +L+L+ N ++
Sbjct: 15 AVLCHRKRFV-AVPE--GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 376 IPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDGSIPP----HLCM 430
P F NL L L L N L+ IP + S+L+ LD+S N + + L
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKI-VILLDYMFQDL-- 127
Query: 431 YQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELY 488
L L +G N L I SL QL L + LT S+P E +L L L L
Sbjct: 128 -YNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR 184
Query: 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE- 547
+ + +L L+ L +S ++ + +L + +I+ +L+ +P+
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243
Query: 548 LGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQM 607
+ + V L+ L+LS N + L +L+ L+ ++L +L P + GL L L +
Sbjct: 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303
Query: 608 GGNIFSGSIPV-ALGQLTALQIALNISHNNLS 638
GN + ++ + L+ L + N L+
Sbjct: 304 SGNQLT-TLEESVFHSVGNLE-TLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-38
Identities = 78/339 (23%), Positives = 134/339 (39%), Gaps = 33/339 (9%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410
++P + T+ LDL N + EF + +L +L+L +N + + P
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPG------- 74
Query: 411 SVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLT 469
+ NNL L L L SNRL IP G +L +L + +N++
Sbjct: 75 -----AFNNL-----------FNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV 117
Query: 470 GSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV-GNLE 528
L F +L NL +LE+ N + L +LE+L L + IP+E +L
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLH 176
Query: 529 HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588
L+ + +++ + L+ L++S + + +NL L ++ L
Sbjct: 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236
Query: 589 TGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNL 648
T ++ L L L + N S L +L LQ + + L+ V PY L
Sbjct: 237 TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ-EIQLVGGQLAVVEPYAFRGL 295
Query: 649 QMLEALYLDDNQLIGEIPASMGEQM-SLLVCNLSNNNLV 686
L L + NQ + + S+ + +L L +N L
Sbjct: 296 NYLRVLNVSGNQ-LTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-32
Identities = 75/311 (24%), Positives = 120/311 (38%), Gaps = 24/311 (7%)
Query: 407 NSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQ 465
++ + ++P + + L LG NR+ + + L +L L +
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNE 65
Query: 466 NQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEI-GKLRNLERLHLSENYFVGYIPSEV 524
N ++ P F NL NL L L NR LIP + L NL +L +SEN V + +
Sbjct: 66 NIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYM 123
Query: 525 -GNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLK 582
+L +L + + N L I H +L++L L + T E L L L +L+
Sbjct: 124 FQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLR 182
Query: 583 LSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIP 642
L + S L RL L++ + ++ L L+I+H NL+ V
Sbjct: 183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS-LSITHCNLTAVPY 241
Query: 643 YELGNLQMLEALYLDDNQLIGEIPASMGEQM-SLLVCNLSNNNLVGTVPNTTVFRRIDSS 701
+ +L L L L N I I SM ++ L L L ++
Sbjct: 242 LAVRHLVYLRFLNLSYNP-ISTIEGSMLHELLRLQEIQLVGGQL----------AVVEPY 290
Query: 702 NFAGNRGLCML 712
F G L +L
Sbjct: 291 AFRGLNYLRVL 301
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-30
Identities = 76/357 (21%), Positives = 123/357 (34%), Gaps = 36/357 (10%)
Query: 69 CT-DFKVTSVDLHGLNLSGILSPRICDLPR-LVEFNISMNFVTGSIPTDLANCSSLEILD 126
C + +V H + P +P ++ N + + A+ LE L+
Sbjct: 7 CECSAQDRAVLCHRKRFVAV--PE--GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELE 62
Query: 127 LCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIP 185
L N + V P + LR L L N + IP + L++L +L I N + +
Sbjct: 63 LNENIVSAVEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVILLD 121
Query: 186 ASISKLRQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTD 244
L L+ + G N L I S LE L L + +L L L L
Sbjct: 122 YMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIV 180
Query: 245 LILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTI 304
L L +++ A+ + SF L RLK L + T+
Sbjct: 181 LRLRHLNIN----------------AIRDYSFKR--------LYRLKVLEISHWPYLDTM 216
Query: 305 PHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHK 364
+ + ++ LT + + L L L N + L +L +L +
Sbjct: 217 TPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQE 276
Query: 365 LDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHI-GVNSHLSVLDVSMNNL 420
+ L L P F+ L YL L + N L T+ + +L L + N L
Sbjct: 277 IQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-23
Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 8/279 (2%)
Query: 75 TSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTD-LANCSSLEILDLCTNRLH 133
++L+ +S + +L L + N + IP S+L LD+ N++
Sbjct: 59 EELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV 117
Query: 134 GVIPFQLFFINTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASISKLR 192
++ + + L+ L + +N + I L SLE+L + NLT ++S L
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLH 176
Query: 193 QLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
L V+R H +++ I L+VL ++ + NLT L + +
Sbjct: 177 GLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235
Query: 252 LSGEIPP-TIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGN 310
L+ +P + ++ L L L N S L +L RL+++ + +L P+
Sbjct: 236 LT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG 294
Query: 311 CTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349
+++S NQLT + NL L L N L
Sbjct: 295 LNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 6e-40
Identities = 79/476 (16%), Positives = 165/476 (34%), Gaps = 29/476 (6%)
Query: 145 TLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSL 204
L + +NYI +I +L+ L L+I N + + ++L + HN L
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 205 SGPIPPEISECEGLEVLGLAQNSLEGF-LPSELEKLRNLTDLILWQNHLSGEIPPTIGNI 263
I L+ L L+ N+ + + E + L L L HL I ++
Sbjct: 82 VK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 264 QSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQ 323
++L + ++ ++ L ++ H + + + +L
Sbjct: 139 NISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE--- 193
Query: 324 LTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNL 383
+ + F ++L L+ ++ + N+ L+
Sbjct: 194 -----LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWH 246
Query: 384 TYLVDLQLFDNHLEGTIPPHIGVNSH-----LSVLDVSMNNLDGSIPPHLCMYQKLIFLS 438
T + + + L+G + S LS+ V + ++ + +
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 439 LGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPP 498
+ + L N LT ++ +L L L L N+ L
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL-SK 365
Query: 499 EIG---KLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHELGNCVNL 554
++++L++L +S+N + L++ N+SSN L+ TI L +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRI 423
Query: 555 QRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGN 610
+ LDL N+ S P+++ +L L+ L ++ N+L L L ++ + N
Sbjct: 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-32
Identities = 69/432 (15%), Positives = 136/432 (31%), Gaps = 31/432 (7%)
Query: 265 SLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQL 324
+L + +N S ++ LS+L+ L + N + +DLS N+L
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 325 TGFIPRELGLIPNLCLLQLFENMLQGSIPR--ELGQLTQLHKLDLSINNLTGTIPLEFQN 382
NL L L N ++P E G ++QL L LS +L + L +
Sbjct: 82 VKISCHPT---VNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 383 LTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSN 442
L L + P + + + + +L +
Sbjct: 138 LNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 443 RLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGK 502
+ + + + L N +L + S + + Q
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV----------W 245
Query: 503 LRNLERLHLSENYFVGYIPSEVG-----NLEHLVTFNISSNSLSGTIPHELGNCVNLQRL 557
+ +S G + +L+ L + S+ + N+
Sbjct: 246 HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK 305
Query: 558 DLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIP 617
+ + + ++ L S+N LT + + G L L L + N +
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364
Query: 618 VALG---QLTALQIALNISHNNLSGVIPYEL-GNLQMLEALYLDDNQLIGEIPASMGEQM 673
Q+ +LQ L+IS N++S + L +L + N L I + ++
Sbjct: 365 KIAEMTTQMKSLQQ-LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRI 423
Query: 674 SLLVCNLSNNNL 685
+L +L +N +
Sbjct: 424 KVL--DLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 69/399 (17%), Positives = 133/399 (33%), Gaps = 32/399 (8%)
Query: 95 LPRLVEFNISMN-FVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCE 153
L ++S N F I + N S L+ L L T L + +N + L +
Sbjct: 89 TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 154 NYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSG------- 206
E+ L ++ T I + V +++
Sbjct: 149 ETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 207 ----PIPPEISECEGLEVLGLAQNSLEGFLPSELEKLR--------NLTDLILWQNHLSG 254
I ++ L L L + +L +++++ L
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266
Query: 255 EIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSA 314
+ + ++++L + + + F S + + +
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 315 VEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELG---QLTQLHKLDLSINN 371
+ +D S N LT + G + L L L N L+ + + Q+ L +LD+S N+
Sbjct: 327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNS 385
Query: 372 LTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCM 430
++ L+ L + N L TI + + VLD+ N + SIP +
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVK 442
Query: 431 YQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQL 468
+ L L++ SN+L ++P G SL ++ L N
Sbjct: 443 LEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 6e-13
Identities = 37/195 (18%), Positives = 67/195 (34%), Gaps = 20/195 (10%)
Query: 520 IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLE 579
+ + L NIS N +S ++ + L+ L +S N+ LE
Sbjct: 19 LSQKTTIL------NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 580 LLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVA--LGQLTALQIALNISHNNL 637
L LS NKL I L L + N F ++P+ G ++ L+ L +S +L
Sbjct: 73 YLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKF-LGLSTTHL 127
Query: 638 SGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRR 697
+ +L + + L + + + L + + +L P F
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETYGEKE-----DPEGL--QDFNTESLHIVFPTNKEFHF 180
Query: 698 IDSSNFAGNRGLCML 712
I + L +
Sbjct: 181 ILDVSVKTVANLELS 195
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 43/255 (16%), Positives = 91/255 (35%), Gaps = 16/255 (6%)
Query: 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR 491
+ + + L + ++ ++ +L L N L+ + L L L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 492 FSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNC 551
++ L L L L+ NY E+ + T + ++N++S + G
Sbjct: 70 LYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRGQ- 120
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTG-AIPSSLGGLARLTELQMGGN 610
+ + L+ N+ T + G ++ L L N++ L L + N
Sbjct: 121 -GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 611 IFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMG 670
+ L+ L++S N L+ + E + + + L +N+L+ I ++
Sbjct: 180 FIY-DVK-GQVVFAKLKT-LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 671 EQMSLLVCNLSNNNL 685
+L +L N
Sbjct: 235 FSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 54/326 (16%), Positives = 104/326 (31%), Gaps = 23/326 (7%)
Query: 376 IPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDGSIPPHLCMYQKL 434
I QN ++ D+ L+ + + ++ LD+S N L L + KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 435 IFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSG 494
L+L SN L L++ +L L L N + E ++ L N S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 495 LIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSG-TIPHELGNCVN 553
+ + + ++L+ N + G + ++ N + +
Sbjct: 114 -VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 554 LQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS 613
L+ L+L N ++ L+ L LS NKL + A +T + + N
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 614 GSIPVALGQLTALQIALNISHNNLS-GVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQ 672
I AL L+ ++ N G + Q ++ + + + E+
Sbjct: 228 -LIEKALRFSQNLEH-FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN----EE 281
Query: 673 MSLLVCNLSNNNLVGTVPNTTVFRRI 698
+ R+
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRL 307
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 50/301 (16%), Positives = 108/301 (35%), Gaps = 16/301 (5%)
Query: 94 DLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCE 153
+ R ++ + + ++ + + +++ LDL N L + L L L L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 154 NYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEIS 213
N + E ++ +L++L L + +N + + + + A +N++S +
Sbjct: 68 NVL-YETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSR- 118
Query: 214 ECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSG-EIPPTIGNIQSLELLALH 272
+G + + LA N + + + L L N + + +LE L L
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 273 ENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPREL 332
N + ++ ++LK L + +N+L + E + I L N+L I + L
Sbjct: 178 YNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 333 GLIPNLCLLQLFENMLQ-GSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQL 391
NL L N G++ + ++ + E + L
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
Query: 392 F 392
+
Sbjct: 294 Y 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-36
Identities = 51/283 (18%), Positives = 96/283 (33%), Gaps = 16/283 (5%)
Query: 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSL 170
+I N + +I + + L + +++L L N + ++ T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 171 EELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEG 230
E L + SN L + L LR + +N + E+ +E L A N++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 231 FLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSG-GLPKELGKLSR 289
+ + ++ L N ++ G ++ L L N +
Sbjct: 114 V---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 290 LKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349
L+ L + N + + ++ +DLS N+L F+ E + + L N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 350 GSIPRELGQLTQLHKLDLSINNLT-GTIPLEFQNLTYLVDLQL 391
I + L L DL N GT+ F + +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 40/216 (18%), Positives = 79/216 (36%), Gaps = 14/216 (6%)
Query: 471 SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHL 530
++ N ++ + + N++ L LS N +++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 531 VTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTG 590
N+SSN L +L + L+ LDL+ N EL ++E L ++N ++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 591 AIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGV-IPYELGNLQ 649
+ S + + N + + G + +Q L++ N + V +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQY-LDLKLNEIDTVNFAELAASSD 169
Query: 650 MLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNL 685
LE L L N + ++ + L +LS+N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVVFA-KLKTLDLSSNKL 203
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 44/267 (16%), Positives = 88/267 (32%), Gaps = 24/267 (8%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRL 132
V +DL G LS I + + +L N+S N + DL + S+L LDL N +
Sbjct: 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV 92
Query: 133 HGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLR 192
+L ++ L+ N I + + + + +N +T
Sbjct: 93 Q-----ELLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRS 144
Query: 193 QLRVIRAGHNSLSG-PIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
+++ + N + + + LE L L N + L L L N
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNK 202
Query: 252 LSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNC 311
L+ + P + + ++L N + K L L+ + N +C
Sbjct: 203 LA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF---------HC 251
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNL 338
+ + ++ + + +
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 67/297 (22%), Positives = 117/297 (39%), Gaps = 47/297 (15%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+F +GRG G V++A + A+K+I+L A + E+ L K+ H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKVMREVKALAKLEHPG 64
Query: 862 IVKLYGFCYHQDS---------NLLLY---EYMENGSLGEQLHGNKQTCLLDWDARYRIA 909
IV+ + +++ + LY + +L + ++G + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID-----------L 958
L AE + +LH ++HRD+K +NI + VGDFGL +D +
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVT 1018
P + G+ Y++PE + + K DI+S G++L EL+ P + +T
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238
Query: 1019 WVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
VR + T + V++M S SP+ RP +I
Sbjct: 239 DVRNLKFPPLFTQKYPC------EYVMVQDML----------SPSPMERPEAINIIE 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
IG G G V+ N + +A+K I+ EGA ++ F+ E + K+ H +V+LY
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQT----CLLDWDARYRIALGAAEGLCYLHYD 922
G C Q L+ E+ME+G L + L + LL + L EG+ YL
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYL--- 120
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYI---APE 977
+IHRD+ + N L+ E V DFG+ + + D S + + + +PE
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-----VKWASPE 175
Query: 978 YAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ + K D++SFGV++ E+ + GK P
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-38
Identities = 60/276 (21%), Positives = 114/276 (41%), Gaps = 25/276 (9%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+ IG G+ G +G +K+I + + E++ L ++H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 862 IVKLYGFCYHQDSNLLLY-EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
IV+ + ++ +L + +Y E G L ++++ K L D + L ++H
Sbjct: 85 IVQYRE-SFEENGSLYIVMDYCEGGDLFKRINAQKGV-LFQEDQILDWFVQICLALKHVH 142
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
I+HRDIKS NI L ++ +GDFG+A++++ + + I G+ Y++PE
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040
K DI++ G VL EL T K ++ + LV + V
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFPPVSLH--------Y 249
Query: 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076
S ++ + +P +RP++ ++
Sbjct: 250 S-----YDLRSLVSQLF---KRNPRDRPSVNSILEK 277
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 7e-38
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
+G G G V +AVK IK EG+ +++ F E T+ K+ H +VK Y
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFY 69
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQT----CLLDWDARYRIALGAAEGLCYLHYD 922
G C + ++ EY+ NG L L + + LL+ + EG+ +L
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE------MCYDVCEGMAFLE-- 121
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYI-----AP 976
IHRD+ + N L+D + V DFG+ + + D Y S+ AP
Sbjct: 122 -SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK------FPVKWSAP 174
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
E + K + K D+++FG+++ E+ + GK P
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 9/211 (4%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
++ IG G+ G K ++G+++ K++ ++E++ L +++H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 862 IVKLYGFCYHQDSNLLLY---EYMENGSLGEQLHGNKQT-CLLDWDARYRIALGAAEGLC 917
IV+ Y +N LY EY E G L + + LD + R+ L
Sbjct: 67 IVRYYD-RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 918 YLHY--DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIA 975
H D ++HRD+K N+ LD + +GDFGLA++++ S + + + G+ Y++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 976 PEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
PE M EK DI+S G +L EL P
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
+G G G V +A+K IK EG+ +++ F+ E + + H +V+LY
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQT----CLLDWDARYRIALGAAEGLCYLHYD 922
G C Q ++ EYM NG L L + LL+ + E + YL
Sbjct: 86 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE------MCKDVCEAMEYLE-- 137
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYI---APE 977
+HRD+ + N L++++ V DFGL++ + D S S + PE
Sbjct: 138 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSPPE 191
Query: 978 YAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
K + K DI++FGV++ E+ + GK P
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-37
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 807 GAVIGRGACGTVYKATLANGEV-IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
+G G G VY+ + +AVK +K E FL E + + +I+H N+V+L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGN-----KQTCLLDWDARYRIALGAAEGLCYLH 920
G C + ++ E+M G+L + L LL +A + + YL
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY------MATQISSAMEYLE 335
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
+ + IHR++ + N L+ E V DFGL++L+ + + + APE
Sbjct: 336 ---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 981 TMKVTEKCDIYSFGVVLLELIT-GKSP 1006
K + K D+++FGV+L E+ T G SP
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 807 GAVIGRGACGTVYKATLANGEV-IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
+G G G VY+ + +AVK +K E FL E + + +I+H N+V+L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGN-----KQTCLLDWDARYRIALGAAEGLCYLH 920
G C + ++ E+M G+L + L LL +A + + YL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY------MATQISSAMEYLE 128
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSA---IAGSYGYIAP 976
+ + IHRD+ + N L+ E V DFGL++L+ Y+ A I + AP
Sbjct: 129 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WTAP 181
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
E K + K D+++FGV+L E+ T G SP
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-37
Identities = 72/404 (17%), Positives = 133/404 (32%), Gaps = 44/404 (10%)
Query: 201 HNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI 260
+ + L L +S+ + +EKL LT LI N+++ + +
Sbjct: 27 AFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TLD--L 81
Query: 261 GNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLS 320
+L LA N + L + L++L L TN+L + + ++ +
Sbjct: 82 SQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCA 135
Query: 321 ENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEF 380
N LT ++ L L N + + TQL LD S N +T L+
Sbjct: 136 RNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDV 187
Query: 381 QNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLG 440
L L N++ + + N L+ LD S N L I +L +
Sbjct: 188 SQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVTPL--TQLTYFDCS 241
Query: 441 SNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEI 500
N L+ + T L L Q L I+ + L + R + ++
Sbjct: 242 VNPLT-ELDVS--TLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRK--IKELDV 293
Query: 501 GKLRNLERLHLSENYFVGYIPS-EVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDL 559
L L I ++ LV +++ L+ + + + L+ L
Sbjct: 294 THNTQLYLLDCQAA----GITELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSC 346
Query: 560 SRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT 603
+ +G++ L ++ + +P LT
Sbjct: 347 VNAHIQDFSS--VGKIPALNNNFEAEGQTI-TMPKETLTNNSLT 387
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-36
Identities = 86/500 (17%), Positives = 154/500 (30%), Gaps = 89/500 (17%)
Query: 95 LPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCEN 154
V M ++L LD + + + + L KL N
Sbjct: 20 FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITDMTGIEKL--TGLTKLICTSN 74
Query: 155 YIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISE 214
I + + T+L L SN LT + ++ L +L + N L+ + +S+
Sbjct: 75 NI-TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQ 125
Query: 215 CEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHEN 274
L L A+N+L ++ LT+L N + L L N
Sbjct: 126 NPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFN 180
Query: 275 SFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGL 334
+ ++ + L +L TN + + L +D S N+LT
Sbjct: 181 KITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI------- 227
Query: 335 IPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDN 394
++ LTQL D S+N LT L+ L+ L L
Sbjct: 228 --------------------DVTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQT 264
Query: 395 HLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKT 454
L I + N+ L + + +L L + ++ + L
Sbjct: 265 DLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQ 316
Query: 455 CRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSEN 514
L+ L L +LT L + + L +L +GK+ L +E
Sbjct: 317 NPKLVYLYLNNTELT-ELDVS--HNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEG 371
Query: 515 YFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQ 574
+ +++NSL+ + +L LD N G
Sbjct: 372 -----------QTITMPKETLTNNSLTIAVSPDL--------LDQFGNPMN--IEPGDGG 410
Query: 575 LVNLELLKLSDNKLTGAIPS 594
+ + ++ L+ P+
Sbjct: 411 VYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-36
Identities = 65/397 (16%), Positives = 124/397 (31%), Gaps = 42/397 (10%)
Query: 290 LKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349
E+ T + +D + +T + + L L N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNIT 77
Query: 350 GSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSH 409
++ L Q T L L N LT L+ LT L L N L + + N
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 410 LSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLT 469
L+ L+ + N L I + +L L N+ + L L N++T
Sbjct: 129 LTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKIT 183
Query: 470 GSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEH 529
++ + L+ L N + L ++ + L L S N +V L
Sbjct: 184 E---LDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI---DVTPLTQ 234
Query: 530 LVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
L F+ S N L+ + + L L + +L L + +
Sbjct: 235 LTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKI 288
Query: 590 GAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQ 649
+ + +L L + + L Q L L +++ L+ + + +
Sbjct: 289 KELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVY-LYLNNTELT-ELD--VSHNT 339
Query: 650 MLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLV 686
L++L + I + + +L + +
Sbjct: 340 KLKSLSCVNAH-IQDFSSVGKIP-ALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-35
Identities = 74/429 (17%), Positives = 134/429 (31%), Gaps = 49/429 (11%)
Query: 166 NLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQ 225
N S ++ L L ++S++ I + GL L
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDC---HNSSITD--MTGIEKLTGLTKLICTS 73
Query: 226 NSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELG 285
N++ +L + NLT L N L+ + + + L L N + ++
Sbjct: 74 NNITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVS 124
Query: 286 KLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFE 345
+ L L N L I + + T E+D N+ + + L L
Sbjct: 125 QNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 346 NMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIG 405
N + + + Q L++L+ NN+T L+ L L N L I +
Sbjct: 180 NKIT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VT 230
Query: 406 VNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQ 465
+ L+ D S+N L + KL L L I L L+
Sbjct: 231 PLTQLTYFDCSVNPLT-ELDVSTL--SKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEG 284
Query: 466 NQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVG 525
+ L + + L L+ + L ++ + L L+L+ + V
Sbjct: 285 CRKIKELDVT--HNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VS 336
Query: 526 NLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQL-----VNLEL 580
+ L + + + + +G L + Q E L V+ +L
Sbjct: 337 HNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
Query: 581 LKLSDNKLT 589
L N +
Sbjct: 395 LDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 70/350 (20%), Positives = 127/350 (36%), Gaps = 37/350 (10%)
Query: 336 PNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNH 395
N +Q + QL L LD +++T + + LT L L N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 396 LEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTC 455
+ T+ + N++L+ L N L ++ KL +L+ +N+L+ + +
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKL-TNLDVTPL--TKLTYLNCDTNKLT-KLD--VSQN 126
Query: 456 RSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENY 515
L L +N LT I+ + L+ L+ + N+ + ++ L L S N
Sbjct: 127 PLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNK 181
Query: 516 FVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQL 575
+V + L N +N+++ + L + L LD S N+ T ++ L
Sbjct: 182 ITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPL 232
Query: 576 VNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHN 635
L S N LT + S L++LT L I L T L
Sbjct: 233 TQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIY-FQAEGC 285
Query: 636 NLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNL 685
+ ++ + L L + E+ + + L+ L+N L
Sbjct: 286 RKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-18
Identities = 54/308 (17%), Positives = 96/308 (31%), Gaps = 34/308 (11%)
Query: 75 TSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHG 134
T +D H I + +L + S N +T D++ L L+ TN +
Sbjct: 151 TELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITK 205
Query: 135 VIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQL 194
+ L L N + EI + LT L N LT +++SKL L
Sbjct: 206 -LDLNQN--IQLTFLDCSSNKL-TEID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTL 259
Query: 195 RVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSG 254
I+ + ++ L L ++ L L ++
Sbjct: 260 HCIQTDLLEID------LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT- 310
Query: 255 EIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSA 314
E+ + L L L+ + L + ++LK L + +G +
Sbjct: 311 ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPAL 363
Query: 315 VEIDLSENQLTGFIP-----RELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSI 369
+E Q L + + LL F N + +I G + ++
Sbjct: 364 NNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM--NIEPGDGGVYDQATNTITW 421
Query: 370 NNLTGTIP 377
NL+ P
Sbjct: 422 ENLSTDNP 429
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 29/221 (13%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+F E +IG G G V+KA +G+ +K++K E A E+ L K+ H N
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA------EREVKALAKLDHVN 65
Query: 862 IVKLYGF-------------CYHQDSNLLLY---EYMENGSLGEQLHGNKQTCLLDWDAR 905
IV G + L+ E+ + G+L + + + L A
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 906 YRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS 965
+ +G+ Y+H +I+RD+K +NI L + Q +GDFGL + +
Sbjct: 126 E-LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDGKRT 179
Query: 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
G+ Y++PE + ++ D+Y+ G++L EL+
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 78/300 (26%), Positives = 124/300 (41%), Gaps = 52/300 (17%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+F E AV+G+GA G V KA + A+KKI+ E ++ L+E+ L + H+
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE---KLSTILSEVMLLASLNHQY 63
Query: 862 IVKLYGF----------CYHQDSNLLLY---EYMENGSLGEQLHGNKQTCLLDWDARYRI 908
+V+ Y L+ EY ENG+L + +H + D +R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH--SENLNQQRDEYWRL 121
Query: 909 ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID----------- 957
E L Y+H IIHRD+K NI +DE +GDFGLAK +
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 958 --LPYSKSMSAIAGSYGYIAPE-YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG 1014
S ++++ G+ Y+A E T EK D+YS G++ E+I S
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV--- 235
Query: 1015 DLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
+++ +R E P FD K+ + + + P RP R ++
Sbjct: 236 NILKKLRSVSIEFPPD---FDDNKMKVEKKIIRLL-I---------DHDPNKRPGARTLL 282
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 63/212 (29%), Positives = 86/212 (40%), Gaps = 29/212 (13%)
Query: 807 GAVIGRGACGTVYKATLA-----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+G G G V GE +AVK +K G EI L + H N
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHEN 84
Query: 862 IVKLYGFCYHQDSN--LLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEG 915
IVK G C N L+ E++ +GSL E L NK L + A+ +G
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY------AVQICKG 138
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI- 974
+ YL +HRD+ + N+L++ E Q +GDFGL K I +
Sbjct: 139 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI---ETDKEYYTVKDDRDSP 192
Query: 975 ----APEYAYTMKVTEKCDIYSFGVVLLELIT 1002
APE K D++SFGV L EL+T
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 31/212 (14%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
+G G G V+ +AVK +K +G+ + ++FLAE + + +++H+ +V+LY
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGN-----KQTCLLDWDARYRIALGAAEGLCYLHY 921
Q+ ++ EYMENGSL + L LLD +A AEG+ ++
Sbjct: 75 AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIE- 126
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYI-----A 975
+ IHRD+++ NIL+ + + DFGLA+LI D Y+ A
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTA 178
Query: 976 PEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
PE T K D++SFG++L E++T G+ P
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 801 TGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH 859
+ V+G+G G VY L+N IA+K+I + EI+ ++H
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKH 78
Query: 860 RNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
+NIV+ G + E + GSL L + EGL YL
Sbjct: 79 KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138
Query: 920 HYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE- 977
H I+HRDIK +N+L++ + DFG +K + + + G+ Y+APE
Sbjct: 139 H---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEI 194
Query: 978 -----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y DI+S G ++E+ TGK P
Sbjct: 195 IDKGPRGYGKAA----DIWSLGCTIIEMATGKPP 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
IG+G G V +V AVK IK ATA FLAE S + ++RH N+V+L
Sbjct: 26 LQTIGKGEFGDVMLGDYRGNKV-AVKCIK---NDATAQA-FLAEASVMTQLRHSNLVQLL 80
Query: 867 GFCYHQDSNLLL-YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
G + L + EYM GSL + L ++ +L D + +L E + YL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE---GN 136
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI---APEYAYTM 982
+ +HRD+ + N+L+ E+ A V DFGL K + ++ + + APE
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP-----VKWTAPEALREK 189
Query: 983 KVTEKCDIYSFGVVLLELIT-GKSP 1006
K + K D++SFG++L E+ + G+ P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 65/252 (25%), Positives = 104/252 (41%), Gaps = 22/252 (8%)
Query: 761 WAMKCRKPAFVPLEEQKNPEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYK 820
W+ K + E + N V+ ++Y E + +GRG+ G V++
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYR---EEVHWMTHQPRVGRGSFGEVHR 76
Query: 821 AT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879
G AVKK++L + + E+ + IV LYG +
Sbjct: 77 MKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129
Query: 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939
E +E GSLG+ + KQ L D A EGL YLH I+H D+K++N+LL
Sbjct: 130 ELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLL 183
Query: 940 DEE-FQAHVGDFGLAKLIDLPYSK----SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFG 994
+ +A + DFG A + + I G+ ++APE K DI+S
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243
Query: 995 VVLLELITGKSP 1006
++L ++ G P
Sbjct: 244 CMMLHMLNGCHP 255
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-36
Identities = 75/415 (18%), Positives = 132/415 (31%), Gaps = 42/415 (10%)
Query: 255 EIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL-GNCTS 313
E+P + + L NS + +L L+ L V I + +S
Sbjct: 27 ELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 314 AVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGS-IPREL-GQLTQLHKLDLSINN 371
+ + L NQ + NL +L L + L G+ + LT L L L NN
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 372 LTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHI---GVNSHLSVLDVSMNNLDGSIPPH 427
+ P F N+ L L N ++ +I H ++L +S L
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITL------- 192
Query: 428 LCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALEL 487
+ L S+ L L N S+ F++ + ++
Sbjct: 193 ---------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 488 YQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE 547
S + F G S ++ ++S + + +
Sbjct: 244 LILSNSYN---MGSSFGHTNFKDPDNFTFKGLEAS---GVKTC---DLSKSKIFALLKSV 294
Query: 548 LGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQM 607
+ +L++L L++N+ L +L L LS N L L +L L +
Sbjct: 295 FSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354
Query: 608 GGNIFSGSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
N ++ + L L+ L + N L V L L+ ++L N
Sbjct: 355 SYNHIR-ALGDQSFLGLPNLKE-LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 76/405 (18%), Positives = 137/405 (33%), Gaps = 35/405 (8%)
Query: 168 TSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQN 226
+ + + N++ S S+L+ L+ ++ + I L +L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 227 SLEGFLPSELEKLRNLTDLILWQNHL-SGEIPPTI-GNIQSLELLALHENSFSGGLPKEL 284
L NL L L Q +L + + SLE+L L +N+ P
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 285 -GKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQL 343
+ R L + N++ +I E ++ T L L L +
Sbjct: 150 FLNMRRFHVLDLTFNKVK-SICEE-------DLLNFQGKHFT-----LLRLSSI-TLQDM 195
Query: 344 FENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPH 403
E L + T + LDLS N ++ F + +Q +
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 404 IGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLM 462
G + + + L+ S + L +++ + + L QL
Sbjct: 256 FGHTNFKDPDNFTFKGLEAS---------GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLT 305
Query: 463 LGQNQLTGSLPIE-FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIP 521
L QN++ + F+ L +L L L QN + L LE L LS N+ +
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-RALG 363
Query: 522 SEV-GNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQRLDLSRNQF 564
+ L +L + +N L ++P +LQ++ L N +
Sbjct: 364 DQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 77/459 (16%), Positives = 141/459 (30%), Gaps = 72/459 (15%)
Query: 68 ECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDL 127
EC+ + L + P + + ++S+N + T + L+ L +
Sbjct: 7 ECSVIG-YNAICINRGLHQV--PEL--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKV 61
Query: 128 CTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPAS 187
VI F L+SL L + N +
Sbjct: 62 EQQTPGLVIRNNTF-----------------------RGLSSLIILKLDYNQFL-QLETG 97
Query: 188 I-SKLRQLRVIRAGHNSL-SGPIPPEI-SECEGLEVLGLAQNSLEGFLPSEL-EKLRNLT 243
+ L L V+ +L + LE+L L N+++ P+ +R
Sbjct: 98 AFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFH 157
Query: 244 DLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGT 303
L L N + + N Q L LS + + L
Sbjct: 158 VLDLTFNKVKSICEEDLLNFQGKHFTLLR--------------LSSITLQDMNEYWLGWE 203
Query: 304 IPHELGNCTSAVEIDLSENQLTGFIPREL-GLIPNLCLLQLFENMLQGSIPRELGQLTQL 362
TS +DLS N + + I + L + +
Sbjct: 204 KCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS------------NSYN 251
Query: 363 HKLDLSINNLTGTIPLEFQNL--TYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNN 419
N F+ L + + L + + + + + + L L ++ N
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNE 310
Query: 420 LDGSIPPHLCM-YQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQLTGSLPIE-F 476
++ I + L+ L+L N L +I + + L L L N + +L + F
Sbjct: 311 IN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSF 367
Query: 477 YNLQNLSALELYQNRFSGLIPPEI-GKLRNLERLHLSEN 514
L NL L L N+ +P I +L +L+++ L N
Sbjct: 368 LGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 39/195 (20%), Positives = 66/195 (33%), Gaps = 15/195 (7%)
Query: 505 NLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHEL-GNCVNLQRLDLSRNQ 563
++ + LS N + L+ L + + I + +L L L NQ
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 564 FTGSAPEELGQLVNLELLKLSDNKLTGAI--PSSLGGLARLTELQMGGNIFSGSIPVAL- 620
F L NLE+L L+ L GA+ + L L L + N P +
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 621 GQLTALQIALNISHNNLSGVIPYELGNLQM--LEALYLDDNQLI--------GEIPASMG 670
+ + L+++ N + + +L N Q L L L E +
Sbjct: 151 LNMRRFHV-LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 671 EQMSLLVCNLSNNNL 685
+ S+ +LS N
Sbjct: 210 KNTSITTLDLSGNGF 224
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 43/224 (19%), Positives = 81/224 (36%), Gaps = 27/224 (12%)
Query: 50 NLESWNSSDMTPCNWIGVECTDF----KVTSVDLHGLNLSGILSPRICDLPRLVE----- 100
L S DM +C + +T++DL G ++ R D +
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 101 ---FNISMNFVTGSIPTDLANC-------SSLEILDLCTNRLHGVIPFQLF-FINTLRKL 149
+ + D N S ++ DL +++ + +F L +L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 150 YLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASI-SKLRQLRVIRAGHNSLSGP 207
L +N I +I + LT L +L + N L +I + + L +L V+ +N +
Sbjct: 305 TLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA- 361
Query: 208 IPPEI-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQN 250
+ + L+ L L N L+ ++L +L + L N
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 9e-36
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
+G+G G V+ T +A+K +K G + +FL E + K+RH +V+LY
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNK-----QTCLLDWDARYRIALGAAEGLCYLHY 921
++ ++ EYM GSL + L G L+D A A G+ Y+
Sbjct: 246 AVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM------AAQIASGMAYVE- 297
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYA 979
R + +HRD+++ NIL+ E V DFGLA+LI + ++ + + APE A
Sbjct: 298 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAA 353
Query: 980 YTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ T K D++SFG++L EL T G+ P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 13/211 (6%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRH 859
NF IGRG VY+A L +G +A+KK+++ + EI L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 860 RNIVKLYGFCYHQDSNLLLY---EYMENGSLGEQLHGNKQT-CLLDWDARYRIALGAAEG 915
N++K Y + L E + G L + K+ L+ ++ +
Sbjct: 92 PNVIKYYASFIEDNE---LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIA 975
L ++H ++HRDIK N+ + +GD GL + + + S + G+ Y++
Sbjct: 149 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 204
Query: 976 PEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
PE + K DI+S G +L E+ +SP
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH--R 860
+S IG G V++ ++ A+K + L +S+ EI+ L K++
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 861 NIVKLYGFCYHQDSNLLLYEYME--NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
I++LY + +Y ME N L L K+ + W+ + E +
Sbjct: 89 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLK--KKKSIDPWERKS-YWKNMLEAVHT 142
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYIAPE 977
+H + I+H D+K N L+ + + DFG+A + S + G+ Y+ PE
Sbjct: 143 IH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 978 -----------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
K++ K D++S G +L + GK+P
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 31/217 (14%)
Query: 807 GAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+ +G+G G+V G ++AVK+++ G D F EI L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD--FQREIQILKALHSDF 85
Query: 862 IVKLYGFCYHQDSN--LLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEG 915
IVK G Y L+ EY+ +G L + L ++ LL + + +G
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQICKG 139
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI- 974
+ YL +HRD+ + NIL++ E + DFGLAKL+ + G
Sbjct: 140 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQSP 193
Query: 975 ----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
APE + + D++SFGVVL EL T
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-35
Identities = 64/249 (25%), Positives = 115/249 (46%), Gaps = 29/249 (11%)
Query: 763 MKCRKPAFVPLEEQKNPEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKAT 822
+ + + + P D + P+E K +G G G V+ AT
Sbjct: 161 LCQKLSVPCMSSKPQKPWEKDAWEIPRESLKL------------EKKLGAGQFGEVWMAT 208
Query: 823 LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882
+AVK +K G+ + +FLAE + + ++H +VKL+ ++ ++ E+M
Sbjct: 209 YNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264
Query: 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE 942
GSL + L ++ + + AEG+ ++ + + IHRD+++ NIL+
Sbjct: 265 AKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSAS 320
Query: 943 FQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYI---APEYAYTMKVTEKCDIYSFGVVLL 998
+ DFGLA++I D Y+ G+ I APE T K D++SFG++L+
Sbjct: 321 LVCKIADFGLARVIEDNEYTAR----EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLM 376
Query: 999 ELIT-GKSP 1006
E++T G+ P
Sbjct: 377 EIVTYGRIP 385
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-35
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
IG+G G V +V AVK IK ATA +FLAE S + ++RH N+V+L
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKV-AVKCIK---NDATAQ-AFLAEASVMTQLRHSNLVQLL 252
Query: 867 GFCYHQDSNLLL-YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
G + L + EYM GSL + L ++ +L D + +L E + YL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE---GN 308
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
+ +HRD+ + N+L+ E+ A V DFGL K + ++ + + APE K +
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFS 364
Query: 986 EKCDIYSFGVVLLELIT-GKSP 1006
K D++SFG++L E+ + G+ P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 807 GAVIGRGACGTVYKATL---ANGEV-IAVKKIKLRGEGATADN--SFLAEISTLGKIRHR 860
+IG G G V L +V +A+K +K G T FL+E S +G+ H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHP 110
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEGL 916
NI++L G +++ EYMENGSL L + L+ G G+
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM------LRGVGAGM 164
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI-- 974
YL +HRD+ + N+L+D V DFGL++++ +A + G I
Sbjct: 165 RYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAYTTTGGKIPI 218
Query: 975 ---APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
APE + D++SFGVV+ E++ G+ P
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-35
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
+G+G G V+ T +A+K +K G + +FL E + K+RH +V+LY
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNK-----QTCLLDWDARYRIALGAAEGLCYLHY 921
++ ++ EYM GSL + L G L+D A A G+ Y+
Sbjct: 329 AVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM------AAQIASGMAYVE- 380
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYA 979
R + +HRD+++ NIL+ E V DFGLA+LI + ++ + + APE A
Sbjct: 381 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAA 436
Query: 980 YTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ T K D++SFG++L EL T G+ P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 807 GAVIGRGACGTVYKATL----ANGEV-IAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
V+G GA GTVYK ++ +A+K+++ A+ L E + + + +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPH 78
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEGLC 917
+ +L G C + L+ + M G L + + +K LL+W + A+G+
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMN 131
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGY---- 973
YL ++HRD+ + N+L+ + DFGLAKL+ A Y
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG----------AEEKEYHAEG 178
Query: 974 -------IAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+A E T + D++S+GV + EL+T G P
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 807 GAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+G+G G+V GEV+AVKK++ E D F EI L ++H N
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDN 72
Query: 862 IVKLYGFCYHQDSN--LLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEG 915
IVK G CY L+ EY+ GSL + L +K+ LL + +G
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKG 126
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI- 974
+ YL IHRD+ + NIL++ E + +GDFGL K++ P K G
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEF-FKVKEPGESP 180
Query: 975 ----APEYAYTMKVTEKCDIYSFGVVLLELIT 1002
APE K + D++SFGVVL EL T
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-35
Identities = 85/477 (17%), Positives = 179/477 (37%), Gaps = 40/477 (8%)
Query: 208 IPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI-GNIQSL 266
+P ++ + L L+QNS+ ++ L L L L N + + + Q L
Sbjct: 46 VPKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102
Query: 267 ELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPH--ELGNCTSAVEIDLSENQL 324
E L + N + ++ L+ L + N+ + +P E GN T + LS +
Sbjct: 103 EYLDVSHNRLQN-IS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 325 TGFIPRELGLIPNLCLLQLFENMLQGSIPR------ELGQLTQLHKLDLSINNLTGTIPL 378
+L + +L L + +++ I ++ T LH + + + + +
Sbjct: 159 RQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNM 215
Query: 379 EFQNLTYLV--DLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQ---- 432
L +L +++L D + + + + ++L+V++ +++ + + ++Q
Sbjct: 216 SVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP 275
Query: 433 -KLIFLSLGSNRLSGNIPPGLKTC-----RSLMQLMLGQNQLTGSLPIEFYNLQNLSALE 486
+ +L++ + ++ I T +SLM + S + ++
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 487 LYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPH 546
L + + + L+ ++N F + L+ L T + N L
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 547 ELGNCVNLQRLDLSRNQFT----GSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARL 602
N+ L+ + ++ +L LS N LTG++ L ++
Sbjct: 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKV 452
Query: 603 TELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
L + N SIP + L ALQ LN++ N L V L L+ ++L DN
Sbjct: 453 KVLDLHNNRIM-SIPKDVTHLQALQE-LNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 84/509 (16%), Positives = 158/509 (31%), Gaps = 44/509 (8%)
Query: 119 CSSLEILDLCTNRLHGV---IPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVI 175
++D L V +P + L L +N I +I L+ L L +
Sbjct: 30 NELESMVDYSNRNLTHVPKDLP------PRTKALSLSQNSISELRMPDISFLSELRVLRL 83
Query: 176 YSNNLTGAIPASI-SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGF-LP 233
N + ++ + + L + HN L I L L L+ N + +
Sbjct: 84 SHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFDVLPVC 139
Query: 234 SELEKLRNLTDLILWQNHLSGEIPPTIGNIQ-SLELLALHENSFSGGLPKELGKLSRLKK 292
E L LT L L + ++ S LL L GG + L +
Sbjct: 140 KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTV 198
Query: 293 LYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSI 352
L++ + + + + + LS +L L+ + +G
Sbjct: 199 LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE--------NCQRLMTFLSELTRGP- 249
Query: 353 PRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLS- 411
L + + +F + L +++ + I S +
Sbjct: 250 -----TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304
Query: 412 ----VLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQ 467
+ V S ++ ++ L + + S L QN
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364
Query: 468 LTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNL 527
T S+ L+ L L L +N +N+ L +
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLKNF-FKVALMTKNMSSLETLDVSLNSLNSHAYDRT 423
Query: 528 ----EHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKL 583
E ++ N+SSN L+G++ L ++ LDL N+ S P+++ L L+ L +
Sbjct: 424 CAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNV 480
Query: 584 SDNKLTGAIPSSLGGLARLTELQMGGNIF 612
+ N+L L L + + N +
Sbjct: 481 ASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-28
Identities = 90/492 (18%), Positives = 171/492 (34%), Gaps = 45/492 (9%)
Query: 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEI-GNLTS 169
+P DL + L L N + + + F++ LR L L N I + +
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQD 101
Query: 170 LEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSL-SGPIPPEISECEGLEVLGLAQNSL 228
LE L + N L I + LR + N P+ E L LGL+
Sbjct: 102 LEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 229 EGFLPSELEKLRNLTDLI-LWQNHLSGEIPPTIGNIQSLEL-LALHENSFSGGLPKELGK 286
+ L L+ L H+ G ++ + L L H NS
Sbjct: 159 RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ--VNMS 216
Query: 287 LSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFEN 346
++ L L + +LN L S + + +T C ++LF+
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE----TTWKCSVKLFQF 272
Query: 347 MLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEG----TIPP 402
+ L++ +T I E + L H++
Sbjct: 273 F----------WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 403 HIGVN-SHLSVLDVSMNNLDGSIPPHLCMYQ--KLIFLSLGSNRLSGNIPPGLKTCRSLM 459
+ + +++ +S+++ +C FL+ N + ++ G T + L
Sbjct: 323 ALYSVFAEMNIKMLSISDT--PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380
Query: 460 QLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKL----RNLERLHLSENY 515
L+L +N L + +N+S+LE + L + ++ L+LS N
Sbjct: 381 TLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM 439
Query: 516 FVGYIPSE-VGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQ 574
G + ++ L ++ +N + +IP ++ + LQ L+++ NQ +
Sbjct: 440 LTGSVFRCLPPKVKVL---DLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDR 495
Query: 575 LVNLELLKLSDN 586
L +L+ + L DN
Sbjct: 496 LTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 4e-12
Identities = 41/255 (16%), Positives = 84/255 (32%), Gaps = 28/255 (10%)
Query: 70 TDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCT 129
+ ++ + + L L+ ++ S + + + I L
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338
Query: 130 NRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASIS 189
+ + ++ L +N + + L L+ L++ N L
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVAL 397
Query: 190 KLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSEL-EKLRNLTDLILW 248
+ + LE L ++ NSL ++ L L
Sbjct: 398 MTKNMSS---------------------LETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436
Query: 249 QNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHE- 307
N L+G + + +++L LH N +PK++ L L++L V +N+L ++P
Sbjct: 437 SNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGV 492
Query: 308 LGNCTSAVEIDLSEN 322
TS I L +N
Sbjct: 493 FDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 29/130 (22%), Positives = 58/130 (44%), Gaps = 10/130 (7%)
Query: 534 NISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIP 593
+ S+ +L+ +P +L + L LS+N + ++ L L +L+LS N++ ++
Sbjct: 37 DYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLD 92
Query: 594 SSL-GGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGV-IPYELGNLQML 651
+ L L + N +I + +L+ L++S N+ + + E GNL L
Sbjct: 93 FHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRH-LDLSFNDFDVLPVCKEFGNLTKL 148
Query: 652 EALYLDDNQL 661
L L +
Sbjct: 149 TFLGLSAAKF 158
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 69/317 (21%), Positives = 119/317 (37%), Gaps = 31/317 (9%)
Query: 310 NCT-SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLS 368
C + S+ L +P+ L P+ LL L N + + L LH L L
Sbjct: 28 RCQCHLRVVQCSDLGLEK-VPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILI 84
Query: 369 INNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPP-- 426
N ++ P F L L L L N L+ +P + L L V N + +
Sbjct: 85 NNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEI-TKVRKSV 140
Query: 427 --HLCMYQKLIFLSLGSNRL-SGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNL 482
L ++I + LG+N L S I G + + L + + +T I +L
Sbjct: 141 FNGL---NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSL 194
Query: 483 SALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLS 541
+ L L N+ + + + L NL +L LS N + + + N HL ++++N L
Sbjct: 195 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNS-ISAVDNGSLANTPHLRELHLNNNKLV 253
Query: 542 GTIPHELGNCVNLQRLDLSRNQFTG------SAPEELGQLVNLELLKLSDNKLTGAI--P 593
+P L + +Q + L N + P + + + L N + P
Sbjct: 254 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312
Query: 594 SSLGGLARLTELQMGGN 610
S+ + +Q+G
Sbjct: 313 STFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 71/308 (23%), Positives = 119/308 (38%), Gaps = 27/308 (8%)
Query: 389 LQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPH-LCMYQKLIFLSLGSNRLSGN 447
+Q D LE +P + + ++LD+ N + I + L L L +N++S
Sbjct: 36 VQCSDLGLE-KVPKDLPPD--TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-K 90
Query: 448 IPPG-LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEI-GKLRN 505
I PG L +L L +NQL LP + + L L +++N + + + L
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQ 146
Query: 506 LERLHLSEN-YFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQ 563
+ + L N I + ++ L I+ +++ TIP L +L L L N+
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 203
Query: 564 FTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQL 623
T L L NL L LS N ++ SL L EL + N +P L
Sbjct: 204 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262
Query: 624 TALQIALNISHNNLSGV------IPYELGNLQMLEALYLDDNQL-IGEIPASMGEQMSLL 676
+Q+ + + +NN+S + P + L N + EI S + +
Sbjct: 263 KYIQV-VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321
Query: 677 VC-NLSNN 683
L N
Sbjct: 322 AAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 59/292 (20%), Positives = 113/292 (38%), Gaps = 29/292 (9%)
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINN 371
+DL N++T + + NL L L N + P L +L +L LS N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 372 LTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNL-DGSIPP-- 426
L +P + + L L ++ +N + + + + + V+++ N L I
Sbjct: 112 LK-ELPEKMPKTLQEL---RVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 166
Query: 427 --HLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLS 483
+ +KL ++ + ++ IP GL SL +L L N++T + L NL+
Sbjct: 167 FQGM---KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLA 219
Query: 484 ALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSG- 542
L L N S + + +L LHL+ N V +P + + +++ + +N++S
Sbjct: 220 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 278
Query: 543 -----TIPHELGNCVNLQRLDLSRNQFTGSA--PEELGQLVNLELLKLSDNK 587
P + + L N P + ++L + K
Sbjct: 279 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 71/386 (18%), Positives = 133/386 (34%), Gaps = 93/386 (24%)
Query: 117 ANCS-SLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEI-GNLTSLEELV 174
C L ++ C++ +P L L L N I EI + NL +L L+
Sbjct: 27 FRCQCHLRVVQ-CSDLGLEKVPKDLP--PDTALLDLQNNKI-TEIKDGDFKNLKNLHTLI 82
Query: 175 IYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPS 234
+ +N ++ P + + L +L + N L +P ++ + L+ L + +N + S
Sbjct: 83 LINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPK--TLQELRVHENEITKVRKS 139
Query: 235 ELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLY 294
L + + L N L + +F G + +L +
Sbjct: 140 VFNGLNQMIVVELGTNPLK--------------SSGIENGAFQG--------MKKLSYI- 176
Query: 295 VYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPR 354
+++ +T IP+ GL P+L L L N + +
Sbjct: 177 -----------------------RIADTNITT-IPQ--GLPPSLTELHLDGNKIT-KVDA 209
Query: 355 E-LGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVL 413
L L L KL LS N+++ N +L +L L +N L +P + + ++ V+
Sbjct: 210 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 268
Query: 414 DVSMNNLDGSIPP-------HLCMYQKLIFLSLGSNRLS-GNIPPGLKTCRSLMQLMLGQ 465
+ NN+ +I + +SL SN + I P
Sbjct: 269 YLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST------------- 314
Query: 466 NQLTGSLPIEFYNLQNLSALELYQNR 491
F + +A++L +
Sbjct: 315 ----------FRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 60/326 (18%), Positives = 112/326 (34%), Gaps = 55/326 (16%)
Query: 74 VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
+DL ++ I +L L + N ++ P A LE L L N+L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 134 GVIPFQLFFINTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLT-GAIPASI-SK 190
+P ++ TL++L + EN I ++ + + L + + + +N L I
Sbjct: 114 -ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 191 LRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQN 250
+++L IR +++ IP + L L L N + + L+ L NL L L N
Sbjct: 170 MKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 226
Query: 251 HLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGN 310
+S A+ S + L++L++ N+L +P L +
Sbjct: 227 SIS----------------AVDNGSLAN--------TPHLRELHLNNNKLV-KVPGGLAD 261
Query: 311 CTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSIN 370
+ L N ++ I + C + L N
Sbjct: 262 HKYIQVVYLHNNNIS-AIGSN-----DFCPPGYNTK------------KASYSGVSLFSN 303
Query: 371 NLTGTI--PLEFQNLTYLVDLQLFDN 394
+ P F+ + +QL +
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 37/159 (23%), Positives = 60/159 (37%), Gaps = 9/159 (5%)
Query: 529 HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588
HL S L +P +L + LDL N+ T + L NL L L +NK+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 589 TGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNL 648
+ P + L +L L + N +P + LQ L + N ++ V L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQE-LRVHENEITKVRKSVFNGL 144
Query: 649 QMLEALYLDDNQL-IGEIPASMGEQM-SLLVCNLSNNNL 685
+ + L N L I + M L +++ N+
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 807 GAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+G+G G+V GEV+AVKK++ E D F EI L ++H N
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDN 103
Query: 862 IVKLYGFCYHQDSN--LLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEG 915
IVK G CY L+ EY+ GSL + L +K+ LL + +G
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKG 157
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI- 974
+ YL IHRD+ + NIL++ E + +GDFGL K++ P K G
Sbjct: 158 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEY-YKVKEPGESP 211
Query: 975 ----APEYAYTMKVTEKCDIYSFGVVLLELIT 1002
APE K + D++SFGVVL EL T
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH--R 860
+S IG G V++ ++ A+K + L +S+ EI+ L K++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 861 NIVKLYGFCYHQDSNLLLYEYME--NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
I++LY + +Y ME N L L K+ + W+ + E +
Sbjct: 70 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLK--KKKSIDPWERKS-YWKNMLEAVHT 123
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYIAPE 977
+H + I+H D+K N L+ + + DFG+A + S + G+ Y+ PE
Sbjct: 124 IH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 978 -----------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
K++ K D++S G +L + GK+P
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-34
Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 26/221 (11%)
Query: 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH-- 859
+S IG G V++ ++ A+K + L +S+ EI+ L K++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 860 RNIVKLYGFCYHQDSNLLLYEYME--NGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
I++LY + +Y ME N L L K+ + W+ + E +
Sbjct: 116 DKIIRLYDYEITDQY---IYMVMECGNIDLNSWLK--KKKSIDPWERKS-YWKNMLEAVH 169
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYIAP 976
+H + I+H D+K N L+ + + DFG+A + S + G+ Y+ P
Sbjct: 170 TIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 977 E-----------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E K++ K D++S G +L + GK+P
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 806 EGAVIGRGACGTVYKATLANGEV---IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
E +G G GTV K +V +AVK +K + LAE + + ++ + I
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQ---TCLLDWDARYRIALGAAEGLCYL 919
V++ G C +S +L+ E E G L + L N+ +++ + G+ YL
Sbjct: 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYL 133
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI----- 974
+ +HRD+ + N+LL + A + DFGL+K + + A ++G
Sbjct: 134 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL---RADENYYKAQTHGKWPVKWY 187
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
APE K + K D++SFGV++ E + G+ P
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 65/215 (30%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 807 GAVIGRGACGTVYKATLAN-----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+G G G V GE++AVK +K G + + EI L + H +
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 862 IVKLYGFCYHQDSN--LLLYEYMENGSLGEQLHGNKQTC--LLDWDARYRIALGAAEGLC 917
I+K G C + L+ EY+ GSL + L + LL + A EG+
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMA 148
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI--- 974
YLH H IHRD+ + N+LLD + +GDFGLAK + G
Sbjct: 149 YLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVF 202
Query: 975 --APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
APE K D++SFGV L EL+T S
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 807 GAVIGRGACGTVYKATLANGE----VIAVKKIKLRGEGATAD--NSFLAEISTLGKIRHR 860
VIGRG G VY TL + + AVK + + FL E + H
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHP 86
Query: 861 NIVKLYGFCYHQDSNLL-LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
N++ L G C + + L + YM++G L + L A+G+ YL
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL 144
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG------Y 973
+HRD+ + N +LDE+F V DFGLA+ + Y K ++ G +
Sbjct: 145 A---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKW 198
Query: 974 IAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+A E T K T K D++SFGV+L EL+T G P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-34
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 34/218 (15%)
Query: 807 GAVIGRGACGTVYKATL--ANGEVI--AVKKIKLRGEGATADNS----FLAEISTLGKIR 858
+G G+ G V + +G+ + AVK +K + F+ E++ + +
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK---PDVLSQPEAMDDFIREVNAMHSLD 79
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQT----CLLDWDARYRIALGAAE 914
HRN+++LYG ++ E GSL ++L ++ L + A+ AE
Sbjct: 80 HRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAE 132
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
G+ YL IHRD+ + N+LL +GDFGL + + + + +
Sbjct: 133 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL---PQNDDHYVMQEHRKV 186
Query: 975 -----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
APE T + D + FGV L E+ T G+ P
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 60/299 (20%), Positives = 110/299 (36%), Gaps = 61/299 (20%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHR 860
F E IG G G+V+K +G + A+K+ K G+ + + L E+ + +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 861 NIVKLYGFCYHQDSNLLLY-EYMENGSLGEQL-HGNKQTCLLDWDARYRIALGAAEGLCY 918
++V+ + + +D ++L+ EY GSL + + + + L GL Y
Sbjct: 72 HVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHV-------------------GDFGLAKLIDLP 959
+H ++H DIK +NI + + GD G I P
Sbjct: 131 IH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 960 YSKSMSAIAGSYGYIAPE-----YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG 1014
+ G ++A E Y + K DI++ + ++ + ++ G
Sbjct: 188 QVE-----EGDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPLPRN----G 234
Query: 1015 DLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
D +R+ +P LS +E T LK+ P RP+ +
Sbjct: 235 DQWHEIRQGRLPRIPQ--------VLS-----QEFTELLKV---MIHPDPERRPSAMAL 277
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-34
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 809 VIGRGACGTVYKATL---ANGEV-IAVKKIKLRGEGATADN--SFLAEISTLGKIRHRNI 862
V+G G G V L + E+ +A+K +K G T FL E S +G+ H NI
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
++L G +++ EYMENGSL L + + G A G+ YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLS-- 164
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI-----APE 977
+HRD+ + NIL++ V DFGL +++ +A G I +PE
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL---EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 978 YAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
K T D++S+G+VL E+++ G+ P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 809 VIGRGACGTVYKATLANGEV-----IAVKKIKLRGEGATADN--SFLAEISTLGKIRHRN 861
VIG G G VYK L +A+K +K G T FL E +G+ H N
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
I++L G +++ EYMENG+L + L + G A G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLA- 164
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI-----AP 976
+ +HRD+ + NIL++ V DFGL++++ + S G I AP
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEATYTTSGGKIPIRWTAP 219
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
E K T D++SFG+V+ E++T G+ P
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-34
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHRNIVKLY 866
IG+G+ G V+K +V+A+K I L E A + EI+ L + + K Y
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDL--EEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 867 GFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
G Y +D+ L ++ EY+ GS + L LD I +GL YLH
Sbjct: 87 G-SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLH---SE 138
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
IHRDIK+ N+LL E + + DFG+A + K + + + ++APE
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYD 197
Query: 986 EKCDIYSFGVVLLELITGKSP 1006
K DI+S G+ +EL G+ P
Sbjct: 198 SKADIWSLGITAIELARGEPP 218
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 807 GAVIGRGACGTVYKATLANGEV----IAVKKIKLRGEGATADNS--FLAEISTLGKIRHR 860
++G G G VY+ N + +AVK K + T DN F++E + + H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQT----CLLDWDARYRIALGAAEGL 916
+IVKL G ++ ++ E G LG L NK + L+ + +L + +
Sbjct: 74 HIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY------SLQICKAM 126
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYGYI- 974
YL + +HRDI NIL+ +GDFGL++ I D Y K+ S +
Sbjct: 127 AYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA------SVTRLP 177
Query: 975 ----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+PE + T D++ F V + E+++ GK P
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 49/212 (23%), Positives = 80/212 (37%), Gaps = 23/212 (10%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHR 860
+F + +G G+ G V+K +G + AVK+ G LAE+ + K+ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 861 NIVKLYGFCYHQDSNLLLY-EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
V+L + + L L E SL + L + L +L
Sbjct: 118 CCVRLEQ-AWEEGGILYLQTELCG-PSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE-- 977
H ++H D+K NI L + +GDFGL + + G Y+APE
Sbjct: 174 H---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--GAGEVQEGDPRYMAPELL 228
Query: 978 ---YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y D++S G+ +LE+
Sbjct: 229 QGSY------GTAADVFSLGLTILEVACNMEL 254
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 48/213 (22%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 810 IGRGACGTVYKATL--ANGEV-IAVKKIKLRGEGATADNS--FLAEISTLGKIRHRNIVK 864
+G G G+V + ++ +A+K +K +G ++ + E + ++ + IV+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQT----CLLDWDARYRIALGAAEGLCYLH 920
L G C ++ +L+ E G L + L G ++ + + + G+ YL
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL------LHQVSMGMKYL- 126
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI---DLPYSKSMSA---IAGSYGYI 974
+ +HRD+ + N+LL A + DFGL+K + D Y+ + + +
Sbjct: 127 --EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WY 180
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
APE K + + D++S+GV + E ++ G+ P
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 807 GAVIGRGACGTVYKATL----ANGEV-IAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
V+G G GTV+K + ++ + +K I+ G + + + +G + H +
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEGLC 917
IV+L G C S L+ +Y+ GSL + + ++ LL+W + A+G+
Sbjct: 77 IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMY 129
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSA---IAGSYG 972
YL ++HR++ + N+LL Q V DFG+A L+ D A I
Sbjct: 130 YLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK---- 182
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++A E + K T + D++S+GV + EL+T G P
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 58/219 (26%), Positives = 90/219 (41%), Gaps = 33/219 (15%)
Query: 806 EGAVIGRGACGTVYKATLANGE----VIAVKKIKLRGEGATAD--NSFLAEISTLGKIRH 859
VIG+G G VY + A+K + +FL E + + H
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNH 81
Query: 860 RNIVKLYGFCYHQD-SNLLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAE 914
N++ L G + +L YM +G L + + ++ L+ L A
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS------FGLQVAR 135
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG-- 972
G+ YL +HRD+ + N +LDE F V DFGLA+ I + ++
Sbjct: 136 GMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHAR 189
Query: 973 ----YIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ A E T + T K D++SFGV+L EL+T G P
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG+GA GTVY A +A G+ +A++++ L + + EI + + ++ NIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIINEILVMRENKNPNIVNYLD- 84
Query: 869 CYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
Y L ++ EY+ GSL + + +D + + L +LH + +
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEK 987
IHRDIKS+NILL + + DFG I SK + + Y ++APE K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPK 196
Query: 988 CDIYSFGVVLLELITGKSP 1006
DI+S G++ +E+I G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G+ G V A +G +AVK + L E+ + +H N+V++Y
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDL--RKQQRRELLFNEVVIMRDYQHFNVVEMYK- 109
Query: 869 CYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
Y L +L E+++ G+L + + + L+ + + + L YLH +
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLH---AQGV 162
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEK 987
IHRDIKS++ILL + + + DFG I K S + Y ++APE +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-WMAPEVISRSLYATE 221
Query: 988 CDIYSFGVVLLELITGKSP 1006
DI+S G++++E++ G+ P
Sbjct: 222 VDIWSLGIMVIEMVDGEPP 240
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-33
Identities = 46/214 (21%), Positives = 78/214 (36%), Gaps = 25/214 (11%)
Query: 809 VIGRGAC--GTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
VIG+G TV A GE + V++I L E+ H NIV
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 866 YGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR 924
+ D+ L ++ +M GS + + + + + Y I G + L Y+H
Sbjct: 92 RA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-ILQGVLKALDYIH---H 146
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI------APE- 977
+HR +K+++IL+ + + ++ + + + +PE
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 978 -----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y K DIYS G+ EL G P
Sbjct: 207 LQQNLQGY----DAKSDIYSVGITACELANGHVP 236
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 54/234 (23%), Positives = 91/234 (38%), Gaps = 26/234 (11%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
++ +G G V L +G A+K+I + E H N
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPN 87
Query: 862 IVKLYGFCYHQDSN----LLLYEYMENGSLGEQL--HGNKQTCLLDWDARYRIALGAAEG 915
I++L +C + LL + + G+L ++ +K L + + LG G
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRG 146
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIA------- 968
L +H HRD+K NILL +E Q + D G + S A+
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 969 -GSYGYIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLV 1017
+ Y APE ++ + + E+ D++S G VL ++ G+ P + GD V
Sbjct: 204 RCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 13/208 (6%)
Query: 801 TGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH 859
F +G G+ G+VYKA G+++A+K++ + + + EIS + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDS 83
Query: 860 RNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
++VK YG Y ++++L ++ EY GS+ + + +T L D I +GL Y
Sbjct: 84 PHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEY 140
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
LH+ IHRDIK+ NILL+ E A + DFG+A + +K + I + ++APE
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEV 196
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ DI+S G+ +E+ GK P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 801 TGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-R 858
G F ++G G G VYK + G++ A+K + + G+ + EI+ L K
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSH 79
Query: 859 HRNIVKLYGFCY------HQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALG 911
HRNI YG + D L L+ E+ GS+ + + K L + Y I
Sbjct: 80 HRNIATYYG-AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICRE 137
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY 971
GL +LH + +IHRDIK N+LL E + + DFG++ +D + + I G+
Sbjct: 138 ILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTP 193
Query: 972 GYIAPEYAYTMKVTE-----KCDIYSFGVVLLELITGKSP 1006
++APE + + K D++S G+ +E+ G P
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 807 GAVIGRGACGTVYKATL---ANGEV-IAVKKIKLRGEGATADNS--FLAEISTLGKIRHR 860
G IG G G V++ N + +A+K K + FL E T+ + H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHP 76
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQT----CLLDWDARYRIALGAAEGL 916
+IVKL G ++ ++ E G L L K + L+ + A + L
Sbjct: 77 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY------AYQLSTAL 129
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSA---IAGSYG 972
YL +HRDI + N+L+ +GDFGL++ + D Y K+ I
Sbjct: 130 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---- 182
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++APE + T D++ FGV + E++ G P
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 807 GAVIGRGACGTVYKATLA----NGEV-IAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
V+G GA GTVYK ++ +A+K+++ A+ L E + + + +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPH 78
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEGLC 917
+ +L G C + L+ + M G L + + +K LL+W + A+G+
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMN 131
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI--- 974
YL ++HRD+ + N+L+ + DFGLAKL+ G +
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG----AEEKEYHAEGGKVPIK 184
Query: 975 --APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
A E T + D++S+GV + EL+T G P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 47/221 (21%), Positives = 82/221 (37%), Gaps = 23/221 (10%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
+ ++G+GA V++ G++ A+K D + E L K+ H+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV-QMREFEVLKKLNHK 67
Query: 861 NIVKLYGFCYHQDSNLLLY---EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
NIVKL+ + + E+ GSL L L + G+
Sbjct: 68 NIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAH----VGDFGLAKLIDLPYSKSMSAIAGSYGY 973
+L I+HR+IK NI+ + DFG A+ ++ + ++ G+ Y
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEY 181
Query: 974 IAPE--------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ P+ + K D++S GV TG P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-33
Identities = 36/313 (11%), Positives = 72/313 (23%), Gaps = 55/313 (17%)
Query: 799 EATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGK 856
+ + G V+ + E A+K + E + ++ +
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 857 IRHRNIVKLYGFC--------------------------YHQDSNLLLYEYMENGSLGEQ 890
+ + + Y + LLL L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELL 177
Query: 891 LHGNKQTC----LLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH 946
A + + L ++H +N+ + + +
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLM 234
Query: 947 VGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY--AYTMKVTEKCDIYSFGVVLLELITGK 1004
+GD A + Y E+ A T T + + G+ + +
Sbjct: 235 LGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
Query: 1005 SPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS--AKRTVEEMTLFLKIALFCSST 1062
P + G +W R S+ S F L K + L
Sbjct: 291 LPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF---LNF------- 339
Query: 1063 SPLNRPTMREVIA 1075
R E +
Sbjct: 340 DRRRRLLPLEAME 352
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
+G GA G VYKA G + A K I+ + E D ++ EI L H IVKL G
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YIVEIEILATCDHPYIVKLLG 83
Query: 868 FCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
Y+ D L ++ E+ G++ + + + E L +LH
Sbjct: 84 -AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK---R 137
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTE 986
IIHRD+K+ N+L+ E + DFG++ K S I Y ++APE + +
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY-WMAPEVVMCETMKD 196
Query: 987 -----KCDIYSFGVVLLELITGKSP 1006
K DI+S G+ L+E+ + P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPP 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 14/205 (6%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA----EISTLGKIRHRN 861
+G G TVY A +A+K + L E+ ++ H+N
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKA--IFIPPRE-KEETLKRFEREVHNSSQLSHQN 72
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
IV + D L+ EY+E +L E + + L D +G+ + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH- 128
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
I+HRDIK NIL+D + DFG+AK + + + G+ Y +PE A
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 982 MKVTEKCDIYSFGVVLLELITGKSP 1006
E DIYS G+VL E++ G+ P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 807 GAVIGRGACGTVYKATLANGE----VIAVKKIKLRGEGATAD--NSFLAEISTLGKIRHR 860
VIGRG G VY TL + + AVK + + FL E + H
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHP 150
Query: 861 NIVKLYGFCYHQDSNLLL-YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
N++ L G C + + L+ YM++G L + L A+G+ +L
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL 208
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI-AGSYGYI---- 974
+HRD+ + N +LDE+F V DFGLA+ + Y K ++ + +
Sbjct: 209 A---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTGAKLPVKW 262
Query: 975 -APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
A E T K T K D++SFGV+L EL+T G P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-32
Identities = 56/207 (27%), Positives = 82/207 (39%), Gaps = 23/207 (11%)
Query: 807 GAVIGRGACGTVYKA--TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK 864
I G G +Y A NG + +K + G+ A A +AE L ++ H +IV+
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 865 LYGFCYHQD--SNLLLY---EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
++ F H D + + Y EY+ SL L L L YL
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYL 198
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA 979
H +++ D+K NI+L EE Q + D G I+ S + G+ G+ APE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPEIV 249
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSP 1006
T T DIY+ G L L
Sbjct: 250 RT-GPTVATDIYTVGRTLAALTLDLPT 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 68/215 (31%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHRNIVKLY 866
VIG GA V A E +A+K+I L E + L EI + + H NIV Y
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 867 GFCYHQDSNL-LLYEYMENGSL-----GEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+ L L+ + + GS+ G ++ +LD I EGL YLH
Sbjct: 80 T-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFG----LAKLIDLPYSKSMSAIAGSYGYIAP 976
+ IHRD+K+ NILL E+ + DFG LA D+ +K G+ ++AP
Sbjct: 139 ---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 977 E-----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E Y K DI+SFG+ +EL TG +P
Sbjct: 196 EVMEQVRGY----DFKADIWSFGITAIELATGAAP 226
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 78/353 (22%), Positives = 128/353 (36%), Gaps = 86/353 (24%)
Query: 778 NPEVIDNYYFPKEG---FKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGE------V 828
N ID P + F + L S G +G GA G V +AT
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRL-------SFGKTLGAGAFGKVVEATAYGLIKSDAAMT 55
Query: 829 IAVKKIKLRGEGATAD--NSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMENG 885
+AVK +K A + ++E+ L + H NIV L G C L++ EY G
Sbjct: 56 VAVKMLK---PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 112
Query: 886 SLGEQLHGNKQTCLLDWDAR---------------YRIALGAAEGLCYLHYDCRPHIIHR 930
L L + + + + + A+G+ +L + IHR
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHR 169
Query: 931 DIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKS---------MSAIAGSYGYIAPEYA 979
D+ + NILL + DFGLA+ I D Y M APE
Sbjct: 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM----------APESI 219
Query: 980 YTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVP----TSELF 1034
+ T + D++S+G+ L EL + G SP + + ++ M+ +E++
Sbjct: 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG-FRMLSPEHAPAEMY 278
Query: 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087
D I C PL RPT ++++ ++ +++
Sbjct: 279 D-------------------IMKTCWDADPLKRPTFKQIVQLIEKQISESTNH 312
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 19/228 (8%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA----EISTLGKIRHRN 861
++GRG G VY+A ++A+K + + +D F E T G+++ +
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKL--MSETLS-SDPVFRTRMQREARTAGRLQEPH 95
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
+V ++ F + + L L L I L H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH- 151
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
HRD+K NIL+ + A++ DFG+A + G+ Y+APE
Sbjct: 152 --AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029
T + DIY+ VL E +TG P Q GD ++ + I++ +P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQ-----GDQLSVMGAHINQAIP 252
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 74/329 (22%), Positives = 130/329 (39%), Gaps = 61/329 (18%)
Query: 807 GAVIGRGACGTVYKATLANGEV---IAVKKIKLRGEGATAD--NSFLAEISTLGKI-RHR 860
VIG G G V KA + + A+K++K E A+ D F E+ L K+ H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHP 86
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY-------------R 907
NI+ L G C H+ L EY +G+L + L ++ A
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 908 IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967
A A G+ YL + IHRD+ + NIL+ E + A + DFGL++ ++ K+M +
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 968 AGSYGYI---APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRS 1023
+ A E T D++S+GV+L E+++ G +P + +L + +
Sbjct: 204 P-----VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQG 257
Query: 1024 IHEMVP----TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079
+ + E++D + C P RP+ +++ +
Sbjct: 258 -YRLEKPLNCDDEVYD-------------------LMRQCWREKPYERPSFAQILVSLNR 297
Query: 1080 ARQSVSDY--PSSPTSETPLEADASSRDS 1106
+ Y + T D S+ ++
Sbjct: 298 MLEERKTYVNTTLYEKFTYAGIDCSAEEA 326
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-32
Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRN 861
+F V+G GA GT+ + + +AVK+I + AD E+ L + H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-SFADR----EVQLLRESDEHPN 79
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
+++ + + + E +L E + K L + + GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLEPI-TLLQQTTSGLAHLH- 135
Query: 922 DCRPHIIHRDIKSNNILLDE-----EFQAHVGDFGLAKLIDLPYS--KSMSAIAGSYGYI 974
+I+HRD+K +NIL+ + +A + DFGL K + + S + G+ G+I
Sbjct: 136 --SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 975 APEY---AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
APE T DI+S G V +I+ S
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVK---KIKLRGEGATADNSFLAEISTLGKI 857
+F G ++G+G+ VY+A + G +A+K K + G E+ ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV--QRVQNEVKIHCQL 68
Query: 858 RHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
+H +I++LY + + + L+ E NG + L N+ + +AR+ + G+
Sbjct: 69 KHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMH-QIITGM 125
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
YLH I+HRD+ +N+LL + DFGLA + +P+ K + + G+ YI+P
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISP 181
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E A + D++S G + L+ G+ P
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHRNIVKLY 866
IG G+ G VY A + N EV+A+KK+ G+ + + E+ L K+RH N ++
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 867 GFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
G CY ++ L+ EY GS + L +K+ A + GA +GL YLH
Sbjct: 121 G-CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAYLHSH--- 173
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVT 985
++IHRD+K+ NILL E +GDFG A ++ + + S + Y ++APE M
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPY-WMAPEVILAMDEG 228
Query: 986 E---KCDIYSFGVVLLELITGKSP 1006
+ K D++S G+ +EL K P
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPP 252
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-32
Identities = 68/265 (25%), Positives = 119/265 (44%), Gaps = 21/265 (7%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLA-EISTLGKIRHRNIVKLY 866
+G G G V+K + +G V+A K I L E A + + E+ L + IV Y
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 867 GFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
G ++ D + + E+M+ GSL + L K+ + ++++ +GL YL
Sbjct: 98 G-AFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKH-- 151
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLA-KLIDLPYSKSMSA-IAGSYGYIAPEYAYTMK 983
I+HRD+K +NIL++ + + DFG++ +LID SM+ G+ Y++PE
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTH 206
Query: 984 VTEKCDIYSFGVVLLELITGKSP---VQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040
+ + DI+S G+ L+E+ G+ P + EL V E P + L+
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 1041 SAKRTVEEMTLFLKIALFCSSTSPL 1065
+ M +F + + P
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPK 291
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 46/224 (20%), Positives = 81/224 (36%), Gaps = 42/224 (18%)
Query: 807 GAVIGRGACGTVYKATLANGEV--------IAVKKIKLRGEGAT-ADNSFLAEISTLGKI 857
+G+G ++K + +K + + SF S + K+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNYSESFFEAASMMSKL 69
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
H+++V YG C D N+L+ E+++ GSL L NK + W + +A A +
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMH 127
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAH--------VGDFGLAKLIDLPYSKSMSAIAG 969
+L +IH ++ + NILL E + D G++ +
Sbjct: 128 FLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL----------PK 174
Query: 970 SYGYI-----APE-YAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
PE + D +SFG L E+ + G P
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 48/220 (21%), Positives = 84/220 (38%), Gaps = 23/220 (10%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+ ++G+GA V++ G++ A+K D + E L K+ H+N
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV-QMREFEVLKKLNHKN 68
Query: 862 IVKLYGFCYHQDSNLLLY---EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
IVKL+ + + E+ GSL L L + G+ +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 919 LHYDCRPHIIHRDIKSNNILL----DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
L I+HR+IK NI+ D + + DFG A+ ++ + ++ G+ Y+
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYL 182
Query: 975 APE--------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
P+ + K D++S GV TG P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-31
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 807 GAVIGRGACGTVYKATLANGE----VIAVKKIKLRGEGATADNS--FLAEISTLGKIRHR 860
G IG G G V++ + E +A+K K + FL E T+ + H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHP 451
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEGL 916
+IVKL G ++ ++ E G L L K + L+ + A + L
Sbjct: 452 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILY------AYQLSTAL 504
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSA---IAGSYG 972
YL +HRDI + N+L+ +GDFGL++ + D Y K+ I
Sbjct: 505 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---- 557
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
++APE + T D++ FGV + E++ G P
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 810 IGRGACGTVYKATLANGE------VIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHRNI 862
+G GA G V+ A N ++AVK +K + A F E L ++H +I
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK---DPTLAARKDFQREAELLTNLQHEHI 79
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYR-------------IA 909
VK YG C D ++++EYM++G L + L + ++ D + R IA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIA 968
A G+ YL H +HRD+ + N L+ +GDFG+++ + Y +
Sbjct: 140 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-----V 191
Query: 969 GSYGYI-----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
G + + PE K T + D++SFGV+L E+ T GK P
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVK---KIKLRGEGATADNSFLAEISTLGKI 857
+ G +G+G ++ + EV A K K L EIS +
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSL 72
Query: 858 RHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
H+++V +G + + + ++ E SL E K L + +ARY G
Sbjct: 73 AHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARY-YLRQIVLGC 128
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
YLH R +IHRD+K N+ L+E+ + +GDFGLA ++ + + G+ YIAP
Sbjct: 129 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 184
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E + + D++S G ++ L+ GK P
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 62/221 (28%), Positives = 88/221 (39%), Gaps = 16/221 (7%)
Query: 799 EATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI 857
+ G + +G G G V + GE +A+K+ + + L EI + K+
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKL 69
Query: 858 RHRNIVKLY------GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALG 911
H N+V D LL EY E G L + L+ + C L +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH---VGDFGLAKLIDLPYSKSMSAIA 968
+ L YLH IIHRD+K NI+L Q + D G AK +D +
Sbjct: 130 ISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV- 184
Query: 969 GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009
G+ Y+APE K T D +SFG + E ITG P
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVK---KIKLRGEGATADNSFLAEISTLGKI 857
+ G +G+G ++ + EV A K K L EIS +
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSL 98
Query: 858 RHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
H+++V +G + + + ++ E SL E ++ L + +ARY G
Sbjct: 99 AHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGC 154
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
YLH R +IHRD+K N+ L+E+ + +GDFGLA ++ + + G+ YIAP
Sbjct: 155 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 210
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E + + D++S G ++ L+ GK P
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 807 GAVIGRGACGTVYKATLANGE------VIAVKKIKLRGEGATAD--NSFLAEISTLGKIR 858
+G+G+ G VY+ +A+K + E A+ FL E S + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFN 86
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR-------YRIALG 911
++V+L G L++ E M G L L + + ++A
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP--YSKSMSAIAG 969
A+G+ YL+ +HRD+ + N ++ E+F +GDFG+ + I Y K G
Sbjct: 147 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK------G 197
Query: 970 SYGYI-----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
G + +PE T D++SFGVVL E+ T + P
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGK-IRHRNIVKL 865
IGRGA G+V K +G+++AVK+I+ + L ++ + + IV+
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRS--TVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 866 YGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARY--RIALGAAEGLCYLHYD 922
YG ++ + + E M + S + +I L + L +L +
Sbjct: 87 YG-ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGL-AKLIDLPYSKSMSAIAGSYGYIAPE---- 977
IIHRDIK +NILLD + DFG+ +L+D S + + AG Y+APE
Sbjct: 145 L--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDP 199
Query: 978 YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
A + D++S G+ L EL TG+ P
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 807 GAVIGRGACGTVYKATLANGE----VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
G ++G G G+V + L + +AVK +KL FL+E + + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 863 VKLYGFCYHQDSN-----LLLYEYMENGSLGEQLHGNK---QTCLLDWDARYRIALGAAE 914
++L G C S +++ +M+ G L L ++ + + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP--YSKSMSAIAGSYG 972
G+ YL + +HRD+ + N +L ++ V DFGL+K I Y + G
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ------GRIA 209
Query: 973 YI-----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ A E T K D+++FGV + E+ T G +P
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVK---KIKLRGEGATADNSFLAEISTLGKI 857
+F G +G+G G VY A + ++A+K K +L G + E+ +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQSHL 66
Query: 858 RHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
RH NI++LYG+ +H + + L+ EY G++ +L K + + A L
Sbjct: 67 RHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANAL 122
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
Y H +IHRDIK N+LL + + DFG + S + + G+ Y+ P
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPP 176
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E EK D++S GV+ E + GK P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-31
Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 23/244 (9%)
Query: 772 PLEEQKNPEVIDNYYFPKEGFKYHNLLEATGNFSE----GAVIGRGACGTVYKAT-LANG 826
++N + F + G+ SE +G GA G V
Sbjct: 7 HSSGRENLYFQGDLQATPGMF----ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62
Query: 827 EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL-LLYEYMENG 885
A+K I+ ++++ L E++ L + H NI+KLY F + N L+ E + G
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGG 121
Query: 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEE 942
L +++ + + DA I G+ YLH + +I+HRD+K N+LL +++
Sbjct: 122 ELFDEI--IHRMKFNEVDAA-VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKD 175
Query: 943 FQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT 1002
+ DFGL+ + + K M G+ YIAPE K EKCD++S GV+L L+
Sbjct: 176 ALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLA 232
Query: 1003 GKSP 1006
G P
Sbjct: 233 GYPP 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA----EISTLGKIRHRN 861
G ++G G V+ A L + +AVK LR + A D SF E + H
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKV--LRADLAR-DPSFYLRFRREAQNAAALNHPA 73
Query: 862 IVKLYGFCYHQDSNLLLY----EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
IV +Y + L EY++ +L + +H + + A + L
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALN 130
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM---SAIAGSYGYI 974
+ H + IIHRD+K NI++ V DFG+A+ I S+ +A+ G+ Y+
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYL 186
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+PE A V + D+YS G VL E++TG+ P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 50/229 (21%), Positives = 84/229 (36%), Gaps = 41/229 (17%)
Query: 807 GAVIGRGACGTVYKATLANGE------VIAVKKIKLRGEGATAD--NSFLAEISTLGKIR 858
+G G VYK L +A+K +K + A F E +++
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQ 70
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYR----------- 907
H N+V L G +++ Y +G L E L + R
Sbjct: 71 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 908 --IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP--YSKS 963
+ A G+ YL H++H+D+ + N+L+ ++ + D GL + + Y
Sbjct: 131 VHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL- 186
Query: 964 MSAIAGSYGYI-----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ APE K + DI+S+GVVL E+ + G P
Sbjct: 187 -----LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 30/221 (13%)
Query: 807 GAVIGRGACGTVYKATLANGE----VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
G ++G+G G+V +A L + +AVK +K ++ FL E + + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 863 VKLYGFCYHQDSN------LLLYEYMENGSLGEQLHGNK---QTCLLDWDARYRIALGAA 913
KL G + +++ +M++G L L ++ L R + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP--YSKSMSAIAGSY 971
G+ YL + IHRD+ + N +L E+ V DFGL++ I Y + G
Sbjct: 148 CGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ------GCA 198
Query: 972 GYI-----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ A E T D+++FGV + E++T G++P
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-30
Identities = 47/208 (22%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 809 VIGRGACGTVYKATL--ANGEV-IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
+G G G+V + ++ +A+K +K +G + E + ++ + IV+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
G C ++ +L+ E G L + L G ++ + + + G+ YL
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEK 455
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLI---DLPYSKSMSA---IAGSYGYIAPEYA 979
+ +HR++ + N+LL A + DFGL+K + D Y+ + + + APE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECI 511
Query: 980 YTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
K + + D++S+GV + E ++ G+ P
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-30
Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 48/248 (19%)
Query: 807 GAVIGRGACGTVYKATLA-----NGEV-IAVKKIKLRGEGATAD--NSFLAEISTLGKI- 857
G +G GA G V +AT + + +AVK +K A AD + ++E+ + +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLG 107
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY----------- 906
+H NIV L G C H L++ EY G L L + D
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 907 RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKS- 963
+ A+G+ +L + IHRD+ + N+LL A +GDFGLA+ I D Y
Sbjct: 168 HFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 964 --------MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGG 1014
M APE + T + D++S+G++L E+ + G +P + +
Sbjct: 225 NARLPVKWM----------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274
Query: 1015 DLVTWVRR 1022
V+
Sbjct: 275 KFYKLVKD 282
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 57/288 (19%)
Query: 768 PAFVPLEEQKN--PEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLAN 825
P +PL+E P + FP++ K G +GRGA G V +A
Sbjct: 3 PDELPLDEHCERLPYDASKWEFPRDRLKL------------GKPLGRGAFGQVIEADAFG 50
Query: 826 GE------VIAVKKIKLRGEGATAD--NSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNL 876
+ +AVK +K EGAT + ++E+ L I H N+V L G C L
Sbjct: 51 IDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107
Query: 877 LL-YEYMENGSLGEQLHGNKQTCLLDWDARYR-------------IALGAAEGLCYLHYD 922
++ E+ + G+L L + + A + A+G+ +L
Sbjct: 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-- 165
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYI-----A 975
IHRD+ + NILL E+ + DFGLA+ I D Y + + A
Sbjct: 166 -SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR------KGDARLPLKWMA 218
Query: 976 PEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRR 1022
PE + T + D++SFGV+L E+ + G SP +++ + ++
Sbjct: 219 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-30
Identities = 56/295 (18%), Positives = 99/295 (33%), Gaps = 37/295 (12%)
Query: 303 TIPHELGNCTSAVEIDLSENQLTGFIPRELGLIP----NLCLLQLFENMLQGSIPRELGQ 358
+I + N S + + N ++G + L N +
Sbjct: 2 SIMLPINNNFS-LSQNSFYNTISG-TYADYFSAWDKWEKQALPGENRNEAVSLLKE--CL 57
Query: 359 LTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMN 418
+ Q +L L+ NL+ ++P + L++ N L ++P L LD N
Sbjct: 58 INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACDN 110
Query: 419 NLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYN 478
L ++P L L + +N+L+ +P L + NQLT LP
Sbjct: 111 RLS-TLPELPA---SLKHLDVDNNQLT-MLPELP---ALLEYINADNNQLT-MLPEL--- 158
Query: 479 LQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHL----VTFN 534
+L L + N+ + L P +LE L +S N +P+ H + F
Sbjct: 159 PTSLEVLSVRNNQLTFL-PELPE---SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
Query: 535 ISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
N ++ IP + + + L N + E L Q +
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 65/408 (15%), Positives = 113/408 (27%), Gaps = 78/408 (19%)
Query: 112 IPTDLANC--SSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTS 169
+ L C + L L L +P L + L + +N + +PE +L
Sbjct: 49 AVSLLKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASLEY 104
Query: 170 LEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLE 229
L+ N L+ +P + L+ L V +N L+ +P + LE + N L
Sbjct: 105 LD---ACDNRLS-TLPELPASLKHLDV---DNNQLTM-LPELPA---LLEYINADNNQLT 153
Query: 230 GFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSR 289
LP E +L L + N L+ +P + LE L + N LP +
Sbjct: 154 -MLP---ELPTSLEVLSVRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHH 204
Query: 290 LKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349
++ ++ EN++T
Sbjct: 205 SEETEIF--------------------FRCRENRIT------------------------ 220
Query: 350 GSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSH 409
IP + L + L N L+ I T D + ++ H
Sbjct: 221 -HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLH 277
Query: 410 LSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLT 469
+ D + + +N S L S + Q+
Sbjct: 278 RPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQVA 336
Query: 470 GSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFV 517
L L + L + L +L + V
Sbjct: 337 AWLE----KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 43/246 (17%), Positives = 81/246 (32%), Gaps = 46/246 (18%)
Query: 459 MQLMLGQNQLTGSLPIEFYN---------------LQNLSALELYQNRFSGLIPPEIGKL 503
M +ML N FYN + + +N L+ +
Sbjct: 1 MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLI 58
Query: 504 RNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQ 563
L L+ +P + + I+ N+L ++P +L+ LD N+
Sbjct: 59 NQFSELQLNRLNLSS-LPDNLPP--QITVLEITQNALI-SLPELPA---SLEYLDACDNR 111
Query: 564 FTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQL 623
+ + PE L + L + +N+LT +P L + N + +P L
Sbjct: 112 LS-TLPELPASLKH---LDVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELPTSL 162
Query: 624 TALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSL----LVCN 679
L++ +N L+ +P +L+ L + N L +PA +
Sbjct: 163 E----VLSVRNNQLT-FLPELPESLEA---LDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213
Query: 680 LSNNNL 685
N +
Sbjct: 214 CRENRI 219
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 33/230 (14%), Positives = 71/230 (30%), Gaps = 15/230 (6%)
Query: 95 LPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRK----LY 150
L ++ N +T +P SLE LD+ TN L +P + +
Sbjct: 159 PTSLEVLSVRNNQLT-FLPELP---ESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
Query: 151 LCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPP 210
EN I IPE I +L +++ N L+ I S+S+ +
Sbjct: 214 CRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSD 270
Query: 211 EISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLA 270
+ S++ ++ + + N S + + +
Sbjct: 271 GQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSG 330
Query: 271 LHENSFSGGLPKELGKLSRL-KKLYVYTNELNGTIPHELGNCTSAVEIDL 319
E + ++L + L ++ + + + + + + L
Sbjct: 331 FREQVAA--WLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTL 378
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 67/306 (21%), Positives = 114/306 (37%), Gaps = 24/306 (7%)
Query: 389 LQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPH-LCMYQKLIFLSLGSNRLSGN 447
+Q D L+ +P I + ++LD+ N++ + Q L L L +N++S
Sbjct: 38 VQCSDLGLK-AVPKEISPD--TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-K 92
Query: 448 IPPG-LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNL 506
I R L +L + +N L +P +L L ++ NR + LRN+
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNM 149
Query: 507 ERLHLSEN-YFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFT 565
+ + N + L IS L+ IP +L L L L N+
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ 206
Query: 566 GSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTA 625
E+L + L L L N++ SL L L EL + N S +P L L
Sbjct: 207 AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265
Query: 626 LQIALNISHNNLSGVIPYELGNLQM------LEALYLDDNQL-IGEIPASMGEQM-SLLV 677
LQ+ + + NN++ V + + + L +N + E+ + + L
Sbjct: 266 LQV-VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324
Query: 678 CNLSNN 683
N
Sbjct: 325 IQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 64/319 (20%), Positives = 114/319 (35%), Gaps = 46/319 (14%)
Query: 303 TIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQL 362
+P E+ +DL N ++ + + +L L L N + + L +L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 363 HKLDLSINNLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLD 421
KL +S N+L IP +L L++ DN + +P GV S L
Sbjct: 105 QKLYISKNHLV-EIPPNLPSSLVE---LRIHDNRIR-KVPK--GVFSGLR---------- 147
Query: 422 GSIPPHLCMYQKLIFLSLGSNRL-SGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQ 480
+ + +G N L + PG L L + + +LT +P + +
Sbjct: 148 -----------NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PE 193
Query: 481 NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNS 539
L+ L L N+ + ++ + L RL L N + I + L L ++ +N
Sbjct: 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ-IRMIENGSLSFLPTLRELHLDNNK 252
Query: 540 LSGTIPHELGNCVNLQRLDLSRNQFTG------SAPEELGQLVNLELLKLSDNKLTGAI- 592
LS +P L + LQ + L N T + + L +N +
Sbjct: 253 LS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311
Query: 593 -PSSLGGLARLTELQMGGN 610
P++ + +Q G
Sbjct: 312 QPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 52/287 (18%), Positives = 97/287 (33%), Gaps = 20/287 (6%)
Query: 288 SRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENM 347
L + N+++ + + L N+++ + + L L + +N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 348 LQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHL-EGTIPPHIGV 406
L IP L + L +L + N + F L + +++ N L P
Sbjct: 114 LV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 407 NSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQ 465
L+ L +S L IP L + L L L N++ I L L +L LG
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH 226
Query: 466 NQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV- 524
NQ+ L L L L N+ S +P + L+ L+ ++L N +
Sbjct: 227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDF 284
Query: 525 ------GNLEHLVTFNISSNSLS-GTIPHELGNCV-NLQRLDLSRNQ 563
+ ++ +N + + CV + + +
Sbjct: 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 67/357 (18%), Positives = 121/357 (33%), Gaps = 60/357 (16%)
Query: 117 ANCS-SLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEE-IGNLTSLEELV 174
C L ++ C++ +P ++ L L N I E+ ++ L L LV
Sbjct: 29 FGCHCHLRVVQ-CSDLGLKAVPKEIS--PDTTLLDLQNNDI-SELRKDDFKGLQHLYALV 84
Query: 175 IYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPS 234
+ +N ++ + S LR+L+ + N L IPP + L L + N +
Sbjct: 85 LVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKG 141
Query: 235 ELEKLRNLTDLILWQNHL-SGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKL 293
LRN+ + + N L + P + L L + E + G+PK+L L +L
Sbjct: 142 VFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNEL 198
Query: 294 YVYTNELNGTIPHE-LGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSI 352
++ N++ I E L + + L NQ+ I N
Sbjct: 199 HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRM--------IENGS----LSF------ 239
Query: 353 PRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSV 412
L L +L L N L+ +P +L L + L N++ + +
Sbjct: 240 ------LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGV--NDFCPVGF 289
Query: 413 LDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLS-GNIPPGLKTC-RSLMQLMLGQNQ 467
+SL +N + + P C + + G +
Sbjct: 290 GVK---------------RAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 14/252 (5%)
Query: 436 FLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGL 495
+ L +P + L L N ++ +F LQ+L AL L N+ S +
Sbjct: 37 VVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKI 93
Query: 496 IPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQ 555
LR L++L++S+N+ V IP + LV I N + N+
Sbjct: 94 HEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMN 150
Query: 556 RLDLSRNQFTGSA-PEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614
+++ N S + L L++S+ KLT IP L L EL + N
Sbjct: 151 CIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ- 206
Query: 615 SIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQM 673
+I + L + + L L + HN + + L L L L+LD+N+L +PA + +
Sbjct: 207 AIELEDLLRYSKLYR-LGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLK 264
Query: 674 SLLVCNLSNNNL 685
L V L NN+
Sbjct: 265 LLQVVYLHTNNI 276
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 66/326 (20%), Positives = 121/326 (37%), Gaps = 37/326 (11%)
Query: 75 TSVDLHGLNLSGILSPRICDLPRLVEF-NISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
V L L + P+ ++ ++ N ++ D L L L N++
Sbjct: 36 RVVQCSDLGLKAV--PK--EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 134 GVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI-SKLR 192
+ + L+KLY+ +N++ EIP + +SL EL I+ N + +P + S LR
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLR 147
Query: 193 QLRVIRAGHNSL-SGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251
+ I G N L + P + L L +++ L G +P +L L +L L N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHNK 204
Query: 252 LSGEIPP-TIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGN 310
+ I + L L L N L L L++L++ N+L+ +P L +
Sbjct: 205 IQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262
Query: 311 CTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSIN 370
+ L N +T + F + + + + L N
Sbjct: 263 LKLLQVVYLHTNNIT-KVGVN-----------DFCPV------GFGVKRAYYNGISLFNN 304
Query: 371 NLTGTI--PLEFQNLTYLVDLQLFDN 394
+ P F+ +T + +Q +
Sbjct: 305 PVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 34/158 (21%), Positives = 58/158 (36%), Gaps = 8/158 (5%)
Query: 529 HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588
HL S L +P E+ + LDL N + ++ L +L L L +NK+
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 589 TGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNL 648
+ + L +L +L + N IP L ++L L I N + V L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVE-LRIHDNRIRKVPKGVFSGL 146
Query: 649 QMLEALYLDDNQL-IGEIPASMGEQMSLLVCNLSNNNL 685
+ + + + N L + + L +S L
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 64/221 (28%), Positives = 86/221 (38%), Gaps = 31/221 (14%)
Query: 807 GAVIGRGACGTVYKATLANGE------VIAVKKIKLRGEGATAD--NSFLAEISTLGKIR 858
+G GA G VY+ ++ +AVK + E + FL E + K
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFN 91
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNK----QTCLLDWDARYRIALGAAE 914
H+NIV+ G +L E M G L L + Q L +A A
Sbjct: 92 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLD---EEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY 971
G YL H IHRDI + N LL A +GDFG+A+ I Y S G
Sbjct: 152 GCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI---YRASYYRKGGC- 204
Query: 972 GYI-----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ PE T K D +SFGV+L E+ + G P
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 67/326 (20%), Positives = 115/326 (35%), Gaps = 81/326 (24%)
Query: 807 GAVIGRGACGTVYKATLANGE------VIAVKKIKLRGEGATAD--NSFLAEISTLGKI- 857
G V+G GA G V AT +AVK +K E A + + ++E+ + ++
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLG 106
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYR---------- 907
H NIV L G C L++EY G L L ++ D
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 908 ----------IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI- 956
A A+G+ +L +HRD+ + N+L+ + DFGLA+ I
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 957 -DLPYSKS---------MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKS 1005
D Y M APE + T K D++S+G++L E+ + G +
Sbjct: 224 SDSNYVVRGNARLPVKWM----------APESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 1006 PVQSLELGGDLVTWVRRSIHEMVP----TSELFDKRLDLSAKRTVEEMTLFLKIALFCSS 1061
P + + + ++ +M T E++ I C +
Sbjct: 274 PYPGIPVDANFYKLIQNG-FKMDQPFYATEEIYI-------------------IMQSCWA 313
Query: 1062 TSPLNRPTMREVIAMMIDARQSVSDY 1087
RP+ + + + +
Sbjct: 314 FDSRKRPSFPNLTSFLGCQLADAEEA 339
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 43/234 (18%)
Query: 804 FSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNI 862
++G G+ GTV G +AVK++ L A EI L + H N+
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALM----EIKLLTESDDHPNV 71
Query: 863 VKLYGFCYHQDSNLLLYEYME--NGSL-----GEQLHGNKQTCLLDWDARYRIALGAAEG 915
++ Y C LY +E N +L + + +++ + A G
Sbjct: 72 IRYY--CSETTDR-FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASG 127
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLD-------------EEFQAHVGDFGLAKLID---LP 959
+ +LH IIHRD+K NIL+ E + + DFGL K +D
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 960 YSKSMSAIAGSYGYIAPE-------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ +++ +G+ G+ APE ++T DI+S G V +++
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 62/225 (27%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 809 VIGRGACGTVYKATLANGE------VIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHRN 861
+G GA G V+ A N ++AVK +K E + + F E L ++H++
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK---EASESARQDFQREAELLTMLQHQH 104
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYR------------IA 909
IV+ +G C L+++EYM +G L L + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP--YSKSMSAI 967
A G+ YL H +HRD+ + N L+ + +GDFG+++ I Y
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV----- 216
Query: 968 AGSYGYI-----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
G + PE K T + D++SFGVVL E+ T GK P
Sbjct: 217 -GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-29
Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 20/220 (9%)
Query: 797 LLEATGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKI-KLRGEGATADNSFLAE 850
+ +T FS+ V+G+G+ G V G+ AVK I K + + T S L E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 851 ISTLGKIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIA 909
+ L ++ H NI+KLY F + L+ E G L +++ + + DA RI
Sbjct: 77 VQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAA-RII 132
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSA 966
G+ Y+H + I+HRD+K N+LL ++ + DFGL+ + SK M
Sbjct: 133 RQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKD 187
Query: 967 IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
G+ YIAPE EKCD++S GV+L L++G P
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGK-IRHRNIVKL 865
+GRGA G V K + +G+++AVK+I+ + + L ++ + + V
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 866 YGFCYHQDSNL-LLYEYMENGSLGEQL-HGNKQTCLLDWDARYRIALGAAEGLCYLHYDC 923
YG ++ ++ + E M + SL + + + D +IA+ + L +LH
Sbjct: 72 YG-ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 924 RPHIIHRDIKSNNILLDEEFQAHVGDFGL-AKLIDLPYSKSMSAIAGSYGYIAPE----- 977
+IHRD+K +N+L++ Q + DFG+ L+D + AG Y+APE
Sbjct: 130 --SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKDIDAGCKPYMAPERINPE 184
Query: 978 ---YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y++ K DI+S G+ ++EL + P
Sbjct: 185 LNQKGYSV----KSDIWSLGITMIELAILRFP 212
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 33/240 (13%), Positives = 61/240 (25%), Gaps = 40/240 (16%)
Query: 804 FSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAE------------ 850
G V+G+ +AT GE V + + E
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 851 -----------ISTLGKIRHRNIVKLYGFCYHQDSN-------LLLYEYMENGSLGEQLH 892
I ++ K+ + L + GE L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 893 GNKQTC-LLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951
+ T L AR ++ L L LH ++H ++ +I+LD+ + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSP 1006
+ A +T D ++ G+ + + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-29
Identities = 60/240 (25%), Positives = 96/240 (40%), Gaps = 26/240 (10%)
Query: 784 NYYFPKEGFKYHNLLEATGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLR- 837
N F + + +G GACG V A + +A++ I R
Sbjct: 113 NKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRK 172
Query: 838 -----GEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLH 892
A + EI L K+ H I+K+ F +D ++L E ME G L +++
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV- 230
Query: 893 GNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGD 949
L + + + YLH IIHRD+K N+LL +E+ + D
Sbjct: 231 -VGNKRLKEATCK-LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD 285
Query: 950 FGLAKLIDLPYSKSMSAIAGSYGYIAPE---YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
FG +K++ + M + G+ Y+APE T D +S GV+L ++G P
Sbjct: 286 FGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-29
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 798 LEATGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEIS 852
L G F+E ++G+G+ G V K + AVK I ++ L E+
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73
Query: 853 TLGKIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALG 911
L K+ H NI+KL+ S+ ++ E G L +++ K+ + DA RI
Sbjct: 74 LLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAA-RIIKQ 129
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAIA 968
G+ Y+H + +I+HRD+K NILL +++ + DFGL+ + M
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI 184
Query: 969 GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
G+ YIAPE EKCD++S GV+L L++G P
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 68/272 (25%), Positives = 107/272 (39%), Gaps = 57/272 (20%)
Query: 767 KPAFVPLEEQKNPEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANG 826
P + E + PE + FP++ G +G GA G V A
Sbjct: 13 DPMLAGVSEYELPE-DPKWEFPRDKLTL------------GKPLGEGAFGQVVMAEAVGI 59
Query: 827 E--------VIAVKKIKLRGEGATAD--NSFLAEISTLGKI-RHRNIVKLYGFCYHQDSN 875
+ +AVK +K + AT + ++E+ + I +H+NI+ L G C
Sbjct: 60 DKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 116
Query: 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYR-------------IALGAAEGLCYLHYD 922
++ EY G+L E L + + R A G+ YL
Sbjct: 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA-- 174
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYI-----A 975
IHRD+ + N+L+ E + DFGLA+ I Y K + G + A
Sbjct: 175 -SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK------TTNGRLPVKWMA 227
Query: 976 PEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
PE + T + D++SFGV++ E+ T G SP
Sbjct: 228 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 62/276 (22%)
Query: 768 PAFVPLEEQKNPEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGE 827
P + ++ K E + FP++ G +G G G V KAT + +
Sbjct: 2 PLSLSVDAFKILE-DPKWEFPRKNLVL------------GKTLGEGEFGKVVKATAFHLK 48
Query: 828 ------VIAVKKIKLRGEGATAD--NSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879
+AVK +K E A+ L+E + L ++ H +++KLYG C LL+
Sbjct: 49 GRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105
Query: 880 EYMENGSLGEQLHGNKQTCLLDWDARY---------------------RIALGAAEGLCY 918
EY + GSL L +++ + A ++G+ Y
Sbjct: 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQY 165
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYI-- 974
L ++HRD+ + NIL+ E + + DFGL++ + + Y K S G I
Sbjct: 166 LA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK------RSQGRIPV 216
Query: 975 ---APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
A E + T + D++SFGV+L E++T G +P
Sbjct: 217 KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNS-FLAEISTLGK-IRHRNIVKL 865
+G G CG V+K G VIAVK+++ G +N L ++ + K IV+
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRR--SGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 866 YGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR 924
+G + ++++ + E M + + + ++ + + L YL
Sbjct: 90 FG-TFITNTDVFIAMELMGTCAEKLKKRMQGP---IPERILGKMTVAIVKALYYLKEK-- 143
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGL-AKLIDLPYSKSMSAIAGSYGYIAPE-----Y 978
+IHRD+K +NILLDE Q + DFG+ +L+D K+ AG Y+APE
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAGCAAYMAPERIDPPD 200
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ D++S G+ L+EL TG+ P
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-29
Identities = 75/273 (27%), Positives = 102/273 (37%), Gaps = 37/273 (13%)
Query: 393 DNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPH-LCMYQKLIFLSLGSNRLSGNIPPG 451
L +P G+ S+ L++ NN+ I L L LG N + I G
Sbjct: 63 RRGLS-EVPQ--GIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVG 117
Query: 452 -LKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSGLIPPEI-GKLRNLER 508
SL L L N LT +P F L L L L N IP ++ +L R
Sbjct: 118 AFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMR 175
Query: 509 LHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSA 568
L L E LE+ IS + G NL+ L+L
Sbjct: 176 LDLGEL----------KKLEY-----ISEGAFEG--------LFNLKYLNLGMCNIK--D 210
Query: 569 PEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQI 628
L LV LE L++S N P S GL+ L +L + + S A L +L
Sbjct: 211 MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVE 270
Query: 629 ALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
LN++HNNLS + L+ L L+L N
Sbjct: 271 -LNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 65/268 (24%), Positives = 101/268 (37%), Gaps = 43/268 (16%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SH 409
+P+ + + L+L NN+ F++L +L LQL N + I +
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124
Query: 410 LSVLDVSMNNLDGSIPP----HLCMYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLG 464
L+ L++ N L IP +L KL L L +N + +IP SLM+L LG
Sbjct: 125 LNTLELFDNWLT-VIPSGAFEYL---SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLG 179
Query: 465 Q-NQLTGSLPIE-FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPS 522
+ +L + F L NL L L + P + L LE L +S N+F
Sbjct: 180 ELKKLE-YISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFP----- 231
Query: 523 EVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLK 582
I S G +L++L + +Q + L +L L
Sbjct: 232 -----------EIRPGSFHGL--------SSLKKLWVMNSQVSLIERNAFDGLASLVELN 272
Query: 583 LSDNKLTGAIPSSLGGLARLTELQMGGN 610
L+ N L+ L L EL + N
Sbjct: 273 LAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 57/263 (21%), Positives = 98/263 (37%), Gaps = 34/263 (12%)
Query: 426 PHLCM-YQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSA 484
P +C + + LS +P G+ + + L L +N + F +L +L
Sbjct: 47 PSVCSCSNQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEV 103
Query: 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544
L+L +N + L +L L L +N L I S +
Sbjct: 104 LQLGRNSIRQIEVGAFNGLASLNTLELFDN-----------WLTV-----IPSGAFEYL- 146
Query: 545 PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD-NKLTGAIPSSLGGLARLT 603
L+ L L N ++ +L L L + KL + GL L
Sbjct: 147 -------SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLK 199
Query: 604 ELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIG 663
L +G +P L L L+ L +S N+ + P L L+ L++ ++Q +
Sbjct: 200 YLNLGMCNIK-DMP-NLTPLVGLEE-LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ-VS 255
Query: 664 EIPASMGEQMSLLVC-NLSNNNL 685
I + + ++ LV NL++NNL
Sbjct: 256 LIERNAFDGLASLVELNLAHNNL 278
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 59/242 (24%), Positives = 93/242 (38%), Gaps = 9/242 (3%)
Query: 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEI-GNLTS 169
+P + S+ L+L N + + ++ L L L N I +I L S
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLAS 124
Query: 170 LEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQ-NS 227
L L ++ N LT + L +LR + +N + IP + L L L +
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKK 183
Query: 228 LEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKL 287
LE E L NL L L ++ P + + LE L + N F P L
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGL 241
Query: 288 SRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENM 347
S LKKL+V ++++ + S VE++L+ N L+ + L L L N
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301
Query: 348 LQ 349
Sbjct: 302 WN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 56/230 (24%), Positives = 89/230 (38%), Gaps = 13/230 (5%)
Query: 75 TSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTD-LANCSSLEILDLCTNRLH 133
++L N+ I + L L + N + I +SL L+L N L
Sbjct: 78 RYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT 136
Query: 134 GVIPFQLFF-INTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASI-SK 190
VIP F ++ LR+L+L N I IP + SL L + I
Sbjct: 137 -VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 191 LRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQN 250
L L+ + G ++ P ++ GLE L ++ N P L +L L + +
Sbjct: 195 LFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 251 HLSGEIPP-TIGNIQSLELLALHENSFSGGLPKE-LGKLSRLKKLYVYTN 298
+S I + SL L L N+ S LP + L L +L+++ N
Sbjct: 253 QVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 26/134 (19%), Positives = 43/134 (32%), Gaps = 16/134 (11%)
Query: 577 NLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNN 636
+ + L+ +P + + L + N L L++ L + N+
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEV-LQLGRNS 110
Query: 637 LSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVC-NLSNNNLVGTVPNTTVF 695
+ + L L L L DN + IP+ E +S L L NN +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPI---------- 159
Query: 696 RRIDSSNFAGNRGL 709
I S F L
Sbjct: 160 ESIPSYAFNRVPSL 173
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-29
Identities = 45/229 (19%), Positives = 86/229 (37%), Gaps = 32/229 (13%)
Query: 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKI------KLRGEGATADNSFLA------ 849
++ + +G + + + A+KK K R + ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 850 ---EISTLGKIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSL------GEQLHGNKQTCL 899
E+ + I++ + G + ++YEYMEN S+ L N +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 900 LDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959
+ I Y+H +I HRD+K +NIL+D+ + + DFG ++ +
Sbjct: 149 PIQVIK-CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-- 203
Query: 960 YSKSMSAIAGSYGYIAPEYAYTMKVT--EKCDIYSFGVVLLELITGKSP 1006
K + G+Y ++ PE+ K DI+S G+ L + P
Sbjct: 204 -DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 801 TGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLG 855
G F+E ++G+G+ G V K + AVK I ++ L E+ L
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 856 KIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEG 915
K+ H NI+KL+ S ++ E G L +++ K+ + DA RI G
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAA-RIIKQVFSG 133
Query: 916 LCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
+ Y+H + +I+HRD+K NILL +++ + DFGL+ + M G+
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAY 188
Query: 973 YIAPE---YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
YIAPE Y EKCD++S GV+L L++G P
Sbjct: 189 YIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPP 221
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 57/246 (23%), Positives = 90/246 (36%), Gaps = 11/246 (4%)
Query: 399 TIPPHIGVNSHLSVLDVSMNNLDGSIPPH-LCMYQKLIFLSLGSNRLS-GNIPPG-LKTC 455
++P I S + L++ N L S+P +L LSL SN LS
Sbjct: 21 SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 456 RSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEI-GKLRNLERLHLSEN 514
SL L L N + ++ F L+ L L+ + + + LRNL L +S
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 515 YFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQRLDLSRNQFTGSAPEEL 572
+ + + L L ++ NS + NL LDLS+ Q +P
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 195
Query: 573 GQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNI 632
L +L++L +S N L L L N S L + LN+
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255
Query: 633 SHNNLS 638
+ N+ +
Sbjct: 256 TQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-23
Identities = 63/283 (22%), Positives = 92/283 (32%), Gaps = 39/283 (13%)
Query: 75 TSVDLHGLNLSGILSPRICDLPR-LVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
T + + L+ + P +P + N + + L L L +N L
Sbjct: 10 TEIRCNSKGLTSV--PT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 134 --GVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI-SK 190
G F +L+ L L N + + L LE L +NL S+
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124
Query: 191 LRQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQNS-LEGFLPSELEKLRNLTDLILW 248
LR L + H I + LEVL +A NS E FLP +LRNLT L L
Sbjct: 125 LRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 249 QNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL 308
Q L L +F+ LS L+ L + N
Sbjct: 184 QCQLE----------------QLSPTAFNS--------LSSLQVLNMSHNNFFSLDTFPY 219
Query: 309 GNCTSAVEIDLSENQLTGFIPREL--GLIPNLCLLQLFENMLQ 349
S +D S N + ++ +L L L +N
Sbjct: 220 KCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 54/277 (19%), Positives = 91/277 (32%), Gaps = 36/277 (12%)
Query: 152 CENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLS--GPIP 209
C + +P I +S L + SN L KL QL + N LS G
Sbjct: 14 CNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 210 PEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPP--TIGNIQSLE 267
L+ L L+ N + + S L L L ++L ++ ++++L
Sbjct: 72 QSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 129
Query: 268 LLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHE-LGNCTSAVEIDLSENQLTG 326
L + LS L+ L + N + + +DLS+ QL
Sbjct: 130 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE- 188
Query: 327 FIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYL 386
+ F + L+ L L++S NN ++ L L
Sbjct: 189 QLSPTA-----------FNS------------LSSLQVLNMSHNNFFSLDTFPYKCLNSL 225
Query: 387 VDLQLFDNHLEGTIPPHI--GVNSHLSVLDVSMNNLD 421
L NH+ T S L+ L+++ N+
Sbjct: 226 QVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 36/170 (21%), Positives = 58/170 (34%), Gaps = 8/170 (4%)
Query: 520 IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFT--GSAPEELGQLVN 577
+P+ + + SN L L +L LS N + G + +
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 578 LELLKLSDNKLTGAIPSSLGGLARLTELQMGGN-IFSGSIPVALGQLTALQIALNISHNN 636
L+ L LS N + + S+ GL +L L + + S L L L+ISH +
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY-LDISHTH 137
Query: 637 LSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMS-LLVCNLSNNNL 685
L LE L + N + ++ L +LS L
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 46/213 (21%), Positives = 78/213 (36%), Gaps = 12/213 (5%)
Query: 73 KVTSVDLHG--LNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTN 130
++T + L L+ G S L ++S N V ++ ++ LE LD +
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 111
Query: 131 RLHGVIPFQLFF-INTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASI 188
L + F +F + L L + + I L+SLE L + N+ I
Sbjct: 112 NLKQMSEFSVFLSLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
Query: 189 -SKLRQLRVIRAGHNSLSGPIPPEISEC-EGLEVLGLAQNSLEGFLPSELEKLRNLTDLI 246
++LR L + L + P L+VL ++ N+ + L +L L
Sbjct: 171 FTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 229
Query: 247 LWQNHLSGEIPPTI--GNIQSLELLALHENSFS 277
NH+ SL L L +N F+
Sbjct: 230 YSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-29
Identities = 67/276 (24%), Positives = 106/276 (38%), Gaps = 57/276 (20%)
Query: 763 MKCRKPAFVPLEEQKNPEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKAT 822
P + E + PE + FP++ G +G G G V A
Sbjct: 55 STADTPMLAGVSEYELPE-DPKWEFPRDKLTL------------GKPLGEGCFGQVVMAE 101
Query: 823 LANGE--------VIAVKKIKLRGEGATAD--NSFLAEISTLGKI-RHRNIVKLYGFCYH 871
+ +AVK +K + AT + ++E+ + I +H+NI+ L G C
Sbjct: 102 AVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158
Query: 872 QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYR-------------IALGAAEGLCY 918
++ EY G+L E L + + R A G+ Y
Sbjct: 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYI-- 974
L IHRD+ + N+L+ E + DFGLA+ I Y K + G +
Sbjct: 219 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK------TTNGRLPV 269
Query: 975 ---APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
APE + T + D++SFGV++ E+ T G SP
Sbjct: 270 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 802 GNFSEGAVIGRGACGTVYKA-TLANGEVIAVK---KIKLRGEGATADNSFLAEISTLGKI 857
+F G +G+G G VY A N ++A+K K +L EG + EI +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHL 71
Query: 858 RHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
RH NI+++Y + +H + L+ E+ G L ++L K + + + A+ L
Sbjct: 72 RHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEE-LADAL 127
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
Y H +IHRDIK N+L+ + + + DFG + ++M G+ Y+ P
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM---CGTLDYLPP 181
Query: 977 E----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E + KV D++ GV+ E + G P
Sbjct: 182 EMIEGKTHDEKV----DLWCAGVLCYEFLVGMPP 211
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 69/253 (27%), Positives = 99/253 (39%), Gaps = 29/253 (11%)
Query: 774 EEQKNPEVIDNYYFPKEGFKYHNLL-EATGNFSE----GAVIGRGACGTVYKAT-LANGE 827
+ +N YF + + G E +G GA G V
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHS 62
Query: 828 VIAVKKIKLRGEGATADNS-----------FLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876
A+K IK + EIS L + H NI+KL+ +
Sbjct: 63 EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122
Query: 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNN 936
L+ E+ E G L EQ+ + + DA I G+CYLH + +I+HRDIK N
Sbjct: 123 LVTEFYEGGELFEQI--INRHKFDECDAA-NIMKQILSGICYLH---KHNIVHRDIKPEN 176
Query: 937 ILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSF 993
ILL + + DFGL+ + G+ YIAPE K EKCD++S
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFS--KDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSC 233
Query: 994 GVVLLELITGKSP 1006
GV++ L+ G P
Sbjct: 234 GVIMYILLCGYPP 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 20/212 (9%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKI---KLRGEGATADNSFLAEISTLGKIRHRNI 862
VIG+G V + G+ AVK + K + E S ++H +I
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQL--HGNKQTCLLDWDARY--RIALGAAEGLC 917
V+L Y D L +++E+M+ L ++ + + A + R L A L
Sbjct: 89 VELLET-YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LR 144
Query: 918 YLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
Y H + +IIHRD+K + +LL + +G FG+A + G+ ++
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRVGTPHFM 200
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
APE + D++ GV+L L++G P
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 64/223 (28%), Positives = 85/223 (38%), Gaps = 35/223 (15%)
Query: 807 GAVIGRGACGTVYKATLANGE------VIAVKKIKLRGEGATAD--NSFLAEISTLGKIR 858
+G GA G VY+ ++ +AVK + E + FL E + K
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFN 132
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNK----QTCLLDWDARYRIALGAAE 914
H+NIV+ G +L E M G L L + Q L +A A
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV---GDFGLAKLIDLP--YSKSMSAIAG 969
G YL H IHRDI + N LL V GDFG+A+ I Y K G
Sbjct: 193 GCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK------G 243
Query: 970 SYGYI-----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
+ PE T K D +SFGV+L E+ + G P
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 62/292 (21%), Positives = 101/292 (34%), Gaps = 20/292 (6%)
Query: 311 CTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSIN 370
C S L IP GL + L L N + +L + L L L+ N
Sbjct: 30 CDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 371 NLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDGSIPPH- 427
+ TI + F +L L L L N+L + S L+ L++ N ++
Sbjct: 87 GIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETS 143
Query: 428 -LCMYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSAL 485
KL L +G+ I L +L + + L P ++QN+S L
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHL 203
Query: 486 ELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV--------GNLEHLVTFNISS 537
L+ + L+ + ++E L L + + SE+ I+
Sbjct: 204 ILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 538 NSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
SL + L L L+ SRNQ +L +L+ + L N
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 54/292 (18%), Positives = 110/292 (37%), Gaps = 23/292 (7%)
Query: 408 SHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQN 466
+ S +L+ SIP L + + L L +NR++ I L+ C +L L+L N
Sbjct: 31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSN 86
Query: 467 QLTGSLPIE-FYNLQNLSALELYQNRFSGLIPPEI-GKLRNLERLHLSENYFVGYIPSEV 524
+ ++ + F +L +L L+L N S + L +L L+L N + + +
Sbjct: 87 GIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSL 144
Query: 525 -GNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLK 582
+L L + + I + L+ L++ + P+ L + N+ L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLI 204
Query: 583 LSDNKLTGAIPSSLGGLARLTELQMGGNIFSG----SIPV----ALGQLTALQIALNISH 634
L + + + + + L++ + +L + + + I+
Sbjct: 205 LHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN-VKITD 263
Query: 635 NNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQM-SLLVCNLSNNNL 685
+L + L + L L NQL +P + +++ SL L N
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 65/324 (20%), Positives = 119/324 (36%), Gaps = 30/324 (9%)
Query: 79 LHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPF 138
+ L+ + R S + SIP+ L +++ LDL NR+ +
Sbjct: 14 IISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNS 70
Query: 139 QLFFINTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASI-SKLRQLRV 196
L L+ L L N I I E+ +L SLE L + N L+ + +S L L
Sbjct: 71 DLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTF 128
Query: 197 IRAGHNSLSGPIPPEI--SECEGLEVLGLAQNSLEGFLPSE-LEKLRNLTDLILWQNHLS 253
+ N + S L++L + + + L L +L + + L
Sbjct: 129 LNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187
Query: 254 GEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTS 313
P ++ +IQ++ L LH L + S ++ L + +L+
Sbjct: 188 SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT----------- 236
Query: 314 AVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLT 373
++L+ L +++ + L + + L Q++ L +L+ S N L
Sbjct: 237 -----FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK 290
Query: 374 GTIPLE-FQNLTYLVDLQLFDNHL 396
++P F LT L + L N
Sbjct: 291 -SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 60/292 (20%), Positives = 105/292 (35%), Gaps = 31/292 (10%)
Query: 208 IPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI-GNIQSL 266
IP ++E ++ L L+ N + S+L++ NL L+L N ++ I ++ SL
Sbjct: 46 IPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102
Query: 267 ELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHE--LGNCTSAVEIDLSENQL 324
E L L N S LS L L + N T+ + T + +
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDT 161
Query: 325 TGFIPREL--GLIPNLCLLQLFENMLQGSIPRE-LGQLTQLHKLDLSINNLTGTIPLEFQ 381
I R+ GL L L++ + LQ S + L + + L L + + +
Sbjct: 162 FTKIQRKDFAGL-TFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219
Query: 382 NLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGS 441
+ + L+L D L+ + L L + +
Sbjct: 220 VTSSVECLELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 442 NRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRF 492
L + L L++L +NQL S+P F L +L + L+ N +
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 47/284 (16%), Positives = 110/284 (38%), Gaps = 21/284 (7%)
Query: 152 CENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPE 211
+ IP + +++ L + +N +T + + + L+ + N ++ I +
Sbjct: 38 GSSGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEED 94
Query: 212 I-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI--GNIQSLEL 268
S LE L L+ N L S + L +LT L L N + T ++ L++
Sbjct: 95 SFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153
Query: 269 LALHENSFSGGLPKE-LGKLSRLKKLYVYTNELNGTIPHE-LGNCTSAVEIDLSENQLTG 326
L + + ++ L+ L++L + ++L + + L + + + L Q
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHIL 212
Query: 327 FIPRELGLIPNLCLLQLFENMLQGSIPREL--------GQLTQLHKLDLSINNLTGTIPL 378
+ + + ++ L+L + L EL + + ++ +L +
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMK 271
Query: 379 EFQNLTYLVDLQLFDNHLEGTIPPHI-GVNSHLSVLDVSMNNLD 421
++ L++L+ N L+ ++P I + L + + N D
Sbjct: 272 LLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 47/259 (18%), Positives = 85/259 (32%), Gaps = 45/259 (17%)
Query: 94 DLPRLVEFNISMNFVTGSIPTDL-ANCSSLEILDLCTNRLHGVIPFQLF-FINTLRKLYL 151
L L ++S N+++ ++ + SSL L+L N + LF + L+ L +
Sbjct: 98 SLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156
Query: 152 CENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPP 210
F +I + LT LEEL I +++L P S+ ++
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN----------------- 199
Query: 211 EISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLA 270
+ L L L ++ ++ L L L
Sbjct: 200 -------VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT---------------- 236
Query: 271 LHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPR 330
H + S G L K + + + L + L + +E++ S NQL
Sbjct: 237 FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDG 295
Query: 331 ELGLIPNLCLLQLFENMLQ 349
+ +L + L N
Sbjct: 296 IFDRLTSLQKIWLHTNPWD 314
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 3e-28
Identities = 37/247 (14%), Positives = 70/247 (28%), Gaps = 51/247 (20%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD----------------- 844
G V+G+ +AT GE V +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 845 ---------NSFLAEISTLGKIRHRNIVKLYGFCYHQDSN--LLLYEYME--NGSLGEQL 891
F+ + + + ++++ LY M+ + GE L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 892 HGNKQTC-LLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDF 950
+ T L AR ++ L L LH ++H ++ +I+LD+ + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 951 GLAKLIDLPYSKSMSAIAGSYGYIAPEY-----------AYTMKVTEKCDIYSFGVVLLE 999
+ S G+ PE +T D ++ G+V+
Sbjct: 251 EHLVRDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 1000 LITGKSP 1006
+ P
Sbjct: 306 IWCADLP 312
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-28
Identities = 64/232 (27%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 807 GAVIGRGACGTVYKATL--------ANGEVIAVKKIKLRGEGATAD--NSFLAEISTLGK 856
G +G GA G V A +AVK +K AT + ++E+ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKM 130
Query: 857 I-RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYR-------- 907
I +H+NI+ L G C ++ EY G+L E L + L
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 908 -----IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPY 960
A A G+ YL IHRD+ + N+L+ E+ + DFGLA+ I Y
Sbjct: 191 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 961 SKSMSAIAGSYGYI-----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
K + G + APE + T + D++SFGV+L E+ T G SP
Sbjct: 248 KK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 56/248 (22%), Positives = 83/248 (33%), Gaps = 51/248 (20%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKI---KLRGEGATADNSFLAEISTLGKIRHRNI 862
IG+G+ G V A + A+K + K+R E+ + K+ H NI
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAA--------- 913
+LY + L+ E G L ++L+
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 914 ----------------------------EGLCYLHYDCRPHIIHRDIKSNNILL--DEEF 943
L YLH I HRDIK N L ++ F
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSF 207
Query: 944 QAHVGDFGLAKLIDLPY---SKSMSAIAGSYGYIAPE--YAYTMKVTEKCDIYSFGVVLL 998
+ + DFGL+K M+ AG+ ++APE KCD +S GV+L
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 999 ELITGKSP 1006
L+ G P
Sbjct: 268 LLLMGAVP 275
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 39/224 (17%), Positives = 69/224 (30%), Gaps = 25/224 (11%)
Query: 803 NFSEGAVIGRGACGTVYKAT------LANGEVIAVKKIKLRGEGATADNSFLAEISTLGK 856
++G GA VY+AT N + +K K + L
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP--WEFYIGTQLMERLKP 123
Query: 857 IRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGE--QLHGNKQTCLLDWDARYRIALGAAE 914
+K Y Q+ ++L+ E G+L L+ N ++ A+
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVG-----------DFGLAK-LIDLPYSK 962
+ +H IIH DIK +N +L F D G + + P
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 963 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+A + G+ E + D + + ++ G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 65/224 (29%), Positives = 95/224 (42%), Gaps = 39/224 (17%)
Query: 801 TGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLG 855
T N + V+G GA V+ G++ A+K IK D+S EI+ L
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR--DSSLENEIAVLK 61
Query: 856 KIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDW----------DAR 905
KI+H NIV L Y ++ Y M+ S GE L D DA
Sbjct: 62 KIKHENIVTLEDI-YESTTH--YYLVMQLVSGGE---------LFDRILERGVYTEKDAS 109
Query: 906 YRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSK 962
+ + YLH I+HRD+K N+L +E + + DFGL+K+ +
Sbjct: 110 -LVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NG 162
Query: 963 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
MS G+ GY+APE ++ D +S GV+ L+ G P
Sbjct: 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 63/237 (26%), Positives = 92/237 (38%), Gaps = 49/237 (20%)
Query: 807 GAVIGRGACGTVYKATLANGE------VIAVKKIKLRGEGATAD--NSFLAEISTLGKIR 858
IG GA G V++A ++AVK +K E A+AD F E + + +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFD 108
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYR----------- 907
+ NIVKL G C LL+EYM G L E L +
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 908 ----------IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957
IA A G+ YL +HRD+ + N L+ E + DFGL++ I
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 958 LP--YSKSMSAIAGSYGYI-----APEYAYTMKVTEKCDIYSFGVVLLELIT-GKSP 1006
Y I PE + + T + D++++GVVL E+ + G P
Sbjct: 226 SADYYKA------DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-27
Identities = 73/275 (26%), Positives = 105/275 (38%), Gaps = 38/275 (13%)
Query: 317 IDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTI 376
+ L +P G+ N LL L EN +Q L L L LS N++ TI
Sbjct: 48 VICVRKNLR-EVPD--GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TI 103
Query: 377 PLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLI 435
+ F L L L+LFDN L TIP G +LS KL
Sbjct: 104 EIGAFNGLANLNTLELFDNRLT-TIPN--GAFVYLS---------------------KLK 139
Query: 436 FLSLGSNRLSGNIPPGL-KTCRSLMQLMLGQ-NQLTGSLPIE-FYNLQNLSALELYQNRF 492
L L +N + +IP SL +L LG+ +L+ + F L NL L L
Sbjct: 140 ELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNL 197
Query: 493 SGLIPPEIGKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHELGNC 551
+ P + L L+ L LS N+ I L HL + + + + N
Sbjct: 198 REI--PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDN 586
+L ++L+ N T + L +LE + L N
Sbjct: 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 65/267 (24%), Positives = 100/267 (37%), Gaps = 36/267 (13%)
Query: 399 TIPPHIGVNSHLSVLDVSMNNLDGSIPPH-LCMYQKLIFLSLGSNRLSGNIPPG-LKTCR 456
+P G++++ +L++ N + I + + L L L N + I G
Sbjct: 57 EVPD--GISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLA 112
Query: 457 SLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSGLIPPEI-GKLRNLERLHLSEN 514
+L L L N+LT ++P F L L L L N IP ++ +L RL L E
Sbjct: 113 NLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGEL 170
Query: 515 YFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQ 574
LS NL+ L+L+ L
Sbjct: 171 -----------------------KRLSYISEGAFEGLSNLRYLNLAMCNLR--EIPNLTP 205
Query: 575 LVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISH 634
L+ L+ L LS N L+ P S GL L +L M + A L +L +N++H
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE-INLAH 264
Query: 635 NNLSGVIPYELGNLQMLEALYLDDNQL 661
NNL+ + L LE ++L N
Sbjct: 265 NNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 60/263 (22%), Positives = 101/263 (38%), Gaps = 34/263 (12%)
Query: 426 PHLCM-YQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSA 484
P +C + + L +P G+ T + L L +NQ+ F +L++L
Sbjct: 36 PSVCSCSNQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEI 92
Query: 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544
L+L +N + L NL L L +N L I + +
Sbjct: 93 LQLSRNHIRTIEIGAFNGLANLNTLELFDN-----------RLTT-----IPNGAFVYL- 135
Query: 545 PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD-NKLTGAIPSSLGGLARLT 603
L+ L L N ++ +L L L + +L+ + GL+ L
Sbjct: 136 -------SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR 188
Query: 604 ELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIG 663
L + IP L L L L++S N+LS + P L L+ L++ +Q I
Sbjct: 189 YLNLAMCNLR-EIP-NLTPLIKLD-ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ-IQ 244
Query: 664 EIPASMGEQM-SLLVCNLSNNNL 685
I + + + SL+ NL++NNL
Sbjct: 245 VIERNAFDNLQSLVEINLAHNNL 267
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 9e-22
Identities = 57/243 (23%), Positives = 95/243 (39%), Gaps = 11/243 (4%)
Query: 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEI-GNLTS 169
+P ++ ++ +L+L N++ + + L L L N+I I L +
Sbjct: 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLAN 113
Query: 170 LEELVIYSNNLTGAIPASI-SKLRQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQ-N 226
L L ++ N LT IP L +L+ + +N + IP + L L L +
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELK 171
Query: 227 SLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGK 286
L E L NL L L +L P + + L+ L L N S P
Sbjct: 172 RLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 287 LSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFEN 346
L L+KL++ +++ + N S VEI+L+ N LT + +L + L N
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
Query: 347 MLQ 349
Sbjct: 290 PWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 6e-15
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 11/207 (5%)
Query: 75 TSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTD-LANCSSLEILDLCTNRLH 133
+ L ++ I L L + N +T +IP S L+ L L N +
Sbjct: 91 EILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE 149
Query: 134 GVIPFQLF-FINTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASISKL 191
IP F I +LR+L L E I E L++L L + NL IP ++ L
Sbjct: 150 -SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPL 206
Query: 192 RQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQN 250
+L + N LS I P L+ L + Q+ ++ + + L++L ++ L N
Sbjct: 207 IKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 251 HLSGEIPP-TIGNIQSLELLALHENSF 276
+L+ +P + LE + LH N +
Sbjct: 266 NLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 25/130 (19%), Positives = 39/130 (30%), Gaps = 16/130 (12%)
Query: 577 NLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNN 636
+ L +P + L + N + L L+I L +S N+
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEI-LQLSRNH 99
Query: 637 LSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQM-SLLVCNLSNNNLVGTVPNTTVF 695
+ + L L L L DN+ + IP + L L NN +
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPI---------- 148
Query: 696 RRIDSSNFAG 705
I S F
Sbjct: 149 ESIPSYAFNR 158
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 26/223 (11%)
Query: 798 LEATGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEIS 852
L G + +G GA G V+ ++G +K I AEI
Sbjct: 14 LYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIE 72
Query: 853 TLGKIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQL--HGNKQTCLLDWDARYRIA 909
L + H NI+K++ + N+ ++ E E G L E++ + L + +
Sbjct: 73 VLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELM 130
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSA 966
L Y H H++H+D+K NIL + DFGLA+L + +
Sbjct: 131 KQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTN 185
Query: 967 IAGSYGYIAPE---YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
AG+ Y+APE T KCDI+S GVV+ L+TG P
Sbjct: 186 AAGTALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTGCLP 224
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 27/227 (11%)
Query: 799 EATGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-------NS 846
+T F E ++GRG V + + AVK I + G G+ + +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 847 FLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR 905
L E+ L K+ H NI++L L+++ M+ G L + L ++ L + + R
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETR 127
Query: 906 YRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS 965
+I E +C LH + +I+HRD+K NILLD++ + DFG + +D + +
Sbjct: 128 -KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLR 181
Query: 966 AIAGSYGYIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ G+ Y+APE ++ D++S GV++ L+ G P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 61/250 (24%), Positives = 116/250 (46%), Gaps = 30/250 (12%)
Query: 772 PLEEQKNPEVIDNYYFPKEGFKYHNLLEATGNFSE------GAVIGRGACGTVYKAT-LA 824
P++ ++ + + P F + + G + ++G G G V+K A
Sbjct: 53 PVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA 112
Query: 825 NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL-LLYEYME 883
G +A K IK RG EIS + ++ H N+++LY + +++ L+ EY++
Sbjct: 113 TGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVD 169
Query: 884 NGSLGEQLHGNKQTCLLDWDARY--RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL-- 939
G L +++ ++ L + D + EG+ ++H + +I+H D+K NIL
Sbjct: 170 GGELFDRII-DESYNLTELDTILFMKQIC---EGIRHMH---QMYILHLDLKPENILCVN 222
Query: 940 DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE---YAYTMKVTEKCDIYSFGVV 996
+ Q + DFGLA+ + + G+ ++APE Y + V+ D++S GV+
Sbjct: 223 RDAKQIKIIDFGLARRYKP--REKLKVNFGTPEFLAPEVVNYDF---VSFPTDMWSVGVI 277
Query: 997 LLELITGKSP 1006
L++G SP
Sbjct: 278 AYMLLSGLSP 287
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 20/222 (9%)
Query: 797 LLEATGNFSE-----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAE 850
++ NF+ +GRG V + + G+ A K +K R G L E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 851 ISTLGKIRHR-NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY--R 907
I+ L + ++ L+ + +L+ EY G + + + D +
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 908 IALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSM 964
L EG+ YLH + +I+H D+K NILL + DFG+++ I ++ +
Sbjct: 139 QIL---EGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--HACEL 190
Query: 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
I G+ Y+APE +T D+++ G++ L+T SP
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKIKLR------GEGATADNSFLAEISTLGKIRH 859
+G GACG V A + +A+K I R A + EI L K+ H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 860 RNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
I+K+ F + + ++ E ME G L +++ L + + + YL
Sbjct: 75 PCIIKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCK-LYFYQMLLAVQYL 130
Query: 920 HYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
H IIHRD+K N+LL +E+ + DFG +K++ + M + G+ Y+AP
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAP 185
Query: 977 E---YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E T D +S GV+L ++G P
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 55/222 (24%), Positives = 87/222 (39%), Gaps = 28/222 (12%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLY 866
V+ G VY+A + +G A+K++ E + + + E+ + K+ H NIV+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 867 GFCYHQDSN-------LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
LL + G L E L + L D +I + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIA----------- 968
H +P IIHRD+K N+LL + + DFG A I S SA
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 969 GSYGYIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ Y PE Y+ + EK DI++ G +L L + P
Sbjct: 212 TTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP 252
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 55/298 (18%), Positives = 97/298 (32%), Gaps = 27/298 (9%)
Query: 308 LGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDL 367
NC A +++L L L + ++ Q + + L +L
Sbjct: 27 AFNCLGAADVELYGG--------GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAA 78
Query: 368 SINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPH 427
I + L ++ L +L L + + GT PP + + + +++ N+ +
Sbjct: 79 RIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDA 138
Query: 428 L------CMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSL-------PI 474
+ L LS+ ++ +L L L N G P+
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198
Query: 475 EFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTF 533
+F LQ L+ SG+ L+ L LS N + L +
Sbjct: 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL 258
Query: 534 NISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGA 591
N+S L +P L L LDLS N+ + +L + L L N +
Sbjct: 259 NLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 44/269 (16%), Positives = 81/269 (30%), Gaps = 21/269 (7%)
Query: 435 IFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLP---IEFYNLQNLSALELYQNR 491
L + SL +L + ++ + + + L L L
Sbjct: 47 YLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLE 106
Query: 492 FSGLIPPEIGKL--RNLERLHLSENYFVG--YIPSEVGNL--EHLVTFNISSNSLSGTIP 545
+G PP + + +L L+L + +E+ L +I+
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSC 166
Query: 546 HELGNCVNLQRLDLSRNQFTGSAPEE----LGQLVNLELLKLSDNKLT---GAIPSSLGG 598
++ L LDLS N G + L++L L + + G +
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226
Query: 599 LARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDD 658
+L L + N + + +LN+S L V G L L L
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK---GLPAKLSVLDLSY 283
Query: 659 NQLIGEIPASMGEQMSLLVCNLSNNNLVG 687
N+L P+ + +L N +
Sbjct: 284 NRL-DRNPSPDELP-QVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 53/253 (20%), Positives = 81/253 (32%), Gaps = 22/253 (8%)
Query: 163 EIGNLTSLEELVIYSNNLTGAIPASISKL---RQLRVIRAGHNSLSGPIPPEISECEG-- 217
+I SL+ L + + + I ++ L+ + + ++G PP + E G
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD 122
Query: 218 LEVLGLAQNSLEGFLPSELE----KLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHE 273
L +L L S E L L + Q H + +L L L +
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 274 NSFSGGLPKE----LGKLSRLKKLYVYTNELN---GTIPHELGNCTSAVEIDLSENQLTG 326
N G K L+ L + + G +DLS N L
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 327 FIPRELGLIP-NLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTY 385
P L L L L+ +P+ L +L LDLS N L P L
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNPS-PDELPQ 297
Query: 386 LVDLQLFDNHLEG 398
+ +L L N
Sbjct: 298 VGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 4e-17
Identities = 46/245 (18%), Positives = 82/245 (33%), Gaps = 22/245 (8%)
Query: 73 KVTSVDLHGLNLSGILSP---RICDLPRLVEFNISMNFVTGSIPTDLANCS--SLEILDL 127
+ + + + + R+ + L E + VTG+ P L + L IL+L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 128 CTNRLHGVIPF----QLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGA 183
+ Q + L+ L + + + E++ +L L + N G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 184 I-------PASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSEL 236
P L+ L + AG + SG + L+ L L+ NSL +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 237 -EKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYV 295
+ L L L L ++P + L +L L N P L ++ L +
Sbjct: 249 CDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSL 303
Query: 296 YTNEL 300
N
Sbjct: 304 KGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 45/244 (18%), Positives = 72/244 (29%), Gaps = 35/244 (14%)
Query: 456 RSLMQLMLGQNQLTGSLPI-EFYNLQNLSALELYQNRFSGLIPPEIGKLRN---LERLHL 511
RSL L+ + + +L L + R I ++ L+ L L
Sbjct: 43 RSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTL 102
Query: 512 SENYFVGYIPSEVGNLEH--LVTFNISSNSLSG--TIPHELGNCV--NLQRLDLSRNQFT 565
G P + L N+ + S + EL + L+ L +++
Sbjct: 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 566 GSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTA 625
+ E++ L L LSDN G + +
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLIS--------------------ALCPLKFPT 202
Query: 626 LQIALNISHNN---LSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQM-SLLVCNLS 681
LQ+ L + + SGV L+ L L N L A + L NLS
Sbjct: 203 LQV-LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 682 NNNL 685
L
Sbjct: 262 FTGL 265
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 38/201 (18%), Positives = 65/201 (32%), Gaps = 14/201 (6%)
Query: 506 LERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFT 565
L+R+ + + +L+ L S + LQ L L + T
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 566 GSAPEELGQLV--NLELLKLSDNKLTG--AIPSSLGGL--ARLTELQMGGNIFSGSIPVA 619
G+AP L + +L +L L + A + L L L +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 620 LGQLTALQIALNISHNNLSG-------VIPYELGNLQMLEALYLDDNQLIGEIPASMGEQ 672
+ AL L++S N G + P + LQ+L G A +
Sbjct: 169 VRVFPALST-LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 673 MSLLVCNLSNNNLVGTVPNTT 693
+ L +LS+N+L +
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 35/201 (17%), Positives = 59/201 (29%), Gaps = 22/201 (10%)
Query: 8 SHTQKLFYFALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGV 67
S + + A + + + L+ L F + L + + SD G+
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191
Query: 68 ECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDL 127
+ L L L N M +G A L+ LDL
Sbjct: 192 ISALCPLKFPTLQVLALR----------------NAGMETPSGVCSALAAARVQLQGLDL 235
Query: 128 CTNRLHGVIPFQLF-FINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPA 186
N L + + L L L + ++P+ + L L + N L P
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGL--PAKLSVLDLSYNRLDR-NP- 290
Query: 187 SISKLRQLRVIRAGHNSLSGP 207
S +L Q+ + N
Sbjct: 291 SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 31/176 (17%), Positives = 65/176 (36%), Gaps = 12/176 (6%)
Query: 526 NLEHLVTFNISSNSLSGTIPHEL-GNCVNLQRLDLSRNQFTGSAP-EELGQLVNLELLKL 583
N S+ + G EL G +L+ L + ++ + ++L+ L +
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 584 SDNKLTGAIPSS---LGGLARLTELQMGGNIFSGSIPVALGQLTALQI-ALNISHNNLSG 639
++ I + G++ L EL + +G+ P L + T + LN+ + + +
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 640 VIPYELGNLQM-----LEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVP 690
L LQ L+ L + + + +L +LS+N +G
Sbjct: 136 -RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 801 TGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLG 855
+ FS+ +G+GA V + G A K I + A E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 856 KIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE 914
K++H NIV+L+ ++S L+++ + G L E + + + DA E
Sbjct: 61 KLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADAS-HCIQQILE 116
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY 971
+ Y H I+HR++K N+LL + + DFGLA ++ S++ AG+
Sbjct: 117 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP 171
Query: 972 GYIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
GY++PE Y ++ DI++ GV+L L+ G P
Sbjct: 172 GYLSPEVLKKDPY----SKPVDIWACGVILYILLVGYPP 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 37/223 (16%)
Query: 801 TGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKI---KLRGEGATADNSFLAEIS 852
G+ ++ IGRG+ G V A A KKI + + F EI
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-----DRFKQEIE 58
Query: 853 TLGKIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALG 911
+ + H NI++LY + ++++ L+ E G L E++ + + DA RI
Sbjct: 59 IMKSLDHPNIIRLYET-FEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAA-RIMKD 114
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAIA 968
+ Y H + ++ HRD+K N L + + DFGLA K M
Sbjct: 115 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKV 169
Query: 969 GSYGYIAPE-----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
G+ Y++P+ Y +CD +S GV++ L+ G P
Sbjct: 170 GTPYYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPP 206
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 53/247 (21%), Positives = 101/247 (40%), Gaps = 23/247 (9%)
Query: 772 PLEEQKNPEVIDNYYFPKEGFK---YHNLLEATGNFSE----GAVIGRGACGTVYKAT-L 823
+ P++ D F ++ +K + G+ + +G GA G V++
Sbjct: 14 VRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEK 73
Query: 824 ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYME 883
A G V K I EIS + ++ H ++ L+ + +L+ E++
Sbjct: 74 ATGRVFVAKFINTPYPLDKYT--VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 884 NGSLGEQLHGNKQTCLLDWDARY--RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL-- 939
G L +++ + + + + R A EGL ++H I+H DIK NI+
Sbjct: 132 GGELFDRI-AAEDYKMSEAEVINYMRQAC---EGLKHMH---EHSIVHLDIKPENIMCET 184
Query: 940 DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLE 999
+ + DFGLA ++ + + + + APE V D+++ GV+
Sbjct: 185 KKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242
Query: 1000 LITGKSP 1006
L++G SP
Sbjct: 243 LLSGLSP 249
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 801 TGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLR----GEGATADNSFLAEI 851
+ G +G G V K + G A K IK R E+
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 852 STLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALG 911
S L ++ H NI+ L+ ++ +L+ E + G L + L ++ L + +A
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEAT-SFIKQ 123
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILL----DEEFQAHVGDFGLAKLIDLPYSKSMSAI 967
+G+ YLH I H D+K NI+L + DFGLA I+ I
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNI 178
Query: 968 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
G+ ++APE + + D++S GV+ L++G SP
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 25/221 (11%)
Query: 801 TGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVK---KIKLRGEGATAD-NSFLAEI 851
+ G +G G V K + G A K K + R E+
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 852 STLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY--RIA 909
S L ++ H N++ L+ ++ +L+ E + G L + L ++ L + +A +
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQI 124
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILL----DEEFQAHVGDFGLAKLIDLPYSKSMS 965
L +G+ YLH I H D+K NI+L + DFGLA I+
Sbjct: 125 L---DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFK 176
Query: 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
I G+ ++APE + + D++S GV+ L++G SP
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 61/262 (23%), Positives = 107/262 (40%), Gaps = 22/262 (8%)
Query: 433 KLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRF 492
I ++ G + ++ + L +T ++ L NL LEL N+
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKDNQI 75
Query: 493 SGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCV 552
+ L P + L + L LS N S + L+ + T +++S ++ P L
Sbjct: 76 TDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLS 129
Query: 553 NLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIF 612
NLQ L L NQ T +P L L NL+ L + + +++ + L L++LT L+ N
Sbjct: 130 NLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185
Query: 613 SGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQ 672
S I L L L +++ +N +S V P L N L + L + + +
Sbjct: 186 S-DIS-PLASLPNLIE-VHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV---FYN 237
Query: 673 MSLLVCNLSNNNLVGTVPNTTV 694
+L+V N+ + T+
Sbjct: 238 NNLVVPNVVKGPSGAPIAPATI 259
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 57/251 (22%), Positives = 97/251 (38%), Gaps = 18/251 (7%)
Query: 356 LGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDV 415
L K+ +N+T T+ +L + L F + TI + ++L L++
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 416 SMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE 475
N + + P L K+ L L N L N+ + +S+ L L Q+T P+
Sbjct: 71 KDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTPLA 126
Query: 476 FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNI 535
L NL L L N+ + + P + L NL+ L + + + NL L T
Sbjct: 127 --GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKA 180
Query: 536 SSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSS 595
N +S I L + NL + L NQ + L NL ++ L++ +T
Sbjct: 181 DDNKIS-DIS-PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFY 236
Query: 596 LGGLARLTELQ 606
L ++
Sbjct: 237 NNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 57/254 (22%), Positives = 103/254 (40%), Gaps = 18/254 (7%)
Query: 336 PNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNH 395
N + ++ + ++ L + L +T TI Q L L+ L+L DN
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ 74
Query: 396 LEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTC 455
+ + P + + ++ L++S N L ++ + Q + L L S +++ ++ P L
Sbjct: 75 IT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQIT-DVTP-LAGL 128
Query: 456 RSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENY 515
+L L L NQ+T P+ L NL L + + S L P + L L L +N
Sbjct: 129 SNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184
Query: 516 FVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQL 575
S + +L +L+ ++ +N +S P L N NL + L+ T L
Sbjct: 185 ISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNL 240
Query: 576 VNLELLKLSDNKLT 589
V ++K
Sbjct: 241 VVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 17/208 (8%)
Query: 478 NLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISS 537
L N + ++ + + L + L V L +L+ +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 538 NSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLG 597
N ++ P L N + L+LS N + L +++ L L+ ++T P L
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 598 GLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLD 657
GL+ L L + N + +I L LT LQ L+I + +S + P L NL L L D
Sbjct: 127 GLSNLQVLYLDLNQIT-NIS-PLAGLTNLQY-LSIGNAQVSDLTP--LANLSKLTTLKAD 181
Query: 658 DNQLIGEIPASMGEQMSLLVCNLSNNNL 685
DN+ I +I + +L+ +L NN +
Sbjct: 182 DNK-ISDISP-LASLPNLIEVHLKNNQI 207
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-22
Identities = 65/312 (20%), Positives = 118/312 (37%), Gaps = 23/312 (7%)
Query: 234 SELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKL 293
L N + +++++ T ++ + L+ + + + L+ L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGL 68
Query: 294 YVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIP 353
+ N++ P L N T E++LS N L + + ++ L L + P
Sbjct: 69 ELKDNQITDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP 124
Query: 354 RELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVL 413
L L+ L L L +N +T PL LT L L + + + + P + S L+ L
Sbjct: 125 --LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVS-DLTP-LANLSKLTTL 178
Query: 414 DVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLP 473
N + I P L LI + L +N++S ++ P L +L + L +T
Sbjct: 179 KADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITN--- 231
Query: 474 IEFYNLQNLSALELYQNRFSGLIPP-EIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVT 532
+ NL + + I P I +L+ N +I + VT
Sbjct: 232 QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN-LTSFINNVSYTFNQSVT 290
Query: 533 FNISSNSLSGTI 544
F ++ SGT+
Sbjct: 291 FKNTTVPFSGTV 302
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 44/279 (15%), Positives = 98/279 (35%), Gaps = 42/279 (15%)
Query: 116 LANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVI 175
++ + + + + + + L + E + L +L L +
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADL--DGITTLSAFGTGV--TTIEGVQYLNNLIGLEL 70
Query: 176 YSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSE 235
N +T ++ L+ L + L L+ N L+ S
Sbjct: 71 KDNQIT-----DLAPLKNL---------------------TKITELELSGNPLKNV--SA 102
Query: 236 LEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYV 295
+ L+++ L L ++ ++ P + + +L++L L N + L L+ L+ L +
Sbjct: 103 IAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSI 158
Query: 296 YTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRE 355
+++ P L N + + +N+++ P L +PNL + L N + P
Sbjct: 159 GNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212
Query: 356 LGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDN 394
L + L + L+ +T NL ++
Sbjct: 213 LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSG 251
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 40/195 (20%), Positives = 84/195 (43%), Gaps = 14/195 (7%)
Query: 75 TSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHG 134
++L ++ + + +L ++ E +S N + ++ +A S++ LDL + ++
Sbjct: 66 IGLELKDNQITDL--APLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD 121
Query: 135 VIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQL 194
V P + L+ LYL N I + LT+L+ L I + ++ P ++ L +L
Sbjct: 122 VTPLAGL--SNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKL 175
Query: 195 RVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSG 254
++A N +S I P ++ L + L N + S L NL + L ++
Sbjct: 176 TTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITN 231
Query: 255 EIPPTIGNIQSLELL 269
+ N+ ++
Sbjct: 232 QPVFYNNNLVVPNVV 246
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 36/217 (16%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+ + +G G G VYKA + G ++A+K+I+L E ++ + EIS L ++ H NI
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE-------- 914
V L + + L++E+ME K+ +LD + L ++
Sbjct: 82 VSLIDVIHSERCLTLVFEFME--------KDLKK--VLD---ENKTGLQDSQIKIYLYQL 128
Query: 915 --GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
G+ + H + I+HRD+K N+L++ + + DFGLA+ +P +S + +
Sbjct: 129 LRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVVTLW 184
Query: 973 YIAPEY-----AYTMKVTEKCDIYSFGVVLLELITGK 1004
Y AP+ Y+ V DI+S G + E+ITGK
Sbjct: 185 YRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 7e-26
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+ IG G G VYKA GE A+KKI+L E ++ + EIS L +++H NI
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 863 VKLYGFCYHQDSNLLLYEYMEN------GSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916
VKLY + + +L++E+++ L L ++ G+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-----LQLL----NGI 113
Query: 917 CYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
Y H ++HRD+K N+L++ E + + DFGLA+ +P + + + Y AP
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAP 169
Query: 977 E-----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
+ Y+ + DI+S G + E++ G
Sbjct: 170 DVLMGSKKYSTTI----DIWSVGCIFAEMVNGT 198
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKI---KLRGEGATAD-NSFLAEISTLGKIRHRN 861
G +G G V K G+ A K I +L E++ L +IRH N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY--RIALGAAEGLCYL 919
I+ L+ ++ +L+ E + G L + L ++ L + +A + L +G+ YL
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLA--EKESLTEDEATQFLKQIL---DGVHYL 124
Query: 920 HYDCRPHIIHRDIKSNNILL----DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIA 975
H I H D+K NI+L + + DFG+A I+ I G+ ++A
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKNIFGTPEFVA 179
Query: 976 PEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
PE + + D++S GV+ L++G SP
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-26
Identities = 56/250 (22%), Positives = 105/250 (42%), Gaps = 20/250 (8%)
Query: 766 RKPAFVPLEEQKNPEVIDNYYFPKEGFKYHNLLEATGNFSE----GAVIGRGACGTVYKA 821
+ V + + + + + + + + + +G GA G V++
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176
Query: 822 T-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880
T A G A K + E EI T+ +RH +V L+ + +++YE
Sbjct: 177 TERATGNNFAAKFVMTPHESDKET--VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 881 YMENGSLGEQLHGNKQTCLLDWDARY--RIALGAAEGLCYLHYDCRPHIIHRDIKSNNIL 938
+M G L E++ ++ + + +A R +GLC++H + +H D+K NI+
Sbjct: 235 FMSGGELFEKV-ADEHNKMSEDEAVEYMRQVC---KGLCHMH---ENNYVHLDLKPENIM 287
Query: 939 LDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVV 996
+ + DFGL +D +S+ G+ + APE A V D++S GV+
Sbjct: 288 FTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345
Query: 997 LLELITGKSP 1006
L++G SP
Sbjct: 346 SYILLSGLSP 355
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+ + IG G GTV+KA E++A+K+++L + +S L EI L +++H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 862 IVKLYGFCYHQDSNLLLYEYMEN------GSLGEQLHGNKQTCLLDWDARYRIALGAAEG 915
IV+L+ + L++E+ + S L L +++ +G
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL-----FQLL----KG 113
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIA 975
L + H +++HRD+K N+L++ + + +FGLA+ +P + SA + Y
Sbjct: 114 LGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRP 169
Query: 976 PE-----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
P+ Y+ + D++S G + EL P
Sbjct: 170 PDVLFGAKLYSTSI----DMWSAGCIFAELANAGRP 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 801 TGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKI---KLRGEGATAD-NSFLAEI 851
N + G +G G V K + G A K I + + E+
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 852 STLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY--RIA 909
S L +I+H N++ L+ ++ +L+ E + G L + L ++ L + +A +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQI 123
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILL----DEEFQAHVGDFGLAKLIDLPYSKSMS 965
L G+ YLH I H D+K NI+L + + + DFGLA ID +
Sbjct: 124 L---NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFK 175
Query: 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
I G+ ++APE + + D++S GV+ L++G SP
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 60/260 (23%), Positives = 94/260 (36%), Gaps = 31/260 (11%)
Query: 429 CMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488
C + + S L +P G+ + ++ L N+++ F +NL+ L L+
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHEL 548
N + + L LE+L LS+N + +
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPAT-----------------------F 101
Query: 549 GNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPS-SLGGLARLTELQM 607
L L L R P L L+ L L DN L A+P + L LT L +
Sbjct: 102 HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFL 160
Query: 608 GGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPA 667
GN S A L +L L + N ++ V P+ +L L LYL N L +P
Sbjct: 161 HGNRISSVPERAFRGLHSLDR-LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPT 218
Query: 668 SMGEQM-SLLVCNLSNNNLV 686
+ +L L++N V
Sbjct: 219 EALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 11/209 (5%)
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINN 371
++ I L N+++ NL +L L N+L L L +LDLS N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 372 LTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDGSIPPHLC 429
++ F L L L L L+ + P + + L L + N L ++P
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 430 MY-QKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALE 486
L L L NR+S ++P + SL +L+L QN++ + F +L L L
Sbjct: 150 RDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207
Query: 487 LYQNRFSGLIPPEI-GKLRNLERLHLSEN 514
L+ N S +P E LR L+ L L++N
Sbjct: 208 LFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 47/224 (20%), Positives = 80/224 (35%), Gaps = 5/224 (2%)
Query: 128 CTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPAS 187
C + +P + ++++L N I +L L ++SN L A+
Sbjct: 18 CPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 188 ISKLRQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLI 246
+ L L + N+ + P L L L + L+ P L L L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 247 LWQNHLSGEIPPTI-GNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIP 305
L N L +P ++ +L L LH N S + L L +L ++ N + P
Sbjct: 136 LQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 306 HELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349
H + + + L N L+ L + L L+L +N
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRG-EGA--TADNSFLAEISTLGKIR 858
+ + +G G TVYK ++A+K+I+L EGA TA + E+S L ++
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA----IREVSLLKDLK 58
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMEN------GSLGEQLHGNKQTCLLDWDARYRIALGA 912
H NIV L+ + + S L++EY++ G ++ + L +++
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL-----FQLL--- 110
Query: 913 AEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
GL Y H R ++HRD+K N+L++E + + DFGLA+ +P +K+ +
Sbjct: 111 -RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDNEVVTLW 165
Query: 973 YIAPEY-----AYTMKVTEKCDIYSFGVVLLELITGK 1004
Y P+ Y+ ++ D++ G + E+ TG+
Sbjct: 166 YRPPDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 800 ATGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD------NSFL 848
A F + VIGRG V + A G AVK +++ E + + +
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 849 AEISTLGKIR-HRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARY 906
E L ++ H +I+ L Y S + L+++ M G L + L ++ L + + R
Sbjct: 148 RETHILRQVAGHPHIITLIDS-YESSSFMFLVFDLMRKGELFDYL--TEKVALSEKETR- 203
Query: 907 RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSA 966
I E + +LH +I+HRD+K NILLD+ Q + DFG + ++ + +
Sbjct: 204 SIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRE 258
Query: 967 IAGSYGYIAPE------YAYTMKVTEKCDIYSFGVVL 997
+ G+ GY+APE ++ D+++ GV+L
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 50/239 (20%), Positives = 90/239 (37%), Gaps = 39/239 (16%)
Query: 850 EISTLGKIRHRNIVKLYGFCYHQDSNLLLY---EYMENGSLGEQLHGNKQTCLLDWDARY 906
+I + +N V + LY + +L + ++ +
Sbjct: 111 KIRRMDPFSTKNTVG---QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167
Query: 907 RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID--------- 957
I + AE + +LH ++HRD+K +NI + VGDFGL +D
Sbjct: 168 HIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 958 --LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGD 1015
+P + + G+ Y++PE + + K DI+S G++L EL+ S
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---VR 281
Query: 1016 LVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
++T VR ++ T + V++M S SP RP ++I
Sbjct: 282 IITDVRNLKFPLLFTQKYPQ------EHMMVQDML----------SPSPTERPEATDII 324
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 798 LEATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGE-GA--TADNSFLAEIST 853
+ ++ F + +G G TVYK G +A+K++KL E G TA + EIS
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA----IREISL 56
Query: 854 LGKIRHRNIVKLYGFCYHQDSNLLLYEYMEN--GSLGEQLHGNKQTCLLDWDARYRIALG 911
+ +++H NIV+LY + ++ L++E+M+N + L+ +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY 971
+GL + H I+HRD+K N+L+++ Q +GDFGLA+ +P + S+ +
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-VNTFSSEVVTL 172
Query: 972 GYIAPEY-----AYTMKVTEKCDIYSFGVVLLELITGK 1004
Y AP+ Y+ + DI+S G +L E+ITGK
Sbjct: 173 WYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 45/205 (21%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
+GRG G V++ ++ + K +K++G EIS L RHRNI+ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHL 66
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY--RIALGAAEGLCYLHYDC 923
+ + ++++E++ + E++ L + + E L +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVC---EALQFLH--- 119
Query: 924 RPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
+I H DI+ NI+ + + +FG A+ + + + + Y APE
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEVHQH 177
Query: 982 MKVTEKCDIYSFGVVLLELITGKSP 1006
V+ D++S G ++ L++G +P
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 797 LLEATGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEI 851
++ A+ FS+ +G+GA V + G A K I + A E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 852 STLGKIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
K++H NIV+L+ ++S L+++ + G L E + + + DA
Sbjct: 80 RICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDI--VAREFYSEADAS-HCIQ 135
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAI 967
E + Y H I+HR++K N+LL + + DFGLA ++ S++
Sbjct: 136 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGF 190
Query: 968 AGSYGYIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
AG+ GY++PE Y ++ DI++ GV+L L+ G P
Sbjct: 191 AGTPGYLSPEVLKKDPY----SKPVDIWACGVILYILLVGYPP 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-25
Identities = 50/221 (22%), Positives = 95/221 (42%), Gaps = 29/221 (13%)
Query: 801 TGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLG 855
F+E +G+GA V + + G+ A I + A E
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 856 KIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARY--RIALGA 912
++H NIV+L+ ++ + L+++ + G L E + + + DA + + L A
Sbjct: 66 LLKHPNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCIQQILEA 122
Query: 913 AEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAIAG 969
+ + H ++HR++K N+LL + + DFGLA ++ ++ AG
Sbjct: 123 ---VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAG 175
Query: 970 SYGYIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ GY++PE Y + D+++ GV+L L+ G P
Sbjct: 176 TPGYLSPEVLRKDPY----GKPVDLWACGVILYILLVGYPP 212
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 42/215 (19%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD---NSFLAEISTLGKIRHRNIVKL 865
+G G TVYKA +++A+KKIKL D + L EI L ++ H NI+ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 866 YGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE---------- 914
+ SN+ L++++ME + ++ + L +
Sbjct: 78 LD-AFGHKSNISLVFDFME--------TDLEV--IIK---DNSLVLTPSHIKAYMLMTLQ 123
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
GL YLH + I+HRD+K NN+LLDE + DFGLAK P +++ + + Y
Sbjct: 124 GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYR 179
Query: 975 APEY-----AYTMKVTEKCDIYSFGVVLLELITGK 1004
APE Y + V D+++ G +L EL+
Sbjct: 180 APELLFGARMYGVGV----DMWAVGCILAELLLRV 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 45/224 (20%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+ +G G G VYKA E +A+K+I+L E + + E+S L +++HRN
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 862 IVKLYGFCYHQDSNLLLYEYME---------NGSLGEQL--HGNKQTCLLDWDARYRIAL 910
I++L +H L++EY E N + ++ Q
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLI------------ 142
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVG-----DFGLAKLIDLPYSKSMS 965
G+ + H +HRD+K N+LL + DFGLA+ +P + +
Sbjct: 143 ---NGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFT 195
Query: 966 AIAGSYGYIAPEY-----AYTMKVTEKCDIYSFGVVLLELITGK 1004
+ Y PE Y+ V DI+S + E++
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 32/188 (17%), Positives = 65/188 (34%), Gaps = 12/188 (6%)
Query: 478 NLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISS 537
+ L Q+ + ++ +L + L+ + + ++ I++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 538 NSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLG 597
+ P + NL+RL + T L L +L LL +S + +I + +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 598 GLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLD 657
L ++ + + N I L L L+ LNI + + + + L LY
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKS-LNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 658 DNQLIGEI 665
IG
Sbjct: 190 SQT-IGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 26/184 (14%), Positives = 63/184 (34%), Gaps = 10/184 (5%)
Query: 95 LPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCEN 154
+ + + + + L + L + + + + ++ L +
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNS---LTYITLANINVTDLTGIEYA--HNIKDLTINNI 76
Query: 155 YIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISE 214
+ I L++LE L I ++T ++S L L ++ H++ I +I+
Sbjct: 77 HA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 215 CEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHEN 274
+ + L+ N + L+ L L L + + + + I + L L
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQ 191
Query: 275 SFSG 278
+ G
Sbjct: 192 TIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 21/179 (11%), Positives = 64/179 (35%), Gaps = 7/179 (3%)
Query: 168 TSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNS 227
++ + + + + +++ L I + +++ + I ++ L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTINNIH 77
Query: 228 LEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKL 287
+ + + L NL L + ++ + P + + SL LL + ++ + ++ L
Sbjct: 78 ATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 288 SRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFEN 346
++ + + N I L +++ + + + + P L L F
Sbjct: 136 PKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-14
Identities = 31/210 (14%), Positives = 64/210 (30%), Gaps = 55/210 (26%)
Query: 357 GQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVS 416
Q+ L + L+ N+T +E + DL + + H ++ + +
Sbjct: 41 AQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHA-----------TNYNPI--- 84
Query: 417 MNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEF 476
+ L L L + ++ + P L
Sbjct: 85 -SGL-----------SNLERLRIMGKDVTSDKIPNLS----------------------- 109
Query: 477 YNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNIS 536
L +L+ L++ + I +I L + + LS N + I + L L + NI
Sbjct: 110 -GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQ 167
Query: 537 SNSLSGTIPHELGNCVNLQRLDLSRNQFTG 566
+ + + + L +L G
Sbjct: 168 FDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 32/185 (17%), Positives = 61/185 (32%), Gaps = 7/185 (3%)
Query: 286 KLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFE 345
S K + T S I L+ +T + N+ L +
Sbjct: 18 PDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 346 NMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIG 405
P + L+ L +L + ++T LT L L + + + +I I
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 406 VNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQ 465
++ +D+S N I P L +L L++ + + + ++ L QL
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFS 190
Query: 466 NQLTG 470
+ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 19/166 (11%), Positives = 50/166 (30%), Gaps = 32/166 (19%)
Query: 526 NLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD 585
+ + + +S + ++ +L + L+ T + N++ L +++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 586 NKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYEL 645
T + ++ L+ L+ L I +++ L
Sbjct: 76 IHAT-----NYNPISGLSNLER----------------------LRIMGKDVTSDKIPNL 108
Query: 646 GNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPN 691
L L L + + I + + +LS N + +
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 24/134 (17%), Positives = 52/134 (38%), Gaps = 5/134 (3%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRL 132
+ + ++ ++ + +P I L L I VT +L+ +SL +LD+ +
Sbjct: 67 NIKDLTINNIHATNY-NP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 133 HGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLR 192
I ++ + + + L N +I + L L+ L I + + I
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFP 181
Query: 193 QLRVIRAGHNSLSG 206
+L + A ++ G
Sbjct: 182 KLNQLYAFSQTIGG 195
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG G+ G V+K G+++A+KK + L EI L +++H N+V L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928
+ L++EY ++ ++ +L ++ + + + H + + I
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT--LQAVNFCH---KHNCI 124
Query: 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE-----YAYTMK 983
HRD+K NIL+ + + DFG A+L+ P S + Y +PE Y
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGP-SDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 984 VTEKCDIYSFGVVLLELITGK 1004
V D+++ G V EL++G
Sbjct: 184 V----DVWAIGCVFAELLSGV 200
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 44/226 (19%)
Query: 806 EGAVIGRGACGTVYKA---TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
EG +GRG G VYKA + + A+K+I+ G +A EI+ L +++H N+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA----CREIALLRELKHPNV 80
Query: 863 VKLYG-FCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE------ 914
+ L F H D + LL++Y E+ L + ++ + + + L
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRAS----KANKKPVQLPRGMVKSLLY 135
Query: 915 ----GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH----VGDFGLAKLIDLPYSKSMSA 966
G+ YLH ++HRD+K NIL+ E + D G A+L + P K ++
Sbjct: 136 QILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP-LKPLAD 191
Query: 967 IAGS---YGYIAPE-----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
+ + Y APE YT + DI++ G + EL+T +
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-24
Identities = 46/233 (19%), Positives = 91/233 (39%), Gaps = 16/233 (6%)
Query: 356 LGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDV 415
+ K +L ++T + L + + ++ ++ ++ I +++ L +
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 72
Query: 416 SMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE 475
+ N L I P L + L +L L N++ ++ LK + L L L N ++ +
Sbjct: 73 NGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDINGLV 128
Query: 476 FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNI 535
+L L +L L N+ + + + +L L+ L L +N + L L +
Sbjct: 129 --HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYL 182
Query: 536 SSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588
S N +S + L NL L+L + LV +K +D L
Sbjct: 183 SKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 6e-24
Identities = 57/288 (19%), Positives = 105/288 (36%), Gaps = 18/288 (6%)
Query: 415 VSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPI 474
++++ I P + + I +L ++ + S+ Q++ + + I
Sbjct: 5 ITVSTPIKQIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGI 61
Query: 475 EFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFN 534
+ L N++ L L N+ + + P + L+NL L L EN + + S + +L+ L + +
Sbjct: 62 Q--YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK-IKDL-SSLKDLKKLKSLS 115
Query: 535 ISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPS 594
+ N +S I L + L+ L L N+ T L +L L+ L L DN+++
Sbjct: 116 LEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI--V 169
Query: 595 SLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEAL 654
L GL +L L + N S + AL L L + L + NL + +
Sbjct: 170 PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDV-LELFSQECLNKPINHQSNLVVPNTV 226
Query: 655 YLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSN 702
D L+ S V
Sbjct: 227 KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKA 274
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 98.3 bits (244), Expect = 4e-21
Identities = 58/294 (19%), Positives = 108/294 (36%), Gaps = 26/294 (8%)
Query: 146 LRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLS 205
+ + I +I + + ++T A+ ++L + I A ++ +
Sbjct: 1 MGETITVSTPI-KQI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 206 GPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQS 265
+ I + L L N L L L+NL L L +N + ++ + +++
Sbjct: 57 S-VQG-IQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKK 110
Query: 266 LELLALHEN---SFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSEN 322
L+ L+L N +G L L +L+ LY+ N++ T L T + L +N
Sbjct: 111 LKSLSLEHNGISDING-----LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDN 163
Query: 323 QLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQN 382
Q++ +P L + L L L +N + S R L L L L+L N
Sbjct: 164 QISDIVP--LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSN 219
Query: 383 LTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIF 436
L ++ D L P I + +V + + + YQ +
Sbjct: 220 LVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTI 271
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.8 bits (209), Expect = 7e-17
Identities = 43/255 (16%), Positives = 100/255 (39%), Gaps = 22/255 (8%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRL 132
+ +L +++ ++ +L + + + + + S+ + ++ L L N+L
Sbjct: 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL 77
Query: 133 HGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLR 192
+ P L L+L EN I ++ + +L L+ L + N ++ I + L
Sbjct: 78 TDIKPLTNL--KNLGWLFLDENKI-KDL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLP 131
Query: 193 QLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHL 252
QL + G+N ++ +S L+ L L N + L L L +L L +NH+
Sbjct: 132 QLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI 187
Query: 253 SGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTI--PHELGN 310
S ++ + +++L++L L L + +G++ P + +
Sbjct: 188 S-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK----NTDGSLVTPEIISD 241
Query: 311 CTSAVEIDLSENQLT 325
+ ++ +
Sbjct: 242 DGDYEKPNVKWHLPE 256
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-24
Identities = 69/218 (31%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKK-----IKLRGEGATADNSFLAEISTLGK 856
F + V+G+G G V + A G++ A KK IK R A A L E L K
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA----LNEKQILEK 240
Query: 857 IRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE- 914
+ R +V L + Y L L+ M G L ++ Q + A + AAE
Sbjct: 241 VNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY----AAEI 295
Query: 915 --GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
GL LH R I++RD+K NILLD+ + D GLA +P +++ G+ G
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRVGTVG 350
Query: 973 YIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y+APE YT D ++ G +L E+I G+SP
Sbjct: 351 YMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 54/241 (22%), Positives = 90/241 (37%), Gaps = 41/241 (17%)
Query: 775 EQKNPEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKK 833
E K V D+Y K+ V+G G G V + G+ A+K
Sbjct: 20 EPKKYAVTDDYQLSKQ------------------VLGLGVNGKVLECFHRRTGQKCALKL 61
Query: 834 IKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFC---YHQDSNLLL-YEYMENGSLG 888
+ E+ + +IV + +H LL+ E ME G L
Sbjct: 62 LYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF 114
Query: 889 EQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQA 945
++ + +A I + +LH +I HRD+K N+L +++
Sbjct: 115 SRIQERGDQAFTEREAA-EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVL 170
Query: 946 HVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKS 1005
+ DFG AK ++ + Y+APE K + CD++S GV++ L+ G
Sbjct: 171 KLTDFGFAKETT---QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227
Query: 1006 P 1006
P
Sbjct: 228 P 228
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+ ++G G+ G V K G ++A+KK + + EI L ++RH N
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
+V L C + L++E++++ ++ + L +Y + G+ + H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI--INGIGFCH- 141
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE---- 977
+IIHRDIK NIL+ + + DFG A+ + P + + Y APE
Sbjct: 142 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYDDEVATRWYRAPELLVG 198
Query: 978 -YAYTMKVTEKCDIYSFGVVLLELITGK 1004
Y V D+++ G ++ E+ G+
Sbjct: 199 DVKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 801 TGNFSE-------GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEIS 852
F + +G G+ K + + AVK I R E T EI+
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK-----EIT 57
Query: 853 TLGKIR-HRNIVKLYGFCYHQDSNLLL-YEYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
L H NIVKL+ +H + L E + G L E++ K+ + +A I
Sbjct: 58 ALKLCEGHPNIVKLHEV-FHDQLHTFLVMELLNGGELFERIK--KKKHFSETEAS-YIMR 113
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAI 967
+ ++H ++HRD+K N+L ++ + + DFG A+L P ++ +
Sbjct: 114 KLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTP 169
Query: 968 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ Y APE E CD++S GV+L +++G+ P
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 36/214 (16%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
+ +GRGA VY+ + A+K +K + EI L ++ H NI+KL
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKL 113
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDW----------DARYRIALGAAEG 915
++ + +E + GE L D DA E
Sbjct: 114 KEIF---ETPTEISLVLELVTGGE---------LFDRIVEKGYYSERDAA-DAVKQILEA 160
Query: 916 LCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
+ YLH + I+HRD+K N+L + + DFGL+K+++ + M + G+ G
Sbjct: 161 VAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPG 215
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y APE + D++S G++ L+ G P
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 37/227 (16%)
Query: 797 LLEATGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEI 851
L + F++ IG G+ + A AVK I T EI
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------EI 66
Query: 852 STLGK-IRHRNIVKLYGFCYHQDSNLLL-YEYMENGSLGEQLHGNKQTCLLDWDARYRIA 909
L + +H NI+ L Y + + E M+ G L +++ +Q + +A +
Sbjct: 67 EILLRYGQHPNIITLKDV-YDDGKYVYVVTELMKGGELLDKIL--RQKFFSEREAS-AVL 122
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH----VGDFGLAKLIDLPYSKSMS 965
+ + YLH ++HRD+K +NIL +E + DFG AK + + +
Sbjct: 123 FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLM 178
Query: 966 AIAGSYGYIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ ++APE Y CDI+S GV+L ++TG +P
Sbjct: 179 TPCYTANFVAPEVLERQGY------DAACDIWSLGVLLYTMLTGYTP 219
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 31/219 (14%)
Query: 801 TGNFSE-----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTL 854
+G F + V+G GA V L + AVK I+ + + E+ L
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEML 64
Query: 855 GKIR-HRNIVKLYGFCYHQDSNLLL-YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGA 912
+ + HRN+++L F + ++ L +E M GS+ +H K+ + +A +
Sbjct: 65 YQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEAS-VVVQDV 120
Query: 913 AEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDL------PYSKS 963
A L +LH I HRD+K NIL ++ + DF L I L +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 964 MSAIAGSYGYIAPE-----YAYTMKVTEKCDIYSFGVVL 997
+ GS Y+APE ++CD++S GV+L
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKK-----IKLRGEGATADNSFLAEISTLGK 856
F + V+GRG G V+ + A G++ A KK +K R A + E L K
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA----MVEKKILAK 241
Query: 857 IRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLH--GNKQTCLLDWDAR-YRIALGA 912
+ R IV L + + ++L L+ M G + ++ + A Y
Sbjct: 242 VHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY-----T 295
Query: 913 AE---GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAG 969
A+ GL +LH + +II+RD+K N+LLD++ + D GLA AG
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTKTKGYAG 351
Query: 970 SYGYIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ G++APE Y V D ++ GV L E+I + P
Sbjct: 352 TPGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 65/220 (29%), Positives = 96/220 (43%), Gaps = 50/220 (22%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSF-LAEISTLGKIRHRNIVKLY 866
VIG G+ G VY+A L +GE++A+KK+ D F E+ + K+ H NIV+L
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHCNIVRLR 113
Query: 867 GFCYHQDSNL------LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE------ 914
F Y L+ +Y+ E ++ + +R + L
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVP-----ETVYR-----VARHYSRAKQTLPVIYVKLYMY 163
Query: 915 ----GLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKLIDLPYSKSMSAIAG 969
L Y+H I HRDIK N+LLD + + DFG AK + ++S I
Sbjct: 164 QLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICS 219
Query: 970 SYGYIAPE-----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
Y Y APE YT + D++S G VL EL+ G+
Sbjct: 220 RY-YRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 25/204 (12%), Positives = 54/204 (26%), Gaps = 42/204 (20%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNS---FLAEISTLGKIRHRNI 862
G ++A A +A+ + +G D+ L+ L +I +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTF--VDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
++ + + L++ E++ GSL E + R A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH-- 146
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
R + + + + + + +
Sbjct: 147 -RAGVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPD------ 178
Query: 983 KVTEKCDIYSFGVVLLELITGKSP 1006
+ DI G L L+ + P
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWP 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 33/213 (15%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVK-----KIKLRGEGATADNSFLAEISTLGKIRHRNI 862
IG+G+ G V ++ A+K K R E E+ + + H +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV----FKELQIMQGLEHPFL 77
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIA-LGAAEGLCYLH 920
V L+ + + + ++ ++ + + G L L + + + I L A L YL
Sbjct: 78 VNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVMA--LDYLQ 132
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE--- 977
IIHRD+K +NILLDE H+ DF +A LP ++ +AG+ Y+APE
Sbjct: 133 ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKPYMAPEMFS 187
Query: 978 ----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y+ V D +S GV EL+ G+ P
Sbjct: 188 SRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-23
Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVK---K---IKLRGEGATADNSFLAEISTLG 855
+F G ++G G+ TV A A A+K K IK E +
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV-----TRERDVMS 85
Query: 856 KIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAA 913
++ H VKLY F + D L Y +NG L + + K + R Y A
Sbjct: 86 RLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFY-----TA 137
Query: 914 E---GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK-LIDLPYSKSMSAIAG 969
E L YLH IIHRD+K NILL+E+ + DFG AK L ++ G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 970 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ Y++PE + D+++ G ++ +L+ G P
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 57/234 (24%), Positives = 90/234 (38%), Gaps = 52/234 (22%)
Query: 799 EATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSF----LAEIST 853
+ F + G+G GTV G +A+KK+ D F L +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-------DPRFRNRELQIMQD 72
Query: 854 LGKIRHRNIVKLYGFCYHQDSN-------LLLYEYMENGSLGEQLHGNKQTCLLDWDARY 906
L + H NIV+L + Y ++ EY+ + LH R
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR-----CCRNYYRR 122
Query: 907 RIALGAAE----------GLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKL 955
++A + LH ++ HRDIK +N+L++E + DFG AK
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 956 IDLPYSKSMSAIAGSYGYIAPE-----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
+ P +++ I Y Y APE YT V DI+S G + E++ G+
Sbjct: 182 LS-PSEPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 60/233 (25%), Positives = 94/233 (40%), Gaps = 49/233 (21%)
Query: 795 HNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSF-LAEIST 853
+ ++ VIG G+ G V++A L + +A+KK+ D F E+
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-------DKRFKNRELQI 85
Query: 854 LGKIRHRNIVKLYGFCYHQDSNL------LLYEYMENGSLGEQLHGNKQTCLLDWDARYR 907
+ ++H N+V L F Y L+ EY+ E ++ A+ +
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYR-----ASRHYAKLK 135
Query: 908 IALGAAE----------GLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKLI 956
+ L Y+H I HRDIK N+LLD + DFG AK++
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192
Query: 957 DLPYSKSMSAIAGSYGYIAPE-----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
++S I Y Y APE YT + DI+S G V+ EL+ G+
Sbjct: 193 I-AGEPNVSYICSRY-YRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-22
Identities = 53/232 (22%), Positives = 90/232 (38%), Gaps = 67/232 (28%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSF----LAEISTLGKIRHRNIVK 864
IG+G G V+KA G+ +A+KK+ + E F L EI L ++H N+V
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENE----KEGFPITALREIKILQLLKHENVVN 80
Query: 865 LYGFCYHQDSNL--------LLYEYMEN--GSLGEQLHGN----------KQTCLLDWDA 904
L C + S L++++ E+ L + +
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL------ 134
Query: 905 RYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964
GL Y+H R I+HRD+K+ N+L+ + + DFGLA+ +S +
Sbjct: 135 ---------NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR----AFSLAK 178
Query: 965 SAIAGSYG-------YIAPEY-----AYTMKVTEKCDIYSFGVVLLELITGK 1004
++ Y Y PE Y + D++ G ++ E+ T
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 46/234 (19%), Positives = 91/234 (38%), Gaps = 16/234 (6%)
Query: 356 LGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDV 415
+ K +L ++T + L + + ++ ++ ++ I +++ L +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75
Query: 416 SMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE 475
+ N L I P L + L +L L N++ ++ LK + L L L N ++ +
Sbjct: 76 NGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDINGLV 131
Query: 476 FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNI 535
+L L +L L N+ + + + +L L+ L L +N + L L +
Sbjct: 132 --HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYL 185
Query: 536 SSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
S N +S + L NL L+L + LV +K +D L
Sbjct: 186 SKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 56/262 (21%), Positives = 99/262 (37%), Gaps = 17/262 (6%)
Query: 428 LCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALEL 487
+ + I +L ++ + S+ Q++ + + I+ L N++ L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFL 75
Query: 488 YQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE 547
N+ + + P + L+NL L L EN V + S + +L+ L + ++ N +S I
Sbjct: 76 NGNKLTDIKP--LANLKNLGWLFLDENK-VKDL-SSLKDLKKLKSLSLEHNGIS-DING- 129
Query: 548 LGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQM 607
L + L+ L L N+ T L +L L+ L L DN+++ L GL +L L +
Sbjct: 130 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYL 185
Query: 608 GGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPA 667
N S + AL L L + L + NL + + D L+
Sbjct: 186 SKNHIS-DLR-ALAGLKNLDV-LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 242
Query: 668 SMGEQMSLLVCNLSNNNLVGTV 689
S V
Sbjct: 243 SDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 53/256 (20%), Positives = 98/256 (38%), Gaps = 18/256 (7%)
Query: 166 NLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQ 225
+ + ++T A+ ++L + I A ++ + + I + L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNG 77
Query: 226 NSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELG 285
N L L L+NL L L +N + ++ + +++ L+ L+L N S L
Sbjct: 78 NKLTDI--KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS--DINGLV 131
Query: 286 KLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFE 345
L +L+ LY+ N++ T L T + L +NQ++ +P L + L L L +
Sbjct: 132 HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 346 NMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIG 405
N + + R L L L L+L NL ++ D L P I
Sbjct: 188 NHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIIS 243
Query: 406 VNSHLSVLDVSMNNLD 421
+ +V + +
Sbjct: 244 DDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 40/228 (17%), Positives = 89/228 (39%), Gaps = 16/228 (7%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRL 132
+ +L +++ ++ +L + + + + + S+ + ++ L L N+L
Sbjct: 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL 80
Query: 133 HGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLR 192
+ P L L+L EN + ++ + +L L+ L + N ++ + L
Sbjct: 81 TDIKPLANL--KNLGWLFLDENKV-KDL-SSLKDLKKLKSLSLEHNGISDING--LVHLP 134
Query: 193 QLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHL 252
QL + G+N ++ +S L+ L L N + L L L +L L +NH+
Sbjct: 135 QLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI 190
Query: 253 SGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNEL 300
S ++ + +++L++L L L + L
Sbjct: 191 S-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 27/114 (23%), Positives = 47/114 (41%), Gaps = 6/114 (5%)
Query: 94 DLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCE 153
LP+L + N +T T L+ + L+ L L N++ ++P L+ LYL +
Sbjct: 132 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVPLAGL--TKLQNLYLSK 187
Query: 154 NYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGP 207
N+I + L +L+ L ++S S L ++ SL P
Sbjct: 188 NHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVK---KIKLRGEGATADNSFLAEISTLGKI 857
G + G ++G G+ G V + AVK K KLR N EI L ++
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRL 63
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYME--NGSLGEQLHGNKQTCLLDWDARYRIALGAA-- 913
RH+N+++L Y+++ + Y ME + E +LD R + A
Sbjct: 64 RHKNVIQLVDVLYNEEKQKM-YMVMEYCVCGMQE---------MLDSVPEKRFPVCQAHG 113
Query: 914 ------EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAI 967
+GL YLH I+H+DIK N+LL + G+A+ + +
Sbjct: 114 YFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 968 A-GSYGYIAPEYAYTMKVTE--KCDIYSFGVVLLELITGKSP 1006
+ GS + PE A + K DI+S GV L + TG P
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-21
Identities = 66/223 (29%), Positives = 95/223 (42%), Gaps = 41/223 (18%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKK-----IKLRGEGATADNSFLAEISTLGK 856
+FS +IGRG G VY G++ A+K IK++ A L E L
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA----LNERIMLSL 245
Query: 857 I---RHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALG 911
+ IV + + +H L + + M G L L + + D R Y
Sbjct: 246 VSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFY----- 297
Query: 912 AAE---GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIA 968
AAE GL ++H +++RD+K NILLDE + D GLA K A
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASV 351
Query: 969 GSYGYIAPE-----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
G++GY+APE AY D +S G +L +L+ G SP
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 49/209 (23%), Positives = 82/209 (39%), Gaps = 22/209 (10%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVK 864
V+G G G V + E A+K ++ E+ + + +IV+
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVR 119
Query: 865 LYGFC---YHQDSNLLL-YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+ Y LL+ E ++ G L ++ + +A I E + YLH
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 178
Query: 921 YDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
+I HRD+K N+L + DFG AK S++ + Y+APE
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTPYYVAPE 233
Query: 978 YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
K + CD++S GV++ L+ G P
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-21
Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 803 NFSEGAVIGRGACGTVYKA--TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-- 858
+ A IG GA G V+KA G +A+K+++++ S + E++ L +
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 859 -HRNIVKLY----GFCYHQDSNLLL-YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGA 912
H N+V+L+ +++ L L +E+++ L L + + + +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQL 129
Query: 913 AEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
GL +LH ++HRD+K NIL+ Q + DFGLA++ +++++ +
Sbjct: 130 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLW 184
Query: 973 YIAPEY----AYTMKVTEKCDIYSFGVVLLELITGK 1004
Y APE +Y V D++S G + E+ K
Sbjct: 185 YRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 61/231 (26%), Positives = 92/231 (39%), Gaps = 41/231 (17%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVK---KIKLRGEGATADNSFLA---EISTL 854
+S + +G GA G V+ A + + VK K K+ + D EI+ L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 855 GKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQL------HGNKQTCLLDWDARY-- 906
++ H NI+K+ ++ ME G L H L + A Y
Sbjct: 84 SRVEHANIIKVLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIF 136
Query: 907 RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSA 966
R + A YL IIHRDIK NI++ E+F + DFG A ++ K
Sbjct: 137 RQLVSAVG---YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYT 188
Query: 967 IAGSYGYIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011
G+ Y APE Y + +++S GV L L+ ++P LE
Sbjct: 189 FCGTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFCELE 234
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKL--RGEGATADNSF-LAEISTLGKIR 858
+ A IG GA GTVYKA +G +A+K +++ G G + E++ L ++
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 859 ---HRNIVKLYGFCYHQDSNL-----LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIAL 910
H N+V+L C ++ L++E+++ L L L + +
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMR 127
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
GL +LH I+HRD+K NIL+ + DFGLA++ +++ + +
Sbjct: 128 QFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVVT 182
Query: 971 YGYIAPEY----AYTMKVTEKCDIYSFGVVLLELITGK 1004
Y APE Y V D++S G + E+ K
Sbjct: 183 LWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 50/225 (22%), Positives = 93/225 (41%), Gaps = 37/225 (16%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVK---KIKLRGEGATADNSFLA-EISTLGK 856
+ G ++G+G GTV+ L + +A+K + ++ G +D+ E++ L K
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 857 IR----HRNIVKLYGFCYHQDSNLLLYEYMENGSLGE-----QLHGNKQTCLLDWDARYR 907
+ H +++L + Q+ +L+ E + G L + +R
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGP----LGEGPSR-C 143
Query: 908 IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKLI-DLPYSKSMS 965
+ + H ++HRDIK NIL+D A + DFG L+ D PY+
Sbjct: 144 FFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF-- 198
Query: 966 AIAGSYGYIAPEY----AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
G+ Y PE+ Y ++S G++L +++ G P
Sbjct: 199 --DGTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIP 238
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 50/223 (22%), Positives = 93/223 (41%), Gaps = 35/223 (15%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVK---KIKLRGEGATADNSFLA-EISTLGK 856
+ G ++G G G+VY +++ +A+K K ++ G + + + E+ L K
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 857 IRHR--NIVKLYGFCYHQDSNLLLYEYMENGSLGE-----QLHGNKQTCLLDWDARYRIA 909
+ +++L + DS +L+ E E + G L + AR
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPV--QDLFDFITERG----ALQEELAR-SFF 155
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKLI-DLPYSKSMSAI 967
E + + H ++HRDIK NIL+D + + DFG L+ D Y+
Sbjct: 156 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---- 208
Query: 968 AGSYGYIAPEY----AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
G+ Y PE+ Y + ++S G++L +++ G P
Sbjct: 209 DGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIP 248
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 58/236 (24%), Positives = 92/236 (38%), Gaps = 40/236 (16%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVK---KIKLR-----------------GEG 840
++ IG+G+ G V A + A+K K KL G
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 841 ATADNSFLA----EISTLGKIRHRNIVKLYGFCYHQDSNLLLY---EYMENGSLGEQLHG 893
+ EI+ L K+ H N+VKL + LY E + G + E
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 894 NKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA 953
L + AR +G+ YLHY IIHRDIK +N+L+ E+ + DFG++
Sbjct: 132 KP---LSEDQAR-FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 954 KLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVT---EKCDIYSFGVVLLELITGKSP 1006
+S G+ ++APE + + D+++ GV L + G+ P
Sbjct: 185 NEFK-GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
GN+ IG+G V A + G +A+K I T+ E+ + + H
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCLLDWDARYRIALGAAEGLCY 918
NIVKL+ + + L+ EY G + + L HG + + +AR + Y
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG----RMKEKEAR-SKFRQIVSAVQY 129
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
H + I+HRD+K+ N+LLD + + DFG + + + A G+ Y APE
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPEL 184
Query: 979 ----AYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y + D++S GV+L L++G P
Sbjct: 185 FQGKKYDGP---EVDVWSLGVILYTLVSGSLP 213
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-20
Identities = 63/221 (28%), Positives = 90/221 (40%), Gaps = 42/221 (19%)
Query: 809 VIGRGACGTVY----KATLANGEVIAVKKIK-----LRGEGATADNSFLAEISTLGKIRH 859
VIGRGA V K T G+V A+K + RGE + F E L
Sbjct: 68 VIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVS----CFREERDVLVNGDR 120
Query: 860 RNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE--- 914
R I +L+ F + ++ L L+ EY G L L + AR Y AE
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFY-----LAEIVM 173
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYG 972
+ +H R +HRDIK +NILLD H+ DFG + + G+
Sbjct: 174 AIDSVH---RLGYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 973 YIAPE-------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y++PE T +CD ++ GV E+ G++P
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 51/225 (22%), Positives = 75/225 (33%), Gaps = 36/225 (16%)
Query: 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLI 496
++ L+ +PP L L L +N L L+ L L + + L
Sbjct: 15 VNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL- 70
Query: 497 PPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQR 556
G L L L LS N L ++P L
Sbjct: 71 -QVDGTLPVLGTLDLS------------------------HNQLQ-SLPLLGQTLPALTV 104
Query: 557 LDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSL-GGLARLTELQMGGNIFSGS 615
LD+S N+ T L L L+ L L N+L +P L +L +L + N +
Sbjct: 105 LDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-E 162
Query: 616 IPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
+P L L L L + N+L IP +L +L N
Sbjct: 163 LPAGLLNGLENLDT-LLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 63/253 (24%), Positives = 98/253 (38%), Gaps = 61/253 (24%)
Query: 241 NLTDLILWQNHLSGEIPPTIGNI-QSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNE 299
+ ++ + +L+ +PP ++ + +L L EN L +RL +L + E
Sbjct: 11 SHLEVNCDKRNLT-ALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 300 LNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQL 359
L T G +DLS NQL S+P L
Sbjct: 67 L--TKLQVDGTLPVLGTLDLSHNQLQ-------------------------SLPLLGQTL 99
Query: 360 TQLHKLDLSINNLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMN 418
L LD+S N LT ++PL + L L +L L N L+ T+PP G+ +
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPP--GLLTPTP------- 148
Query: 419 NLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQLTGSLPIEFY 477
KL LSL +N L+ +P GL +L L+L +N L ++P F+
Sbjct: 149 --------------KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 478 NLQNLSALELYQN 490
L L+ N
Sbjct: 193 GSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 56/215 (26%), Positives = 77/215 (35%), Gaps = 36/215 (16%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410
++P +L L LS N L T L L L L + V+ L
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-----KLQVDGTL 76
Query: 411 SVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTG 470
L L L N+L ++P +T +L L + N+LT
Sbjct: 77 P---------------------VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT- 113
Query: 471 SLPIE-FYNLQNLSALELYQNRFSGLIPPEI-GKLRNLERLHLSENYFVGYIPSEV-GNL 527
SLP+ L L L L N L PP + LE+L L+ N +P+ + L
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTL-PPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGL 171
Query: 528 EHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRN 562
E+L T + NSL TIP L L N
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 54/212 (25%), Positives = 82/212 (38%), Gaps = 33/212 (15%)
Query: 475 EFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFN 534
E + + + + + +PP++ ++ LHLSEN + + + L N
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 535 ISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPS 594
+ L+ + G L LDLS NQ S P L L +L +S N+LT
Sbjct: 62 LDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 595 SLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEAL 654
+L GL L EL + GN +L L G+ L LE L
Sbjct: 119 ALRGLGELQELYLKGN-----------ELKTLP----------PGL----LTPTPKLEKL 153
Query: 655 YLDDNQLIGEIPASMGEQMSLLVC-NLSNNNL 685
L +N L E+PA + + L L N+L
Sbjct: 154 SLANNNL-TELPAGLLNGLENLDTLLLQENSL 184
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 49/190 (25%), Positives = 77/190 (40%), Gaps = 10/190 (5%)
Query: 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSL 170
++P DL IL L N L+ L L +L L + ++ + G L L
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVL 79
Query: 171 EELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQNSLE 229
L + N L ++P L L V+ N L+ +P L+ L L N L+
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK 137
Query: 230 GFLPSELEKLRNLTDLILWQNHLSGEIPPTI-GNIQSLELLALHENSFSGGLPKELGKLS 288
P L L L L N+L+ E+P + +++L+ L L ENS +PK
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH 195
Query: 289 RLKKLYVYTN 298
L +++ N
Sbjct: 196 LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 51/206 (24%), Positives = 75/206 (36%), Gaps = 19/206 (9%)
Query: 75 TSVDLHGLNL----SGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTN 130
V+ NL + D L ++S N + L + L L+L
Sbjct: 13 LEVNCDKRNLTALPPDLPK----DTTIL---HLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 131 RLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI-S 189
L + + L L L N + +P L +L L + N LT ++P
Sbjct: 66 ELTKLQVDG--TLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121
Query: 190 KLRQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILW 248
L +L+ + N L +PP + + LE L LA N+L L L NL L+L
Sbjct: 122 GLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 249 QNHLSGEIPPTIGNIQSLELLALHEN 274
+N L IP L LH N
Sbjct: 181 ENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 53/257 (20%), Positives = 92/257 (35%), Gaps = 53/257 (20%)
Query: 335 IP-NLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLE-FQNLTYLVDLQLF 392
+P + L L N L+ +L LDLS + TI +Q+L++L L L
Sbjct: 26 LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILT 84
Query: 393 DNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL 452
N ++ ++ G S LS L L L+ ++
Sbjct: 85 GNPIQ-SLAL--GAFSGLS---------------------SLQKLVAVETNLA-SLENFP 119
Query: 453 -KTCRSLMQLMLGQNQLTGSLPIE--FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERL 509
++L +L + N + S + F NL NL L+L N+ + ++ L + L
Sbjct: 120 IGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 510 HLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAP 569
+LS ++S N ++ I + L+ L L NQ
Sbjct: 179 NLS--------------------LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPD 217
Query: 570 EELGQLVNLELLKLSDN 586
+L +L+ + L N
Sbjct: 218 GIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 52/223 (23%), Positives = 86/223 (38%), Gaps = 22/223 (9%)
Query: 400 IPPHIGVNSHLSVLDVSMNNLDGSIPPH-LCMYQKLIFLSLGSNRLSGNIPPG----LKT 454
IP ++ + LD+S N L + + + +L L L + I G L
Sbjct: 22 IPDNLPFS--TKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS- 76
Query: 455 CRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSE 513
L L+L N + SL + F L +L L + + L IG L+ L+ L+++
Sbjct: 77 --HLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 514 NYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQ----RLDLSRNQFTGS 567
N + E NL +L ++SSN + +I L + LDLS N
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-F 191
Query: 568 APEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGN 610
+ + L+ L L N+L L L ++ + N
Sbjct: 192 IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 48/232 (20%), Positives = 84/232 (36%), Gaps = 39/232 (16%)
Query: 437 LSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSG 494
L L N L ++ + L L L + ++ ++ + +L +LS L L N
Sbjct: 33 LDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ- 89
Query: 495 LIPPEI-GKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHEL-GNCV 552
+ L +L++L E N++S + + G+
Sbjct: 90 SLALGAFSGLSSLQKLVAVET-------------------NLAS------LENFPIGHLK 124
Query: 553 NLQRLDLSRNQFTG-SAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT----ELQM 607
L+ L+++ N PE L NLE L LS NK+ + L L ++ L +
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 608 GGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
N + I + L+ L + N L V L L+ ++L N
Sbjct: 185 SLNPMN-FIQPGAFKEIRLKE-LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 44/190 (23%), Positives = 73/190 (38%), Gaps = 15/190 (7%)
Query: 505 NLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHEL-GNCVNLQRLDLSRN 562
+ + L LS N ++ S + L ++S + TI + +L L L+ N
Sbjct: 29 STKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 563 QFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSL-GGLARLTELQMGGN-IFSGSIPVAL 620
A L +L+ L + L ++ + G L L EL + N I S +P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 621 GQLTALQIALNISHNNLSGVIPYE----LGNLQMLEA-LYLDDNQLIGEIPASMGEQMSL 675
LT L+ L++S N + I L + +L L L N + I +++ L
Sbjct: 146 SNLTNLEH-LDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPGAFKEIRL 202
Query: 676 LVCNLSNNNL 685
L N L
Sbjct: 203 KELALDTNQL 212
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 52/253 (20%), Positives = 92/253 (36%), Gaps = 42/253 (16%)
Query: 152 CENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPE 211
C F +IP+ + S + L + N L S +L+V+ + I
Sbjct: 14 CMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDG 70
Query: 212 I-SECEGLEVLGLAQNSLEGFLPSEL-EKLRNLTDLILWQNHLSGEIPP-TIGNIQSLEL 268
L L L N ++ L L +L L+ + +L+ + IG++++L+
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKE 128
Query: 269 LALHENSF-SGGLPKELGKLSRLKKLYVYTNELNGTIPHE----LGNCTS-AVEIDLSEN 322
L + N S LP+ L+ L+ L + +N++ +I L + +DLS N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 323 QLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLE-FQ 381
+ I + +L +L L N L ++P F
Sbjct: 188 PMN-------------------------FIQPGAFKEIRLKELALDTNQLK-SVPDGIFD 221
Query: 382 NLTYLVDLQLFDN 394
LT L + L N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 17/233 (7%)
Query: 75 TSVDLHGLNLSGILSPRICDLP-RLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
+ LN I P +LP ++S N + + L++LDL +
Sbjct: 10 ITYQCMELNFYKI--PD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 134 GVIPFQLFFINT-LRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASI-SK 190
I + + L L L N I + L+SL++LV NL ++
Sbjct: 66 -TIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH 122
Query: 191 LRQLRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQNSLEGFLPSELEKLRNLT----DL 245
L+ L+ + HN + PE S LE L L+ N ++ ++L L + L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 246 ILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTN 298
L N ++ I P L+ LAL N +L+ L+K++++TN
Sbjct: 183 DLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 28/112 (25%), Positives = 50/112 (44%), Gaps = 5/112 (4%)
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSL-GGLARLTELQMGGN 610
+ + LDLS N L++L LS ++ I L+ L+ L + GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 611 IFSGSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
S+ + A L++LQ L NL+ + + +G+L+ L+ L + N +
Sbjct: 87 PIQ-SLALGAFSGLSSLQK-LVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVKKIK-----LRGEGATADNSFLAEISTLGKIRHRNI 862
VIGRGA G V L +V A+K + R E A F E L + I
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA----CFREERDVLVNGDSKWI 136
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE---GLC 917
L+ + + D+NL L+ +Y G L L + + AR Y AE +
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFY-----LAEMVIAID 189
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYGYIA 975
+H + H +HRDIK +NIL+D H+ DFG + + S G+ YI+
Sbjct: 190 SVH---QLHYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 976 PEYAYTMKVTEK-----CDIYSFGVVLLELITGKSP 1006
PE M+ + CD +S GV + E++ G++P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-19
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 43/218 (19%)
Query: 809 VIGRGACGTVY----KATLANGEVIAVK-----KIKLRGEGATADNSFLAEISTLGKIRH 859
V+G+G+ G V+ + ++ A+K +K+R T E L ++ H
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-----KMERDILVEVNH 85
Query: 860 RNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE--- 914
IVKL+ + + + L L+ +++ G L +L K+ + D + Y AE
Sbjct: 86 PFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFTEEDVKFY-----LAELAL 137
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYG 972
L +LH II+RD+K NILLDEE H+ DFGL+K + + K + G+
Sbjct: 138 ALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKE-SIDHEKKAYSFCGTVE 191
Query: 973 YIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y+APE +T D +SFGV++ E++TG P
Sbjct: 192 YMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-19
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 808 AVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADN---SFLAEISTLGKIRHRNIV 863
++G+G G V A G A+K L+ E A + L E L RH +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 864 KLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE---GLCY 918
L + + L + EY G L L ++ + AR Y AE L Y
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFY-----GAEIVSALDY 263
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE- 977
LH + ++++RD+K N++LD++ + DFGL K + +M G+ Y+APE
Sbjct: 264 LHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPEV 320
Query: 978 ---YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y V D + GVV+ E++ G+ P
Sbjct: 321 LEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 52/263 (19%), Positives = 92/263 (34%), Gaps = 20/263 (7%)
Query: 309 GNCT-SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDL 367
C S E+++T IP L N L+ L+ L K+++
Sbjct: 5 RICHCSNRVFLCQESKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI 61
Query: 368 SINNLTGTIPLE-FQNLTYLVDLQLFD-NHLEGTIPPHIGVN-SHLSVLDVSMNNLDGSI 424
S N++ I + F NL L ++++ N+L I P N +L L +S + +
Sbjct: 62 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI-KHL 119
Query: 425 PPHLCMY-QKLIFLSLGSNRLSGNIPPGL--KTCRSLMQLMLGQNQLTGSLPIEFYNLQN 481
P ++ + + L + N I + L L +N + + +N
Sbjct: 120 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQ 178
Query: 482 LSALELYQNRFSGLIPPEI-GKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNS 539
L L L N +P ++ L +S +PS NL+ L + +
Sbjct: 179 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK 237
Query: 540 LSGTIPHELGNCVNLQRLDLSRN 562
+P L V L L+
Sbjct: 238 ---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 1e-18
Identities = 44/242 (18%), Positives = 80/242 (33%), Gaps = 14/242 (5%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN-SH 409
IP +L +L + L F L +++ N + I + N
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 410 LSVLDVSMNNLDGSIPPHLCMY-QKLIFLSLGSNRLSGNIPPGLKT-CRSLMQLMLGQNQ 467
L + + N I P L +L + + + ++P K + L + N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
Query: 468 LTGSLPIE-FYNLQ-NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV- 524
++ F L L L +N I L+ L+LS+N + +P++V
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVF 198
Query: 525 GNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLS 584
V +IS + + L N L+ + + L +LV L L+
Sbjct: 199 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT----LEKLVALMEASLT 254
Query: 585 DN 586
Sbjct: 255 YP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 45/252 (17%), Positives = 89/252 (35%), Gaps = 14/252 (5%)
Query: 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLI 496
++++ IP L + ++L +L F +L +E+ QN +I
Sbjct: 14 FLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 497 PPEI-GKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHEL-GNCVN 553
++ L L + + + + YI E NL +L IS+ + +P + +
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQ 129
Query: 554 LQRLDLSRNQFTGSAPEEL--GQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNI 611
LD+ N + G +L L+ N + S+ G N
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNN 189
Query: 612 FSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGE 671
+ I L+IS + + Y L NL+ L A + + ++P
Sbjct: 190 LEELPNDVFHGASGPVI-LDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEK- 244
Query: 672 QMSLLVCNLSNN 683
++L+ +L+
Sbjct: 245 LVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 9e-18
Identities = 48/233 (20%), Positives = 72/233 (30%), Gaps = 15/233 (6%)
Query: 434 LIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNR 491
I L +L I G L ++ + QN + + + F NL L + + +
Sbjct: 32 AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 492 FSGLIPPEI-GKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHEL- 548
I PE L NL+ L +S ++P + V +I N TI
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 549 -GNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQM 607
G L L++N EL +N L G + L +
Sbjct: 150 VGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209
Query: 608 GGNIFSGSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
S+P L L L+ S NL + L L L L
Sbjct: 210 SRTRIH-SLPSYGLENLKKLRA---RSTYNLKKLPT--LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 52/243 (21%), Positives = 85/243 (34%), Gaps = 16/243 (6%)
Query: 208 IPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPP-TIGNIQSL 266
IP ++ L L +L + + QN + I N+ L
Sbjct: 24 IPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 267 -ELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL-GNCTSAVEIDLSENQL 324
E+ N+ P+ L L+ L + + +P + V +D+ +N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNIN 140
Query: 325 TGFIPREL--GLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLE-FQ 381
I R GL +L L +N +Q I TQL +L+LS NN +P + F
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
Query: 382 NLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLG 440
+ V L + + ++P + N L S NL +P L L+ SL
Sbjct: 200 GASGPVILDISRTRIH-SLPSYGLENLKKLRAR--STYNLK-KLPT-LEKLVALMEASLT 254
Query: 441 SNR 443
Sbjct: 255 YPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 40/241 (16%), Positives = 86/241 (35%), Gaps = 33/241 (13%)
Query: 449 PPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLER 508
+ C S + ++++T +P + +N L + + +LE+
Sbjct: 3 HHRICHC-SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 58
Query: 509 LHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSR-NQFTGS 567
+ +S+N + I ++V F+ N L + + + N
Sbjct: 59 IEISQNDVLEVIEADV--------FS---------------NLPKLHEIRIEKANNLLYI 95
Query: 568 APEELGQLVNLELLKLSDNKLTGAIPS-SLGGLARLTELQMGGNIFSGSIPV-ALGQLTA 625
PE L NL+ L +S+ + +P + L + NI +I + L+
Sbjct: 96 NPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF 154
Query: 626 LQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVC-NLSNNN 684
+ L ++ N + + Q+ E D+N + E+P + S V ++S
Sbjct: 155 ESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNN-LEELPNDVFHGASGPVILDISRTR 213
Query: 685 L 685
+
Sbjct: 214 I 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 47/247 (19%), Positives = 84/247 (34%), Gaps = 16/247 (6%)
Query: 152 CENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPE 211
C+ EIP ++ + EL L + S L I N + I +
Sbjct: 16 CQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 212 I-SECEGLEVLGLAQ-NSLEGFLPSELEKLRNLTDLILWQNHLSGEIPP-TIGNIQSLEL 268
+ S L + + + N+L P + L NL L++ + +P + L
Sbjct: 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVL 132
Query: 269 LALHENSFSGGLPKEL--GKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSE-NQLT 325
L + +N + + G L++ N + I + N T E++LS+ N L
Sbjct: 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE 191
Query: 326 GFIPRELGLIPNLCLLQLFENMLQGSIPRE-LGQLTQLHKLDLSINNLTGTIPLEFQNLT 384
+L + + S+P L L +L NL + L
Sbjct: 192 ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLKKLPT--LEKLV 246
Query: 385 YLVDLQL 391
L++ L
Sbjct: 247 ALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 38/232 (16%), Positives = 76/232 (32%), Gaps = 13/232 (5%)
Query: 75 TSVDLHGLNLSGILSPRICDLPR-LVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLH 133
++ I P DLPR +E + + + LE +++ N +
Sbjct: 12 RVFLCQESKVTEI--PS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67
Query: 134 GVIPFQLFF-INTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASI-SK 190
VI +F + L ++ + + I E NL +L+ L+I + + +P
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIH 126
Query: 191 LRQLRVIRAGHNSLSGPIPPEISE--CEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILW 248
Q ++ N I +L L +N ++ S + +
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSD 186
Query: 249 QNHLSGEIPPTI-GNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNE 299
N+L E+P + +L + L L +L+ Y +
Sbjct: 187 NNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 36/254 (14%), Positives = 74/254 (29%), Gaps = 45/254 (17%)
Query: 62 CNWIGVECTDFKVTSV-----------DLHGLNLSGILSPRICDLPRLVEFNISMNFVTG 110
C+ C + KVT + L I L + IS N V
Sbjct: 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 111 SIPTD--------------------------LANCSSLEILDLCTNRLHGVIPFQLFFIN 144
I D N +L+ L + + +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128
Query: 145 TLRKLYLCENYIFGEIPEE-IGNLTS-LEELVIYSNNLTGAIPASISKLRQLRVIRAGHN 202
L + +N I L+ L + N + ++ + + + + +N
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNN 188
Query: 203 SLSGPIPPEI-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIG 261
+L +P ++ G +L +++ + LE L+ L + ++P +
Sbjct: 189 NLEE-LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-LE 243
Query: 262 NIQSLELLALHENS 275
+ +L +L S
Sbjct: 244 KLVALMEASLTYPS 257
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 51/217 (23%), Positives = 79/217 (36%), Gaps = 35/217 (16%)
Query: 809 VIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSF---------LAEISTLGKIRH 859
I G+ G V + G +A+K++ N L EI L H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 860 RNIVKLYGFCYHQDSNL-----LLYEYMENGSLGEQLHGNKQTCLLDWDARYRI--ALGA 912
NI+ L H + L+ E M L + +H + + +Y + L
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ-RIVISPQHIQYFMYHIL-- 144
Query: 913 AEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
GL LH ++HRD+ NILL + + DF LA+ + +
Sbjct: 145 -LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT--ADANKTHYVTHRW 198
Query: 973 YIAPE-----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
Y APE +T V D++S G V+ E+ K
Sbjct: 199 YRAPELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 41/240 (17%)
Query: 784 NYYFPKEGFKYHNLL---EATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGE 839
N + P+E + Y + + ++ +GRG V++A + N E + VK +K
Sbjct: 15 NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--- 71
Query: 840 GATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSN--LLLYEYMENGSLGEQLHGNKQ 896
EI L +R NI+ L S L++E++ N Q
Sbjct: 72 --VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF----KQLYQ 125
Query: 897 TCLLDWDARYRI--ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLA 953
T L D+D R+ + L + L Y H I+HRD+K +N+++D E + + D+GLA
Sbjct: 126 T-LTDYDIRFYMYEIL---KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178
Query: 954 KLIDLPYSKSMSAIAGSYGYIAPE-------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ + + S + PE Y Y++ D++S G +L +I K P
Sbjct: 179 EFYH--PGQEYNVRVASRYFKGPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEP 230
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
++ +G GA G V A E +AVK + ++ +N EI + H
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHE 65
Query: 861 NIVKLYGFCYHQDSNLLLY---EYMENGSLGEQLHGNKQTCLLDWDARYR----IALGAA 913
N+VK YG H+ + Y EY G L +++ + + + DA+ +A
Sbjct: 66 NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA---- 116
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYG 972
G+ YLH I HRDIK N+LLDE + DFGLA + + ++ + G+
Sbjct: 117 -GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 973 YIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y+APE + E D++S G+VL ++ G+ P
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELP 207
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 71/294 (24%), Positives = 110/294 (37%), Gaps = 41/294 (13%)
Query: 804 FSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-----EISTLGKI 857
+ IG GA G V A +A+KK+ N A E+ + +
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-----SRPFQNQTHAKRAYRELVLMKCV 81
Query: 858 RHRNIVKLYGFCYHQDSNL------LLYEYMENGSLGEQLHGNKQTCLLDWDARYRI--A 909
H+NI+ L Q S ++ E M+ L Q L Y +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQMELDHERMSYLLYQM 136
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAG 969
L G+ +LH IIHRD+K +NI++ + + DFGLA+ S M+
Sbjct: 137 L---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVV 188
Query: 970 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029
+ Y APE M E DI+S G ++ E+I G L G D + + + E +
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQWNK-VIEQLG 243
Query: 1030 T-SELFDKRLDLSAKRTVEEMTLFLKI---ALFCSSTSPLNRPTMREVIAMMID 1079
T F K+L + + VE + LF P + + + D
Sbjct: 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 809 VIGRGACGTVY----KATLANGEVIAVKKIK-----LRGEGATADNSFLAEISTLGKIRH 859
VIGRGA G V K+T +V A+K + R + A F E +
Sbjct: 76 VIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSA----FFWEERDIMAFANS 128
Query: 860 RNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAEGLC 917
+V+L+ + + D L ++ EYM G G+ ++ + + AR Y AE +
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYM-PG--GDLVNLMSNYDVPEKWARFY-----TAEVVL 179
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYGYIA 975
L IHRD+K +N+LLD+ H+ DFG ++ G+ YI+
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 976 PE--------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
PE Y +CD +S GV L E++ G +P
Sbjct: 238 PEVLKSQGGDGYYGR----ECDWWSVGVFLYEMLVGDTP 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 35/214 (16%)
Query: 808 AVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADN---SFLAEISTLGKIRHRNIV 863
++G+G G V A G A+K LR E A + + E L RH +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 864 KLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE---GLCY 918
L + + L + EY G L L ++ + AR Y AE L Y
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFY-----GAEIVSALEY 120
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
LH +++RDIK N++LD++ H+ DFGL K + +M G+ Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKE-GISDGATMKTFCGTPEYLAP 174
Query: 977 E----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
E Y V D + GVV+ E++ G+ P
Sbjct: 175 EVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 2e-18
Identities = 78/389 (20%), Positives = 132/389 (33%), Gaps = 121/389 (31%)
Query: 771 VPLEEQKN--PEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKATL----- 823
+PL+E P + FP++ K G +GRGA G V +A
Sbjct: 1 LPLDEHCERLPYDASKWEFPRDRLKL------------GKPLGRGAFGQVIEADAFGIDK 48
Query: 824 -ANGEVIAVKKIKLRGEGATAD--NSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLL- 878
A +AVK +K EGAT + ++E+ L I H N+V L G C L++
Sbjct: 49 TATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105
Query: 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALG--------------------------- 911
E+ + G+L L + + R G
Sbjct: 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS 165
Query: 912 ---AAEGLCYLHYDCRPHIIHRDIKSNNILL----------------------------- 939
+ L + + P +++D + L+
Sbjct: 166 GFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 225
Query: 940 -DEEFQAHVGDFGLAKLI--DLPYSKSMSA---IAGSYGYIAPEYAYTMKVTEKCDIYSF 993
E+ + DFGLA+ I D Y + A + ++APE + T + D++SF
Sbjct: 226 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPETIFDRVYTIQSDVWSF 281
Query: 994 GVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVP----TSELFDKRLDLSAKRTVEE 1048
GV+L E+ + G SP +++ + ++ M T E++
Sbjct: 282 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-TRMRAPDYTTPEMYQ------------- 327
Query: 1049 MTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
L C P RPT E++ +
Sbjct: 328 ------TMLDCWHGEPSQRPTFSELVEHL 350
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
++ +G GA G V A E +AVK + ++ +N EI + H
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHE 65
Query: 861 NIVKLYGFCYHQDSNLLLY---EYMENGSLGEQLHGNKQTCLLDWDARYR----IALGAA 913
N+VK YG H+ + Y EY G L +++ + + + DA+ +A
Sbjct: 66 NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA---- 116
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIAGSYG 972
G+ YLH I HRDIK N+LLDE + DFGLA + + ++ + G+
Sbjct: 117 -GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 973 YIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y+APE + E D++S G+VL ++ G+ P
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELP 207
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 87.9 bits (217), Expect = 6e-18
Identities = 46/294 (15%), Positives = 82/294 (27%), Gaps = 40/294 (13%)
Query: 288 SRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENM 347
L + T S E L +++ + R+ L +L
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRCELSVEK 360
Query: 348 LQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQ---LFDNHLEGTIPPHI 404
+ EL +L +L+ TI L + L L+ + + + L+ P
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419
Query: 405 GVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLG 464
+ Y + L L L+ + L+ + L L
Sbjct: 420 AYLDD------LRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLS 471
Query: 465 QNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV 524
N+L +LP L+ L L+ N + + L L+ L L N +
Sbjct: 472 HNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNN--------RL 520
Query: 525 GNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNL 578
+ L +C L L+L N +L +
Sbjct: 521 QQSAAIQ---------------PLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 84.4 bits (208), Expect = 7e-17
Identities = 50/306 (16%), Positives = 93/306 (30%), Gaps = 19/306 (6%)
Query: 365 LDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSI 424
+ L+ + + L L + ++ + + S+
Sbjct: 250 VSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASL 309
Query: 425 PPHLCMYQKLIFLSLGSNRLSGNI--------PPGLKTCRSLMQLMLGQNQLTGSLPIEF 476
L + + + ++ + T L + L + T L E
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSEL 368
Query: 477 YNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNIS 536
+ + L LE I I +R L+ L + + + + +
Sbjct: 369 ESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL 425
Query: 537 SNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSL 596
+ +++ L L+ T L QL+ + L LS N+L A+P +L
Sbjct: 426 RSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPAL 482
Query: 597 GGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGV-IPYELGNLQMLEALY 655
L L LQ N ++ + L LQ L + +N L L + L L
Sbjct: 483 AALRCLEVLQASDNALE-NVD-GVANLPRLQE-LLLCNNRLQQSAAIQPLVSCPRLVLLN 539
Query: 656 LDDNQL 661
L N L
Sbjct: 540 LQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 83.7 bits (206), Expect = 1e-16
Identities = 53/340 (15%), Positives = 100/340 (29%), Gaps = 48/340 (14%)
Query: 262 NIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSE 321
++ ++ E S + L SR+ L + +E ++ + +
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302
Query: 322 NQLTGFIPRELGLIPNLCLLQLFENMLQ--------GSIPRELGQLTQLHKLDLSINNLT 373
+ + +L + ++ + R+ QL + +LS+ T
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362
Query: 374 GTIPLEFQNLTYLVDLQLFDNHLEGTI---PPHIGVNSHLSVLDVSMNNLDGSIPPHLCM 430
+ E ++ L +L+ + TI + + + L P
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421
Query: 431 YQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQN 490
L L N + ++ L L LT
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRV------LHLAHKDLT--------------------- 454
Query: 491 RFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGN 550
+ + +L + L LS N +P + L L S N+L + + N
Sbjct: 455 -----VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVAN 506
Query: 551 CVNLQRLDLSRNQFTG-SAPEELGQLVNLELLKLSDNKLT 589
LQ L L N+ +A + L L LL L N L
Sbjct: 507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 78.3 bits (192), Expect = 6e-15
Identities = 52/307 (16%), Positives = 103/307 (33%), Gaps = 18/307 (5%)
Query: 313 SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSI----PRELGQLTQLHKLDLS 368
V + E L+ R L + + L L + S+ P + + + DL
Sbjct: 246 CCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLP 305
Query: 369 INNLTGTIPLEFQNLTYLVDLQLFDNHLE----GTIPPHIGVNSHLSVLDVSMNNLDGSI 424
+L +P + + + L + L ++S+ +
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364
Query: 425 PPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSA 484
L ++L L + I + R+L L+ + L ++ + +
Sbjct: 365 QSELESCKELQELEPENKWCLLTIILLM---RALDPLLYEKETLQYFSTLKAVDPMRAAY 421
Query: 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544
L+ +++F + ++ LHL+ + + L + ++S N L +
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-AL 478
Query: 545 PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTG-AIPSSLGGLARLT 603
P L L+ L S N + + L L+ L L +N+L A L RL
Sbjct: 479 PPALAALRCLEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 536
Query: 604 ELQMGGN 610
L + GN
Sbjct: 537 LLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 6e-11
Identities = 46/318 (14%), Positives = 87/318 (27%), Gaps = 31/318 (9%)
Query: 6 ISSHTQKLFYFALIFCFSNVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWI 65
+ + ++ +++ +L+ + + TP
Sbjct: 236 LGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPL-SVEWRTPDGRN 294
Query: 66 GVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEIL 125
L I + + + D A L
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRC 354
Query: 126 DLCTNRLHGVIPFQLFFINTLRKLYLCENY---IFGEIPEEIGNLTSLEELVIYSNNLTG 182
+L + V+ +L L++L + + + L +E + Y + L
Sbjct: 355 ELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 183 AIP------------------ASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLA 224
P + +RV+ H L+ + + + + L L+
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLS 471
Query: 225 QNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLP--K 282
N L LP L LR L L N L + + N+ L+ L L N +
Sbjct: 472 HNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ-QSAAIQ 527
Query: 283 ELGKLSRLKKLYVYTNEL 300
L RL L + N L
Sbjct: 528 PLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 3e-10
Identities = 29/171 (16%), Positives = 56/171 (32%), Gaps = 7/171 (4%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRL 132
+ + L + + D R + + + + +L L L
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 133 HGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLR 192
+ + + + L L N + +P + L LE L N L + ++ L
Sbjct: 454 TVLCHLEQLLL--VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLP 508
Query: 193 QLRVIRAGHNSLSG-PIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNL 242
+L+ + +N L + C L +L L NSL E+L +
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 8e-10
Identities = 53/303 (17%), Positives = 87/303 (28%), Gaps = 15/303 (4%)
Query: 385 YLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRL 444
Y L + H+ + S GS L + LS+
Sbjct: 231 YHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTP 290
Query: 445 SGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLR 504
G P L L + + + + L ++R +
Sbjct: 291 DGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDE 349
Query: 505 NLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQF 564
L R LS + SE+ + + L + TI + L + F
Sbjct: 350 QLFRCELSVE-KSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF 408
Query: 565 TGSAPEELGQLVNLELLKLSD--NKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQ 622
L + + L D +K A + L + + + L Q
Sbjct: 409 -----STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQ 461
Query: 623 LTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSN 682
L + L++SHN L +P L L+ LE L DN + + + L L N
Sbjct: 462 LLLVTH-LDLSHNRLR-ALPPALAALRCLEVLQASDNA-LENVD-GVANLPRLQELLLCN 517
Query: 683 NNL 685
N L
Sbjct: 518 NRL 520
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 33/196 (16%), Positives = 66/196 (33%), Gaps = 17/196 (8%)
Query: 82 LNLSGILSPRICDLPRLVEFNISMNFVTGSI--PTDLANCSSLEILD--------LCTNR 131
+ + + L+ + M + + L S+L+ +D ++
Sbjct: 369 ESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSK 428
Query: 132 LHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKL 191
+R L+L + + + L + L + N L A+P +++ L
Sbjct: 429 FLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAAL 485
Query: 192 RQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGF-LPSELEKLRNLTDLILWQN 250
R L V++A N+L ++ L+ L L N L+ L L L L N
Sbjct: 486 RCLEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
Query: 251 HLSGEIPPTIGNIQSL 266
L + + +
Sbjct: 544 SLC-QEEGIQERLAEM 558
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-18
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 41/220 (18%)
Query: 809 VIGRGACGTVY----KATLANGEVIAVKKIK----LRGEGATADNSFLAEISTLGKIRHR 860
V+G GA G V+ + G++ A+K +K ++ T E L IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE--HTRTERQVLEHIRQS 118
Query: 861 N-IVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE--- 914
+V L+ + + ++ L L+ +Y+ G L L +++ + + + Y E
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIY-----VGEIVL 170
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYG 972
L +LH + II+RDIK NILLD HV DFGL+K ++ G+
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 973 YIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y+AP+ + V D +S GV++ EL+TG SP
Sbjct: 226 YMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 50/247 (20%), Positives = 82/247 (33%), Gaps = 72/247 (29%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKI------KLRGEGATADNSFLAEISTLGKIRHRN 861
+G G+ G V + + +G+ A+KK+ K R E+ + + H N
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR------------ELDIMKVLDHVN 61
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR---------------- 905
I+KL + Y + N
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 906 ---YRIALGAAE-------------------GLCYLHYDCRPHIIHRDIKSNNILLDEE- 942
+++ + ++H I HRDIK N+L++ +
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKD 178
Query: 943 FQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE-----YAYTMKVTEKCDIYSFGVVL 997
+ DFG AK + P S++ I + Y APE YT + D++S G V
Sbjct: 179 NTLKLCDFGSAKKLI-PSEPSVAYICSRF-YRAPELMLGATEYTPSI----DLWSIGCVF 232
Query: 998 LELITGK 1004
ELI GK
Sbjct: 233 GELILGK 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 1e-17
Identities = 56/211 (26%), Positives = 84/211 (39%), Gaps = 32/211 (15%)
Query: 808 AVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-----EISTLGKIRHRN 861
IG GA G V A +A+KK+ N A E+ + + H+N
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKL-----SRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 862 IVKLYGFCYHQDSNL------LLYEYMENGSLGEQLHGNKQTCLLDWDARYRI--ALGAA 913
I+ L Q + L+ E M+ L Q L Y + L
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-----NLCQVIQMELDHERMSYLLYQML--- 174
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGY 973
G+ +LH IIHRD+K +NI++ + + DFGLA+ S M+ + Y
Sbjct: 175 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYY 229
Query: 974 IAPEYAYTMKVTEKCDIYSFGVVLLELITGK 1004
APE M E DI+S G ++ E++ K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-17
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 808 AVIGRGACGTVY----KATLANGEVIAVKKIK----LRGEGATADNSFLAEISTLGKIRH 859
V+G+G G V+ G++ A+K +K +R TA AE + L +++H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA--HTKAERNILEEVKH 80
Query: 860 RNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE--- 914
IV L + + L L+ EY+ G L QL ++ ++ A Y AE
Sbjct: 81 PFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE--REGIFMEDTACFY-----LAEISM 132
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYG 972
L +LH + II+RD+K NI+L+ + HV DFGL K + G+
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKE-SIHDGTVTHTFCGTIE 186
Query: 973 YIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y+APE + V D +S G ++ +++TG P
Sbjct: 187 YMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 39/236 (16%)
Query: 788 PKEGFKYHNLL----EATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGAT 842
K+GF ++ E + +G GA G+V A +GE +A+KK+
Sbjct: 6 RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-----SRP 60
Query: 843 ADNSFLA-----EISTLGKIRHRNIVKLYGFCYHQDSNL------LLYEYMENGSLGEQL 891
+ A E+ L ++H N++ L S L+ +M+ L
Sbjct: 61 FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDL 115
Query: 892 HGNKQTCLLDWDARYRI--ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGD 949
+ +Y + L +GL Y+H ++HRD+K N+ ++E+ + + D
Sbjct: 116 QKIMGLKFSEEKIQYLVYQML---KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILD 169
Query: 950 FGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGK 1004
FGLA+ D M+ + Y APE + M + DI+S G ++ E++TGK
Sbjct: 170 FGLARHAD----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 43/212 (20%), Positives = 78/212 (36%), Gaps = 16/212 (7%)
Query: 451 GLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLH 510
+ ++ LG+ +T + + L + + L + NL+ LH
Sbjct: 14 PDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLAG--MQFFTNLKELH 69
Query: 511 LSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPE 570
LS N P + +L L +++ N L L RL L N+ +
Sbjct: 70 LSHNQISDLSP--LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--TD 122
Query: 571 ELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIAL 630
L L NLE+L + +NKL LG L++L L + GN + + L +L + +
Sbjct: 123 SLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNW-I 177
Query: 631 NISHNNLSGVIPYELGNLQMLEALYLDDNQLI 662
+++ L + + D + I
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 41/220 (18%), Positives = 76/220 (34%), Gaps = 17/220 (7%)
Query: 370 NNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLC 429
+ P L V L + + S + + +N+ S+ +
Sbjct: 7 TPINQVFPDP--GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQ 60
Query: 430 MYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQ 489
+ L L L N++S ++ P LK L +L + +N+L + LS L L
Sbjct: 61 FFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDN 115
Query: 490 NRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELG 549
N + L+NLE L + N +G L L ++ N ++ T L
Sbjct: 116 NELRDTDS--LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNTGG--LT 169
Query: 550 NCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
+ +DL+ + + +L +K D +
Sbjct: 170 RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 43/234 (18%), Positives = 82/234 (35%), Gaps = 17/234 (7%)
Query: 92 ICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYL 151
L V+ N+ VT + S ++ + + + + Q F L++L+L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAGMQFF--TNLKELHL 70
Query: 152 CENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPE 211
N I ++ + +LT LEEL + N L + L +L + +N L
Sbjct: 71 SHNQI-SDL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFL---DNNELRDTDS-- 123
Query: 212 ISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLAL 271
+ + LE+L + N L+ L L L L L N ++ + ++ + + L
Sbjct: 124 LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDL 179
Query: 272 HENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLT 325
K +L + P+ + N S V+ +
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 42/262 (16%), Positives = 79/262 (30%), Gaps = 20/262 (7%)
Query: 284 LGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQL 343
L+ K + + + + + + + + NL L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHL 70
Query: 344 FENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPH 403
N + + L LT+L +L ++ N L + L+ L L +N L
Sbjct: 71 SHNQIS-DLS-PLKDLTKLEELSVNRNRLKNLNGIPSACLSR---LFLDNNEL--RDTDS 123
Query: 404 IGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLML 463
+ +L +L + N L SI L KL L L N ++ N L + + + L
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDL 179
Query: 464 GQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPE-IGKLRNLERLHLSENYFVGYIPS 522
+ + P+ L ++ I P I + + Y
Sbjct: 180 TGQKCV-NEPV--KYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWEL-PVYTDE 235
Query: 523 EVGNLEHLVTFNISSNSLSGTI 544
+ + GT+
Sbjct: 236 VSYKFSEYINVGETEAIFDGTV 257
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 41/247 (16%), Positives = 84/247 (34%), Gaps = 43/247 (17%)
Query: 449 PPGLKTCRSLMQLMLGQNQLTG--SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNL 506
C + + SLP + L+L + + L N+
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQRIPSLP------PSTQTLKLIETHLRTIPSHAFSNLPNI 57
Query: 507 ERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG 566
R+++S + + + S F N + +++ +
Sbjct: 58 SRIYVSIDVTLQQLESHS--------FY---------------NLSKVTHIEIRNTRNLT 94
Query: 567 S-APEELGQLVNLELLKLSDNKLTGAIP--SSLGGLARLTELQMGGNIFSGSIPV-ALGQ 622
P+ L +L L+ L + + L P + + L++ N + SIPV A
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
Query: 623 LTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPAS----MGEQMSLLVC 678
L + L + +N + + N L+A+YL+ N+ + I + SLL
Sbjct: 154 LCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL-- 210
Query: 679 NLSNNNL 685
++S ++
Sbjct: 211 DVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 41/239 (17%), Positives = 82/239 (34%), Gaps = 17/239 (7%)
Query: 425 PPHLCMYQKLIFLSLGSNRLSG--NIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNL 482
C + + + ++PP +T L L + L F NL N+
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQRIPSLPPSTQT------LKLIETHLRTIPSHAFSNLPNI 57
Query: 483 SALELYQNRFSGLIPPEI-GKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSL 540
S + + + + L + + + + YI + L L I + L
Sbjct: 58 SRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL 117
Query: 541 SGTIPHE--LGNCVNLQRLDLSRNQFTGSAPEEL--GQLVNLELLKLSDNKLTGAIPSSL 596
P + + L+++ N + S P G LKL +N T ++
Sbjct: 118 K-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYA 175
Query: 597 GGLARLTELQMGGNIFSGSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEAL 654
+L + + N + I A G + + L++S +++ + L +L+ L A
Sbjct: 176 FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 48/277 (17%), Positives = 92/277 (33%), Gaps = 58/277 (20%)
Query: 311 CTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRE-LGQLTQLHKLDLSI 369
C + ++ + IP L P+ L+L E L+ +IP L + ++ +SI
Sbjct: 10 CHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSI 64
Query: 370 NNLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHL 428
+ + F NL+ + +++ + I P L
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP--DALKELP----------------- 105
Query: 429 CMYQKLIFLSLGSNRLSGNIPPG--LKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSA- 484
L FL + + L P + + L + N S+P+ F L N +
Sbjct: 106 ----LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160
Query: 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544
L+LY N F+ + L+ ++L++N ++ I + + +
Sbjct: 161 LKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDA--FGGVYS------------ 205
Query: 545 PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELL 581
LD+S+ T + L L L
Sbjct: 206 --------GPSLLDVSQTSVTALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 30/196 (15%), Positives = 67/196 (34%), Gaps = 11/196 (5%)
Query: 217 GLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI-GNIQSLELLALHENS 275
+ L L + L L N++ + + + ++ N+ + + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 276 FSGGLPKE-LGKLSRLKKLYVYTNELNGTIPHE--LGNCTSAVEIDLSENQLTGFIPREL 332
+ + L +L LK L ++ L P + + +++++N IP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 333 --GLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLE-FQNL-TYLVD 388
GL L+L+ N S+ T+L + L+ N I + F + +
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 389 LQLFDNHLEGTIPPHI 404
L + + +P
Sbjct: 210 LDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 37/192 (19%), Positives = 72/192 (37%), Gaps = 16/192 (8%)
Query: 532 TFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGA 591
F ++ + IP + Q L L L N+ + +S +
Sbjct: 15 DFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 592 IPS-SLGGLARLTELQMGGNIFSGSIPV-ALGQLTALQIALNISHNNLSGVIP--YELGN 647
+ S S L+++T +++ I AL +L L+ L I + L + P ++ +
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF-LGIFNTGLK-MFPDLTKVYS 128
Query: 648 LQMLEALYLDDNQLIGEIPASMGEQMS--LLVCNLSNNNLVGTVPNTTVFR--RIDSSNF 703
+ L + DN + IP + + + L L NN +V F ++D+
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYA-FNGTKLDAVYL 186
Query: 704 AGNRGLCMLGSD 715
N+ L ++ D
Sbjct: 187 NKNKYLTVIDKD 198
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 36/239 (15%), Positives = 73/239 (30%), Gaps = 18/239 (7%)
Query: 69 CTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTD-LANCSSLEILDL 127
C + + ++ I P + P + + +IP+ +N ++ + +
Sbjct: 8 CECHQEEDFRVTCKDIQRI--PSL--PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYV 62
Query: 128 CTNRLHGVIPFQLFF-INTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIP 185
+ + F+ ++ + + + I + L L+ L I++ L P
Sbjct: 63 SIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP 121
Query: 186 A--SISKLRQLRVIRAGHNSLSGPIPPEI--SECEGLEVLGLAQNSLEGFLPSELEKLRN 241
+ ++ N IP C L L N +
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTK 180
Query: 242 LTDLILWQNHLSGEIPPTI--GNIQSLELLALHENSFSGGLPKE-LGKLSRLKKLYVYT 297
L + L +N I G LL + + S + LP + L L L +T
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 5e-17
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADN---SFLAEISTLGKI- 857
+F+ V+G+G+ G V + E+ AVK L+ + D+ + E L
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 858 RHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE- 914
+ + +L+ C+ L + EY+ G L + + + A Y AAE
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFKEPHAVFY-----AAEI 451
Query: 915 --GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
GL +L II+RD+K +N++LD E + DFG+ K ++ + G+
Sbjct: 452 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPD 507
Query: 973 YIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
YIAPE Y V D ++FGV+L E++ G++P
Sbjct: 508 YIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 49/248 (19%), Positives = 82/248 (33%), Gaps = 61/248 (24%)
Query: 768 PAFVPLEEQKNPEVIDNYYFPKEGFKYHNLLEATGNFSEGAVIGRGACGTVYKAT-LANG 826
P + K +ID+Y + V+G G G V +
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQ------------------VLGLGINGKVLQIFNKRTQ 43
Query: 827 EVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFC---YHQDSNLLL-YEY 881
E A+K ++ E+ + + +IV++ Y LL+ E
Sbjct: 44 EKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96
Query: 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL-- 939
++ G L ++ + +A I E + YLH +I HRD+K N+L
Sbjct: 97 LDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTS 152
Query: 940 -DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLL 998
+ DFG AK Y + CD++S GV++
Sbjct: 153 KRPNAILKLTDFGFAKET----------TGEKYD-------------KSCDMWSLGVIMY 189
Query: 999 ELITGKSP 1006
L+ G P
Sbjct: 190 ILLCGYPP 197
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 40/220 (18%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKK------IKLRGEGATADNSFLAEISTLG 855
F +G G+ G V +G A+K +KL+ T L E L
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----LNEKRILQ 96
Query: 856 KIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAA 913
+ +VKL F + +SNL ++ EY+ G + L + + AR Y AA
Sbjct: 97 AVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFY-----AA 148
Query: 914 E---GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
+ YLH +I+RD+K N+L+D++ V DFG AK + + G+
Sbjct: 149 QIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGT 201
Query: 971 YGYIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+APE Y V D ++ GV++ E+ G P
Sbjct: 202 PEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 808 AVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADN---SFLAEISTLGKI-RHRNI 862
VIGRG+ V L + A+K ++ E D E + H +
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE---GLC 917
V L+ C+ +S L + EY+ G L + +Q L + AR Y +AE L
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFY-----SAEISLALN 124
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
YLH II+RD+K +N+LLD E + D+G+ K L + S G+ YIAPE
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPE 180
Query: 978 ----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y V D ++ GV++ E++ G+SP
Sbjct: 181 ILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 40/236 (16%)
Query: 789 KEGFKYHNLL----EATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATA 843
+ GF + E + + +G GA G V A G +A+KK+
Sbjct: 8 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-----YRPF 62
Query: 844 DNSFLA-----EISTLGKIRHRNIVKLYGFCYHQDSNL------LLYEYMENGSLGEQLH 892
+ A E+ L +RH N++ L ++ L+ +M LG+ +
Sbjct: 63 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK 121
Query: 893 GNKQTCLLDWDARYRI--ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDF 950
K L + ++ + L +GL Y+H IIHRD+K N+ ++E+ + + DF
Sbjct: 122 HEK---LGEDRIQFLVYQML---KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 172
Query: 951 GLAKLIDLPYSKSMSA-IAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGK 1004
GLA+ D M+ + + Y APE M+ T+ DI+S G ++ E+ITGK
Sbjct: 173 GLARQAD----SEMTGYVVTRW-YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 808 AVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADN---SFLAEISTLGKI-RHRNI 862
V+G+G+ G V A + G++ AVK L+ + D+ + E L H +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE---GLC 917
+L+ C+ L + E++ G L + K + AR Y AAE L
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ--KSRRFDEARARFY-----AAEIISALM 138
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
+LH II+RD+K +N+LLD E + DFG+ K + + + G+ YIAPE
Sbjct: 139 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATFCGTPDYIAPE 194
Query: 978 ----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y V D ++ GV+L E++ G +P
Sbjct: 195 ILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 25/215 (11%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-EISTLGKIRH 859
G++ G +G G G V G +AVK + + + + EI L RH
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 860 RNIVKLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCLLDWDARYRIALGAAEGLC 917
+I+KLY ++ EY+ G L + + HG + + +AR R+ +
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR----VEEMEAR-RLFQQILSAVD 125
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
Y H R ++HRD+K N+LLD A + DFGL+ ++ + + GS Y APE
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCGSPNYAAPE 180
Query: 978 ------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
YA + DI+S GV+L L+ G P
Sbjct: 181 VISGRLYA-----GPEVDIWSCGVILYALLCGTLP 210
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-16
Identities = 83/448 (18%), Positives = 137/448 (30%), Gaps = 90/448 (20%)
Query: 264 QSLELLALHENSFSGGLPKELGK-LSRLKKLYVYTNELNGT----IPHELGNCTSAVEID 318
++ L + S EL L + + + + L I L + E++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 319 LSENQLTGFIPREL--GLIPNLCLLQ---LFENMLQ----GSIPRELGQLTQLHKLDLSI 369
L N+L + GL C +Q L L G + L L L +L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 370 NNLTGT-----IPLEFQNLTYLVDLQLFDNHLEGTIPPHIG----VNSHLSVLDVSMNNL 420
N L L LQL L + L VS N++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 421 DGSIPPHLC-----MYQKLIFLSLGSNRLS----GNIPPGLKTCRSLMQLMLGQNQLTGS 471
+ + LC +L L L S ++ ++ + + SL +L LG N+L
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 472 LPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLV 531
+ L L+ + L L + E
Sbjct: 243 ------GMAELCPGLLHPSS-------------RLRTLWIWEC----------------- 266
Query: 532 TFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLV-----NLELLKLSDN 586
I++ + L +L+ L L+ N+ L + + LE L +
Sbjct: 267 --GITAKGCGD-LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323
Query: 587 KLTG----AIPSSLGGLARLTELQMGGNIFSGSIPVALGQL-----TALQIALNISHNNL 637
T S L L ELQ+ N + L Q + L++ L ++ ++
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV-LWLADCDV 382
Query: 638 SGV----IPYELGNLQMLEALYLDDNQL 661
S + L L L L +N L
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-13
Identities = 82/467 (17%), Positives = 150/467 (32%), Gaps = 78/467 (16%)
Query: 168 TSLEELVIYSNNLT-GAIPASISKLRQLRVIRAGHNSLS----GPIPPEISECEGLEVLG 222
++ L I L+ + L+Q +V+R L+ I + L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 223 LAQNSLEG----FLPSELEKL-RNLTDLILWQNHLSGE----IPPTIGNIQSLELLALHE 273
L N L + L+ + L L L+G + T+ + +L+ L L +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 274 NSFSGGLPKELGKL-----SRLKKLYVYTNELNGT----IPHELGNCTSAVEIDLSENQL 324
N + L + RL+KL + L+ + L E+ +S N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 325 TGFIPREL--GLIPNLCLLQ---LFENMLQ----GSIPRELGQLTQLHKLDLSINNLTGT 375
R L GL + C L+ L + + + L +L L N L
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 376 -----IPLEFQNLTYLVDLQLFDNHLE----GTIPPHIGVNSHLSVLDVSMNNLDGSIPP 426
P + L L +++ + G + + L L ++ N L
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302
Query: 427 HLC-----MYQKLIFLSLGSNRLSG----NIPPGLKTCRSLMQLMLGQNQLTGSLPIEFY 477
LC +L L + S + + L R L++L + N+L +
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA------ 356
Query: 478 NLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYF----VGYIPSEVGNLEHLVTF 533
++ L GL P L L L++ + + + L
Sbjct: 357 GVRELCQ---------GLGQP----GSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403
Query: 534 NISSNSLSGTIPHELG-----NCVNLQRLDLSRNQFTGSAPEELGQL 575
++S+N L +L L++L L ++ + L L
Sbjct: 404 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 450
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-12
Identities = 75/402 (18%), Positives = 125/402 (31%), Gaps = 90/402 (22%)
Query: 116 LANCSSLEILDLCTNRL--HGVIPFQLFFIN---TLRKLYLCENYIFGE----IPEEIGN 166
L +L L+L +N L GV ++KL L + G + +
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 167 LTSLEELVIYSNNLTGAIPASISKLRQ-----LRVIRAGHNSLSGPIPPEISECEGLEVL 221
L +L+EL + N L A + + L ++ + SLS E L
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS---------AASCEPL 162
Query: 222 GLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLA--LHENSFSGG 279
L + +L + N ++ + +L L ++
Sbjct: 163 ASV-----------LRAKPDFKELTVSNNDINEA---------GVRVLCQGLKDSP---- 198
Query: 280 LPKELGKLSRLKKLYVYTNELN----GTIPHELGNCTSAVEIDLSENQLTGFIPRELG-- 333
+L+ L + + + + + + S E+ L N+L EL
Sbjct: 199 --------CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPG 250
Query: 334 -LIPNLCL--LQLFENMLQ----GSIPRELGQLTQLHKLDLSINNLTGT------IPLEF 380
L P+ L L ++E + G + R L L +L L+ N L L
Sbjct: 251 LLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLE 310
Query: 381 QNLTYLVDLQLFDNHLEGTIPPHIG----VNSHLSVLDVSMNNLDGSIPPHLC-----MY 431
L L + H N L L +S N L+ + LC
Sbjct: 311 PGCQ-LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPG 369
Query: 432 QKLIFLSLGSNRLS----GNIPPGLKTCRSLMQLMLGQNQLT 469
L L L +S ++ L SL +L L N L
Sbjct: 370 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 8e-12
Identities = 61/305 (20%), Positives = 100/305 (32%), Gaps = 58/305 (19%)
Query: 406 VNSHLSVLDVSMNNLDGSIPPHLCMY-QKLIFLSLGSNRLS----GNIPPGLKTCRSLMQ 460
++ + LD+ L + L Q+ + L L+ +I L+ +L +
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 461 LMLGQNQLTGS--------LPIEFYNLQNLSALELYQNRFS----GLIPPEIGKLRNLER 508
L L N+L L +Q LS L + G++ + L L+
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLS---LQNCCLTGAGCGVLSSTLRTLPTLQE 117
Query: 509 LHLSENYFVGYIPSEVG----------NLEHLVTFNISSNSLSGT----IPHELGNCVNL 554
LHLS+N + G L + SLS + L +
Sbjct: 118 LHLSDNLL-----GDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDF 172
Query: 555 QRLDLSRNQFTGSAPEELGQL-----VNLELLKLSDNKLT----GAIPSSLGGLARLTEL 605
+ L +S N + L Q LE LKL +T + + A L EL
Sbjct: 173 KELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLREL 232
Query: 606 QMGGNIFSGS-----IPVALGQLTALQIALNISHNNLSGV----IPYELGNLQMLEALYL 656
+G N P L + L+ L I ++ + L + L+ L L
Sbjct: 233 ALGSNKLGDVGMAELCPGLLHPSSRLRT-LWIWECGITAKGCGDLCRVLRAKESLKELSL 291
Query: 657 DDNQL 661
N+L
Sbjct: 292 AGNEL 296
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 808 AVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADN---SFLAEISTLGKI-RHRNI 862
VIGRG+ V L + A++ ++ E D E + H +
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE---GLC 917
V L+ C+ +S L + EY+ G L + +Q L + AR Y +AE L
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFY-----SAEISLALN 167
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
YLH II+RD+K +N+LLD E + D+G+ K L + S G+ YIAPE
Sbjct: 168 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPE 223
Query: 978 ----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y V D ++ GV++ E++ G+SP
Sbjct: 224 ILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-16
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 808 AVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADN---SFLAEISTLGKI-RHRNI 862
V+G+G+ G V + E+ AVK L+ + D+ + E L + +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE---GLC 917
+L+ C+ L + EY+ G L + + + A Y AAE GL
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFKEPHAVFY-----AAEIAIGLF 135
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
+L II+RD+K +N++LD E + DFG+ K ++ + G+ YIAPE
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPE 191
Query: 978 ----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
Y V D ++FGV+L E++ G++P
Sbjct: 192 IIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-16
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 808 AVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADN---SFLAEISTLGK-IRHRNI 862
VIG+G+ G V A A AVK L+ + ++E + L K ++H +
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE---GLC 917
V L+ F + L + +Y+ G L L ++ C L+ AR Y AAE L
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQ--RERCFLEPRARFY-----AAEIASALG 153
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYGYIA 975
YLH +I++RD+K NILLD + H+ DFGL K ++ ++ + S G+ Y+A
Sbjct: 154 YLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLA 207
Query: 976 PE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
PE Y V D + G VL E++ G P
Sbjct: 208 PEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-16
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 40/217 (18%)
Query: 808 AVIGRGACGTVYKATL-ANGEVIAVKKIK-----LRGEGATADNSFLAEISTLGK-IRHR 860
++G+G+ G V+ A + A+K +K + + + E L H
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE----CTMVEKRVLSLAWEHP 78
Query: 861 NIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAAE---G 915
+ ++ + NL + EY+ G L + A Y AAE G
Sbjct: 79 FLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFY-----AAEIILG 130
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYGY 973
L +LH I++RD+K +NILLD++ H+ DFG+ K ++ + G+ Y
Sbjct: 131 LQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKE-NMLGDAKTNTFCGTPDY 184
Query: 974 IAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
IAPE Y V D +SFGV+L E++ G+SP
Sbjct: 185 IAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 9e-16
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 40/220 (18%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVK---K---IKLRGEGATADNSFLAEISTLG 855
+F +G G+ G V+ NG A+K K ++L+ T E L
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-----NDERLMLS 61
Query: 856 KIRHRNIVKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDAR-YRIALGAA 913
+ H I++++ + + ++ +Y+E G L L K + A+ Y AA
Sbjct: 62 IVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFY-----AA 113
Query: 914 E---GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGS 970
E L YLH II+RD+K NILLD+ + DFG AK + + G+
Sbjct: 114 EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGT 166
Query: 971 YGYIAPE----YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
YIAPE Y + D +SFG+++ E++ G +P
Sbjct: 167 PDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 55/236 (23%), Positives = 96/236 (40%), Gaps = 50/236 (21%)
Query: 794 YHNLLEATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATA-DNSFLA-- 849
+ + ++ + IG GA G V A N +A+KKI + ++
Sbjct: 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-------SPFEHQTYCQR 71
Query: 850 ---EISTLGKIRHRNIVKLYGFCYHQDSNL-----LLYEYMENGSLGEQLHGNKQTCLLD 901
EI L + RH NI+ + ++ + ME L + L L +
Sbjct: 72 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH---LSN 127
Query: 902 WDARY------RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955
Y R GL Y+H +++HRD+K +N+LL+ + DFGLA++
Sbjct: 128 DHICYFLYQILR-------GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 956 IDLPYSKS--MSAIAGSYGYIAPE-----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
D + + ++ + Y APE YT + DI+S G +L E+++ +
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-15
Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-----EISTLGKIRHRNI 862
++G GA G V AT GE++A+KKI+ D A EI L +H NI
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIE------PFDKPLFALRTLREIKILKHFKHENI 71
Query: 863 VKLYGFCYHQDSNL-----LLYEYMENGSLGEQLHGNKQTCLLDWDARY------RIALG 911
+ ++ ++ E M+ L + L D +Y R
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQM---LSDDHIQYFIYQTLR---- 123
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY 971
+ LH ++IHRD+K +N+L++ V DFGLA++ID + +
Sbjct: 124 ---AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 972 G---------YIAPE-----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
G Y APE Y+ + D++S G +L EL +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 54/257 (21%), Positives = 92/257 (35%), Gaps = 76/257 (29%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-----EISTLGKIRHRNI 862
+IG G+ G V +A V+A+KKI ++ EI+ L ++ H ++
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILR-----VFEDLIDCKRILREIAILNRLNHDHV 114
Query: 863 VKLYGFCYHQDSNL-----LLYEYME---------NGSLGEQLHGNKQTCLLDWDARYRI 908
VK+ +D ++ E + L E H +T L Y +
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL-H--IKTLL------YNL 165
Query: 909 ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIA 968
+ G+ Y+H I+HRD+K N L++++ V DFGLA+ +D P + +
Sbjct: 166 LV----GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 969 GSYG--------------------------YIAPE-----YAYTMKVTEKCDIYSFGVVL 997
Y APE YT + D++S G +
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIGCIF 274
Query: 998 LELITGKSPVQSLELGG 1014
EL+ +
Sbjct: 275 AELLNMIKENVAYHADR 291
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 57/227 (25%), Positives = 85/227 (37%), Gaps = 57/227 (25%)
Query: 437 LSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSG 494
L L SN+LS ++P L L L N+L +LP F L+NL L + N+
Sbjct: 42 LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA 99
Query: 495 LIPPEI-GKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVN 553
L P + +L NL L L N SL + L
Sbjct: 100 L-PIGVFDQLVNLAELRLDRNQL---------------------KSLPPRVFDSL---TK 134
Query: 554 LQRLDLSRNQFTGSAPEEL-GQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIF 612
L L L N+ S P+ + +L +L+ L+L +N+L +P F
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPE---------------GAF 177
Query: 613 SGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
LT L+ L + +N L V +L+ L+ L L +N
Sbjct: 178 DK--------LTELKT-LKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 59/208 (28%), Positives = 82/208 (39%), Gaps = 34/208 (16%)
Query: 360 TQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNN 419
KLDL N L+ F LT L L L DN L+ T+P G+ L
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPA--GIFKELK-------- 85
Query: 420 LDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTC-RSLMQLMLGQNQLTGSLPIE-FY 477
L L + N+L +P G+ +L +L L +NQL SLP F
Sbjct: 86 -------------NLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD 130
Query: 478 NLQNLSALELYQNRFSGLIPPEI-GKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNI 535
+L L+ L L N L P + KL +L+ L L N + +P L L T +
Sbjct: 131 SLTKLTYLSLGYNELQSL-PKGVFDKLTSLKELRLYNN-QLKRVPEGAFDKLTELKTLKL 188
Query: 536 SSNSLSGTIPHEL-GNCVNLQRLDLSRN 562
+N L +P + L+ L L N
Sbjct: 189 DNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 13/185 (7%)
Query: 505 NLERLHLSENYFVGYIPSEVGNLEHLVTFNISSN---SLSGTIPHELGNCVNLQRLDLSR 561
+ ++L L N L L ++ N +L I EL NL+ L ++
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL---KNLETLWVTD 94
Query: 562 NQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSL-GGLARLTELQMGGNIFSGSIPV-A 619
N+ QLVNL L+L N+L ++P + L +LT L +G N S+P
Sbjct: 95 NKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 620 LGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQM-SLLVC 678
+LT+L+ L + +N L V L L+ L LD+NQL +P + + L +
Sbjct: 153 FDKLTSLKE-LRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKML 210
Query: 679 NLSNN 683
L N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 54/196 (27%), Positives = 83/196 (42%), Gaps = 20/196 (10%)
Query: 208 IPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI-GNIQSL 266
IP I + L L N L +L L L L N L +P I +++L
Sbjct: 31 IPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 267 ELLALHENSFSGGLPKEL-GKLSRLKKLYVYTNELNGTIP----HELGNCTSAVEIDLSE 321
E L + +N LP + +L L +L + N+L ++P L T + L
Sbjct: 88 ETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLT---YLSLGY 142
Query: 322 NQLTGFIPREL--GLIPNLCLLQLFENMLQGSIPREL-GQLTQLHKLDLSINNLTGTIPL 378
N+L +P+ + L +L L+L+ N L+ +P +LT+L L L N L
Sbjct: 143 NELQ-SLPKGVFDKL-TSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEG 199
Query: 379 EFQNLTYLVDLQLFDN 394
F +L L LQL +N
Sbjct: 200 AFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 32/112 (28%), Positives = 51/112 (45%), Gaps = 5/112 (4%)
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSL-GGLARLTELQMGGN 610
+ ++LDL N+ + + +L L LL L+DNKL +P+ + L L L + N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 611 IFSGSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
++P+ QL L L + N L + P +L L L L N+L
Sbjct: 96 KLQ-ALPIGVFDQLVNLAE-LRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL 145
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 48/182 (26%), Positives = 73/182 (40%), Gaps = 8/182 (4%)
Query: 145 TLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI-SKLRQLRVIRAGHNS 203
+KL L N + + LT L L + N L +PA I +L+ L + N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 204 LSGPIPPEI-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI-G 261
L +P + + L L L +N L+ P + L LT L L N L +P +
Sbjct: 97 LQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 262 NIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL-GNCTSAVEIDLS 320
+ SL+ L L+ N KL+ LK L + N+L +P + + L
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQ 213
Query: 321 EN 322
EN
Sbjct: 214 EN 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 4e-15
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-EISTLGKIRH 859
G++ G +G G G V G +AVK + + + + EI L RH
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 860 RNIVKLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCLLDWDAR--YRIALGAAEG 915
+I+KLY ++ EY+ G L + + +G L + ++R ++ L +
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVD- 130
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIA 975
Y H R ++HRD+K N+LLD A + DFGL+ ++ + + GS Y A
Sbjct: 131 --YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTSCGSPNYAA 183
Query: 976 PE------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
PE YA + DI+S GV+L L+ G P
Sbjct: 184 PEVISGRLYA-----GPEVDIWSSGVILYALLCGTLP 215
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 63/232 (27%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-----EISTLGKIRHRNI 862
+G G G V+ A + +A+KKI L + EI + ++ H NI
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVL-------TDPQSVKHALREIKIIRRLDHDNI 70
Query: 863 VKLY-------GFCYHQDSNL-------LLYEYMENGSLGEQLHGNKQTCLLDWDARYRI 908
VK++ +L ++ EYME L L LL+ AR +
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP---LLEEHARLFM 126
Query: 909 --ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAKLIDLPYSKS-- 963
L GL Y+H +++HRD+K N+ ++ E +GDFGLA+++D YS
Sbjct: 127 YQLL---RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 964 MSAIAGSYGYI------APE-----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
+S + +P YT + D+++ G + E++TGK
Sbjct: 181 LS------EGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-15
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 44/224 (19%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-EISTLGKIRH 859
G + +G G+ G V AT + +A+K I + + + + EIS L +RH
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 860 RNIVKLYGFCYHQDSNLLLYEY---------MENGSLGEQLHGNKQTCLLDWDAR--YRI 908
+I+KLY +++ EY +E + E + R ++
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTED------------EGRRFFQQ 116
Query: 909 ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIA 968
+ A E Y H R I+HRD+K N+LLD+ + DFGL+ ++ +
Sbjct: 117 IICAIE---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSC 168
Query: 969 GSYGYIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
GS Y APE YA + D++S G+VL ++ G+ P
Sbjct: 169 GSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLP 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 40/237 (16%)
Query: 788 PKEGFKYHNLL----EATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGAT 842
+ F L E + + +G GA G+V A G +AVKK+
Sbjct: 11 ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----SRP 65
Query: 843 ADNSFLA-----EISTLGKIRHRNIVKLYGFCYHQDSNL------LLYEYMENGSLGEQL 891
+ A E+ L ++H N++ L S L+ M L +
Sbjct: 66 FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV 124
Query: 892 HGNKQTCLLDWDARYRI--ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGD 949
K L D ++ I L GL Y+H IIHRD+K +N+ ++E+ + + D
Sbjct: 125 KCQK---LTDDHVQFLIYQIL---RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 175
Query: 950 FGLAKLIDLPYSKSMSA-IAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGK 1004
FGLA+ + M+ +A + Y APE M + DI+S G ++ EL+TG+
Sbjct: 176 FGLAR----HTADEMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 59/223 (26%), Positives = 85/223 (38%), Gaps = 43/223 (19%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
+ IG G G E++AVK I+ GA D + EI +RH
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHP 76
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQL--HGNKQTCLLDWDARYR----IALGAAE 914
NIV+ ++ EY G L E++ G + +AR+ ++
Sbjct: 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR----FSEDEARFFFQQLLS----- 127
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH--VGDFGLAKLI---DLPYSKSMSAIAG 969
G+ Y H I HRD+K N LLD + DFG +K P S G
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----G 179
Query: 970 SYGYIAPE------YAYTMKVTEKCDIYSFGVVLLELITGKSP 1006
+ YIAPE Y + D++S GV L ++ G P
Sbjct: 180 TPAYIAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVGAYP 217
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 56/251 (22%), Positives = 91/251 (36%), Gaps = 71/251 (28%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-----EISTLGKIRHRNI 862
+IGRG+ G VY A + +A+KK+ ++ EI+ L +++ I
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKV-----NRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 863 VKLYGFCYHQDSNL-----LLYEYME---------NGSLGEQLHGNKQTCLLDWDARYRI 908
++LY D ++ E + L E+ H +T L Y +
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE-H--IKTIL------YNL 138
Query: 909 ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIA 968
L G ++H IIHRD+K N LL+++ V DFGLA+ I+ ++
Sbjct: 139 LL----GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 969 GSYG---------------------YIAPE-----YAYTMKVTEKCDIYSFGVVLLELIT 1002
Y APE YT + DI+S G + EL+
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFAELLN 247
Query: 1003 GKSPVQSLELG 1013
+
Sbjct: 248 MLQSHINDPTN 258
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 45/175 (25%), Positives = 66/175 (37%), Gaps = 19/175 (10%)
Query: 520 IPSEVGNLEHLVTFNISSNSLSGTIPHE--LGNCVNLQRLDLSRNQFTGSAPEELGQLVN 577
+PS L ++S N+LS + E NL L LS N + E + N
Sbjct: 37 LPSYTALL------DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89
Query: 578 LELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPV-ALGQLTALQIALNISHNN 636
L L LS N L L L L + N + A + LQ L +S N
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQK-LYLSQNQ 147
Query: 637 LSGVIP---YELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCN---LSNNNL 685
+S + L L L L N+ + ++P + +++ V N L NN L
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSSNK-LKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 50/230 (21%), Positives = 73/230 (31%), Gaps = 56/230 (24%)
Query: 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE--FYNLQNLSALELYQNRFSG 494
LS +L N+P L + L L N L+ L E L NL +L L N +
Sbjct: 23 LSCSKQQLP-NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN- 77
Query: 495 LIPPEI-GKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVN 553
I E + NL L LS N +L + S
Sbjct: 78 FISSEAFVPVPNLRYLDLSSN-----------HLH-----TLDEFLFSDL--------QA 113
Query: 554 LQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS 613
L+ L L N + L+ L LS N+++ + +L +L
Sbjct: 114 LEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLM------- 166
Query: 614 GSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQML--EALYLDDNQL 661
L++S N L + +L L LYL +N L
Sbjct: 167 ---------------LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 41/175 (23%), Positives = 66/175 (37%), Gaps = 15/175 (8%)
Query: 255 EIPPTIGNIQSLELLALHENSFSGGLPKE-LGKLSRLKKLYVYTNELNGTIPHE-LGNCT 312
+P ++ + LL L N+ S + +L+ L L + N LN I E
Sbjct: 32 NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 313 SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRE-LGQLTQLHKLDLSINN 371
+ +DLS N L + L +L L+ N + + R + QL KL LS N
Sbjct: 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147
Query: 372 LTGTIPLE-FQNLTYLVDLQ---LFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDG 422
++ P+E ++ L L L N L+ +P L + L
Sbjct: 148 IS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPL--TDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 50/239 (20%), Positives = 88/239 (36%), Gaps = 18/239 (7%)
Query: 159 EIPEEIGNLTSLEELVIYSNNLTGAIPASI--SKLRQLRVIRAGHNSLSGPIPPEI-SEC 215
+P+ + + L + NNL+ + A ++L L + HN L+ I E
Sbjct: 32 NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPV 87
Query: 216 EGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI-GNIQSLELLALHEN 274
L L L+ N L L+ L L+L+ NH+ + ++ L+ L L +N
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 275 ---SFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVE--IDLSENQLT---- 325
F L K+ KL +L L + +N+L +L + V+ + L N L
Sbjct: 147 QISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206
Query: 326 GFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLT 384
+ L + F+ L ++L + L + S + LT
Sbjct: 207 LYQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKESAWEAHLGDTLT 265
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 49/239 (20%), Positives = 88/239 (36%), Gaps = 29/239 (12%)
Query: 62 CNWIGVECTDFKVTSV-----------DLHGLNLSGILSPRI-CDLPRLVEFNISMNFVT 109
C + C+ ++ +V DL NLS + + L L +S N +
Sbjct: 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN 77
Query: 110 GSIPTD-LANCSSLEILDLCTNRLHGVIPFQLFFINT-LRKLYLCENYIFGEIPEEI-GN 166
I ++ +L LDL +N LH + LF L L L N+I + +
Sbjct: 78 -FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFED 134
Query: 167 LTSLEELVIYSNNLTGAIPA----SISKLRQLRVIRAGHNSLSGPIPPEISECEGL--EV 220
+ L++L + N ++ P +KL +L ++ N L ++ +
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 221 LGLAQNSL----EGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENS 275
L L N L + + + R L+ ++ +Q L + NI SL+ E
Sbjct: 194 LYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYK 252
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 48/219 (21%), Positives = 83/219 (37%), Gaps = 33/219 (15%)
Query: 808 AVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-------- 858
+G G TV+ A + N +A+K ++ A EI L ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA---EDEIKLLQRVNDADNTKED 81
Query: 859 ---HRNIVKLYGFCYHQDSNL----LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALG 911
+I+KL H+ N +++E + +L + + + + +I+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQ 139
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH------VGDFGLAKLIDLPYSKSMS 965
GL Y+H C IIH DIK N+L++ + D G A D + +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD----EHYT 193
Query: 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK 1004
+ Y +PE DI+S ++ ELITG
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-14
Identities = 63/236 (26%), Positives = 93/236 (39%), Gaps = 63/236 (26%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-----EISTLGKIR-HRN 861
+G+GA G V+K+ GEV+AVKKI NS A EI L ++ H N
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKI-----FDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 862 IVKLYGFCYHQDSN--LLLYEYMENGSLGEQLHGNKQTCLLDWDARY------RIALGAA 913
IV L + L+++YME L + N L +Y +
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI---LEPVHKQYVVYQLIK------ 120
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG- 972
+ YLH ++HRD+K +NILL+ E V DFGL++ + +
Sbjct: 121 -VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 973 -------------------YIAPE-----YAYTMKVTEKCDIYSFGVVLLELITGK 1004
Y APE YT + D++S G +L E++ GK
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILGEILCGK 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 45/218 (20%)
Query: 808 AVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSF----LAEISTLGKIRHR-- 860
VIG+G+ G V KA + +A+K ++ + F EI L +R +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLRKQDK 155
Query: 861 ----NIVKLYGFCYHQD-----SNLL---LYEYMENGSLGEQLHGNKQTCLLDWDARYRI 908
N++ + ++ LL LYE ++ + G +
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKN----KFQG------FSLPLVRKF 205
Query: 909 ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH--VGDFGLAKLIDLPYSKSMSA 966
A + L LH + IIH D+K NILL ++ ++ V DFG + + +
Sbjct: 206 AHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----QRVYT 258
Query: 967 IAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK 1004
S Y APE + D++S G +L EL+TG
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 48/221 (21%), Positives = 81/221 (36%), Gaps = 49/221 (22%)
Query: 808 AVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSF----LAEISTLGKIRHR-- 860
++IG+G+ G V KA E +A+K IK +F E+ L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLELMNKHDT 112
Query: 861 ----NIVKLYGFCYHQD-----SNLL---LYEYM-ENGSLGEQLHGNKQTCLLDWDARYR 907
IV L ++ +L LY+ + G + + +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-----------VSLNLTRK 161
Query: 908 IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL----PYSKS 963
A L +L IIH D+K NILL ++ + K++D +
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI------KIVDFGSSCQLGQR 214
Query: 964 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK 1004
+ S Y +PE M D++S G +L+E+ TG+
Sbjct: 215 IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 41/168 (24%), Positives = 63/168 (37%), Gaps = 33/168 (19%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPL-EFQNLTYLVDLQLFDNHLEGTIPPHIGVNSH 409
IP + Q T +L L+ N T F+ L L + +N + I G
Sbjct: 25 KIPEHIPQYTA--ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEE--GAFEG 79
Query: 410 LSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQL 468
S + + L SNRL N+ + K SL LML N++
Sbjct: 80 AS---------------------GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI 117
Query: 469 TGSLPIE-FYNLQNLSALELYQNRFSGLIPPEI-GKLRNLERLHLSEN 514
T + + F L ++ L LY N+ + + P L +L L+L N
Sbjct: 118 T-CVGNDSFIGLSSVRLLSLYDNQITT-VAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 26/145 (17%), Positives = 54/145 (37%), Gaps = 12/145 (8%)
Query: 520 IPSEVGNLEHLVTFNISSNSLSGTIPH-ELGNCVNLQRLDLSRNQFTGSAPEELGQLVNL 578
IP L +++N + L++++ S N+ T +
Sbjct: 30 IPQYTAELR------LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 579 ELLKLSDNKLTGAIPSSL-GGLARLTELQMGGNIFSGSIPV-ALGQLTALQIALNISHNN 636
+ L+ N+L + + GL L L + N + + + L+++++ L++ N
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRL-LSLYDNQ 140
Query: 637 LSGVIPYELGNLQMLEALYLDDNQL 661
++ V P L L L L N
Sbjct: 141 ITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 36/143 (25%), Positives = 58/143 (40%), Gaps = 7/143 (4%)
Query: 159 EIPEEIGNLTSLEELVIYSNNLTGAIP-ASISKLRQLRVIRAGHNSLSGPIPPEI-SECE 216
+IPE I EL + +N T KL QLR I +N ++ I
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGAS 81
Query: 217 GLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPP-TIGNIQSLELLALHENS 275
G+ + L N LE + L +L L+L N ++ + + + S+ LL+L++N
Sbjct: 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 276 FSGGLPKELGKLSRLKKLYVYTN 298
+ P L L L + N
Sbjct: 141 ITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 38/219 (17%), Positives = 64/219 (29%), Gaps = 68/219 (31%)
Query: 62 CNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSS 121
C V+C++ K+ + P IP
Sbjct: 11 CEGTTVDCSNQKLNKI------------PE-------------------HIPQY------ 33
Query: 122 LEILDLCTNRLHGVIPFQLFF-INTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNN 179
L L N + +F + LRK+ N I +I E + + E+++ SN
Sbjct: 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNR 92
Query: 180 LTGAIPASI-SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEK 238
L + + L L+ L L N +
Sbjct: 93 LE-NVQHKMFKGLESLK------------------------TLMLRSNRITCVGNDSFIG 127
Query: 239 LRNLTDLILWQNHLSGEIPP-TIGNIQSLELLALHENSF 276
L ++ L L+ N ++ + P + SL L L N F
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 29/142 (20%), Positives = 50/142 (35%), Gaps = 7/142 (4%)
Query: 208 IPPEISECEGLEVLGLAQNSLEGFLPS-ELEKLRNLTDLILWQNHLSGEIPPTI-GNIQS 265
IP I + L L N + +KL L + N ++ +I
Sbjct: 26 IPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82
Query: 266 LELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL-GNCTSAVEIDLSENQL 324
+ + L N K L LK L + +N + + ++ +S + L +NQ+
Sbjct: 83 VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
Query: 325 TGFIPRELGLIPNLCLLQLFEN 346
T P + +L L L N
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 37/166 (22%), Positives = 64/166 (38%), Gaps = 30/166 (18%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410
IP L + ++ L N + P F L + L +N + + P L
Sbjct: 25 EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP--DAFQGL 79
Query: 411 SVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQLT 469
L L L N+++ +P L + SL L+L N++
Sbjct: 80 R---------------------SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN 117
Query: 470 GSLPIE-FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSEN 514
L ++ F +L NL+ L LY N+ + LR ++ +HL++N
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 35/133 (26%), Positives = 64/133 (48%), Gaps = 10/133 (7%)
Query: 437 LSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSG 494
+ L N + IPPG + L ++ L NQ++ L + F L++L++L LY N+ +
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 495 LIPPEI-GKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHE-LGNC 551
L P + L +L+ L L+ N + + + +L +L ++ N L TI
Sbjct: 95 L-PKSLFEGLFSLQLLLLNANK-INCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPL 151
Query: 552 VNLQRLDLSRNQF 564
+Q + L++N F
Sbjct: 152 RAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 30/145 (20%), Positives = 55/145 (37%), Gaps = 18/145 (12%)
Query: 256 IPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIP----HELGNC 311
+P TI + L +N+ P +L+++ + N+++ + L +
Sbjct: 30 LPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQ-LTQLHKLDLSIN 370
+ L N++T + +L LL L N + + + Q L L+ L L N
Sbjct: 83 N---SLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138
Query: 371 NLTGTIPLE-FQNLTYLVDLQLFDN 394
L TI F L + + L N
Sbjct: 139 KLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 27/111 (24%), Positives = 48/111 (43%), Gaps = 3/111 (2%)
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNI 611
+ + L +N P L + LS+N+++ P + GL L L + GN
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 612 FSGSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
+ +P L +LQ+ L ++ N ++ + +L L L L DN+L
Sbjct: 92 IT-ELPKSLFEGLFSLQL-LLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 30/175 (17%), Positives = 54/175 (30%), Gaps = 49/175 (28%)
Query: 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544
+ L QN + P + L R+ LS N + + + + L
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNN-QISELAPDA--FQGLR------------- 80
Query: 545 PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTE 604
+L L L N+ T L +L+LL L+ NK+ + L
Sbjct: 81 --------SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRV--DAFQDLHN 129
Query: 605 LQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
L + L++ N L + L+ ++ ++L N
Sbjct: 130 LNL----------------------LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 39/168 (23%), Positives = 65/168 (38%), Gaps = 30/168 (17%)
Query: 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEI-GNLTS 169
IPT+L ++ + L N + + P LR++ L N I E+ + L S
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRS 81
Query: 170 LEELVIYSNNLTGAIPASI-SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSL 228
L LV+Y N +T +P S+ L L++ L L N +
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQL------------------------LLLNANKI 116
Query: 229 EGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSF 276
+ L NL L L+ N L T +++++ + L +N F
Sbjct: 117 NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 33/176 (18%)
Query: 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR 491
+ + ++ + G++ ++ L LG N+L + L NL+ L L N+
Sbjct: 41 NSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQ 96
Query: 492 FSGLIPPEI-GKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGN 550
L P + KL NL+ L L EN SL + +L
Sbjct: 97 LQSL-PNGVFDKLTNLKELVLVEN---------------------QLQSLPDGVFDKL-- 132
Query: 551 CVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQ 606
NL L+L+ NQ +L NL L LS N+L ++P G +LT+L+
Sbjct: 133 -TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPE--GVFDKLTQLK 184
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 50/226 (22%), Positives = 80/226 (35%), Gaps = 57/226 (25%)
Query: 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLI 496
+L ++ + + S+ Q++ + + S+ L N+ L L N+ +
Sbjct: 24 ANLKKKSVT-DAVTQNEL-NSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI- 78
Query: 497 PPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQR 556
+ +L NL L L+ N SL + +L NL+
Sbjct: 79 -SALKELTNLTYLILTGNQLQ---------------------SLPNGVFDKL---TNLKE 113
Query: 557 LDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSL-GGLARLTELQMGGNIFSGS 615
L L NQ +L NL L L+ N+L ++P + L LTEL + N
Sbjct: 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYN----- 167
Query: 616 IPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
QL +L GV +L L+ L L NQL
Sbjct: 168 ------QLQSLP----------EGVFD-KLTQLK---DLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 50/196 (25%), Positives = 80/196 (40%), Gaps = 22/196 (11%)
Query: 208 IPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLE 267
P + E L + S+ ++ +L ++ +I + + I + ++
Sbjct: 13 FPDDAF-AET-IKANLKKKSVTD-AVTQ-NELNSIDQIIANNSDIKSV--QGIQYLPNVR 66
Query: 268 LLALHENSFSGGLPKELG---KLSRLKKLYVYTNELN---GTIPHELGNCTSAVEIDLSE 321
LAL N ++ +L+ L L + N+L + +L N E+ L E
Sbjct: 67 YLALGGNKL-----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK---ELVLVE 118
Query: 322 NQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLE-F 380
NQL + NL L L N LQ +LT L +LDLS N L ++P F
Sbjct: 119 NQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVF 177
Query: 381 QNLTYLVDLQLFDNHL 396
LT L DL+L+ N L
Sbjct: 178 DKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 53/228 (23%), Positives = 84/228 (36%), Gaps = 27/228 (11%)
Query: 176 YSNNLTGAIPASIS-KLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPS 234
+ P + + + + ++ + + S++G
Sbjct: 6 STPIKQ-IFPDDAFAETIKANLKKKSVTDAVTQNE--LNSIDQIIANNSDIKSVQGI--- 59
Query: 235 ELEKLRNLTDLILWQNHLSGEIPPTIG---NIQSLELLALHENSFSGGLPKELGKLSRLK 291
+ L N+ L L N L I + +L L L N KL+ LK
Sbjct: 60 --QYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112
Query: 292 KLYVYTNELN---GTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENML 348
+L + N+L + +L N T ++L+ NQL + NL L L N L
Sbjct: 113 ELVLVENQLQSLPDGVFDKLTNLT---YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL 169
Query: 349 QGSIPREL-GQLTQLHKLDLSINNLTGTIPLE-FQNLTYLVDLQLFDN 394
Q S+P + +LTQL L L N L ++P F LT L + L DN
Sbjct: 170 Q-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 55/193 (28%), Positives = 83/193 (43%), Gaps = 32/193 (16%)
Query: 312 TSAVEIDLSENQLTGF--IPRELGLIPNLCLLQLFENMLQGSIPRELG---QLTQLHKLD 366
S +I + + + I +PN+ L L N L ++ +LT L L
Sbjct: 41 NSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLH-----DISALKELTNLTYLI 91
Query: 367 LSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLS---VLDVSMNNLDGS 423
L+ N L F LT L +L L +N L+ ++P GV L+ L+++ N L S
Sbjct: 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPD--GVFDKLTNLTYLNLAHNQLQ-S 147
Query: 424 IPP----HLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQLTGSLPIE-FY 477
+P L L L L N+L ++P G+ L L L QNQL S+P F
Sbjct: 148 LPKGVFDKLT---NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFD 202
Query: 478 NLQNLSALELYQN 490
L +L + L+ N
Sbjct: 203 RLTSLQYIWLHDN 215
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 50/172 (29%), Positives = 72/172 (41%), Gaps = 17/172 (9%)
Query: 496 IPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIP----HELGNC 551
+P I + E+L L + L L N+ N L T+ +L
Sbjct: 29 VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDL--- 82
Query: 552 VNLQRLDLSRNQFTGSAPEEL-GQLVNLELLKLSDNKLTGAIPSSL-GGLARLTELQMGG 609
L L L+ NQ S P + L L+ L L N+L ++PS + L +L EL++
Sbjct: 83 TELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNT 140
Query: 610 NIFSGSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQ 660
N SIP A +LT LQ L++S N L V L L+ + L NQ
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQT-LSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 48/181 (26%), Positives = 67/181 (37%), Gaps = 28/181 (15%)
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPREL-GQLTQLHKLDLSIN 370
++DL L + L L L N LQ ++ + LT+L L L+ N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93
Query: 371 NLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCM 430
L F +LT L L L N L+ ++P GV L+
Sbjct: 94 QLASLPLGVFDHLTQLDKLYLGGNQLK-SLPS--GVFDRLT------------------- 131
Query: 431 YQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQ 489
KL L L +N+L +IP G +L L L NQL F L L + L+
Sbjct: 132 --KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188
Query: 490 N 490
N
Sbjct: 189 N 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 50/171 (29%), Positives = 75/171 (43%), Gaps = 12/171 (7%)
Query: 399 TIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRS 457
++P I ++ LD+ L KL +L+L N+L + G+
Sbjct: 28 SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 458 LMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSGLIPPEI-GKLRNLERLHLSENY 515
L L L NQL SLP+ F +L L L L N+ L P + +L L+ L L+ N
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSL-PSGVFDRLTKLKELRLNTNQ 142
Query: 516 FVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQRLDLSRNQF 564
IP+ L +L T ++S+N L ++PH LQ + L NQF
Sbjct: 143 LQS-IPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 36/137 (26%), Positives = 58/137 (42%), Gaps = 7/137 (5%)
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSL-GGLARLTELQMGGN 610
+ ++LDL + L L L L N+L + + + L L L + N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93
Query: 611 IFSGSIPVAL-GQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASM 669
+ S+P+ + LT L L + N L + L L+ L L+ NQL IPA
Sbjct: 94 QLA-SLPLGVFDHLTQLDK-LYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL-QSIPAGA 150
Query: 670 GEQMS-LLVCNLSNNNL 685
++++ L +LS N L
Sbjct: 151 FDKLTNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 43/168 (25%), Positives = 66/168 (39%), Gaps = 10/168 (5%)
Query: 160 IPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEI-SECEGL 218
+P I E+L + S L A+ L +L + +N L + + + L
Sbjct: 29 VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTEL 85
Query: 219 EVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI-GNIQSLELLALHENSFS 277
LGLA N L + L L L L N L +P + + L+ L L+ N
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144
Query: 278 GGLPKEL-GKLSRLKKLYVYTNELNGTIPHE-LGNCTSAVEIDLSENQ 323
+P KL+ L+ L + TN+L ++PH I L NQ
Sbjct: 145 -SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 35/155 (22%), Positives = 60/155 (38%), Gaps = 6/155 (3%)
Query: 147 RKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASI-SKLRQLRVIRAGHNSLS 205
KL L + LT L L + N L + A + L +L + +N L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 206 GPIPPEI-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI-GNI 263
+P + L+ L L N L+ ++L L +L L N L IP +
Sbjct: 97 S-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 264 QSLELLALHENSFSGGLPKELGKLSRLKKLYVYTN 298
+L+ L+L N +L +L+ + ++ N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 4e-12
Identities = 107/663 (16%), Positives = 190/663 (28%), Gaps = 202/663 (30%)
Query: 8 SHTQKLFYFALIFCFSNVS-VTSLTEEGVS-----LLE-FKASLIDPSNNLESWNSSDMT 60
S T +LF+ V EE + L+ K PS +
Sbjct: 62 SGTLRLFW---TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 61 PCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRL-VEFNISMNFVTGSIPTDLAN- 118
N + V+ + + L L R L L N+ ++ V GS T +A
Sbjct: 119 LYN-DNQVFAKYNVSRLQPY-LKL------RQA-LLELRPAKNVLIDGVLGSGKTWVALD 169
Query: 119 -CSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYS 177
C S ++ + F++F++N + N S E ++
Sbjct: 170 VCLSYKVQC--------KMDFKIFWLN-------------------LKNCNSPETVLEML 202
Query: 178 NNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELE 237
L L Q+ + S I I Q L L S+
Sbjct: 203 QKL----------LYQIDPNWTSRSDHSSNIKLRIHS---------IQAELRRLLKSKPY 243
Query: 238 K-----LRNLTDLILWQ------------------NHLSG---------EIPPTIGNIQS 265
+ L N+ + W + LS T+ +
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV 303
Query: 266 LELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLT 325
LL K L +L P E + +
Sbjct: 304 KSLLL--------------------KYLDCRPQDL----PRE------VLTTN------- 326
Query: 326 GFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTY 385
PR L +I ++ + + ++ S+N L P E++
Sbjct: 327 ---PRRLSIIAE--SIRDGLATWDNW--KHVNCDKLTTIIESSLNVLE---PAEYRK--M 374
Query: 386 LVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLS 445
L +F IP + LS++ ++ S + KL SL +
Sbjct: 375 FDRLSVFPPSAH--IPTIL-----LSLI---WFDVIKSDVMV--VVNKLHKYSL----VE 418
Query: 446 GNIPPGLKTCRSLMQLMLGQNQLTGSL---PIEFYNLQNLSALELYQNRFSGLIPPEIGK 502
+ S+ + + + +L ++ YN+ + + + LIPP +
Sbjct: 419 KQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIP-----KTFDS--DDLIPPYL-- 469
Query: 503 LRNLERLHLSENYFVGYIPSEVGNLEH----------LVTFNISSNSL--SGTIPHELGN 550
+ YF +I + N+EH + F + T + G+
Sbjct: 470 ----------DQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519
Query: 551 CVN-LQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGG 609
+N LQ+L + + P + +LVN +L I S L R+ +
Sbjct: 520 ILNTLQQLKFYKPYICDNDP-KYERLVN-AILDFLPKIEENLICSKYTDLLRIALMAEDE 577
Query: 610 NIF 612
IF
Sbjct: 578 AIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 2e-09
Identities = 93/561 (16%), Positives = 174/561 (31%), Gaps = 132/561 (23%)
Query: 388 DLQLFDNHLEGTIPPHIGVNSHLSVLDVSMN-NLDGSIPPHLCMY----QKLIFLSLGSN 442
D Q+F + + P++ + L L + N +DG + + S
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG-------VLGSGKTWVALDVCLSY 174
Query: 443 RLSGNIPPG-----LKTCRSLMQLMLGQNQLTGSLPIEFYNL-QNLSALELYQNRFSGLI 496
++ + LK C S ++ +L Y + N ++ + + I
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQKL-------LYQIDPNWTSRSDHSSN----I 223
Query: 497 PPEIGKLRN-LERLHLSENYFVGY-IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNL 554
I ++ L RL S+ Y + V N + FN+S L T ++ + ++
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283
Query: 555 QR-----LDLSRNQFTGSAPEEL-GQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMG 608
LD T + L + ++ L LT P L +A ++ G
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN-PRRLSIIAES--IRDG 340
Query: 609 GNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNL-QMLEALYLDDNQLIGEIPA 667
+ V +LT + S N L P E + L +++ IP
Sbjct: 341 LATWDNWKHVNCDKLTT---IIESSLNVLE---PAEYRKMFDRL-SVFPPSAH----IPT 389
Query: 668 SMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQLMPPSHTPK 727
+ +SL+ ++ ++ V V N L +
Sbjct: 390 IL---LSLIWFDVIKSD-VMVVVNKLH-----------KYSLV----------------E 418
Query: 728 KNWIKGGSTKEKLVSIISV-------IVGLISL-SFIIGICWAMKCRKPAFVPLEEQKNP 779
K KE +SI S+ + +L I+ K + P
Sbjct: 419 KQP------KESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDS------DDLIP 466
Query: 780 EVIDNYYFPKEGFKYH-NLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRG 838
+D Y++ G +H +E + ++ + + +KI+
Sbjct: 467 PYLDQYFYSHIG--HHLKNIEHPERMTL------------FRMVFLDFRFLE-QKIRHDS 511
Query: 839 EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMEN-GSLGEQLHGNKQT 897
A S L + L + I L+ ++ + E L +K T
Sbjct: 512 TAWNASGSILNTLQQLKFYK-PYICD-----NDPKYERLVNAILDFLPKIEENLICSKYT 565
Query: 898 CLLDWDARYRIALGAAEGLCY 918
LL RIAL A + +
Sbjct: 566 DLL------RIALMAEDEAIF 580
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 5e-12
Identities = 51/324 (15%), Positives = 83/324 (25%), Gaps = 79/324 (24%)
Query: 800 ATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLR------GEGATADNSFLAEIST 853
T IG G G V++ + V A+K I + G L EI
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 854 LGKI---------RHRNIVKLYGFC------------------------------YHQDS 874
++ R + L + D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKS 934
++ E+ G EQ+ L I L HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 935 NNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEK--CDIYS 992
N+LL + + K +P S G YT+ E+ ++
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIP----------SCGLQVSIIDYTLSRLERDGIVVFC 240
Query: 993 FGVVLLELITGKSPVQS-------LELGGDL--------VTWVRRSIHEMVPTSELFDKR 1037
+ +L TG Q E V W+ +M+ K
Sbjct: 241 DVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300
Query: 1038 LDLSAKRTVEEMTLFLKIALFCSS 1061
+ K+ ++ F + L SS
Sbjct: 301 NTPAMKQIKRKIQEFHRTMLNFSS 324
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 55/361 (15%), Positives = 103/361 (28%), Gaps = 65/361 (18%)
Query: 356 LGQLTQLHKLDLSINNLT--GTIPL--EFQNLTYLVDLQLFDNHL--EGT--IPPHIGVN 407
+ + + + L ++ +T + + ++ L N + E + +I
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 408 SHLSVLDVSMNNLD----------GSIPPHLCMYQKLIFLSLGSNRLSGN----IPPGLK 453
L + + S + L KL + L N + L
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 454 TCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSE 513
L L L N L + ++ + + + L +
Sbjct: 120 KHTPLEHLYLHNNGLG-----------PQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 514 NYF----VGYIPSEVGNLEHLVTFNISSNSL-----SGTIPHELGNCVNLQRLDLSRNQF 564
N + + L T + N + + L C L+ LDL N F
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 565 TGSAPEELGQLV----NLELLKLSDNKLTG----AIPSSLGGLA--RLTELQMGGNIFSG 614
T L + NL L L+D L+ A+ + L L L++ N
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288
Query: 615 SIPVALGQ-----LTALQIALNISHNNLS--GVIPYELGNL----QMLEALYLDDNQLIG 663
L + L L ++ N S + E+ + E LDD + +
Sbjct: 289 DAVRTLKTVIDEKMPDLLF-LELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELT 347
Query: 664 E 664
+
Sbjct: 348 D 348
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 58/325 (17%), Positives = 108/325 (33%), Gaps = 63/325 (19%)
Query: 218 LEVLGLAQNSL--EGF--LPSELEKLRNLTDLILWQNHLSGE----IPPTIGNIQSLELL 269
+E L +++ E + + L + ++ +++L N + E + I + + LE+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 270 ALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIP 329
+ F+G + E+ + R + L C + LS+N
Sbjct: 66 EFSDI-FTGRVKDEIPEALR-------------LLLQALLKCPKLHTVRLSDNAFGPTAQ 111
Query: 330 RELG--LIPNLCL--LQLFENML-------------QGSIPRELGQLTQLHKLDLSINNL 372
L L + L L L N L + ++ ++ L + N L
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
Query: 373 T--GTIPL--EFQNLTYLVDLQLFDNHL-----EGTIPPHIGVNSHLSVLDVSMNNL--D 421
FQ+ L +++ N + E + + L VLD+ N
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL 231
Query: 422 G--SIPPHLCMYQKLIFLSLGSNRLSGN----IPPGLKTC--RSLMQLMLGQNQLT--GS 471
G ++ L + L L L LS + L L L N++
Sbjct: 232 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 291
Query: 472 LPIEFY---NLQNLSALELYQNRFS 493
++ + +L LEL NRFS
Sbjct: 292 RTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 50/349 (14%), Positives = 107/349 (30%), Gaps = 70/349 (20%)
Query: 24 NVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDF---------KV 74
++ + ++T E + +++ ++++ S N IG E + +
Sbjct: 10 SLKLDAITTEDEKSV---FAVLLEDDSVKEIVLSG----NTIGTEAARWLSENIASKKDL 62
Query: 75 TSVDLHGLNLSGI----------LSPRICDLPRLVEFNISMNFVTG----SIPTDLANCS 120
+ + + L + P+L +S N + L+ +
Sbjct: 63 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 122
Query: 121 SLEILDLCTNRL-------------HGVIPFQLFFINTLRKLYLCENYIFGE----IPEE 163
LE L L N L + + LR + N + +
Sbjct: 123 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182
Query: 164 IGNLTSLEELVIYSNNLT-----GAIPASISKLRQLRVIRAGHNSLSGP----IPPEISE 214
+ L + + N + + ++ ++L+V+ N+ + + +
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 215 CEGLEVLGLAQNSL--EG--FLPSELEKLRN--LTDLILWQNHLSGEIPPTIG-----NI 263
L LGL L G + KL N L L L N + + T+ +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 302
Query: 264 QSLELLALHENSFS--GGLPKELGK-LSRLKKLYVYTNELNGTIPHELG 309
L L L+ N FS + E+ + S + + + + E
Sbjct: 303 PDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTDEEE 351
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 40/132 (30%), Positives = 57/132 (43%), Gaps = 9/132 (6%)
Query: 267 ELLALHENSFSGGLPKELGKLSRLKKLYVYTNEL----NGTIPHELGNCTSAVEIDLSEN 322
++L LH+N + P L LK+LY+ +N+L G + L T +DL N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDSLTQLT---VLDLGTN 98
Query: 323 QLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQN 382
QLT + +L L + N L +PR + +LT L L L N L F
Sbjct: 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 383 LTYLVDLQLFDN 394
L+ L LF N
Sbjct: 158 LSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 44/147 (29%), Positives = 62/147 (42%), Gaps = 17/147 (11%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410
S+P + Q L L N +T P F +L L +L L N L +P GV L
Sbjct: 33 SVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPV--GVFDSL 87
Query: 411 S---VLDVSMNNLDGSIPP----HLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLML 463
+ VLD+ N L +P L L L + N+L+ +P G++ L L L
Sbjct: 88 TQLTVLDLGTNQLT-VLPSAVFDRL---VHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142
Query: 464 GQNQLTGSLPIEFYNLQNLSALELYQN 490
QNQL F L +L+ L+ N
Sbjct: 143 DQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 7/130 (5%)
Query: 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSGL 495
L L N+++ P + +L +L LG NQL +LP+ F +L L+ L+L N+ + L
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 496 IPPEI-GKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHE-LGNCVN 553
P + +L +L+ L + N +P + L HL + N L +IPH +
Sbjct: 104 -PSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSS 160
Query: 554 LQRLDLSRNQ 563
L L N
Sbjct: 161 LTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 42/154 (27%), Positives = 59/154 (38%), Gaps = 31/154 (20%)
Query: 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544
L L+ N+ + L P L NL+ L+L N +L +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQL---------------------GALPVGV 83
Query: 545 PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTE 604
L L LDL NQ T +LV+L+ L + NKLT +P + L LT
Sbjct: 84 FDSL---TQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTH 139
Query: 605 LQMGGNIFSGSIPV-ALGQLTALQ-IALNISHNN 636
L + N SIP A +L++L L N
Sbjct: 140 LALDQNQLK-SIPHGAFDRLSSLTHAYL---FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 5/148 (3%)
Query: 152 CENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPE 211
C + +P I T+ + L ++ N +T P L L+ + G N L +P
Sbjct: 26 CRSKRHASVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVG 82
Query: 212 I-SECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLA 270
+ L VL L N L + ++L +L +L + N L+ E+P I + L LA
Sbjct: 83 VFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141
Query: 271 LHENSFSGGLPKELGKLSRLKKLYVYTN 298
L +N +LS L Y++ N
Sbjct: 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 39/112 (34%), Positives = 55/112 (49%), Gaps = 6/112 (5%)
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSL-GGLARLTELQMGGN 610
N Q L L NQ T P L+NL+ L L N+L A+P + L +LT L +G N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 611 IFSGSIPVAL-GQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
+ +P A+ +L L+ L + N L+ +P + L L L LD NQL
Sbjct: 99 QLT-VLPSAVFDRLVHLKE-LFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 40/115 (34%), Positives = 55/115 (47%), Gaps = 4/115 (3%)
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPREL-GQLTQLHKLDLSIN 370
T+A + L +NQ+T P + NL L L N L ++P + LTQL LDL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 371 NLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIP 425
LT F L +L +L + N L +P I +HL+ L + N L SIP
Sbjct: 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP 151
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 41/233 (17%), Positives = 73/233 (31%), Gaps = 57/233 (24%)
Query: 808 AVIGRGACGTVYKA--TLANGEVIAVKKIKLRGEGATADNSF----LAEISTLGKIRHR- 860
+G G G V + +A+K I+ + EI+ L KI+ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVLKKIKEKD 77
Query: 861 -----NIVKLYGFCYHQD-----SNLL---LYEYM-ENGSLGEQLHGNKQTCLLDWDARY 906
V + + LL +E++ EN L +
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR----------- 126
Query: 907 RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-----------KL 955
+A L +LH + H D+K NIL + + + ++
Sbjct: 127 HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 956 IDL----PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK 1004
D + + I + Y PE + + CD++S G +L E G
Sbjct: 184 ADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 47/233 (20%), Positives = 85/233 (36%), Gaps = 57/233 (24%)
Query: 808 AVIGRGACGTVYKA--TLANGEVIAVKKIKLRGEGATADNSF----LAEISTLGKIRHR- 860
+G GA G V + A G +AVK +K + + +EI L +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHLNTTD 72
Query: 861 -----NIVKLYGFCYHQD-----SNLL---LYEYM-ENGSLGEQLHGNKQTCLLDWDARY 906
V++ + H LL Y+++ ENG L +L +
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR----------- 121
Query: 907 RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA-----------KL 955
++A + + +LH + H D+K NIL + + + K+
Sbjct: 122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 956 IDL----PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK 1004
+D + S + + Y APE + ++ CD++S G +L+E G
Sbjct: 179 VDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 55/237 (23%), Positives = 78/237 (32%), Gaps = 61/237 (25%)
Query: 808 AVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSF----LAEISTLGKIRHR-- 860
+G G G V + N + AVK ++ + E L KI++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQNDDI 93
Query: 861 ---NIVKLYGFCYHQD-----SNLL---LYEYM-ENGSLGEQLHGNKQTCLLDWDARYRI 908
NIVK +G + D L LYE + N G +
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNG-----------FHIEDIKLY 142
Query: 909 ALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA--------------- 953
+ + L YL + H D+K NILLD+ +
Sbjct: 143 CIEILKALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 954 --KLIDL----PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK 1004
KLID S +I + Y APE + D++SFG VL EL TG
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 30/130 (23%), Positives = 50/130 (38%), Gaps = 7/130 (5%)
Query: 544 IPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT 603
+ L + L LS N L + NL +L L N + I + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 604 ELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYE-LGNLQMLEALYLDDNQLI 662
EL + N + S+ + +L L++ L +S+N ++ + L L LE L L N L
Sbjct: 97 ELWISYNQIA-SLS-GIEKLVNLRV-LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153
Query: 663 GEIPASMGEQ 672
+ +
Sbjct: 154 NDYKENNATS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 33/162 (20%), Positives = 58/162 (35%), Gaps = 39/162 (24%)
Query: 433 KLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRF 492
+ + L + + L T ++ L L N + + +LS
Sbjct: 26 EKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE--------KISSLS--------- 67
Query: 493 SGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLV----TFNISSNSLSGTIPHEL 548
+ NL L L N ++ NL+ + IS N ++ ++ +
Sbjct: 68 ---------GMENLRILSLGRNLI-----KKIENLDAVADTLEELWISYNQIA-SLSG-I 111
Query: 549 GNCVNLQRLDLSRNQFTGSAP-EELGQLVNLELLKLSDNKLT 589
VNL+ L +S N+ T ++L L LE L L+ N L
Sbjct: 112 EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 30/184 (16%), Positives = 62/184 (33%), Gaps = 35/184 (19%)
Query: 146 LRKLYLCENYIFGEIPEEIGNLTSLEELVIY--SNNLTGAIPASISKLRQLRVIRAGHNS 203
+ K ++ I + T E++ ++ + + A++S L+ + + N
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTN- 58
Query: 204 LSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNI 263
I + L + NL L L +N + +I
Sbjct: 59 -------NIEKISSLS------------------GMENLRILSLGRNLIK-KIENLDAVA 92
Query: 264 QSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPH--ELGNCTSAVEIDLSE 321
+LE L + N + + KL L+ LY+ N++ +L ++ L+
Sbjct: 93 DTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAG 149
Query: 322 NQLT 325
N L
Sbjct: 150 NPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 35/138 (25%), Positives = 53/138 (38%), Gaps = 39/138 (28%)
Query: 112 IPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNL---- 167
+ L+ + + L L TN + + L + LR L L N I ++I NL
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLI-----KKIENLDAVA 92
Query: 168 TSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNS 227
+LEEL I N + SLSG I + L VL ++ N
Sbjct: 93 DTLEELWISYNQIA---------------------SLSG-----IEKLVNLRVLYMSNNK 126
Query: 228 LEGFLPSELEKLRNLTDL 245
+ + E++KL L L
Sbjct: 127 ITNW--GEIDKLAALDKL 142
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 30/169 (17%), Positives = 59/169 (34%), Gaps = 40/169 (23%)
Query: 352 IPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLS 411
+ L L L LS NN+ + +L+ + +L+
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLR--------------------- 73
Query: 412 VLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGS 471
+L + N + I + L L + N+++ ++ G++ +L L + N++T
Sbjct: 74 ILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNW 130
Query: 472 LPIEF-YNLQNLSALELYQNRFSGLIPPE----------IGKLRNLERL 509
I+ L L L L N + +L NL++L
Sbjct: 131 GEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 70/540 (12%), Positives = 155/540 (28%), Gaps = 102/540 (18%)
Query: 73 KVTSVDLHGLNLSGILSPRICDL----PRLVEFNISMNFVTGSIPTDLA--NCSSLEILD 126
+ +L N G ++P + ++ +L + V+ LA LE L
Sbjct: 85 RAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK 144
Query: 127 LCTNRLHGVIPFQLFFI----NTLRKLYLCENYIFGEIPEEIG----NLTSLEELVIYSN 178
L ++ G L I ++ L + E+ + + + + TSLE L Y
Sbjct: 145 L--DKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMT 202
Query: 179 NLTG-------AIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGF 231
I + L ++V L G + E L ++
Sbjct: 203 EFAKISPKDLETIARNCRSLVSVKVGDFEILELVG-FFKAAANLEEFCGGSLNEDIGMPE 261
Query: 232 LPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSG-GLPKELGKLSRL 290
L R L L L + +P + L L + K L
Sbjct: 262 KYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320
Query: 291 KKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQG 350
+ L + + C + + + E GL+ L+ L +
Sbjct: 321 EVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG---- 376
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEF-QNLTYLVDLQLFDNHLEGTIPPHIGVNSH 409
+L + + ++++T L L D +L + ++
Sbjct: 377 --------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRL------------VLLDRE 416
Query: 410 LSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQL 468
+ D+ ++N S+ ++ L L+ + + ++ ++LG
Sbjct: 417 ERITDLPLDNGVRSLLIGCKKLRRF-AFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGE 475
Query: 469 TGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLE 528
+ + +E + NL++L +
Sbjct: 476 S-----------DEGLMEFSRG------------CPNLQKLEMRGC-------------- 498
Query: 529 HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQ---LVNLELLKLSD 585
S +++ + +L+ L + + + + + + N+EL+
Sbjct: 499 -----CFSERAIA----AAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRR 549
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 66/409 (16%), Positives = 125/409 (30%), Gaps = 49/409 (11%)
Query: 213 SECEGLEVLGLAQNSL--EGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNI----QSL 266
+ + LE L L + S L S + R + L++ ++ S + + + SL
Sbjct: 135 ARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194
Query: 267 ELLALHENSFSG----GLPKELGKLSRLKKLYVYTNEL--NGTIPHELGNCTSAVEIDLS 320
E+L + F+ L L + V E+ N L+
Sbjct: 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLN 254
Query: 321 ENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLE- 379
E+ L LC L L M +P Q+ KLDL L
Sbjct: 255 EDIGMPEKYMNLVFPRKLCRLGLS-YMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTL 313
Query: 380 FQNLTYLVDLQLFDNHLEGTIPPHIGVN-SHLSVLDVSMNNLDGSIPPHLCMYQKLIFLS 438
Q L L+ + + + + L L + + + + + ++
Sbjct: 314 IQKCPNLEVLETRNVIGDRGLE-VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIA 372
Query: 439 LGSNRLSGNIPPGLKTCRSLMQLMLGQNQLT----GSLPIEFYNLQNLSALELYQNRFSG 494
L C+ L + + + +T S+ NL + + L +
Sbjct: 373 LAQG------------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERIT 420
Query: 495 LIPPEIG------KLRNLERLHLSENYF------VGYIPSEVGNLEHLVTFNISSNSLSG 542
+P + G + L R + YI N+ + + S
Sbjct: 421 DLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWM---LLGYVGESD 477
Query: 543 T-IPHELGNCVNLQRLDLSRNQFTGSAPEEL-GQLVNLELLKLSDNKLT 589
+ C NLQ+L++ F+ A +L +L L + + +
Sbjct: 478 EGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 52/299 (17%), Positives = 102/299 (34%), Gaps = 39/299 (13%)
Query: 455 CRSLMQLMLGQNQLTGSLPIEFYNLQNL--------SALELYQNRFSGLIPPEI----GK 502
R + + L L F NL++L + L + G + P +
Sbjct: 51 TREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNN 110
Query: 503 LRNLERLHLSENY-----FVGYIPSEVGNLEHLV---TFNISSNSLSGTIPHELGNCVNL 554
LR L+ +H + +LE L +++ L + +C +
Sbjct: 111 LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLL----SIVTHCRKI 166
Query: 555 QRLDLSRNQFTGSAPEELGQLV----NLELLKLSDNKLTGAIPSSLGGLAR----LTELQ 606
+ L + + F+ + L +L +LE+L + P L +AR L ++
Sbjct: 167 KTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVK 226
Query: 607 MGG--NIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEAL---YLDDNQL 661
+G + A L +++ + L + L L Y+ N++
Sbjct: 227 VGDFEILELVGFFKAAANLEEFCG-GSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEM 285
Query: 662 IGEIPASMG-EQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQL 719
P + ++ LL L + + +++ N G+RGL +L C QL
Sbjct: 286 PILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQL 344
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 48/372 (12%), Positives = 98/372 (26%), Gaps = 53/372 (14%)
Query: 310 NCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSI 369
+C + + E+ + + L + T L L+ +
Sbjct: 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHN--------------------TSLEVLNFYM 201
Query: 370 NNLTG----TIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIP 425
+ +N LV +++ D + + ++L N D +P
Sbjct: 202 TEFAKISPKDLETIARNCRSLVSVKVGDFEI-LELVGFFKAAANLEEFCGGSLNEDIGMP 260
Query: 426 PHLCMYQKLIFLSLGSNRLSGN--IPPGLKTCRSLMQLML-GQNQLTGSLPIEFYNLQNL 482
L G +P + +L L T NL
Sbjct: 261 EKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320
Query: 483 SALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSG 542
LE + + L+RL + + E G + ++
Sbjct: 321 EVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG---- 376
Query: 543 TIPHELGNCVNLQRLDLSRNQFTGSAPEELGQ----LVNLELLKLS------DNKLTGAI 592
C L+ + + + T + E +G L + L+ L D L +
Sbjct: 377 --------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGV 428
Query: 593 PSSLGGLARLTEL--QMGGNIFSGSIPVALGQLTALQIALNISHNNLSGV-IPYELGNLQ 649
S L G +L + + +GQ + + + + S +
Sbjct: 429 RSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCP 488
Query: 650 MLEALYLDDNQL 661
L+ L +
Sbjct: 489 NLQKLEMRGCCF 500
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 25/102 (24%), Positives = 32/102 (31%), Gaps = 3/102 (2%)
Query: 586 NKLTGAIPSSLGGLARLTELQMGGNIFSGSIP-VALGQLTALQIALNISHNNLSGVIPYE 644
L G LTEL + + L L L+ L I + L V P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN-LTIVKSGLRFVAPDA 75
Query: 645 LGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLV 686
L L L N L + + +SL LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 3e-08
Identities = 21/92 (22%), Positives = 33/92 (35%), Gaps = 2/92 (2%)
Query: 520 IPSEVGNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQRLDLSRNQFTGSAPEELGQLVNL 578
+ E+L I + + L L+ L + ++ AP+ L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 579 ELLKLSDNKLTGAIPSSLGGLARLTELQMGGN 610
L LS N L ++ GL L EL + GN
Sbjct: 83 SRLNLSFNALESLSWKTVQGL-SLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 22/95 (23%), Positives = 34/95 (35%), Gaps = 2/95 (2%)
Query: 496 IPPEIGKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHELGNCVNL 554
+ NL L++ + ++ L L I + L P L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 555 QRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
RL+LS N S + Q ++L+ L LS N L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 21/113 (18%), Positives = 35/113 (30%), Gaps = 5/113 (4%)
Query: 311 CTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRE-LGQLTQLHKLDLSI 369
+ + + + L NL L + + L L +L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 370 NNLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLD 421
+ L + + F L L L N LE ++ L L +S N L
Sbjct: 66 SGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 20/97 (20%), Positives = 37/97 (38%), Gaps = 4/97 (4%)
Query: 423 SIPPHLCMYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIE-FYNLQ 480
HL + L L + + + ++ L+ L L + ++ L + + F+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 481 NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFV 517
LS L L N L + + +L+ L LS N
Sbjct: 81 RLSRLNLSFNALESL-SWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 19/102 (18%), Positives = 35/102 (34%), Gaps = 4/102 (3%)
Query: 441 SNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSGLIPPE 499
+ + + L +L +L + Q L + L L L + ++ + P+
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 500 I-GKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSL 540
L RL+LS N + + L +S N L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 21/111 (18%), Positives = 35/111 (31%), Gaps = 3/111 (2%)
Query: 119 CSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEE-IGNLTSLEELVIYS 177
L CT L L +LY+ + + L L L I
Sbjct: 7 PHGSSGLR-CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 178 NNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSL 228
+ L P + +L + N+L + + + L+ L L+ N L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 24/102 (23%), Positives = 35/102 (34%), Gaps = 3/102 (2%)
Query: 537 SNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEE-LGQLVNLELLKLSDNKLTGAIPSS 595
+ + H L NL L + Q L L L L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 596 LGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNL 637
RL+ L + N S+ Q +LQ L +S N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE-LVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 19/96 (19%), Positives = 32/96 (33%), Gaps = 4/96 (4%)
Query: 399 TIPPHIGVNSHLSVLDVSMNNLDGSIPPH-LCMYQKLIFLSLGSNRLSGNIPPG-LKTCR 456
H+ +L+ L + + L +L L++ + L + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 457 SLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRF 492
L +L L N L SL + +L L L N
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 22/102 (21%), Positives = 39/102 (38%), Gaps = 4/102 (3%)
Query: 297 TNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRE-LGLIPNLCLLQLFENMLQGSIPRE 355
T + H L + E+ + Q + L + L L + ++ L+ + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 356 -LGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHL 396
+L +L+LS N L Q L+ L +L L N L
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 24/115 (20%), Positives = 36/115 (31%), Gaps = 3/115 (2%)
Query: 68 ECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPT-DLANCSSLEILD 126
C + + L + L E I + DL L L
Sbjct: 4 ACCPHGSSGLRCTRDGALDSL-HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 127 LCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLT 181
+ + L V P F L +L L N + + + SL+ELV+ N L
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 20/126 (15%), Positives = 34/126 (26%), Gaps = 26/126 (20%)
Query: 152 CENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPA-SISKLRQLRVIRAGHNSLSGPIPP 210
C + + +L EL I + + + L +LR + + L + P
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAP 73
Query: 211 EISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLA 270
+ L+ L L N L + SL+ L
Sbjct: 74 DA-----------------------FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELV 109
Query: 271 LHENSF 276
L N
Sbjct: 110 LSGNPL 115
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 27/115 (23%), Positives = 43/115 (37%), Gaps = 7/115 (6%)
Query: 547 ELGNCVNLQRLDLSRNQFTGSAPEELG-QLVNLELLKLSDNKLTGAIPSSLGGLARLTEL 605
+ N V + LDL + E LG L + + SDN++ L RL L
Sbjct: 14 QYTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 69
Query: 606 QMGGNIFSGSIPVALGQLTALQIALNISHNNLSGV-IPYELGNLQMLEALYLDDN 659
+ N L L L +++N+L + L +L+ L L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTE-LILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 20/119 (16%), Positives = 40/119 (33%), Gaps = 10/119 (8%)
Query: 475 EFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLV--- 531
++ N L+L + +I L + + S+N ++ L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRLK 67
Query: 532 TFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAP-EELGQLVNLELLKLSDNKLT 589
T +++N + +L L L+ N + L L +L L + N +T
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 25/120 (20%), Positives = 40/120 (33%), Gaps = 10/120 (8%)
Query: 450 PGLKTCRSLMQLMLGQNQLTGSLPIE--FYNLQNLSALELYQNRFSGLIPPEIGKLRNLE 507
+L L ++ IE L A++ N L LR L+
Sbjct: 13 AQYTNAVRDRELDLRGYKIP---VIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLK 67
Query: 508 RLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLS--GTIPHELGNCVNLQRLDLSRNQFT 565
L ++ N L L +++NSL G + L + +L L + RN T
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 21/135 (15%), Positives = 40/135 (29%), Gaps = 26/135 (19%)
Query: 116 LANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVI 175
N LDL ++ + + +N I + L L+ L++
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGATLDQ-FDAIDFSDNEI--RKLDGFPLLRRLKTLLV 71
Query: 176 YSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSE 235
+N + L L + +N + E L+
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNN--------SLVELGDLD---------------P 108
Query: 236 LEKLRNLTDLILWQN 250
L L++LT L + +N
Sbjct: 109 LASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 21/116 (18%), Positives = 35/116 (30%), Gaps = 8/116 (6%)
Query: 234 SELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFS--GGLPKELGKLSRLK 291
++ +L L + I + + + +N G P L RLK
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPL----LRRLK 67
Query: 292 KLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGF-IPRELGLIPNLCLLQLFEN 346
L V N + E+ L+ N L L + +L L + N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 21/132 (15%), Positives = 36/132 (27%), Gaps = 29/132 (21%)
Query: 162 EEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVL 221
+ N EL + I + L + + + +
Sbjct: 13 AQYTNAVRDRELDLRGYK--------IPVIENLG-----------------ATLDQFDAI 47
Query: 222 GLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLP 281
+ N + LR L L++ N + + L L L NS
Sbjct: 48 DFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE--L 103
Query: 282 KELGKLSRLKKL 293
+L L+ LK L
Sbjct: 104 GDLDPLASLKSL 115
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 52/233 (22%), Positives = 91/233 (39%), Gaps = 43/233 (18%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH- 859
++ G IG G+ G +++ T L N + +A+K E +D L + K+
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAG 64
Query: 860 -RNIVKLYGFCYHQDSNLLLYEYMENG-SLGE--QLHGNK---QTCLLDWDARYRIALGA 912
I +Y F N+L+ + + G SL + L G K +T A
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVA-------MAAKQM 115
Query: 913 AEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-----QAHVGDFGLAKL-ID------LPY 960
+ +H +++RDIK +N L+ +V DFG+ K D +PY
Sbjct: 116 LARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 172
Query: 961 SKSMSAIAGSYGY--IAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011
+ + G+ Y I + + D+ + G V + + G P Q L+
Sbjct: 173 REKKNLS-GTARYMSINTHLGREQ--SRRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 32/172 (18%), Positives = 58/172 (33%), Gaps = 39/172 (22%)
Query: 810 IGRGACGTVYKAT---------LANGEVIAVK----KIKLRGEGA----TADNSFLAEIS 852
R G +Y+A + ++K +L E A + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 853 TLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR------- 905
L I GF HQD Y ++ SLG L LD +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-----ALDVSPKHVLSERS 160
Query: 906 -YRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL--DEEFQAHVGDFGLAK 954
++A + L +LH + +H ++ + NI + +++ Q + +G A
Sbjct: 161 VLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 3e-08
Identities = 32/183 (17%), Positives = 58/183 (31%), Gaps = 25/183 (13%)
Query: 446 GNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIG--KL 503
++ P L L L + +L I NL +LE+ + +I L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 504 RNLERLHL---SENYFVGYIPSEV------GNLEHLVTFNISSNSLSGTIPHELGNCV-- 552
NLE+L L E+Y + +L I +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 553 -NLQRLDLSRNQFTGSAPEELGQ----LVNLELLKLSDNKLTG----AIPSSLGGLARLT 603
L+ +D+S T L + +L+ + + N L+ + SL ++
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338
Query: 604 ELQ 606
+ Q
Sbjct: 339 DSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 2e-05
Identities = 28/223 (12%), Positives = 72/223 (32%), Gaps = 45/223 (20%)
Query: 481 NLSALELYQNRFS----GLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNIS 536
++ + S + P + + L L + + NL+ L I
Sbjct: 145 FWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL---EII 201
Query: 537 SNSLSGTIPHELG--NCVNLQRLDL---SRNQFTGSAPEEL------GQLVNLELLKLSD 585
S L ++ ++ + NL++L L + + NL+ L + D
Sbjct: 202 SGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVD 261
Query: 586 NKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGV----I 641
+ + L +L+ ++IS L+ +
Sbjct: 262 AEEQNVVVEMFLESDILPQLET----------------------MDISAGVLTDEGARLL 299
Query: 642 PYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNN 684
+ ++ L+ + + N L E+ + + + + + ++S++
Sbjct: 300 LDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKI-DVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.5 bits (109), Expect = 3e-05
Identities = 31/177 (17%), Positives = 65/177 (36%), Gaps = 21/177 (11%)
Query: 422 GSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFY--NL 479
+ P L L L + + + N+ G K +L L + L S+ + +L
Sbjct: 162 VDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 480 QNLSALELY--QNRFSGLIPPEI-------GKLRNLERLHLSENYFVGYIPS---EVGNL 527
NL L LY + + + NL+ L + + + E L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 528 EHLVTFNISSNSLSGT----IPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLEL 580
L T +IS+ L+ + + +L+ +++ N + +EL + + +++
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKI 335
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 1e-04
Identities = 27/164 (16%), Positives = 55/164 (33%), Gaps = 21/164 (12%)
Query: 110 GSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIG--NL 167
+ L L L + + L+ L + + + E+I +L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPR---PNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 168 TSLEELVIY---SNNLTGAIPASIS------KLRQLRVIRAGHNSLSGPIPPEISEC--- 215
+LE+LV+Y + + L+ + + E
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 216 EGLEVLGLAQNSL--EGF--LPSELEKLRNLTDLILWQNHLSGE 255
LE + ++ L EG L ++K+++L + + N+LS E
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 7e-04
Identities = 18/165 (10%), Positives = 49/165 (29%), Gaps = 16/165 (9%)
Query: 42 ASLIDPSNNLESWNSSDMTPCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEF 101
+ ++D L + + + K + GL S + DLP L +
Sbjct: 165 SPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL 224
Query: 102 NISM---NFVTGSIPTDLA------NCSSLEILDLCTNRLHGVIPFQLF---FINTLRKL 149
+ + ++ +L+ L + V+ + L +
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284
Query: 150 YLCENYI----FGEIPEEIGNLTSLEELVIYSNNLTGAIPASISK 190
+ + + + + + L+ + + N L+ + + K
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 55/324 (16%), Positives = 102/324 (31%), Gaps = 63/324 (19%)
Query: 406 VNSHLSVLDVSMNNLDGSIPPHLCM-----YQKLIFLSLGSNRLSGNIPPGLKTCRSLMQ 460
+ ++ LD+S+NNL L + L+L N L G K L+Q
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL------GFKNSDELVQ 73
Query: 461 LMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKL-----RNLERLHLSENY 515
++ N+++L L N S E+ K + L L N
Sbjct: 74 ILAAIPA-------------NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 516 F----VGYIPSEVGNLE-HLVTFNISSNSLSGTIPHELG------NCVNLQRLDLSRNQF 564
F NL + + N+ N L EL N+ L+L N
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA-NVNSLNLRGNNL 179
Query: 565 TGSAPEELGQLV-----NLELLKLSDNKLTGAIPSSLGGL-----ARLTELQMGGNIFSG 614
EL + + ++ L LS N L + L + + L + N G
Sbjct: 180 ASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239
Query: 615 S----IPVALGQLTALQIALNISHNNLSGVIPYE-------LGNLQMLEALYLDDNQLIG 663
+ + L LQ + + ++ + + + N+Q + + + ++
Sbjct: 240 PSLENLKLLKDSLKHLQT-VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298
Query: 664 EIPASMGEQMSLLVCNLSNNNLVG 687
+ + L +L+
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLN 322
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 55/355 (15%), Positives = 102/355 (28%), Gaps = 72/355 (20%)
Query: 308 LGNCTSAVEIDLSENQLTGFIPREL--GLIPNLCLLQ---LFENMLQGSIPRELGQL--- 359
+DLS N L EL + L N L EL Q+
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 360 --TQLHKLDLSINNLT--GTIP----LEFQNLTYLVDLQLFDNHLEGTIPPHIG-----V 406
+ L+LS N L+ + L T + L L N +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT-ITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 407 NSHLSVLDVSMNNLDGSIPPHLC-----MYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQL 461
+ ++ L++ N+L L + + L+L N L K C L +
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL------ASKNCAELAKF 190
Query: 462 MLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKL-----RNLERLHLSENYF 516
+ ++++L+L N E+ + ++ L+L N
Sbjct: 191 LASIPA-------------SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237
Query: 517 ----VGYIPSEVGNLEHLVTFNISSNSLSGT-------IPHELGNCVNLQRLDLSRNQFT 565
+ + +L+HL T + + + + N + +D + +
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
Query: 566 GSAPEELGQLV-----NLELLKLSDNKLTGA-----IPSSLGGLARLTELQMGGN 610
S + L+ ++ L + L A L L E
Sbjct: 298 PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCK 352
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 49/351 (13%), Positives = 100/351 (28%), Gaps = 60/351 (17%)
Query: 116 LANCSSLEILDLCTNRLH--GVIPFQLFFIN---TLRKLYLCENYIFGEIPEEIG----- 165
+ + LDL N L+ + F N ++ L L N + + +E+
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 166 NLTSLEELVIYSNNLTGAIPASISKL-----RQLRVIRAGHNSLSGPIPPEISE-----C 215
++ L + N L+ + K + V+ G N S E +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 216 EGLEVLGLAQNSL--EG--FLPSELEKL-RNLTDLILWQNHLSGEIPPTIGNI-----QS 265
+ L L N L + L L + N+ L L N+L+ + + S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 266 LELLALHENSFSGGLPKELGKL-----SRLKKLYVYTNELNGT----IPHELGNCTSAVE 316
+ L L N EL + + + L + N L+G + +
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 317 IDLSENQLTGFIPRELGLI-------PNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSI 369
+ L + + + + + L+ + S + L + +
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317
Query: 370 NNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNL 420
+L + Q ++ + L + L
Sbjct: 318 PSLLNQCLIFAQKHQTNIEDL--------------NIPDELRESIQTCKPL 354
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 41/160 (25%), Positives = 66/160 (41%), Gaps = 19/160 (11%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-EISTLGKIRH 859
+ G IG G+ G +Y T +A GE +A+K E + L E ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-----ECVKTKHPQLHIESKIYKMMQG 63
Query: 860 -RNIVKLYGFCYHQDSNLLLYEYMENG-SLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
I + D N+++ E + G SL E L N + +A +
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL--GPSL-EDLF-NFCSRKFSLKTVLLLADQMISRIE 119
Query: 918 YLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAK 954
Y+H + IHRD+K +N L+ + ++ DFGLAK
Sbjct: 120 YIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-08
Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 10/117 (8%)
Query: 478 NLQNLSALELYQNRFSGLIPPEIG-KLRNLERLHLSENYFVGYIPSEVGNLEHLV---TF 533
++ L L +R + + + LE L + + NL L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKL 69
Query: 534 NISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG-SAPEELGQLVNLELLKLSDNKLT 589
+S N +SG + C NL L+LS N+ S E L +L NL+ L L + ++T
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 7e-07
Identities = 27/112 (24%), Positives = 49/112 (43%), Gaps = 5/112 (4%)
Query: 550 NCVNLQRLDLSRNQFTGSAPEELG-QLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMG 608
+++ L L ++ E L + LE L + LT ++L L +L +L++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 609 GNIFSGSIPVALGQLTALQIALNISHNNLSGV-IPYELGNLQMLEALYLDDN 659
N SG + V + L LN+S N + + L L+ L++L L +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTH-LNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 25/108 (23%), Positives = 44/108 (40%), Gaps = 4/108 (3%)
Query: 505 NLERLHLSENYF-VGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQ 563
+++ L L + G + E L + + L+ +I + L L++L+LS N+
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNR 75
Query: 564 FTGSAPEELGQLVNLELLKLSDNKLTG-AIPSSLGGLARLTELQMGGN 610
+G + NL L LS NK+ + L L L L +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 26/107 (24%), Positives = 39/107 (36%), Gaps = 6/107 (5%)
Query: 187 SISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLI 246
+ S +++L + S G + E E LE L L + L KL L L
Sbjct: 15 TPSDVKELVL--DNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLE 70
Query: 247 LWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKL 293
L N +SG + +L L L N + L +L+ L
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENL 115
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 412 VLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGS 471
VLD S +N +G + +++L FLS + L+ +I L L +L L N+++G
Sbjct: 23 VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGG 79
Query: 472 LPIEFYNLQNLSALELYQNRFSGL-IPPEIGKLRNLERLHLSEN 514
L + NL+ L L N+ L + KL NL+ L L
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 18/86 (20%), Positives = 31/86 (36%), Gaps = 4/86 (4%)
Query: 110 GSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTS 169
G + LE L L + N L+KL L +N + G + +
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLTSIANLPKL--NKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 170 LEELVIYSNNLTGAIPASISKLRQLR 195
L L + N + ++I L++L
Sbjct: 90 LTHLNLSGNKIKD--LSTIEPLKKLE 113
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 26/117 (22%), Positives = 46/117 (39%), Gaps = 4/117 (3%)
Query: 451 GLKTCRSLMQLMLGQNQLT-GSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERL 509
+T + +L+L ++ G L + L L + + + KL L++L
Sbjct: 12 RNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKL 69
Query: 510 HLSENYFVGYIPSEVGNLEHLVTFNISSNSLSG-TIPHELGNCVNLQRLDLSRNQFT 565
LS+N G + +L N+S N + + L NL+ LDL + T
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 26/110 (23%), Positives = 49/110 (44%), Gaps = 8/110 (7%)
Query: 241 NLTDLILWQNHLS-GEIPPTIGNIQSLELLALHENSFS--GGLPKELGKLSRLKKLYVYT 297
++ +L+L + + G++ + LE L+ + LPK L++LKKL +
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLKKLELSD 73
Query: 298 NELNGTIPHELGNCTSAVEIDLSENQLTGF-IPRELGLIPNLCLLQLFEN 346
N ++G + C + ++LS N++ L + NL L LF
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 41/167 (24%), Positives = 62/167 (37%), Gaps = 31/167 (18%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH- 859
NF G IG G G + L E +A+K E + L K
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-----EPMKSRAPQLHLEYRFYKQLGS 63
Query: 860 -RNIVKLYGFCYHQDSNLLLYEYMENG-SLGE--QLHGNK---QTCLLDWDARYRIALGA 912
I ++Y F N ++ E + G SL + L +T L IA+
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVL-------MIAIQL 114
Query: 913 AEGLCYLHYDCRPHIIHRDIKSNNILL-----DEEFQAHVGDFGLAK 954
+ Y+H ++I+RD+K N L+ + H+ DF LAK
Sbjct: 115 ISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 48/149 (32%), Positives = 70/149 (46%), Gaps = 20/149 (13%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410
S+P + T LDL N+L F LT L L L N L+ ++P GV + L
Sbjct: 21 SVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPN--GVFNKL 75
Query: 411 S---VLDVSMNNLDGSIPP----HLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLM 462
+ L++S N L S+P L +L L+L +N+L ++P G+ L L
Sbjct: 76 TSLTYLNLSTNQLQ-SLPNGVFDKL---TQLKELALNTNQLQ-SLPDGVFDKLTQLKDLR 130
Query: 463 LGQNQLTGSLPIE-FYNLQNLSALELYQN 490
L QNQL S+P F L +L + L+ N
Sbjct: 131 LYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 37/168 (22%), Positives = 57/168 (33%), Gaps = 33/168 (19%)
Query: 496 IPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSN---SLSGTIPHELGNCV 552
+P I L L N L L + N SL + ++L
Sbjct: 22 VPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKL---T 76
Query: 553 NLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIF 612
+L L+LS NQ +L L+ L L+ N+L ++P G +LT+L+
Sbjct: 77 SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPD--GVFDKLTQLKD----- 128
Query: 613 SGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQ 660
L + N L V L L+ ++L DN
Sbjct: 129 -----------------LRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 40/132 (30%), Positives = 55/132 (41%), Gaps = 8/132 (6%)
Query: 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSGL 495
L L +N L SL QL LG N+L SLP F L +L+ L L N+ L
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 496 IPPEI-GKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHE-LGNCV 552
P + KL L+ L L+ N +P V L L + N L ++P
Sbjct: 92 -PNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 148
Query: 553 NLQRLDLSRNQF 564
+LQ + L N +
Sbjct: 149 SLQYIWLHDNPW 160
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 32/112 (28%), Positives = 44/112 (39%), Gaps = 11/112 (9%)
Query: 555 QRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614
LDL N +L +L L L NKL L LT L + N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 615 SIPVAL-GQLTALQIALNISHNNLSGVIPY----ELGNLQMLEALYLDDNQL 661
S+P + +LT L+ L ++ N L +P +L L+ L L NQL
Sbjct: 90 SLPNGVFDKLTQLKE-LALNTNQLQ-SLPDGVFDKLTQLKD---LRLYQNQL 136
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 30/117 (25%), Positives = 44/117 (37%), Gaps = 10/117 (8%)
Query: 478 NLQNLSALELYQNRFS-GLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLV---TF 533
+ L L + + G I + NLE L L V NL L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKL 76
Query: 534 NISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG-SAPEELGQLVNLELLKLSDNKLT 589
+S N + G + NL L+LS N+ S E L +L L+ L L + ++T
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 31/120 (25%), Positives = 53/120 (44%), Gaps = 9/120 (7%)
Query: 546 HELGNCVNLQRLDLSRNQFTGSAPEELG-QLVNLELLKLSDNKLTGAIPSSLGGLARLTE 604
++ L L + E L + VNLE L L + L S+L L +L +
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKK 75
Query: 605 LQMGGNIFSGSIPVALGQLTALQIALNISHNN---LSGVIPYELGNLQMLEALYLDDNQL 661
L++ N G + + +L L LN+S N +S + P L L+ L++L L + ++
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTH-LNLSGNKLKDISTLEP--LKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 29/129 (22%), Positives = 50/129 (38%), Gaps = 5/129 (3%)
Query: 483 SALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSG 542
S +++ + L +R L L ++ G I +L ++ + L
Sbjct: 6 SGMDMKRRIHLELRNRTPAAVRELV-LDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI- 62
Query: 543 TIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTG-AIPSSLGGLAR 601
++ + L L++L+LS N+ G +L NL L LS NKL + L L
Sbjct: 63 SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLEC 121
Query: 602 LTELQMGGN 610
L L +
Sbjct: 122 LKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 32/104 (30%), Positives = 47/104 (45%), Gaps = 4/104 (3%)
Query: 412 VLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGS 471
VLD +N DG I + L FLSL + L ++ L L +L L +N++ G
Sbjct: 30 VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIFGG 86
Query: 472 LPIEFYNLQNLSALELYQNRFSGLIPPE-IGKLRNLERLHLSEN 514
L + L NL+ L L N+ + E + KL L+ L L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 25/86 (29%), Positives = 35/86 (40%), Gaps = 4/86 (4%)
Query: 110 GSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTS 169
G I A +LE L L L V L+KL L EN IFG + L +
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLISVSNLPKL--PKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 170 LEELVIYSNNLTGAIPASISKLRQLR 195
L L + N L +++ L++L
Sbjct: 97 LTHLNLSGNKLKD--ISTLEPLKKLE 120
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 28/107 (26%), Positives = 41/107 (38%), Gaps = 6/107 (5%)
Query: 187 SISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLI 246
+ + +R+L + S G I +E LE L L L S L KL L L
Sbjct: 22 TPAAVRELVL--DNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLE 77
Query: 247 LWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKL 293
L +N + G + + +L L L N L L +L+ L
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECL 122
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 36/120 (30%), Positives = 53/120 (44%), Gaps = 15/120 (12%)
Query: 520 IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLE 579
IP +V L + N + +P EL N +L +DLS N+ + + + + L
Sbjct: 29 IPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 580 LLKLSDNKLTGAIPSSL-GGLARLTELQMGGNIFSGSIPV-ALGQLTALQ-IALNISHNN 636
L LS N+L IP GL L L + GN S +P A L+AL +A+ N
Sbjct: 82 TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAI---GAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 34/142 (23%), Positives = 56/142 (39%), Gaps = 31/142 (21%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410
+P+ + + +L L N T +P E N +L + L +N + T+ S++
Sbjct: 24 VLPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSN--QSFSNM 77
Query: 411 SVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQLT 469
+ +L+ L L NRL IPP +SL L L N ++
Sbjct: 78 T---------------------QLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS 115
Query: 470 GSLPIE-FYNLQNLSALELYQN 490
+P F +L LS L + N
Sbjct: 116 -VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 24/107 (22%), Positives = 38/107 (35%), Gaps = 26/107 (24%)
Query: 555 QRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614
L L NQFT P+EL +L L+ LS+N+++ S + +L L + N
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN---- 88
Query: 615 SIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661
+L + L+ L L L N +
Sbjct: 89 -------RLRCIP----------PRT----FDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 23/80 (28%), Positives = 37/80 (46%), Gaps = 5/80 (6%)
Query: 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSGL 495
L L N+ + +P L + L + L N+++ +L + F N+ L L L NR +
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 496 IPPEI-GKLRNLERLHLSEN 514
PP L++L L L N
Sbjct: 94 -PPRTFDGLKSLRLLSLHGN 112
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 36/129 (27%), Positives = 47/129 (36%), Gaps = 27/129 (20%)
Query: 341 LQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTI 400
L L N +P+EL L +DLS N ++ F N+T L+ L L N L I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 401 PPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRSLM 459
PP L L LSL N +S +P G +L
Sbjct: 94 PP--RTFDGLK---------------------SLRLLSLHGNDIS-VVPEGAFNDLSALS 129
Query: 460 QLMLGQNQL 468
L +G N L
Sbjct: 130 HLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 29/128 (22%), Positives = 45/128 (35%), Gaps = 29/128 (22%)
Query: 269 LALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFI 328
L L N F+ +PKEL L + + N ++ N T + + LS N+L
Sbjct: 36 LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR--- 91
Query: 329 PRELGLIPNLCLLQLFENMLQGSIPREL-GQLTQLHKLDLSINNLTGTIPLE-FQNLTYL 386
IP L L L L N+++ +P F +L+ L
Sbjct: 92 ----------------------CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSAL 128
Query: 387 VDLQLFDN 394
L + N
Sbjct: 129 SHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 30/122 (24%), Positives = 46/122 (37%), Gaps = 28/122 (22%)
Query: 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544
L L N+F+ L+P E+ ++L + LS N + L + F+
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNN--------RISTLSNQS-FS---------- 75
Query: 545 PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTE 604
N L L LS N+ P L +L LL L N ++ +P G L+
Sbjct: 76 -----NMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPE--GAFNDLSA 127
Query: 605 LQ 606
L
Sbjct: 128 LS 129
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 36/169 (21%), Positives = 68/169 (40%), Gaps = 33/169 (19%)
Query: 810 IGRGACGTVYKATLANGEVIAVKK---IK--------LRGEGAT----ADNSFLAEISTL 854
IG+G G +Y A + + E + +K L E A + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 855 GKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR-------YR 907
K+++ + K +G H + Y +M G L + + +A+ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQ-----KIYEANAKRFSRKTVLQ 156
Query: 908 IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD--EEFQAHVGDFGLAK 954
++L + L Y+H +H DIK++N+LL+ Q ++ D+GLA
Sbjct: 157 LSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 29/111 (26%), Positives = 47/111 (42%), Gaps = 5/111 (4%)
Query: 552 VNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSL-GGLARLTELQMGGN 610
+ RL+L N+ +L L L LS N++ ++P + L +LT L + N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 611 IFSGSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQ 660
S+P +LT L+ L + N L V L L+ ++L N
Sbjct: 87 KLQ-SLPNGVFDKLTQLKE-LALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 36/133 (27%), Positives = 53/133 (39%), Gaps = 28/133 (21%)
Query: 360 TQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNN 419
+ +L+L N L F LT L L L N ++ ++P GV L+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPD--GVFDKLT-------- 76
Query: 420 LDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQLTGSLPIE-FY 477
KL L L N+L ++P G+ L +L L NQL S+P F
Sbjct: 77 -------------KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFD 121
Query: 478 NLQNLSALELYQN 490
L +L + L+ N
Sbjct: 122 RLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 34/119 (28%), Positives = 52/119 (43%), Gaps = 8/119 (6%)
Query: 448 IPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEI-GKLRNL 506
+P G+ + S +L L N+L F L L+ L L QN+ L P + KL L
Sbjct: 22 VPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSL-PDGVFDKLTKL 78
Query: 507 ERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHE-LGNCVNLQRLDLSRNQ 563
L+L EN +P+ V L L + +N L ++P +LQ++ L N
Sbjct: 79 TILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 135
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 46/235 (19%), Positives = 77/235 (32%), Gaps = 19/235 (8%)
Query: 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR 491
Q +I + + + R + +L L L L R
Sbjct: 70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 129
Query: 492 FSGLIPPEIGKLRNLERLHLS-----ENYFVGYIPSEVGNLEHLV---TFNISSNSLSGT 543
S I + K NL RL+LS + + + S L+ L F+ + +
Sbjct: 130 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 189
Query: 544 IPHELGNCVNLQRLDLS--RNQFTGSAPEELGQ-LVNLELLKLSD-NKLTGAIPSSLGGL 599
+ H + +L+LS R S L + NL L LSD L L
Sbjct: 190 VAH---VSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 246
Query: 600 ARLTELQMGG--NIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLE 652
L L + +I ++ + LG++ L+ L + G + L L+
Sbjct: 247 NYLQHLSLSRCYDIIPETL-LELGEIPTLK-TLQVFGIVPDGTLQLLKEALPHLQ 299
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 31/226 (13%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLA-EISTLGKIR- 858
F G IG G+ G +Y T + E +A+K E + L E ++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKIYRILQG 61
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENG-SLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
I + F D N+L+ + + G SL E L N + L +A +
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL--GPSL-EDLF-NFCSRKLSLKTVLMLADQMINRVE 117
Query: 918 YLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKL-ID------LPYSKSMSAI 967
++H +HRDIK +N L+ Q ++ DFGLAK D +PY ++ +
Sbjct: 118 FVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 968 AGSYGY--IAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011
G+ Y + + + D+ S G VL+ + G P Q L+
Sbjct: 175 -GTARYASVNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 4/107 (3%)
Query: 555 QRLDLSRNQFTGSAPEEL-GQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS 613
L L+ N+ + + L G+L +L L+L N+LTG P++ G + + ELQ+G N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 614 GSIPV-ALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN 659
I L L+ LN+ N +S V+P +L L +L L N
Sbjct: 92 -EISNKMFLGLHQLKT-LNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 5/107 (4%)
Query: 291 KKLYVYTNELNGTIPHEL-GNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349
+L + NEL L G V+++L NQLTG P ++ LQL EN ++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 350 GSIPREL-GQLTQLHKLDLSINNLTGTIPLE-FQNLTYLVDLQLFDN 394
I ++ L QL L+L N ++ + F++L L L L N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 26/93 (27%), Positives = 41/93 (44%), Gaps = 4/93 (4%)
Query: 312 TSAVEIDLSENQLTGFIPREL-GLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSIN 370
E+ L++N+L L G +P+L L+L N L G P + + +L L N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 371 NLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPP 402
+ I + F L L L L+DN + + P
Sbjct: 89 KIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMP 119
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 22/81 (27%), Positives = 37/81 (45%), Gaps = 5/81 (6%)
Query: 437 LSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQLTGSLPIE-FYNLQNLSALELYQNRFSG 494
L L N L GL L++L L +NQLT + F ++ L+L +N+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE 92
Query: 495 LIPPEI-GKLRNLERLHLSEN 514
+ ++ L L+ L+L +N
Sbjct: 93 I-SNKMFLGLHQLKTLNLYDN 112
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 35/143 (24%), Positives = 52/143 (36%), Gaps = 31/143 (21%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPL-EFQNLTYLVDLQLFDNHLEGTIPPHIGVNSH 409
IPR++ T +L L+ N L F L +LV L+L N L I P
Sbjct: 22 EIPRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEP--NAFEG 76
Query: 410 LSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL-KTCRSLMQLMLGQNQL 468
S + L LG N++ I + L L L NQ+
Sbjct: 77 AS---------------------HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI 114
Query: 469 TGSLPIE-FYNLQNLSALELYQN 490
+ + F +L +L++L L N
Sbjct: 115 S-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 31/121 (25%), Positives = 51/121 (42%), Gaps = 15/121 (12%)
Query: 520 IPSEVGNLEHLVTFNISSNSLSGTIPHEL-GNCVNLQRLDLSRNQFTGSAPEELGQLVNL 578
IP L ++ N L L G +L +L+L RNQ TG P ++
Sbjct: 27 IPLHTTELL------LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 579 ELLKLSDNKLTGAIPSSL-GGLARLTELQMGGNIFSGSIPV-ALGQLTALQ-IALNISHN 635
+ L+L +NK+ I + + GL +L L + N S + + L +L + L +
Sbjct: 81 QELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNL---AS 135
Query: 636 N 636
N
Sbjct: 136 N 136
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 34/166 (20%), Positives = 58/166 (34%), Gaps = 30/166 (18%)
Query: 810 IGRGACGTVYKAT-LANGEVIAVKKIK--------LRGEGAT----ADNSFLAEISTLGK 856
IG G G +Y A E A +K L E A + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 857 IRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR------YRIAL 910
+ + I YG + Y +M LG L + + ++ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRS-YRFMVMERLGIDLQK-----ISGQNGTFKKSTVLQLGI 158
Query: 911 GAAEGLCYLHYDCRPHIIHRDIKSNNILLD--EEFQAHVGDFGLAK 954
+ L Y+H + +H DIK+ N+LL Q ++ D+GL+
Sbjct: 159 RMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 5e-07
Identities = 70/412 (16%), Positives = 133/412 (32%), Gaps = 58/412 (14%)
Query: 215 CEGLEVLGLAQNSL--EGFLPSELEKLRNLTDLILWQNHLSG-------EIPPTIGNIQS 265
+ +VL L+ L + RNL +L L ++ + P T ++ S
Sbjct: 129 FKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188
Query: 266 LELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLS----- 320
L + L L + + + LK L + + L E+
Sbjct: 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAE 248
Query: 321 -ENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLE 379
+ + L L L F + + +P ++L L+LS + ++
Sbjct: 249 VRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVK 308
Query: 380 F-QNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLS 438
L L + D I L VL + +L L ++ F+
Sbjct: 309 LLCQCPKLQRLWVLDY---------IEDAG-LEVLASTCKDLR-----ELRVFPSEPFVM 353
Query: 439 LGSNRLSGNIPPGLKT----CRSLMQLMLGQNQLTG-SLPIEFYNLQNLSALELYQNRFS 493
+ L+ GL + C L ++ Q+T +L N N++ L
Sbjct: 354 EPNVALTEQ---GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPK 410
Query: 494 GLIPPEIG-----------KLRNLERLHLSE---NYFVGYIPSEVGNLEHLVTFNISSNS 539
+ ++L RL LS + YI + +E L +++
Sbjct: 411 APDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEML---SVAFAG 467
Query: 540 LSGT-IPHELGNCVNLQRLDLSRNQFTGSA-PEELGQLVNLELLKLSDNKLT 589
S + H L C +L++L++ F A +L + L +S ++
Sbjct: 468 DSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 62/358 (17%), Positives = 99/358 (27%), Gaps = 105/358 (29%)
Query: 810 IGRGACGTVYKA-TLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR--------HR 860
+G G TV+ + + + +A+K +K L EI L +R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA---LDEIRLLKSVRNSDPNDPNRE 101
Query: 861 NIVKLYGFCYHQDSN----LLLYEYMENG-SLGEQLHGNKQTCLLDWDARYRIALGAAEG 915
+V+L N +++E + G L + + + L + +I +G
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQG 158
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEE--------------------------------- 942
L YLH C IIH DIK NILL
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 943 --------FQAHVGDFGLAKLIDLPYS----KSMSAIAGSYGYIAPEYAYTMKVTEKCDI 990
+ + K+ DL + K + + Y + E DI
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI 276
Query: 991 YSFGVVLLELITGKSPVQSLELGGDLVT-----------------WVRRSIHEMVPTSEL 1033
+S + EL TG + + + + E
Sbjct: 277 WSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY----SKEF 332
Query: 1034 FDKRLDLSAKRTV-----------------EEMTLFLKIALFCSSTSPLNRPTMREVI 1074
F K+ DL + EE F L P R T E +
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 29/87 (33%), Positives = 41/87 (47%), Gaps = 8/87 (9%)
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELG---QLTQLHKLDLS 368
T+ + L +NQ+T P + L L L N L +P G +LTQL +L L+
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPA--GVFDKLTQLTQLSLN 86
Query: 369 INNLTGTIPLE-FQNLTYLVDLQLFDN 394
N L +IP F NL L + L +N
Sbjct: 87 DNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 26/79 (32%), Positives = 35/79 (44%), Gaps = 14/79 (17%)
Query: 532 TFNISSNSL----SGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNK 587
T + S SL +G IP Q L L NQ T P +L L L L +N+
Sbjct: 13 TVDCSGKSLASVPTG-IP------TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQ 65
Query: 588 LTGAIPSSLGGLARLTELQ 606
LT +P+ G +LT+L
Sbjct: 66 LT-VLPA--GVFDKLTQLT 81
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 31/87 (35%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 312 TSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELG---QLTQLHKLDLS 368
T + L+ NQ+T P + NL L N L +IP G +LTQL +LDL+
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPT--GVFDKLTQLTQLDLN 89
Query: 369 INNLTGTIPL-EFQNLTYLVDLQLFDN 394
N+L +IP F NL L + L++N
Sbjct: 90 DNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 29/79 (36%), Positives = 38/79 (48%), Gaps = 14/79 (17%)
Query: 532 TFNISSNSL----SGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNK 587
N + L +G IP + QRL L+ NQ T P LVNL+ L + NK
Sbjct: 16 LVNCQNIRLASVPAG-IP------TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNK 68
Query: 588 LTGAIPSSLGGLARLTELQ 606
LT AIP+ G +LT+L
Sbjct: 69 LT-AIPT--GVFDKLTQLT 84
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1109 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.57 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.53 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.39 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.36 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.3 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.27 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.25 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.24 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.18 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.17 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.03 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.01 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.95 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.92 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.81 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.8 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.7 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.47 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.4 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.4 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.07 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.0 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.79 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.64 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.6 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.49 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.49 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.45 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.38 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.17 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.09 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.98 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.94 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.89 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.75 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.59 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.44 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.38 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.25 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.22 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.16 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.16 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.68 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.58 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.2 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.32 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.93 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.43 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.68 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-97 Score=939.99 Aligned_cols=686 Identities=33% Similarity=0.480 Sum_probs=645.6
Q ss_pred cccCCCchhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCccceeeecCCeEEEEeccCcccccc---ccccccCccccce
Q 001274 24 NVSVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDFKVTSVDLHGLNLSGI---LSPRICDLPRLVE 100 (1109)
Q Consensus 24 ~~~~~~~~~~~~all~~k~~~~~~~~~~~~W~~~~~~~c~w~gv~C~~~~v~~l~l~~~~l~g~---~~~~~~~l~~L~~ 100 (1109)
++...+.++|++|||+||+++.||. .+++|+.+ .|||.|.||+|+.++|+++||++.++.|. +++++++|++|+.
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~~-~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLPDKN-LLPDWSSN-KNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT-SCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred CccccCCHHHHHHHHHHHhhCCCcc-cccCCCCC-CCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 4445557889999999999999998 89999854 58999999999988999999999999999 9999999999999
Q ss_pred eecccCccCCCCCccccCCCCCceEEccCCcccccCCc--hhhccccceEEEcccccccccccccc-cCcCCCceEEeec
Q 001274 101 FNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPF--QLFFINTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYS 177 (1109)
Q Consensus 101 L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~--~l~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~ 177 (1109)
++++.|++.. +|..++++++|++|||++|.+.|.+|. .++.+++|++|+|++|.+.+.+|..+ +++++|++|+|++
T Consensus 82 l~~~~~~~~~-l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 82 LFLSNSHING-SVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp EECTTSCEEE-CCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred cCCcCCCcCC-CchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 9999887753 678999999999999999999999998 99999999999999999999999876 8999999999999
Q ss_pred CCCCCCCCcc---cccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccC
Q 001274 178 NNLTGAIPAS---ISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSG 254 (1109)
Q Consensus 178 n~l~~~~p~~---~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 254 (1109)
|++++..|.. +.++++|++|++++|.+++..|. +.+++|++|+|++|.+++.+|. ++++++|++|+|++|++++
T Consensus 161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~ 237 (768)
T 3rgz_A 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSG 237 (768)
T ss_dssp SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCS
T ss_pred CccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCC
Confidence 9999988877 89999999999999999987764 8899999999999999998887 9999999999999999999
Q ss_pred CCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCC-CcCcEEEccCCcccCCCccccc
Q 001274 255 EIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNC-TSAVEIDLSENQLTGFIPRELG 333 (1109)
Q Consensus 255 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l-~~L~~L~Ls~n~l~~~~p~~l~ 333 (1109)
.+|..++++++|++|++++|.+++.+|.. .+++|++|++++|.+++.+|..+... ++|++|+|++|++++.+|..++
T Consensus 238 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~ 315 (768)
T 3rgz_A 238 DFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315 (768)
T ss_dssp CHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGG
T ss_pred cccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHh
Confidence 99999999999999999999999988875 89999999999999999999998875 9999999999999999999999
Q ss_pred CCCCcceEecccccccCccccc-ccCCCCccEEEcccCcccCCCCcchhccc-ccceEEcccccccccCCCcccc--cCc
Q 001274 334 LIPNLCLLQLFENMLQGSIPRE-LGQLTQLHKLDLSINNLTGTIPLEFQNLT-YLVDLQLFDNHLEGTIPPHIGV--NSH 409 (1109)
Q Consensus 334 ~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~--~~~ 409 (1109)
.+++|+.|++++|.+.+.+|.. +..+++|++|++++|++++.+|..+.+++ +|+.|++++|++++.+|..+.. +++
T Consensus 316 ~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~ 395 (768)
T 3rgz_A 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395 (768)
T ss_dssp GCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCC
T ss_pred cCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCC
Confidence 9999999999999999888876 99999999999999999999999999998 9999999999999999998877 889
Q ss_pred CcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceecccc
Q 001274 410 LSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQ 489 (1109)
Q Consensus 410 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 489 (1109)
|++|++++|++++.+|..++.+++|++|+|++|++++.+|..+..+++|++|++++|++++.+|..|..+++|++|+|++
T Consensus 396 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 475 (768)
T 3rgz_A 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475 (768)
T ss_dssp CCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCS
T ss_pred ccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCC
Q 001274 490 NRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAP 569 (1109)
Q Consensus 490 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 569 (1109)
|++++.+|..+.++++|++|+|++|++++.+|.+++++++|++|+|++|++++.+|..++++++|++|||++|+++|.+|
T Consensus 476 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip 555 (768)
T 3rgz_A 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555 (768)
T ss_dssp SCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCC
T ss_pred CcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc----------------------------------------------ceecccccccccccCcccCCCcccc
Q 001274 570 EELGQLVNL----------------------------------------------ELLKLSDNKLTGAIPSSLGGLARLT 603 (1109)
Q Consensus 570 ~~l~~l~~L----------------------------------------------~~L~Ls~N~l~~~~p~~~~~l~~L~ 603 (1109)
..+.....+ +.++++.|.+.|.+|..|+.+++|+
T Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~ 635 (768)
T 3rgz_A 556 AAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMM 635 (768)
T ss_dssp GGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCC
T ss_pred hHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccccc
Confidence 887664433 3445566889999999999999999
Q ss_pred eeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEccCc
Q 001274 604 ELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNN 683 (1109)
Q Consensus 604 ~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N 683 (1109)
.|||++|+++|.+|.++++++.|+ .|+|++|+++|.+|..|+++++|++|||++|+++|.||..++.+++|++||||+|
T Consensus 636 ~LdLs~N~l~g~ip~~l~~l~~L~-~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N 714 (768)
T 3rgz_A 636 FLDMSYNMLSGYIPKEIGSMPYLF-ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714 (768)
T ss_dssp EEECCSSCCBSCCCGGGGGCTTCC-EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred EEECcCCcccccCCHHHhccccCC-EEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence 999999999999999999999997 5999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccCCcccCCCCcccc-CCCccc
Q 001274 684 NLVGTVPNTTVFRRIDSSNFAGNRGLCML-GSDCHQ 718 (1109)
Q Consensus 684 ~l~g~~p~~~~~~~~~~~~~~~n~~~c~~-~~~c~~ 718 (1109)
+|+|.||.+++|.+|+..+|.||+++||. .+.|..
T Consensus 715 ~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~ 750 (768)
T 3rgz_A 715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750 (768)
T ss_dssp EEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred cccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence 99999999999999999999999999997 457865
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-77 Score=753.88 Aligned_cols=604 Identities=32% Similarity=0.473 Sum_probs=559.7
Q ss_pred EeccCcccccccc--ccccCccccceeecccCccCCCCCc--cccCCCCCceEEccCCcccccCCchh-hccccceEEEc
Q 001274 77 VDLHGLNLSGILS--PRICDLPRLVEFNISMNFVTGSIPT--DLANCSSLEILDLCTNRLHGVIPFQL-FFINTLRKLYL 151 (1109)
Q Consensus 77 l~l~~~~l~g~~~--~~~~~l~~L~~L~ls~n~~~~~~p~--~l~~l~~L~~L~Ls~n~l~~~~~~~l-~~l~~L~~L~L 151 (1109)
+++.++...|..+ +.++++++|++|+|++|.++|.+|. .+++|++|++|||++|.+.+.+|..+ ..+++|++|+|
T Consensus 79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L 158 (768)
T 3rgz_A 79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158 (768)
T ss_dssp CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence 3344444444444 7899999999999999999999998 99999999999999999999999876 78999999999
Q ss_pred cccccccccccc---ccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccc
Q 001274 152 CENYIFGEIPEE---IGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSL 228 (1109)
Q Consensus 152 ~~n~l~~~~p~~---l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 228 (1109)
++|.+++..|.. ++++++|++|+|++|++++.+|. +++++|++|++++|.+++.+|. ++++++|++|+|++|.+
T Consensus 159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l 235 (768)
T 3rgz_A 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 235 (768)
T ss_dssp CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCC
T ss_pred CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcC
Confidence 999999998887 89999999999999999987664 8999999999999999988887 99999999999999999
Q ss_pred cccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhcc-CccceEEeecccccCccCcc
Q 001274 229 EGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKL-SRLKKLYVYTNELNGTIPHE 307 (1109)
Q Consensus 229 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~l~~n~l~~~~~~~ 307 (1109)
++.+|..+.++++|++|+|++|++++.+|.. .+++|++|++++|++++.+|..++.+ ++|++|++++|.+++.+|..
T Consensus 236 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~ 313 (768)
T 3rgz_A 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313 (768)
T ss_dssp CSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGG
T ss_pred CCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchH
Confidence 9999999999999999999999999888876 89999999999999999999999876 99999999999999999999
Q ss_pred cCCCCcCcEEEccCCcccCCCccc-ccCCCCcceEecccccccCcccccccCCC-CccEEEcccCcccCCCCcchhc--c
Q 001274 308 LGNCTSAVEIDLSENQLTGFIPRE-LGLIPNLCLLQLFENMLQGSIPRELGQLT-QLHKLDLSINNLTGTIPLEFQN--L 383 (1109)
Q Consensus 308 l~~l~~L~~L~Ls~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~--l 383 (1109)
++++++|++|+|++|++++.+|.. +..+++|+.|++++|.+.+.+|..+..++ +|++|++++|++++.+|..+.. +
T Consensus 314 ~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~ 393 (768)
T 3rgz_A 314 FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393 (768)
T ss_dssp GGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTT
T ss_pred HhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhccc
Confidence 999999999999999999888865 89999999999999999999999999987 9999999999999989888877 8
Q ss_pred cccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeec
Q 001274 384 TYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLML 463 (1109)
Q Consensus 384 ~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 463 (1109)
++|++|++++|.+++.+|..+..+++|++|++++|++++.+|..+..+++|++|++++|.+++.+|..+..+++|++|++
T Consensus 394 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 473 (768)
T 3rgz_A 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473 (768)
T ss_dssp CCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred CCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEe
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCccccc
Q 001274 464 GQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGT 543 (1109)
Q Consensus 464 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 543 (1109)
++|++++.+|..|.++++|++|+|++|++++.+|.+++.+++|++|+|++|++++.+|..++++++|++|+|++|+++|.
T Consensus 474 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 553 (768)
T 3rgz_A 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT 553 (768)
T ss_dssp CSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESB
T ss_pred cCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCCCC----------------------------------------------eeecCCCcCccCCCcccccccc
Q 001274 544 IPHELGNCVNLQ----------------------------------------------RLDLSRNQFTGSAPEELGQLVN 577 (1109)
Q Consensus 544 ~p~~~~~l~~L~----------------------------------------------~L~Ls~N~l~~~~p~~l~~l~~ 577 (1109)
+|.++..+..+. .++++.|.++|.+|..+..+++
T Consensus 554 ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~ 633 (768)
T 3rgz_A 554 IPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633 (768)
T ss_dssp CCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBC
T ss_pred CChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccc
Confidence 998876654433 3455668889999999999999
Q ss_pred cceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecC
Q 001274 578 LELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLD 657 (1109)
Q Consensus 578 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 657 (1109)
|+.|+|++|+++|.+|..|+++++|+.|+|++|.++|.+|..+++++.|+ .||||+|+++|.+|..++.+++|++|||+
T Consensus 634 L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~-~LdLs~N~l~g~ip~~l~~l~~L~~L~ls 712 (768)
T 3rgz_A 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN-ILDLSSNKLDGRIPQAMSALTMLTEIDLS 712 (768)
T ss_dssp CCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC-EEECCSSCCEECCCGGGGGCCCCSEEECC
T ss_pred ccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCC-EEECCCCcccCcCChHHhCCCCCCEEECc
Confidence 99999999999999999999999999999999999999999999999998 59999999999999999999999999999
Q ss_pred CCccccCCchhhhccccceEEEccCccccc
Q 001274 658 DNQLIGEIPASMGEQMSLLVCNLSNNNLVG 687 (1109)
Q Consensus 658 ~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g 687 (1109)
+|+|+|.||.. +.+..+....+.+|+--|
T Consensus 713 ~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lc 741 (768)
T 3rgz_A 713 NNNLSGPIPEM-GQFETFPPAKFLNNPGLC 741 (768)
T ss_dssp SSEEEEECCSS-SSGGGSCGGGGCSCTEEE
T ss_pred CCcccccCCCc-hhhccCCHHHhcCCchhc
Confidence 99999999964 334445555677886433
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-64 Score=633.21 Aligned_cols=589 Identities=22% Similarity=0.210 Sum_probs=440.2
Q ss_pred EeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccc
Q 001274 77 VDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYI 156 (1109)
Q Consensus 77 l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l 156 (1109)
+|+++++++ .+|..+. +++++|+|++|.+++..+..++++++|++|+|++|.+++..|..+..+++|++|+|++|.+
T Consensus 9 ~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 85 (680)
T 1ziw_A 9 ADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85 (680)
T ss_dssp EECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCC
T ss_pred eECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCcc
Confidence 556666665 3555554 7899999999999998888899999999999999999999999999999999999999999
Q ss_pred cccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhh
Q 001274 157 FGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSEL 236 (1109)
Q Consensus 157 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 236 (1109)
++..+..|+++++|++|+|++|++++..|..|+++++|++|++++|.+++..|..++++++|++|++++|.+++..+..+
T Consensus 86 ~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 165 (680)
T 1ziw_A 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165 (680)
T ss_dssp CCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHH
T ss_pred CccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHh
Confidence 86666689999999999999999998778899999999999999999999999999999999999999999998888876
Q ss_pred h--ccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhh---ccCccceEEeecccccCccCcccCCC
Q 001274 237 E--KLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELG---KLSRLKKLYVYTNELNGTIPHELGNC 311 (1109)
Q Consensus 237 ~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~---~l~~L~~L~l~~n~l~~~~~~~l~~l 311 (1109)
. .+++|++|+|++|++++..|..+..+.+|+.|++++|.+.+.....+. ..++|+.|++++|.+++..|..+.++
T Consensus 166 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l 245 (680)
T 1ziw_A 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245 (680)
T ss_dssp GGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGG
T ss_pred hccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhcc
Confidence 5 458999999999999988899999999999999999988754443332 34789999999999988888888887
Q ss_pred Cc--CcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCC-----CCc----ch
Q 001274 312 TS--AVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGT-----IPL----EF 380 (1109)
Q Consensus 312 ~~--L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-----~p~----~~ 380 (1109)
+. |++|+|++|++++..|..++.+++|+.|++++|.+.+..|..|..+++|++|++++|...+. +|. .|
T Consensus 246 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~ 325 (680)
T 1ziw_A 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325 (680)
T ss_dssp GGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTT
T ss_pred CcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhc
Confidence 65 99999999998888888888888888888888888888888888888888888887655432 221 45
Q ss_pred hcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccc--ccc
Q 001274 381 QNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTC--RSL 458 (1109)
Q Consensus 381 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L 458 (1109)
..+++|+.|++++|.+.+..+..|..+++|++|++++|.+.... .....|..+ ++|
T Consensus 326 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~----------------------l~~~~f~~~~~~~L 383 (680)
T 1ziw_A 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT----------------------LTNETFVSLAHSPL 383 (680)
T ss_dssp TTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCE----------------------ECTTTTGGGTTSCC
T ss_pred ccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhh----------------------cchhhhcccccCcC
Confidence 55555555555555555555555555555555555555432211 111122222 345
Q ss_pred ceeecccccccccCCccccCCcccceeccccccccCCCC-ccccccccccEEEccCCccCCCCChhhcccccccEEeccc
Q 001274 459 MQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIP-PEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISS 537 (1109)
Q Consensus 459 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 537 (1109)
+.|++++|++++..|..|.++++|++|+|++|.+++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++
T Consensus 384 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~ 463 (680)
T 1ziw_A 384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463 (680)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTT
T ss_pred ceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcc
Confidence 555555555555555555555566666666665554333 4555566666666666666555555566666666666666
Q ss_pred Cccc--ccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccC--------cccCCCcccceeec
Q 001274 538 NSLS--GTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIP--------SSLGGLARLTELQM 607 (1109)
Q Consensus 538 N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~l 607 (1109)
|.++ +.+|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|++++..+ ..|.++++|+.|++
T Consensus 464 n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L 543 (680)
T 1ziw_A 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543 (680)
T ss_dssp SCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEEC
T ss_pred ccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEEC
Confidence 6554 3455566666666666666666665555556666666666666666654322 23667777777777
Q ss_pred cCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhh-ccccceEEEccCcccc
Q 001274 608 GGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMG-EQMSLLVCNLSNNNLV 686 (1109)
Q Consensus 608 ~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~-~l~~L~~l~ls~N~l~ 686 (1109)
++|.++...+..|.+++.|+ .|+|++|+|++..+..|..+++|+.|+|++|+|++.+|..+. .+++|+.+++++|++.
T Consensus 544 ~~N~l~~i~~~~~~~l~~L~-~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~ 622 (680)
T 1ziw_A 544 ESNGFDEIPVEVFKDLFELK-IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCC-EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCC
T ss_pred CCCCCCCCCHHHcccccCcc-eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcc
Confidence 77777743334567777776 478888888877777889999999999999999988888887 7899999999999999
Q ss_pred cccCC
Q 001274 687 GTVPN 691 (1109)
Q Consensus 687 g~~p~ 691 (1109)
|.++.
T Consensus 623 c~c~~ 627 (680)
T 1ziw_A 623 CTCES 627 (680)
T ss_dssp BCCCC
T ss_pred cCCcc
Confidence 98774
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-63 Score=621.67 Aligned_cols=585 Identities=23% Similarity=0.206 Sum_probs=410.9
Q ss_pred ceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecC
Q 001274 99 VEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSN 178 (1109)
Q Consensus 99 ~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 178 (1109)
+.++.++++++ .+|..+. +++++|+|++|.+++..+..+..+++|++|+|++|.+++..|..++++++|++|+|++|
T Consensus 7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 34566666665 3555443 56666666666666555555666666666666666666555555666666666666666
Q ss_pred CCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCC
Q 001274 179 NLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPP 258 (1109)
Q Consensus 179 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 258 (1109)
++++..+..|+++++|++|++++|++++..|..|+++++|++|+|++|.+++..|..+.++++|++|+|
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L----------- 152 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLL----------- 152 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEEC-----------
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEc-----------
Confidence 655333334555555555555555555444444555555555555555554444444444444444444
Q ss_pred CccccccccceeeeeccceecCchhhh--ccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCccccc---
Q 001274 259 TIGNIQSLELLALHENSFSGGLPKELG--KLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELG--- 333 (1109)
Q Consensus 259 ~l~~l~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~--- 333 (1109)
++|.+++..+..++ .+++|++|++++|.+++..|..+..+.+|+.|++++|.+.+.....+.
T Consensus 153 -------------~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l 219 (680)
T 1ziw_A 153 -------------SNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219 (680)
T ss_dssp -------------CSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHH
T ss_pred -------------cCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHh
Confidence 44444444443332 234455555555555544444455555555555555444321111110
Q ss_pred CCCCcceEecccccccCcccccccCCCC--ccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCc
Q 001274 334 LIPNLCLLQLFENMLQGSIPRELGQLTQ--LHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLS 411 (1109)
Q Consensus 334 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~ 411 (1109)
..++|+.|++++|.+.+..|.+|..++. |++|++++|++++..|..|.++++|+.|++++|++.+..|..+..+++|+
T Consensus 220 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 299 (680)
T 1ziw_A 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299 (680)
T ss_dssp TTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCC
T ss_pred hhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCcc
Confidence 1245555555555555555555555433 66666666666655555666666666666666666666666666666666
Q ss_pred EEEeccccccC-----ccc----hhhhcccccceeecCCccccCCCCCCCccccccceeeccccccc--ccCCccccCC-
Q 001274 412 VLDVSMNNLDG-----SIP----PHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLT--GSLPIEFYNL- 479 (1109)
Q Consensus 412 ~L~Ls~N~l~~-----~~~----~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l- 479 (1109)
+|++++|...+ .+| ..|..+++|++|++++|.+++..+..|..+++|++|++++|.+. ...+..|..+
T Consensus 300 ~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~ 379 (680)
T 1ziw_A 300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379 (680)
T ss_dssp EEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGT
T ss_pred EEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccc
Confidence 66666554332 122 36778889999999999999888888999999999999998754 3334455544
Q ss_pred -cccceeccccccccCCCCccccccccccEEEccCCccCCCCC-hhhcccccccEEecccCcccccCCcCCCCCCCCCee
Q 001274 480 -QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIP-SEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRL 557 (1109)
Q Consensus 480 -~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 557 (1109)
++|+.|++++|+++++.|..|..+++|+.|+|++|++++.+| ..|.++++|++|++++|++.+..+..|..+++|+.|
T Consensus 380 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L 459 (680)
T 1ziw_A 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459 (680)
T ss_dssp TSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEE
T ss_pred cCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccc
Confidence 589999999999999999999999999999999999987655 789999999999999999999999999999999999
Q ss_pred ecCCCcCc--cCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccccccc--------ccccccchhh
Q 001274 558 DLSRNQFT--GSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIP--------VALGQLTALQ 627 (1109)
Q Consensus 558 ~Ls~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--------~~~~~l~~l~ 627 (1109)
++++|.++ +..|..|..+++|+.|+|++|++++..+..|.++++|++|++++|++++..+ ..+.+++.|+
T Consensus 460 ~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~ 539 (680)
T 1ziw_A 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539 (680)
T ss_dssp ECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCC
T ss_pred hhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCC
Confidence 99999987 5789999999999999999999999889999999999999999999986422 2377888887
Q ss_pred hhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEccCcccccccCCCc--ccccccCCcccC
Q 001274 628 IALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTT--VFRRIDSSNFAG 705 (1109)
Q Consensus 628 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~--~~~~~~~~~~~~ 705 (1109)
.|+|++|+++...+..|+++++|+.|||++|+|++..|..|..+++|++|+|++|++++..|... .+..+....+.|
T Consensus 540 -~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~ 618 (680)
T 1ziw_A 540 -ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618 (680)
T ss_dssp -EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTT
T ss_pred -EEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccC
Confidence 59999999997666789999999999999999997666778999999999999999999777532 456677778999
Q ss_pred CCCccc
Q 001274 706 NRGLCM 711 (1109)
Q Consensus 706 n~~~c~ 711 (1109)
||..|.
T Consensus 619 N~~~c~ 624 (680)
T 1ziw_A 619 NPFDCT 624 (680)
T ss_dssp CCCCBC
T ss_pred CCcccC
Confidence 999993
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=571.34 Aligned_cols=533 Identities=20% Similarity=0.211 Sum_probs=440.9
Q ss_pred EEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEccccc
Q 001274 76 SVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENY 155 (1109)
Q Consensus 76 ~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~ 155 (1109)
.+++.+.++. .+|..+. +++++|+|++|.+++..|..|+++++|++|+|++|++.+..|..+..+++|++|+|++|.
T Consensus 16 ~~~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEECCCCCcc-cCcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 3455556655 3455554 378999999999999889999999999999999999999999999999999999999999
Q ss_pred ccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchh
Q 001274 156 IFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSE 235 (1109)
Q Consensus 156 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 235 (1109)
+++..|..|+++++|++|+|++|++++..|..++++++|++|++++|.+++..++.+..+++|++|++++|.+++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 99999999999999999999999999877889999999999999999999755455666999999999999999999999
Q ss_pred hhcccccc--ceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccC-----ccCccc
Q 001274 236 LEKLRNLT--DLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNG-----TIPHEL 308 (1109)
Q Consensus 236 l~~l~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~-----~~~~~l 308 (1109)
++.+++|+ +|++++|++++..|..+.. .+|+.|++++|. ..+..+..+.+++...+..+.+.+ ..+..+
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~ 248 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHh
Confidence 99999999 8999999999777776654 689999999987 456667777776666555444331 112233
Q ss_pred CCCC--cCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhccccc
Q 001274 309 GNCT--SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYL 386 (1109)
Q Consensus 309 ~~l~--~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 386 (1109)
..+. +|++|++++|.+++..+..++.+++|+.|++++|.++ .+|..+..+++|++|++++|++++..|..+.++++|
T Consensus 249 ~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 327 (606)
T 3t6q_A 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327 (606)
T ss_dssp GGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTC
T ss_pred chhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcC
Confidence 3333 7888999999988888888888888888888888888 677788888888888888888887778888888888
Q ss_pred ceEEcccccccccCCCc-ccccCcCcEEEeccccccCcc--chhhhcccccceeecCCccccCCCCCCCccccccceeec
Q 001274 387 VDLQLFDNHLEGTIPPH-IGVNSHLSVLDVSMNNLDGSI--PPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLML 463 (1109)
Q Consensus 387 ~~L~L~~N~l~~~~p~~-~~~~~~L~~L~Ls~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 463 (1109)
+.|++++|.+.+.+|.. +..+++|++|++++|.+.+.. +..+..+++|++|++++|++.+..|..|..+++|++|++
T Consensus 328 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 407 (606)
T 3t6q_A 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407 (606)
T ss_dssp SEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred CEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence 88888888887666554 788888888888888888766 667888888888888888888887888888888888888
Q ss_pred ccccccccCCcc-ccCCcccceeccccccccCCCCccccccccccEEEccCCccCCC---CChhhcccccccEEecccCc
Q 001274 464 GQNQLTGSLPIE-FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGY---IPSEVGNLEHLVTFNISSNS 539 (1109)
Q Consensus 464 ~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~ 539 (1109)
++|++++..+.. |.++++|++|++++|.+++..|..+..+++|++|++++|++++. .+..+..+++|++|+|++|+
T Consensus 408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~ 487 (606)
T 3t6q_A 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487 (606)
T ss_dssp TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence 888888766543 77888888888888888887788888888888888888888762 33567888888888888888
Q ss_pred ccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccccccc
Q 001274 540 LSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 540 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 617 (1109)
+++..|..|.++++|++|+|++|++++..|..|..+++| .|+|++|++++..|..|..+++|+.|++++|++.+..+
T Consensus 488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred cCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 887778888888888888888888888888888888888 88888888888878888888888888888888876554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=571.42 Aligned_cols=534 Identities=21% Similarity=0.207 Sum_probs=336.1
Q ss_pred eeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCC
Q 001274 100 EFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNN 179 (1109)
Q Consensus 100 ~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 179 (1109)
.++.++.+++ .+|..+.. .+++|||++|.+++..|..+..+++|++|+|++|.+++..|.+|+++++|++|+|++|+
T Consensus 16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 4555555555 45554433 56666666666665555555555555555555555555555555555555555555555
Q ss_pred CCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCCC
Q 001274 180 LTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPT 259 (1109)
Q Consensus 180 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 259 (1109)
+++..|..|+++++|++|++++|.++ +..|..+.++++|++|+|++|++++..+..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~------------------------~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 148 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGIS------------------------SIDFIPLHNQKTLESLYLGSNHISSIKLPK 148 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCS------------------------CGGGSCCTTCTTCCEEECCSSCCCCCCCCT
T ss_pred ccccChhhhcccccccEeeccccCcc------------------------cCCcchhccCCcccEEECCCCcccccCccc
Confidence 55444555555555555555555544 443444555666666666666666433333
Q ss_pred ccccccccceeeeeccceecCchhhhccCccc--eEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCC
Q 001274 260 IGNIQSLELLALHENSFSGGLPKELGKLSRLK--KLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPN 337 (1109)
Q Consensus 260 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~--~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~ 337 (1109)
+..+++|++|++++|.+++..|..++.+++|+ .|++++|.+++..|..+.. .+|++|++++|. .++..+..+.+
T Consensus 149 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~ 224 (606)
T 3t6q_A 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKN 224 (606)
T ss_dssp TCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTT
T ss_pred ccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccc
Confidence 33466777777777777766666777777777 6677777777655554433 567777777765 22333334444
Q ss_pred cceEeccccccc-----CcccccccCCC--CccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcC
Q 001274 338 LCLLQLFENMLQ-----GSIPRELGQLT--QLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410 (1109)
Q Consensus 338 L~~L~L~~n~l~-----~~~p~~l~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L 410 (1109)
+....+.-+.+. ...+..+..+. +|+.|++++|++++..+..|.++++|+.|++++|+++ .+|..+..+++|
T Consensus 225 ~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L 303 (606)
T 3t6q_A 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTL 303 (606)
T ss_dssp CEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTC
T ss_pred cchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccC
Confidence 333333222111 11122233222 6777888888887776777777888888888888777 667777777788
Q ss_pred cEEEeccccccCccchhhhcccccceeecCCccccCCCCC-CCccccccceeecccccccccC--CccccCCcccceecc
Q 001274 411 SVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPP-GLKTCRSLMQLMLGQNQLTGSL--PIEFYNLQNLSALEL 487 (1109)
Q Consensus 411 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L 487 (1109)
++|++++|.+.+..|..+..+++|++|++++|.+.+.++. .+..+++|++|++++|++++.. +..|.++++|++|++
T Consensus 304 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l 383 (606)
T 3t6q_A 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383 (606)
T ss_dssp CEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEEC
T ss_pred CEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEEC
Confidence 8888888877777777777777777777777777755544 3667777777777777776655 566667777777777
Q ss_pred ccccccCCCCccccccccccEEEccCCccCCCCCh-hhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCcc
Q 001274 488 YQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPS-EVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG 566 (1109)
Q Consensus 488 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 566 (1109)
++|++.+..|..|..+++|++|++++|++++..|. .+.++++|++|++++|.+++..|..+..+++|++|+|++|++++
T Consensus 384 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 463 (606)
T 3t6q_A 384 SYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463 (606)
T ss_dssp CSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGG
T ss_pred CCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCc
Confidence 77777666666677777777777777777655443 36666677777777777766666666666677777777776664
Q ss_pred C---CCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccc
Q 001274 567 S---APEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPY 643 (1109)
Q Consensus 567 ~---~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~ 643 (1109)
. .+..+..+++|+.|++++|++++..|..|.++++|++|++++|++ ++.+|.
T Consensus 464 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l-------------------------~~~~~~ 518 (606)
T 3t6q_A 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL-------------------------TSSSIE 518 (606)
T ss_dssp GEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC-------------------------CGGGGG
T ss_pred cccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCcc-------------------------CcCChh
Confidence 2 224456666666666666666665566666666666555555544 455566
Q ss_pred cccCccccceeecCCCccccCCchhhhccccceEEEccCcccccccCC
Q 001274 644 ELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPN 691 (1109)
Q Consensus 644 ~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~p~ 691 (1109)
.+..++.| .|||++|++++.+|..+..+++|+.+++++|++.|.++.
T Consensus 519 ~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 519 ALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp GGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred HhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 66667777 777777777776677777777777777777777776653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-58 Score=586.37 Aligned_cols=559 Identities=21% Similarity=0.193 Sum_probs=296.0
Q ss_pred eeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccc-cccccCcCCCceEEeecC
Q 001274 100 EFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEI-PEEIGNLTSLEELVIYSN 178 (1109)
Q Consensus 100 ~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~n 178 (1109)
..+.++++++. +|. -.++|++|||++|.+++..|..+..+++|++|+|++|.+.+.+ |.+|+++++|++|+|++|
T Consensus 8 ~~dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 34555555553 454 3456666666666666666666666666666666666554444 455666666666666666
Q ss_pred CCCCCCCcccccccccceeccccccccCCCCcc--ccccccchhhhcccccccccCc-hhhhccccccceecccccccCC
Q 001274 179 NLTGAIPASISKLRQLRVIRAGHNSLSGPIPPE--ISECEGLEVLGLAQNSLEGFLP-SELEKLRNLTDLILWQNHLSGE 255 (1109)
Q Consensus 179 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~--l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~ 255 (1109)
++++..|..|+++++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++.
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 666555666666666666666666665544433 5555555555555555554332 3455555555555555555544
Q ss_pred CCCCcccc--ccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCccccc
Q 001274 256 IPPTIGNI--QSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELG 333 (1109)
Q Consensus 256 ~p~~l~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~ 333 (1109)
.+..++.+ ++|+.|+++.|.+.+..|..++.+++ .+.+ .+|++|+|++|.+++..+..+.
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~-----------------~~~~-~~L~~L~Ls~n~l~~~~~~~~~ 225 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN-----------------PFRN-MVLEILDVSGNGWTVDITGNFS 225 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSC-----------------TTTT-CCBSEEBCSSCCSSTTTTSGGG
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCC-----------------cccc-CceeEEecCCCcCchhHHHHHH
Confidence 44444444 44555555555554444444333332 0000 0155555555555444443332
Q ss_pred CC---CCcceEeccc---------ccccCcccccccCC--CCccEEEcccCcccCCCCcchhcccccceEEccccccccc
Q 001274 334 LI---PNLCLLQLFE---------NMLQGSIPRELGQL--TQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGT 399 (1109)
Q Consensus 334 ~l---~~L~~L~L~~---------n~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 399 (1109)
.. .+++.|.+.. +.+.+..+..|..+ ++|+.|++++|.+.+..+..|..+++|+.|+|++|++++.
T Consensus 226 ~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~ 305 (844)
T 3j0a_A 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKI 305 (844)
T ss_dssp GTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEE
T ss_pred hhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCC
Confidence 21 2333333332 22222333333332 4566666666666555555555566666666666666555
Q ss_pred CCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCC
Q 001274 400 IPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNL 479 (1109)
Q Consensus 400 ~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 479 (1109)
.|..|..+++|++|+|++|++.+..|..|..+++|++|++++|++++..+..|..+++|++|+|++|.+++. ..+
T Consensus 306 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~ 380 (844)
T 3j0a_A 306 ADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFI 380 (844)
T ss_dssp CTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSC
T ss_pred ChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCC
Confidence 555555555555555555555555555555555555555555555555455555555555555555555432 124
Q ss_pred cccceeccccccccCCCCccccccccccEEEccCCccCCCCC-hhhcccccccEEecccCcccccCCc-CCCCCCCCCee
Q 001274 480 QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIP-SEVGNLEHLVTFNISSNSLSGTIPH-ELGNCVNLQRL 557 (1109)
Q Consensus 480 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L 557 (1109)
++|+.|++++|+++.+ |.. ..+++.|++++|++++... ..+.++++|++|+|++|++++..+. .+..+++|+.|
T Consensus 381 ~~L~~L~l~~N~l~~l-~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L 456 (844)
T 3j0a_A 381 PSIPDIFLSGNKLVTL-PKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456 (844)
T ss_dssp CSCSEEEEESCCCCCC-CCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBC
T ss_pred CCcchhccCCCCcccc-ccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccc
Confidence 4555555555555522 221 2344555555555554211 1233455555555555555433221 23334455555
Q ss_pred ecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccc
Q 001274 558 DLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNL 637 (1109)
Q Consensus 558 ~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l 637 (1109)
+|++|.+++..+. +..+..|.++++|+.|+|++|.+++.+|..+..++.|+ .|+|++|+|
T Consensus 457 ~Ls~N~l~~~~~~-------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l 516 (844)
T 3j0a_A 457 FLGENMLQLAWET-------------------ELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR-GLSLNSNRL 516 (844)
T ss_dssp EEESCCCSSSCCS-------------------CCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCS-EEEEESCCC
T ss_pred cCCCCcccccccc-------------------ccchhhhcCcccccEEECCCCcccccChhHccchhhhh-eeECCCCCC
Confidence 5555554411100 22334455555555555555555555555555555554 355666666
Q ss_pred cccccccccCccccceeecCCCccccCCchhhhccccceEEEccCcccccccCCCcccccccCCcccCCCCcccc--CCC
Q 001274 638 SGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCML--GSD 715 (1109)
Q Consensus 638 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~--~~~ 715 (1109)
++.+|..+. ++|+.|||++|+|++.+|..+. +|+.+++++|++.|.++-. .|......+|..+||. ...
T Consensus 517 ~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~~~----~f~~~~~~~~~~~~~~~~~~~ 587 (844)
T 3j0a_A 517 TVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECELS----TFINWLNHTNVTIAGPPADIY 587 (844)
T ss_dssp SSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSSCC----SHHHHHHHTTTTTCCCGGGCC
T ss_pred CccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCcccccccH----HHHHHHHhcCcccccccccCc
Confidence 655555555 7899999999999999987764 7889999999999988743 2222223345555554 345
Q ss_pred ccc
Q 001274 716 CHQ 718 (1109)
Q Consensus 716 c~~ 718 (1109)
|..
T Consensus 588 C~~ 590 (844)
T 3j0a_A 588 CVY 590 (844)
T ss_dssp CSS
T ss_pred cCC
Confidence 643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-59 Score=575.17 Aligned_cols=487 Identities=17% Similarity=0.235 Sum_probs=377.6
Q ss_pred hhHHHHHHHHHHhcCCC-CC-------CCCCCCCCCCCCCcc---ceeeecC-CeEEEEeccCccccccccccccCcccc
Q 001274 31 TEEGVSLLEFKASLIDP-SN-------NLESWNSSDMTPCNW---IGVECTD-FKVTSVDLHGLNLSGILSPRICDLPRL 98 (1109)
Q Consensus 31 ~~~~~all~~k~~~~~~-~~-------~~~~W~~~~~~~c~w---~gv~C~~-~~v~~l~l~~~~l~g~~~~~~~~l~~L 98 (1109)
..|+.||.+||+++.++ +. ..++|+.+ .|||.| .||+|+. +||++++|++++++|.+|+++++|++|
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L 107 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccc
Confidence 35889999999998543 22 34589875 599999 9999975 699999999999999999999999999
Q ss_pred ceeecccCcc------CC------CCCccccCCCCCceEEccCCcccccCCchhhc-cccceEEEcc-------------
Q 001274 99 VEFNISMNFV------TG------SIPTDLANCSSLEILDLCTNRLHGVIPFQLFF-INTLRKLYLC------------- 152 (1109)
Q Consensus 99 ~~L~ls~n~~------~~------~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~-l~~L~~L~L~------------- 152 (1109)
++|+|++|.+ .| .+|... +..|+ +++++|.+.+.+|..+.. +..+..+++.
T Consensus 108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~ 184 (636)
T 4eco_A 108 EVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184 (636)
T ss_dssp CEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred eEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence 9999999976 44 566554 66777 999999999988877663 2223333332
Q ss_pred -------cccccccccccccCcCCCceEEeecCCCCCC-----------------CCcccc--cccccceeccccccccC
Q 001274 153 -------ENYIFGEIPEEIGNLTSLEELVIYSNNLTGA-----------------IPASIS--KLRQLRVIRAGHNSLSG 206 (1109)
Q Consensus 153 -------~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-----------------~p~~~~--~l~~L~~L~l~~n~l~~ 206 (1109)
.|.++| +|++|+++++|++|+|++|++++. +|..++ ++++|++|++++|++.+
T Consensus 185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~ 263 (636)
T 4eco_A 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263 (636)
T ss_dssp TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS
T ss_pred hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc
Confidence 688998 999999999999999999999986 999999 99999999999999999
Q ss_pred CCCccccccccchhhhccccc-ccc-cCchhhhcc------ccccceecccccccCCCCC--Cccccccccceeeeeccc
Q 001274 207 PIPPEISECEGLEVLGLAQNS-LEG-FLPSELEKL------RNLTDLILWQNHLSGEIPP--TIGNIQSLELLALHENSF 276 (1109)
Q Consensus 207 ~~p~~l~~l~~L~~L~L~~n~-l~~-~~p~~l~~l------~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~l 276 (1109)
.+|..|+++++|++|+|++|+ +++ .+|..++++ ++|++|+|++|+++ .+|. .++++++|++|++++|++
T Consensus 264 ~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l 342 (636)
T 4eco_A 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQL 342 (636)
T ss_dssp SCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCC
T ss_pred cChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcC
Confidence 999999999999999999998 998 899999887 99999999999999 8888 899999999999999999
Q ss_pred eecCchhhhccCccceEEeecccccCccCcccCCCCc-CcEEEccCCcccCCCcccccCCC--CcceEecccccccCccc
Q 001274 277 SGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTS-AVEIDLSENQLTGFIPRELGLIP--NLCLLQLFENMLQGSIP 353 (1109)
Q Consensus 277 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~-L~~L~Ls~n~l~~~~p~~l~~l~--~L~~L~L~~n~l~~~~p 353 (1109)
+|.+| .++++++|++|++++|+++ .+|..+.++++ |++|++++|+++ .+|..+...+ +|+.|++++|.+.+.+|
T Consensus 343 ~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p 419 (636)
T 4eco_A 343 EGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419 (636)
T ss_dssp EEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTT
T ss_pred ccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcch
Confidence 98999 8999999999999999998 88888999998 999999999998 6777776654 78888888888888888
Q ss_pred cccc-------CCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccch
Q 001274 354 RELG-------QLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPP 426 (1109)
Q Consensus 354 ~~l~-------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~ 426 (1109)
..+. .+++|++|+|++|+++...+..+..+++|+.|+|++|+++ .+|..+.... +.
T Consensus 420 ~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~----------------~~ 482 (636)
T 4eco_A 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDE----------------NE 482 (636)
T ss_dssp CSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEET----------------TE
T ss_pred hhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccc----------------cc
Confidence 8877 7778888888888888444444556788888888888877 4444332211 00
Q ss_pred hhhcccccceeecCCccccCCCCCCCc--cccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccc
Q 001274 427 HLCMYQKLIFLSLGSNRLSGNIPPGLK--TCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLR 504 (1109)
Q Consensus 427 ~l~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 504 (1109)
.+.++++|++|+|++|+++ .+|..+. .+++|++|+|++|++++ +|..+.++++|++|+|++|+
T Consensus 483 ~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~------------- 547 (636)
T 4eco_A 483 NFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR------------- 547 (636)
T ss_dssp ECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB-------------
T ss_pred cccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc-------------
Confidence 0112235555555555555 3444443 55566666666666665 55566666666666666554
Q ss_pred cccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCcc
Q 001274 505 NLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG 566 (1109)
Q Consensus 505 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 566 (1109)
++++|++.+.+|..++++++|++|+|++|+++ .+|..+. ++|+.|||++|++..
T Consensus 548 -----~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 548 -----DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp -----CTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTCCEEECCSCTTCE
T ss_pred -----ccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcCCEEECcCCCCcc
Confidence 45566666666666666777777777777773 5666554 577777777776653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-57 Score=559.51 Aligned_cols=539 Identities=20% Similarity=0.182 Sum_probs=430.9
Q ss_pred CCCCccceeeecCCeEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCc
Q 001274 59 MTPCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPF 138 (1109)
Q Consensus 59 ~~~c~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~ 138 (1109)
.+||.|. |. -..+++++++++ .+|..+. ++|++|+|++|.+++..|..++++++|++|+|++|.+++..|.
T Consensus 4 ~~~c~~~---~~---~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~ 74 (606)
T 3vq2_A 4 LNPCIEV---VP---NITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74 (606)
T ss_dssp --CCEEE---ET---TTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTT
T ss_pred CCCceec---CC---CCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHH
Confidence 3668772 21 124677777776 3455444 7899999999999998888999999999999999999998899
Q ss_pred hhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccC-CCCcccccccc
Q 001274 139 QLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSG-PIPPEISECEG 217 (1109)
Q Consensus 139 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~ 217 (1109)
.+..+++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..++++++|++|++++|.+++ .+|..|+++++
T Consensus 75 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~ 154 (606)
T 3vq2_A 75 AWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN 154 (606)
T ss_dssp TTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTT
T ss_pred HhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCC
Confidence 99999999999999999999889999999999999999999998888899999999999999999986 67999999999
Q ss_pred chhhhcccccccccCchhhhcccccc----ceecccccccCCCCCCccccccccceeeeeccce-ecCchhhhccCccce
Q 001274 218 LEVLGLAQNSLEGFLPSELEKLRNLT----DLILWQNHLSGEIPPTIGNIQSLELLALHENSFS-GGLPKELGKLSRLKK 292 (1109)
Q Consensus 218 L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~ 292 (1109)
|++|+|++|++++..|..++.+++|+ +|++++|.+++..+..+... +|+.|++++|.++ +..|..++++++|+.
T Consensus 155 L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~ 233 (606)
T 3vq2_A 155 LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHV 233 (606)
T ss_dssp CCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEE
T ss_pred CCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccc
Confidence 99999999999999899899888776 79999999996555555554 9999999999987 567888999999999
Q ss_pred EEeecccccCc------cCcccCCCC--cCcEEEc-cCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCcc
Q 001274 293 LYVYTNELNGT------IPHELGNCT--SAVEIDL-SENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLH 363 (1109)
Q Consensus 293 L~l~~n~l~~~------~~~~l~~l~--~L~~L~L-s~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 363 (1109)
+++..+.+.+. .+..+..+. +++.+++ ..|.+.+.+|. +..+++|+.|++++|.+.. +| .+..+++|+
T Consensus 234 l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~ 310 (606)
T 3vq2_A 234 HRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQ 310 (606)
T ss_dssp EEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCS
T ss_pred ccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCC
Confidence 99987665421 111222222 4566777 67778777776 7888888888888888864 44 778888888
Q ss_pred EEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCcc--chhhhcccccceeecCC
Q 001274 364 KLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSI--PPHLCMYQKLIFLSLGS 441 (1109)
Q Consensus 364 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~--~~~l~~l~~L~~L~L~~ 441 (1109)
+|++++|++ +.+| .+ .+++|+.|++++|...+.. .+..+++|++|++++|++++.. +..+..+++|++|++++
T Consensus 311 ~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~ 385 (606)
T 3vq2_A 311 SLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385 (606)
T ss_dssp EEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCS
T ss_pred EEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCC
Confidence 888888888 4677 44 8888888888888654433 5667888888888888887663 77788888888888888
Q ss_pred ccccCCCCCCCccccccceeecccccccccCC-ccccCCcccceeccccccccCCCCccccccccccEEEccCCccCC-C
Q 001274 442 NRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLP-IEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVG-Y 519 (1109)
Q Consensus 442 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~ 519 (1109)
|.+++ +|..+..+++|++|++++|++.+..| ..|.++++|++|++++|.+.+..|..+..+++|++|++++|++++ .
T Consensus 386 n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 464 (606)
T 3vq2_A 386 NGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464 (606)
T ss_dssp CSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Ccccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcc
Confidence 88875 45777778888888888888877766 577778888888888888877777778888888888888888776 3
Q ss_pred CChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCC
Q 001274 520 IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599 (1109)
Q Consensus 520 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 599 (1109)
+|..++++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|+++ .+|..+..+
T Consensus 465 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l 543 (606)
T 3vq2_A 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHF 543 (606)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGS
T ss_pred hHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhh
Confidence 6777777888888888888887777777788888888888888887777777888888888888888877 455557777
Q ss_pred c-ccceeeccCcccccccc
Q 001274 600 A-RLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 600 ~-~L~~L~l~~N~l~~~~p 617 (1109)
+ +|+.|++++|++.+..+
T Consensus 544 ~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 544 PKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CTTCCEEECCSCCCCCSST
T ss_pred cccCcEEEccCCCcccCCc
Confidence 6 47888888887775443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=569.55 Aligned_cols=508 Identities=19% Similarity=0.228 Sum_probs=365.3
Q ss_pred chhHHHHHHHHHHhcCCCCCCCCCCCCCC----CCC--Ccc------------ceeeecC-CeEEEEeccCccccccccc
Q 001274 30 LTEEGVSLLEFKASLIDPSNNLESWNSSD----MTP--CNW------------IGVECTD-FKVTSVDLHGLNLSGILSP 90 (1109)
Q Consensus 30 ~~~~~~all~~k~~~~~~~~~~~~W~~~~----~~~--c~w------------~gv~C~~-~~v~~l~l~~~~l~g~~~~ 90 (1109)
..+|++||++||+++.|| +|+.++ .+| |.| .||+|+. +||++|+|++++|.|.+|+
T Consensus 267 ~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred chHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 356899999999999887 887653 355 999 9999984 7999999999999999999
Q ss_pred cccCccccceeec-ccCccCCCCCccccCC----CCCceEEc------------cCCcccccC-----------Cchhhc
Q 001274 91 RICDLPRLVEFNI-SMNFVTGSIPTDLANC----SSLEILDL------------CTNRLHGVI-----------PFQLFF 142 (1109)
Q Consensus 91 ~~~~l~~L~~L~l-s~n~~~~~~p~~l~~l----~~L~~L~L------------s~n~l~~~~-----------~~~l~~ 142 (1109)
+|++|++|+.|+| ++|.++|..|-..... +..+...+ ....+.+.. +.....
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 9999999999999 8999988855332111 00000000 000000000 111112
Q ss_pred cccceEEEccc--ccccccccccccCcCCCceEEeecCCCCC-----------------CCCcccc--cccccceecccc
Q 001274 143 INTLRKLYLCE--NYIFGEIPEEIGNLTSLEELVIYSNNLTG-----------------AIPASIS--KLRQLRVIRAGH 201 (1109)
Q Consensus 143 l~~L~~L~L~~--n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-----------------~~p~~~~--~l~~L~~L~l~~ 201 (1109)
...++.+.+.. |.+++ +|..|+++++|++|+|++|+|++ .+|..++ ++++|++|+|++
T Consensus 422 ~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred ccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence 22344444443 77777 77778888888888888888877 3788877 888888888888
Q ss_pred ccccCCCCccccccccchhhhccccc-ccc-cCchhhhccc-------cccceecccccccCCCCC--Ccccccccccee
Q 001274 202 NSLSGPIPPEISECEGLEVLGLAQNS-LEG-FLPSELEKLR-------NLTDLILWQNHLSGEIPP--TIGNIQSLELLA 270 (1109)
Q Consensus 202 n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~ 270 (1109)
|++.+.+|..|+++++|++|+|++|+ +++ .+|..+++++ +|++|+|++|+++ .+|. .++++++|++|+
T Consensus 501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~ 579 (876)
T 4ecn_A 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLD 579 (876)
T ss_dssp CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEE
T ss_pred CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEE
Confidence 88888888888888888888888887 777 7787777776 8888888888888 7887 888888888888
Q ss_pred eeeccceecCchhhhccCccceEEeecccccCccCcccCCCCc-CcEEEccCCcccCCCcccccCCCC--cceEeccccc
Q 001274 271 LHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTS-AVEIDLSENQLTGFIPRELGLIPN--LCLLQLFENM 347 (1109)
Q Consensus 271 L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~-L~~L~Ls~n~l~~~~p~~l~~l~~--L~~L~L~~n~ 347 (1109)
|++|+++ .+| .|+++++|+.|++++|.++ .+|..+.++++ |++|+|++|+++ .+|..+..++. |+.|++++|.
T Consensus 580 Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~ 655 (876)
T 4ecn_A 580 CVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNK 655 (876)
T ss_dssp CTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSC
T ss_pred CCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCc
Confidence 8888888 777 7888888888888888888 78888888888 888888888888 66776666544 7788888887
Q ss_pred ccCcccccc---c--CCCCccEEEcccCcccCCCCcc-hhcccccceEEcccccccccCCCcccccCcCcEEEecccccc
Q 001274 348 LQGSIPREL---G--QLTQLHKLDLSINNLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLD 421 (1109)
Q Consensus 348 l~~~~p~~l---~--~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~ 421 (1109)
+.+.+|... . .+++|++|+|++|+++ .+|.. +..+++|+.|+|++|+++ .+|..+....
T Consensus 656 l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~------------- 720 (876)
T 4ecn_A 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPK------------- 720 (876)
T ss_dssp TTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCT-------------
T ss_pred CCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccc-------------
Confidence 777655322 2 2347888888888887 44444 446777888888777777 4444332211
Q ss_pred CccchhhhcccccceeecCCccccCCCCCCCc--cccccceeecccccccccCCccccCCcccceeccccccccCCCCcc
Q 001274 422 GSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLK--TCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPE 499 (1109)
Q Consensus 422 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 499 (1109)
+..+.++++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+.++++|+.|+|++|+
T Consensus 721 ---~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~-------- 787 (876)
T 4ecn_A 721 ---DGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR-------- 787 (876)
T ss_dssp ---TSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB--------
T ss_pred ---cccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC--------
Confidence 001122335555555555555 4455554 56666666666666665 56666677777777777765
Q ss_pred ccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccc
Q 001274 500 IGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLE 579 (1109)
Q Consensus 500 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 579 (1109)
++++|++.+.+|..+.++++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+..+.....+.
T Consensus 788 ----------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~ 854 (876)
T 4ecn_A 788 ----------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAG 854 (876)
T ss_dssp ----------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTT
T ss_pred ----------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccch
Confidence 5667777777888888888888888888888 47777765 5888888888888766677777777777
Q ss_pred eecccccccc
Q 001274 580 LLKLSDNKLT 589 (1109)
Q Consensus 580 ~L~Ls~N~l~ 589 (1109)
.+.|.+|++.
T Consensus 855 ~~~L~~n~~~ 864 (876)
T 4ecn_A 855 MYVLLYDKTQ 864 (876)
T ss_dssp CCEEECCTTS
T ss_pred heeecCCCcc
Confidence 8888888766
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-57 Score=574.30 Aligned_cols=533 Identities=20% Similarity=0.207 Sum_probs=437.7
Q ss_pred EEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccC-CchhhccccceEEEcccc
Q 001274 76 SVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVI-PFQLFFINTLRKLYLCEN 154 (1109)
Q Consensus 76 ~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-~~~l~~l~~L~~L~L~~n 154 (1109)
.+|.++++++.. |. -.++|+.|+|++|.+++..|..++++++|++|||++|...+.+ |..+..+++|++|+|++|
T Consensus 8 ~~dcs~~~L~~v-P~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLTQV-PQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSSCC-CS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCCCC-CC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 356777788754 33 4589999999999999999999999999999999999777776 778999999999999999
Q ss_pred cccccccccccCcCCCceEEeecCCCCCCCCcc--cccccccceeccccccccCCCC-ccccccccchhhhccccccccc
Q 001274 155 YIFGEIPEEIGNLTSLEELVIYSNNLTGAIPAS--ISKLRQLRVIRAGHNSLSGPIP-PEISECEGLEVLGLAQNSLEGF 231 (1109)
Q Consensus 155 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~ 231 (1109)
.+++..|+.|+++++|++|+|++|++++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++.
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999999999999999999999999999877766 9999999999999999997765 5799999999999999999999
Q ss_pred Cchhhhcc--ccccceecccccccCCCCCCcccccc------ccceeeeeccceecCchhhhcc---CccceEEeecccc
Q 001274 232 LPSELEKL--RNLTDLILWQNHLSGEIPPTIGNIQS------LELLALHENSFSGGLPKELGKL---SRLKKLYVYTNEL 300 (1109)
Q Consensus 232 ~p~~l~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~------L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~l~~n~l 300 (1109)
.+..+..+ ++|+.|+|++|.+++..|..++.+.+ |+.|++++|.+++..|..+... ++++.|.++.+.+
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 99999988 89999999999999999888877765 9999999999888888777653 5667777765443
Q ss_pred cCccCcccCCCCcCcEEEccCCcccCCCcccccCC--CCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCc
Q 001274 301 NGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLI--PNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPL 378 (1109)
Q Consensus 301 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 378 (1109)
.. +++.+.+.+..+..+..+ ++|+.|++++|.+.+..+..|..+++|+.|+|++|++++..|.
T Consensus 244 ~~---------------~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 308 (844)
T 3j0a_A 244 GA---------------GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE 308 (844)
T ss_dssp BC---------------SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTT
T ss_pred cc---------------cccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChH
Confidence 21 123344444444455544 7899999999999989999999999999999999999998899
Q ss_pred chhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCcccccc
Q 001274 379 EFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSL 458 (1109)
Q Consensus 379 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 458 (1109)
.|.++++|+.|+|++|.+++..|..|..+++|++|++++|++.+..+..|..+++|++|+|++|.+++. ..+++|
T Consensus 309 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L 383 (844)
T 3j0a_A 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSI 383 (844)
T ss_dssp TTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSC
T ss_pred HhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCc
Confidence 999999999999999999988899999999999999999999998888999999999999999999853 237899
Q ss_pred ceeecccccccccCCccccCCcccceeccccccccCCCC-ccccccccccEEEccCCccCCCCCh-hhcccccccEEecc
Q 001274 459 MQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIP-PEIGKLRNLERLHLSENYFVGYIPS-EVGNLEHLVTFNIS 536 (1109)
Q Consensus 459 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls 536 (1109)
+.|++++|+++. +|.. ..+++.|++++|++++... ..+..+++|+.|+|++|++++..+. .+..+++|+.|+|+
T Consensus 384 ~~L~l~~N~l~~-l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls 459 (844)
T 3j0a_A 384 PDIFLSGNKLVT-LPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459 (844)
T ss_dssp SEEEEESCCCCC-CCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEE
T ss_pred chhccCCCCccc-cccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCC
Confidence 999999999994 4443 4679999999999997532 2456899999999999999976543 46678999999999
Q ss_pred cCcccc-----cCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcc
Q 001274 537 SNSLSG-----TIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNI 611 (1109)
Q Consensus 537 ~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 611 (1109)
+|.+++ ..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. ++|+.|++++|
T Consensus 460 ~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N- 536 (844)
T 3j0a_A 460 ENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRN- 536 (844)
T ss_dssp SCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEE-
T ss_pred CCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCC-
Confidence 999973 3344566666666666666666666666666666666666666666655555444 45555555554
Q ss_pred ccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCc
Q 001274 612 FSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIP 666 (1109)
Q Consensus 612 l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip 666 (1109)
+|++.+|..|. +|+.|+|++|++.+..+
T Consensus 537 ------------------------~l~~~~~~~~~---~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 537 ------------------------QLLAPNPDVFV---SLSVLDITHNKFICECE 564 (844)
T ss_dssp ------------------------CCCCCCSCCCS---SCCEEEEEEECCCCSSS
T ss_pred ------------------------cCCCCChhHhC---CcCEEEecCCCcccccc
Confidence 55555554443 67788888888877554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-57 Score=559.75 Aligned_cols=539 Identities=19% Similarity=0.148 Sum_probs=405.0
Q ss_pred CCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccc
Q 001274 121 SLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAG 200 (1109)
Q Consensus 121 ~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~ 200 (1109)
..++++.+++.++ .+|..+. +++++|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+++
T Consensus 12 ~~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls 88 (606)
T 3vq2_A 12 PNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88 (606)
T ss_dssp TTTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECC
Confidence 3467888888887 5666553 788899999999888777788888999999999888887778888888888888888
Q ss_pred cccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccC-CCCCCccccccccceeeeeccceec
Q 001274 201 HNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSG-EIPPTIGNIQSLELLALHENSFSGG 279 (1109)
Q Consensus 201 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~ 279 (1109)
+|.+++..|..|+++++|++|+|++|.+++..+..++++++|++|+|++|++++ .+|..++++++|++|++++|++++.
T Consensus 89 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~ 168 (606)
T 3vq2_A 89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168 (606)
T ss_dssp TCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEE
T ss_pred CCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceec
Confidence 888887778888888888888888888887776778888888888888888875 5677888888888888888888877
Q ss_pred CchhhhccCccc----eEEeecccccCccCcccCCCCcCcEEEccCCccc-CCCcccccCCCCcceEecccccccCcccc
Q 001274 280 LPKELGKLSRLK----KLYVYTNELNGTIPHELGNCTSAVEIDLSENQLT-GFIPRELGLIPNLCLLQLFENMLQGSIPR 354 (1109)
Q Consensus 280 ~p~~l~~l~~L~----~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~ 354 (1109)
.|..++.+++|+ +|++++|.+++..+..+... +|++|++++|.++ +..|..++.+++|+.+++..+.+.+..
T Consensus 169 ~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~-- 245 (606)
T 3vq2_A 169 TVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER-- 245 (606)
T ss_dssp CTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSC--
T ss_pred ChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCC--
Confidence 777777766665 67777777775444444443 7777777777765 344555666666666665544332210
Q ss_pred cccCCCCccEEEcccCcccCCCCcchhccc--ccceEEc-ccccccccCCCcccccCcCcEEEeccccccCccchhhhcc
Q 001274 355 ELGQLTQLHKLDLSINNLTGTIPLEFQNLT--YLVDLQL-FDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMY 431 (1109)
Q Consensus 355 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L-~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l 431 (1109)
.+....+..+.++. .++.+++ ..|.+.+.+|. +..+++|+.|++++|.+.. +| .+..+
T Consensus 246 ----------------~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~ 306 (606)
T 3vq2_A 246 ----------------NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKH 306 (606)
T ss_dssp ----------------CCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTT
T ss_pred ----------------cccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hcccc
Confidence 00001111122221 3455555 55666666665 6667777777777777753 33 66667
Q ss_pred cccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCC--CCccccccccccEE
Q 001274 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGL--IPPEIGKLRNLERL 509 (1109)
Q Consensus 432 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L 509 (1109)
++|+.|++++|.+ +.+| .+ .+++|++|++++|+..+.. .+..+++|++|++++|++++. .|..+..+++|++|
T Consensus 307 ~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L 381 (606)
T 3vq2_A 307 FKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381 (606)
T ss_dssp CCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEE
T ss_pred ccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEe
Confidence 7777777777777 4555 34 7777777777777554333 566778888888888887765 36677778888888
Q ss_pred EccCCccCCCCChhhcccccccEEecccCcccccCC-cCCCCCCCCCeeecCCCcCccCCCcccccccccceeccccccc
Q 001274 510 HLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIP-HELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588 (1109)
Q Consensus 510 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 588 (1109)
++++|.+++ +|..+.++++|+.|++++|++++..| ..+.++++|++|++++|.+++..|..+..+++|+.|++++|++
T Consensus 382 ~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 460 (606)
T 3vq2_A 382 DLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSF 460 (606)
T ss_dssp ECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEE
T ss_pred ECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcC
Confidence 888888775 55777788888888888888887766 6778888888888888888877788888888888888888888
Q ss_pred cc-ccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCch
Q 001274 589 TG-AIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPA 667 (1109)
Q Consensus 589 ~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~ 667 (1109)
++ .+|..|+.+++|++|++++|.+++..|..+.+++.|+ .|+|++|++++.+|..|+.+++|++|||++|+|+ .+|.
T Consensus 461 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~ 538 (606)
T 3vq2_A 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ-LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKG 538 (606)
T ss_dssp GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC-EEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEES
T ss_pred CCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCC-EEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCH
Confidence 87 4678888888888888888888888888888888886 4888888898888999999999999999999998 7888
Q ss_pred hhhccc-cceEEEccCcccccccCCC
Q 001274 668 SMGEQM-SLLVCNLSNNNLVGTVPNT 692 (1109)
Q Consensus 668 ~~~~l~-~L~~l~ls~N~l~g~~p~~ 692 (1109)
.+..++ +|+++++++|++.|.++..
T Consensus 539 ~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 539 ILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp CGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred hHhhhcccCcEEEccCCCcccCCccH
Confidence 899987 5999999999999988753
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=504.36 Aligned_cols=512 Identities=21% Similarity=0.203 Sum_probs=363.6
Q ss_pred EeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccc
Q 001274 77 VDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYI 156 (1109)
Q Consensus 77 l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l 156 (1109)
++..+.++.. +|..+. ++++.|+|++|.+++..+.+++++++|++|||++|++++..|..+..+++|++|+|++|.+
T Consensus 12 ~~c~~~~l~~-ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCSS-CCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCccc-cCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 5555556553 444332 5799999999999998888999999999999999999988888899999999999999999
Q ss_pred cccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccC-CCCccccccccchhhhcccccccccCchh
Q 001274 157 FGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSG-PIPPEISECEGLEVLGLAQNSLEGFLPSE 235 (1109)
Q Consensus 157 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 235 (1109)
++..|..|+++++|++|++++|++++..+..++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..|..
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~ 168 (570)
T 2z63_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (570)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGG
T ss_pred CccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHH
Confidence 98888999999999999999999997666689999999999999999987 57999999999999999999999888899
Q ss_pred hhccccc----cceecccccccCCCCCCccccccccceeeeecccee-cCchhhhccCccceEEeecccccCccCcccCC
Q 001274 236 LEKLRNL----TDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSG-GLPKELGKLSRLKKLYVYTNELNGTIPHELGN 310 (1109)
Q Consensus 236 l~~l~~L----~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~ 310 (1109)
++.+++| ++|++++|.+++..|..+..+ +|+.|++++|.... .++..+..+++++.+.+..+.+...
T Consensus 169 ~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~------- 240 (570)
T 2z63_A 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE------- 240 (570)
T ss_dssp GHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCC-------
T ss_pred ccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCc-------
Confidence 9999998 889999999998777777766 89999999885432 3566778888888877765443311
Q ss_pred CCcCcEEEccCCcccCCCcccccCCC--CcceEecccc-cccCcccccccCCCCccEEEcccCcccCCCCcchhcccccc
Q 001274 311 CTSAVEIDLSENQLTGFIPRELGLIP--NLCLLQLFEN-MLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLV 387 (1109)
Q Consensus 311 l~~L~~L~Ls~n~l~~~~p~~l~~l~--~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 387 (1109)
.+++ ++.... +..++ .++.+++.++ .+.+..|..+..+++|++|++++|.++ .+|..+..+ +|+
T Consensus 241 -~~l~--~~~~~~--------~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~ 307 (570)
T 2z63_A 241 -GNLE--KFDKSA--------LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQ 307 (570)
T ss_dssp -SSCE--ECCTTT--------TGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCS
T ss_pred -hhhh--hcchhh--------hccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-Ccc
Confidence 1111 011111 11111 1333444444 444444555555555555555555554 344444444 555
Q ss_pred eEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCC--CCCCccccccceeeccc
Q 001274 388 DLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNI--PPGLKTCRSLMQLMLGQ 465 (1109)
Q Consensus 388 ~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~ 465 (1109)
.|++++|.+. .+|. ..+++|++|++++|.+.+..+. ..+++|++|++++|.+++.. +..+..+++|++|++++
T Consensus 308 ~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~ 382 (570)
T 2z63_A 308 HLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382 (570)
T ss_dssp EEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCS
T ss_pred EEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCC
Confidence 5555555554 3332 2445555555555555444333 44555555555555555432 34455556666666666
Q ss_pred ccccccCCccccCCcccceeccccccccCCCC-ccccccccccEEEccCCccCCCCChhhcccccccEEecccCccc-cc
Q 001274 466 NQLTGSLPIEFYNLQNLSALELYQNRFSGLIP-PEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLS-GT 543 (1109)
Q Consensus 466 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~ 543 (1109)
|++++..+. |.++++|++|++++|.+.+..| ..+..+++|++|++++|++.+..|..+.++++|++|+|++|+++ +.
T Consensus 383 n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 461 (570)
T 2z63_A 383 NGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461 (570)
T ss_dssp CSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Ccccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCcccc
Confidence 666644433 6677777777777777776554 45677777777777777777777777777777777777777776 46
Q ss_pred CCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccc
Q 001274 544 IPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPV 618 (1109)
Q Consensus 544 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 618 (1109)
+|..+..+++|++|+|++|++++..|..|..+++|+.|++++|++++..|..|..+++|+.|++++|++++..|.
T Consensus 462 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred chhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 777777777777777777777776677777777777777777777777777777777777777777777776654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=500.72 Aligned_cols=488 Identities=19% Similarity=0.188 Sum_probs=368.7
Q ss_pred eEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcc
Q 001274 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLC 152 (1109)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~ 152 (1109)
+++.+||+++++++..+.++.++++|++|+|++|.+++..|..++++++|++|+|++|.+++..|..+..+++|++|+|+
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 68899999999999888899999999999999999999888899999999999999999998888999999999999999
Q ss_pred cccccccccccccCcCCCceEEeecCCCCC-CCCcccccccccceeccccccccCCCCccccccccc----hhhhccccc
Q 001274 153 ENYIFGEIPEEIGNLTSLEELVIYSNNLTG-AIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGL----EVLGLAQNS 227 (1109)
Q Consensus 153 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L----~~L~L~~n~ 227 (1109)
+|.+++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|.+++..|..++.+++| ++|++++|.
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~ 188 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC
Confidence 999987766689999999999999999997 579999999999999999999998888899999999 899999999
Q ss_pred ccccCchhhhccccccceecccccccC-CCCCCccccccccceeeeecccee------cCchhhhccCc--cceEEeecc
Q 001274 228 LEGFLPSELEKLRNLTDLILWQNHLSG-EIPPTIGNIQSLELLALHENSFSG------GLPKELGKLSR--LKKLYVYTN 298 (1109)
Q Consensus 228 l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~------~~p~~l~~l~~--L~~L~l~~n 298 (1109)
+++..|..+..+ +|+.|++++|.... .++..+..++.++.+.+..+.+.. .....+..+++ ++.++++++
T Consensus 189 l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 267 (570)
T 2z63_A 189 MNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267 (570)
T ss_dssp CCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEET
T ss_pred ceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcc
Confidence 999888888766 89999999986542 345566677777777666543321 11222232222 334444444
Q ss_pred -cccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCC
Q 001274 299 -ELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIP 377 (1109)
Q Consensus 299 -~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 377 (1109)
.+.+.+|..+..+++|++|++++|.++ .+|..+..+ +|++|++++|.+. .+|
T Consensus 268 ~~~~~~~~~~~~~l~~L~~L~l~~~~l~-------------------------~l~~~~~~~-~L~~L~l~~n~~~-~l~ 320 (570)
T 2z63_A 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIE-------------------------RVKDFSYNF-GWQHLELVNCKFG-QFP 320 (570)
T ss_dssp TEEESCSTTTTGGGTTCSEEEEESCEEC-------------------------SCCBCCSCC-CCSEEEEESCBCS-SCC
T ss_pred hhhhhhchhhhcCcCcccEEEecCccch-------------------------hhhhhhccC-CccEEeeccCccc-ccC
Confidence 444445555555555555555555554 244445555 5666666666655 333
Q ss_pred cchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCcc--chhhhcccccceeecCCccccCCCCCCCccc
Q 001274 378 LEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSI--PPHLCMYQKLIFLSLGSNRLSGNIPPGLKTC 455 (1109)
Q Consensus 378 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 455 (1109)
. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++.+.. +..+..+++|++|++++|.+++..+. +..+
T Consensus 321 ~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l 395 (570)
T 2z63_A 321 T--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGL 395 (570)
T ss_dssp B--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETC
T ss_pred c--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-cccc
Confidence 3 3455666666666665544443 45666666666666666543 56666777777777777777654443 6677
Q ss_pred cccceeecccccccccCC-ccccCCcccceeccccccccCCCCccccccccccEEEccCCccC-CCCChhhcccccccEE
Q 001274 456 RSLMQLMLGQNQLTGSLP-IEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFV-GYIPSEVGNLEHLVTF 533 (1109)
Q Consensus 456 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L 533 (1109)
++|++|++++|++.+..+ ..|.++++|++|++++|.+.+..|..|..+++|++|++++|+++ +.+|..+..+++|++|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 777777777777776655 45777778888888888887777777778888888888888876 4677777888888888
Q ss_pred ecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccC
Q 001274 534 NISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIP 593 (1109)
Q Consensus 534 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 593 (1109)
+|++|++++..|.+|.++++|++|+|++|++++..|..|..+++|+.|++++|++++..|
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 888888887777788888888888888888887777777888888888888888876654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=499.08 Aligned_cols=491 Identities=20% Similarity=0.244 Sum_probs=308.1
Q ss_pred CCccceeeecCCeEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchh
Q 001274 61 PCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQL 140 (1109)
Q Consensus 61 ~c~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l 140 (1109)
.|.|.|| |+ +++++++ .+|+.+. ++|++|+|++|.+++..|..++++++|++|+|++|++++..|..+
T Consensus 3 ~C~~~~~-c~--------~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~ 70 (549)
T 2z81_A 3 SCDASGV-CD--------GRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70 (549)
T ss_dssp EECTTSE-EE--------CTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTT
T ss_pred cCCCCce-EE--------CCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhc
Confidence 4999998 84 4455555 3444443 567777777777776666677777777777777777766666666
Q ss_pred hccccceEEEcccccccccccccccCcCCCceEEeecCCCCC-CCCcccccccccceeccccccccCCCCccccccccch
Q 001274 141 FFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTG-AIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLE 219 (1109)
Q Consensus 141 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~ 219 (1109)
..+++|++|+|++|.+++..|..|+++++|++|+|++|++++ .+|..++++++|++|++++|.+.+.+|
T Consensus 71 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~---------- 140 (549)
T 2z81_A 71 YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR---------- 140 (549)
T ss_dssp TTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC----------
T ss_pred cccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccC----------
Confidence 666666666666666665555556666666666666666654 234455555555555555554222222
Q ss_pred hhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchh-hhccCccceEEeecc
Q 001274 220 VLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKE-LGKLSRLKKLYVYTN 298 (1109)
Q Consensus 220 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~l~~n 298 (1109)
+..|.++++|++|++++|++++.+|..++.+++|++|+++.|.+.. +|.. ++.+++|++|++++|
T Consensus 141 -------------~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n 206 (549)
T 2z81_A 141 -------------RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRDT 206 (549)
T ss_dssp -------------TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEESC
T ss_pred -------------HhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccc-cchhhHhhcccccEEEccCC
Confidence 2345555555555555555555555555555555556655555542 2322 344566666666666
Q ss_pred cccCcc--C-cccCCCCcCcEEEccCCcccCCCcc----cccCCCCcceEecccccccCcc------cccccCCCCccEE
Q 001274 299 ELNGTI--P-HELGNCTSAVEIDLSENQLTGFIPR----ELGLIPNLCLLQLFENMLQGSI------PRELGQLTQLHKL 365 (1109)
Q Consensus 299 ~l~~~~--~-~~l~~l~~L~~L~Ls~n~l~~~~p~----~l~~l~~L~~L~L~~n~l~~~~------p~~l~~l~~L~~L 365 (1109)
.+++.. | .....+++|+.|++++|.+++..+. .+..+++|+.+++.+|.+.+.. ...+..+.+|+.|
T Consensus 207 ~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L 286 (549)
T 2z81_A 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV 286 (549)
T ss_dssp BCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEE
T ss_pred ccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccc
Confidence 665421 1 1123345566666666655543322 1222333333333333333210 1122334444555
Q ss_pred EcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhh-hcccccceeecCCccc
Q 001274 366 DLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHL-CMYQKLIFLSLGSNRL 444 (1109)
Q Consensus 366 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l-~~l~~L~~L~L~~N~l 444 (1109)
+++++.+.... .+. .++..+....+|+.|++++|.+. .+|..+ ..+++|++|++++|++
T Consensus 287 ~l~~~~i~~~~--~~~-----------------~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l 346 (549)
T 2z81_A 287 TIRRLHIPQFY--LFY-----------------DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLM 346 (549)
T ss_dssp EEESCBCSCGG--GSC-----------------CCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCC
T ss_pred cccccccchhh--hcc-----------------cchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCcc
Confidence 55444433110 000 11111233456777777777776 344444 5677788888888877
Q ss_pred cCCCC---CCCccccccceeecccccccccCC--ccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCC
Q 001274 445 SGNIP---PGLKTCRSLMQLMLGQNQLTGSLP--IEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGY 519 (1109)
Q Consensus 445 ~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 519 (1109)
++.+| ..+..+++|++|++++|++++..+ ..|..+++|++|+|++|+++ .+|..+..+++|++|++++|++++
T Consensus 347 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~- 424 (549)
T 2z81_A 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV- 424 (549)
T ss_dssp CHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-
T ss_pred ccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-
Confidence 76553 346777888888888888876543 45788888999999999888 457788888899999999998875
Q ss_pred CChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCC
Q 001274 520 IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599 (1109)
Q Consensus 520 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 599 (1109)
+|..+ .++|++|+|++|+|++.+ ..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|++++.+|..|..+
T Consensus 425 l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 496 (549)
T 2z81_A 425 VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRL 496 (549)
T ss_dssp CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGC
T ss_pred ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcC
Confidence 34333 258899999999988642 57788999999999998 5665 5678899999999999998888888999
Q ss_pred cccceeeccCcccccccc
Q 001274 600 ARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 600 ~~L~~L~l~~N~l~~~~p 617 (1109)
++|+.|++++|++.+..|
T Consensus 497 ~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 497 TSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp TTCCEEECCSSCBCCCHH
T ss_pred cccCEEEecCCCccCCCc
Confidence 999999999999887766
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=500.15 Aligned_cols=463 Identities=17% Similarity=0.201 Sum_probs=311.8
Q ss_pred CCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceecc
Q 001274 120 SSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRA 199 (1109)
Q Consensus 120 ~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l 199 (1109)
.+++.|+|++|.+.|.+|.+++.+++|++|+|++|.+... +..++.. .+...+|... +..|+ +++
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~-~~~~~~~-----------~~~~~~~~~~--~~~l~-l~l 145 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN-ERLFGPK-----------GISANMSDEQ--KQKMR-MHY 145 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGT-CCSBSTT-----------SBCTTCCHHH--HHHHH-THH
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccC-Ccccccc-----------ccccCchHHH--HHHHH-hhH
Confidence 3677788888888777777777777777777777765211 0001100 0011333333 45566 666
Q ss_pred ccccccCCCCccccc-cccchhhhcccccccccCchhhhccccccceecc--cccccCCCCCCccccccccceeeeeccc
Q 001274 200 GHNSLSGPIPPEISE-CEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILW--QNHLSGEIPPTIGNIQSLELLALHENSF 276 (1109)
Q Consensus 200 ~~n~l~~~~p~~l~~-l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~--~N~l~~~~p~~l~~l~~L~~L~L~~N~l 276 (1109)
++|.+.+.+|..++. +..+..+++....+.. .....++.+.+. .|++++ +|..++++++|++|+|++|.+
T Consensus 146 ~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l 218 (636)
T 4eco_A 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218 (636)
T ss_dssp HHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCC
T ss_pred HHhhhccCchhhHHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcc
Confidence 666666666666553 3455555555433321 112233333333 466666 666677777777777777776
Q ss_pred eec-----------------Cchhhh--ccCccceEEeecccccCccCcccCCCCcCcEEEccCCc-ccC-CCcccccCC
Q 001274 277 SGG-----------------LPKELG--KLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQ-LTG-FIPRELGLI 335 (1109)
Q Consensus 277 ~~~-----------------~p~~l~--~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~-l~~-~~p~~l~~l 335 (1109)
++. +|+.++ ++++|++|++++|.+.+.+|..++++++|++|+|++|+ +++ .+|..++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L 298 (636)
T 4eco_A 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298 (636)
T ss_dssp CGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHH
T ss_pred ccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhh
Confidence 664 777777 77777777777777777777777777777777777777 776 677766665
Q ss_pred ------CCcceEecccccccCcccc--cccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCccccc
Q 001274 336 ------PNLCLLQLFENMLQGSIPR--ELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVN 407 (1109)
Q Consensus 336 ------~~L~~L~L~~n~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 407 (1109)
++|+.|++++|.++ .+|. .+..+++|++|++++|+++|.+| .|.++++|+.|+|++|+++ .+|..+..+
T Consensus 299 ~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 375 (636)
T 4eco_A 299 ADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGF 375 (636)
T ss_dssp HHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEE
T ss_pred hccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhh
Confidence 77777777777777 6666 77778888888888888877777 7777888888888888877 677777777
Q ss_pred Cc-CcEEEeccccccCccchhhhccc--ccceeecCCccccCCCCCCCc-------cccccceeecccccccccCCcccc
Q 001274 408 SH-LSVLDVSMNNLDGSIPPHLCMYQ--KLIFLSLGSNRLSGNIPPGLK-------TCRSLMQLMLGQNQLTGSLPIEFY 477 (1109)
Q Consensus 408 ~~-L~~L~Ls~N~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~ 477 (1109)
++ |++|++++|+++ .+|..+..+. +|++|++++|++++.+|..+. .+++|++|+|++|+++.+.+..|.
T Consensus 376 ~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~ 454 (636)
T 4eco_A 376 TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454 (636)
T ss_dssp CTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHH
T ss_pred cccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHc
Confidence 77 888888888877 5666666544 788888888888777777777 667777888888877755445566
Q ss_pred CCcccceeccccccccCCCCcccccc-------ccccEEEccCCccCCCCChhhc--ccccccEEecccCcccccCCcCC
Q 001274 478 NLQNLSALELYQNRFSGLIPPEIGKL-------RNLERLHLSENYFVGYIPSEVG--NLEHLVTFNISSNSLSGTIPHEL 548 (1109)
Q Consensus 478 ~l~~L~~L~L~~N~l~~~~p~~~~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~ 548 (1109)
.+++|++|+|++|+++.+.+..+..+ ++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+
T Consensus 455 ~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~ 532 (636)
T 4eco_A 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQP 532 (636)
T ss_dssp TTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGG
T ss_pred cCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhh
Confidence 67778888888887774433333333 27777777777777 5666665 77777777777777775 67777
Q ss_pred CCCCCCCeeecC------CCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccc
Q 001274 549 GNCVNLQRLDLS------RNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 549 ~~l~~L~~L~Ls------~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 613 (1109)
.++++|+.|+|+ +|++.+.+|..+..+++|+.|+|++|++ +.+|..+. ++|+.|++++|++.
T Consensus 533 ~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 533 LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp GGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred hcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 777777777773 4556666666666666777777777766 35555544 56666666666655
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=488.23 Aligned_cols=494 Identities=18% Similarity=0.160 Sum_probs=281.2
Q ss_pred CCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceecc
Q 001274 120 SSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRA 199 (1109)
Q Consensus 120 ~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l 199 (1109)
+...+.|.++|.++ .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|++
T Consensus 5 ~~~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 5 DASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp CTTSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 33444567777776 4555443 56667777776666666666666666666666666666555566666666666666
Q ss_pred ccccccCCCCccccccccchhhhcccccccc-cCchhhhccccccceecccccccCCCC-CCccccccccceeeeeccce
Q 001274 200 GHNSLSGPIPPEISECEGLEVLGLAQNSLEG-FLPSELEKLRNLTDLILWQNHLSGEIP-PTIGNIQSLELLALHENSFS 277 (1109)
Q Consensus 200 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~ 277 (1109)
++|.+++..|..|+++++|++|+|++|.+++ ..|..+.++++|++|+|++|++.+.+| ..++++++|++|++++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 6666665544445555555555555555554 234455555555555555555322332 34555555555555555555
Q ss_pred ecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCccccccc
Q 001274 278 GGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELG 357 (1109)
Q Consensus 278 ~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 357 (1109)
+..|..++++++|++|+++.|.+.......+..+++|++|++++|++++.... ......
T Consensus 162 ~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~---------------------~~~~~~ 220 (549)
T 2z81_A 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS---------------------PLPVDE 220 (549)
T ss_dssp EECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCC---------------------CCSSCC
T ss_pred ccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcccccccc---------------------ccchhh
Confidence 55555555555555555555554422111223345555555555555432100 001122
Q ss_pred CCCCccEEEcccCcccCCCCc----chhcccccceEEcccccccccC------CCcccccCcCcEEEeccccccCccchh
Q 001274 358 QLTQLHKLDLSINNLTGTIPL----EFQNLTYLVDLQLFDNHLEGTI------PPHIGVNSHLSVLDVSMNNLDGSIPPH 427 (1109)
Q Consensus 358 ~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~------p~~~~~~~~L~~L~Ls~N~l~~~~~~~ 427 (1109)
.+++|++|++++|.+++..+. .+..+++|+.|++++|.+.+.. ...+..+.+|+.|+++++.+.....
T Consensus 221 ~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~-- 298 (549)
T 2z81_A 221 VSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL-- 298 (549)
T ss_dssp CCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG--
T ss_pred hhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhh--
Confidence 345566666666665543322 2234455555555555554321 1122334445555555444331100
Q ss_pred hhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccc-cCCcccceeccccccccCCCC---cccccc
Q 001274 428 LCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEF-YNLQNLSALELYQNRFSGLIP---PEIGKL 503 (1109)
Q Consensus 428 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l 503 (1109)
+. ..+..+....+|++|++++|+++ .+|..+ .++++|++|+|++|++++.+| ..++.+
T Consensus 299 ~~-----------------~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l 360 (549)
T 2z81_A 299 FY-----------------DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360 (549)
T ss_dssp SC-----------------CCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSS
T ss_pred cc-----------------cchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhcc
Confidence 00 00111122345666666666665 344433 456777777777777766543 235667
Q ss_pred ccccEEEccCCccCCCCC--hhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCccccccccccee
Q 001274 504 RNLERLHLSENYFVGYIP--SEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELL 581 (1109)
Q Consensus 504 ~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 581 (1109)
++|++|+|++|++++..+ ..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+. ++|+.|
T Consensus 361 ~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L 436 (549)
T 2z81_A 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVL 436 (549)
T ss_dssp TTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEE
T ss_pred ccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEE
Confidence 777777777777765432 34677777777777777777 56667777777777777777776 3443332 466777
Q ss_pred cccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCcc
Q 001274 582 KLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQL 661 (1109)
Q Consensus 582 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 661 (1109)
+|++|++++.+ ..+++|++|++++|+++ .+|. .+.+++|++|||++|+|
T Consensus 437 ~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~--------------------------~ip~-~~~l~~L~~L~Ls~N~l 485 (549)
T 2z81_A 437 DVSNNNLDSFS----LFLPRLQELYISRNKLK--------------------------TLPD-ASLFPVLLVMKISRNQL 485 (549)
T ss_dssp ECCSSCCSCCC----CCCTTCCEEECCSSCCS--------------------------SCCC-GGGCTTCCEEECCSSCC
T ss_pred ECCCCChhhhc----ccCChhcEEECCCCccC--------------------------cCCC-cccCccCCEEecCCCcc
Confidence 77777666532 35566666666655554 2333 34567788888888888
Q ss_pred ccCCchhhhccccceEEEccCcccccccCCC
Q 001274 662 IGEIPASMGEQMSLLVCNLSNNNLVGTVPNT 692 (1109)
Q Consensus 662 ~~~ip~~~~~l~~L~~l~ls~N~l~g~~p~~ 692 (1109)
++.+|..+..+++|++|++++|++.|.+|..
T Consensus 486 ~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 516 (549)
T 2z81_A 486 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 516 (549)
T ss_dssp CCCCTTGGGGCTTCCEEECCSSCBCCCHHHH
T ss_pred CCcCHHHHhcCcccCEEEecCCCccCCCccH
Confidence 8877778888888888888888888888743
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=444.19 Aligned_cols=263 Identities=29% Similarity=0.427 Sum_probs=207.6
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+++++.++||+|+||+||+|++++ .||||+++.........+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567788999999999999999753 59999998666666667889999999999999999999998864 568999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC-
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY- 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 960 (1109)
|++|+|.++++..... ++|.++..|+.|||+||+||| +++||||||||+|||+++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~~~~--l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQETK--FQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTSCCC--CCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhcCCC--CCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999765443 999999999999999999999 6799999999999999999999999999998764322
Q ss_pred CCCccccccccceeccccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
.......+||+.|||||++.+ ++|+.++|||||||++|||+||+.||.+..........+...... |....
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~--p~~~~---- 261 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS--PDLSK---- 261 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC--CCSTT----
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC--CCccc----
Confidence 223355689999999999864 468999999999999999999999998643222222222211111 10000
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
........+.+++.+||+.||++||||+||+++|+.+....
T Consensus 262 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 262 ------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp ------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 01122346789999999999999999999999998876544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=485.64 Aligned_cols=555 Identities=20% Similarity=0.181 Sum_probs=446.2
Q ss_pred CCCCCCCCCCCCCCCCCccceeeecCCeEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceE
Q 001274 46 DPSNNLESWNSSDMTPCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEIL 125 (1109)
Q Consensus 46 ~~~~~~~~W~~~~~~~c~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L 125 (1109)
|+...+++|+.+ -|..|..-.|.... +.++.++.+|+. +|+.|. +++++|||++|.|++..|.+|+++++|++|
T Consensus 8 ~~~~~~~~~~~~--~p~~~~~c~~~~~~-~~~~c~~~~l~~-vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L 81 (635)
T 4g8a_A 8 DDDDKLAAANSS--IPESWEPCVEVVPN-ITYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVL 81 (635)
T ss_dssp -------------------CCSEEEETT-TEEECTTSCCSS-CCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCcchhhcccCC--CCCCCCCccccCCC-CEEECCCCCcCc-cCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEE
Confidence 444568888764 34556554443221 235777777773 454442 479999999999998888899999999999
Q ss_pred EccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceecccccccc
Q 001274 126 DLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLS 205 (1109)
Q Consensus 126 ~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~ 205 (1109)
||++|++++..|..|..+++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|+++++|++|++++|.++
T Consensus 82 ~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~ 161 (635)
T 4g8a_A 82 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 161 (635)
T ss_dssp ECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccc
Confidence 99999999888888999999999999999999877788999999999999999999877788999999999999999997
Q ss_pred C-CCCccccccccchhhhcccccccccCchhhhcccccc----ceecccccccCCCCCCccccccccceeeeeccceec-
Q 001274 206 G-PIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLT----DLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGG- 279 (1109)
Q Consensus 206 ~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~- 279 (1109)
+ ..|..++.+++|++|+|++|++++..|..+..+.+++ .++++.|.++...+ .......++.+++.+|..+..
T Consensus 162 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~-~~~~~~~~~~l~l~~n~~~~~~ 240 (635)
T 4g8a_A 162 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-GAFKEIRLHKLTLRNNFDSLNV 240 (635)
T ss_dssp CCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECT-TTTTTCEEEEEEEESCCSSHHH
T ss_pred cCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCc-ccccchhhhhhhhhcccccccc
Confidence 5 4688899999999999999999999999998887765 57889999985444 444455788899999876543
Q ss_pred CchhhhccCccceEEeeccccc------CccCcccCCCCcCcEEEccCCcccC---CCcccccCCCCcceEecccccccC
Q 001274 280 LPKELGKLSRLKKLYVYTNELN------GTIPHELGNCTSAVEIDLSENQLTG---FIPRELGLIPNLCLLQLFENMLQG 350 (1109)
Q Consensus 280 ~p~~l~~l~~L~~L~l~~n~l~------~~~~~~l~~l~~L~~L~Ls~n~l~~---~~p~~l~~l~~L~~L~L~~n~l~~ 350 (1109)
.+..+..+..++...+..+... ......+..+..+...++..+.... ..+..+....+++.+.+.++.+..
T Consensus 241 ~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~ 320 (635)
T 4g8a_A 241 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIER 320 (635)
T ss_dssp HHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEE
T ss_pred cchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccc
Confidence 3456778888888777654432 2334456666677777766554432 234456677889999999998875
Q ss_pred cccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccC--ccchhh
Q 001274 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDG--SIPPHL 428 (1109)
Q Consensus 351 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~--~~~~~l 428 (1109)
.. .+.....|+.|++++|.+.+..+ ..+..|+.+.+.+|.+... .....+++|++|++++|.+.. ..+..+
T Consensus 321 ~~--~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~ 393 (635)
T 4g8a_A 321 VK--DFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSD 393 (635)
T ss_dssp CG--GGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHH
T ss_pred cc--ccccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccch
Confidence 43 35667789999999999985544 3467788999999987643 234578999999999998864 456677
Q ss_pred hcccccceeecCCccccCCCCCCCccccccceeecccccccccCC-ccccCCcccceeccccccccCCCCcccccccccc
Q 001274 429 CMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLP-IEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLE 507 (1109)
Q Consensus 429 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 507 (1109)
..+.+|++|++..|.+.. .+..+..+++|+.+++..|+.....+ ..|.++.+++.++++.|.+.+..+..+..+++|+
T Consensus 394 ~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~ 472 (635)
T 4g8a_A 394 FGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 472 (635)
T ss_dssp HSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred hhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhh
Confidence 888999999999999875 45678889999999999988876654 5688999999999999999999999999999999
Q ss_pred EEEccCCcc-CCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceeccccc
Q 001274 508 RLHLSENYF-VGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDN 586 (1109)
Q Consensus 508 ~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 586 (1109)
.|+|++|++ .+..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 473 ~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N 552 (635)
T 4g8a_A 473 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 552 (635)
T ss_dssp EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTS
T ss_pred hhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCC
Confidence 999999985 4467889999999999999999999999999999999999999999999888889999999999999999
Q ss_pred ccccccCcccCCC-cccceeeccCcccccc
Q 001274 587 KLTGAIPSSLGGL-ARLTELQMGGNIFSGS 615 (1109)
Q Consensus 587 ~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~ 615 (1109)
+|++..|..|..+ ++|+.|+|++|++...
T Consensus 553 ~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 553 HIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred cCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 9999999999998 6899999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=440.95 Aligned_cols=262 Identities=26% Similarity=0.404 Sum_probs=212.0
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++|.+.++||+|+||+||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 46778899999999999999863 4788999999743 334567899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCC----------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 001274 876 LLLYEYMENGSLGEQLHGNK----------QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQA 945 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 945 (1109)
++|||||++|+|.++++..+ ....++|.++..|+.||++||+||| +++||||||||+|||++.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcE
Confidence 99999999999999997643 2235999999999999999999999 6799999999999999999999
Q ss_pred EEeeccccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHh
Q 001274 946 HVGDFGLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRS 1023 (1109)
Q Consensus 946 kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~ 1023 (1109)
||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+... .+.+...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~----~~~~~~i 243 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEVIECI 243 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH
Confidence 99999999866432222 2234568999999999999999999999999999999999 8999986432 2222222
Q ss_pred hhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1024 IHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
..+..+.. +......+.+++.+||+.||++||||+||.+.|+.+....+
T Consensus 244 ~~~~~~~~-------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 244 TQGRVLQR-------------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HHTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HcCCCCCC-------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 22221100 11122457899999999999999999999999988765543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=442.78 Aligned_cols=260 Identities=26% Similarity=0.389 Sum_probs=205.7
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
.+|.+.++||+|+||+||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35667789999999999999864 4789999999743 334567899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCC------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 001274 876 LLLYEYMENGSLGEQLHGNKQ------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF 943 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 943 (1109)
++|||||++|+|.++++.... ...++|.++..|+.||++||+||| +++||||||||+|||++.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCC
Confidence 999999999999999976532 134899999999999999999999 77999999999999999999
Q ss_pred ceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHH
Q 001274 944 QAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVR 1021 (1109)
Q Consensus 944 ~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~ 1021 (1109)
.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+... .+.+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~----~~~~~ 271 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN----TEAID 271 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH----HHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 999999999987643222 22345679999999999999999999999999999999999 8999986432 22222
Q ss_pred HhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1022 RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
....+..+.. +......+.+++.+||+.||++||||+||+++|+.+.+.
T Consensus 272 ~i~~g~~~~~-------------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CITQGRELER-------------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHTCCCCC-------------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCCCCC-------------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 2222111100 111224578999999999999999999999999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=439.82 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=208.4
Q ss_pred CCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++++.++||+|+||+||+|++. +++.||||+++... .....++|.+|+.++++++|||||+++|+|..++..+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4566789999999999999862 46889999997443 2344578999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 001274 877 LLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF 943 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 943 (1109)
+|||||++|+|.+++..... ...++|.++.+|+.|||+||+||| +++||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence 99999999999999965432 134899999999999999999999 77999999999999999999
Q ss_pred ceEEeeccccccccCCC-CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHH
Q 001274 944 QAHVGDFGLAKLIDLPY-SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVR 1021 (1109)
Q Consensus 944 ~~kl~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~ 1021 (1109)
.+||+|||+|+...... ........||++|||||++.++.|+.++|||||||++|||+| |+.||.+.. ..+.+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~----~~~~~~ 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----NQDVVE 258 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC----HHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC----HHHHHH
Confidence 99999999998764322 223355689999999999999999999999999999999999 899998643 222222
Q ss_pred HhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1022 RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
....+..+. .+..+...+.+++.+||+.||++||||+||+++|+.
T Consensus 259 ~i~~~~~~~-------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 259 MIRNRQVLP-------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHcCCCCC-------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 222221110 011223457899999999999999999999999964
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=447.25 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=209.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|++. +|+.||||++..........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999965 69999999998665555566789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||+||+|.+++...+.. .+++..++.++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGV-LFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999999999765432 3789999999999999999999 779999999999999999999999999999876421
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+. ...+.+........+.. .
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~i~~~~~~~~---~----- 246 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG----SMKNLVLKIISGSFPPV---S----- 246 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHTCCCCC---C-----
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHHHHcCCCCCC---C-----
Confidence 11224567999999999999999999999999999999999999999753 34444444444333211 0
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
......+.+++.+||+.||++|||++|++++-+.
T Consensus 247 -----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 280 (350)
T 4b9d_A 247 -----LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280 (350)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred -----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHh
Confidence 0112357799999999999999999999987543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=436.20 Aligned_cols=254 Identities=23% Similarity=0.380 Sum_probs=211.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
..|+..++||+|+||+||+|+++ +|+.||||++...... ..+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46888899999999999999975 6999999999765433 34668899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||+||+|.+++.... +++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 152 y~~gg~L~~~l~~~~----l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 223 (346)
T 4fih_A 152 FLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 223 (346)
T ss_dssp CCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred CCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC-
Confidence 999999999997532 899999999999999999999 779999999999999999999999999999876532
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. ..+.+........+..+..
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~~~~~~~~~------ 293 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIRDNLPPRLKNL------ 293 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSSCCCCSCG------
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHHcCCCCCCCcc------
Confidence 233456789999999999999999999999999999999999999997532 2233332222221111110
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
......+.+++.+||+.||++|||++|+++|-+..
T Consensus 294 -----~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~ 328 (346)
T 4fih_A 294 -----HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 328 (346)
T ss_dssp -----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred -----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence 11123577899999999999999999999986654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=435.08 Aligned_cols=257 Identities=26% Similarity=0.292 Sum_probs=210.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+.|+..++||+|+||+||+|+++ +|+.||||+++... ...+|+.++++++|||||++++++.+++..|+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46778889999999999999975 69999999997432 22479999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeeccccccccCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~ 959 (1109)
||+||+|.++++..+. +++..+..++.||+.||+||| +++||||||||+|||++.+| .+||+|||+|+.....
T Consensus 131 y~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred ccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999986543 999999999999999999999 88999999999999999998 6999999999876532
Q ss_pred CCC----CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 960 YSK----SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 960 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+............ ...+..+.
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~~~~-- 278 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EPPPIREI-- 278 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SCCGGGGS--
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CCCCchhc--
Confidence 211 12345799999999999999999999999999999999999999987654444333222 11111111
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
.......+.+++.+||+.||++|||+.|+++++..+.+....
T Consensus 279 ---------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 279 ---------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred ---------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 111224577899999999999999999999999998876543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=473.36 Aligned_cols=456 Identities=21% Similarity=0.224 Sum_probs=321.0
Q ss_pred ceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccc
Q 001274 123 EILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHN 202 (1109)
Q Consensus 123 ~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n 202 (1109)
++||+++|+++ .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|++++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46777777777 4666554 67777777777777666667777777777777777777666677777777777777777
Q ss_pred cccCCCCccccccccchhhhcccccccc-cCchhhhccccccceecccccccCCCCCCccccccc--cceeeeeccceec
Q 001274 203 SLSGPIPPEISECEGLEVLGLAQNSLEG-FLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSL--ELLALHENSFSGG 279 (1109)
Q Consensus 203 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l~~~ 279 (1109)
+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++ ..++.+++| ++|++++|.+.+
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~- 152 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG- 152 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT-
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc-
Confidence 766 34443 55555555555555554 245555555555555555555543 233344444 445555544400
Q ss_pred CchhhhccCccceEEeecccccCccCcccCCCC-cCcEEEccCCcccCCCc-ccccCCCCcceEeccccc-------ccC
Q 001274 280 LPKELGKLSRLKKLYVYTNELNGTIPHELGNCT-SAVEIDLSENQLTGFIP-RELGLIPNLCLLQLFENM-------LQG 350 (1109)
Q Consensus 280 ~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~-~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~L~~n~-------l~~ 350 (1109)
.+..|..+..+. +...+++++|++.+.++ ..+..+++|+.|++++|. +.+
T Consensus 153 ---------------------~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 211 (520)
T 2z7x_B 153 ---------------------EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211 (520)
T ss_dssp ---------------------SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHH
T ss_pred ---------------------cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeec
Confidence 444444444433 23344555555554333 244455666666666655 555
Q ss_pred cccccccCCCCccEEEcccCcccCCCCcchh---cccccceEEcccccccccCCCcc-----cccCcCcEEEeccccccC
Q 001274 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQ---NLTYLVDLQLFDNHLEGTIPPHI-----GVNSHLSVLDVSMNNLDG 422 (1109)
Q Consensus 351 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~-----~~~~~L~~L~Ls~N~l~~ 422 (1109)
.+| .+..+++|+.|++++|.+++..+..+. ..++|+.|++++|+++|.+|..+ +.+++|+.+++++|.+
T Consensus 212 ~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-- 288 (520)
T 2z7x_B 212 ILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-- 288 (520)
T ss_dssp HHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--
T ss_pred chh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--
Confidence 555 677777888888888777653322221 23578888888888888888877 7888888888888888
Q ss_pred ccc-hhhhcc---cccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccC--CC
Q 001274 423 SIP-PHLCMY---QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSG--LI 496 (1109)
Q Consensus 423 ~~~-~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~ 496 (1109)
.+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++..|..|.++++|++|+|++|++++ .+
T Consensus 289 ~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~ 366 (520)
T 2z7x_B 289 GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKI 366 (520)
T ss_dssp CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHH
T ss_pred ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccc
Confidence 344 555555 67889999998886542 22678889999999999998888889999999999999999986 44
Q ss_pred CccccccccccEEEccCCccCCCCCh-hhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccc
Q 001274 497 PPEIGKLRNLERLHLSENYFVGYIPS-EVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQL 575 (1109)
Q Consensus 497 p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 575 (1109)
|..+..+++|++|++++|++++.+|. .+..+++|++|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+
T Consensus 367 ~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l 443 (520)
T 2z7x_B 367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKL 443 (520)
T ss_dssp HHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGC
T ss_pred hHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcC
Confidence 56788899999999999999874554 488889999999999999888887765 78999999999998 788888899
Q ss_pred cccceecccccccccccCcccCCCcccceeeccCcccccccc
Q 001274 576 VNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 576 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 617 (1109)
++|+.|+|++|++++..+..|..+++|++|++++|++.+..+
T Consensus 444 ~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 444 EALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 999999999999995444458899999999999999887654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=486.21 Aligned_cols=377 Identities=19% Similarity=0.231 Sum_probs=252.2
Q ss_pred ccccccCchhhhccccccceecccccccC-----------------CCCCCcc--ccccccceeeeeccceecCchhhhc
Q 001274 226 NSLEGFLPSELEKLRNLTDLILWQNHLSG-----------------EIPPTIG--NIQSLELLALHENSFSGGLPKELGK 286 (1109)
Q Consensus 226 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-----------------~~p~~l~--~l~~L~~L~L~~N~l~~~~p~~l~~ 286 (1109)
|++++ +|..|+++++|++|+|++|++++ .+|..++ ++++|++|+|++|++.+.+|..|++
T Consensus 435 N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~ 513 (876)
T 4ecn_A 435 NRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513 (876)
T ss_dssp CEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGG
T ss_pred Ccccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhC
Confidence 55555 55555555555555555555554 2566655 6666666666666666666666666
Q ss_pred cCccceEEeeccc-ccC-ccCcccCCCC-------cCcEEEccCCcccCCCcc--cccCCCCcceEecccccccCccccc
Q 001274 287 LSRLKKLYVYTNE-LNG-TIPHELGNCT-------SAVEIDLSENQLTGFIPR--ELGLIPNLCLLQLFENMLQGSIPRE 355 (1109)
Q Consensus 287 l~~L~~L~l~~n~-l~~-~~~~~l~~l~-------~L~~L~Ls~n~l~~~~p~--~l~~l~~L~~L~L~~n~l~~~~p~~ 355 (1109)
+++|+.|++++|+ +++ .+|..+++++ +|++|+|++|+++ .+|. .++.+++|+.|+|++|.+. .+| .
T Consensus 514 L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~ 590 (876)
T 4ecn_A 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-A 590 (876)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-C
T ss_pred CCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-h
Confidence 6666666666665 555 5555444443 6666666666666 5555 5666666666666666666 555 5
Q ss_pred ccCCCCccEEEcccCcccCCCCcchhcccc-cceEEcccccccccCCCcccccCc--CcEEEeccccccCccchhh---h
Q 001274 356 LGQLTQLHKLDLSINNLTGTIPLEFQNLTY-LVDLQLFDNHLEGTIPPHIGVNSH--LSVLDVSMNNLDGSIPPHL---C 429 (1109)
Q Consensus 356 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~~~~--L~~L~Ls~N~l~~~~~~~l---~ 429 (1109)
|..+++|++|+|++|+++ .+|..+.++++ |+.|+|++|.++ .+|..+..++. |+.|+|++|++.+.+|... .
T Consensus 591 ~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~ 668 (876)
T 4ecn_A 591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668 (876)
T ss_dssp CCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTT
T ss_pred hcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhc
Confidence 666666666666666666 56666666666 666666666666 55555555433 6666666666665544322 1
Q ss_pred --cccccceeecCCccccCCCCCCCccccccceeecccccccccCCcccc-------CCcccceeccccccccCCCCccc
Q 001274 430 --MYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFY-------NLQNLSALELYQNRFSGLIPPEI 500 (1109)
Q Consensus 430 --~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~ 500 (1109)
.+.+|+.|+|++|+++...+..+..+++|+.|+|++|+++.+.+..|. ++++|++|+|++|+|+ .+|..+
T Consensus 669 ~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l 747 (876)
T 4ecn_A 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDF 747 (876)
T ss_dssp TCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGG
T ss_pred cccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHh
Confidence 223566666666666633222234566666666666666633333333 2237777777777777 456666
Q ss_pred c--ccccccEEEccCCccCCCCChhhcccccccEEeccc------CcccccCCcCCCCCCCCCeeecCCCcCccCCCccc
Q 001274 501 G--KLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISS------NSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEEL 572 (1109)
Q Consensus 501 ~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 572 (1109)
. .+++|+.|+|++|+|++ +|..+.++++|+.|+|++ |++.+.+|..|.++++|+.|+|++|+| +.+|..+
T Consensus 748 ~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l 825 (876)
T 4ecn_A 748 RATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL 825 (876)
T ss_dssp STTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC
T ss_pred hhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhh
Confidence 5 77777777777777776 577777777777777765 889999999999999999999999999 5888887
Q ss_pred ccccccceecccccccccccCcccCCCcccceeeccCcccc
Q 001274 573 GQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 573 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 613 (1109)
. ++|+.|+|++|++....+..+.....+..+.|.+|++.
T Consensus 826 ~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 826 T--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp C--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred c--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 6 69999999999999888888877777888888888765
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=427.76 Aligned_cols=250 Identities=27% Similarity=0.385 Sum_probs=202.6
Q ss_pred CCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe----CCceEEEE
Q 001274 805 SEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH----QDSNLLLY 879 (1109)
Q Consensus 805 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 879 (1109)
+..++||+|+||+||+|++. +++.||||++..........+.|.+|++++++++|||||++++++.. ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999875 68999999998665555566789999999999999999999999875 24578999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeCC-CCceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH--IIHRDIKSNNILLDE-EFQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~ 956 (1109)
|||++|+|.+++.+... +++..+..++.||+.||+||| +++ ||||||||+|||++. ++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999986543 899999999999999999999 556 999999999999974 799999999999864
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
. .......+||+.|||||++.+ +|+.++||||+||++|||+||+.||.+.. ......+.......+ . .+++
T Consensus 183 ~---~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~---~~~~~~~~i~~~~~~-~-~~~~ 253 (290)
T 3fpq_A 183 R---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVKP-A-SFDK 253 (290)
T ss_dssp C---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS---SHHHHHHHHTTTCCC-G-GGGG
T ss_pred C---CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC---cHHHHHHHHHcCCCC-C-CCCc
Confidence 3 223456789999999998865 69999999999999999999999997532 222333322222211 1 1111
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
. ....+.+++.+||+.||++|||++|+++|-+.
T Consensus 254 ~----------~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 254 V----------AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp C----------CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred c----------CCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1 11246789999999999999999999987543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=467.70 Aligned_cols=450 Identities=18% Similarity=0.197 Sum_probs=237.3
Q ss_pred EEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEccccc
Q 001274 76 SVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENY 155 (1109)
Q Consensus 76 ~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~ 155 (1109)
.+|+++++|+ .+|..+. ++|++|+|++|.+++..|..++++++|++|+|++|++++..|..+..+++|++|+|++|.
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 4666666666 3454444 666666666666666555666666666666666666666556666666666666666666
Q ss_pred ccccccccccCcCCCceEEeecCCCCC-CCCcccccccccceeccccccccCCCCccccccccc--hhhhcccccc--cc
Q 001274 156 IFGEIPEEIGNLTSLEELVIYSNNLTG-AIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGL--EVLGLAQNSL--EG 230 (1109)
Q Consensus 156 l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L--~~L~L~~n~l--~~ 230 (1109)
++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|.+++ ..+..+++| ++|++++|.+ .+
T Consensus 81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccc
Confidence 65 45544 56666666666666665 355666666666666666666654 234455555 6666666665 55
Q ss_pred cCchhhhccc-cccceecccccccCCCC-CCccccccccceeeeecc-------ceecCchhhhccCccceEEeeccccc
Q 001274 231 FLPSELEKLR-NLTDLILWQNHLSGEIP-PTIGNIQSLELLALHENS-------FSGGLPKELGKLSRLKKLYVYTNELN 301 (1109)
Q Consensus 231 ~~p~~l~~l~-~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~-------l~~~~p~~l~~l~~L~~L~l~~n~l~ 301 (1109)
..|..+..+. +...+++++|++.+.++ ..+.++++|+.|++++|. +.+.+| .++.+++|+.|++++|.++
T Consensus 155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~ 233 (520)
T 2z7x_B 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETT 233 (520)
T ss_dssp CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEE
T ss_pred cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccC
Confidence 5555555444 23344555555554433 234555555555555554 444443 4555555555555555444
Q ss_pred CccCcccC---CCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccc-----cCCCCccEEEcccCccc
Q 001274 302 GTIPHELG---NCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPREL-----GQLTQLHKLDLSINNLT 373 (1109)
Q Consensus 302 ~~~~~~l~---~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~ 373 (1109)
+..+..+. .+++|++|++++|++++ .+|..+ ..+++|+.+++++|.+
T Consensus 234 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~------------------------~~p~~~~~~~~~~l~~L~~l~l~~n~~- 288 (520)
T 2z7x_B 234 WNSFIRILQLVWHTTVWYFSISNVKLQG------------------------QLDFRDFDYSGTSLKALSIHQVVSDVF- 288 (520)
T ss_dssp HHHHHHHHHHHHTSSCSEEEEEEEEEES------------------------CCCCCCCCCCSCCCCEEEEEEEEECCC-
T ss_pred HHHHHHHHHHhhhCcccEEEeecccccC------------------------ccccchhhcccccCceeEeccccccce-
Confidence 32111100 01233333333333333 333333 3444444444444444
Q ss_pred CCCC-cchhcc---cccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCC
Q 001274 374 GTIP-LEFQNL---TYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIP 449 (1109)
Q Consensus 374 ~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 449 (1109)
.+| ..+..+ .+|+.|++++|.+ .... .+..+++|++|++++|++++.+|
T Consensus 289 -~~p~~~~~~~~~~~~L~~L~l~~n~l------------------------~~~~--~~~~l~~L~~L~Ls~n~l~~~~~ 341 (520)
T 2z7x_B 289 -GFPQSYIYEIFSNMNIKNFTVSGTRM------------------------VHML--CPSKISPFLHLDFSNNLLTDTVF 341 (520)
T ss_dssp -CSCTHHHHHHHHTCCCSEEEEESSCC------------------------CCCC--CCSSCCCCCEEECCSSCCCTTTT
T ss_pred -ecchhhhhcccccCceeEEEcCCCcc------------------------cccc--chhhCCcccEEEeECCccChhhh
Confidence 222 222222 2334444444333 2211 01234444444444444444444
Q ss_pred CCCccccccceeecccccccc--cCCccccCCcccceeccccccccCCCCc-cccccccccEEEccCCccCCCCChhhcc
Q 001274 450 PGLKTCRSLMQLMLGQNQLTG--SLPIEFYNLQNLSALELYQNRFSGLIPP-EIGKLRNLERLHLSENYFVGYIPSEVGN 526 (1109)
Q Consensus 450 ~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 526 (1109)
..+..+++|++|++++|++++ .+|..|.++++|++|+|++|++++.+|. .+..+++|++|++++|++++..|..+.
T Consensus 342 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~- 420 (520)
T 2z7x_B 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP- 420 (520)
T ss_dssp TTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-
T ss_pred hhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-
Confidence 445555555555555555554 2334555566666666666666552332 355566666666666666555444433
Q ss_pred cccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcc-cccccccceecccccccccc
Q 001274 527 LEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEE-LGQLVNLELLKLSDNKLTGA 591 (1109)
Q Consensus 527 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~ 591 (1109)
++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++ +|.. |..+++|+.|++++|++++.
T Consensus 421 -~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 421 -PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp -TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred -ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCccc
Confidence 45666666666666 555555566666666666666663 4433 66666666666666666543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=441.85 Aligned_cols=273 Identities=25% Similarity=0.387 Sum_probs=219.6
Q ss_pred CCHHHHHHHhcCCCCCceEecCCcceEEEEEecC------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCC-Cceee
Q 001274 792 FKYHNLLEATGNFSEGAVIGRGACGTVYKATLAN------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH-RNIVK 864 (1109)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~ 864 (1109)
+...+++...++|++.++||+|+||+||+|++.. ++.||||+++.. ......+.|.+|++++++++| ||||+
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 3334444456789999999999999999998642 367999999743 233445789999999999965 89999
Q ss_pred EEEEEEeC-CceEEEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 001274 865 LYGFCYHQ-DSNLLLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHR 930 (1109)
Q Consensus 865 l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 930 (1109)
++|+|... +..++|||||++|+|.++++.... ...+++.++..++.|||+||+||| +++||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecC
Confidence 99999765 567999999999999999975432 234899999999999999999999 7799999
Q ss_pred CCCCCceeeCCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 001274 931 DIKSNNILLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQ 1008 (1109)
Q Consensus 931 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~ 1008 (1109)
||||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987643322 22345679999999999999999999999999999999998 999998
Q ss_pred CcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1009 SLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
+......+...+....+...| ......+.+++.+||+.||++||||+||+++|..+.+..
T Consensus 290 ~~~~~~~~~~~i~~g~~~~~p----------------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 290 GVKIDEEFCRRLKEGTRMRAP----------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp TCCCSHHHHHHHHHTCCCCCC----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHHHHHcCCCCCCC----------------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 765444444444332221111 011235778999999999999999999999999987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=417.22 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=196.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|++. +|+.||||++...... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999965 6999999999754322 233567999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+ +|+|.+++...+. +++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp ECC-CEEHHHHHHHSCS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 999 6899999987654 999999999999999999999 77999999999999999999999999999986542
Q ss_pred CCCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.......+||+.|+|||++.+..| +.++||||+||++|||+||+.||.+. ......+.......+....
T Consensus 165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~----~~~~~~~~i~~~~~~~p~~----- 234 (275)
T 3hyh_A 165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----SIPVLFKNISNGVYTLPKF----- 234 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCCCCTT-----
T ss_pred -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHcCCCCCCCC-----
Confidence 233456789999999999998886 57999999999999999999999753 3333333333332221111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
....+.+++.+|++.||++|||++|++++-+..
T Consensus 235 ---------~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 235 ---------LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp ---------SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred ---------CCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 113467899999999999999999999987653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=427.87 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=209.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.++||+|+||+||+|++. +++.||||++..... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999965 799999999974321 1224567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
|||+||+|.+++.+.+. +++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~---l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999987553 999999999999999999999 779999999999999999999999999999976532
Q ss_pred C-CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 Y-SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+. +..+.............+.
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~i~~~~~~~p~~----- 256 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEGLIFAKIIKLEYDFPEK----- 256 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCCCCTT-----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCcc-----
Confidence 2 23345678999999999999999999999999999999999999999753 3333333333333221111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
....+.+++.+|++.||++|||++|+..+
T Consensus 257 ---------~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 257 ---------FFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ---------CCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ---------cCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 11346789999999999999999986443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=437.97 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=211.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+.|+..++||+|+||+||+|++. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 56889999999999999999975 699999999975543 345678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||+||+|.+++.... +++.++..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+.....
T Consensus 229 y~~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~- 300 (423)
T 4fie_A 229 FLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 300 (423)
T ss_dssp CCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-
T ss_pred CCCCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-
Confidence 999999999997543 899999999999999999999 779999999999999999999999999999876532
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. ..+.+........+.....
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~~~~~~~~~------ 370 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIRDNLPPRLKNL------ 370 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSCCCCCSCT------
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHHcCCCCCCccc------
Confidence 233456789999999999999999999999999999999999999997532 2233332222221111100
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
......+.+|+.+||+.||++|||++|+++|-+..
T Consensus 371 -----~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~ 405 (423)
T 4fie_A 371 -----HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 405 (423)
T ss_dssp -----TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred -----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence 01123577999999999999999999999986554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=425.19 Aligned_cols=252 Identities=25% Similarity=0.279 Sum_probs=202.9
Q ss_pred cCCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||+||+|+.. .++.||||+++...........+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999852 47899999997543333344578899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
|||||+||+|.+++.+.+. +++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999987553 999999999999999999999 7799999999999999999999999999998654
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
. ........+||+.|||||++.+..|+.++||||+||++|||+||+.||.+. +..+..........+..+.
T Consensus 178 ~-~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~i~~~~~~~p~~---- 248 (304)
T 3ubd_A 178 D-HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK----DRKETMTMILKAKLGMPQF---- 248 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCCCCCTT----
T ss_pred C-CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc----CHHHHHHHHHcCCCCCCCc----
Confidence 2 223345678999999999999999999999999999999999999999753 3333344333333222111
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMI 1078 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~ 1078 (1109)
....+.+++.+||+.||++||| ++|+++|-+
T Consensus 249 ----------~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 249 ----------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp ----------SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred ----------CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 1134678999999999999998 468887654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=424.20 Aligned_cols=268 Identities=25% Similarity=0.313 Sum_probs=202.1
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC----ceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD----SNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 877 (1109)
++|.+.++||+|+||+||+|++ +|+.||||+++.. ......+.+|+..+.+++|||||+++|+|.+++ ..++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4577788999999999999998 4899999999633 122233445666677889999999999998764 4689
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC-----RPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
|||||++|+|.++++... ++|..+.+++.|++.||+|||+++ .++||||||||+|||++.++.+||+|||+
T Consensus 79 V~Ey~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999998653 899999999999999999999542 34899999999999999999999999999
Q ss_pred cccccCCCCC---CccccccccceeccccccCC------CCCccchhHHHHHHHHHHHhCCCCCCCccc----------C
Q 001274 953 AKLIDLPYSK---SMSAIAGSYGYIAPEYAYTM------KVTEKCDIYSFGVVLLELITGKSPVQSLEL----------G 1013 (1109)
Q Consensus 953 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvll~elltg~~pf~~~~~----------~ 1013 (1109)
|+........ .....+||+.|||||++.+. .++.++|||||||++|||+||+.||..... .
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 9876532221 22345799999999998764 467899999999999999999877643221 1
Q ss_pred C-cHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1014 G-DLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1014 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
. .............. ++.+.. .....+....+.+++.+||+.||++||||+||+++|+++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~------rp~~p~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKL------RPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCCHHHHHHHHTTSCC------CCCCCG-GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cchHHHHHHHHhcccC------CCCCCc-cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 1 12222222211111 001100 1113345667889999999999999999999999999887653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=465.55 Aligned_cols=532 Identities=19% Similarity=0.161 Sum_probs=356.9
Q ss_pred cCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCC
Q 001274 128 CTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGP 207 (1109)
Q Consensus 128 s~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~ 207 (1109)
++-.++ .+|..+ .+++++|||++|.|++..|.+|+++++|++|+|++|+|++..|.+|++|++|++|+|++|+|++.
T Consensus 39 ~~~~l~-~vP~~l--p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l 115 (635)
T 4g8a_A 39 MELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 115 (635)
T ss_dssp TTSCCS-SCCSSS--CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred CCCCcC-ccCCCC--CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCC
Confidence 333454 566544 24678888888888766667788888888888888888766666777777788888877777765
Q ss_pred CCccccccccchhhhcccccccccCchhhhccccccceecccccccC-CCCCCccccccccceeeeeccceecCchhhhc
Q 001274 208 IPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSG-EIPPTIGNIQSLELLALHENSFSGGLPKELGK 286 (1109)
Q Consensus 208 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 286 (1109)
.+..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++ .+|..++.+++|++|+|++|++++..|..+..
T Consensus 116 ~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 195 (635)
T 4g8a_A 116 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 195 (635)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred CHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccc
Confidence 55667777777777777777776666667777777777777777764 34566666777777777777777666666665
Q ss_pred cCccc----eEEeecccccCccCcccCCCCcCcEEEccCCcccCC-CcccccCCCCcceEecccccccCcccccccCCCC
Q 001274 287 LSRLK----KLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGF-IPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQ 361 (1109)
Q Consensus 287 l~~L~----~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 361 (1109)
+.+++ .++++.|.++...+. ......+..+++++|..... .+..+..++.++...+..+....
T Consensus 196 L~~l~~~~~~~~ls~n~l~~i~~~-~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~----------- 263 (635)
T 4g8a_A 196 LHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN----------- 263 (635)
T ss_dssp HHTCTTCCCEEECTTCCCCEECTT-TTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTT-----------
T ss_pred hhhhhhhhhhhhcccCcccccCcc-cccchhhhhhhhhcccccccccchhhcCCccccccccccccccc-----------
Confidence 55443 455556665533332 22333445555555544321 12223333333333332221110
Q ss_pred ccEEEcccCcccCCCCcchhcccccceEEccccccc---ccCCCcccccCcCcEEEeccccccCccchhhhcccccceee
Q 001274 362 LHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLE---GTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLS 438 (1109)
Q Consensus 362 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 438 (1109)
...+.......+..+..+..+.+..+... ...+..+....+++.+++.+|.+.... .+.....|+.|+
T Consensus 264 -------~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~ 334 (635)
T 4g8a_A 264 -------EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLE 334 (635)
T ss_dssp -------SCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEE
T ss_pred -------ccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhh
Confidence 01112222333444444444444433322 123344555666777777777665432 344556677777
Q ss_pred cCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccC--CCCccccccccccEEEccCCcc
Q 001274 439 LGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSG--LIPPEIGKLRNLERLHLSENYF 516 (1109)
Q Consensus 439 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l 516 (1109)
+.+|.+.+..+. .+..|+.+++..|.+... ..+.++++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+
T Consensus 335 l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~ 409 (635)
T 4g8a_A 335 LVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGV 409 (635)
T ss_dssp EESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSE
T ss_pred cccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccc
Confidence 777777654433 345666777777776543 234567778888888877743 3455566677788888888877
Q ss_pred CCCCChhhcccccccEEecccCcccccCC-cCCCCCCCCCeeecCCCcCccCCCcccccccccceeccccccc-ccccCc
Q 001274 517 VGYIPSEVGNLEHLVTFNISSNSLSGTIP-HELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL-TGAIPS 594 (1109)
Q Consensus 517 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~~~p~ 594 (1109)
.. .+..+..+++|+.+++++|+.....+ ..+..+++++.+++++|.+++..+..+..+++|+.|+|++|++ .+..|.
T Consensus 410 ~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~ 488 (635)
T 4g8a_A 410 IT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 488 (635)
T ss_dssp EE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECS
T ss_pred cc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCch
Confidence 64 45567777888888888777665443 4567788888888888888877777888888888888888874 445777
Q ss_pred ccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhcc-c
Q 001274 595 SLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQ-M 673 (1109)
Q Consensus 595 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~ 673 (1109)
.|..+++|++|+|++|++++.+|..|.+++.|+ .|+|++|+|++..|..|+++++|++|||++|+|++.+|..+..+ .
T Consensus 489 ~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~-~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 567 (635)
T 4g8a_A 489 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 567 (635)
T ss_dssp CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC-EEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCT
T ss_pred hhhhccccCEEECCCCccCCcChHHHcCCCCCC-EEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhC
Confidence 888888888888888888888888888888886 48888999998888899999999999999999999999999988 6
Q ss_pred cceEEEccCcccccccC
Q 001274 674 SLLVCNLSNNNLVGTVP 690 (1109)
Q Consensus 674 ~L~~l~ls~N~l~g~~p 690 (1109)
+|++|+|++|+++|...
T Consensus 568 ~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 568 SLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TCCEEECTTCCBCCSGG
T ss_pred cCCEEEeeCCCCcccCC
Confidence 89999999999998775
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=412.71 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=192.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-------
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD------- 873 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 873 (1109)
++|++.+.||+|+||+||+|+++ +|+.||||+++... .....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35888999999999999999975 79999999997543 2334567899999999999999999999987654
Q ss_pred -----ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 001274 874 -----SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVG 948 (1109)
Q Consensus 874 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 948 (1109)
..|+|||||++|+|.+++.........++..++.++.||++||+||| +++||||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence 35899999999999999987665444667778899999999999999 7799999999999999999999999
Q ss_pred eccccccccCCCCC-----------CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHH
Q 001274 949 DFGLAKLIDLPYSK-----------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLV 1017 (1109)
Q Consensus 949 DFG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~ 1017 (1109)
|||+|+........ .....+||+.|||||++.+..|+.++||||+||++|||++ ||.+.. +..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~~~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---ERV 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---HHH
Confidence 99999876532211 1234579999999999999999999999999999999996 775321 111
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
..+........ .+. .........+++.+||+.||++|||+.|++++-+
T Consensus 235 ~~~~~~~~~~~--p~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 235 RTLTDVRNLKF--PPL-----------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp HHHHHHHTTCC--CHH-----------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHhcCCC--CCC-----------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 11111111111 111 1112234567999999999999999999998643
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=448.01 Aligned_cols=459 Identities=20% Similarity=0.171 Sum_probs=277.3
Q ss_pred ceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecC
Q 001274 99 VEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSN 178 (1109)
Q Consensus 99 ~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 178 (1109)
+++++++|++++ +|..+. ++|++|+|++|.+++..|..+..+++|++|+|++|.+++..|+.|+++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 556666666663 554443 55555555555555544445555555555555555555444555555555555555555
Q ss_pred CCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCC
Q 001274 179 NLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPP 258 (1109)
Q Consensus 179 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 258 (1109)
+++ .+|.. .+++|++|++++|++++. .+|..|+++++|++|+|++|++++ .
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l-----------------------~~p~~~~~l~~L~~L~L~~n~l~~---~ 161 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVL-----------------------PVCKEFGNLTKLTFLGLSAAKFRQ---L 161 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBC-----------------------CCCGGGGGCTTCCEEEEECSBCCT---T
T ss_pred cCC-ccCcc--ccccCCEEECCCCCcccc-----------------------CchHhhcccCcccEEecCCCcccc---C
Confidence 554 34433 444444444444444431 223455555555555555555543 1
Q ss_pred Cccccccc--cceeeeeccc--eecCchhhhccC-ccceEEeecccccCccCc-ccCCCCcCcEEEccCCcccCCCcccc
Q 001274 259 TIGNIQSL--ELLALHENSF--SGGLPKELGKLS-RLKKLYVYTNELNGTIPH-ELGNCTSAVEIDLSENQLTGFIPREL 332 (1109)
Q Consensus 259 ~l~~l~~L--~~L~L~~N~l--~~~~p~~l~~l~-~L~~L~l~~n~l~~~~~~-~l~~l~~L~~L~Ls~n~l~~~~p~~l 332 (1109)
.+..+++| ++|++++|.+ ++..|..+..+. ..-.++++.|.+.+.++. .+.++++|+.|++++|+..-.
T Consensus 162 ~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~----- 236 (562)
T 3a79_B 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ----- 236 (562)
T ss_dssp TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH-----
T ss_pred chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccc-----
Confidence 23333333 5555555555 445555444433 111334455555443332 344455555555555531100
Q ss_pred cCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCC----CcchhcccccceEEcccccccccCCCcc----
Q 001274 333 GLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTI----PLEFQNLTYLVDLQLFDNHLEGTIPPHI---- 404 (1109)
Q Consensus 333 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~---- 404 (1109)
.+. .....+..+++|+.|+++++.+++.. +.. ...++|++|++++|.++|.+|..+
T Consensus 237 --------------~l~-~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~ 300 (562)
T 3a79_B 237 --------------RLM-TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF-FWPRPVEYLNIYNLTITERIDREEFTYS 300 (562)
T ss_dssp --------------HHH-HHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHH-HTTSSEEEEEEEEEEECSCCCCCCCCCC
T ss_pred --------------hHH-HHHHHHhccCcceEEEecCCcCcHHHHHHHHHh-hhcccccEEEEeccEeeccccchhhhcc
Confidence 000 01122344445555555544443211 111 112366666666666666666655
Q ss_pred -cccCcCcEEEeccccccCccc-hhhhcc---cccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCC
Q 001274 405 -GVNSHLSVLDVSMNNLDGSIP-PHLCMY---QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNL 479 (1109)
Q Consensus 405 -~~~~~L~~L~Ls~N~l~~~~~-~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 479 (1109)
..+..|+.++++.|.+ .+| ..+..+ .+|+.|++++|.+.... ....+++|++|++++|++++..|..|.++
T Consensus 301 ~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 376 (562)
T 3a79_B 301 ETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTL 376 (562)
T ss_dssp SCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSC
T ss_pred cccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhccc
Confidence 5556666666666665 233 333322 56788888888775332 12577888888888888888888888888
Q ss_pred cccceeccccccccCCC--CccccccccccEEEccCCccCCCCC-hhhcccccccEEecccCcccccCCcCCCCCCCCCe
Q 001274 480 QNLSALELYQNRFSGLI--PPEIGKLRNLERLHLSENYFVGYIP-SEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQR 556 (1109)
Q Consensus 480 ~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 556 (1109)
++|++|+|++|+++++. |..|..+++|++|++++|++++.+| ..+..+++|++|+|++|++++.+|..+. ++|++
T Consensus 377 ~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~ 454 (562)
T 3a79_B 377 KRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKV 454 (562)
T ss_dssp SSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSE
T ss_pred CCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCE
Confidence 88888888888888643 4568888889999999998887444 4578888999999999999877777665 68999
Q ss_pred eecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccccccc
Q 001274 557 LDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 557 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 617 (1109)
|+|++|+|+ .+|..+..+++|+.|+|++|++++..+..|..+++|+.|++++|++.+..|
T Consensus 455 L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 455 LDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp EECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred EECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 999999998 677777789999999999999985444448889999999999999887655
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=447.03 Aligned_cols=460 Identities=18% Similarity=0.224 Sum_probs=323.5
Q ss_pred EEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEccc
Q 001274 74 VTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCE 153 (1109)
Q Consensus 74 v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~ 153 (1109)
...+|++++++++ +|..+. ++|+.|+|++|.+++..|..++++++|++|+|++|++++..|..+..+++|++|+|++
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 3779999999996 666554 8999999999999998889999999999999999999998899999999999999999
Q ss_pred ccccccccccccCcCCCceEEeecCCCCC-CCCcccccccccceeccccccccCCCCccccccccc--hhhhcccccc--
Q 001274 154 NYIFGEIPEEIGNLTSLEELVIYSNNLTG-AIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGL--EVLGLAQNSL-- 228 (1109)
Q Consensus 154 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L--~~L~L~~n~l-- 228 (1109)
|.++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|.+++. .+..+++| ++|++++|.+
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 9998 67777 89999999999999996 4578999999999999999999853 35555555 8888888888
Q ss_pred cccCchhhhccc-cccceecccccccCCCCC-Cccccccccceeeeecc-----ceecCchhhhccCccceEEeeccccc
Q 001274 229 EGFLPSELEKLR-NLTDLILWQNHLSGEIPP-TIGNIQSLELLALHENS-----FSGGLPKELGKLSRLKKLYVYTNELN 301 (1109)
Q Consensus 229 ~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~-----l~~~~p~~l~~l~~L~~L~l~~n~l~ 301 (1109)
++..|..+..+. ...++++++|.+.+.++. .+..+++|+.|++++|+ +.+ .+..+..+++|+.|++.++.++
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEEC
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCc
Confidence 777787777654 122557778877765543 45667788888888774 222 2234566666666666655544
Q ss_pred CccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccc-----cCCCCccEEEcccCcccCCC
Q 001274 302 GTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPREL-----GQLTQLHKLDLSINNLTGTI 376 (1109)
Q Consensus 302 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~ 376 (1109)
+ |.+.+..+ .+ ..++|+.|++++|.+.+.+|..+ ..++.|+.++++.|.+ .+
T Consensus 263 ~-------------------~~~~~~~~-~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~ 319 (562)
T 3a79_B 263 W-------------------KCSVKLFQ-FF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LF 319 (562)
T ss_dssp H-------------------HHHHHHHH-HH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SS
T ss_pred H-------------------HHHHHHHH-hh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ec
Confidence 2 11111111 11 11244444444444444444444 4555555556655555 23
Q ss_pred C-cchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccc
Q 001274 377 P-LEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTC 455 (1109)
Q Consensus 377 p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 455 (1109)
| ..+..+ ....+|++|++++|.+.... ....+++|++|++++|++++.+|..+..+
T Consensus 320 p~~~~~~~---------------------~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 376 (562)
T 3a79_B 320 SKEALYSV---------------------FAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTL 376 (562)
T ss_dssp CHHHHHHH---------------------HHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSC
T ss_pred Chhhhhhh---------------------hccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhccc
Confidence 3 222221 00123444555555443221 11345566666666666666666666677
Q ss_pred cccceeecccccccccC--CccccCCcccceeccccccccC-CCCccccccccccEEEccCCccCCCCChhhcccccccE
Q 001274 456 RSLMQLMLGQNQLTGSL--PIEFYNLQNLSALELYQNRFSG-LIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVT 532 (1109)
Q Consensus 456 ~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 532 (1109)
++|++|++++|++++.. |..|.++++|++|+|++|++++ +.+..+..+++|++|++++|++++.+|..+. ++|++
T Consensus 377 ~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~ 454 (562)
T 3a79_B 377 KRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKV 454 (562)
T ss_dssp SSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSE
T ss_pred CCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCE
Confidence 77777777777776532 4567778888888888888877 4344577788888888888888766555443 67888
Q ss_pred EecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcc-cccccccceecccccccccccC
Q 001274 533 FNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEE-LGQLVNLELLKLSDNKLTGAIP 593 (1109)
Q Consensus 533 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p 593 (1109)
|+|++|+|+ .+|..+..+++|++|+|++|+|++ +|.. |..+++|+.|+|++|++.+..+
T Consensus 455 L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 455 LDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp EECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred EECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 888888888 677777788888888888888884 5554 8888888888888888876433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=410.84 Aligned_cols=269 Identities=22% Similarity=0.307 Sum_probs=208.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC------Cc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ------DS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 874 (1109)
++|++.++||+|+||+||+|++. +|+.||||+++.........+.+.+|+++|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 799999999976555555567789999999999999999999997643 56
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.|+|||||+ |+|.+++...+. +++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~---l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQP---LTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 799999995 689999976543 999999999999999999999 7799999999999999999999999999998
Q ss_pred cccCC---CCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCC-
Q 001274 955 LIDLP---YSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP- 1029 (1109)
Q Consensus 955 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 1029 (1109)
.+... ........+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.. ..+.+.........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~----~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN----YVHQLQLIMMVLGTP 282 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS----HHHHHHHHHHHHCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC----HHHHHHHHHHhcCCC
Confidence 76422 12234567899999999998875 46999999999999999999999998543 22222222211111
Q ss_pred Cchhhhh-----------hcchhhccc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1030 TSELFDK-----------RLDLSAKRT-----VEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1030 ~~~~~~~-----------~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
....... ......... ......+.+++.+||..||++|||++|+++|-+...
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 1111000 000000000 011245779999999999999999999999876543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=402.31 Aligned_cols=295 Identities=31% Similarity=0.491 Sum_probs=257.7
Q ss_pred CCCchhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCc--cceeeecC----CeEEEEeccCccccc--cccccccCcccc
Q 001274 27 VTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCN--WIGVECTD----FKVTSVDLHGLNLSG--ILSPRICDLPRL 98 (1109)
Q Consensus 27 ~~~~~~~~~all~~k~~~~~~~~~~~~W~~~~~~~c~--w~gv~C~~----~~v~~l~l~~~~l~g--~~~~~~~~l~~L 98 (1109)
+.|.++|++||++||+++.||. .+++|+.+ .+||. |.||+|+. ++|+.++|+++++.| .+|+.++++++|
T Consensus 1 ~~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 1 ELCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CCSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCCHHHHHHHHHHHHhcCCcc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 3688999999999999999987 79999865 48998 99999985 689999999999999 899999999999
Q ss_pred ceeecc-cCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeec
Q 001274 99 VEFNIS-MNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYS 177 (1109)
Q Consensus 99 ~~L~ls-~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 177 (1109)
++|+|+ +|.+++.+|..++++++|++|+|++|.+++.+|..+..+++|++|+|++|.+++.+|..++++++|++|+|++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 999999 4999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccc-ccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCC
Q 001274 178 NNLTGAIPASISKLR-QLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEI 256 (1109)
Q Consensus 178 n~l~~~~p~~~~~l~-~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 256 (1109)
|++++.+|..+++++ +|++|++++|.+++.+|..++.+. |++|+|++|.+++..|..|..+++|++|+|++|++++.+
T Consensus 159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (313)
T 1ogq_A 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence 999989999999988 899999999999888888888887 888888888888888888888888888888888888655
Q ss_pred CCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCc-ccC
Q 001274 257 PPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQ-LTG 326 (1109)
Q Consensus 257 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~-l~~ 326 (1109)
|. +..+++|++|+|++|++++.+|..++.+++|++|++++|++++.+|.. ..+++|+.|++++|+ +.|
T Consensus 238 ~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 238 GK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp GG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred Cc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 54 777788888888888888788888888888888888888887777765 677777777777776 443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=410.51 Aligned_cols=426 Identities=26% Similarity=0.304 Sum_probs=222.3
Q ss_pred cccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccc
Q 001274 161 PEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLR 240 (1109)
Q Consensus 161 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 240 (1109)
|+.+ ..++|++|++++|++ |.+|.+|+++++|++|++++|.++|.+|.+++++.+|+.+++..|.. .
T Consensus 5 p~~~-~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~ 71 (454)
T 1jl5_A 5 PRNV-SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------R 71 (454)
T ss_dssp -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------H
T ss_pred cccc-ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------c
Confidence 3444 468999999999999 79999999999999999999999999999999999999999987753 5
Q ss_pred cccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEcc
Q 001274 241 NLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLS 320 (1109)
Q Consensus 241 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 320 (1109)
++++|++++|++++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|++++ ++.. .++|++|+++
T Consensus 72 ~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~ 139 (454)
T 1jl5_A 72 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS 139 (454)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred CCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECc
Confidence 68899999999984 4442 3578888888888886 5543 3677777777777764 2221 1567777777
Q ss_pred CCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccC
Q 001274 321 ENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTI 400 (1109)
Q Consensus 321 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 400 (1109)
+|++++ +| .++.+++|+.|++++|.+++ +|..+ .+|++|++++|++++ +| .+.++++|+.|++++|++++ +
T Consensus 140 ~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l 210 (454)
T 1jl5_A 140 NNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-L 210 (454)
T ss_dssp SSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-C
T ss_pred CCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-C
Confidence 777765 44 36666666666666666654 33322 355666666666554 33 35555555555555555553 2
Q ss_pred CCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCc
Q 001274 401 PPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQ 480 (1109)
Q Consensus 401 p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 480 (1109)
|... + +|++|++++|+++ .+| .+..+++|++|++++|++++ +|.. ++
T Consensus 211 ~~~~---~------------------------~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~ 257 (454)
T 1jl5_A 211 PDLP---L------------------------SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PP 257 (454)
T ss_dssp CCCC---T------------------------TCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CT
T ss_pred CCCc---C------------------------cccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---cc
Confidence 2211 2 4445555555554 233 24555555555555555553 2221 25
Q ss_pred ccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecC
Q 001274 481 NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLS 560 (1109)
Q Consensus 481 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 560 (1109)
+|++|++++|++++ +|.. .++|++|++++|++++. |.. .++|++|++++|++++ ++.. .++|++|+++
T Consensus 258 ~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls 325 (454)
T 1jl5_A 258 SLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVS 325 (454)
T ss_dssp TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECC
T ss_pred ccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECC
Confidence 66666666666665 2332 25677777777776652 111 1467777777777764 2221 1467777787
Q ss_pred CCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccc--cccccccccchhhhhhccCCcccc
Q 001274 561 RNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG--SIPVALGQLTALQIALNISHNNLS 638 (1109)
Q Consensus 561 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~l~~~L~Ls~N~l~ 638 (1109)
+|++++ +|.. +++|+.|++++|++++ +|. .+++|++|++++|++++ .+|.++++ |+.|++.
T Consensus 326 ~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~---------L~~n~~~ 388 (454)
T 1jl5_A 326 NNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED---------LRMNSHL 388 (454)
T ss_dssp SSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE---------EECCC--
T ss_pred CCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh---------hhhcccc
Confidence 777775 5543 4677788888888774 454 36778888888888887 67776643 3457777
Q ss_pred ccccccccCccccceeecCCCcccc--CCchhhhccccceEEEccCcccccccCC
Q 001274 639 GVIPYELGNLQMLEALYLDDNQLIG--EIPASMGEQMSLLVCNLSNNNLVGTVPN 691 (1109)
Q Consensus 639 ~~~p~~~~~l~~L~~L~Ls~N~l~~--~ip~~~~~l~~L~~l~ls~N~l~g~~p~ 691 (1109)
|.+|.. +++|+.||+++|+++| .+|.++ +.+.+++|.+.+.+|.
T Consensus 389 ~~i~~~---~~~L~~L~ls~N~l~~~~~iP~sl------~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 389 AEVPEL---PQNLKQLHVETNPLREFPDIPESV------EDLRMNSERVVDPYEF 434 (454)
T ss_dssp -------------------------------------------------------
T ss_pred cccccc---cCcCCEEECCCCcCCccccchhhH------hheeCcCcccCCcccc
Confidence 777763 5789999999999987 777654 4566788888887764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=410.09 Aligned_cols=426 Identities=26% Similarity=0.274 Sum_probs=250.0
Q ss_pred ccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhh
Q 001274 142 FINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVL 221 (1109)
Q Consensus 142 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L 221 (1109)
..+.|++|++++|.+ |.+|++|+++++|++|++++|+++|.+|.+++++++|+.+++..|.. .++++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 458899999999999 89999999999999999999999999999999999999999887753 568899
Q ss_pred hcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeeccccc
Q 001274 222 GLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELN 301 (1109)
Q Consensus 222 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 301 (1109)
++++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|+++
T Consensus 77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 77 ELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLE 144 (454)
T ss_dssp ECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCS
T ss_pred EecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCC
Confidence 999999986 3432 3789999999999996 7754 3789999999999985 3322 269999999999999
Q ss_pred CccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchh
Q 001274 302 GTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQ 381 (1109)
Q Consensus 302 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 381 (1109)
+ +| .++++++|++|++++|++++ +|.. +++|+.|++++|.+++ +| .+..+++|++|++++|++++ +|...
T Consensus 145 ~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~- 214 (454)
T 1jl5_A 145 K-LP-ELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP- 214 (454)
T ss_dssp S-CC-CCTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC-
T ss_pred C-Cc-ccCCCCCCCEEECCCCcCcc-cCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc-
Confidence 6 77 69999999999999999996 5543 3699999999999997 55 69999999999999999996 45433
Q ss_pred cccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCcccccccee
Q 001274 382 NLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQL 461 (1109)
Q Consensus 382 ~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 461 (1109)
++|+.|++++|.++ .+|. ++.+++|++|++++|++++. |. .+++|+.|++++|++++ +|.. .++|++|
T Consensus 215 --~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~l-~~---~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L 282 (454)
T 1jl5_A 215 --LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKTL-PD---LPPSLEALNVRDNYLTD-LPEL---PQSLTFL 282 (454)
T ss_dssp --TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSSC-CS---CCTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred --CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCcc-cc---cccccCEEECCCCcccc-cCcc---cCcCCEE
Confidence 58999999999998 6674 88899999999999998863 33 23667777777777765 3322 2455666
Q ss_pred ecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCccc
Q 001274 462 MLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLS 541 (1109)
Q Consensus 462 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 541 (1109)
++++|++++... . .++|++|++++|+++++ + .+ .++|++|++++|+++
T Consensus 283 ~ls~N~l~~l~~-~---~~~L~~L~l~~N~l~~i-~----~~-----------------------~~~L~~L~Ls~N~l~ 330 (454)
T 1jl5_A 283 DVSENIFSGLSE-L---PPNLYYLNASSNEIRSL-C----DL-----------------------PPSLEELNVSNNKLI 330 (454)
T ss_dssp ECCSSCCSEESC-C---CTTCCEEECCSSCCSEE-C----CC-----------------------CTTCCEEECCSSCCS
T ss_pred ECcCCccCcccC-c---CCcCCEEECcCCcCCcc-c----CC-----------------------cCcCCEEECCCCccc
Confidence 666666554211 0 13445555555554432 1 11 124455555555554
Q ss_pred ccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceeccccccccc--ccCcccCCCcccceeeccCcccccccccc
Q 001274 542 GTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTG--AIPSSLGGLARLTELQMGGNIFSGSIPVA 619 (1109)
Q Consensus 542 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 619 (1109)
+ +|.. +++|++|++++|+++ .+|. .+++|++|++++|++++ .+|.++.. ++.|.+.|.+|..
T Consensus 331 ~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~ 394 (454)
T 1jl5_A 331 E-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL 394 (454)
T ss_dssp C-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------
T ss_pred c-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc
Confidence 3 3332 244555555555555 2333 24555555555555554 34443332 2234455555553
Q ss_pred ccccchhhhhhccCCccccc--cccccccCccccceeecCCCccccCCchhhhc
Q 001274 620 LGQLTALQIALNISHNNLSG--VIPYELGNLQMLEALYLDDNQLIGEIPASMGE 671 (1109)
Q Consensus 620 ~~~l~~l~~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~ 671 (1109)
+ +.|+ .|++++|.+++ .+|. +|+.|.+.+|.+.+.+|.+...
T Consensus 395 ~---~~L~-~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~~~~~~~~~~~ 438 (454)
T 1jl5_A 395 P---QNLK-QLHVETNPLREFPDIPE------SVEDLRMNSERVVDPYEFAHET 438 (454)
T ss_dssp ------------------------------------------------------
T ss_pred c---CcCC-EEECCCCcCCccccchh------hHhheeCcCcccCCccccCHHH
Confidence 2 2333 35666666665 4553 3556667777777776655443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=399.87 Aligned_cols=198 Identities=26% Similarity=0.360 Sum_probs=169.9
Q ss_pred HhcCCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCc
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 874 (1109)
..++|++.++||+|+||+||+|+++ .++.||||++... .....+.+|+++++.+ +|||||++++++.+.++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 3578999999999999999999853 4678999998633 2345688999999988 69999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEeecccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLA 953 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a 953 (1109)
.|+||||+++|+|.+++.. +++.+++.++.||+.||+||| +++||||||||+|||++.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 9999999999999999842 889999999999999999999 7799999999999999876 79999999999
Q ss_pred ccccCCCC---------------------------CCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCC
Q 001274 954 KLIDLPYS---------------------------KSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKS 1005 (1109)
Q Consensus 954 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~ 1005 (1109)
+....... ......+||+.|+|||++.+.+ |+.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86532211 1123457999999999998764 8999999999999999999999
Q ss_pred CCCCc
Q 001274 1006 PVQSL 1010 (1109)
Q Consensus 1006 pf~~~ 1010 (1109)
||...
T Consensus 246 Pf~~~ 250 (361)
T 4f9c_A 246 PFYKA 250 (361)
T ss_dssp SSSCC
T ss_pred CCCCC
Confidence 99653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=411.53 Aligned_cols=254 Identities=24% Similarity=0.264 Sum_probs=205.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC----CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG----EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.++||+|+||+||+|+.+ +|+.||||++.... ...........++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57899999999999999999975 69999999996432 11111223334567788889999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+|||||+||+|.+++...+. +++..++.++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+..
T Consensus 269 lVmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999987553 999999999999999999999 889999999999999999999999999999876
Q ss_pred cCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.. ......+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.+.... +.....+............
T Consensus 343 ~~---~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-~~~~i~~~i~~~~~~~p~~-- 416 (689)
T 3v5w_A 343 SK---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTLTMAVELPDS-- 416 (689)
T ss_dssp SS---CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-CHHHHHHHHHHCCCCCCTT--
T ss_pred CC---CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhcCCCCCCCcc--
Confidence 52 23355789999999999974 57999999999999999999999999864422 2333333333322211111
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMID 1079 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~~ 1079 (1109)
....+.+++.+|++.||++|++ ++||++|-+.
T Consensus 417 ------------~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 417 ------------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp ------------SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred ------------CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 1134679999999999999998 7999988654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=403.27 Aligned_cols=363 Identities=20% Similarity=0.237 Sum_probs=238.5
Q ss_pred cccceecccccccCCCCCCccccccccceeeeeccceecC-chhhhccCccceEEeecccccCccCcccCCCCcCcEEEc
Q 001274 241 NLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGL-PKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDL 319 (1109)
Q Consensus 241 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 319 (1109)
+|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|++++|.+++..|..+.++++|++|+|
T Consensus 31 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 110 (455)
T 3v47_A 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTL 110 (455)
T ss_dssp TCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEEC
T ss_pred ccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeC
Confidence 3444444444444434444444444444444444443222 333444444444444444444444444444555555555
Q ss_pred cCCcccCCCccc--ccCCCCcceEecccccccCccccc-ccCCCCccEEEcccCcccCCCCcchhcc--cccceEEcccc
Q 001274 320 SENQLTGFIPRE--LGLIPNLCLLQLFENMLQGSIPRE-LGQLTQLHKLDLSINNLTGTIPLEFQNL--TYLVDLQLFDN 394 (1109)
Q Consensus 320 s~n~l~~~~p~~--l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~N 394 (1109)
++|++++.++.. ++.+++|+.|++++|.+.+..|.. +..+++|++|++++|++++..+..+..+ .+|+.|++++|
T Consensus 111 ~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n 190 (455)
T 3v47_A 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI 190 (455)
T ss_dssp TTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTC
T ss_pred CCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccC
Confidence 555554433222 444555555555555555444443 5556666666666666666656555555 55666666666
Q ss_pred cccccCCCc--------ccccCcCcEEEeccccccCccchhhhcc---cccceeecCCccccCCCCCCCccccccceeec
Q 001274 395 HLEGTIPPH--------IGVNSHLSVLDVSMNNLDGSIPPHLCMY---QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLML 463 (1109)
Q Consensus 395 ~l~~~~p~~--------~~~~~~L~~L~Ls~N~l~~~~~~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 463 (1109)
.+.+..+.. +..+++|++|++++|++.+..|..+... .+|+.|++++|.+.+.. +
T Consensus 191 ~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~ 256 (455)
T 3v47_A 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------F 256 (455)
T ss_dssp BCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------T
T ss_pred cccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------c
Confidence 666544433 2355778888888888887777777655 77888888888765431 1
Q ss_pred ccccccccCCccccCC--cccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCccc
Q 001274 464 GQNQLTGSLPIEFYNL--QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLS 541 (1109)
Q Consensus 464 ~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 541 (1109)
..+.+....+..|.++ ++|++|++++|.+++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 336 (455)
T 3v47_A 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG 336 (455)
T ss_dssp TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccC
Confidence 2233333333444433 57888888888888888888888888888888888888877888888888888888888888
Q ss_pred ccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccccccc
Q 001274 542 GTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 542 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 617 (1109)
+..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..|
T Consensus 337 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 337 SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp EECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 7778888888888888888888887778888888888888888888887777778888888888888888887776
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=413.08 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=210.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+.+..|+|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 69999999997432 3345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC--CceEEeeccccccccC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE--FQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFG~a~~~~~ 958 (1109)
||+||+|.+++..... .+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 235 ~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 235 FMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred ecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999999975443 3899999999999999999999 7799999999999999854 8999999999997752
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. ..+...................
T Consensus 310 --~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~- 382 (573)
T 3uto_A 310 --KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDETLRNVKSCDWNMDDSAFSG- 382 (573)
T ss_dssp --TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHTTCCCCCSGGGTT-
T ss_pred --CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHHhCCCCCCcccccC-
Confidence 233456789999999999999999999999999999999999999997532 3333333333222211111111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
....+.+|+.+||+.||++|||+.|+++|-+
T Consensus 383 ---------~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 383 ---------ISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp ---------SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred ---------CCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 1234678999999999999999999998754
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=401.66 Aligned_cols=386 Identities=19% Similarity=0.228 Sum_probs=267.7
Q ss_pred ceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcc-cccccCCCCccEEEccc
Q 001274 291 KKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSI-PRELGQLTQLHKLDLSI 369 (1109)
Q Consensus 291 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~Ls~ 369 (1109)
+.++.+++.++ .+|. +. ++|++|||++|.+++..|..++.+++|++|++++|.+.+.+ +..|..+++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 35666777766 4454 22 67788888888887777777777777777777777776444 45677777777777777
Q ss_pred CcccCCCCcchhcccccceEEcccccccccCCCc--ccccCcCcEEEeccccccCccchh-hhcccccceeecCCccccC
Q 001274 370 NNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPH--IGVNSHLSVLDVSMNNLDGSIPPH-LCMYQKLIFLSLGSNRLSG 446 (1109)
Q Consensus 370 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~~~~L~~L~Ls~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~ 446 (1109)
|++++..|..|.++++|++|+|++|.+++..+.. +..+++|++|+|++|++.+..|.. +.++++|++|++++|++++
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 7777666777777777777777777776644333 666777777777777777665654 6667777777777777776
Q ss_pred CCCCCCccc--cccceeecccccccccCCccc--------cCCcccceeccccccccCCCCcccccc---ccccEEEccC
Q 001274 447 NIPPGLKTC--RSLMQLMLGQNQLTGSLPIEF--------YNLQNLSALELYQNRFSGLIPPEIGKL---RNLERLHLSE 513 (1109)
Q Consensus 447 ~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~--------~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~ 513 (1109)
..+..+..+ .+|+.|++++|.+.+..+..+ ..+++|++|+|++|++++..|..+..+ ++|+.|++++
T Consensus 169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~ 248 (455)
T 3v47_A 169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248 (455)
T ss_dssp CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTT
T ss_pred cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecc
Confidence 666666655 566666666666665444332 234555556666665555545444433 4555555555
Q ss_pred CccCCCCChhhcccccccEEecccCcccccCCcCCCC--CCCCCeeecCCCcCccCCCcccccccccceecccccccccc
Q 001274 514 NYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGN--CVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGA 591 (1109)
Q Consensus 514 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 591 (1109)
|.+.+.. +..+.+.+..+..+.. .++|+.|++++|.+++..|..|..+++|+.|+|++|++++.
T Consensus 249 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 314 (455)
T 3v47_A 249 SYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI 314 (455)
T ss_dssp CTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred ccccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccccc
Confidence 5443211 0111222222222222 25777888888888777777777788888888888888777
Q ss_pred cCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhc
Q 001274 592 IPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGE 671 (1109)
Q Consensus 592 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~ 671 (1109)
.|..|.++++|++|++++|.+++..|..+.+++.|+ .|+|++|++++..|..|+.+++|++|||++|++++..+..+..
T Consensus 315 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 393 (455)
T 3v47_A 315 DDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLE-VLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDR 393 (455)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCC-EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred ChhHhcCcccCCEEECCCCccCCcChhHhcCcccCC-EEECCCCcccccChhhccccccccEEECCCCccccCCHhHhcc
Confidence 777788888888888888888777777777777776 4888888888888889999999999999999999766677889
Q ss_pred cccceEEEccCcccccccCCCccc
Q 001274 672 QMSLLVCNLSNNNLVGTVPNTTVF 695 (1109)
Q Consensus 672 l~~L~~l~ls~N~l~g~~p~~~~~ 695 (1109)
+++|++|+|++|+++|.+|....+
T Consensus 394 l~~L~~L~l~~N~l~~~~~~~~~l 417 (455)
T 3v47_A 394 LTSLQKIWLHTNPWDCSCPRIDYL 417 (455)
T ss_dssp CTTCCEEECCSSCBCCCTTTTHHH
T ss_pred CCcccEEEccCCCcccCCCcchHH
Confidence 999999999999999999965444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=381.20 Aligned_cols=288 Identities=42% Similarity=0.729 Sum_probs=235.9
Q ss_pred CCCCHHHHHHHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEE
Q 001274 790 EGFKYHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC 869 (1109)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 869 (1109)
..+++.++....++|++.+.||+|+||+||+|+.++++.||||++..... ......+.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 34677888999999999999999999999999988899999999975432 22334689999999999999999999999
Q ss_pred EeCCceEEEEEeccCCCHHHHhccCCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 001274 870 YHQDSNLLLYEYMENGSLGEQLHGNKQ-TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVG 948 (1109)
Q Consensus 870 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 948 (1109)
...+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999987543 2348999999999999999999995444499999999999999999999999
Q ss_pred eccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcc----cCCcHHHHHHHhh
Q 001274 949 DFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE----LGGDLVTWVRRSI 1024 (1109)
Q Consensus 949 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~----~~~~~~~~~~~~~ 1024 (1109)
|||+++..............||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ......+|+....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999998775444444455679999999999999999999999999999999999999997322 3344555555433
Q ss_pred hccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1025 HEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.... .....+.... .....+....+.+++.+||+.||++|||++|++++|++..
T Consensus 257 ~~~~-~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKK-LEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCC-STTSSCTTCT--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchh-hhhhcChhhc--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 3321 2233332222 2345677788999999999999999999999999998743
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=376.53 Aligned_cols=281 Identities=37% Similarity=0.600 Sum_probs=227.9
Q ss_pred HHHHHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 796 NLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 796 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++...+++|+..+.||+|+||+||+|++++++.||||++.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 3445668999999999999999999998889999999886442 33567899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQ-TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
++||||+++|+|.+++..... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999976542 224899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC--CcHHHHHHHhhhccCCCc
Q 001274 955 LIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG--GDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 955 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~ 1031 (1109)
....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....|........ ...
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 266 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG-QLE 266 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT-CCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc-cHH
Confidence 6542222 2224456899999999999999999999999999999999999999765422 23444443322211 122
Q ss_pred hhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1032 ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
...++... .....+....+.+++.+||+.||++|||++|++++|+.+....
T Consensus 267 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 267 QIVDPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSSSSCT--TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhcChhhc--cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 22222221 1235567788999999999999999999999999999887543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=377.86 Aligned_cols=264 Identities=30% Similarity=0.420 Sum_probs=207.1
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.++|++.+.||+|+||+||+|++ +++.||||++..........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46888999999999999999987 48899999997665555556789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH--IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|+++|+|.+++........+++..+..++.||+.||+||| +.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999987654344899999999999999999999 678 99999999999999999999999999986542
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+........... .+ .
T Consensus 192 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~~~~~~~~-~~-~---- 260 (309)
T 3p86_A 192 T-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP----AQVVAAVGFKCKR-LE-I---- 260 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHHHHHHSCCC-CC-C----
T ss_pred c-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCC-CC-C----
Confidence 2 2223456799999999999999999999999999999999999999975431 2222211111100 00 0
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
.......+.+++.+||+.||++|||++++++.|+.......
T Consensus 261 ------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 261 ------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred ------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 11112357899999999999999999999999999886653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=368.19 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=209.9
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|++ .+++.||||++...... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 36899999999999999999986 47899999999755432 3567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 e~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 97 EYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp ECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ECCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999997643 899999999999999999999 779999999999999999999999999999876532
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............+....
T Consensus 170 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~~------ 238 (297)
T 3fxz_A 170 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATNGTPELQN------ 238 (297)
T ss_dssp -TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHHCSCCCSC------
T ss_pred -ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCCC------
Confidence 2234456799999999999999999999999999999999999999975332 12222111111110000
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.......+.+++.+||+.||++|||++|++++-+..
T Consensus 239 -----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~ 274 (297)
T 3fxz_A 239 -----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274 (297)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred -----ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence 111123577999999999999999999999876543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=366.21 Aligned_cols=285 Identities=36% Similarity=0.549 Sum_probs=230.9
Q ss_pred CCCCHHHHHHHhcCCCCC------ceEecCCcceEEEEEecCCcEEEEEEeeccC--CCcchhHHHHHHHHHhccCCCCc
Q 001274 790 EGFKYHNLLEATGNFSEG------AVIGRGACGTVYKATLANGEVIAVKKIKLRG--EGATADNSFLAEISTLGKIRHRN 861 (1109)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~n 861 (1109)
..+.+.++..++++|... +.||+|+||+||+|+. +++.||||++.... ......+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457888899999988877 9999999999999997 58899999997542 22334577999999999999999
Q ss_pred eeeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC
Q 001274 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE 941 (1109)
Q Consensus 862 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 941 (1109)
|+++++++...+..++||||+++|+|.+++........+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcC
Confidence 99999999999999999999999999999976544445899999999999999999999 779999999999999999
Q ss_pred CCceEEeeccccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHH
Q 001274 942 EFQAHVGDFGLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWV 1020 (1109)
Q Consensus 942 ~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~ 1020 (1109)
++.+||+|||+++........ ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||...........+.
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876532222 1234578999999998765 58999999999999999999999998765544444444
Q ss_pred HHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1021 RRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
..............++... .........+.+++.+||+.||++|||+.+++++|+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMN---DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCS---CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHhhhhhhhhhhhcccccc---ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 4333322222233332221 2345566788999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=373.98 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=213.8
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|++ .+|+.||||++..........+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36899999999999999999997 47999999999866555556677899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++...+. +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV- 166 (328)
T ss_dssp CCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS-
T ss_pred ECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC-
Confidence 99999999999976543 899999999999999999999 77999999999999999999999999999986642
Q ss_pred CCCCccccccccceeccccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVT-EKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.......+||+.|+|||++.+..++ .++||||+||++|||++|+.||.+. ...+...............
T Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~p~~----- 236 (328)
T 3fe3_A 167 -GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY----- 236 (328)
T ss_dssp -SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCCCCCTT-----
T ss_pred -CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCCC-----
Confidence 2334567899999999999988875 7999999999999999999999753 3333333333332211111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
....+.+++.+||+.||++|||++|++++-+..
T Consensus 237 ---------~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 269 (328)
T 3fe3_A 237 ---------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269 (328)
T ss_dssp ---------SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred ---------CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence 123467899999999999999999999986654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=363.90 Aligned_cols=273 Identities=23% Similarity=0.350 Sum_probs=216.4
Q ss_pred ccCCCCCCCCHHHHHHHhcC----------CCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHH
Q 001274 784 NYYFPKEGFKYHNLLEATGN----------FSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEIS 852 (1109)
Q Consensus 784 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~ 852 (1109)
+.++....++++++.++++. |...++||+|+||+||+|++. +|+.||||++..... ...+.+.+|+.
T Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~ 94 (321)
T 2c30_A 17 NLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVV 94 (321)
T ss_dssp --------CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHH
T ss_pred ceeecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHH
Confidence 44555566788888777764 666789999999999999976 799999999975432 34567889999
Q ss_pred HhccCCCCceeeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 001274 853 TLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDI 932 (1109)
Q Consensus 853 ~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 932 (1109)
++++++||||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||+||| +.+|+||||
T Consensus 95 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dl 167 (321)
T 2c30_A 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167 (321)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred HHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCC
Confidence 999999999999999999999999999999999999998753 2899999999999999999999 779999999
Q ss_pred CCCceeeCCCCceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCccc
Q 001274 933 KSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLEL 1012 (1109)
Q Consensus 933 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~ 1012 (1109)
||+||+++.++.+||+|||+++..... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 168 kp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~- 245 (321)
T 2c30_A 168 KSDSILLTLDGRVKLSDFGFCAQISKD-VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS- 245 (321)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSS-SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-
T ss_pred CHHHEEECCCCcEEEeeeeeeeecccC-ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-
Confidence 999999999999999999999876532 222345679999999999999999999999999999999999999997532
Q ss_pred CCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1013 GGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
..+..........+... . .......+.+++.+||+.||++|||++|++++-+...
T Consensus 246 ---~~~~~~~~~~~~~~~~~--~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 246 ---PVQAMKRLRDSPPPKLK--N---------SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp ---HHHHHHHHHHSSCCCCT--T---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred ---HHHHHHHHhcCCCCCcC--c---------cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 22222222111111100 0 0011235778999999999999999999999866543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=360.60 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=213.1
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.+.||+|+||+||+|++.+++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT---SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc---ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 578888999999999999999988999999999743 23456799999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999976544 3899999999999999999999 77999999999999999999999999999986653322
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... ..+.............
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~----~~~~~~~~~~~~~~~~--------- 228 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTGFRLYK--------- 228 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTTCCCCC---------
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC----HHHHHHHHhcCccCCC---------
Confidence 33344567889999999999999999999999999999999 999997533 2222222222111100
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++||+++|++++|+++..+
T Consensus 229 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 ----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 001123578999999999999999999999999988754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=366.48 Aligned_cols=270 Identities=24% Similarity=0.342 Sum_probs=208.1
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||+||+|++.+++.||+|++..........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 68999999999999999999998899999999976554444557889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++ ++.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 101 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~ 173 (311)
T 3niz_A 101 MEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-V 173 (311)
T ss_dssp CSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-C
T ss_pred CCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-c
Confidence 974 88888876544 3899999999999999999999 779999999999999999999999999999876522 2
Q ss_pred CCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc-hhhhh---
Q 001274 962 KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS-ELFDK--- 1036 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 1036 (1109)
.......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+........ .....+.. .....
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI-LGTPNPREWPQVQELPL 252 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHH-HCCCCTTTSGGGTTSHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-HCCCChHHhhhhhccch
Confidence 22344578999999999876 56899999999999999999999999876544444333332 22111100 00000
Q ss_pred ----hcchh-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1037 ----RLDLS-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1037 ----~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
..... ..........+.+++.+|++.||++|||++|++++-+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 00000 00011122457799999999999999999999987543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=368.40 Aligned_cols=264 Identities=27% Similarity=0.338 Sum_probs=208.8
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc----eEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS----NLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~l 877 (1109)
++|++.++||+|+||+||+|++. ++.||||++... ......+.+|+.++++++||||+++++++..... .++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 67889999999999999999986 799999999643 2334556679999999999999999999988554 599
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCC----------CeEecCCCCCceeeCCCCceEE
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP----------HIIHRDIKSNNILLDEEFQAHV 947 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~Dlkp~NIll~~~~~~kl 947 (1109)
||||+++|+|.++++... +++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 999999999999997643 899999999999999999999 77 9999999999999999999999
Q ss_pred eeccccccccCCCC-CCccccccccceeccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCC-------
Q 001274 948 GDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSFGVVLLELITGKSPVQSLELGG------- 1014 (1109)
Q Consensus 948 ~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~------- 1014 (1109)
+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.....
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999987653322 22344679999999999886 356678999999999999999999997643211
Q ss_pred -----cHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1015 -----DLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1015 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
....+......... ...... ..........+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKK--RPVLRD-----YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCC--CCCCCG-----GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccC--CCCccc-----cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11222221111111 000000 001223456689999999999999999999999999988654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=368.79 Aligned_cols=262 Identities=23% Similarity=0.366 Sum_probs=210.3
Q ss_pred cCCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||+||+|++. .+..||||+++.. ......+.+.+|++++++++||||+++++++.+.+..++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 57888999999999999999974 3556999999743 233455779999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999976543 3899999999999999999999 7799999999999999999999999999998765
Q ss_pred CCCCCC--ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 958 LPYSKS--MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 958 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
...... .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... ..+............
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~----~~~~~~~~~~~~~~~---- 274 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT----NRDVISSVEEGYRLP---- 274 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC----HHHHHHHHHTTCCCC----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC----HHHHHHHHHcCCCCC----
Confidence 322221 233456788999999999999999999999999999999 999997543 222222221111100
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
........+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 275 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 275 ---------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ---------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 0111224578999999999999999999999999999866543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=367.92 Aligned_cols=255 Identities=24% Similarity=0.281 Sum_probs=209.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc----chhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA----TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.+.||+|+||+||+|+.+ +|+.||+|+++...... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 67899999999999999999976 68999999997653321 13467899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC----ceEEeeccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF----QAHVGDFGL 952 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~ 952 (1109)
+||||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||+
T Consensus 92 lv~e~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSC---CBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999976543 899999999999999999999 77999999999999998877 799999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
++.... ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.. ..+..............
T Consensus 166 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~ 239 (361)
T 2yab_A 166 AHEIED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANITAVSYDFDE 239 (361)
T ss_dssp CEECCT--TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHTTCCCCCH
T ss_pred ceEcCC--CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCc
Confidence 987653 223355679999999999999999999999999999999999999997532 22333332222222111
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.+.. .....+.+++.+||..||++|||+.|++++-+
T Consensus 240 ~~~~----------~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 240 EFFS----------QTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp HHHT----------TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred hhcc----------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 1111 11235779999999999999999999997654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=365.88 Aligned_cols=258 Identities=27% Similarity=0.462 Sum_probs=212.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|++. +++.||+|++.. ......+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 57888999999999999999975 689999998853 234456789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.+++...... +++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CCTTCBHHHHHHHCCTT--SCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999875443 899999999999999999999 7799999999999999999999999999998764322
Q ss_pred CCC-------------ccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC-----cHHHHHHH
Q 001274 961 SKS-------------MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG-----DLVTWVRR 1022 (1109)
Q Consensus 961 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~-----~~~~~~~~ 1022 (1109)
... .....||+.|+|||++.+..++.++||||+|+++|||++|..||....... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 111 124579999999999999999999999999999999999999987543211 11111111
Q ss_pred hhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
.. .......+.+++.+||+.||++|||++++++.|+.+......
T Consensus 243 ~~--------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 243 YC--------------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp TC--------------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred cC--------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00 011123477899999999999999999999999998766543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=376.18 Aligned_cols=262 Identities=24% Similarity=0.389 Sum_probs=212.8
Q ss_pred cCCCCCceEecCCcceEEEEEec--------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
++|++.+.||+|+||+||+|++. ++..||||+++.. ......+.+.+|+++++++ +||||+++++++...
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 57888999999999999999852 3567999999743 2233456799999999999 899999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 939 (1109)
+..++||||+++|+|.+++..... ...+++.++..++.||+.||+||| +.+|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 999999999999999999976542 124789999999999999999999 7799999999999999
Q ss_pred CCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLV 1017 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~ 1017 (1109)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+... ....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHH
Confidence 9999999999999986643222 22344567889999999999999999999999999999999 9999986432 2222
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
..+........ .......+.+++.+||+.||++||++.|++++|+.+....
T Consensus 316 ~~~~~~~~~~~----------------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 316 KLLKEGHRMDK----------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHTTCCCCC----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCC----------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 22221111110 1112235789999999999999999999999999987654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=364.96 Aligned_cols=274 Identities=20% Similarity=0.250 Sum_probs=219.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC--ceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD--SNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 878 (1109)
++|++.++||+|+||+||+|++. +++.||||++..... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 57889999999999999999976 589999999974322 223567889999999999999999999998765 67999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee----CCCCceEEeeccccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL----DEEFQAHVGDFGLAK 954 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~a~ 954 (1109)
|||+++++|.+++........+++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987654445899999999999999999999 7799999999999999 888889999999998
Q ss_pred cccCCCCCCccccccccceecccccc--------CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAY--------TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
..... .......||+.|+|||++. +..++.++||||+||++|||++|+.||..........+.+......
T Consensus 165 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 76532 2334567999999999886 5778999999999999999999999998655444334444443333
Q ss_pred cCCC--c---------hhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1027 MVPT--S---------ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1027 ~~~~--~---------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
..+. . ..+.................+.+++.+||+.||++|||++|++++..+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 2110 0 00011112222334566778899999999999999999999999997654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=360.37 Aligned_cols=264 Identities=25% Similarity=0.354 Sum_probs=209.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|++. +++.||+|++...... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 67999999999999999999965 6899999998654332 334567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999976543 899999999999999999999 779999999999999999999999999999876533
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.........||+.|+|||++.+..++.++||||+|+++|||++|+.||.+.. .............+.. ...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~---~~~-- 235 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET----AVSIAIKHIQDSVPNV---TTD-- 235 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC----HHHHHHHHHSSCCCCH---HHH--
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhhccCCCc---chh--
Confidence 3333445679999999999999999999999999999999999999997532 2222222223222111 000
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhcc
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRP-TMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~ 1084 (1109)
........+.+++.+|++.||++|| +++++.+.++.+....
T Consensus 236 ----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 236 ----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp ----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0111224578999999999999998 8999999888776543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=363.21 Aligned_cols=257 Identities=20% Similarity=0.228 Sum_probs=211.7
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|++. +++.||+|++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 368899999999999999999976 6889999998733 334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC--CCceEEeecccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE--EFQAHVGDFGLAKLID 957 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~~ 957 (1109)
||+++|+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 81 EFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EeCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999999976543 3899999999999999999999 779999999999999987 7899999999998765
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
. ........||+.|+|||++.+..++.++||||+||++|||++|..||.+.. ..+.................+
T Consensus 156 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~- 228 (321)
T 1tki_A 156 P--GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIENIMNAEYTFDEEAFK- 228 (321)
T ss_dssp T--TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHTCCCCCHHHHT-
T ss_pred C--CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC----HHHHHHHHHcCCCCCChhhhc-
Confidence 2 223345679999999999999889999999999999999999999997532 223333332222221111100
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.....+.+++.+|++.||++|||+.|++++-+-..
T Consensus 229 ---------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 229 ---------EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---------cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 11235779999999999999999999999887653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=358.13 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=212.6
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.++|++.+.||+|+||+||+|++++++.||||+++... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 36788999999999999999999888899999997432 245678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.++......
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999976543 3899999999999999999999 7799999999999999999999999999998765433
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... ................
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~~~~~~~~~-------- 226 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT----NSEVVLKVSQGHRLYR-------- 226 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC----HHHHHHHHHTTCCCCC--------
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC----hHHHHHHHHcCCCCCC--------
Confidence 333344567788999999999899999999999999999999 999997543 1222222111111100
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++|||++|++++|+.+...
T Consensus 227 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 -----PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -----CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -----CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000123577999999999999999999999999888654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=380.60 Aligned_cols=378 Identities=19% Similarity=0.197 Sum_probs=277.1
Q ss_pred CCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecc
Q 001274 169 SLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILW 248 (1109)
Q Consensus 169 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 248 (1109)
.++..........+..+.+++++++|++|++++|.+++. | .++.+++|++|+|++|++++. | ++.+++|++|+|+
T Consensus 19 ~l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls 93 (457)
T 3bz5_A 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACD 93 (457)
T ss_dssp HHHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECC
T ss_pred HHHHHHHHhcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECc
Confidence 344444455566666777888888888888888888854 5 688888888888888888864 3 7888888888888
Q ss_pred cccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCC
Q 001274 249 QNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFI 328 (1109)
Q Consensus 249 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 328 (1109)
+|++++. + ++++++|++|++++|++++ +| ++++++|++|++++|++++. .++++++|++|++++|+..+.+
T Consensus 94 ~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~ 164 (457)
T 3bz5_A 94 SNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL 164 (457)
T ss_dssp SSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC
T ss_pred CCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc
Confidence 8888853 3 7788888888888888886 34 78888888888888888763 3777888888888888655444
Q ss_pred cccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccC
Q 001274 329 PRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNS 408 (1109)
Q Consensus 329 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 408 (1109)
.++.+++|+.|++++|.+++. | +..+++|++|++++|++++. .+..+++|+.|++++|++++ +| ++.++
T Consensus 165 --~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~ 233 (457)
T 3bz5_A 165 --DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLT 233 (457)
T ss_dssp --CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCT
T ss_pred --ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccC
Confidence 366777888888888877763 3 67777788888888887754 36777777778888877776 44 66777
Q ss_pred cCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccc
Q 001274 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488 (1109)
Q Consensus 409 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 488 (1109)
+|++|++++|++++.. +..+++|+.|++++|+ |+.|++++|.+.+.+| +.++++|+.|+|+
T Consensus 234 ~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls 294 (457)
T 3bz5_A 234 QLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVT 294 (457)
T ss_dssp TCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCT
T ss_pred CCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECC
Confidence 7777777777777653 3456667777766653 4567777787776665 5677888888888
Q ss_pred cccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCC
Q 001274 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSA 568 (1109)
Q Consensus 489 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 568 (1109)
+|.+.+.+|. ...+|+.|++++| ++|++|+|++|++++. + ++++++|+.|++++|+|++
T Consensus 295 ~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-- 353 (457)
T 3bz5_A 295 HNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD-- 353 (457)
T ss_dssp TCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--
T ss_pred CCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--
Confidence 8877666553 3345555555544 5788888888888864 3 7888888888888888875
Q ss_pred CcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccc
Q 001274 569 PEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQ 622 (1109)
Q Consensus 569 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 622 (1109)
++.|..|++++|+++|. +.+..|..+++++|+++|.+|..+.+
T Consensus 354 ------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 354 ------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp ------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred ------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhc
Confidence 24667778888888865 34566777788888888888776543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=378.44 Aligned_cols=367 Identities=21% Similarity=0.244 Sum_probs=176.5
Q ss_pred ccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccC
Q 001274 226 NSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIP 305 (1109)
Q Consensus 226 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~ 305 (1109)
....+..+..++++++|++|+|++|.+++ +| .++.+++|++|+|++|++++. | ++.+++|++|++++|.+++. +
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~ 101 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D 101 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C
T ss_pred cCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e
Confidence 33333444455555555555555555553 23 455555555555555555542 2 55555555555555555542 2
Q ss_pred cccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccc
Q 001274 306 HELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTY 385 (1109)
Q Consensus 306 ~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 385 (1109)
++++++|++|++++|++++. | ++.+++|+.|++++|.+++. .++.+++|++|++++|+..+.+ .+..+++
T Consensus 102 --~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~ 171 (457)
T 3bz5_A 102 --VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQ 171 (457)
T ss_dssp --CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTT
T ss_pred --cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCc
Confidence 55555555555555555542 2 44444455555555444442 1444555555555555333333 2444455
Q ss_pred cceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeeccc
Q 001274 386 LVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQ 465 (1109)
Q Consensus 386 L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 465 (1109)
|+.|++++|++++ +| ++.+++|++|++++|++++. .+..+++|++|++++|++++ +| +..+++|++|++++
T Consensus 172 L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~ 242 (457)
T 3bz5_A 172 LTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSV 242 (457)
T ss_dssp CCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCS
T ss_pred CCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeC
Confidence 5555555555543 22 44444455555555544433 13444444444444444443 22 34444444444444
Q ss_pred ccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCC
Q 001274 466 NQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIP 545 (1109)
Q Consensus 466 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 545 (1109)
|++++.. +..+++|+.|++++| +|+.|++++|++.+.+| ++.+++|+.|+|++|...+.+|
T Consensus 243 N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~ 303 (457)
T 3bz5_A 243 NPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLD 303 (457)
T ss_dssp SCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEE
T ss_pred CcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceec
Confidence 4444322 223334444444333 23334444444444333 3344555555555555444444
Q ss_pred cCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccch
Q 001274 546 HELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTA 625 (1109)
Q Consensus 546 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 625 (1109)
. ...+|+.|++++| ++|+.|++++|++++. + ++.+++|+.|++++|++++ + +.
T Consensus 304 ~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-l-------~~ 356 (457)
T 3bz5_A 304 C---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD-F-------SS 356 (457)
T ss_dssp C---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB-C-------TT
T ss_pred c---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC-c-------cc
Confidence 2 2233444444433 3555666666666653 2 5556666666666666554 1 12
Q ss_pred hhhhhccCCccccccccccccCccccceeecCCCccccCCchhh
Q 001274 626 LQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASM 669 (1109)
Q Consensus 626 l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~ 669 (1109)
+. .|++++|.++|. +.+..|+.++|++|+++|.||..+
T Consensus 357 L~-~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 357 VG-KIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp GG-GSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred cc-cccccCCcEEec-----ceeeecCccccccCcEEEEcChhH
Confidence 22 245555555554 244455555555555555555443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=361.98 Aligned_cols=270 Identities=24% Similarity=0.361 Sum_probs=204.6
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.+.||+|+||+||+|++.+++.||||++..........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57888999999999999999998899999999975544334457788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++ +|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-V 154 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-c
Confidence 975 99999876543 3899999999999999999999 779999999999999999999999999999876422 1
Q ss_pred CCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC---CCc---hhh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV---PTS---ELF 1034 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~---~~~ 1034 (1109)
.......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+...........+....... +.. ..+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 223445789999999998764 5899999999999999999999999864322222222221111000 000 000
Q ss_pred hhhcchh-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1035 DKRLDLS-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1035 ~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
++..... ..........+.+++.+||+.||++|||++|++++-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0000000 0000112345779999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=366.22 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=206.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|++. +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 68999999999999999999876 789999999964432 2234678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999976543 899999999999999999999 7799999999999999999999999999998654222
Q ss_pred -CCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 961 -SKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 961 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............... ....... .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~~~~~~~-~---- 231 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---KKTYLNP-W---- 231 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT---TCTTSTT-G----
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc---ccccCCc-c----
Confidence 222345689999999999988776 78999999999999999999999865432221111111 1100000 0
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
......+.+++.+||+.||++|||++|++++-+..
T Consensus 232 -------~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 266 (323)
T 3tki_A 232 -------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (323)
T ss_dssp -------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred -------ccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence 01123467899999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=363.70 Aligned_cols=253 Identities=21% Similarity=0.252 Sum_probs=208.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+.+ +++.||+|+++.... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57889999999999999999975 689999999974321 1223467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS- 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred eCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc-
Confidence 99999999999976543 899999999999999999999 77999999999999999999999999999986432
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. .................
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~p~------- 226 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLFELILMEEIRFPR------- 226 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCT-------
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC----HHHHHHHHHcCCCCCCC-------
Confidence 2233456789999999999999999999999999999999999999997532 22222222222211111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMID 1079 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~ 1079 (1109)
.....+.+++.+||+.||++|| +++|+++|-+.
T Consensus 227 -------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 227 -------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp -------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred -------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence 1123567899999999999999 99999988543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=361.14 Aligned_cols=259 Identities=22% Similarity=0.349 Sum_probs=210.5
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.++|++.+.||+|+||+||+|++.+++.||||+++.. ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT---SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC---CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3578889999999999999999988889999999743 2345679999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++......
T Consensus 100 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999976433 3899999999999999999999 7799999999999999999999999999998764332
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+.............
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~~~~~~~~-------- 242 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEHIAQGLRLYR-------- 242 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHHHTTCCCCC--------
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----hHHHHHHhcccCCCC--------
Confidence 223344567889999999999999999999999999999998 9999985432 122222111111000
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.......+.+++.+||+.||++|||+++++++|.++....
T Consensus 243 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 243 -----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 0001235779999999999999999999999999987653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=368.02 Aligned_cols=257 Identities=21% Similarity=0.258 Sum_probs=210.6
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|+++ +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999875 6899999999866555555678899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC---CceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE---FQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~~~ 956 (1109)
||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.+ +.+||+|||+++..
T Consensus 108 e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTTCSC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999976543 899999999999999999999 7799999999999999765 45999999999876
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+.................
T Consensus 182 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~- 254 (362)
T 2bdw_A 182 ND--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPEW- 254 (362)
T ss_dssp TT--CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHTCCCCCTTGG-
T ss_pred cC--CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhCCCCCCcccc-
Confidence 52 223345689999999999999999999999999999999999999997532 22222222222211111000
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
......+.+++.+||+.||++||++.|++++-+.
T Consensus 255 ---------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 255 ---------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp ---------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred ---------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 0112357799999999999999999999987554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=372.00 Aligned_cols=260 Identities=24% Similarity=0.394 Sum_probs=200.4
Q ss_pred cCCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||+||+|++. ++..||||+++... .....+.+.+|++++++++||||+++++++...+..++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 58999999999999999999864 57789999997432 33445689999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|+|.++++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999987543 3899999999999999999999 7799999999999999999999999999998765
Q ss_pred CCCCCC--ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 958 LPYSKS--MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 958 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+............
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~----~~~~~~~i~~~~~~~---- 270 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS----NQDVIKAVDEGYRLP---- 270 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC----HHHHHHHHHTTEECC----
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcCCCCC----
Confidence 322211 122345778999999999999999999999999999998 999997543 122222211111000
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
........+.+++.+||+.||++||++.+++++|+.+....
T Consensus 271 ---------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 271 ---------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ---------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ---------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 01112245789999999999999999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=358.95 Aligned_cols=260 Identities=30% Similarity=0.472 Sum_probs=203.4
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.+.||+|+||+||+|++. ++.||||++.. ....+.+.+|++++++++||||+++++++. +..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 57888899999999999999985 78999999862 234577999999999999999999999876 458999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc-eEEeeccccccccCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ-AHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DFG~a~~~~~~~ 960 (1109)
+++|+|.+++........+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-- 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-- 158 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc--
Confidence 999999999987654444788999999999999999999432279999999999999998886 79999999976542
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .............+. .
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~--~------- 225 (307)
T 2eva_A 159 --HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAVHNGTRPP--L------- 225 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--HHHHHHHHHTTCCCC--C-------
T ss_pred --ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--HHHHHHHHhcCCCCC--c-------
Confidence 223446899999999999999999999999999999999999999754322 222221111111110 0
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 1087 (1109)
.......+.+++.+||+.||++|||+++++++|..+.+.....
T Consensus 226 ----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 226 ----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp ----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred ----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 0111235778999999999999999999999999988776443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=375.43 Aligned_cols=259 Identities=19% Similarity=0.217 Sum_probs=210.5
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
..++|++.+.||+|+||+||+|++. +|+.||+|++..........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3467999999999999999999864 789999999986654445567789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceEEeecccccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD---EEFQAHVGDFGLAKL 955 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a~~ 955 (1109)
|||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999987654 899999999999999999999 77999999999999998 467899999999987
Q ss_pred ccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 956 IDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.. ..+.................
T Consensus 163 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~ 237 (444)
T 3soa_A 163 VEGE-QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED----QHRLYQQIKAGAYDFPSPEW 237 (444)
T ss_dssp CCTT-CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHTCCCCCTTTT
T ss_pred ecCC-CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHhCCCCCCcccc
Confidence 6532 223345689999999999999999999999999999999999999997532 22222222222211111000
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
......+.+++.+||+.||++|||++|++++-+-
T Consensus 238 ----------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 238 ----------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp ----------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred ----------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 0112357799999999999999999999988554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=357.99 Aligned_cols=264 Identities=26% Similarity=0.369 Sum_probs=204.2
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhcc--CCCCceeeEEEEEEeC----Cc
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGK--IRHRNIVKLYGFCYHQ----DS 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~ 874 (1109)
.++|++.+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 36899999999999999999998 5899999998632 34556667666655 7999999999987653 34
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCceeeCCCCceEEee
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC-----RPHIIHRDIKSNNILLDEEFQAHVGD 949 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~D 949 (1109)
.++||||+++|+|.++++.. .+++..+..++.|++.||+|||+.. +.+|+||||||+||+++.++.+||+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 78999999999999999643 3899999999999999999999422 45999999999999999999999999
Q ss_pred ccccccccCCCCC---CccccccccceeccccccCC------CCCccchhHHHHHHHHHHHhC----------CCCCCCc
Q 001274 950 FGLAKLIDLPYSK---SMSAIAGSYGYIAPEYAYTM------KVTEKCDIYSFGVVLLELITG----------KSPVQSL 1010 (1109)
Q Consensus 950 FG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvll~elltg----------~~pf~~~ 1010 (1109)
||+++........ ......||+.|+|||++.+. .++.++||||+||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9999866432221 12344799999999999876 456799999999999999999 8888765
Q ss_pred ccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1011 ELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.........+.............-. ..........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPN------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCG------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCCh------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 4333332323322211111111100 011234456789999999999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=359.61 Aligned_cols=255 Identities=23% Similarity=0.303 Sum_probs=208.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc----chhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA----TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.+.||+|+||+||+|++. +++.||+|+++...... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56889999999999999999975 68999999997553321 23567899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC----ceEEeeccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF----QAHVGDFGL 952 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~ 952 (1109)
+||||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSC---CBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHhcCC---cCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999976543 899999999999999999999 77999999999999998887 899999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+..............
T Consensus 165 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~ 238 (326)
T 2y0a_A 165 AHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANVSAVNYEFED 238 (326)
T ss_dssp CEECCTT--SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHHTCCCCCH
T ss_pred CeECCCC--CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHHHhcCCCcCc
Confidence 9876522 23345679999999999999999999999999999999999999997532 22222222221111111
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
... ......+.+++.+||+.||++|||+.|++++-+
T Consensus 239 ~~~----------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 239 EYF----------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp HHH----------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred ccc----------ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 110 011235779999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=356.53 Aligned_cols=268 Identities=22% Similarity=0.349 Sum_probs=207.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|++. +++.||||++..........+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999975 68999999998665555556788999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++ ++.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....+
T Consensus 82 ~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp CCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence 9975 66666654333 3899999999999999999999 779999999999999999999999999999876522
Q ss_pred CCCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCchhhhhhc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSELFDKRL 1038 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1038 (1109)
........||+.|+|||++.+.. ++.++||||+||++|||++|..||.... ...+.......... +..+.+....
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~---~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS---SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC---CHHHHHHHHHHHhCCCChhhhhhhc
Confidence 23334567899999999998766 8999999999999999999988864322 22222222221111 0111100000
Q ss_pred c--------------hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1039 D--------------LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1039 ~--------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
. ............+.+++.+|++.||++|||++|++++-+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 0 0000111223457799999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=376.86 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=209.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|++. +++.||||+++.. ......+.+.+|++++++++||||+++++++...+..++|||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 57888899999999999999976 7899999998743 223344678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.++++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999976543 3899999999999999999999 7799999999999999999999999999998654221
Q ss_pred CCCc-cccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 961 SKSM-SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 961 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.... ....+++.|+|||++.+..++.++|||||||++|||++ |..||..... ......+.... ..+.
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~--~~~~-------- 336 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKGG--RLPC-------- 336 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-HHHHHHHHTTC--CCCC--------
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCC--CCCC--------
Confidence 1111 22345778999999998999999999999999999999 9999976431 11112111110 0110
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++|||++++++.|+.+...
T Consensus 337 ------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 337 ------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 011123577999999999999999999999999988653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=365.99 Aligned_cols=259 Identities=23% Similarity=0.283 Sum_probs=203.9
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 368999999999999999999976 78999999997432 23467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc--eEEeecccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ--AHVGDFGLAKLID 957 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~~~ 957 (1109)
||+++|+|.+++...+. +++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++...
T Consensus 96 e~~~~~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 96 EYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp ECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999976543 899999999999999999999 779999999999999987765 9999999997543
Q ss_pred CCCCCCccccccccceeccccccCCCCCcc-chhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEK-CDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.........||+.|+|||++.+..++.+ +||||+||++|||++|+.||.+..........+.............
T Consensus 170 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 244 (361)
T 3uc3_A 170 --LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD--- 244 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT---
T ss_pred --ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc---
Confidence 1222345679999999999988888765 8999999999999999999987665566665555443332211110
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
. .....+.+++.+||+.||++|||+.|+++|-+....
T Consensus 245 -~--------~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 245 -I--------RISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -S--------CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -C--------CCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 0 011357799999999999999999999999877543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=352.68 Aligned_cols=263 Identities=19% Similarity=0.253 Sum_probs=213.1
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|++ .+++.||||++.... ..+.+.+|+++++++ +|++++++++++......++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 5789999999999999999996 478999999986432 334688999999999 7999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc-----eEEeeccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ-----AHVGDFGLAK 954 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFG~a~ 954 (1109)
||+ +++|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 9999999986543 3899999999999999999999 789999999999999987776 9999999998
Q ss_pred cccCCCCC------CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc--
Q 001274 955 LIDLPYSK------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE-- 1026 (1109)
Q Consensus 955 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~-- 1026 (1109)
........ ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~ 238 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIGEKKQ 238 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-HHHHHHHhhcc
Confidence 76533221 234567999999999999999999999999999999999999999875432222 111111111
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
..+..+. .......+.+++.+||+.||++||++++|++.|+++......
T Consensus 239 ~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 239 STPLREL-----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HSCHHHH-----------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CccHHHH-----------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 0111110 011224678999999999999999999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=356.91 Aligned_cols=249 Identities=21% Similarity=0.265 Sum_probs=198.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.++||+|+||+||+|++. +++.||||++............+..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 799999999875544444555666677666555 8999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+ +++|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 7799999876543 3999999999999999999999 679999999999999999999999999999876422
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... . ......... ...+.
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~-~~~~~~~~~--~~~~~---- 274 (311)
T 3p1a_A 211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------G-WQQLRQGYL--PPEFT---- 274 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------H-HHHHTTTCC--CHHHH----
T ss_pred --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------H-HHHHhccCC--Ccccc----
Confidence 22344569999999998876 79999999999999999999977765321 1 111111111 11111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
......+.+++.+||+.||++|||++|++++-+
T Consensus 275 ------~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 275 ------AGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp ------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ------cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 112246789999999999999999999998654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=373.58 Aligned_cols=272 Identities=25% Similarity=0.405 Sum_probs=216.3
Q ss_pred CCHHHHHHHhcCCCCCceEecCCcceEEEEEe------cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceee
Q 001274 792 FKYHNLLEATGNFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVK 864 (1109)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 864 (1109)
+....+....++|++.+.||+|+||.||+|++ .+++.||||+++.. ......+.+.+|+++++++ +||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 33444445568899999999999999999973 24688999999743 2333456799999999999 7899999
Q ss_pred EEEEEEeCCc-eEEEEEeccCCCHHHHhccCCC-----------------------------------------------
Q 001274 865 LYGFCYHQDS-NLLLYEYMENGSLGEQLHGNKQ----------------------------------------------- 896 (1109)
Q Consensus 865 l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------- 896 (1109)
+++++...+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999976542
Q ss_pred ----------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 897 ----------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 897 ----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 112889999999999999999999 7799999999999999999999999999998664322
Q ss_pred C-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 961 S-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 961 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
. .......||+.|+|||++.+..++.++||||+||++|||++ |+.||.+..........+........+ .
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~------ 319 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--D------ 319 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--T------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCC--C------
Confidence 2 22344568899999999999999999999999999999998 999998654433333333322111111 0
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.....+.+++.+||+.||++|||++|++++|+.+...
T Consensus 320 --------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 320 --------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1123577899999999999999999999999988754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=372.51 Aligned_cols=275 Identities=20% Similarity=0.222 Sum_probs=210.6
Q ss_pred hcCCCCCceEecC--CcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 801 TGNFSEGAVIGRG--ACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 801 ~~~~~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
.++|++.++||+| +||+||+|++. +++.||||++..........+.+.+|++++++++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3689999999999 99999999976 69999999998765555556788899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|+|.+++...... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999765322 3899999999999999999999 7799999999999999999999999999986542
Q ss_pred CCC------CCCccccccccceeccccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCC
Q 001274 958 LPY------SKSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 958 ~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 1029 (1109)
... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..........+.........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 111 111233478999999999987 679999999999999999999999998755433333222211110000
Q ss_pred Cchhhhhh-----------------c-----------chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1030 TSELFDKR-----------------L-----------DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1030 ~~~~~~~~-----------------~-----------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
........ . .............+.+++.+||+.||++|||++|++++-+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 00000000 0 00000111223458899999999999999999999988543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=383.63 Aligned_cols=267 Identities=21% Similarity=0.214 Sum_probs=211.1
Q ss_pred HHHHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC
Q 001274 796 NLLEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 796 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 873 (1109)
++....++|++.++||+|+||+||+|+++ +++.||||+++.... .......+.+|+.++..++||||+++++++.+.+
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 33445678999999999999999999976 578999999974211 1112345889999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA 953 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 953 (1109)
..|+||||+++|+|.+++..... .+++..++.++.||+.||+||| +.+||||||||+|||++.++.+||+|||+|
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999987433 3899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
+.............+||+.|+|||++. +..++.++||||+||++|||++|+.||.+....+.....+........
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence 876533333334568999999999987 567899999999999999999999999854322222222111111111
Q ss_pred CCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHHHHh
Q 001274 1029 PTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLN--RPTMREVIAMMIDA 1080 (1109)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~L~~~ 1080 (1109)
|. . .......+.+++.+|+..+|++ ||+++|+++|-+..
T Consensus 303 p~--~-----------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 303 PT--Q-----------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp CS--S-----------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred Cc--c-----------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 10 0 0011235678999999988888 99999999986653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=360.88 Aligned_cols=261 Identities=18% Similarity=0.240 Sum_probs=211.0
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 5788999999999999999996 478999999987442 234688999999999 9999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc-----eEEeeccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ-----AHVGDFGLAK 954 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFG~a~ 954 (1109)
||+ +++|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EeC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999 9999999986533 3999999999999999999999 779999999999999998887 9999999998
Q ss_pred cccCCCCC------CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 955 LIDLPYSK------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 955 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ....+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-DTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-SSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-ccHHHHHHHHHhhhc
Confidence 76433221 12456799999999999999999999999999999999999999987542 223222222111110
Q ss_pred C-CchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1029 P-TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1029 ~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
+ ..+.. ..... .+.+++.+||+.||.+||++.+|.+.|.++....
T Consensus 238 ~~~~~~~----------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 238 ATPIEVL----------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HSCHHHH----------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCHHHH----------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0 00000 00011 6889999999999999999999999999886654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=373.15 Aligned_cols=345 Identities=27% Similarity=0.395 Sum_probs=212.4
Q ss_pred cccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEE
Q 001274 239 LRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEID 318 (1109)
Q Consensus 239 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 318 (1109)
+++|+.|++++|.++ .+| .+..+++|++|+|++|.+++..| ++++++|++|++++|.+++..+ +.++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 344555555555554 233 24445555555555555553322 5555555555555555553333 55555555555
Q ss_pred ccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccc
Q 001274 319 LSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEG 398 (1109)
Q Consensus 319 Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 398 (1109)
+++|++++..+ +..+++|+.|++++|.+.+. + .+..+++|++|+++ |.+.+.. .+.++++|+.|++++|.+++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC
Confidence 55555554322 45555555555555555542 2 35555666666664 3333222 25566666666666666553
Q ss_pred cCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccC
Q 001274 399 TIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYN 478 (1109)
Q Consensus 399 ~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 478 (1109)
. ..+..+++|++|++++|.+.+..+ +..+++|+.|++++|++++. +.+..+++|++|++++|++++..+ +.+
T Consensus 192 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 263 (466)
T 1o6v_A 192 I--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSG 263 (466)
T ss_dssp C--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred C--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhc
Confidence 2 235556666666666666665444 55566666666666666643 345666677777777777765544 667
Q ss_pred CcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeee
Q 001274 479 LQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLD 558 (1109)
Q Consensus 479 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 558 (1109)
+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..| +..+++|++|+
T Consensus 264 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 337 (466)
T 1o6v_A 264 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 337 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEE
T ss_pred CCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeE
Confidence 7777777777777776533 6777777777777777776543 6777777777777777776554 66777788888
Q ss_pred cCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccc
Q 001274 559 LSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614 (1109)
Q Consensus 559 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 614 (1109)
+++|.+++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 338 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 338 FYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 888877753 467777778888888888777766 7777788888888887775
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=364.13 Aligned_cols=276 Identities=23% Similarity=0.347 Sum_probs=197.0
Q ss_pred hcCCCCCceEecCCcceEEEEEecC-C---cEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce-
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLAN-G---EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN- 875 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~- 875 (1109)
.++|++.+.||+|+||+||+|++.. + ..||||+++.........+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3689999999999999999998653 3 2799999976554555678899999999999999999999999887665
Q ss_pred -----EEEEEeccCCCHHHHhccCCC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 001274 876 -----LLLYEYMENGSLGEQLHGNKQ---TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV 947 (1109)
Q Consensus 876 -----~lv~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 947 (1109)
++||||+++|+|.+++..... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence 899999999999999864321 124899999999999999999999 779999999999999999999999
Q ss_pred eeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhh
Q 001274 948 GDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIH 1025 (1109)
Q Consensus 948 ~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 1025 (1109)
+|||+++....... .......+++.|+|||++.+..++.++||||+||++|||++ |+.||.+..... ....+..
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~~~~~--- 254 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYNYLIG--- 254 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHT---
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-HHHHHhc---
Confidence 99999986643222 22234457889999999999999999999999999999999 999998654322 2221111
Q ss_pred ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCCCCCcccc
Q 001274 1026 EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSSPTSETP 1096 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~ 1096 (1109)
..... ........+.+++.+||+.||++|||+.++++.++++.....-...++.+...
T Consensus 255 ~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~ 312 (323)
T 3qup_A 255 GNRLK-------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYI 312 (323)
T ss_dssp TCCCC-------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------------
T ss_pred CCCCC-------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCC
Confidence 11000 01111235789999999999999999999999999998776555555444333
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=364.72 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=206.2
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.++|++.+.||+|+||+||+|++ .+++.||||++..... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999996 4789999999964311 112245788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+ +|+|.+++..... +++.++..++.||+.|++||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 7899999876543 899999999999999999999 67999999999999999999999999999986642
Q ss_pred CCCCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+....... .... ...
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--------~~i~------~~~ 224 (336)
T 3h4j_B 161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--------KKVN------SCV 224 (336)
T ss_dssp --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------CCCC------SSC
T ss_pred --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------HHHH------cCC
Confidence 223355679999999999998876 78999999999999999999999754311100 0000 000
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.. .+......+.+++.+||+.||.+|||++|++++-+...
T Consensus 225 ~~----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 225 YV----MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CC----CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred CC----CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 00 01111235779999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=375.20 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=210.1
Q ss_pred HHHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc
Q 001274 797 LLEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 797 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 874 (1109)
+....++|++.++||+|+||+||+|+++ +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3345578999999999999999999976 589999999964211 11223458899999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.|+||||+++|+|.+++.... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999997642 899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCCCccccccccceeccccccCCC----CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
.............+||+.|+|||++.+.. ++.++||||+||++|||++|+.||.+..........+........+.
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 76533322334678999999999998765 78999999999999999999999985332211112111111111111
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHHHHh
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLN--RPTMREVIAMMIDA 1080 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~L~~~ 1080 (1109)
.. .....+.+++.+|++.+|.+ ||+++||++|-+..
T Consensus 297 ~~--------------~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~ 334 (410)
T 3v8s_A 297 DN--------------DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 334 (410)
T ss_dssp TC--------------CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred cc--------------cccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence 00 11235678999999999998 99999999997664
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=383.15 Aligned_cols=258 Identities=24% Similarity=0.408 Sum_probs=210.3
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.++|++.+.||+|+||+||+|++++++.||||+++.. ....+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC---CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 4678888999999999999999988899999999743 234678999999999999999999999986 667899999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.++++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 9999999999975432 13789999999999999999999 7799999999999999999999999999998764322
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... .....+...... +.
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~~~~~~--~~--------- 406 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERGYRM--PR--------- 406 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHHTCCC--CC---------
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCC--CC---------
Confidence 222234457889999999999999999999999999999999 99999854321 111222211110 00
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++||||.+|++.|+.....
T Consensus 407 -----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 407 -----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 111224578999999999999999999999999887654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=366.58 Aligned_cols=254 Identities=23% Similarity=0.292 Sum_probs=204.0
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 877 (1109)
.++|++.++||+|+||+||+|+++ +++.||||+++.... .....+.+.+|.++++.+ +||||+++++++...+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999975 689999999974311 122345678999999988 79999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 102 v~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999976543 899999999999999999999 7799999999999999999999999999998543
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+...............
T Consensus 176 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~---- 246 (353)
T 3txo_A 176 C-NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN----EDDLFEAILNDEVVYPTW---- 246 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCTT----
T ss_pred c-CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCC----
Confidence 1 2233455689999999999999999999999999999999999999997532 233333333322211111
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTM------REVIAMMID 1079 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~evl~~L~~ 1079 (1109)
....+.+++.+|++.||++||++ .|+++|-+.
T Consensus 247 ----------~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 247 ----------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp ----------SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred ----------CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 11346789999999999999999 888877543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=360.19 Aligned_cols=274 Identities=23% Similarity=0.361 Sum_probs=195.9
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|++. +++.||+|+++... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 468999999999999999999865 68999999997543 2234467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCC---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNK---QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
||++ |+|.+++.... ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 59999886432 1124899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
... ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+............. ... +....+.
T Consensus 159 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~--~~~~~~~ 234 (317)
T 2pmi_A 159 GIP-VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI-MGT--PNESLWP 234 (317)
T ss_dssp TSC-CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCS--CCTTTCG
T ss_pred CCC-cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCC--CChhHhh
Confidence 522 222345578999999999876 46899999999999999999999999864322222111111 110 0000000
Q ss_pred h---------hcch----------hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1036 K---------RLDL----------SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1036 ~---------~~~~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
. .... ...........+.+++.+||+.||++|||++|++++-+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 0 0000 0000001224688999999999999999999999986655433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.43 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=211.9
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.+.||+|+||.||+|++.+++.||+|++.... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 5788889999999999999999888999999997432 2346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.++.......
T Consensus 85 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999987543 3899999999999999999999 77999999999999999999999999999986643222
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||++.+..++.++||||+|+++|||++ |+.||.... ..+.............
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~i~~~~~~~~--------- 226 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTGFRLYK--------- 226 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTTCCCCC---------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC----HHHHHHHHhcCCcCCC---------
Confidence 22334567889999999998999999999999999999999 899997532 2222222211111000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++||++++++++|.++..+
T Consensus 227 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 227 ----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 001123577999999999999999999999999988653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=357.20 Aligned_cols=259 Identities=22% Similarity=0.307 Sum_probs=199.2
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce----
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN---- 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 875 (1109)
++|++.+.||+|+||+||+|++ .+++.||||+++..... ......+.+|++++++++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 6899999999999999999996 47899999999754322 23346788999999999999999999998876544
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++||||+++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 999999999999999976543 899999999999999999999 77999999999999999999999999999986
Q ss_pred ccCCCC--CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 956 IDLPYS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 956 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.+.. ..................
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~ 241 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS----PVSVAYQHVREDPIPPSA 241 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHCCCCCHHH
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCCCCCccc
Confidence 643222 12234568999999999999999999999999999999999999997533 222222222222111111
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.. ......+.+++.+||+.||++||++.+++.+-...
T Consensus 242 ~~----------~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 242 RH----------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HS----------TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cc----------CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 10 11123577999999999999999877777654443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=364.98 Aligned_cols=258 Identities=20% Similarity=0.256 Sum_probs=206.2
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 877 (1109)
.++|++.++||+|+||+||+|+.+ +++.||+|+++..... ....+.+.+|..+++++ +||||+++++++...+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357899999999999999999976 5889999999754322 23345688899999877 89999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|+|..++..... +++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 131 V~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999986543 899999999999999999999 7799999999999999999999999999998533
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC----cHHH-HHHHhhhccCCCch
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG----DLVT-WVRRSIHEMVPTSE 1032 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~----~~~~-~~~~~~~~~~~~~~ 1032 (1109)
. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...+ .............
T Consensus 205 ~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p- 282 (396)
T 4dc2_A 205 R-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP- 282 (396)
T ss_dssp C-TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC-
T ss_pred c-CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC-
Confidence 2 2233456789999999999999999999999999999999999999997543111 1111 1122222211111
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHHHH
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTM------REVIAMMID 1079 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~evl~~L~~ 1079 (1109)
......+.+++.+||+.||++||++ +|++++-+.
T Consensus 283 -------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 283 -------------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp -------------TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred -------------CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 1112356799999999999999985 788877543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.32 Aligned_cols=254 Identities=21% Similarity=0.332 Sum_probs=208.2
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--CceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+++ ++.||||+++.........+.+.+|++++++++||||+++++++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57889999999999999999986 88999999987655556667899999999999999999999999887 6789999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH--IIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||+++|+|.+++..... ..+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999987543 24899999999999999999999 667 9999999999999999999999999876432
Q ss_pred CCCCCCccccccccceeccccccCCCCCc---cchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTE---KCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
.....+|+.|+|||++.+..++. ++||||+|+++|||++|+.||..... .+............ ..
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~--~~ 232 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN----MEIGMKVALEGLRP--TI 232 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----HHHHHHHHHSCCCC--CC
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----HHHHHHHHhcCCCC--CC
Confidence 22346899999999998766544 89999999999999999999975432 22222222111110 00
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
.......+.+++.+||+.||++|||++|+++.|..+..
T Consensus 233 ----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 ----------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01112357899999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=355.12 Aligned_cols=250 Identities=22% Similarity=0.271 Sum_probs=207.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+.. +|+.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57889999999999999999975 699999999974321 1123466789999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999999987543 899999999999999999999 88999999999999999999999999999986542
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. .................
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~p~------- 224 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----TMKTYEKILNAELRFPP------- 224 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHCCCCCCT-------
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCC-------
Confidence 2345679999999999999999999999999999999999999997532 22223332222221111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMID 1079 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~ 1079 (1109)
.....+.+++.+|++.||++|| +++|+++|-+.
T Consensus 225 -------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 225 -------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262 (318)
T ss_dssp -------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred -------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence 1113577999999999999999 89999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=363.34 Aligned_cols=254 Identities=21% Similarity=0.302 Sum_probs=207.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57899999999999999999865 68899999996432 11223467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVH---FKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR- 167 (384)
T ss_dssp CCCTTEEHHHHHHTTCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred ecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC-
Confidence 99999999999987543 899999999999999999999 77999999999999999999999999999987642
Q ss_pred CCCCccccccccceeccccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...................
T Consensus 168 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~p~---- 241 (384)
T 4fr4_A 168 -ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVVTYPS---- 241 (384)
T ss_dssp -TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT-SCHHHHHHHHHHCCCCCCT----
T ss_pred -CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC-ccHHHHHHHHhhcccCCCC----
Confidence 233456789999999999874 4589999999999999999999999975432 2223333322222211111
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT-MREVIAMMI 1078 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~~L~ 1078 (1109)
.....+.+++.+||+.||++||+ ++++.++-+
T Consensus 242 ----------~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 242 ----------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274 (384)
T ss_dssp ----------TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred ----------cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence 11235779999999999999999 788876543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=370.16 Aligned_cols=346 Identities=29% Similarity=0.409 Sum_probs=166.8
Q ss_pred ccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhh
Q 001274 142 FINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVL 221 (1109)
Q Consensus 142 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L 221 (1109)
.+++++.|++++|.+.. +| .+..+++|++|+|++|.+++..| ++++++|++|++++|.+++..+ +++
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~------- 110 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LAN------- 110 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTT-------
T ss_pred HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcC-------
Confidence 35566666666666543 33 25556666666666666654322 5555555555555555553322 444
Q ss_pred hcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeeccccc
Q 001274 222 GLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELN 301 (1109)
Q Consensus 222 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 301 (1109)
+++|++|+|++|++++..+ +.++++|++|++++|.+++ ++ .++++++|++|+++ |.+.
T Consensus 111 -----------------l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~ 168 (466)
T 1o6v_A 111 -----------------LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVT 168 (466)
T ss_dssp -----------------CTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCC
T ss_pred -----------------CCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-Cccc
Confidence 4444444554444443221 4455555555555555543 22 35555555555554 3333
Q ss_pred CccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchh
Q 001274 302 GTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQ 381 (1109)
Q Consensus 302 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 381 (1109)
+.. .+.++++|++|++++|.+++. ..+..+++|+.|++++|.+.+..| +..+++|++|++++|++++. ..+.
T Consensus 169 ~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~ 240 (466)
T 1o6v_A 169 DLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 240 (466)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGG
T ss_pred Cch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhh
Confidence 221 255555555666655555532 123444444444444444443333 44455555555555555432 2344
Q ss_pred cccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCcccccccee
Q 001274 382 NLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQL 461 (1109)
Q Consensus 382 ~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 461 (1109)
.+++|+.|++++|.+++..+ +..+++|++|++++|.+.+..+ +..+++|+.|++++|+++
T Consensus 241 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~---------------- 300 (466)
T 1o6v_A 241 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE---------------- 300 (466)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS----------------
T ss_pred cCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCccc----------------
Confidence 44455555555554443322 3444444444444444443322 344444444444444444
Q ss_pred ecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCccc
Q 001274 462 MLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLS 541 (1109)
Q Consensus 462 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 541 (1109)
+..+ +..+++|++|+|++|++++..| +..+++|++|++++|++++. ..+.++++|+.|++++|+++
T Consensus 301 --------~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~ 366 (466)
T 1o6v_A 301 --------DISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQIS 366 (466)
T ss_dssp --------CCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred --------Cchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccC
Confidence 3222 3444445555555555444332 44445555555555555443 24445555555555555555
Q ss_pred ccCCcCCCCCCCCCeeecCCCcCcc
Q 001274 542 GTIPHELGNCVNLQRLDLSRNQFTG 566 (1109)
Q Consensus 542 ~~~p~~~~~l~~L~~L~Ls~N~l~~ 566 (1109)
+..| +..+++|+.|++++|.+++
T Consensus 367 ~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 367 DLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp BCGG--GTTCTTCCEEECCCEEEEC
T ss_pred ccch--hhcCCCCCEEeccCCcccC
Confidence 4443 4455555555555555543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=350.69 Aligned_cols=259 Identities=21% Similarity=0.261 Sum_probs=212.0
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|++. +++.||+|++..........+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 368999999999999999999875 6899999999866555556678899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc---eEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ---AHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~a~~~ 956 (1109)
||+++++|.+++..... +++..+..++.|++.|++||| +.+|+||||||+||+++.++. +||+|||.+...
T Consensus 85 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999998876543 899999999999999999999 779999999999999986655 999999999866
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... ...................
T Consensus 159 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~-- 230 (284)
T 3kk8_A 159 ND--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDYPSPE-- 230 (284)
T ss_dssp CS--SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHTCCCCCTTT--
T ss_pred cc--CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc----hhHHHHHHHhccccCCchh--
Confidence 52 223345679999999999999999999999999999999999999997532 2222222222211111000
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.......+.+++.+||+.||++|||++|++++-+-..
T Consensus 231 --------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 231 --------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp --------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred --------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 0011235779999999999999999999999876544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=360.06 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=204.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcE----EEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEV----IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.+.||+|+||+||+|++. +++. ||+|.+.... .......+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 57888999999999999999864 4443 7788775332 2234456789999999999999999999886 56689
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++|+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999987543 3899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 957 DLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 957 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
...... ......+|..|+|||++.+..++.++||||+||++|||++ |+.||.+... ......+....... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~--~~~~- 241 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVPDLLEKGERLA--QPQI- 241 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-THHHHHHHTTCBCC--CCTT-
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-HHHHHHHHcCCCCC--CCCc-
Confidence 533222 2345567889999999999999999999999999999999 9999986432 22222222211111 1111
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
....+.+++.+||+.||++||++++++++|..+....
T Consensus 242 -------------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 242 -------------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -------------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -------------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1123568999999999999999999999999886543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=367.91 Aligned_cols=274 Identities=16% Similarity=0.223 Sum_probs=210.2
Q ss_pred hcCCCCCceEecCCcceEEEEEecC------CcEEEEEEeeccCCCcc---------hhHHHHHHHHHhccCCCCceeeE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLAN------GEVIAVKKIKLRGEGAT---------ADNSFLAEISTLGKIRHRNIVKL 865 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l 865 (1109)
.++|++.++||+|+||+||+|++.. ++.||||++........ ....+..|+..++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3589999999999999999998754 47899999874321100 11234456667788899999999
Q ss_pred EEEEEeC----CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-
Q 001274 866 YGFCYHQ----DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD- 940 (1109)
Q Consensus 866 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~- 940 (1109)
++++... ...++||||+ +++|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence 9998775 4479999999 9999999987543 3999999999999999999999 77999999999999998
Q ss_pred -CCCceEEeeccccccccCCCCC------CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC
Q 001274 941 -EEFQAHVGDFGLAKLIDLPYSK------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG 1013 (1109)
Q Consensus 941 -~~~~~kl~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~ 1013 (1109)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999866422111 113456999999999999999999999999999999999999999864433
Q ss_pred CcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 001274 1014 GDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087 (1109)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 1087 (1109)
.............. ..+..++.+.. ......+.+++..||+.||++||++.++++.|+.+.......
T Consensus 268 ~~~~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 268 PKYVRDSKIRYREN--IASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHHHHHHHC--HHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhhhh--HHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 33333333322221 22222222110 111346789999999999999999999999999988765433
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=359.17 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=202.7
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc-----
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS----- 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 874 (1109)
.++|++.+.||+|+||+||+|++. +++.||||+++... .....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 357889999999999999999976 79999999997543 33455789999999999999999999999866542
Q ss_pred ----------------------------------------------------eEEEEEeccCCCHHHHhccCCCCCCCCh
Q 001274 875 ----------------------------------------------------NLLLYEYMENGSLGEQLHGNKQTCLLDW 902 (1109)
Q Consensus 875 ----------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~l~~ 902 (1109)
.++||||+++|+|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 7899999999999999988766555777
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC-----------CCcccccccc
Q 001274 903 DARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS-----------KSMSAIAGSY 971 (1109)
Q Consensus 903 ~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-----------~~~~~~~gt~ 971 (1109)
..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 789999999999999999 77999999999999999999999999999987653321 1224457999
Q ss_pred ceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHH
Q 001274 972 GYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTL 1051 (1109)
Q Consensus 972 ~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
.|+|||++.+..++.++||||+||++|||++|..|+... ............ ... .......
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------~~~~~~~~~~~~--~~~-----------~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------VRIITDVRNLKF--PLL-----------FTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------HHHHHHHHTTCC--CHH-----------HHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------HHHHHHhhccCC--Ccc-----------cccCChh
Confidence 999999999999999999999999999999988775321 111111111111 100 1222345
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1052 FLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1052 ~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
+.+++.+||+.||++|||++|++++-
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhch
Confidence 67899999999999999999999763
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=362.37 Aligned_cols=260 Identities=19% Similarity=0.235 Sum_probs=207.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC---CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG---EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||+||+|++. +++.||||++.... ......+.+.+|+++++.++||||+++++++...+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 57889999999999999999865 68999999986431 122245678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc---eEEeecccc
Q 001274 878 LYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ---AHVGDFGLA 953 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~a 953 (1109)
||||+++|+|.+++.... ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988875432 1223899999999999999999999 779999999999999986654 999999999
Q ss_pred ccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. .+...............
T Consensus 181 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 181 IQLGES-GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-----ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp EECCTT-SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HHHHHHHHHTCCCCCHH
T ss_pred eEecCC-CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-----HHHHHHHHcCCCCCCcc
Confidence 876532 222345679999999999999999999999999999999999999997532 12222222222111110
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.. ......+.+++.+||+.||++|||+.|++++-+..
T Consensus 255 ~~----------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 255 QW----------SHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp HH----------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred cc----------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 00 01123577999999999999999999999875543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=352.69 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=197.5
Q ss_pred cCCCCCceEecCCcceEEEEEecC----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||+||+|++.. +..||+|+++.. ......+.+.+|+.++++++||||+++++++. ++..++
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 678899999999999999998642 457999988643 23344567899999999999999999999974 567899
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999986543 3899999999999999999999 7799999999999999999999999999998765
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
...........+|+.|+|||++.+..++.++||||+|+++|||++ |..||.+.... .....+.... ..+.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-~~~~~i~~~~--~~~~------ 238 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGE--RLPM------ 238 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTC--CCCC------
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-HHHHHHHcCC--CCCC------
Confidence 333333344567889999999999999999999999999999997 99999865422 2222222110 0110
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 239 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 239 --------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111224577999999999999999999999999988654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=365.32 Aligned_cols=266 Identities=23% Similarity=0.384 Sum_probs=211.4
Q ss_pred HhcCCCCCceEecCCcceEEEEEe------cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
..++|++.+.||+|+||+||+|++ .+++.||||+++... .....+.+.+|+++++++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 346889999999999999999986 246689999997432 233457899999999999 899999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCCC--------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQT--------------------CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDI 932 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 932 (1109)
+..++||||+++|+|.+++...... ..+++..+..++.||+.||+||| +.+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 9999999999999999999765431 23789999999999999999999 779999999
Q ss_pred CCCceeeCCCCceEEeeccccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCc
Q 001274 933 KSNNILLDEEFQAHVGDFGLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSL 1010 (1109)
Q Consensus 933 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~ 1010 (1109)
||+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |..||.+.
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999866532221 1234567889999999999999999999999999999998 99999865
Q ss_pred ccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1011 ELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
.........+........+ ......+.+++.+||+.||++|||+.+++++|+.......
T Consensus 279 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQP----------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCC----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcHHHHHHHHhcCCCCCCC----------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 4433333333322111110 1112357899999999999999999999999999876554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.35 Aligned_cols=261 Identities=29% Similarity=0.457 Sum_probs=200.2
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||+||+|++. ..||||+++.........+.+.+|++++++++||||+++++++ ..+..++||||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred cceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 68999999999999999999875 3599999987666656667899999999999999999999965 55678999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC-
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY- 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 960 (1109)
+++++|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 101 CEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred cCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999976543 3899999999999999999999 7799999999999999999999999999998654211
Q ss_pred CCCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
........||+.|+|||++. +..++.++||||+|+++|||++|+.||............+....... .....
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~---- 250 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-DLSKV---- 250 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-CTTSS----
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-chhhc----
Confidence 22234567899999999986 66789999999999999999999999986543222222222211110 00000
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
.......+.+++.+||+.||++|||++++++.|+++..
T Consensus 251 -------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 251 -------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11122468899999999999999999999999988754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=365.92 Aligned_cols=266 Identities=25% Similarity=0.360 Sum_probs=215.1
Q ss_pred cCCCCCceEecCCcceEEEEEec--------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
++|.+.++||+|+||+||+|++. +++.||||+++.. ......+.+.+|+++++++ +||||+++++++...
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 67888999999999999999852 2467999999744 3334457789999999999 999999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 939 (1109)
+..++||||+++|+|.+++..... ...+++..+..++.||+.||+||| +.+|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 999999999999999999976542 124899999999999999999999 7799999999999999
Q ss_pred CCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLV 1017 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~ 1017 (1109)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~----~~ 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VE 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----HH
Confidence 9999999999999986653222 22344567889999999999999999999999999999999 999997543 22
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCC
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYP 1088 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 1088 (1109)
+............. .......+.+++.+||+.||++|||++|++++|+.+........
T Consensus 301 ~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 301 ELFKLLKEGHRMDK-------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHHHHHTTCCCCC-------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 22222211111000 01112357899999999999999999999999999987664443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=355.09 Aligned_cols=269 Identities=26% Similarity=0.348 Sum_probs=207.1
Q ss_pred HHHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC--CCCceeeEEEEEEeC---
Q 001274 798 LEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI--RHRNIVKLYGFCYHQ--- 872 (1109)
Q Consensus 798 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~--- 872 (1109)
....++|++.++||+|+||+||+|++. ++.||||++... ....+.+|.+++... +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 344578999999999999999999986 899999998632 334455666665554 999999999999887
Q ss_pred -CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCC--------CeEecCCCCCceeeCCCC
Q 001274 873 -DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP--------HIIHRDIKSNNILLDEEF 943 (1109)
Q Consensus 873 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~Dlkp~NIll~~~~ 943 (1109)
...++||||+++|+|.++++... +++..+..++.|++.||+||| +. +|+||||||+||+++.++
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCceEEEEeccCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCC
Confidence 67899999999999999997643 899999999999999999999 66 999999999999999999
Q ss_pred ceEEeeccccccccCCCCCC---ccccccccceeccccccCCCCCcc------chhHHHHHHHHHHHhC----------C
Q 001274 944 QAHVGDFGLAKLIDLPYSKS---MSAIAGSYGYIAPEYAYTMKVTEK------CDIYSFGVVLLELITG----------K 1004 (1109)
Q Consensus 944 ~~kl~DFG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvll~elltg----------~ 1004 (1109)
.+||+|||+++......... .....||+.|+|||++.+..++.+ +|||||||++|||+|| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997664322211 134579999999999988776655 9999999999999999 6
Q ss_pred CCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1005 SPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1005 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.||..................... ....+.... ...+....+.+++.+||+.||++|||+.|++++|+.+..+.
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKK-LRPSFPNRW-----SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSC-CCCCCCGGG-----GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccHhhhcCCCCchhhhHHHHhhhc-cCccccccc-----hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 676654433322222222211111 011111110 12245567899999999999999999999999999988765
Q ss_pred C
Q 001274 1085 S 1085 (1109)
Q Consensus 1085 ~ 1085 (1109)
+
T Consensus 334 ~ 334 (337)
T 3mdy_A 334 D 334 (337)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=383.01 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=212.2
Q ss_pred cCCCCCceEecCCcceEEEEEecC-CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.+|++.++||+|+||+||+|+++. ++.||||+++... ...+.|.+|++++++++||||++++++|...+..++|||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 568888999999999999999764 8899999997432 346789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.++++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 9999999999986432 23899999999999999999999 7799999999999999999999999999998765333
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.... .....+........
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~----------- 440 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYRMER----------- 440 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCCCCC-----------
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCC-----------
Confidence 233344567889999999999999999999999999999999 99999865422 22222222111100
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
.......+.+++.+||+.||++||||.++++.|+.+.+
T Consensus 441 -----~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 441 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -----CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11122457899999999999999999999999988753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=368.70 Aligned_cols=262 Identities=26% Similarity=0.324 Sum_probs=210.5
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++|++.+.||+|+||+||+|++. +++.||||+++.. ........+.+|+.++++++||||+++++++...+..
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 57888999999999999999843 4678999999633 2334556789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCC----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---ceEEe
Q 001274 876 LLLYEYMENGSLGEQLHGNKQ----TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF---QAHVG 948 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 948 (1109)
++||||+++|+|.+++..... ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976431 134899999999999999999999 77999999999999999555 59999
Q ss_pred eccccccccCC-CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhc
Q 001274 949 DFGLAKLIDLP-YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 949 DFG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
|||+++..... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+........
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~----~~~~~~~i~~~ 302 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS----NQEVLEFVTSG 302 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHHHHHTT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcC
Confidence 99999865322 2223344568999999999999999999999999999999998 999997532 22222222221
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
..... .......+.+++.+||+.||++||++.+|+++++.+.+..
T Consensus 303 ~~~~~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 303 GRMDP-------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCC-------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 11000 0111235779999999999999999999999999987664
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=347.97 Aligned_cols=253 Identities=27% Similarity=0.500 Sum_probs=202.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchh-----HHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATAD-----NSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++|++.+.||+|+||+||+|++. +++.||||++.......... +.+.+|++++++++||||+++++++....
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 67888999999999999999974 78999999997544332222 67899999999999999999999986544
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeCCCCc-----eEEe
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH--IIHRDIKSNNILLDEEFQ-----AHVG 948 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl~ 948 (1109)
++||||+++|+|.+++..... .+++..+..++.|++.|++||| +.+ |+||||||+||+++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999999876544 3899999999999999999999 678 999999999999988776 9999
Q ss_pred eccccccccCCCCCCccccccccceecccccc--CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 949 DFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY--TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 949 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
|||+++... .......||+.|+|||++. ...++.++||||+|+++|||++|+.||....... ..........
T Consensus 172 Dfg~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~ 245 (287)
T 4f0f_A 172 DFGLSQQSV----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--IKFINMIREE 245 (287)
T ss_dssp CCTTCBCCS----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH--HHHHHHHHHS
T ss_pred CCCcccccc----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH--HHHHHHHhcc
Confidence 999998543 2334567999999999984 5567899999999999999999999998644221 1222221111
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.... .+ .......+.+++.+||+.||++|||++|+++.|++
T Consensus 246 ~~~~--~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 GLRP--TI----------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCC--CC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCC--CC----------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1110 00 11112457899999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=370.03 Aligned_cols=276 Identities=20% Similarity=0.251 Sum_probs=220.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC--ceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD--SNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 878 (1109)
++|++.++||+|+||+||+|++. +++.||||++..... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 57889999999999999999976 589999999974322 233567889999999999999999999998765 67999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee----CCCCceEEeeccccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL----DEEFQAHVGDFGLAK 954 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~a~ 954 (1109)
|||+++|+|.+++........+++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999987654445899999999999999999999 7799999999999999 788889999999998
Q ss_pred cccCCCCCCccccccccceeccccccC--------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYT--------MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........+.+.....+
T Consensus 165 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 76522 22345679999999999865 567889999999999999999999998665444444444444433
Q ss_pred cCCCc-h----------hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1027 MVPTS-E----------LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1027 ~~~~~-~----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
..+.. . .+.................+.+++.+||+.||++||+++|+++.+..+...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 22100 0 001111122233456677889999999999999999999999999888664
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=358.14 Aligned_cols=263 Identities=26% Similarity=0.439 Sum_probs=215.3
Q ss_pred cCCCCCceEecCCcceEEEEEe------cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 874 (1109)
++|++.+.||+|+||+||+|++ .+++.||||+++... .....+.+.+|+++++++ +||||+++++++...+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 5788899999999999999985 246889999997432 234457899999999999 99999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQT---------------CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 939 (1109)
.++||||+++|+|.+++...... ..+++..+..++.||+.||+||| +.+|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 99999999999999999765421 23899999999999999999999 7799999999999999
Q ss_pred CCCCceEEeeccccccccCCCCCC-ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYSKS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLV 1017 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~ 1017 (1109)
+.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 999999999999998765332221 234457889999999999999999999999999999999 999998655433333
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
..+........+ ......+.+++.+||+.||++|||+.|++++|++.....
T Consensus 259 ~~~~~~~~~~~~----------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 259 KMIKEGFRMLSP----------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHTCCCCCC----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhccCCCCCCc----------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 333332111110 011235789999999999999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=361.57 Aligned_cols=265 Identities=25% Similarity=0.380 Sum_probs=211.7
Q ss_pred HhcCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 873 (1109)
..++|++.+.||+|+||+||+|++. +++.||||+++... .....+.+.+|++++++++||||+++++++...+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 3468999999999999999999874 34889999997432 3344577999999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCC---------------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQ---------------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDI 932 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 932 (1109)
..++||||+++|+|.+++..... ...+++.++..++.||++||+||| +.+|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 99999999999999999976431 134899999999999999999999 779999999
Q ss_pred CCCceeeCCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCc
Q 001274 933 KSNNILLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSL 1010 (1109)
Q Consensus 933 kp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~ 1010 (1109)
||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999986542221 22244568899999999999999999999999999999999 99999754
Q ss_pred ccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1011 ELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
. ..+..........+. . .......+.+++.+||+.||++||++.+++++|+++.....
T Consensus 281 ~----~~~~~~~~~~~~~~~---~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 281 A----HEEVIYYVRDGNILA---C----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp C----HHHHHHHHHTTCCCC---C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred C----hHHHHHHHhCCCcCC---C----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 3 222222222221110 0 01112357899999999999999999999999999876553
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=357.27 Aligned_cols=257 Identities=21% Similarity=0.251 Sum_probs=206.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 878 (1109)
++|++.+.||+|+||+||+|+++ +++.||+|+++..... ....+.+.+|..+++++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888999999999999999975 6899999999755332 23346688999999887 899999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++|+|.+++..... +++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999976543 899999999999999999999 77999999999999999999999999999986432
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC-----cHHHHHHHhhhccCCCchh
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG-----DLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 1033 (1109)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .................
T Consensus 163 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-- 239 (345)
T 3a8x_A 163 -PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 239 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC--
T ss_pred -CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC--
Confidence 1233455689999999999999999999999999999999999999997532111 11111111111111111
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTM------REVIAMMID 1079 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~evl~~L~~ 1079 (1109)
......+.+++.+||+.||++||++ .|+++|-+.
T Consensus 240 ------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 240 ------------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp ------------TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred ------------CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 1112357789999999999999995 788877543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=361.77 Aligned_cols=255 Identities=20% Similarity=0.224 Sum_probs=207.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|++. +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 67999999999999999999875 68999999987432 2344578899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC--CCceEEeeccccccccC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE--EFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~~~ 958 (1109)
|+++|+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 129 ~~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 129 FLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999999976543 3899999999999999999999 779999999999999974 57899999999987652
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+................
T Consensus 204 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~---- 273 (387)
T 1kob_A 204 D--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----DLETLQNVKRCDWEFDEDA---- 273 (387)
T ss_dssp T--SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHHCCCCCCSST----
T ss_pred C--cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCccc----
Confidence 2 22344579999999999999999999999999999999999999997532 2222222222221111100
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......+.+++.+||+.||++|||+.|++++-+.
T Consensus 274 ------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 274 ------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp ------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred ------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence 01112357799999999999999999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=350.54 Aligned_cols=254 Identities=21% Similarity=0.291 Sum_probs=198.7
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC------------------------cchhHHHHHHHHHhc
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG------------------------ATADNSFLAEISTLG 855 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~ 855 (1109)
.++|++.+.||+|+||+||+|++. +++.||||++...... ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999865 6899999999754311 112356889999999
Q ss_pred cCCCCceeeEEEEEEe--CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 001274 856 KIRHRNIVKLYGFCYH--QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIK 933 (1109)
Q Consensus 856 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 933 (1109)
+++||||+++++++.+ .+..++||||+++++|.+++... .+++..+..++.||+.||+||| +.+|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence 9999999999999987 56789999999999998865432 3899999999999999999999 7799999999
Q ss_pred CCceeeCCCCceEEeeccccccccCCCCCCccccccccceeccccccCCC---CCccchhHHHHHHHHHHHhCCCCCCCc
Q 001274 934 SNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMK---VTEKCDIYSFGVVLLELITGKSPVQSL 1010 (1109)
Q Consensus 934 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvll~elltg~~pf~~~ 1010 (1109)
|+||+++.++.+||+|||+++..... ........||+.|+|||++.+.. ++.++||||+||++|||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS-DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS-SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCccccccc-cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999876522 22234567999999999998765 478899999999999999999999753
Q ss_pred ccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1011 ELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
. ................. .......+.+++.+||+.||++|||+.|++++-+
T Consensus 244 ~----~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 244 R----IMCLHSKIKSQALEFPD------------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp S----HHHHHHHHHHCCCCCCS------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred c----HHHHHHHHhcccCCCCC------------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 2 22222222221111100 0011235779999999999999999999998755
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=358.78 Aligned_cols=250 Identities=19% Similarity=0.211 Sum_probs=208.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|++. +++.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57889999999999999999975 689999999964321 1223467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 99999999999986543 899999999999999999999 77999999999999999999999999999987542
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+..............
T Consensus 194 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~p~------- 259 (350)
T 1rdq_E 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQIYEKIVSGKVRFPS------- 259 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCT-------
T ss_pred ---CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC----HHHHHHHHHcCCCCCCC-------
Confidence 2345679999999999999999999999999999999999999997532 22333332222221111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMID 1079 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~~ 1079 (1109)
.....+.+++.+||+.||++||+ ++|++++-+.
T Consensus 260 -------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 260 -------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp -------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred -------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence 11235779999999999999998 9999987654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=375.02 Aligned_cols=344 Identities=21% Similarity=0.191 Sum_probs=226.6
Q ss_pred EEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCcc
Q 001274 364 KLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNR 443 (1109)
Q Consensus 364 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 443 (1109)
.++.++++++ .+|..+. +.++.|+|++|++++..+..|..+++|++|+|++|.+.+..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 4455555554 3333331 345555555555555555555555556666666665555555556666666666666666
Q ss_pred ccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChh
Q 001274 444 LSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSE 523 (1109)
Q Consensus 444 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 523 (1109)
+++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|.++++.+..|.++++|++|+|++|++++..+..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence 66555555666666666666666666666666666666666666666666666666666666677777766666655556
Q ss_pred hcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccc
Q 001274 524 VGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT 603 (1109)
Q Consensus 524 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 603 (1109)
+.++++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|+.|+|++|++++..+..|..+++|+
T Consensus 172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 251 (477)
T 2id5_A 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR 251 (477)
T ss_dssp HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCC
T ss_pred hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccC
Confidence 66666777777777776666666666667777777776666656666555555677777777777655445666677777
Q ss_pred eeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEccCc
Q 001274 604 ELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNN 683 (1109)
Q Consensus 604 ~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N 683 (1109)
.|+|++|.+++..+..+.++..|+ .|+|++|++++..|..|..+++|+.|||++|+|++..+..|..+++|++|+|++|
T Consensus 252 ~L~Ls~n~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 252 FLNLSYNPISTIEGSMLHELLRLQ-EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp EEECCSSCCCEECTTSCTTCTTCC-EEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred eeECCCCcCCccChhhccccccCC-EEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 777777777666666666666665 4777777777777888888888888888888888766677788888888888888
Q ss_pred ccccccCCCcccccccCCcccCCCCccc
Q 001274 684 NLVGTVPNTTVFRRIDSSNFAGNRGLCM 711 (1109)
Q Consensus 684 ~l~g~~p~~~~~~~~~~~~~~~n~~~c~ 711 (1109)
++.|..+....+.......+.++...|.
T Consensus 331 ~l~c~c~~~~~~~~~~~~~~~~~~~~C~ 358 (477)
T 2id5_A 331 PLACDCRLLWVFRRRWRLNFNRQQPTCA 358 (477)
T ss_dssp CEECSGGGHHHHTTTTSSCCTTCCCBEE
T ss_pred CccCccchHhHHhhhhccccCccCceeC
Confidence 8888776544444444456777777774
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=360.40 Aligned_cols=258 Identities=23% Similarity=0.389 Sum_probs=201.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCc----EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGE----VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.++||+|+||+||+|++. +++ +||+|.+.... .....+.+.+|++++++++||||+++++++.... .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 57888999999999999999864 444 35888775332 2344578999999999999999999999998754 78
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+|+||+++|+|.+++...... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999999875543 899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 957 DLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 957 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+....... .
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~~~--~---- 240 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLP--Q---- 240 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHHTTCCCC--C----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-HHHHHHHHcCCCCC--C----
Confidence 533222 2234457889999999999999999999999999999999 9999986432 22222222211111 0
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++||++.|++++|+.+...
T Consensus 241 ----------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 241 ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ----------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 111123577899999999999999999999999887653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=361.25 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=206.4
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 876 (1109)
..++|++.+.||+|+||+||+|+++ +++.||||+++.... .....+.+..|..+++.+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999975 689999999974321 112345678899998876 9999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999976543 899999999999999999999 779999999999999999999999999999864
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+..............
T Consensus 169 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~p~---- 239 (345)
T 1xjd_A 169 ML-GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMDNPFYPR---- 239 (345)
T ss_dssp CC-TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCT----
T ss_pred cc-CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC----HHHHHHHHHhCCCCCCc----
Confidence 32 1223456689999999999999999999999999999999999999997532 22222222222211111
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMR-EVIAMMI 1078 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~-evl~~L~ 1078 (1109)
. ....+.+++.+||+.||++||++. +++++-+
T Consensus 240 ~----------~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 240 W----------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp T----------SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred c----------cCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 0 123577899999999999999998 8876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=354.92 Aligned_cols=264 Identities=28% Similarity=0.380 Sum_probs=205.0
Q ss_pred cCCCCCceEecCCcceEEEEEe-----cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--Cc
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 874 (1109)
++|++.++||+|+||+||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 6788999999999999999984 26889999998633 234456789999999999999999999998654 45
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+++|+|.+++...... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGG--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhcccc--cCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 79999999999999999876543 899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCC--CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC-----------CcHHHHHH
Q 001274 955 LIDLPYS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG-----------GDLVTWVR 1021 (1109)
Q Consensus 955 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~-----------~~~~~~~~ 1021 (1109)
....... .......++..|+|||++.+..++.++||||+|+++|||++|..||...... ......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 7643221 1223445778899999999999999999999999999999999998643200 00000111
Q ss_pred HhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1022 RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
........ ..........+.+++.+||+.||++|||++|++++|+.+....
T Consensus 243 ~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 ELLKNNGR------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHTTCC------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHhccCc------------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11111000 0011122346889999999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=356.03 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=212.1
Q ss_pred cCCCCCceEecCCcceEEEEEe------cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++|.+.+.||+|+||.||+|++ .+++.||||+++.. ......+.+.+|++++++++||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 6788899999999999999986 23578999999743 2334557789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCC---------------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 001274 876 LLLYEYMENGSLGEQLHGNKQ---------------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKS 934 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 934 (1109)
++||||+++|+|.+++..... ...+++..+..++.||++||+||| +.+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 999999999999999976542 123889999999999999999999 77999999999
Q ss_pred CceeeCCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCccc
Q 001274 935 NNILLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLEL 1012 (1109)
Q Consensus 935 ~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~ 1012 (1109)
+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.+...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986643222 12234467889999999999999999999999999999999 9999976442
Q ss_pred CCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1013 GGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
. .....+........ .......+.+++.+||+.||++||++.|++++|+++...
T Consensus 259 ~-~~~~~~~~~~~~~~----------------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 E-RLFNLLKTGHRMER----------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp G-GHHHHHHTTCCCCC----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred H-HHHHHhhcCCcCCC----------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 2 22222221111000 111124578999999999999999999999999988754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=357.23 Aligned_cols=270 Identities=21% Similarity=0.334 Sum_probs=204.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|++. +++.||||++..........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67899999999999999999975 58999999997655444456778899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++.....
T Consensus 83 ~~~~~~l~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP- 155 (311)
T ss_dssp CCSEEHHHHHHHTSSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhhcC---CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-
Confidence 9999999998876543 899999999999999999999 779999999999999999999999999999876522
Q ss_pred CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc-------h
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS-------E 1032 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~ 1032 (1109)
........+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||.+....+.. ..+........+.. .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL-YLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHHHHTCG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhccccccccccccccc
Confidence 222345578999999999876 66899999999999999999999999764322111 11222111111000 0
Q ss_pred hhhh-------hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1033 LFDK-------RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1033 ~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.+.. ...............+.+++.+||+.||++|||++|++++-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 288 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence 0000 0000000001223457899999999999999999999988544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=375.76 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=204.3
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||+||+|+++++..||||+++... ...+.|.+|++++++++||||+++++++.. +..++||||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 5688889999999999999999888889999997432 235679999999999999999999999876 678999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++|+|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 999999999975321 23899999999999999999999 77999999999999999999999999999987653332
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..+.......... ..
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~----~~~~~~~i~~~~~-~~--------- 401 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYR-MP--------- 401 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTTCC-CC---------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcCCC-CC---------
Confidence 33344567889999999999999999999999999999999 999997543 1222222111110 00
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
........+.+++.+||+.||++|||++++++.|+......
T Consensus 402 ---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 402 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 01112245789999999999999999999999999886544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=371.93 Aligned_cols=266 Identities=21% Similarity=0.197 Sum_probs=209.1
Q ss_pred HHHHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC
Q 001274 796 NLLEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 796 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 873 (1109)
+.....++|++.++||+|+||+||+|+.+ +++.||||+++.... .....+.+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 33345678999999999999999999975 699999999964211 1123355889999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA 953 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 953 (1109)
..|+||||+++|+|.+++...+. .+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999976543 3899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccceecccccc-------CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAY-------TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
+.............+||+.|+|||++. +..++.++||||+||++|||++|+.||.+..........+......
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence 876533322334568999999999987 4578999999999999999999999997543211111111111011
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHHHHHh
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNR---PTMREVIAMMIDA 1080 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Pt~~evl~~L~~~ 1080 (1109)
..+. .. ......+.+++.+|+. +|++| |+++|+++|-+..
T Consensus 290 ~~p~---~~----------~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~ 332 (412)
T 2vd5_A 290 SLPL---VD----------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332 (412)
T ss_dssp CCC-----------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred CCCc---cc----------cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence 1110 00 0112357799999999 99998 6999999886653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=346.75 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=206.6
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.++|++.+.||+|+||+||+|++. +++.||||++...... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 367889999999999999999865 5789999998643211 12345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++|+|.+++..... +++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999976543 899999999999999999999 78999999999999999999999999999865432
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.... ..+...............
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~----- 229 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQETYKRISRVEFTFPDF----- 229 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHTCCCCCTT-----
T ss_pred ---ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc----HHHHHHHHHhCCCCCCCc-----
Confidence 22344578999999999999999999999999999999999999997532 222222222211111111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
....+.+++.+||+.||++|||+.|++++-+-....
T Consensus 230 ---------~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 230 ---------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp ---------SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ---------CCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 123567899999999999999999999998765543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=363.97 Aligned_cols=264 Identities=25% Similarity=0.417 Sum_probs=212.7
Q ss_pred HhcCCCCCceEecCCcceEEEEEecC------CcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLAN------GEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
..++|++.+.||+|+||+||+|++.. ...||+|++.... .....+.+.+|+++++++ +||||+++++++...
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 34789999999999999999998642 2479999997432 334457789999999999 899999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCC-----------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQ-----------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE 941 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 941 (1109)
+..++||||+++|+|.+++..... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECC
Confidence 999999999999999999975321 123799999999999999999999 779999999999999999
Q ss_pred CCceEEeeccccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHH
Q 001274 942 EFQAHVGDFGLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTW 1019 (1109)
Q Consensus 942 ~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~ 1019 (1109)
++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |..||.+..........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 999999999999866432221 1234457889999999999999999999999999999999 99999865433333333
Q ss_pred HHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1020 VRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
+........+ ......+.+++.+||+.||++|||+.|++++|+.....
T Consensus 280 ~~~~~~~~~~----------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 280 VKDGYQMAQP----------------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHTCCCCCC----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCCCCC----------------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 3332111110 00123577899999999999999999999999887654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=351.38 Aligned_cols=255 Identities=24% Similarity=0.277 Sum_probs=209.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc----chhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA----TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.+.||+|+||+||+|++. +++.||||+++...... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 57899999999999999999976 68999999997653322 13567999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC----ceEEeeccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF----QAHVGDFGL 952 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~ 952 (1109)
+||||+++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSC---EEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999976543 899999999999999999999 77999999999999999888 799999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
++..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.+.. ..+..............
T Consensus 166 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~ 239 (321)
T 2a2a_A 166 AHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANITSVSYDFDE 239 (321)
T ss_dssp CEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHTTCCCCCH
T ss_pred ceecCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhcccccCh
Confidence 9876532 22345679999999999999999999999999999999999999997532 22233222222211111
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
... ......+.+++.+||+.||++|||+.|++++-+
T Consensus 240 ~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 240 EFF----------SHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp HHH----------TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred hhh----------cccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 111 011235779999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=357.95 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=191.6
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|++. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 367899999999999999999976 58899999997432 3456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE---EFQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~ 956 (1109)
||+++|+|.+++..... +++.++..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHTTCSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999976543 899999999999999999999 779999999999999975 889999999999866
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...................
T Consensus 202 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~i~~~~~~~~~~~~- 275 (349)
T 2w4o_A 202 EH--QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---QFMFRRILNCEYYFISPWW- 275 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---HHHHHHHHTTCCCCCTTTT-
T ss_pred Cc--ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---HHHHHHHHhCCCccCCchh-
Confidence 42 22234567999999999999999999999999999999999999999753321 1122222221111110000
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
......+.+++.+||+.||++|||+.|++++-+.
T Consensus 276 ---------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 276 ---------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp ---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ---------hhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 1112357799999999999999999999987544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.40 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=193.4
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCC--cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEG--ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|++. ++.||||+++..... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888999999999999999985 899999998754322 223467899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC---eEecCCCCCceeeCC--------CCceEEe
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH---IIHRDIKSNNILLDE--------EFQAHVG 948 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~Dlkp~NIll~~--------~~~~kl~ 948 (1109)
||+++++|.+++... .+++..+..++.|++.|++||| +.+ |+||||||+||+++. ++.+||+
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999998643 3899999999999999999999 556 999999999999986 7789999
Q ss_pred eccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 949 DFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 949 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
|||.++..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.+... ............
T Consensus 159 Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~ 231 (271)
T 3dtc_A 159 DFGLAREWHRT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----LAVAYGVAMNKL 231 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHHHHHTSCC
T ss_pred cCCcccccccc---cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHhhhcCCC
Confidence 99999865422 22345789999999999999999999999999999999999999985431 111111111111
Q ss_pred CCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1029 PTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
... ........+.+++.+||+.||++|||+.|++++|+.
T Consensus 232 ~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 ALP------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCC------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 000 011112457899999999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.12 Aligned_cols=264 Identities=22% Similarity=0.271 Sum_probs=202.5
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.++|++.+.||+|+||+||+|++. +++.||+|++...... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 6899999999754322 22346788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999986543 899999999999999999999 77999999999999999999999999999987653
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
..........+++.|+|||++.+..++.++||||+|+++|||++|+.||.... ...+........+......+
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~-- 259 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-----LSVMGAHINQAIPRPSTVRP-- 259 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH-----HHHHHHHHHSCCCCGGGTST--
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch-----HHHHHHHhccCCCCccccCC--
Confidence 33333345678999999999999999999999999999999999999997532 12222222222221111111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhccC
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRP-TMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~ 1085 (1109)
.....+.+++.+||+.||++|| +++++++.|+.+.....
T Consensus 260 --------~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 260 --------GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp --------TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred --------CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 1123577899999999999999 99999999998876553
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=358.24 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=207.3
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 877 (1109)
.++|++.+.||+|+||+||+|+.+ +++.||||+++.... .....+.+.+|..++..+ +||+|+++++++...+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999976 478999999974321 122346688999999988 89999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999986543 899999999999999999999 7799999999999999999999999999998643
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+..............
T Consensus 173 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~~i~~~~~~~p~----- 242 (353)
T 2i0e_A 173 W-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----EDELFQSIMEHNVAYPK----- 242 (353)
T ss_dssp C-TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCT-----
T ss_pred c-CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC----HHHHHHHHHhCCCCCCC-----
Confidence 1 2223456689999999999999999999999999999999999999997532 22333332222221111
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMI 1078 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~ 1078 (1109)
.....+.+++.+||+.||++||+ ++|++++-+
T Consensus 243 ---------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 243 ---------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp ---------TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred ---------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 11235778999999999999995 688887754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=372.65 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=207.4
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC-ceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD-SNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 879 (1109)
.++|++.++||+|+||+||+|++. ++.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 357888899999999999999986 7899999997432 4567999999999999999999999987765 689999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 267 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~- 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 341 (450)
T ss_dssp ECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-
Confidence 99999999999986543 23789999999999999999999 77999999999999999999999999999985432
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+........
T Consensus 342 ---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~~~~~~~~---------- 407 (450)
T 1k9a_A 342 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDA---------- 407 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-THHHHHHTTCCCCC----------
T ss_pred ---cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCC----------
Confidence 1223367889999999999999999999999999999999 99999865432 22222222111110
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 408 ------p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 ------PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 111224678999999999999999999999999988754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=369.26 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=209.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|.+.+.||+|+||+||+|++. +|+.||||++..... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67889999999999999999976 799999999974321 1123457889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++...+. +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~- 168 (476)
T 2y94_A 96 EYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 168 (476)
T ss_dssp ECCSSEEHHHHTTSSSS---CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT-
T ss_pred eCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccc-
Confidence 99999999999976543 899999999999999999999 78999999999999999999999999999987652
Q ss_pred CCCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.. ..................
T Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~----- 238 (476)
T 2y94_A 169 -GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH----VPTLFKKICDGIFYTPQY----- 238 (476)
T ss_dssp -TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS----SHHHHHHHHTTCCCCCTT-----
T ss_pred -cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC----HHHHHHHHhcCCcCCCcc-----
Confidence 223345689999999999998776 689999999999999999999997532 222222222222111110
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
....+.+++.+||+.||++|||++|++++-+..
T Consensus 239 ---------~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 239 ---------LNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp ---------CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred ---------CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 113467899999999999999999999986654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=355.25 Aligned_cols=253 Identities=23% Similarity=0.253 Sum_probs=198.0
Q ss_pred cCCCCCceEecCCcceEEEEEe----cCCcEEEEEEeeccCC--CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATL----ANGEVIAVKKIKLRGE--GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++|++.+.||+|+||+||+|+. .+++.||+|+++.... .......+.+|++++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5788999999999999999986 4789999999975422 122345678999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++||||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGI---FMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999976543 889999999999999999999 77999999999999999999999999999975
Q ss_pred ccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 956 IDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. .................
T Consensus 171 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~p~--- 242 (327)
T 3a62_A 171 SIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN----RKKTIDKILKCKLNLPP--- 242 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHTCCCCCT---
T ss_pred cccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhCCCCCCC---
Confidence 4321 222345679999999999999999999999999999999999999997532 22222322222211111
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMID 1079 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~ 1079 (1109)
.....+.+++.+||+.||++|| ++.|+++|-+.
T Consensus 243 -----------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 243 -----------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp -----------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred -----------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 1123577999999999999999 88899987654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=372.83 Aligned_cols=264 Identities=23% Similarity=0.286 Sum_probs=200.7
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC------
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD------ 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 873 (1109)
.++|++.++||+|+||+||+|++. +++.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999865 6899999999755444555678899999999999999999999997653
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA 953 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 953 (1109)
..|+||||+++ ++.+.+.. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 46999999976 56666643 2889999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCch
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSE 1032 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 1032 (1109)
+.... .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.. ..+.+........ +..+
T Consensus 212 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~----~~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD----YIDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCSCCHH
T ss_pred eecCC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCCHH
Confidence 87652 233456789999999999999999999999999999999999999998643 2222222211111 1111
Q ss_pred hhhh--------------------------hc-chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1033 LFDK--------------------------RL-DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1033 ~~~~--------------------------~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.+.. .. .............+.+++.+||+.||++|||++|+++|-+.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 1100 00 00000111224568899999999999999999999988544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=354.25 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=186.1
Q ss_pred CceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEEEEeccC
Q 001274 807 GAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
.+.||+|+||+||+|++. +++.||||++... ....+.+|+.+++.++ ||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 478999999999999975 6899999999732 4567889999999996 99999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---ceEEeeccccccccCCCC
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF---QAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~~~~~~ 961 (1109)
|+|.+++..... +++.++..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||+++.... ..
T Consensus 91 ~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~-~~ 163 (325)
T 3kn6_A 91 GELFERIKKKKH---FSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DN 163 (325)
T ss_dssp CBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC-CC
Confidence 999999987643 899999999999999999999 77999999999999997765 899999999986542 22
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCccc---CCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLEL---GGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .....+..........+......
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~--- 240 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW--- 240 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHH---
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccc---
Confidence 333456789999999999999999999999999999999999999986432 12333333333333222111110
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
......+.+++.+||+.||++|||++|++++-+..
T Consensus 241 -------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~ 275 (325)
T 3kn6_A 241 -------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275 (325)
T ss_dssp -------HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred -------cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence 11224578999999999999999999999886543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=359.43 Aligned_cols=251 Identities=22% Similarity=0.254 Sum_probs=199.5
Q ss_pred CceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 807 GAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 568999999999999864 68999999997432 234577999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee--CCCCceEEeeccccccccCCCCCC
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL--DEEFQAHVGDFGLAKLIDLPYSKS 963 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DFG~a~~~~~~~~~~ 963 (1109)
+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+++..... ..
T Consensus 172 ~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~~ 244 (373)
T 2x4f_A 172 ELFDRIIDESY--NLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EK 244 (373)
T ss_dssp EEHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--CB
T ss_pred cHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--cc
Confidence 99999876543 3899999999999999999999 7799999999999999 67789999999999876522 22
Q ss_pred ccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhc
Q 001274 964 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAK 1043 (1109)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+.+..............
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~--------- 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN----DAETLNNILACRWDLEDEE--------- 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHTCCCSCSGG---------
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCCCChhh---------
Confidence 344579999999999999999999999999999999999999997543 2222332222222111100
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1044 RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1044 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.......+.+++.+||+.||++|||+.|++++-+..
T Consensus 312 -~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 312 -FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp -GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred -hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 011123578999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=358.85 Aligned_cols=268 Identities=22% Similarity=0.242 Sum_probs=206.9
Q ss_pred HHHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC---CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC
Q 001274 797 LLEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG---EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 797 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 872 (1109)
+.+..++|++.+.||+|+||+||+|++. +++.||+|++.... ......+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4456688999999999999999999875 68899999996431 2234567899999999999999999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCC-------------------------------------CCCCChHHHHHHHHHHHHH
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQ-------------------------------------TCLLDWDARYRIALGAAEG 915 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~~ 915 (1109)
+..++||||+++|+|.+++..... ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852110 1124677788999999999
Q ss_pred HHHHhhcCCCCeEecCCCCCceeeCCCC--ceEEeeccccccccCCCC---CCccccccccceeccccccC--CCCCccc
Q 001274 916 LCYLHYDCRPHIIHRDIKSNNILLDEEF--QAHVGDFGLAKLIDLPYS---KSMSAIAGSYGYIAPEYAYT--MKVTEKC 988 (1109)
Q Consensus 916 l~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 988 (1109)
|+||| +.+|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999 77999999999999998776 899999999986543221 12345679999999999875 6789999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCC
Q 001274 989 DIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP 1068 (1109)
Q Consensus 989 DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 1068 (1109)
||||+||++|||++|+.||.+... .+................ .......+.+++.+||+.||++||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND----ADTISQVLNKKLCFENPN----------YNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCTTSGG----------GGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh----HHHHHHHHhcccccCCcc----------cccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999975432 222222222221111100 001123577999999999999999
Q ss_pred CHHHHHHHHHHhh
Q 001274 1069 TMREVIAMMIDAR 1081 (1109)
Q Consensus 1069 t~~evl~~L~~~~ 1081 (1109)
++.|++++-+...
T Consensus 324 s~~~~l~hp~~~~ 336 (345)
T 3hko_A 324 DAMRALQHPWISQ 336 (345)
T ss_dssp CHHHHHHSHHHHT
T ss_pred CHHHHhcChhhcc
Confidence 9999999876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=348.75 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=210.4
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.+.||+|+||+||+|+..+++.||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 5788899999999999999998888899999997432 24567999999999999999999999886 4568999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++.......
T Consensus 89 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999975421 13899999999999999999999 77999999999999999999999999999987653333
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||++.+..++.++||||+|+++|||++ |+.||.+.. ..+............ .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~~~~~~~~~~~~---~------ 231 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQNLERGYRMV---R------ 231 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTTCCCC---C------
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC----HHHHHHHHhcccCCC---C------
Confidence 33344567889999999998899999999999999999999 999997533 122222211111100 0
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
.......+.+++.+||+.||++|||+.++++.|+.......
T Consensus 232 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 01112457899999999999999999999999999876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=356.62 Aligned_cols=257 Identities=21% Similarity=0.245 Sum_probs=206.2
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 878 (1109)
.++|++.+.||+|+||+||+|+++ +++.||||++..... ...+|++++.++ +||||+++++++.+.+..|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 357999999999999999999975 689999999974322 245788888887 799999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC----CceEEeeccccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE----FQAHVGDFGLAK 954 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~ 954 (1109)
|||+++|+|.+++...+. +++..+..++.||+.||+||| +.+|+||||||+||++..+ +.+||+|||+++
T Consensus 95 ~E~~~gg~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp ECCCCSCBHHHHHHTCTT---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999999976543 899999999999999999999 7799999999999998433 359999999998
Q ss_pred cccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
..... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .....+................
T Consensus 169 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~~~~i~~~~~~~~~~~ 246 (342)
T 2qr7_A 169 QLRAE-NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-DDTPEEILARIGSGKFSLSGGY 246 (342)
T ss_dssp ECBCT-TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-TSCHHHHHHHHHHCCCCCCSTT
T ss_pred cCcCC-CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-cCCHHHHHHHHccCCcccCccc
Confidence 76532 223345678999999999998889999999999999999999999997532 2333333333333322211111
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.. .....+.+++.+||+.||++||++.|++++-+...
T Consensus 247 ~~----------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 247 WN----------SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TT----------TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cc----------cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 11 11235778999999999999999999999887643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=359.71 Aligned_cols=265 Identities=22% Similarity=0.360 Sum_probs=211.8
Q ss_pred HHHhcCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe
Q 001274 798 LEATGNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH 871 (1109)
Q Consensus 798 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 871 (1109)
....++|++.+.||+|+||+||+|++. +++.||||++... ........+.+|++++++++||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 344578999999999999999999754 3678999999743 223345678999999999999999999999999
Q ss_pred CCceEEEEEeccCCCHHHHhccCCC-------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 001274 872 QDSNLLLYEYMENGSLGEQLHGNKQ-------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ 944 (1109)
Q Consensus 872 ~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 944 (1109)
.+..++||||+++|+|.+++..... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCe
Confidence 9999999999999999999975321 123789999999999999999999 779999999999999999999
Q ss_pred eEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHH
Q 001274 945 AHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRR 1022 (1109)
Q Consensus 945 ~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~ 1022 (1109)
+||+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... ..+....
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~~~~ 252 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----NEQVLRF 252 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----HHHHHHH
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC----HHHHHHH
Confidence 99999999986542221 12233457889999999999999999999999999999999 899987543 2222222
Q ss_pred hhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
......+.. .......+.+++.+||+.||++|||+.|++++|++....
T Consensus 253 ~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 253 VMEGGLLDK-------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHcCCcCCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 222111100 111123577999999999999999999999999887553
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.63 Aligned_cols=256 Identities=22% Similarity=0.255 Sum_probs=208.3
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|++. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 367999999999999999999976 578999999975433 24567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~ 956 (1109)
||+++++|.+++..... +++..+..++.|++.|++||| +.+|+||||||+||++ +.++.+||+|||.+...
T Consensus 86 e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp ECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 99999999999876543 899999999999999999999 7799999999999999 78899999999999876
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. ........||+.|+|||++.+. ++.++||||+|+++|||++|+.||.... ..+.................
T Consensus 160 ~~--~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~- 231 (277)
T 3f3z_A 160 KP--GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT----DSEVMLKIREGTFTFPEKDW- 231 (277)
T ss_dssp CT--TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCHHHH-
T ss_pred cC--ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhCCCCCCchhh-
Confidence 52 2233456799999999988654 8999999999999999999999997533 22222222222221111100
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
......+.+++.+|++.||++|||+.|++++-+...
T Consensus 232 ---------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 ---------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ---------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ---------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 011245789999999999999999999998866543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=359.49 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=203.2
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCC--CceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH--RNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 878 (1109)
.++|++.+.||+|+||+||+|+..+++.||||++..........+.+.+|++++++++| +||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35788999999999999999998889999999998665555556789999999999976 9999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
||+ .+++|.+++..... +++.++..++.||+.||+||| +.+|+||||||+||+++ ++.+||+|||+++....
T Consensus 88 ~e~-~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp ECC-CSEEHHHHHHHSCC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EeC-CCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 994 58899999987553 899999999999999999999 77999999999999997 67899999999987653
Q ss_pred CCCC-CccccccccceeccccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 959 PYSK-SMSAIAGSYGYIAPEYAYT-----------MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 959 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ............
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~~~~~~ 236 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---NQISKLHAIIDP 236 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC---SHHHHHHHHHCT
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh---hHHHHHHHHhcC
Confidence 2221 2245679999999999865 678999999999999999999999997532 112222222211
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.... .+. ......+.+++.+||+.||++|||+.|++++.+...
T Consensus 237 ~~~~--~~~----------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 237 NHEI--EFP----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp TSCC--CCC----------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred Cccc--CCc----------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 1100 000 001135779999999999999999999999987654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=352.29 Aligned_cols=270 Identities=23% Similarity=0.316 Sum_probs=204.7
Q ss_pred HhcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCC---cchhHHHHHHHHHhccCC---CCceeeEEEEEEeC
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEG---ATADNSFLAEISTLGKIR---HRNIVKLYGFCYHQ 872 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 872 (1109)
..++|++.++||+|+||+||+|++ .+++.||||++...... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999996 47899999999754321 222356778888877764 99999999999876
Q ss_pred C-----ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 001274 873 D-----SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV 947 (1109)
Q Consensus 873 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 947 (1109)
. ..++||||+. |+|.+++...... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence 5 4689999996 6999999876532 3899999999999999999999 779999999999999999999999
Q ss_pred eeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc
Q 001274 948 GDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM 1027 (1109)
Q Consensus 948 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 1027 (1109)
+|||+++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+............. ...
T Consensus 162 ~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~- 237 (308)
T 3g33_A 162 ADFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGL- 237 (308)
T ss_dssp CSCSCTTTSTT--CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH-HCC-
T ss_pred eeCccccccCC--CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCC-
Confidence 99999986642 23345568999999999999999999999999999999999999999764322222222221 110
Q ss_pred CCCchhhhhhcc-------hh-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1028 VPTSELFDKRLD-------LS-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1028 ~~~~~~~~~~~~-------~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
+....+..... .. .....+....+.+++.+|++.||++|||+.|++++-+.
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 238 -PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300 (308)
T ss_dssp -CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred -CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence 01111100000 00 00011223467899999999999999999999987543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=364.10 Aligned_cols=277 Identities=24% Similarity=0.323 Sum_probs=207.0
Q ss_pred cCCCCCceEecCCcceEEEEEe-----cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--CCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--QDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 874 (1109)
++|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 5788999999999999999984 36889999998643 23445678999999999999999999999874 456
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+++++|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 7899999999999999976443 3899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCC--CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC----------CcHHHHHHH
Q 001274 955 LIDLPYSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG----------GDLVTWVRR 1022 (1109)
Q Consensus 955 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~----------~~~~~~~~~ 1022 (1109)
........ ......+|..|+|||++.+..++.++||||+|+++|||++|+.||...... ......+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76432221 223456888899999999999999999999999999999999998643210 000000111
Q ss_pred hhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCCCCCccccc
Q 001274 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSSPTSETPL 1097 (1109)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~ 1097 (1109)
....... ..........+.+++.+||+.||++|||++|++++|+.+..........+.+..|.
T Consensus 256 ~~~~~~~------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~p~ 318 (327)
T 3lxl_A 256 LLEEGQR------------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPE 318 (327)
T ss_dssp HHHTTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----------------
T ss_pred HhhcccC------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccccccCcC
Confidence 1110000 00111223467899999999999999999999999999887766555544444333
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.99 Aligned_cols=264 Identities=20% Similarity=0.276 Sum_probs=205.5
Q ss_pred HhcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEE-EeCCceEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC-YHQDSNLL 877 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 877 (1109)
..++|++.+.||+|+||+||+|++ .+++.||||++.... ....+.+|+++++.++|++++..++++ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 347899999999999999999996 478999999876432 234588999999999887766665555 66777899
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEeeccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAK 954 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~ 954 (1109)
||||+ +++|.+++...... +++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 83 v~e~~-~~~L~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEcc-CCCHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 99999 99999999854433 899999999999999999999 7799999999999999 789999999999998
Q ss_pred cccCCCC------CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC--cH-HHHHHHhhh
Q 001274 955 LIDLPYS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG--DL-VTWVRRSIH 1025 (1109)
Q Consensus 955 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~--~~-~~~~~~~~~ 1025 (1109)
....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .. .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 7653322 12235679999999999999999999999999999999999999998654222 11 111111111
Q ss_pred ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1026 EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
. + .+... ......+.+++.+||+.||++|||++++++.|+.+......
T Consensus 237 ~--~-~~~~~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 237 T--P-IEVLC----------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp S--C-HHHHT----------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred c--h-hhhhh----------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 1 0 00000 01124678999999999999999999999999998876643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=361.55 Aligned_cols=254 Identities=22% Similarity=0.253 Sum_probs=195.1
Q ss_pred cCCCCC-ceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhc-cCCCCceeeEEEEEEe----CCc
Q 001274 802 GNFSEG-AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLG-KIRHRNIVKLYGFCYH----QDS 874 (1109)
Q Consensus 802 ~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~ 874 (1109)
++|.+. +.||+|+||+||+|++. +++.||||++. ....+.+|++++. ..+||||+++++++.. .+.
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~-------~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-------CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeC-------cchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 456665 68999999999999875 68999999996 2345778888874 4589999999999876 556
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEeecc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE---EFQAHVGDFG 951 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG 951 (1109)
.|+||||+++|+|.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 7999999999999999987542 24899999999999999999999 779999999999999987 7899999999
Q ss_pred ccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC---cHHHHHHHhhhccC
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG---DLVTWVRRSIHEMV 1028 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~ 1028 (1109)
+++.... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+... ..
T Consensus 210 ~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~---~~ 284 (400)
T 1nxk_A 210 FAKETTS--HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG---QY 284 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT---CC
T ss_pred cccccCC--CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC---cc
Confidence 9986542 223345678999999999999999999999999999999999999997654221 122222211 11
Q ss_pred CCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1029 PTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
...... .......+.+++.+||+.||++|||+.|++++-+...
T Consensus 285 ~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 285 EFPNPE----------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp CCCTTT----------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cCCCcc----------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 100000 0111235779999999999999999999999977653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=366.51 Aligned_cols=269 Identities=25% Similarity=0.323 Sum_probs=197.0
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCC--ce
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQD--SN 875 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 875 (1109)
..++|++.+.||+|+||+||+|++. +++.||||++..........+.+.+|+.+++++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999865 6899999999755455556677889999999997 999999999998654 67
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
|+||||++ |+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 6899998764 2899999999999999999999 77999999999999999999999999999986
Q ss_pred ccCC--------------------CCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 001274 956 IDLP--------------------YSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGG 1014 (1109)
Q Consensus 956 ~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~ 1014 (1109)
.... ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 1112244689999999999886 678999999999999999999999998643222
Q ss_pred cHHHHHHHhhhccCCCchhhhhhcc-----------h---------------------hhcccHHHHHHHHHHHHhccCC
Q 001274 1015 DLVTWVRRSIHEMVPTSELFDKRLD-----------L---------------------SAKRTVEEMTLFLKIALFCSST 1062 (1109)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~---------------------~~~~~~~~~~~~~~li~~cl~~ 1062 (1109)
.+...+. .. ..|..+.+..... . ...........+.+++.+||+.
T Consensus 239 ~~~~i~~-~~--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 239 QLERIIG-VI--DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHH-HH--CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHH-hc--CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 1111111 11 1111111100000 0 0000001134578999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 001274 1063 SPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1063 dP~~RPt~~evl~~L~~ 1079 (1109)
||++|||++|+++|-+.
T Consensus 316 dP~~R~t~~e~l~Hp~~ 332 (388)
T 3oz6_A 316 NPNKRISANDALKHPFV 332 (388)
T ss_dssp SGGGSCCHHHHTTSTTT
T ss_pred CcccCCCHHHHhCCHHH
Confidence 99999999999998553
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=356.19 Aligned_cols=266 Identities=22% Similarity=0.263 Sum_probs=210.1
Q ss_pred HHHHHHhcCCCCC-ceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEe
Q 001274 795 HNLLEATGNFSEG-AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYH 871 (1109)
Q Consensus 795 ~~~~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 871 (1109)
.......++|.+. +.||+|+||+||+|+.. +++.||||+++...........+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3344555677777 89999999999999876 689999999986655555567899999999999 56999999999999
Q ss_pred CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEe
Q 001274 872 QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE---EFQAHVG 948 (1109)
Q Consensus 872 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 948 (1109)
.+..++||||+++|+|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 9999999999999999999865432 24899999999999999999999 779999999999999987 7899999
Q ss_pred eccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 949 DFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 949 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
|||+++..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .+..........
T Consensus 177 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~ 250 (327)
T 3lm5_A 177 DFGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN----QETYLNISQVNV 250 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCC
T ss_pred eCccccccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHhccc
Confidence 99999876522 223456799999999999999999999999999999999999999975332 222221111111
Q ss_pred CCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1029 PTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
...... .......+.+++.+||+.||++|||++|++++-+..
T Consensus 251 ~~~~~~----------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~ 292 (327)
T 3lm5_A 251 DYSEET----------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292 (327)
T ss_dssp CCCTTT----------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred ccCchh----------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence 111100 111223577999999999999999999999986653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=350.09 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=214.4
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|++. +++.||+|++... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 467888999999999999999976 4889999999732 335678999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++.....
T Consensus 89 e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999976443 24899999999999999999999 679999999999999999999999999999876544
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.........+|+.|+|||++.+..++.++||||+|+++|+|++ |..||...... .....+........
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~~~~~~~~~~~---------- 233 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYRMER---------- 233 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCCCCC----------
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhccCCCCC----------
Confidence 3333445567889999999999999999999999999999999 99999764322 22222222111110
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+|++.||++|||++++++.|+.....
T Consensus 234 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 234 ------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 111124578999999999999999999999999887664
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=357.86 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=205.9
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcc------hhHHHHHHHHHhccCCCCceeeEEEEEEeC
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGAT------ADNSFLAEISTLGKIRHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 872 (1109)
..++|++.+.||+|+||+||+|++. +++.||||+++....... ....+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3468999999999999999999864 689999999975532211 334677899999999999999999999999
Q ss_pred CceEEEEEeccCC-CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 873 DSNLLLYEYMENG-SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 873 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
+..++||||+.+| +|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99999987654 899999999999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
+++.... ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... .......
T Consensus 176 ~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~~~ 243 (335)
T 3dls_A 176 SAAYLER--GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------VEAAIHP 243 (335)
T ss_dssp TCEECCT--TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------TTTCCCC
T ss_pred cceECCC--CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------HhhccCC
Confidence 9987652 223345679999999999998887 78999999999999999999999753210 0000000
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.. .....+.+++.+||+.||++|||++|++++-+.
T Consensus 244 ----------~~----~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 244 ----------PY----LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp ----------SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred ----------Cc----ccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 00 012357799999999999999999999998654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=356.24 Aligned_cols=272 Identities=25% Similarity=0.381 Sum_probs=216.3
Q ss_pred CHHHHHHHhcCCCCCceEecCCcceEEEEEe------cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeE
Q 001274 793 KYHNLLEATGNFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKL 865 (1109)
Q Consensus 793 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 865 (1109)
...++....++|++.+.||+|+||+||+|++ .+++.||||+++.. ......+.+.+|+++++++ +||||+++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3344444567899999999999999999974 24688999999743 2333456789999999999 79999999
Q ss_pred EEEEEeCC-ceEEEEEeccCCCHHHHhccCCCC-------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 001274 866 YGFCYHQD-SNLLLYEYMENGSLGEQLHGNKQT-------------CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRD 931 (1109)
Q Consensus 866 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 931 (1109)
++++...+ ..++||||+++|+|.+++...... ..+++..+..++.|++.||.||| +.+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 99988765 489999999999999999875431 22789999999999999999999 77999999
Q ss_pred CCCCceeeCCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 001274 932 IKSNNILLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQS 1009 (1109)
Q Consensus 932 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~ 1009 (1109)
|||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.+
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986643222 12234567889999999999999999999999999999998 9999986
Q ss_pred cccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1010 LELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
..........+........ . ......+.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~--~--------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDEEFCRRLKEGTRMRA--P--------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSHHHHHHHHHTCCCCC--C--------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHhccCccCCC--C--------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 5433333333322111111 0 011235779999999999999999999999999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=352.99 Aligned_cols=262 Identities=24% Similarity=0.403 Sum_probs=204.0
Q ss_pred cCCCCCceEecCCcceEEEEEecC-----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN-----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
.+|+..+.||+|+||+||+|++.. +..||||+++... .......+.+|++++++++||||+++++++...+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 467778999999999999998642 2469999997432 3344567899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++|+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999986543 3899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCC--CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 957 DLPYSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 957 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
...... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... ..+.............
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~----~~~~~~~~~~~~~~~~-- 271 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----NHEVMKAINDGFRLPT-- 271 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTTCCCCC--
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC----HHHHHHHHHCCCcCCC--
Confidence 532211 1223356789999999999999999999999999999999 999997543 1222222111111000
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
.......+.+++.+||+.||++||++++++++|+++......
T Consensus 272 -----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 272 -----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp -----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 111123578999999999999999999999999988765433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=357.90 Aligned_cols=269 Identities=21% Similarity=0.311 Sum_probs=197.8
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
..++|++.++||+|+||+||+|++. +++.||||+++.........+.+.+|++++++++||||+++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3468999999999999999999865 789999999976544444456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee-----CCCCceEEeecccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL-----DEEFQAHVGDFGLA 953 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DFG~a 953 (1109)
|||++ |+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99997 599999987654 899999999999999999999 7799999999999999 45556999999999
Q ss_pred ccccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
+..... ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+.......... .+...
T Consensus 185 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---~~~~~ 260 (329)
T 3gbz_A 185 RAFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG---LPDDT 260 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC---CCCTT
T ss_pred cccCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC---CCchh
Confidence 876522 2223445789999999999875 489999999999999999999999976432222222222111 01110
Q ss_pred hhhh---------hcch------hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1033 LFDK---------RLDL------SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1033 ~~~~---------~~~~------~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.+.. .... ...........+.+++.+||+.||++|||++|++++-+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 0000 0000 000000122457899999999999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=373.35 Aligned_cols=258 Identities=25% Similarity=0.283 Sum_probs=210.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888899999999999999975 799999999964321 1223456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||++||+|.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 264 Ey~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp CCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 99999999999976543 23899999999999999999999 77999999999999999999999999999987642
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||........................ .
T Consensus 339 -~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~--- 410 (576)
T 2acx_A 339 -GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----E--- 410 (576)
T ss_dssp -TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----T---
T ss_pred -CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----c---
Confidence 22334568999999999999999999999999999999999999999865433333332222222111111 0
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMID 1079 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~ 1079 (1109)
.....+.+++.+||+.||++|| +++|+++|-+.
T Consensus 411 -------~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF 448 (576)
T 2acx_A 411 -------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448 (576)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGG
T ss_pred -------cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhh
Confidence 1123577999999999999999 88999988554
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=357.13 Aligned_cols=251 Identities=23% Similarity=0.264 Sum_probs=196.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHH-hccCCCCceeeEEEEEEeCCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEIST-LGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
++|++.+.||+|+||+||+|+.+ +++.||||+++..... ......+.+|..+ ++.++||||+++++++...+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57889999999999999999976 5889999999754322 2234556777777 5778999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++|+|.+++..... +++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999976543 899999999999999999999 77999999999999999999999999999986432
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+..............
T Consensus 192 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~~i~~~~~~~~~------ 260 (373)
T 2r5t_A 192 -HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAEMYDNILNKPLQLKP------ 260 (373)
T ss_dssp -CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB----HHHHHHHHHHSCCCCCS------
T ss_pred -CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcccCCCC------
Confidence 2233456789999999999999999999999999999999999999997533 22222322222211110
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHH----HHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMR----EVIAMM 1077 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~----evl~~L 1077 (1109)
.....+.+++.+||+.||++||++. ++.++-
T Consensus 261 --------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~ 295 (373)
T 2r5t_A 261 --------NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295 (373)
T ss_dssp --------SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred --------CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence 1123567899999999999999974 555543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=369.88 Aligned_cols=253 Identities=21% Similarity=0.250 Sum_probs=199.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.++||+|+||+||+|+.. +++.||||+++... ........+.+|+++++.++||||+++++++...+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 57899999999999999999865 68999999997432 12233456789999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR-PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
||+++|+|.+++..... +++..+..++.||+.||+||| + .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 228 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 228 EYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CCCSSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred eeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999976543 899999999999999999999 5 6999999999999999999999999999986432
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .................
T Consensus 302 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~p~------ 370 (446)
T 4ejn_A 302 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELILMEEIRFPR------ 370 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCT------
T ss_pred -CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHHHHHHHhCCCCCCc------
Confidence 2233455789999999999999999999999999999999999999997532 22222322222221111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMID 1079 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~ 1079 (1109)
.....+.+++.+||+.||++|| +++|+++|-+.
T Consensus 371 --------~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 371 --------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp --------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred --------cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 1123577999999999999999 99999987554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=354.03 Aligned_cols=264 Identities=23% Similarity=0.378 Sum_probs=211.5
Q ss_pred cCCCCCceEecCCcceEEEEEec--------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
++|++.+.||+|+||+||+|++. +++.||||+++.. ......+.+.+|+++++++ +||||+++++++...
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 68889999999999999999863 4678999999743 2334456789999999999 899999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 939 (1109)
+..++||||+++|+|.+++..... ...+++..+..++.||+.||+||| +.+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 999999999999999999986542 123889999999999999999999 7799999999999999
Q ss_pred CCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLV 1017 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~ 1017 (1109)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.+.. ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~ 266 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VE 266 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC----HH
Confidence 9999999999999987653221 12234467889999999998899999999999999999999 999997543 22
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
+............ ........+.+++.+||+.||++|||+.|++++|+.+......
T Consensus 267 ~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 267 ELFKLLKEGHRMD-------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHHHTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcCCCCC-------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 2222211111100 0111123578999999999999999999999999999776543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=345.70 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=205.6
Q ss_pred hcCCCCCceEecCCcceEEEEEecC----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
.++|++.+.||+|+||+||+|++.+ +..||||++.... .....+.+.+|++++++++||||+++++++.. +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 3678889999999999999998542 3469999987432 33456789999999999999999999999765 4578
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++++|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999976543 3899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+..... .+...
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~~~~~~~~~--~~~~~--- 237 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGVLEKGDR--LPKPD--- 237 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHHHHHHHTCC--CCCCT---
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHHHHHhcCCC--CCCCC---
Confidence 5433333344567889999999998999999999999999999998 99999754322 22222222111 11110
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.....+.+++.+||+.||++||++.|++++|+.+.+.
T Consensus 238 -----------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 238 -----------LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1123577999999999999999999999999987654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=352.76 Aligned_cols=267 Identities=24% Similarity=0.393 Sum_probs=202.0
Q ss_pred HhcCCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc-
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS- 874 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 874 (1109)
..++|.+.+.||+|+||+||+|++. .++.||||+++.........+.+.+|++++++++||||+++++++...+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3468899999999999999999754 34589999998665555556789999999999999999999999987653
Q ss_pred ----eEEEEEeccCCCHHHHhccCC---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 001274 875 ----NLLLYEYMENGSLGEQLHGNK---QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV 947 (1109)
Q Consensus 875 ----~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 947 (1109)
.++||||+++|+|.+++.... ....+++..+..++.||++||.||| +.+|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence 499999999999999985321 2234899999999999999999999 789999999999999999999999
Q ss_pred eeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhh
Q 001274 948 GDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIH 1025 (1109)
Q Consensus 948 ~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 1025 (1109)
+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||...... .....+.....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~ 267 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-EMYDYLLHGHR 267 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHHHHHcCCC
Confidence 99999986643221 22234467889999999999999999999999999999999 88898764322 22222211111
Q ss_pred ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1026 EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
... .......+.+++.+||+.||++|||+.+++++|+.+....++
T Consensus 268 ~~~----------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 268 LKQ----------------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp CCC----------------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CCC----------------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 000 111123578999999999999999999999999999876643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=360.82 Aligned_cols=259 Identities=25% Similarity=0.272 Sum_probs=210.2
Q ss_pred cCCCCCceEecCCcceEEEEEe----cCCcEEEEEEeeccCC--CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATL----ANGEVIAVKKIKLRGE--GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 874 (1109)
++|++.+.||+|+||+||+|+. .+++.||||+++.... .....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5789999999999999999987 3689999999864321 122345677899999999 69999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999976543 899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCCCccccccccceeccccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............+.......+..
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 286 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP- 286 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC-
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC-
Confidence 764333333445679999999999986 34789999999999999999999999865544444444444333222111
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHHh
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMIDA 1080 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~~ 1080 (1109)
......+.+++.+||+.||++|| +++|++++.+..
T Consensus 287 -------------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 287 -------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp -------------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred -------------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 11123567899999999999999 999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=361.73 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=203.9
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC--CCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR--HRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+..+++.||||++..........+.+.+|++++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 468999999999999999999888999999999866555555678999999999996 599999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
| +.+++|.+++..... +++.++..++.||+.||+||| +.+|+||||||+||+++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCSS---CCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 568899999987653 889999999999999999999 78999999999999995 579999999999876532
Q ss_pred CCC-CccccccccceeccccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc
Q 001274 960 YSK-SMSAIAGSYGYIAPEYAYT-----------MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM 1027 (1109)
Q Consensus 960 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 1027 (1109)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+.......
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---NQISKLHAIIDPN 284 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC---CHHHHHHHHHCTT
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh---HHHHHHHHHhCcc
Confidence 221 2345679999999999865 468999999999999999999999997532 1222222222211
Q ss_pred CCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.... +.. .. ...+.+++.+||+.||++|||+.|++++.+...
T Consensus 285 ~~~~--~~~-------~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 285 HEIE--FPD-------IP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp SCCC--CCC-------CS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ccCC--CCc-------cc---hHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 1100 000 00 235779999999999999999999999876643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.95 Aligned_cols=265 Identities=21% Similarity=0.328 Sum_probs=211.1
Q ss_pred cCCCCCc-eEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGA-VIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|.+.. .||+|+||+||+|++. +++.||||+++.. ......+.+.+|++++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 3455555 8999999999999853 5788999999743 2334567799999999999999999999999 5567899
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++++|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999975543 3899999999999999999999 7799999999999999999999999999998764
Q ss_pred CCCC--CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 958 LPYS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 958 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
.... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... ......+.. ...+. .
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~i~~---~~~~~---~ 234 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQ---GKRME---C 234 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHHT---TCCCC---C
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHhc---CCcCC---C
Confidence 3222 11233456889999999998899999999999999999999 9999976432 112222211 11000 0
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCCC
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSS 1090 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~ 1090 (1109)
.......+.+++.+||+.||++||++.+++++|+.+..+.......
T Consensus 235 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 235 ----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp ----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred ----------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 1112246789999999999999999999999999998776554433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=356.52 Aligned_cols=268 Identities=23% Similarity=0.312 Sum_probs=199.3
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHH--hccCCCCceeeEEEEEEeC-----Cc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEIST--LGKIRHRNIVKLYGFCYHQ-----DS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~-----~~ 874 (1109)
++|++.+.||+|+||+||+|+. +++.||||++... ....+..|.++ +..++||||+++++++... ..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 6888999999999999999987 5899999999733 23344445444 5568999999999866432 24
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCC---------CeEecCCCCCceeeCCCCce
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP---------HIIHRDIKSNNILLDEEFQA 945 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~Dlkp~NIll~~~~~~ 945 (1109)
.++||||+++|+|.+++.... .++..+..++.||+.||+||| +. +|+||||||+||+++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcE
Confidence 589999999999999997654 588999999999999999999 66 99999999999999999999
Q ss_pred EEeeccccccccCCC-------CCCccccccccceeccccccC-------CCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 001274 946 HVGDFGLAKLIDLPY-------SKSMSAIAGSYGYIAPEYAYT-------MKVTEKCDIYSFGVVLLELITGKSPVQSLE 1011 (1109)
Q Consensus 946 kl~DFG~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvll~elltg~~pf~~~~ 1011 (1109)
||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999998764321 111234579999999999987 456789999999999999999988765432
Q ss_pred cCCcHH-------------HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1012 LGGDLV-------------TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1012 ~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
...... ..+........ . .+...............+.+++.+||+.||++|||++|+++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREK-Q----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-C----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccc-c----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 111100 00010000000 0 00011111112234557899999999999999999999999999
Q ss_pred HhhhccCCC
Q 001274 1079 DARQSVSDY 1087 (1109)
Q Consensus 1079 ~~~~~~~~~ 1087 (1109)
++.......
T Consensus 315 ~ll~~~~~~ 323 (336)
T 3g2f_A 315 ELMMIWERN 323 (336)
T ss_dssp HHHHCCCC-
T ss_pred HHHHHHHhc
Confidence 988766443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=347.30 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=185.5
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.++|++.+.||+|+||+||+|+. .+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788999999999999999997 47999999999643211 12246788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++++|.+++..... .+++..+..++.|+++|++||| +.+|+||||||+||+++.++.+||+|||.+.....
T Consensus 90 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999986543 3899999999999999999999 77999999999999999999999999999987642
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||......... ..........
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~-------- 231 (278)
T 3cok_A 165 PH-EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NKVVLADYEM-------- 231 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCC--------
T ss_pred CC-CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----HHHhhcccCC--------
Confidence 22 2223457899999999999999999999999999999999999999754322111 1111111000
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......+.+++.+||+.||++|||+++++++-+.
T Consensus 232 ------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 266 (278)
T 3cok_A 232 ------PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266 (278)
T ss_dssp ------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTT
T ss_pred ------ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccc
Confidence 01112357799999999999999999999987543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=347.67 Aligned_cols=271 Identities=22% Similarity=0.342 Sum_probs=203.3
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 36799999999999999999986 4789999999975332 334456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 879 YEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
|||+++++|.+++.... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986421 1223899999999999999999999 7799999999999999999999999999998654
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
.. ........+++.|+|||++.+..++.++||||||+++|||++|+.||.+.. ...............+.. ..
T Consensus 188 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~--~~-- 260 (310)
T 2wqm_A 188 SK-TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKIEQCDYPPL--PS-- 260 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-----CCHHHHHHHHHTTCSCCC--CT--
T ss_pred CC-CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc--hhHHHHHHHhhcccCCCC--cc--
Confidence 22 222334578999999999999999999999999999999999999997532 122222222222211110 00
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPS 1089 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 1089 (1109)
......+.+++.+||+.||++|||+.+++++++++........+
T Consensus 261 --------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 261 --------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred --------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 01123577999999999999999999999999999877765544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=349.98 Aligned_cols=251 Identities=21% Similarity=0.321 Sum_probs=201.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CC-------cEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NG-------EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 873 (1109)
++|++.+.||+|+||+||+|++. ++ +.||+|++.... ....+.+.+|++++++++||||+++++++..++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 57888999999999999999865 23 579999986432 234577999999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc--------e
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ--------A 945 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~ 945 (1109)
..++||||+++|+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999987543 3899999999999999999999 779999999999999998887 9
Q ss_pred EEeeccccccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhh
Q 001274 946 HVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSI 1024 (1109)
Q Consensus 946 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~ 1024 (1109)
||+|||.+.... ......+|+.|+|||++.+ ..++.++||||+|+++|||++|..|+.... ........ .
T Consensus 161 kl~Dfg~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~-~ 231 (289)
T 4fvq_A 161 KLSDPGISITVL-----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL---DSQRKLQF-Y 231 (289)
T ss_dssp EECCCCSCTTTS-----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS---CHHHHHHH-H
T ss_pred eeccCccccccc-----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc---chHHHHHH-h
Confidence 999999997543 1233467889999999987 679999999999999999999655543221 11111111 1
Q ss_pred hccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1025 HEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
.......... ...+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 232 ~~~~~~~~~~--------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDRHQLPAPK--------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTTCCCCCCS--------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hccCCCCCCC--------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111000 1246789999999999999999999999988864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=344.07 Aligned_cols=264 Identities=20% Similarity=0.266 Sum_probs=208.3
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEE-EeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFC-YHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv 878 (1109)
.++|++.+.||+|+||+||+|++ .+++.||||++.... ..+.+.+|+++++.++|++++..+.++ ...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46899999999999999999996 579999999987433 234688999999999987766555555 566777999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEeecccccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~ 955 (1109)
|||+ +++|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||.++.
T Consensus 84 ~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 9999 9999999975443 3899999999999999999999 7799999999999999 4889999999999987
Q ss_pred ccCCCCC------CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC--CcHHHHHHHhhhcc
Q 001274 956 IDLPYSK------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG--GDLVTWVRRSIHEM 1027 (1109)
Q Consensus 956 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~--~~~~~~~~~~~~~~ 1027 (1109)
....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 6533221 124567999999999999999999999999999999999999999865422 12222222111110
Q ss_pred CCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
+ .+... ......+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 238 -~-~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 238 -P-IEVLC----------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -C-HHHHT----------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -c-hHHHH----------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0 00000 11124578999999999999999999999999998877644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=344.93 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=203.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe----CCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH----QDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 876 (1109)
..|++.+.||+|+||+||+|++. +++.||+|++..........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45777889999999999999865 68899999998666555667789999999999999999999999875 34578
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeC-CCCceEEeecccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH--IIHRDIKSNNILLD-EEFQAHVGDFGLA 953 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DFG~a 953 (1109)
+||||+++|+|.+++..... +++..+..++.|++.||+||| +.+ |+||||||+||+++ .++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHHccC---CCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999976543 899999999999999999999 667 99999999999997 7899999999999
Q ss_pred ccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
..... .......||+.|+|||++. +.++.++||||+|+++|+|++|+.||.... ..............+ ..
T Consensus 180 ~~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~--~~ 250 (290)
T 1t4h_A 180 TLKRA---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVKP--AS 250 (290)
T ss_dssp GGCCT---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS---SHHHHHHHHTTTCCC--GG
T ss_pred ccccc---cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC---cHHHHHHHHhccCCc--cc
Confidence 75442 2234457899999999876 459999999999999999999999997533 222333322222111 11
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
++.. ....+.+++.+||+.||++|||++|++++-+
T Consensus 251 ~~~~----------~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 251 FDKV----------AIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp GGGC----------CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cCCC----------CCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 1111 1135789999999999999999999998743
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=343.25 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=210.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|.+.+.||+|+||+||+|++. +++.||+|++..... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 67889999999999999999976 588999999975432 2334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++..... +++..+..++.|+++|++||| +.+|+||||||+||+++.++.+||+|||.++.....
T Consensus 95 e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp ECCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999876543 899999999999999999999 779999999999999999999999999999876422
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ..+..............
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~------- 236 (294)
T 2rku_A 169 -GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKETYLRIKKNEYSIPK------- 236 (294)
T ss_dssp -TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHTTCCCCCT-------
T ss_pred -ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhhccCCCcc-------
Confidence 222344678999999999999999999999999999999999999997533 22222222121111111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.....+.+++.+||+.||++|||++|++++-+...
T Consensus 237 -------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 237 -------HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred -------ccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 11235778999999999999999999999877653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=340.54 Aligned_cols=256 Identities=23% Similarity=0.302 Sum_probs=205.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc----chhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA----TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.+.||+|+||+||+|++. +++.||+|+++...... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999976 68999999997653221 23577999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC----ceEEeeccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF----QAHVGDFGL 952 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~ 952 (1109)
+||||+++++|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999976443 899999999999999999999 77999999999999998877 899999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
++..... .......+++.|+|||++.+..++.++||||+|+++|+|++|+.||.... ..+..............
T Consensus 159 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~ 232 (283)
T 3bhy_A 159 AHKIEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET----KQETLTNISAVNYDFDE 232 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHTTCCCCCH
T ss_pred ceeccCC--CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc----hHHHHHHhHhcccCCcc
Confidence 9876422 22344568999999999999999999999999999999999999997532 22222222111111111
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
... ......+.+++.+||+.||++||++.|++++-+.
T Consensus 233 ~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 233 EYF----------SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp HHH----------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred hhc----------ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 100 1112357899999999999999999999987543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=354.68 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=200.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcE----EEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEV----IAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.++||+|+||+||+|++. +++. ||+|.+... ......+.+.+|++++++++||||+++++++.... .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 57889999999999999999864 4544 577776533 23345678999999999999999999999998754 78
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+|+||+++|+|.+++...... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999876543 899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 957 DLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 957 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
..... .......+|+.|+|||++.+..++.++||||+||++|||++ |+.||.+... ......+..... .+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-~~~~~~~~~~~~--~~~~--- 241 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGER--LPQP--- 241 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHHTTCC--CCCC---
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCC--CCCC---
Confidence 43222 22234457889999999999999999999999999999999 9999986432 222222222111 1110
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
......+.+++.+||+.||++||++.|+++.|..+...
T Consensus 242 -----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 242 -----------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11123577899999999999999999999999988643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=357.46 Aligned_cols=264 Identities=27% Similarity=0.370 Sum_probs=207.7
Q ss_pred CCCCceEecCCcceEEEEEec-----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--CceE
Q 001274 804 FSEGAVIGRGACGTVYKATLA-----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DSNL 876 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 876 (1109)
|++.++||+|+||+||+|.+. +++.||||+++.. ......+.+.+|++++++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 488899999999999988642 5889999999744 2334467799999999999999999999999884 5678
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++..
T Consensus 112 lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999997653 899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCC--CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC--------CcHH--HHHHHhh
Q 001274 957 DLPYS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG--------GDLV--TWVRRSI 1024 (1109)
Q Consensus 957 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~--------~~~~--~~~~~~~ 1024 (1109)
..... .......+|..|+|||++.+..++.++||||+|+++|||++|+.||...... .... ..+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 53221 1123456788899999999999999999999999999999999998753210 0000 0001101
Q ss_pred hccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 001274 1025 HEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087 (1109)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 1087 (1109)
.... . ..........+.+++.+||+.||++|||+.|+++.|+.+.......
T Consensus 265 ~~~~----------~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 265 ERGE----------R--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HTTC----------C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred hccc----------C--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 0000 0 0011122346889999999999999999999999999987766443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=356.08 Aligned_cols=264 Identities=23% Similarity=0.278 Sum_probs=198.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC------c
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD------S 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 874 (1109)
++|++.+.||+|+||+||+|++. +++.||||++..........+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 68999999999999999999865 6899999999865444455677889999999999999999999998765 6
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||++ |+|.+++.. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 799999997 478888853 2889999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCchh
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSEL 1033 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1033 (1109)
.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+... .+.+........ +..+.
T Consensus 176 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 176 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHC-CCCCCHHH
T ss_pred cccc--ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHH
Confidence 6542 2223456789999999999999999999999999999999999999985431 222222211111 01110
Q ss_pred hhh--------------------------hc-chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1034 FDK--------------------------RL-DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1034 ~~~--------------------------~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
+.. .. .............+.+++.+||+.||++|||++|++++-+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 000 00 000001122345788999999999999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=356.55 Aligned_cols=271 Identities=15% Similarity=0.186 Sum_probs=204.4
Q ss_pred cCCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcc---------hhHHHHHHHHHhccCCCCceeeEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGAT---------ADNSFLAEISTLGKIRHRNIVKLYGF 868 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~ 868 (1109)
++|++.+.||+|+||+||+|++. ++..||||++........ ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57889999999999999999975 578899999874422111 12346788889999999999999999
Q ss_pred EEe----CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-
Q 001274 869 CYH----QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF- 943 (1109)
Q Consensus 869 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~- 943 (1109)
+.. ....++||||+ +++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence 988 67889999999 999999998655 3899999999999999999999 77999999999999998877
Q ss_pred -ceEEeeccccccccCCCC------CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcH
Q 001274 944 -QAHVGDFGLAKLIDLPYS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDL 1016 (1109)
Q Consensus 944 -~~kl~DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~ 1016 (1109)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999986642211 1114457999999999999999999999999999999999999999753322222
Q ss_pred HHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1017 VTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
............+ ........ .......+.+++.+||+.||++||++++|++.|+........
T Consensus 270 ~~~~~~~~~~~~~--~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 332 (345)
T 2v62_A 270 VQTAKTNLLDELP--QSVLKWAP-----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP 332 (345)
T ss_dssp HHHHHHHHHHTTT--HHHHHHSC-----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCC
T ss_pred HHHHHHhhccccc--HHHHhhcc-----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccC
Confidence 2222222222221 11111100 001224688999999999999999999999999887654433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.83 Aligned_cols=262 Identities=27% Similarity=0.370 Sum_probs=205.0
Q ss_pred cCCCCCceEecCCcceEEEEEe-----cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--Cc
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ--DS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 874 (1109)
++|++.+.||+|+||.||+|++ .+++.||||+++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4688889999999999999983 368999999997543 233457789999999999999999999999876 56
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+++|+|.+++...... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTT--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcccc--CCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 79999999999999999654433 899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCC--CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcc----------cCCcHHHHHHH
Q 001274 955 LIDLPYS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLE----------LGGDLVTWVRR 1022 (1109)
Q Consensus 955 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~----------~~~~~~~~~~~ 1022 (1109)
....... .......+|..|+|||++.+..++.++||||+|+++|||++|+.|+.... ........+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 7653322 12244568889999999999999999999999999999999999865321 00001111111
Q ss_pred hhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
....... ..........+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 255 ~~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGKR------------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTCC------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCC------------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111000 0011122346889999999999999999999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=371.04 Aligned_cols=256 Identities=24% Similarity=0.329 Sum_probs=203.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|++. +++.||||++............+.+|+++++.++||||+++++++...+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 57999999999999999999976 68999999998655444456789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEeecccccccc
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE---EFQAHVGDFGLAKLID 957 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~~ 957 (1109)
|+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||+++...
T Consensus 117 ~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999998876543 899999999999999999999 779999999999999976 4559999999998765
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
.. .......||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.. ..+.................+
T Consensus 191 ~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~- 262 (494)
T 3lij_A 191 NQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT----DQEILRKVEKGKYTFDSPEWK- 262 (494)
T ss_dssp TT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHTCCCCCSGGGT-
T ss_pred CC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCchhcc-
Confidence 32 2344567999999999876 569999999999999999999999997533 223333322222211111100
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.....+.+++.+||+.||++|||+.|++++-+-.
T Consensus 263 ---------~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 263 ---------NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp ---------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred ---------cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 1123577999999999999999999999886543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=358.51 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=197.6
Q ss_pred CCCCCceEecCCcceEEEEEec--CC--cEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe-CCceEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA--NG--EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH-QDSNLL 877 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 877 (1109)
.|+..+.||+|+||+||+|++. ++ ..||||.++.. ......+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4666789999999999999853 22 46899988643 233456789999999999999999999998764 457799
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|+|.+++...... +++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCC--CBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhcccC--CCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999999865443 889999999999999999999 7799999999999999999999999999998654
Q ss_pred CCCCC---CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 958 LPYSK---SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 958 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ......+........
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-~~~~~~~~~~~~~~~----- 317 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLLQ----- 317 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-SCHHHHHHTTCCCCC-----
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-HHHHHHHHcCCCCCC-----
Confidence 22211 1234567889999999999999999999999999999999 6777765432 233322222111000
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
.......+.+++.+||+.||++||++.|++++|+.+.....
T Consensus 318 -----------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 318 -----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00112357899999999999999999999999999887654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=357.58 Aligned_cols=271 Identities=23% Similarity=0.382 Sum_probs=205.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|++. +++.||||++..........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57899999999999999999976 58999999997665554556678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.++...... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++.....
T Consensus 105 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 177 (331)
T 4aaa_A 105 FVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP- 177 (331)
T ss_dssp CCSEEHHHHHHHSTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC-
Confidence 9999999888765443 899999999999999999999 779999999999999999999999999999865422
Q ss_pred CCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC-chhhh---
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT-SELFD--- 1035 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 1035 (1109)
........+|+.|+|||++.+. .++.++||||+||++|||++|+.||............+.. .....+. ...+.
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC-LGNLIPRHQELFNKNP 256 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCSCCHHHHHHHHHCG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCChhhhhHhhhcc
Confidence 2223445789999999998875 7899999999999999999999999864322222221111 0000000 00000
Q ss_pred -------hhcc---hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1036 -------KRLD---LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1036 -------~~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
+... ............+.+++.+||+.||++|||++|++++-+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~ 311 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence 0000 00000112235688999999999999999999999886554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=353.23 Aligned_cols=270 Identities=22% Similarity=0.335 Sum_probs=200.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|++. +++.||||++...... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57889999999999999999976 7899999999644321 222345679999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|++ |+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 997 599999877554 3899999999999999999999 779999999999999999999999999999865422
Q ss_pred CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+.. ..+....... ..+.+.....
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~--~~~~~~~~~~ 230 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL-HFIFRILGTP--TEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCC--CTTTSTTGGG
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCC--ChHhchhhhc
Confidence 222344578999999999876 56899999999999999999999999864322221 1222111111 1111111000
Q ss_pred hh---------------hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1040 LS---------------AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1040 ~~---------------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
.. ..........+.+++.+|++.||++|||++|++++-+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 00 00011122457899999999999999999999998765433
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=356.95 Aligned_cols=253 Identities=29% Similarity=0.430 Sum_probs=204.5
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|+..+.||+|+||+||+|+. .+++.||||++...... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999996 47899999999754332 223467899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||++ |++.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9997 688888864433 3899999999999999999999 77999999999999999999999999999986542
Q ss_pred CCCCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 960 YSKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ....+........+.. ..
T Consensus 207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~----~~~~~~~~~~~~~~~~--~~- 275 (348)
T 1u5q_A 207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIAQNESPAL--QS- 275 (348)
T ss_dssp ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSCCCCC--CC-
T ss_pred ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCC--CC-
Confidence 23457999999999984 5678999999999999999999999997543 2222222222221110 00
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
......+.+++.+||+.||++|||+++++++.+...
T Consensus 276 ---------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 276 ---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---------CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 011235779999999999999999999998877643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=340.50 Aligned_cols=256 Identities=24% Similarity=0.337 Sum_probs=207.0
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|++. +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 467899999999999999999975 689999999975433 234577899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+......
T Consensus 85 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999999976543 899999999999999999999 779999999999999999999999999999865422
Q ss_pred C-CCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 960 Y-SKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 960 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
. ........||+.|+|||++.+..+ +.++||||+|+++|||++|+.||............... ..... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~----~~- 230 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---KKTYL----NP- 230 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---TCTTS----TT-
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---ccccc----Cc-
Confidence 1 122345678999999999988775 78999999999999999999999865432221111111 10000 00
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.......+.+++.+||+.||++|||++|++++-+
T Consensus 231 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 231 -------WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp -------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred -------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 0011235678999999999999999999998644
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=361.43 Aligned_cols=262 Identities=21% Similarity=0.286 Sum_probs=208.0
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCC-CceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH-RNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv 878 (1109)
.++|++.++||+|+||+||+|++ .+++.||||++..... ...+.+|+++++.++| +++..+..++...+..++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 36899999999999999999996 4789999998874432 3458899999999976 6677777777888888999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEeecccccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~ 955 (1109)
|||+ +++|.+++...... +++..++.++.||+.||+||| +.+||||||||+|||+ +.++.+||+|||+++.
T Consensus 82 me~~-g~sL~~ll~~~~~~--l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EECC-CCBHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EECC-CCCHHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 9999 99999999864433 999999999999999999999 7799999999999999 6889999999999987
Q ss_pred ccCCCCC------CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc-C
Q 001274 956 IDLPYSK------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-V 1028 (1109)
Q Consensus 956 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~ 1028 (1109)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+......... +....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~-~~~i~~~~~~ 234 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-YEKISEKKVA 234 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH-HHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH-HHHHhhcccc
Confidence 6533221 12356799999999999999999999999999999999999999987543322221 11111110 0
Q ss_pred CCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1029 PTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
...+.+. ......+.+++.+||+.+|++||++.+|++.|+++...
T Consensus 235 ~~~~~l~----------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 235 TSIEALC----------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp SCHHHHH----------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccHHHHh----------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000 01124688999999999999999999999999988554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=345.45 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=208.5
Q ss_pred CCCCCceEecCCcceEEEEEec-C---CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce-EE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-N---GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN-LL 877 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~l 877 (1109)
.|...++||+|+||+||+|++. + +..||+|++... ......+.+.+|++++++++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4556689999999999999853 2 237999998632 2334457889999999999999999999999876665 99
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+.+|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999987443 3899999999999999999999 7799999999999999999999999999998654
Q ss_pred CCC---CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 958 LPY---SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 958 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
... ........+|+.|+|||.+.+..++.++||||+|+++|||++|..|+............+....... ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~--- 250 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP--QP--- 250 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC--CC---
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC--CC---
Confidence 221 1222445688999999999999999999999999999999997666544333333333333211111 00
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 1087 (1109)
......+.+++.+||+.||++|||+.++++.|+++.......
T Consensus 251 -----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 251 -----------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp -----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred -----------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 011235789999999999999999999999999998776443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=368.94 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=210.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|...+.||+|+||+||+|+++ +|+.||+|++...... ......+.+|++++++++||||+++++++...+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888899999999999999975 6999999999643211 123467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 880 EYMENGSLGEQLHGNKQ-TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
||++||+|.+++..... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999976532 234899999999999999999999 77999999999999999999999999999987652
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.............+...........
T Consensus 342 ~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~------ 414 (543)
T 3c4z_A 342 G-QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD------ 414 (543)
T ss_dssp T-CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT------
T ss_pred C-CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc------
Confidence 2 222344689999999999999999999999999999999999999998654333444444433332221111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTM-----REVIAMMI 1078 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~~L~ 1078 (1109)
.....+.+++.+||+.||++||++ +++++|-+
T Consensus 415 --------~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf 451 (543)
T 3c4z_A 415 --------KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451 (543)
T ss_dssp --------TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred --------ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence 112356789999999999999964 77877643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=367.58 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=208.9
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.++||+|+||+||+|++. +++.||||++............+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 367999999999999999999975 7899999999754333344677899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD---EEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a~~~ 956 (1109)
||+++|+|.+++..... +++..+..++.||+.||.||| +.+|+||||||+||+++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999999876543 899999999999999999999 77999999999999995 5668999999999866
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. ........||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.. ..+..........+......
T Consensus 175 ~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~- 246 (486)
T 3mwu_A 175 QQ--NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDILKRVETGKYAFDLPQW- 246 (486)
T ss_dssp CC--C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHTCCCSCSGGG-
T ss_pred CC--CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCCccc-
Confidence 42 223345679999999999876 59999999999999999999999997533 22333332222221110000
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
......+.+++.+||+.||++|||+.|++++-+....
T Consensus 247 ---------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 247 ---------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp ---------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred ---------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 0112357799999999999999999999999776543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=364.41 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=198.8
Q ss_pred HHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC------CcchhHHHHHHHHHhccCCCCceeeEEEEEEe
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE------GATADNSFLAEISTLGKIRHRNIVKLYGFCYH 871 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 871 (1109)
...++|.+.+.||+|+||+||+|++. +++.||||++..... .......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999865 689999999975421 1122345889999999999999999999975
Q ss_pred CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC---CceEEe
Q 001274 872 QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE---FQAHVG 948 (1109)
Q Consensus 872 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~ 948 (1109)
.+..++||||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.+ +.+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEe
Confidence 4557999999999999999876543 899999999999999999999 7799999999999999654 459999
Q ss_pred eccccccccCCCCCCccccccccceeccccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhh
Q 001274 949 DFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIH 1025 (1109)
Q Consensus 949 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~ 1025 (1109)
|||+++.... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||............+.....
T Consensus 285 DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 285 DFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred ecccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 9999987652 223345679999999999863 56889999999999999999999999865544454444432211
Q ss_pred ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1026 EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
... .+.. ......+.+++.+||+.||++|||++|++++-+.
T Consensus 363 ~~~--~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 363 NFI--PEVW-----------AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp CCC--HHHH-----------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CCC--chhh-----------cccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 110 0000 0112357899999999999999999999987553
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=349.17 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=209.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|.+.+.||+|+||.||+|++. +++.||+|++..... .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 67889999999999999999976 588999999975432 2334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++..... +++.++..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~~~~L~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999876443 899999999999999999999 779999999999999999999999999999876422
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ..+..............
T Consensus 195 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~------- 262 (335)
T 2owb_A 195 -GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKETYLRIKKNEYSIPK------- 262 (335)
T ss_dssp -TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHTCCCCCT-------
T ss_pred -cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHHhcCCCCCCc-------
Confidence 222345678999999999999999999999999999999999999997532 22222221111111111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.....+.+++.+||+.||++||+++|++++-+...
T Consensus 263 -------~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 263 -------HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred -------cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 11135678999999999999999999999876543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=349.38 Aligned_cols=271 Identities=24% Similarity=0.358 Sum_probs=213.5
Q ss_pred HHHHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhcc--CCCCceeeEEEEEEeCC-
Q 001274 797 LLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGK--IRHRNIVKLYGFCYHQD- 873 (1109)
Q Consensus 797 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~- 873 (1109)
.....++|++.+.||+|+||+||+|++. ++.||||++.. .....+.+|+++++. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 3445678999999999999999999984 89999999863 245667888888877 79999999999998876
Q ss_pred ---ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCceeeCCCCce
Q 001274 874 ---SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC-----RPHIIHRDIKSNNILLDEEFQA 945 (1109)
Q Consensus 874 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~ 945 (1109)
..++||||+++|+|.+++.... +++..+..++.|++.||+|||... +.+|+||||||+||+++.++.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred ccceeEEEEeecCCCcHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 7899999999999999997642 899999999999999999999321 3589999999999999999999
Q ss_pred EEeeccccccccCCCCC---CccccccccceeccccccCC------CCCccchhHHHHHHHHHHHhC----------CCC
Q 001274 946 HVGDFGLAKLIDLPYSK---SMSAIAGSYGYIAPEYAYTM------KVTEKCDIYSFGVVLLELITG----------KSP 1006 (1109)
Q Consensus 946 kl~DFG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvll~elltg----------~~p 1006 (1109)
||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876533221 22445799999999998876 234789999999999999999 788
Q ss_pred CCCcccCC-cHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1007 VQSLELGG-DLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1007 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
|....... ....+.......... .. +.... ...+....+.+++.+||+.||++|||+.||+++|+.+.++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLR-PN-IPNRW-----QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCC-CC-CCGGG-----GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccCcCcccHHHHHHHHHHHHhC-CC-Ccccc-----cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 87654332 333333332222111 00 11010 13345567899999999999999999999999999987654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=354.42 Aligned_cols=272 Identities=26% Similarity=0.323 Sum_probs=203.2
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc---chhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA---TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
..++|++.+.||+|+||+||+|++. +|+.||||++....... ...+.+.+|++++++++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999975 68999999997532221 1235688999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++||||+++ +|.+++..... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999975 89888876543 3889999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 956 IDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
.... ........+|+.|+|||++.+. .++.++||||+||++|||++|..||.+......+......... +..+.+
T Consensus 162 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~---~~~~~~ 237 (346)
T 1ua2_A 162 FGSP-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT---PTEEQW 237 (346)
T ss_dssp TTSC-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC---CCTTTS
T ss_pred ccCC-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC---CChhhh
Confidence 6522 2233456789999999998764 5899999999999999999999998754322222222221111 111111
Q ss_pred hhhcc------h--hh-----cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1035 DKRLD------L--SA-----KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1035 ~~~~~------~--~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
..... . .. .........+.+++.+||+.||++|||++|++++-+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 00000 0 00 000112346889999999999999999999999876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=354.71 Aligned_cols=270 Identities=21% Similarity=0.322 Sum_probs=207.2
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC--------
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ-------- 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 872 (1109)
++|++.++||+|+||+||+|++ .+++.||||++............+.+|+++++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999997 4789999999976655555566788999999999999999999999874
Q ss_pred CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
+..++||||+++ ++.+.+...... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVK--FTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 457899999975 787777665433 899999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCC---CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 953 AKLIDLPY---SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 953 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
++...... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+...... ...+.......
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~- 248 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSI- 248 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC-
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCC-
Confidence 98764222 222345678999999999876 4589999999999999999999999986432211 12222211111
Q ss_pred CCchhhhhhcc-----------hhhcccHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1029 PTSELFDKRLD-----------LSAKRTVE------EMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1029 ~~~~~~~~~~~-----------~~~~~~~~------~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
+ .+.+..... .......+ ....+.+++.+||+.||++|||++|++++-+..
T Consensus 249 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 249 T-PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp C-TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred C-hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 1 111100000 00000000 123578999999999999999999999987653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=355.49 Aligned_cols=264 Identities=24% Similarity=0.339 Sum_probs=201.4
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC------
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD------ 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 873 (1109)
.++|++.+.||+|+||+||+|++. +|+.||||++..........+.+.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367899999999999999999974 6999999999655444445677899999999999999999999998763
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLA 953 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 953 (1109)
..|+||||+ +++|.+++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 359999999 88999999763 2899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCc
Q 001274 954 KLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTS 1031 (1109)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 1031 (1109)
+.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.. ..+.+........ +..
T Consensus 176 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD----HLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCH
T ss_pred ccccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCCH
Confidence 87542 2345678999999999887 679999999999999999999999998543 2222222221111 111
Q ss_pred hhhhhhcch---------------h-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1032 ELFDKRLDL---------------S-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1032 ~~~~~~~~~---------------~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
+........ . ..........+.+++.+|++.||++|||++|++++-+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~ 312 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence 111100000 0 000112234678999999999999999999999986543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=340.13 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=202.8
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC--CcchhHHHHHHHHHhccCCCCceeeEEEEEE--eCCce
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE--GATADNSFLAEISTLGKIRHRNIVKLYGFCY--HQDSN 875 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 875 (1109)
.++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+.+.+|++++++++||||+++++++. ..+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999975 689999999974321 1234567999999999999999999999984 44578
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
++||||++++ +.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||.+..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 7777765432 24899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCC-CCCccccccccceeccccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 956 IDLPY-SKSMSAIAGSYGYIAPEYAYTMK--VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 956 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
..... ........||+.|+|||++.+.. ++.++||||+|+++|||++|+.||.... .............+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~i~~~~~~~~- 233 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----IYKLFENIGKGSYAIP- 233 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHCCCCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHHHHhcCCCCCC-
Confidence 64221 22224556899999999987654 4789999999999999999999997532 2222222222211111
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
......+.+++.+||+.||++|||++|++++-+....
T Consensus 234 -------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 234 -------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp -------------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred -------------CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 1112357799999999999999999999998766543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=346.59 Aligned_cols=261 Identities=26% Similarity=0.378 Sum_probs=204.3
Q ss_pred cCCCCCceEecCCcceEEEEEecC----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe-CCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH-QDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 876 (1109)
.+|++.++||+|+||+||+|++.+ ...||+|++... ......+.+.+|++++++++||||+++++++.. ++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 468888999999999999998642 235889988642 233445778999999999999999999998654 55779
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999976543 3899999999999999999999 779999999999999999999999999999866
Q ss_pred cCCCC---CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhC-CCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 957 DLPYS---KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITG-KSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 957 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
..... .......+|+.|+|||++.+..++.++||||+|+++|||++| ..||.... .......+........ .
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~- 254 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRLLQ--P- 254 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-TTTHHHHHHTTCCCCC--C-
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-HHHHHHHHhcCCCCCC--C-
Confidence 43221 122345678899999999999999999999999999999994 55555433 2233222222111110 0
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
......+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 255 -------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 255 -------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0012357899999999999999999999999999877553
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=354.70 Aligned_cols=263 Identities=25% Similarity=0.287 Sum_probs=204.6
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-----CCceeeEEEEEEeCC
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-----HRNIVKLYGFCYHQD 873 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~ 873 (1109)
..++|++.++||+|+||+||+|++. +++.||||+++. .......+..|+++++.++ ||||+++++++...+
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 3478999999999999999999974 689999999962 2334566788999998886 999999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC------------
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE------------ 941 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------------ 941 (1109)
..++||||+ +++|.+++...... .+++..+..++.||+.||+||| +.+|+||||||+||+++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhc
Confidence 999999999 99999999865432 3899999999999999999999 779999999999999975
Q ss_pred -------------CCceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001274 942 -------------EFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQ 1008 (1109)
Q Consensus 942 -------------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 1008 (1109)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 78999999999986442 2345678999999999999999999999999999999999999997
Q ss_pred CcccCCcHHHHHHHhhhccCCCchhhhhhcc-----------------hhh--------------cccHHHHHHHHHHHH
Q 001274 1009 SLELGGDLVTWVRRSIHEMVPTSELFDKRLD-----------------LSA--------------KRTVEEMTLFLKIAL 1057 (1109)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~--------------~~~~~~~~~~~~li~ 1057 (1109)
.....+ ....+.... ...+ ......... ... .........+.+++.
T Consensus 261 ~~~~~~-~~~~~~~~~-~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 261 THEHME-HLAMMESII-QPIP-KNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp CSSHHH-HHHHHHHHT-CCCC-HHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCcHHH-HHHHHHHhc-CCCC-HHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 543211 111111111 1111 000000000 000 000001146779999
Q ss_pred hccCCCCCCCCCHHHHHHHH
Q 001274 1058 FCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1058 ~cl~~dP~~RPt~~evl~~L 1077 (1109)
+||+.||++|||++|++++-
T Consensus 338 ~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTSG
T ss_pred HHhcCChhhCCCHHHHhcCc
Confidence 99999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=378.39 Aligned_cols=255 Identities=21% Similarity=0.333 Sum_probs=202.4
Q ss_pred eEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 809 VIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 809 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
+||+|+||+||+|.+. ++..||||+++.. ......+.+.+|++++++++||||+++++++.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 7999999999999764 4667999999744 223456789999999999999999999999876 5689999999999
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC--C
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK--S 963 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~ 963 (1109)
+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++........ .
T Consensus 421 ~L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 421 PLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp BHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred cHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999976543 3899999999999999999999 779999999999999999999999999999876432211 1
Q ss_pred ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhh
Q 001274 964 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042 (1109)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1109)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+... ......+........
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~~~~~i~~~~~~~~-------------- 560 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRMEC-------------- 560 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-HHHHHHHHTTCCCCC--------------
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCCCC--------------
Confidence 123345789999999999999999999999999999998 9999986432 122222221111000
Q ss_pred cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 001274 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087 (1109)
Q Consensus 1043 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 1087 (1109)
.......+.+++.+||+.||++||++.++++.|+.........
T Consensus 561 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 561 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp --CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred --CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 1112246789999999999999999999999999987776443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=378.73 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=209.4
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||+||+|+++++..||||+++... ...+.|.+|++++++++|+||+++++++.+ +..++||||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 5688889999999999999999888889999997432 235679999999999999999999999876 678999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++|+|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 999999999975321 23899999999999999999999 77999999999999999999999999999986643222
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..+.......... ..
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~----~~~~~~~i~~~~~-~~--------- 484 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYR-MP--------- 484 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC----HHHHHHHHHTTCC-CC---------
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcCCC-CC---------
Confidence 22234457889999999999999999999999999999999 999997543 1222222111110 00
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
........+.++|.+||+.||++|||+++|++.|+.+....
T Consensus 485 ---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 485 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 01112245789999999999999999999999999876543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=348.59 Aligned_cols=263 Identities=24% Similarity=0.405 Sum_probs=207.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEE--EEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVI--AVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||.||+|++. +++.+ |||.++.. ......+.+.+|+++++++ +||||+++++++...+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 57889999999999999999865 56644 99988743 2233456789999999999 89999999999999999999
Q ss_pred EEEeccCCCHHHHhccCC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 001274 878 LYEYMENGSLGEQLHGNK-------------QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ 944 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 944 (1109)
||||+++|+|.+++.... ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence 999999999999997653 1234899999999999999999999 779999999999999999999
Q ss_pred eEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHh
Q 001274 945 AHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRS 1023 (1109)
Q Consensus 945 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~ 1023 (1109)
+||+|||+++.... ........+++.|+|||++.+..++.++||||+|+++|||++ |+.||.+.. ..+.....
T Consensus 181 ~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~----~~~~~~~~ 254 (327)
T 1fvr_A 181 AKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYEKL 254 (327)
T ss_dssp EEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHG
T ss_pred EEEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc----HHHHHHHh
Confidence 99999999974331 122233457889999999998889999999999999999998 999997533 22222222
Q ss_pred hhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 001274 1024 IHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 1087 (1109)
...... . ........+.+++.+||+.||++|||++|++++|..+.......
T Consensus 255 ~~~~~~-~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 255 PQGYRL-E------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp GGTCCC-C------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred hcCCCC-C------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 111110 0 01111235789999999999999999999999999988766443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=339.51 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=208.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57889999999999999999975 678999999964321 1123467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++..... +++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 99999999999976543 899999999999999999999 78999999999999999999999999999976542
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.......|++.|+|||++.+..++.++||||+|+++|||++|+.||.... ..+.............
T Consensus 167 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~-------- 232 (284)
T 2vgo_A 167 --LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS----HTETHRRIVNVDLKFP-------- 232 (284)
T ss_dssp --SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHTTCCCCC--------
T ss_pred --cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC----HhHHHHHHhccccCCC--------
Confidence 22344678999999999999999999999999999999999999997532 2222222222111111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
......+.+++.+|++.||++||++.|++++-+...
T Consensus 233 ------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 233 ------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp ------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred ------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 011235679999999999999999999999876554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=340.99 Aligned_cols=255 Identities=25% Similarity=0.319 Sum_probs=199.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|.+.++||+|+||+||+|+.. +++.||+|++..... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 57889999999999999999865 689999999975532 2345778999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEeeccccccc
Q 001274 881 YMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~ 956 (1109)
|+++|+|.+++.... ....+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999985431 1123899999999999999999999 7799999999999999 45688999999999865
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. ........||+.|+|||++. +.++.++||||+|+++|||++|+.||.+.. ..+............... ..
T Consensus 178 ~~--~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~-~~ 249 (285)
T 3is5_A 178 KS--DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEVQQKATYKEPNYAVE-CR 249 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCC---C
T ss_pred CC--cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC----HHHHHhhhccCCcccccc-cC
Confidence 42 22234567899999999875 568999999999999999999999997532 222222211111111000 00
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.....+.+++.+||+.||++|||++|++++-+
T Consensus 250 ----------~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 250 ----------PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp ----------CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred ----------cCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 01235678999999999999999999997643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=357.20 Aligned_cols=267 Identities=15% Similarity=0.166 Sum_probs=208.0
Q ss_pred cCCCCCceEecCCcceEEEEEecC---------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceee--------
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN---------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVK-------- 864 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 864 (1109)
++|++.+.||+|+||+||+|++.. ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 689999999999999999998763 789999998732 46889999999999999887
Q ss_pred -------EEEEEEe-CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 001274 865 -------LYGFCYH-QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNN 936 (1109)
Q Consensus 865 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 936 (1109)
+++++.. .+..++||||+ +++|.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+|
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~N 189 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAEN 189 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHH
Confidence 6777776 67789999999 9999999986521 24999999999999999999999 7799999999999
Q ss_pred eeeCCCC--ceEEeeccccccccCCCC------CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001274 937 ILLDEEF--QAHVGDFGLAKLIDLPYS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQ 1008 (1109)
Q Consensus 937 Ill~~~~--~~kl~DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 1008 (1109)
|+++.++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 999999999986643211 11234579999999999999999999999999999999999999998
Q ss_pred CcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCC
Q 001274 1009 SLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDY 1087 (1109)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 1087 (1109)
.................... ......... .......+.+++.+||+.||++||+++++++.|+++.......
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKP--GPFVGPCGH-----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSC--CCEECTTSC-----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCCcCHHHHHHHHHhccCCh--hhhhhhccc-----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 65422221111111111111 111110000 0011245789999999999999999999999999998776433
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=368.75 Aligned_cols=258 Identities=26% Similarity=0.322 Sum_probs=206.7
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc-----------chhHHHHHHHHHhccCCCCceeeEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA-----------TADNSFLAEISTLGKIRHRNIVKLYGF 868 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~~ 868 (1109)
.++|++.++||+|+||+||+|++. +++.||||++....... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 468999999999999999999975 68899999997543221 235678999999999999999999999
Q ss_pred EEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---ce
Q 001274 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF---QA 945 (1109)
Q Consensus 869 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~ 945 (1109)
+.+.+..++||||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999876543 899999999999999999999 77999999999999998776 69
Q ss_pred EEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhh
Q 001274 946 HVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIH 1025 (1109)
Q Consensus 946 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~ 1025 (1109)
||+|||+++.... ........||+.|+|||++. +.++.++||||+||++|+|++|+.||.+.. ..+.+.....
T Consensus 189 kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~ 261 (504)
T 3q5i_A 189 KIVDFGLSSFFSK--DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN----DQDIIKKVEK 261 (504)
T ss_dssp EECCCTTCEECCT--TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH
T ss_pred EEEECCCCEEcCC--CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHc
Confidence 9999999987653 23345567999999999876 469999999999999999999999997532 2333333322
Q ss_pred ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1026 EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
..........+ .....+.+++.+|++.||++|||++|++++-+-..
T Consensus 262 ~~~~~~~~~~~----------~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 262 GKYYFDFNDWK----------NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp CCCCCCHHHHT----------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCCccccC----------CCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 22211110000 11235779999999999999999999999877654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=345.58 Aligned_cols=259 Identities=23% Similarity=0.331 Sum_probs=205.5
Q ss_pred cCCCCCc-eEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGA-VIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|.+.+ .||+|+||+||+|.+. .++.||||+++.........+.+.+|+++++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 5677777 9999999999999642 468899999976544444567899999999999999999999998 5677899
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 95 v~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhCcC---CCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999987543 899999999999999999999 7799999999999999999999999999998765
Q ss_pred CCCCC--CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 958 LPYSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 958 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
..... ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+..........+. .
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~~---~ 241 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKGERMG---C 241 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCC---C
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCC---C
Confidence 32221 1123346789999999998889999999999999999999 9999985431 11111111111100 0
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.......+.+++.+||+.||++||++.++++.|+......
T Consensus 242 ----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 242 ----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1112245789999999999999999999999999887654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=366.84 Aligned_cols=273 Identities=22% Similarity=0.274 Sum_probs=191.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-----Cce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ-----DSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 875 (1109)
++|++.++||+|+||+||+|++. +++.||||++..........+.+.+|++++++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 68999999999999999999865 689999999975544555567899999999999999999999998543 467
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
|+||||+ +|+|.+++..... +++..+..++.||+.||+||| +.+||||||||+|||++.++.+||+|||+|+.
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhcccCCC---CCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999998 5799999976543 899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCC--------------------------CCccccccccceeccccc-cCCCCCccchhHHHHHHHHHHHh------
Q 001274 956 IDLPYS--------------------------KSMSAIAGSYGYIAPEYA-YTMKVTEKCDIYSFGVVLLELIT------ 1002 (1109)
Q Consensus 956 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvll~ellt------ 1002 (1109)
...... ......+||+.|+|||++ .+..|+.++||||+||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 642211 123456789999999986 46679999999999999999999
Q ss_pred -----CCCCCCCcccCC----------------cHHHHHHHhhhcc-CCCchhhhhhcch----------------hhcc
Q 001274 1003 -----GKSPVQSLELGG----------------DLVTWVRRSIHEM-VPTSELFDKRLDL----------------SAKR 1044 (1109)
Q Consensus 1003 -----g~~pf~~~~~~~----------------~~~~~~~~~~~~~-~~~~~~~~~~~~~----------------~~~~ 1044 (1109)
|+.+|.+..... ...+.+....... .+..+.+...... -...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 555565422100 0011111111100 0111111000000 0000
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1045 TVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1045 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.......+.+++.+||..||++|||++|+++|-+...
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 1112346789999999999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=344.96 Aligned_cols=260 Identities=22% Similarity=0.266 Sum_probs=198.7
Q ss_pred cCCCCC-ceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEE
Q 001274 802 GNFSEG-AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 878 (1109)
++|++. +.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 467774 78999999999999864 78999999997443 23456789999999885 799999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc---eEEeecccccc
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ---AHVGDFGLAKL 955 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~a~~ 955 (1109)
|||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRH---FNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEcCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999976543 899999999999999999999 779999999999999988776 99999999976
Q ss_pred ccCCCC------CCccccccccceeccccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc---------
Q 001274 956 IDLPYS------KSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGD--------- 1015 (1109)
Q Consensus 956 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~--------- 1015 (1109)
...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 532111 11234469999999999875 5689999999999999999999999986532210
Q ss_pred --HHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1016 --LVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1016 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
................... .......+.+++.+||+.||++|||++|++++-+.
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKD----------WAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHH----------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred hHHHHHHHHHhccCcccCchh----------cccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 0111111111111111000 00112457899999999999999999999987553
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=348.17 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=207.3
Q ss_pred HHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc------chhHHHHHHHHHhccC-CCCceeeEEEEE
Q 001274 798 LEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA------TADNSFLAEISTLGKI-RHRNIVKLYGFC 869 (1109)
Q Consensus 798 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 869 (1109)
....++|++.+.||+|+||.||+|++. +|+.||||++....... ...+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 345578999999999999999999975 79999999997543221 1135678999999999 899999999999
Q ss_pred EeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 001274 870 YHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGD 949 (1109)
Q Consensus 870 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 949 (1109)
...+..++||||+++++|.+++..... +++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVA---LSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999999976433 899999999999999999999 77999999999999999999999999
Q ss_pred ccccccccCCCCCCccccccccceeccccccC------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHh
Q 001274 950 FGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT------MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRS 1023 (1109)
Q Consensus 950 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~ 1023 (1109)
||++..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ........
T Consensus 244 fG~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~i 317 (365)
T 2y7j_A 244 FGFSCHLEP--GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----QILMLRMI 317 (365)
T ss_dssp CTTCEECCT--TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH
T ss_pred cCcccccCC--CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC----HHHHHHHH
Confidence 999987652 223345679999999998863 358899999999999999999999997532 22222222
Q ss_pred hhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1024 IHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
............ ......+.+++.+||+.||++|||+.|++++-+
T Consensus 318 ~~~~~~~~~~~~----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 318 MEGQYQFSSPEW----------DDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp HHTCCCCCHHHH----------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HhCCCCCCCccc----------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 222111110000 011235779999999999999999999998743
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=342.20 Aligned_cols=255 Identities=24% Similarity=0.296 Sum_probs=206.0
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|.+.+.||+|+||+||+|++. +++.||+|+++.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 357889999999999999999975 789999999974322 23456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~ 956 (1109)
||+++++|.+++...+. +++..+..++.|++.|++||| +.+|+||||||+||++ +.++.+||+|||.++..
T Consensus 86 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 86 QLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EcCCCccHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999999876543 899999999999999999999 7799999999999999 78899999999999754
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ....................
T Consensus 160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~- 231 (304)
T 2jam_A 160 QN---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET----ESKLFEKIKEGYYEFESPFW- 231 (304)
T ss_dssp CC---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHCCCCCCTTTT-
T ss_pred CC---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHcCCCCCCcccc-
Confidence 32 22344568999999999999999999999999999999999999997532 22222222222211111110
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
......+.+++.+|++.||++|||+.|++++-+..
T Consensus 232 ---------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (304)
T 2jam_A 232 ---------DDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266 (304)
T ss_dssp ---------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred ---------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence 11123577999999999999999999999987654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=362.29 Aligned_cols=322 Identities=22% Similarity=0.202 Sum_probs=205.7
Q ss_pred ceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEeccccc
Q 001274 268 LLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENM 347 (1109)
Q Consensus 268 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~ 347 (1109)
.++.++++++ .+|..+. ++++.|++++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|+.|+|++|.
T Consensus 15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 4555555555 3444332 345555555555555445555555555555555555555445555555555555555555
Q ss_pred ccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchh
Q 001274 348 LQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPH 427 (1109)
Q Consensus 348 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~ 427 (1109)
+.+..+..|..+++|++|+|++|+++ +..+..|..+++|++|++++|.+.+..+..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 147 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIV------------------------ILLDYMFQDLYNLKSLEVGDNDLVYISHRA 147 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCC------------------------EECTTTTTTCTTCCEEEECCTTCCEECTTS
T ss_pred CCccCcccccCCCCCCEEECCCCccc------------------------cCChhHccccccCCEEECCCCccceeChhh
Confidence 44444444444445555555555544 444444444444555555555544444444
Q ss_pred hhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCcccccccccc
Q 001274 428 LCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLE 507 (1109)
Q Consensus 428 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 507 (1109)
|..+++|+.|+|++|++++..+..|..+++|+.|++++|++.+..+..|.++++|++|++++|.+.+.+|..+....+|+
T Consensus 148 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~ 227 (477)
T 2id5_A 148 FSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227 (477)
T ss_dssp STTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCS
T ss_pred ccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCcccc
Confidence 55555555555555555544444455555555566666666655566666777777777777766666666666666888
Q ss_pred EEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccc
Q 001274 508 RLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNK 587 (1109)
Q Consensus 508 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 587 (1109)
+|+|++|++++..+..+.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+
T Consensus 228 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 307 (477)
T 2id5_A 228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307 (477)
T ss_dssp EEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSC
T ss_pred EEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCc
Confidence 88888888886555678888888888888888887777778888888888888888888778888888888888888888
Q ss_pred cccccCcccCCCcccceeeccCccccccc
Q 001274 588 LTGAIPSSLGGLARLTELQMGGNIFSGSI 616 (1109)
Q Consensus 588 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 616 (1109)
+++..+..|..+++|++|++++|++.+..
T Consensus 308 l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 308 LTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp CSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred CceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 88777778888888888888888887543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=365.53 Aligned_cols=258 Identities=26% Similarity=0.353 Sum_probs=211.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.++||+|+||+||+|+.. +++.||||++...... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57899999999999999999976 7899999999754332 334677999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL---DEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~ 956 (1109)
||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+++..
T Consensus 106 e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp CCCCSCBHHHHHHTCSC---CBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred ecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999976553 899999999999999999999 7799999999999999 56789999999999876
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. ........||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.. ..+.................
T Consensus 180 ~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~- 251 (484)
T 3nyv_A 180 EA--SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN----EYDILKKVEKGKYTFELPQW- 251 (484)
T ss_dssp CC--CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCSGGG-
T ss_pred cc--ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHcCCCCCCCccc-
Confidence 52 233345679999999999876 69999999999999999999999998543 22333332222221110000
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
......+.+++.+||+.||++|||+.|++++-+....
T Consensus 252 ---------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 252 ---------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp ---------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred ---------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 0112357799999999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=354.04 Aligned_cols=272 Identities=23% Similarity=0.371 Sum_probs=207.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|++. +++.||+|++.... .....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 57889999999999999999976 68999999997542 33445778999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP-HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
|+++++|.+++..... +++..+..++.|++.|++||| +. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999976543 899999999999999999999 53 8999999999999999999999999999765321
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-----------
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV----------- 1028 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----------- 1028 (1109)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .............
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-LELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH-HHHHHC------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccCCCCCCCcccCC
Confidence 2234578999999999999999999999999999999999999997533111 0000000000000
Q ss_pred -----------C---Cchhhhhhcchh--hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1029 -----------P---TSELFDKRLDLS--AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1029 -----------~---~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
+ ..+..+...... ..........+.+++.+||+.||++|||++|++++-+......
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 0 000000000000 0000011345889999999999999999999999877654443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=342.93 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=192.0
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|++. +++.||||+++.........+.+.++...++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 367889999999999999999974 7899999999754333333344555566688899999999999999999999999
Q ss_pred EeccCCCHHHHhccC-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 880 EYMENGSLGEQLHGN-KQTCLLDWDARYRIALGAAEGLCYLHYDCRP-HIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||++ |+|.+++... .....+++..+..++.|++.|++||| +. +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 5888777541 11123899999999999999999999 65 99999999999999999999999999998664
Q ss_pred CCCCCCccccccccceeccccc----cCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYA----YTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
.. .......||+.|+|||++ .+..++.++||||+|+++|||++|+.||.... .....+........+...
T Consensus 162 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~- 235 (290)
T 3fme_A 162 DD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG---TPFQQLKQVVEEPSPQLP- 235 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS---CHHHHHHHHHHSCCCCCC-
T ss_pred cc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC---chHHHHHHHhccCCCCcc-
Confidence 22 222344789999999996 56678999999999999999999999997532 222222222222211110
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
. ......+.+++.+||+.||++|||++|++++-+....
T Consensus 236 -~----------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 236 -A----------DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp -T----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -c----------ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 0 0112357899999999999999999999998766543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=338.35 Aligned_cols=256 Identities=24% Similarity=0.339 Sum_probs=201.1
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
+|.....||+|+||+||+|++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 4555679999999999999964 68899999997543 23456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeeccccccccCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-EFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~ 960 (1109)
+++++|.+++........+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||.++.....
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~- 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI- 176 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence 999999999987654444778899999999999999999 779999999999999987 899999999999866422
Q ss_pred CCCccccccccceeccccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMK--VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
........|++.|+|||++.+.. ++.++||||||+++|||++|+.||...... .............+. +
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~---~---- 247 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMFKVHPE---I---- 247 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHHHHHHCCCCC---C----
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHhhcccccccc---c----
Confidence 22234557899999999987654 889999999999999999999999753311 111111111111000 0
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.......+.+++.+||+.||++||++.|++++-+.
T Consensus 248 ------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 282 (295)
T 2clq_A 248 ------PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282 (295)
T ss_dssp ------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred ------cccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 11112357789999999999999999999987544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=346.72 Aligned_cols=254 Identities=27% Similarity=0.362 Sum_probs=200.3
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC------CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE------GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 873 (1109)
.++|++.+.||+|+||.||+|++. +++.||||++..... .......+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999875 589999999864321 1122346889999999999999999999987654
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc---eEEeec
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ---AHVGDF 950 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DF 950 (1109)
.++||||+++++|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999999976543 899999999999999999999 779999999999999987654 999999
Q ss_pred cccccccCCCCCCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc
Q 001274 951 GLAKLIDLPYSKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM 1027 (1109)
Q Consensus 951 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 1027 (1109)
|+++.... ........||+.|+|||++. +..++.++||||+||++|||++|+.||............+.......
T Consensus 162 g~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 162 GHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239 (322)
T ss_dssp TTCEECCC--CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred ccceeccc--ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence 99987642 11223456899999999874 56789999999999999999999999986654445544443321111
Q ss_pred CCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
. .+. . ......+.+++.+||+.||++||+++|++++
T Consensus 240 ~--~~~-~----------~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 240 I--PEV-W----------AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp C--HHH-H----------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred C--chh-h----------hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0 000 0 0112457899999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.95 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=208.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+.|+..+.||+|+||+||+|++. +++.||||++..... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 56888999999999999999864 689999999975432 3346789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 172 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT- 172 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT-
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc-
Confidence 99999999999753 3899999999999999999999 779999999999999999999999999999876532
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ............+. ..
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~---~~----- 240 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLIPKNNPPT---LE----- 240 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSCCCC---CC-----
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HHHHHHhhcCCCCC---Cc-----
Confidence 2223456789999999999999999999999999999999999999975331 11111111111100 00
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
......+.+++.+||+.||++|||+.|++++.+...
T Consensus 241 -----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 241 -----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp -----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred -----cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 011235779999999999999999999999876654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=336.84 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=199.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 67899999999999999999976 799999999964321 1223457889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+......
T Consensus 91 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999976543 899999999999999999999 679999999999999999999999999999876422
Q ss_pred CCCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.......+++.|+|||++.+..+ +.++||||+|+++|+|++|+.||.... .................
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~------ 232 (276)
T 2h6d_A 165 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----VPTLFKKIRGGVFYIPE------ 232 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCT------
T ss_pred --cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHhhcCcccCch------
Confidence 22234578999999999988776 689999999999999999999997532 22222222111111111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.....+.+++.+||+.||++|||+.|++++-+..
T Consensus 233 --------~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~ 266 (276)
T 2h6d_A 233 --------YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266 (276)
T ss_dssp --------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred --------hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence 0123577899999999999999999999986643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.80 Aligned_cols=258 Identities=22% Similarity=0.360 Sum_probs=205.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--CCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--QDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 878 (1109)
++|++.+.||+|+||+||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++.. ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 57889999999999999999975 68999999998665555566789999999999999999999998854 5678999
Q ss_pred EEeccCCCHHHHhccCCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCC-----eEecCCCCCceeeCCCCceEEeeccc
Q 001274 879 YEYMENGSLGEQLHGNKQ-TCLLDWDARYRIALGAAEGLCYLHYDCRPH-----IIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
|||+++++|.+++..... ...+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999975321 223899999999999999999999 556 99999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
++..... ........|++.|+|||++.+..++.++||||+|+++|||++|+.||.... ..+..........+.
T Consensus 163 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~i~~~~~~~-- 235 (279)
T 2w5a_A 163 ARILNHD-TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QKELAGKIREGKFRR-- 235 (279)
T ss_dssp HHHC----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHTCCCC--
T ss_pred heeeccc-cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC----HHHHHHHHhhccccc--
Confidence 9865422 111234568999999999999999999999999999999999999998543 122222211111110
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
. .......+.+++.+||+.||++||++.|++++++..
T Consensus 236 -~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 236 -I----------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp -C----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred -C----------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 0 001123577999999999999999999999877543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=340.75 Aligned_cols=251 Identities=23% Similarity=0.374 Sum_probs=204.0
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--------
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH-------- 871 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 871 (1109)
.++|++.+.||+|+||.||+|++. +++.||+|+++.. .+.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC------SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 467899999999999999999976 7999999999743 2457799999999999999999998864
Q ss_pred --------CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 001274 872 --------QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF 943 (1109)
Q Consensus 872 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 943 (1109)
....++||||+++|+|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCC
Confidence 3447899999999999999975432 23899999999999999999999 77999999999999999999
Q ss_pred ceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHh
Q 001274 944 QAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRS 1023 (1109)
Q Consensus 944 ~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~ 1023 (1109)
.+||+|||+++..... .......+|+.|+|||++.+..++.++||||+|+++|||++|..||... .......
T Consensus 160 ~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~~~~~~ 231 (284)
T 2a19_B 160 QVKIGDFGLVTSLKND--GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------SKFFTDL 231 (284)
T ss_dssp EEEECCCTTCEESSCC--SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------HHHHHHH
T ss_pred CEEECcchhheecccc--ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------HHHHHHh
Confidence 9999999999876532 2234457899999999999999999999999999999999999987531 1111111
Q ss_pred hhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1024 IHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
..... ... ....+.+++.+||+.||++|||+.|++++++.......
T Consensus 232 ~~~~~--~~~--------------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 232 RDGII--SDI--------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HTTCC--CTT--------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred hcccc--ccc--------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11111 000 11346789999999999999999999999998876543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=374.79 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=200.9
Q ss_pred ceEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
++||+|+||+||+|.+. .++.||||+++.........+++.+|++++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 4678999999865544455678999999999999999999999986 4568899999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC--C
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS--K 962 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~ 962 (1109)
|+|.+++..... +++..+..++.||+.||+||| +.+||||||||+||+++.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999976543 899999999999999999999 77999999999999999999999999999987643221 2
Q ss_pred CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 963 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+... .+............
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~~i~~~~~~~----------- 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKGERMG----------- 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCC-----------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCC-----------
Confidence 2233457889999999999999999999999999999998 9999986432 12222111111100
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
........+.+++.+||+.||++||++++|++.|+.....
T Consensus 593 --~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 593 --CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0111224678999999999999999999999999987654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=358.68 Aligned_cols=273 Identities=22% Similarity=0.265 Sum_probs=202.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-----Cce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ-----DSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 875 (1109)
++|++.+.||+|+||+||+|++. +++.||||++..........+.+.+|++++++++||||+++++++... +..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 68999999999999999999865 688999999975545555567899999999999999999999999776 568
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
|+||||++ |+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~~---l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPIF---LTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCC-cCHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 99999996 699999976543 899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCC---------------------CCccccccccceeccccc-cCCCCCccchhHHHHHHHHHHHhCCCCCCCccc-
Q 001274 956 IDLPYS---------------------KSMSAIAGSYGYIAPEYA-YTMKVTEKCDIYSFGVVLLELITGKSPVQSLEL- 1012 (1109)
Q Consensus 956 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~- 1012 (1109)
...... ......+||+.|+|||++ .+..++.++||||+||++|||++|..||.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 643221 123567899999999986 566799999999999999999986555432210
Q ss_pred ------CCc-----------------HHHHHHHhhhccC-CCchhhhhhc-----------chhh-----cccHHHHHHH
Q 001274 1013 ------GGD-----------------LVTWVRRSIHEMV-PTSELFDKRL-----------DLSA-----KRTVEEMTLF 1052 (1109)
Q Consensus 1013 ------~~~-----------------~~~~~~~~~~~~~-~~~~~~~~~~-----------~~~~-----~~~~~~~~~~ 1052 (1109)
+.. ..+.+........ +..+.+.... .... .........+
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 000 1111111111111 1111100000 0000 0001123467
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1053 LKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1053 ~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
.+++.+||+.||++|||++|++++-+...
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 89999999999999999999999866543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=347.83 Aligned_cols=262 Identities=26% Similarity=0.313 Sum_probs=206.3
Q ss_pred cCCCCCceEecCCcceEEEEEe------cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++|++.+.||+|+||+||+|++ .+++.||||++... ........+.+|+.++++++||||+++++++...+..
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 6899999999999999999984 25778999999633 2334556789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCCCC----CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEe
Q 001274 876 LLLYEYMENGSLGEQLHGNKQT----CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE---EFQAHVG 948 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 948 (1109)
++||||+++|+|.+++...... ..+++..+..++.||+.||.||| +.+|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999865421 34889999999999999999999 779999999999999984 4569999
Q ss_pred eccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhc
Q 001274 949 DFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 949 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... ..+........
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~~~~~~~ 261 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS----NQEVLEFVTSG 261 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHHHHHTT
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC----HHHHHHHHhcC
Confidence 9999986542221 22234567899999999999999999999999999999998 999997532 22222222111
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
..+.. .......+.+++.+||+.||++||++.+++++++.+....
T Consensus 262 ~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 262 GRMDP-------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCC-------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 11000 0111235779999999999999999999999999887654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=345.82 Aligned_cols=261 Identities=22% Similarity=0.332 Sum_probs=203.2
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe----CCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH----QDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 876 (1109)
++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++++.++||||+++++++.. ....+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 6789999999999999999997 47999999998643 23456778999999999999999999999873 34678
Q ss_pred EEEEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 877 LLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
+||||+++|+|.+++.... ....+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||.+..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999987521 1224899999999999999999999 77999999999999999999999999999876
Q ss_pred ccCCCCCC--------ccccccccceeccccccCCC---CCccchhHHHHHHHHHHHhCCCCCCCccc-CCcHHHHHHHh
Q 001274 956 IDLPYSKS--------MSAIAGSYGYIAPEYAYTMK---VTEKCDIYSFGVVLLELITGKSPVQSLEL-GGDLVTWVRRS 1023 (1109)
Q Consensus 956 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvll~elltg~~pf~~~~~-~~~~~~~~~~~ 1023 (1109)
........ .....||+.|+|||++.+.. ++.++||||+|+++|||++|+.||..... .......+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 43111110 12345799999999987654 78999999999999999999999975321 22222222110
Q ss_pred hhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1024 IHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
. ..+. .......+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 264 ~--~~~~--------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 264 L--SIPQ--------------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp ----CCC--------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred C--CCCc--------------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 0 0010 011123578999999999999999999999999887643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=347.24 Aligned_cols=262 Identities=21% Similarity=0.235 Sum_probs=200.8
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEe--CCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYH--QDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l 877 (1109)
++|++.++||+|+||+||+|++ .+++.||||+++. ...+.+.+|++++++++ ||||+++++++.. ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 6799999999999999999986 4789999999862 23567899999999997 9999999999988 567899
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeeccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAKLI 956 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~ 956 (1109)
||||+++++|.+++.. +++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||+++..
T Consensus 111 v~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 9999999999999853 788999999999999999999 77999999999999999777 8999999999866
Q ss_pred cCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhh----------
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIH---------- 1025 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~---------- 1025 (1109)
... .......++..|+|||++.+ ..++.++||||+||++|||++|+.||............+.....
T Consensus 182 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 182 HPG--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp CTT--CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC--CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 522 23345578999999999887 67899999999999999999999999643211111111110000
Q ss_pred ccCCCchhhhhhcch----------hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1026 EMVPTSELFDKRLDL----------SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
........+...... ...........+.+++.+||+.||++|||++|++++-+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence 000000000000000 000011123468899999999999999999999987543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=357.22 Aligned_cols=264 Identities=23% Similarity=0.271 Sum_probs=204.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC------CCCceeeEEEEEEeCCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI------RHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 874 (1109)
.+|++.++||+|+||+||+|++. +++.||||+++. .......+.+|+++++.+ .|+||+++++++...+.
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 57999999999999999999865 589999999963 223345677788877766 57799999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc--eEEeeccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ--AHVGDFGL 952 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~ 952 (1109)
.++||||+. ++|.+++...... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999995 6999998775432 3899999999999999999999 669999999999999999987 99999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
++... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+...+.. . ..+..+
T Consensus 249 a~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~-~--~~p~~~ 321 (429)
T 3kvw_A 249 SCYEH----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL-L--GMPSQK 321 (429)
T ss_dssp CEETT----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-H--CCCCHH
T ss_pred ceecC----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-c--CCCCHH
Confidence 97643 2234567899999999999999999999999999999999999999864322222222211 0 011111
Q ss_pred hhhhhcc--------------------------------------hhhccc------HHHHHHHHHHHHhccCCCCCCCC
Q 001274 1033 LFDKRLD--------------------------------------LSAKRT------VEEMTLFLKIALFCSSTSPLNRP 1068 (1109)
Q Consensus 1033 ~~~~~~~--------------------------------------~~~~~~------~~~~~~~~~li~~cl~~dP~~RP 1068 (1109)
+.+.... ...... ......+.+++.+||++||++||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 1110000 000000 01134588999999999999999
Q ss_pred CHHHHHHHHHHh
Q 001274 1069 TMREVIAMMIDA 1080 (1109)
Q Consensus 1069 t~~evl~~L~~~ 1080 (1109)
|++|++++-+..
T Consensus 402 ta~e~L~Hpw~~ 413 (429)
T 3kvw_A 402 TPGQALRHPWLR 413 (429)
T ss_dssp CHHHHHTSTTTC
T ss_pred CHHHHhCChhhc
Confidence 999999986644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=340.19 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=202.2
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 878 (1109)
.++|++.+.||+|+||+||+|++. +++.||||+++...........+.+|+..+..+ +||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999976 799999999986655555677889999999999 999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC---------------
Q 001274 879 YEYMENGSLGEQLHGNKQ-TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE--------------- 942 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--------------- 942 (1109)
|||+++++|.+++..... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976421 123899999999999999999999 7799999999999999844
Q ss_pred ----CceEEeeccccccccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHH
Q 001274 943 ----FQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLV 1017 (1109)
Q Consensus 943 ----~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~ 1017 (1109)
..+||+|||.+...... ....||+.|+|||++.+. .++.++||||+||++|||++|..++... ...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~ 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQW 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHH
T ss_pred cCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHH
Confidence 47999999999876532 224589999999999876 5678999999999999999999876532 111
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
..+. ....+. +. ......+.+++.+||+.||++|||+.|++++-+
T Consensus 238 ~~~~---~~~~~~---~~----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 238 HEIR---QGRLPR---IP----------QVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp HHHH---TTCCCC---CS----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred HHHH---cCCCCC---CC----------cccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 1111 111110 00 011235779999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=353.45 Aligned_cols=263 Identities=24% Similarity=0.315 Sum_probs=188.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC------Cc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ------DS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 874 (1109)
++|++.+.||+|+||.||+|++. +|+.||||++..........+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 68999999999999999999864 689999999975544445567888999999999999999999998764 45
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++|+||+ +++|.+++... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred EEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 79999999 78999888653 3899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCch
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSE 1032 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 1032 (1109)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... .+.+........ +..+
T Consensus 181 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 181 HTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLILRLVGTPGAE 252 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCHH
T ss_pred cccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHH
Confidence 6542 2345678999999999887 6789999999999999999999999986432 222222211111 1111
Q ss_pred hhhhhcch-----------hhcc-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1033 LFDKRLDL-----------SAKR-----TVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1033 ~~~~~~~~-----------~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.+...... .... .......+.+++.+||+.||++|||++|++++-+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 11100000 0000 011124578999999999999999999999986654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=347.75 Aligned_cols=265 Identities=24% Similarity=0.299 Sum_probs=191.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEe--------
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYH-------- 871 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-------- 871 (1109)
.+|++.++||+|+||+||+|++. +++.||||++... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 57889999999999999999965 6899999998643 2344567899999999996 9999999999953
Q ss_pred CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeCCCCceEEee
Q 001274 872 QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH--IIHRDIKSNNILLDEEFQAHVGD 949 (1109)
Q Consensus 872 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~D 949 (1109)
....++||||+. |+|.+++........+++..+..++.||+.||+||| +.+ |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEec
Confidence 334689999995 799998875333334999999999999999999999 667 99999999999999999999999
Q ss_pred ccccccccCCCCCC-----------ccccccccceeccccc---cCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc
Q 001274 950 FGLAKLIDLPYSKS-----------MSAIAGSYGYIAPEYA---YTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGD 1015 (1109)
Q Consensus 950 FG~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~ 1015 (1109)
||+++......... .....+|+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 99998764322111 1244689999999998 5667899999999999999999999999753211
Q ss_pred HHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCCCCCCCC
Q 001274 1016 LVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSSPT 1092 (1109)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~ 1092 (1109)
.......... ... .....+.+++.+||+.||++|||+.|++++|+.+.......+.++.
T Consensus 260 --~~~~~~~~~~--~~~--------------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~ 318 (337)
T 3ll6_A 260 --RIVNGKYSIP--PHD--------------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI 318 (337)
T ss_dssp --------CCCC--TTC--------------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred --HhhcCcccCC--ccc--------------ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccH
Confidence 1111111100 000 0012366899999999999999999999999999876655444433
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=346.89 Aligned_cols=279 Identities=22% Similarity=0.254 Sum_probs=196.4
Q ss_pred HHHHHHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC
Q 001274 795 HNLLEATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD 873 (1109)
Q Consensus 795 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 873 (1109)
.......++|++.+.||+|+||+||+|++. +++.||||++.... .....+.+|++.++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 344567789999999999999999999975 68999999986432 23345678888888899999999999997644
Q ss_pred c-------eEEEEEeccCCCHHHHhcc-CCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCc
Q 001274 874 S-------NLLLYEYMENGSLGEQLHG-NKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-EFQ 944 (1109)
Q Consensus 874 ~-------~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~ 944 (1109)
. .++||||+++ ++...+.. ......+++..+..++.|++.|+.|||.. +.+|+||||||+||+++. ++.
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCc
Confidence 3 6899999986 54444332 11222488999999999999999999944 569999999999999996 899
Q ss_pred eEEeeccccccccCCCCCCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHh
Q 001274 945 AHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRS 1023 (1109)
Q Consensus 945 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~ 1023 (1109)
+||+|||+++.... ........||+.|+|||++.+.. ++.++||||+||++|||++|+.||.+..........++..
T Consensus 171 ~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 171 LKLCDFGSAKKLSP--SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEECCCTTCBCCCT--TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEeeCCCceecCC--CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 99999999987652 22334567899999999987654 8999999999999999999999998644222222222211
Q ss_pred hhccCCCchhhhhhc--------------c---hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1024 IHEMVPTSELFDKRL--------------D---LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~--------------~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
. .+..+.+.... . .-..........+.+++.+||+.||++|||+.|++++-+.....
T Consensus 249 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 249 G---CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp C---CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred C---CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0 01111110000 0 00001112345688999999999999999999999987665443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.12 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=208.7
Q ss_pred HHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
...++|++.+.||+|+||+||+|++. +++.||||++..........+.+.+|++++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34468999999999999999999976 68999999997655444556789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC---CceEEeeccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE---FQAHVGDFGLAK 954 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~ 954 (1109)
||||+++++|.+++..... +++..+..++.||+.||+||| +.+++||||||+||+++.+ +.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999998876443 899999999999999999999 7799999999999999654 479999999998
Q ss_pred cccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
..... .......+|+.|+|||++.+ .++.++||||+|+++|+|++|+.||.... ..+................
T Consensus 173 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~ 245 (287)
T 2wei_A 173 CFQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDILKRVETGKYAFDLPQ 245 (287)
T ss_dssp TBCCC--SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCSGG
T ss_pred eecCC--CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCchh
Confidence 76522 22334568999999998875 48999999999999999999999997543 2222222222221111000
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.......+.+++.+||+.||++|||+.|++++-+..
T Consensus 246 ----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~ 281 (287)
T 2wei_A 246 ----------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (287)
T ss_dssp ----------GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred ----------hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence 011123577999999999999999999999976544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=348.89 Aligned_cols=254 Identities=18% Similarity=0.216 Sum_probs=204.1
Q ss_pred hcCCCCCceEecCCcceEEEEE------ecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC---CCceeeEEEEEEe
Q 001274 801 TGNFSEGAVIGRGACGTVYKAT------LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR---HRNIVKLYGFCYH 871 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 871 (1109)
.++|.+.++||+|+||+||+|+ ..+++.||||+++.. ...++..|++++++++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4678899999999999999994 346889999999632 3456778888888876 9999999999999
Q ss_pred CCceEEEEEeccCCCHHHHhccCC--CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC--------
Q 001274 872 QDSNLLLYEYMENGSLGEQLHGNK--QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-------- 941 (1109)
Q Consensus 872 ~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------- 941 (1109)
.+..++||||+++|+|.+++.... ....+++..+..++.||+.||+||| +.+||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999997421 1234999999999999999999999 789999999999999998
Q ss_pred ---CCceEEeeccccccccC-CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHH
Q 001274 942 ---EFQAHVGDFGLAKLIDL-PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLV 1017 (1109)
Q Consensus 942 ---~~~~kl~DFG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~ 1017 (1109)
++.+||+|||+|+.... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||.....+..
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 89999999999976532 122333556799999999999999999999999999999999999999864332100
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHHhhhcc
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNR-PTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R-Pt~~evl~~L~~~~~~~ 1084 (1109)
. ....+. +. .....+.+++.+|++.+|.+| |+++++.+.+++.....
T Consensus 294 -------~----~~~~~~-~~--------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 -------K----PEGLFR-RL--------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -------E----ECSCCT-TC--------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------e----echhcc-cc--------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0 000000 00 012356689999999999998 67888888888877654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=341.08 Aligned_cols=255 Identities=26% Similarity=0.381 Sum_probs=202.5
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||.||+|++. +|+.||||++.... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 468999999999999999999876 58999999997432 3467899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++..... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 104 e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999974332 3899999999999999999999 779999999999999999999999999999876532
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ............+. ...
T Consensus 179 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~--~~~---- 247 (314)
T 3com_A 179 -MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----MRAIFMIPTNPPPT--FRK---- 247 (314)
T ss_dssp -BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSCCCC--CSS----
T ss_pred -ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCCCcc--cCC----
Confidence 2223455789999999999999999999999999999999999999975431 11111111111100 000
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.......+.+++.+||+.||++|||+.+++++-+..
T Consensus 248 -----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 248 -----PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp -----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred -----cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 001123578999999999999999999999876543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=344.05 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=199.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 68999999999999999999976 58999999986443 2345788999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... .+++..+..++.||+.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999876433 2899999999999999999999 779999999999999999999999999998643211
Q ss_pred CCCccccccccceeccccc-----cCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYA-----YTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
........||+.|+|||++ .+..++.++||||+|+++|||++|+.||..... ............+.. ...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~-~~~ 245 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSDPPTL-LTP 245 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSCCCCC-SSG
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----HHHHHHHhccCCccc-CCc
Confidence 1112345689999999988 467789999999999999999999999975432 222222222211110 000
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
......+.+++.+||+.||++|||+.+++++-
T Consensus 246 ----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 246 ----------SKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp ----------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred ----------cccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 11123577999999999999999999998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=354.08 Aligned_cols=277 Identities=19% Similarity=0.232 Sum_probs=202.6
Q ss_pred HHHHHHHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcc---------hhHHHHHHHHHhccCCCCceee
Q 001274 794 YHNLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGAT---------ADNSFLAEISTLGKIRHRNIVK 864 (1109)
Q Consensus 794 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~ 864 (1109)
..++....++|++.+.||+|+||.||+|++.+++.||||++........ ..+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 3466777899999999999999999999988899999999965433211 1267899999999999999999
Q ss_pred EEEEEEeCC-----ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 001274 865 LYGFCYHQD-----SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939 (1109)
Q Consensus 865 l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 939 (1109)
+++++...+ ..++||||++ |+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--VISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence 999986533 5699999997 688888876543 3899999999999999999999 7799999999999999
Q ss_pred CCCCceEEeeccccccccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVT 1018 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~ 1018 (1109)
+.++.+||+|||+++.... ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTA--DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cCCCCEEEEecCccccccc--ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999985442 222345678999999999887 6789999999999999999999999986432211111
Q ss_pred HHHHhhhccCCCchh-----------hhhhcch-----hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1019 WVRRSIHEMVPTSEL-----------FDKRLDL-----SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1019 ~~~~~~~~~~~~~~~-----------~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.+... . ..+.... ....... ...........+.+++.+||+.||++|||+.|++++-+..
T Consensus 246 i~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 321 (362)
T 3pg1_A 246 IVEVV-G-TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321 (362)
T ss_dssp HHHHH-C-CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHc-C-CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhh
Confidence 11110 0 0000000 0000000 0000111234578999999999999999999999886543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=339.35 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=199.0
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-CceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ-DSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|+++ ++.||||+++.. ...+.+.+|++++++++||||+++++++... +..++|||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 57889999999999999999885 889999998632 2456789999999999999999999997654 46899999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++++|.+++..... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 9999999999975432 13788999999999999999999 779999999999999999999999999999865422
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.....+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+. ....+.
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~---~~~~~~--------- 234 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVE---KGYKMD--------- 234 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHHHHHT---TTCCCC---------
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHh---cCCCCC---------
Confidence 223457889999999999999999999999999999998 99999754321 2221111 111000
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
........+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 235 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 235 ----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 01112245789999999999999999999999999987643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=345.02 Aligned_cols=270 Identities=23% Similarity=0.347 Sum_probs=205.7
Q ss_pred HhcCCCCCceEecCCcceEEEEEe--cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC---CCCceeeEEEEEE----
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATL--ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI---RHRNIVKLYGFCY---- 870 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 870 (1109)
..++|++.+.||+|+||+||+|++ .+++.||+|+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 347899999999999999999997 3688999999976544333445677888877766 8999999999987
Q ss_pred -eCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 001274 871 -HQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGD 949 (1109)
Q Consensus 871 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 949 (1109)
.....++||||++ |+|.+++...... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence 4556789999997 6999999765432 3899999999999999999999 77999999999999999999999999
Q ss_pred ccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCC
Q 001274 950 FGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 950 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 1029 (1109)
||.++.... ........+|+.|+|||++.+..++.++||||+|+++|||++|+.||.+..........+.. ... +
T Consensus 164 fg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~--~ 238 (326)
T 1blx_A 164 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV-IGL--P 238 (326)
T ss_dssp CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCC--C
T ss_pred CcccccccC--CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH-cCC--C
Confidence 999986542 12234567899999999999999999999999999999999999999864322212121111 100 0
Q ss_pred Cchhhhhhc------------chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1030 TSELFDKRL------------DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1030 ~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
..+.+.... .............+.+++.+||+.||++|||+.|++++-+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 300 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence 000000000 00000111223457799999999999999999999987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=373.73 Aligned_cols=254 Identities=22% Similarity=0.276 Sum_probs=208.9
Q ss_pred HhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceE
Q 001274 800 ATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 800 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 876 (1109)
..++|++.++||+|+||+||+|++. +++.||||+++.... .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468999999999999999999965 688999999974311 122456788899999988 7999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++|+|.+++..... +++..++.++.||+.||+||| +.+||||||||+|||++.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999987543 899999999999999999999 779999999999999999999999999999864
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
.. ........+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+. +..+..............
T Consensus 493 ~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~----~~~~~~~~i~~~~~~~p~---- 563 (674)
T 3pfq_A 493 IW-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQSIMEHNVAYPK---- 563 (674)
T ss_dssp CC-TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHSSCCCCCT----
T ss_pred cc-CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC----CHHHHHHHHHhCCCCCCc----
Confidence 32 223345678999999999999999999999999999999999999999853 233333333333222111
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTM-----REVIAMMI 1078 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~~L~ 1078 (1109)
.....+.+++.+||+.||++||++ +||+++-+
T Consensus 564 ----------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 564 ----------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600 (674)
T ss_dssp ----------TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred ----------cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence 112357799999999999999997 88887643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=358.01 Aligned_cols=247 Identities=16% Similarity=0.144 Sum_probs=191.6
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccC-CCcchhHHHHHHH---HHhccCCCCceeeEE-------EE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRG-EGATADNSFLAEI---STLGKIRHRNIVKLY-------GF 868 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 868 (1109)
.++|++.+.||+|+||+||+|++ .+|+.||||++.... ......+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36788899999999999999996 469999999997542 2334557889999 555666899999998 66
Q ss_pred EEeCCc-----------------eEEEEEeccCCCHHHHhccCCC----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCe
Q 001274 869 CYHQDS-----------------NLLLYEYMENGSLGEQLHGNKQ----TCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927 (1109)
Q Consensus 869 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 927 (1109)
+...+. .++||||+ +|+|.+++..... ...+++..+..++.||+.||+||| +.+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 665532 78999999 6899999976432 112345888899999999999999 7799
Q ss_pred EecCCCCCceeeCCCCceEEeeccccccccCCCCCCccccccccceeccccccCC-----------CCCccchhHHHHHH
Q 001274 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM-----------KVTEKCDIYSFGVV 996 (1109)
Q Consensus 928 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvl 996 (1109)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999998643 23344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 997 LLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 997 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
+|||++|+.||........ ........ ......+.+++.+||+.||++|||+.|++++
T Consensus 303 l~elltg~~Pf~~~~~~~~--------------~~~~~~~~--------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG--------------SEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CC--------------SGGGGSSC--------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccc--------------hhhhhhhc--------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999975331111 00000000 0112357789999999999999999999986
Q ss_pred HH
Q 001274 1077 MI 1078 (1109)
Q Consensus 1077 L~ 1078 (1109)
-+
T Consensus 361 p~ 362 (377)
T 3byv_A 361 PE 362 (377)
T ss_dssp HH
T ss_pred hH
Confidence 44
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=337.40 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=206.3
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc-------chhHHHHHHHHHhccCC-CCceeeEEEEEEe
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA-------TADNSFLAEISTLGKIR-HRNIVKLYGFCYH 871 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 871 (1109)
.++|++.+.||+|+||.||+|++. +++.||||++....... ...+.+.+|++++++++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999975 68999999997543211 12356789999999995 9999999999999
Q ss_pred CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 872 QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 872 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
.+..++||||+++++|.+++..... +++..+..++.||+.||+||| +.+++||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999976433 899999999999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccceecccccc------CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhh
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAY------TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIH 1025 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~ 1025 (1109)
.+..... ........+++.|+|||++. ...++.++||||+|+++|||++|+.||.... ..........
T Consensus 170 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~ 243 (298)
T 1phk_A 170 FSCQLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----QMLMLRMIMS 243 (298)
T ss_dssp TCEECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH
T ss_pred chhhcCC--CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc----HHHHHHHHhc
Confidence 9987652 22334567899999999885 4568899999999999999999999997532 2222222222
Q ss_pred ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1026 EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
......... .......+.+++.+||+.||++|||+.|++++-+.
T Consensus 244 ~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (298)
T 1phk_A 244 GNYQFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287 (298)
T ss_dssp TCCCCCTTT----------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred CCcccCccc----------ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence 211111000 01112357899999999999999999999986543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=343.56 Aligned_cols=263 Identities=27% Similarity=0.373 Sum_probs=207.1
Q ss_pred cCCCCCceEecCCcceEEEEEe-----cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC--c
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-----ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD--S 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~ 874 (1109)
++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++...+ .
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 5688899999999999999983 36899999998743 2345578999999999999999999999987654 6
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+++++|.+++...... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTS--SCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 79999999999999999876443 899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCC--CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCccc--------CC---cHHHHHH
Q 001274 955 LIDLPYSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLEL--------GG---DLVTWVR 1021 (1109)
Q Consensus 955 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~--------~~---~~~~~~~ 1021 (1109)
........ ......++..|+|||++.+..++.++||||+|+++|||++|..||..... .. .....+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 76532221 12334577889999999988899999999999999999999999864210 00 0000111
Q ss_pred HhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1022 RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
........ ..........+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 274 ~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 274 ELLKNNGR------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHTTCC------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhcCCC------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111000 000112234688999999999999999999999999988764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=355.12 Aligned_cols=265 Identities=24% Similarity=0.279 Sum_probs=196.5
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc------e
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS------N 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~ 875 (1109)
.+|++.++||+|+||+||+|++..+..||+|++..... ...+|+++++.++||||+++++++...+. .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 57889999999999999999987777799999863321 22379999999999999999999965443 6
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-CCCceEEeeccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD-EEFQAHVGDFGLAK 954 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~ 954 (1109)
++||||++++.+............+++..+..++.||+.||+||| +.+|+||||||+||+++ .++.+||+|||+|+
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 899999987544333321111224899999999999999999999 77999999999999999 79999999999998
Q ss_pred cccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
.... ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+.+...++... .+..+.
T Consensus 191 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g---~p~~~~ 265 (394)
T 4e7w_A 191 ILIA--GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG---TPSREQ 265 (394)
T ss_dssp ECCT--TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC---CCCHHH
T ss_pred cccC--CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC---CCCHHH
Confidence 7642 2233456789999999998765 589999999999999999999999986442222222222110 000000
Q ss_pred hhh--------hc------chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1034 FDK--------RL------DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1034 ~~~--------~~------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
+.. .. .............+.+++.+||+.||++|||+.|+++|-+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 000 00 000000111234688999999999999999999999986543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=352.19 Aligned_cols=266 Identities=24% Similarity=0.249 Sum_probs=197.1
Q ss_pred HHhcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-----
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ----- 872 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 872 (1109)
...++|++.+.||+|+||+||+|++ .+++.||||++.... ....+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3457899999999999999999986 479999999986432 1233799999999999999999998543
Q ss_pred ---------------------------------CceEEEEEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHH
Q 001274 873 ---------------------------------DSNLLLYEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCY 918 (1109)
Q Consensus 873 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~ 918 (1109)
...++||||++ |+|.+.+.... ....+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 33789999998 58777765311 11238999999999999999999
Q ss_pred HhhcCCCCeEecCCCCCceeeC-CCCceEEeeccccccccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHH
Q 001274 919 LHYDCRPHIIHRDIKSNNILLD-EEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVV 996 (1109)
Q Consensus 919 LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvl 996 (1109)
|| +.+|+||||||+||+++ .++.+||+|||+|+.... ........+|+.|+|||++.+. .++.++||||+||+
T Consensus 157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP--SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT--TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC--CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99 88999999999999997 688999999999987642 2233456789999999998875 48999999999999
Q ss_pred HHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh-----------h---cchhhcccHHHHHHHHHHHHhccCC
Q 001274 997 LLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK-----------R---LDLSAKRTVEEMTLFLKIALFCSST 1062 (1109)
Q Consensus 997 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~---~~~~~~~~~~~~~~~~~li~~cl~~ 1062 (1109)
+|||++|+.||.+....+.+...++... .+..+.+.. . ..............+.+++.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g---~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMG---TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHC---CCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhC---CCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999986432222222222110 011100000 0 0000001111234578999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 001274 1063 SPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1063 dP~~RPt~~evl~~L~~ 1079 (1109)
||++|||+.|++++-+.
T Consensus 309 dP~~R~t~~e~l~hp~f 325 (383)
T 3eb0_A 309 EPDLRINPYEAMAHPFF 325 (383)
T ss_dssp SGGGSCCHHHHHTSGGG
T ss_pred ChhhCCCHHHHhcCHHH
Confidence 99999999999987543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=350.15 Aligned_cols=266 Identities=19% Similarity=0.269 Sum_probs=206.9
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcch---------------hHHHHHHHHHhccCCCCceeeEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATA---------------DNSFLAEISTLGKIRHRNIVKLY 866 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------~~~~~~E~~~l~~l~h~niv~l~ 866 (1109)
++|++.+.||+|+||+||+|++ +++.||||++......... .+.+.+|++++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 6899999999999999999999 8999999999754222111 17899999999999999999999
Q ss_pred EEEEeCCceEEEEEeccCCCHHHH------hccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCceee
Q 001274 867 GFCYHQDSNLLLYEYMENGSLGEQ------LHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR-PHIIHRDIKSNNILL 939 (1109)
Q Consensus 867 ~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll 939 (1109)
+++...+..++||||+++|+|.++ +.... ...+++..+..++.|++.||+||| + .+|+||||||+||++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 999999999999999999999998 55421 234899999999999999999999 5 799999999999999
Q ss_pred CCCCceEEeeccccccccCCCCCCccccccccceeccccccCC-CCCc-cchhHHHHHHHHHHHhCCCCCCCcccCCcHH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTE-KCDIYSFGVVLLELITGKSPVQSLELGGDLV 1017 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvll~elltg~~pf~~~~~~~~~~ 1017 (1109)
+.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||+|+++|||++|+.||.........
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~- 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL- 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH-
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-
Confidence 99999999999999876422 33456789999999999887 6666 999999999999999999999864432222
Q ss_pred HHHHHhhhccCCCch----hhhhhcchh-hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1018 TWVRRSIHEMVPTSE----LFDKRLDLS-AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
............. ......... ..........+.+++.+||+.||++|||++|++++-+
T Consensus 262 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 262 --FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp --HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred --HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 2222222111110 000000000 0000122346789999999999999999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=346.20 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=202.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce-----
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN----- 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----- 875 (1109)
++|.+.+.||+|+||+||+|++. +|+.||||++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 68889999999999999999865 689999999976544444567889999999999999999999999877655
Q ss_pred -EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 876 -LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 876 -~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
++||||++ ++|.+++.. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 122 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred EEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 688888743 2899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc-CCCch
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-VPTSE 1032 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 1032 (1109)
.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... .+.+....... .+..+
T Consensus 193 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 193 HADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTGVPGTE 264 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCHH
T ss_pred cccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCcHH
Confidence 6542 2345678999999999887 6799999999999999999999999985432 22222221111 11111
Q ss_pred hhhhhc-----------chh-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1033 LFDKRL-----------DLS-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1033 ~~~~~~-----------~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
...... ... ..........+.+++.+|++.||++|||++|++++-+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 111000 000 000111235688999999999999999999999986654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=348.31 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=198.5
Q ss_pred HHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEe-----
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYH----- 871 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 871 (1109)
...++|++.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 34578999999999999999999974 78999999997432 3456788999999998 89999999999987
Q ss_pred -CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 001274 872 -QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDF 950 (1109)
Q Consensus 872 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 950 (1109)
.+..++||||+++|+|.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 4578999999999999999976532 24899999999999999999999 779999999999999999999999999
Q ss_pred cccccccCCCCCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhh
Q 001274 951 GLAKLIDLPYSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIH 1025 (1109)
Q Consensus 951 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~ 1025 (1109)
|++...... ........||+.|+|||++. +..++.++||||+||++|||++|+.||..... .........
T Consensus 174 g~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~ 248 (326)
T 2x7f_A 174 GVSAQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRALFLIPR 248 (326)
T ss_dssp TTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHH
T ss_pred cCceecCcC-ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhhc
Confidence 999866422 12234457899999999987 56789999999999999999999999975431 111111111
Q ss_pred ccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1026 EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
...+ .... ......+.+++.+||+.||++||++++++++-+.
T Consensus 249 ~~~~--~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~ 290 (326)
T 2x7f_A 249 NPAP--RLKS----------KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290 (326)
T ss_dssp SCCC--CCSC----------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred Cccc--cCCc----------cccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence 1111 0000 0112357899999999999999999999987554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.62 Aligned_cols=260 Identities=22% Similarity=0.366 Sum_probs=202.7
Q ss_pred hcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.++|++.+.||+|+||+||+|++++ .||+|+++.........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4688899999999999999999863 49999997665545555678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC-
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP- 959 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~- 959 (1109)
|+++++|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++ ++.+||+|||+++.....
T Consensus 110 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999987543 3899999999999999999999 77999999999999998 679999999998755321
Q ss_pred ---CCCCccccccccceeccccccC---------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc
Q 001274 960 ---YSKSMSAIAGSYGYIAPEYAYT---------MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM 1027 (1109)
Q Consensus 960 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 1027 (1109)
.........|++.|+|||++.+ ..++.++||||||+++|||++|+.||.... ............
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~ 259 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP----AEAIIWQMGTGM 259 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC----HHHHHHHHHTTC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHhccCC
Confidence 1122234468999999999874 457899999999999999999999997533 222222222221
Q ss_pred CCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.+.. ... .....+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 260 ~~~~--~~~----------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 260 KPNL--SQI----------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCC--CCS----------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCC--CcC----------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1110 000 01124778999999999999999999999998887654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=343.20 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=197.5
Q ss_pred cCCCCCceEecCCcceEEEEEec--CCc--EEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--NGE--VIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.+.||+|+||+||+|++. +++ .||||+++.... .....+.+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57889999999999999999853 233 689999875432 2345678999999999999999999999988754 88
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++++|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999976533 3899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCC--CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 957 DLPYSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 957 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
...... ......+|..|+|||++.+..++.++||||+|+++|||++ |+.||.... ..+.............
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~~~~~~~~~-- 245 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----GSQILHKIDKEGERLP-- 245 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTSCCCCC--
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC----HHHHHHHHHccCCCCC--
Confidence 432211 1233457889999999998889999999999999999999 999997543 2223332222211110
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
........+.+++.+||+.||++|||+.+++++|.++...
T Consensus 246 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 246 ----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0111224578999999999999999999999999988654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=352.01 Aligned_cols=265 Identities=22% Similarity=0.219 Sum_probs=203.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC--------CCceeeEEEEEE--
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR--------HRNIVKLYGFCY-- 870 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~-- 870 (1109)
++|++.++||+|+||+||+|++. +++.||||+++. .....+.+.+|++++++++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 68999999999999999999864 688999999962 2334567889999999885 788999999987
Q ss_pred --eCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCceeeCCCC----
Q 001274 871 --HQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP-HIIHRDIKSNNILLDEEF---- 943 (1109)
Q Consensus 871 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~---- 943 (1109)
.....++||||+ ++++.+++..... ..+++..+..++.||+.||+||| ++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhh
Confidence 455789999999 5667666654432 23899999999999999999999 66 999999999999999775
Q ss_pred ---------------------------------------------ceEEeeccccccccCCCCCCccccccccceecccc
Q 001274 944 ---------------------------------------------QAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978 (1109)
Q Consensus 944 ---------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~ 978 (1109)
.+||+|||.++.... ......||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----CSCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----cCccCCCCCcccCChh
Confidence 799999999987642 2344578999999999
Q ss_pred ccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc--HHHHHHHhhh--ccCCCchh---------hh----------
Q 001274 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGD--LVTWVRRSIH--EMVPTSEL---------FD---------- 1035 (1109)
Q Consensus 979 ~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~--~~~~~~~~~~--~~~~~~~~---------~~---------- 1035 (1109)
+.+..++.++||||+||++|||++|+.||........ ....+..... +..+...+ +.
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999986543221 1111111111 11110000 00
Q ss_pred -------hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1036 -------KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1036 -------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
..+........+....+.+++.+||+.||++|||++|++++-+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 0000111234566678999999999999999999999998743
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=344.79 Aligned_cols=266 Identities=22% Similarity=0.262 Sum_probs=204.8
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CC-----ceeeEEEEEEeCC
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HR-----NIVKLYGFCYHQD 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~ 873 (1109)
.++|++.+.||+|+||+||+|++. +++.||||+++.. ......+..|+++++.++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 478999999999999999999865 6889999999732 233456778888888774 44 4999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC--CCCceEEeecc
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD--EEFQAHVGDFG 951 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFG 951 (1109)
..++||||++ |+|.+++...... .+++..+..++.|++.||.|||+. +.+|+||||||+||+++ .++.+||+|||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999996 5999999875422 389999999999999999999954 46899999999999994 57889999999
Q ss_pred ccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.....+.. .. .+..
T Consensus 207 ~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~-~~--~~~~ 279 (382)
T 2vx3_A 207 SSCQLGQ----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LG--IPPA 279 (382)
T ss_dssp TCEETTC----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-HC--SCCH
T ss_pred Cceeccc----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hC--CCCH
Confidence 9987642 234567899999999999999999999999999999999999999864322222111111 10 1111
Q ss_pred hhhhhhc-------------------------------------------------chhhcccHHHHHHHHHHHHhccCC
Q 001274 1032 ELFDKRL-------------------------------------------------DLSAKRTVEEMTLFLKIALFCSST 1062 (1109)
Q Consensus 1032 ~~~~~~~-------------------------------------------------~~~~~~~~~~~~~~~~li~~cl~~ 1062 (1109)
...+... .........+...+.+++.+||+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 1100000 000011233446789999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 001274 1063 SPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1063 dP~~RPt~~evl~~L~~ 1079 (1109)
||++|||++|++++-+.
T Consensus 360 dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFF 376 (382)
T ss_dssp CTTTSCCHHHHTTSGGG
T ss_pred ChhhCCCHHHHhcCccc
Confidence 99999999999987543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.47 Aligned_cols=266 Identities=28% Similarity=0.390 Sum_probs=187.7
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|++. +++.||||++..... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 468999999999999999999864 689999999864422 234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccC-----CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 880 EYMENGSLGEQLHGN-----KQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
||+++++|.+++... .....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||.+.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998641 11224899999999999999999999 7799999999999999999999999999997
Q ss_pred cccCCC----CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCC
Q 001274 955 LIDLPY----SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 955 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 1029 (1109)
...... ........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||........... ......+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~ 245 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML----TLQNDPP 245 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH----HHTSSCC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH----HhccCCC
Confidence 654221 111234578999999999876 5689999999999999999999999986543222211 1111111
Q ss_pred CchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1030 TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
......... .........+.+++.+||+.||++||++.|++++-+
T Consensus 246 ~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 246 SLETGVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp CTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred ccccccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 100000000 000111235789999999999999999999998743
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=342.25 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=203.1
Q ss_pred HHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC--CCceeeEEEEEEeCCceE
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR--HRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~ 876 (1109)
...++|++.+.||+|+||.||+|++.+++.||||++..........+.+.+|++++++++ |+||+++++++...+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345679999999999999999999888999999999866555556678999999999997 599999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||| +.+++|.+++..... +++..+..++.|+++||+||| +.+|+||||||+||++++ +.+||+|||+++..
T Consensus 105 lv~e-~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEe-cCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999 568899999987553 899999999999999999999 779999999999999964 89999999999876
Q ss_pred cCCCCC-CccccccccceeccccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhh
Q 001274 957 DLPYSK-SMSAIAGSYGYIAPEYAYT-----------MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSI 1024 (1109)
Q Consensus 957 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~ 1024 (1109)
...... ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.... .....+....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~~~~~~~~~~ 253 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---NQISKLHAII 253 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC---SHHHHHHHHH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH---HHHHHHHHHH
Confidence 432221 2234578999999999875 468899999999999999999999997532 1122222222
Q ss_pred hccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1025 HEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
...... . +. ......+.+++.+||+.||++||+++|++++-+...
T Consensus 254 ~~~~~~-~-~~----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 254 DPNHEI-E-FP----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp CTTSCC-C-CC----------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred hccccc-C-Cc----------ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 111100 0 00 001235779999999999999999999999877654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=350.25 Aligned_cols=264 Identities=26% Similarity=0.291 Sum_probs=195.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC------c
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD------S 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 874 (1109)
.+|+..+.||+|+||+||+|++. +++.||||++.... ....+|++++++++||||+++++++.... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46888899999999999999975 68999999986332 22347999999999999999999986422 2
Q ss_pred eEEEEEeccCCCHHHHhccC-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEeeccc
Q 001274 875 NLLLYEYMENGSLGEQLHGN-KQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGL 952 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~ 952 (1109)
.++||||+++ ++.+.+... .....+++..+..++.||++||+||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 5689999975 666655421 11223899999999999999999999 7899999999999999965 5789999999
Q ss_pred cccccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
++.... ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+.+...++..- .+..
T Consensus 204 a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg---~p~~ 278 (420)
T 1j1b_A 204 AKQLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG---TPTR 278 (420)
T ss_dssp CEECCT--TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC---SCCH
T ss_pred hhhccc--CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC---CCCH
Confidence 987642 2233456789999999998765 799999999999999999999999986432222222222110 0011
Q ss_pred hhhh-----------hhcc---hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1032 ELFD-----------KRLD---LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1032 ~~~~-----------~~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
+.+. +... ............+.+++.+||+.||++|||+.|+++|-+..
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 0000 0000 00000111234678999999999999999999999886653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=346.77 Aligned_cols=269 Identities=24% Similarity=0.306 Sum_probs=206.3
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-----Cc
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ-----DS 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 874 (1109)
.++|++.+.||+|+||+||+|++. +++.||||++... ......+.+.+|++++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 368999999999999999999865 6889999999733 2333457789999999999999999999999765 35
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||++ |+|.+++.... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||.++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~~----~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQH----LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 799999997 59999987643 899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCC--CccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 955 LIDLPYSK--SMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 955 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+........ ... +..
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~--~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGS--PSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH-HCS--CCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH-hCC--CCH
Confidence 76432221 1245689999999998764 45899999999999999999999999865433332222211 111 111
Q ss_pred hhhhhhcch-----------h-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1032 ELFDKRLDL-----------S-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1032 ~~~~~~~~~-----------~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
+.+...... . ..........+.+++.+|++.||++|||++|++++-+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 111000000 0 0000112245789999999999999999999999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=338.93 Aligned_cols=262 Identities=21% Similarity=0.300 Sum_probs=204.3
Q ss_pred cCCCCCceEecCCcceEEEEEe-c-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCC------ceeeEEEEEEeCC
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-A-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR------NIVKLYGFCYHQD 873 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~ 873 (1109)
++|++.+.||+|+||+||+|++ . +++.||||+++.. ....+.+.+|+++++.++|+ +++++++++...+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 5899999999999999999986 3 6889999999632 23456788999998888655 5999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC------------
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE------------ 941 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------------ 941 (1109)
..++||||+ +++|.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 8899999977543 23889999999999999999999 779999999999999987
Q ss_pred -------CCceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 001274 942 -------EFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG 1014 (1109)
Q Consensus 942 -------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~ 1014 (1109)
++.+||+|||.++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 67899999999986442 2344578999999999999999999999999999999999999998543211
Q ss_pred cHHHHHHHhhhccCCCchhhhh-----------------------------hcchhhcccHHHHHHHHHHHHhccCCCCC
Q 001274 1015 DLVTWVRRSIHEMVPTSELFDK-----------------------------RLDLSAKRTVEEMTLFLKIALFCSSTSPL 1065 (1109)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~ 1065 (1109)
....+.... ...+ ...... ...............+.+++.+||+.||+
T Consensus 242 -~~~~~~~~~-~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 242 -HLAMMERIL-GPLP-KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp -HHHHHHHHH-CSCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred -HHHHHHHHh-CCCC-HHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 111111111 1111 000000 00000011233456789999999999999
Q ss_pred CCCCHHHHHHHHH
Q 001274 1066 NRPTMREVIAMMI 1078 (1109)
Q Consensus 1066 ~RPt~~evl~~L~ 1078 (1109)
+|||++|++++-+
T Consensus 319 ~Rpt~~ell~hp~ 331 (339)
T 1z57_A 319 KRITLREALKHPF 331 (339)
T ss_dssp TSCCHHHHTTSGG
T ss_pred cccCHHHHhcCHH
Confidence 9999999998744
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=344.79 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=180.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHH-HhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEIS-TLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|+..+.||+|+||+||+|++. +++.||||+++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 67889999999999999999975 789999999975432 233445566665 778889999999999999999999999
Q ss_pred EeccCCCHHHHhccC--CCCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGN--KQTCLLDWDARYRIALGAAEGLCYLHYDCRP-HIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
||+++ +|.+++... .....+++..+..++.|++.|+.||| +. +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 887777531 11123899999999999999999999 66 9999999999999999999999999999866
Q ss_pred cCCCCCCccccccccceeccccc----cCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYA----YTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
... .......||+.|+|||++ .+..++.++||||||+++|||++|+.||...... .+.+........+.
T Consensus 177 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~-- 249 (327)
T 3aln_A 177 VDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV---FDQLTQVVKGDPPQ-- 249 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCC--
T ss_pred ccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH---HHHHHHHhcCCCCC--
Confidence 422 222334789999999998 4667899999999999999999999999753211 11111111111000
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
+.. .........+.+++.+||+.||++||++.|++++-+...
T Consensus 250 -~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 250 -LSN------SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp -CCC------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -CCC------cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 000 000112245789999999999999999999998765543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=352.82 Aligned_cols=272 Identities=23% Similarity=0.359 Sum_probs=187.7
Q ss_pred CCCC-CceEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--CCceE
Q 001274 803 NFSE-GAVIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--QDSNL 876 (1109)
Q Consensus 803 ~~~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 876 (1109)
.|.+ +++||+|+||+||+|+++ +++.||||++.... ....+.+|++++++++||||+++++++.. ....+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 3554 568999999999999965 57899999996432 23568899999999999999999999965 56789
Q ss_pred EEEEeccCCCHHHHhccCC------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee----CCCCceE
Q 001274 877 LLYEYMENGSLGEQLHGNK------QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL----DEEFQAH 946 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~k 946 (1109)
+||||++ |+|.+++.... ....+++..++.++.||+.||+||| +.+|+||||||+||++ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 58888775321 1123899999999999999999999 7799999999999999 7788999
Q ss_pred EeeccccccccCCCC--CCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccC-----CcHHH
Q 001274 947 VGDFGLAKLIDLPYS--KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELG-----GDLVT 1018 (1109)
Q Consensus 947 l~DFG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~-----~~~~~ 1018 (1109)
|+|||+|+....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ....+
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987653221 223456799999999999874 5899999999999999999999999754321 00111
Q ss_pred HHHHhhhcc-CCCchhhhhhcch------------h-h----------cccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001274 1019 WVRRSIHEM-VPTSELFDKRLDL------------S-A----------KRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074 (1109)
Q Consensus 1019 ~~~~~~~~~-~~~~~~~~~~~~~------------~-~----------~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl 1074 (1109)
.+....... .+....+...... . . .........+.+++.+||+.||++|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 122111111 1111111100000 0 0 00000023577999999999999999999999
Q ss_pred HHHHHhhh
Q 001274 1075 AMMIDARQ 1082 (1109)
Q Consensus 1075 ~~L~~~~~ 1082 (1109)
++-+....
T Consensus 333 ~hp~f~~~ 340 (405)
T 3rgf_A 333 QDPYFLED 340 (405)
T ss_dssp TSGGGTSS
T ss_pred cChhhccC
Confidence 99876543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=368.26 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=204.5
Q ss_pred hcCCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
.++|++.+.||+|+||+||+|++. .+..||||+++.. ......+.+.+|+.++++++||||+++++++. ++..+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 367888999999999999999864 2467999988643 22334577999999999999999999999985 46689
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999986543 3899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+... .+............ .
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~~~~~~i~~~~~~~---~- 613 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGERLP---M- 613 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHHTCCCC---C-
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHcCCCCC---C-
Confidence 5333333344567889999999999999999999999999999997 9999985432 22222211111100 0
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++|||+.++++.|..+...
T Consensus 614 ---------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 614 ---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 111124577999999999999999999999999988653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=350.12 Aligned_cols=258 Identities=11% Similarity=0.010 Sum_probs=183.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHH---HHhccCCCCceeeEE-------EEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEI---STLGKIRHRNIVKLY-------GFC 869 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~ 869 (1109)
.+|++.+.||+|+||+||+|++. +++.||||++...... ....+.+.+|+ ++++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45888899999999999999965 7899999999865432 23345677774 45555 799988755 455
Q ss_pred EeCC-----------------ceEEEEEeccCCCHHHHhccCCCCCCCChHHH------HHHHHHHHHHHHHHhhcCCCC
Q 001274 870 YHQD-----------------SNLLLYEYMENGSLGEQLHGNKQTCLLDWDAR------YRIALGAAEGLCYLHYDCRPH 926 (1109)
Q Consensus 870 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~ 926 (1109)
...+ ..++||||++ |+|.+++..... .+++..+ ..++.||+.||+||| +.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQ---SKG 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence 4432 3699999998 899999986432 2455666 788899999999999 779
Q ss_pred eEecCCCCCceeeCCCCceEEeeccccccccCCCCCCccccccccceeccccccC--CCCCccchhHHHHHHHHHHHhCC
Q 001274 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSFGVVLLELITGK 1004 (1109)
Q Consensus 927 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvll~elltg~ 1004 (1109)
|+||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986542 1224567799999999987 67999999999999999999999
Q ss_pred CCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1005 SPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1005 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.||......... ..... ............. ........+.+++.+||+.||++|||+.|++++-+.
T Consensus 291 ~Pf~~~~~~~~~------~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 291 LPFGLVTPGIKG------SWKRP-SLRVPGTDSLAFG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp CSTTBCCTTCTT------CCCBC-CTTSCCCCSCCCT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred CCCCCcCccccc------chhhh-hhhhccccccchh--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 999865321100 00000 0000000000000 001223467899999999999999999999987544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=345.17 Aligned_cols=268 Identities=20% Similarity=0.210 Sum_probs=204.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-----------CCceeeEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-----------HRNIVKLYGFC 869 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 869 (1109)
++|++.+.||+|+||+||+|++. +++.||||++.. .....+.+.+|++++++++ |+||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 68999999999999999999964 789999999862 2334567889999988876 89999999999
Q ss_pred EeCC----ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCceeeC----
Q 001274 870 YHQD----SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP-HIIHRDIKSNNILLD---- 940 (1109)
Q Consensus 870 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~---- 940 (1109)
...+ ..++||||+ +++|.+++...... .+++..+..++.||+.||+||| +. +|+||||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCC
Confidence 8654 678999999 89999999765432 3899999999999999999999 66 999999999999994
Q ss_pred --CCCceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC--CcH
Q 001274 941 --EEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG--GDL 1016 (1109)
Q Consensus 941 --~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~--~~~ 1016 (1109)
..+.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCC----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 445899999999987642 233457899999999999999999999999999999999999999864311 111
Q ss_pred HHHHHHhhhccCCCchhh----------------------------hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCC
Q 001274 1017 VTWVRRSIHEMVPTSELF----------------------------DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP 1068 (1109)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 1068 (1109)
...+........+....+ .................+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 111111111111111000 0001111223456677899999999999999999
Q ss_pred CHHHHHHHHHHhh
Q 001274 1069 TMREVIAMMIDAR 1081 (1109)
Q Consensus 1069 t~~evl~~L~~~~ 1081 (1109)
|++|++++-+...
T Consensus 327 t~~ell~hp~f~~ 339 (373)
T 1q8y_A 327 DAGGLVNHPWLKD 339 (373)
T ss_dssp CHHHHHTCGGGTT
T ss_pred CHHHHhhChhhhc
Confidence 9999999876543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=337.15 Aligned_cols=254 Identities=29% Similarity=0.446 Sum_probs=193.8
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--------
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH-------- 871 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 871 (1109)
.++|++.+.||+|+||+||+|++. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 467899999999999999999975 7999999999632 2345678899999999999999999999865
Q ss_pred -----CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 001274 872 -----QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAH 946 (1109)
Q Consensus 872 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 946 (1109)
.+..++||||+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEE
Confidence 3456899999999999999986543 3788999999999999999999 77999999999999999999999
Q ss_pred EeeccccccccCCC-------------CCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCccc
Q 001274 947 VGDFGLAKLIDLPY-------------SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLEL 1012 (1109)
Q Consensus 947 l~DFG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~ 1012 (1109)
|+|||.++...... ........||+.|+|||++.+. .++.++||||+||++|||++ ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 99999998654221 1122345689999999998865 68999999999999999998 554321
Q ss_pred CCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1013 GGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
................... ........+.+++.+||+.||++|||+++++++-+
T Consensus 233 --~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 233 --ERVNILKKLRSVSIEFPPD----------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp --HHHHHHHHHHSTTCCCCTT----------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred --hHHHHHHhccccccccCcc----------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 1112222211111111111 11122345779999999999999999999998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=341.53 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=184.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|+..+.||+|+||+||+|++. +++.||||++..........+.+.++..+++.++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 57888899999999999999975 68999999997554333333444555567888899999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP-HIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
|+ ++.+..+...... .+++..+..++.|+++||.||| +. +|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~-~~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 5566555543222 3899999999999999999999 53 8999999999999999999999999999765422
Q ss_pred CCCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 960 YSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
.......+|+.|+|||++. +..++.++||||+|+++|||++|+.||.... ...+.+........+....
T Consensus 179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~- 252 (318)
T 2dyl_A 179 --KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK---TDFEVLTKVLQEEPPLLPG- 252 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC---SHHHHHHHHHHSCCCCCCS-
T ss_pred --ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC---ccHHHHHHHhccCCCCCCc-
Confidence 2233457899999999984 5568999999999999999999999997532 2222233322222111100
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
. ......+.+++.+||+.||++||+++|++++-+..
T Consensus 253 --~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (318)
T 2dyl_A 253 --H--------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288 (318)
T ss_dssp --S--------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred --c--------CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence 0 01123577999999999999999999999876543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=341.92 Aligned_cols=262 Identities=22% Similarity=0.308 Sum_probs=200.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc------
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS------ 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 874 (1109)
++|...+.||+|+||+||+|++. +|+.||||++..........+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888999999999999999975 68999999997554444445778999999999999999999999987654
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||++ ++|.+++.. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 399999997 688887743 2899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc-CCCch
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM-VPTSE 1032 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 1032 (1109)
.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... .+.+....... .+..+
T Consensus 175 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 175 HADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTGVPGTE 246 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH----HHHHHHHHHHHCBCCHH
T ss_pred CCCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHH
Confidence 6542 2344578999999999887 6789999999999999999999999986432 22222111110 01111
Q ss_pred hhhhhcc-----------h-----hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1033 LFDKRLD-----------L-----SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1033 ~~~~~~~-----------~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
....... . -..........+.+++.+|++.||++|||++|++++-+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 1100000 0 0000112235688999999999999999999999886543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.97 Aligned_cols=259 Identities=21% Similarity=0.234 Sum_probs=175.9
Q ss_pred hcCCCCCc-eEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHH-HHhccCCCCceeeEEEEEEe----CC
Q 001274 801 TGNFSEGA-VIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEI-STLGKIRHRNIVKLYGFCYH----QD 873 (1109)
Q Consensus 801 ~~~~~~~~-~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~----~~ 873 (1109)
.++|.+.+ .||+|+||+||+|++. +++.||||++... ....+|+ ..++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 36788854 6999999999999976 6999999999621 1222333 34566799999999999876 34
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEeec
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE---EFQAHVGDF 950 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DF 950 (1109)
..++||||+++|+|.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred eEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 57899999999999999987543 24899999999999999999999 779999999999999976 456999999
Q ss_pred cccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 951 GLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 951 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
|+++.... .......+|+.|+|||++.+..++.++||||+|+++|+|++|+.||.......................
T Consensus 176 g~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 176 GFAKETTQ---NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccceeccc---cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 99986542 223445789999999999888999999999999999999999999975432211111111111111000
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
... ........+.+++.+||+.||++|||++|++++-+.....
T Consensus 253 ~~~----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 253 PNP----------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CTT----------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred Cch----------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 000 0011224577999999999999999999999988765433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=335.12 Aligned_cols=266 Identities=23% Similarity=0.332 Sum_probs=196.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEE----------
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCY---------- 870 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------- 870 (1109)
++|++.+.||+|+||+||+|++. +++.||||++... .....+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 68899999999999999999976 5899999998743 2345577899999999999999999999874
Q ss_pred ----eCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-CCCce
Q 001274 871 ----HQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD-EEFQA 945 (1109)
Q Consensus 871 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 945 (1109)
.....++||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeE
Confidence 3356789999997 6999999653 2899999999999999999999 77999999999999997 56799
Q ss_pred EEeeccccccccCCC--CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHH
Q 001274 946 HVGDFGLAKLIDLPY--SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRR 1022 (1109)
Q Consensus 946 kl~DFG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~ 1022 (1109)
||+|||.++...... ........+|..|+|||++.+ ..++.++||||+|+++|||++|+.||.+... .+....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~ 236 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE----LEQMQL 236 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 999999998764221 122244567899999998865 6789999999999999999999999986432 122221
Q ss_pred hhhccCCCc-hh-----------hhhhcchh----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1023 SIHEMVPTS-EL-----------FDKRLDLS----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1023 ~~~~~~~~~-~~-----------~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
......... +. ........ ..........+.+++.+||+.||++|||++|++++-+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 111111000 00 00000000 0001112356889999999999999999999999877653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=342.88 Aligned_cols=350 Identities=21% Similarity=0.186 Sum_probs=231.9
Q ss_pred CCCCCCCCCCCCc-cceeeecCCeEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccC
Q 001274 51 LESWNSSDMTPCN-WIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCT 129 (1109)
Q Consensus 51 ~~~W~~~~~~~c~-w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~ 129 (1109)
+++|... .+||. |.++.|....| .++-.... ......-..+++++.|++++|.++..-+..+..+++|++|+|++
T Consensus 3 ~~~~~~~-~~C~~~~~~~~c~~~~~-~i~~~~~~--~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~ 78 (390)
T 3o6n_A 3 VKPRQPE-YKCIDSNLQYDCVFYDV-HIDMQTQD--VYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 78 (390)
T ss_dssp ----CCE-ECBCC------EEEESC-EECSSCCC--CEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTT
T ss_pred cCCCCCc-cceehhhhhhccceeee-eeeccccc--ccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCC
Confidence 6889875 46664 66665632111 11222111 11222223567888888888887754444578888888888888
Q ss_pred CcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCC
Q 001274 130 NRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIP 209 (1109)
Q Consensus 130 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p 209 (1109)
|.+++..+..+..+++|++|+|++|.+++..|..++++++|++|+|++|+++...+..|+++++|++|++++|.+++..|
T Consensus 79 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~ 158 (390)
T 3o6n_A 79 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED 158 (390)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred CcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccCh
Confidence 88887777788888888888888888887777778888888888888888884444446788888888888888887777
Q ss_pred ccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCc
Q 001274 210 PEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSR 289 (1109)
Q Consensus 210 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 289 (1109)
..|+.+++|++|++++|++++. .+..+++|++|++++|.+++. ...++|++|++++|.++.. |.. ..++
T Consensus 159 ~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~ 227 (390)
T 3o6n_A 159 DTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNVE 227 (390)
T ss_dssp TTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSS
T ss_pred hhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--cccc
Confidence 7788888888888888888754 356677788888888877632 2334677777777777644 322 2466
Q ss_pred cceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEccc
Q 001274 290 LKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSI 369 (1109)
Q Consensus 290 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 369 (1109)
|+.|++++|.+++. ..+..+++|++|+|++|.+++..|..+..+++|+.|++++|.+++ +|..+..+++|++|++++
T Consensus 228 L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~ 304 (390)
T 3o6n_A 228 LTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSH 304 (390)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCS
T ss_pred ccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCC
Confidence 77777777777643 456677777777777777776666677777777777777777664 344555666777777777
Q ss_pred CcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccC
Q 001274 370 NNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDG 422 (1109)
Q Consensus 370 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~ 422 (1109)
|+++ .+|..+..+++|+.|++++|.++.. + +..+++|++|++++|++..
T Consensus 305 n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 305 NHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp SCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred Ccce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 7766 4555566666677777777766533 2 4455666666666666653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=340.15 Aligned_cols=269 Identities=24% Similarity=0.325 Sum_probs=201.9
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-----Cc
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ-----DS 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 874 (1109)
.++|++.+.||+|+||+||+|++. +|+.||||++... ........+.+|++++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 368999999999999999999975 6899999999633 2233456788999999999999999999988764 56
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 799999997 6999998763 2899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCC---------CccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhh
Q 001274 955 LIDLPYSK---------SMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSI 1024 (1109)
Q Consensus 955 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~ 1024 (1109)
........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~ 239 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI-FGII 239 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-HHHh
Confidence 76422111 1233578999999998764 67899999999999999999999999864321111111 1111
Q ss_pred hccCCCchhhh-----------hhcchh-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1025 HEMVPTSELFD-----------KRLDLS-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1025 ~~~~~~~~~~~-----------~~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.. ........ ...... ..........+.+++.+||+.||++|||++|++++-+..
T Consensus 240 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 240 GT-PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp CC-CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred CC-CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 10 00000000 000000 000112234578999999999999999999999986654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=361.25 Aligned_cols=334 Identities=20% Similarity=0.212 Sum_probs=259.6
Q ss_pred CCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceee
Q 001274 359 LTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLS 438 (1109)
Q Consensus 359 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 438 (1109)
+.+++.|++++|.+....+..|.++++|+.|+|++|.+++..|..|+.+++|++|+|++|.+.+..|..|.++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 45667777777777755555667777777777777777766666777777777777777777777777777777777777
Q ss_pred cCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCC
Q 001274 439 LGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVG 518 (1109)
Q Consensus 439 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 518 (1109)
|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|.+++. .+..+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc
Confidence 777777766666677778888888888888877777788888888888888888765 25567778888888887764
Q ss_pred CCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCC
Q 001274 519 YIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGG 598 (1109)
Q Consensus 519 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 598 (1109)
+...++|+.|++++|.++.. |..+ .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|++
T Consensus 207 -----l~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 276 (597)
T 3oja_B 207 -----LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276 (597)
T ss_dssp -----EECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred -----ccCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcC
Confidence 33456788888888888744 3333 2578888888888885 467888888888888888888888888888
Q ss_pred CcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEE
Q 001274 599 LARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVC 678 (1109)
Q Consensus 599 l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l 678 (1109)
+++|+.|+|++|.+++ +|..+..++.|. .|+|++|.++ .+|..++.+++|+.|||++|++++. | +..+++|+.|
T Consensus 277 l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~-~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L 350 (597)
T 3oja_B 277 MQRLERLYISNNRLVA-LNLYGQPIPTLK-VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNL 350 (597)
T ss_dssp CSSCCEEECTTSCCCE-EECSSSCCTTCC-EEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEE
T ss_pred ccCCCEEECCCCCCCC-CCcccccCCCCc-EEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEE
Confidence 8888888888888885 577777777876 5889999988 5677889999999999999999854 3 6678899999
Q ss_pred EccCcccccccCCCcccccccCCcccCCCCcccc
Q 001274 679 NLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCML 712 (1109)
Q Consensus 679 ~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~ 712 (1109)
+|++|+++|..+. ..+..+....+.++...|+.
T Consensus 351 ~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 351 TLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp ECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCT
T ss_pred EeeCCCCCChhHH-HHHHHHhhhccccccccCCc
Confidence 9999999988643 35677888889999999964
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=339.48 Aligned_cols=333 Identities=20% Similarity=0.217 Sum_probs=263.7
Q ss_pred CCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceee
Q 001274 359 LTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLS 438 (1109)
Q Consensus 359 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 438 (1109)
+.++++|++++|.++...+..|.++++|++|+|++|.+++..+..|..+++|++|++++|.+.+..|..|..+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 56777888888877755555577778888888888888777677777888888888888888877777788888888888
Q ss_pred cCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCC
Q 001274 439 LGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVG 518 (1109)
Q Consensus 439 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 518 (1109)
|++|+++...+..|..+++|++|++++|++++..+..|.++++|++|++++|++++. .+..+++|+.|++++|.+++
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc
Confidence 888888866555677888888888888888877777888888888888888888765 35667888888888888764
Q ss_pred CCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCC
Q 001274 519 YIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGG 598 (1109)
Q Consensus 519 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 598 (1109)
+...++|+.|++++|+++.. |... .++|+.|++++|++++. ..+..+++|+.|+|++|++++..|..|..
T Consensus 201 -----~~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~ 270 (390)
T 3o6n_A 201 -----LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVK 270 (390)
T ss_dssp -----EECCSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred -----cCCCCcceEEECCCCeeeec-cccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccc
Confidence 23456788888888888844 4332 47888899999988853 57888888999999999988888888888
Q ss_pred CcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEE
Q 001274 599 LARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVC 678 (1109)
Q Consensus 599 l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l 678 (1109)
+++|+.|++++|++++ +|..+..++.|+ .|+|++|+++ .+|..++.+++|+.|+|++|++++ +| +..++.|+.|
T Consensus 271 l~~L~~L~L~~n~l~~-~~~~~~~l~~L~-~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L 344 (390)
T 3o6n_A 271 MQRLERLYISNNRLVA-LNLYGQPIPTLK-VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNL 344 (390)
T ss_dssp CSSCCEEECCSSCCCE-EECSSSCCTTCC-EEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEE
T ss_pred cccCCEEECCCCcCcc-cCcccCCCCCCC-EEECCCCcce-ecCccccccCcCCEEECCCCccce-eC--chhhccCCEE
Confidence 8999999999998884 566667778886 5899999998 457778899999999999999984 44 6778899999
Q ss_pred EccCcccccccCCCcccccccCCcccCCCCccc
Q 001274 679 NLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCM 711 (1109)
Q Consensus 679 ~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~ 711 (1109)
++++|++.|.... ..+..+....+.+++..|.
T Consensus 345 ~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~ 376 (390)
T 3o6n_A 345 TLSHNDWDCNSLR-ALFRNVARPAVDDADQHCK 376 (390)
T ss_dssp ECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCC
T ss_pred EcCCCCccchhHH-HHHHHHHhhcccccCceec
Confidence 9999999986543 3456667777888877774
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=337.17 Aligned_cols=279 Identities=20% Similarity=0.271 Sum_probs=167.9
Q ss_pred CCCchhHHHHHHHHHHhc-CCCCCCCCCCC---CCCCCCCccceeeecC----------CeEEEEeccCccccccccccc
Q 001274 27 VTSLTEEGVSLLEFKASL-IDPSNNLESWN---SSDMTPCNWIGVECTD----------FKVTSVDLHGLNLSGILSPRI 92 (1109)
Q Consensus 27 ~~~~~~~~~all~~k~~~-~~~~~~~~~W~---~~~~~~c~w~gv~C~~----------~~v~~l~l~~~~l~g~~~~~~ 92 (1109)
.++..+|++||++||+++ .||.+.+++|. ....++|.|.||+|+. .+|+.++|+++++. .+|+.+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 345678999999999999 58877789994 3345889999999952 45666666666665 555556
Q ss_pred cCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCce
Q 001274 93 CDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEE 172 (1109)
Q Consensus 93 ~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 172 (1109)
+++++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++.+++|++|+|++|.+.+.+|..++..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~----- 173 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST----- 173 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE-----
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc-----
Confidence 66666666666666666 56666666666666666666665 555556666666666666655555555554430
Q ss_pred EEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccc
Q 001274 173 LVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHL 252 (1109)
Q Consensus 173 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l 252 (1109)
.++..+.++++|++|++++|+++ .+|..++.+++|++|+|++|.+++ +|..+..+++|++|+|++|.+
T Consensus 174 ----------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~ 241 (328)
T 4fcg_A 174 ----------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA 241 (328)
T ss_dssp ----------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTT
T ss_pred ----------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcc
Confidence 00001112455555555555554 444455555555555555555553 334455555555566655555
Q ss_pred cCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCccc
Q 001274 253 SGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLT 325 (1109)
Q Consensus 253 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~ 325 (1109)
.+.+|..++.+++|++|+|++|++.+.+|..++++++|++|++++|.+.+.+|..++++++|+.+++..+.+.
T Consensus 242 ~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 242 LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 5555555556666666666665555556655666666666666666666566666666666666665554443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=335.88 Aligned_cols=264 Identities=21% Similarity=0.289 Sum_probs=203.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CC-cEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCc------eeeEEEEEEeCC
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NG-EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN------IVKLYGFCYHQD 873 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 873 (1109)
++|++.+.||+|+||+||+|++. ++ +.||||+++. .....+.+.+|++++++++|++ ++.+++++...+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 68999999999999999999875 34 7899999963 2334567888999999887655 999999999999
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee--------------
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL-------------- 939 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-------------- 939 (1109)
..++||||+ ++++.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccc
Confidence 999999999 6677777765442 23899999999999999999999 7899999999999999
Q ss_pred -----CCCCceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 001274 940 -----DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG 1014 (1109)
Q Consensus 940 -----~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~ 1014 (1109)
+.++.+||+|||+++... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDH----EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETT----SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCcccccc----ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999998643 22344679999999999999999999999999999999999999998543211
Q ss_pred cHHHHHHHhhhccCCCchhhhhh-----------------------------cchhhcccHHHHHHHHHHHHhccCCCCC
Q 001274 1015 DLVTWVRRSIHEMVPTSELFDKR-----------------------------LDLSAKRTVEEMTLFLKIALFCSSTSPL 1065 (1109)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~li~~cl~~dP~ 1065 (1109)
....+.... ...| ....... ..............+.+++.+||+.||+
T Consensus 247 -~~~~~~~~~-~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 247 -HLVMMEKIL-GPIP-SHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp -HHHHHHHHH-CCCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred -HHHHHHHHc-CCCc-HHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 111111111 1111 1110000 0000011223345788999999999999
Q ss_pred CCCCHHHHHHHHHHh
Q 001274 1066 NRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1066 ~RPt~~evl~~L~~~ 1080 (1109)
+|||++|++++-+..
T Consensus 324 ~Rpt~~e~l~hp~f~ 338 (355)
T 2eu9_A 324 QRITLAEALLHPFFA 338 (355)
T ss_dssp TSCCHHHHTTSGGGG
T ss_pred hCcCHHHHhcChhhc
Confidence 999999999875543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=335.28 Aligned_cols=245 Identities=21% Similarity=0.343 Sum_probs=200.8
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc----chhHHHHHHHHHhccCC--CCceeeEEEEEEeCC
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA----TADNSFLAEISTLGKIR--HRNIVKLYGFCYHQD 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 873 (1109)
.++|++.+.||+|+||+||+|++. +++.||||++....... ...+.+.+|+.++++++ |+||+++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 368999999999999999999864 68999999997654322 12355778999999996 599999999999999
Q ss_pred ceEEEEEeccC-CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-CCCceEEeecc
Q 001274 874 SNLLLYEYMEN-GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD-EEFQAHVGDFG 951 (1109)
Q Consensus 874 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG 951 (1109)
..++|||++.+ ++|.+++..... +++..+..++.||++||+||| +.+|+||||||+||+++ .++.+||+|||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cEEEEEEcCCCCccHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999986 899999976543 899999999999999999999 77999999999999999 78999999999
Q ss_pred ccccccCCCCCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
+++.... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ... ......
T Consensus 196 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~----~~~~~~ 262 (320)
T 3a99_A 196 SGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII----RGQVFF 262 (320)
T ss_dssp TCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH----HCCCCC
T ss_pred ccccccc---ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhh----cccccc
Confidence 9987652 22344578999999999887776 688999999999999999999997521 111 111100
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.. .....+.+++.+||+.||++|||++|++++-+
T Consensus 263 ----~~----------~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 263 ----RQ----------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp ----SS----------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ----cc----------cCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 00 01235779999999999999999999998754
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=357.93 Aligned_cols=350 Identities=20% Similarity=0.163 Sum_probs=199.1
Q ss_pred CCCCCCCCCCCCCCCCc----cceeeecCCeEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCC
Q 001274 47 PSNNLESWNSSDMTPCN----WIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSL 122 (1109)
Q Consensus 47 ~~~~~~~W~~~~~~~c~----w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L 122 (1109)
....+++|..+ .+||. |.++.|+. .++........ ...-..+++++.|++++|.+++..+..++++++|
T Consensus 5 ~~~~l~~~~~~-~~C~~~~~~~~c~~~~~----~i~~~~~~~~~--~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L 77 (597)
T 3oja_B 5 QRYNVKPRQPE-YKCIDSNLQYDCVFYDV----HIDMQTQDVYF--GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77 (597)
T ss_dssp ------CCCSE-ECCCCC--CCSEEECSC----EECSSCCCCEE--SCSSGGGCCCSEEEESSCEESEECTHHHHHCCCC
T ss_pred ccccccCCCCC-CcCcccCcCceeEecCc----eeccccccccc--CcccccCCCceEEEeeCCCCCCcCHHHHccCCCC
Confidence 34468899875 46664 66655531 12222222111 1112245677777777777765545556777777
Q ss_pred ceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccc
Q 001274 123 EILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHN 202 (1109)
Q Consensus 123 ~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n 202 (1109)
++|+|++|.+++..|..++.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|++|
T Consensus 78 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N 157 (597)
T 3oja_B 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN 157 (597)
T ss_dssp SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCC
Confidence 77777777777766667777777777777777777766667777777777777777777544444577777777777777
Q ss_pred cccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCch
Q 001274 203 SLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPK 282 (1109)
Q Consensus 203 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 282 (1109)
.+++..|..|+.+++|++|+|++|.+++.. +..+++|++|++++|.+++ +....+|+.|++++|.++...+.
T Consensus 158 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~ 229 (597)
T 3oja_B 158 NLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP 229 (597)
T ss_dssp CCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECS
T ss_pred cCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccccccc
Confidence 777666666777777777777777766542 4455666666666666653 22234566666666666533221
Q ss_pred hhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCc
Q 001274 283 ELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQL 362 (1109)
Q Consensus 283 ~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 362 (1109)
+ .++|+.|++++|.+++ +..+..+++|++|+|++|.+++.+|..++.+++|+.|+|++|.+.+ +|..+..+++|
T Consensus 230 -~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L 303 (597)
T 3oja_B 230 -V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTL 303 (597)
T ss_dssp -C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTC
T ss_pred -c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCC
Confidence 1 1455555555555553 2445555555555555555555555555555555555555555543 23344445555
Q ss_pred cEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEecccccc
Q 001274 363 HKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLD 421 (1109)
Q Consensus 363 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~ 421 (1109)
++|+|++|.++ .+|..+..+++|+.|+|++|.+.+.. +..+++|++|++++|.+.
T Consensus 304 ~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~ 358 (597)
T 3oja_B 304 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWD 358 (597)
T ss_dssp CEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEE
T ss_pred cEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCC
Confidence 55555555554 34444444555555555555544321 333344444444444443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=329.66 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=181.7
Q ss_pred ccceeecccccccc--cCCccccCCcccceecccc-ccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEE
Q 001274 457 SLMQLMLGQNQLTG--SLPIEFYNLQNLSALELYQ-NRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTF 533 (1109)
Q Consensus 457 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 533 (1109)
+++.|+|++|++++ .+|..|.++++|++|+|++ |.+.+.+|..|.++++|++|+|++|++++.+|..|.++++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 45555555555555 5555566666666666663 56665556666666666666666666665566666666666666
Q ss_pred ecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCccccccc-ccceecccccccccccCcccCCCcccceeeccCccc
Q 001274 534 NISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLV-NLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIF 612 (1109)
Q Consensus 534 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 612 (1109)
+|++|++++.+|..+..+++|++|+|++|++++.+|..+..++ +|+.|+|++|++++.+|..|..++ |+.|++++|.+
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 6666666666666666666666666666666655666666665 666666666666666666666655 66666666666
Q ss_pred cccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEccCcccccccCCC
Q 001274 613 SGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNT 692 (1109)
Q Consensus 613 ~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~p~~ 692 (1109)
++.+|..+.+++.|+ .|+|++|.+++.+|. +..+++|++|||++|+++|.+|..+..+++|++|+|++|+++|.+|..
T Consensus 210 ~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQ-KIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EECCGGGCCTTSCCS-EEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred cCcCCHHHhcCCCCC-EEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 666666666666665 366777777666665 788899999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccCCCCcccc-CCCc
Q 001274 693 TVFRRIDSSNFAGNRGLCML-GSDC 716 (1109)
Q Consensus 693 ~~~~~~~~~~~~~n~~~c~~-~~~c 716 (1109)
..++++....+.||+.+||. .+.|
T Consensus 288 ~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred ccccccChHHhcCCCCccCCCCCCC
Confidence 88999999999999999985 4455
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=335.77 Aligned_cols=248 Identities=19% Similarity=0.302 Sum_probs=193.2
Q ss_pred HHhcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc----chhHHHHHHHHHhccC----CCCceeeEEEEE
Q 001274 799 EATGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA----TADNSFLAEISTLGKI----RHRNIVKLYGFC 869 (1109)
Q Consensus 799 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~l~~~~ 869 (1109)
...++|++.+.||+|+||.||+|++. +++.||||++....... .....+.+|+.+++++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34478999999999999999999864 68999999997543221 1234466788888888 899999999999
Q ss_pred EeCCceEEEEEe-ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-CCCceEE
Q 001274 870 YHQDSNLLLYEY-MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD-EEFQAHV 947 (1109)
Q Consensus 870 ~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl 947 (1109)
...+..++|||| +++++|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 789999999986543 899999999999999999999 67999999999999999 8899999
Q ss_pred eeccccccccCCCCCCccccccccceeccccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 948 GDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVT-EKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 948 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
+|||+++.... .......|+..|+|||++.+..+. .++||||+|+++|||++|+.||.... .... .
T Consensus 182 ~dfg~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~----~ 248 (312)
T 2iwi_A 182 IDFGSGALLHD---EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE----A 248 (312)
T ss_dssp CCCSSCEECCS---SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH----T
T ss_pred EEcchhhhccc---CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh----h
Confidence 99999987652 223456789999999998877764 58999999999999999999997421 1111 1
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.... .......+.+++.+||+.||++|||++|++++-+.
T Consensus 249 ~~~~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 249 ELHF--------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp CCCC--------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred ccCC--------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 1100 00112357789999999999999999999987654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=343.16 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=188.1
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 345556889999999998776667999999998732 345678999999876 89999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCC----CCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-------------C
Q 001274 881 YMENGSLGEQLHGNKQTC----LLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-------------F 943 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~ 943 (1109)
|+. |+|.+++....... ..++..+..++.||+.||+||| +.+|+||||||+||+++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCce
Confidence 995 69999997654311 1133456789999999999999 7799999999999999654 4
Q ss_pred ceEEeeccccccccCCCCC---CccccccccceeccccccC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCccc
Q 001274 944 QAHVGDFGLAKLIDLPYSK---SMSAIAGSYGYIAPEYAYT-------MKVTEKCDIYSFGVVLLELIT-GKSPVQSLEL 1012 (1109)
Q Consensus 944 ~~kl~DFG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~ 1012 (1109)
.+||+|||+++........ ......||+.|+|||++.+ ..++.++||||+||++|||++ |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999876532211 1234579999999999876 678999999999999999999 9999975321
Q ss_pred CCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1013 GGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.....+. ........ ...........+.+++.+||+.||++|||+.|++++-
T Consensus 246 --~~~~i~~----~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 246 --RESNIIR----GIFSLDEM-------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp --HHHHHHH----TCCCCCCC-------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred --hHHHHhc----CCCCcccc-------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 1111111 11111110 0011233445788999999999999999999999754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=353.64 Aligned_cols=273 Identities=25% Similarity=0.296 Sum_probs=203.9
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe------CC
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH------QD 873 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 873 (1109)
.++|++.++||+|+||+||+|++. +|+.||||++... ......+.+.+|++++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 478999999999999999999864 6899999998643 234446779999999999999999999998765 56
Q ss_pred ceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc---eEEeec
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ---AHVGDF 950 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DF 950 (1109)
..++||||+++|+|.+++........+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 77999999999999999987665445899999999999999999999 779999999999999987665 999999
Q ss_pred cccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhh------
Q 001274 951 GLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSI------ 1024 (1109)
Q Consensus 951 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~------ 1024 (1109)
|.++..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ....|.....
T Consensus 169 G~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~---~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 169 GYAKELDQG--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW---QPVQWHGKVREKSNEH 243 (676)
T ss_dssp CCCCBTTSC--CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC---HHHHSSTTCC------
T ss_pred ccccccccc--cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc---chhhhhhhhhcccchh
Confidence 999876522 23345679999999999999999999999999999999999999997531 1111111000
Q ss_pred ---hccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHH-----HHHHHHhhh
Q 001274 1025 ---HEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREV-----IAMMIDARQ 1082 (1109)
Q Consensus 1025 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ev-----l~~L~~~~~ 1082 (1109)
.........+.................+.+++.+||++||++|||++|+ .+.+..+..
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000000111111111223345678899999999999999999884 445555443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=341.10 Aligned_cols=250 Identities=23% Similarity=0.299 Sum_probs=187.4
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.+|...++||+|+||+||.....+++.||||++... ....+.+|+++++.+ +||||+++++++.+.+..++|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE-----CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT-----TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 468888999999999977655567999999998632 223466899999999 89999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-----CCceEEeecccccc
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-----EFQAHVGDFGLAKL 955 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFG~a~~ 955 (1109)
|++ |+|.+++...... ..+..+..++.||+.||+||| +.+|+||||||+||+++. ...+||+|||+|+.
T Consensus 99 ~~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 6999999865532 555667899999999999999 779999999999999943 33688999999987
Q ss_pred ccCCCC--CCccccccccceecccccc---CCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCC
Q 001274 956 IDLPYS--KSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVP 1029 (1109)
Q Consensus 956 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 1029 (1109)
...... .......||+.|+|||++. +..++.++||||+||++|||++ |..||..... ........ ...
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~~~~~~~-~~~ 246 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQANILLG-ACS 246 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HHHHHHTT-CCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HHHHHHhc-cCC
Confidence 642211 2234567999999999997 4567889999999999999999 9999864221 11111111 111
Q ss_pred CchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1030 TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.. ... ........+.+++.+||+.||++|||++|++++-
T Consensus 247 ~~-~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 247 LD-CLH--------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp CT-TSC--------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred cc-ccC--------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 10 000 0112234577899999999999999999999653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=324.28 Aligned_cols=237 Identities=13% Similarity=0.083 Sum_probs=184.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|++. +++.||||++...... ....+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999976 5899999999754332 233478999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++++|.+++... ....++.+++.|++.||+||| +.+|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999542 355678899999999999999 7799999999999999999999998543
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
|++ +++.++|||||||++|||+||+.||.+........... .......+...
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~------- 226 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-RDTAGQPIEPA------- 226 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-BCTTSCBCCHH-------
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-HHhccCCCChh-------
Confidence 333 36889999999999999999999998643221100000 00000000000
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccCC
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 1086 (1109)
.........+.+++.+||+.||++| |+.|+++.|+++......
T Consensus 227 ---~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~ 269 (286)
T 3uqc_A 227 ---DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR 269 (286)
T ss_dssp ---HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred ---hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence 0011122457899999999999999 999999999998766543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=319.52 Aligned_cols=307 Identities=26% Similarity=0.367 Sum_probs=177.5
Q ss_pred ccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcc
Q 001274 260 IGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLC 339 (1109)
Q Consensus 260 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~ 339 (1109)
+..+++|++|++++|.+.. +| .+..+++|++|++++|.+++..+ +..+++|++|++++|.+++. + .+..
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~-~-~~~~----- 108 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI-S-ALQN----- 108 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTT-----
T ss_pred chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc-h-HHcC-----
Confidence 3456667777777776653 33 36666666666666666664322 66666666666666666532 1 3444
Q ss_pred eEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEecccc
Q 001274 340 LLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNN 419 (1109)
Q Consensus 340 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~ 419 (1109)
+++|++|++++|++++. +. +..+++|+.|++++|.....++ .+..+++|++|++++|.
T Consensus 109 -------------------l~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~ 166 (347)
T 4fmz_A 109 -------------------LTNLRELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESK 166 (347)
T ss_dssp -------------------CTTCSEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSC
T ss_pred -------------------CCcCCEEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCC
Confidence 44444444444444422 11 4444445555554443332222 24445555555555555
Q ss_pred ccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCcc
Q 001274 420 LDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPE 499 (1109)
Q Consensus 420 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 499 (1109)
+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|++++..+
T Consensus 167 ~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-- 238 (347)
T 4fmz_A 167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238 (347)
T ss_dssp CCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred cCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--
Confidence 543322 4555555555555555554322 5555566666666666654433 5566666666666666665433
Q ss_pred ccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccc
Q 001274 500 IGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLE 579 (1109)
Q Consensus 500 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 579 (1109)
+..+++|++|++++|++++. ..+..+++|++|++++|++++. ..+..+++|+.|++++|++++..|..+..+++|+
T Consensus 239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 314 (347)
T 4fmz_A 239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence 66666777777777766653 3566667777777777777643 3466667777777777777766666677777777
Q ss_pred eecccccccccccCcccCCCcccceeeccCcccc
Q 001274 580 LLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 580 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 613 (1109)
.|++++|++++..| +..+++|++|++++|+++
T Consensus 315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 77777777776555 666677777777777654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=319.26 Aligned_cols=307 Identities=27% Similarity=0.400 Sum_probs=181.6
Q ss_pred hhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCc
Q 001274 236 LEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAV 315 (1109)
Q Consensus 236 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 315 (1109)
+..+++|++|++++|.++ .++ .+..+++|++|++++|++++..+ +.++++|++|++++|.+++ + ..+.++++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-I-SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCS
T ss_pred chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-c-hHHcCCCcCC
Confidence 456677777777777776 343 36677777777777777774333 7777777777777777764 2 3577777888
Q ss_pred EEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEccccc
Q 001274 316 EIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNH 395 (1109)
Q Consensus 316 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 395 (1109)
+|++++|++++..+ +..+++|+.|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|.
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~ 188 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence 88888877775433 5556666666666664443333 25666666666666666653322 5555666666666665
Q ss_pred ccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCcc
Q 001274 396 LEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE 475 (1109)
Q Consensus 396 l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 475 (1109)
+.+..+ +..+++|++|++++|.+.+..+ +..+++ |++|++++|++++..+
T Consensus 189 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~------------------------L~~L~l~~n~l~~~~~-- 238 (347)
T 4fmz_A 189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR------------------------LNSLKIGNNKITDLSP-- 238 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTT------------------------CCEEECCSSCCCCCGG--
T ss_pred cccccc--ccCCCccceeecccCCCCCCch--hhcCCc------------------------CCEEEccCCccCCCcc--
Confidence 553222 4445555555555555543322 444444 4444444444443322
Q ss_pred ccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCC
Q 001274 476 FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQ 555 (1109)
Q Consensus 476 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 555 (1109)
+..+++|++|++++|.+++. +.+..+++|++|++++|++++. ..+..+++|+.|++++|++++..|..+..+++|+
T Consensus 239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 314 (347)
T 4fmz_A 239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence 55555555666666655543 3455566666666666666643 3456666666666666666666666666666666
Q ss_pred eeecCCCcCccCCCcccccccccceecccccccc
Q 001274 556 RLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589 (1109)
Q Consensus 556 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 589 (1109)
+|+|++|++++..| +..+++|+.|++++|+++
T Consensus 315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 66666666665444 666666666666666654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=333.36 Aligned_cols=244 Identities=17% Similarity=0.145 Sum_probs=178.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC-CCcchhHHHHHHHHHhccCCC-Cce----------e-----
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRH-RNI----------V----- 863 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~ni----------v----- 863 (1109)
..|...+.||+|+||+||+|++. +|+.||||+++... ......+.+.+|+.+++.++| ++. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45777889999999999999954 79999999987432 223346779999999999987 211 1
Q ss_pred ------eEEEEEEe-----CCceEEEEEeccCCCHHHHhccC----CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 001274 864 ------KLYGFCYH-----QDSNLLLYEYMENGSLGEQLHGN----KQTCLLDWDARYRIALGAAEGLCYLHYDCRPHII 928 (1109)
Q Consensus 864 ------~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 928 (1109)
.+..++.. ....+++|+++ +++|.+++... .....+++..+..++.||++||+||| +.+|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 11111111 12346677765 68999988421 11224788899999999999999999 77999
Q ss_pred ecCCCCCceeeCCCCceEEeeccccccccCCCCCCccccccccceeccccc----------cCCCCCccchhHHHHHHHH
Q 001274 929 HRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA----------YTMKVTEKCDIYSFGVVLL 998 (1109)
Q Consensus 929 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvll~ 998 (1109)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865422 344567 999999999 5666889999999999999
Q ss_pred HHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 999 ELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 999 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
||++|+.||........ ....+... .. ....+.+++.+||+.||++||++.+++++
T Consensus 309 elltg~~Pf~~~~~~~~--------------~~~~~~~~----~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG--------------SEWIFRSC----KN----IPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHSSCCCCTTGGGSC--------------SGGGGSSC----CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHCCCCCCCcchhhh--------------HHHHHhhc----cc----CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999975431110 01111100 01 12457899999999999999998777544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=314.86 Aligned_cols=238 Identities=20% Similarity=0.261 Sum_probs=182.8
Q ss_pred cCCCCC-ceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHh-ccCCCCceeeEEEEEEe----CCc
Q 001274 802 GNFSEG-AVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTL-GKIRHRNIVKLYGFCYH----QDS 874 (1109)
Q Consensus 802 ~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~ 874 (1109)
++|.+. +.||+|+||+||+|++. +++.||+|+++ ....+.+|++++ +..+||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-------~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-------CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEec-------ccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 466666 78999999999999874 68999999996 234677898887 56699999999999987 667
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEeecc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE---EFQAHVGDFG 951 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG 951 (1109)
.++||||+++|+|.+++...... .+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 89999999999999999875432 3899999999999999999999 779999999999999998 7899999999
Q ss_pred ccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
++.... +..++.++||||+||++|||++|+.||........ ........
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~~~~~~~~--- 214 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMKTRI--- 214 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSCCSS---
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----hHHHHHHH---
Confidence 997533 23567899999999999999999999975331100 00000000
Q ss_pred hhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1032 ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
..................+.+++.+||+.||++|||+.|++++-+.....
T Consensus 215 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 215 --RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp --CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred --hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00000000000011234678999999999999999999999987765443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=349.00 Aligned_cols=240 Identities=25% Similarity=0.335 Sum_probs=192.8
Q ss_pred cCCCCCceEecCCcceEEEEEec--CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc-----
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS----- 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 874 (1109)
++|++.+.||+|+||+||+|++. +++.||||++... ........+.+|++++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 68999999999999999999975 5899999998643 223445678899999999999999999999988766
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.|+||||+++++|.+++.. .+++.++..++.||+.||.||| +.+||||||||+||+++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987754 2899999999999999999999 7799999999999999986 89999999998
Q ss_pred cccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||.+.... ..+...
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------~~~~~~-- 288 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-------------GLPEDD-- 288 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-------------SCCTTC--
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-------------cccccc--
Confidence 76422 4457999999999987654 89999999999999999999887643211 000000
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHHHhh
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT-MREVIAMMIDAR 1081 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~~L~~~~ 1081 (1109)
........+.+++.+||+.||++||+ ++++.+.+....
T Consensus 289 ---------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 289 ---------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ---------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 01112245789999999999999996 555555565543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-32 Score=306.42 Aligned_cols=288 Identities=23% Similarity=0.300 Sum_probs=183.1
Q ss_pred cCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcc
Q 001274 313 SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLF 392 (1109)
Q Consensus 313 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 392 (1109)
+++.+++++|.++ .+|..+ .++|+.|++++|.+.+..|..|..+++|++|++++|++++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCC--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCC--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4455555555554 233322 2455555555555555555556666666666666666665556666666666666666
Q ss_pred cccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCcccc--CCCCCCCccccccceeecccccccc
Q 001274 393 DNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLS--GNIPPGLKTCRSLMQLMLGQNQLTG 470 (1109)
Q Consensus 393 ~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~ 470 (1109)
+|+++ .+|..+. ++|++|++++|++.+..+..|..+++|+.|++++|.++ +..+..+..+ +|++|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 66665 3444333 56666777777666655556666777777777777664 2555666666 67777777777765
Q ss_pred cCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCC
Q 001274 471 SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGN 550 (1109)
Q Consensus 471 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 550 (1109)
+|..+. ++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 343332 56777777777777766677777777777777777777766667777777777777777777 66667777
Q ss_pred CCCCCeeecCCCcCccCCCcccccc------cccceecccccccc--cccCcccCCCcccceeeccCcc
Q 001274 551 CVNLQRLDLSRNQFTGSAPEELGQL------VNLELLKLSDNKLT--GAIPSSLGGLARLTELQMGGNI 611 (1109)
Q Consensus 551 l~~L~~L~Ls~N~l~~~~p~~l~~l------~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~l~~N~ 611 (1109)
+++|+.|++++|+|++..+..|... .+|+.|++++|++. +..|..|..+++|+.+++++|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 7777777777777776555555443 45677777777766 5566677777777777777664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-31 Score=303.52 Aligned_cols=289 Identities=22% Similarity=0.293 Sum_probs=188.1
Q ss_pred cCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcc
Q 001274 313 SAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLF 392 (1109)
Q Consensus 313 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 392 (1109)
+++.++++++.++. +|..+ .++++.|++++|.+++..+..|..+++|++|++++|++++..|..|.++++|++|+++
T Consensus 32 ~l~~l~~~~~~l~~-lp~~~--~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLEK-VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCCS-CCCSC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCccc-cCccC--CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 44455555555442 23222 2455555555555555555556666666666666666665556666666666666666
Q ss_pred cccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccC--CCCCCCccccccceeecccccccc
Q 001274 393 DNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSG--NIPPGLKTCRSLMQLMLGQNQLTG 470 (1109)
Q Consensus 393 ~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~ 470 (1109)
+|+++ .+|..+. ++|++|++++|++.+..+..|..+++|++|++++|.++. ..+..+..+++|++|++++|+++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 66666 3444333 567777777777776666677777777777777777753 556666777777777777777764
Q ss_pred cCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCC
Q 001274 471 SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGN 550 (1109)
Q Consensus 471 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 550 (1109)
+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|.++..
T Consensus 186 -l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 -IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp -CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 333332 67777777777777776777777777777777777777766667777777777777777777 66777777
Q ss_pred CCCCCeeecCCCcCccCCCcccccc------cccceeccccccccc--ccCcccCCCcccceeeccCcc
Q 001274 551 CVNLQRLDLSRNQFTGSAPEELGQL------VNLELLKLSDNKLTG--AIPSSLGGLARLTELQMGGNI 611 (1109)
Q Consensus 551 l~~L~~L~Ls~N~l~~~~p~~l~~l------~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~ 611 (1109)
+++|++|+|++|+|++..+..|... ..|+.|++++|++.. ..|..|..+.+++.++|++|+
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 7777777777777776555555432 566777777777653 455667777777777777663
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-31 Score=302.31 Aligned_cols=287 Identities=21% Similarity=0.319 Sum_probs=194.2
Q ss_pred cceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEccc
Q 001274 290 LKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSI 369 (1109)
Q Consensus 290 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 369 (1109)
++.++++++.++ .+|..+. +++++|+|++|.+++..|..+..+++|+.|++++|.+++..|..|..+++|++|++++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 444444444443 3333332 3445555555555544444455555555555555555555555555566666666666
Q ss_pred CcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEecccccc--CccchhhhcccccceeecCCccccCC
Q 001274 370 NNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLD--GSIPPHLCMYQKLIFLSLGSNRLSGN 447 (1109)
Q Consensus 370 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~--~~~~~~l~~l~~L~~L~L~~N~l~~~ 447 (1109)
|+++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|.++ +..+..+..+ +|++|++++|++++
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~- 186 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG- 186 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence 6665 3333332 55666666666666544445666666666666666664 2455566666 77777777777775
Q ss_pred CCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhccc
Q 001274 448 IPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNL 527 (1109)
Q Consensus 448 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 527 (1109)
+|..+. ++|++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+
T Consensus 187 l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 263 (332)
T 2ft3_A 187 IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263 (332)
T ss_dssp CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence 344433 67888888888888887788888899999999999998887778888999999999999988 677788889
Q ss_pred ccccEEecccCcccccCCcCCCC------CCCCCeeecCCCcCc--cCCCcccccccccceecccccc
Q 001274 528 EHLVTFNISSNSLSGTIPHELGN------CVNLQRLDLSRNQFT--GSAPEELGQLVNLELLKLSDNK 587 (1109)
Q Consensus 528 ~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~Ls~N~ 587 (1109)
++|++|+|++|+|++..+..|.. ..+|+.|++++|.+. +..|..|..+++|+.|++++|+
T Consensus 264 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp TTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 99999999999998777776665 367899999999987 6778889999999999999885
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=299.81 Aligned_cols=289 Identities=20% Similarity=0.285 Sum_probs=192.9
Q ss_pred cccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecc
Q 001274 265 SLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLF 344 (1109)
Q Consensus 265 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~ 344 (1109)
+++.++++++.++ .+|..+. ++|+.|++++|.+++..+..+.++++|++|+|++|++++..|..
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~------------- 95 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA------------- 95 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT-------------
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHH-------------
Confidence 5666666666655 3443332 34555555555555444445555555555555555555444444
Q ss_pred cccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccC--
Q 001274 345 ENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDG-- 422 (1109)
Q Consensus 345 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~-- 422 (1109)
|..+++|++|++++|+++ .+|..+. ++|++|++++|.+++..+..+..+++|++|++++|.+..
T Consensus 96 -----------~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 161 (330)
T 1xku_A 96 -----------FAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161 (330)
T ss_dssp -----------TTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred -----------hcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC
Confidence 444555555555555554 2333222 445555555555554444445555555555555555532
Q ss_pred ccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccc
Q 001274 423 SIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGK 502 (1109)
Q Consensus 423 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 502 (1109)
..+..+..+++|++|++++|.++. +|..+. ++|++|++++|++++..|..|.++++|++|+|++|++++..+..+..
T Consensus 162 ~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 238 (330)
T 1xku_A 162 IENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238 (330)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred cChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccC
Confidence 445566666777777777777764 343333 67888888888888888888888999999999999998887778888
Q ss_pred cccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCC------CCCCCeeecCCCcCcc--CCCccccc
Q 001274 503 LRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGN------CVNLQRLDLSRNQFTG--SAPEELGQ 574 (1109)
Q Consensus 503 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~p~~l~~ 574 (1109)
+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|.. .+.|+.|++++|.+.. ..|..|..
T Consensus 239 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence 999999999999988 57888888999999999999998776666654 3788999999999863 56788999
Q ss_pred ccccceecccccc
Q 001274 575 LVNLELLKLSDNK 587 (1109)
Q Consensus 575 l~~L~~L~Ls~N~ 587 (1109)
+.+|+.++|++|+
T Consensus 318 ~~~l~~l~L~~N~ 330 (330)
T 1xku_A 318 VYVRAAVQLGNYK 330 (330)
T ss_dssp CCCGGGEEC----
T ss_pred ccceeEEEecccC
Confidence 9999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-33 Score=320.18 Aligned_cols=246 Identities=15% Similarity=0.135 Sum_probs=186.1
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCC------CcchhHHHHHHHHHhccCC---------CCceeeEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGE------GATADNSFLAEISTLGKIR---------HRNIVKLY 866 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~l~ 866 (1109)
++|++.++||+|+||+||+|++ +|+.||||++..... .....+.+.+|+++++.++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 5788999999999999999998 689999999986532 1223367889999988885 88888888
Q ss_pred EEEE------------------------------eCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHH
Q 001274 867 GFCY------------------------------HQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGL 916 (1109)
Q Consensus 867 ~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l 916 (1109)
+++. ..+..++||||+++|++.+.+.+. .+++..+..++.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----CCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----CCCHHHHHHHHHHHHHHH
Confidence 8753 257789999999999777776442 389999999999999999
Q ss_pred HHHh-hcCCCCeEecCCCCCceeeCCCC--------------------ceEEeeccccccccCCCCCCccccccccceec
Q 001274 917 CYLH-YDCRPHIIHRDIKSNNILLDEEF--------------------QAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIA 975 (1109)
Q Consensus 917 ~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~a 975 (1109)
+||| +. +|+||||||+|||++.++ .+||+|||+|+.... ....||+.|+|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccC
Confidence 9999 44 899999999999999887 899999999987652 23479999999
Q ss_pred cccccCCCCCccchhHHHHHH-HHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHH
Q 001274 976 PEYAYTMKVTEKCDIYSFGVV-LLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLK 1054 (1109)
Q Consensus 976 PE~~~~~~~~~~~DvwSlGvl-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1109)
||++.+.. +.++||||+|++ .+++++|..||....... ........... ..... ...........+.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~---~~~~~~~~~~~-~~~~~------~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH---YLTDKMLKQMT-FKTKC------NTPAMKQIKRKIQE 314 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH---HHHHHHHHTCC-CSSCC------CSHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh---HHHHhhhhhhc-cCccc------chhhhhhcCHHHHH
Confidence 99998776 899999998777 788889999985311000 01111110000 00000 00112334567899
Q ss_pred HHHhccCCCCCCCCCHHHHH-HHH
Q 001274 1055 IALFCSSTSPLNRPTMREVI-AMM 1077 (1109)
Q Consensus 1055 li~~cl~~dP~~RPt~~evl-~~L 1077 (1109)
++.+||+.| |++|++ +|-
T Consensus 315 li~~~L~~d-----sa~e~l~~Hp 333 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLLCQHS 333 (336)
T ss_dssp HHHHGGGSS-----SHHHHHHHCG
T ss_pred HHHHHhccC-----CHHHHHhcCC
Confidence 999999976 999998 653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-35 Score=350.14 Aligned_cols=385 Identities=19% Similarity=0.143 Sum_probs=175.8
Q ss_pred cccceeecccCccCCCCCc-cccCCCCCceEEccCCccccc----CCchhhccccceEEEccccccccccccccc-CcC-
Q 001274 96 PRLVEFNISMNFVTGSIPT-DLANCSSLEILDLCTNRLHGV----IPFQLFFINTLRKLYLCENYIFGEIPEEIG-NLT- 168 (1109)
Q Consensus 96 ~~L~~L~ls~n~~~~~~p~-~l~~l~~L~~L~Ls~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~- 168 (1109)
++|++|+|++|.++..... .+..+++|++|+|++|.+++. ++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 4566777777666543322 255666667777776666542 334444556666666666666554333322 233
Q ss_pred ---CCceEEeecCCCCC----CCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhcccc
Q 001274 169 ---SLEELVIYSNNLTG----AIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRN 241 (1109)
Q Consensus 169 ---~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 241 (1109)
+|++|+|++|+++. .+|..+.++++|++|++++|.+++..+..+... .....++
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~-------------------l~~~~~~ 143 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG-------------------LLDPQCR 143 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH-------------------HTSTTCC
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHH-------------------HhcCCCc
Confidence 46666666665553 234555555555555555555543222222110 0001233
Q ss_pred ccceecccccccCCC----CCCccccccccceeeeeccceecCchhhhc-----cCccceEEeecccccCc----cCccc
Q 001274 242 LTDLILWQNHLSGEI----PPTIGNIQSLELLALHENSFSGGLPKELGK-----LSRLKKLYVYTNELNGT----IPHEL 308 (1109)
Q Consensus 242 L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~-----l~~L~~L~l~~n~l~~~----~~~~l 308 (1109)
|++|+|++|++++.. +..+..+++|++|++++|.+++..+..+.. .++|++|++++|.+++. ++..+
T Consensus 144 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 223 (461)
T 1z7x_W 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223 (461)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHH
T ss_pred ceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHH
Confidence 444555444444321 223333444444455444444333333321 33555555555555432 23444
Q ss_pred CCCCcCcEEEccCCcccCCC-----cccccCCCCcceEecccccccCc----ccccccCCCCccEEEcccCcccCCCCcc
Q 001274 309 GNCTSAVEIDLSENQLTGFI-----PRELGLIPNLCLLQLFENMLQGS----IPRELGQLTQLHKLDLSINNLTGTIPLE 379 (1109)
Q Consensus 309 ~~l~~L~~L~Ls~n~l~~~~-----p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 379 (1109)
..+++|++|+|++|++++.. +..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+++..+..
T Consensus 224 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~ 303 (461)
T 1z7x_W 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303 (461)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred HhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHH
Confidence 44555555555555544321 11111233444444444443332 2333444445555555555444322222
Q ss_pred hhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCc----cchhhhcccccceeecCCccccCCCCCCCcc-
Q 001274 380 FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGS----IPPHLCMYQKLIFLSLGSNRLSGNIPPGLKT- 454 (1109)
Q Consensus 380 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~- 454 (1109)
+...- ....++|++|++++|.+++. ++..+..+++|++|+|++|.+++..+..+..
T Consensus 304 l~~~l-------------------~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 364 (461)
T 1z7x_W 304 LCETL-------------------LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364 (461)
T ss_dssp HHHHH-------------------TSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHH
T ss_pred HHHHh-------------------ccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHH
Confidence 22210 00012344444444444332 2233334444444444444444332222211
Q ss_pred ----ccccceeecccccccc----cCCccccCCcccceeccccccccCCCCcccc-----ccccccEEEccCCccCC
Q 001274 455 ----CRSLMQLMLGQNQLTG----SLPIEFYNLQNLSALELYQNRFSGLIPPEIG-----KLRNLERLHLSENYFVG 518 (1109)
Q Consensus 455 ----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~ 518 (1109)
.++|++|++++|++++ .+|..+..+++|++|+|++|++++.....+. ...+|+.|.+.++.+..
T Consensus 365 l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred HcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 3455666666665554 4555566666666777776666543111111 12356677776666554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-35 Score=348.59 Aligned_cols=383 Identities=21% Similarity=0.151 Sum_probs=214.5
Q ss_pred ccchhhhcccccccccCchh-hhccccccceecccccccC----CCCCCccccccccceeeeeccceecCchhhh-ccC-
Q 001274 216 EGLEVLGLAQNSLEGFLPSE-LEKLRNLTDLILWQNHLSG----EIPPTIGNIQSLELLALHENSFSGGLPKELG-KLS- 288 (1109)
Q Consensus 216 ~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-~l~- 288 (1109)
++|++|+|++|+++...... +..+++|++|+|++|++++ .++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45677777777776443333 5666777777777777663 2344455556666666666666554443333 233
Q ss_pred ---ccceEEeecccccC----ccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCC
Q 001274 289 ---RLKKLYVYTNELNG----TIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQ 361 (1109)
Q Consensus 289 ---~L~~L~l~~n~l~~----~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 361 (1109)
+|++|++++|.++. .++..+..+++|++|+|++|.+++..+..+.. ......++
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~-------------------~l~~~~~~ 143 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE-------------------GLLDPQCR 143 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH-------------------HHTSTTCC
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH-------------------HHhcCCCc
Confidence 46666666665552 33455555555555555555554332221111 00111334
Q ss_pred ccEEEcccCcccCCC----CcchhcccccceEEcccccccccCCCccc-----ccCcCcEEEeccccccCc----cchhh
Q 001274 362 LHKLDLSINNLTGTI----PLEFQNLTYLVDLQLFDNHLEGTIPPHIG-----VNSHLSVLDVSMNNLDGS----IPPHL 428 (1109)
Q Consensus 362 L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~~~~L~~L~Ls~N~l~~~----~~~~l 428 (1109)
|++|++++|++++.. +..+..+++|++|++++|.+.+..+..+. ..++|++|++++|.++.. ++..+
T Consensus 144 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 223 (461)
T 1z7x_W 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223 (461)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHH
T ss_pred ceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHH
Confidence 555555555555322 33344455555555555555433322222 134566666666666543 34555
Q ss_pred hcccccceeecCCccccCCC-----CCCCccccccceeeccccccccc----CCccccCCcccceeccccccccCCCCcc
Q 001274 429 CMYQKLIFLSLGSNRLSGNI-----PPGLKTCRSLMQLMLGQNQLTGS----LPIEFYNLQNLSALELYQNRFSGLIPPE 499 (1109)
Q Consensus 429 ~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 499 (1109)
..+++|+.|++++|.++... +..+..+++|++|++++|+++.. ++..+.++++|++|+|++|.+.+..+..
T Consensus 224 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~ 303 (461)
T 1z7x_W 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303 (461)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred HhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHH
Confidence 56666666666666655321 11222456667777777766643 4555666777777777777776443333
Q ss_pred cccc-----ccccEEEccCCccCCC----CChhhcccccccEEecccCcccccCCcCCCC-----CCCCCeeecCCCcCc
Q 001274 500 IGKL-----RNLERLHLSENYFVGY----IPSEVGNLEHLVTFNISSNSLSGTIPHELGN-----CVNLQRLDLSRNQFT 565 (1109)
Q Consensus 500 ~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~ 565 (1109)
+... ++|++|++++|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|++|+|++|.++
T Consensus 304 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 3322 5777777777777654 3455666677777777777776544433332 567777888888777
Q ss_pred c----CCCcccccccccceecccccccccccCcccC-----CCcccceeeccCcccccccc
Q 001274 566 G----SAPEELGQLVNLELLKLSDNKLTGAIPSSLG-----GLARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 566 ~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~~~p 617 (1109)
+ .+|..+..+++|+.|+|++|++++.....+. ...+|+.|++.+|.+....+
T Consensus 384 ~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~ 444 (461)
T 1z7x_W 384 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 444 (461)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred hhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHH
Confidence 5 5677777777777778877777643211111 12345666666655554333
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-33 Score=342.96 Aligned_cols=449 Identities=13% Similarity=0.063 Sum_probs=255.1
Q ss_pred CCccceeeecCCeEEEEeccCccccccccccccCccccceeecccCcc---CCCCCcccc------------CCCCCceE
Q 001274 61 PCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFV---TGSIPTDLA------------NCSSLEIL 125 (1109)
Q Consensus 61 ~c~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~---~~~~p~~l~------------~l~~L~~L 125 (1109)
|++|.+|.+...+... +. +.....++..+..+++|++|+|+++.. .|.+|..++ .+++|++|
T Consensus 41 ck~W~~~~~~~~~~l~--~~-~~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L 117 (592)
T 3ogk_B 41 CRRWFKIDSETREHVT--MA-LCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSV 117 (592)
T ss_dssp CHHHHHHHHHHCCEEE--ES-CGGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEE
T ss_pred hHHHHHhhhccccEEE--Ee-eccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeE
Confidence 4489999765433322 22 223334445566789999999987532 245554444 68889999
Q ss_pred EccCCcccccCCchhhcc--ccceEEEccccc-ccc-cccccccCcCCCceEEeecCCCCCC----CCccccccccccee
Q 001274 126 DLCTNRLHGVIPFQLFFI--NTLRKLYLCENY-IFG-EIPEEIGNLTSLEELVIYSNNLTGA----IPASISKLRQLRVI 197 (1109)
Q Consensus 126 ~Ls~n~l~~~~~~~l~~l--~~L~~L~L~~n~-l~~-~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L 197 (1109)
+|++|.+++..+..+... ++|++|+|++|. ++. .++..+.++++|++|+|++|.+++. ++..+.++++|+.|
T Consensus 118 ~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L 197 (592)
T 3ogk_B 118 HFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVL 197 (592)
T ss_dssp EEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEE
T ss_pred EeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEE
Confidence 999888887777777663 448888888876 221 2333345778888888888887765 33345667778888
Q ss_pred ccccccccC----CCCccccccccchhhhcccccccccCchhhhccccccceeccccccc---CCCCCCcccccccccee
Q 001274 198 RAGHNSLSG----PIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLS---GEIPPTIGNIQSLELLA 270 (1109)
Q Consensus 198 ~l~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~---~~~p~~l~~l~~L~~L~ 270 (1109)
++++|.+++ .++..+.++++|++|++++|.+.+ +|..+.++++|++|+++..... +..+..+..+++|+.|+
T Consensus 198 ~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ 276 (592)
T 3ogk_B 198 NFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLG 276 (592)
T ss_dssp ECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEE
T ss_pred EeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccC
Confidence 888877762 333444566777777777776664 5566667777777777643222 22334455555555555
Q ss_pred eeeccceecCchhhhccCccceEEeecccccCccC-cccCCCCcCcEEEccCCcccCCCcccccCCCCcceEeccccccc
Q 001274 271 LHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIP-HELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349 (1109)
Q Consensus 271 L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 349 (1109)
++++.. +.+|..+..+++|++|++++|.+++... ..+..+++|++|+++ +.+. .
T Consensus 277 l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~-----------------------~ 331 (592)
T 3ogk_B 277 LSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIG-----------------------D 331 (592)
T ss_dssp ETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGH-----------------------H
T ss_pred ccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccC-----------------------H
Confidence 555422 2344455555555555555555443222 223445555555555 2222 1
Q ss_pred CcccccccCCCCccEEEcc-----------cCcccCC-CCcchhcccccceEEcccccccccCCCcccc-cCcCcEEEec
Q 001274 350 GSIPRELGQLTQLHKLDLS-----------INNLTGT-IPLEFQNLTYLVDLQLFDNHLEGTIPPHIGV-NSHLSVLDVS 416 (1109)
Q Consensus 350 ~~~p~~l~~l~~L~~L~Ls-----------~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~~L~~L~Ls 416 (1109)
+.++..+..+++|++|+++ .|.+++. ++..+..+++|+.|+++.|.+++..+..++. +++|+.|+++
T Consensus 332 ~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~ 411 (592)
T 3ogk_B 332 RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411 (592)
T ss_dssp HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEE
T ss_pred HHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEe
Confidence 2222223344555555555 2333322 1112334555555555555555444444433 5555555554
Q ss_pred ----cccccCc-----cchhhhcccccceeecCCc--cccCCCCCCCc-cccccceeecccccccc-cCCccccCCcccc
Q 001274 417 ----MNNLDGS-----IPPHLCMYQKLIFLSLGSN--RLSGNIPPGLK-TCRSLMQLMLGQNQLTG-SLPIEFYNLQNLS 483 (1109)
Q Consensus 417 ----~N~l~~~-----~~~~l~~l~~L~~L~L~~N--~l~~~~~~~~~-~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~ 483 (1109)
.|.+++. ++..+.++++|+.|+++.+ .+++.....+. .+++|++|++++|++++ .++..+.++++|+
T Consensus 412 ~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~ 491 (592)
T 3ogk_B 412 LLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQ 491 (592)
T ss_dssp ECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCC
T ss_pred ecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccC
Confidence 4455442 3333555666666666532 23332222222 25667777777777664 2344456778888
Q ss_pred eeccccccccCC-CCccccccccccEEEccCCccCCCCChhh-cccccccEEecccC
Q 001274 484 ALELYQNRFSGL-IPPEIGKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSN 538 (1109)
Q Consensus 484 ~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N 538 (1109)
+|+|++|.+++. ++..+..+++|++|+|++|++++.....+ ..++.+....+..+
T Consensus 492 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 492 KLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp EEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred eeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 888888887643 23344567888888888888775433333 34566666555544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-30 Score=293.83 Aligned_cols=278 Identities=22% Similarity=0.189 Sum_probs=194.9
Q ss_pred EEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccc
Q 001274 389 LQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQL 468 (1109)
Q Consensus 389 L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 468 (1109)
.++++|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|++
T Consensus 36 c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 36 CKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 444444444 3333332 3566666666666655555666666666666666666666666677777777777777777
Q ss_pred cccCCccccCCcccceeccccccccCCCC-ccccccccccEEEccCC-ccCCCCChhhcccccccEEecccCcccccCCc
Q 001274 469 TGSLPIEFYNLQNLSALELYQNRFSGLIP-PEIGKLRNLERLHLSEN-YFVGYIPSEVGNLEHLVTFNISSNSLSGTIPH 546 (1109)
Q Consensus 469 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 546 (1109)
++..+..|.++++|++|+|++|+++++.+ ..|..+++|++|++++| .+.+..+..|.++++|++|++++|++++..|.
T Consensus 113 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 192 (353)
T 2z80_A 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192 (353)
T ss_dssp SSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred CcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHH
Confidence 76555557778888888888888876544 46778888888888887 46666677788888888888888888877788
Q ss_pred CCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccC---CCcccceeeccCcccccccccccccc
Q 001274 547 ELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLG---GLARLTELQMGGNIFSGSIPVALGQL 623 (1109)
Q Consensus 547 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~~p~~~~~l 623 (1109)
.+.++++|++|++++|+++...+..+..+++|+.|++++|++++..+..+. ....++.+++++|.++
T Consensus 193 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~---------- 262 (353)
T 2z80_A 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT---------- 262 (353)
T ss_dssp TTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCC----------
T ss_pred HHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcccccccccc----------
Confidence 888888888888888888643333345578888888888888866554433 2344555555554433
Q ss_pred chhhhhhccCCccccccccccccCccccceeecCCCccccCCchh-hhccccceEEEccCcccccccCC
Q 001274 624 TALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPAS-MGEQMSLLVCNLSNNNLVGTVPN 691 (1109)
Q Consensus 624 ~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~-~~~l~~L~~l~ls~N~l~g~~p~ 691 (1109)
+|.+. .+|..++.+++|+.|||++|+++ .+|.. |..+++|++|+|++|++.|.+|.
T Consensus 263 ----------~~~l~-~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 263 ----------DESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp ----------HHHHH-HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ----------Ccchh-hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 23333 46778889999999999999998 67766 58899999999999999998874
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-31 Score=328.73 Aligned_cols=424 Identities=14% Similarity=0.051 Sum_probs=212.4
Q ss_pred hhhhccccccceecccccc---cCCCCCCcc------------ccccccceeeeeccceecCchhhhcc--CccceEEee
Q 001274 234 SELEKLRNLTDLILWQNHL---SGEIPPTIG------------NIQSLELLALHENSFSGGLPKELGKL--SRLKKLYVY 296 (1109)
Q Consensus 234 ~~l~~l~~L~~L~L~~N~l---~~~~p~~l~------------~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~l~ 296 (1109)
..+..+++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..++.+ .+|++|+++
T Consensus 67 ~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~ 146 (592)
T 3ogk_B 67 RLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLD 146 (592)
T ss_dssp HHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEE
T ss_pred HHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECc
Confidence 3445566666666655321 123333333 55677777777777766666666653 347777777
Q ss_pred ccc-ccC-ccCcccCCCCcCcEEEccCCcccCC----CcccccCCCCcceEeccccccc----CcccccccCCCCccEEE
Q 001274 297 TNE-LNG-TIPHELGNCTSAVEIDLSENQLTGF----IPRELGLIPNLCLLQLFENMLQ----GSIPRELGQLTQLHKLD 366 (1109)
Q Consensus 297 ~n~-l~~-~~~~~l~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~~L~ 366 (1109)
+|. ++. .++....++++|++|+|++|.+++. ++..+..+++|+.|++++|.++ +.++..+.++++|++|+
T Consensus 147 ~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~ 226 (592)
T 3ogk_B 147 KCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVK 226 (592)
T ss_dssp SCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEE
T ss_pred CCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEe
Confidence 665 221 1222234567777777777776654 2233445566666666666665 23344445667777777
Q ss_pred cccCcccCCCCcchhcccccceEEccccccc---ccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCcc
Q 001274 367 LSINNLTGTIPLEFQNLTYLVDLQLFDNHLE---GTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNR 443 (1109)
Q Consensus 367 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 443 (1109)
+++|.+.+ ++..+.++++|++|+++.+... +..+..+..+++|+.|+++++.. ..+|..+..+++|++|+|++|.
T Consensus 227 L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~ 304 (592)
T 3ogk_B 227 VGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYAL 304 (592)
T ss_dssp CSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCC
T ss_pred ccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCc
Confidence 77777764 5566777777777777653222 22334445556666666665422 2344445555555555555555
Q ss_pred ccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEcc-----------
Q 001274 444 LSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLS----------- 512 (1109)
Q Consensus 444 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls----------- 512 (1109)
+++... +..+.++++|++|+++++-..+.++..+..+++|++|+++
T Consensus 305 l~~~~~-----------------------~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~ 361 (592)
T 3ogk_B 305 LETEDH-----------------------CTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDE 361 (592)
T ss_dssp CCHHHH-----------------------HHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSST
T ss_pred CCHHHH-----------------------HHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccc
Confidence 432211 0113344444444444221111122222334445555555
Q ss_pred CCccCCC-CChhhcccccccEEecccCcccccCCcCCCC-CCCCCeeecC----CCcCccC-----CCccccccccccee
Q 001274 513 ENYFVGY-IPSEVGNLEHLVTFNISSNSLSGTIPHELGN-CVNLQRLDLS----RNQFTGS-----APEELGQLVNLELL 581 (1109)
Q Consensus 513 ~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~l~~l~~L~~L 581 (1109)
.|.+++. ++..+..+++|++|+++.|++++..+..++. +++|+.|+++ .|.+++. ++..+.++++|+.|
T Consensus 362 ~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L 441 (592)
T 3ogk_B 362 EGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRF 441 (592)
T ss_dssp TCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEE
T ss_pred cCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEE
Confidence 2333321 1111233455555555555555443333333 4555555553 4444432 22234445555555
Q ss_pred ccccc--ccccccCcccC-CCcccceeeccCccccc-cccccccccchhhhhhccCCcccccc-ccccccCccccceeec
Q 001274 582 KLSDN--KLTGAIPSSLG-GLARLTELQMGGNIFSG-SIPVALGQLTALQIALNISHNNLSGV-IPYELGNLQMLEALYL 656 (1109)
Q Consensus 582 ~Ls~N--~l~~~~p~~~~-~l~~L~~L~l~~N~l~~-~~p~~~~~l~~l~~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L 656 (1109)
+|++| .+++..+..+. .+++|++|++++|.+++ .++..+..++.|+ .|+|++|.+++. ++..+..+++|+.|+|
T Consensus 442 ~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~-~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 520 (592)
T 3ogk_B 442 AFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQ-KLEMRGCCFSERAIAAAVTKLPSLRYLWV 520 (592)
T ss_dssp EEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCC-EEEEESCCCBHHHHHHHHHHCSSCCEEEE
T ss_pred EEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccC-eeeccCCCCcHHHHHHHHHhcCccCeeEC
Confidence 55432 23433333332 24555555555555543 2233333344443 245555554433 3333456777888888
Q ss_pred CCCccccCCchhh-hccccceEEEccCc
Q 001274 657 DDNQLIGEIPASM-GEQMSLLVCNLSNN 683 (1109)
Q Consensus 657 s~N~l~~~ip~~~-~~l~~L~~l~ls~N 683 (1109)
++|++++.--..+ ..++.+....+..+
T Consensus 521 s~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 521 QGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp ESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred cCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 8888775533333 24555555544443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=288.31 Aligned_cols=257 Identities=20% Similarity=0.196 Sum_probs=197.8
Q ss_pred CccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecC
Q 001274 361 QLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLG 440 (1109)
Q Consensus 361 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 440 (1109)
+|++|++++|++++..+..|.++++|+.|++++|++++..|..|..+++|++|++++|++++..+..|.++++|++|+++
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence 56777777777765555567777777777777777776666677777777778888887776666667888888888888
Q ss_pred CccccCCCC-CCCccccccceeecccc-cccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCC
Q 001274 441 SNRLSGNIP-PGLKTCRSLMQLMLGQN-QLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVG 518 (1109)
Q Consensus 441 ~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 518 (1109)
+|++++..+ ..+..+++|++|++++| .++...+..|.++++|++|++++|++++..|..+..+++|++|++++|+++.
T Consensus 133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 212 (353)
T 2z80_A 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212 (353)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT
T ss_pred CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc
Confidence 888886544 47788888888888888 4776677788888899999999999888888888889999999999998875
Q ss_pred CCChhhcccccccEEecccCcccccCCcCCC---CCCCCCeeecCCCcCcc----CCCcccccccccceecccccccccc
Q 001274 519 YIPSEVGNLEHLVTFNISSNSLSGTIPHELG---NCVNLQRLDLSRNQFTG----SAPEELGQLVNLELLKLSDNKLTGA 591 (1109)
Q Consensus 519 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~ 591 (1109)
..+..+..+++|++|+|++|++++..+..+. ....++.++|++|.+++ .+|..+..+++|+.|+|++|+++..
T Consensus 213 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i 292 (353)
T 2z80_A 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSV 292 (353)
T ss_dssp HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCC
T ss_pred chhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCcc
Confidence 4444556688899999999998876554443 35667888888888765 3677888899999999999999855
Q ss_pred cCcccCCCcccceeeccCcccccccc
Q 001274 592 IPSSLGGLARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 592 ~p~~~~~l~~L~~L~l~~N~l~~~~p 617 (1109)
.+..|..+++|++|++++|++.+..|
T Consensus 293 ~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 293 PDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 44456889999999999998887654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-29 Score=278.19 Aligned_cols=249 Identities=21% Similarity=0.238 Sum_probs=172.1
Q ss_pred EEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCc--cchhhhcccccceeecCC
Q 001274 364 KLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGS--IPPHLCMYQKLIFLSLGS 441 (1109)
Q Consensus 364 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~--~~~~l~~l~~L~~L~L~~ 441 (1109)
.++++++.++ .+|..+. ++|++|+|++|+++...+..|..+++|++|+|++|++... .+..+..+++|++|+|++
T Consensus 11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 4555555555 3333222 3555555555555533333455556666666666665522 245555666666666666
Q ss_pred ccccCCCCCCCccccccceeecccccccccCC-ccccCCcccceeccccccccCCCCccccccccccEEEccCCccCC-C
Q 001274 442 NRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLP-IEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVG-Y 519 (1109)
Q Consensus 442 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~ 519 (1109)
|.++. +|..+..+++|++|++++|++++..+ ..|.++++|++|++++|.+.+..+..|..+++|++|++++|.+++ .
T Consensus 88 n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 88 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp CSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Ccccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 66663 34456666677777777777765544 467777777777777777777777777777888888888887775 5
Q ss_pred CChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCC
Q 001274 520 IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599 (1109)
Q Consensus 520 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 599 (1109)
.|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+..+
T Consensus 167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCC
T ss_pred chhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhh
Confidence 67777788888888888888887777788888888888888888887666677888888888888888888888888877
Q ss_pred c-ccceeeccCccccccc
Q 001274 600 A-RLTELQMGGNIFSGSI 616 (1109)
Q Consensus 600 ~-~L~~L~l~~N~l~~~~ 616 (1109)
+ +|++|++++|++++..
T Consensus 247 ~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 247 PSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp CTTCCEEECTTCCEECSG
T ss_pred hccCCEEEccCCCeeccc
Confidence 4 7888888888887653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=276.97 Aligned_cols=230 Identities=27% Similarity=0.254 Sum_probs=123.0
Q ss_pred CCcceEecccccccCcccccccCCCCccEEEcccCcccCC--CCcchhcccccceEEcccccccccCCCcccccCcCcEE
Q 001274 336 PNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGT--IPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVL 413 (1109)
Q Consensus 336 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L 413 (1109)
++|+.|++++|.++...+..|..+++|++|++++|+++.. .+..+..+++|++|+|++|.+. .+|..+..+++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence 3444444444444433333455555666666666655521 2344455555555555555555 234445555555555
Q ss_pred EeccccccCccc-hhhhcccccceeecCCccccCCCCCCCccccccceeecccccccc-cCCccccCCcccceecccccc
Q 001274 414 DVSMNNLDGSIP-PHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTG-SLPIEFYNLQNLSALELYQNR 491 (1109)
Q Consensus 414 ~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~ 491 (1109)
++++|++.+..+ ..+..+++|++|++++|.+++..+..+..+++|++|++++|++++ ..|..|.++++|++|+|++|+
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence 555555554433 345555555555555555555555555555555555555555544 345555555555555555555
Q ss_pred ccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCC-CCCeeecCCCcCcc
Q 001274 492 FSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCV-NLQRLDLSRNQFTG 566 (1109)
Q Consensus 492 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 566 (1109)
+++..|..|..+++|++|+|++|++++..+..+..+++|++|+|++|++++..|..+..++ +|++|+|++|.+++
T Consensus 187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 5555555555555555555555555554444555555555555555555555555555552 55555555555543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=277.85 Aligned_cols=288 Identities=19% Similarity=0.251 Sum_probs=229.7
Q ss_pred HHhcCCCCCCCCCCCCCC-CCCCccceeeecCC--eEEEEeccCccccccccccc--cCccccceeecccCccCCCCCcc
Q 001274 41 KASLIDPSNNLESWNSSD-MTPCNWIGVECTDF--KVTSVDLHGLNLSGILSPRI--CDLPRLVEFNISMNFVTGSIPTD 115 (1109)
Q Consensus 41 k~~~~~~~~~~~~W~~~~-~~~c~w~gv~C~~~--~v~~l~l~~~~l~g~~~~~~--~~l~~L~~L~ls~n~~~~~~p~~ 115 (1109)
|+++.|+...+..|+..- .|||.|.++-|+.. ........+..+. .++..+ ...++++.|+|++|.++ .+|..
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~-~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~ 99 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQ 99 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHH-HHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchh-hhHHHHhcccccceeEEEccCCCch-hcChh
Confidence 445567666788897521 37899999888321 0000111111111 011111 23477888888888887 77888
Q ss_pred ccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccc
Q 001274 116 LANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLR 195 (1109)
Q Consensus 116 l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 195 (1109)
++++++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|+|++|++.+.+|..++..
T Consensus 100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~---- 173 (328)
T 4fcg_A 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST---- 173 (328)
T ss_dssp GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE----
T ss_pred hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc----
Confidence 888888888888888887 77777888888888888888877 677778888888888888877777777766541
Q ss_pred eeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeecc
Q 001274 196 VIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENS 275 (1109)
Q Consensus 196 ~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 275 (1109)
..+..|+++++|++|+|++|+++ .+|..+.++++|++|+|++|+++ .+|..++.+++|++|+|++|+
T Consensus 174 -----------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~ 240 (328)
T 4fcg_A 174 -----------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCT 240 (328)
T ss_dssp -----------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCT
T ss_pred -----------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCc
Confidence 22345677999999999999999 78999999999999999999999 577789999999999999999
Q ss_pred ceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEeccccccc
Q 001274 276 FSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349 (1109)
Q Consensus 276 l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 349 (1109)
+.+.+|..++++++|++|++++|.+.+.+|..+.++++|++|+|++|++.+.+|..++.+++|+.+.+..+.+.
T Consensus 241 ~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 241 ALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred chhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999887665
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=270.93 Aligned_cols=236 Identities=22% Similarity=0.200 Sum_probs=142.8
Q ss_pred cCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeeccccc-ccccCCccccCCcccceecc
Q 001274 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQ-LTGSLPIEFYNLQNLSALEL 487 (1109)
Q Consensus 409 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L 487 (1109)
+|++|++++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|++|++++|+ ++...|..|.++++|++|+|
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 34444444444444433444444444445555554444445555555555555555554 55444556666666666666
Q ss_pred ccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccC
Q 001274 488 YQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGS 567 (1109)
Q Consensus 488 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 567 (1109)
++|.+++..|..|..+++|++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 66666666666666667777777777777665556666777777777777777755555677777777777777777766
Q ss_pred CCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCcccccccccccc
Q 001274 568 APEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELG 646 (1109)
Q Consensus 568 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~ 646 (1109)
.|..|..+++|+.|++++|++++..+..|..+++|+.|++++|++.+..+.. .-...+ ..+..+.|.+.+..|..+.
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l-~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWL-QKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHH-HHCCSEECCCBEEESGGGT
T ss_pred CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHH-HhcccccCccccCCchHhC
Confidence 6777777777777777777777666666777777777777777776544321 001111 1244555555555555543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=269.26 Aligned_cols=233 Identities=24% Similarity=0.263 Sum_probs=133.3
Q ss_pred ccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCc-cCCCCChhhcccccccEEec
Q 001274 457 SLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENY-FVGYIPSEVGNLEHLVTFNI 535 (1109)
Q Consensus 457 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L 535 (1109)
+|++|++++|++++..+..|.++++|++|+|++|.++++.|..|..+++|++|++++|+ +.+..|..+..+++|++|+|
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 45555555555554444455555555555555555555555555555555555555554 44444555555555555555
Q ss_pred ccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccccc
Q 001274 536 SSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGS 615 (1109)
Q Consensus 536 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 615 (1109)
++|++++..|..+.++++|++|++++|++++..+..|..+++|+.|+|++|++++..+..|.++++|++|++++|.+++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 55555555555555555555555555555544444455555555555555555554444555555666555555555555
Q ss_pred ccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEccCcccccccCC
Q 001274 616 IPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPN 691 (1109)
Q Consensus 616 ~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~p~ 691 (1109)
.|..+.+++.|+ .|++++|++++..+..+..+++|+.|+|++|++++..+.. .-...++.+..+.|.+.|..|.
T Consensus 193 ~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 193 HPHAFRDLGRLM-TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp CTTTTTTCTTCC-EEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESG
T ss_pred CHhHccCccccc-EeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCch
Confidence 555555555554 3555566666555566777778888888888887655432 1123345555677777777775
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=283.10 Aligned_cols=247 Identities=19% Similarity=0.205 Sum_probs=156.0
Q ss_pred ccccceeecCCccccCCCCCCCccccccceeeccccccc-ccCCcccc-------CCcccceeccccccccCCCCccc--
Q 001274 431 YQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLT-GSLPIEFY-------NLQNLSALELYQNRFSGLIPPEI-- 500 (1109)
Q Consensus 431 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~-- 500 (1109)
.++|+.|++++|.+ .+|..+... |+.|+|++|+++ ..+|..+. ++++|++|+|++|++++..|..+
T Consensus 42 ~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 117 (312)
T 1wwl_A 42 GRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117 (312)
T ss_dssp EEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSS
T ss_pred CCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHH
Confidence 33444444444444 233322222 455555555552 23333333 56666677777777666666654
Q ss_pred cccccccEEEccCCccCCCCChhhccc-----ccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccC--CCccc-
Q 001274 501 GKLRNLERLHLSENYFVGYIPSEVGNL-----EHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGS--APEEL- 572 (1109)
Q Consensus 501 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~l- 572 (1109)
..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+.+++|++|+|++|++.+. .|..+
T Consensus 118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 196 (312)
T 1wwl_A 118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196 (312)
T ss_dssp CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSC
T ss_pred hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHH
Confidence 6666777777777777665 6666665 6677777777777666666677777777777777766543 23333
Q ss_pred -ccccccceeccccccccc---ccCcccCCCcccceeeccCcccccccc-ccccccchhhhhhccCCccccccccccccC
Q 001274 573 -GQLVNLELLKLSDNKLTG---AIPSSLGGLARLTELQMGGNIFSGSIP-VALGQLTALQIALNISHNNLSGVIPYELGN 647 (1109)
Q Consensus 573 -~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~ 647 (1109)
..+++|+.|+|++|++++ .....+.++++|++|++++|.+++.+| ..+..++.|+ .|+|++|+|+ .+|..+.
T Consensus 197 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~-~L~Ls~N~l~-~ip~~~~- 273 (312)
T 1wwl_A 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN-SLNLSFTGLK-QVPKGLP- 273 (312)
T ss_dssp TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCC-EEECTTSCCS-SCCSSCC-
T ss_pred hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCC-EEECCCCccC-hhhhhcc-
Confidence 666777777777777662 122334566677777777777776664 3344456665 4777777777 5666665
Q ss_pred ccccceeecCCCccccCCchhhhccccceEEEccCcccccc
Q 001274 648 LQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGT 688 (1109)
Q Consensus 648 l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~ 688 (1109)
++|++|||++|+|++. |. +..+++|++|+|++|++++.
T Consensus 274 -~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 274 -AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp -SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred -CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 7889999999998865 66 88888999999999988763
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=285.80 Aligned_cols=252 Identities=21% Similarity=0.251 Sum_probs=145.1
Q ss_pred cCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccc
Q 001274 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488 (1109)
Q Consensus 409 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 488 (1109)
....++.+++.++. +|..+. +++++|+|++|+|++..+..|..+++|++|+|++|+++++.+..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 34556666666653 333222 456666666666665555566666666666666666665555556666666666666
Q ss_pred cccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEeccc-CcccccCCcCCCCCCCCCeeecCCCcCccC
Q 001274 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISS-NSLSGTIPHELGNCVNLQRLDLSRNQFTGS 567 (1109)
Q Consensus 489 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 567 (1109)
+|+++++.+..|..+++|++|+|++|+++++.+..|.++++|+.|+|++ |.+....+..|.++++|++|+|++|++++
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~- 210 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD- 210 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-
Confidence 6666555555555566666666666665554445555555666666655 33333333345555555555555555553
Q ss_pred CCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccC
Q 001274 568 APEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGN 647 (1109)
Q Consensus 568 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~ 647 (1109)
+| .+..+++|+.|+|++|++++..|..|.++++|+.|+ |++|++++..|..|..
T Consensus 211 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~-------------------------L~~n~l~~~~~~~~~~ 264 (452)
T 3zyi_A 211 MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW-------------------------VMNSQVSLIERNAFDG 264 (452)
T ss_dssp CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEE-------------------------CTTSCCCEECTTTTTT
T ss_pred cc-cccccccccEEECcCCcCcccCcccccCccCCCEEE-------------------------eCCCcCceECHHHhcC
Confidence 23 345555555555555555555555555555555555 4555555555566666
Q ss_pred ccccceeecCCCccccCCchhhhccccceEEEccCcccccccC
Q 001274 648 LQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVP 690 (1109)
Q Consensus 648 l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~p 690 (1109)
+++|+.|||++|+|++..+..+..+++|+.|+|++|++.|...
T Consensus 265 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 6677777777777765555566666777777777777666554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-28 Score=284.14 Aligned_cols=252 Identities=24% Similarity=0.262 Sum_probs=153.0
Q ss_pred cCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccc
Q 001274 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488 (1109)
Q Consensus 409 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 488 (1109)
....++.+++.++. +|..+. ++++.|+|++|++++..+..|..+++|++|+|++|+++++.+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCSS-CCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcCc-CCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 34566666666663 333332 456666666666666655666666666666666666665555666666666666666
Q ss_pred cccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEeccc-CcccccCCcCCCCCCCCCeeecCCCcCccC
Q 001274 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISS-NSLSGTIPHELGNCVNLQRLDLSRNQFTGS 567 (1109)
Q Consensus 489 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 567 (1109)
+|+|+++.+..|..+++|++|+|++|++++..+..|.++++|++|+|++ |.+....+..|.++++|++|+|++|+++ .
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~ 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-S
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-c
Confidence 6666655555566666666666666666655555566666666666665 3333333335556666666666666665 3
Q ss_pred CCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccC
Q 001274 568 APEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGN 647 (1109)
Q Consensus 568 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~ 647 (1109)
+| .+..+++|+.|+|++|++++..|..|.++++|+.|+|+ +|+|++..|..|..
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~-------------------------~n~l~~~~~~~~~~ 253 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI-------------------------QSQIQVIERNAFDN 253 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECT-------------------------TCCCCEECTTSSTT
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECC-------------------------CCceeEEChhhhcC
Confidence 33 35555555555555555555555555555555555554 55555555666677
Q ss_pred ccccceeecCCCccccCCchhhhccccceEEEccCcccccccC
Q 001274 648 LQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVP 690 (1109)
Q Consensus 648 l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~p 690 (1109)
+++|+.|||++|+|++..+..+..+++|+.|+|++|++.|...
T Consensus 254 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred CCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence 7777777777777776666667777777777777777776554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=281.12 Aligned_cols=249 Identities=23% Similarity=0.228 Sum_probs=214.1
Q ss_pred CccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecC
Q 001274 361 QLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLG 440 (1109)
Q Consensus 361 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 440 (1109)
....++.++++++ .+|..+. ++++.|+|++|++++..+..|..+++|++|+|++|++.+..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3567777777777 5565543 577888888888887777888888888888888888888888888888999999999
Q ss_pred CccccCCCCCCCccccccceeecccccccccCCccccCCcccceecccc-ccccCCCCccccccccccEEEccCCccCCC
Q 001274 441 SNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQ-NRFSGLIPPEIGKLRNLERLHLSENYFVGY 519 (1109)
Q Consensus 441 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 519 (1109)
+|+|++..+..|..+++|++|+|++|+++...+..|.++++|++|+|++ |.+..+.+..|.++++|++|+|++|+++.
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~- 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE- 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-
Confidence 9999877777888899999999999999888888899999999999998 45565556678999999999999999985
Q ss_pred CChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCC
Q 001274 520 IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599 (1109)
Q Consensus 520 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 599 (1109)
+| .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..+..|..+
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 44 48889999999999999998889999999999999999999998888899999999999999999998888889999
Q ss_pred cccceeeccCccccc
Q 001274 600 ARLTELQMGGNIFSG 614 (1109)
Q Consensus 600 ~~L~~L~l~~N~l~~ 614 (1109)
++|+.|+|++|++..
T Consensus 279 ~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 279 HHLERIHLHHNPWNC 293 (440)
T ss_dssp TTCCEEECCSSCEEC
T ss_pred cCCCEEEcCCCCccC
Confidence 999999999999874
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=295.89 Aligned_cols=292 Identities=25% Similarity=0.337 Sum_probs=169.0
Q ss_pred CCCCCCCCCCCCCCCccceeeec--------CCeEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCC
Q 001274 48 SNNLESWNSSDMTPCNWIGVECT--------DFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANC 119 (1109)
Q Consensus 48 ~~~~~~W~~~~~~~c~w~gv~C~--------~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l 119 (1109)
...+++|... .+||.|.|..|. ...++.+++++++|+ .+|..+. ++|+.|+|++|.++ .+|. .+
T Consensus 9 ~~~w~~W~~~-~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l 80 (622)
T 3g06_A 9 DAVWSAWRRA-APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LP 80 (622)
T ss_dssp -CHHHHHHHT-CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CC
T ss_pred HHHHHHHHhc-CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cC
Confidence 3456778764 378999876542 234666666666665 4454443 56666666666665 3444 34
Q ss_pred CCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceecc
Q 001274 120 SSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRA 199 (1109)
Q Consensus 120 ~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l 199 (1109)
++|++|+|++|++++ +|. .+++|++|+|++|.+++ +|. .+++|++|+|++|++++ +|.. +
T Consensus 81 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l-------- 140 (622)
T 3g06_A 81 PELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---P-------- 140 (622)
T ss_dssp TTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---C--------
T ss_pred CCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---C--------
Confidence 556666666666552 333 34555555555555543 232 34455555555555542 3332 2
Q ss_pred ccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceec
Q 001274 200 GHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGG 279 (1109)
Q Consensus 200 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 279 (1109)
++|++|+|++|++++ +|. .+.+|+.|++++|+++ .+| ..+++|+.|++++|++++
T Consensus 141 ----------------~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~-~l~---~~~~~L~~L~Ls~N~l~~- 195 (622)
T 3g06_A 141 ----------------PGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLT-SLP---MLPSGLQELSVSDNQLAS- 195 (622)
T ss_dssp ----------------TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-
T ss_pred ----------------CCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCC-CCc---ccCCCCcEEECCCCCCCC-
Confidence 444445555554443 222 2244555566666665 244 334556666666666653
Q ss_pred CchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCC
Q 001274 280 LPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQL 359 (1109)
Q Consensus 280 ~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 359 (1109)
+|.. +++|+.|++++|.++ .+|.. +++|++|+|++|++++ +| ..+++|+.|++++|.++. +|. .+
T Consensus 196 l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~ 260 (622)
T 3g06_A 196 LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LP 260 (622)
T ss_dssp CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CC
T ss_pred CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---cc
Confidence 3322 356666666666666 33332 3567777777777765 33 345667777777777763 343 45
Q ss_pred CCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccC
Q 001274 360 TQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNS 408 (1109)
Q Consensus 360 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 408 (1109)
++|++|+|++|+|+ .+|..|.++++|+.|+|++|.+++..|..+..++
T Consensus 261 ~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 261 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred ccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 67888888888887 6677788888888888888888877766555443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=283.58 Aligned_cols=249 Identities=20% Similarity=0.202 Sum_probs=189.5
Q ss_pred ccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCC
Q 001274 362 LHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGS 441 (1109)
Q Consensus 362 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 441 (1109)
...++.+++.++ .+|..+. ++++.|+|++|++++..|..|..+++|++|+|++|++.+..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 455666666666 4454332 4667777777777766666777777777777777777766667777777777777777
Q ss_pred ccccCCCCCCCccccccceeecccccccccCCccccCCcccceecccc-ccccCCCCccccccccccEEEccCCccCCCC
Q 001274 442 NRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQ-NRFSGLIPPEIGKLRNLERLHLSENYFVGYI 520 (1109)
Q Consensus 442 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 520 (1109)
|++++..+..|..+++|++|+|++|+++.+.+..|.++++|++|+|++ |.+..+.+..|.++++|++|+|++|++++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM- 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-
Confidence 777766666677777888888888888777777788888888888887 455555555688888888888888888754
Q ss_pred ChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCc
Q 001274 521 PSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLA 600 (1109)
Q Consensus 521 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 600 (1109)
| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 3 477788888888888888877788888888888888888888877788888888888888888888877778888888
Q ss_pred ccceeeccCcccccc
Q 001274 601 RLTELQMGGNIFSGS 615 (1109)
Q Consensus 601 ~L~~L~l~~N~l~~~ 615 (1109)
+|+.|+|++|++...
T Consensus 291 ~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 291 YLVELHLHHNPWNCD 305 (452)
T ss_dssp TCCEEECCSSCEECS
T ss_pred CCCEEEccCCCcCCC
Confidence 888888888888743
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=273.68 Aligned_cols=252 Identities=23% Similarity=0.252 Sum_probs=158.7
Q ss_pred cccccccceeccccccccCCCCccccccccchhhhcccccc-cccCchhhh-------ccccccceecccccccCCCCCC
Q 001274 188 ISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSL-EGFLPSELE-------KLRNLTDLILWQNHLSGEIPPT 259 (1109)
Q Consensus 188 ~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l-~~~~p~~l~-------~l~~L~~L~L~~N~l~~~~p~~ 259 (1109)
++..++|+.|++++|.+ .+|..+... |++|+|++|.+ ...+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 46667788888888887 667666554 88888888888 445666665 6788888888888888777776
Q ss_pred c--cccccccceeeeeccceecCchhhhcc-----CccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCC--cc
Q 001274 260 I--GNIQSLELLALHENSFSGGLPKELGKL-----SRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFI--PR 330 (1109)
Q Consensus 260 l--~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~--p~ 330 (1109)
+ +.+++|++|+|++|++++. |..++.+ ++|++|++++|++++..|..++++++|++|+|++|++.+.+ +.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 6 7788888888888888866 7777776 78888888888887777777778888888888888766542 22
Q ss_pred cc--cCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCC-Cccccc
Q 001274 331 EL--GLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIP-PHIGVN 407 (1109)
Q Consensus 331 ~l--~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~~ 407 (1109)
.+ +.+++|+.|++++|.+++.. ......+.++++|+.|+|++|++++..| ..+..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~---------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 252 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPS---------------------GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHH---------------------HHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred HHHhccCCCCCEEECCCCcCcchH---------------------HHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence 22 44455555555555444210 1111222344445555555555544432 233344
Q ss_pred CcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccc
Q 001274 408 SHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTG 470 (1109)
Q Consensus 408 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 470 (1109)
++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|++|++++|++++
T Consensus 253 ~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 253 SQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp TTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 55555555555555 3344333 5566666666666554 33 5666666666666666653
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-29 Score=278.39 Aligned_cols=265 Identities=21% Similarity=0.177 Sum_probs=158.5
Q ss_pred EEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEccccc
Q 001274 316 EIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNH 395 (1109)
Q Consensus 316 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 395 (1109)
..+++.+.+...+...+..+++|+.|++++|.+++..|..|..+++|++|+|++|++++..+ |..+++|++|++++|+
T Consensus 14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~ 91 (317)
T 3o53_A 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY 91 (317)
T ss_dssp EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSE
T ss_pred EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCc
Confidence 34455555544444444444555555555555555555556666666666666666654333 5566666666666666
Q ss_pred ccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCcc
Q 001274 396 LEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE 475 (1109)
Q Consensus 396 l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 475 (1109)
+++.. ..++|++|++++|++.+..+.. +++|++|++++|++++..+..+..+++|++|++++|++++..+..
T Consensus 92 l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 163 (317)
T 3o53_A 92 VQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163 (317)
T ss_dssp EEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGG
T ss_pred ccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHH
Confidence 65322 2256666666666666544332 455666666666666655556666666666666666666655555
Q ss_pred cc-CCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCC
Q 001274 476 FY-NLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNL 554 (1109)
Q Consensus 476 ~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 554 (1109)
+. .+++|++|+|++|.+++. + ....+++|++|+|++|++++. |..+..+++|++|+|++|+|+ .+|..+..+++|
T Consensus 164 ~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L 239 (317)
T 3o53_A 164 LAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239 (317)
T ss_dssp GGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTC
T ss_pred HhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCC
Confidence 53 566777777777776654 2 223466677777777777643 334666677777777777776 456666666777
Q ss_pred CeeecCCCcCc-cCCCcccccccccceeccc-ccccccccCc
Q 001274 555 QRLDLSRNQFT-GSAPEELGQLVNLELLKLS-DNKLTGAIPS 594 (1109)
Q Consensus 555 ~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls-~N~l~~~~p~ 594 (1109)
+.|+|++|.++ +.+|..+..+++|+.|+++ .+.++|..|.
T Consensus 240 ~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred CEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 77777777766 5566666666666666666 3345544443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-29 Score=280.53 Aligned_cols=269 Identities=21% Similarity=0.187 Sum_probs=170.4
Q ss_pred ceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccc
Q 001274 339 CLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMN 418 (1109)
Q Consensus 339 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N 418 (1109)
+.++++.+.+.......+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+ +..+++|++|++++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 344555555554444445555566666666666666555666666666666666666654443 555556666666666
Q ss_pred cccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCc
Q 001274 419 NLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPP 498 (1109)
Q Consensus 419 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 498 (1109)
++++.. ..++|++|++++|++++..+.. +++|++|++++|++++..+.
T Consensus 91 ~l~~l~-----------------------------~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~ 138 (317)
T 3o53_A 91 YVQELL-----------------------------VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDL 138 (317)
T ss_dssp EEEEEE-----------------------------ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGB
T ss_pred cccccc-----------------------------CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccch
Confidence 555322 1244555555555555443332 45566677777777666666
Q ss_pred cccccccccEEEccCCccCCCCChhh-cccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccc
Q 001274 499 EIGKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVN 577 (1109)
Q Consensus 499 ~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 577 (1109)
.+..+++|++|+|++|++++..+..+ ..+++|++|+|++|++++. |. ...+++|++|+|++|++++ +|..+..+++
T Consensus 139 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~ 215 (317)
T 3o53_A 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAG 215 (317)
T ss_dssp CTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTT
T ss_pred hhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCc
Confidence 66677777777777777776555555 3567777777777777744 32 3347777777777777774 4445777777
Q ss_pred cceecccccccccccCcccCCCcccceeeccCcccc-ccccccccccchhhhhhccC-Ccccccccccccc
Q 001274 578 LELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS-GSIPVALGQLTALQIALNIS-HNNLSGVIPYELG 646 (1109)
Q Consensus 578 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~l~~~L~Ls-~N~l~~~~p~~~~ 646 (1109)
|+.|+|++|+++ .+|..+..+++|+.|++++|++. +.+|..+.+++.++ .++++ .+.++|..|....
T Consensus 216 L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~-~l~l~~~~~l~~~~~~~~~ 284 (317)
T 3o53_A 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVAKQTVKKLTGQNEEECT 284 (317)
T ss_dssp CSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHH-HHHHHHHHHHHSSSSCCCS
T ss_pred ccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccce-EEECCCchhccCCchhccC
Confidence 777777777777 45666777777888888888777 66777777777776 47776 4566666554443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=280.11 Aligned_cols=262 Identities=29% Similarity=0.340 Sum_probs=135.6
Q ss_pred CccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecC
Q 001274 361 QLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLG 440 (1109)
Q Consensus 361 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 440 (1109)
+++.|++++|+++ .+|..+. ++|+.|+|++|.++ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence 3555555555555 3444332 45555555555555 2333 34555555555555553 222 44555555555
Q ss_pred CccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCC
Q 001274 441 SNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYI 520 (1109)
Q Consensus 441 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 520 (1109)
+|++++..+ .+++|+.|++++|++++ +|.. +++|++|+|++|+++++ |. .+++|+.|++++|+|++ +
T Consensus 110 ~N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l 176 (622)
T 3g06_A 110 SNPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS-L 176 (622)
T ss_dssp SCCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-C
T ss_pred CCcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-C
Confidence 555554322 34455556666665554 2222 35566666666666543 22 23456666666666664 3
Q ss_pred ChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCc
Q 001274 521 PSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLA 600 (1109)
Q Consensus 521 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 600 (1109)
| ..+++|+.|+|++|+|++ +|.. +++|+.|++++|.++ .+|.. +++|+.|+|++|+|++ +| ..++
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~ 241 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPS 241 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCT
T ss_pred c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCC
Confidence 3 334566666666666663 3332 245666666666665 34432 3556666666666654 33 3335
Q ss_pred ccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEc
Q 001274 601 RLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNL 680 (1109)
Q Consensus 601 ~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~l 680 (1109)
+|+.|++++|.++ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 242 ~L~~L~Ls~N~L~-~lp~----------------------------~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 242 ELKELMVSGNRLT-SLPM----------------------------LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TCCEEECCSSCCS-CCCC----------------------------CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred cCcEEECCCCCCC-cCCc----------------------------ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 5555555555554 2332 3344555555555555 45555555555555555
Q ss_pred cCcccccccCC
Q 001274 681 SNNNLVGTVPN 691 (1109)
Q Consensus 681 s~N~l~g~~p~ 691 (1109)
++|+++|.+|.
T Consensus 292 ~~N~l~~~~~~ 302 (622)
T 3g06_A 292 EGNPLSERTLQ 302 (622)
T ss_dssp CSCCCCHHHHH
T ss_pred cCCCCCCcCHH
Confidence 55555555443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-28 Score=286.83 Aligned_cols=234 Identities=22% Similarity=0.183 Sum_probs=145.6
Q ss_pred ccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEcc
Q 001274 433 KLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLS 512 (1109)
Q Consensus 433 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 512 (1109)
+|+.|+|++|.+++..|..|..+++|++|+|++|.+++..| |.++++|++|+|++|.|+++.+ .++|+.|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 45555555555554444455555555555555555554443 5556666666666666654321 2566666666
Q ss_pred CCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccc-cccccceecccccccccc
Q 001274 513 ENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELG-QLVNLELLKLSDNKLTGA 591 (1109)
Q Consensus 513 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~ 591 (1109)
+|.|++..+. .+++|+.|+|++|.+++..|..++++++|+.|+|++|.+++..|..+. .+++|+.|+|++|.+++.
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 6666654432 345666666666666666666666666666666666666665666554 566666666666666655
Q ss_pred cCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccc-cCCchhhh
Q 001274 592 IPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLI-GEIPASMG 670 (1109)
Q Consensus 592 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~ip~~~~ 670 (1109)
.+ +..+++|+.|+|++|.+++ +|..+..++.|. .|+|++|.|++ +|..++.+++|+.|+|++|+++ +.+|..+.
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~-~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVT-WISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCS-EEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred cc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCcc-EEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 22 2246667777777776664 333466666665 46777777775 5666777888888888888887 67777788
Q ss_pred ccccceEEEcc
Q 001274 671 EQMSLLVCNLS 681 (1109)
Q Consensus 671 ~l~~L~~l~ls 681 (1109)
.++.|..++++
T Consensus 260 ~l~~L~~l~~~ 270 (487)
T 3oja_A 260 KNQRVQTVAKQ 270 (487)
T ss_dssp TCHHHHHHHHH
T ss_pred hCCCCcEEecc
Confidence 88777777775
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-30 Score=317.15 Aligned_cols=456 Identities=14% Similarity=0.122 Sum_probs=266.6
Q ss_pred CCCccceeeecCCeEEEEeccCcccccccc-ccccCccccceeecccCccCC---CCCcc------------ccCCCCCc
Q 001274 60 TPCNWIGVECTDFKVTSVDLHGLNLSGILS-PRICDLPRLVEFNISMNFVTG---SIPTD------------LANCSSLE 123 (1109)
Q Consensus 60 ~~c~w~gv~C~~~~v~~l~l~~~~l~g~~~-~~~~~l~~L~~L~ls~n~~~~---~~p~~------------l~~l~~L~ 123 (1109)
-|++|.++... ....+++.... +..+ ..+..+++|+.|+++++.... ..|.. ...+++|+
T Consensus 33 vck~W~~~~~~--~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~ 108 (594)
T 2p1m_B 33 VCKSWYEIERW--CRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE 108 (594)
T ss_dssp SCHHHHHHHHH--HCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred HHHHHHHhhhh--hceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence 34579988322 23445554322 2222 335577889999998875322 12211 24577888
Q ss_pred eEEccCCcccccCCchhh-ccccceEEEcccc-ccccc-ccccccCcCCCceEEeecCCCCCCCCcccc----cccccce
Q 001274 124 ILDLCTNRLHGVIPFQLF-FINTLRKLYLCEN-YIFGE-IPEEIGNLTSLEELVIYSNNLTGAIPASIS----KLRQLRV 196 (1109)
Q Consensus 124 ~L~Ls~n~l~~~~~~~l~-~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~----~l~~L~~ 196 (1109)
+|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|+.
T Consensus 109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~ 188 (594)
T 2p1m_B 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188 (594)
T ss_dssp EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence 888888887777666665 5778888888877 44433 444455778888888888877765544443 4456777
Q ss_pred ecccccc--ccC-CCCccccccccchhhhcccc-cccccCchhhhccccccceecccccccCCCCCCccccccccceeee
Q 001274 197 IRAGHNS--LSG-PIPPEISECEGLEVLGLAQN-SLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALH 272 (1109)
Q Consensus 197 L~l~~n~--l~~-~~p~~l~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 272 (1109)
|++++|. ++. .++..+..+++|++|+|++| .+++ +|..+.++++|++|+++.+.. ++.
T Consensus 189 L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~-----------------~~~ 250 (594)
T 2p1m_B 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTA-----------------EVR 250 (594)
T ss_dssp EECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCC-----------------CCC
T ss_pred EEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccC-----------------ccc
Confidence 7777665 110 01111223455666666655 2332 455555555555555433221 023
Q ss_pred eccceecCchhhhccCccceE-EeecccccCccCcccCCCCcCcEEEccCCcccCCC-cccccCCCCcceEecccccccC
Q 001274 273 ENSFSGGLPKELGKLSRLKKL-YVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFI-PRELGLIPNLCLLQLFENMLQG 350 (1109)
Q Consensus 273 ~N~l~~~~p~~l~~l~~L~~L-~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~ 350 (1109)
.|.+.+ ++..+.++++|+.| .+.+... +.++..+..+++|++|+|++|.+++.. +..+..+++|+.|++.+| +..
T Consensus 251 ~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~ 327 (594)
T 2p1m_B 251 PDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IED 327 (594)
T ss_dssp HHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHH
T ss_pred hhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCH
Confidence 333442 33456666666666 2332221 233444445666777777776655332 222445667777777766 332
Q ss_pred c-ccccccCCCCccEEEcc---------cCcccCCCCcchh-cccccceEEcccccccccCCCccc-ccCcCcEEEec--
Q 001274 351 S-IPRELGQLTQLHKLDLS---------INNLTGTIPLEFQ-NLTYLVDLQLFDNHLEGTIPPHIG-VNSHLSVLDVS-- 416 (1109)
Q Consensus 351 ~-~p~~l~~l~~L~~L~Ls---------~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~~~~L~~L~Ls-- 416 (1109)
. ++.....+++|++|+++ .+.+++.....+. ++++|+.|.+..|.+++.....+. .+++|+.|+++
T Consensus 328 ~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~ 407 (594)
T 2p1m_B 328 AGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCII 407 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEES
T ss_pred HHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecc
Confidence 2 22222346777777773 3444432222232 467777777777777655444443 46778888887
Q ss_pred c----ccccCc-----cchhhhcccccceeecCCccccCCCCCCCcc-ccccceeecccccccccCCccc-cCCccccee
Q 001274 417 M----NNLDGS-----IPPHLCMYQKLIFLSLGSNRLSGNIPPGLKT-CRSLMQLMLGQNQLTGSLPIEF-YNLQNLSAL 485 (1109)
Q Consensus 417 ~----N~l~~~-----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L 485 (1109)
+ |.++.. ++..+..+++|+.|+|++ .+++.....+.. +++|++|+|++|.+++.....+ .++++|++|
T Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L 486 (594)
T 2p1m_B 408 EPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKL 486 (594)
T ss_dssp STTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEE
T ss_pred cCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEE
Confidence 3 445421 223356677888888866 555443334443 6788888888888876555444 668899999
Q ss_pred ccccccccCCCCc-cccccccccEEEccCCccCCCCChhh-cccccccEEecccCccc
Q 001274 486 ELYQNRFSGLIPP-EIGKLRNLERLHLSENYFVGYIPSEV-GNLEHLVTFNISSNSLS 541 (1109)
Q Consensus 486 ~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~ 541 (1109)
+|++|.+++.... .+..+++|++|++++|+++......+ ..+++|+...+..+.-.
T Consensus 487 ~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~ 544 (594)
T 2p1m_B 487 EIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP 544 (594)
T ss_dssp EEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred ECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence 9999998644333 44568899999999998853323333 45677877777666543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=281.49 Aligned_cols=234 Identities=22% Similarity=0.194 Sum_probs=123.8
Q ss_pred CccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecC
Q 001274 361 QLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLG 440 (1109)
Q Consensus 361 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 440 (1109)
+|++|+|++|.+++..|..|.++++|+.|+|++|.+++..| +..+++|++|+|++|.|++..+ .++|++|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 56666666666665555556666666666666666554443 5555555666666555553321 1444455555
Q ss_pred CccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCC
Q 001274 441 SNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYI 520 (1109)
Q Consensus 441 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 520 (1109)
+|.+++..+. .+++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++.+
T Consensus 108 ~N~l~~~~~~---------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (487)
T 3oja_A 108 NNNISRVSCS---------------------------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (487)
T ss_dssp SSCCCCEEEC---------------------------CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEE
T ss_pred CCcCCCCCcc---------------------------ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcC
Confidence 5444433222 1234455555555555444445555555555555555555544
Q ss_pred Chhhc-ccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCC
Q 001274 521 PSEVG-NLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599 (1109)
Q Consensus 521 p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 599 (1109)
|..+. .+++|++|+|++|.|++..+ +..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|++++ +|..+..+
T Consensus 161 ~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l 236 (487)
T 3oja_A 161 FAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFS 236 (487)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCC
T ss_pred hHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccC
Confidence 44443 45555555555555554321 2235556666666666654 33335556666666666666653 44455556
Q ss_pred cccceeeccCcccc-ccccccccccchhhhhhccC
Q 001274 600 ARLTELQMGGNIFS-GSIPVALGQLTALQIALNIS 633 (1109)
Q Consensus 600 ~~L~~L~l~~N~l~-~~~p~~~~~l~~l~~~L~Ls 633 (1109)
++|+.|++++|++. +.+|..+..++.+. .++++
T Consensus 237 ~~L~~L~l~~N~l~c~~~~~~~~~l~~L~-~l~~~ 270 (487)
T 3oja_A 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVAKQ 270 (487)
T ss_dssp TTCCEEECTTCCBCHHHHHHHHTTCHHHH-HHHHH
T ss_pred CCCCEEEcCCCCCcCcchHHHHHhCCCCc-EEecc
Confidence 66666666666665 45555555555554 24443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=287.52 Aligned_cols=186 Identities=17% Similarity=0.081 Sum_probs=131.5
Q ss_pred EecCCcceEEEEEe-cCCcEEEEEEeeccCCC--------cchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEEEE
Q 001274 810 IGRGACGTVYKATL-ANGEVIAVKKIKLRGEG--------ATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 810 lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.+.|++|.+..++. --|+.||+|++...... ....++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 56777777766653 35889999999754221 12235799999999999 7999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||++|++|.+++...+. ++.. +|+.||+.||+|+| ++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999987654 5543 58899999999999 789999999999999999999999999999876532
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP 1006 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~p 1006 (1109)
.......+||++|+|||++.+ .+..++|+||+|++.+++.++..+
T Consensus 393 -~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 -CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 233456789999999999876 467789999999998887666544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=246.66 Aligned_cols=214 Identities=21% Similarity=0.265 Sum_probs=129.3
Q ss_pred CCCccceeeecC-CeEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCc
Q 001274 60 TPCNWIGVECTD-FKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPF 138 (1109)
Q Consensus 60 ~~c~w~gv~C~~-~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~ 138 (1109)
++|.|.|+.|+. ..++.+++++++++. +|..+. ++|+.|+|++|.+++..+..++++++|++|+|++|.++...+.
T Consensus 3 ~~C~~~~~~C~c~~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~ 79 (270)
T 2o6q_A 3 ALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG 79 (270)
T ss_dssp CCBGGGTCSBEEETTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTT
T ss_pred ccCCCCCCCCEeCCCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChh
Confidence 789999999975 356788888888874 454443 5677777777777766666777777777777777777644444
Q ss_pred hhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccc
Q 001274 139 QLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGL 218 (1109)
Q Consensus 139 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L 218 (1109)
.+..+++|++|+|++|.+++..+..+.++++|++|+|++|++++..+..|+++++|++|++++|.+++..+..|..+++|
T Consensus 80 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 159 (270)
T 2o6q_A 80 IFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSL 159 (270)
T ss_dssp TTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred hhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCccc
Confidence 45566666666666666665555556666666666666666665555555666666666666665554444444555555
Q ss_pred hhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccc
Q 001274 219 EVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSF 276 (1109)
Q Consensus 219 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 276 (1109)
++|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|.+
T Consensus 160 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (270)
T 2o6q_A 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217 (270)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred ceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCe
Confidence 5555555555444444444444444444444444433333344444444444444443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-28 Score=304.19 Aligned_cols=426 Identities=15% Similarity=0.104 Sum_probs=273.8
Q ss_pred cccCCCCCceEEccCCccccc---CCc------------hhhccccceEEEccccccccccccccc-CcCCCceEEeecC
Q 001274 115 DLANCSSLEILDLCTNRLHGV---IPF------------QLFFINTLRKLYLCENYIFGEIPEEIG-NLTSLEELVIYSN 178 (1109)
Q Consensus 115 ~l~~l~~L~~L~Ls~n~l~~~---~~~------------~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n 178 (1109)
.+.++++|++|+|+++..... .|. ....+++|++|+|++|.+++..+..+. .+++|++|+|++|
T Consensus 61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~ 140 (594)
T 2p1m_B 61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC 140 (594)
T ss_dssp HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence 356778888888888753211 111 112345566666666665555554444 4556666666655
Q ss_pred -CCCCC-CCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceeccccc--ccC
Q 001274 179 -NLTGA-IPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH--LSG 254 (1109)
Q Consensus 179 -~l~~~-~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~--l~~ 254 (1109)
.++.. ++..+.++++|++|++++|.+++..+..+.. ....+++|++|+|++|. ++.
T Consensus 141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~--------------------~~~~~~~L~~L~l~~~~~~~~~ 200 (594)
T 2p1m_B 141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSH--------------------FPDTYTSLVSLNISCLASEVSF 200 (594)
T ss_dssp EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGG--------------------SCTTCCCCCEEECTTCCSCCCH
T ss_pred CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHH--------------------HhhcCCcCcEEEecccCCcCCH
Confidence 33321 2222334555555555555544332222211 11234466666666665 110
Q ss_pred C-CCCCccccccccceeeeec-cceecCchhhhccCccceEEee-------cccccCccCcccCCCCcCcEE-EccCCcc
Q 001274 255 E-IPPTIGNIQSLELLALHEN-SFSGGLPKELGKLSRLKKLYVY-------TNELNGTIPHELGNCTSAVEI-DLSENQL 324 (1109)
Q Consensus 255 ~-~p~~l~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~l~-------~n~l~~~~~~~l~~l~~L~~L-~Ls~n~l 324 (1109)
. ++..+.++++|++|++++| .++ .+|..+..+++|++|++. .|.+.+ ++..+.++++|+.| ++.+...
T Consensus 201 ~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~ 278 (594)
T 2p1m_B 201 SALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP 278 (594)
T ss_dssp HHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG
T ss_pred HHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch
Confidence 0 1111233467777777777 344 377777888888888854 444443 44578899999999 4554433
Q ss_pred cCCCcccccCCCCcceEecccccccCcccc-cccCCCCccEEEcccCcccCC-CCcchhcccccceEEccc---------
Q 001274 325 TGFIPRELGLIPNLCLLQLFENMLQGSIPR-ELGQLTQLHKLDLSINNLTGT-IPLEFQNLTYLVDLQLFD--------- 393 (1109)
Q Consensus 325 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~--------- 393 (1109)
+.++..+..+++|+.|++++|.+++.... .+..+++|++|++++| ++.. ++.....+++|++|++.+
T Consensus 279 -~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~ 356 (594)
T 2p1m_B 279 -AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPN 356 (594)
T ss_dssp -GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCS
T ss_pred -hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccC
Confidence 34555566789999999999997755433 3568899999999998 5422 233344689999999943
Q ss_pred ccccccCCCccc-ccCcCcEEEeccccccCccchhhh-cccccceeecC--C----ccccCCCC-----CCCccccccce
Q 001274 394 NHLEGTIPPHIG-VNSHLSVLDVSMNNLDGSIPPHLC-MYQKLIFLSLG--S----NRLSGNIP-----PGLKTCRSLMQ 460 (1109)
Q Consensus 394 N~l~~~~p~~~~-~~~~L~~L~Ls~N~l~~~~~~~l~-~l~~L~~L~L~--~----N~l~~~~~-----~~~~~l~~L~~ 460 (1109)
+.+++.....+. .+++|++|+++.|.+++.....+. .+++|+.|+++ + |.++.... ..+..+++|++
T Consensus 357 ~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~ 436 (594)
T 2p1m_B 357 VALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRR 436 (594)
T ss_dssp SCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCE
T ss_pred CCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccE
Confidence 455433322332 478999999999999877666665 58999999999 4 56653211 12567889999
Q ss_pred eecccccccccCCccccC-CcccceeccccccccCCCCccc-cccccccEEEccCCccCCCCCh-hhcccccccEEeccc
Q 001274 461 LMLGQNQLTGSLPIEFYN-LQNLSALELYQNRFSGLIPPEI-GKLRNLERLHLSENYFVGYIPS-EVGNLEHLVTFNISS 537 (1109)
Q Consensus 461 L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~ 537 (1109)
|++++ .+++..+..+.. +++|++|+|++|.+++..+..+ ..+++|++|+|++|.+++.... .+..+++|++|++++
T Consensus 437 L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~ 515 (594)
T 2p1m_B 437 LSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515 (594)
T ss_dssp EECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEES
T ss_pred EeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeC
Confidence 99987 666555555554 8999999999999976544444 6789999999999999654333 445689999999999
Q ss_pred CcccccCCcCC-CCCCCCCeeecCCCcCc
Q 001274 538 NSLSGTIPHEL-GNCVNLQRLDLSRNQFT 565 (1109)
Q Consensus 538 N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~ 565 (1109)
|+++......+ ..+++|+...+..+.-.
T Consensus 516 ~~~~~~~~~~l~~~lp~l~i~~~~~~~~~ 544 (594)
T 2p1m_B 516 CSVSFGACKLLGQKMPKLNVEVIDERGAP 544 (594)
T ss_dssp SCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred CCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence 99964433334 45677877777766543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=246.26 Aligned_cols=232 Identities=23% Similarity=0.251 Sum_probs=141.5
Q ss_pred eecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCcc
Q 001274 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYF 516 (1109)
Q Consensus 437 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 516 (1109)
++..+..++ .+|..+. ++|++|++++|++++..+..|.++++|++|+|++|+++++.+..|..+++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 444444444 2333332 3566666666666655555566666666666666666555555555566666666666665
Q ss_pred CCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccC-CCcccccccccceecccccccccccCcc
Q 001274 517 VGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGS-APEELGQLVNLELLKLSDNKLTGAIPSS 595 (1109)
Q Consensus 517 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 595 (1109)
++..+..|.++++|++|++++|++++..+..+..+++|++|++++|++++. +|..|..+++|+.|+|++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 555555555555555555555555544444555555555555555555532 3555555555555555555555444444
Q ss_pred cCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccc
Q 001274 596 LGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSL 675 (1109)
Q Consensus 596 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L 675 (1109)
|..+++|+.++ ..|++++|.+++..+..+.. .+|+.|+|++|++++..+..+..+++|
T Consensus 169 ~~~l~~L~~l~---------------------l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L 226 (276)
T 2z62_A 169 LRVLHQMPLLN---------------------LSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSL 226 (276)
T ss_dssp GHHHHTCTTCC---------------------EEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSC
T ss_pred hhhhhhccccc---------------------eeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccc
Confidence 44444333211 14777888888666655554 489999999999997666678899999
Q ss_pred eEEEccCcccccccCCCc
Q 001274 676 LVCNLSNNNLVGTVPNTT 693 (1109)
Q Consensus 676 ~~l~ls~N~l~g~~p~~~ 693 (1109)
+.|+|++|+++|..|...
T Consensus 227 ~~L~l~~N~~~c~c~~l~ 244 (276)
T 2z62_A 227 QKIWLHTNPWDCSCPRID 244 (276)
T ss_dssp CEEECCSSCBCCCTTTTH
T ss_pred cEEEccCCcccccCCchH
Confidence 999999999999888653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=242.77 Aligned_cols=207 Identities=22% Similarity=0.279 Sum_probs=128.2
Q ss_pred cCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccc
Q 001274 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488 (1109)
Q Consensus 409 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 488 (1109)
+|++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555554444455555555555555555555545555556666666666666665555666666666666666
Q ss_pred cccccCCCCccccccccccEEEccCCccCCC-CChhhcccccccEEecccCcccccCCcCCCCCCCCC----eeecCCCc
Q 001274 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGY-IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQ----RLDLSRNQ 563 (1109)
Q Consensus 489 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~ 563 (1109)
+|++.+..+..+..+++|++|++++|++++. +|..+.++++|++|+|++|++++..+..+..+++|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 6666665555566666666666666666653 366666666666666666666655555565555555 66777777
Q ss_pred CccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccc
Q 001274 564 FTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSI 616 (1109)
Q Consensus 564 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 616 (1109)
+++..+..+ ...+|+.|+|++|++++..+..|..+++|+.|++++|++.+..
T Consensus 189 l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 189 MNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp CCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred ccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence 764433333 3346777777777777666666677777777777777777544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.1e-25 Score=240.38 Aligned_cols=16 Identities=6% Similarity=0.167 Sum_probs=6.9
Q ss_pred hcccccceEEcccccc
Q 001274 381 QNLTYLVDLQLFDNHL 396 (1109)
Q Consensus 381 ~~l~~L~~L~L~~N~l 396 (1109)
..+++|+.|++++|.+
T Consensus 38 ~~l~~L~~L~l~~~~i 53 (272)
T 3rfs_A 38 NELNSIDQIIANNSDI 53 (272)
T ss_dssp HHHTTCCEEECTTSCC
T ss_pred ccccceeeeeeCCCCc
Confidence 3344444444444444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.6e-24 Score=231.61 Aligned_cols=205 Identities=25% Similarity=0.303 Sum_probs=153.5
Q ss_pred cCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccc
Q 001274 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELY 488 (1109)
Q Consensus 409 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 488 (1109)
..+.+++++|+++. +|..+. ++|+.|+|++|++++..+..|..+++|++|++++|+++.+.+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 34555666665553 333222 456666666666666666667777777777777777776666667778888888888
Q ss_pred cccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCC
Q 001274 489 QNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSA 568 (1109)
Q Consensus 489 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 568 (1109)
+|+++++.+..|..+++|++|++++|++++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 88887776677788888888888888888777777888888888888888888666666788888888888888888766
Q ss_pred CcccccccccceecccccccccccCcccCCCcccceeeccCccccccc
Q 001274 569 PEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSI 616 (1109)
Q Consensus 569 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 616 (1109)
+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++...-
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 667888888888888888888777777888888888888888887543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=236.78 Aligned_cols=211 Identities=23% Similarity=0.261 Sum_probs=127.5
Q ss_pred cccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccce
Q 001274 405 GVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSA 484 (1109)
Q Consensus 405 ~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 484 (1109)
..+++|+.|++++|.+... ..+..+++|++|++++|.+++. +.+..+++|++|++++|++++..+..|.++++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 113 (272)
T 3rfs_A 38 NELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113 (272)
T ss_dssp HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence 3445555555555555422 2345555555555555555542 24555555666666666666555555666666666
Q ss_pred eccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcC
Q 001274 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQF 564 (1109)
Q Consensus 485 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 564 (1109)
|+|++|++++..+..|..+++|++|++++|++++..+..++.+++|++|+|++|++++..+..+..+++|++|+|++|++
T Consensus 114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (272)
T 3rfs_A 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcC
Confidence 66666666655555566666666666666666655555566666666666666666655555566666666666666666
Q ss_pred ccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchh
Q 001274 565 TGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTAL 626 (1109)
Q Consensus 565 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l 626 (1109)
++..|..|..+++|+.|+|++|++.+. +++|+.|++..|.++|.+|.+++.+...
T Consensus 194 ~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~~ 248 (272)
T 3rfs_A 194 KSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAPD 248 (272)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred CccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCCC
Confidence 665555566666666666666666533 3456666677777777777766666554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.4e-24 Score=235.64 Aligned_cols=205 Identities=27% Similarity=0.331 Sum_probs=122.6
Q ss_pred cCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCe
Q 001274 477 YNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQR 556 (1109)
Q Consensus 477 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 556 (1109)
.++++++++++++|.++.+ |..+. ++++.|+|++|++++..+..|.++++|++|+|++|+|++..+ .+.+++|++
T Consensus 7 ~~l~~l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 81 (290)
T 1p9a_G 7 SKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGT 81 (290)
T ss_dssp ECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCE
T ss_pred cccCCccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCE
Confidence 3444445555555554432 22222 345555555555554444555555555555555555553222 144555555
Q ss_pred eecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCcc
Q 001274 557 LDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNN 636 (1109)
Q Consensus 557 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~ 636 (1109)
|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..+..++.|+ .|+|++|+
T Consensus 82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~ 159 (290)
T 1p9a_G 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE-KLSLANNN 159 (290)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC-EEECTTSC
T ss_pred EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCC-EEECCCCc
Confidence 555555555 3455555555555555555555555555555555555555555555544444445555554 36666666
Q ss_pred ccccccccccCccccceeecCCCccccCCchhhhccccceEEEccCccccccc
Q 001274 637 LSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTV 689 (1109)
Q Consensus 637 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~ 689 (1109)
|++..+..|..+++|+.|+|++|+|+ .+|..+..+..|+.++|++|++.|..
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 66666666788899999999999998 78888888889999999999988765
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-26 Score=259.18 Aligned_cols=265 Identities=15% Similarity=0.175 Sum_probs=183.0
Q ss_pred CCCccceeeecCCeEEEEeccCccccccccccccCc--cccceeecccCccCCCCCccccCCCCCceEEccCCccccc-C
Q 001274 60 TPCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDL--PRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGV-I 136 (1109)
Q Consensus 60 ~~c~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l--~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~ 136 (1109)
-|..|.++.|+...++.+|++++++. +..++.+ ++++.|++++|.+++..+. +.++++|++|+|++|.+++. +
T Consensus 35 vc~~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 35 VCKRWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp SCHHHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHH
Confidence 35579999998777889999998876 4556666 8899999999999887765 56789999999999988876 7
Q ss_pred CchhhccccceEEEcccccccccccccccCcCCCceEEeecC-CCCCC-CCcccccccccceeccccc-cccCC-CCccc
Q 001274 137 PFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSN-NLTGA-IPASISKLRQLRVIRAGHN-SLSGP-IPPEI 212 (1109)
Q Consensus 137 ~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~l~~n-~l~~~-~p~~l 212 (1109)
|..+..+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~ 190 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 190 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred HHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH
Confidence 777888889999999999888888888888888999999888 67753 5666777888888888888 77643 45556
Q ss_pred cccc-cchhhhcccc--ccc-ccCchhhhccccccceeccccc-ccCCCCCCccccccccceeeeecc-ceecCchhhhc
Q 001274 213 SECE-GLEVLGLAQN--SLE-GFLPSELEKLRNLTDLILWQNH-LSGEIPPTIGNIQSLELLALHENS-FSGGLPKELGK 286 (1109)
Q Consensus 213 ~~l~-~L~~L~L~~n--~l~-~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~l~~ 286 (1109)
..++ +|++|+|++| .++ +.+|..+..+++|++|+|++|. +++..+..++.+++|++|++++|. +.......+++
T Consensus 191 ~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~ 270 (336)
T 2ast_B 191 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 270 (336)
T ss_dssp HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGG
T ss_pred HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhc
Confidence 6677 7777777777 344 3455566666677777777766 555555566666666666666663 22222224555
Q ss_pred cCccceEEeecccccCccCcccCCC-CcCcEEEccCCcccCCCcccc
Q 001274 287 LSRLKKLYVYTNELNGTIPHELGNC-TSAVEIDLSENQLTGFIPREL 332 (1109)
Q Consensus 287 l~~L~~L~l~~n~l~~~~~~~l~~l-~~L~~L~Ls~n~l~~~~p~~l 332 (1109)
+++|++|++++| ++.. .+..+ .++..|+++.|++++..|..+
T Consensus 271 ~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 271 IPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp CTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred CCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCcc
Confidence 555666655555 2211 12222 124444455555555444433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-25 Score=256.62 Aligned_cols=261 Identities=18% Similarity=0.200 Sum_probs=160.9
Q ss_pred EecccccccCcccccccCCCCccEEEcccCcccCCCC----cchhccc-ccceEEcccccccccCCCccccc-----CcC
Q 001274 341 LQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIP----LEFQNLT-YLVDLQLFDNHLEGTIPPHIGVN-----SHL 410 (1109)
Q Consensus 341 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~~-----~~L 410 (1109)
+.++.|.+++.+|..+...++|++|||++|++++..+ ..|.+++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 5677777777777777766678888888888776555 5566666 67777777777766555555553 666
Q ss_pred cEEEeccccccCccchhhhcc-----cccceeecCCccccCCCCCCCccccccceeecccccccccCCccccC-Ccccce
Q 001274 411 SVLDVSMNNLDGSIPPHLCMY-----QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYN-LQNLSA 484 (1109)
Q Consensus 411 ~~L~Ls~N~l~~~~~~~l~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~ 484 (1109)
++|+|++|.+.+..+..++.. ++|++|+|++|++++..+..+.. .+.. .++|++
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~--------------------~l~~~~~~L~~ 142 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ--------------------AFSNLPASITS 142 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH--------------------HHTTSCTTCCE
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH--------------------HHHhCCCceeE
Confidence 666666666665555443332 45555555555554332222111 1222 246666
Q ss_pred eccccccccCCCC----ccccccc-cccEEEccCCccCCCCChhhcc----c-ccccEEecccCccccc----CCcCCCC
Q 001274 485 LELYQNRFSGLIP----PEIGKLR-NLERLHLSENYFVGYIPSEVGN----L-EHLVTFNISSNSLSGT----IPHELGN 550 (1109)
Q Consensus 485 L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l~~~----~p~~~~~ 550 (1109)
|+|++|.+++..+ ..+..++ +|++|+|++|++++..+..+.. + ++|++|+|++|.|++. ++..+..
T Consensus 143 L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~ 222 (362)
T 3goz_A 143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222 (362)
T ss_dssp EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred EEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence 6666666654322 2233343 6777777777776655544433 3 4777777777777642 3444444
Q ss_pred -CCCCCeeecCCCcCccCCC----cccccccccceecccccccccc-------cCcccCCCcccceeeccCccccccccc
Q 001274 551 -CVNLQRLDLSRNQFTGSAP----EELGQLVNLELLKLSDNKLTGA-------IPSSLGGLARLTELQMGGNIFSGSIPV 618 (1109)
Q Consensus 551 -l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l~~~~p~ 618 (1109)
.++|++|||++|.+++..+ ..+..+++|+.|+|++|.+.+. ++..+..+++|+.||+++|++.+..+.
T Consensus 223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~ 302 (362)
T 3goz_A 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI 302 (362)
T ss_dssp SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence 3477888888887775443 2345667788888888874433 334677888888999999988876555
Q ss_pred ccc
Q 001274 619 ALG 621 (1109)
Q Consensus 619 ~~~ 621 (1109)
.+.
T Consensus 303 ~~~ 305 (362)
T 3goz_A 303 PIS 305 (362)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-23 Score=229.77 Aligned_cols=203 Identities=24% Similarity=0.271 Sum_probs=108.2
Q ss_pred hcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccce
Q 001274 381 QNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQ 460 (1109)
Q Consensus 381 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 460 (1109)
.++++++++++++|.++ .+|..+. +++++|+|++|.+.+..+..|..+++|++|+|++|.|++..+. .
T Consensus 7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~------- 74 (290)
T 1p9a_G 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--G------- 74 (290)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--S-------
T ss_pred cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--C-------
Confidence 34444444444444444 2333222 4555566666665555555555555555555555555532221 3
Q ss_pred eecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcc
Q 001274 461 LMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSL 540 (1109)
Q Consensus 461 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 540 (1109)
.+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 75 -----------------~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l 136 (290)
T 1p9a_G 75 -----------------TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136 (290)
T ss_dssp -----------------CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC
T ss_pred -----------------CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCC
Confidence 3444444444444444 2344445555555555555555554445555555555555555555
Q ss_pred cccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccc
Q 001274 541 SGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614 (1109)
Q Consensus 541 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 614 (1109)
++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++ .+|..+..+.+|+.|+|++|++..
T Consensus 137 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 5444455555556666666666665444444555666666666666665 445555556667777777776653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-24 Score=259.96 Aligned_cols=187 Identities=18% Similarity=0.227 Sum_probs=146.8
Q ss_pred CCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcc------hhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 805 SEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGAT------ADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 805 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
...++||+|+||+||+|+. .++.+|+|+......... ..+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999965 478899998754332211 134588999999999999999666666678888999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
|||+++++|.+++.. +..++.|+++||+||| +++|+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999875 4579999999999999 779999999999999999 999999999997653
Q ss_pred CCCCC------ccccccccceeccccccC--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 001274 959 PYSKS------MSAIAGSYGYIAPEYAYT--MKVTEKCDIYSFGVVLLELITGKSPVQ 1008 (1109)
Q Consensus 959 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvll~elltg~~pf~ 1008 (1109)
..... .....||+.|+|||++.. ..|+.++|+|+..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 21111 135679999999999987 568888999999999998888877764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-25 Score=254.87 Aligned_cols=260 Identities=16% Similarity=0.151 Sum_probs=123.5
Q ss_pred eecccCccCCCCCccccCCCCCceEEccCCcccccCC----chhhccc-cceEEEcccccccccccccccCc-----CCC
Q 001274 101 FNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIP----FQLFFIN-TLRKLYLCENYIFGEIPEEIGNL-----TSL 170 (1109)
Q Consensus 101 L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~----~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l-----~~L 170 (1109)
++++.|.++|.+|..+...++|++|||++|.+++..+ ..+..++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4555566666666555555556666666666655444 3444455 56666666666655555555443 566
Q ss_pred ceEEeecCCCCCCCCcccccc-----cccceeccccccccCCCCccccc-----cccchhhhcccccccccCchh----h
Q 001274 171 EELVIYSNNLTGAIPASISKL-----RQLRVIRAGHNSLSGPIPPEISE-----CEGLEVLGLAQNSLEGFLPSE----L 236 (1109)
Q Consensus 171 ~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~p~~l~~-----l~~L~~L~L~~n~l~~~~p~~----l 236 (1109)
++|+|++|++++..+..++.. ++|++|++++|.+++..+..+.. .++|++|+|++|.+++..+.. +
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 666666666655444433332 45555555555555443333322 134555555555554322222 2
Q ss_pred hccc-cccceecccccccCCCCCCcccc-----ccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCC
Q 001274 237 EKLR-NLTDLILWQNHLSGEIPPTIGNI-----QSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGN 310 (1109)
Q Consensus 237 ~~l~-~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~ 310 (1109)
..++ +|++|+|++|++++..+..++.. ++|++|+|++|.+++.... .++..+..
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~--------------------~l~~~l~~ 222 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA--------------------ELAYIFSS 222 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH--------------------HHHHHHHH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH--------------------HHHHHHhc
Confidence 2332 45555555555544333322221 3444444444444431111 12222222
Q ss_pred -CCcCcEEEccCCcccCCCc----ccccCCCCcceEecccccccCc-------ccccccCCCCccEEEcccCcccCCCCc
Q 001274 311 -CTSAVEIDLSENQLTGFIP----RELGLIPNLCLLQLFENMLQGS-------IPRELGQLTQLHKLDLSINNLTGTIPL 378 (1109)
Q Consensus 311 -l~~L~~L~Ls~n~l~~~~p----~~l~~l~~L~~L~L~~n~l~~~-------~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 378 (1109)
.++|++|||++|++++..+ ..+..+++|+.|++++|.+.+. ++..+..+++|++||+++|++.+..+.
T Consensus 223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~ 302 (362)
T 3goz_A 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI 302 (362)
T ss_dssp SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence 2244444444444443322 1122333344444444432221 233455666777777777777655444
Q ss_pred ch
Q 001274 379 EF 380 (1109)
Q Consensus 379 ~~ 380 (1109)
.+
T Consensus 303 ~~ 304 (362)
T 3goz_A 303 PI 304 (362)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=235.25 Aligned_cols=200 Identities=20% Similarity=0.164 Sum_probs=105.1
Q ss_pred ccceEEEcccccccccccccc--cCcCCCceEEeecCCCCCCCC----cccccccccceeccccccccCCCCcccccccc
Q 001274 144 NTLRKLYLCENYIFGEIPEEI--GNLTSLEELVIYSNNLTGAIP----ASISKLRQLRVIRAGHNSLSGPIPPEISECEG 217 (1109)
Q Consensus 144 ~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~ 217 (1109)
++|++|+|++|.+++.+|..+ +.+++|++|+|++|++++..+ ..+..+++|++|++++|.+++..|..|+.+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 445555555555555555554 555555555555555554333 22334555555555555555555555555555
Q ss_pred chhhhccccccccc--C--chhhhccccccceecccccccCCCCC----CccccccccceeeeeccceecCchhhhcc--
Q 001274 218 LEVLGLAQNSLEGF--L--PSELEKLRNLTDLILWQNHLSGEIPP----TIGNIQSLELLALHENSFSGGLPKELGKL-- 287 (1109)
Q Consensus 218 L~~L~L~~n~l~~~--~--p~~l~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~L~~N~l~~~~p~~l~~l-- 287 (1109)
|++|+|++|++.+. + +..+..+++|++|+|++|+++ .++. .++++++|++|+|++|++++..|..++.+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 55555555554431 1 112244555555555555554 2222 13444555555555555555545554444
Q ss_pred -CccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEeccccccc
Q 001274 288 -SRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349 (1109)
Q Consensus 288 -~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 349 (1109)
++|++|++++|+++ .+|..+. ++|++|||++|++++. |. +..+++|+.|++++|.++
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 45666666666665 4454443 5666666666666643 22 455566666666666655
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-23 Score=223.13 Aligned_cols=190 Identities=19% Similarity=0.249 Sum_probs=118.9
Q ss_pred CCCccceeeecCCeEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCch
Q 001274 60 TPCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQ 139 (1109)
Q Consensus 60 ~~c~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~ 139 (1109)
+||.|.|++|.. ..+.++++++++.. +|..+. ++++.|+|++|.+++..|..++++++|++|+|++|.+++..+..
T Consensus 3 ~Cp~~~gC~C~~-~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 78 (251)
T 3m19_A 3 TCETVTGCTCNE-GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV 78 (251)
T ss_dssp -CHHHHSSEEEG-GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTT
T ss_pred cCCCCCceEcCC-CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhH
Confidence 688999999953 24467888888773 444443 56777777777777776777777777777777777777666666
Q ss_pred hhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccch
Q 001274 140 LFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLE 219 (1109)
Q Consensus 140 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~ 219 (1109)
+..+++|++|+|++|.+++..+..++.+++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|+.+++|+
T Consensus 79 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 158 (251)
T 3m19_A 79 FDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQ 158 (251)
T ss_dssp TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCC
Confidence 66666666666666666655555666666666666666666654444455666666666666666544444455555555
Q ss_pred hhhcccccccccCchhhhccccccceeccccccc
Q 001274 220 VLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLS 253 (1109)
Q Consensus 220 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 253 (1109)
+|+|++|++++..+..+..+++|++|+|++|.++
T Consensus 159 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 159 TLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred EEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence 5555555555444444444444444444444444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.9e-23 Score=221.64 Aligned_cols=196 Identities=19% Similarity=0.229 Sum_probs=111.2
Q ss_pred ccceeccccccccCCCCccccccccccEEEccCCc-cCCCCChhhcccccccEEeccc-CcccccCCcCCCCCCCCCeee
Q 001274 481 NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENY-FVGYIPSEVGNLEHLVTFNISS-NSLSGTIPHELGNCVNLQRLD 558 (1109)
Q Consensus 481 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 558 (1109)
+|++|+|++|+++++.+..|..+++|++|++++|+ ++++.+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555554444445555555555555554 4444444455555555555555 555544444555555555555
Q ss_pred cCCCcCccCCCcccccccccc---eeccccc-ccccccCcccCCCcccc-eeeccCccccccccccccccchhhhhhccC
Q 001274 559 LSRNQFTGSAPEELGQLVNLE---LLKLSDN-KLTGAIPSSLGGLARLT-ELQMGGNIFSGSIPVALGQLTALQIALNIS 633 (1109)
Q Consensus 559 Ls~N~l~~~~p~~l~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls 633 (1109)
+++|++++ +|. |..+++|+ .|++++| ++++..+..|.++++|+ +|++++|.++ .+|...+..+.|+ .|+|+
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~-~L~L~ 187 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD-AVYLN 187 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEE-EEECT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCC-EEEcC
Confidence 55555553 343 45555554 5555555 55555555555555665 6666666555 4444333334443 36666
Q ss_pred Ccc-ccccccccccCc-cccceeecCCCccccCCchhhhccccceEEEccCc
Q 001274 634 HNN-LSGVIPYELGNL-QMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNN 683 (1109)
Q Consensus 634 ~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N 683 (1109)
+|. +++..+..|..+ ++|+.|||++|+++ .+|.. .+..|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence 663 666666777888 88888888888887 45544 5667778887765
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.7e-25 Score=254.96 Aligned_cols=246 Identities=19% Similarity=0.171 Sum_probs=125.0
Q ss_pred CCCccccCCCCCceEEccCCcccccCCch----hhccccceEEEcccc---cccccccccc-------cCcCCCceEEee
Q 001274 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQ----LFFINTLRKLYLCEN---YIFGEIPEEI-------GNLTSLEELVIY 176 (1109)
Q Consensus 111 ~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~----l~~l~~L~~L~L~~n---~l~~~~p~~l-------~~l~~L~~L~L~ 176 (1109)
.++..+..+++|++|+|++|.+++..+.. +..+++|++|+|++| .+++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 45566677777777777777777654433 445666777777664 3444445444 456666666666
Q ss_pred cCCCCC----CCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhcc---------cccc
Q 001274 177 SNNLTG----AIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKL---------RNLT 243 (1109)
Q Consensus 177 ~n~l~~----~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l---------~~L~ 243 (1109)
+|++++ .+|..+.++++|++|+|++|.+++..+..+.. .+..+ ++|+
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~--------------------~l~~l~~~~~~~~~~~L~ 162 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--------------------ALQELAVNKKAKNAPPLR 162 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--------------------HHHHHHHHHHHHTCCCCC
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHH--------------------HHHHHhhhhhcccCCCCc
Confidence 666664 24455555555555555555554322222221 11111 4555
Q ss_pred ceeccccccc-CCCC---CCccccccccceeeeecccee-----cCchhhhccCccceEEeeccccc----CccCcccCC
Q 001274 244 DLILWQNHLS-GEIP---PTIGNIQSLELLALHENSFSG-----GLPKELGKLSRLKKLYVYTNELN----GTIPHELGN 310 (1109)
Q Consensus 244 ~L~L~~N~l~-~~~p---~~l~~l~~L~~L~L~~N~l~~-----~~p~~l~~l~~L~~L~l~~n~l~----~~~~~~l~~ 310 (1109)
+|+|++|+++ +.++ ..+..+++|++|+|++|+++. ..|..+..+++|++|+|++|.++ +.+|..+..
T Consensus 163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~ 242 (386)
T 2ca6_A 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242 (386)
T ss_dssp EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence 5555555554 2222 233344455555555554441 12224445555555555555553 334444555
Q ss_pred CCcCcEEEccCCcccCC----Ccccc--cCCCCcceEecccccccC----cccccc-cCCCCccEEEcccCcccCCC
Q 001274 311 CTSAVEIDLSENQLTGF----IPREL--GLIPNLCLLQLFENMLQG----SIPREL-GQLTQLHKLDLSINNLTGTI 376 (1109)
Q Consensus 311 l~~L~~L~Ls~n~l~~~----~p~~l--~~l~~L~~L~L~~n~l~~----~~p~~l-~~l~~L~~L~Ls~N~l~~~~ 376 (1109)
+++|++|+|++|++++. ++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|++|++++|.+++..
T Consensus 243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 55555555555555433 23333 124444555555554444 244444 33555556666665555443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=217.51 Aligned_cols=181 Identities=23% Similarity=0.280 Sum_probs=144.9
Q ss_pred ccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEcc
Q 001274 433 KLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLS 512 (1109)
Q Consensus 433 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 512 (1109)
..+.++++++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4556666666666 3444443 467788888888887777778888888888888888888777778888888888888
Q ss_pred CCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceeccccccccccc
Q 001274 513 ENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAI 592 (1109)
Q Consensus 513 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 592 (1109)
+|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 88888777778888888888888888888776677788888888888888888766667888888888888888888887
Q ss_pred CcccCCCcccceeeccCccccccc
Q 001274 593 PSSLGGLARLTELQMGGNIFSGSI 616 (1109)
Q Consensus 593 p~~~~~l~~L~~L~l~~N~l~~~~ 616 (1109)
+..|..+++|+.|++++|++.+..
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTTS
T ss_pred HHHHhCCCCCCEEEeeCCceeCCc
Confidence 888888889999999999888653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9.4e-25 Score=253.16 Aligned_cols=249 Identities=17% Similarity=0.185 Sum_probs=146.4
Q ss_pred cchhhhcccccceeecCCccccCCCC----CCCccccccceeeccccc---ccccCCccccCCcccceeccccccccCCC
Q 001274 424 IPPHLCMYQKLIFLSLGSNRLSGNIP----PGLKTCRSLMQLMLGQNQ---LTGSLPIEFYNLQNLSALELYQNRFSGLI 496 (1109)
Q Consensus 424 ~~~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 496 (1109)
++..+..+++|+.|+|++|.++...+ ..+..+++|++|+|++|. +++.+|..+.. +
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~-----------------l 86 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL-----------------L 86 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH-----------------H
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHH-----------------H
Confidence 44455566666666666666654322 224445555555555532 22222322200 0
Q ss_pred CccccccccccEEEccCCccCC----CCChhhcccccccEEecccCcccccCCcCCC----CC---------CCCCeeec
Q 001274 497 PPEIGKLRNLERLHLSENYFVG----YIPSEVGNLEHLVTFNISSNSLSGTIPHELG----NC---------VNLQRLDL 559 (1109)
Q Consensus 497 p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l---------~~L~~L~L 559 (1109)
...+..+++|++|+|++|++++ .+|..+..+++|++|+|++|.++...+..+. .+ ++|++|+|
T Consensus 87 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L 166 (386)
T 2ca6_A 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 166 (386)
T ss_dssp HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEEC
T ss_pred HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEEC
Confidence 0112445555555555555554 2444555555555555555555432222222 22 56666666
Q ss_pred CCCcCc-cCCC---cccccccccceecccccccc--c---ccCcccCCCcccceeeccCcccc----ccccccccccchh
Q 001274 560 SRNQFT-GSAP---EELGQLVNLELLKLSDNKLT--G---AIPSSLGGLARLTELQMGGNIFS----GSIPVALGQLTAL 626 (1109)
Q Consensus 560 s~N~l~-~~~p---~~l~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~l 626 (1109)
++|+++ +.+| ..+..+++|+.|+|++|+++ | ..|..+..+++|+.|+|++|.++ +.+|..+..++.|
T Consensus 167 ~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L 246 (386)
T 2ca6_A 167 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 246 (386)
T ss_dssp CSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTC
T ss_pred CCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCc
Confidence 666665 2333 34555666666666666665 2 23445666666666666666664 4566666666666
Q ss_pred hhhhccCCcccccc----ccccc--cCccccceeecCCCcccc----CCchhh-hccccceEEEccCcccccccC
Q 001274 627 QIALNISHNNLSGV----IPYEL--GNLQMLEALYLDDNQLIG----EIPASM-GEQMSLLVCNLSNNNLVGTVP 690 (1109)
Q Consensus 627 ~~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~ip~~~-~~l~~L~~l~ls~N~l~g~~p 690 (1109)
+ .|+|++|.+++. +|..+ +.+++|++|+|++|++++ .+|..+ .++++|++|+|++|++++..|
T Consensus 247 ~-~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 247 R-ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp C-EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred C-EEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 5 377777777655 55666 448999999999999997 588888 668999999999999987654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=7.9e-23 Score=229.18 Aligned_cols=226 Identities=20% Similarity=0.234 Sum_probs=115.3
Q ss_pred CccEEEcccCcccCCCC---cchhcccccceEEcccccccccCCCcc--cccCcCcEEEeccccccCccc----hhhhcc
Q 001274 361 QLHKLDLSINNLTGTIP---LEFQNLTYLVDLQLFDNHLEGTIPPHI--GVNSHLSVLDVSMNNLDGSIP----PHLCMY 431 (1109)
Q Consensus 361 ~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~~~--~~~~~L~~L~Ls~N~l~~~~~----~~l~~l 431 (1109)
.++.|.+.++.++...- ..+..+++|++|++++|.+.+..|..+ ..+++|++|+|++|.+.+..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 45666666665542110 012234557777777777777666666 667777777777777765433 233455
Q ss_pred cccceeecCCccccCCCCCCCccccccceeeccccccccc---C-CccccCCcccceeccccccccCCCCc----ccccc
Q 001274 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGS---L-PIEFYNLQNLSALELYQNRFSGLIPP----EIGKL 503 (1109)
Q Consensus 432 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~-p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l 503 (1109)
++|++|+|++|++++..+..|..+++|++|+|++|++.+. . +..+.++++|++|+|++|+++.. +. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETP-TGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCH-HHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCch-HHHHHHHHhcC
Confidence 6666666666666655555555555555555555555431 1 11224455555555555555421 11 12344
Q ss_pred ccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecc
Q 001274 504 RNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKL 583 (1109)
Q Consensus 504 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 583 (1109)
++|++|+|++|++++..|..+..+. .+++|++|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~---------------------~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~L 279 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCM---------------------WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDL 279 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCC---------------------CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEEC
T ss_pred CCCCEEECCCCCCCccchhhHHhcc---------------------CcCcCCEEECCCCCCC-chhhhhc--CCCCEEEC
Confidence 4444444444444444444333331 0034555555555554 3344332 45555555
Q ss_pred cccccccccCcccCCCcccceeeccCcccc
Q 001274 584 SDNKLTGAIPSSLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 584 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 613 (1109)
++|++++. |. +..+++|+.|++++|+++
T Consensus 280 s~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 280 SSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred CCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 55555532 22 344555555555555554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-22 Score=225.66 Aligned_cols=208 Identities=24% Similarity=0.341 Sum_probs=115.3
Q ss_pred EEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCcc
Q 001274 364 KLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNR 443 (1109)
Q Consensus 364 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 443 (1109)
.+.+..+.+++. ..+..+++|+.|++++|.++. ++ .+..+++|++|++++|.+.+..+ +..+++|++|+|++|+
T Consensus 23 ~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~ 96 (308)
T 1h6u_A 23 KIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (308)
T ss_dssp HHHTTCSSTTSE--ECHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCce--ecHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence 334455555432 234556677777777776663 33 45566666666666666664433 5555555555555555
Q ss_pred ccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChh
Q 001274 444 LSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSE 523 (1109)
Q Consensus 444 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 523 (1109)
+++. + .+..+++|++|+|++|++++. + .+..+++|++|++++|++++..+
T Consensus 97 l~~~--~------------------------~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~-- 146 (308)
T 1h6u_A 97 LKNV--S------------------------AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP-- 146 (308)
T ss_dssp CSCC--G------------------------GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--
T ss_pred CCCc--h------------------------hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--
Confidence 5532 1 344555555555555555543 1 25555555555555555554322
Q ss_pred hcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccc
Q 001274 524 VGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT 603 (1109)
Q Consensus 524 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 603 (1109)
+..+++|++|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+
T Consensus 147 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~ 220 (308)
T 1h6u_A 147 LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLF 220 (308)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCC
T ss_pred ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCC
Confidence 5555566666666666653322 5556666666666666653322 5556666666666666664432 55666666
Q ss_pred eeeccCcccc
Q 001274 604 ELQMGGNIFS 613 (1109)
Q Consensus 604 ~L~l~~N~l~ 613 (1109)
.|++++|+++
T Consensus 221 ~L~l~~N~i~ 230 (308)
T 1h6u_A 221 IVTLTNQTIT 230 (308)
T ss_dssp EEEEEEEEEE
T ss_pred EEEccCCeee
Confidence 6666666665
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=217.26 Aligned_cols=196 Identities=16% Similarity=0.205 Sum_probs=110.7
Q ss_pred cCcEEEeccccccCccchhhhcccccceeecCCcc-ccCCCCCCCccccccceeeccc-ccccccCCccccCCcccceec
Q 001274 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNR-LSGNIPPGLKTCRSLMQLMLGQ-NQLTGSLPIEFYNLQNLSALE 486 (1109)
Q Consensus 409 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 486 (1109)
+|++|++++|++++..+..|..+++|++|++++|+ ++++.+..|..+++|++|++++ |+++++.+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555554444455555555555555554 5444444555555566666655 555555555566666666666
Q ss_pred cccccccCCCCcccccccccc---EEEccCC-ccCCCCChhhccccccc-EEecccCcccccCCcCCCCCCCCCeeecCC
Q 001274 487 LYQNRFSGLIPPEIGKLRNLE---RLHLSEN-YFVGYIPSEVGNLEHLV-TFNISSNSLSGTIPHELGNCVNLQRLDLSR 561 (1109)
Q Consensus 487 L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 561 (1109)
+++|++++ +|. |..+++|+ +|++++| +++++.+..|.++++|+ +|++++|+++ .+|......++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 66666664 333 55555555 6666666 66655555566666666 6666666666 3333222225666666666
Q ss_pred Cc-CccCCCcccccc-cccceecccccccccccCcccCCCcccceeeccCc
Q 001274 562 NQ-FTGSAPEELGQL-VNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGN 610 (1109)
Q Consensus 562 N~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 610 (1109)
|+ +++..+..|..+ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 63 665445556666 6666666666666643332 3455566665554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-23 Score=247.43 Aligned_cols=209 Identities=27% Similarity=0.375 Sum_probs=131.9
Q ss_pred CCCCCCCCCCCC-----cccee-eecCCeEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCce
Q 001274 51 LESWNSSDMTPC-----NWIGV-ECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEI 124 (1109)
Q Consensus 51 ~~~W~~~~~~~c-----~w~gv-~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~ 124 (1109)
+.+|... .++| .|.|+ .|...+++.++|++++|++ +|+.+. ++|+.|+|++|.++ .+| ..+++|++
T Consensus 33 l~~W~~~-~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 33 WDKWEKQ-ALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHHHHTT-CCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHHHhcc-CCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 4566543 3678 79999 8987788888888888887 666553 77888888888877 566 44677777
Q ss_pred EEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccc
Q 001274 125 LDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSL 204 (1109)
Q Consensus 125 L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l 204 (1109)
|+|++|++++ +|. +.. +|++|+|++|.+++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|
T Consensus 105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQL 172 (571)
T ss_dssp EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCC
Confidence 7777777776 555 443 67777777777765 554 46666666666666664 444 345566666666665
Q ss_pred cCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCCCccccccc-------cceeeeeccce
Q 001274 205 SGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSL-------ELLALHENSFS 277 (1109)
Q Consensus 205 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-------~~L~L~~N~l~ 277 (1109)
++ +|. |. ++|++|+|++|+|+ .+|. +.. +| +.|+|++|+|+
T Consensus 173 ~~-lp~-l~--------------------------~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~ 220 (571)
T 3cvr_A 173 TF-LPE-LP--------------------------ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT 220 (571)
T ss_dssp SC-CCC-CC--------------------------TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC
T ss_pred CC-cch-hh--------------------------CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce
Confidence 53 443 33 44555555555555 3444 333 44 66666666665
Q ss_pred ecCchhhhccCccceEEeecccccCccCcccCCCC
Q 001274 278 GGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCT 312 (1109)
Q Consensus 278 ~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~ 312 (1109)
.+|..+..+++|+.|+|++|.+++.+|..+..++
T Consensus 221 -~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 221 -HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp -CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred -ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 4555555666666666666666666665555443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-23 Score=239.65 Aligned_cols=254 Identities=19% Similarity=0.197 Sum_probs=129.0
Q ss_pred CCceEEccCCcccccCCchhhcc--ccceEEEcccccccccccccccCcCCCceEEeecCCCCCC-CCccccccccccee
Q 001274 121 SLEILDLCTNRLHGVIPFQLFFI--NTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGA-IPASISKLRQLRVI 197 (1109)
Q Consensus 121 ~L~~L~Ls~n~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L 197 (1109)
.++.||+++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+.++++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3667777777765 3445555 6677777777777655444 44566666666666666544 55555666666666
Q ss_pred ccccccccCCCCccccccccchhhhcccc-cccc-cCchhhhccccccceecccc-cccCCCCCCccccccccceeeeec
Q 001274 198 RAGHNSLSGPIPPEISECEGLEVLGLAQN-SLEG-FLPSELEKLRNLTDLILWQN-HLSGEIPPTIGNIQSLELLALHEN 274 (1109)
Q Consensus 198 ~l~~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~-~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N 274 (1109)
++++|.+++..+..++.+++|++|+|++| .+++ .++..+.++++|++|+|++| .+++.
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~------------------- 184 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK------------------- 184 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH-------------------
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH-------------------
Confidence 66666655555555555555555555555 3443 13444444555555555554 44422
Q ss_pred cceecCchhhhccC-ccceEEeecc--ccc-CccCcccCCCCcCcEEEccCCc-ccCCCcccccCCCCcceEeccccc-c
Q 001274 275 SFSGGLPKELGKLS-RLKKLYVYTN--ELN-GTIPHELGNCTSAVEIDLSENQ-LTGFIPRELGLIPNLCLLQLFENM-L 348 (1109)
Q Consensus 275 ~l~~~~p~~l~~l~-~L~~L~l~~n--~l~-~~~~~~l~~l~~L~~L~Ls~n~-l~~~~p~~l~~l~~L~~L~L~~n~-l 348 (1109)
.++..+..++ +|++|++++| .++ +.++..+.++++|++|+|++|. +++..+..+..+++|+.|++++|. +
T Consensus 185 ----~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~ 260 (336)
T 2ast_B 185 ----HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDI 260 (336)
T ss_dssp ----HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTC
T ss_pred ----HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCC
Confidence 0233344444 4444444444 222 2233333444444444444444 333333334444444444444442 1
Q ss_pred cCcccccccCCCCccEEEcccCcccCCCCcchhccc-ccceEEcccccccccCCCccc
Q 001274 349 QGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLT-YLVDLQLFDNHLEGTIPPHIG 405 (1109)
Q Consensus 349 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~ 405 (1109)
.......+.++++|++|++++| ++ ...+..+. .+..|++++|++++..|..++
T Consensus 261 ~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 261 IPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp CGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 1111124555666666666666 32 12233332 255555666666655555443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=7.4e-22 Score=220.73 Aligned_cols=208 Identities=25% Similarity=0.335 Sum_probs=144.8
Q ss_pred eEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEecccc
Q 001274 340 LLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNN 419 (1109)
Q Consensus 340 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~ 419 (1109)
.+.+..+.+.+.+ .+..+++|++|++++|.++. ++ .+..+++|+.|+|++|.+++..+ +..+++|++|++++|+
T Consensus 23 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~ 96 (308)
T 1h6u_A 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (308)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence 3344445444432 35568899999999999984 45 68999999999999999996555 8999999999999999
Q ss_pred ccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCcc
Q 001274 420 LDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPE 499 (1109)
Q Consensus 420 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 499 (1109)
+.+. +.+..+++|++|++++|++++.. .+..+++|++|++++|++++..+ +.++++|++|+|++|++++..+
T Consensus 97 l~~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-- 168 (308)
T 1h6u_A 97 LKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-- 168 (308)
T ss_dssp CSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred CCCc--hhhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--
Confidence 9864 36888999999999999988643 26666777777777777765433 5666666666666666665422
Q ss_pred ccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCc
Q 001274 500 IGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFT 565 (1109)
Q Consensus 500 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 565 (1109)
+..+++|+.|++++|++++..+ +..+++|++|+|++|++++..| +..+++|+.|+|++|+++
T Consensus 169 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 5666666666666666654322 5555666666666666654332 555555666666666555
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=205.53 Aligned_cols=185 Identities=22% Similarity=0.236 Sum_probs=137.7
Q ss_pred CCccceeeecCCeEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchh
Q 001274 61 PCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQL 140 (1109)
Q Consensus 61 ~c~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l 140 (1109)
.|.|.+|.|+....+. +|..+ .++|++|++++|.+++..+..++++++|++|+|++|++++..+..+
T Consensus 6 ~C~~~~v~c~~~~l~~-----------~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTS-----------VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72 (208)
T ss_dssp EEETTEEECCSSCCSS-----------CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred EECCCEEEecCCCccC-----------CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhc
Confidence 4899999997643322 22222 3578889999998887767778888899999999888886666667
Q ss_pred hccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchh
Q 001274 141 FFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEV 220 (1109)
Q Consensus 141 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~ 220 (1109)
..+++|++|+|++|.+++..+..++++++|++|+|++|++++..+..+.++++|++|++++|.+++..+..+..+++|++
T Consensus 73 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 152 (208)
T 2o6s_A 73 NKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY 152 (208)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred CCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccE
Confidence 78888888888888888666666788888888888888888666666778888888888888887665556777777777
Q ss_pred hhcccccccccCchhhhccccccceecccccccCCCCCCcccccc
Q 001274 221 LGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQS 265 (1109)
Q Consensus 221 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 265 (1109)
|+|++|.+.+ .+++|++|+++.|+++|.+|.+++.++.
T Consensus 153 L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 153 IWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp EECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred EEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 7777776654 3446777777777777777777665543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=221.03 Aligned_cols=181 Identities=18% Similarity=0.110 Sum_probs=83.3
Q ss_pred CcceEecccccccCcccccccCCCCccEEEcccCcccCCCC-cchhcccccce-EEcccccccccCCCcccccCcCcEEE
Q 001274 337 NLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIP-LEFQNLTYLVD-LQLFDNHLEGTIPPHIGVNSHLSVLD 414 (1109)
Q Consensus 337 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~~~~L~~L~ 414 (1109)
+++.|+|++|+|+...+.+|.++++|++|+|++|++.+.+| ..|.+++++++ +.+..|+++...|..|..+++|++|+
T Consensus 31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~ 110 (350)
T 4ay9_X 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110 (350)
T ss_dssp TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence 34444444444443333455555666666666666543333 34555555443 34444555555555555555555555
Q ss_pred eccccccCccchhhhcccccceeecCC-ccccCCCCCCCcccc-ccceeecccccccccCCccccCCcccceecccc-cc
Q 001274 415 VSMNNLDGSIPPHLCMYQKLIFLSLGS-NRLSGNIPPGLKTCR-SLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQ-NR 491 (1109)
Q Consensus 415 Ls~N~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~ 491 (1109)
+++|++....+..+....++..|++.+ |++..+.+..|..+. .++.|+|++|+|+.+.+..| ...+|++|++++ |.
T Consensus 111 l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~ 189 (350)
T 4ay9_X 111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNN 189 (350)
T ss_dssp EEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTT
T ss_pred ccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCc
Confidence 555555544444444444455555433 344433333343332 24444444444443322222 223344444432 33
Q ss_pred ccCCCCccccccccccEEEccCCccCC
Q 001274 492 FSGLIPPEIGKLRNLERLHLSENYFVG 518 (1109)
Q Consensus 492 l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 518 (1109)
++.+.++.|..+++|++|+|++|+|+.
T Consensus 190 l~~i~~~~f~~l~~L~~LdLs~N~l~~ 216 (350)
T 4ay9_X 190 LEELPNDVFHGASGPVILDISRTRIHS 216 (350)
T ss_dssp CCCCCTTTTTTEECCSEEECTTSCCCC
T ss_pred ccCCCHHHhccCcccchhhcCCCCcCc
Confidence 333333334444444444444444443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.1e-21 Score=220.10 Aligned_cols=54 Identities=11% Similarity=0.145 Sum_probs=23.9
Q ss_pred eEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccc
Q 001274 388 DLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRL 444 (1109)
Q Consensus 388 ~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l 444 (1109)
.++.++++++ .+|..+ .+++++|+|++|+|+.+.+..|.++++|++|+|++|++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i 66 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTT
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCC
Confidence 3444555554 334333 23444455555544433333444444444444444444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=8.5e-22 Score=216.51 Aligned_cols=164 Identities=18% Similarity=0.125 Sum_probs=125.8
Q ss_pred HHHHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCc----------------chhHHHHHHHHHhccCCCC
Q 001274 797 LLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGA----------------TADNSFLAEISTLGKIRHR 860 (1109)
Q Consensus 797 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~ 860 (1109)
+......|.+.+.||+|+||.||+|++.+|+.||||+++...... .....+.+|++++++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 334455666779999999999999999779999999996432111 134568899999999984
Q ss_pred ceeeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 001274 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD 940 (1109)
Q Consensus 861 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~ 940 (1109)
+++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.||| +.+|+||||||+|||++
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS 227 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence 555554433 56699999999999988 421 124579999999999999 77999999999999999
Q ss_pred CCCceEEeeccccccccCCCCCCccccccccceeccccccC----------CCCCccchhHH
Q 001274 941 EEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT----------MKVTEKCDIYS 992 (1109)
Q Consensus 941 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DvwS 992 (1109)
++.+||+|||+|+... .|.|||++.+ .+|+.++|+|.
T Consensus 228 -~~~vkl~DFG~a~~~~--------------~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 228 -EEGIWIIDFPQSVEVG--------------EEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp -TTEEEECCCTTCEETT--------------STTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred -CCcEEEEECCCCeECC--------------CCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999999999997432 3788997653 34555556654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.1e-22 Score=246.50 Aligned_cols=230 Identities=19% Similarity=0.212 Sum_probs=135.9
Q ss_pred CchhHHHHHHHHHHhcC-CCCCCCCCCCCCCCCCCccceeeecCCeEEEEeccCccccccccccccCccccceeecccCc
Q 001274 29 SLTEEGVSLLEFKASLI-DPSNNLESWNSSDMTPCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNF 107 (1109)
Q Consensus 29 ~~~~~~~all~~k~~~~-~~~~~~~~W~~~~~~~c~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~ 107 (1109)
....+++||+++...+. +.+..-++|......++.|.+++++..+++.++|.++++... +..+ |+.++|+.|.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~-~~~~-----l~~l~Ls~~~ 202 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEA-NQAL-----LQHKKLSQYS 202 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcc-hhhH-----hhcCccCccc
Confidence 34567899999998873 334456678665556789999999999999999999988763 3333 3344444444
Q ss_pred cCC---------CCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecC
Q 001274 108 VTG---------SIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSN 178 (1109)
Q Consensus 108 ~~~---------~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 178 (1109)
+.+ ..|..+..++.|++|+|++|.+. .+|..++.+++|++|+|++|.|+ .+|..|+++++|++|+|++|
T Consensus 203 i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N 280 (727)
T 4b8c_D 203 IDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHN 280 (727)
T ss_dssp -------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTS
T ss_pred ccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCC
Confidence 333 44778899999999999999998 78888889999999999999998 88999999999999999999
Q ss_pred CCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhcccc-ccceecccccccCCCC
Q 001274 179 NLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRN-LTDLILWQNHLSGEIP 257 (1109)
Q Consensus 179 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~p 257 (1109)
+|+ .+|..|++|++|++|+|++|.|+ .+|..|+++++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|
T Consensus 281 ~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 281 RLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp CCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred cCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 999 88999999999999999999997 78888999999999999999999988888876543 3457899999998887
Q ss_pred CCccccccccceeeeec
Q 001274 258 PTIGNIQSLELLALHEN 274 (1109)
Q Consensus 258 ~~l~~l~~L~~L~L~~N 274 (1109)
.. |+.|+++.|
T Consensus 359 ~~------l~~l~l~~n 369 (727)
T 4b8c_D 359 HE------RRFIEINTD 369 (727)
T ss_dssp CC---------------
T ss_pred cc------cceeEeecc
Confidence 64 455666666
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.1e-20 Score=196.39 Aligned_cols=162 Identities=23% Similarity=0.222 Sum_probs=85.8
Q ss_pred ccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecc
Q 001274 457 SLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNIS 536 (1109)
Q Consensus 457 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 536 (1109)
+|++|++++|++++..+..|.++++|++|+|++|+++++.+..|..+++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44444444444444444444555555555555555554444445555555555555555554444445555555555555
Q ss_pred cCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccc
Q 001274 537 SNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSI 616 (1109)
Q Consensus 537 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 616 (1109)
+|+|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|.+.+ .+++|+.|+++.|.++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCcee
Confidence 555554444445555555555555555554444445555555555555555442 2345556666666666666
Q ss_pred cccccccch
Q 001274 617 PVALGQLTA 625 (1109)
Q Consensus 617 p~~~~~l~~ 625 (1109)
|..++.+..
T Consensus 182 p~~~~~l~~ 190 (208)
T 2o6s_A 182 RNSAGSVAP 190 (208)
T ss_dssp BCTTSSBCT
T ss_pred eccCccccC
Confidence 666555443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=225.69 Aligned_cols=168 Identities=26% Similarity=0.350 Sum_probs=103.7
Q ss_pred ccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEcc
Q 001274 433 KLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLS 512 (1109)
Q Consensus 433 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 512 (1109)
+|++|+|++|+|+ .+| ..+++|++|+|++|++++ +|. |.+ +|++|+|++|+|++ +|. .+++|+.|+|+
T Consensus 81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 148 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINAD 148 (571)
T ss_dssp TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCC
Confidence 3444444444444 222 223455555555555554 333 433 66666666666665 333 45667777777
Q ss_pred CCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCccccccccc-------ceecccc
Q 001274 513 ENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNL-------ELLKLSD 585 (1109)
Q Consensus 513 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L-------~~L~Ls~ 585 (1109)
+|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++
T Consensus 149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~ 216 (571)
T 3cvr_A 149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRE 216 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCS
T ss_pred CCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCC
Confidence 777765 443 45677777777777774 555 54 67777777777777 4555 444 56 7778888
Q ss_pred cccccccCcccCCCcccceeeccCccccccccccccccch
Q 001274 586 NKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTA 625 (1109)
Q Consensus 586 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 625 (1109)
|+|+ .+|..+..+++|+.|+|++|++++.+|..+.++..
T Consensus 217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 8777 46666666788888888888888777777766554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=9.5e-20 Score=220.94 Aligned_cols=191 Identities=21% Similarity=0.295 Sum_probs=94.4
Q ss_pred cccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeec
Q 001274 384 TYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLML 463 (1109)
Q Consensus 384 ~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 463 (1109)
..+..+.+..+.+.+..+ +..+++|+.|++++|.+... + .+..+++|+.|+|++|+|++..
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~--------------- 81 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--------------- 81 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCG---------------
T ss_pred HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCCh---------------
Confidence 334445555555543322 34455555555555555432 1 3444555555555555554433
Q ss_pred ccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCccccc
Q 001274 464 GQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGT 543 (1109)
Q Consensus 464 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 543 (1109)
+ |..+++|+.|+|++|.|+++ +.+..+++|+.|+|++|+|.+. ..+..+++|+.|+|++|+|++.
T Consensus 82 ---------~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l 146 (605)
T 1m9s_A 82 ---------P--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI 146 (605)
T ss_dssp ---------G--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred ---------h--hccCCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc
Confidence 3 44445555555555555432 2344555555555555555432 2345555555555555555532
Q ss_pred CCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccc
Q 001274 544 IPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614 (1109)
Q Consensus 544 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 614 (1109)
..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+
T Consensus 147 --~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 147 --TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp --GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred --hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 344555555555555555554333 55555555555555555542 235555555555555555553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=201.45 Aligned_cols=188 Identities=22% Similarity=0.316 Sum_probs=102.0
Q ss_pred cceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeeccc
Q 001274 386 LVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQ 465 (1109)
Q Consensus 386 L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 465 (1109)
+..+.+..+.+.+.. .+..+++|++|++++|.+... +.+..+++|++|++++|++++..+ +..+++|++|++++
T Consensus 26 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 444445555554322 234566677777777766643 235566666666666666665433 55556666666666
Q ss_pred ccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCC
Q 001274 466 NQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIP 545 (1109)
Q Consensus 466 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 545 (1109)
|++++. ..+.++++|++|+|++|++++. +.+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..|
T Consensus 100 n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 100 NKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 665542 1255555555555555555543 3455555555555555555543 345555555555555555554333
Q ss_pred cCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccc
Q 001274 546 HELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589 (1109)
Q Consensus 546 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 589 (1109)
+..+++|+.|+|++|+|++ +| .+..+++|+.|++++|+++
T Consensus 174 --l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 174 --LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp --GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred --hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCccc
Confidence 5555555555555555553 22 2555555555555555554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=220.02 Aligned_cols=191 Identities=21% Similarity=0.312 Sum_probs=120.1
Q ss_pred CCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceee
Q 001274 359 LTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLS 438 (1109)
Q Consensus 359 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 438 (1109)
+..+..+.++.+.+.+.. .+..++.|+.|++++|.+.. ++ .+..+++|+.|+|++|+|.+..+ +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCccccc--chhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 445667788888887544 36789999999999999985 34 58999999999999999998765 89999999999
Q ss_pred cCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCC
Q 001274 439 LGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVG 518 (1109)
Q Consensus 439 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 518 (1109)
|++|.|++. +.+..+++|++|+|++|++.+. ..+..+++|+.|+|++|+++++ ..+..+++|+.|+|++|+|++
T Consensus 94 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 94 LDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred CcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence 999998753 2556666666666666666542 2344455555555555555443 334444444444444444444
Q ss_pred CCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCc
Q 001274 519 YIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFT 565 (1109)
Q Consensus 519 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 565 (1109)
..| +..+++|+.|+|++|+|++. | .+..+++|+.|+|++|+++
T Consensus 168 ~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 168 IVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEE
T ss_pred chh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCc
Confidence 333 44444444444444444422 1 2444444444444444443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=190.79 Aligned_cols=157 Identities=18% Similarity=0.208 Sum_probs=96.6
Q ss_pred cEEEccCCccCCCCChhhcccccccEEecccCcccccCC-cCCCCCCCCCeeecCCCcCccCCCcccccccccceecccc
Q 001274 507 ERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIP-HELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD 585 (1109)
Q Consensus 507 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 585 (1109)
+.+++++|.++. +|..+. +.+++|+|++|+|++..| ..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 356666666653 344332 234556666666654433 3355555566666666655554444555555555555555
Q ss_pred cccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCC
Q 001274 586 NKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEI 665 (1109)
Q Consensus 586 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i 665 (1109)
|++++..+..|.++++|++| +|++|+|++..|..|..+++|+.|+|++|+|++.+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L-------------------------~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 145 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTL-------------------------MLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVA 145 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEE-------------------------ECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBC
T ss_pred CccCccCHhHhcCCcCCCEE-------------------------ECCCCcCCeECHhHcCCCccCCEEECCCCcCCEEC
Confidence 55555555555555555555 45555555566667777777888888888888777
Q ss_pred chhhhccccceEEEccCcccccccCC
Q 001274 666 PASMGEQMSLLVCNLSNNNLVGTVPN 691 (1109)
Q Consensus 666 p~~~~~l~~L~~l~ls~N~l~g~~p~ 691 (1109)
|..|..+++|++|+|++|++.|.++-
T Consensus 146 ~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 146 PGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp TTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred HHHhcCCCCCCEEEecCcCCcCCCch
Confidence 77788888888888888888877664
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-19 Score=200.36 Aligned_cols=170 Identities=25% Similarity=0.348 Sum_probs=79.0
Q ss_pred cccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEE
Q 001274 430 MYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERL 509 (1109)
Q Consensus 430 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 509 (1109)
.+++|+.|++++|.++.. +.+..+++|++|++++|++++..+ +.++++|++|+|++|++++. +.+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEE
Confidence 344455555555544432 224444455555555555544333 44445555555555554432 224444555555
Q ss_pred EccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccc
Q 001274 510 HLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589 (1109)
Q Consensus 510 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 589 (1109)
++++|++++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++..| +..+++|+.|+|++|+++
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 5555554432 2344445555555555555432 334444555555555555543222 444455555555555544
Q ss_pred cccCcccCCCcccceeeccCcccc
Q 001274 590 GAIPSSLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 590 ~~~p~~~~~l~~L~~L~l~~N~l~ 613 (1109)
+. | .+..+++|+.|++++|++.
T Consensus 192 ~l-~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 192 DL-R-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp BC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred CC-h-hhccCCCCCEEECcCCccc
Confidence 32 2 2444455555555555444
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.5e-20 Score=227.69 Aligned_cols=228 Identities=22% Similarity=0.227 Sum_probs=129.7
Q ss_pred cccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEc
Q 001274 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHL 511 (1109)
Q Consensus 432 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 511 (1109)
+.++.|+|.+|.+... + ...|+.++|+.|.|. .++++.|++. ..|+.|..+++|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~~-~-----~~~l~~l~Ls~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-N-----QALLQHKKLSQYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCcc-h-----hhHhhcCccCccccc--------------Ccccccccee-cChhhhccCCCCcEEEC
Confidence 3456666666666542 1 122444555555444 2345566666 56788999999999999
Q ss_pred cCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccc
Q 001274 512 SENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGA 591 (1109)
Q Consensus 512 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 591 (1109)
++|++. .+|..+.++++|++|+|++|+|+ .+|..|+++++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .
T Consensus 232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-T 307 (727)
T ss_dssp TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-c
Confidence 999998 57777779999999999999999 88999999999999999999999 78999999999999999999997 6
Q ss_pred cCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCC--------cccc
Q 001274 592 IPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDN--------QLIG 663 (1109)
Q Consensus 592 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N--------~l~~ 663 (1109)
+|..|+.+++|+.|+|++|+|++.+|..+..+......++|++|.++|.+|. .|+.|++++| .|.+
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~~ 381 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEPQREYDSLQQ 381 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------------------
T ss_pred cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecccccccccCCccc
Confidence 7888999999999999999999999999988766655689999999999886 4566778777 4555
Q ss_pred CCchhhhccccceEEEccCcccccccC
Q 001274 664 EIPASMGEQMSLLVCNLSNNNLVGTVP 690 (1109)
Q Consensus 664 ~ip~~~~~l~~L~~l~ls~N~l~g~~p 690 (1109)
.++..+.++..+....+++|-+.+...
T Consensus 382 ~~~~~~~~l~~~~~~~ls~Nil~~~~~ 408 (727)
T 4b8c_D 382 STEHLATDLAKRTFTVLSYNTLCQHYA 408 (727)
T ss_dssp --------------------CCCGGGC
T ss_pred cccchhhcccccceeeeeccccccccC
Confidence 555556667777777888887765433
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.2e-19 Score=204.16 Aligned_cols=176 Identities=26% Similarity=0.233 Sum_probs=121.0
Q ss_pred eeecCCccccCCCCCCCccccccceeecccccccccCCcccc-CCcccceeccccccccCCCCccccccccccEEEccCC
Q 001274 436 FLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFY-NLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSEN 514 (1109)
Q Consensus 436 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 514 (1109)
.+++++|.++. +|..+. +.++.|+|++|+|++..+..|. ++++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 45555555553 333332 2466677777777766666666 7777777777777777776667777777777777777
Q ss_pred ccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCccc---ccccccceecccccccccc
Q 001274 515 YFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEEL---GQLVNLELLKLSDNKLTGA 591 (1109)
Q Consensus 515 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l---~~l~~L~~L~Ls~N~l~~~ 591 (1109)
+|+++.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 7776666677777777777777777777667777777777777777777775333334 4577777777777777766
Q ss_pred cCcccCCCcc--cceeeccCccccc
Q 001274 592 IPSSLGGLAR--LTELQMGGNIFSG 614 (1109)
Q Consensus 592 ~p~~~~~l~~--L~~L~l~~N~l~~ 614 (1109)
.+..|..++. ++.|+|++|++..
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CHHHhhhccHhhcceEEecCCCccC
Confidence 6666776766 3777888887764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.9e-19 Score=187.47 Aligned_cols=156 Identities=21% Similarity=0.189 Sum_probs=101.3
Q ss_pred CCCccceeeecCCeEEEEeccCccccccccccccCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCch
Q 001274 60 TPCNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQ 139 (1109)
Q Consensus 60 ~~c~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~ 139 (1109)
+.|.|.+|.|+..+++ .+|..+. ++|+.|+|++|.+++..|..++++++|++|+|++|+++...+..
T Consensus 17 ~~Cs~~~v~c~~~~l~-----------~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~ 83 (229)
T 3e6j_A 17 CSCSGTTVDCRSKRHA-----------SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV 83 (229)
T ss_dssp CEEETTEEECTTSCCS-----------SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred CEEeCCEeEccCCCcC-----------ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhh
Confidence 6799999999754322 2333332 67788888888888777777777888888888888776544455
Q ss_pred hhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccch
Q 001274 140 LFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLE 219 (1109)
Q Consensus 140 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~ 219 (1109)
+..+++|++|+|++|.+++..+..+..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..|..+++|+
T Consensus 84 ~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 162 (229)
T 3e6j_A 84 FDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162 (229)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred cccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCC
Confidence 566667777777777666555555666666666666666666 5566666666666666666666544444455555555
Q ss_pred hhhccccccc
Q 001274 220 VLGLAQNSLE 229 (1109)
Q Consensus 220 ~L~L~~n~l~ 229 (1109)
+|+|++|.+.
T Consensus 163 ~L~l~~N~~~ 172 (229)
T 3e6j_A 163 HAYLFGNPWD 172 (229)
T ss_dssp EEECTTSCBC
T ss_pred EEEeeCCCcc
Confidence 5555555544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-19 Score=196.96 Aligned_cols=169 Identities=22% Similarity=0.327 Sum_probs=88.4
Q ss_pred cccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEc
Q 001274 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHL 511 (1109)
Q Consensus 432 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 511 (1109)
.++..+++++|.+++.. .+..+++|++|++++|+++. ++ .+..+++|++|+|++|++++..+ +..+++|++|+|
T Consensus 19 ~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 33444444444444322 34444445555555554442 22 34555555555555555554432 555555555555
Q ss_pred cCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccc
Q 001274 512 SENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGA 591 (1109)
Q Consensus 512 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 591 (1109)
++|++++. |. +.. ++|++|+|++|++++. + .+..+++|+.|+|++|+|++. + .+..+++|+.|+|++|++++.
T Consensus 93 ~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 93 NRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCCc-Cc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 55555542 22 112 5566666666666532 2 355566666666666666542 2 455666666666666666554
Q ss_pred cCcccCCCcccceeeccCcccccc
Q 001274 592 IPSSLGGLARLTELQMGGNIFSGS 615 (1109)
Q Consensus 592 ~p~~~~~l~~L~~L~l~~N~l~~~ 615 (1109)
..+..+++|+.|++++|++.+.
T Consensus 166 --~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 --GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp --TTSTTCCCCCEEEEEEEEEECC
T ss_pred --HHhccCCCCCEEeCCCCcccCC
Confidence 4555666666666666666544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.5e-19 Score=186.32 Aligned_cols=155 Identities=22% Similarity=0.264 Sum_probs=95.2
Q ss_pred eeecccccccccCCccccCCcccceeccccccccCCCC-ccccccccccEEEccCCccCCCCChhhcccccccEEecccC
Q 001274 460 QLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIP-PEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSN 538 (1109)
Q Consensus 460 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 538 (1109)
.+++++|.++. +|..+. ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 44444444442 233221 234556666666655533 34566666666666666666555556666666666666666
Q ss_pred cccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccccccc
Q 001274 539 SLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 539 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 617 (1109)
+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|++.+..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 6665555556666666666666666666666666666667777777777766666777777777777777777765443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.2e-19 Score=203.23 Aligned_cols=182 Identities=23% Similarity=0.203 Sum_probs=130.4
Q ss_pred ceeccccccccCCCCccccccccccEEEccCCccCCCCChhhc-ccccccEEecccCcccccCCcCCCCCCCCCeeecCC
Q 001274 483 SALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVG-NLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSR 561 (1109)
Q Consensus 483 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 561 (1109)
+.+++++|.++. +|..+. +.++.|+|++|+|++..+..+. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 578888888875 455444 3578888888888877777776 788888888888888877777788888888888888
Q ss_pred CcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccc
Q 001274 562 NQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVI 641 (1109)
Q Consensus 562 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~ 641 (1109)
|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|.+++ +|..+.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~-------------------- 156 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELI-------------------- 156 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGT--------------------
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHh--------------------
Confidence 88887666678888888888888888887777788888888888777777763 222210
Q ss_pred cccccCccccceeecCCCccccCCchhhhcccc--ceEEEccCccccccc
Q 001274 642 PYELGNLQMLEALYLDDNQLIGEIPASMGEQMS--LLVCNLSNNNLVGTV 689 (1109)
Q Consensus 642 p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~--L~~l~ls~N~l~g~~ 689 (1109)
..+..+++|+.|||++|+|++..+..+..++. ++.|+|++|++.|..
T Consensus 157 -~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 157 -KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp -C----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred -cCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 00145667777777777777544466666665 366777777777654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=8.6e-19 Score=185.40 Aligned_cols=152 Identities=22% Similarity=0.302 Sum_probs=99.1
Q ss_pred eeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCc
Q 001274 460 QLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNS 539 (1109)
Q Consensus 460 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 539 (1109)
.+++++|.++. +|..+. ++|+.|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 34444555442 233222 456666666666666555566666666666666666666666666666667777777777
Q ss_pred ccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccc
Q 001274 540 LSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614 (1109)
Q Consensus 540 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 614 (1109)
|+...+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++..
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 665555556667777777777777776666667777777777777777776666677777777777777777764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.9e-21 Score=229.13 Aligned_cols=216 Identities=21% Similarity=0.182 Sum_probs=143.4
Q ss_pred cCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccce
Q 001274 357 GQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIF 436 (1109)
Q Consensus 357 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 436 (1109)
...++|+.|+|++|+++ .+|..++++++|+.|++++|......|. .+..+.+.+..|..+..+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence 55677888888888887 6777788888888887766542111111 01122344566777777777777
Q ss_pred ee-cCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCc
Q 001274 437 LS-LGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENY 515 (1109)
Q Consensus 437 L~-L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 515 (1109)
|+ ++.|.+ .+|..+.+++|.++...+ ..|+.|+|++|.|+++ |. |+.+++|+.|+|++|+
T Consensus 414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HCGGGHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSC
T ss_pred Ccchhhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecCccc
Confidence 77 666644 356667777777764332 2367777777777763 44 7777777777777777
Q ss_pred cCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCC-CcccccccccceecccccccccccCc
Q 001274 516 FVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSA-PEELGQLVNLELLKLSDNKLTGAIPS 594 (1109)
Q Consensus 516 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~ 594 (1109)
|+ .+|..++++++|+.|+|++|+|++ +| .++++++|+.|+|++|+|++.. |..|..+++|+.|+|++|++++.+|.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 77 567777777777777777777774 55 6777777777777777777655 77777777777777777777765442
Q ss_pred c---cCCCcccceee
Q 001274 595 S---LGGLARLTELQ 606 (1109)
Q Consensus 595 ~---~~~l~~L~~L~ 606 (1109)
. +..+++|+.|+
T Consensus 552 ~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 552 QERLAEMLPSVSSIL 566 (567)
T ss_dssp TTHHHHHCTTCSEEE
T ss_pred HHHHHHHCcccCccC
Confidence 1 22356666654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=184.10 Aligned_cols=151 Identities=23% Similarity=0.290 Sum_probs=106.0
Q ss_pred eeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCc
Q 001274 436 FLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENY 515 (1109)
Q Consensus 436 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 515 (1109)
.+++++|.++. +|..+. ++|++|++++|+++++.+..|.++++|++|+|++|+|+++.|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 44555555552 333332 456677777777776666677777777777777777777767777777777777777777
Q ss_pred cCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccc
Q 001274 516 FVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589 (1109)
Q Consensus 516 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 589 (1109)
|+++.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 77665666677777777777777777777777777777777777777777666666777777777777777775
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.1e-20 Score=222.92 Aligned_cols=201 Identities=19% Similarity=0.167 Sum_probs=111.8
Q ss_pred cCcCCCceEEeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccc
Q 001274 165 GNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTD 244 (1109)
Q Consensus 165 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 244 (1109)
..+++|+.|+|++|+++ .+|.+++++++|+.|++++|..... +.. .+..+.+.+..|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~----------l~~-ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLT----------IIL-LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHH----------HHH-HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhh----------HHH-HHHhcccccCCHHHHHHHHhccc
Confidence 34455555555555554 4555555555555555544321100 000 01111245566777777777777
Q ss_pred ee-cccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCc
Q 001274 245 LI-LWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQ 323 (1109)
Q Consensus 245 L~-L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~ 323 (1109)
|+ ++.|++ ..|+.+.+++|.++...+ ..|+.|++++|.|++ +|. ++++++|++|+|++|+
T Consensus 414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HCGGGHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred Ccchhhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence 77 666654 356666777777664322 136677777777764 454 6667777777777777
Q ss_pred ccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCC-CcchhcccccceEEccccccccc
Q 001274 324 LTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTI-PLEFQNLTYLVDLQLFDNHLEGT 399 (1109)
Q Consensus 324 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~ 399 (1109)
|+ .+|..++.+++|+.|+|++|.+++ +| .++.+++|++|+|++|+|++.. |..|.++++|+.|+|++|.+++.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 66 445555555555555555555554 33 5555555566666655555444 55555555555555555555543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-18 Score=182.86 Aligned_cols=156 Identities=22% Similarity=0.257 Sum_probs=126.3
Q ss_pred cceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEeccc
Q 001274 458 LMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISS 537 (1109)
Q Consensus 458 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 537 (1109)
.+.+++++++++. +|..+. ++|++|+|++|+|+++.|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus 21 ~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 4556666766663 443332 7788888888888888788888888888888888888876667788888888888888
Q ss_pred CcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccccccc
Q 001274 538 NSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 538 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 617 (1109)
|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+..+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 8888777777888888999999999988 678888888999999999999987777888889999999999998886543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.5e-18 Score=187.17 Aligned_cols=80 Identities=24% Similarity=0.307 Sum_probs=35.2
Q ss_pred cccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeec
Q 001274 480 QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDL 559 (1109)
Q Consensus 480 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 559 (1109)
++|++|+|++|++++. +.+..+++|+.|+|++|++++. + .+..+++|++|+|++|++++. ..+..+++|+.|++
T Consensus 106 ~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l 179 (263)
T 1xeu_A 106 ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179 (263)
T ss_dssp SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEE
T ss_pred CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeC
Confidence 3444444444444432 2344444444444444444432 1 344444444444444444433 33444444444444
Q ss_pred CCCcCc
Q 001274 560 SRNQFT 565 (1109)
Q Consensus 560 s~N~l~ 565 (1109)
++|.++
T Consensus 180 ~~N~~~ 185 (263)
T 1xeu_A 180 TGQKCV 185 (263)
T ss_dssp EEEEEE
T ss_pred CCCccc
Confidence 444444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=3.7e-17 Score=168.90 Aligned_cols=132 Identities=25% Similarity=0.386 Sum_probs=88.9
Q ss_pred ceeccccccccCCCCccccccccccEEEccCCccCCCCCh-hhcccccccEEecccCcccccCCcCCCCCCCCCeeecCC
Q 001274 483 SALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPS-EVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSR 561 (1109)
Q Consensus 483 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 561 (1109)
+++++++|.++. +|..+.. +|++|++++|+|++..+. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~~-ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCc-CccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 455555555542 3443332 566666666666655543 366677777777777777766667777777777777777
Q ss_pred CcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccccccc
Q 001274 562 NQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 562 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 617 (1109)
|+|++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++.+..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 77776666667777777777777777777777777777777778888887776654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-17 Score=173.86 Aligned_cols=153 Identities=17% Similarity=0.308 Sum_probs=67.8
Q ss_pred cCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccce
Q 001274 117 ANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRV 196 (1109)
Q Consensus 117 ~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 196 (1109)
+.+++|++|++++|.+. .+| .+..+++|++|++++|.++ .++.++.+++|++|++++|++++..|..++++++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44444555555555444 233 3444444444444444332 1224444455555555555554444444444444444
Q ss_pred eccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceeccccc-ccCCCCCCccccccccceeeeecc
Q 001274 197 IRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH-LSGEIPPTIGNIQSLELLALHENS 275 (1109)
Q Consensus 197 L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~ 275 (1109)
|++++|.+++.. |..+..+++|++|+|++|+ ++ .+| .+..+++|++|++++|.
T Consensus 117 L~Ls~n~i~~~~------------------------~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 117 LDISHSAHDDSI------------------------LTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EECCSSBCBGGG------------------------HHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBC
T ss_pred EEecCCccCcHh------------------------HHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCC
Confidence 444444444333 3444444444444444444 32 222 34444444444444444
Q ss_pred ceecCchhhhccCccceEEeeccccc
Q 001274 276 FSGGLPKELGKLSRLKKLYVYTNELN 301 (1109)
Q Consensus 276 l~~~~p~~l~~l~~L~~L~l~~n~l~ 301 (1109)
+++ ++ .+..+++|++|++++|++.
T Consensus 171 i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 171 VHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CcC-hH-HhccCCCCCEEEeeCcccC
Confidence 443 22 4445555555555555543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=9.7e-18 Score=174.18 Aligned_cols=153 Identities=15% Similarity=0.205 Sum_probs=118.6
Q ss_pred cCccccceeecccCccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCce
Q 001274 93 CDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEE 172 (1109)
Q Consensus 93 ~~l~~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 172 (1109)
+++++|+.|++++|.++ .+| .+..+++|++|+|++|.+. .+..+..+++|++|+|++|.+++..|..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 56788899999999888 566 6889999999999999665 3457888999999999999999888889999999999
Q ss_pred EEeecCCCCCCCCcccccccccceecccccc-ccCCCCccccccccchhhhcccccccccCchhhhccccccceeccccc
Q 001274 173 LVIYSNNLTGAIPASISKLRQLRVIRAGHNS-LSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNH 251 (1109)
Q Consensus 173 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~-l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~ 251 (1109)
|+|++|++++..|..++++++|++|++++|. ++ .+| .+..+++|++|++++|++++. + .+..+++|++|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 9999999998888889999999999999887 55 444 466666666666666666642 2 45556666666666665
Q ss_pred cc
Q 001274 252 LS 253 (1109)
Q Consensus 252 l~ 253 (1109)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-17 Score=188.85 Aligned_cols=102 Identities=18% Similarity=0.216 Sum_probs=51.3
Q ss_pred CcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhccccccc-EEecccCcccccCCcCCCCCCCCCee
Q 001274 479 LQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLV-TFNISSNSLSGTIPHELGNCVNLQRL 557 (1109)
Q Consensus 479 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L 557 (1109)
+++|+.|+|++|+++.+.+..|.++++|+.|+|.+| ++.+.+..|.++++|+ .+++.+ +++.+.+.+|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 344555555555554444444555555555555554 4444444455555555 555554 4443444555555555555
Q ss_pred ecCCCcCccCCCcccccccccceec
Q 001274 558 DLSRNQFTGSAPEELGQLVNLELLK 582 (1109)
Q Consensus 558 ~Ls~N~l~~~~p~~l~~l~~L~~L~ 582 (1109)
++++|+++...+..|.++++|+.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 5555555544444555555555543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.3e-18 Score=190.37 Aligned_cols=267 Identities=12% Similarity=0.028 Sum_probs=152.7
Q ss_pred cccccceeccccccc--CCCCCCccccccccceeeeeccceecCchhhhc--------cCccceEEeecccccCccCccc
Q 001274 239 LRNLTDLILWQNHLS--GEIPPTIGNIQSLELLALHENSFSGGLPKELGK--------LSRLKKLYVYTNELNGTIPHEL 308 (1109)
Q Consensus 239 l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~--------l~~L~~L~l~~n~l~~~~~~~l 308 (1109)
+++|++|||++|++. ...+. .++.+..+.+..|.| .+..|.+ +++|+.|++.+ .++...+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccc---ccccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 566777777777766 21111 122233444444422 2234444 66666666666 5554555566
Q ss_pred CCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccc-
Q 001274 309 GNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLV- 387 (1109)
Q Consensus 309 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~- 387 (1109)
.+|++|++|++++|.++...+..|....++..+.+..+... ..........|.++..|+
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~--------------------~~~~~i~~~~f~~~~~L~~ 180 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAY--------------------RFKNRWEHFAFIEGEPLET 180 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHH--------------------HTSTTTTTSCEEESCCCEE
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhh--------------------hccccccccccccccccce
Confidence 66666666666666665444444444444444433331110 001111222333344443
Q ss_pred eEEccccc-ccccCCCcccccCcCcEEEeccccccCccchhh-hcccccceeecCCccccCCCCCCCccccccceeeccc
Q 001274 388 DLQLFDNH-LEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHL-CMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQ 465 (1109)
Q Consensus 388 ~L~L~~N~-l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 465 (1109)
.+.+.... +...+...-....++..+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+..|.+|++|++|+|.+
T Consensus 181 ~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 181 TIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred eEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 22222111 00000000112344555555554221 111222 2367788888888888877777788888888888888
Q ss_pred ccccccCCccccCCcccc-eeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEec
Q 001274 466 NQLTGSLPIEFYNLQNLS-ALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNI 535 (1109)
Q Consensus 466 N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 535 (1109)
| ++.+.+.+|.++++|+ .+++.+ .++.+.+..|.++++|+.|++++|+++.+.+..|.++++|+.++.
T Consensus 260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 260 N-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp T-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred c-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 7 7777778888888888 888887 777677788888888888888888888777778888888888763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.7e-17 Score=177.35 Aligned_cols=140 Identities=21% Similarity=0.225 Sum_probs=106.8
Q ss_pred CCCCceEecCCcceEEEEEe-cCCcE--EEEEEeeccCCCc----------------------chhHHHHHHHHHhccCC
Q 001274 804 FSEGAVIGRGACGTVYKATL-ANGEV--IAVKKIKLRGEGA----------------------TADNSFLAEISTLGKIR 858 (1109)
Q Consensus 804 ~~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 858 (1109)
|.+.+.||+|+||.||+|++ .+|+. ||||+++...... .....+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 67888 9999975431110 01136789999999998
Q ss_pred CCce--eeEEEEEEeCCceEEEEEeccC-C----CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 001274 859 HRNI--VKLYGFCYHQDSNLLLYEYMEN-G----SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRD 931 (1109)
Q Consensus 859 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 931 (1109)
|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.|+.|||. +.+|+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCC
Confidence 7753 344432 367899999942 4 67666432 2345678899999999999993 24899999
Q ss_pred CCCCceeeCCCCceEEeecccccccc
Q 001274 932 IKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 932 lkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
|||+|||++. .++|+|||+|....
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999998 99999999998653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=5e-17 Score=167.90 Aligned_cols=113 Identities=28% Similarity=0.389 Sum_probs=56.6
Q ss_pred CCCeeecCCCcCccCCCc-ccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhc
Q 001274 553 NLQRLDLSRNQFTGSAPE-ELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALN 631 (1109)
Q Consensus 553 ~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ 631 (1109)
+|++|+|++|+|++..+. .|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+.+++.|+ .|+
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~ 108 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLK-TLN 108 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCC-EEE
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCC-EEE
Confidence 444444444444432222 244444444444444444444444444444444444444444433333333333333 244
Q ss_pred cCCccccccccccccCccccceeecCCCccccCCc
Q 001274 632 ISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIP 666 (1109)
Q Consensus 632 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip 666 (1109)
|++|+|++.+|..|+.+++|++|+|++|++++..+
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 44455555556666777777777777777777665
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=7.9e-16 Score=155.25 Aligned_cols=132 Identities=24% Similarity=0.253 Sum_probs=75.6
Q ss_pred cccceeeccccccc-ccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEe
Q 001274 456 RSLMQLMLGQNQLT-GSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFN 534 (1109)
Q Consensus 456 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 534 (1109)
++|++|++++|+++ +.+|..|..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34455555555554 34455555555666666666665544 4556666666666666666655555555566666666
Q ss_pred cccCcccccC-CcCCCCCCCCCeeecCCCcCccCCC---cccccccccceecccccccc
Q 001274 535 ISSNSLSGTI-PHELGNCVNLQRLDLSRNQFTGSAP---EELGQLVNLELLKLSDNKLT 589 (1109)
Q Consensus 535 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~Ls~N~l~ 589 (1109)
|++|++++.. +..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6666665321 1455666666666666666664333 25555666666666666555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8e-16 Score=155.21 Aligned_cols=132 Identities=20% Similarity=0.149 Sum_probs=71.6
Q ss_pred CCCceEEccCCccc-ccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCCCCCCCCcccccccccceec
Q 001274 120 SSLEILDLCTNRLH-GVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIR 198 (1109)
Q Consensus 120 ~~L~~L~Ls~n~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 198 (1109)
++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34455555555544 34444444455555555555554433 4555566666666666666555555555556666666
Q ss_pred cccccccCCC-CccccccccchhhhcccccccccCc---hhhhccccccceeccccccc
Q 001274 199 AGHNSLSGPI-PPEISECEGLEVLGLAQNSLEGFLP---SELEKLRNLTDLILWQNHLS 253 (1109)
Q Consensus 199 l~~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p---~~l~~l~~L~~L~L~~N~l~ 253 (1109)
+++|.+++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6666555321 1445555555555555555554433 35556666666666666655
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.61 E-value=6.4e-15 Score=169.79 Aligned_cols=242 Identities=14% Similarity=0.123 Sum_probs=147.7
Q ss_pred CccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecC
Q 001274 361 QLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLG 440 (1109)
Q Consensus 361 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 440 (1109)
+|+.+++..| ++......|.+. +|+.+.+.+ .++...+..|..+++|+.+++++|+++.+....|. ..+|+.+.|.
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp 211 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP 211 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence 3455554433 333333444442 355555543 34434444555555555555555555544444444 3556666665
Q ss_pred CccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccC---
Q 001274 441 SNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFV--- 517 (1109)
Q Consensus 441 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--- 517 (1109)
++ ++.+....|.++++|+.+.+..| ++.+...+|.+ .+|+.+.| .|.++.+....|.++++|+.+++.+|.+.
T Consensus 212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~ 287 (401)
T 4fdw_A 212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDP 287 (401)
T ss_dssp TT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCT
T ss_pred Cc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCc
Confidence 33 55455566666666666666654 45455666666 66777777 44555566667777777777777776654
Q ss_pred --CCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcc
Q 001274 518 --GYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSS 595 (1109)
Q Consensus 518 --~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 595 (1109)
.+.+..|.++++|+.++|. |.++.+-..+|.++++|+.++|..| ++...+.+|.++ +|+.+++++|.+....+..
T Consensus 288 ~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~ 364 (401)
T 4fdw_A 288 EAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKV 364 (401)
T ss_dssp TCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSS
T ss_pred ccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCccccccc
Confidence 3455677777777777777 4466566677777777887777554 555556677777 7788888777777666677
Q ss_pred cCCCc-ccceeeccCcccc
Q 001274 596 LGGLA-RLTELQMGGNIFS 613 (1109)
Q Consensus 596 ~~~l~-~L~~L~l~~N~l~ 613 (1109)
|.+++ +++.|++..|.+.
T Consensus 365 F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 365 WYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CCCSCTTCCEEEECGGGHH
T ss_pred ccCCCCCccEEEeCHHHHH
Confidence 77774 6677777666543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.8e-15 Score=154.65 Aligned_cols=128 Identities=26% Similarity=0.401 Sum_probs=89.9
Q ss_pred ceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCC
Q 001274 483 SALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRN 562 (1109)
Q Consensus 483 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 562 (1109)
+.+++++|.++. +|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 345556666553 343332 46777777777776 45667777777777777777777666667777777777777777
Q ss_pred cCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccc
Q 001274 563 QFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614 (1109)
Q Consensus 563 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 614 (1109)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 7776666677777777777777777776666677778888888888887764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-15 Score=150.65 Aligned_cols=127 Identities=22% Similarity=0.260 Sum_probs=67.2
Q ss_pred cccceeeccccccc-ccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEe
Q 001274 456 RSLMQLMLGQNQLT-GSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFN 534 (1109)
Q Consensus 456 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 534 (1109)
++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34444455555444 34444455555555555555555544 4455555555566655555554555555555555555
Q ss_pred cccCccccc-CCcCCCCCCCCCeeecCCCcCccCCC---cccccccccceeccc
Q 001274 535 ISSNSLSGT-IPHELGNCVNLQRLDLSRNQFTGSAP---EELGQLVNLELLKLS 584 (1109)
Q Consensus 535 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~Ls 584 (1109)
+++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555532 22455555555555555555554333 345555555555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.3e-14 Score=167.25 Aligned_cols=161 Identities=12% Similarity=0.159 Sum_probs=95.1
Q ss_pred ccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceecccccccc-----CCCC
Q 001274 423 SIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFS-----GLIP 497 (1109)
Q Consensus 423 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~p 497 (1109)
+....|.++.+|+.+++..| ++.+....|.+ .+|+.+.+ .|.++.+...+|.++++|+.+++.+|.+. .+.+
T Consensus 217 I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~ 293 (401)
T 4fdw_A 217 IGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHP 293 (401)
T ss_dssp ECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECT
T ss_pred ehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECH
Confidence 33344444444444444432 33333444444 45555555 33344455556666666666666665543 3445
Q ss_pred ccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCccccccc-
Q 001274 498 PEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLV- 576 (1109)
Q Consensus 498 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~- 576 (1109)
..|.++++|+.++|.+ .++.+....|.++++|+.++|..| ++.+-+.+|.++ +|+.+++++|.+....+..|.+++
T Consensus 294 ~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~ 370 (401)
T 4fdw_A 294 YCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPD 370 (401)
T ss_dssp TTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCT
T ss_pred HHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCC
Confidence 5667777777777763 366555666777777777777544 555566677777 777777777777655556666664
Q ss_pred ccceecccccccc
Q 001274 577 NLELLKLSDNKLT 589 (1109)
Q Consensus 577 ~L~~L~Ls~N~l~ 589 (1109)
+++.|++..|.+.
T Consensus 371 ~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 371 DITVIRVPAESVE 383 (401)
T ss_dssp TCCEEEECGGGHH
T ss_pred CccEEEeCHHHHH
Confidence 5777777766554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=6.4e-16 Score=152.50 Aligned_cols=128 Identities=25% Similarity=0.276 Sum_probs=93.1
Q ss_pred Ccccceecccccccc-CCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCee
Q 001274 479 LQNLSALELYQNRFS-GLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRL 557 (1109)
Q Consensus 479 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 557 (1109)
.++|+.|++++|.++ +.+|..+..+++|++|++++|++++. ..++++++|++|+|++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 467778888888877 56677777777888888888877765 667777777777777777776667666667777777
Q ss_pred ecCCCcCccC-CCcccccccccceecccccccccccC---cccCCCcccceeecc
Q 001274 558 DLSRNQFTGS-APEELGQLVNLELLKLSDNKLTGAIP---SSLGGLARLTELQMG 608 (1109)
Q Consensus 558 ~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~ 608 (1109)
++++|++++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.||++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 7777777752 23667777777777777777776555 467777777777765
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.3e-15 Score=151.25 Aligned_cols=132 Identities=19% Similarity=0.263 Sum_probs=84.8
Q ss_pred ceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCC
Q 001274 483 SALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRN 562 (1109)
Q Consensus 483 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 562 (1109)
+.+++++|+++.+ |..+. ++|++|++++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~~~-p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTSV-PTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSSC-CTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCccC-CCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 4455555555533 32222 45666666666666655555666666677777777666555555666777777777777
Q ss_pred cCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccccccc
Q 001274 563 QFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIP 617 (1109)
Q Consensus 563 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 617 (1109)
+|++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|++.+..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 7775555556677777777777777776666666777777777777777776544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.9e-15 Score=151.72 Aligned_cols=109 Identities=25% Similarity=0.369 Sum_probs=68.9
Q ss_pred cccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeec
Q 001274 480 QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDL 559 (1109)
Q Consensus 480 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 559 (1109)
++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 35566666666665 33456666666666666666666655566666666666666666666655566666666666666
Q ss_pred CCCcCccCCCcccccccccceecccccccc
Q 001274 560 SRNQFTGSAPEELGQLVNLELLKLSDNKLT 589 (1109)
Q Consensus 560 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 589 (1109)
++|+|++..+..|..+++|+.|+|++|++.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 666666544445666666666666666665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-15 Score=170.99 Aligned_cols=139 Identities=14% Similarity=0.150 Sum_probs=101.7
Q ss_pred CCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCC---c---------chhH--------HHHHHHHHhccCCCCce
Q 001274 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEG---A---------TADN--------SFLAEISTLGKIRHRNI 862 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~---------~~~~--------~~~~E~~~l~~l~h~ni 862 (1109)
=|++.+.||+|+||.||+|+..+|+.||||+++..... . .... ...+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38889999999999999999989999999997632110 0 0001 12356667777654443
Q ss_pred --eeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 001274 863 --VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD 940 (1109)
Q Consensus 863 --v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~ 940 (1109)
...+++ ...++||||++|++|.++... .....++.|++.+|.||| +.|||||||||.|||++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEe
Confidence 222222 235899999999888654321 234568899999999999 77999999999999998
Q ss_pred CCC----------ceEEeecccccccc
Q 001274 941 EEF----------QAHVGDFGLAKLID 957 (1109)
Q Consensus 941 ~~~----------~~kl~DFG~a~~~~ 957 (1109)
+++ .+.|+||+.+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 776 38999999887654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=9e-15 Score=148.86 Aligned_cols=112 Identities=22% Similarity=0.269 Sum_probs=64.6
Q ss_pred cccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeec
Q 001274 480 QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDL 559 (1109)
Q Consensus 480 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 559 (1109)
++|++|++++|++++..+..|..+++|++|++++|++++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 45555555555555554445555556666666666665554455555666666666666666555555556666666666
Q ss_pred CCCcCccCCCcccccccccceecccccccccc
Q 001274 560 SRNQFTGSAPEELGQLVNLELLKLSDNKLTGA 591 (1109)
Q Consensus 560 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 591 (1109)
++|++++..+..|..+++|+.|+|++|++.+.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 66666644444455566666666666666543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-16 Score=165.62 Aligned_cols=133 Identities=29% Similarity=0.287 Sum_probs=72.1
Q ss_pred CccccceeecccCccCCCCCc------cccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCc
Q 001274 94 DLPRLVEFNISMNFVTGSIPT------DLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNL 167 (1109)
Q Consensus 94 ~l~~L~~L~ls~n~~~~~~p~------~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 167 (1109)
..+.++.++++.+.++|.+|. .++++++|++|+|++|.+++ +| .+..+++|++|+|++|.++ .+|..+..+
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~ 92 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA 92 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence 344555566666666665554 56666666666666666654 44 5555666666666666655 455555555
Q ss_pred CCCceEEeecCCCCCCCCcccccccccceeccccccccCCCC-ccccccccchhhhccccccccc
Q 001274 168 TSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIP-PEISECEGLEVLGLAQNSLEGF 231 (1109)
Q Consensus 168 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~ 231 (1109)
++|++|+|++|++++ +| .++++++|++|++++|.+++..+ ..+..+++|++|++++|.+++.
T Consensus 93 ~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 93 DTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred CcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 566666666666553 33 35555555555555555542111 2344444444444444444433
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-13 Score=158.72 Aligned_cols=237 Identities=11% Similarity=0.070 Sum_probs=104.6
Q ss_pred ccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccc
Q 001274 354 RELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQK 433 (1109)
Q Consensus 354 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~ 433 (1109)
.+|.++++|+.+.+..+..+ .....|.++.+|+.+.+..| ++......|..+..|+.+.+..+... +........+
T Consensus 156 ~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~ 231 (394)
T 4fs7_A 156 EAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTG 231 (394)
T ss_dssp TTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCC
T ss_pred hhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCC
Confidence 34555555555555443222 33444555555555555443 33233344444455555544443221 1111222234
Q ss_pred cceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccC
Q 001274 434 LIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSE 513 (1109)
Q Consensus 434 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 513 (1109)
|+.+.+..+ ++.+....|..+..|+.+.+..+... +....|.++..++.+....+.+. ...|..+.+|+.+.+.+
T Consensus 232 l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~ 306 (394)
T 4fs7_A 232 VKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLD 306 (394)
T ss_dssp CCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECT
T ss_pred CceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---ccccccccccccccccc
Confidence 444444322 22223334444555555555444332 34444555555555544443322 22444555555555543
Q ss_pred CccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccC
Q 001274 514 NYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIP 593 (1109)
Q Consensus 514 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 593 (1109)
+ ++.+...+|.++.+|+.++|.++ ++.+-..+|.++++|+.+++..| ++..-..+|.++.+|+.+++..+ ++ .+.
T Consensus 307 ~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~ 381 (394)
T 4fs7_A 307 S-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYR 381 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGG
T ss_pred c-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-Ehh
Confidence 3 33333444555555555555432 44333445555555555555444 33333444555555555555433 22 123
Q ss_pred cccCCCcccce
Q 001274 594 SSLGGLARLTE 604 (1109)
Q Consensus 594 ~~~~~l~~L~~ 604 (1109)
.+|.++++|+.
T Consensus 382 ~~F~~c~~L~~ 392 (394)
T 4fs7_A 382 YDFEDTTKFKW 392 (394)
T ss_dssp GGBCTTCEEEE
T ss_pred heecCCCCCcE
Confidence 34444444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.2e-13 Score=156.27 Aligned_cols=315 Identities=10% Similarity=0.019 Sum_probs=213.8
Q ss_pred cCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccC
Q 001274 279 GLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQ 358 (1109)
Q Consensus 279 ~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 358 (1109)
....+|.++++|+.+.+..+ ++.....+|.+|++|+.++|.++ ++......|....+|+.+.+..+ +......+|..
T Consensus 62 Ig~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~ 138 (394)
T 4fs7_A 62 IGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKG 138 (394)
T ss_dssp ECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred hHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeec
Confidence 33345555555555555432 44333445666666666666543 44333445555555555554433 33344455666
Q ss_pred CCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceee
Q 001274 359 LTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLS 438 (1109)
Q Consensus 359 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 438 (1109)
...++....... .......|.++++|+.+.+.++. .......|..+.+|+.+++..| ++.+....|.+...|+.+.
T Consensus 139 ~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~ 214 (394)
T 4fs7_A 139 CDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENME 214 (394)
T ss_dssp CCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCC
T ss_pred ccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceee
Confidence 544433333222 22345678899999999997664 3356667888899999999876 5556677888888888888
Q ss_pred cCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCC
Q 001274 439 LGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVG 518 (1109)
Q Consensus 439 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 518 (1109)
+..+... +...+....+|+.+.+..+ ++.+....|.++.+|+.+.+..+... +....|..+..++.+....+.+.
T Consensus 215 ~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~- 289 (394)
T 4fs7_A 215 FPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP- 289 (394)
T ss_dssp CCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC-
T ss_pred cCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec-
Confidence 8776543 3344455677888887654 34466678888999999988877554 66678888888998888777543
Q ss_pred CCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCC
Q 001274 519 YIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGG 598 (1109)
Q Consensus 519 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 598 (1109)
...|..+.+|+.+.+..+ ++.+-..+|.++++|+.++|..+ ++.+-..+|.++.+|+.+++..| ++.+-..+|.+
T Consensus 290 --~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~ 364 (394)
T 4fs7_A 290 --EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQG 364 (394)
T ss_dssp --TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTT
T ss_pred --cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhC
Confidence 356788889999988765 66566778889999999999755 66556678889999999999877 77677788999
Q ss_pred CcccceeeccCc
Q 001274 599 LARLTELQMGGN 610 (1109)
Q Consensus 599 l~~L~~L~l~~N 610 (1109)
+++|+.+++..+
T Consensus 365 C~~L~~i~lp~~ 376 (394)
T 4fs7_A 365 CINLKKVELPKR 376 (394)
T ss_dssp CTTCCEEEEEGG
T ss_pred CCCCCEEEECCC
Confidence 999998887644
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.4e-16 Score=163.77 Aligned_cols=161 Identities=24% Similarity=0.304 Sum_probs=91.8
Q ss_pred hhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCcccccccccc
Q 001274 428 LCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLE 507 (1109)
Q Consensus 428 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 507 (1109)
+.....++.++++.|.+.+..|. ++ .+|..|..+++|++|+|++|.+++ +| .+..+++|+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~-----------------l~-~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~ 73 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPP-----------------IE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLR 73 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTT-----------------CC-CCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCC
T ss_pred HHhcccccCcchheeEeccccCc-----------------Hh-hhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCC
Confidence 44455666666666666654443 01 122255556666666666666665 33 566666666
Q ss_pred EEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCC-cccccccccceeccccc
Q 001274 508 RLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAP-EELGQLVNLELLKLSDN 586 (1109)
Q Consensus 508 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N 586 (1109)
+|++++|+++ .+|..+..+++|++|+|++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|++|++++|
T Consensus 74 ~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N 150 (198)
T 1ds9_A 74 ILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150 (198)
T ss_dssp EEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSC
T ss_pred EEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCC
Confidence 6666666666 345555555666666666666663 33 45566666666666666653221 35566666666666666
Q ss_pred ccccccCcc----------cCCCcccceeeccCcccc
Q 001274 587 KLTGAIPSS----------LGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 587 ~l~~~~p~~----------~~~l~~L~~L~l~~N~l~ 613 (1109)
++++..|.. +..+++|+.|| +|+++
T Consensus 151 ~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred ccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 666554432 55666666665 55554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.2e-14 Score=147.85 Aligned_cols=104 Identities=21% Similarity=0.258 Sum_probs=48.1
Q ss_pred ccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCc--CCCCCCCCCeee
Q 001274 481 NLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPH--ELGNCVNLQRLD 558 (1109)
Q Consensus 481 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~ 558 (1109)
+|++|+|++|.|++. +.|..+++|++|+|++|+|++..+..+..+++|++|+|++|+|+ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 444444444444433 34444455555555555554433333344555555555555553 2333 444445555555
Q ss_pred cCCCcCccCCCcc----cccccccceeccccccc
Q 001274 559 LSRNQFTGSAPEE----LGQLVNLELLKLSDNKL 588 (1109)
Q Consensus 559 Ls~N~l~~~~p~~----l~~l~~L~~L~Ls~N~l 588 (1109)
+++|.++ .+|.. +..+++|+.|++++|.+
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 5555554 23332 44444444444444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=8e-15 Score=149.03 Aligned_cols=133 Identities=16% Similarity=0.165 Sum_probs=100.4
Q ss_pred cccCCcccceeccccccccCCCCccccccc-cccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCC
Q 001274 475 EFYNLQNLSALELYQNRFSGLIPPEIGKLR-NLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVN 553 (1109)
Q Consensus 475 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 553 (1109)
.|.++.+|++|+|++|.++.+ |. +..+. +|++|++++|+|++. ..+..+++|++|+|++|+|++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 466677888888888888754 43 44444 888888888888865 56788888888888888888554455578888
Q ss_pred CCeeecCCCcCccCCCc--ccccccccceecccccccccccCc----ccCCCcccceeeccCcccc
Q 001274 554 LQRLDLSRNQFTGSAPE--ELGQLVNLELLKLSDNKLTGAIPS----SLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 554 L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~ 613 (1109)
|++|+|++|+|+ .+|. .+..+++|+.|++++|+++. +|. .+..+++|+.||+++|...
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 888888888886 4565 77888888888888888874 454 3777888888888887665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=4.3e-13 Score=135.15 Aligned_cols=107 Identities=21% Similarity=0.288 Sum_probs=70.9
Q ss_pred ccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccc
Q 001274 506 LERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD 585 (1109)
Q Consensus 506 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 585 (1109)
.+.+++++|+++. +|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 3556666666663 44433 25666666666666666666666777777777777777655555566777777777777
Q ss_pred cccccccCcccCCCcccceeeccCcccccc
Q 001274 586 NKLTGAIPSSLGGLARLTELQMGGNIFSGS 615 (1109)
Q Consensus 586 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 615 (1109)
|+|++..+..|..+++|+.|+|++|++.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 777766666677777777777777777644
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.39 E-value=8e-13 Score=133.16 Aligned_cols=86 Identities=20% Similarity=0.251 Sum_probs=44.4
Q ss_pred ccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecc
Q 001274 504 RNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKL 583 (1109)
Q Consensus 504 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 583 (1109)
++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 44455555555555444555555555555555555555444444455555555555555555444444555555555555
Q ss_pred cccccc
Q 001274 584 SDNKLT 589 (1109)
Q Consensus 584 s~N~l~ 589 (1109)
++|+++
T Consensus 110 ~~N~~~ 115 (170)
T 3g39_A 110 LNNPWD 115 (170)
T ss_dssp CSSCBC
T ss_pred CCCCCC
Confidence 555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=8e-13 Score=133.64 Aligned_cols=105 Identities=20% Similarity=0.287 Sum_probs=62.4
Q ss_pred cEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceeccccc
Q 001274 507 ERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDN 586 (1109)
Q Consensus 507 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 586 (1109)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 44555555554 2343332 45566666666666555556666666666666666666544444566666666666666
Q ss_pred ccccccCcccCCCcccceeeccCccccc
Q 001274 587 KLTGAIPSSLGGLARLTELQMGGNIFSG 614 (1109)
Q Consensus 587 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 614 (1109)
+|++..+..|..+++|+.|+|++|++..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 6665555556667777777777776663
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.2e-12 Score=132.24 Aligned_cols=104 Identities=20% Similarity=0.257 Sum_probs=54.9
Q ss_pred ceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccC
Q 001274 459 MQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSN 538 (1109)
Q Consensus 459 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 538 (1109)
+.+++++|+++ .+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34445555444 2333322 45555555555555555555555555555555555555544444555555555555555
Q ss_pred cccccCCcCCCCCCCCCeeecCCCcCc
Q 001274 539 SLSGTIPHELGNCVNLQRLDLSRNQFT 565 (1109)
Q Consensus 539 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 565 (1109)
+|++..+..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555444444555555555555555555
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.30 E-value=6.6e-11 Score=136.76 Aligned_cols=133 Identities=12% Similarity=0.173 Sum_probs=61.9
Q ss_pred cCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCC
Q 001274 471 SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGN 550 (1109)
Q Consensus 471 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 550 (1109)
+...+|.++.+|+.+.+..+..+ +....|.++++|+.+.+. +.++.+....|.++.+|+.++|..+ ++.+-..+|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 33445555555555555443322 334455555555555554 2344344445555555555555433 44344455555
Q ss_pred CCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCc
Q 001274 551 CVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGN 610 (1109)
Q Consensus 551 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 610 (1109)
+.+|+.+.|..+ ++.+-..+|.++.+|+.+++.+|.... ..|....+|+.+.+..|
T Consensus 333 C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 333 CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPG 388 (394)
T ss_dssp CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC--------
T ss_pred CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCC
Confidence 555555555433 343334455555555555555554321 23444445555544444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.27 E-value=7.4e-11 Score=136.38 Aligned_cols=333 Identities=12% Similarity=0.123 Sum_probs=194.2
Q ss_pred cCchhhhccc-cccceecccccccCCCCCCccccccccceeeeecc---ceecCchhhhccCccceEEeecccccCccCc
Q 001274 231 FLPSELEKLR-NLTDLILWQNHLSGEIPPTIGNIQSLELLALHENS---FSGGLPKELGKLSRLKKLYVYTNELNGTIPH 306 (1109)
Q Consensus 231 ~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~---l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~ 306 (1109)
+-..+|.+.+ .|+.+.+..+ ++..-..+|.++++|+.+.+..|. ++.....+|.++.+|+.+.+..+ ++.....
T Consensus 54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~ 131 (394)
T 4gt6_A 54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSE 131 (394)
T ss_dssp ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTT
T ss_pred cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhh
Confidence 3445566653 4777777654 554455677777778877777653 55444566777777776666543 3334445
Q ss_pred ccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhccccc
Q 001274 307 ELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYL 386 (1109)
Q Consensus 307 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 386 (1109)
.|..+.+|+.+.+..+ ++......|....+|+.+.+.++ +..+...+|.. .+|+.+.+..+-.. .....|.++..+
T Consensus 132 aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l 207 (394)
T 4gt6_A 132 AFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFAL 207 (394)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTC
T ss_pred hhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcccc
Confidence 6677777777777543 33344445556666666666543 33233334433 45666665543322 334455555555
Q ss_pred ceEEcccccccccCCCcc-cccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeeccc
Q 001274 387 VDLQLFDNHLEGTIPPHI-GVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQ 465 (1109)
Q Consensus 387 ~~L~L~~N~l~~~~p~~~-~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 465 (1109)
.......+.... +...+ .......... ..+.....+..+.+. +.++.+....|.++..|+.+.+..
T Consensus 208 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~ 274 (394)
T 4gt6_A 208 STITSDSESYPA-IDNVLYEKSANGDYAL-----------IRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPD 274 (394)
T ss_dssp CEEEECCSSSCB-SSSCEEEECTTSCEEE-----------EECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCT
T ss_pred ceeccccccccc-ccceeecccccccccc-----------cccccccccceEEcC-CcceEcccceeeecccccEEeccc
Confidence 555544433321 11111 0000000000 001111223333332 234445566788888888888876
Q ss_pred ccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCC
Q 001274 466 NQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIP 545 (1109)
Q Consensus 466 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 545 (1109)
+... +...+|.++++|+.+.+. +.++.+....|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.|..+ ++.+-.
T Consensus 275 ~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~ 350 (394)
T 4gt6_A 275 SVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPE 350 (394)
T ss_dssp TCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCG
T ss_pred ccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhH
Confidence 6544 667788888999998885 5566666778888899999999765 66566678899999999999654 665666
Q ss_pred cCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccc
Q 001274 546 HELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589 (1109)
Q Consensus 546 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 589 (1109)
.+|.++++|+.+++.+|.... ..+....+|+.+.+..|.+.
T Consensus 351 ~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 351 SAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp GGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred hHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 789999999999998886542 46777788888888776553
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=4.9e-14 Score=160.80 Aligned_cols=172 Identities=22% Similarity=0.186 Sum_probs=78.6
Q ss_pred cccceeecccCccCCCCCccccCC-----CCCceEEccCCcccccCCchhh-ccccceEEEcccccccccccccc-----
Q 001274 96 PRLVEFNISMNFVTGSIPTDLANC-----SSLEILDLCTNRLHGVIPFQLF-FINTLRKLYLCENYIFGEIPEEI----- 164 (1109)
Q Consensus 96 ~~L~~L~ls~n~~~~~~p~~l~~l-----~~L~~L~Ls~n~l~~~~~~~l~-~l~~L~~L~L~~n~l~~~~p~~l----- 164 (1109)
++|+.|+|++|.++......+... ++|++|+|++|.+++.....+. .+++|++|+|++|.++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 345555555555553322222221 4555555555555443333332 24455555555555544333332
Q ss_pred cCcCCCceEEeecCCCCCC----CCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccc
Q 001274 165 GNLTSLEELVIYSNNLTGA----IPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLR 240 (1109)
Q Consensus 165 ~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 240 (1109)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++.... .++..+...+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--------------------~L~~~L~~~~ 211 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--------------------LLAAQLDRNR 211 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--------------------HHHHHGGGCS
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--------------------HHHHHHhcCC
Confidence 1234555555555555421 222223344444444444444321100 1233344455
Q ss_pred cccceecccccccCC----CCCCccccccccceeeeeccceecCchhhhcc
Q 001274 241 NLTDLILWQNHLSGE----IPPTIGNIQSLELLALHENSFSGGLPKELGKL 287 (1109)
Q Consensus 241 ~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 287 (1109)
+|++|+|++|.|++. ++..+...++|++|+|++|.|+......+..+
T Consensus 212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 262 (372)
T 3un9_A 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDL 262 (372)
T ss_dssp CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHC
T ss_pred CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHH
Confidence 566666666655532 22223334566666666666655544444433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=8.8e-14 Score=158.69 Aligned_cols=186 Identities=18% Similarity=0.159 Sum_probs=114.2
Q ss_pred CCCceEEccCCcccccCCchhhcc-----ccceEEEcccccccccccccc-cCcCCCceEEeecCCCCCCCCcccccccc
Q 001274 120 SSLEILDLCTNRLHGVIPFQLFFI-----NTLRKLYLCENYIFGEIPEEI-GNLTSLEELVIYSNNLTGAIPASISKLRQ 193 (1109)
Q Consensus 120 ~~L~~L~Ls~n~l~~~~~~~l~~l-----~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 193 (1109)
+.|++|+|++|.++......+... ++|++|+|++|.++......+ ..+++|++|+|++|++++.....++.
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~--- 148 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRD--- 148 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHH---
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHH---
Confidence 567777777777765544444433 566677777666654433332 23455666666666665333322211
Q ss_pred cceeccccccccCCCCccc-cccccchhhhcccccccc----cCchhhhccccccceecccccccCC----CCCCccccc
Q 001274 194 LRVIRAGHNSLSGPIPPEI-SECEGLEVLGLAQNSLEG----FLPSELEKLRNLTDLILWQNHLSGE----IPPTIGNIQ 264 (1109)
Q Consensus 194 L~~L~l~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~ 264 (1109)
.+ ...++|++|+|++|.|+. .++..+...++|++|+|++|+|++. ++..+...+
T Consensus 149 -----------------~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~ 211 (372)
T 3un9_A 149 -----------------LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR 211 (372)
T ss_dssp -----------------HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS
T ss_pred -----------------HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC
Confidence 11 123456666666666653 2344556778899999999988753 245667778
Q ss_pred cccceeeeeccceecC----chhhhccCccceEEeecccccCccCcccCCCC-----cCcEEE--ccCCccc
Q 001274 265 SLELLALHENSFSGGL----PKELGKLSRLKKLYVYTNELNGTIPHELGNCT-----SAVEID--LSENQLT 325 (1109)
Q Consensus 265 ~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~-----~L~~L~--Ls~n~l~ 325 (1109)
+|++|+|++|.|+... +..+...++|++|+|++|.|++.....+..+. .|+.+. +..|.+.
T Consensus 212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 9999999999998643 34556679999999999999865444443332 166666 6666654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.18 E-value=3.5e-11 Score=136.67 Aligned_cols=103 Identities=22% Similarity=0.262 Sum_probs=60.5
Q ss_pred EEccCC-ccCCCCChhhcccccccEEeccc-CcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceeccccc
Q 001274 509 LHLSEN-YFVGYIPSEVGNLEHLVTFNISS-NSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDN 586 (1109)
Q Consensus 509 L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 586 (1109)
++++++ +|++ +|. +..+++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455554 5553 444 55555566666654 5665555555666666666666666666555555666666666666666
Q ss_pred ccccccCcccCCCcccceeeccCccccc
Q 001274 587 KLTGAIPSSLGGLARLTELQMGGNIFSG 614 (1109)
Q Consensus 587 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 614 (1109)
+|++..+..|..++ |+.|+|++|++..
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 66655555555554 6667777776654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.17 E-value=3.8e-11 Score=136.31 Aligned_cols=102 Identities=22% Similarity=0.201 Sum_probs=65.0
Q ss_pred eecccc-cccccCCccccCCcccceecccc-ccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccC
Q 001274 461 LMLGQN-QLTGSLPIEFYNLQNLSALELYQ-NRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSN 538 (1109)
Q Consensus 461 L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 538 (1109)
++++++ ++++ +|. +..+++|++|+|++ |+|+++.+..|.+|++|+.|+|++|+|+++.|..|.++++|+.|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455555 5553 444 66666666666664 6666666666666666777777777666666666666777777777777
Q ss_pred cccccCCcCCCCCCCCCeeecCCCcCc
Q 001274 539 SLSGTIPHELGNCVNLQRLDLSRNQFT 565 (1109)
Q Consensus 539 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 565 (1109)
+|++..+..|..++ |+.|+|++|.+.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 77655444454444 777777777765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.6e-10 Score=125.44 Aligned_cols=147 Identities=16% Similarity=0.074 Sum_probs=114.4
Q ss_pred HHHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceE
Q 001274 798 LEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 798 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 876 (1109)
......|+.....+.|+++.||++... ++.+++|+....... ....+.+|+++++.+. +..+.++++++...+..+
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 344567888888888999999999865 688999998643211 2345889999998884 667889999999888999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD---------------------------------- 922 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------- 922 (1109)
+||||++|.++.+.+.. ......++.++++++..||..
T Consensus 87 lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999999876421 123447888999999999961
Q ss_pred ----------------------CCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 923 ----------------------CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 923 ----------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
....++|+|++|.||+++++..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014599999999999998766667999998763
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.03 E-value=1.1e-08 Score=117.39 Aligned_cols=144 Identities=13% Similarity=0.174 Sum_probs=69.3
Q ss_pred CCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhccccc
Q 001274 450 PGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEH 529 (1109)
Q Consensus 450 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 529 (1109)
..+..+.+|+.+.+..+ +..+...+|.++.+|+.+.+..+ ++.+....|.++.+|+.+.+..+ ++.+....|.++++
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~ 287 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN 287 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence 34444455555555433 23244445555555555555443 33344445555555555555433 33333344555555
Q ss_pred ccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCC
Q 001274 530 LVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGG 598 (1109)
Q Consensus 530 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 598 (1109)
|+.+++.++.++.+-..+|.++.+|+.++|..+ ++.+-..+|.++.+|+.+.+..+ ++.+-..+|.+
T Consensus 288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~ 354 (379)
T 4h09_A 288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEG 354 (379)
T ss_dssp CCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred cccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhC
Confidence 555555555555444455555555555555433 33333344555555555555433 33333344443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.5e-08 Score=116.41 Aligned_cols=318 Identities=9% Similarity=0.024 Sum_probs=190.3
Q ss_pred hhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcC
Q 001274 235 ELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSA 314 (1109)
Q Consensus 235 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 314 (1109)
++....+|+.+.+.. .++.....+|.++.+|+.+.|..+ ++.....+|.+. +|+.+.+..+ ++.....+|.. .+|
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDL 115 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCC
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCc
Confidence 455566777777754 355344567778888888888643 554555666665 5666666543 33233334444 367
Q ss_pred cEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccc
Q 001274 315 VEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDN 394 (1109)
Q Consensus 315 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 394 (1109)
+.+++..+- +......|.. .+|+.+.+..+ +.......|.....++.+.+..++..... .........
T Consensus 116 ~~i~lp~~~-~~i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~-------- 183 (379)
T 4h09_A 116 DDFEFPGAT-TEIGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVA-ENYVLYNKN-------- 183 (379)
T ss_dssp SEEECCTTC-CEECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEE-ETTEEEETT--------
T ss_pred ccccCCCcc-cccccccccc-ceeeeeeccce-eeccccchhcccccccccccccccceeec-ccceecccc--------
Confidence 777776542 2122223322 23444443332 22233445555566666655544332110 000000000
Q ss_pred cccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCc
Q 001274 395 HLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPI 474 (1109)
Q Consensus 395 ~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 474 (1109)
......+.....+..+.+..+. .......+....+|+.+.+..+ ++.+....|.++..|+.+.+..+ ++.+...
T Consensus 184 ---~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~ 257 (379)
T 4h09_A 184 ---KTILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSF 257 (379)
T ss_dssp ---SSEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTT
T ss_pred ---cceeccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcc
Confidence 0111122233344444443322 2233455666677777777554 44455667788888888888776 6656677
Q ss_pred cccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCC
Q 001274 475 EFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNL 554 (1109)
Q Consensus 475 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 554 (1109)
+|.++.+|+.+.+..+ +..+....|.++++|+.+.+.++.++.+....|.++.+|+.++|..+ ++.+-..+|.++++|
T Consensus 258 aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 335 (379)
T 4h09_A 258 LLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKAL 335 (379)
T ss_dssp TTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred ccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCC
Confidence 8888888998888654 55566678888899999999888888777788999999999999755 665667789999999
Q ss_pred CeeecCCCcCccCCCccccccccc
Q 001274 555 QRLDLSRNQFTGSAPEELGQLVNL 578 (1109)
Q Consensus 555 ~~L~Ls~N~l~~~~p~~l~~l~~L 578 (1109)
+.+.+..+ ++.+-..+|.++..+
T Consensus 336 ~~i~ip~~-v~~I~~~aF~~c~~~ 358 (379)
T 4h09_A 336 STISYPKS-ITLIESGAFEGSSIT 358 (379)
T ss_dssp CCCCCCTT-CCEECTTTTTTSSCC
T ss_pred CEEEECCc-cCEEchhHhhCCCCC
Confidence 99998765 554556677776443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.95 E-value=7.5e-10 Score=120.01 Aligned_cols=129 Identities=16% Similarity=0.063 Sum_probs=96.8
Q ss_pred ecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCc--eeeEEEEEEeCCceEEEEEeccCCCHH
Q 001274 811 GRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN--IVKLYGFCYHQDSNLLLYEYMENGSLG 888 (1109)
Q Consensus 811 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~ 888 (1109)
+.|..+.||++...+|+.+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 455669999998777888999987532 2345788999998885444 556888888877889999999998884
Q ss_pred HHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 001274 889 EQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC--------------------------------------------- 923 (1109)
Q Consensus 889 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------------- 923 (1109)
... .+ ...++.++++.+..||...
T Consensus 104 --~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 --SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp --TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred --cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2356778888888888421
Q ss_pred ----------CCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 924 ----------RPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 924 ----------~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
...++|+|++|.||++++++.+.|+|||.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998863
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.92 E-value=2.8e-10 Score=128.43 Aligned_cols=83 Identities=19% Similarity=0.233 Sum_probs=42.0
Q ss_pred cccccceecccccccCCCCCCc---cccccccceeeeeccceecC----chhhhccCccceEEeecccccCccCcccCC-
Q 001274 239 LRNLTDLILWQNHLSGEIPPTI---GNIQSLELLALHENSFSGGL----PKELGKLSRLKKLYVYTNELNGTIPHELGN- 310 (1109)
Q Consensus 239 l~~L~~L~L~~N~l~~~~p~~l---~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~- 310 (1109)
+++|++|+|++|.+++..+..+ ..+++|++|+|+.|.+++.. +..+..+++|+.|++++|.++...-..+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 3445555555544443222111 13456666666666665432 233345666777777777665433333322
Q ss_pred CCcCcEEEccCCc
Q 001274 311 CTSAVEIDLSENQ 323 (1109)
Q Consensus 311 l~~L~~L~Ls~n~ 323 (1109)
+ ...++++.++
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 1 3557777766
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.90 E-value=1.2e-10 Score=131.63 Aligned_cols=204 Identities=17% Similarity=0.164 Sum_probs=114.4
Q ss_pred CeEEEEeccCccccc-c-------ccccccCccccceeecccCccC---------CCCCccccCCCCCceEEccCCcccc
Q 001274 72 FKVTSVDLHGLNLSG-I-------LSPRICDLPRLVEFNISMNFVT---------GSIPTDLANCSSLEILDLCTNRLHG 134 (1109)
Q Consensus 72 ~~v~~l~l~~~~l~g-~-------~~~~~~~l~~L~~L~ls~n~~~---------~~~p~~l~~l~~L~~L~Ls~n~l~~ 134 (1109)
.+|+++.+...+..| . +..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 367777776555443 2 2344556778888877654321 224444556667777777666211
Q ss_pred cCCchhhccccceEEEccccccccccccccc--CcCCCceEEeec--CCCCCCCCcccccccccceeccccccccCCCCc
Q 001274 135 VIPFQLFFINTLRKLYLCENYIFGEIPEEIG--NLTSLEELVIYS--NNLTGAIPASISKLRQLRVIRAGHNSLSGPIPP 210 (1109)
Q Consensus 135 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~ 210 (1109)
.++. + .+++|++|+|..+.+.......++ .+++|++|+|+. |...+.. . +. .+..
T Consensus 186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~----------------~~-~l~~ 244 (362)
T 2ra8_A 186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--D----------------MN-VFRP 244 (362)
T ss_dssp BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--C----------------GG-GTGG
T ss_pred eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--h----------------HH-HHHH
Confidence 1222 2 256666666666665544333343 566666666642 1111110 0 00 0001
Q ss_pred cc--cccccchhhhcccccccccCchhhh---ccccccceecccccccCC----CCCCccccccccceeeeeccceecCc
Q 001274 211 EI--SECEGLEVLGLAQNSLEGFLPSELE---KLRNLTDLILWQNHLSGE----IPPTIGNIQSLELLALHENSFSGGLP 281 (1109)
Q Consensus 211 ~l--~~l~~L~~L~L~~n~l~~~~p~~l~---~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p 281 (1109)
.+ ..+++|++|+|.+|.+.+..+..+. .+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.++...-
T Consensus 245 ~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~ 324 (362)
T 2ra8_A 245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK 324 (362)
T ss_dssp GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHH
T ss_pred HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHH
Confidence 11 2356677777777766544333343 467888888888888753 44555677888888888888876555
Q ss_pred hhhhc-cCccceEEeeccc
Q 001274 282 KELGK-LSRLKKLYVYTNE 299 (1109)
Q Consensus 282 ~~l~~-l~~L~~L~l~~n~ 299 (1109)
..+.. + ...++++.++
T Consensus 325 ~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 325 KELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHC--CSEEECCSBC
T ss_pred HHHHHHc--CCEEEecCCc
Confidence 55544 3 3567887776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.81 E-value=9.1e-09 Score=117.16 Aligned_cols=143 Identities=14% Similarity=0.181 Sum_probs=105.6
Q ss_pred CCceEecCCcceEEEEEecCCcEEEEEEee--ccCCCcchhHHHHHHHHHhccCC--CCceeeEEEEEEeC---CceEEE
Q 001274 806 EGAVIGRGACGTVYKATLANGEVIAVKKIK--LRGEGATADNSFLAEISTLGKIR--HRNIVKLYGFCYHQ---DSNLLL 878 (1109)
Q Consensus 806 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv 878 (1109)
..+.++.|.++.||+++..+ ..+++|+.. ... .......+.+|+.+++.+. +..+.+++.++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678999999999998764 678888764 221 1122456888999999886 45578888888776 447999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC----------------------------------- 923 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 923 (1109)
|||++|..+.+... ..++..++..++.++++.|..||...
T Consensus 120 me~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999987744211 12678888899999999999999620
Q ss_pred --------------------CCCeEecCCCCCceeeCCCCc--eEEeecccccc
Q 001274 924 --------------------RPHIIHRDIKSNNILLDEEFQ--AHVGDFGLAKL 955 (1109)
Q Consensus 924 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~ 955 (1109)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998874
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.80 E-value=8.3e-11 Score=125.72 Aligned_cols=160 Identities=18% Similarity=0.136 Sum_probs=77.2
Q ss_pred CCccceeeecCC--eEEEEeccC---ccccccccc-cccCccccceeecccCccCCCCCc-cccCCCCCce--EEccCCc
Q 001274 61 PCNWIGVECTDF--KVTSVDLHG---LNLSGILSP-RICDLPRLVEFNISMNFVTGSIPT-DLANCSSLEI--LDLCTNR 131 (1109)
Q Consensus 61 ~c~w~gv~C~~~--~v~~l~l~~---~~l~g~~~~-~~~~l~~L~~L~ls~n~~~~~~p~-~l~~l~~L~~--L~Ls~n~ 131 (1109)
.|+|.|+.|+.. +|+.+-..+ ..+.|.+.+ .+..+.. .|...+|.-++.+.- .+...+.|+. ++++.|+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 489999999753 666555544 344555543 2222222 223334433333321 1444444444 5555553
Q ss_pred cc---ccCCchhhccccceEEEcccccccc--cccccccCcCCCceEEeecCCCCCCCCcccccccccceeccccccccC
Q 001274 132 LH---GVIPFQLFFINTLRKLYLCENYIFG--EIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSG 206 (1109)
Q Consensus 132 l~---~~~~~~l~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~ 206 (1109)
.. +.++.....+++|+.|+|++|.|++ .+|..++.+++|++|+|++|+|++. ..+..++
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~-------------- 218 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIK-------------- 218 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGT--------------
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcc--------------
Confidence 22 1111111234555555555555554 3344445555555555555555532 2222222
Q ss_pred CCCccccccccchhhhcccccccccCc-------hhhhcccccccee
Q 001274 207 PIPPEISECEGLEVLGLAQNSLEGFLP-------SELEKLRNLTDLI 246 (1109)
Q Consensus 207 ~~p~~l~~l~~L~~L~L~~n~l~~~~p-------~~l~~l~~L~~L~ 246 (1109)
.+ +|++|+|++|.+.+.+| ..+..+++|+.||
T Consensus 219 -------~l-~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 219 -------GL-KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp -------TS-CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred -------cC-CcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 11 55555555555554443 2366777887776
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.70 E-value=5.5e-09 Score=115.92 Aligned_cols=187 Identities=20% Similarity=0.169 Sum_probs=121.7
Q ss_pred CceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCc--eeeEEEEEEeCC---ceEEEEE
Q 001274 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRN--IVKLYGFCYHQD---SNLLLYE 880 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e 880 (1109)
.+.++.|....||++. +.+++|+... ......+.+|+++++.+. +.. +.+++......+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999874 4588887642 134567889999998873 322 344554443333 3489999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhc--------------------------------------
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD-------------------------------------- 922 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------- 922 (1109)
+++|.++.+.... .++..++..++.++++.+..||..
T Consensus 97 ~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 97 KIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred ccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999888653321 267777888888888888888851
Q ss_pred -----------------CCCCeEecCCCCCceeeCC--CCceEEeeccccccccCCCCCCc--cc-----------cccc
Q 001274 923 -----------------CRPHIIHRDIKSNNILLDE--EFQAHVGDFGLAKLIDLPYSKSM--SA-----------IAGS 970 (1109)
Q Consensus 923 -----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~~~~~~~~~--~~-----------~~gt 970 (1109)
....++|+|++|.||++++ +..+.|+||+.+.......+-.. .. ....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 0245899999999999998 55688999999875431100000 00 0000
Q ss_pred cceec-cccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001274 971 YGYIA-PEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQ 1008 (1109)
Q Consensus 971 ~~y~a-PE~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 1008 (1109)
.++.. |+.... .....+.|++|.++|++.+|+.+|.
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01111 221111 1223689999999999999988753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.47 E-value=9.4e-09 Score=104.66 Aligned_cols=120 Identities=23% Similarity=0.216 Sum_probs=77.4
Q ss_pred ccccccccCccccceeecccC-ccCCC----CCccccCCCCCceEEccCCcccccCCc----hhhccccceEEEcccccc
Q 001274 86 GILSPRICDLPRLVEFNISMN-FVTGS----IPTDLANCSSLEILDLCTNRLHGVIPF----QLFFINTLRKLYLCENYI 156 (1109)
Q Consensus 86 g~~~~~~~~l~~L~~L~ls~n-~~~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~~~----~l~~l~~L~~L~L~~n~l 156 (1109)
..+...+...+.|++|+|++| .++.. +...+...+.|++|+|++|.+.+.... .+...++|++|+|++|.|
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 344556667788888888888 77642 445566678888888888888764333 333446788888888877
Q ss_pred ccc----ccccccCcCCCceEEe--ecCCCCCCCC----cccccccccceecccccccc
Q 001274 157 FGE----IPEEIGNLTSLEELVI--YSNNLTGAIP----ASISKLRQLRVIRAGHNSLS 205 (1109)
Q Consensus 157 ~~~----~p~~l~~l~~L~~L~L--~~n~l~~~~p----~~~~~l~~L~~L~l~~n~l~ 205 (1109)
... +...+...++|++|+| ++|.|+.... ..+...+.|+.|+|++|.+.
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 654 4556666777777777 6677764422 22333355555555555553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.40 E-value=4e-08 Score=104.92 Aligned_cols=67 Identities=27% Similarity=0.319 Sum_probs=36.4
Q ss_pred cccccccEEEccCCccCCC--CChhhcccccccEEecccCcccccCCcCCCCCC--CCCeeecCCCcCccCCC
Q 001274 501 GKLRNLERLHLSENYFVGY--IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCV--NLQRLDLSRNQFTGSAP 569 (1109)
Q Consensus 501 ~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p 569 (1109)
.++++|+.|+|++|+|+++ +|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 3455666666666666652 234555566666666666666543 2233333 56666666666654433
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.30 E-value=3.6e-08 Score=100.37 Aligned_cols=122 Identities=16% Similarity=0.103 Sum_probs=73.3
Q ss_pred CCccccCCCCCceEEccCC-cccccCCc----hhhccccceEEEccccccccc----ccccccCcCCCceEEeecCCCCC
Q 001274 112 IPTDLANCSSLEILDLCTN-RLHGVIPF----QLFFINTLRKLYLCENYIFGE----IPEEIGNLTSLEELVIYSNNLTG 182 (1109)
Q Consensus 112 ~p~~l~~l~~L~~L~Ls~n-~l~~~~~~----~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~ 182 (1109)
+...+...+.|++|+|++| .+...... .+...++|++|+|++|.|... +...+...++|++|+|++|.|++
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 4455677888999999998 88764333 334457788888888887653 34445556777777777777764
Q ss_pred C----CCcccccccccceecc--ccccccCCCCccccccccchhhhcccccccccCchhhhccccccceeccccccc
Q 001274 183 A----IPASISKLRQLRVIRA--GHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLS 253 (1109)
Q Consensus 183 ~----~p~~~~~l~~L~~L~l--~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 253 (1109)
. +...+...+.|++|+| ++|.|+..... .+...+...++|++|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~--------------------~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEM--------------------EIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH--------------------HHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHH--------------------HHHHHHHhCCCcCEEeccCCCCC
Confidence 3 2333444444555555 44444421111 12233445567777777777665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=7.5e-06 Score=88.80 Aligned_cols=135 Identities=21% Similarity=0.150 Sum_probs=99.3
Q ss_pred eEecCCcc-eEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEEEEeccCC
Q 001274 809 VIGRGACG-TVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 809 ~lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
.+..|..| .||+.... +++.+++|+-.. .....+.+|+..++.+. +--+.++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45667666 69998765 467788988752 23456888999988874 334678888999999999999999998
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD------------------------------------------- 922 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------- 922 (1109)
++.+..... ......++.++++.+..||..
T Consensus 106 ~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 106 TAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 887665432 123345666777777777732
Q ss_pred ------------CCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 923 ------------CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 923 ------------~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
....++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012389999999999999887778999998863
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.4e-05 Score=88.25 Aligned_cols=136 Identities=22% Similarity=0.211 Sum_probs=93.9
Q ss_pred CceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCC---ceeeEEEEEE-eCCceEEEEEec
Q 001274 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR---NIVKLYGFCY-HQDSNLLLYEYM 882 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~ 882 (1109)
.+.++.|....||+. ++.+++|+.. .......+.+|+++++.+.+. .+.+.+.++. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 356888999999988 5668888743 223456788999999998642 3566666664 345678999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD---------------------------------------- 922 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------- 922 (1109)
+|..+.+.... .++..+...++.++++.+..||..
T Consensus 96 ~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 96 QGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 99888663211 134444555555555555555521
Q ss_pred -----------------CCCCeEecCCCCCceeeCC---CCc-eEEeecccccc
Q 001274 923 -----------------CRPHIIHRDIKSNNILLDE---EFQ-AHVGDFGLAKL 955 (1109)
Q Consensus 923 -----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DFG~a~~ 955 (1109)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1346799999999999987 455 48999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=2.7e-05 Score=88.21 Aligned_cols=82 Identities=6% Similarity=0.039 Sum_probs=55.1
Q ss_pred ceE-ecCCcceEEEEEec-------CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCC-C--CceeeEEEEEEeC---
Q 001274 808 AVI-GRGACGTVYKATLA-------NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIR-H--RNIVKLYGFCYHQ--- 872 (1109)
Q Consensus 808 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 872 (1109)
+.| +.|....+|+.... +++.+++|+...... .......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 467 78889999998754 266788887642210 0001245778888888874 2 3467788777655
Q ss_pred CceEEEEEeccCCCHHH
Q 001274 873 DSNLLLYEYMENGSLGE 889 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~ 889 (1109)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.64 E-value=1.3e-05 Score=79.24 Aligned_cols=81 Identities=7% Similarity=0.075 Sum_probs=36.3
Q ss_pred ccceeecccCccCCCCCccccCCCCCceEEccCC-cccccCCchhhcc----ccceEEEccccc-ccccccccccCcCCC
Q 001274 97 RLVEFNISMNFVTGSIPTDLANCSSLEILDLCTN-RLHGVIPFQLFFI----NTLRKLYLCENY-IFGEIPEEIGNLTSL 170 (1109)
Q Consensus 97 ~L~~L~ls~n~~~~~~p~~l~~l~~L~~L~Ls~n-~l~~~~~~~l~~l----~~L~~L~L~~n~-l~~~~p~~l~~l~~L 170 (1109)
+|+.||++++.++..--..+..|++|++|+|++| .+++..-..+..+ ++|++|+|++|. ++..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 4555555555555443344555555555555555 2444333333332 234444444432 333322333444444
Q ss_pred ceEEeec
Q 001274 171 EELVIYS 177 (1109)
Q Consensus 171 ~~L~L~~ 177 (1109)
++|+|++
T Consensus 142 ~~L~L~~ 148 (176)
T 3e4g_A 142 KYLFLSD 148 (176)
T ss_dssp CEEEEES
T ss_pred CEEECCC
Confidence 4444444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.60 E-value=2.7e-05 Score=76.90 Aligned_cols=86 Identities=17% Similarity=0.189 Sum_probs=71.0
Q ss_pred CCCceEEccCCcccccCCchhhccccceEEEccccc-ccccccccccCc----CCCceEEeecC-CCCCCCCcccccccc
Q 001274 120 SSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENY-IFGEIPEEIGNL----TSLEELVIYSN-NLTGAIPASISKLRQ 193 (1109)
Q Consensus 120 ~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~p~~l~~l----~~L~~L~L~~n-~l~~~~p~~~~~l~~ 193 (1109)
-+|++|||+++.++...-..+..+++|++|+|++|. ++..--..|+.+ ++|++|+|++| ++|+..-..++++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999988877788889999999999985 776655667664 47999999997 488777777889999
Q ss_pred cceecccccc-cc
Q 001274 194 LRVIRAGHNS-LS 205 (1109)
Q Consensus 194 L~~L~l~~n~-l~ 205 (1109)
|+.|+++++. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999875 44
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00018 Score=80.77 Aligned_cols=140 Identities=20% Similarity=0.257 Sum_probs=79.0
Q ss_pred ceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-----CCceeeEE-E--EEEeCCceEEEE
Q 001274 808 AVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-----HRNIVKLY-G--FCYHQDSNLLLY 879 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~ 879 (1109)
+.|+.|..+.||++...+| .+++|+... . ...+..|+.+++.+. .|.++... | +....+..++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR---P---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS---C---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC---C---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 3456677899999987655 488998863 1 223344555555442 34433310 0 123456778999
Q ss_pred EeccCCCHH--------------HHhcc----CC-C-C-----CCCChHHH-----------------------------
Q 001274 880 EYMENGSLG--------------EQLHG----NK-Q-T-----CLLDWDAR----------------------------- 905 (1109)
Q Consensus 880 e~~~~gsL~--------------~~l~~----~~-~-~-----~~l~~~~~----------------------------- 905 (1109)
||++|..+. ..++. .. . . ..-.|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 01111 10 0 0 00122211
Q ss_pred --HHHHHHHHHHHHHHhh----------cCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 906 --YRIALGAAEGLCYLHY----------DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 906 --~~i~~~i~~~l~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
..+...+.+++++|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666652 125789999999999999888899999999875
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.49 E-value=8.9e-06 Score=81.97 Aligned_cols=90 Identities=20% Similarity=0.132 Sum_probs=61.0
Q ss_pred cccccCccccceeecccC-ccCC----CCCccccCCCCCceEEccCCcccccCCchhh----ccccceEEEccccccccc
Q 001274 89 SPRICDLPRLVEFNISMN-FVTG----SIPTDLANCSSLEILDLCTNRLHGVIPFQLF----FINTLRKLYLCENYIFGE 159 (1109)
Q Consensus 89 ~~~~~~l~~L~~L~ls~n-~~~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~----~l~~L~~L~L~~n~l~~~ 159 (1109)
...+.+-+.|+.|+|++| .+.. .+...+..-+.|+.|+|++|++.+.....|. .-+.|++|+|++|.|...
T Consensus 34 ~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~ 113 (197)
T 1pgv_A 34 NRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPE 113 (197)
T ss_dssp HHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHH
T ss_pred HHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHH
Confidence 334455677888888875 6653 2455667777888888888888765444443 457788888888888754
Q ss_pred ----ccccccCcCCCceEEeecC
Q 001274 160 ----IPEEIGNLTSLEELVIYSN 178 (1109)
Q Consensus 160 ----~p~~l~~l~~L~~L~L~~n 178 (1109)
+.+.+..-+.|++|+|++|
T Consensus 114 Ga~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 114 LLARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHHHhhCCceeEEECCCC
Confidence 3445666667888888754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00041 Score=79.59 Aligned_cols=77 Identities=12% Similarity=0.088 Sum_probs=49.7
Q ss_pred CceEecCCcceEEEEEec-CCcEEEEEEeeccCC----C-cchhHHHHHHHHHhccCCC--C-ceeeEEEEEEeCCceEE
Q 001274 807 GAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE----G-ATADNSFLAEISTLGKIRH--R-NIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~-~~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 877 (1109)
.+.+|.|.++.||+++.. +++.|+||....... . ......+..|+++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357899999999999754 468899998653211 0 1123456788888887632 3 34455543 4556789
Q ss_pred EEEeccCC
Q 001274 878 LYEYMENG 885 (1109)
Q Consensus 878 v~e~~~~g 885 (1109)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00087 Score=73.54 Aligned_cols=138 Identities=20% Similarity=0.219 Sum_probs=91.8
Q ss_pred CceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC---CCceeeEEEEEEeCCceEEEEEecc
Q 001274 807 GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR---HRNIVKLYGFCYHQDSNLLLYEYME 883 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 883 (1109)
.+.|+.|....+|+.... ++.+++|+.... ....+..|++.++.+. ...+.+++.++...+..++||||++
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 457899999999999874 678888887622 3566889999988883 3568888888888888999999999
Q ss_pred CCCHH--------H---HhccCCC--CC-----------------CCChHHHH---HHHH----------------HHHH
Q 001274 884 NGSLG--------E---QLHGNKQ--TC-----------------LLDWDARY---RIAL----------------GAAE 914 (1109)
Q Consensus 884 ~gsL~--------~---~l~~~~~--~~-----------------~l~~~~~~---~i~~----------------~i~~ 914 (1109)
+..+. + .++.... .- .-+|.... ++.. .+++
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87642 1 1222211 00 02344321 1111 1111
Q ss_pred H-HHHHhh-cCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 915 G-LCYLHY-DCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 915 ~-l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
. ...|.. .....++|+|+.+.|++++.++ +.|.||+
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223321 1256899999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0016 Score=70.98 Aligned_cols=79 Identities=22% Similarity=0.288 Sum_probs=56.0
Q ss_pred CCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-C--CceeeEEEEEEeCCceEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-H--RNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~ 879 (1109)
+....+.+|.|..+.||+.+..+|+.|++|+..... ......|..|+..|+.+. . --+.+++++ +..++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence 344457799999999999999999999999865322 223346788999888773 2 134455543 2358999
Q ss_pred EeccCCCH
Q 001274 880 EYMENGSL 887 (1109)
Q Consensus 880 e~~~~gsL 887 (1109)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00063 Score=78.63 Aligned_cols=78 Identities=14% Similarity=0.085 Sum_probs=49.9
Q ss_pred CCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCccccc--cccceeccccccCCC---CCccchhHHHHHHHH
Q 001274 924 RPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIA--GSYGYIAPEYAYTMK---VTEKCDIYSFGVVLL 998 (1109)
Q Consensus 924 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~~~DvwSlGvll~ 998 (1109)
...++|+|+++.|||++.++ ++++||+.+...... .+..... -...|.+|+...... -....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~--~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG--FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH--HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH--HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 67899999999999999876 999999988753211 0111111 123467776554211 122355667888888
Q ss_pred HHHhCC
Q 001274 999 ELITGK 1004 (1109)
Q Consensus 999 elltg~ 1004 (1109)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0051 Score=68.26 Aligned_cols=160 Identities=12% Similarity=0.102 Sum_probs=88.2
Q ss_pred CCCCHHHHHHHhcCCCC-----CceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCC--ce
Q 001274 790 EGFKYHNLLEATGNFSE-----GAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR--NI 862 (1109)
Q Consensus 790 ~~~~~~~~~~~~~~~~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--ni 862 (1109)
...+...+......|.. ...++ |....||++...+|+.+++|..... ......+..|..+++.+... .+
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~---~~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCC---CCCHHHHHHHHHHHHHHHHcCCee
Confidence 33444444444443422 34577 8888999998777878999988622 12345667788877776321 23
Q ss_pred eeEEEE-----EEeCCceEEEEEeccCCCHH-----HH---------hcc----CC--CCCCCChHHH----HH------
Q 001274 863 VKLYGF-----CYHQDSNLLLYEYMENGSLG-----EQ---------LHG----NK--QTCLLDWDAR----YR------ 907 (1109)
Q Consensus 863 v~l~~~-----~~~~~~~~lv~e~~~~gsL~-----~~---------l~~----~~--~~~~l~~~~~----~~------ 907 (1109)
++++.. ....+..++||||++|..+. .+ ++. .. .....++... ..
T Consensus 85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 333332 12345567899999875432 00 111 00 0001121111 00
Q ss_pred ---------HHHHHHHHHHHHhhc----CCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 908 ---------IALGAAEGLCYLHYD----CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 908 ---------i~~~i~~~l~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
+...+.+.++.+... ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 011111222222211 245789999999999999 4 899999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0018 Score=70.98 Aligned_cols=73 Identities=7% Similarity=0.062 Sum_probs=45.3
Q ss_pred CCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCce-eeEEEEEEeCCceEEEEEec-
Q 001274 805 SEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI-VKLYGFCYHQDSNLLLYEYM- 882 (1109)
Q Consensus 805 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~- 882 (1109)
.-.+.|+.|....+|++ +.+++|+..... .......+|+.+++.+...++ .+++++ +.+..++|+||+
T Consensus 21 ~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 21 TGPLERLGGLTNLVFRA-----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CSCEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred cceeEcCCcccccccee-----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 33678999999999999 458888775321 111223567777776632222 355543 444568999999
Q ss_pred cCCCH
Q 001274 883 ENGSL 887 (1109)
Q Consensus 883 ~~gsL 887 (1109)
++.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 65444
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.89 E-value=8.8e-05 Score=74.69 Aligned_cols=68 Identities=21% Similarity=0.088 Sum_probs=39.4
Q ss_pred cccCCCCCceEEccCC-cccccCC----chhhccccceEEEccccccccc----ccccccCcCCCceEEeecCCCCC
Q 001274 115 DLANCSSLEILDLCTN-RLHGVIP----FQLFFINTLRKLYLCENYIFGE----IPEEIGNLTSLEELVIYSNNLTG 182 (1109)
Q Consensus 115 ~l~~l~~L~~L~Ls~n-~l~~~~~----~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~ 182 (1109)
.+.+-+.|++|+|++| ++..... ..+..-+.|+.|+|++|.|... +.+.+..-+.|++|+|++|.|++
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 4455567888888875 6664322 2333445666666666666543 23334455666666666666653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0035 Score=69.76 Aligned_cols=141 Identities=16% Similarity=0.129 Sum_probs=72.4
Q ss_pred eEecCCcce-EEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCC--CceeeEEEEEEeCCceEEEEEeccCC
Q 001274 809 VIGRGACGT-VYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH--RNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 809 ~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
.++.|+... +|+....+++.+++|...... ...+..|+.+++.+.. -.+.+++.+.. +.-+++||++.+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~ 97 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDA 97 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSC
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCc
Confidence 455555544 667766446777777554211 1234466776666632 23455666533 2337899999776
Q ss_pred CHHHHhccCCC---------------------C--CCCChHHHH-------H-------------HHHHHHHHHHHHh--
Q 001274 886 SLGEQLHGNKQ---------------------T--CLLDWDARY-------R-------------IALGAAEGLCYLH-- 920 (1109)
Q Consensus 886 sL~~~l~~~~~---------------------~--~~l~~~~~~-------~-------------i~~~i~~~l~~LH-- 920 (1109)
.+.+++..... . ..++..... . ....+.+.++.+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 66544322110 0 001111100 0 0001111222221
Q ss_pred -hcCCCCeEecCCCCCceeeCCC----CceEEeeccccccc
Q 001274 921 -YDCRPHIIHRDIKSNNILLDEE----FQAHVGDFGLAKLI 956 (1109)
Q Consensus 921 -~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~~~ 956 (1109)
......++|||+.+.|||++.+ +.+.|+||+.+...
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1125689999999999999875 68999999988743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0051 Score=68.03 Aligned_cols=157 Identities=13% Similarity=0.135 Sum_probs=85.4
Q ss_pred CHHHHHHHhcCCCCC-----ceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCc--eeeE
Q 001274 793 KYHNLLEATGNFSEG-----AVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN--IVKL 865 (1109)
Q Consensus 793 ~~~~~~~~~~~~~~~-----~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 865 (1109)
+.+++.....+|... +.|+.|....+|+....++ .+++|..... .....+..|+.+++.+...+ +.++
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 344455555556542 3566788899999987655 5788887632 12334566777776663212 2222
Q ss_pred EEE------EEeCCceEEEEEeccCCCHHH--------------HhccC----CCC-----CCCChHHHHH---------
Q 001274 866 YGF------CYHQDSNLLLYEYMENGSLGE--------------QLHGN----KQT-----CLLDWDARYR--------- 907 (1109)
Q Consensus 866 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~-----~~l~~~~~~~--------- 907 (1109)
+.. ....+..+++|+|++|..+.. .++.. ... ....|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 211 123456689999999865321 01110 100 0011222100
Q ss_pred ---HHHHHHHHHHHHhhc----CCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 908 ---IALGAAEGLCYLHYD----CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 908 ---i~~~i~~~l~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
+...+.+.+++++.. ...+++|+|+++.||++++++.+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011133445555421 14579999999999999987666899999876
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.004 Score=70.16 Aligned_cols=141 Identities=18% Similarity=0.192 Sum_probs=82.3
Q ss_pred ceEecCCcceEEEEEec--------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEE
Q 001274 808 AVIGRGACGTVYKATLA--------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 878 (1109)
+.+..|-...+|++... +++.|++|+... .........+|.++++.+. +.-..++++++.. .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 46777888999999864 257899988632 1223456678999988874 3223566665543 399
Q ss_pred EEeccCCCHHHH-----------------hccCCC--CCCCC--hHHHHHHHHHHHH-------------------HHHH
Q 001274 879 YEYMENGSLGEQ-----------------LHGNKQ--TCLLD--WDARYRIALGAAE-------------------GLCY 918 (1109)
Q Consensus 879 ~e~~~~gsL~~~-----------------l~~~~~--~~~l~--~~~~~~i~~~i~~-------------------~l~~ 918 (1109)
|||++|.++..- ++.... ..... +.++.++..++.. .++.
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998654311 111110 01122 3444444443321 2233
Q ss_pred Hhh-----cCCCCeEecCCCCCceeeCCC----CceEEeecccccc
Q 001274 919 LHY-----DCRPHIIHRDIKSNNILLDEE----FQAHVGDFGLAKL 955 (1109)
Q Consensus 919 LH~-----~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~~ 955 (1109)
|.. .....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 321 124579999999999999876 7899999998863
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0045 Score=71.37 Aligned_cols=72 Identities=19% Similarity=0.259 Sum_probs=48.4
Q ss_pred ceEecCCcceEEEEEecC--------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCc-eeeEEEEEEeCCceEEE
Q 001274 808 AVIGRGACGTVYKATLAN--------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN-IVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 878 (1109)
+.|+.|....||++...+ ++.|++|+.... . ....+.+|..+++.+...+ ..++++.+. + .+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v 150 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 150 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence 467888899999998653 578999887421 1 1245668999888874333 356666543 2 389
Q ss_pred EEeccCCCH
Q 001274 879 YEYMENGSL 887 (1109)
Q Consensus 879 ~e~~~~gsL 887 (1109)
+||++|.++
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0035 Score=58.85 Aligned_cols=58 Identities=17% Similarity=0.200 Sum_probs=42.5
Q ss_pred hccCCcccc-ccccccccCccccceeecCCCccccCCchhhhccccceEEEccCccccccc
Q 001274 630 LNISHNNLS-GVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTV 689 (1109)
Q Consensus 630 L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~ 689 (1109)
++.+++.|+ ..+|..+. .+|+.|||++|+|+...+..|..++.|++|+|++|++.+..
T Consensus 13 v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC 71 (130)
T 3rfe_A 13 VDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDC 71 (130)
T ss_dssp EECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSG
T ss_pred EEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccC
Confidence 567777776 24454432 46888999999998555566788888999999988887644
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.22 E-value=0.012 Score=68.01 Aligned_cols=73 Identities=16% Similarity=0.139 Sum_probs=46.9
Q ss_pred ceEecCCcceEEEEEecC-CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCce-eeEEEEEEeCCceEEEEEeccCC
Q 001274 808 AVIGRGACGTVYKATLAN-GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI-VKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
+.|+.|-...+|++...+ ++.|++|+..... ....+..+|..+++.+...++ .++++++. + .+||||++|.
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 568888899999998764 4788888774221 111123578888888854444 56776652 2 3699999875
Q ss_pred CH
Q 001274 886 SL 887 (1109)
Q Consensus 886 sL 887 (1109)
++
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.006 Score=57.27 Aligned_cols=36 Identities=31% Similarity=0.408 Sum_probs=19.6
Q ss_pred cceecccccccccccCcccCCCcccceeeccCcccc
Q 001274 578 LELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 578 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 613 (1109)
|+.|+|++|+|+.+.+..|..+++|+.|+|++|++.
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 444555555554444445555556666666666554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0054 Score=69.39 Aligned_cols=73 Identities=10% Similarity=0.099 Sum_probs=43.1
Q ss_pred ceEecCCcceEEEEEecC---------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCc-eeeEEEEEEeCCceEE
Q 001274 808 AVIGRGACGTVYKATLAN---------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN-IVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l 877 (1109)
+.++.|....+|++...+ ++.+++|+.... .........|.++++.+...+ +.++++.. . .++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 357788888999998653 267888876521 111123457888887774323 34566543 2 378
Q ss_pred EEEeccCCCH
Q 001274 878 LYEYMENGSL 887 (1109)
Q Consensus 878 v~e~~~~gsL 887 (1109)
||||++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.70 E-value=0.017 Score=64.30 Aligned_cols=32 Identities=25% Similarity=0.351 Sum_probs=28.5
Q ss_pred CCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 924 RPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 924 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
...++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45799999999999999888999999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.58 E-value=0.21 Score=50.46 Aligned_cols=121 Identities=17% Similarity=0.137 Sum_probs=75.1
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCCCc
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 964 (1109)
-+|.+.|...+.. +++++++.++.|.+.+|.-.-.. ..+ ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~P--lsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQP--INEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCCC--cCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 3789999877654 99999999999999998776211 011 1333457899999999988864 2111
Q ss_pred cccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCC-CCCcccCCcHHHHHHHhh
Q 001274 965 SAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSP-VQSLELGGDLVTWVRRSI 1024 (1109)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~p-f~~~~~~~~~~~~~~~~~ 1024 (1109)
.....+.|||... ...+.+.=|||+|+++|.-+--..| -+...-...+...+..+.
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt 154 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMA 154 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHH
Confidence 1122477888653 3456788999999999999874433 333333344555554443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.20 E-value=0.064 Score=61.20 Aligned_cols=73 Identities=10% Similarity=0.055 Sum_probs=47.2
Q ss_pred ceEecCCcceEEEEEecC--------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEE
Q 001274 808 AVIGRGACGTVYKATLAN--------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 878 (1109)
+.+..|-...+|+....+ ++.|++|+.... .....+..+|..+++.+. +.-..++++.+ . .+.|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~---t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH---VGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC---C-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC---cchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 467778888999998753 578888886422 122223457888887774 22234555433 2 3789
Q ss_pred EEeccCCCH
Q 001274 879 YEYMENGSL 887 (1109)
Q Consensus 879 ~e~~~~gsL 887 (1109)
|||++|.++
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.32 E-value=1.1 Score=50.64 Aligned_cols=30 Identities=30% Similarity=0.410 Sum_probs=25.5
Q ss_pred CeEecCCCCCceee------CCCCceEEeecccccc
Q 001274 926 HIIHRDIKSNNILL------DEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 926 ~ivH~Dlkp~NIll------~~~~~~kl~DFG~a~~ 955 (1109)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567899999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.93 E-value=2.5 Score=42.64 Aligned_cols=124 Identities=10% Similarity=0.113 Sum_probs=82.2
Q ss_pred HHHHhccCCCCceeeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 001274 850 EISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIH 929 (1109)
Q Consensus 850 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 929 (1109)
|+..+.. .||+.++. .+-...+...+.|+.-+.+.=...+++ .+...+++++.+|+....+++ .-+|
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~------~~~~eKlr~l~ni~~l~~~~~-----~r~t 102 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS------FTKNEKLRYLLNIKNLEEVNR-----TRYT 102 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG------SCHHHHHHHHHHGGGGGGGGG-----SSEE
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh------cCHHHHHHHHHHHHHHHHHhc-----CceE
Confidence 3444433 67888865 455555655555554432211122322 778899999999999887777 2388
Q ss_pred cCCCCCceeeCCCCceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 001274 930 RDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQS 1009 (1109)
Q Consensus 930 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~ 1009 (1109)
--++|+|++++.++.+++.-.|+...+ +|. .++...=.-.+=+++..+++++..|+.
T Consensus 103 f~L~P~NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 103 FVLAPDELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CCCSGGGEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEecceEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999999999999876654322 222 222333355677899999999998863
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.43 E-value=3.6 Score=41.56 Aligned_cols=115 Identities=10% Similarity=0.075 Sum_probs=78.9
Q ss_pred CCCceeeEEEEEEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHH-HHhhcCCCCeEecCCCCCc
Q 001274 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC-YLHYDCRPHIIHRDIKSNN 936 (1109)
Q Consensus 858 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~Dlkp~N 936 (1109)
.||+. -..+-..++...+.++.-+++.=...++. ++..++++++.+|+.... +++ .-+|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence 67877 33344566666666776544433333432 778899999999998877 666 45888999999
Q ss_pred eeeCCCCceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001274 937 ILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQ 1008 (1109)
Q Consensus 937 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 1008 (1109)
++++.++.+++.-.|+-.. ++|. .++...=.-.+=+++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~~~------------------lpP~-----e~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES------------------LPPD-----EWDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTT------------------BSSC-----SCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCccc------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999987665432 2332 12222234567788888999988876
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.68 E-value=0.18 Score=58.45 Aligned_cols=63 Identities=11% Similarity=0.034 Sum_probs=17.9
Q ss_pred CCceEecCCcceEEEEEecC-CcEEEE------EEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe
Q 001274 806 EGAVIGRGACGTVYKATLAN-GEVIAV------KKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH 871 (1109)
Q Consensus 806 ~~~~lG~G~fg~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 871 (1109)
..+++| ||.||+|.+.. ..+||| |..+......+....+.+|..+++..+|+|+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345566 99999998763 467888 7665433334445678899999999999999998887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1109 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-34 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-29 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-27 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.004 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-23 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 7e-67
Identities = 78/287 (27%), Positives = 125/287 (43%), Gaps = 24/287 (8%)
Query: 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
G + G IG G+ GTVYK +G+V AVK + + +F E+ L K RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
I+ G+ ++ ++ E SL LH + + IA A+G+ YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA 122
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID-LPYSKSMSAIAGSYGYIAPEYAY 980
IIHRD+KSNNI L E+ +GDFGLA + S ++GS ++APE
Sbjct: 123 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 981 TMK---VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037
+ + D+Y+FG+VL EL+TG+ P + + + + +L R
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084
+ ++ C RP +++A + +S+
Sbjct: 236 SNCPKA--------MKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 8e-63
Identities = 64/281 (22%), Positives = 115/281 (40%), Gaps = 24/281 (8%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+ IG G G V+ N + +A+K I+ EGA ++ F+ E + K+ H +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
V+LYG C Q L++E+ME+G L + + Q L + + L EG+ Y
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGM---AYL 117
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
+IHRD+ + N L+ E V DFG+ + + S + + +PE
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042
+ + K D++SFGV++ E+ + ++V + P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP--RLASTHV---- 231
Query: 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083
+I C P +RP ++ + + +S
Sbjct: 232 ----------YQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 3e-62
Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 24/275 (8%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+G G G V+ +AVK +K +G+ + ++FLAE + + +++H+ +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRL 70
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
V+LY Q+ ++ EYMENGSL + L L + +A AEG+ ++
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE-- 126
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
+ IHRD+++ NIL+ + + DFGLA+LI+ + + APE
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042
T K D++SFG++L E++T +++ + R + P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP------------- 232
Query: 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
EE+ ++ C P +RPT + +++
Sbjct: 233 DNCPEEL---YQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-60
Identities = 66/300 (22%), Positives = 124/300 (41%), Gaps = 36/300 (12%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+F + + +G G G V+K + +G V+A K I L + A N + E+ L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-IRNQIIRELQVLHECNSPY 65
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
IV YG Y + E+M+ GSL + L + + ++++ +GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
+ I+HRD+K +NIL++ + + DFG++ + + S G+ Y++PE
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQG 177
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQS-----------LELGGDLVTWVRRSIHEMVPT 1030
+ + DI+S G+ L+E+ G+ P+ ++ GD R P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 1031 SELF-DKRLDLSAKRTVEEMTLFLKIALFCSSTS--------------PLNRPTMREVIA 1075
S D R ++ ++ + L S P R +++++
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 9e-60
Identities = 69/275 (25%), Positives = 112/275 (40%), Gaps = 24/275 (8%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+ +G+G G V+ T +A+K +K G + +FL E + K+RH +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
V+LY + ++ EYM GSL + L G L +A A G+ Y+
Sbjct: 75 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER- 131
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
+ +HRD+++ NIL+ E V DFGLA+LI+ + + APE A
Sbjct: 132 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042
+ T K D++SFG++L EL T + +++ V R P +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP--------ECPE 241
Query: 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
+ C P RPT + A +
Sbjct: 242 S--------LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 1e-59
Identities = 58/277 (20%), Positives = 108/277 (38%), Gaps = 24/277 (8%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+ + +G G G V +A+K IK EG+ +++ F+ E + + H +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
V+LYG C Q ++ EYM NG L L + + E + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES- 118
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
+HRD+ + N L++++ V DFGL++ + S + PE
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042
K + K DI++FGV++ E+ + + + + + P L +++
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP--HLASEKV---- 230
Query: 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079
I C RPT + +++ ++D
Sbjct: 231 ----------YTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-58
Identities = 63/278 (22%), Positives = 117/278 (42%), Gaps = 24/278 (8%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
++ IG G+ G K ++G+++ K++ ++E++ L +++H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 862 IVKLYGFCYHQDSNLL--LYEYMENGSLGEQLH-GNKQTCLLDWDARYRIALGAAEGLCY 918
IV+ Y + + L + EY E G L + G K+ LD + R+ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 919 LHY--DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAP 976
H D ++HRD+K N+ LD + +GDFGLA++++ S A G+ Y++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSP 183
Query: 977 EYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036
E M EK DI+S G +L EL P + ++ + + +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---------QKELAGKIREGKFRRI 234
Query: 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
S + +I + +RP++ E++
Sbjct: 235 PYRYSDE--------LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 5e-58
Identities = 71/291 (24%), Positives = 116/291 (39%), Gaps = 30/291 (10%)
Query: 809 VIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGF 868
IG+G G V++ GE +AVK R E AEI +RH NI+
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 65
Query: 869 CYHQDSNL----LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC- 923
+ L+ +Y E+GSL + L+ + + ++AL A GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 924 ----RPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP---YSKSMSAIAGSYGYIAP 976
+P I HRD+KS NIL+ + + D GLA D + + G+ Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 977 EYAYTM------KVTEKCDIYSFGVVLLELITGKSPVQSLELGGD---LVTWVRRSIHEM 1027
E + ++ DIY+ G+V E+ S E + S+ EM
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 1028 VPTSELFDKRLDLSAK-RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
R ++ + ++ E + + KI C + R T + +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-58
Identities = 68/276 (24%), Positives = 112/276 (40%), Gaps = 30/276 (10%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
IG+G G V G +AVK IK +FLAE S + ++RH N+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNL 62
Query: 863 VKLYGFCYHQDSNL-LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
V+L G + L ++ EYM GSL + L ++ +L D + +L E + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE- 120
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
+ +HRD+ + N+L+ E+ A V DFGL K S + + APE
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALRE 174
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041
K + K D++SFG++L E+ + D+V V + ++D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------GYKMDAP 222
Query: 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
++ C RP+ ++ +
Sbjct: 223 DGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 7e-57
Identities = 68/304 (22%), Positives = 119/304 (39%), Gaps = 41/304 (13%)
Query: 792 FKYHNLLEATGNFSE---------GAVIGRGACGTVYKATLA----NGEVIAVKKIKLRG 838
F + + EA F++ VIG G G V L +A+K +K G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SG 65
Query: 839 EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTC 898
FL+E S +G+ H N++ L G +++ E+MENGSL L N
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 899 LLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID- 957
+ G A G+ YL + +HRD+ + NIL++ V DFGL++ ++
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 958 ---LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELG 1013
P S + APE K T D++S+G+V+ E+++ G+ P +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-- 238
Query: 1014 GDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
+ + + +D + ++ L C +RP ++
Sbjct: 239 -------NQDVINAIEQDYRLPPPMDCPSA--------LHQLMLDCWQKDRNHRPKFGQI 283
Query: 1074 IAMM 1077
+ +
Sbjct: 284 VNTL 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-56
Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 29/274 (10%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKKI-KLRGEGATADNSFLAEISTLGKIRHR 860
+F G +G+G G VY A + ++A+K + K + E A ++ E+ +RH
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
NI++LYG+ + L+ EY G++ +L + D A L Y H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH 123
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
+IHRDIK N+LL + + DFG + S + + G+ Y+ PE
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIE 177
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040
EK D++S GV+ E + GK P + + + I + T F +
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFE-----ANTYQETYKRISRVEFT---FPDFVTE 229
Query: 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
A+ + + +P RP +REV+
Sbjct: 230 GARDLISRLL----------KHNPSQRPMLREVL 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 63/275 (22%), Positives = 112/275 (40%), Gaps = 30/275 (10%)
Query: 809 VIGRGACGTVYKATLAN---GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
+G G GTV K + +AVK +K + LAE + + ++ + IV++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
G C +S +L+ E E G L + L N+ + + + G+ YL
Sbjct: 74 IGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---S 126
Query: 926 HIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAYTMK 983
+ +HRD+ + N+LL + A + DFGL+K + D Y K+ + + APE K
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 984 VTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042
+ K D++SFGV++ E + G+ P + ++ + M+ E
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMK---------GSEVTAMLEKGERMGCPAGCPR 237
Query: 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
+ + C + NRP V +
Sbjct: 238 E--------MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 8e-56
Identities = 69/272 (25%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 809 VIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
IGRG+ TVYK +A +++ R + F E L ++H NIV+ Y
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 868 FCYHQDSN----LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC 923
+L+ E M +G+L L K + +GL +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH-TR 131
Query: 924 RPHIIHRDIKSNNILL-DEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
P IIHRD+K +NI + +GD GLA L ++K+ + G+ ++APE Y
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEM-YEE 187
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042
K E D+Y+FG+ +LE+ T + P + R + V + FDK
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPAS-FDKVAIPEV 242
Query: 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
K I C + R ++++++
Sbjct: 243 KE----------IIEGCIRQNKDERYSIKDLL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-55
Identities = 64/298 (21%), Positives = 122/298 (40%), Gaps = 35/298 (11%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGE-----VIAVKKIKLRGEGATADNSFLAEISTLGKI 857
+ VIG G G VYK L +A+K +K G FL E +G+
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQF 66
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
H NI++L G +++ EYMENG+L + ++ + G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGM- 123
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIA 975
Y + +HRD+ + NIL++ V DFGL++++ D + + S + A
Sbjct: 124 --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 976 PEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035
PE K T D++SFG+V+ E++T +++ + P
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP------ 235
Query: 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM------IDARQSVSDY 1087
++ + ++ + C RP ++++++ D+ ++++D+
Sbjct: 236 ----------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 283
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (484), Expect = 6e-55
Identities = 63/288 (21%), Positives = 113/288 (39%), Gaps = 26/288 (9%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+ + +G G G VY+ +AVK +K E FL E + + +I+H N
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPN 74
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
+V+L G C + ++ E+M G+L + L + + +A + + YL
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLE- 132
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
+ + IHRD+ + N L+ E V DFGL++L+ + + + APE
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041
K + K D+++FGV+L E+ T + + + P
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK------ 244
Query: 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ--SVSDY 1087
++ C +P +RP+ E+ Q S+SD
Sbjct: 245 ----------VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (485), Expect = 1e-54
Identities = 71/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 804 FSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRN 861
FS+ IG G+ G VY A + N EV+A+KK+ G + + E+ L K+RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
++ G + + L+ EY + K L + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLH- 132
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
++IHRD+K+ NILL E +GDFG A ++ ++ G+ ++APE
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILA 185
Query: 982 M---KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038
M + K D++S G+ +EL K P+ + ++ + P L
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYHIAQNESP--ALQSGHW 239
Query: 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
+ V+ C P +RPT ++
Sbjct: 240 SEYFRNFVDS----------CLQKIPQDRPTSEVLL 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-54
Identities = 64/275 (23%), Positives = 106/275 (38%), Gaps = 25/275 (9%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
++ +G GA G V A E +AVK + ++ + EI + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHE 63
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
N+VK YG + L EY G L +++ + + R G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH 120
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP-YSKSMSAIAGSYGYIAPEYA 979
I HRDIK N+LLDE + DFGLA + + ++ + G+ Y+APE
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 980 YTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038
+ E D++S G+VL ++ G+ P + + + P ++ L
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
L K +P R T+ ++
Sbjct: 238 ALLHK---------------ILVENPSARITIPDI 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-54
Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 803 NFSEGAVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIR 858
+F+E VIGRG G VY TL + AVK + R + FL E +
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFS 86
Query: 859 HRNIVKLYGFCYHQDSNLLL-YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
H N++ L G C + + L+ YM++G L + +T L A+G+
Sbjct: 87 HPNVLSLLGICLRSEGSPLVVLPYMKHGDL--RNFIRNETHNPTVKDLIGFGLQVAKGM- 143
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI---DLPYSKSMSAIAGSYGYI 974
+ +HRD+ + N +LDE+F V DFGLA+ + + + + ++
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034
A E T K T K D++SFGV+L EL+T +P D+ ++ + + P
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP----- 256
Query: 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083
+ + + ++ L C RP+ E+++ + +
Sbjct: 257 --------EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (478), Expect = 6e-54
Identities = 69/303 (22%), Positives = 113/303 (37%), Gaps = 48/303 (15%)
Query: 803 NFSEGAVIGRGACGTVYKATLAN------GEVIAVKKIKLRGEGATADNSFLAEISTLGK 856
N IG GA G V++A ++AVK +K A F E + + +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAE 72
Query: 857 IRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCL----------------- 899
+ NIVKL G C LL+EYM G L E L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 900 ----LDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955
L + IA A G+ YL +HRD+ + N L+ E + DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 956 I-DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGG 1014
I Y K+ A ++ PE + + T + D++++GVVL E+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 1015 DLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
+++ +VR P + + + C S P +RP+ +
Sbjct: 250 EVIYYVRDGNILACPENCPLE----------------LYNLMRLCWSKLPADRPSFCSIH 293
Query: 1075 AMM 1077
++
Sbjct: 294 RIL 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-53
Identities = 61/273 (22%), Positives = 106/273 (38%), Gaps = 29/273 (10%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYG 867
+G GA G VYKA + A K I + E D ++ EI L H NIVKL
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED--YMVEIDILASCDHPNIVKLLD 76
Query: 868 FCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHI 927
Y++++ +L E+ G++ + ++ L + + L YLH I
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 928 IHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM----- 982
IHRD+K+ NIL + + DFG++ + + G+ ++APE
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETSKDR 190
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042
K D++S G+ L+E+ + P V I + P + R +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPP-----HHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
K +++ + R T +++
Sbjct: 246 KDFLKKCL----------EKNVDARWTTSQLLQ 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-53
Identities = 57/283 (20%), Positives = 113/283 (39%), Gaps = 30/283 (10%)
Query: 810 IGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLY 866
+G G G+V + +A+K +K E A + + E + ++ + IV+L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLI 75
Query: 867 GFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH 926
G C ++ +L+ E G L + L G ++ + + + G+ YL +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE---KN 129
Query: 927 IIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIAPEYAYTMKV 984
+HRD+ + N+LL A + DFGL+K + D Y + SA + APE K
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 985 TEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAK 1043
+ + D++S+GV + E ++ G+ P + ++ + + + + + +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMK---------GPEVMAFIEQGKRMECPPECPPE 240
Query: 1044 RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSD 1086
+ C +RP V M S++
Sbjct: 241 --------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-52
Identities = 66/309 (21%), Positives = 114/309 (36%), Gaps = 39/309 (12%)
Query: 803 NFSEGAVIGRGACGTVYKATLANG---EVIAVKKIKLRGEGATADNSFLAEISTLGKI-R 858
+ VIG G G V KA + A+K++K F E+ L K+
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGH 69
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCL-------------LDWDAR 905
H NI+ L G C H+ L EY +G+L + L ++ L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 906 YRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMS 965
A A G+ Y + IHRD+ + NIL+ E + A + DFGL++ + +
Sbjct: 130 LHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--VYVKKT 184
Query: 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIH 1025
++A E T D++S+GV+L E+++ +L
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------- 236
Query: 1026 EMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085
E +P +K L+ + + C P RP+ +++ + +
Sbjct: 237 EKLPQGYRLEKPLNCDDE--------VYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
Query: 1086 DYPSSPTSE 1094
Y ++ E
Sbjct: 289 TYVNTTLYE 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-52
Identities = 63/304 (20%), Positives = 117/304 (38%), Gaps = 49/304 (16%)
Query: 803 NFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGK 856
N G V+G GA G V AT +AVK +K + + ++ + ++E+ + +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQ 96
Query: 857 I-RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQT------------------ 897
+ H NIV L G C L++EY G L L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 898 --CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955
+L ++ A A+G+ +L +HRD+ + N+L+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 956 IDLP-YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELG 1013
I ++APE + T K D++S+G++L E+ + G +P + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 1014 GDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
+ ++ ++D T E I C + RP+ +
Sbjct: 274 ANFYKLIQN------------GFKMDQPFYATEE----IYIIMQSCWAFDSRKRPSFPNL 317
Query: 1074 IAMM 1077
+ +
Sbjct: 318 TSFL 321
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-51
Identities = 63/275 (22%), Positives = 114/275 (41%), Gaps = 26/275 (9%)
Query: 801 TGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH 859
++ IG+GA GTVY A +A G+ +A++++ L+ + + EI + + ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKN 76
Query: 860 RNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
NIV D ++ EY+ GSL + + D + + L +L
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFL 132
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA 979
H +IHRDIKS+NILL + + DFG I SK S + G+ ++APE
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVV 188
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039
K DI+S G++ +E+I G+ P + + + P + ++L
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL----NENPLRALYLIATNGTPELQ-NPEKLS 243
Query: 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
+ + R + +E++
Sbjct: 244 AIFRDFLNRCL----------DMDVEKRGSAKELL 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-51
Identities = 67/299 (22%), Positives = 113/299 (37%), Gaps = 44/299 (14%)
Query: 803 NFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGK 856
S G +G GA G V +AT +AVK +K T + ++E+ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSY 82
Query: 857 I-RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCL---------------L 900
+ H NIV L G C L++ EY G L L + + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 901 DWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLP 959
D + + A+G+ +L + IHRD+ + NILL + DFGLA+ I +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPV-QSLELGGDLVT 1018
++APE + T + D++S+G+ L EL + S + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 1019 WVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
++ + P + I C PL RPT ++++ ++
Sbjct: 260 MIKEGFRMLSPEHAPAE----------------MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 7e-51
Identities = 59/286 (20%), Positives = 110/286 (38%), Gaps = 28/286 (9%)
Query: 803 NFSEGAVIGRGACGTVYKATL----ANGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKI 857
+ +G G+ G V + +AVK +K A + F+ E++ + +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
HRN+++LYG ++ E GSL ++L ++ R A+ AEG+
Sbjct: 69 DHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMG 125
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYGYIA 975
YL IHRD+ + N+LL +GDFGL + + + + + + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 976 PEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035
PE T + D + FGV L E+ T G ++ + + + +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242
Query: 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081
+ + C + P +RPT + +++A+
Sbjct: 243 D---------------IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (459), Expect = 8e-51
Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 30/298 (10%)
Query: 782 IDNYYFPKEG-FKYHNLLEATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGE 839
I Y+P+ K+ ++L+ ++ +G GA G V++ T A G A K + E
Sbjct: 8 IWKQYYPQPVEIKHDHVLD---HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 64
Query: 840 GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCL 899
+ + EI T+ +RH +V L+ + +++YE+M G L E++
Sbjct: 65 --SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-- 120
Query: 900 LDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLID 957
+ D +GLC++H + +H D+K NI+ + + DFGL +D
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177
Query: 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLV 1017
+S+ G+ + APE A V D++S GV+ L++G SP G +
Sbjct: 178 --PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG----GENDD 231
Query: 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
+R + + K + ++ P R T+ + +
Sbjct: 232 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL----------LADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 9e-51
Identities = 59/274 (21%), Positives = 106/274 (38%), Gaps = 27/274 (9%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHR 860
+F G ++G G+ TV A LA A+K ++ R E + ++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
VKLY + Y +NG L + + D AE + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDET---CTRFYTAEIVSALE 122
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKS-MSAIAGSYGYIAPEYA 979
Y IIHRD+K NILL+E+ + DFG AK++ ++ ++ G+ Y++PE
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039
+ D+++ G ++ +L+ G P + + + I ++ F ++
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQKIIKLEYD---FPEKFF 234
Query: 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
A+ VE++ R E+
Sbjct: 235 PKARDLVEKLL----------VLDATKRLGCEEM 258
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-50
Identities = 64/299 (21%), Positives = 116/299 (38%), Gaps = 29/299 (9%)
Query: 804 FSEGAVIGRGACGTVYKAT-LANGEV----IAVKKIKLRGEGATADNSFLAEISTLGKIR 858
F + V+G GA GTVYK + GE +A+K+++ A+ L E + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 69
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
+ ++ +L G C + L+ + M G L + + +K + A+G+ Y
Sbjct: 70 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNY 126
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP-YSKSMSAIAGSYGYIAPE 977
L ++HRD+ + N+L+ + DFGLAKL+ ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 978 YAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037
T + D++S+GV + EL+T S ++ + + + +R
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------GER 231
Query: 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPSSPTSETP 1096
L T++ I + C +RP RE+I + Y E
Sbjct: 232 LPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 57/284 (20%), Positives = 102/284 (35%), Gaps = 27/284 (9%)
Query: 803 NFSEGAVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIR 858
G IG G G V++ + +A+K K + + FL E T+ +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFD 66
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
H +IVKL G ++ ++ E G L + + LD + A + L Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
L +HRDI + N+L+ +GDFGL++ ++ S ++APE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038
+ T D++ FGV + E++ D++ + +P
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP-------- 232
Query: 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082
+ + C + P RP E+ A + +
Sbjct: 233 NCPPT--------LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (442), Expect = 2e-48
Identities = 64/314 (20%), Positives = 117/314 (37%), Gaps = 29/314 (9%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
+ +G GA G V++ A G V K I + EIS + ++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 86
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
++ L+ + +L+ E++ G L +++ + A EGL ++H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH 144
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYGYIAPEY 978
I+H DIK NI+ + + + V DFGLA ++ + + + + APE
Sbjct: 145 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEI 199
Query: 979 AYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038
V D+++ GV+ L++G SP G D + ++ E +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFA----GEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA---MMIDARQSVSDYPSSPTSET 1095
AK ++ + P R T+ + + + D S PSS ++
Sbjct: 256 SPEAKDFIKNLL----------QKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKI 305
Query: 1096 PLEADASSRDSIAP 1109
+ D AP
Sbjct: 306 RQKIKEKYADWPAP 319
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 2e-47
Identities = 62/306 (20%), Positives = 112/306 (36%), Gaps = 34/306 (11%)
Query: 803 NFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGK 856
+ +G+G+ G VY+ +A+K + FL E S + +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKE 79
Query: 857 IRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCL-------LDWDARYRIA 909
++V+L G L++ E M G L L + ++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 910 LGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPYSKSMSAIA 968
A+G+ YL +HRD+ + N ++ E+F +GDFG+ + I + Y +
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 969 GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028
+++PE T D++SFGVVL E+ T ++ +V
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250
Query: 1029 PTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYP 1088
L DK + ++ C +P RP+ E+I+ + + +
Sbjct: 251 --GGLLDKPDNCPDM--------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
Query: 1089 SSPTSE 1094
S SE
Sbjct: 301 SFYYSE 306
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 3e-47
Identities = 53/270 (19%), Positives = 105/270 (38%), Gaps = 27/270 (10%)
Query: 807 GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKL 865
+GRG G V++ ++ + K +K++G T EIS L RHRNI+ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHL 66
Query: 866 YGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRP 925
+ + ++++E++ + E+++ + L+ E L +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLH---SH 121
Query: 926 HIIHRDIKSNNILLDEEFQAHV--GDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMK 983
+I H DI+ NI+ + + +FG A+ + + + + Y APE
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 984 VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSAK 1043
V+ D++S G ++ L++G +P + ++ E K + + A
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFL----AETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 1044 RTVEEMTLFLKIALFCSSTSPLNRPTMREV 1073
V+ + +R T E
Sbjct: 236 DFVDRLL----------VKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 4e-47
Identities = 57/273 (20%), Positives = 99/273 (36%), Gaps = 21/273 (7%)
Query: 804 FSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+ V+G GA V A +++A+K I + + S EI+ L KI+H NI
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL-EGKEGSMENEIAVLHKIKHPNI 69
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
V L L+ + + G L +++ R+ + + YLH
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDL 126
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
H + LDE+ + + DFGL+K+ D +S G+ GY+APE
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGYVAPEVLAQK 184
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLSA 1042
++ D +S GV+ L+ G P + + + + + SA
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFY----DENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 1043 KRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
K + + P R T + +
Sbjct: 241 KDFIRHLM----------EKDPEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (422), Expect = 1e-46
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 29/287 (10%)
Query: 801 TGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLR-GEGATADNSFLAEISTLGKIR 858
+ + G ++G G V+ A L +AVK ++ + F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 859 HRNIVKLYGFCYHQDSNL----LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE 914
H IV +Y + ++ EY++ +L + +H + + A +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS--KSMSAIAGSYG 972
L ++ + IIHRD+K NI++ V DFG+A+ I + +A+ G+
Sbjct: 123 AL---NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032
Y++PE A V + D+YS G VL E++TG+ P G V+ + + E
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDSPVSVAYQHVREDPIPPS 235
Query: 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP-TMREVIAMMI 1078
+ L V + + +P NR T E+ A ++
Sbjct: 236 ARHEGLSADLDAVVLKAL----------AKNPENRYQTAAEMRADLV 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (420), Expect = 5e-46
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 12/206 (5%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHR 860
+F +G G+ G V+ NG A+K +K E L + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
I++++G ++ +Y+E G L L Q Y AAE L
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNPVAKFY-----AAEVCLALE 118
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
Y II+RD+K NILLD+ + DFG AK + + G+ YIAPE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVS 174
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSP 1006
T + D +SFG+++ E++ G +P
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 163 bits (414), Expect = 1e-45
Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 17/284 (5%)
Query: 803 NFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI 862
+ IG G G VYKA GE A+KKI+L E ++ + EIS L +++H NI
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 863 VKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
VKLY + + +L++E+++ L+ L G+ Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH-- 117
Query: 923 CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTM 982
++HRD+K N+L++ E + + DFGLA+ +P K I + +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 983 KVTEKCDIYSFGVVLLELITGKSPVQS----------LELGGDLVTWVRRSIHEMVPTSE 1032
K + DI+S G + E++ G + G + ++ E+
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 1033 LFDKRLDLSAKRTVEEMT-LFLKIALFCSSTSPLNRPTMREVIA 1075
F L + ++ + + + P R T ++ +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (411), Expect = 3e-45
Identities = 64/288 (22%), Positives = 110/288 (38%), Gaps = 37/288 (12%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADN-------SFLAEISTL 854
N+ ++GRG V + + AVK I + G G+ + + L E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 855 GKIR-HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAA 913
K+ H NI++L L+++ M+ G L + L L +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALL 120
Query: 914 EGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGY 973
E +C LH + +I+HRD+K NILLD++ + DFG + +D + + + G+ Y
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSY 175
Query: 974 IAPEYAYTM------KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM 1027
+APE ++ D++S GV++ L+ G P + +R +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW----HRKQMLMLRMIMSGN 231
Query: 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
+ K V P R T E +A
Sbjct: 232 YQFGSPEWDDYSDTVKDLVSRFL----------VVQPQKRYTAEEALA 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 8e-45
Identities = 73/303 (24%), Positives = 119/303 (39%), Gaps = 41/303 (13%)
Query: 803 NFSEGAVIGRGACGTVYKAT------LANGEVIAVKKIKLRGEGATADNSFLAEISTLGK 856
G +GRGA G V +A A +AVK +K G + + ++E+ L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIH 72
Query: 857 IRHR-NIVKLYGFCYHQDSNLLL-YEYMENGSLGEQLHGNKQTCL-------------LD 901
I H N+V L G C L++ E+ + G+L L + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 902 WDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLPY 960
+ + A+G+ +L IHRD+ + NILL E+ + DFGLA+ I P
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWV 1020
++APE + T + D++SFGV+L E+ + + G +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---GVKIDEEF 246
Query: 1021 RRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080
R + E R+ T E + L C P RPT E++ + +
Sbjct: 247 CRRLKE--------GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
Query: 1081 RQS 1083
Q+
Sbjct: 295 LQA 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 69/298 (23%), Positives = 113/298 (37%), Gaps = 43/298 (14%)
Query: 803 NFSEGAVIGRGACGTVYKATL--------ANGEVIAVKKIKLRGEGATADNSFLAEISTL 854
G +G GA G V A +AVK +K + ++E+ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMM 72
Query: 855 GKI-RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCL-------------L 900
I +H+NI+ L G C ++ EY G+L E L + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 901 DWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI-DLP 959
A A G+ YL IHRD+ + N+L+ E+ + DFGLA+ I +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTW 1019
Y K + ++APE + T + D++SFGV+L E+ T +L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 1020 VRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
++ R+D + T E + C P RPT ++++ +
Sbjct: 250 LKE------------GHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-44
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 10/207 (4%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGK-IRH 859
+F ++G+G+ G V+ A + A+K +K D + E L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 860 RNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
+ ++ +++ + EY+ G L + + D A GL +L
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFL 119
Query: 920 HYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA 979
I++RD+K +NILLD++ + DFG+ K L +K + G+ YIAPE
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEIL 175
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSP 1006
K D +SFGV+L E++ G+SP
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (410), Expect = 4e-44
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 15/210 (7%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRG----EGATADNSFLAEISTLGKI 857
+FS +IGRG G VY G++ A+K + + +G T + +S +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 858 RHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLC 917
IV + + D + + M G L L + A GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGLE 121
Query: 918 YLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPE 977
++H +++RD+K NILLDE + D GLA K A G++GY+APE
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPE 175
Query: 978 YAYT-MKVTEKCDIYSFGVVLLELITGKSP 1006
+ D +S G +L +L+ G SP
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-44
Identities = 66/313 (21%), Positives = 117/313 (37%), Gaps = 38/313 (12%)
Query: 792 FKYHNLLEATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLR----GEGATADNS 846
F+ N+ + + G +G G V K + G A K IK R +
Sbjct: 3 FRQENVDD---YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 847 FLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARY 906
E+S L +I+H N++ L+ ++ +L+ E + G L + L + L +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 116
Query: 907 RIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE----FQAHVGDFGLAKLIDLPYSK 962
G ++Y I H D+K NI+L + + + DFGLA ID +
Sbjct: 117 EFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGN 171
Query: 963 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRR 1022
I G+ ++APE + + D++S GV+ L++G SP G +
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL----GDTKQETLAN 227
Query: 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM----MI 1078
+ + AK + + P R T+++ +
Sbjct: 228 VSAVNYEFEDEYFSNTSALAKDFIRRLL----------VKDPKKRMTIQDSLQHPWIKPK 277
Query: 1079 DARQSVSDYPSSP 1091
D +Q++S S P
Sbjct: 278 DTQQALSSAWSHP 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 9e-44
Identities = 61/285 (21%), Positives = 106/285 (37%), Gaps = 17/285 (5%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
NF + IG G G VYKA GEV+A+KKI+L E ++ + EIS L ++ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
IVKL + ++ L++E++ + + +GL +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFC-- 118
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
++HRD+K N+L++ E + DFGLA+ +P + +
Sbjct: 119 -HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQS----------LELGGDLVTWVRRSIHEMVPTS 1031
+ DI+S G + E++T ++ G V + M
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 1032 ELFDKRLDLSAKRTVEEMT-LFLKIALFCSSTSPLNRPTMREVIA 1075
F K + V + + P R + + +A
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-43
Identities = 74/288 (25%), Positives = 118/288 (40%), Gaps = 32/288 (11%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADN---SFLAEISTLGKIRHRNIVK 864
+G G TVYKA +++A+KKIKL D + L EI L ++ H NI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 865 LYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCR 924
L H+ + L++++ME + + +L L +GL YLH +
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---Q 118
Query: 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV 984
I+HRD+K NN+LLDE + DFGLAK P ++ + + Y APE + ++
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARM 177
Query: 985 -TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV--PTSELFDKRLDLS 1041
D+++ G +L EL+ + GD I E + PT E + L
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLP-----GDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 1042 AKRTVEEMTLFLKIALF-------------CSSTSPLNRPTMREVIAM 1076
T + +F +P R T + + M
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 4e-43
Identities = 73/327 (22%), Positives = 127/327 (38%), Gaps = 23/327 (7%)
Query: 796 NLLEATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTL 854
+ + ++ + IG GA G V A N +A+KKI E T L EI L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKIL 60
Query: 855 GKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE 914
+ RH NI+ + + Y+ +G L+ +T L D
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI--DLPYSKSMSAIAGSYG 972
GL Y+H +++HRD+K +N+LL+ + DFGLA++ D ++ ++ +
Sbjct: 121 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 973 YIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSP------VQSLELGGDLVTWVRRSIH 1025
Y APE T+ DI+S G +L E+++ + + L ++ +
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 1026 EMVPTSELFDKRLDLSAKRTVEEMTLF-------LKIALFCSSTSPLNRPTMREVIAMMI 1078
+ + + L L K V LF L + + +P R + + +A
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH-- 295
Query: 1079 DARQSVSDYPSSPTSETPLEADASSRD 1105
+ D P +E P + D D
Sbjct: 296 PYLEQYYDPSDEPIAEAPFKFDMELDD 322
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (395), Expect = 6e-43
Identities = 47/302 (15%), Positives = 103/302 (34%), Gaps = 31/302 (10%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
++ G IG G+ G +++ T L N + +A+K R + E T +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGC 60
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+ + + + +L + SL + L + A + +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIH 118
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVG-----DFGLAKLIDLPYSKS------MSAIAG 969
+++RDIK +N L+ + DFG+ K P +K ++G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 970 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVP 1029
+ Y++ + + + D+ + G V + + G P Q L+ + + R I E
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER--IGEKKQ 233
Query: 1030 TSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVSDYPS 1089
++ L + + F K + + + P + + + ++
Sbjct: 234 STPLRELCAGFPEE--------FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
Query: 1090 SP 1091
Sbjct: 286 EN 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-43
Identities = 56/298 (18%), Positives = 107/298 (35%), Gaps = 32/298 (10%)
Query: 800 ATGNFSEGAVIGRGACGTVYKAT--LANGEVIAVKKIKLRGEGATADNSFLAEI---STL 854
A + A IG GA G V+KA G +A+K+++++ S + E+ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 855 GKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGE---QLHGNKQTCLLDWDARYRIALG 911
H N+V+L+ C ++ + + + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 912 AAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSY 971
GL +LH ++HRD+K NIL+ Q + DFGLA++ + +++++ +
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTL 179
Query: 972 GYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031
Y APE D++S G + E+ K + G I +++
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR-----GSSDVDQLGKILDVIGLP 234
Query: 1032 ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTS--------------PLNRPTMREVIA 1075
D D++ R I F + P R + ++
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-42
Identities = 73/292 (25%), Positives = 110/292 (37%), Gaps = 29/292 (9%)
Query: 803 NFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
++++ VIG G+ G VY+A L +GE++A+KK+ E+ + K+ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCN 74
Query: 862 IVKLYGFCYHQDSN------LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEG 915
IV+L F Y L+ +Y+ H ++ L
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYI 974
L Y+H I HRDIK N+LLD + + DFG AK + ++S I Y
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYYRA 190
Query: 975 APEYAYTMKVTEKCDIYSFGVVLLELITGKSP-------VQSLELGGDLVTWVRRSIHEM 1027
T D++S G VL EL+ G+ Q +E+ L T R I EM
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 1028 VPTSELFD----KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
P F K + + + +P R T E A
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-42
Identities = 53/288 (18%), Positives = 108/288 (37%), Gaps = 23/288 (7%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN 861
+ + IG G GTV+KA E++A+K+++L + +S L EI L +++H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 862 IVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHY 921
IV+L+ + L++E+ + N + + L L +
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFL---FQLLKGLGF 116
Query: 922 DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYT 981
+++HRD+K N+L++ + + +FGLA+ +P + + +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 982 MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041
+ D++S G + EL P+ D + + R + PT E + L
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT--PTEEQWPSMTKLP 234
Query: 1042 AKRTVEEMTLFLKIALFCSSTS--------------PLNRPTMREVIA 1075
+ + + P+ R + E +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 2e-42
Identities = 52/287 (18%), Positives = 98/287 (34%), Gaps = 31/287 (10%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
+ G IG G+ G +Y T +A GE +A+K ++ T E ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGG 62
Query: 861 NIVKLYGFCYHQDSNLLLY-EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYL 919
+ +C + ++ E + +++ +A + Y+
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYI 119
Query: 920 HYDCRPHIIHRDIKSNNIL---LDEEFQAHVGDFGLAKLIDLPYSKSM------SAIAGS 970
H + IHRD+K +N L + ++ DFGLAK + + G+
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 971 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030
Y + ++ + + D+ S G VL+ G P Q L+ + R S +M
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077
E+ K FC S ++P + +
Sbjct: 237 IEVLCKGYPSEFA----------TYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 2e-40
Identities = 61/301 (20%), Positives = 111/301 (36%), Gaps = 33/301 (10%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
+ + A IG+G G V+KA G+ +A+KK+ + E + L EI L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 861 NIVKLYGFCYHQDSN--------LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGA 912
N+V L C + S L++++ E+ G + + R+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVM--- 123
Query: 913 AEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP---YSKSMSAIAG 969
L L+Y R I+HRD+K+ N+L+ + + DFGLA+ L +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 970 SYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSP------VQSLELGGDLVTWVRR 1022
+ Y PE + D++ G ++ E+ T L L L +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 1023 SIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALF--------CSSTSPLNRPTMREVI 1074
+ V EL++K + ++ + L + P R + +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 1075 A 1075
Sbjct: 304 N 304
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 51/283 (18%), Positives = 101/283 (35%), Gaps = 41/283 (14%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD----NSFLAEISTLGK 856
+ G ++G G G+VY +++ +A+K ++ + E+ L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 857 IR--HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAE 914
+ +++L + DS +L+ E E + L + E
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121
Query: 915 GLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKLIDLPYSKSMSAIAGSYGY 973
+ + ++HRDIK NIL+D + + DFG L+ + G+ Y
Sbjct: 122 AVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVY 175
Query: 974 IAPEY-AYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032
PE+ Y ++S G++L +++ G P + E E++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRGQV 221
Query: 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIA 1075
F +R+ + + + P +RPT E+
Sbjct: 222 FFRQRVSSECQHLIRWCL----------ALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-40
Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 9/206 (4%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHR 860
+F ++G+G G V A G A+K ++ A + + E L RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+ L D + EY G L L + + + R AE + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEE---RARFYGAEIVSALE 119
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
Y +++RDIK N++LD++ + DFGL K +M G+ Y+APE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLE 178
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSP 1006
D + GVV+ E++ G+ P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 5e-39
Identities = 54/275 (19%), Positives = 95/275 (34%), Gaps = 32/275 (11%)
Query: 809 VIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLY 866
V+G G G V + E A+K ++ E+ + + +IV++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIV 71
Query: 867 GFCYHQDSN----LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD 922
+ + L++ E ++ G L ++ I E + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLH-- 128
Query: 923 CRPHIIHRDIKSNNILLDEEFQ---AHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYA 979
+I HRD+K N+L + + DFG AK + S++ + Y+APE
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 185
Query: 980 YTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039
K + CD++S GV++ L+ G P S R +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVI 1074
K + + T P R T+ E +
Sbjct: 246 EEVKMLIRNLL----------KTEPTQRMTITEFM 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 68/343 (19%), Positives = 118/343 (34%), Gaps = 34/343 (9%)
Query: 789 KEGFKYHNLLEATGNFSE----GAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATA 843
+ GF + + +G GA G V A G +A+KK+ +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 844 DNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGN-KQTCLLDW 902
E+ L +RH N++ L ++ ++ G + L
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 120
Query: 903 DARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962
D + +GL Y+H IIHRD+K N+ ++E+ + + DFGLA+ D
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----S 173
Query: 963 SMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVR 1021
M+ + Y APE M+ T+ DI+S G ++ E+ITGK+ + + L
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---HLDQLKE 230
Query: 1022 RSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALF----------------CSSTSPL 1065
P +E + AK ++ + K
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 1066 NRPTMREVIAM-MIDARQSVSDYPSSPTSETPLEADASSRDSI 1107
R T E +A ++ D P + + + D
Sbjct: 291 QRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEW 333
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 61/256 (23%), Positives = 101/256 (39%), Gaps = 19/256 (7%)
Query: 803 NFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLR--GEGATADNSFLAEISTLGK 856
NF V+G GA G V+ G++ A+K +K + A E L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 857 IRHR-NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEG 915
IR +V L+ + L+ +Y+ G L L ++ + + E
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ------IYVGEI 138
Query: 916 LCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIA 975
+ L + + II+RDIK NILLD + DFGL+K ++ G+ Y+A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 976 PEYAYTMK--VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033
P+ + D +S GV++ EL+TG SP RR + P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP---- 254
Query: 1034 FDKRLDLSAKRTVEEM 1049
+ + + AK ++ +
Sbjct: 255 YPQEMSALAKDLIQRL 270
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 2e-36
Identities = 45/206 (21%), Positives = 76/206 (36%), Gaps = 12/206 (5%)
Query: 803 NFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATAD-NSFLAEISTLGKIRHR 860
F +G G+ G V +G A+K + + L E L +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
+VKL + ++ EY+ G + L + A YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH 158
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
+I+RD+K N+L+D++ V DFG AK + G+ +APE
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIIL 211
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSP 1006
+ + D ++ GV++ E+ G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-35
Identities = 69/334 (20%), Positives = 119/334 (35%), Gaps = 40/334 (11%)
Query: 799 EATGNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI 857
E + + +G GA G+V A G +AVKK+ + E+ L +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 858 RHRNIVKLYGFCYHQDS-----NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGA 912
+H N++ L S ++ L ++ L + K L D +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQI 130
Query: 913 AEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYG 972
GL Y+H IIHRD+K +N+ ++E+ + + DFGLA+ D +A +
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWY 184
Query: 973 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV--PT 1030
M + DI+S G ++ EL+TG++ G + I +V P
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP-----GTDHIDQLKLILRLVGTPG 239
Query: 1031 SELFDKRLDLSAKRTVEEMTLFLKIALF----------------CSSTSPLNRPTMREVI 1074
+EL K SA+ ++ +T K+ R T + +
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
Query: 1075 AM-MIDARQSVSDYPSSPTSETPLEADASSRDSI 1107
A D P + + E+ D
Sbjct: 300 AHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEW 333
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (336), Expect = 8e-35
Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 25/228 (10%)
Query: 788 PKEGFKYHNLLEATGN---FSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATA 843
P+E + Y + + GN + +GRG V++A + N E + VK +K
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVK 72
Query: 844 DNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNL--LLYEYMENGSLGEQLHGNKQTCLL 900
EI L +R NI+ L S L++E++ N + L
Sbjct: 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLT 127
Query: 901 DWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAKLIDLP 959
D+D R + L Y H I+HRD+K +N+++D E + + D+GLA+
Sbjct: 128 DYDIR-FYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-- 181
Query: 960 YSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSP 1006
+ + S + PE + D++S G +L +I K P
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-34
Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 13/282 (4%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
+ IG GA G V A +A+KK+ + T E+ + + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 861 NIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLH 920
NI+ L Q + L E+ + + E + N + R++ + LC +
Sbjct: 77 NIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 921 YDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAY 980
+ IIHRD+K +NI++ + + DFGLA+ S M+ + Y APE
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 191
Query: 981 TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040
M E DI+S G ++ E++ K G D + + I ++ F K+L
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFP----GRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 1041 SAKRTVEEMTLFLKIA---LFCSSTSPLNRPTMREVIAMMID 1079
+ + VE + + LF S P + + + D
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 117 bits (292), Expect = 3e-29
Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 16/300 (5%)
Query: 316 EIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGT 375
+ S+ L +P++L P+ LL L N + + L LH L L N ++
Sbjct: 14 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 376 IPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLI 435
P F L L L L N L+ L V + + + S+ L +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV- 129
Query: 436 FLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGL 495
L + SG + + L + + +T I +L+ L L N+ + +
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKV 186
Query: 496 IPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQ 555
+ L NL +L LS N + N HL ++++N L +P L + +Q
Sbjct: 187 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ 245
Query: 556 RLDLSRNQFTG------SAPEELGQLVNLELLKLSDNKLT--GAIPSSLGGLARLTELQM 607
+ L N + P + + + L N + PS+ + +Q+
Sbjct: 246 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.0 bits (240), Expect = 2e-22
Identities = 57/288 (19%), Positives = 106/288 (36%), Gaps = 15/288 (5%)
Query: 208 IPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLE 267
+P ++ +L L N + + + L+NL LIL N +S P + LE
Sbjct: 25 VPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 268 LLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGF 327
L L +N K L L+ ++ ++ + L VE+ + + +G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV-VELGTNPLKSSGI 141
Query: 328 IPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLV 387
+ L +++ + + +IP+ G L +L L N +T + L L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 388 DLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSG- 446
L L N + + HL L ++ N L +P L ++ + + L +N +S
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257
Query: 447 -----NIPPGLKTCRSLMQLMLGQNQLTGS--LPIEFYNLQNLSALEL 487
P S + L N + P F + +A++L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.5 bits (236), Expect = 6e-22
Identities = 59/289 (20%), Positives = 102/289 (35%), Gaps = 15/289 (5%)
Query: 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSL 170
+P DL +LDL N++ + + L L L N I P L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 171 EELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEG 230
E L + N L L++LRV + + +++ +E LG G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSG 140
Query: 231 FLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRL 290
+ ++ L+ + + +++ IP G SL L L N + L L+ L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 291 KKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQG 350
KL + N ++ L N E+ L+ N+L +P L + ++ L N +
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
Query: 351 ------SIPRELGQLTQLHKLDLSINNLTGT--IPLEFQNLTYLVDLQL 391
P + + L N + P F+ + +QL
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.8 bits (229), Expect = 5e-21
Identities = 57/283 (20%), Positives = 105/283 (37%), Gaps = 15/283 (5%)
Query: 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQL 468
HL V+ S L+ +P L L L +N+++ K ++L L+L N++
Sbjct: 11 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 469 TGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLE 528
+ P F L L L L +N+ L L+ L + + + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 529 HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588
+ SG L + ++ T G +L L L NK+
Sbjct: 128 VVELGTNP-LKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKI 183
Query: 589 TGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNL 648
T +SL GL L +L + N S +L L+ ++++N L +P L +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL-HLNNNKLV-KVPGGLADH 241
Query: 649 QMLEALYLDDNQLIG------EIPASMGEQMSLLVCNLSNNNL 685
+ ++ +YL +N + P ++ S +L +N +
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.2 bits (191), Expect = 5e-16
Identities = 45/225 (20%), Positives = 79/225 (35%), Gaps = 7/225 (3%)
Query: 496 IPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQ 555
+P ++ + L L N + NL++L T + +N +S P V L+
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 556 RLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGS 615
RL LS+NQ + L L + + K+ ++ + L + EL SG
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSGI 141
Query: 616 IPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSL 675
A + L I+ N++ + G L L+LD N++ AS+ +L
Sbjct: 142 ENGAFQGMKKLSYI-RIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 676 LVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQLM 720
LS N++ + N L +
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 68.5 bits (166), Expect = 7e-13
Identities = 35/205 (17%), Positives = 65/205 (31%), Gaps = 11/205 (5%)
Query: 532 TFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGA 591
S L +P +L + LDL N+ T + L NL L L +NK++
Sbjct: 14 VVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 592 IPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQML 651
P + L +L L + N ++ L + N ++ V L +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPE----KMPKTLQELRVHENEITKVRKSVFNGLNQM 126
Query: 652 EALYLDDNQL--IGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGL 709
+ L N L G + L +++ N+ T + + + GN+
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI--TTIPQGLPPSLTELHLDGNKIT 184
Query: 710 CMLGSDCHQLMPPSHTPKKNWIKGG 734
+ + L +
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISA 209
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 2e-28
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 21/223 (9%)
Query: 802 GNFSEGAVIGRGACGTVYKAT-LANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHR 860
+ +G G TV+ A + N +A+K ++ + EI L ++
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDA 69
Query: 861 N-----------IVKLYGFCYHQDSNLLLYEYM--ENGSLGEQLHGNKQTCLLDWDARYR 907
+ I+KL H+ N + + G L + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 908 IALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE-FQAHVGDFGLAKLID-LPYSKSMS 965
I+ GL Y+H R IIH DIK N+L++ ++ +A L + Y + +
Sbjct: 130 ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 966 AIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQ 1008
+ Y +PE DI+S ++ ELITG +
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 112 bits (281), Expect = 3e-27
Identities = 84/390 (21%), Positives = 143/390 (36%), Gaps = 41/390 (10%)
Query: 237 EKLRNLTDLILWQNHLSGEIPPT-IGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYV 295
L +L + +++ + T + + +L+ L S G + L+ L ++
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73
Query: 296 YTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRE 355
N+L P L N T V+I ++ NQ+ P L + +
Sbjct: 74 SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131
Query: 356 ---------------LGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTI 400
+ L+ L L T NLT L L + N +
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK--VSD 189
Query: 401 PPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQ 460
+ ++L L + N + P + L LSL N+L L + +L
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTD 245
Query: 461 LMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYI 520
L L NQ++ P L L+ L+L N+ S + P + L L L L+EN
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 301
Query: 521 PSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLEL 580
P NL++L + N++S P + + LQRL + N+ + L L N+
Sbjct: 302 PIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 581 LKLSDNKLTGAIPSSLGGLARLTELQMGGN 610
L N+++ P L L R+T+L +
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 112 bits (279), Expect = 7e-27
Identities = 77/387 (19%), Positives = 142/387 (36%), Gaps = 35/387 (9%)
Query: 189 SKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILW 248
+ L + G +++ + ++ + + L + ++ +E L NLT +
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 74
Query: 249 QNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHEL 308
N L+ P + N+ L + ++ N + P L+ + +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 309 GN-------------CTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRE 355
+ L + + L L +L + + S
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 356 LGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDV 415
L +LT L L + N ++ P LT L +L L N L+ + ++L+ LD+
Sbjct: 193 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 416 SMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIE 475
+ N + P L KL L LG+N++S P T + ++L Q +
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE----DISP 302
Query: 476 FYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNI 535
NL+NL+ L LY N S + P + L L+RL + N S + NL ++ +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 536 SSNSLSGTIPHELGNCVNLQRLDLSRN 562
N +S P L N + +L L+
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 110 bits (275), Expect = 2e-26
Identities = 81/386 (20%), Positives = 135/386 (34%), Gaps = 58/386 (15%)
Query: 310 NCTSAVEIDLSENQLTGFIP-RELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLS 368
++ L + +T + +L + L +L + G + L L +++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 369 INNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIP--- 425
N LT P +NLT LVD+ + +N + P N L + +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 426 ------------PHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLP 473
+ L L S L +L +L + N+++
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--I 190
Query: 474 IEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTF 533
L NL +L N+ S + P I NL+ L L+ N + +L +L
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDL 246
Query: 534 NISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAP--------------------EELG 573
++++N +S P L L L L NQ + +P +
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS 304
Query: 574 QLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNIS 633
L NL L L N ++ P + L +L L N S +L LT + L+
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW-LSAG 359
Query: 634 HNNLSGVIPYELGNLQMLEALYLDDN 659
HN +S + P L NL + L L+D
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 107 bits (267), Expect = 3e-25
Identities = 74/380 (19%), Positives = 133/380 (35%), Gaps = 35/380 (9%)
Query: 148 KLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGP 207
K L + + + + +L + L + + L L I +N L+
Sbjct: 26 KTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI 81
Query: 208 IPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPP--------- 258
P + L + + N + P L Q +
Sbjct: 82 TP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139
Query: 259 ---TIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELN-GTIPHELGNCTSA 314
TI +I +L L + G +L L+ L L N + L T+
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199
Query: 315 VEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTG 374
+ + NQ++ P ++ NL L L N L+ L LT L LDL+ N ++
Sbjct: 200 ESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255
Query: 375 TIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKL 434
P LT L +L+L N + P ++ ++ +N + + L
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISPLA----GLTALTNLELNENQLEDISPISNLKNL 309
Query: 435 IFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSG 494
+L+L N +S P + + L +L N+++ NL N++ L N+ S
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 495 LIPPEIGKLRNLERLHLSEN 514
L P + L + +L L++
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.8 bits (224), Expect = 8e-20
Identities = 76/359 (21%), Positives = 123/359 (34%), Gaps = 57/359 (15%)
Query: 73 KVTSVDLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDL----- 127
+VT++ L + I + L L + N S N +T P L N + L + +
Sbjct: 45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
Query: 128 -------------------------CTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPE 162
+ + NT+ + +
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 163 EIGNLTSLEEL-------VIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISEC 215
+T L+ L + ++ + + ++KL L + A +N +S P I
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--L 218
Query: 216 EGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENS 275
L+ L L N L+ L L NLTDL L N +S P + + L L L N
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 276 FSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLI 335
S P L L+ L L + N+L P N + + L N ++ P + +
Sbjct: 275 ISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSL 328
Query: 336 PNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDN 394
L L N + L LT ++ L N ++ PL NLT + L L D
Sbjct: 329 TKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-27
Identities = 64/262 (24%), Positives = 101/262 (38%), Gaps = 6/262 (2%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410
++P + +Q ++ L N ++ F+ L L L N L + L
Sbjct: 25 AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 411 SVLDVSMNNLDGSIPP-HLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLT 469
LD+S N S+ P +L L L L P + +L L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 470 GSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEH 529
F +L NL+ L L+ NR S + L +L+RL L +N P +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 530 LVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
L+T + +N+LS L LQ L L+ N + L+ + S +++
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVP 261
Query: 590 GAIPSSLGG--LARLTELQMGG 609
++P L G L RL + G
Sbjct: 262 CSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (213), Expect = 5e-19
Identities = 60/264 (22%), Positives = 93/264 (35%), Gaps = 7/264 (2%)
Query: 208 IPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLE 267
+P I + + L N + + RNLT L L N L+ + LE
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 268 LLALHENSFSGGL-PKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTG 326
L L +N+ + P L RL L++ L P + + L +N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 327 FIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYL 386
+ NL L L N + R L L +L L N + P F++L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 387 VDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSG 446
+ L LF N+L + L L ++ N ++ L S+ +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPC 262
Query: 447 NIPPGLKTCRSLMQLMLGQNQLTG 470
++P L R L + L N L G
Sbjct: 263 SLPQRLAG-RDLKR--LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (208), Expect = 2e-18
Identities = 61/307 (19%), Positives = 101/307 (32%), Gaps = 32/307 (10%)
Query: 69 CTDFKVTSVDLHGLNLSGILSPRICDLPRLVE-FNISMNFVTGSIPTDLANCSSLEILDL 127
C + + L + +P + + N ++ C +L IL L
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPV----GIPAASQRIFLHGNRISHVPAASFRACRNLTILWL 63
Query: 128 CTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPAS 187
+N L + + L +L L +N + PA+
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD-----------------------PAT 100
Query: 188 ISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLIL 247
L +L + L P L+ L L N+L+ L NLT L L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160
Query: 248 WQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHE 307
N +S + SL+ L LH+N + P L RL LY++ N L+
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220
Query: 308 LGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDL 367
L + + L++N R L L + + + S+P+ L L
Sbjct: 221 LAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRL 276
Query: 368 SINNLTG 374
+ N+L G
Sbjct: 277 AANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (204), Expect = 6e-18
Identities = 63/282 (22%), Positives = 94/282 (33%), Gaps = 9/282 (3%)
Query: 407 NSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQN 466
N L ++P + + L NR+S + CR+L L L N
Sbjct: 10 NEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSN 66
Query: 467 QLTGSLPIEFYNLQNLSALELYQNRFSGLIPP-EIGKLRNLERLHLSENYFVGYIPSEVG 525
L F L L L+L N + P L L LHL P
Sbjct: 67 VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR 126
Query: 526 NLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD 585
L L + N+L + NL L L N+ + L +L+ L L
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 586 NKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYEL 645
N++ P + L RL L + N S AL L ALQ L ++ N
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY-LRLNDNPWVCDCR-AR 244
Query: 646 GNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVG 687
L+ +++ +P + + L L+ N+L G
Sbjct: 245 PLWAWLQKFRGSSSEVPCSLPQRLAGR-DLK--RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.2 bits (196), Expect = 6e-17
Identities = 41/255 (16%), Positives = 73/255 (28%), Gaps = 6/255 (2%)
Query: 26 SVTSLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCNWIGVECTDFKVTSVDLHGL--N 83
+ + G + A+ NL T +
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 84 LSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFI 143
L + L RL ++ + P ++L+ L L N L + +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 144 NTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNS 203
L L+L N I L SL+ L+++ N + P + L +L + N+
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 204 LSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNI 263
LS ++ L+ L L N L + + +P +
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQ---RL 268
Query: 264 QSLELLALHENSFSG 278
+L L N G
Sbjct: 269 AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (192), Expect = 2e-16
Identities = 59/278 (21%), Positives = 95/278 (34%), Gaps = 29/278 (10%)
Query: 290 LKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349
++++++ N ++ C + + L N L + L L L +N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 350 GSI-PRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNS 408
S+ P L +LH L L L+ P +
Sbjct: 94 RSVDPATFHGLGRLHTLHLD------------------------RCGLQELGPGLFRGLA 129
Query: 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQL 468
L L + N L L L L NR+S + SL +L+L QN++
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 469 TGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLE 528
P F +L L L L+ N S L + LR L+ L L++N +V +
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWA 248
Query: 529 HLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG 566
L F SS+ + ++P L L+ N G
Sbjct: 249 WLQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (184), Expect = 2e-15
Identities = 54/243 (22%), Positives = 85/243 (34%), Gaps = 4/243 (1%)
Query: 471 SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHL 530
++P+ + L+ NR S + RNL L L N + L L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 531 VTFNISSNSLSGTI-PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
++S N+ ++ P L L L R P L L+ L L DN L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 590 GAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQ 649
+ L LT L + GN S A L +L + N ++ V P+ +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLG 201
Query: 650 MLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGL 709
L LYL N L ++ +L L++N V ++ + + +
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVP 261
Query: 710 CML 712
C L
Sbjct: 262 CSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (119), Expect = 4e-07
Identities = 38/190 (20%), Positives = 57/190 (30%), Gaps = 29/190 (15%)
Query: 528 EHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNK 587
E VT + L +P + QR+ L N+ + NL +L L N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 588 -------------------------LTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQ 622
L P++ GL RL L + P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 623 LTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSN 682
L ALQ + N L + +L L L+L N++ + SL L
Sbjct: 128 LAALQYL-YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 683 NNLVGTVPNT 692
N + P+
Sbjct: 187 NRVAHVHPHA 196
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 102 bits (254), Expect = 3e-24
Identities = 77/329 (23%), Positives = 122/329 (37%), Gaps = 33/329 (10%)
Query: 32 EEGVSLLEFKASLIDPSNNLESWN-SSDMTPCNWIGVECTD----FKVTSVDLHGLNLSG 86
++ +LL+ K L +P+ L SW ++D W+GV C ++V ++DL GLNL
Sbjct: 6 QDKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 87 ILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTN-RLHGVIPFQLFFINT 145
IP+ LAN L L + L G IP + +
Sbjct: 65 PYP----------------------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 146 LRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLS 205
L LY+ + G IP+ + + +L L N L+G +P SIS L L I N +S
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 206 GPIPPEISECEGLEV-LGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQ 264
G IP L + +++N L G +P L + +
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222
Query: 265 SLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQL 324
+ ++ + L K L N + GT+P L +++S N L
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 325 TGFIPRELGLIPNLCLLQLFENMLQGSIP 353
G IP + G + + N P
Sbjct: 281 CGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 98.3 bits (243), Expect = 9e-23
Identities = 67/281 (23%), Positives = 106/281 (37%), Gaps = 27/281 (9%)
Query: 315 VEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSIN-NLT 373
+DLS L P IP L L L+ L + NL
Sbjct: 53 NNLDLSGLNLPKPYP----------------------IPSSLANLPYLNFLYIGGINNLV 90
Query: 374 GTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQK 433
G IP LT L L + ++ G IP + L LD S N L G++PP +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 434 LIFLSLGSNRLSGNIPPGLKTCRSLMQ-LMLGQNQLTGSLPIEFYNLQNLSALELYQNRF 492
L+ ++ NR+SG IP + L + + +N+LTG +P F NL
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE 210
Query: 493 SGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCV 552
+ + + + +VG ++L ++ +N + GT+P L
Sbjct: 211 G--DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268
Query: 553 NLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIP 593
L L++S N G P + G L ++ ++NK P
Sbjct: 269 FLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 94.8 bits (234), Expect = 1e-21
Identities = 71/265 (26%), Positives = 107/265 (40%), Gaps = 7/265 (2%)
Query: 357 GQLTQLHKLDLSINNLTG--TIPLEFQNLTYLVDLQLFDNH-LEGTIPPHIGVNSHLSVL 413
Q +++ LDLS NL IP NL YL L + + L G IPP I + L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 414 DVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLP 473
++ N+ G+IP L + L+ L N LSG +PP + + +L+ + N+++G++P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 474 IEFYNLQNLSA-LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVT 532
+ + L + + +NR +G IPP L +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 533 FNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAI 592
++ NL LDL N+ G+ P+ L QL L L +S N L G I
Sbjct: 227 HLAKNSLAFDLGKVG--LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 593 PSSLGGLARLTELQMGGNIFSGSIP 617
P G L R N P
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 85.6 bits (210), Expect = 2e-18
Identities = 76/265 (28%), Positives = 108/265 (40%), Gaps = 6/265 (2%)
Query: 405 GVNSHLSVLDVSMNNLDG--SIPPHLCMYQKLIFLSLGSN-RLSGNIPPGLKTCRSLMQL 461
++ LD+S NL IP L L FL +G L G IPP + L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 462 MLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIP 521
+ ++G++P ++ L L+ N SG +PP I L NL + N G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 522 SEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELL 581
G+ L T S + +NL +DLSRN G A G N + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 582 KLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVI 641
L+ N L + + N G++P L QL L LN+S NNL G I
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLD-LRNNRIYGTLPQGLTQLKFLHS-LNVSFNNLCGEI 284
Query: 642 PYELGNLQMLEALYLDDNQLIGEIP 666
P + GNLQ + +N+ + P
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 81.7 bits (200), Expect = 4e-17
Identities = 69/257 (26%), Positives = 110/257 (42%), Gaps = 7/257 (2%)
Query: 458 LMQLMLGQNQLTGSLPI--EFYNLQNLSALELYQN-RFSGLIPPEIGKLRNLERLHLSEN 514
+ L L L PI NL L+ L + G IPP I KL L L+++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 515 YFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQ 574
G IP + ++ LVT + S N+LSGT+P + + NL + N+ +G+ P+ G
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 575 LVNLEL-LKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNIS 633
L + +S N+LTG IP + L + + + +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVL---FGSDKNTQKIHL 228
Query: 634 HNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNTT 693
N ++G + L L L +N++ G +P + + L N+S NNL G +P
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288
Query: 694 VFRRIDSSNFAGNRGLC 710
+R D S +A N+ LC
Sbjct: 289 NLQRFDVSAYANNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.9 bits (133), Expect = 9e-09
Identities = 19/63 (30%), Positives = 28/63 (44%), Gaps = 3/63 (4%)
Query: 150 YLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSL--SGP 207
L N I+G +P+ + L L L + NNL G IP L++ V +N P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
Query: 208 IPP 210
+P
Sbjct: 309 LPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 38.2 bits (87), Expect = 0.004
Identities = 29/105 (27%), Positives = 43/105 (40%), Gaps = 2/105 (1%)
Query: 589 TGAIPSSLGGLARLTELQMGGNIFSG--SIPVALGQLTALQIALNISHNNLSGVIPYELG 646
G + + R+ L + G IP +L L L NNL G IP +
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 647 NLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPN 691
L L LY+ + G IP + + +L+ + S N L GT+P
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.2 bits (236), Expect = 6e-23
Identities = 26/166 (15%), Positives = 52/166 (31%), Gaps = 18/166 (10%)
Query: 807 GAVIGRGACGTVYKATLANGEVIAVKKIKL--------RGEGATADNSFLAEISTLGKIR 858
G ++G G V+ VK K+ + + D F +
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 859 HRNIVKLYGFCYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCY 918
R + KL G + Y + N L E + + + + + E +
Sbjct: 65 FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAK 118
Query: 919 LHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSKSM 964
+ I+H D+ N+L+ E + DF + + + +
Sbjct: 119 FY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREI 160
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.0 bits (162), Expect = 1e-12
Identities = 50/236 (21%), Positives = 75/236 (31%), Gaps = 35/236 (14%)
Query: 307 ELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLD 366
E+ S +E++ + LT ++P +L + T L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-------------------------ALPPDLPKDTT--ILH 37
Query: 367 LSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGS--I 424
LS N L T L L +L+ + V+ L VL + + +
Sbjct: 38 LSENLLYTFSLATLMPYTRLTQL-----NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL 92
Query: 425 PPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSA 484
P L L + NRL+ L+ L +L L N+L P L
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152
Query: 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSL 540
L L N + L + L NL+ L L EN IP L + N
Sbjct: 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 52/210 (24%), Positives = 74/210 (35%), Gaps = 11/210 (5%)
Query: 187 SISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLI 246
+SK+ + +L+ +PP++ + +L L++N L F + L LT L
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQL- 60
Query: 247 LWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKEL--GKLSRLKKLYVYTNELNGTI 304
+L + +L +L + S + L L L L V N L
Sbjct: 61 ----NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 305 PHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHK 364
L E+ L N+L P L P L L L N L L L L
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 365 LDLSINNLTGTIPLEFQNLTYLVDLQLFDN 394
L L N+L TIP F L L N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 48/211 (22%), Positives = 75/211 (35%), Gaps = 10/211 (4%)
Query: 68 ECTDF-KVTSVDLHGLNLSGILSPRICDLPR-LVEFNISMNFVTGSIPTDLANCSSLEIL 125
E + V+ NL+ + DLP+ ++S N + L + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPP----DLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 126 DLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIP 185
+L L Q+ + + +P L +L L + N LT
Sbjct: 61 NLDRAELT---KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 186 ASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDL 245
++ L +L+ + N L P ++ LE L LA N+L L L NL L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 246 ILWQNHLSGEIPPTIGNIQSLELLALHENSF 276
+L +N L IP L LH N +
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 47/206 (22%), Positives = 75/206 (36%), Gaps = 8/206 (3%)
Query: 457 SLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYF 516
S +++ + LT +LP + ++ + L L +N + L +L+L
Sbjct: 11 SHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 517 VGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLV 576
G L L T ++S N L L LD+S N+ T L L
Sbjct: 68 --TKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 577 NLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNN 636
L+ L L N+L P L +L +L + N + L L L L + N+
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT-LLLQENS 183
Query: 637 LSGVIPYELGNLQMLEALYLDDNQLI 662
L IP +L +L N +
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 41/235 (17%), Positives = 68/235 (28%), Gaps = 33/235 (14%)
Query: 523 EVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLK 582
EV + + N +L+ +P +L + L LS N + L L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 583 LSDNK-LTGAIPSSLGGLARLTELQMGGNIFSG-------------------SIPVALGQ 622
L + + +L L L S+P+ +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 623 LTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSN 682
L + N L + P L LE L L +N L + +L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 683 NNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQLMPPSHTPKKNWIKGGSTK 737
N+L + + GN LC +C L + W++ +
Sbjct: 182 NSLYTIPKGFFGSHLLPFAFLHGNPWLC----NCEIL------YFRRWLQDNAEN 226
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 4e-07
Identities = 42/207 (20%), Positives = 64/207 (30%), Gaps = 7/207 (3%)
Query: 118 NCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYS 177
+S ++ C R +P L L+L EN ++ + T L +L +
Sbjct: 8 KVASHLEVN-CDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 178 NNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELE 237
LT + + + + L+V + N L L
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV---SFNRLTSLPLGALR 121
Query: 238 KLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYT 297
L L +L L N L P + LE L+L N+ + L L L L +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 298 NELNGTIPHELGNCTSAVEIDLSENQL 324
N L TIP L N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.4 bits (150), Expect = 5e-11
Identities = 42/284 (14%), Positives = 91/284 (32%), Gaps = 24/284 (8%)
Query: 317 IDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTG-T 375
+DL+ L + L L + + + + + E ++ +DLS + + T
Sbjct: 5 LDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVST 62
Query: 376 IPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLI 435
+ + L +L L L I + NS+L L++S + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS--- 119
Query: 436 FLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGL 495
L + + ++ + L+ +N
Sbjct: 120 -------------CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 166
Query: 496 IPPEIGKLRNLERLHLSENYFVGY-IPSEVGNLEHLVTFNISS-NSLSGTIPHELGNCVN 553
+ + + NL L LS++ + E L +L ++S + ELG
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226
Query: 554 LQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLG 597
L+ L + G+ L + L+++ + T ++G
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 4e-09
Identities = 52/279 (18%), Positives = 98/279 (35%), Gaps = 24/279 (8%)
Query: 247 LWQ------NHLSGEIPPTIGNIQSLELLALH-ENSFSGGLPKELGKLSRLKKLYVYTNE 299
LWQ +L P G + S ++A SF E R++ + + +
Sbjct: 1 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSV 57
Query: 300 LNG-TIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLF--ENMLQGSIPREL 356
+ T+ L C+ + L +L+ I L NL L L + ++ L
Sbjct: 58 IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117
Query: 357 GQLTQLHKLDL------SINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHL 410
++L +L+L + ++ + + +T L N + + + +L
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177
Query: 411 SVLDVSMN-NLDGSIPPHLCMYQKLIFLSL-GSNRLSGNIPPGLKTCRSLMQLMLGQNQL 468
LD+S + L L LSL + L +L L +
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237
Query: 469 TGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLE 507
G+L + L + L++ + F+ + P IG +N E
Sbjct: 238 DGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 1e-06
Identities = 26/177 (14%), Positives = 49/177 (27%), Gaps = 8/177 (4%)
Query: 555 QRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614
Q LDL+ L + + + + + R+ + + ++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60
Query: 615 -SIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQM 673
++ L Q + LQ L++ LS I L L L L E
Sbjct: 61 STLHGILSQCSKLQ-NLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 674 SLLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQLMPPSHTPKKNW 730
L NL T ++ ++ + L S + + S
Sbjct: 120 ---CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL-SGYRKNLQKSDLSTLVR 172
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 6e-04
Identities = 40/260 (15%), Positives = 80/260 (30%), Gaps = 38/260 (14%)
Query: 48 SNNLESWNSSDMTPCNWIGVECTDFKVTSVDLHGLNLSGI-LSPRICDLPRLVEFNISMN 106
S + ++ + + F+V +DL + L + +L ++
Sbjct: 22 SQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81
Query: 107 FVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGN 166
++ I LA S+L L+L Q + R L ++ F + +
Sbjct: 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 141
Query: 167 LTSLEELVIYSNNLTG---------------------------------AIPASISKLRQ 193
+ I NL+G +L
Sbjct: 142 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201
Query: 194 LRVIR-AGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHL 252
L+ + + + E+ E L+ L + +G L E L +L + +H
Sbjct: 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHF 258
Query: 253 SGEIPPTIGNIQSLELLALH 272
+ PTIGN ++ E+ +
Sbjct: 259 TTIARPTIGNKKNQEIWGIK 278
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 59.7 bits (143), Expect = 2e-10
Identities = 38/228 (16%), Positives = 71/228 (31%), Gaps = 18/228 (7%)
Query: 358 QLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSM 417
L K+ +N+T T+ +L + L F + + ++L L++
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 418 NNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFY 477
N + P + LS + I + + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 478 NLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISS 537
L + +GL + +LS + + NL L T
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQ----------YLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 538 NSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD 585
N +S P L + NL + L NQ + +P L NL ++ L++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.3 bits (129), Expect = 1e-08
Identities = 37/219 (16%), Positives = 72/219 (32%), Gaps = 24/219 (10%)
Query: 456 RSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENY 515
+ +++ G++ +T ++ +L ++ L + + + + L NL L L +N
Sbjct: 19 ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 516 FVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQL 575
P + + + + I + + L L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 576 VNLELLKLSDNKLTGAI--------------PSSLGGLARLTELQMGGNIFSGSIPVALG 621
+ + L G + L L++LT L+ N S P L
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 622 QLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQ 660
L L +++ +N +S V P L N L + L NQ
Sbjct: 193 SLPNLIE-VHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 5e-07
Identities = 41/227 (18%), Positives = 79/227 (34%), Gaps = 18/227 (7%)
Query: 310 NCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSI 369
+A++I ++ +T + + + + L F + +I + L L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQAD--LDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 370 NNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLC 429
N +T PL+ ++L I + + + + + L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTL------DLTSTQITDVTPLA 126
Query: 430 MYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQ 489
L L L N+++ P T + + Q S NL L+ L+
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQV----SDLTPLANLSKLTTLKADD 182
Query: 490 NRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNIS 536
N+ S + P + L NL +HL N P + N +L ++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 4e-05
Identities = 33/215 (15%), Positives = 63/215 (29%), Gaps = 22/215 (10%)
Query: 191 LRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQN 250
L I AG ++++ + ++ +G+ L + ++ L NL L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 251 HLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYT------------- 297
++ P + L+ + + + T
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 298 -NELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPREL 356
I + LS L + L L+ +N + P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 357 GQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQL 391
L L ++ L N ++ PL N + L + L
Sbjct: 192 ASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 12/63 (19%), Positives = 25/63 (39%), Gaps = 4/63 (6%)
Query: 526 NLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD 585
L + + ++++ T+ + + L T E + L NL L+L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 586 NKL 588
N++
Sbjct: 73 NQI 75
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 58.3 bits (139), Expect = 2e-09
Identities = 52/329 (15%), Positives = 95/329 (28%), Gaps = 25/329 (7%)
Query: 311 CTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSIN 370
A E++L+ L+ +P L P+L L N L +P L L + ++
Sbjct: 37 DRQAHELELNNLGLSS-LPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91
Query: 371 NLTGTIPL-----------EFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNN 419
L+ PL E + ++ + L + N
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151
Query: 420 LDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNL 479
L+ + I+ S + ++P L++ + ++ +L +
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 480 QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNS 539
N L S F+ + L L N+
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271
Query: 540 LSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599
S I +L+ L++S N+ P LE L S N L +P
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQ-- 324
Query: 600 ARLTELQMGGNIFSGSIPVALGQLTALQI 628
L +L + N P + L++
Sbjct: 325 -NLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 3e-09
Identities = 58/343 (16%), Positives = 103/343 (30%), Gaps = 31/343 (9%)
Query: 240 RNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNE 299
R +L L LS +P +++SL NS + LP+ L L
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESLVA---SCNSLTE-LPELPQSLKSLLVDNNNLKA 92
Query: 300 LNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQL 359
L+ P S +++ + + + +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPEL---------------QNSSFLKIIDVDNNSLKKLPD 137
Query: 360 TQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNN 419
++ N E QNL +L + +N L+ + + S ++ ++
Sbjct: 138 LPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEEL 197
Query: 420 LDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLM--LGQNQLTGSLPIEFY 477
+ P L L L ++ L L F
Sbjct: 198 PELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFS 257
Query: 478 NLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISS 537
L L Y N S I +LE L++S N + +P+ LE L S
Sbjct: 258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASF 313
Query: 538 NSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLEL 580
N L+ +P NL++L + N P+ + +L +
Sbjct: 314 NHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.4 bits (134), Expect = 9e-09
Identities = 52/333 (15%), Positives = 89/333 (26%), Gaps = 27/333 (8%)
Query: 211 EISEC--EGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLEL 268
+ +C L L L LP +L L+ N L+ E+P +++SL +
Sbjct: 31 RLRDCLDRQAHELELNNLGLSS-LPELPP---HLESLVASCNSLT-ELPELPQSLKSLLV 85
Query: 269 LALHENSFSGGLPKELGKLSRLKK-----------LYVYTNELNGTIPHELGNCTSAVEI 317
+ + S P + + N ++ S I
Sbjct: 86 DNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFI 145
Query: 318 DLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIP 377
NQL + +P L + + + + L
Sbjct: 146 AAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPF 205
Query: 378 LEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFL 437
L + L D +L
Sbjct: 206 LTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 265
Query: 438 SLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIP 497
N S I SL +L + N+L LP L+ L N + +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLAEV-- 319
Query: 498 PEIGKLRNLERLHLSENYFVGYIPSEVGNLEHL 530
PE+ +NL++LH+ N P ++E L
Sbjct: 320 PEL--PQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 3e-08
Identities = 55/330 (16%), Positives = 97/330 (29%), Gaps = 27/330 (8%)
Query: 334 LIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFD 393
L L+L L S+P L L S N+LT +P Q+L L+
Sbjct: 36 LDRQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNL 90
Query: 394 NHLEGTIP-----------PHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSN 442
L P S ++ + S+ + L F++ G+N
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 443 RLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGK 502
+L + + + LP+ ++ + + L
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 503 LRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRN 562
N L + + N + S + + L N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270
Query: 563 QFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQ 622
+ +LE L +S+NKL +P+ RL L N + +P
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN 325
Query: 623 LTALQIALNISHNNLSGV--IPYELGNLQM 650
L L++ +N L IP + +L+M
Sbjct: 326 LK----QLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 22/96 (22%), Positives = 36/96 (37%), Gaps = 9/96 (9%)
Query: 101 FNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEI 160
+N + I + SLE L++ N+L + L +L N++ E+
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHL-AEV 319
Query: 161 PEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRV 196
PE NL L + N L P + LR+
Sbjct: 320 PELPQNLKQLH---VEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 5e-06
Identities = 26/93 (27%), Positives = 37/93 (39%), Gaps = 10/93 (10%)
Query: 150 YLCENYIFGEIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIP 209
N EI SLEEL + +N L +PA +L +L N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIA---SFNHLAE-VP 320
Query: 210 PEISECEGLEVLGLAQNSLEGF--LPSELEKLR 240
L+ L + N L F +P +E LR
Sbjct: 321 ELPQ---NLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 23/91 (25%), Positives = 35/91 (38%), Gaps = 9/91 (9%)
Query: 201 HNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTI 260
N+ S I LE L ++ N L LP+ +L L I NHL+ E+P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLA-EVPELP 323
Query: 261 GNIQSLELLALHENSFSGGLPKELGKLSRLK 291
N++ L + N P + L+
Sbjct: 324 QNLKQLH---VEYNPLR-EFPDIPESVEDLR 350
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.0 bits (129), Expect = 3e-09
Identities = 27/111 (24%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 555 QRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614
+ L L+ T L QL+ + L LS N+L P+ LA L L++ +
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNA 54
Query: 615 SIPVALGQLTALQIALNISHNNLSGV-IPYELGNLQMLEALYLDDNQLIGE 664
V L + +N L L + L L L N L E
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.6 bits (128), Expect = 4e-09
Identities = 30/119 (25%), Positives = 41/119 (34%), Gaps = 7/119 (5%)
Query: 485 LELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544
L L + L + +L + L LS N P+ + L L S N+L
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 545 PHELGNCVNLQRLDLSRNQFTG-SAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARL 602
N LQ L L N+ +A + L L LL L N L LA +
Sbjct: 60 GVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 3e-07
Identities = 25/123 (20%), Positives = 46/123 (37%), Gaps = 6/123 (4%)
Query: 365 LDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSI 424
L L+ +LT + + L + L L N L P + + + + ++
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP---ALAALRCLEVLQASDNALEN 57
Query: 425 PPHLCMYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLS 483
+ +L L L +NRL + L +C L+ L L N L I+ + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 484 ALE 486
++
Sbjct: 118 SVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 4e-07
Identities = 32/124 (25%), Positives = 52/124 (41%), Gaps = 7/124 (5%)
Query: 532 TFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGA 591
+++ L T+ L + + LDLS N+ P L L LE+L+ SDN L
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALE-- 56
Query: 592 IPSSLGGLARLTELQMGGN-IFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQM 650
+ L RL EL + N + + L L + LN+ N+L + +M
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL-LNLQGNSLCQEEGIQERLAEM 115
Query: 651 LEAL 654
L ++
Sbjct: 116 LPSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 4e-06
Identities = 24/118 (20%), Positives = 45/118 (38%), Gaps = 7/118 (5%)
Query: 78 DLHGLNLSGILSPRICDLPRLVEFNISMNFVTGSIPTDLANCSSLEILDLCTNRLHGVIP 137
L +L+ + + L + ++S N + P LA LE+L N L V
Sbjct: 4 HLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDG 60
Query: 138 FQLFFINTLRKLYLCENYIFG-EIPEEIGNLTSLEELVIYSNNLTGAIPASISKLRQL 194
+ L++L LC N + + + + L L + N+L +L ++
Sbjct: 61 V--ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 7e-06
Identities = 34/126 (26%), Positives = 55/126 (43%), Gaps = 9/126 (7%)
Query: 220 VLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGG 279
VL LA L LE+L +T L L N L +PP + ++ LE+L +N+
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58
Query: 280 LPKELGKLSRLKKLYVYTNELNGT-IPHELGNCTSAVEIDLSENQLT---GFIPRELGLI 335
L RL++L + N L + L +C V ++L N L G R ++
Sbjct: 59 DGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 336 PNLCLL 341
P++ +
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 26/119 (21%), Positives = 44/119 (36%), Gaps = 7/119 (5%)
Query: 389 LQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNI 448
L L L T+ H+ ++ LD+S N L +PP L + L L ++ +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQ--ASDNALEN 57
Query: 449 PPGLKTCRSLMQLMLGQNQLTG-SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNL 506
G+ L +L+L N+L + + L L L N +L +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 3e-04
Identities = 25/126 (19%), Positives = 44/126 (34%), Gaps = 12/126 (9%)
Query: 269 LALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFI 328
L L + L +L + L + N L P L + S+N L
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 329 PRELGLIPNLCLLQLFENMLQG-SIPRELGQLTQLHKLDLSINNLTGTIPLE------FQ 381
+P L L L N LQ + + L +L L+L N+L ++
Sbjct: 60 GVAN--LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 382 NLTYLV 387
+++ ++
Sbjct: 118 SVSSIL 123
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (135), Expect = 8e-09
Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 6/97 (6%)
Query: 552 VNLQRLDLSRNQFTGSAPEEL-GQLVNLELLKLSDNKLTG----AIPSSLGGLARLTELQ 606
+++Q LD+ + + + EL L ++++L D LT I S+L L EL
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 607 MGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPY 643
+ N + Q + I +L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTP-SCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 2e-08
Identities = 58/467 (12%), Positives = 115/467 (24%), Gaps = 32/467 (6%)
Query: 169 SLEELVIYSNNLTGA-IPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNS 227
++ L I L+ A + L+Q +V+R L+ + + A
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTE---------ARCKDISSA--- 50
Query: 228 LEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLP--KELG 285
L L +L L N L + + + S G
Sbjct: 51 --------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102
Query: 286 KLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFE 345
LS + EL+ + + L + Q + + +
Sbjct: 103 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162
Query: 346 NMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIG 405
++L+ + ++ + + L + L L I
Sbjct: 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 222
Query: 406 VNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQ 465
+ +N G + L S K C L +++ +
Sbjct: 223 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 282
Query: 466 NQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVG 525
L + L G + ++ +
Sbjct: 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 342
Query: 526 NLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLV----NLELL 581
+ + + L+ L L+ + S+ L + +L L
Sbjct: 343 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402
Query: 582 KLSDNKLTGAIPSSLGGLAR-----LTELQMGGNIFSGSIPVALGQL 623
LS+N L A L R L +L + +S + L L
Sbjct: 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 7e-05
Identities = 15/82 (18%), Positives = 31/82 (37%), Gaps = 10/82 (12%)
Query: 577 NLELLKLSDNKLTG----AIPSSLGGLARLTELQMGGNIFSGSIPVALGQ-----LTALQ 627
L +L L+D ++ ++ ++L L EL + N + + L + L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 628 IALNISHNNLSGVIPYELGNLQ 649
L + S + L L+
Sbjct: 430 Q-LVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 20/86 (23%), Positives = 30/86 (34%), Gaps = 9/86 (10%)
Query: 215 CEGLEVLGLAQNSLEG----FLPSELEKLRNLTDLILWQNHLSGEIPPTIG-----NIQS 265
L VL LA + L + L +L +L L N L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 266 LELLALHENSFSGGLPKELGKLSRLK 291
LE L L++ +S + L L + K
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 18/85 (21%), Positives = 34/85 (40%), Gaps = 9/85 (10%)
Query: 288 SRLKKLYVYTNELNGT----IPHELGNCTSAVEIDLSENQLTGFIPREL--GLIPNLCLL 341
S L+ L++ +++ + + L S E+DLS N L +L + CLL
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 342 Q---LFENMLQGSIPRELGQLTQLH 363
+ L++ + L L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 20/91 (21%), Positives = 31/91 (34%), Gaps = 13/91 (14%)
Query: 336 PNLCLLQLFENMLQG----SIPRELGQLTQLHKLDLSINNLTGTIPLEF-----QNLTYL 386
L +L L + + S+ L L +LDLS N L L+ Q L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 387 VDLQLFDNHLEGTIPPHIG----VNSHLSVL 413
L L+D + + + L V+
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 15/91 (16%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 121 SLEILDLCTNRLHGVIPFQLF-FINTLRKLYLCENYI----FGEIPEEIGNLTSLEELVI 175
++ LD+ L +L + + + L + + +I + +L EL +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 176 YSNNLTGAIPASISKLRQLRVIRAGHNSLSG 206
SN L + + Q + SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.003
Identities = 16/96 (16%), Positives = 29/96 (30%), Gaps = 10/96 (10%)
Query: 407 NSHLSVLDVSMNNLDGSIPPHLCMY-QKLIFLSLGSNRLSG----NIPPGLKTCRSLMQL 461
+ + LD+ L + L Q+ + L L+ +I L+ +L +L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 462 MLGQNQLTGSLPIEF-----YNLQNLSALELYQNRF 492
L N+L + L L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 53.3 bits (126), Expect = 8e-08
Identities = 43/338 (12%), Positives = 98/338 (28%), Gaps = 30/338 (8%)
Query: 292 KLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTG----FIPRELGLIPNLCLLQLFENM 347
KL T E ++ L S EI LS N + ++ + +L + + +
Sbjct: 11 KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70
Query: 348 ---LQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHI 404
++ IP L L Q ++ + + + L + + H
Sbjct: 71 TGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHN 130
Query: 405 GVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLG 464
+ ++ + ++ L + G NRL +L+
Sbjct: 131 NGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL-- 188
Query: 465 QNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEV 524
+QN E ++ + + + + + +
Sbjct: 189 ---------HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239
Query: 525 GNLEHLVTFNISSNSLSGTIPHELGNCV------NLQRLDLSRNQFTGSAPEEL-----G 573
+ +L ++ LS + + LQ L L N+ A L
Sbjct: 240 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 299
Query: 574 QLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNI 611
++ +L L+L+ N+ + + + + G +
Sbjct: 300 KMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGEL 336
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.8 bits (109), Expect = 8e-06
Identities = 41/324 (12%), Positives = 97/324 (29%), Gaps = 33/324 (10%)
Query: 214 ECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGE----IPPTIGNIQSLELL 269
E + L++ + + + + L + ++ +++L N + E + I + + LE+
Sbjct: 6 EGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 270 ALHENS---FSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTG 326
+ +P+ L L + + + + + LS++
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 327 FIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLT-GTIPLEFQNLTY 385
+ + ++ + + ++ ++ L + N L G++ +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 386 LVDLQLFDNHLEGTIPPHIGVNSHLSVLD------------VSMNNLDGSIPPHLCMYQK 433
L G P I + + ++ L +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 434 LIFLSLGSNRLSGNIPPGLKTC------RSLMQLMLGQNQLTGSLPIE-----FYNLQNL 482
L L L LS + L L L N++ + +L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 483 SALELYQNRFSGLIPPEIGKLRNL 506
LEL NRFS + ++R +
Sbjct: 305 LFLELNGNRFSEE-DDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.003
Identities = 44/352 (12%), Positives = 95/352 (26%), Gaps = 49/352 (13%)
Query: 255 EIPPTIGNIQSLELLALHENSFSG----GLPKELGKLSRLKKLYVYTN---ELNGTIPHE 307
+ + S++ + L N+ L + + L+ + IP
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 308 LGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDL 367
L A+ + + + L ++ + L +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 368 SINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPH 427
+ + + +N L + N LE L ++ + I P
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 428 LCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALEL 487
+ L L + +Q + + +L I + NL L L
Sbjct: 202 GIEHLLLEGL-----------AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 250
Query: 488 YQNRFSGLIPPEIG------KLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLS 541
S + + L+ L L N I +++
Sbjct: 251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN-------------------EIELDAVR 291
Query: 542 GTIPHELGNCVNLQRLDLSRNQFT--GSAPEELGQLVNL----ELLKLSDNK 587
+L L+L+ N+F+ +E+ ++ + EL +L D +
Sbjct: 292 TLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDME 343
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 38/349 (10%), Positives = 88/349 (25%), Gaps = 38/349 (10%)
Query: 337 NLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTG----TIPLEFQNLTYLVDLQLF 392
+L L + + S+ L + + ++ LS N + + + L +
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 393 DNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGL 452
D L + L + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG--------PTAQEPLIDFLSK 119
Query: 453 KTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLS 512
T + L I + + I +L N +
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179
Query: 513 ENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEEL 572
+ + + V +++ + + L + + V + + + + + L
Sbjct: 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239
Query: 573 GQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNI 632
NL L L+D L+ +++ + + LQ L +
Sbjct: 240 KSWPNLRELGLNDCLLSARGAAAVVD------------------AFSKLENIGLQT-LRL 280
Query: 633 SHNNLSGVIPYEL-----GNLQMLEALYLDDNQLIGEIPASMGEQMSLL 676
+N + L + L L L+ N+ E + E +
Sbjct: 281 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR-FSEEDDVVDEIREVF 328
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 2e-07
Identities = 28/217 (12%), Positives = 50/217 (23%), Gaps = 6/217 (2%)
Query: 351 SIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYL--VDLQLFDNHLEGTIPPHIGVNS 408
IP +L +L + L F L +++ D +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQ--N 466
+ NNL P L +L + + + + L + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 467 QLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGN 526
T L L +N + + E N
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 527 LEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQ 563
V +IS + + L N L+ +
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 5e-07
Identities = 31/194 (15%), Positives = 63/194 (32%), Gaps = 28/194 (14%)
Query: 337 NLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHL 396
L + + ++ + +L + ++ + +++ + Q L + L L N L
Sbjct: 25 ETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGI--QYLPNVTKLFLNGNKL 80
Query: 397 EG------------------TIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLS 438
+ + + +S+ + S L +L L
Sbjct: 81 TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLY 140
Query: 439 LGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPP 498
LG+N+++ T + L Q + L L L L +N S L
Sbjct: 141 LGNNKITDITVLSRLTKLDTLSLEDNQIS----DIVPLAGLTKLQNLYLSKNHISDL--R 194
Query: 499 EIGKLRNLERLHLS 512
+ L+NL+ L L
Sbjct: 195 ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 39/223 (17%), Positives = 72/223 (32%), Gaps = 22/223 (9%)
Query: 176 YSNNLTGAIPASISK------LRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLE 229
+ T +P I + + S++ + +E ++ + + ++
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 59
Query: 230 GFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSR 289
++ L N+T L L N L+ I+ L L F + +
Sbjct: 60 SVQG--IQYLPNVTKLFLNGNKLTD--------IKPLANLKNLGWLFLDENKVKDLSSLK 109
Query: 290 LKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQ 349
K + + I G L L + L L L +N +
Sbjct: 110 DLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS 169
Query: 350 GSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLF 392
+P L LT+L L LS N+++ + L L L+LF
Sbjct: 170 DIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 47/201 (23%), Positives = 78/201 (38%), Gaps = 17/201 (8%)
Query: 456 RSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENY 515
++ L + +T ++ L ++ + + + I L N+ +L L+ N
Sbjct: 24 AETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79
Query: 516 FVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQL 575
P + NL++L + N + + LS S L L
Sbjct: 80 LTDIKP--LANLKNLGWLFLDEN----KVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 576 VNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHN 635
LE L L +NK+T S L +L L + N S +P L LT LQ L +S N
Sbjct: 134 PQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQN-LYLSKN 188
Query: 636 NLSGVIPYELGNLQMLEALYL 656
++S + L L+ L+ L L
Sbjct: 189 HISDLRA--LAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 34/203 (16%), Positives = 62/203 (30%), Gaps = 16/203 (7%)
Query: 382 NLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGS 441
+ L + + + + + + +++ + + L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 442 NRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIG 501
N+L+ P + L + + SL +
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL------SLEHNGISDINGLV 131
Query: 502 KLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSR 561
L LE L+L N L L T ++ N +S +P L LQ L LS+
Sbjct: 132 HLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 562 NQFTGSAPEELGQLVNLELLKLS 584
N + L L NL++L+L
Sbjct: 188 NHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 10/65 (15%), Positives = 24/65 (36%), Gaps = 4/65 (6%)
Query: 526 NLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD 585
+ N+ S++ + ++ ++ + + + L N+ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 586 NKLTG 590
NKLT
Sbjct: 78 NKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 33/193 (17%), Positives = 63/193 (32%), Gaps = 26/193 (13%)
Query: 432 QKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNR 491
+ I +L ++ + S+ Q++ + + I+ L N++ L L N+
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNK 79
Query: 492 FSGLIPPEIGKLRNLERLHLSENYFV-----------------GYIPSEVGNLEHLVTFN 534
+ + L+NL L L EN S++ L HL
Sbjct: 80 LTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 535 ISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPS 594
+ + + + + L L L+ L LS N ++
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD--LR 194
Query: 595 SLGGLARLTELQM 607
+L GL L L++
Sbjct: 195 ALAGLKNLDVLEL 207
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.7 bits (109), Expect = 4e-06
Identities = 41/188 (21%), Positives = 78/188 (41%), Gaps = 8/188 (4%)
Query: 411 SVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKT-CRSLMQLMLGQNQLT 469
+ +D + L IP + ++ L L N L GL L++L L +NQLT
Sbjct: 11 TTVDCTGRGLK-EIPRDIPLH--TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 470 GSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEH 529
G P F ++ L+L +N+ + L L+ L+L +N +P +L
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 530 LVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLT 589
L + N++SN + L++ L+ AP ++ ++++ L ++
Sbjct: 128 LTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKVR---DVQIKDLPHSEFK 183
Query: 590 GAIPSSLG 597
+ +S G
Sbjct: 184 CSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 34/158 (21%), Positives = 56/158 (35%), Gaps = 5/158 (3%)
Query: 288 SRLKKLYVYTNELNGTIPHEL-GNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFEN 346
+L + NEL L G V+++L NQLTG P ++ LQL EN
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 347 MLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGV 406
++ + L QL L+L N ++ +P F++L L L L N
Sbjct: 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA 148
Query: 407 NSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRL 444
++ P + + + L +
Sbjct: 149 EWLRK-KSLNGGAARCGAPSKV---RDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 29/165 (17%), Positives = 49/165 (29%), Gaps = 3/165 (1%)
Query: 555 QRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSG 614
+D + P ++ + L L+DN+L L G
Sbjct: 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 615 SIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMS 674
I + + L + N + + L L+ L L DNQ+ +P S S
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 675 LLVCNLSNNNLVGTVPNTTVFRRIDSSNFAGNRGLCMLGSDCHQL 719
L NL++N + + G C S +
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDV 172
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.9 bits (86), Expect = 0.003
Identities = 39/186 (20%), Positives = 67/186 (36%), Gaps = 18/186 (9%)
Query: 62 CNWIGVECTDFKVTSVDLHGLNLSGILSPRICDLPR-LVEFNISMNFVTGSI-PTDLANC 119
C V+CT + + PR D+P E ++ N +
Sbjct: 8 CEGTTVDCTGRGLKEI------------PR--DIPLHTTELLLNDNELGRISSDGLFGRL 53
Query: 120 SSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNN 179
L L+L N+L G+ P + +++L L EN I + L L+ L +Y N
Sbjct: 54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQ 113
Query: 180 LTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKL 239
++ +P S L L + N + E L L + PS++ +
Sbjct: 114 ISCVMPGSFEHLNSLTSLNLASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDV 172
Query: 240 RNLTDL 245
+ + DL
Sbjct: 173 Q-IKDL 177
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (103), Expect = 2e-05
Identities = 24/137 (17%), Positives = 48/137 (35%), Gaps = 5/137 (3%)
Query: 471 SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHL 530
L + + S L P++ L+ + + N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPEL 67
Query: 531 VTFNISSNSLSGT--IPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKL 588
++ N+S+N L + + NL+ L+LS N+ + + + LE L L N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 589 TGAIPSSLGGLARLTEL 605
+ ++ + E
Sbjct: 128 SDTFRDQSTYISAIRER 144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 1e-04
Identities = 21/131 (16%), Positives = 43/131 (32%), Gaps = 6/131 (4%)
Query: 569 PEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQI 628
+ + + L L L L + + ++ + + L
Sbjct: 13 KLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLS 69
Query: 629 ALNISHNNLSGV--IPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLV 686
LN+S+N L + + + L+ L L N+L E + + L L N+L
Sbjct: 70 -LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 687 GTVPNTTVFRR 697
T + + +
Sbjct: 129 DTFRDQSTYIS 139
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 25/134 (18%), Positives = 48/134 (35%), Gaps = 6/134 (4%)
Query: 318 DLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIP 377
+L Q+ + + + L L+ +L L+ +++ T+
Sbjct: 3 ELKPEQVEQ-LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLR 58
Query: 378 LEFQNLTYLVDLQLFDNHLEGT--IPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLI 435
+ +N+ L+ L L +N L + + +L +L++S N L KL
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 436 FLSLGSNRLSGNIP 449
L L N LS
Sbjct: 119 ELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 29/173 (16%), Positives = 51/173 (29%), Gaps = 26/173 (15%)
Query: 255 EIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSA 314
++ + AL +L + L ++ + T+ N
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPEL 67
Query: 315 VEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTG 374
+ ++LS N+L + + + L L+LS N L
Sbjct: 68 LSLNLSNNRLYRLDD----------------------MSSIVQKAPNLKILNLSGNELKS 105
Query: 375 TIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDG-SIPP 426
L+ L +L L N L T S + + LDG +PP
Sbjct: 106 ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPP 158
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 2e-05
Identities = 25/175 (14%), Positives = 47/175 (26%), Gaps = 28/175 (16%)
Query: 311 CTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSIN 370
+ + + + L L +L +
Sbjct: 7 PHGSSGLRCTRDGAL-------------------------DSLHHLPGAENLTELYIENQ 41
Query: 371 NLTGTIPLE-FQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLC 429
+ L + L L +L + + L P LS L++S N L+ S+
Sbjct: 42 QHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTV 100
Query: 430 MYQKLIFLSLGSNRLSGNIPPG-LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLS 483
L L L N L + L+ + + +L ++ N S
Sbjct: 101 QGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 8e-05
Identities = 22/134 (16%), Positives = 46/134 (34%), Gaps = 4/134 (2%)
Query: 475 EFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFN 534
++ N L+L + I L + + S+N L L T
Sbjct: 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69
Query: 535 ISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG-SAPEELGQLVNLELLKLSDNKLTGAIP 593
+++N + +L L L+ N + L L +L L + N +T
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 594 SSLGGLARLTELQM 607
L + ++ ++++
Sbjct: 130 YRLYVIYKVPQVRV 143
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 41/193 (21%), Positives = 70/193 (36%), Gaps = 30/193 (15%)
Query: 336 PNLCLLQLFENMLQGSIPR-ELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDN 394
L + + ++ + +L Q+T L L I ++ G + L L + +N
Sbjct: 18 AEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNN 72
Query: 395 HLEG------------------TIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIF 436
L I + + ++ +++ N + L L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 437 LSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLI 496
L L SN + + L SL QL NQ+T P+ NL L L++ N+ S +
Sbjct: 133 LELSSNTI--SDISALSGLTSLQQLNFSSNQVTDLKPLA--NLTTLERLDISSNKVSDI- 187
Query: 497 PPEIGKLRNLERL 509
+ KL NLE L
Sbjct: 188 -SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 39/199 (19%), Positives = 69/199 (34%), Gaps = 17/199 (8%)
Query: 456 RSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENY 515
M+ +LG+ +T ++ +L ++ L+ + + + L NL +++ S N
Sbjct: 18 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 73
Query: 516 FVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQL 575
L + L + F +
Sbjct: 74 LTDIT--------PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 125
Query: 576 VNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHN 635
L +L + T + S+L GL L +L N + P L LT L+ L+IS N
Sbjct: 126 NLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLER-LDISSN 182
Query: 636 NLSGVIPYELGNLQMLEAL 654
+S + L L LE+L
Sbjct: 183 KVSDISV--LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 45/223 (20%), Positives = 71/223 (31%), Gaps = 40/223 (17%)
Query: 359 LTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMN 418
L + K L N+T T+ +L + LQ + + ++L+ ++ S N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 72
Query: 419 NLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYN 478
L P I ++ + + + N
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDI------DPLKN 126
Query: 479 LQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSN 538
L NL+ LEL N S + L L N SSN
Sbjct: 127 LTNLNRLELSSNTI--------------------------SDISALSGLTSLQQLNFSSN 160
Query: 539 SLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELL 581
++ P L N L+RLD+S N+ + L +L NLE L
Sbjct: 161 QVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1109 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.81 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.47 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.2 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.39 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.17 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.82 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.52 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.37 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.27 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.9 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.66 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.5 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.57 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.33 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=425.30 Aligned_cols=263 Identities=29% Similarity=0.442 Sum_probs=208.8
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||+||+|+++ ..||||+++.........+.|.+|++++++++|||||++++++.. +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 67899999999999999999875 359999998666566667889999999999999999999998754 568999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
|++|+|.+++...+.. +++..+..++.||++||+||| +++||||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~~g~L~~~l~~~~~~--~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTSCCC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999765443 899999999999999999999 67999999999999999999999999999987653222
Q ss_pred -CCccccccccceeccccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 962 -KSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 962 -~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
.......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+..........+...... +....
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--p~~~~---- 233 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS--PDLSK---- 233 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC--CCGGG----
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC--Ccchh----
Confidence 23355689999999999864 358999999999999999999999998654322222222221111 10000
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
........+.+++.+||+.||++||||+||+++|+.+.+..
T Consensus 234 ------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 234 ------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp ------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 01112346789999999999999999999999999887654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=426.18 Aligned_cols=257 Identities=24% Similarity=0.416 Sum_probs=201.1
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|+..++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|..++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 467888999999999999999988899999999743 33457899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++|+|.+++..... .+++..+..++.|||.||+||| +.+|+||||||+||+++.++.+||+|||+|+.......
T Consensus 82 ~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp CTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred cCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999876544 3899999999999999999999 77999999999999999999999999999987754433
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......||+.|+|||++.+..|+.++|||||||++|||+|+..|+............+........|
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p------------ 224 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP------------ 224 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC------------
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc------------
Confidence 44455678999999999999999999999999999999999654443222222222222221111110
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
......+.+++.+||+.||++||||+||+++|+++.+
T Consensus 225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 0112357799999999999999999999999998865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=417.09 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=205.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|+++ +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 57889999999999999999975 699999999975432 2334678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.+++..... +++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~~~---l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999976543 999999999999999999999 7799999999999999999999999999998764322
Q ss_pred -CCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 961 -SKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 961 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
.......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||............... ... .... .+
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~---~~~-~~~~-~~-- 230 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---KKT-YLNP-WK-- 230 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT---TCT-TSTT-GG--
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc---CCC-CCCc-cc--
Confidence 223356789999999999988876 57899999999999999999999764432222211111 110 0000 00
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.....+.+++.+||+.||++|||++|++++-+
T Consensus 231 --------~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 231 --------KIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp --------GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred --------cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 01134668999999999999999999988754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=417.16 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=210.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|++. +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 47999999999999999999964 6999999999755432 35679999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||++|+|.+++.... +++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 98 y~~gg~L~~~~~~~~----l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~- 169 (293)
T d1yhwa1 98 YLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169 (293)
T ss_dssp CCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred ecCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc-
Confidence 999999999887542 899999999999999999999 779999999999999999999999999999876532
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......+||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.. ..+.+........+.... .
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~~~~~~~~~~~~-~----- 239 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----PLRALYLIATNGTPELQN-P----- 239 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHHCSCCCSS-G-----
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC----HHHHHHHHHhCCCCCCCC-c-----
Confidence 233456689999999999999999999999999999999999999997533 222222222222111100 0
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
......+.+++.+||+.||++|||++|+++|-+.
T Consensus 240 -----~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 240 -----EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp -----GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred -----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 0112357789999999999999999999987544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=420.20 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=208.8
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||+||+|++++++.||||+++.. ....+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC---cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 467888999999999999999988899999999743 2345679999999999999999999998754 567999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++|+|.+++..... ..+++..+.+++.||++||+||| +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 89 ~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999999998865432 23899999999999999999999 77999999999999999999999999999998764443
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......||+.|+|||++.++.++.++|||||||++|||+||..|+..... ..+.+........+..
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---~~~~~~~i~~~~~~~~---------- 231 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVIQNLERGYRMVR---------- 231 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCCCCC----------
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC---HHHHHHHHHhcCCCCC----------
Confidence 444566799999999999999999999999999999999997666543322 2222222212111100
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
+......+.+++.+||+.||++||||+||++.|+....
T Consensus 232 ---p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 01112357799999999999999999999999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=412.17 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=210.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+++ +++.||||++..... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999975 689999999864321 1223567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
|||++|+|.+++..... +++..+..++.||++||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred eecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 99999999999986543 899999999999999999999 77999999999999999999999999999986542
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+. ...+..........+..+.
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~------ 226 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----TYQETYKRISRVEFTFPDF------ 226 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTTCCCCCTT------
T ss_pred --CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC----CHHHHHHHHHcCCCCCCcc------
Confidence 2334567999999999999999999999999999999999999999753 2333333322222211111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
....+.+++.+||+.||++|||++|+++|-+-.
T Consensus 227 --------~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 227 --------VTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp --------SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred --------CCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence 123567899999999999999999999876543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-48 Score=425.82 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=212.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|+++ +++.||||+++.. ....++|.+|++++++++|||||+++++|.+++..++|||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 57888899999999999999976 5889999998743 3345679999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||++|+|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 94 ~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999999999976433 24899999999999999999999 6799999999999999999999999999999776443
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
........|++.|+|||++.+..|+.++|||||||++|||++|+.||..........+.+........
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~------------ 237 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER------------ 237 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC------------
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCC------------
Confidence 33445566899999999999999999999999999999999987776543222222222222111110
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 238 ----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 238 ----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111123578999999999999999999999999877543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=409.25 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=212.9
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|+..++||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 5789999999999999999999888999999998432 3456899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++|++.+++...... +++..+.+++.||++||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~g~l~~~~~~~~~~--~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp CTTEEHHHHHHSGGGC--CCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred cCCCcHHHhhhccccC--CcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 9999999997665443 899999999999999999999 77999999999999999999999999999987764444
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcch
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDL 1040 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1109)
.......+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+.............
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----~~~~~~i~~~~~~~~--------- 222 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEHIAQGLRLYR--------- 222 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHHHHHHTTCCCCC---------
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----HHHHHHHHhCCCCCC---------
Confidence 44456779999999999999999999999999999999998 8999986532 222222211111000
Q ss_pred hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1041 SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
+....+.+.+++.+||+.||++||||++++++|.+
T Consensus 223 ----p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 ----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ----cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 01112467899999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-47 Score=418.18 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=199.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CC---cEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NG---EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.++||+|+||+||+|+++ ++ ..||||++... ......+.|.+|++++++++|||||+++|++..++..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45667789999999999999875 23 35888887633 233445689999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
|||||++|+|.+++...... +++.++..++.||++||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~--l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTC--SCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeeccccCC--CCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999998875443 899999999999999999999 7799999999999999999999999999998765
Q ss_pred CCCCCC----ccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 958 LPYSKS----MSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 958 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.. ..+.+.....+..+..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~----~~~~~~~i~~~~~~~~- 254 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT----NQDVINAIEQDYRLPP- 254 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTTCCCCC-
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC----HHHHHHHHHcCCCCCC-
Confidence 322211 123467999999999999999999999999999999998 899997543 2222222222111100
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
..+....+.+++.+||+.||++||||+||+++|+++.+.
T Consensus 255 ------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 255 ------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 111234578999999999999999999999999988653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=408.36 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=200.4
Q ss_pred CCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe----CCceEEEE
Q 001274 805 SEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH----QDSNLLLY 879 (1109)
Q Consensus 805 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 879 (1109)
+..++||+|+||+||+|++. +++.||+|++..........+.+.+|++++++++|||||++++++.. +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999975 68899999998665555566789999999999999999999999875 34568999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeC-CCCceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPH--IIHRDIKSNNILLD-EEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~ 956 (1109)
||+++|+|.+++..... +++..++.++.||++||+||| +++ |+||||||+|||++ .++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhcccc---ccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999976543 899999999999999999999 556 99999999999996 5789999999999864
Q ss_pred cCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
. .......+||+.|+|||++.+ +++.++||||+||++|||++|+.||.+.. ......+.......+ . .+++
T Consensus 166 ~---~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~---~~~~~~~~i~~~~~~-~-~~~~ 236 (270)
T d1t4ha_ 166 R---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVKP-A-SFDK 236 (270)
T ss_dssp C---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS---SHHHHHHHHTTTCCC-G-GGGG
T ss_pred c---CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc---cHHHHHHHHHcCCCC-c-ccCc
Confidence 3 223345689999999998865 69999999999999999999999997532 222222322222211 1 1111
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
. ....+.+++.+||+.||++|||++|+++|-
T Consensus 237 ~----------~~~~~~~li~~~l~~dp~~R~s~~ell~Hp 267 (270)
T d1t4ha_ 237 V----------AIPEVKEIIEGCIRQNKDERYSIKDLLNHA 267 (270)
T ss_dssp C----------CCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred c----------CCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence 1 112467899999999999999999998763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=412.56 Aligned_cols=257 Identities=22% Similarity=0.359 Sum_probs=196.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--CCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--QDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 878 (1109)
++|++.+.||+|+||+||+|+++ +|+.||||++..........+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57889999999999999999865 68999999997665555556779999999999999999999999865 4557899
Q ss_pred EEeccCCCHHHHhccCC-CCCCCChHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 879 YEYMENGSLGEQLHGNK-QTCLLDWDARYRIALGAAEGLCYLHYDC--RPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
||||++|+|.+++.... ....+++..++.++.||+.||+|||+.. ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 1224899999999999999999999541 23599999999999999999999999999987
Q ss_pred ccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 956 IDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.... ........||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.. ..+..........+. ..
T Consensus 164 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~----~~~~~~~i~~~~~~~---~~ 235 (269)
T d2java1 164 LNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QKELAGKIREGKFRR---IP 235 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHTCCCC---CC
T ss_pred cccC-CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC----HHHHHHHHHcCCCCC---CC
Confidence 6532 223345789999999999999999999999999999999999999997543 222222222222110 00
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAM 1076 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 1076 (1109)
......+.+++.+||+.||++|||++|++++
T Consensus 236 ----------~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 236 ----------YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0112357799999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-47 Score=414.02 Aligned_cols=254 Identities=24% Similarity=0.314 Sum_probs=206.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
+.|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 46788899999999999999975 68999999997543 3456789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||++|+|.+++..... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 y~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~- 163 (288)
T d2jfla1 90 FCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 163 (288)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC-
Confidence 9999999999865433 3899999999999999999999 779999999999999999999999999999765321
Q ss_pred CCCccccccccceecccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
........||+.|+|||++. +..|+.++||||+||++|||+||+.||.+....+..... .....+....
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i----~~~~~~~~~~-- 237 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----AKSEPPTLAQ-- 237 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH----HHSCCCCCSS--
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH----HcCCCCCCCc--
Confidence 11224567999999999984 456899999999999999999999999865433322222 2221111100
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.......+.+++.+||+.||++|||++|+++|-+
T Consensus 238 ---------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 238 ---------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp ---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred ---------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0111235779999999999999999999998743
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=410.88 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=202.5
Q ss_pred cCCCCCceEecCCcceEEEEEecCC-----cEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANG-----EVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
..|+..++||+|+||+||+|++++. ..||||++... .......+|.+|++++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4577889999999999999986532 47999998643 23344567999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+.+|++.+++...... +++.++..++.||+.|++||| +++|+||||||+|||++.++.+||+|||+|+..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~--~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTC--SCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhccccc--ccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999988765443 999999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCC--CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 957 DLPYS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 957 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
..... .......||+.|+|||++.++.++.++|||||||++|||++|..|+............+....+...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~------ 234 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT------ 234 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC------
Confidence 43222 1223456899999999999999999999999999999999977665533222222222222111111
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++||||.||+++|+++.+.
T Consensus 235 ----------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 235 ----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 111224578999999999999999999999999987764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=420.53 Aligned_cols=269 Identities=22% Similarity=0.359 Sum_probs=207.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|++. +|+.||+|+++... .....+.+.+|++++++++|||||+++++|.+++..++|||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999965 68999999997543 23345678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.+++.+.+. +++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred cCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence 9999999999986543 89999999999999999999942 3899999999999999999999999999987642
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhcc-------------
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEM------------- 1027 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------- 1027 (1109)
......+||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+.........+.. ...+.
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC-QVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-HhcCCcccCCcccccccc
Confidence 223456899999999999999999999999999999999999999976432111000000 00000
Q ss_pred ---------CCCchhh---hhhcchh--hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1028 ---------VPTSELF---DKRLDLS--AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1028 ---------~~~~~~~---~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.+..... +...... ..........+.+++.+||+.||++|||++|+++|-+-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~ 302 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence 0000000 0000000 000001124578999999999999999999999985543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=409.37 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=207.0
Q ss_pred CCCCCc-eEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEE
Q 001274 803 NFSEGA-VIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 803 ~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
+|.+.+ +||+|+||+||+|.++ ++..||||+++.. ......++|.+|++++++++|||||+++|++.. +..++|
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 445555 4999999999999754 3568999999743 334456789999999999999999999999865 568999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
||||++|+|.+++...+. .+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+|+....
T Consensus 87 mE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999876544 3899999999999999999999 77999999999999999999999999999987653
Q ss_pred CCC--CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 959 PYS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 959 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... ......+........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~~~~i~~~~~~~~------- 233 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRMEC------- 233 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHHTTCCCCC-------
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCC-------
Confidence 222 22234568999999999999999999999999999999998 9999986432 222222222111111
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
+......+.+++.+||+.||++||||.+|++.|+....+.
T Consensus 234 ---------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 234 ---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1112245779999999999999999999999998776544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=404.51 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=198.9
Q ss_pred ceEecCCcceEEEEEec---CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEeccC
Q 001274 808 AVIGRGACGTVYKATLA---NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYMEN 884 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 884 (1109)
++||+|+||+||+|.++ .++.||||+++.........+.|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 35689999997655445556789999999999999999999999864 567899999999
Q ss_pred CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC--
Q 001274 885 GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK-- 962 (1109)
Q Consensus 885 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-- 962 (1109)
|+|.++++.... +++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+........
T Consensus 92 g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999987654 899999999999999999999 779999999999999999999999999999876432221
Q ss_pred CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 963 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... .+.......+..+..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~~i~~~~~~~~---------- 231 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKGERMGC---------- 231 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCCC----------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----HHHHHHHHcCCCCCC----------
Confidence 2234578999999999999999999999999999999998 8999986432 222222111111100
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
+......+.+++.+||+.||++||||++|++.|+...
T Consensus 232 ---p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 232 ---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1111245779999999999999999999998887654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=409.42 Aligned_cols=259 Identities=28% Similarity=0.417 Sum_probs=204.1
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++. ++..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 5788999999999999999999888899999997432 34567999999999999999999999985 4568999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+++|++.+++...... .++|.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 93 ~~~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 93 MSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CTTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999998754322 3899999999999999999999 67999999999999999999999999999987654444
Q ss_pred CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcchh
Q 001274 962 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLDLS 1041 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1109)
.......||+.|+|||++.++.++.++|||||||++|||++|..||............+...... +.
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~--~~----------- 235 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--PC----------- 235 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CC-----------
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--CC-----------
Confidence 44455679999999999999999999999999999999999777765433222223332221111 11
Q ss_pred hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1042 AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1042 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.....+.+.+++.+||+.||++||+|.+|+++|+......
T Consensus 236 ---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 236 ---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1111235789999999999999999999999998866543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=408.99 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=205.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|++. +++.||||++..... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46889999999999999999975 689999999974321 1223467899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+++|+|.+++...+. +++..+..++.|++.||+||| +.+||||||||+|||+++++.+||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999886554 899999999999999999999 779999999999999999999999999999876532
Q ss_pred C-CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 960 Y-SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 960 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
. .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+. +..+.............+ .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~~~i~~~~~~~p~----~- 232 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEYLIFQKIIKLEYDFPE----K- 232 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHTTCCCCCT----T-
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc----CHHHHHHHHHcCCCCCCc----c-
Confidence 2 22334568999999999999999999999999999999999999999853 222333332222221111 1
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
....+.+++.+||+.||++|||++|+.++-+
T Consensus 233 ---------~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 233 ---------FFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ---------CCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ---------CCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 1134679999999999999999999765543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-45 Score=408.94 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=192.9
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|+++ +++.||||++...... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56889999999999999999975 6899999999754332 234568899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceEEeecccccccc
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD---EEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a~~~~ 957 (1109)
||+||+|.+++...+. +++.++..++.||+.||+||| +++|+||||||+||++. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTCSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhcccC---CCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999976543 999999999999999999999 77999999999999994 57899999999998664
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
. .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.. ..+.................+
T Consensus 162 ~--~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~- 234 (307)
T d1a06a_ 162 P--GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----DAKLFEQILKAEYEFDSPYWD- 234 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHTTCCCCCTTTTT-
T ss_pred C--CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHhccCCCCCCcccc-
Confidence 2 223345689999999999999999999999999999999999999997532 222223222222211111111
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.....+.+++.+||+.||++|||++|+++|-+
T Consensus 235 ---------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 235 ---------DISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp ---------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred ---------CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 11235779999999999999999999998744
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=416.61 Aligned_cols=257 Identities=23% Similarity=0.394 Sum_probs=207.5
Q ss_pred cCCCCCceEecCCcceEEEEEecC-C-----cEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN-G-----EVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 874 (1109)
++|++.++||+|+||+||+|++.. + ..||||++.... .......+.+|+.+++++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 578889999999999999998642 2 369999886442 233456789999999998 89999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCC--------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQT--------------------CLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKS 934 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 934 (1109)
.++|||||++|+|.++++..... ..+++..++.++.||+.||+||| +++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence 99999999999999999765321 24899999999999999999999 77999999999
Q ss_pred CceeeCCCCceEEeeccccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCccc
Q 001274 935 NNILLDEEFQAHVGDFGLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLEL 1012 (1109)
Q Consensus 935 ~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~ 1012 (1109)
+||+++.++.+||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876533222 2245678999999999999999999999999999999998 8999987654
Q ss_pred CCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1013 GGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
...+...+........ +......+.+++.+||+.||++||||+||+++|.
T Consensus 273 ~~~~~~~~~~~~~~~~----------------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANFYKLIQNGFKMDQ----------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHHHHHHHTTCCCCC----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCC----------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 4444444333221111 0111235789999999999999999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=402.09 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=210.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC----cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG----ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.+.||+|+||+||+|+++ +|+.||||+++..... ....+.+.+|++++++++|||||++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999974 7999999999754322 223567999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC----ceEEeeccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF----QAHVGDFGL 952 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~ 952 (1109)
+|||||++|+|.+++...+. +++..++.++.||+.||+||| +.+|+||||||+||+++.++ .+|++|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~~~---l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhccccc---cchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999976543 999999999999999999999 77999999999999998776 599999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
|+.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+..............
T Consensus 164 a~~~~~--~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i~~~~~~~~~ 237 (293)
T d1jksa_ 164 AHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANVSAVNYEFED 237 (293)
T ss_dssp CEECTT--SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHTTCCCCCH
T ss_pred hhhcCC--CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC----HHHHHHHHHhcCCCCCc
Confidence 987652 233455679999999999999999999999999999999999999998532 22333332222222111
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
...+ .....+.+++.+||+.||++|||++|++++-+.
T Consensus 238 ~~~~----------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 238 EYFS----------NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp HHHT----------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred hhcC----------CCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1111 112357789999999999999999999987543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-46 Score=409.16 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=205.0
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
.|+..++||+|+||+||+|++. +++.||||++...... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5888899999999999999865 6899999999755432 2334678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
||++|++..++..... +++.++..++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~~~---l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999877765443 899999999999999999999 77999999999999999999999999999986542
Q ss_pred CCCccccccccceeccccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 961 SKSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
.....||+.|+|||++.+ ++|+.++||||+||++|||++|+.||.+.. ..+.+........+.. ..
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~----~~~~~~~i~~~~~~~~--~~-- 236 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIAQNESPAL--QS-- 236 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSCCCCC--SC--
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhCCCCCC--CC--
Confidence 234679999999999864 468999999999999999999999997533 2233333222222111 00
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
......+.+++.+||+.||++|||++|+++|-+-
T Consensus 237 --------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 237 --------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred --------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 0112357799999999999999999999987544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.4e-45 Score=410.93 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=209.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57999999999999999999975 79999999996432 3345678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC--CCCceEEeeccccccccC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD--EEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFG~a~~~~~ 958 (1109)
||++|+|.+++..... .+++..+..++.||+.||+||| +.+||||||||+|||++ .++.+||+|||+|+....
T Consensus 104 ~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 104 FMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred cCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999999965443 3999999999999999999999 77999999999999995 467899999999987652
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+. ...+.................+
T Consensus 179 --~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~-- 250 (350)
T d1koaa2 179 --KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----NDDETLRNVKSCDWNMDDSAFS-- 250 (350)
T ss_dssp --TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCCSCCGGGG--
T ss_pred --ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCccccc--
Confidence 23345578999999999999999999999999999999999999999753 2333333333222211111111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.....+.+++.+||+.||++|||++|+++|-+
T Consensus 251 --------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 251 --------GISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp --------GCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred --------CCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 11235778999999999999999999998743
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.5e-45 Score=408.89 Aligned_cols=253 Identities=20% Similarity=0.235 Sum_probs=209.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57999999999999999999964 79999999987432 2345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC--CCCceEEeeccccccccC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD--EEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFG~a~~~~~ 958 (1109)
||++|+|.+++..... .+++.+++.++.||+.||+||| +.+||||||||+|||++ .++.+||+|||+|+....
T Consensus 107 ~~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 107 FLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999999998876543 3999999999999999999999 77999999999999997 678999999999987652
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
........||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.. ..+..........+.......
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~-- 253 (352)
T d1koba_ 182 --DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----DLETLQNVKRCDWEFDEDAFS-- 253 (352)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHHCCCCCCSSTTT--
T ss_pred --CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCccccc--
Confidence 233455689999999999999999999999999999999999999997532 233333333322221111111
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
.....+.+++.+||+.||++|||++|+++|-
T Consensus 254 --------~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp 284 (352)
T d1koba_ 254 --------SVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284 (352)
T ss_dssp --------TSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred --------CCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 1123577999999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=401.51 Aligned_cols=252 Identities=21% Similarity=0.256 Sum_probs=210.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57899999999999999999974 799999999974321 1224567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
|||++|+|.+++..... +++..++.++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~- 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS- 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred eccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccccc-
Confidence 99999999999987654 899999999999999999999 77999999999999999999999999999986542
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.. ..+..+............
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~----~~~~~~~i~~~~~~~p~~------ 227 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLFELILMEEIRFPRT------ 227 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCTT------
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC----HHHHHHHHhcCCCCCCcc------
Confidence 2333456789999999999999999999999999999999999999998533 333333333332221111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMI 1078 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~ 1078 (1109)
....+.+++.+||+.||++||+ ++|+++|-+
T Consensus 228 --------~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 228 --------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp --------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred --------CCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 1134678999999999999994 899998743
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=398.06 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=198.0
Q ss_pred cCCCCCceEecCCcceEEEEEecC----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.+.||+|+||+||+|++.. +..||||+++.. ......+.+.+|++++++++|||||++++++. ++..++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 578889999999999999998642 356888888533 23344567999999999999999999999986 467899
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLID 957 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 957 (1109)
||||+++|++.+++..... .+++..+..++.||++||+||| +.+||||||||+||+++.++.+||+|||+|+...
T Consensus 85 v~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998876544 3899999999999999999999 7799999999999999999999999999998765
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDK 1036 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1109)
...........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.... .....+...... +.
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-~~~~~i~~~~~~--~~------ 230 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERL--PM------ 230 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTCCC--CC------
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCCC--CC------
Confidence 444444455678999999999999999999999999999999998 88898765432 222222221111 11
Q ss_pred hcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1037 RLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.......+.+++.+||+.||++||||.||+++|..+.+.
T Consensus 231 --------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 231 --------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111124578999999999999999999999999887654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-44 Score=397.87 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=208.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|+++ +|+.||||+++.... .....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46889999999999999999975 699999999974321 1223567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
|||+||++..++..... +++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc-
Confidence 99999999999987654 788999999999999999999 88999999999999999999999999999987642
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
.....+||+.|+|||++.+..|+.++||||+||++|||+||+.||.+. ...+...............
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~------ 223 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNAELRFPPF------ 223 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHCCCCCCTT------
T ss_pred ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc----CHHHHHHHHHcCCCCCCCC------
Confidence 234568999999999999999999999999999999999999999753 3333333333332221111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMM 1077 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 1077 (1109)
....+.+++.+|++.||++|+ |++|+++|-
T Consensus 224 --------~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp 258 (316)
T d1fota_ 224 --------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258 (316)
T ss_dssp --------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred --------CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCc
Confidence 113467899999999999996 999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.7e-44 Score=391.16 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=205.5
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc----e
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS----N 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~ 875 (1109)
++|++.+.||+|+||+||+|++. +|+.||||+++..... ....+.+.+|+++++.++|||||++++++...+. .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 67999999999999999999964 7999999999754332 3345679999999999999999999999987553 6
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
|+||||++||+|.+++...+. +++.+++.++.||+.||+||| +.+|+||||||+||+++.++.++++|||.+..
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence 899999999999999876654 899999999999999999999 77999999999999999999999999999876
Q ss_pred ccCCCC--CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 956 IDLPYS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 956 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
...... ......+||+.|+|||++.+..++.++||||+||++|||+||+.||.+. ...+...............
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~~~~~~~~~~~~~~ 236 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD----SPVSVAYQHVREDPIPPSA 236 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHCCCCCGGG
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc----CHHHHHHHHHhcCCCCCch
Confidence 542222 2334567999999999999999999999999999999999999999753 2333333333333221111
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhh
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP-TMREVIAMMIDAR 1081 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 1081 (1109)
..+. ....+.+++.+||+.||++|| |++++.+.|.++.
T Consensus 237 ~~~~----------~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 237 RHEG----------LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp TSSS----------CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred hccC----------CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111 123577999999999999999 8999999988765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-44 Score=401.04 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=208.8
Q ss_pred hcCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCc
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 874 (1109)
.++|++.+.||+|+||+||+|+++ +++.||||+++.. ......++|.+|++++++++||||++++++|...+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 357889999999999999999864 3578999998743 333446789999999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCC---------------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQ---------------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIK 933 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 933 (1109)
.++||||+++|+|.++++.... ...+++..+..++.|++.||+||| +++|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence 9999999999999999965321 123889999999999999999999 7799999999
Q ss_pred CCceeeCCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCC-CCCCCcc
Q 001274 934 SNNILLDEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK-SPVQSLE 1011 (1109)
Q Consensus 934 p~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~-~pf~~~~ 1011 (1109)
|+|||++.++.+||+|||+|+....... .......+|+.|+|||++.+..|+.++|||||||++|||++|. .||.+..
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999986643222 2234567899999999999999999999999999999999986 5676432
Q ss_pred cCCcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 001274 1012 LGGDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDAR 1081 (1109)
Q Consensus 1012 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 1081 (1109)
..+.......+..+.. +......+.+++.+||+.||++||||.||+++|+++.
T Consensus 248 ----~~e~~~~v~~~~~~~~-------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 ----HEEVIYYVRDGNILAC-------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ----HHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----HHHHHHHHHcCCCCCC-------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2222222222221100 1111235789999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-45 Score=392.78 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=198.7
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe-CCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH-QDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 880 (1109)
++|++.++||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++||||++++|+|.+ .+..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 46778899999999999999985 789999999632 245679999999999999999999999865 456799999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+++|+|.+++..... ..+++..+++++.||+.||.||| +.+|+||||||+||+++.++.+|++|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp CCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC--
Confidence 9999999999975432 23899999999999999999999 77999999999999999999999999999986542
Q ss_pred CCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
......+|+.|+|||++.++.++.++|||||||++|||+| |+.||.... ..+....+....+...
T Consensus 156 --~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-~~~~~~~i~~~~~~~~----------- 221 (262)
T d1byga_ 156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDA----------- 221 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-GGGHHHHHTTTCCCCC-----------
T ss_pred --CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcCCCCCC-----------
Confidence 2234567899999999999999999999999999999998 677776543 3344444432211111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
......++.+++.+||+.||++||||+|++++|++++.
T Consensus 222 -----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 -----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11112357799999999999999999999999988764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.9e-44 Score=389.33 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=206.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcc-------hhHHHHHHHHHhccCC-CCceeeEEEEEEeC
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGAT-------ADNSFLAEISTLGKIR-HRNIVKLYGFCYHQ 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 872 (1109)
++|++.+.||+|+||+||+|++. +++.||||+++....... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57899999999999999999964 799999999976543221 1246889999999997 99999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
+..|+|||||++|+|.++++..+. +++..++.++.||++||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999976553 899999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccceeccccccC------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhc
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYT------MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
++.... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.. ..+........
T Consensus 157 a~~~~~--~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~----~~~~~~~i~~~ 230 (277)
T d1phka_ 157 SCQLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----QMLMLRMIMSG 230 (277)
T ss_dssp CEECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHT
T ss_pred eeEccC--CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC----HHHHHHHHHhC
Confidence 987653 223455789999999998863 347889999999999999999999998543 22222222222
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
........ .....+++.+++.+||+.||++|||++|+++|-
T Consensus 231 ~~~~~~~~----------~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~ 271 (277)
T d1phka_ 231 NYQFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 271 (277)
T ss_dssp CCCCCTTT----------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred CCCCCCcc----------cccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 21111000 111223577999999999999999999998774
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=393.66 Aligned_cols=255 Identities=20% Similarity=0.225 Sum_probs=210.0
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
.++|++.+.||+|+||+||+|+++ +++.||||+++.. ......+.+|+++++.++|||||++++++.+++..|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 367999999999999999999975 6899999999743 234456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC--CceEEeecccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEE--FQAHVGDFGLAKLID 957 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFG~a~~~~ 957 (1109)
|||+||+|.+++...+. .+++.++..++.||+.||+||| +++|+||||||+|||++.+ ..+||+|||+++...
T Consensus 81 E~~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 81 EFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999999976543 3899999999999999999999 7799999999999999854 589999999998764
Q ss_pred CCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhh
Q 001274 958 LPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKR 1037 (1109)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1109)
. ........+|+.|+|||...+..|+.++||||+||++|||++|+.||.+.. ..+.................+.
T Consensus 156 ~--~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 229 (321)
T d1tkia_ 156 P--GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIENIMNAEYTFDEEAFKE 229 (321)
T ss_dssp T--TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHTCCCCCHHHHTT
T ss_pred c--CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCChhhccC
Confidence 2 223345678999999999999999999999999999999999999997532 2333333333332222111111
Q ss_pred cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1038 LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
....+.+++.+|++.||++|||++|+++|-+.
T Consensus 230 ----------~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 230 ----------ISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp ----------SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ----------CCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 12346799999999999999999999997554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=395.80 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=196.8
Q ss_pred cCCCCCceEecCCcceEEEEEec--C--CcEEEEEEeeccCC-CcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA--N--GEVIAVKKIKLRGE-GATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.+.||+|+||+||+|++. + ...||||+++.... .....++|.+|++++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888999999999999999853 2 24789999865432 23345789999999999999999999999965 4678
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++|++.+++..... .+++..+..++.||++||.||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999998876543 3999999999999999999999 779999999999999999999999999999976
Q ss_pred cCCCCC--CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 957 DLPYSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 957 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
...... ......||..|+|||++.+..++.++|||||||++|||+| |+.||.+.. ..+.+........... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~----~~~~~~~i~~~~~~~~-~ 236 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----GSQILHKIDKEGERLP-R 236 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTSCCCCC-C
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC----HHHHHHHHHhCCCCCC-C
Confidence 533222 1234567889999999999999999999999999999998 899997543 2233333222221110 0
Q ss_pred hhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1034 FDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.......+.+++.+||+.||++||||+||++.|.++
T Consensus 237 -----------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 237 -----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 011123577999999999999999999999999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=397.54 Aligned_cols=262 Identities=25% Similarity=0.398 Sum_probs=201.4
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCC-
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQD- 873 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 873 (1109)
++|++.++||+|+||+||+|++. +++.||||+++... .....+.+.+|..++.++ +|+||+.+++++...+
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 57889999999999999999853 24689999987432 334456788888888777 6899999999987654
Q ss_pred ceEEEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 001274 874 SNLLLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD 940 (1109)
Q Consensus 874 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~ 940 (1109)
..++|||||++|+|.++++.... ...+++.++..++.||++||+||| +++||||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence 57899999999999999975432 123899999999999999999999 77999999999999999
Q ss_pred CCCceEEeeccccccccCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhC-CCCCCCcccCCcHHH
Q 001274 941 EEFQAHVGDFGLAKLIDLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITG-KSPVQSLELGGDLVT 1018 (1109)
Q Consensus 941 ~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg-~~pf~~~~~~~~~~~ 1018 (1109)
.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+|| ..||.+......+..
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999866433222 23456799999999999999999999999999999999996 457775544333333
Q ss_pred HHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1019 WVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.+........+ ......+.+++.+||+.||++||||+|++++|+.++++
T Consensus 249 ~~~~~~~~~~~----------------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 249 RLKEGTRMRAP----------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHTCCCCCC----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCC----------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 33332221111 01123577999999999999999999999999998765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=398.20 Aligned_cols=257 Identities=24% Similarity=0.401 Sum_probs=203.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCc----EEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGE----VIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
.+|++.++||+|+||+||+|++. +|+ +||||+++.. ......+.|.+|++++++++|||||+++|+|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46889999999999999999864 444 5888888633 2334567899999999999999999999999764 567
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+++||+.+|+|.+++...... +++..+..++.||+.||+||| +++||||||||+||+++.++.+||+|||+|+..
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~--~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEEeccCCcccccccccccC--CCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 889999999999998876543 899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCC-CccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHHHHHHHhhhccCCCchhh
Q 001274 957 DLPYSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLVTWVRRSIHEMVPTSELF 1034 (1109)
Q Consensus 957 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1109)
...... ......||+.|+|||++.++.|+.++|||||||++|||+| |+.||.+... ..+...+....+...+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~~~~~i~~~~~~~~p----- 235 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLPQP----- 235 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GGHHHHHHHTCCCCCC-----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCCCCC-----
Confidence 533222 2234568999999999999999999999999999999999 7888876432 2333333332211111
Q ss_pred hhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1035 DKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
......+.+++.+||+.||++||||.||++++..+..
T Consensus 236 -----------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 236 -----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1112357799999999999999999999999988754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-43 Score=399.04 Aligned_cols=249 Identities=19% Similarity=0.220 Sum_probs=208.6
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccC-CCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRG-EGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.++||+|+||+||+|+++ +|+.||||++.... ......+.+.+|+++++.++|||||++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47899999999999999999975 79999999986432 11223467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCC
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLP 959 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 959 (1109)
||+.+|+|.+++...+. +++..+..++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 99999999999977654 899999999999999999999 77999999999999999999999999999987652
Q ss_pred CCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 960 YSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
......||+.|+|||++.+..++.++||||+||++|||+||+.||.+. ..................
T Consensus 194 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~i~~~~~~~p~------- 259 (350)
T d1rdqe_ 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----QPIQIYEKIVSGKVRFPS------- 259 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCCCCCT-------
T ss_pred ---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc----CHHHHHHHHhcCCCCCCc-------
Confidence 234568999999999999999999999999999999999999999753 233333333333221111
Q ss_pred hhhcccHHHHHHHHHHHHhccCCCCCCC-----CCHHHHHHHHH
Q 001274 1040 LSAKRTVEEMTLFLKIALFCSSTSPLNR-----PTMREVIAMMI 1078 (1109)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~cl~~dP~~R-----Pt~~evl~~L~ 1078 (1109)
.....+.+++.+||+.||++| ||++|+++|-+
T Consensus 260 -------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 260 -------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp -------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -------cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence 112357799999999999999 49999998744
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=392.67 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=204.7
Q ss_pred CceEecCCcceEEEEEecC----CcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-CceEEEEEe
Q 001274 807 GAVIGRGACGTVYKATLAN----GEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ-DSNLLLYEY 881 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 881 (1109)
.++||+|+||+||+|++.+ ...||||+++.. ......++|.+|++++++++||||++++|++... +..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 4689999999999998643 236899998632 3444567899999999999999999999998764 578999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
|++|+|.+++...... .++..+.+++.|+++||.|+| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~~~~~--~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHCTTCC--CBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred eecCchhhhhcccccc--chHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999876543 788899999999999999999 77999999999999999999999999999987643322
Q ss_pred C---CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 962 K---SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 962 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
. ......||+.|+|||++.+..++.++||||||+++|||+||+.||.......+....+....+...|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p--------- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--------- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC---------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc---------
Confidence 2 2234578999999999999999999999999999999999888877543333333333322111110
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
......+.+++.+||+.||++||+|.||+++|+.+....
T Consensus 257 -------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 011235779999999999999999999999999997653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=396.61 Aligned_cols=261 Identities=24% Similarity=0.378 Sum_probs=205.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCc--EEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGE--VIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 877 (1109)
++|++.++||+|+||+||+|+++ ++. .||||+++... .....+.|.+|+++++++ +|||||+++|+|.+.+..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 47888899999999999999875 444 47788775332 233456799999999998 79999999999999999999
Q ss_pred EEEeccCCCHHHHhccCC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 001274 878 LYEYMENGSLGEQLHGNK-------------QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQ 944 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 944 (1109)
||||+++|+|.++++... ....+++..+..++.||++||.|+| +++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCc
Confidence 999999999999997642 2234899999999999999999999 779999999999999999999
Q ss_pred eEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCC-CCCCcccCCcHHHHHHHh
Q 001274 945 AHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKS-PVQSLELGGDLVTWVRRS 1023 (1109)
Q Consensus 945 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~-pf~~~~~~~~~~~~~~~~ 1023 (1109)
+||+|||+|+.... ........||..|+|||.+.+..++.++|||||||++|||++|.. ||.+. ...+.....
T Consensus 166 ~kl~DfG~a~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~----~~~~~~~~i 239 (309)
T d1fvra_ 166 AKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCAELYEKL 239 (309)
T ss_dssp EEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHG
T ss_pred eEEccccccccccc--cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC----CHHHHHHHH
Confidence 99999999986542 222234568999999999999999999999999999999999765 56542 233333322
Q ss_pred hhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhccC
Q 001274 1024 IHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSVS 1085 (1109)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 1085 (1109)
.....+. ........+.+++.+||+.||++||||.||+++|+++.+...
T Consensus 240 ~~~~~~~-------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 240 PQGYRLE-------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp GGTCCCC-------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HhcCCCC-------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 2211110 011122467899999999999999999999999999876543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-43 Score=398.49 Aligned_cols=253 Identities=24% Similarity=0.263 Sum_probs=203.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCC-cchhHHH---HHHHHHhccCCCCceeeEEEEEEeCCceE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEG-ATADNSF---LAEISTLGKIRHRNIVKLYGFCYHQDSNL 876 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 876 (1109)
++|++.++||+|+||+||+|++. +|+.||||++...... ......+ .+|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999975 6999999998643211 1112223 34577888889999999999999999999
Q ss_pred EEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccc
Q 001274 877 LLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 877 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 956 (1109)
+||||+++|+|.+++..... +++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999977553 889999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhh
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFD 1035 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1109)
.. .......||+.|+|||++.+ ..|+.++||||+||++|||+||+.||.+... .......+...........
T Consensus 158 ~~---~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~--- 230 (364)
T d1omwa3 158 SK---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHEIDRMTLTMAVELPD--- 230 (364)
T ss_dssp SS---SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-SCHHHHHHHSSSCCCCCCS---
T ss_pred CC---CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccCCCCCCC---
Confidence 52 23345689999999999875 5689999999999999999999999986432 2333333332222211111
Q ss_pred hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHH
Q 001274 1036 KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPT-----MREVIAMMI 1078 (1109)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~ 1078 (1109)
.....+.+++.+||+.||++||| ++|+++|-+
T Consensus 231 -----------~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 231 -----------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp -----------SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred -----------CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 11235779999999999999999 799988744
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=395.83 Aligned_cols=255 Identities=21% Similarity=0.236 Sum_probs=199.9
Q ss_pred cCCCCCc-eEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhcc-CCCCceeeEEEEEEe----CCc
Q 001274 802 GNFSEGA-VIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGK-IRHRNIVKLYGFCYH----QDS 874 (1109)
Q Consensus 802 ~~~~~~~-~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~ 874 (1109)
++|.+.. .||+|+||+||+|++ .+++.||||+++ ....+.+|++++.+ .+|||||++++++.+ ...
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~-------~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE-------CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC-------CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 5787764 699999999999986 478999999986 23567889998755 489999999999876 356
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEeecc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE---EFQAHVGDFG 951 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG 951 (1109)
.|+|||||+||+|.+++...+. ..+++.+++.++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccc
Confidence 7999999999999999986543 24899999999999999999999 779999999999999975 5679999999
Q ss_pred ccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
+|+.... ........||+.|+|||++.+..|+.++||||+||++|||+||+.||.+......................
T Consensus 160 ~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 160 FAKETTS--HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp TCEECCC--CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred eeeeccC--CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 9987653 23345568999999999999999999999999999999999999999764322221111111111111100
Q ss_pred hhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1032 ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
. .........+.+++.+|++.||++|||+.|+++|-+.
T Consensus 238 ~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 238 N----------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275 (335)
T ss_dssp T----------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred C----------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence 0 0011223467899999999999999999999998554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=387.90 Aligned_cols=269 Identities=26% Similarity=0.319 Sum_probs=202.0
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC----ceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD----SNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 877 (1109)
++|...++||+|+||+||+|++ +|+.||||+++... .....+..|+..+++++|||||++++++...+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567778999999999999997 48999999986331 12222334555667789999999999998754 4689
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC-----RPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
|||||++|+|.+++++.. ++|..+.+++.|++.||+|+|+.+ +++||||||||+|||++.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999998653 899999999999999999999531 36999999999999999999999999999
Q ss_pred cccccCCCCC---CccccccccceeccccccCCC------CCccchhHHHHHHHHHHHhCCCCCCCcccC----------
Q 001274 953 AKLIDLPYSK---SMSAIAGSYGYIAPEYAYTMK------VTEKCDIYSFGVVLLELITGKSPVQSLELG---------- 1013 (1109)
Q Consensus 953 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvll~elltg~~pf~~~~~~---------- 1013 (1109)
++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9876533221 224567999999999987643 677999999999999999999887543211
Q ss_pred CcHHHHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1014 GDLVTWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
......+........ .++.+. ......+....+.+++.+||+.||++||||.||+++|+++.+..
T Consensus 235 ~~~~~~~~~~~~~~~-----~~p~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQK-----LRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCCHHHHHHHHTTSC-----CCCCCC-GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccc-----cCCCCC-cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 111122222111111 000010 01113345567889999999999999999999999999887654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=393.64 Aligned_cols=262 Identities=26% Similarity=0.441 Sum_probs=212.8
Q ss_pred cCCCCCceEecCCcceEEEEEe------cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeCCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATL------ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 874 (1109)
++|++.++||+|+||.||+|++ .+++.||||+++... .......+.+|+.+++++ +|||||+++++|...+.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 5788889999999999999975 246789999997443 334556799999999999 69999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCC---------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQ---------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 939 (1109)
.++|||||++|+|.++++.... ...+++..+..++.||++|++||| +++||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence 9999999999999999976532 124899999999999999999999 7799999999999999
Q ss_pred CCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLV 1017 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~ 1017 (1109)
+.++.+|++|||.++....... .......||+.|+|||++.++.++.++|||||||++|||+| |..||........+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987653322 22345678999999999999999999999999999999999 555555443333344
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
..+........+ ......+.+++.+||+.||++||||+||+++|+++...
T Consensus 259 ~~i~~~~~~~~~----------------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 KMIKEGFRMLSP----------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHTCCCCCC----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCc----------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 444433222211 01123578999999999999999999999999887654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=387.54 Aligned_cols=267 Identities=24% Similarity=0.340 Sum_probs=201.9
Q ss_pred cCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|++ .+|+.||||+++.........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999996 479999999997554444456789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
|+.++ +.+++..... ..+++..+..++.||+.||+||| +.+||||||||+|||++.++.+||+|||.|+....+
T Consensus 82 ~~~~~-~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~- 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 155 (298)
T ss_dssp CCSEE-HHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-
T ss_pred ecCCc-hhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC-
Confidence 99754 4444433222 23999999999999999999999 779999999999999999999999999999876532
Q ss_pred CCCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhcc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRLD 1039 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1109)
........||+.|+|||++.... ++.++||||+||++|||++|+.||.+.. ..+.+...........+...+...
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC----HHHHHHHHHHhcCCCchhhccccc
Confidence 23345568999999999877666 5789999999999999999999997533 222222222111111111110000
Q ss_pred h----------h-----hcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1040 L----------S-----AKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1040 ~----------~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
. . ..........+.+++.+|++.||++|||++|+++|-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f 285 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence 0 0 0001112246789999999999999999999998843
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=391.07 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=204.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCC-CcchhHHHHHHHHHhc-cCCCCceeeEEEEEEeCCceEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGE-GATADNSFLAEISTLG-KIRHRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 878 (1109)
++|++.++||+|+||+||+|++. +++.||||+++.... .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999975 699999999974321 1123455667777665 68999999999999999999999
Q ss_pred EEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccC
Q 001274 879 YEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDL 958 (1109)
Q Consensus 879 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 958 (1109)
||||++|+|.+++..... +++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999987554 899999999999999999999 77999999999999999999999999999986542
Q ss_pred CCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchhhhhhc
Q 001274 959 PYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSELFDKRL 1038 (1109)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1109)
. ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.. ..+.............. .
T Consensus 156 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~~~i~~~~~~~p~----~- 225 (320)
T d1xjda_ 156 G-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMDNPFYPR----W- 225 (320)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCCT----T-
T ss_pred c-cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCc----c-
Confidence 2 333455689999999999999999999999999999999999999997532 22333322222211111 1
Q ss_pred chhhcccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 001274 1039 DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMR-EVIAM 1076 (1109)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~-evl~~ 1076 (1109)
....+.+++.+||+.||++||++. |+++|
T Consensus 226 ---------~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 226 ---------LEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ---------SCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ---------CCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 123477999999999999999995 78765
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4e-43 Score=392.88 Aligned_cols=294 Identities=31% Similarity=0.478 Sum_probs=262.2
Q ss_pred CchhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCc--cceeeecC----CeEEEEeccCccccc--cccccccCccccce
Q 001274 29 SLTEEGVSLLEFKASLIDPSNNLESWNSSDMTPCN--WIGVECTD----FKVTSVDLHGLNLSG--ILSPRICDLPRLVE 100 (1109)
Q Consensus 29 ~~~~~~~all~~k~~~~~~~~~~~~W~~~~~~~c~--w~gv~C~~----~~v~~l~l~~~~l~g--~~~~~~~~l~~L~~ 100 (1109)
|.++|++||++||+++.||. .+++|+.+ .|||. |.||+|+. .||+++||++++++| .+|++|++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 88999999999999999985 69999865 49994 99999975 379999999999998 57899999999999
Q ss_pred eeccc-CccCCCCCccccCCCCCceEEccCCcccccCCchhhccccceEEEcccccccccccccccCcCCCceEEeecCC
Q 001274 101 FNISM-NFVTGSIPTDLANCSSLEILDLCTNRLHGVIPFQLFFINTLRKLYLCENYIFGEIPEEIGNLTSLEELVIYSNN 179 (1109)
Q Consensus 101 L~ls~-n~~~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 179 (1109)
|+|++ |+++|.+|+++++|++|++|+|++|++.+..+..+..+.+|+++++++|.+.+.+|.++++++.|+++++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99996 89999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccccc-ceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccccCCCCC
Q 001274 180 LTGAIPASISKLRQL-RVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPP 258 (1109)
Q Consensus 180 l~~~~p~~~~~l~~L-~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 258 (1109)
+++.+|..+..+.++ +.+++++|++++..|..++.+..+ +++++.+...+.+|..+..+++|+.|++++|.+++.+|
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~- 238 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG- 238 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-
T ss_pred cccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-
Confidence 999999999988876 889999999999888888877655 68888888888888888888999999999998886654
Q ss_pred CccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCc-ccCC
Q 001274 259 TIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQ-LTGF 327 (1109)
Q Consensus 259 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~-l~~~ 327 (1109)
.++.+++|+.|+|++|+++|.+|+.|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+ +.|.
T Consensus 239 ~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 678888899999999999888888888888899899888888888874 5778888888888887 4443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=388.18 Aligned_cols=261 Identities=26% Similarity=0.307 Sum_probs=196.9
Q ss_pred CceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc---chhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEec
Q 001274 807 GAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA---TADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEYM 882 (1109)
Q Consensus 807 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 882 (1109)
.++||+|+||+||+|+++ +|+.||||+++...... ...+.+.+|++++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999975 69999999996543221 12357889999999999999999999999999999999999
Q ss_pred cCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCCC
Q 001274 883 ENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYSK 962 (1109)
Q Consensus 883 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 962 (1109)
+++++..+..... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||.|+..... ..
T Consensus 83 ~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NR 155 (299)
T ss_dssp SEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CC
T ss_pred cchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC-cc
Confidence 9887776665433 3899999999999999999999 779999999999999999999999999999876532 22
Q ss_pred CccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC-CCchhhhhhcc-
Q 001274 963 SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV-PTSELFDKRLD- 1039 (1109)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~- 1039 (1109)
.....+||+.|+|||++.+. .|+.++||||+||++|||+||+.||.+.... +.+........ +..+.+.....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~----~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL----DQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH----HHHHHHHHhcCCCChhhccchhcc
Confidence 33456799999999998754 5799999999999999999999999754322 22222111100 00000000000
Q ss_pred -------hhhc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1040 -------LSAK-----RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1040 -------~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.... ........+.+++.+|++.||++|||++|+++|-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 0000 00112346889999999999999999999998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=390.44 Aligned_cols=260 Identities=22% Similarity=0.360 Sum_probs=209.5
Q ss_pred cCCCCCceEecCCcceEEEEEec------CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCce
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA------NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSN 875 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 875 (1109)
++|+..++||+|+||+||+|++. +++.||||+++.. ........|.+|++++++++|||||++++++..++..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 57888899999999999999863 3578999999743 2334456789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhccCC-------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 001274 876 LLLYEYMENGSLGEQLHGNK-------QTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVG 948 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 948 (1109)
++||||+++|+|.+++.... ....+++..+.+++.|+++||.||| +++|+||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence 99999999999999986432 1223788999999999999999999 6799999999999999999999999
Q ss_pred eccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCC-CCCCCcccCCcHHHHHHHhhhc
Q 001274 949 DFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK-SPVQSLELGGDLVTWVRRSIHE 1026 (1109)
Q Consensus 949 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~-~pf~~~~~~~~~~~~~~~~~~~ 1026 (1109)
|||+|+....... .......+|+.|+|||.+.+..++.++||||||+++|||+||. .||.+. ...+........
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~----~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----SNEQVLRFVMEG 251 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CHHHHHHHHHTT
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHhC
Confidence 9999987643222 2224456899999999999999999999999999999999985 667643 223333322222
Q ss_pred cCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1027 MVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
..+.. .......+.+++.+||+.+|++||||.||+++|++..+
T Consensus 252 ~~~~~-------------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GLLDK-------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCC-------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11100 01112458899999999999999999999999987654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.9e-43 Score=384.33 Aligned_cols=269 Identities=23% Similarity=0.330 Sum_probs=203.4
Q ss_pred cCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEEe
Q 001274 802 GNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYEY 881 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 881 (1109)
++|++.++||+|+||+||+|++++|+.||||+++.........+.+.+|+.++++++|||||++++++...+..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57889999999999999999999999999999976544444567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCCC
Q 001274 882 MENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPYS 961 (1109)
Q Consensus 882 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 961 (1109)
+.++.+..+....+. +++..+..++.||+.||+||| +.+||||||||+|||++.++.+|++|||.|.....+ .
T Consensus 82 ~~~~~~~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-V 154 (286)
T ss_dssp CSEEHHHHHHTSTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcCC---cchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC-c
Confidence 988777666654433 999999999999999999999 779999999999999999999999999999876532 2
Q ss_pred CCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC-chhh-----
Q 001274 962 KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT-SELF----- 1034 (1109)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~----- 1034 (1109)
.......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+......+......... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 233455789999999998754 568999999999999999999999975432221111111110000000 0000
Q ss_pred hhhcch-----hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 001274 1035 DKRLDL-----SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMM 1077 (1109)
Q Consensus 1035 ~~~~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 1077 (1109)
...... ...........+.+++.+|++.||++|||++|+++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp 282 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 000000 0000111224578999999999999999999999763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=387.37 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=204.6
Q ss_pred cCCCCCceEecCCcceEEEEEecC--------CcEEEEEEeeccCCCcchhHHHHHHHHHhccC-CCCceeeEEEEEEeC
Q 001274 802 GNFSEGAVIGRGACGTVYKATLAN--------GEVIAVKKIKLRGEGATADNSFLAEISTLGKI-RHRNIVKLYGFCYHQ 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 872 (1109)
++|++++.||+|+||.||+|+... +..||||+++.. .......++.+|+..+.++ +|||||+++++|.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 578888999999999999998532 347999999743 3334457788999999888 899999999999999
Q ss_pred CceEEEEEeccCCCHHHHhccCCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQ-------------TCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILL 939 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 939 (1109)
+..++||||+++|+|.+++..... ...+++.++.+++.||+.||+||| +.+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 999999999999999999976542 134899999999999999999999 7799999999999999
Q ss_pred CCCCceEEeeccccccccCCCC-CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCcHH
Q 001274 940 DEEFQAHVGDFGLAKLIDLPYS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT-GKSPVQSLELGGDLV 1017 (1109)
Q Consensus 940 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~~ 1017 (1109)
+.++.+||+|||+++....... .......+|+.|+|||++.++.|+.++|||||||++|||++ |..||.+... ....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-HHHH
Confidence 9999999999999987653322 22345678999999999999999999999999999999998 6888875332 1122
Q ss_pred HHHHHhhhccCCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 001274 1018 TWVRRSIHEMVPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQ 1082 (1109)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 1082 (1109)
..+.. +..+. .. ......+.+++.+||+.||++||||.||++.|+++..
T Consensus 248 ~~i~~---~~~~~---~p----------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 KLLKE---GHRMD---KP----------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHT---TCCCC---CC----------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHc---CCCCC---CC----------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 22221 11110 00 0112357899999999999999999999999988753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=386.73 Aligned_cols=267 Identities=22% Similarity=0.335 Sum_probs=201.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-C-CcEEEEEEeeccCCCcchhHHHHHHHHHhccC---CCCceeeEEEEEEe-----
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-N-GEVIAVKKIKLRGEGATADNSFLAEISTLGKI---RHRNIVKLYGFCYH----- 871 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 871 (1109)
++|++.++||+|+||+||+|++. + ++.||||+++...........+.+|+++++.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999974 4 67799999976544444455677888877666 79999999999864
Q ss_pred CCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 001274 872 QDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFG 951 (1109)
Q Consensus 872 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 951 (1109)
....+++|||++++.+......... .+++..++.++.|++.||+||| +++||||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence 2356899999998877655544333 3899999999999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 952 LAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 952 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
.++... .........||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+....+.+...... ... +..
T Consensus 162 ~~~~~~--~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~--~~~ 236 (305)
T d1blxa_ 162 LARIYS--FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV-IGL--PGE 236 (305)
T ss_dssp SCCCCC--GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCC--CCG
T ss_pred hhhhhc--ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh-hCC--Cch
Confidence 998654 223345678999999999999999999999999999999999999999854322211111111 100 001
Q ss_pred hhhhhhc------------chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1032 ELFDKRL------------DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1032 ~~~~~~~------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
..+.... ...........+.+.+++.+||+.||++|||++|+++|-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 1000000 0000011112245778999999999999999999998744
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=380.10 Aligned_cols=244 Identities=21% Similarity=0.346 Sum_probs=198.8
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCc----chhHHHHHHHHHhccCC--CCceeeEEEEEEeCCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGA----TADNSFLAEISTLGKIR--HRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 874 (1109)
++|++.++||+|+||+||+|++. +|+.||||++....... .....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 67999999999999999999965 78999999997543221 12244678999999986 8999999999999999
Q ss_pred eEEEEEeccC-CCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeeccc
Q 001274 875 NLLLYEYMEN-GSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-EFQAHVGDFGL 952 (1109)
Q Consensus 875 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~ 952 (1109)
.++||||+.+ +++.+++..... +++.+++.++.||++||+||| +++|+||||||+||+++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~---l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 578888876543 899999999999999999999 779999999999999985 47999999999
Q ss_pred cccccCCCCCCccccccccceeccccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc
Q 001274 953 AKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS 1031 (1109)
Q Consensus 953 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1109)
|+.... .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ... ......
T Consensus 158 a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~----~~~~~~- 223 (273)
T d1xwsa_ 158 GALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII----RGQVFF- 223 (273)
T ss_dssp CEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH----HCCCCC-
T ss_pred ceeccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHh----hcccCC-
Confidence 986542 23455789999999999987775 577999999999999999999997521 111 111111
Q ss_pred hhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1032 ELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.+. ....+.+++.+||+.||++|||++|++++-+
T Consensus 224 ---~~~----------~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 224 ---RQR----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp ---SSC----------CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ---CCC----------CCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 111 1135778999999999999999999998743
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-41 Score=373.93 Aligned_cols=269 Identities=22% Similarity=0.316 Sum_probs=201.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEe--------C
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYH--------Q 872 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 872 (1109)
++|++.++||+|+||+||+|++. +|+.||||++..........+.+.+|++++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999974 79999999997665555566789999999999999999999999865 3
Q ss_pred CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 001274 873 DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGL 952 (1109)
Q Consensus 873 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 952 (1109)
+..++||||++++.+..+..... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+|++|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecce
Confidence 45789999998877665554433 2899999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCC---CCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccC
Q 001274 953 AKLIDLPY---SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMV 1028 (1109)
Q Consensus 953 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 1028 (1109)
++...... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+...... ...+........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~ 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSIT 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH-HHHHHHhcCCCC
Confidence 97664322 1222445799999999998765 689999999999999999999999975432111 111222111110
Q ss_pred CCchhhhhh--------c--chhhccc-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 001274 1029 PTSELFDKR--------L--DLSAKRT-------VEEMTLFLKIALFCSSTSPLNRPTMREVIAMMID 1079 (1109)
Q Consensus 1029 ~~~~~~~~~--------~--~~~~~~~-------~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 1079 (1109)
.+..... . ....... ......+.+++.+|++.||++|||++|+++|-+.
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 243 --PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp --TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred --hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 0000000 0 0000000 1112356789999999999999999999998764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.1e-40 Score=361.98 Aligned_cols=262 Identities=19% Similarity=0.261 Sum_probs=209.0
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCC-CceeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH-RNIVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 879 (1109)
++|+++++||+|+||+||+|++. +|+.||||++.... ....+.+|+++++.++| +|++.+++++......++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 68999999999999999999965 68999999886432 23457788999988865 89999999999999999999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-----CCceEEeeccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDE-----EFQAHVGDFGLAK 954 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFG~a~ 954 (1109)
||+ +++|.+++...... +++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+|+
T Consensus 81 e~~-~~~l~~~~~~~~~~--~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp ECC-CCBHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHhhccc--hhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999 78999998765543 899999999999999999999 889999999999999964 5789999999998
Q ss_pred cccCCCCC------CccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhh-hcc
Q 001274 955 LIDLPYSK------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSI-HEM 1027 (1109)
Q Consensus 955 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~-~~~ 1027 (1109)
........ ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+...........+-.. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 76532221 23456799999999999999999999999999999999999999986543333222111110 011
Q ss_pred CCCchhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhcc
Q 001274 1028 VPTSELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQSV 1084 (1109)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 1084 (1109)
.+..+. . ...++++.+++..|+..+|++||+++.+.+.+.++....
T Consensus 235 ~~~~~l-~----------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 235 TPLREL-C----------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp SCHHHH-T----------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CChHHh-c----------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 111111 0 111245788999999999999999999999998877654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=367.91 Aligned_cols=267 Identities=22% Similarity=0.329 Sum_probs=209.7
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCCceEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQDSNLLLYE 880 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 880 (1109)
++|++.++||+|+||+||+|++. +++.||||+++.........+.+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 78999999997665555567889999999999999999999999999999999999
Q ss_pred eccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccccccCCC
Q 001274 881 YMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKLIDLPY 960 (1109)
Q Consensus 881 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 960 (1109)
++.++++..++...+. +++..++.++.|++.||+||| +.+||||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~- 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp CCSEEHHHHHHHTTTC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-
T ss_pred eccccccccccccccc---cchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCC-
Confidence 9999999888776544 899999999999999999999 779999999999999999999999999999876532
Q ss_pred CCCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCc-hhhhhhc
Q 001274 961 SKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTS-ELFDKRL 1038 (1109)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1038 (1109)
........+++.|+|||++.+.. ++.++||||+||++|||++|+.||.... +..+..........+.. ..+....
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS---SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC---CHHHHHHHHHhhcCCCChhhhhhhh
Confidence 22334456788999999987665 6899999999999999999999975432 23333322211111100 0000000
Q ss_pred --------------chhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1039 --------------DLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1039 --------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
.............+.+++.+|++.||.+||||+|+++|-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 0000111122345788999999999999999999998743
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-40 Score=363.93 Aligned_cols=262 Identities=21% Similarity=0.265 Sum_probs=199.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCc-eeeEEEEEEeCCceEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRN-IVKLYGFCYHQDSNLLLY 879 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 879 (1109)
++|++.+.||+|+||+||+|++. +|+.||||++.... ..+++..|+++++.++|++ |+.+.+++...+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 57999999999999999999864 68999999987542 2345789999999998765 555566667788889999
Q ss_pred EeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceEEeeccccccc
Q 001274 880 EYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLD---EEFQAHVGDFGLAKLI 956 (1109)
Q Consensus 880 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a~~~ 956 (1109)
||+ ++++.+.+..... .+++..+..++.|++.||+||| +++||||||||+|||++ .+..+|++|||+|+..
T Consensus 83 e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEc-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999 5677776655443 3899999999999999999999 77999999999999985 4557999999999877
Q ss_pred cCCCC------CCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCC
Q 001274 957 DLPYS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPT 1030 (1109)
Q Consensus 957 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1109)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.............+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 53222 122456799999999999999999999999999999999999999986543332222211111111000
Q ss_pred chhhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhc
Q 001274 1031 SELFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDARQS 1083 (1109)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 1083 (1109)
.+.. ......++.+++.+||+.+|++||+++++.+.|+.....
T Consensus 237 ~~~~----------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 IEVL----------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHH----------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhHh----------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0100 011124578999999999999999999998888876543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=375.53 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=197.3
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC------c
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD------S 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 874 (1109)
++|++.++||+|+||+||+|++. +|+.||||+++.........+.+.+|++++++++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 68999999999999999999965 6999999999755444455678899999999999999999999998755 4
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.|+||||+ +.+|..+.+... +++..++.++.||+.||+||| +.+|+||||||+|||++.++.+|++|||.|+
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~~----l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecc-cccHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence 69999999 668887775432 999999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCCCccccccccceeccccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+............. .. .+..+.
T Consensus 170 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~--~~-~~~~~~ 242 (346)
T d1cm8a_ 170 QAD----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV--TG-TPPAEF 242 (346)
T ss_dssp ECC----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH--HC-CCCHHH
T ss_pred ccC----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc--cC-CCcHHH
Confidence 754 233556899999999998764 5689999999999999999999999764321111111111 00 011111
Q ss_pred hhhhc-----------ch-----hhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1034 FDKRL-----------DL-----SAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1034 ~~~~~-----------~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
..... .. ...........+.+++.+|++.||++|||++|+++|-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 00000 00 00001111235678999999999999999999999843
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=375.89 Aligned_cols=262 Identities=26% Similarity=0.296 Sum_probs=193.7
Q ss_pred CCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC------Cce
Q 001274 803 NFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ------DSN 875 (1109)
Q Consensus 803 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 875 (1109)
+|+..++||+|+||+||+|++. +|+.||||+++.... ...+|++++++++||||+++++++... .+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5778899999999999999975 699999999974322 234799999999999999999998653 246
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeeccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAK 954 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~ 954 (1109)
++|||||+++..............+++.+++.++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+++
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 899999987644433322222234999999999999999999999 88999999999999999775 89999999998
Q ss_pred cccCCCCCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
.... ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.+....+.. +. +..+.
T Consensus 172 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~--g~-~~~~~ 246 (350)
T d1q5ka_ 172 QLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL--GT-PTREQ 246 (350)
T ss_dssp ECCT--TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH--CC-CCHHH
T ss_pred hccC--CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHh--CC-ChHHh
Confidence 7652 233445689999999998775 568999999999999999999999997543222221111100 00 00000
Q ss_pred hhhhc-----------c---hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1034 FDKRL-----------D---LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1034 ~~~~~-----------~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
+.... . ............+.+++.+|++.||++|||++|+++|-+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 00000 0 000001112345789999999999999999999998754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-41 Score=372.15 Aligned_cols=257 Identities=25% Similarity=0.283 Sum_probs=210.8
Q ss_pred cCCCCCceEecCCcceEEEEEec----CCcEEEEEEeeccCC--CcchhHHHHHHHHHhccCCC-CceeeEEEEEEeCCc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA----NGEVIAVKKIKLRGE--GATADNSFLAEISTLGKIRH-RNIVKLYGFCYHQDS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 874 (1109)
++|++.++||+|+||+||+|+.. +|+.||||+++.... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 488999999864321 12234678899999999976 899999999999999
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.++||||+.+|+|.+++..... +++..+..++.||+.|++|+| +.+||||||||+||+++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999987654 788999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCCCccccccccceeccccccCC--CCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTM--KVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
..............|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+...........+.......+..
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~- 256 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP- 256 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC-
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc-
Confidence 7654444444567899999999998765 4688999999999999999999999877655555555554433332211
Q ss_pred hhhhhcchhhcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHH
Q 001274 1033 LFDKRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRP-----TMREVIAMMI 1078 (1109)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~ 1078 (1109)
......+.+++.+||+.||++|| |++|+++|-+
T Consensus 257 -------------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 257 -------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp -------------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -------------ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 11224678899999999999999 5899988744
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-40 Score=369.89 Aligned_cols=267 Identities=23% Similarity=0.289 Sum_probs=197.9
Q ss_pred hcCCCCCceEecCCcceEEEEEe-cCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeCC----ce
Q 001274 801 TGNFSEGAVIGRGACGTVYKATL-ANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQD----SN 875 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 875 (1109)
+.+|++.++||+|+||+||+|++ .+|+.||||++.... .....+.+.+|++++++++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35799999999999999999986 479999999996432 3344567899999999999999999999987653 23
Q ss_pred EEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 876 LLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 876 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
+++++|+.+|+|.+++.... +++..++.++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~----l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcCC----CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 56667777999999997542 899999999999999999999 77999999999999999999999999999986
Q ss_pred ccCCC--CCCccccccccceeccccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCch
Q 001274 956 IDLPY--SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSE 1032 (1109)
Q Consensus 956 ~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1109)
..... .......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+....+........ . ..+...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~-~--~~~~~~ 235 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-L--GSPSQE 235 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-H--CSCCHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh-c--cCCChh
Confidence 54222 122355679999999999854 56789999999999999999999999754321111111110 0 001110
Q ss_pred hhhhhcc-----------hhhc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1033 LFDKRLD-----------LSAK-----RTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1033 ~~~~~~~-----------~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
....... .... ........+.+++.+|++.||++|||++|++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 0000000 0000 00011235789999999999999999999998843
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.6e-40 Score=367.10 Aligned_cols=261 Identities=21% Similarity=0.251 Sum_probs=198.1
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeC--CceEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQ--DSNLL 877 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~l 877 (1109)
++|++.++||+|+||+||+|++. +++.||||+++. ...+.+.+|++++++++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 57999999999999999999974 789999999863 23567889999999995 99999999999754 45789
Q ss_pred EEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeeccccccc
Q 001274 878 LYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF-QAHVGDFGLAKLI 956 (1109)
Q Consensus 878 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~ 956 (1109)
||||+++++|..+.+ .+++..++.++.||+.||+||| +++||||||||+|||++.++ .+||+|||+|+..
T Consensus 110 v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceec
Confidence 999999999977643 2899999999999999999999 77999999999999998655 6999999999876
Q ss_pred cCCCCCCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhh----------
Q 001274 957 DLPYSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIH---------- 1025 (1109)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~---------- 1025 (1109)
.. ........+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||.......+....+.....
T Consensus 181 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 181 HP--GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CT--TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cC--CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 52 23345567899999999987654 799999999999999999999999754322111111111100
Q ss_pred ccCCCchhhhhhcc----------hhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 001274 1026 EMVPTSELFDKRLD----------LSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMI 1078 (1109)
Q Consensus 1026 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 1078 (1109)
........+..... ............+.+++.+|++.||++|||++|+++|-+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 00000000000000 000001112245789999999999999999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-40 Score=372.34 Aligned_cols=268 Identities=21% Similarity=0.250 Sum_probs=195.4
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC------Cc
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ------DS 874 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 874 (1109)
++|++.++||+|+||+||+|++. +|+.||||++..........+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999976 699999999986655555566789999999999999999999999643 56
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.|+||||+.++.+ +.+.. .+++..++.++.||+.||+||| +.||+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence 7999999976544 44432 2899999999999999999999 7799999999999999999999999999988
Q ss_pred cccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHh-----------
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRS----------- 1023 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~----------- 1023 (1109)
.... ........+|+.|+|||++.+..++.++||||+||++|||++|+.||.+..........+...
T Consensus 168 ~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 6542 233455679999999999999999999999999999999999999997543111111111100
Q ss_pred -------hhccCCCc-----hhhhhh-cchhhcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1024 -------IHEMVPTS-----ELFDKR-LDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1024 -------~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
........ ..+... ..............+.+++.+|++.||++||||+|+++|-+-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 00000000 000000 0001111233456688999999999999999999999886543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=365.86 Aligned_cols=266 Identities=24% Similarity=0.323 Sum_probs=201.0
Q ss_pred hcCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCceeeEEEEEEeC-----Cc
Q 001274 801 TGNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNIVKLYGFCYHQ-----DS 874 (1109)
Q Consensus 801 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 874 (1109)
.++|++.++||+|+||+||+|++. +|+.||||+++.........+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 357999999999999999999964 799999999986655555667889999999999999999999998643 34
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
.+++|+|+.+|+|.+++...+ +++.+++.++.||+.||+||| +++|+||||||+|||++.++.+|++|||.+.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~----l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccccc----ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence 477788888999999996532 999999999999999999999 7799999999999999999999999999997
Q ss_pred cccCCCCCCccccccccceeccccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCcHHHHHHHhhhccCCCchh
Q 001274 955 LIDLPYSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSFGVVLLELITGKSPVQSLELGGDLVTWVRRSIHEMVPTSEL 1033 (1109)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1109)
... .......||+.|+|||+..+.. ++.++||||+||++|+|++|+.||.+...........+. .. .+..+.
T Consensus 170 ~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~-~~--~~~~~~ 242 (348)
T d2gfsa1 170 HTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VG--TPGAEL 242 (348)
T ss_dssp CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HC--CCCHHH
T ss_pred ccC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cC--CCChHH
Confidence 653 2334567899999999877654 689999999999999999999999754321111111111 10 001111
Q ss_pred hhhh-----------cchhhcc-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 001274 1034 FDKR-----------LDLSAKR-----TVEEMTLFLKIALFCSSTSPLNRPTMREVIAMMIDA 1080 (1109)
Q Consensus 1034 ~~~~-----------~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 1080 (1109)
.... ....... .......+.+++.+|++.||++|||++|+++|-+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 0000 0000000 011224577999999999999999999999985543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-35 Score=334.87 Aligned_cols=270 Identities=21% Similarity=0.169 Sum_probs=194.2
Q ss_pred cCCCCCceEecCCcceEEEEEec-CCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-----------CCceeeEEEEE
Q 001274 802 GNFSEGAVIGRGACGTVYKATLA-NGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-----------HRNIVKLYGFC 869 (1109)
Q Consensus 802 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 869 (1109)
++|+++++||+|+||+||+|++. +|+.||||+++.. ....+.+.+|+++++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 46999999999999999999974 7999999999732 233456788998887774 57899999988
Q ss_pred EeC--CceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC----
Q 001274 870 YHQ--DSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEF---- 943 (1109)
Q Consensus 870 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 943 (1109)
... ...+++|+++..+..............+++..+..++.||+.|++|||+ ..+|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence 654 4556777776655443333333333348999999999999999999994 26899999999999998665
Q ss_pred --ceEEeeccccccccCCCCCCccccccccceeccccccCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC--CcHHHH
Q 001274 944 --QAHVGDFGLAKLIDLPYSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKSPVQSLELG--GDLVTW 1019 (1109)
Q Consensus 944 --~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~--~~~~~~ 1019 (1109)
.++++|||.|.... .......||+.|+|||++.+..++.++||||+||+++||++|+.||...... ....+.
T Consensus 168 ~~~~kl~dfg~s~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYD----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETT----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeecccccccc----cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 39999999998654 2234567999999999999999999999999999999999999999754321 111111
Q ss_pred HHHhhhccC-CCchhhh---------------------------hhcchhhcccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 001274 1020 VRRSIHEMV-PTSELFD---------------------------KRLDLSAKRTVEEMTLFLKIALFCSSTSPLNRPTMR 1071 (1109)
Q Consensus 1020 ~~~~~~~~~-~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ 1071 (1109)
......... ...+... ................+.+++.+|++.||++||||+
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111111000 0001000 000111223455667899999999999999999999
Q ss_pred HHHHHHHHh
Q 001274 1072 EVIAMMIDA 1080 (1109)
Q Consensus 1072 evl~~L~~~ 1080 (1109)
|+++|-+..
T Consensus 324 e~L~Hp~f~ 332 (362)
T d1q8ya_ 324 GLVNHPWLK 332 (362)
T ss_dssp HHHTCGGGT
T ss_pred HHhcCcccC
Confidence 999885443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=2e-32 Score=305.35 Aligned_cols=257 Identities=30% Similarity=0.483 Sum_probs=222.2
Q ss_pred ccceeecccccccc--cCCccccCCcccceecccc-ccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEE
Q 001274 457 SLMQLMLGQNQLTG--SLPIEFYNLQNLSALELYQ-NRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTF 533 (1109)
Q Consensus 457 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 533 (1109)
.++.|+|++|.+.+ .+|.++.++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 46777777777776 3677888888888888876 78888888888888888888888888888888888888888888
Q ss_pred ecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCccccccccc-ceecccccccccccCcccCCCcccceeeccCccc
Q 001274 534 NISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNL-ELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIF 612 (1109)
Q Consensus 534 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 612 (1109)
++++|++.+.+|..+.+++.|+.+++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 888888888888888888888888888888888888888888776 778888888888888888776554 688888888
Q ss_pred cccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccCCchhhhccccceEEEccCcccccccCCC
Q 001274 613 SGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGEIPASMGEQMSLLVCNLSNNNLVGTVPNT 692 (1109)
Q Consensus 613 ~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~l~ls~N~l~g~~p~~ 692 (1109)
.|.+|..++.+..+. .+++++|.+++.+| .++.+++|+.|||++|+|+|.+|.+++++++|++|||++|+|+|.+|..
T Consensus 210 ~~~~~~~~~~~~~l~-~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~ 287 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQ-KIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EECCGGGCCTTSCCS-EEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccccccccccccccc-cccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCc
Confidence 888888888888886 48899999988766 6889999999999999999999999999999999999999999999998
Q ss_pred cccccccCCcccCCCCcccc-CCCc
Q 001274 693 TVFRRIDSSNFAGNRGLCML-GSDC 716 (1109)
Q Consensus 693 ~~~~~~~~~~~~~n~~~c~~-~~~c 716 (1109)
+.+..+....+.||+.+||. .|.|
T Consensus 288 ~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred ccCCCCCHHHhCCCccccCCCCCCC
Confidence 88999999999999999986 6777
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.1e-28 Score=283.43 Aligned_cols=357 Identities=24% Similarity=0.305 Sum_probs=228.5
Q ss_pred hhcccccccccCchhhhccccccceecccccccCCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccc
Q 001274 221 LGLAQNSLEGFLPSELEKLRNLTDLILWQNHLSGEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNEL 300 (1109)
Q Consensus 221 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l 300 (1109)
..++.+.+++.+. ...+.+|++|++++|.|+. + ++++.+++|++|+|++|+|++. | .++++++|++|++++|.+
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccc
Confidence 3445555554332 2455566666666666663 3 3566666677777777776643 2 266677777777777776
Q ss_pred cCccCcccCCCCcCcEEEccCCcccCCCcccccCCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcch
Q 001274 301 NGTIPHELGNCTSAVEIDLSENQLTGFIPRELGLIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEF 380 (1109)
Q Consensus 301 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 380 (1109)
.+.. .++++++|+.|++++|.+++..+ ......+..+....|.+....+.................. ...+
T Consensus 101 ~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 171 (384)
T d2omza2 101 ADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPL 171 (384)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGG
T ss_pred cccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccch-----hhhh
Confidence 6432 26666777777777777664433 2334455556666665554433333332222222222221 1233
Q ss_pred hcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccce
Q 001274 381 QNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQ 460 (1109)
Q Consensus 381 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 460 (1109)
...+.........|... ....+..+++++.+++++|.+++..| +...++|+.|++++|+++.. +.+..+++|+.
T Consensus 172 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 245 (384)
T d2omza2 172 ANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTD 245 (384)
T ss_dssp TTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred ccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccch
Confidence 34444444455554443 34445666777777777777776544 34566777777777777643 35667777888
Q ss_pred eecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcc
Q 001274 461 LMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSL 540 (1109)
Q Consensus 461 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 540 (1109)
|++++|++++..+ +..+++|++|++++|++++.. .+..++.++.+++++|++++. ..+..+++++.|++++|++
T Consensus 246 L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l 319 (384)
T d2omza2 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNI 319 (384)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCC
T ss_pred hccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCC
Confidence 8888887776443 667788888888888887653 367777888888888888753 4577778888888888888
Q ss_pred cccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCc
Q 001274 541 SGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGN 610 (1109)
Q Consensus 541 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 610 (1109)
++.. .+..+++|++|++++|+|++ ++ .+.++++|++|++++|++++..| +.++++|++|+|++|
T Consensus 320 ~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 320 SDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 7543 27778888888888888874 44 57888888888888888887654 778888888888877
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=8.7e-29 Score=284.32 Aligned_cols=356 Identities=25% Similarity=0.356 Sum_probs=210.8
Q ss_pred EeecCCCCCCCCcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceeccccccc
Q 001274 174 VIYSNNLTGAIPASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHLS 253 (1109)
Q Consensus 174 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 253 (1109)
.+..+.+++.+. ...+.+|+.|+++++.|+. + +.+..+++|++|+|++|+|++.. .++++++|++|++++|+++
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc
Confidence 444555554433 2455666666666666653 2 24555666666666666665432 2555666666666666655
Q ss_pred CCCCCCccccccccceeeeeccceecCchhhhccCccceEEeecccccCccCcccCCCCcCcEEEccCCcccCCCccccc
Q 001274 254 GEIPPTIGNIQSLELLALHENSFSGGLPKELGKLSRLKKLYVYTNELNGTIPHELGNCTSAVEIDLSENQLTGFIPRELG 333 (1109)
Q Consensus 254 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~ 333 (1109)
+.. .++++++|+.|++++|.+++..+ ......+..+....|.+....+.................
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~----------- 166 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT----------- 166 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----------
T ss_pred ccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc-----------
Confidence 322 25555555555555555553222 233344445555555444222222111111111111111
Q ss_pred CCCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEE
Q 001274 334 LIPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVL 413 (1109)
Q Consensus 334 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L 413 (1109)
....+...+.........|... ....+..+++++.+++++|.+++..| +...++|++|
T Consensus 167 ------------------~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L 224 (384)
T d2omza2 167 ------------------DLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 224 (384)
T ss_dssp ------------------CCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred ------------------hhhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEE
Confidence 1122333344444444444433 23445556666666666666654433 3445566666
Q ss_pred EeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceecccccccc
Q 001274 414 DVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFS 493 (1109)
Q Consensus 414 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 493 (1109)
++++|+++.. +.+..+++|+.|++++|.+++..+ +..+++|++|++++|++++.. .+.++..++.+++++|.++
T Consensus 225 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~ 298 (384)
T d2omza2 225 SLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLE 298 (384)
T ss_dssp ECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCS
T ss_pred ECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccccccccc
Confidence 6666666542 345666777777777777765432 666677777777777777543 3667778888888888887
Q ss_pred CCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccc
Q 001274 494 GLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELG 573 (1109)
Q Consensus 494 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 573 (1109)
+. ..+..+++++.|++++|++++.. .+..+++|++|+|++|+|++ ++ .+.++++|++|++++|+|++..| +.
T Consensus 299 ~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~ 370 (384)
T d2omza2 299 DI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LA 370 (384)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GT
T ss_pred cc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hc
Confidence 54 45777788888888888888653 37788888888888888874 44 57888888888888888886544 78
Q ss_pred cccccceeccccc
Q 001274 574 QLVNLELLKLSDN 586 (1109)
Q Consensus 574 ~l~~L~~L~Ls~N 586 (1109)
++++|+.|+|++|
T Consensus 371 ~l~~L~~L~L~~N 383 (384)
T d2omza2 371 NLTRITQLGLNDQ 383 (384)
T ss_dssp TCTTCSEEECCCE
T ss_pred cCCCCCEeeCCCC
Confidence 8888888888887
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=5.3e-26 Score=249.02 Aligned_cols=266 Identities=22% Similarity=0.210 Sum_probs=192.4
Q ss_pred EcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeec-ccccc
Q 001274 390 QLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLML-GQNQL 468 (1109)
Q Consensus 390 ~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L-~~N~l 468 (1109)
+.++++++ .+|..+. +.+++|+|++|+|+.+.+..|.++++|++|++++|++.++.+..+..+..++.+.. ..|.+
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 34444444 3444332 45666777777776665566777777777777777777766677777777777654 45667
Q ss_pred cccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCC
Q 001274 469 TGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHEL 548 (1109)
Q Consensus 469 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 548 (1109)
+.+.+..|.++++|++|++++|.+....+..+....+|+.+++++|+|+++.+..|..+++|+.|+|++|++++..+.+|
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f 173 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhh
Confidence 76777888888888888888888887777788888888888888888887777888888888999999999888888888
Q ss_pred CCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhh
Q 001274 549 GNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQI 628 (1109)
Q Consensus 549 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~ 628 (1109)
.++++|+.+++++|++++..|..|..+++|++|++++|++.+..|..|+++++|++|++++|++.+.-+. ..+.....
T Consensus 174 ~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~--~~l~~~l~ 251 (284)
T d1ozna_ 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA--RPLWAWLQ 251 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG--HHHHHHHH
T ss_pred ccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc--hHHHHHHH
Confidence 8889999999999998888888888888999999999999888888888899999999999988865431 11121112
Q ss_pred hhccCCccccccccccccCccccceeecCCCcccc
Q 001274 629 ALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIG 663 (1109)
Q Consensus 629 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 663 (1109)
.+....+++....|..+.+ +..++++.|.|+|
T Consensus 252 ~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 252 KFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp HCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred hCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 3444555565555554432 3333444444443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=6.8e-25 Score=242.94 Aligned_cols=124 Identities=20% Similarity=0.238 Sum_probs=62.7
Q ss_pred cccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeec
Q 001274 480 QNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDL 559 (1109)
Q Consensus 480 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 559 (1109)
++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|.+|.++++|++|+|
T Consensus 171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L 249 (305)
T d1xkua_ 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249 (305)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence 34444555555544444444555555555555555555444455555555555555555554 34445555555555555
Q ss_pred CCCcCccCCCc------ccccccccceecccccccc--cccCcccCCCcccce
Q 001274 560 SRNQFTGSAPE------ELGQLVNLELLKLSDNKLT--GAIPSSLGGLARLTE 604 (1109)
Q Consensus 560 s~N~l~~~~p~------~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~ 604 (1109)
++|+|+..... .+..+.+|+.|+|++|+++ ...|.+|..+.....
T Consensus 250 s~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~ 302 (305)
T d1xkua_ 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 302 (305)
T ss_dssp CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGG
T ss_pred CCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCcc
Confidence 55555532211 2234455666666666654 344555555444433
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=7.7e-25 Score=242.50 Aligned_cols=257 Identities=22% Similarity=0.289 Sum_probs=153.7
Q ss_pred cceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEecc
Q 001274 338 LCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSM 417 (1109)
Q Consensus 338 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~ 417 (1109)
+++|+|++|.|+...+.+|.++++|++|++++|.+....|..|.++++|+.|++++|+++. +|..+ ...+..|++++
T Consensus 33 l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~ 109 (305)
T d1xkua_ 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHE 109 (305)
T ss_dssp CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCS
T ss_pred CCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhccc
Confidence 3333333333333333344555555555555555554444455555555555555555542 33221 23455555555
Q ss_pred ccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCC
Q 001274 418 NNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIP 497 (1109)
Q Consensus 418 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 497 (1109)
|.+.+..+..+.....+..++...|... .....+..|..+++|+.+++++|.++.+ |
T Consensus 110 n~l~~l~~~~~~~~~~~~~l~~~~n~~~----------------------~~~~~~~~~~~l~~L~~l~l~~n~l~~l-~ 166 (305)
T d1xkua_ 110 NEITKVRKSVFNGLNQMIVVELGTNPLK----------------------SSGIENGAFQGMKKLSYIRIADTNITTI-P 166 (305)
T ss_dssp SCCCBBCHHHHTTCTTCCEEECCSSCCC----------------------GGGBCTTGGGGCTTCCEEECCSSCCCSC-C
T ss_pred cchhhhhhhhhhcccccccccccccccc----------------------ccCCCccccccccccCccccccCCcccc-C
Confidence 5555544444444444444544444322 1112344566666777777777777643 3
Q ss_pred ccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccc
Q 001274 498 PEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVN 577 (1109)
Q Consensus 498 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 577 (1109)
..+ +++|+.|++++|.+++..+..|.+++.+++|++++|.+++..+.++.++++|++|+|++|.|+ .+|..|..+++
T Consensus 167 ~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~ 243 (305)
T d1xkua_ 167 QGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243 (305)
T ss_dssp SSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSS
T ss_pred ccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccC
Confidence 332 467778888888877777777777888888888888887777777777888888888888887 46777777888
Q ss_pred cceecccccccccccCccc------CCCcccceeeccCcccc-cccccccccc
Q 001274 578 LELLKLSDNKLTGAIPSSL------GGLARLTELQMGGNIFS-GSIPVALGQL 623 (1109)
Q Consensus 578 L~~L~Ls~N~l~~~~p~~~------~~l~~L~~L~l~~N~l~-~~~p~~~~~l 623 (1109)
|+.|+|++|+|+......| ..+.+|+.|+|++|++. ..++...+++
T Consensus 244 L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~ 296 (305)
T d1xkua_ 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296 (305)
T ss_dssp CCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcc
Confidence 8888888888775543333 34567778888888774 3444444433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.6e-25 Score=240.75 Aligned_cols=267 Identities=21% Similarity=0.204 Sum_probs=171.8
Q ss_pred EEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeec-CCcc
Q 001274 365 LDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSL-GSNR 443 (1109)
Q Consensus 365 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L-~~N~ 443 (1109)
++.++++++ .+|..+. +.+++|+|++|+|+...+..|..+++|++|++++|++..+.+..+..+..++.+.. ..|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 344444444 3343321 34555555555555444445555566666666666666555555555666666544 3455
Q ss_pred ccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChh
Q 001274 444 LSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSE 523 (1109)
Q Consensus 444 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 523 (1109)
++...+..|.++++|++|++++|.+....+..+....+|+.+++++|+|+++.+..|..+++|+.|++++|++++..+..
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~ 172 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence 55555666777777777777777776666666777777777777777777666667777777777777777777767777
Q ss_pred hcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccc
Q 001274 524 VGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLT 603 (1109)
Q Consensus 524 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 603 (1109)
|.++++|+.+++++|++++..|..|.++++|++||+++|++++..+..|..+++|++|+|++|++...-+. -.-...++
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~ 251 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQ 251 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHH
T ss_pred hccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHH
Confidence 77777777777777777777777777777777777777777776667777777777788877777643221 11112355
Q ss_pred eeeccCccccccccccccccchhhhhhccCCccccc
Q 001274 604 ELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSG 639 (1109)
Q Consensus 604 ~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~ 639 (1109)
.+....+.+....|..+.+.. ..+++.+.|+|
T Consensus 252 ~~~~~~~~~~C~~p~~l~g~~----l~~l~~~~l~g 283 (284)
T d1ozna_ 252 KFRGSSSEVPCSLPQRLAGRD----LKRLAANDLQG 283 (284)
T ss_dssp HCCSEECCCBEEESGGGTTCB----GGGSCGGGSCC
T ss_pred hCcCCCCceEeCCchHHcCCc----cccCCHHHCCC
Confidence 566666677766776665422 24566666654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=2.4e-23 Score=225.11 Aligned_cols=180 Identities=29% Similarity=0.336 Sum_probs=109.5
Q ss_pred cccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceeccc
Q 001274 505 NLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLS 584 (1109)
Q Consensus 505 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 584 (1109)
+|++|+|++|+|+++.+..|.++++|++|+|++|+|+. +| .++.+++|++|+|++|+++ ..+..+..+++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc-cccccccccccccccccc
Confidence 44455555555544444445555555555555555542 22 2344555555555555554 234445555555555555
Q ss_pred ccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccccccccCccccceeecCCCccccC
Q 001274 585 DNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVIPYELGNLQMLEALYLDDNQLIGE 664 (1109)
Q Consensus 585 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 664 (1109)
+|++.+..+..+..+.++++|++++|.+.+..+..+..+..+. .+++++|+|++..+..|+.+++|++|||++|+|+ .
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~-~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE-KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC-EEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred ccccceeeccccccccccccccccccccceeccccccccccch-hcccccccccccCccccccccccceeecccCCCc-c
Confidence 5555555555555555555555555555544444444455544 3666666677677777888899999999999988 8
Q ss_pred CchhhhccccceEEEccCccccccc
Q 001274 665 IPASMGEQMSLLVCNLSNNNLVGTV 689 (1109)
Q Consensus 665 ip~~~~~l~~L~~l~ls~N~l~g~~ 689 (1109)
+|..+..+.+|+.|+|++|++.|..
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cChhHCCCCCCCEEEecCCCCCCCc
Confidence 8888888899999999999887754
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.8e-22 Score=218.06 Aligned_cols=198 Identities=26% Similarity=0.259 Sum_probs=101.2
Q ss_pred ccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecc
Q 001274 385 YLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLG 464 (1109)
Q Consensus 385 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 464 (1109)
.+.+++.+++.++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+... .+..+++|++|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccccccc
Confidence 3344444455544 2344332 35566666666666555555666666666666666555321 12334444444444
Q ss_pred cccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccC
Q 001274 465 QNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544 (1109)
Q Consensus 465 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 544 (1109)
+|++ +. .+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++...
T Consensus 86 ~N~l------------------------~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~ 140 (266)
T d1p9ag_ 86 HNQL------------------------QS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140 (266)
T ss_dssp SSCC------------------------SS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCC
T ss_pred cccc------------------------cc-cccccccccccccccccccccceeeccccccccccccccccccccceec
Confidence 4444 42 2334444444555555555544444444445555555555555555444
Q ss_pred CcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcccc
Q 001274 545 PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFS 613 (1109)
Q Consensus 545 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 613 (1109)
+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 141 ~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 444455555555555555555444444555555555555555555 44545555566666666666655
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=6.3e-22 Score=202.07 Aligned_cols=166 Identities=19% Similarity=0.180 Sum_probs=121.0
Q ss_pred CCCceEecCCcceEEEEEecCCcEEEEEEeeccCCC----------------cchhHHHHHHHHHhccCCCCceeeEEEE
Q 001274 805 SEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEG----------------ATADNSFLAEISTLGKIRHRNIVKLYGF 868 (1109)
Q Consensus 805 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 868 (1109)
.++++||+|+||+||+|++.+|+.||||+++..... ........+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356899999999999999888999999987532110 0011334568889999999999988765
Q ss_pred EEeCCceEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 001274 869 CYHQDSNLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDCRPHIIHRDIKSNNILLDEEFQAHVG 948 (1109)
Q Consensus 869 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 948 (1109)
. ..+++|||++++.+.+ ++......++.|++++++||| +.+|+||||||+|||++++ .++++
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEE
Confidence 3 3489999998755432 444556789999999999999 7799999999999999976 58999
Q ss_pred eccccccccCCCCCCccccccccceeccc-----cccCCCCCccchhHHHHHHH
Q 001274 949 DFGLAKLIDLPYSKSMSAIAGSYGYIAPE-----YAYTMKVTEKCDIYSFGVVL 997 (1109)
Q Consensus 949 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DvwSlGvll 997 (1109)
|||.|+....+... .|.... .+..+.|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999865422111 111110 01246788999999965433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.81 E-value=1.1e-18 Score=196.50 Aligned_cols=76 Identities=30% Similarity=0.312 Sum_probs=43.1
Q ss_pred ccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccc
Q 001274 506 LERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD 585 (1109)
Q Consensus 506 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 585 (1109)
....++..|.+.+. ...+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +.+|+.|+|++
T Consensus 266 ~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~ 333 (353)
T d1jl5a_ 266 LYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEY 333 (353)
T ss_dssp CCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCS
T ss_pred hcccccccCccccc----cccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcC
Confidence 34455555554422 223456666666666666 45543 355666777777766 45532 34566777777
Q ss_pred cccccccCc
Q 001274 586 NKLTGAIPS 594 (1109)
Q Consensus 586 N~l~~~~p~ 594 (1109)
|+|+ .+|.
T Consensus 334 N~L~-~lp~ 341 (353)
T d1jl5a_ 334 NPLR-EFPD 341 (353)
T ss_dssp SCCS-SCCC
T ss_pred CcCC-CCCc
Confidence 7766 3454
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.80 E-value=2.1e-18 Score=194.02 Aligned_cols=150 Identities=27% Similarity=0.293 Sum_probs=78.7
Q ss_pred CccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhccccccc
Q 001274 452 LKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLV 531 (1109)
Q Consensus 452 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 531 (1109)
+..++.|+.+++++|.... .+. ...++..+.+.+|.+... +. ....+...++..|.+.+.. . -.....
T Consensus 200 ~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~~---~~~~l~~~~~~~~~~~~l~-~---l~~~~~ 267 (353)
T d1jl5a_ 200 LQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-PE---LPQSLTFLDVSENIFSGLS-E---LPPNLY 267 (353)
T ss_dssp CTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSEES-C---CCTTCC
T ss_pred ccccccccccccccccccc-ccc---cccccccccccccccccc-cc---ccccccccccccccccccc-c---ccchhc
Confidence 3445555555555555442 221 233455555555555432 11 2234555555555444211 0 012344
Q ss_pred EEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCcc
Q 001274 532 TFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNI 611 (1109)
Q Consensus 532 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 611 (1109)
..++..|.+.+. + ..+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|++++|+
T Consensus 268 ~~~~~~~~~~~~-~---~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~ 335 (353)
T d1jl5a_ 268 YLNASSNEIRSL-C---DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNP 335 (353)
T ss_dssp EEECCSSCCSEE-C---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSC
T ss_pred ccccccCccccc-c---ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCc
Confidence 556666666532 2 23456777777777776 45543 456777777777776 34432 3467777777777
Q ss_pred ccccccccccccchh
Q 001274 612 FSGSIPVALGQLTAL 626 (1109)
Q Consensus 612 l~~~~p~~~~~l~~l 626 (1109)
++ .+|.....+..|
T Consensus 336 L~-~lp~~~~~L~~L 349 (353)
T d1jl5a_ 336 LR-EFPDIPESVEDL 349 (353)
T ss_dssp CS-SCCCCCTTCCEE
T ss_pred CC-CCCccccccCee
Confidence 66 555544444444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=3.2e-18 Score=174.32 Aligned_cols=172 Identities=21% Similarity=0.306 Sum_probs=110.7
Q ss_pred ceeccccccccCCCCccccccccccEEEccCCccCCC-CChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCC
Q 001274 483 SALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGY-IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSR 561 (1109)
Q Consensus 483 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 561 (1109)
++++.++|+++. +|..+. +++++|+|++|+|++. .+..|.++++|+.|+|++|++.+..+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 345555566553 344332 4667777777777653 345567777777777777777777777777777777777777
Q ss_pred CcCccCCCcccccccccceecccccccccccCcccCCCcccceeeccCccccccccccccccchhhhhhccCCccccccc
Q 001274 562 NQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMGGNIFSGSIPVALGQLTALQIALNISHNNLSGVI 641 (1109)
Q Consensus 562 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~Ls~N~l~~~~ 641 (1109)
|+|++..|..|.++++|+.|+|++|+|+++.|++|.++++|++|+|++|++.+..+... +......+++..|.++...
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~--~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW--FAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH--HHHHHHHHCCSGGGCBBCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH--HhhhhhhhcccCCCeEeCC
Confidence 77776666677777777777777777777777778888888888888888775443221 1111123455566666555
Q ss_pred cccccCccccceeecCCCccc
Q 001274 642 PYELGNLQMLEALYLDDNQLI 662 (1109)
Q Consensus 642 p~~~~~l~~L~~L~Ls~N~l~ 662 (1109)
|.. ++.++.+||+.|++.
T Consensus 166 p~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 166 PSK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp STT---TTTSBGGGSCTTTCC
T ss_pred Chh---hcCCEeeecCHhhCc
Confidence 533 334455566666554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=2.8e-18 Score=180.10 Aligned_cols=207 Identities=23% Similarity=0.305 Sum_probs=118.1
Q ss_pred CCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeec
Q 001274 360 TQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSL 439 (1109)
Q Consensus 360 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 439 (1109)
.++..++++.+++++.. .+..+.+|+.|++.+|.++. + +.+..+++|++|++++|++.+..| +..+++|+++++
T Consensus 19 ~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~ 92 (227)
T d1h6ua2 19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL 92 (227)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred HHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccccc
Confidence 33445566666666432 45666777777777777763 3 246666666666666666664432 555555555555
Q ss_pred CCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCC
Q 001274 440 GSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGY 519 (1109)
Q Consensus 440 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 519 (1109)
++|.++.. . .+.++++|+.+++++|...+. ..+...+.++.+.++++.+...
T Consensus 93 ~~n~~~~i--~------------------------~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~ 144 (227)
T d1h6ua2 93 SGNPLKNV--S------------------------AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI 144 (227)
T ss_dssp CSCCCSCC--G------------------------GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC
T ss_pred cccccccc--c------------------------ccccccccccccccccccccc--chhccccchhhhhchhhhhchh
Confidence 55555421 1 244455555555555555433 2244455566666666655532
Q ss_pred CChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCcccCCC
Q 001274 520 IPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGL 599 (1109)
Q Consensus 520 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 599 (1109)
..+.++++|+.|++++|.+++.. .+.++++|++|+|++|++++ ++ .+.++++|++|+|++|++++..| ++++
T Consensus 145 --~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l 216 (227)
T d1h6ua2 145 --SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANT 216 (227)
T ss_dssp --GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTC
T ss_pred --hhhccccccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccC
Confidence 23555566666666666665322 25666666666666666663 32 25666666666666666664432 5666
Q ss_pred cccceeecc
Q 001274 600 ARLTELQMG 608 (1109)
Q Consensus 600 ~~L~~L~l~ 608 (1109)
++|+.|+++
T Consensus 217 ~~L~~L~ls 225 (227)
T d1h6ua2 217 SNLFIVTLT 225 (227)
T ss_dssp TTCCEEEEE
T ss_pred CCCCEEEee
Confidence 666666665
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.5e-18 Score=180.57 Aligned_cols=199 Identities=15% Similarity=0.089 Sum_probs=97.0
Q ss_pred cCcEEEeccccccCccchhhhcccccceeecCCccccCCC-CCCCccccccceeecc-cccccccCCccccCCcccceec
Q 001274 409 HLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNI-PPGLKTCRSLMQLMLG-QNQLTGSLPIEFYNLQNLSALE 486 (1109)
Q Consensus 409 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~ 486 (1109)
++++|++++|+|+...+..|.++++|++|++++|.+...+ +..|.+++.++++.+. .|++....+..|.++++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 3444444444444333334444444444444444443322 2234445555555443 2445445555555556666666
Q ss_pred cccccccCCCCc-cccccccccEEEccCCccCCCCChhhcccc-cccEEecccCcccccCCcCCCCCCCCCe-eecCCCc
Q 001274 487 LYQNRFSGLIPP-EIGKLRNLERLHLSENYFVGYIPSEVGNLE-HLVTFNISSNSLSGTIPHELGNCVNLQR-LDLSRNQ 563 (1109)
Q Consensus 487 L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~ 563 (1109)
+++|.+....+. .+..+..+..+..+++++..+.+..|.+++ .++.|++++|+++...+..+ +.++++. +++++|+
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~ 188 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNN 188 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTT
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-cchhhhccccccccc
Confidence 666555433221 233344444455555555544444554443 55566666666653333322 3333333 3455556
Q ss_pred CccCCCcccccccccceecccccccccccCcccCCCcccceeecc
Q 001274 564 FTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMG 608 (1109)
Q Consensus 564 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 608 (1109)
++...+..|.++++|+.|+|++|+++...+..|.++++|+.+++.
T Consensus 189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 654333445666666666666666665444555555555555543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=5.7e-18 Score=177.69 Aligned_cols=207 Identities=23% Similarity=0.288 Sum_probs=130.2
Q ss_pred CCCcceEecccccccCcccccccCCCCccEEEcccCcccCCCCcchhcccccceEEcccccccccCCCcccccCcCcEEE
Q 001274 335 IPNLCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTIPLEFQNLTYLVDLQLFDNHLEGTIPPHIGVNSHLSVLD 414 (1109)
Q Consensus 335 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ 414 (1109)
+.++..+++..+.+.+.+ .+..+.+|++|++++|+|+. + ..+.++++|++|++++|++.+..| +..+++|++++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 344455677777777654 45678899999999999985 4 468999999999999999986544 88999999999
Q ss_pred eccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccC
Q 001274 415 VSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSG 494 (1109)
Q Consensus 415 Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 494 (1109)
+++|.++.. ..+.++++|++++++++...+. ..+...+.+..+.++.+.+.... .+.++++|++|++++|.+.+
T Consensus 92 ~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhcccccccccccccccccc
Confidence 999998753 3578889999999988877643 22444455555555555554322 24444555555555555443
Q ss_pred CCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeec
Q 001274 495 LIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDL 559 (1109)
Q Consensus 495 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 559 (1109)
. ..+.++++|++|+|++|+++++ + .+.++++|++|+|++|+|++. + .+.++++|+.|++
T Consensus 166 ~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~l 224 (227)
T d1h6ua2 166 L--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTL 224 (227)
T ss_dssp C--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEE
T ss_pred c--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEe
Confidence 2 1244444445555544444432 1 244444444444444444422 1 1344444444444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=4.4e-21 Score=224.61 Aligned_cols=109 Identities=17% Similarity=0.194 Sum_probs=63.0
Q ss_pred ccceeecccCccCCC-CCccccCCCCCceEEccCCccccc----CCchhhccccceEEEccccccccc----cccccc-C
Q 001274 97 RLVEFNISMNFVTGS-IPTDLANCSSLEILDLCTNRLHGV----IPFQLFFINTLRKLYLCENYIFGE----IPEEIG-N 166 (1109)
Q Consensus 97 ~L~~L~ls~n~~~~~-~p~~l~~l~~L~~L~Ls~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~----~p~~l~-~ 166 (1109)
+|+.||++.|++++. +..-+..+++++.|+|++|.++.. ++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 567777777777653 234455667777777777776642 233445566677777777766532 222222 1
Q ss_pred cCCCceEEeecCCCCCC----CCcccccccccceecccccccc
Q 001274 167 LTSLEELVIYSNNLTGA----IPASISKLRQLRVIRAGHNSLS 205 (1109)
Q Consensus 167 l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~l~~n~l~ 205 (1109)
.++|++|+|++|++++. ++..+..+++|++|++++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 23566666666666533 2344455556666666666554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=2.1e-20 Score=218.76 Aligned_cols=349 Identities=21% Similarity=0.198 Sum_probs=152.0
Q ss_pred cccceecccccccCCC-CCCccccccccceeeeecccee----cCchhhhccCccceEEeecccccCc----cCcccC-C
Q 001274 241 NLTDLILWQNHLSGEI-PPTIGNIQSLELLALHENSFSG----GLPKELGKLSRLKKLYVYTNELNGT----IPHELG-N 310 (1109)
Q Consensus 241 ~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~l~~n~l~~~----~~~~l~-~ 310 (1109)
+|+.||++.|++++.. ...+..+++|+.|+|++|.++. .+...+..+++|++|+|++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5667777777776421 2334556666677777776653 2234455666666666666666421 122222 2
Q ss_pred CCcCcEEEccCCcccCC----CcccccCCCCcceEecccccccCccccccc-----CCCCccEEEcccCcccCCC----C
Q 001274 311 CTSAVEIDLSENQLTGF----IPRELGLIPNLCLLQLFENMLQGSIPRELG-----QLTQLHKLDLSINNLTGTI----P 377 (1109)
Q Consensus 311 l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-----~l~~L~~L~Ls~N~l~~~~----p 377 (1109)
..+|++|+|++|++++. ++..+...++|+.|++++|.+.......+. ..............+.... -
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 23566666666666532 233444555666666666655432221111 1112233333333222110 0
Q ss_pred cchhcccccceEEcccccccccCC----Ccc-cccCcCcEEEeccccccCcc----chhhhcccccceeecCCccccCC-
Q 001274 378 LEFQNLTYLVDLQLFDNHLEGTIP----PHI-GVNSHLSVLDVSMNNLDGSI----PPHLCMYQKLIFLSLGSNRLSGN- 447 (1109)
Q Consensus 378 ~~~~~l~~L~~L~L~~N~l~~~~p----~~~-~~~~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~- 447 (1109)
..+.....++.+.++++......- ..+ ........+++..+.+.... ...+.....++.+++++|.+...
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 112233445555555544331100 000 11123444555555443211 12233345555555555544211
Q ss_pred ----CCCCCccccccceeecccccccccC----CccccCCcccceeccccccccCCCCccc-----cccccccEEEccCC
Q 001274 448 ----IPPGLKTCRSLMQLMLGQNQLTGSL----PIEFYNLQNLSALELYQNRFSGLIPPEI-----GKLRNLERLHLSEN 514 (1109)
Q Consensus 448 ----~~~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N 514 (1109)
..........++.+++++|.+.... ...+...+.++.+++++|.+.......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 1112223344555555555554221 1122334455555555555532111111 11234555555555
Q ss_pred ccCCCCChh----hcccccccEEecccCccccc----CCcCCC-CCCCCCeeecCCCcCccC----CCccccccccccee
Q 001274 515 YFVGYIPSE----VGNLEHLVTFNISSNSLSGT----IPHELG-NCVNLQRLDLSRNQFTGS----APEELGQLVNLELL 581 (1109)
Q Consensus 515 ~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L 581 (1109)
.++...... +...++|++|+|++|+|+.. ++..+. ..+.|++|+|++|.|+.. +++.+..+++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 554322222 22234455555555555421 112221 234455555555555421 22334444555555
Q ss_pred cccccccc
Q 001274 582 KLSDNKLT 589 (1109)
Q Consensus 582 ~Ls~N~l~ 589 (1109)
+|++|+++
T Consensus 403 ~Ls~N~i~ 410 (460)
T d1z7xw1 403 DLSNNCLG 410 (460)
T ss_dssp ECCSSSCC
T ss_pred ECCCCcCC
Confidence 55555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.6e-17 Score=176.29 Aligned_cols=199 Identities=15% Similarity=0.062 Sum_probs=88.1
Q ss_pred cceEecccccccCcccccccCCCCccEEEcccCcccCCC-CcchhcccccceEEccc-ccccccCCCcccccCcCcEEEe
Q 001274 338 LCLLQLFENMLQGSIPRELGQLTQLHKLDLSINNLTGTI-PLEFQNLTYLVDLQLFD-NHLEGTIPPHIGVNSHLSVLDV 415 (1109)
Q Consensus 338 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~~~~L~~L~L 415 (1109)
++.|++++|.++...+..|.++++|++|++++|.+...+ +..|.+++.++++.+.. |.+....+..|..+++|++|++
T Consensus 31 l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l 110 (242)
T d1xwdc1 31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 110 (242)
T ss_dssp CSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEE
T ss_pred CCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccccc
Confidence 344444444443333334555555555555555554322 23445555555554432 4444444444555555555555
Q ss_pred ccccccCccc-hhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccC
Q 001274 416 SMNNLDGSIP-PHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSG 494 (1109)
Q Consensus 416 s~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 494 (1109)
++|++....+ ..+..++.+..+..+++.+....+..|..++ ..++.|++++|+++.
T Consensus 111 ~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~-----------------------~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 111 SNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS-----------------------FESVILWLNKNGIQE 167 (242)
T ss_dssp ESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB-----------------------SSCEEEECCSSCCCE
T ss_pred chhhhccccccccccccccccccccccccccccccccccccc-----------------------ccceeeecccccccc
Confidence 5555543221 1122333344444444444433333333332 134444444454443
Q ss_pred CCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeec
Q 001274 495 LIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDL 559 (1109)
Q Consensus 495 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 559 (1109)
+.+..|.....++.+++++|+++.+.+..|.++++|++|+|++|+|+...+..|.++++|+.|++
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 33322222211222234445555433344555555555555555555333344555555555544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=4.7e-18 Score=173.05 Aligned_cols=127 Identities=26% Similarity=0.357 Sum_probs=69.7
Q ss_pred eeecCCccccCCCCCCCccccccceeecccccccc-cCCccccCCcccceeccccccccCCCCccccccccccEEEccCC
Q 001274 436 FLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTG-SLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSEN 514 (1109)
Q Consensus 436 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 514 (1109)
.++.++|+++ .+|..+. +++++|+|++|+|++ ..+..|.++++|++|+|++|++..+.+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3444555554 2333332 345555555555543 23444555555666666666655555555555556666666666
Q ss_pred ccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCc
Q 001274 515 YFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFT 565 (1109)
Q Consensus 515 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 565 (1109)
+|+.+.|..|.++++|++|+|++|+|+++.|.+|..+++|++|+|++|.+.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 655555555555556666666666665555555555555666666555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1.5e-17 Score=171.77 Aligned_cols=122 Identities=28% Similarity=0.383 Sum_probs=54.4
Q ss_pred cCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCe
Q 001274 477 YNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQR 556 (1109)
Q Consensus 477 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 556 (1109)
.++++|++|++++|+++++ | .+..+++|+.|++++|.+... ..+..+++|+.+++++|.+++ +..+..+++|+.
T Consensus 87 ~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~ 160 (210)
T d1h6ta2 87 ANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDT 160 (210)
T ss_dssp TTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSE
T ss_pred ccCcccccccccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccc--cccccccccccc
Confidence 3444444444444444432 1 244444444444444444321 234444444444544444442 122344445555
Q ss_pred eecCCCcCccCCCcccccccccceecccccccccccCcccCCCcccceeecc
Q 001274 557 LDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPSSLGGLARLTELQMG 608 (1109)
Q Consensus 557 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 608 (1109)
+++++|++++ ++ .+.++++|+.|+|++|+++. +| .|.++++|+.|+|+
T Consensus 161 l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 161 LSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp EECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cccccccccc-cc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 5555555543 22 24445555555555555542 22 34555555555544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=1.6e-17 Score=170.23 Aligned_cols=160 Identities=29% Similarity=0.402 Sum_probs=80.1
Q ss_pred ccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEE
Q 001274 431 YQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLH 510 (1109)
Q Consensus 431 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 510 (1109)
+.+++.|++++|.++.. +++..+++|++|++++|++++..| +.++++|++|++++|.+... +.+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI--TPLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc--ccccccccccccc
Confidence 44444455555544422 234445555555555555554322 55555555555555555433 1255555555555
Q ss_pred ccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceeccccccccc
Q 001274 511 LSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTG 590 (1109)
Q Consensus 511 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 590 (1109)
+++|.+... ..+..+++|+.|++++|++.. ++ .+..+++|++|++++|++++. + .+.++++|+.|++++|++++
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC
Confidence 555555432 234555555555555555542 22 355555555555555555532 2 25555555555555555553
Q ss_pred ccCcccCCCcccce
Q 001274 591 AIPSSLGGLARLTE 604 (1109)
Q Consensus 591 ~~p~~~~~l~~L~~ 604 (1109)
. + .+..+++|++
T Consensus 187 i-~-~l~~L~~L~~ 198 (199)
T d2omxa2 187 I-S-VLAKLTNLES 198 (199)
T ss_dssp C-G-GGGGCTTCSE
T ss_pred C-c-cccCCCCCCc
Confidence 2 2 3444555544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=5.6e-17 Score=167.48 Aligned_cols=185 Identities=22% Similarity=0.279 Sum_probs=136.0
Q ss_pred ccceEEcccccccccCCCcccccCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecc
Q 001274 385 YLVDLQLFDNHLEGTIPPHIGVNSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLG 464 (1109)
Q Consensus 385 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 464 (1109)
......+..+.+.+.++. ..+.+|++|++++|.++... .+..+++|++|+|++|+|++.. .++.+++|++|+++
T Consensus 25 ~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~ 98 (210)
T d1h6ta2 25 ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLD 98 (210)
T ss_dssp HHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred HHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccc
Confidence 334445666666654432 34677888888888887543 3677888888888888887643 36778888888888
Q ss_pred cccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccC
Q 001274 465 QNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTI 544 (1109)
Q Consensus 465 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 544 (1109)
+|+++++ | .+.++++|+.|++++|.+... +.+..+++|+.+++++|.+++ +..+..+++|+++++++|++++.
T Consensus 99 ~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i- 171 (210)
T d1h6ta2 99 ENKVKDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI- 171 (210)
T ss_dssp SSCCCCG-G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-
T ss_pred ccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccc--ccccccccccccccccccccccc-
Confidence 8888753 3 477788888888888887643 457788888888888888874 34577788888888888888753
Q ss_pred CcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccc
Q 001274 545 PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSD 585 (1109)
Q Consensus 545 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 585 (1109)
+ .+.++++|+.|+|++|+|++ +| .|.++++|++|+|++
T Consensus 172 ~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 172 V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 3 37788888888888888874 44 588888888888764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=2.9e-17 Score=168.22 Aligned_cols=161 Identities=29% Similarity=0.443 Sum_probs=104.8
Q ss_pred cCcCcEEEeccccccCccchhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceec
Q 001274 407 NSHLSVLDVSMNNLDGSIPPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALE 486 (1109)
Q Consensus 407 ~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 486 (1109)
+.++++|++++|.++.. ..+..+++|++|++++|++++..+ +.++++|++|++++|.+.... .+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--cccccccccccc
Confidence 34444444444444422 124455555555555555554332 556666666666666665432 366777778888
Q ss_pred cccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCcc
Q 001274 487 LYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTG 566 (1109)
Q Consensus 487 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 566 (1109)
+++|.+... +.+..+++|+.|++++|++... ..+..+++|+.|++++|++++. + .++++++|++|++++|++++
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC
Confidence 877777654 3467778888888888887642 3577788888888888888753 3 37788888888888888874
Q ss_pred CCCccccccccccee
Q 001274 567 SAPEELGQLVNLELL 581 (1109)
Q Consensus 567 ~~p~~l~~l~~L~~L 581 (1109)
++ .+.++++|+.|
T Consensus 187 -i~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 -IS-VLAKLTNLESL 199 (199)
T ss_dssp -CG-GGGGCTTCSEE
T ss_pred -Cc-cccCCCCCCcC
Confidence 43 57777777765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=2.2e-15 Score=163.17 Aligned_cols=92 Identities=26% Similarity=0.283 Sum_probs=43.0
Q ss_pred CCcCcEEEccCC-cccCCCcccccCCCCcceEecccc-cccCcccccccCCCCccEEEcccCcccC-CCCcchhcccccc
Q 001274 311 CTSAVEIDLSEN-QLTGFIPRELGLIPNLCLLQLFEN-MLQGSIPRELGQLTQLHKLDLSINNLTG-TIPLEFQNLTYLV 387 (1109)
Q Consensus 311 l~~L~~L~Ls~n-~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~ 387 (1109)
+++|++|++++| .+++.....+..+++|++|++++| .+++.....++++++|++|+++++ ++. .++.....++
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp--- 249 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALP--- 249 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHST---
T ss_pred cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCc---
Confidence 344444444443 233333344444444455555442 344444445666677777777665 321 1111122333
Q ss_pred eEEcccccccccCCCcccc
Q 001274 388 DLQLFDNHLEGTIPPHIGV 406 (1109)
Q Consensus 388 ~L~L~~N~l~~~~p~~~~~ 406 (1109)
.|.+..+.+++..++.++.
T Consensus 250 ~L~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 250 HLQINCSHFTTIARPTIGN 268 (284)
T ss_dssp TSEESCCCSCCTTCSSCSS
T ss_pred cccccCccCCCCCCCccCc
Confidence 3445666666555555443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=4e-15 Score=161.03 Aligned_cols=62 Identities=32% Similarity=0.376 Sum_probs=37.4
Q ss_pred cCCCCcceEecccc-cccCcccccccCCCCccEEEcccC-cccCCCCcchhcccccceEEcccc
Q 001274 333 GLIPNLCLLQLFEN-MLQGSIPRELGQLTQLHKLDLSIN-NLTGTIPLEFQNLTYLVDLQLFDN 394 (1109)
Q Consensus 333 ~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N 394 (1109)
..+++|+.|++++| .+++.....+.++++|++|+++++ ++++.....+.++++|+.|+++++
T Consensus 172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 34566666666664 355555556666666666666663 455444455666666666666665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=2.9e-14 Score=139.59 Aligned_cols=107 Identities=21% Similarity=0.137 Sum_probs=46.0
Q ss_pred cccceeecccccccccCCccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEec
Q 001274 456 RSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNI 535 (1109)
Q Consensus 456 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 535 (1109)
.++++|+|++|+|+.+ +..+..+++|+.|+|++|+|+.+ +.|..+++|++|++++|+++...+..+..+++|+.|++
T Consensus 18 ~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 3344444444444422 33334444444444444444433 22444444444444444444433333444444444444
Q ss_pred ccCcccccCC-cCCCCCCCCCeeecCCCcCc
Q 001274 536 SSNSLSGTIP-HELGNCVNLQRLDLSRNQFT 565 (1109)
Q Consensus 536 s~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 565 (1109)
++|+|+.... ..+..+++|++|++++|.++
T Consensus 95 ~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 95 TNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccccccccccccccccccccchhhcCCCccc
Confidence 4444442110 23344444444444444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.9e-14 Score=140.91 Aligned_cols=128 Identities=16% Similarity=0.144 Sum_probs=82.5
Q ss_pred cccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCC
Q 001274 475 EFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNL 554 (1109)
Q Consensus 475 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 554 (1109)
.|.+..+|++|+|++|+|+.+ +..+..+++|+.|+|++|+|+.+ ..|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 355666777777777777754 55556677777777777777643 236677777777777777775444445567777
Q ss_pred CeeecCCCcCccCCC--cccccccccceeccccccccccc---CcccCCCcccceee
Q 001274 555 QRLDLSRNQFTGSAP--EELGQLVNLELLKLSDNKLTGAI---PSSLGGLARLTELQ 606 (1109)
Q Consensus 555 ~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 606 (1109)
+.|++++|+|+. ++ ..+..+++|++|++++|+++... +..+..+++|+.||
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 777777777763 33 35666677777777777765332 12355566666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=8.6e-14 Score=129.36 Aligned_cols=102 Identities=28% Similarity=0.347 Sum_probs=58.8
Q ss_pred ceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCC
Q 001274 483 SALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRN 562 (1109)
Q Consensus 483 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 562 (1109)
|+|+|++|+|+.. + .+..+++|++|++++|+|++ +|..++.+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 3456666666533 2 35666666666666666653 45556666666666666666663 33 3566666666666666
Q ss_pred cCccCC-Ccccccccccceecccccccc
Q 001274 563 QFTGSA-PEELGQLVNLELLKLSDNKLT 589 (1109)
Q Consensus 563 ~l~~~~-p~~l~~l~~L~~L~Ls~N~l~ 589 (1109)
+|+... ...+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 665322 134555666666666666655
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.44 E-value=2.1e-15 Score=168.72 Aligned_cols=91 Identities=19% Similarity=0.151 Sum_probs=48.0
Q ss_pred hhccCccceEEeecccccCc----cCcccCCCCcCcEEEccCCcccCCCcccc----c--CCCCcceEecccccccCcc-
Q 001274 284 LGKLSRLKKLYVYTNELNGT----IPHELGNCTSAVEIDLSENQLTGFIPREL----G--LIPNLCLLQLFENMLQGSI- 352 (1109)
Q Consensus 284 l~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l----~--~l~~L~~L~L~~n~l~~~~- 352 (1109)
+..+++|+.|++++|.++.. +...+..+++|++|+|++|.|++.....+ . ..+.|+.|++++|.+....
T Consensus 211 l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~ 290 (344)
T d2ca6a1 211 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 290 (344)
T ss_dssp GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHH
T ss_pred hcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHH
Confidence 34445555555555554321 22334455555555555555543221111 1 1244666666666655332
Q ss_pred ---ccccc-CCCCccEEEcccCcccC
Q 001274 353 ---PRELG-QLTQLHKLDLSINNLTG 374 (1109)
Q Consensus 353 ---p~~l~-~l~~L~~L~Ls~N~l~~ 374 (1109)
...+. ++++|++|+|++|++..
T Consensus 291 ~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 291 RTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHHHHccCCCCCEEECCCCcCCC
Confidence 22332 46789999999999873
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=1.4e-13 Score=127.85 Aligned_cols=103 Identities=24% Similarity=0.321 Sum_probs=88.0
Q ss_pred cEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCcccccccccceeccccc
Q 001274 507 ERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDN 586 (1109)
Q Consensus 507 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 586 (1109)
+.|+|++|+++.. + .+.++++|++|++++|+|+ .+|..++.+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 5799999999854 4 4889999999999999998 677789999999999999999984 44 5899999999999999
Q ss_pred ccccccC-cccCCCcccceeeccCccccc
Q 001274 587 KLTGAIP-SSLGGLARLTELQMGGNIFSG 614 (1109)
Q Consensus 587 ~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 614 (1109)
+++.... ..+..+++|+.|++++|++++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 9986543 578889999999999998873
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.42 E-value=3.6e-15 Score=166.75 Aligned_cols=253 Identities=17% Similarity=0.172 Sum_probs=146.0
Q ss_pred CCCccccCCCCCceEEccCCcccccCCch----hhccccceEEEccccccccc----------ccccccCcCCCceEEee
Q 001274 111 SIPTDLANCSSLEILDLCTNRLHGVIPFQ----LFFINTLRKLYLCENYIFGE----------IPEEIGNLTSLEELVIY 176 (1109)
Q Consensus 111 ~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~----l~~l~~L~~L~L~~n~l~~~----------~p~~l~~l~~L~~L~L~ 176 (1109)
.+...+.+.+.|++|+|++|.+....... +...++|+.|+++++..... +...+..+++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 34556677777888888888776543333 33456667777665543211 12223445556666666
Q ss_pred cCCCCCCC----CcccccccccceeccccccccCCCCccccccccchhhhcccccccccCchhhhccccccceecccccc
Q 001274 177 SNNLTGAI----PASISKLRQLRVIRAGHNSLSGPIPPEISECEGLEVLGLAQNSLEGFLPSELEKLRNLTDLILWQNHL 252 (1109)
Q Consensus 177 ~n~l~~~~----p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l 252 (1109)
+|.++... ...+...++|+.|++++|.++......++ ..|..+... .....
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~--~~l~~~~~~---------~~~~~-------------- 156 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQELAVN---------KKAKN-------------- 156 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--HHHHHHHHH---------HHHHT--------------
T ss_pred ccccccccccchhhhhcccccchheeccccccccccccccc--ccccccccc---------ccccc--------------
Confidence 66555331 12222334444444444443311000000 001111000 00111
Q ss_pred cCCCCCCccccccccceeeeeccceec----CchhhhccCccceEEeecccccCc-----cCcccCCCCcCcEEEccCCc
Q 001274 253 SGEIPPTIGNIQSLELLALHENSFSGG----LPKELGKLSRLKKLYVYTNELNGT-----IPHELGNCTSAVEIDLSENQ 323 (1109)
Q Consensus 253 ~~~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~n~l~~~-----~~~~l~~l~~L~~L~Ls~n~ 323 (1109)
.+.|+.|++++|.++.. +...+...+.|+.|++++|+++.. +...+..+++|++|+|++|.
T Consensus 157 ----------~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~ 226 (344)
T d2ca6a1 157 ----------APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 226 (344)
T ss_dssp ----------CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSC
T ss_pred ----------Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccc
Confidence 23445555555554422 233455677888888888887632 34567788999999999999
Q ss_pred ccCC----CcccccCCCCcceEecccccccCcccccc----cC--CCCccEEEcccCcccCCC----Ccchh-cccccce
Q 001274 324 LTGF----IPRELGLIPNLCLLQLFENMLQGSIPREL----GQ--LTQLHKLDLSINNLTGTI----PLEFQ-NLTYLVD 388 (1109)
Q Consensus 324 l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~p~~l----~~--l~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~ 388 (1109)
++.. +...+...++|+.|+|++|.+++.....+ .. .+.|++|++++|+|+... ...+. ++++|+.
T Consensus 227 i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~ 306 (344)
T d2ca6a1 227 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306 (344)
T ss_dssp CHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCE
T ss_pred ccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCE
Confidence 8743 34556788999999999999986543333 22 467999999999987432 22332 5678999
Q ss_pred EEcccccccc
Q 001274 389 LQLFDNHLEG 398 (1109)
Q Consensus 389 L~L~~N~l~~ 398 (1109)
|+|++|++..
T Consensus 307 L~l~~N~~~~ 316 (344)
T d2ca6a1 307 LELNGNRFSE 316 (344)
T ss_dssp EECTTSBSCT
T ss_pred EECCCCcCCC
Confidence 9999999863
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=4.8e-14 Score=143.09 Aligned_cols=128 Identities=25% Similarity=0.298 Sum_probs=78.2
Q ss_pred CccccCCcccceeccccccccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecccCcccccCCcCCCCCC
Q 001274 473 PIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNISSNSLSGTIPHELGNCV 552 (1109)
Q Consensus 473 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 552 (1109)
+..+..+++|++|+|++|+|+.+ + .+..+++|++|+|++|+|+. +|..+..+++|++|++++|+|+. ++ .+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-GIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCC-HH-HHHHHH
T ss_pred hhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-ccccccccccccccccccccccc-cc-cccccc
Confidence 34566666777777777777644 2 46667777777777777663 44445555667777777777663 22 355666
Q ss_pred CCCeeecCCCcCccCCC--cccccccccceecccccccccccCcc----------cCCCcccceee
Q 001274 553 NLQRLDLSRNQFTGSAP--EELGQLVNLELLKLSDNKLTGAIPSS----------LGGLARLTELQ 606 (1109)
Q Consensus 553 ~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~ 606 (1109)
+|+.|+|++|+|+. ++ ..+..+++|+.|+|++|++....+.. +..+++|+.||
T Consensus 116 ~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 116 NLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 67777777777663 22 34666667777777777665443322 34456666655
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=5.2e-12 Score=122.33 Aligned_cols=106 Identities=19% Similarity=0.151 Sum_probs=68.9
Q ss_pred cceeecccccccccCCccccCCcccceeccccc-cccCCCCccccccccccEEEccCCccCCCCChhhcccccccEEecc
Q 001274 458 LMQLMLGQNQLTGSLPIEFYNLQNLSALELYQN-RFSGLIPPEIGKLRNLERLHLSENYFVGYIPSEVGNLEHLVTFNIS 536 (1109)
Q Consensus 458 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 536 (1109)
...++++++.+. ..|..+.++++|++|++++| .|+.+.++.|.++++|+.|+|++|+|+.+.|..|.++++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344555555555 34555666667777777554 3666666667777777777777777776666777777777777777
Q ss_pred cCcccccCCcCCCCCCCCCeeecCCCcCc
Q 001274 537 SNSLSGTIPHELGNCVNLQRLDLSRNQFT 565 (1109)
Q Consensus 537 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 565 (1109)
+|+|+...+..|.. .+|+.|+|++|.+.
T Consensus 89 ~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CCCCcccChhhhcc-ccccccccCCCccc
Confidence 77777433344433 46777777777764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.27 E-value=1.3e-13 Score=139.85 Aligned_cols=112 Identities=23% Similarity=0.262 Sum_probs=51.5
Q ss_pred chhhhcccccceeecCCccccCCCCCCCccccccceeecccccccccCCccccCCcccceeccccccccCCCCccccccc
Q 001274 425 PPHLCMYQKLIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQNQLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLR 504 (1109)
Q Consensus 425 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 504 (1109)
+..+..+++|++|+|++|+|+.+ +.+..+++|++|+|++|+++. +|..+..+++|++|++++|+++.+ +.+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhHHhcccccceeECcccCCCCc--ccccCCccccChhhccccccc-cccccccccccccccccccccccc--ccccccc
Confidence 34555666666666666666532 234455555555555555542 233333334444455555444432 2244444
Q ss_pred cccEEEccCCccCCCCC-hhhcccccccEEecccCccc
Q 001274 505 NLERLHLSENYFVGYIP-SEVGNLEHLVTFNISSNSLS 541 (1109)
Q Consensus 505 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 541 (1109)
+|+.|++++|+|+.... ..+..+++|+.|+|++|.+.
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccc
Confidence 44444444444443211 23344444444444444443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.20 E-value=8.4e-12 Score=120.86 Aligned_cols=106 Identities=20% Similarity=0.148 Sum_probs=71.6
Q ss_pred cceeecCCccccCCCCCCCccccccceeecccc-cccccCCccccCCcccceeccccccccCCCCccccccccccEEEcc
Q 001274 434 LIFLSLGSNRLSGNIPPGLKTCRSLMQLMLGQN-QLTGSLPIEFYNLQNLSALELYQNRFSGLIPPEIGKLRNLERLHLS 512 (1109)
Q Consensus 434 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 512 (1109)
.+.++.+++.+. ..|..+..+++|++|++++| .++.+.+.+|.++++|+.|+|++|+|+.+.|..|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344555555554 34555666667777777554 4666666677777777777777777777777777777777777777
Q ss_pred CCccCCCCChhhcccccccEEecccCccc
Q 001274 513 ENYFVGYIPSEVGNLEHLVTFNISSNSLS 541 (1109)
Q Consensus 513 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 541 (1109)
+|+|+.+.+..|..+ +|+.|+|++|.+.
T Consensus 89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCCcccChhhhccc-cccccccCCCccc
Confidence 777775555555444 5777777777764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=7.8e-09 Score=100.24 Aligned_cols=82 Identities=24% Similarity=0.279 Sum_probs=38.3
Q ss_pred cccccccEEecccCcccccC--CcCCCCCCCCCeeecCCCcCccCCCcccccccccceecccccccccccCc-------c
Q 001274 525 GNLEHLVTFNISSNSLSGTI--PHELGNCVNLQRLDLSRNQFTGSAPEELGQLVNLELLKLSDNKLTGAIPS-------S 595 (1109)
Q Consensus 525 ~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-------~ 595 (1109)
..+++|++|+|++|+|+..- +..+..+++|+.|||++|+|+...+-.+.+..+|+.|++++|++...... .
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 34445555555555554221 22234455555555555555532222223334455555555555543321 2
Q ss_pred cCCCcccceee
Q 001274 596 LGGLARLTELQ 606 (1109)
Q Consensus 596 ~~~l~~L~~L~ 606 (1109)
+..+|+|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 44556666554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=1.6e-08 Score=97.98 Aligned_cols=82 Identities=22% Similarity=0.197 Sum_probs=43.0
Q ss_pred cccccccEEEccCCccCCCC--ChhhcccccccEEecccCcccccCCcCCCCCCCCCeeecCCCcCccCCCc-------c
Q 001274 501 GKLRNLERLHLSENYFVGYI--PSEVGNLEHLVTFNISSNSLSGTIPHELGNCVNLQRLDLSRNQFTGSAPE-------E 571 (1109)
Q Consensus 501 ~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~ 571 (1109)
..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|.++..... .
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 34455555555555555432 23345556666666666666533222222334566677777766643332 2
Q ss_pred cccccccceec
Q 001274 572 LGQLVNLELLK 582 (1109)
Q Consensus 572 l~~l~~L~~L~ 582 (1109)
+..+++|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 45567777665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.17 E-value=2.8e-06 Score=89.03 Aligned_cols=149 Identities=17% Similarity=0.095 Sum_probs=99.4
Q ss_pred HHHHHhcCCCCCceEecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCc
Q 001274 796 NLLEATGNFSEGAVIGRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDS 874 (1109)
Q Consensus 796 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 874 (1109)
++......|+..+..+-++.+.||+...+ ++.+++|+....... ....+.+|+..++.+. +--+.+++.++..++.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 34444556665555444445689998754 566778877533222 2335678888877663 3346777888888888
Q ss_pred eEEEEEeccCCCHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 001274 875 NLLLYEYMENGSLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYDC------------------------------- 923 (1109)
Q Consensus 875 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------- 923 (1109)
.++||++++|.++.+..... .....++.++++.++.||...
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred eEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 99999999998886554321 122334555666666666310
Q ss_pred -------------------------CCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 924 -------------------------RPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 924 -------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 22489999999999999877677999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.82 E-value=1.8e-05 Score=82.29 Aligned_cols=130 Identities=17% Similarity=0.071 Sum_probs=86.5
Q ss_pred eEecCCc-ceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCC--CceeeEEEEEEeCCceEEEEEeccCC
Q 001274 809 VIGRGAC-GTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRH--RNIVKLYGFCYHQDSNLLLYEYMENG 885 (1109)
Q Consensus 809 ~lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 885 (1109)
.+..|.. +.||+...+++..+++|..... ....+.+|+..++.+.. -.+.+++.+..+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3455554 5799999888888888876522 23346778888776632 33667788888888889999999986
Q ss_pred CHHHHhccCCCCCCCChHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 001274 886 SLGEQLHGNKQTCLLDWDARYRIALGAAEGLCYLHYD------------------------------------------- 922 (1109)
Q Consensus 886 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------- 922 (1109)
++.+.. ... ...+.++++.+.-||+.
T Consensus 92 ~~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 92 DLLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp ETTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 653210 111 11223333444444421
Q ss_pred ------------CCCCeEecCCCCCceeeCCCCceEEeeccccc
Q 001274 923 ------------CRPHIIHRDIKSNNILLDEEFQAHVGDFGLAK 954 (1109)
Q Consensus 923 ------------~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 954 (1109)
....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 02348999999999999988777899999876
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.52 E-value=9.4e-06 Score=78.28 Aligned_cols=88 Identities=18% Similarity=0.134 Sum_probs=56.7
Q ss_pred CccccceeecccC-ccCCC----CCccccCCCCCceEEccCCcccccCCch----hhccccceEEEccccccccc----c
Q 001274 94 DLPRLVEFNISMN-FVTGS----IPTDLANCSSLEILDLCTNRLHGVIPFQ----LFFINTLRKLYLCENYIFGE----I 160 (1109)
Q Consensus 94 ~l~~L~~L~ls~n-~~~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~~~~----l~~l~~L~~L~L~~n~l~~~----~ 160 (1109)
+.+.|+.|+|+++ .++.. +-..+...+.|++|+|++|.+....... +...+.|++|+|++|.++.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4577888888763 45432 3345667777888888888777543333 33456777777777777654 3
Q ss_pred cccccCcCCCceEEeecCCCC
Q 001274 161 PEEIGNLTSLEELVIYSNNLT 181 (1109)
Q Consensus 161 p~~l~~l~~L~~L~L~~n~l~ 181 (1109)
-..+...++|++|+|++|++.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 344666677777777777654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.37 E-value=1.2e-05 Score=77.62 Aligned_cols=66 Identities=21% Similarity=0.148 Sum_probs=38.7
Q ss_pred cCCCCCceEEccCC-ccccc----CCchhhccccceEEEccccccccc----ccccccCcCCCceEEeecCCCCC
Q 001274 117 ANCSSLEILDLCTN-RLHGV----IPFQLFFINTLRKLYLCENYIFGE----IPEEIGNLTSLEELVIYSNNLTG 182 (1109)
Q Consensus 117 ~~l~~L~~L~Ls~n-~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~ 182 (1109)
.+.+.|++|+|+++ .++.. +-..+...++|++|+|++|.+... +...+...+.|++|+|++|.++.
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~ 86 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 86 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence 34577888888864 45543 222344456677777777766543 22334455666666666666653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.27 E-value=0.00065 Score=74.79 Aligned_cols=77 Identities=16% Similarity=0.171 Sum_probs=48.2
Q ss_pred ceEecCCcceEEEEEec-CCcEEEEEEeecc----CCC-cchhHHHHHHHHHhccC-CC--CceeeEEEEEEeCCceEEE
Q 001274 808 AVIGRGACGTVYKATLA-NGEVIAVKKIKLR----GEG-ATADNSFLAEISTLGKI-RH--RNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~-~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~lv 878 (1109)
+.||.|....||+++.. +++.|+||.-... +.. .....+...|++.++.+ .+ ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999865 4678899865321 111 11223455688777766 22 345556544 55667899
Q ss_pred EEeccCCC
Q 001274 879 YEYMENGS 886 (1109)
Q Consensus 879 ~e~~~~gs 886 (1109)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.90 E-value=3.4e-05 Score=74.18 Aligned_cols=90 Identities=27% Similarity=0.295 Sum_probs=54.6
Q ss_pred ccCccccceeeccc-CccCCC----CCccccCCCCCceEEccCCcccccCCch----hhccccceEEEccccccccc---
Q 001274 92 ICDLPRLVEFNISM-NFVTGS----IPTDLANCSSLEILDLCTNRLHGVIPFQ----LFFINTLRKLYLCENYIFGE--- 159 (1109)
Q Consensus 92 ~~~l~~L~~L~ls~-n~~~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~~~~----l~~l~~L~~L~L~~n~l~~~--- 159 (1109)
..+.+.|++|+|++ +.++.. +-..+...+.|++|+|++|.++...... +...+.++.|++++|.+...
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34567788888876 445432 3345566777888888888776543333 33456677777777776543
Q ss_pred -ccccccCcCCCceEEe--ecCCCC
Q 001274 160 -IPEEIGNLTSLEELVI--YSNNLT 181 (1109)
Q Consensus 160 -~p~~l~~l~~L~~L~L--~~n~l~ 181 (1109)
+...+...++|++++| ++|.+.
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHhCccccEEeeccCCCcCc
Confidence 3345566666665444 345554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.66 E-value=0.0019 Score=69.04 Aligned_cols=136 Identities=12% Similarity=0.061 Sum_probs=76.9
Q ss_pred cceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCce--eeEE-----EEEEeCCceEEEEEeccCCCH
Q 001274 815 CGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI--VKLY-----GFCYHQDSNLLLYEYMENGSL 887 (1109)
Q Consensus 815 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~gsL 887 (1109)
.-.||+++.++|+.|++|+... +....+++..|...+..+....+ +..+ ..+...+..+.++++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp---~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRP---ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECT---TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCC---CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 4589999999999999998862 23345667788888777642221 1111 112345567889999876432
Q ss_pred H-----HH-------------hccCC--CCCC-------------------CChHHH---HHHHHHHHHHHHHH-hhcCC
Q 001274 888 G-----EQ-------------LHGNK--QTCL-------------------LDWDAR---YRIALGAAEGLCYL-HYDCR 924 (1109)
Q Consensus 888 ~-----~~-------------l~~~~--~~~~-------------------l~~~~~---~~i~~~i~~~l~~L-H~~~~ 924 (1109)
. .+ ..... .... ++.... ...+..+...+.-. .....
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 1 00 01100 0001 111111 12222232222221 12225
Q ss_pred CCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 925 PHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 925 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
.++||+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 679999999999999754 45899998874
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.50 E-value=0.00012 Score=70.17 Aligned_cols=67 Identities=18% Similarity=0.110 Sum_probs=43.5
Q ss_pred ccCCCCCceEEccC-CcccccCCc----hhhccccceEEEccccccccc----ccccccCcCCCceEEeecCCCCC
Q 001274 116 LANCSSLEILDLCT-NRLHGVIPF----QLFFINTLRKLYLCENYIFGE----IPEEIGNLTSLEELVIYSNNLTG 182 (1109)
Q Consensus 116 l~~l~~L~~L~Ls~-n~l~~~~~~----~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~ 182 (1109)
..+.+.|++|+|++ +.++...-. .+...++|++|+|++|.++.. +...+...++|++|++++|.++.
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence 45668888899887 456544332 333567788888888877654 23345566777777777777653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.57 E-value=0.017 Score=60.82 Aligned_cols=159 Identities=12% Similarity=0.078 Sum_probs=82.9
Q ss_pred CCHHHHHHHhcCCCCCceE-----ecCCcceEEEEEecCCcEEEEEEeeccCCCcchhHHHHHHHHHhccCCCCce--ee
Q 001274 792 FKYHNLLEATGNFSEGAVI-----GRGACGTVYKATLANGEVIAVKKIKLRGEGATADNSFLAEISTLGKIRHRNI--VK 864 (1109)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~l-----G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~ 864 (1109)
.+.+++.....+|.+++.. ..|.--+.|+.+..+|+ +++|++... . ..+++..|++++..+...++ ..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~-~---~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR-V---EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC-C---CHHHHHHHHHHHHhhhhccccccc
Confidence 3455666777778776544 35666788999887665 888887532 1 23345556666666632221 11
Q ss_pred EEE------EEEeCCceEEEEEeccCCCHHH--------------Hhc----cCCCCC--C------------------C
Q 001274 865 LYG------FCYHQDSNLLLYEYMENGSLGE--------------QLH----GNKQTC--L------------------L 900 (1109)
Q Consensus 865 l~~------~~~~~~~~~lv~e~~~~gsL~~--------------~l~----~~~~~~--~------------------l 900 (1109)
.+. +....+....++.+..+..... .++ ...... . .
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 110 1122344566777766533210 000 000000 0 0
Q ss_pred ChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCCCCceEEeecccccc
Q 001274 901 DWDARYRIALGAAEGLCYLHY-DCRPHIIHRDIKSNNILLDEEFQAHVGDFGLAKL 955 (1109)
Q Consensus 901 ~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 955 (1109)
........+..+...+...+. ....++||+|+.++||+++++...-|.||+.+..
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111111222222222222221 2356899999999999999998788999998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.33 E-value=0.015 Score=63.45 Aligned_cols=72 Identities=18% Similarity=0.247 Sum_probs=47.9
Q ss_pred ceEecCCcceEEEEEecC--------CcEEEEEEeeccCCCcchhHHHHHHHHHhccCC-CCceeeEEEEEEeCCceEEE
Q 001274 808 AVIGRGACGTVYKATLAN--------GEVIAVKKIKLRGEGATADNSFLAEISTLGKIR-HRNIVKLYGFCYHQDSNLLL 878 (1109)
Q Consensus 808 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 878 (1109)
+.|+.|-.-.+|++..++ .+.|.+++.. . ........+|..+++.+. +.-..++++++. ..+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N---PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceE
Confidence 568888888999998653 3456666654 2 112334568888888874 433457777654 3689
Q ss_pred EEeccCCCH
Q 001274 879 YEYMENGSL 887 (1109)
Q Consensus 879 ~e~~~~gsL 887 (1109)
+||++|..+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987543
|